Name	Gene(s)	Condition(s)	Clinical significance (Last reviewed)	Review status	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	
LRG_216t1:c.512_513insAlu	MLH1	Lynch syndrome I	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter					617615	609011
NM_133433.3(NIPBL):c.3856-?_4239+?del	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Jan 12, 2018)	no assertion criteria provided					545662	536158
NM_004409.4:c.*224_*283CTG[(260_320)]CCGCTGCTG[(10_14)]CTG[(15_23)]	DMPK	Steinert myotonic dystrophy syndrome	Pathogenic(Last reviewed: Mar 14, 2018)	no assertion criteria provided					523756	514412
NM_004409.4:c.*224_*283CTG[(200_300)]CCG[1]CTG[(41_59)]	DMPK	Steinert myotonic dystrophy syndrome	Pathogenic(Last reviewed: Mar 14, 2018)	no assertion criteria provided					523755	514411
NM_004409.4:c.*224_*283CTG[(180_240)]CCGCTG[(53_67)]CTG[(53_67)]	DMPK	Steinert myotonic dystrophy syndrome	Pathogenic(Last reviewed: Mar 14, 2018)	no assertion criteria provided					523754	514410
NM_000280.4:c.1267A>T	PAX6	Optic nerve hypoplasia, bilateral	Likely pathogenic	criteria provided, single submitter					522379	512990
NM_057157.2:c.1184T>C	CYP26A1	Optic nerve hypoplasia	Uncertain significance	criteria provided, single submitter					522175	512780
NM_000527.4(LDLR):c.(1586+1_1587-1)_(1845+1_1846-1)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Oct 19, 2017)	no assertion criteria provided					446149	439496
LRG_293t1:c.156_157insAlu	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic	no assertion criteria provided					403703	390673
NM_000527.4(LDLR):c.(2389+1_2390-1)_(*_?)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter					403661	390645
NM_000527.4(LDLR):c.(2311+1_2312-1)_(2547+1_2548-1)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter					403660	390644
NM_000527.4(LDLR):c.(1845+1_1846-1)_(*_?)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter					403659	390643
NM_000527.4(LDLR):c.(1845+1_1846-1)_(2140+1_2141-1)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter					403658	390642
NM_000527.4(LDLR):c.(1586+1_1587-1)_(2547+1_2548-1)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter					403657	390641
NM_000527.4(LDLR):c.(940+1_941-1)_(1845+1_1846-1)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter					403656	390640
NM_000527.4(LDLR):c.(940+1_941-1)_(1586+1_1587-1)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter					403655	390639
NM_000527.4(LDLR):c.(940+1_941-1)_(1186+1_1187-1)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter					403654	390638
NM_000527.4(LDLR):c.(313+1_314-1)_(940+1_941-1)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter					403653	390637
NM_000527.4(LDLR):c.(313+1_314-1)_(1586+1_1587-1)dup	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter					403652	390636
NM_000527.4(LDLR):c.(67+1_68-1)_(2311+1_2312-1)dup	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter					403651	390635
NM_000527.4(LDLR):c.(?_-1)_(1845+1_1846-1)dup	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter					403650	390634
NM_000527.4(LDLR):c.(?_-1)_(67+1_68-1)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter					403649	390633
NM_000527.4(LDLR):c.(67+1_68-1)_(1586+1_1587-1)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter					403645	390632
der(6)t(6;10)(p25.2;q26.3)		Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Apr 13, 2015)	no assertion criteria provided					375433	362209
TNNT2, IVS15, G-A, +1	TNNT2	Familial hypertrophic cardiomyopathy 2	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided					12410	27449
F8, 1-BP DEL	F8	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 15, 2000)	no assertion criteria provided					10350	25389
SLC36A2, IVS1, G-A, +1	SLC36A2	Hyperglycinuria|Iminoglycinuria	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided					2385	17424
GRCh37/hg19 1p36.33-36.32(chr1:852863-4203509)x3	CDK11B|DFFB|DVL1|MEGF6|GABRD|GNB1|PEX10|PRKCZ|SCNN1D|SKI|TP73|TNFRSF4|MMP23B|TNFRSF14|TNFRSF18|ISG15|PLCH2|CEP104|SLC35E2A|RER1|NOC2L|ARHGEF16|SSU72|WRAP73|SDF4|MXRA8|INTS11|C1orf159|AURKAIP1|MRPL20|ATAD3A|PANK4|LRRC47|HES4|PRDM16|VWA1|NADK|MMEL1|MORN1|CPTP|CCNL2|TAS1R3|ATAD3B|PLEKHN1|CFAP74|ACAP3|UBE2J2|PUSL1|B3GALT6|TPRG1L|PRXL2B|ACTRT2|MIB2|SAMD11|CCDC27|CALML6|FAAP20|ATAD3C|TTLL10|C1orf174|KLHL17|TMEM240|TMEM52|AGRN|C1QTNF12|HES5|SMIM1|RNF223|MIR200A|MIR200B|ANKRD65|MIR429|TMEM88B|FNDC10|MIR551A|CDK11A|SLC35E2B|TTC34	Distal trisomy 1p36	Pathogenic(Last reviewed: Mar 25, 2016)	no assertion criteria provided	1	852863 - 4203509			427642	417078
NM_004421.2(DVL1):c.1615del (p.Ser539Alafs)	DVL1	Robinow syndrome, autosomal dominant 2	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	1	1273381	1	1338001	208047	204306
NM_004421.2(DVL1):c.1570_1571delTTinsC (p.Phe524Profs)	DVL1	Robinow syndrome, autosomal dominant 2	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	1	1273425 - 1273426	1	1338045 - 1338046	208043	204308
NM_004421.2(DVL1):c.1529del (p.Gly510Valfs)	DVL1	Robinow syndrome, autosomal dominant 2	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	1	1273467	1	1338087	208048	204310
NM_004421.2(DVL1):c.1522del (p.Pro508Leufs)	DVL1	Robinow syndrome, autosomal dominant 2	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	1	1273474	1	1338094	219223	217239
NM_004421.2(DVL1):c.1519delT (p.Trp507Glyfs)	DVL1	Robinow syndrome, autosomal dominant 2	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	1	1273477	1	1338097	208045	204311
NM_004421.2(DVL1):c.1508delC (p.Pro503Argfs)	DVL1	Robinow syndrome, autosomal dominant 2	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	1	1273488	1	1338108	208046	204313
NM_001170535.2(ATAD3A):c.1582C>T (p.Arg528Trp)	ATAD3A	not provided|Harel-Yoon syndrome	Likely pathogenic(Last reviewed: Apr 26, 2016)	criteria provided, single submitter	1	1464679	1	1529299	225696	227511
NM_002074.4(GNB1):c.230G>C (p.Gly77Ala)	GNB1	Mental retardation, autosomal dominant 42	Likely pathogenic	criteria provided, single submitter	1	1737951	1	1806512	431082	424605
NM_003036.3(SKI):c.103C>T (p.Pro35Ser)	SKI	Shprintzen-Goldberg syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 9, 2018)	criteria provided, conflicting interpretations	1	2160308	1	2228869	39786	48385
NM_015215.3(CAMTA1):c.981C>T (p.Asn327=)	CAMTA1	not specified	Likely benign	no assertion criteria provided	1	7723588	1	7663528	128566	134015
NM_015215.3(CAMTA1):c.1350G>A (p.Ser450=)	CAMTA1	not specified	Likely benign	no assertion criteria provided	1	7723957	1	7663897	128564	134013
NM_015215.3(CAMTA1):c.3230A>G (p.Tyr1077Cys)	CAMTA1	Cerebellar ataxia, nonprogressive, with mental retardation	Likely pathogenic(Last reviewed: Apr 22, 2014)	criteria provided, single submitter	1	7796567	1	7736507	216897	213522
NM_015215.3(CAMTA1):c.3531C>G (p.Asn1177Lys)	CAMTA1	not specified	Likely benign	no assertion criteria provided	1	7797503	1	7737443	128565	134014
NM_016831.2(PER3):c.1240C>G (p.Pro414Ala)	PER3	Advanced sleep phase syndrome, familial, 3	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	1	7869953	1	7809893	242410	226735
NM_016831.2(PER3):c.1247A>G (p.His416Arg)	PER3	Advanced sleep phase syndrome, familial, 3	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	1	7869960	1	7809900	242411	226734
NM_012102.3(RERE):c.4304A>G (p.His1435Arg)	RERE	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	1	8418291	1	8358231	522858	513409
NM_005026.4(PIK3CD):c.1573G>A (p.Glu525Lys)	PIK3CD	Immunodeficiency 14	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	1	9780851	1	9720793	132807	136556
NM_005026.4(PIK3CD):c.3061G>A (p.Glu1021Lys)	PIK3CD	not specified|not provided|Immunodeficiency 14	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	1	9787030	1	9726972	88675	94255
NM_014874.3(MFN2):c.280C>T (p.Arg94Trp)	MFN2	Charcot-Marie-Tooth disease, type 2A2A|Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease, type 2|Short stature|Failure to thrive|not provided|Abnormality of the dentition|Microcephaly|Abnormality of dental enamel|Hyperpigmentation of the skin|Alopecia of scalp|Distal muscle weakness|EMG abnormality|Decreased body weight|Scarring alopecia of scalp|Abnormal blistering of the skin|Nail dystrophy|Scarring	Pathogenic(Last reviewed: Jun 17, 2018)	criteria provided, multiple submitters, no conflicts	1	12052716	1	11992659	2276	17315
NM_014874.3(MFN2):c.281G>A (p.Arg94Gln)	MFN2	Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	1	12052717	1	11992660	2268	17307
NM_014874.3(MFN2):c.310C>T (p.Arg104Trp)	MFN2	Charcot-Marie-Tooth disease, type 2A2A|Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	1	12052746	1	11992689	2281	17320
NM_014874.3(MFN2):c.436C>T (p.Leu146Phe)	MFN2	Charcot-Marie-Tooth disease, type 2A2A|not provided	Likely pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, multiple submitters, no conflicts	1	12056337	1	11996280	217163	213787
NM_001127660.1(MFN2):c.479T>G (p.Val160Gly)	MFN2	Charcot-Marie-Tooth disease, type 2A2A	Likely pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	1	12057358	1	11997301	243073	244147
NM_014874.3(MFN2):c.494A>G (p.His165Arg)	MFN2	Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	1	12057373	1	11997316	217164	213788
NM_014874.3(MFN2):c.707C>T (p.Thr236Met)	MFN2	Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, type 2|Distal muscle weakness|Peripheral axonal neuropathy|Distal lower limb amyotrophy	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	1	12058934	1	11998877	217165	213789
NM_001127660.1(MFN2):c.730G>A (p.Val244Met)	MFN2	Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, multiple submitters, no conflicts	1	12059066	1	11999009	243066	244149
NM_001127660.1(MFN2):c.730G>T (p.Val244Leu)	MFN2	Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	1	12059066	1	11999009	243057	244137
NM_001127660.1(MFN2):c.746C>T (p.Ser249Phe)	MFN2	Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	1	12059082	1	11999025	202171	198602
NM_014874.3(MFN2):c.1090C>T (p.Arg364Trp)	MFN2	Charcot-Marie-Tooth disease, type 2A2A|Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	1	12062090	1	12002033	2278	17317
NM_014874.3(MFN2):c.1126A>G (p.Met376Val)	MFN2	Charcot-Marie-Tooth disease, type 2A2A	Likely pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	1	12062126	1	12002069	217161	213790
NM_014874.3(MFN2):c.1837_1838insG (p.Thr614Aspfs)	MFN2	Hereditary motor and sensory neuropathy with optic atrophy	Likely pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	1	12066716	1	12006658 - 12006659	488546	481414
NM_001127660.1(MFN2):c.1946G>C (p.Arg649Pro)	MFN2	Charcot-Marie-Tooth disease, type 2A2A	Likely pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	1	12067183	1	12007126	243067	244150
NM_014874.3(MFN2):c.2219G>C (p.Trp740Ser)	MFN2	Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	1	12071567	1	12011510	2269	17308
NM_014874.3(MFN2):c.2256C>A (p.Tyr752Ter)	MFN2	Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: Aug 20, 2015)	criteria provided, single submitter	1	12071604	1	12011547	217162	213791
NM_003000.2(SDHB):c.716C>G (p.Ser239Cys)	SDHB	Pheochromocytoma	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	1	17349152	1	17022657	161385	171052
NM_003000.2(SDHB):c.575G>C (p.Cys192Ser)	SDHB	Gastrointestinal stroma tumor	Likely pathogenic(Last reviewed: Sep 13, 2013)	criteria provided, single submitter	1	17350535	1	17024040	44645	53812
NM_003000.2(SDHB):c.445_446insTATGG (p.Gln149Leufs)	SDHB	Hereditary Paraganglioma-Pheochromocytoma Syndromes	Likely pathogenic(Last reviewed: Jul 21, 2016)	criteria provided, single submitter	1	17354338 - 17354339	1	17027843 - 17027844	504902	496596
NM_003000.2(SDHB):c.343C>T (p.Arg115Ter)	SDHB	Gastrointestinal stroma tumor|Paragangliomas 4|Pheochromocytoma|Hereditary Paraganglioma-Pheochromocytoma Syndromes|not provided	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	1	17355175	1	17028680	197210	194371
NM_003000.2(SDHB):c.338G>C (p.Cys113Ser)	SDHB	Pheochromocytoma	Likely pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	1	17355180	1	17028685	219152	217064
NM_003000.2(SDHB):c.268C>T (p.Arg90Ter)	SDHB	Gastrointestinal stroma tumor|Paragangliomas 4|Pheochromocytoma|Hereditary Paraganglioma-Pheochromocytoma Syndromes|not provided|Hereditary Paragangliomas and Pheochromocytomas|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 13, 2018)	criteria provided, multiple submitters, no conflicts	1	17359573	1	17033078	12778	27817
NM_003000.2(SDHB):c.260T>C (p.Leu87Ser)	SDHB	Gastrointestinal stroma tumor|Paragangliomas 4|Pheochromocytoma|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Conflicting interpretations of pathogenicity(Last reviewed: Apr 19, 2018)	criteria provided, conflicting interpretations	1	17359581	1	17033086	178686	172493
NM_003000.2(SDHB):c.251A>C (p.Asp84Ala)	SDHB	Pheochromocytoma	Likely pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	1	17359590	1	17033095	219153	217065
NM_003000.2(SDHB):c.227T>G (p.Leu76Ter)	SDHB	Pheochromocytoma	Likely pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	1	17359614	1	17033119	219154	217066
NM_003000.2(SDHB):c.170A>G (p.His57Arg)	SDHB	Gastrointestinal stroma tumor|Paraganglioma and gastric stromal sarcoma|Paragangliomas 4|Pheochromocytoma|not specified|not provided|Hereditary cancer-predisposing syndrome|Cowden syndrome	Benign/Likely benign(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	1	17371286	1	17044791	135192	138931
NM_003000.2(SDHB):c.131_139delTCTATCGAT (p.Ile44_Trp47delinsArg)	SDHB	Pheochromocytoma	Likely pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	1	17371317 - 17371325	1	17044822 - 17044830	219155	217067
NM_003000.2(SDHB):c.137G>A (p.Arg46Gln)	SDHB	Gastrointestinal stroma tumor|Paragangliomas 4|Pheochromocytoma|Hereditary Paraganglioma-Pheochromocytoma Syndromes|not provided|Hereditary cancer-predisposing syndrome|SDHB-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	1	17371319	1	17044824	183793	181624
NM_003000.2(SDHB):c.79C>G (p.Arg27Gly)	SDHB	Gastrointestinal stroma tumor|Paragangliomas 4|Pheochromocytoma|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	1	17371377	1	17044882	161386	171053
NM_003000.2(SDHB):c.32G>A (p.Arg11His)	SDHB	Gastrointestinal stroma tumor|Paragangliomas 4|Pheochromocytoma|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Renal cell carcinoma, papillary, 1|not specified|Hereditary cancer-predisposing syndrome|Cowden syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	1	17380483	1	17053988	36768	45429
NM_015047.2(EMC1):c.1411G>C (p.Gly471Arg)	EMC1|EMC1-AS1	not specified|Cerebellar atrophy, visual impairment, and psychomotor retardation	Uncertain significance	criteria provided, single submitter	1	19561645	1	19235151	219102	216791
NM_001791.3(CDC42):c.191A>G (p.Tyr64Cys)	CDC42	not provided|Takenouchi-Kosaki syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	1	22412944	1	22086451	218950	215784
NM_006015.5(ARID1A):c.1348C>T (p.Gln450Ter)	ARID1A	Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	1	27056352	1	26729861	560946	552043
NM_006015.4(ARID1A):c.5001G>A (p.Pro1667=)	ARID1A	not specified	Likely benign	no assertion criteria provided	1	27102075	1	26775584	126310	131842
NM_006015.4(ARID1A):c.5114A>G (p.Asn1705Ser)	ARID1A	not specified	Likely benign	no assertion criteria provided	1	27102188	1	26775697	126311	131843
NM_006015.5(ARID1A):c.6134_6138del (p.Lys2045Argfs)	ARID1A	Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	1	27106522 - 27106527	1	26780032 - 26780036	560947	552044
NM_001029882.3(AHDC1):c.2898delC (p.Tyr967Thrfs)	AHDC1	Global developmental delay|Delayed speech and language development|Xia-Gibbs syndrome|Intellectual disability|Global developmental delay|Neonatal hypotonia|Sleep apnea|Muscular hypotonia|Muscular hypotonia	Pathogenic(Last reviewed: May 1, 2014)	criteria provided, single submitter	1	27875729	1	27549218	133327	137064
NM_001029882.3(AHDC1):c.2547delC (p.Ser850Profs)	AHDC1	Global developmental delay|Delayed speech and language development|Xia-Gibbs syndrome|Intellectual disability|Global developmental delay|Neonatal hypotonia|Sleep apnea|Muscular hypotonia|Muscular hypotonia	Pathogenic(Last reviewed: May 1, 2014)	criteria provided, single submitter	1	27876080	1	27549569	133328	137065
NM_001029882.3(AHDC1):c.2373_2374delTG (p.Cys791Trpfs)	AHDC1	Global developmental delay|not provided|Delayed speech and language development|Xia-Gibbs syndrome|Intellectual disability|Global developmental delay|Neonatal hypotonia|Sleep apnea|Muscular hypotonia|Muscular hypotonia	Pathogenic(Last reviewed: Mar 29, 2016)	criteria provided, multiple submitters, no conflicts	1	27876253 - 27876254	1	27549742 - 27549743	133326	137063
NM_001029882.3(AHDC1):c.1519A>T (p.Lys507Ter)	AHDC1	Xia-Gibbs syndrome	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	1	27877108	1	27550597	488466	481334
NM_001029882.3(AHDC1):c.1402dup (p.Cys468Leufs)	AHDC1	Cerebral visual impairment and intellectual disability	Pathogenic(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	1	27877225	1	27550714	224806	226643
NM_003680.3(YARS):c.586G>C (p.Glu196Gln)	YARS	Charcot-Marie-Tooth disease, dominant intermediate C	Likely pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	1	33263369	1	32797768	243071	244151
NM_004700.3(KCNQ4):c.140T>C (p.Leu47Pro)	KCNQ4	DFNA 2 Nonsyndromic Hearing Loss	Pathogenic(Last reviewed: Oct 20, 2017)	no assertion criteria provided	1	41249905	1	40784233	585006	576062
NM_004700.3(KCNQ4):c.211delC (p.Gln71Serfs)	KCNQ4	DFNA 2 Nonsyndromic Hearing Loss	Pathogenic(Last reviewed: Feb 17, 2011)	no assertion criteria provided	1	41249976	1	40784304	6248	21287
NM_004700.3(KCNQ4):c.211_223delCAGCGCTCCTCGG (p.Gln71Profs)	KCNQ4	DFNA 2 Nonsyndromic Hearing Loss	Pathogenic(Last reviewed: Sep 27, 2016)	no assertion criteria provided	1	41249976 - 41249988	1	40784304 - 40784316	6245	21284
NM_004700.3(KCNQ4):c.459delC (p.Ala154Profs)	KCNQ4	Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Aug 14, 2013)	criteria provided, single submitter	1	41283889	1	40818217	179111	172583
NM_004700.3(KCNQ4):c.720C>G (p.Thr240=)	KCNQ4	Nonsyndromic hearing loss and deafness|not specified	Likely benign(Last reviewed: Sep 28, 2018)	reviewed by expert panel	1	41285030	1	40819358	227469	228470
NM_004700.4(KCNQ4):c.796G>T (p.Asp266Tyr)	KCNQ4	DFNA 2 Nonsyndromic Hearing Loss	Pathogenic(Last reviewed: Dec 7, 2017)	no assertion criteria provided	1	41285106	1	40819434	591002	581958
NM_004700.3(KCNQ4):c.825G>C (p.Trp275Cys)	KCNQ4	Nonsyndromic hearing loss and deafness|not specified	Likely pathogenic(Last reviewed: Sep 10, 2018)	reviewed by expert panel	1	41285135	1	40819463	505302	496205
NM_004700.3(KCNQ4):c.827G>C (p.Trp276Ser)	KCNQ4	DFNA 2 Nonsyndromic Hearing Loss|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Jun 24, 2014)	criteria provided, single submitter	1	41285137	1	40819465	6242	21281
NM_004700.3(KCNQ4):c.853G>T (p.Gly285Cys)	KCNQ4	DFNA 2 Nonsyndromic Hearing Loss	Pathogenic(Last reviewed: Feb 17, 2011)	no assertion criteria provided	1	41285565	1	40819893	6244	21283
NM_004700.3(KCNQ4):c.853G>A (p.Gly285Ser)	KCNQ4	DFNA 2 Nonsyndromic Hearing Loss|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Sep 11, 2018)	reviewed by expert panel	1	41285565	1	40819893	6241	21280
NM_004700.3(KCNQ4):c.1671_1672insACGAC (p.Val558Thrfs)	KCNQ4	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	1	41300696 - 41300697	1	40835024 - 40835025	505873	496627
NM_006516.3(SLC2A1):c.1268A>G (p.Gln423Arg)	SLC2A1	not specified	Likely benign(Last reviewed: May 6, 2013)	criteria provided, single submitter	1	43393286	1	42927615	159923	167986
NM_006516.3(SLC2A1):c.1261T>C (p.Cys421Arg)	SLC2A1	GLUT1 deficiency syndrome 1	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	1	43393293	1	42927622	565292	556476
NM_006516.2(SLC2A1):c.1089delG (p.Trp363Terfs)	SLC2A1	GLUT1 deficiency syndrome 1	Pathogenic(Last reviewed: May 7, 2014)	criteria provided, single submitter	1	43393465	1	42927794	159922	167987
NM_006516.3(SLC2A1):c.1065A>G (p.Leu355=)	SLC2A1	GLUT1 deficiency syndrome 1, autosomal recessive|Dystonia|not specified|Glucose transporter type 1 deficiency syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	1	43394612	1	42928941	95407	101306
NM_006516.3(SLC2A1):c.1011C>T (p.His337=)	SLC2A1	GLUT1 deficiency syndrome 1, autosomal recessive|Dystonia|not specified|Glucose transporter type 1 deficiency syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	1	43394666	1	42928995	95406	101305
NM_006516.2(SLC2A1):c.1007_1009delTGC (p.Leu336del)	SLC2A1	GLUT1 deficiency syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	43394668 - 43394670	1	42928997 - 42928999	159920	167988
NM_006516.3(SLC2A1):c.988C>T (p.Arg330Ter)	SLC2A1	GLUT1 deficiency syndrome 1|GLUT1 deficiency syndrome 1, autosomal recessive|Epilepsy|not provided|Microcephaly|Inborn genetic diseases|intellectual deficiency	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	1	43394689	1	42929018	207196	201142
NM_006516.3(SLC2A1):c.966C>T (p.Val322=)	SLC2A1	GLUT1 deficiency syndrome 1, autosomal recessive|Dystonia|not specified|Glucose transporter type 1 deficiency syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	1	43394887	1	42929216	95418	101317
NM_006516.3(SLC2A1):c.847C>T (p.Gln283Ter)	SLC2A1	GLUT1 deficiency syndrome 1	Pathogenic(Last reviewed: Sep 17, 2014)	criteria provided, multiple submitters, no conflicts	1	43395284	1	42929613	159930	167989
NM_006516.3(SLC2A1):c.823G>A (p.Ala275Thr)	SLC2A1	GLUT1 deficiency syndrome 1|GLUT1 deficiency syndrome 2|not provided	Pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, multiple submitters, no conflicts	1	43395308	1	42929637	16114	31153
NM_006516.3(SLC2A1):c.777C>T (p.Ile259=)	SLC2A1	GLUT1 deficiency syndrome 1|GLUT1 deficiency syndrome 1, autosomal recessive|Dystonia|not specified|not provided|Glucose transporter type 1 deficiency syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2017)	criteria provided, conflicting interpretations	1	43395354	1	42929683	95417	101316
NM_006516.3(SLC2A1):c.764A>C (p.Lys255Thr)	SLC2A1	not specified	Likely benign(Last reviewed: Mar 13, 2017)	criteria provided, multiple submitters, no conflicts	1	43395367	1	42929696	159929	167990
NM_006516.3(SLC2A1):c.748C>T (p.Gln250Ter)	SLC2A1	GLUT1 deficiency syndrome 1|not provided	Pathogenic(Last reviewed: Jan 10, 2014)	criteria provided, multiple submitters, no conflicts	1	43395383	1	42929712	159928	167991
NM_006516.3(SLC2A1):c.746G>A (p.Arg249Gln)	SLC2A1	not specified	Likely benign(Last reviewed: Jan 11, 2013)	criteria provided, single submitter	1	43395385	1	42929714	159927	167992
NM_006516.2(SLC2A1):c.732delG (p.Met244Ilefs)	SLC2A1	GLUT1 deficiency syndrome 1	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	1	43395399	1	42929728	488600	481468
NM_006516.3(SLC2A1):c.680-10G>T	SLC2A1	GLUT1 deficiency syndrome 1|Dystonia|not specified|Glucose transporter type 1 deficiency syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 2, 2018)	criteria provided, conflicting interpretations	1	43395461	1	42929790	159926	167993
NM_006516.3(SLC2A1):c.679+7G>T	SLC2A1	GLUT1 deficiency syndrome 1, autosomal recessive|Dystonia|not specified|Glucose transporter type 1 deficiency syndrome	Benign/Likely benign(Last reviewed: Dec 6, 2017)	criteria provided, multiple submitters, no conflicts	1	43395537	1	42929866	139161	142864
NM_006516.3(SLC2A1):c.679+7G>C	SLC2A1	GLUT1 deficiency syndrome 1, autosomal recessive|Dystonia|not specified|not provided|Glucose transporter type 1 deficiency syndrome	Benign(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	1	43395537	1	42929866	95416	101315
NM_006516.3(SLC2A1):c.679+4C>A	SLC2A1	GLUT1 deficiency syndrome 1|GLUT1 deficiency syndrome 1, autosomal recessive|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 28, 2017)	criteria provided, conflicting interpretations	1	43395540	1	42929869	159925	167994
NM_006516.3(SLC2A1):c.588G>A (p.Pro196=)	SLC2A1	GLUT1 deficiency syndrome 1|Dystonia|not specified|Glucose transporter type 1 deficiency syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	1	43395635	1	42929964	95414	101313
NM_006516.3(SLC2A1):c.543C>T (p.Gly181=)	SLC2A1	GLUT1 deficiency syndrome 1|GLUT1 deficiency syndrome 1, autosomal recessive|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2017)	criteria provided, conflicting interpretations	1	43395680	1	42930009	139159	142862
NM_006516.3(SLC2A1):c.417C>T (p.Phe139=)	SLC2A1	GLUT1 deficiency syndrome 1, autosomal recessive|Dystonia|not specified|Glucose transporter type 1 deficiency syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 10, 2018)	criteria provided, multiple submitters, no conflicts	1	43396396	1	42930725	95412	101311
NM_006516.3(SLC2A1):c.399C>T (p.Cys133=)	SLC2A1	Dystonia|not specified|not provided|Glucose transporter type 1 deficiency syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	1	43396414	1	42930743	95411	101310
NM_006516.3(SLC2A1):c.377G>A (p.Arg126His)	SLC2A1	GLUT1 deficiency syndrome 1|Epilepsy, idiopathic generalized, susceptibility to, 12|not provided	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, multiple submitters, no conflicts	1	43396436	1	42930765	16111	31150
NM_006516.3(SLC2A1):c.376C>T (p.Arg126Cys)	SLC2A1	Dystonia 9|GLUT1 deficiency syndrome 1|GLUT1 deficiency syndrome 2|GLUT1 deficiency syndrome 1, autosomal recessive|Epilepsy, idiopathic generalized, susceptibility to, 12|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	1	43396437	1	42930766	16118	31157
NM_006516.3(SLC2A1):c.100A>G (p.Asn34Asp)	SLC2A1	GLUT1 deficiency syndrome 1	Likely pathogenic(Last reviewed: Jun 6, 2013)	criteria provided, single submitter	1	43408911	1	42943240	159921	167995
NM_006516.3(SLC2A1):c.45C>T (p.Ala15=)	SLC2A1	GLUT1 deficiency syndrome 1|Dystonia|not specified|Glucose transporter type 1 deficiency syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	1	43408966	1	42943295	95413	101312
NM_006516.2(SLC2A1):c.19_28delAAGCTGACGG (p.Lys7Valfs)	SLC2A1	GLUT1 deficiency syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	43408983 - 43408992	1	42943312 - 42943321	159924	167996
NM_006516.3(SLC2A1):c.27G>A (p.Thr9=)	SLC2A1	GLUT1 deficiency syndrome 1, autosomal recessive|Dystonia|not specified|Glucose transporter type 1 deficiency syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	1	43408984	1	42943313	139155	142858
NM_006516.2(SLC2A1):c.-2C>T	SLC2A1	not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Mar 10, 2017)	criteria provided, conflicting interpretations	1	43424324	1	42958653	159919	167997
NM_001128425.1(MUTYH):c.1187G>A (p.Gly396Asp)	MUTYH	Endometrial carcinoma|MYH-associated polyposis|Pilomatrixoma|Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas|Carcinoma of colon|Neoplasm of stomach|not specified|not provided|Hereditary cancer-predisposing syndrome|Small intestine carcinoid|MUTYH-associated polyposis	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	1	45797228	1	45331556	5294	20333
NM_012186.3(FOXE3):c.334C>T (p.Pro112Ser)	FOXE3|LINC01389	Acute aortic dissections|Familial thoracic aortic aneurysms	Likely benign(Last reviewed: Feb 8, 2016)	no assertion criteria provided	1	47882321	1	47416649	617853	609191
NM_012186.2(FOXE3):c.410G>A (p.Gly137Asp)	FOXE3|LINC01389	Aortic aneurysm, familial thoracic 11, susceptibility to|Acute aortic dissections|Familial thoracic aortic aneurysms	Likely pathogenic, risk factor(Last reviewed: Jan 6, 2018)	no assertion criteria provided	1	47882397	1	47416725	375652	362493
NM_012186.2(FOXE3):c.457G>C (p.Asp153His)	FOXE3|LINC01389	Aortic aneurysm, familial thoracic 11, susceptibility to|Acute aortic dissections|Familial thoracic aortic aneurysms	Likely pathogenic, risk factor(Last reviewed: Jan 6, 2018)	no assertion criteria provided	1	47882444	1	47416772	375651	362492
NM_012186.3(FOXE3):c.466G>A (p.Asp156Asn)	FOXE3|LINC01389	Acute aortic dissections|Familial thoracic aortic aneurysms	Uncertain significance(Last reviewed: Feb 8, 2016)	no assertion criteria provided	1	47882453	1	47416781	617852	609192
NM_012186.3(FOXE3):c.490C>A (p.Arg164Ser)	FOXE3|LINC01389	Acute aortic dissections|Familial thoracic aortic aneurysms	Likely pathogenic(Last reviewed: Feb 8, 2016)	no assertion criteria provided	1	47882477	1	47416805	617851	609193
NM_012186.3(FOXE3):c.605C>T (p.Pro202Leu)	FOXE3|LINC01389	Acute aortic dissections|Familial thoracic aortic aneurysms	Likely benign(Last reviewed: Feb 8, 2016)	no assertion criteria provided	1	47882592	1	47416920	617854	609194
NM_174936.3(PCSK9):c.42_43insTG (p.Leu15Cysfs)	PCSK9	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	1	55505552 - 55505553	1	55039879 - 55039880	431555	424994
NM_174936.3(PCSK9):c.60_65dupGCTGCT (p.Leu23_Gly24insLeuLeu)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 5, 2018)	criteria provided, conflicting interpretations	1	55505570 - 55505575	1	55039897 - 55039902	265916	260592
NM_174936.3(PCSK9):c.63_65delGCT (p.Leu23del)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2018)	criteria provided, conflicting interpretations	1	55505573 - 55505575	1	55039900 - 55039902	265917	260593
NM_174936.3(PCSK9):c.85delC (p.Arg29Valfs)	PCSK9	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 10, 2017)	criteria provided, multiple submitters, no conflicts	1	55505595	1	55039922	496566	486884
NM_174936.3(PCSK9):c.137G>T (p.Arg46Leu)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Low density lipoprotein cholesterol level quantitative trait locus 1|Familial hypercholesterolemia|not specified|Hypocholesterolemia	Conflicting interpretations of pathogenicity, association(Last reviewed: Aug 11, 2017)	criteria provided, conflicting interpretations	1	55505647	1	55039974	2878	17917
NM_174936.3(PCSK9):c.141C>T (p.Ser47=)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	1	55505651	1	55039978	262902	249983
NM_174936.3(PCSK9):c.169G>A (p.Glu57Lys)	PCSK9	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	1	55505679	1	55040006	548104	538521
NM_174936.3(PCSK9):c.185C>A (p.Ala62Asp)	PCSK9	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	1	55505695	1	55040022	265918	260594
NM_174936.3(PCSK9):c.314G>A (p.Arg105Gln)	PCSK9	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	1	55509622	1	55043949	548107	538522
NM_174936.3(PCSK9):c.336G>A (p.Leu112=)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia	Benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	1	55509644	1	55043971	413317	391359
NM_174936.3(PCSK9):c.381T>A (p.Ser127Arg)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	1	55509689	1	55044016	2873	17912
NM_174936.3(PCSK9):c.386A>G (p.Asp129Gly)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 18, 2018)	criteria provided, conflicting interpretations	1	55509694	1	55044021	438332	431938
NM_174936.3(PCSK9):c.449_450delTT (p.Phe150Cysfs)	PCSK9	Familial hypercholesterolemia	Likely benign	criteria provided, single submitter	1	55512245 - 55512246	1	55046572 - 55046573	189307	187182
NM_174936.3(PCSK9):c.493C>T (p.Arg165Trp)	PCSK9	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	1	55512289	1	55046616	548110	538523
NM_174936.3(PCSK9):c.494G>A (p.Arg165Gln)	PCSK9	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	1	55512290	1	55046617	548111	538524
NM_174936.3(PCSK9):c.609C>T (p.Thr203=)	PCSK9	Familial hypercholesterolemia|not specified	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	1	55518036	1	55052363	517066	498556
NM_174936.3(PCSK9):c.610G>A (p.Asp204Asn)	PCSK9	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	1	55518037	1	55052364	189308	187183
NM_174936.3(PCSK9):c.705C>T (p.Ser235=)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2018)	criteria provided, conflicting interpretations	1	55518370	1	55052697	265932	260608
NM_174936.3(PCSK9):c.709C>T (p.Arg237Trp)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jul 25, 2017)	criteria provided, conflicting interpretations	1	55518374	1	55052701	265933	260609
NM_174936.3(PCSK9):c.720C>T (p.Gly240=)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 22, 2018)	criteria provided, conflicting interpretations	1	55518385	1	55052712	242028	238334
NM_174936.3(PCSK9):c.753C>T (p.Arg251=)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	1	55518418	1	55052745	262907	249987
NM_174936.3(PCSK9):c.993C>T (p.Pro331=)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia|not provided	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	1	55521859	1	55056186	496568	486922
NM_174936.3(PCSK9):c.1061A>T (p.Asn354Ile)	PCSK9	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	1	55523068	1	55057395	438337	431943
NM_174936.3(PCSK9):c.1120G>C (p.Asp374His)	PCSK9	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	1	55523127	1	55057454	265939	260615
NM_174936.3(PCSK9):c.1120G>T (p.Asp374Tyr)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	1	55523127	1	55057454	2875	17914
NM_174936.3(PCSK9):c.1227C>T (p.Ala409=)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	1	55523755	1	55058082	413314	391518
NM_174936.3(PCSK9):c.1251C>A (p.His417Gln)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	1	55523779	1	55058106	369875	354066
NM_174936.3(PCSK9):c.1326C>T (p.Ala442=)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypobetalipoproteinemia|Familial hypercholesterolemia	Benign/Likely benign(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	1	55523854	1	55058181	297701	282665
NM_174936.3(PCSK9):c.1327G>A (p.Ala443Thr)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 12, 2018)	criteria provided, conflicting interpretations	1	55523855	1	55058182	262900	249990
NM_174936.3(PCSK9):c.1354+9G>T	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 8, 2018)	criteria provided, conflicting interpretations	1	55523891	1	55058218	413316	391339
NM_174936.3(PCSK9):c.1399C>G (p.Pro467Ala)	PCSK9	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	1	55524216	1	55058543	265944	260620
NM_174936.3(PCSK9):c.1405C>T (p.Arg469Trp)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2017)	criteria provided, conflicting interpretations	1	55524222	1	55058549	201128	196756
NM_174936.3(PCSK9):c.1487G>A (p.Arg496Gln)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	1	55524304	1	55058631	438338	431944
NM_174936.3(PCSK9):c.1537A>G (p.Asn513Asp)	PCSK9	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	1	55525192	1	55059519	369876	354067
NM_174936.3(PCSK9):c.1671C>T (p.His557=)	PCSK9	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	1	55525326	1	55059653	548103	538525
NM_174936.3(PCSK9):c.1792G>A (p.Ala598Thr)	PCSK9	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	1	55527158	1	55061485	548105	538526
NM_174936.3(PCSK9):c.1864-13C>T	PCSK9	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	1	55529029	1	55063356	548106	538527
NM_174936.3(PCSK9):c.1869C>T (p.Thr623=)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia|not provided	Benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	1	55529047	1	55063374	468295	448374
NM_174936.3(PCSK9):c.1948G>A (p.Val650Ile)	PCSK9	Familial hypercholesterolemia	Uncertain significance	criteria provided, single submitter	1	55529126	1	55063453	369877	354068
NM_174936.3(PCSK9):c.2038C>T (p.Arg680Trp)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	1	55529216	1	55063543	375843	362660
NC_000001.10:g.57832716_57832797ins[(ATTTT)60-79(ATTTC)31-75(ATTTT)58-90]	DAB1	Spinocerebellar ataxia 37	Pathogenic(Last reviewed: Nov 20, 2018)	no assertion criteria provided	1	57832716 - 57832797			430691	424219
NM_002227.3(JAK1):c.1901C>A (p.Ala634Asp)	JAK1	Lymphoblastic leukemia, acute, with lymphomatous features|Inborn genetic diseases	Likely pathogenic	criteria provided, single submitter	1	65312418	1	64846735	225075	226887
NM_144573.3(NEXN):c.1063G>C (p.Asp355His)	NEXN	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	1	78398976	1	77933291	492981	485931
NM_053274.2(GLMN):c.1630G>T (p.Glu544Ter)	GLMN	Blue rubber bleb nevus	Pathogenic	criteria provided, single submitter	1	92712657	1	92247100	549853	540578
NM_001328664.1(ARHGAP29):c.2109+1G>A	ARHGAP29	Nonsyndromic cleft lip with or without cleft palate	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	1	94650427	1	94184871	242343	243894
NM_001328664.1(ARHGAP29):c.1475C>A (p.Ser492Ter)	ARHGAP29	Nonsyndromic cleft lip with or without cleft palate	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	1	94654873	1	94189317	242340	243891
NM_001328664.1(ARHGAP29):c.698-1G>C	ARHGAP29	Nonsyndromic cleft lip with or without cleft palate	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	1	94669551	1	94203995	242341	243892
NM_133496.4(SLC30A7):c.490_491delCAinsAG (p.His164Ser)	SLC30A7	Joubert syndrome 1	Pathogenic	no assertion criteria provided	1	101377773 - 101377774	1	100912217 - 100912218	375382	362132
NM_001854.3(COL11A1):c.2754+5G>A	COL11A1	Stickler syndrome, type 2|not provided	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	1	103444259	1	102978703	374386	361277
NM_013386.4(SLC25A24):c.650G>A (p.Arg217His)	SLC25A24	Fontaine progeroid syndrome	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	1	108700103	1	108157481	370032	354272
NM_013386.4(SLC25A24):c.649C>T (p.Arg217Cys)	SLC25A24	Fontaine progeroid syndrome	Pathogenic	criteria provided, single submitter	1	108700104	1	108157482	369980	354197
NM_001408.2(CELSR2):c.6859G>A (p.Val2287Ile)	CELSR2	Idiopathic scoliosis	Uncertain significance(Last reviewed: Jan 27, 2017)	no assertion criteria provided	1	109812092	1	109269470	397652	384625
NM_004980.4(KCND3):c.1153T>C (p.Ser385Pro)	KCND3	Spinocerebellar ataxia 19	Pathogenic	no assertion criteria provided	1	112329682	1	111787060	375399	362133
NM_004980.4(KCND3):c.264C>T (p.Pro88=)	KCND3	not specified|Cardiovascular phenotype	Benign(Last reviewed: Sep 28, 2016)	criteria provided, multiple submitters, no conflicts	1	112525085	1	111982463	129314	134760
NM_003051.3(SLC16A1):c.1470T>A (p.Asp490Glu)	SLC16A1	not specified|Hyperinsulinism, Dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	113456546	1	112913924	130315	135762
NM_002524.4(NRAS):c.34G>A (p.Gly12Ser)	NRAS	Malignant melanoma of skin|Multiple myeloma|Non-small cell lung cancer|Acute myeloid leukemia|Myelodysplastic syndrome|not provided|Rasopathy|Cutaneous melanoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	1	115258748	1	114716127	177778	172332
GRCh37/hg19 1q21.1-21.3(chr1:144927578-153223600)x3	ARNT|BCL9|CTSK|CTSS|ECM1|ENSA|FCGR1A|FLG|FMO5|GJA5|GJA8|IVL|MCL1|SMCP|PDZK1|PI4KB|PRKAB2|PSMB4|PSMD4|RFX5|RORC|S100A10|S100A11|SPRR1A|SPRR1B|SPRR2A|SPRR2B|SPRR2D|SPRR2E|SPRR2F|SPRR2G|SPRR3|VPS72|TCHH|TRN-GTT2-1|TUFT1|HIST2H2AA3|HIST2H2AC|HIST2H2BE|HIST2H4A|PIP5K1A|ANXA9|ITGA10|PEX11B|SELENBP1|PRPF3|CHD1L|PDE4DIP|SETDB1|SV2A|RBM8A|SF3B4|PIAS3|SEMA6C|POLR3C|TXNIP|MTMR11|MLLT11|TDRKH|CD160|CELF3|VPS45|POGZ|RPRD2|CA14|LCE2B|RNF115|TMOD4|CERS2|CRNN|BOLA1|APH1A|PLEKHO1|ACP6|GPR89B|OAZ3|MRPS21|ADAMTSL4|CRCT1|C1orf56|GOLPH3L|MINDY1|CDC42SE1|OTUD7B|CGN|ZNF687|PRUNE1|MRPL9|SCNM1|TNFAIP8L2|C1orf54|TARS2|SNX27|ANP32E|HORMAD1|POLR3GL|LCE3D|THEM4|GABPB2|TCHHL1|RPTN|HIST2H3C|LIX1L|CIART|HJV|ANKRD35|NBPF12|LELP1|BNIPL|SPRR4|LCE4A|NBPF11|NUDT17|LCE5A|RIIAD1|THEM5|NBPF15|ANKRD34A|HIST2H2AB|HIST2H3A|LINGO4|LCE1A|LCE1B|LCE1C|LCE1D|LCE1E|LCE1F|LCE2A|LCE2C|LCE2D|LCE3A|LCE3B|LCE3C|LCE3E|NOTCH2NLA|LYSMD1|HRNR|FLG2|HIST2H2BF|KPRP|LCE6A|FAM72C|HIST2H4B|PRR9|PPIAL4D|GPR89A|PPIAL4C|HIST2H3D|HIST2H2AA4|PPIAL4F|PPIAL4E|C1orf68|NBPF10|TRN-GTT9-1|TRH-GTG2-1|TRQ-CTG3-1|C2CD4D|FALEC	Chromosome 1q21.1 duplication syndrome	Pathogenic(Last reviewed: Dec 22, 2015)	no assertion criteria provided	1	144927578 - 153223600			225520	227427
NM_004284.5(CHD1L):c.707G>A (p.Arg236His)	CHD1L	Congenital anomalies of kidney and urinary tract	Uncertain significance	criteria provided, single submitter	1	146736211	1	147264552	224340	226070
NM_001256338.2(CHD1L):c.1594A>G (p.Ile532Val)	CHD1L	Congenital anomalies of kidney and urinary tract	Uncertain significance	criteria provided, single submitter	1	146758162	1	147286485	224341	226071
NM_001256338.2(CHD1L):c.1666G>A (p.Ala556Thr)	CHD1L	Congenital anomalies of kidney and urinary tract	Uncertain significance	criteria provided, single submitter	1	146759370	1	147287691	224339	226072
NM_005266.6(GJA5):c.586T>G (p.Cys196Gly)	GJA5	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	1	147230761	1	147758653	427968	419262
NM_005267.4(GJA8):c.151G>C (p.Asp51His)	GJA8	Cataract 1|Microphthalmia and cataract	Uncertain significance(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	1	147380233	1	147908106	446264	439651
NM_005267.4(GJA8):c.827C>T (p.Ser276Phe)	GJA8	Cataract 1	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	1	147380909	1	147908782	427758	417647
NM_005850.4(SF3B4):c.827delC (p.Pro276Hisfs)	SF3B4	Hereditary hearing loss and deafness|not provided	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	1	149897814	1	149925922	446295	439700
NM_005850.4(SF3B4):c.682T>C (p.Leu228=)	SF3B4	Nager syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	149898292	1	149926400	130291	135738
NM_015100.3(POGZ):c.2935C>T (p.Arg979Ter)	POGZ	Inborn genetic diseases|White-sutton syndrome	Pathogenic(Last reviewed: Dec 1, 2014)	criteria provided, single submitter	1	151378576	1	151406100	218149	214794
NM_015100.3(POGZ):c.2780dupT (p.Leu927Phefs)	POGZ	White-sutton syndrome	Pathogenic(Last reviewed: Nov 10, 2015)	no assertion criteria provided	1	151378731	1	151406255	218150	214795
NM_015100.3(POGZ):c.2763dupC (p.Thr922Hisfs)	POGZ	not provided|White-sutton syndrome	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	1	151378748	1	151406272	218147	214796
NM_015100.3(POGZ):c.2321_2324delCTCT (p.Ser774Cysfs)	POGZ	White-sutton syndrome|Smith-Magenis Syndrome-like	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	1	151380627 - 151380630	1	151408151 - 151408154	218146	214797
NM_015100.3(POGZ):c.833C>G (p.Ser278Ter)	POGZ	White-sutton syndrome	Pathogenic(Last reviewed: Jan 6, 2016)	no assertion criteria provided	1	151400625	1	151428149	218148	214798
NM_001083964.1(TDRKH):c.851G>A (p.Arg284His)	TDRKH	Distal spinal muscular atrophy	Likely pathogenic(Last reviewed: Dec 23, 2017)	no assertion criteria provided	1	151748973	1	151776497	518454	509044
NM_002016.1(FLG):c.4279G>A (p.Ala1427Thr)	FLG	Ichthyosis vulgaris	Uncertain significance(Last reviewed: Oct 20, 2014)	no assertion criteria provided	1	152283083	1	152310607	374307	361156
NM_002016.1(FLG):c.2282_2285delCAGT (p.Ser761Cysfs)	FLG	Dermatitis, atopic, 2|Ichthyosis vulgaris|Dermatitis, atopic, 2, susceptibility to|not provided|FLG-Related Disorder	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Aug 8, 2018)	criteria provided, conflicting interpretations	1	152285077 - 152285080	1	152312601 - 152312604	16320	31359
NM_020699.3(GATAD2B):c.1075C>T (p.Gln359Ter)	GATAD2B	Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	1	153788890	1	153816414	584436	575485
NM_020699.3(GATAD2B):c.694C>T (p.Gln232Ter)	GATAD2B	Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: Apr 30, 2014)	no assertion criteria provided	1	153790551	1	153818075	374387	361157
NM_000748.2(CHRNB2):c.210+9A>G	CHRNB2	Autosomal dominant nocturnal frontal lobe epilepsy|not specified	Benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	1	154542092	1	154569616	158333	167982
NM_000748.2(CHRNB2):c.1191G>C (p.Gln397His)	CHRNB2	Epilepsy, nocturnal frontal lobe, type 3|Autosomal dominant nocturnal frontal lobe epilepsy|not specified|Seizures|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2018)	criteria provided, conflicting interpretations	1	154544490	1	154572014	158330	167983
NM_000748.2(CHRNB2):c.1338+14G>T	CHRNB2	not specified	Benign(Last reviewed: Mar 16, 2016)	criteria provided, multiple submitters, no conflicts	1	154544651	1	154572175	158331	167984
NM_001111.5(ADAR):c.3019G>A (p.Gly1007Arg)	ADAR	Symmetrical dyschromatosis of extremities|Aicardi-Goutieres syndrome 6	Likely pathogenic(Last reviewed: May 14, 2013)	criteria provided, single submitter	1	154560601	1	154588125	39458	48057
NM_001005741.2(GBA):c.1294T>A (p.Trp432Arg)	GBA|LOC106627981	Parkinson disease, late-onset	Pathogenic	no assertion criteria provided	1	155205566	1	155235775	599275	590519
NM_006912.5(RIT1):c.284G>C (p.Gly95Ala)	RIT1	Noonan syndrome|not provided|Noonan syndrome 8	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	1	155874247	1	155904456	60509	75096
NM_006912.5(RIT1):c.270G>C (p.Met90Ile)	RIT1	not provided|Noonan syndrome 8	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, multiple submitters, no conflicts	1	155874261	1	155904470	190305	188134
NM_006912.5(RIT1):c.270G>A (p.Met90Ile)	RIT1	Noonan syndrome|not provided|Noonan syndrome 8	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	1	155874261	1	155904470	120250	125844
NM_006912.5(RIT1):c.251C>T (p.Ala84Val)	RIT1	Noonan syndrome|not provided	Likely pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, multiple submitters, no conflicts	1	155874280	1	155904489	183410	181506
NM_006912.5(RIT1):c.246T>A (p.Phe82Leu)	RIT1	not provided|Noonan syndrome 8	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	1	155874285	1	155904494	370035	354275
NM_006912.5(RIT1):c.242A>G (p.Glu81Gly)	RIT1	Noonan syndrome|not specified|not provided|Noonan syndrome 8	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	1	155874289	1	155904498	183405	181511
NM_006912.5(RIT1):c.229G>C (p.Ala77Pro)	RIT1	Noonan syndrome|Noonan syndrome 8	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, multiple submitters, no conflicts	1	155874530	1	155904739	228289	228269
NM_006912.5(RIT1):c.229G>A (p.Ala77Thr)	RIT1	Noonan syndrome|not provided|Noonan syndrome 8	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2018)	criteria provided, multiple submitters, no conflicts	1	155874530	1	155904739	183403	181513
NM_006912.5(RIT1):c.170C>G (p.Ala57Gly)	RIT1	Noonan syndrome|not provided|Noonan syndrome 8	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	1	155874589	1	155904798	60506	75093
NM_006912.5(RIT1):c.104G>C (p.Ser35Thr)	RIT1	Noonan syndrome|not provided|Noonan syndrome 8	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, multiple submitters, no conflicts	1	155880449	1	155910658	183401	181515
NM_005572.3(LMNA):c.51C>T (p.Ser17=)	LMNA	Primary dilated cardiomyopathy|Hutchinson-Gilford syndrome|Lethal tight skin contracture syndrome|Congenital muscular dystrophy, LMNA-related|Charcot-Marie-Tooth disease, type 2|Emery-Dreifuss muscular dystrophy|Mandibuloacral dysplasia|not specified|not provided|Familial partial lipodystrophy|Cardiovascular phenotype|Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	Benign/Likely benign(Last reviewed: Aug 28, 2017)	criteria provided, multiple submitters, no conflicts	1	156084760	1	156114969	36479	45141
NM_170707.3(LMNA):c.80C>G (p.Thr27Ser)	LMNA	Ventricular fibrillation, idiopathic	Uncertain significance(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	1	156084789	1	156114998	217834	214482
NM_170707.3(LMNA):c.91_93delGAG (p.Glu31del)	LMNA	Congenital muscular dystrophy, LMNA-related	Likely pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	1	156084800 - 156084802	1	156115009 - 156115011	218376	215103
NM_170707.3(LMNA):c.234G>T (p.Lys78Asn)	LMNA	Arrhythmogenic right ventricular cardiomyopathy, type 9	Likely pathogenic	criteria provided, single submitter	1	156084943	1	156115152	444011	437672
NM_170707.3(LMNA):c.244G>A (p.Glu82Lys)	LMNA	Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	1	156084953	1	156115162	66882	77779
NM_170707.3(LMNA):c.357C>T (p.Arg119=)	LMNA	Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease, type 2|Emery-Dreifuss muscular dystrophy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 28, 2018)	criteria provided, conflicting interpretations	1	156100408	1	156130617	48062	57226
NM_005572.3(LMNA):c.513+1G>C	LMNA	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Apr 4, 2014)	criteria provided, single submitter	1	156100565	1	156130774	48069	57233
NM_170707.3(LMNA):c.513+45T>G	LMNA	Benign scapuloperoneal muscular dystrophy with cardiomyopathy	Pathogenic(Last reviewed: Apr 26, 2016)	no assertion criteria provided	1	156100609	1	156130818	236201	237758
NM_001257374.2(LMNA):c.229C>T (p.Arg77Trp)	LMNA	Primary dilated cardiomyopathy|not provided	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	1	156104245	1	156134454	66906	77803
NM_001282624.1(LMNA):c.342C>G (p.Asn114Lys)	LMNA	Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|not provided	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, multiple submitters, no conflicts	1	156104265	1	156134474	14483	29522
NM_170707.3(LMNA):c.608A>G (p.Glu203Gly)	LMNA	Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|not provided	Pathogenic(Last reviewed: Aug 21, 2015)	criteria provided, single submitter	1	156104288	1	156134497	14484	29523
NM_005572.3(LMNA):c.673C>T (p.Arg225Ter)	LMNA	Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|Limb-girdle muscular dystrophy, type 1B|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	1	156104629	1	156134838	48074	57238
NM_170707.3(LMNA):c.695G>A (p.Gly232Glu)	LMNA	Benign scapuloperoneal muscular dystrophy with cardiomyopathy|not provided	Likely pathogenic(Last reviewed: Jun 19, 2015)	criteria provided, single submitter	1	156104651	1	156134860	66925	77822
NM_170707.3(LMNA):c.725C>T (p.Ala242Val)	LMNA	Primary dilated cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 11, 2017)	criteria provided, conflicting interpretations	1	156104681	1	156134890	48076	57240
NM_005572.3(LMNA):c.745C>T (p.Arg249Trp)	LMNA	Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Congenital muscular dystrophy, LMNA-related|not provided	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, multiple submitters, no conflicts	1	156104701	1	156134910	14524	29563
NM_170707.3(LMNA):c.746G>A (p.Arg249Gln)	LMNA	Dilated cardiomyopathy 1A|Charcot-Marie-Tooth disease type 2B1|Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Charcot-Marie-Tooth disease, type 2|Muscular dystrophy|not provided	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, multiple submitters, no conflicts	1	156104702	1	156134911	66931	77828
NM_170707.3(LMNA):c.768G>A (p.Val256=)	LMNA	Primary dilated cardiomyopathy|not provided	Pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, multiple submitters, no conflicts	1	156104724	1	156134933	200941	196470
NM_005572.3(LMNA):c.784G>T (p.Glu262Ter)	LMNA	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Sep 26, 2012)	criteria provided, single submitter	1	156104740	1	156134949	48081	57245
NM_170707.3(LMNA):c.810+1G>C	LMNA	Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Limb-girdle muscular dystrophy, type 1B|Congenital muscular dystrophy, LMNA-related	Pathogenic(Last reviewed: Jul 29, 2014)	criteria provided, single submitter	1	156104767	1	156134976	216958	213515
NM_005572.3(LMNA):c.861T>C (p.Ala287=)	LMNA	Hutchinson-Gilford syndrome|Lethal tight skin contracture syndrome|Congenital muscular dystrophy, LMNA-related|Charcot-Marie-Tooth disease, type 2|Emery-Dreifuss muscular dystrophy|Mandibuloacral dysplasia|not specified|not provided|Familial partial lipodystrophy|Cardiovascular phenotype|Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	Benign(Last reviewed: Jul 26, 2017)	criteria provided, multiple submitters, no conflicts	1	156105028	1	156135237	48088	57252
NM_170707.3(LMNA):c.895A>G (p.Ile299Val)	LMNA	Charcot-Marie-Tooth disease, type 2|not specified|not provided|Partial lipodystrophy, Dunnigan|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2017)	criteria provided, conflicting interpretations	1	156105062	1	156135271	48092	57256
NM_005572.3(LMNA):c.898G>A (p.Asp300Asn)	LMNA	not provided|Lipodystrophy	Likely pathogenic(Last reviewed: Jun 24, 2014)	criteria provided, single submitter	1	156105065	1	156135274	66952	77849
NM_170707.3(LMNA):c.949G>A (p.Glu317Lys)	LMNA	Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, multiple submitters, no conflicts	1	156105704	1	156135913	48093	57257
NM_001257374.2(LMNA):c.665G>A (p.Ser222Asn)	LMNA	Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease, type 2|not specified|not provided	Uncertain significance(Last reviewed: Mar 16, 2018)	criteria provided, multiple submitters, no conflicts	1	156105756	1	156135965	161292	171048
NM_005572.3(LMNA):c.1003C>T (p.Arg335Trp)	LMNA	Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome|Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease type 2B1|Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Heart-hand syndrome, Slovenian type|Hutchinson-Gilford syndrome|Familial partial lipodystrophy 2|Mandibuloacral dysostosis|Limb-girdle muscular dystrophy, type 1B|Lethal tight skin contracture syndrome|Congenital muscular dystrophy, LMNA-related|Charcot-Marie-Tooth disease, type 2|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	1	156105758	1	156135967	36473	45135
NM_170707.3(LMNA):c.1129C>T (p.Arg377Cys)	LMNA	Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 30, 2018)	criteria provided, multiple submitters, no conflicts	1	156105884	1	156136093	48031	57195
NM_170707.3(LMNA):c.1146C>T (p.Gly382=)	LMNA	Dilated cardiomyopathy 1A|Limb-girdle muscular dystrophy|Charcot-Marie-Tooth disease, type 2|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	1	156105901	1	156136110	48032	57196
NM_005572.3(LMNA):c.1300_1307delGCACGCAC (p.Ala434Terfs)	LMNA	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jun 24, 2014)	criteria provided, single submitter	1	156106147 - 156106154	1	156136356 - 156136363	179384	172487
NM_170707.3(LMNA):c.1303C>T (p.Arg435Cys)	LMNA	Primary dilated cardiomyopathy|Hutchinson-Gilford syndrome|Charcot-Marie-Tooth disease, type 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 12, 2017)	criteria provided, conflicting interpretations	1	156106150	1	156136359	66802	77699
NM_005572.3(LMNA):c.1338T>C (p.Asp446=)	LMNA	Charcot-Marie-Tooth disease type 2B1|Hutchinson-Gilford syndrome|Limb-girdle muscular dystrophy, type 1B|Lethal tight skin contracture syndrome|Congenital muscular dystrophy, LMNA-related|Charcot-Marie-Tooth disease, type 2|Emery-Dreifuss muscular dystrophy|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Mandibuloacral dysplasia|not specified|not provided|Familial partial lipodystrophy|Cardiovascular phenotype|Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	Benign(Last reviewed: May 9, 2017)	criteria provided, multiple submitters, no conflicts	1	156106185	1	156136394	48037	57201
NM_005572.3(LMNA):c.1385A>C (p.Gln462Pro)	LMNA	Benign scapuloperoneal muscular dystrophy with cardiomyopathy	Likely pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	1	156106716	1	156136925	488542	481410
NM_170707.4(LMNA):c.1412G>C (p.Arg471Pro)	LMNA	Benign scapuloperoneal muscular dystrophy with cardiomyopathy	Uncertain significance(Last reviewed: Feb 11, 2019)	no assertion criteria provided			1	156136952	617763	609160
NM_170707.3(LMNA):c.1445G>A (p.Arg482Gln)	LMNA	Familial partial lipodystrophy 2|Charcot-Marie-Tooth disease, type 2|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|not provided|Partial lipodystrophy, Dunnigan|Laminopathy|Monogenic diabetes	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	1	156106776	1	156136985	14486	29525
NM_170707.3(LMNA):c.1517A>C (p.His506Pro)	LMNA	Charcot-Marie-Tooth disease, type 2|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jul 21, 2017)	criteria provided, multiple submitters, no conflicts	1	156106932	1	156137141	242003	238151
NM_170707.3(LMNA):c.1580G>A (p.Arg527His)	LMNA	Mandibuloacral dysostosis|Mandibuloacral dysplasia with type A lipodystrophy, atypical|Charcot-Marie-Tooth disease, type 2|Mandibuloacral dysplasia|not provided	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	1	156106995	1	156137204	14499	29538
NM_170707.3(LMNA):c.1608+1G>A	LMNA	Limb-girdle muscular dystrophy|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	1	156107024	1	156137233	66853	77750
NM_170707.3(LMNA):c.1621C>T (p.Arg541Cys)	LMNA	Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease, type 2|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	1	156107457	1	156137666	48046	57210
NM_170707.3(LMNA):c.1622G>A (p.Arg541His)	LMNA	Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease, type 2|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, multiple submitters, no conflicts	1	156107458	1	156137667	66860	77757
NM_005572.3(LMNA):c.1698C>T (p.His566=)	LMNA	Charcot-Marie-Tooth disease type 2B1|Hutchinson-Gilford syndrome|Limb-girdle muscular dystrophy, type 1B|Lethal tight skin contracture syndrome|Congenital muscular dystrophy, LMNA-related|Charcot-Marie-Tooth disease, type 2|Emery-Dreifuss muscular dystrophy|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Mandibuloacral dysplasia|not specified|not provided|Familial partial lipodystrophy|Cardiovascular phenotype|Mandibuloacral dysplasia with type A lipodystrophy|Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	Benign(Last reviewed: May 1, 2017)	criteria provided, multiple submitters, no conflicts	1	156107534	1	156137743	48048	57212
NM_005572.3(LMNA):c.1711C>A (p.Arg571Ser)	LMNA	Dilated cardiomyopathy 1A|Charcot-Marie-Tooth disease, type 2|not provided	Uncertain significance(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	1	156107547	1	156137756	14485	29524
NM_170707.3(LMNA):c.1804G>A (p.Gly602Ser)	LMNA	Charcot-Marie-Tooth disease, type 2|not specified|not provided|Insulin resistance syndrome, type A|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 25, 2018)	criteria provided, conflicting interpretations	1	156108384	1	156138593	48052	57216
NM_001257374.2(LMNA):c.1534C>T (p.Arg512Cys)	LMNA	Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	1	156108450	1	156138659	161293	171049
NM_001257374.2(LMNA):c.1556G>A (p.Gly519Asp)	LMNA	not provided|Metabolic disease	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	1	156108472	1	156138681	66873	77770
NM_170707.3(LMNA):c.1930C>T (p.Arg644Cys)	LMNA	Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease, type 2|Variant of unknown significance|Charcot-Marie-Tooth disease|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	1	156108510	1	156138719	14527	29566
NM_170707.3(LMNA):c.1931G>A (p.Arg644His)	LMNA	Congenital muscular dystrophy|Charcot-Marie-Tooth disease, type 2|not specified|not provided|Cardiovascular phenotype	Uncertain significance(Last reviewed: Feb 28, 2018)	criteria provided, multiple submitters, no conflicts	1	156108511	1	156138720	161291	171050
NM_001193300.1(SEMA4A):c.1301T>C (p.Met434Thr)	SEMA4A	not provided|Colorectal cancer	Uncertain significance(Last reviewed: Mar 4, 2015)	criteria provided, single submitter	1	156142783	1	156172992	96033	101927
NM_003126.3(SPTA1):c.137G>T (p.Gly46Val)	SPTA1	Elliptocytosis 2	Likely pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	1	158655025	1	158685235	12850	27889
NM_000702.3(ATP1A2):c.129G>A (p.Lys43=)	ATP1A2	Familial hemiplegic migraine|not specified|not provided	Benign(Last reviewed: Feb 19, 2018)	criteria provided, multiple submitters, no conflicts	1	160090993	1	160121203	128478	133927
NM_000702.3(ATP1A2):c.340G>A (p.Gly114Ser)	ATP1A2	Familial hemiplegic migraine|not specified|not provided	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	1	160093165	1	160123375	128485	133934
NM_000702.3(ATP1A2):c.1119G>A (p.Ser373=)	ATP1A2	Familial hemiplegic migraine|not specified|not provided|Alternating hemiplegia of childhood	Benign(Last reviewed: Jan 10, 2018)	criteria provided, multiple submitters, no conflicts	1	160098543	1	160128753	128477	133926
NM_000702.3(ATP1A2):c.1704C>T (p.Phe568=)	ATP1A2	Familial hemiplegic migraine|not specified|Alternating hemiplegia of childhood	Benign/Likely benign(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	1	160100264	1	160130474	128479	133928
NM_000702.3(ATP1A2):c.1980C>T (p.Cys660=)	ATP1A2	Familial hemiplegic migraine type 2|Familial hemiplegic migraine|not specified|Alternating hemiplegia of childhood	Benign/Likely benign(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	1	160104950	1	160135160	128480	133929
NM_000702.3(ATP1A2):c.2259C>T (p.Ala753=)	ATP1A2	Familial hemiplegic migraine|not specified|Alternating hemiplegia of childhood	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	160105367	1	160135577	128481	133930
NM_000702.3(ATP1A2):c.2438T>A (p.Met813Lys)	ATP1A2	Familial hemiplegic migraine type 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	1	160105782	1	160135992	204898	201097
NM_000702.3(ATP1A2):c.2520G>A (p.Lys840=)	ATP1A2	not provided	Uncertain significance(Last reviewed: Aug 27, 2013)	criteria provided, single submitter	1	160106117	1	160136327	128482	133931
NM_000702.3(ATP1A2):c.2563+4C>T	ATP1A2	Familial hemiplegic migraine|not specified|Alternating hemiplegia of childhood	Benign/Likely benign(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	1	160106164	1	160136374	128483	133932
NM_000702.3(ATP1A2):c.2961C>T (p.Cys987=)	ATP1A2	Familial hemiplegic migraine|not specified|not provided|Alternating hemiplegia of childhood	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	1	160109701	1	160139911	128484	133933
NM_001098398.1(COPA):c.728A>G (p.Asp243Gly)	COPA	Autoimmune interstitial lung, joint, and kidney disease	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	1	160283894	1	160314104	199255	196415
NM_001098398.1(COPA):c.721G>A (p.Glu241Lys)	COPA	Autoimmune interstitial lung, joint, and kidney disease	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	1	160283901	1	160314111	199256	196416
NM_001098398.1(COPA):c.698G>A (p.Arg233His)	COPA	Autoimmune interstitial lung, joint, and kidney disease	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	1	160293229	1	160323439	199254	196414
NM_001098398.1(COPA):c.690G>T (p.Lys230Asn)	COPA	Autoimmune interstitial lung, joint, and kidney disease	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	1	160293237	1	160323447	218941	215775
NM_001122764.1(PPOX):c.199delC (p.Leu67Terfs)	PPOX	Variegate porphyria	Pathogenic(Last reviewed: Mar 24, 2014)	criteria provided, single submitter	1	161137001	1	161167211	189241	187104
NC_000001.10:g.161275598_161279773dup	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b	Likely pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	1	161275598 - 161279773			243058	244139
NM_000530.6(MPZ):c.684C>T (p.Ser228=)	MPZ	Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease, demyelinating, type 1b|Roussy-Lvy syndrome|Congenital hypomyelinating neuropathy 1, autosomal recessive|Charcot-Marie-Tooth disease, type I|not specified|not provided|Charcot-Marie-Tooth, Intermediate	Benign/Likely benign(Last reviewed: Aug 4, 2017)	criteria provided, multiple submitters, no conflicts	1	161275729	1	161305939	129619	135065
NM_000530.7(MPZ):c.646-10_650del	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Aug 7, 2015)	criteria provided, single submitter	1	161275763 - 161275777	1	161305973 - 161305987	217234	213792
NM_000530.7(MPZ):c.558delG (p.Arg186Serfs)	MPZ	Dejerine-Sottas disease	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	1	161276145	1	161306355	488548	481416
NM_000530.7(MPZ):c.499G>C (p.Gly167Arg)	MPZ	Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease dominant intermediate 3|Roussy-Lvy syndrome|Dejerine-Sottas disease|Congenital hypomyelinating neuropathy 1, autosomal recessive|Dejerine-Sottas syndrome, autosomal dominant	Pathogenic(Last reviewed: Mar 11, 2014)	criteria provided, single submitter	1	161276204	1	161306414	14170	29209
NM_000530.7(MPZ):c.451C>A (p.Pro151Thr)	MPZ	Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease dominant intermediate 3|Roussy-Lvy syndrome|Dejerine-Sottas disease|Congenital hypomyelinating neuropathy 1, autosomal recessive	Likely pathogenic(Last reviewed: Feb 19, 2013)	criteria provided, single submitter	1	161276252	1	161306462	216963	213517
NM_000530.7(MPZ):c.410G>A (p.Gly137Asp)	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Sep 3, 2015)	criteria provided, single submitter	1	161276536	1	161306746	217233	213793
NM_000530.7(MPZ):c.403A>C (p.Ile135Leu)	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	1	161276543	1	161306753	243089	244171
NM_000530.7(MPZ):c.293G>A (p.Arg98His)	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|not provided|Decreased nerve conduction velocity|Sensory neuropathy|Pes cavus|Distal muscle weakness|Distal lower limb amyotrophy	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, multiple submitters, no conflicts	1	161276653	1	161306863	14176	29215
NM_000530.7(MPZ):c.293G>C (p.Arg98Pro)	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, multiple submitters, no conflicts	1	161276653	1	161306863	14174	29213
NM_000530.7(MPZ):c.292C>T (p.Arg98Cys)	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|not provided	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, multiple submitters, no conflicts	1	161276654	1	161306864	14175	29214
NM_000530.7(MPZ):c.270C>A (p.Asp90Glu)	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, multiple submitters, no conflicts	1	161276676	1	161306886	14167	29206
NM_000530.7(MPZ):c.242A>G (p.His81Arg)	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b|not provided	Pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	1	161276704	1	161306914	14179	29218
NM_000530.7(MPZ):c.233C>T (p.Ser78Leu)	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type 1b, with focally folded myelin sheaths|Charcot-Marie-Tooth disease, type I|not provided	Pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, multiple submitters, no conflicts	1	161277049	1	161307259	14188	29227
NM_000530.7(MPZ):c.116A>C (p.His39Pro)	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|not provided	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	1	161277166	1	161307376	217232	213794
NM_000530.7(MPZ):c.90C>G (p.Ile30Met)	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|not provided	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, multiple submitters, no conflicts	1	161277192	1	161307402	217235	213795
NC_000001.11:g.161309667_161329606del19940	MPZ|SDHC	Charcot-Marie-Tooth disease, demyelinating, type 1b	Likely pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	1	161279434 - 161299373	1	161309667 - 161329606	243060	244141
NM_001035511.1(SDHC):c.8C>T (p.Ala3Val)	SDHC	Gastrointestinal stroma tumor|Pheochromocytoma|Paragangliomas 3|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 1, 2018)	criteria provided, multiple submitters, no conflicts	1	161284203	1	161314413	161387	171051
NM_003001.3(SDHC):c.21-3_22delCAGAC	SDHC	Hereditary Paraganglioma-Pheochromocytoma Syndromes	Likely pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	1	161293401 - 161293405	1	161323611 - 161323615	517289	496595
NM_003001.3(SDHC):c.43C>T (p.Arg15Ter)	SDHC	Gastrointestinal stroma tumor|Paragangliomas 3|Hereditary Paraganglioma-Pheochromocytoma Syndromes|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, multiple submitters, no conflicts	1	161293426	1	161323636	41776	50215
NM_003001.3(SDHC):c.397C>T (p.Arg133Ter)	SDHC	Gastrointestinal stroma tumor|Paragangliomas 3|Hereditary Paraganglioma-Pheochromocytoma Syndromes|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	1	161326622	1	161356832	183753	181600
NM_003001.3(SDHC):c.*84G>C	SDHC	Pheochromocytoma|Paragangliomas 3|not specified|not provided	Benign/Likely benign(Last reviewed: Mar 7, 2018)	criteria provided, multiple submitters, no conflicts	1	161332307	1	161362517	41773	50212
NM_002585.3(PBX1):c.412_418delGGGGCAG (p.Gly138Valfs)	PBX1	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	1	164761877 - 164761883	1	164792640 - 164792646	488567	481435
NC_000001.10:g.169095250_175778910del6683661	FASLG|SERPINC1|ATP1B1|F5|FMO1|FMO2|FMO3|FMO4|MYOC|PIGC|PRRX1|SELE|SELL|SELP|TNR|TNFSF4|BLZF1|VAMP4|TNFSF18|GPR52|PRDX6|KIAA0040|RABGAP1L|SLC19A2|KIFAP3|PRRC2C|DNM3|CACYBP|KLHL20|NME7|SUCO|EEF1AKNMT|DARS2|C1orf112|SCYL3|CCDC181|GAS5|TNN|MRPS14|MROH9|ZBTB37|CENPL|METTL18|GORAB|C1orf105|RC3H1|METTL11B|SLC9C2|ANKRD45|MIR199A2|MIR214|MIR3120|DNM3OS	1q24-q25 microdeletion syndrome	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	1	169095250 - 175778910			558766	549494
NM_000261.1(MYOC):c.1111T>C (p.Tyr371His)	MYOC	Primary open angle glaucoma	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	1	171605469	1	171636329	242274	243828
NM_000488.3(SERPINC1):c.1256C>T (p.Ala419Val)	SERPINC1	Reduced antithrombin III activity|Antithrombin deficiency	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	1	173873166	1	173904028	18038	33077
NM_000488.3(SERPINC1):c.1246G>T (p.Ala416Ser)	SERPINC1	Reduced antithrombin III activity|not specified|Antithrombin deficiency	Likely benign(Last reviewed: Jan 9, 2018)	criteria provided, multiple submitters, no conflicts	1	173873176	1	173904038	18023	33062
NM_000488.3(SERPINC1):c.886G>C (p.Ala296Pro)	SERPINC1	Antithrombin deficiency	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	1	173878957	1	173909819	161390	171055
NM_000488.3(SERPINC1):c.482G>A (p.Arg161Gln)	SERPINC1	Reduced antithrombin III activity|Antithrombin deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2014)	no assertion criteria provided	1	173881079	1	173911941	18030	33069
NM_000488.3(SERPINC1):c.236G>A (p.Arg79His)	SERPINC1	Reduced antithrombin III activity|Antithrombin deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2014)	no assertion criteria provided	1	173883863	1	173914725	18014	33053
NM_000488.3(SERPINC1):c.218C>T (p.Pro73Leu)	SERPINC1	Reduced antithrombin III activity|Antithrombin deficiency	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, multiple submitters, no conflicts	1	173883881	1	173914743	18011	33050
NM_003285.2(TNR):c.1774A>G (p.Thr592Ala)	TNR	Parkinson disease, age at onset, susceptibility to|Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	1	175355171	1	175386035	224861	226703
NM_003285.2(TNR):c.1732C>T (p.Arg578Ter)	TNR	Parkinson disease, age at onset, susceptibility to|Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	1	175355213	1	175386077	224862	226704
NM_003285.2(TNR):c.538A>C (p.Asn180His)	TNR	Parkinson disease, age at onset, susceptibility to|Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	1	175372714	1	175403578	224863	226705
NM_003285.2(TNR):c.496A>G (p.Thr166Ala)	TNR	Parkinson disease, age at onset, susceptibility to|Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	1	175375355	1	175406219	224864	226706
NM_003285.2(TNR):c.463T>A (p.Cys155Ser)	TNR	Parkinson disease, age at onset, susceptibility to|Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	1	175375388	1	175406252	224865	226707
NM_033343.3(LHX4):c.452-2A>C	ACBD6|LHX4|LHX4-AS1	Pituitary hormone deficiency, combined 4	Pathogenic(Last reviewed: Jan 27, 2014)	criteria provided, single submitter	1	180240513	1	180271378	189234	187106
NM_001194999.1(MR1):c.116A>G (p.His39Arg)	MR1	not specified	Likely benign	no assertion criteria provided	1	181018236	1	181049100	129620	135066
NM_001194999.1(MR1):c.138G>A (p.Ser46=)	MR1	not specified	Likely benign	no assertion criteria provided	1	181018258	1	181049122	129621	135067
NM_003783.3(B3GALT2):c.367T>G (p.Tyr123Asp)	B3GALT2|CDC73	Hyperparathyroidism 2	Likely benign(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	1	193150326	1	193181196	226036	227841
NM_024529.4(CDC73):c.1066+8T>C	CDC73	Parathyroid carcinoma|Hyperparathyroidism 2	Likely benign(Last reviewed: Dec 10, 2017)	criteria provided, multiple submitters, no conflicts	1	193181238	1	193212108	21681	34533
NM_000069.2(CACNA1S):c.5570G>A (p.Ser1857Asn)	CACNA1S	Hypokalemic periodic paralysis 1|Malignant hyperthermia susceptibility type 5|Malignant hyperthermia susceptibility|Hypokalemic periodic paralysis|not specified|not provided|Malignant hyperthermia	Likely benign(Last reviewed: Mar 2, 2018)	criteria provided, multiple submitters, no conflicts	1	201009011	1	201039883	254850	249594
NM_000069.2(CACNA1S):c.4060A>T (p.Thr1354Ser)	CACNA1S	Hypokalemic periodic paralysis 1|Malignant hyperthermia, susceptibility to, 1|Malignant hyperthermia susceptibility type 5|Malignant hyperthermia susceptibility|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 26, 2018)	criteria provided, conflicting interpretations	1	201020165	1	201051037	161208	171056
NM_000069.2(CACNA1S):c.3526-2A>G	CACNA1S	Hypokalemic periodic paralysis 1	Pathogenic(Last reviewed: Oct 22, 2014)	criteria provided, single submitter	1	201027621	1	201058493	209137	205724
NM_000069.2(CACNA1S):c.3256C>T (p.Arg1086Cys)	CACNA1S	Hypokalemic periodic paralysis 1|Malignant hyperthermia susceptibility type 5|Hypokalemic periodic paralysis	Uncertain significance(Last reviewed: May 18, 2018)	criteria provided, single submitter	1	201029944	1	201060816	21035	33887
NM_000069.2(CACNA1S):c.2992G>A (p.Asp998Asn)	CACNA1S	Hypokalemic periodic paralysis 1|Malignant hyperthermia susceptibility type 5|Malignant hyperthermia susceptibility|Hypokalemic periodic paralysis|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 6, 2017)	criteria provided, conflicting interpretations	1	201031133	1	201062005	225282	227189
NM_000069.2(CACNA1S):c.1583G>A (p.Arg528His)	CACNA1S	Hypokalemic periodic paralysis 1|Malignant hyperthermia susceptibility type 5|not provided	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	1	201047043	1	201077915	17625	32664
NM_000069.2(CACNA1S):c.1547C>T (p.Ser516Leu)	CACNA1S	Hypokalemic periodic paralysis 1|Malignant hyperthermia susceptibility type 5|Malignant hyperthermia susceptibility|Hypokalemic periodic paralysis|not specified	Benign/Likely benign(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	1	201047079	1	201077951	225281	227190
NM_000069.2(CACNA1S):c.530C>T (p.Ser177Leu)	CACNA1S	Hypokalemic periodic paralysis 1|Malignant hyperthermia susceptibility type 5|Malignant hyperthermia susceptibility|Hypokalemic periodic paralysis|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	1	201061111	1	201091983	199686	196500
NM_001001430.2(TNNT2):c.861G>A (p.Trp287Ter)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, multiple submitters, no conflicts	1	201328344	1	201359216	181636	178913
NM_001001430.2(TNNT2):c.860G>A (p.Trp287Ter)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 29, 2018)	criteria provided, multiple submitters, no conflicts	1	201328345	1	201359217	177636	172354
NM_000364.3(TNNT2):c.878G>A (p.Arg293His)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2018)	criteria provided, conflicting interpretations	1	201328348	1	201359220	43677	52846
NM_000364.3(TNNT2):c.877C>T (p.Arg293Cys)	TNNT2	Familial hypertrophic cardiomyopathy 2|Familial hypertrophic cardiomyopathy 1|not specified|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 22, 2017)	criteria provided, conflicting interpretations	1	201328349	1	201359221	43676	52845
NM_001001430.2(TNNT2):c.833G>C (p.Arg278Pro)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial hypertrophic cardiomyopathy 1|Familial restrictive cardiomyopathy 3|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 17, 2018)	criteria provided, conflicting interpretations	1	201328372	1	201359244	177635	172355
NM_001001430.2(TNNT2):c.833G>A (p.Arg278His)	TNNT2	Familial hypertrophic cardiomyopathy 1|not specified	Uncertain significance(Last reviewed: Feb 11, 2015)	criteria provided, single submitter	1	201328372	1	201359244	43674	52843
NM_000364.3(TNNT2):c.853C>T (p.Arg285Cys)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial hypertrophic cardiomyopathy 1|Familial restrictive cardiomyopathy 3|Costello syndrome|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	1	201328373	1	201359245	12411	27450
NM_000364.3(TNNT2):c.833A>T (p.Asn278Ile)	TNNT2	Familial hypertrophic cardiomyopathy 2	Likely pathogenic	criteria provided, single submitter	1	201328760	1	201359632	217495	214101
NM_000364.3(TNNT2):c.753G>T (p.Glu251Asp)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Primary familial hypertrophic cardiomyopathy|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 28, 2017)	criteria provided, conflicting interpretations	1	201330455	1	201361327	43667	52836
NM_000364.3(TNNT2):c.673G>T (p.Val225Leu)	TNNT2	Familial hypertrophic cardiomyopathy 1|not specified	Uncertain significance(Last reviewed: Jun 4, 2015)	criteria provided, multiple submitters, no conflicts	1	201331078	1	201361950	43662	52831
NM_000364.3(TNNT2):c.653T>C (p.Ile218Thr)	TNNT2	Familial hypertrophic cardiomyopathy 2	Likely pathogenic	criteria provided, single submitter	1	201331098	1	201361970	217496	214102
NM_001001430.2(TNNT2):c.629_631delAGA (p.Lys210del)	TNNT2	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	1	201331099 - 201331101	1	201361971 - 201361973	43659	52828
NM_001001430.2(TNNT2):c.518G>A (p.Arg173Gln)	TNNT2	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	1	201332476	1	201363348	43649	52818
NM_001001430.2(TNNT2):c.517C>T (p.Arg173Trp)	TNNT2	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|not provided	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	1	201332477	1	201363349	228409	228285
NM_001001430.2(TNNT2):c.514G>T (p.Ala172Ser)	TNNT2	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Apr 28, 2016)	criteria provided, single submitter	1	201332480	1	201363352	181612	178935
NM_001001430.2(TNNT2):c.487_489delGAG (p.Glu163del)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, multiple submitters, no conflicts	1	201332505 - 201332507	1	201363377 - 201363379	43648	52817
NM_001001430.2(TNNT2):c.450C>A (p.Asn150Lys)	TNNT2	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Dec 17, 2014)	criteria provided, single submitter	1	201333435	1	201364307	192311	190101
NM_001001430.2(TNNT2):c.430C>T (p.Arg144Trp)	TNNT2	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Dilated cardiomyopathy 1DD	Conflicting interpretations of pathogenicity(Last reviewed: Sep 5, 2017)	criteria provided, conflicting interpretations	1	201333455	1	201364327	132943	136692
NM_001001430.2(TNNT2):c.421C>T (p.Arg141Trp)	TNNT2	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Cardiomyopathy|not provided|Familial isolated dilated cardiomyopathy	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	1	201333464	1	201364336	12414	27453
NM_000364.3(TNNT2):c.430C>G (p.Arg144Gly)	TNNT2	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Feb 21, 2014)	criteria provided, single submitter	1	201333485	1	201364357	43639	52808
NM_001001430.2(TNNT2):c.392G>A (p.Arg131Gln)	TNNT2	Primary dilated cardiomyopathy|not provided	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, multiple submitters, no conflicts	1	201333493	1	201364365	43637	52806
NM_001001430.2(TNNT2):c.391C>T (p.Arg131Trp)	TNNT2	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, multiple submitters, no conflicts	1	201333494	1	201364366	12415	27454
NM_000364.3(TNNT2):c.382G>A (p.Glu128Lys)	TNNT2	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jan 14, 2013)	criteria provided, single submitter	1	201334348	1	201365220	43634	52803
NM_001001430.2(TNNT2):c.330T>G (p.Phe110Leu)	TNNT2	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, multiple submitters, no conflicts	1	201334370	1	201365242	177807	172501
NM_001001430.2(TNNT2):c.291G>T (p.Lys97Asn)	TNNT2	Primary familial hypertrophic cardiomyopathy|not specified	Likely pathogenic(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	1	201334409	1	201365281	43631	52800
NM_001001430.2(TNNT2):c.281G>A (p.Arg94His)	TNNT2	Familial hypertrophic cardiomyopathy 2|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, multiple submitters, no conflicts	1	201334419	1	201365291	43628	52797
NM_001001430.2(TNNT2):c.280C>T (p.Arg94Cys)	TNNT2	Familial hypertrophic cardiomyopathy 2|Familial restrictive cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	1	201334420	1	201365292	165549	172503
NM_001001430.2(TNNT2):c.275G>A (p.Arg92Gln)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 2, 2018)	criteria provided, multiple submitters, no conflicts	1	201334425	1	201365297	12409	27448
NM_000364.3(TNNT2):c.304C>T (p.Arg102Trp)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, multiple submitters, no conflicts	1	201334426	1	201365298	43627	52796
NM_000364.3(TNNT2):c.294T>G (p.Asp98Glu)	TNNT2	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	1	201334738	1	201365610	43625	52794
NM_001001430.2(TNNT2):c.257A>C (p.Asp86Ala)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 28, 2017)	criteria provided, conflicting interpretations	1	201334745	1	201365617	43626	52795
NM_001001430.2(TNNT2):c.244G>A (p.Gly82Arg)	TNNT2	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2016)	criteria provided, multiple submitters, no conflicts	1	201334758	1	201365630	177644	172365
NM_001001430.2(TNNT2):c.236T>A (p.Ile79Asn)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, multiple submitters, no conflicts	1	201334766	1	201365638	12408	27447
NM_000364.3(TNNT2):c.260C>T (p.Pro87Leu)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not specified	Uncertain significance(Last reviewed: Sep 23, 2017)	criteria provided, multiple submitters, no conflicts	1	201334772	1	201365644	43619	52788
NM_000364.3(TNNT2):c.113C>T (p.Ala38Val)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Increased left ventricular wall thickness	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	1	201337340	1	201368212	43675	52844
NM_002725.3(PRELP):c.778G>A (p.Gly260Arg)	PRELP	PRELP-related osteosclerosis	Uncertain significance(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	1	203453090	1	203483962	584444	575486
NM_015375.2(DSTYK):c.2368C>T (p.Arg790Cys)	DSTYK	Congenital anomalies of kidney and urinary tract 1, susceptibility to	Uncertain significance	criteria provided, single submitter	1	205119907	1	205150779	224359	226073
NM_199462.2(DSTYK):c.1819-3C>T	DSTYK	Congenital anomalies of kidney and urinary tract 1, susceptibility to	Uncertain significance	criteria provided, single submitter	1	205130518	1	205161390	224360	226074
NM_199462.2(DSTYK):c.1775G>A (p.Arg592Gln)	DSTYK	Congenital anomalies of kidney and urinary tract 1, susceptibility to	Uncertain significance	criteria provided, single submitter	1	205131207	1	205162079	224356	226075
NM_015375.2(DSTYK):c.1253A>G (p.Asp418Gly)	DSTYK	Congenital anomalies of kidney and urinary tract 1, susceptibility to	Uncertain significance	criteria provided, single submitter	1	205138362	1	205169234	224361	226076
NM_015375.2(DSTYK):c.358G>A (p.Asp120Asn)	DSTYK	Congenital anomalies of kidney and urinary tract 1, susceptibility to	Uncertain significance	criteria provided, single submitter	1	205156842	1	205187714	224357	226077
NM_199462.2(DSTYK):c.53C>T (p.Pro18Leu)	DSTYK	Congenital anomalies of kidney and urinary tract 1, susceptibility to	Uncertain significance	criteria provided, single submitter	1	205180611	1	205211483	224358	226078
NM_002389.4(CD46):c.286+2T>G	CD46	Atypical hemolytic uremic syndrome	Likely pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	1	207930549	1	207757204	505831	496599
NM_025179.3(PLXNA2):c.2206G>A (p.Gly736Ser)	PLXNA2	atypical cerebral palsy	Likely pathogenic	criteria provided, single submitter	1	208257817	1	208084472	431732	425204
NM_000228.2(LAMB3):c.3383-1G>A	LAMB3	Amelogenesis imperfecta, type IA	Pathogenic(Last reviewed: Mar 1, 2017)	no assertion criteria provided	1	209788753	1	209615408	393553	380444
NM_000228.2(LAMB3):c.3340G>T (p.Glu1114Ter)	LAMB3	Amelogenesis imperfecta, type IA	Pathogenic(Last reviewed: Mar 1, 2017)	no assertion criteria provided	1	209789858	1	209616513	393554	380445
NM_006147.3(IRF6):c.1234C>T (p.Arg412Ter)	IRF6	Orofacial cleft 6, susceptibility to|Popliteal pterygium syndrome|Van der Woude syndrome	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, multiple submitters, no conflicts	1	209961935	1	209788590	458682	447762
NM_006147.3(IRF6):c.113T>C (p.Ile38Thr)	IRF6	Van der Woude syndrome	Pathogenic	criteria provided, single submitter	1	209974646	1	209801301	397639	384611
NM_002238.3(KCNH1):c.1405G>A (p.Gly469Arg)	KCNH1	Zimmermann-Laband syndrome 1|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	1	210977485	1	210804143	183418	181517
NM_003238.4(TGFB2):c.458G>A (p.Arg153His)	TGFB2	Loeys-Dietz syndrome 4	Likely pathogenic(Last reviewed: Nov 12, 2014)	no assertion criteria provided	1	218578622	1	218405280	374302	361158
NM_032890.4(DISP1):c.743C>T (p.Ala248Val)	DISP1	Holoprosencephaly sequence	Uncertain significance	criteria provided, single submitter	1	223164941	1	222991599	397657	384630
NM_002296.3(LBR):c.1747C>T (p.Arg583Ter)	LBR	Pelger-Hut anomaly|Retrognathia|Femoral bowing|Short long bone|Disproportionate short stature|Rhizomelic arm shortening|Rhizomelic leg shortening	Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, multiple submitters, no conflicts	1	225591106	1	225403404	369680	353887
NM_002107.4(H3F3A):c.377A>G (p.Gln126Arg)	H3F3A	Inborn genetic diseases|H3F3A-related condition	Likely pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, multiple submitters, no conflicts	1	226259146	1	226071445	520774	511233
NM_052843.3(OBSCN):c.727G>C (p.Gly243Arg)	OBSCN|OBSCN-AS1	Inborn genetic diseases	Uncertain significance	criteria provided, single submitter	1	228400211	1	228212510	225073	226875
NM_001100.3(ACTA1):c.739G>C (p.Gly247Arg)	ACTA1	Nemaline myopathy 3|not provided|ACTA1 gene related myopathy	Pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	1	229567810	1	229432063	381639	364928
NM_001100.3(ACTA1):c.539T>C (p.Leu180Pro)	ACTA1	Nemaline myopathy 3	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	1	229568094	1	229432347	560935	552039
NM_001100.3(ACTA1):c.478G>A (p.Gly160Ser)	ACTA1	Nemaline myopathy 3|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	1	229568155	1	229432408	420707	405080
NM_001100.3(ACTA1):c.442G>A (p.Gly148Ser)	ACTA1	Nemaline myopathy 3	Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, multiple submitters, no conflicts	1	229568315	1	229432568	93549	99454
NM_001100.3(ACTA1):c.133G>T (p.Val45Phe)	ACTA1	Nemaline myopathy 3	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	1	229568624	1	229432877	93548	99453
NM_001100.3(ACTA1):c.109G>T (p.Val37Leu)	ACTA1	Nemaline myopathy 3	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	1	229568754	1	229433007	464114	447779
NM_001100.3(ACTA1):c.82G>C (p.Ala28Pro)	ACTA1	Nemaline myopathy 3	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	1	229568781	1	229433034	560936	552040
NM_001103.3(ACTN2):c.343G>A (p.Val115Met)	ACTN2	not specified	Uncertain significance(Last reviewed: Oct 16, 2014)	criteria provided, single submitter	1	236882295	1	236718995	43936	53105
NM_001103.3(ACTN2):c.355G>A (p.Ala119Thr)	ACTN2	Dilated cardiomyopathy 1AA|Cardiomyopathy|Familial hypertrophic cardiomyopathy 23	Pathogenic(Last reviewed: Dec 2, 2014)	criteria provided, single submitter	1	236882307	1	236719007	162727	172928
NM_001103.3(ACTN2):c.1369C>T (p.Arg457Cys)	ACTN2	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Jun 22, 2015)	criteria provided, single submitter	1	236908039	1	236744739	217833	214483
NM_001103.3(ACTN2):c.2147C>T (p.Thr716Met)	ACTN2	Familial hypertrophic cardiomyopathy 1|Dilated cardiomyopathy 1AA|Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|not specified|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 9, 2017)	criteria provided, conflicting interpretations	1	236918491	1	236755191	35650	44315
NM_001035.2(RYR2):c.556G>A (p.Val186Met)	RYR2	Ventricular tachycardia, polymorphic	Uncertain significance(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	1	237540715	1	237377415	161382	171057
NM_001035.2(RYR2):c.1258C>T (p.Arg420Trp)	RYR2	Arrhythmogenic right ventricular dysplasia, familial, 2|Catecholaminergic polymorphic ventricular tachycardia type 1|not provided|Ventricular fibrillation|Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy 2|Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, multiple submitters, no conflicts	1	237608788	1	237445488	201214	196540
NM_001035.2(RYR2):c.1298T>C (p.Leu433Pro)	RYR2	Arrhythmogenic right ventricular dysplasia, familial, 2|Long QT syndrome|Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Feb 4, 2015)	criteria provided, single submitter	1	237617696	1	237454396	12959	27998
NM_001035.2(RYR2):c.1392C>A (p.His464Gln)	RYR2	not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Oct 10, 2017)	criteria provided, multiple submitters, no conflicts	1	237617790	1	237454490	427953	419263
NM_001035.2(RYR2):c.1396C>G (p.Pro466Ala)	RYR2	not specified|Ventricular tachycardia, polymorphic	Uncertain significance(Last reviewed: Apr 5, 2018)	criteria provided, multiple submitters, no conflicts	1	237617794	1	237454494	161383	171058
NM_001035.2(RYR2):c.3038G>A (p.Arg1013Gln)	RYR2	Catecholaminergic polymorphic ventricular tachycardia type 1|not specified|not provided|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia	Conflicting interpretations of pathogenicity(Last reviewed: Jul 5, 2018)	criteria provided, conflicting interpretations	1	237711862	1	237548562	161381	171059
NM_001035.2(RYR2):c.4186G>A (p.Asp1396Asn)	RYR2	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	1	237755064	1	237591764	427954	419264
NM_001035.2(RYR2):c.4196C>A (p.Thr1399Lys)	RYR2	Arrhythmogenic right ventricular dysplasia, familial 1	Uncertain significance(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	1	237755074	1	237591774	226037	227842
NM_001035.2(RYR2):c.4235A>G (p.Asp1412Gly)	RYR2	Brugada syndrome 1	Uncertain significance(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	1	237755113	1	237591813	492987	485930
NM_001035.2(RYR2):c.5822G>A (p.Arg1941His)	RYR2	Arrhythmogenic right ventricular cardiomyopathy	Uncertain significance(Last reviewed: Aug 1, 2016)	no assertion criteria provided	1	237780692	1	237617392	375865	362734
NM_001035.2(RYR2):c.7493C>T (p.Ala2498Val)	RYR2	Catecholaminergic polymorphic ventricular tachycardia type 1	Likely benign(Last reviewed: Jun 1, 2014)	no assertion criteria provided	1	237811894	1	237648594	161380	171060
NM_001035.2(RYR2):c.11996T>C (p.Met3999Thr)	RYR2	Ventricular tachycardia, catecholaminergic polymorphic, 2	Likely pathogenic(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	1	237947008	1	237783708	427948	419265
NM_001035.2(RYR2):c.13666G>A (p.Ala4556Thr)	RYR2	not provided|Ventricular tachycardia, polymorphic	Uncertain significance(Last reviewed: Mar 25, 2018)	criteria provided, single submitter	1	237955507	1	237792207	161384	171061
NM_001035.2(RYR2):c.14650A>G (p.Met4884Val)	RYR2	Sudden cardiac death	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	1	237991740	1	237828440	427951	419266
NM_001035.2(RYR2):c.14876G>A (p.Arg4959Gln)	RYR2	Catecholaminergic polymorphic ventricular tachycardia type 1|not provided|Catecholaminergic polymorphic ventricular tachycardia	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	1	237995919	1	237832619	201365	196751
NM_000143.3(FH):c.1127A>C (p.Gln376Pro)	FH	Fumarase deficiency|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 5, 2018)	criteria provided, conflicting interpretations	1	241665852	1	241502552	42094	51260
NM_000143.3(FH):c.521C>G (p.Pro174Arg)	FH	Fumarase deficiency|Multiple cutaneous leiomyomas|not provided|Hereditary cancer-predisposing syndrome|Multiple Cutaneous and Uterine Leiomyomas	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	1	241675301	1	241512001	29705	38660
NC_000001.11:g.242100310_244396371del2296062	CEP170|AKT3|ZBTB18|SDCCAG8|PLD5|C1orf100|LOC339529|LINC01347|MIR4677|LOC110120698|LOC111828504	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2	Pathogenic(Last reviewed: Nov 12, 2015)	criteria provided, single submitter	1	242263612 - 244559673	1	242100310 - 244396371	243062	244143
NM_005465.4(AKT3):c.548T>A (p.Val183Asp)	AKT3	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2	Likely pathogenic	criteria provided, single submitter	1	243800926	1	243637624	273671	263837
NM_205768.2(ZBTB18):c.1118delG (p.Ser373Thrfs)	ZBTB18	Inborn genetic diseases	Likely pathogenic	criteria provided, single submitter	1	244218194	1	244054892	225891	227704
NM_031844.2(HNRNPU):c.2270_2271delCT (p.Pro757Argfs)	HNRNPU	not provided|Epileptic encephalopathy	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	1	245018807 - 245018808	1	244855505 - 244855506	267739	263008
NM_031844.2(HNRNPU):c.1714C>T (p.Arg572Ter)	HNRNPU	Seizures|Intellectual disability|Epileptic encephalopathy	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	1	245020059	1	244856757	267737	263009
NM_031844.2(HNRNPU):c.1089G>A (p.Trp363Ter)	HNRNPU	Epileptic encephalopathy	Pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, single submitter	1	245022605	1	244859303	267736	263010
NM_031844.2(HNRNPU):c.651_660del (p.Gly218Alafs)	HNRNPU	Epileptic encephalopathy	Pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, single submitter	1	245026950 - 245026959	1	244863648 - 244863657	267738	263011
NM_004501.3(HNRNPU):c.149_156del (p.Arg50Hisfs)	HNRNPU	Seizures|Intellectual disability	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	1	245027453 - 245027461	1	244864152 - 244864159	561030	552042
NM_015446.4(AHCTF1):c.3700C>T (p.Arg1234Ter)	AHCTF1	Delayed speech and language development|Strabismus|Intellectual disability	Uncertain significance(Last reviewed: Feb 7, 2019)	no assertion criteria provided	1	247025323	1	246862021	619032	610430
NM_004895.4(NLRP3):c.2182A>G (p.Ser728Gly)	NLRP3	Chronic infantile neurological, cutaneous and articular syndrome|Familial amyloid nephropathy with urticaria AND deafness|Familial cold urticaria|not specified|Familial cold autoinflammatory syndrome|Cryopyrin associated periodic syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	1	247592912	1	247429610	234290	231483
NC_000001.10:g.(146560564_?)_(?_147416122)del	BCL9|FMO5|GJA5|GJA8|PRKAB2|CHD1L|ACP6|GPR89B	1q21.1 recurrent microdeletion	Pathogenic	no assertion criteria provided	1	146560564 - 147416122			374371	361272
NM_001035.2(RYR2):c.(?_169)_(273_?)del (p.(?))	RYR2	Catecholaminergic polymorphic ventricular tachycardia	Pathogenic/Likely pathogenic(Last reviewed: Jan 16, 2017)	criteria provided, multiple submitters, no conflicts	1	237494178 - 237494282	1	237330878 - 237330982	228290	228252
NM_170707.3(LMNA):c.(?_1)_(356_?)del (p.(?))	LMNA	Laminopathy	Pathogenic(Last reviewed: Nov 25, 2014)	criteria provided, single submitter	1	156084710 - 156085065	1	156114919 - 156115274	180106	172880
NM_003108.4(SOX11):c.293del (p.Phe98Serfs)	SOX11	Mental retardation, autosomal dominant 27	Likely pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	2	5833146	2	5693014	598747	589817
NM_003108.3(SOX11):c.1286G>A (p.Trp429Ter)	SOX11	Mental retardation, autosomal dominant 27	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	2	5834139	2	5694007	374396	361177
NM_020738.3(KIDINS220):c.4138C>T (p.Gln1380Ter)	KIDINS220	Spastic paraplegia, intellectual disability, nystagmus, and obesity	Likely pathogenic	criteria provided, single submitter	2	8872028	2	8731898	431718	425212
NM_003597.4(KLF11):c.185A>G (p.Gln62Arg)	KLF11	Maturity onset diabetes mellitus in young|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	10186419	2	10046292	129431	134877
NM_003597.4(KLF11):c.410A>G (p.Asp137Gly)	KLF11	not specified|Monogenic diabetes	Benign/Likely benign(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	2	10187874	2	10047747	129430	134876
NM_003597.4(KLF11):c.467G>T (p.Gly156Val)	KLF11	not provided	Uncertain significance(Last reviewed: Jun 27, 2013)	criteria provided, single submitter	2	10187931	2	10047804	129432	134878
NM_000384.2(APOB):c.13680T>C (p.Thr4560=)	APOB|APOB3'MAR	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21224614	2	21001742	477801	450442
NM_000384.2(APOB):c.13480_13482delCAG (p.Gln4494del)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 2, 2018)	criteria provided, conflicting interpretations	2	21224812 - 21224814	2	21001940 - 21001942	265896	260627
NM_000384.2(APOB):c.13452G>A (p.Thr4484=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21224842	2	21001970	412951	392470
NM_000384.2(APOB):c.13451C>T (p.Thr4484Met)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 13, 2018)	criteria provided, conflicting interpretations	2	21224843	2	21001971	255978	250516
NM_000384.2(APOB):c.13302C>T (p.Ser4434=)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21224992	2	21002120	334070	284413
NM_000384.2(APOB):c.13160A>T (p.Glu4387Val)	APOB	Familial hypercholesterolemia|not specified	Uncertain significance	criteria provided, single submitter	2	21225134	2	21002262	369883	354069
NM_000384.2(APOB):c.13158del (p.Glu4387Asnfs)	APOB	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	2	21225136	2	21002264	265895	260628
NM_000384.2(APOB):c.13116A>G (p.Gln4372=)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21225178	2	21002306	548037	538528
NM_000384.2(APOB):c.13013G>A (p.Ser4338Asn)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Benign/Likely benign(Last reviewed: Jun 27, 2017)	criteria provided, multiple submitters, no conflicts	2	21225281	2	21002409	128418	133867
NM_000384.2(APOB):c.12940A>G (p.Ile4314Val)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2018)	criteria provided, conflicting interpretations	2	21225354	2	21002482	237739	238599
NM_000384.2(APOB):c.12809G>C (p.Arg4270Thr)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Aug 22, 2017)	criteria provided, conflicting interpretations	2	21225485	2	21002613	255977	250517
NM_000384.2(APOB):c.12794T>C (p.Val4265Ala)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21225500	2	21002628	237738	238600
NM_000384.2(APOB):c.12697T>A (p.Ser4233Thr)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|not provided|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 22, 2018)	criteria provided, conflicting interpretations	2	21225597	2	21002725	255976	250518
NM_000384.2(APOB):c.12541G>A (p.Glu4181Lys)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Benign/Likely benign(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	2	21225753	2	21002881	128417	133866
NM_000384.2(APOB):c.12382G>A (p.Val4128Met)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	2	21225912	2	21003040	384812	366335
NM_000384.2(APOB):c.12343G>A (p.Val4115Ile)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21225951	2	21003079	544070	517691
NM_000384.2(APOB):c.12318A>G (p.Arg4106=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21225976	2	21003104	412954	392541
NM_000384.2(APOB):c.12310C>A (p.Leu4104Met)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21225984	2	21003112	334079	285073
NM_000384.2(APOB):c.12252T>C (p.Tyr4084=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 10, 2018)	criteria provided, conflicting interpretations	2	21226042	2	21003170	74412	85303
NM_000384.2(APOB):c.11965C>T (p.Arg3989Cys)	APOB	Familial hypercholesterolemia	Uncertain significance	criteria provided, single submitter	2	21227263	2	21004391	369878	354070
NM_000384.2(APOB):c.11934C>T (p.Ile3978=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21227294	2	21004422	544124	517658
NM_000384.2(APOB):c.11904-7C>T	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21227331	2	21004459	255975	250519
NM_000384.2(APOB):c.11833A>G (p.Thr3945Ala)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 8, 2018)	criteria provided, conflicting interpretations	2	21227503	2	21004631	334091	285075
NM_000384.2(APOB):c.11808C>T (p.Ile3936=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 22, 2018)	criteria provided, multiple submitters, no conflicts	2	21227528	2	21004656	255974	250520
NM_000384.2(APOB):c.11789-2A>C	APOB	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	2	21227549	2	21004677	431502	425002
NM_000384.2(APOB):c.11509G>T (p.Ala3837Ser)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21228231	2	21005359	548035	538529
NM_000384.2(APOB):c.11477C>T (p.Thr3826Met)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Mar 8, 2018)	criteria provided, conflicting interpretations	2	21228263	2	21005391	237735	238603
NM_000384.2(APOB):c.11401T>A (p.Ser3801Thr)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2018)	criteria provided, conflicting interpretations	2	21228339	2	21005467	237734	238604
NM_000384.2(APOB):c.11362G>A (p.Glu3788Lys)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia|Hypercholesterolemia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	21228378	2	21005506	334100	287155
NM_000384.2(APOB):c.11356C>T (p.Leu3786Phe)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21228384	2	21005512	548034	538530
NM_000384.2(APOB):c.10913G>A (p.Arg3638Gln)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Benign/Likely benign(Last reviewed: Jun 27, 2017)	criteria provided, multiple submitters, no conflicts	2	21228827	2	21005955	128416	133865
NM_000384.2(APOB):c.10780T>C (p.Trp3594Arg)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Sep 21, 2017)	criteria provided, conflicting interpretations	2	21228960	2	21006088	369881	354071
NM_000384.2(APOB):c.10740C>T (p.Asn3580=)	APOB	Familial hypercholesterolemia|not provided	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21229000	2	21006128	495856	486938
NM_000384.2(APOB):c.10737C>T (p.Thr3579=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 22, 2018)	criteria provided, multiple submitters, no conflicts	2	21229003	2	21006131	255972	250522
NM_000384.2(APOB):c.10701G>A (p.Thr3567=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2018)	criteria provided, conflicting interpretations	2	21229039	2	21006167	265893	260630
NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not provided|Hypobetalipoproteinemia, familial, 1|Hypobetalipoproteinemia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2018)	criteria provided, conflicting interpretations	2	21229160	2	21006288	17890	32929
NM_000384.2(APOB):c.10579C>T (p.Arg3527Trp)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not provided|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jul 3, 2018)	criteria provided, conflicting interpretations	2	21229161	2	21006289	40223	48709
NM_000384.2(APOB):c.10508C>T (p.Ser3503Leu)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21229232	2	21006360	548033	538531
NM_000384.2(APOB):c.10371C>T (p.Ser3457=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21229369	2	21006497	477785	450435
NM_000384.2(APOB):c.10367C>T (p.Ser3456Phe)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21229373	2	21006501	548032	538532
NM_000384.2(APOB):c.10294C>G (p.Gln3432Glu)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|not provided|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	2	21229446	2	21006574	180279	178500
NM_000384.2(APOB):c.10186G>A (p.Ala3396Thr)	APOB	Hypercholesterolemia, autosomal dominant, type B	Likely pathogenic(Last reviewed: Oct 19, 2017)	no assertion criteria provided	2	21229554	2	21006682	444010	437671
NM_000384.2(APOB):c.10182G>T (p.Lys3394Asn)	APOB	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	2	21229558	2	21006686	438310	431948
NM_000384.2(APOB):c.10131G>A (p.Leu3377=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	2	21229609	2	21006737	265890	260633
NM_000384.2(APOB):c.10061C>G (p.Ala3354Gly)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Sep 21, 2017)	criteria provided, conflicting interpretations	2	21229679	2	21006807	369882	354072
NM_000384.2(APOB):c.10037G>T (p.Ser3346Ile)	APOB	Familial hypercholesterolemia	Likely benign	criteria provided, single submitter	2	21229703	2	21006831	189299	187184
NM_000384.2(APOB):c.9883T>C (p.Tyr3295His)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21229857	2	21006985	334108	287185
NM_000384.2(APOB):c.9880T>C (p.Ser3294Pro)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|not provided|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 22, 2018)	criteria provided, conflicting interpretations	2	21229860	2	21006988	255990	250523
NM_000384.2(APOB):c.9855C>T (p.Ile3285=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21229885	2	21007013	490405	483208
NM_000384.2(APOB):c.9835A>G (p.Ser3279Gly)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2018)	criteria provided, conflicting interpretations	2	21229905	2	21007033	218452	215238
NM_000384.2(APOB):c.9811G>A (p.Gly3271Ser)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	21229929	2	21007057	334109	287196
NM_000384.2(APOB):c.9694A>G (p.Lys3232Glu)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21230046	2	21007174	548073	538533
NM_000384.2(APOB):c.9639C>A (p.Asn3213Lys)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|not provided|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21230101	2	21007229	402375	389497
NM_000384.2(APOB):c.9633C>A (p.Asn3211Lys)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21230107	2	21007235	548072	538534
NM_000384.2(APOB):c.9477G>A (p.Lys3159=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21230263	2	21007391	334113	284434
NM_000384.2(APOB):c.9471C>T (p.Gly3157=)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21230269	2	21007397	548071	538535
NM_000384.2(APOB):c.9387T>G (p.Pro3129=)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21230353	2	21007481	548070	538536
NM_000384.2(APOB):c.9294C>T (p.Tyr3098=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21230446	2	21007574	334114	285092
NM_000384.2(APOB):c.9175C>T (p.Arg3059Cys)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 16, 2017)	criteria provided, conflicting interpretations	2	21230565	2	21007693	69508	80399
NM_000384.2(APOB):c.9105T>C (p.Asn3035=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21230635	2	21007763	237752	238608
NM_000384.2(APOB):c.9095C>A (p.Thr3032Asn)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21230645	2	21007773	548069	538537
NM_000384.2(APOB):c.8877G>A (p.Leu2959=)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21230863	2	21007991	490403	483210
NM_000384.2(APOB):c.8693T>C (p.Leu2898Pro)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21231047	2	21008175	548066	538538
NM_000384.2(APOB):c.8550T>G (p.Ile2850Met)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Uncertain significance(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	2	21231190	2	21008318	402376	389499
NM_000384.2(APOB):c.8469T>C (p.Ala2823=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21231271	2	21008399	477820	450571
NM_000384.2(APOB):c.8462C>T (p.Pro2821Leu)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21231278	2	21008406	218451	215239
NM_000384.2(APOB):c.8353A>C (p.Asn2785His)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 15, 2018)	criteria provided, conflicting interpretations	2	21231387	2	21008515	218450	215240
NM_000384.2(APOB):c.8216C>T (p.Pro2739Leu)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Benign/Likely benign(Last reviewed: Jun 27, 2017)	criteria provided, multiple submitters, no conflicts	2	21231524	2	21008652	128426	133875
NM_000384.2(APOB):c.8148C>T (p.Ile2716=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21231592	2	21008720	237751	238609
NM_000384.2(APOB):c.7696G>A (p.Glu2566Lys)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2018)	criteria provided, conflicting interpretations	2	21232044	2	21009172	189300	187185
NM_000384.2(APOB):c.7615G>A (p.Val2539Ile)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Feb 23, 2018)	criteria provided, conflicting interpretations	2	21232125	2	21009253	334125	287224
NM_000384.2(APOB):c.7612C>T (p.Leu2538=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2018)	criteria provided, conflicting interpretations	2	21232128	2	21009256	255988	250525
NM_000384.2(APOB):c.7545C>T (p.Thr2515=)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Benign/Likely benign(Last reviewed: Jun 27, 2017)	criteria provided, multiple submitters, no conflicts	2	21232195	2	21009323	128425	133874
NM_000384.2(APOB):c.7367C>A (p.Ala2456Asp)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|not provided|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 22, 2018)	criteria provided, conflicting interpretations	2	21232373	2	21009501	255987	250526
NM_000384.2(APOB):c.7330C>T (p.Arg2444Cys)	APOB	Familial hypercholesterolemia	Uncertain significance	criteria provided, single submitter	2	21232410	2	21009538	369884	354073
NM_000384.2(APOB):c.7296C>T (p.Tyr2432=)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21232444	2	21009572	548065	538539
NM_000384.2(APOB):c.7285T>A (p.Ser2429Thr)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|not provided|Hypobetalipoproteinemia, familial, 1|Hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 19, 2017)	criteria provided, conflicting interpretations	2	21232455	2	21009583	218448	215242
NM_000384.2(APOB):c.7152T>C (p.Val2384=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21232588	2	21009716	255986	250527
NM_000384.2(APOB):c.7134C>A (p.Ser2378Arg)	APOB	Familial hypercholesterolemia	Likely benign	criteria provided, single submitter	2	21232606	2	21009734	189301	187186
NM_000384.2(APOB):c.6943G>A (p.Glu2315Lys)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21232797	2	21009925	548064	538540
NM_000384.2(APOB):c.6936C>T (p.Asp2312=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	2	21232804	2	21009932	128424	133873
NM_000384.2(APOB):c.6895G>C (p.Asp2299His)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2018)	criteria provided, conflicting interpretations	2	21232845	2	21009973	252485	246910
NM_000384.2(APOB):c.6815A>G (p.His2272Arg)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21232925	2	21010053	548063	538541
NM_000384.2(APOB):c.6639_6641delTGA (p.Asp2213del)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 8, 2018)	criteria provided, conflicting interpretations	2	21233099 - 21233101	2	21010227 - 21010229	180280	178503
NM_000384.2(APOB):c.6261C>A (p.Thr2087=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21233479	2	21010607	477813	450471
NM_000384.2(APOB):c.6125T>C (p.Met2042Thr)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21233615	2	21010743	334133	287583
NM_000384.2(APOB):c.5863G>A (p.Val1955Met)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21233877	2	21011005	548062	538542
NM_000384.2(APOB):c.5741A>G (p.Asn1914Ser)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21233999	2	21011127	218447	215243
NM_000384.2(APOB):c.5715G>A (p.Met1905Ile)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21234025	2	21011153	548061	538543
NM_000384.2(APOB):c.5690G>A (p.Arg1897His)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21234050	2	21011178	265888	260635
NM_000384.2(APOB):c.5654A>G (p.Tyr1885Cys)	APOB	Familial hypercholesterolemia	Likely benign	criteria provided, single submitter	2	21234086	2	21011214	189303	187188
NM_000384.2(APOB):c.5646C>G (p.Ser1882Arg)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21234094	2	21011222	548060	538544
NM_000384.2(APOB):c.5616C>T (p.Ile1872=)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21234124	2	21011252	548059	538545
NM_000384.2(APOB):c.5560G>A (p.Asp1854Asn)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21234180	2	21011308	548058	538546
NM_000384.2(APOB):c.5066G>A (p.Arg1689His)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Nov 30, 2017)	criteria provided, conflicting interpretations	2	21234674	2	21011802	189304	187189
NM_000384.2(APOB):c.4929G>A (p.Ala1643=)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21234811	2	21011939	334139	287248
NM_000384.2(APOB):c.4825T>C (p.Leu1609=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	2	21234915	2	21012043	477809	450581
NM_000384.2(APOB):c.4663A>G (p.Ile1555Val)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21235077	2	21012205	431500	425004
NM_000384.2(APOB):c.4651C>T (p.Gln1551Ter)	APOB	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	2	21235089	2	21012217	431499	425005
NM_000384.2(APOB):c.4590del (p.Asn1531Thrfs)	APOB	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	2	21235150	2	21012278	431498	425006
NM_000384.2(APOB):c.4532C>T (p.Thr1511Ile)	APOB	Familial hypercholesterolemia|not specified	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21235208	2	21012336	450695	443153
NM_000384.2(APOB):c.4365C>T (p.Phe1455=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	2	21235375	2	21012503	334144	284451
NM_000384.2(APOB):c.4111G>A (p.Ala1371Thr)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21236137	2	21013265	548055	538547
NM_000384.2(APOB):c.3851G>A (p.Arg1284Gln)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21236397	2	21013525	548054	538548
NM_000384.2(APOB):c.3656C>T (p.Thr1219Ile)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21237985	2	21015113	548053	538549
NM_000384.2(APOB):c.3634C>A (p.Leu1212Met)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2018)	criteria provided, conflicting interpretations	2	21238007	2	21015135	218444	215246
NM_000384.2(APOB):c.3595G>A (p.Asp1199Asn)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21238046	2	21015174	334152	287263
NM_000384.2(APOB):c.3509-10G>A	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 22, 2018)	criteria provided, multiple submitters, no conflicts	2	21238142	2	21015270	255984	250529
NM_000384.2(APOB):c.3509-11C>T	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21238143	2	21015271	334153	284455
NM_000384.2(APOB):c.3491G>C (p.Arg1164Thr)	APOB	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2016)	criteria provided, conflicting interpretations	2	21238259	2	21015387	265885	260638
NM_000384.2(APOB):c.3427C>T (p.Pro1143Ser)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21238323	2	21015451	237744	238615
NM_000384.2(APOB):c.3426G>A (p.Ser1142=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 4, 2018)	criteria provided, conflicting interpretations	2	21238324	2	21015452	334155	284456
NM_000384.2(APOB):c.3383G>A (p.Arg1128His)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|not provided|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 25, 2018)	criteria provided, conflicting interpretations	2	21238367	2	21015495	281142	265379
NM_000384.2(APOB):c.3337G>C (p.Asp1113His)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2018)	criteria provided, conflicting interpretations	2	21238413	2	21015541	218443	215247
NM_000384.2(APOB):c.3122-6G>A	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Feb 22, 2018)	criteria provided, conflicting interpretations	2	21239527	2	21016655	255982	250530
NM_000384.2(APOB):c.3096C>G (p.Thr1032=)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21241889	2	21019017	548049	538550
NM_000384.2(APOB):c.3052G>A (p.Ala1018Thr)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21241933	2	21019061	548048	538551
NM_000384.2(APOB):c.3051C>T (p.Ser1017=)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21241934	2	21019062	548047	538552
NM_000384.2(APOB):c.3012del (p.Glu1004Aspfs)	APOB	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	2	21241973	2	21019101	431494	425010
NM_000384.2(APOB):c.2988_2994del (p.Gly997Profs)	APOB	Hypobetalipoproteinemia, familial, 1	Pathogenic(Last reviewed: Dec 17, 2014)	no assertion criteria provided	2	21242600 - 21242606	2	21019728 - 21019734	374255	361171
NM_000384.2(APOB):c.2981C>T (p.Pro994Leu)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2018)	criteria provided, conflicting interpretations	2	21242613	2	21019741	237743	238616
NM_000384.2(APOB):c.2968G>A (p.Ala990Thr)	APOB	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21242626	2	21019754	431493	425011
NM_000384.2(APOB):c.2950G>A (p.Ala984Thr)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21242644	2	21019772	548046	538553
NM_000384.2(APOB):c.2630C>T (p.Pro877Leu)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21245889	2	21023017	490389	483249
NM_000384.2(APOB):c.2604+15G>C	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21246382	2	21023510	255980	250532
NM_000384.2(APOB):c.2585T>C (p.Val862Ala)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 6, 2017)	criteria provided, conflicting interpretations	2	21246416	2	21023544	189305	187190
NM_000384.2(APOB):c.2308G>A (p.Val770Ile)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21247933	2	21025061	548045	538554
NM_000384.2(APOB):c.2222C>A (p.Thr741Asn)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2018)	criteria provided, conflicting interpretations	2	21249682	2	21026810	218442	215248
NM_000384.2(APOB):c.2068-4T>A	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21249840	2	21026968	402372	389506
NM_000384.2(APOB):c.1853C>T (p.Ala618Val)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Benign/Likely benign(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	2	21250914	2	21028042	128420	133869
NM_000384.2(APOB):c.1785C>G (p.Ser595=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 18, 2018)	criteria provided, multiple submitters, no conflicts	2	21251243	2	21028371	334171	285193
NM_000384.2(APOB):c.1773C>T (p.Asn591=)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21251255	2	21028383	548043	538555
NM_000384.2(APOB):c.1734C>T (p.Val578=)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21251294	2	21028422	548042	538556
NM_000384.2(APOB):c.1648G>C (p.Asp550His)	APOB	Hypercholesterolemia, autosomal dominant, type B|not specified|Hypobetalipoproteinemia, familial, 1|Hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2017)	criteria provided, conflicting interpretations	2	21251380	2	21028508	375860	362735
NM_000384.2(APOB):c.1618-13C>T	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21251423	2	21028551	548041	538557
NM_000384.2(APOB):c.1617+7T>C	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21252504	2	21029632	548040	538558
NM_000384.2(APOB):c.1594C>T (p.Arg532Trp)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21252534	2	21029662	255979	250533
NM_000384.2(APOB):c.1493C>T (p.Thr498Ile)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21252635	2	21029763	548039	538559
NM_000384.2(APOB):c.1470+15T>C	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21252755	2	21029883	265881	260642
NM_000384.2(APOB):c.1402A>G (p.Asn468Asp)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21252838	2	21029966	548038	538560
NM_000384.2(APOB):c.1353-12C>T	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 12, 2018)	criteria provided, conflicting interpretations	2	21252899	2	21030027	265880	260643
NM_000384.2(APOB):c.1198C>T (p.Arg400Cys)	APOB	Familial hypercholesterolemia	Uncertain significance	criteria provided, single submitter	2	21255380	2	21032508	369880	354074
NM_000384.2(APOB):c.1061A>G (p.Glu354Gly)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21256234	2	21033362	334175	285211
NM_000384.2(APOB):c.905-15C>G	APOB	Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 4, 2018)	criteria provided, conflicting interpretations	2	21256405	2	21033533	265876	260646
NM_000384.2(APOB):c.900T>C (p.Gly300=)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21257692	2	21034820	548068	538561
NM_000384.2(APOB):c.889C>T (p.Arg297Cys)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21257703	2	21034831	548067	538562
NM_000384.2(APOB):c.830G>T (p.Gly277Val)	APOB	Familial hypercholesterolemia	Uncertain significance	criteria provided, single submitter	2	21257762	2	21034890	369879	354075
NM_000384.2(APOB):c.690C>A (p.Gly230=)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21259975	2	21037103	477816	450308
NM_000384.2(APOB):c.689G>T (p.Gly230Val)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21259976	2	21037104	404401	392489
NM_000384.2(APOB):c.607A>G (p.Ile203Val)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21260058	2	21037186	334179	284515
NM_000384.2(APOB):c.606A>T (p.Glu202Asp)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not provided|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21260059	2	21037187	235263	236950
NM_000384.2(APOB):c.581C>T (p.Thr194Met)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	2	21260084	2	21037212	334181	284527
NM_000384.2(APOB):c.538-9C>T	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 25, 2018)	criteria provided, multiple submitters, no conflicts	2	21260136	2	21037264	334182	284529
NM_000384.2(APOB):c.499C>T (p.Pro167Ser)	APOB	Familial hypercholesterolemia	Likely benign	criteria provided, single submitter	2	21260868	2	21037996	189306	187191
NM_000384.2(APOB):c.433C>T (p.Pro145Ser)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21260934	2	21038062	334184	287334
NM_000384.2(APOB):c.293C>T (p.Thr98Ile)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Benign/Likely benign(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	2	21263900	2	21041028	128422	133871
NM_000384.2(APOB):c.218C>A (p.Ala73Asp)	APOB|LOC106560211	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21265252	2	21042380	548044	538563
NM_000384.2(APOB):c.122-6C>T	APOB|LOC106560211	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21265354	2	21042482	548036	538564
NM_000384.2(APOB):c.42_43delGC (p.Pro15Cysfs)	APOB|LOC106560211	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21266775 - 21266776	2	21043903 - 21043904	548056	538565
NM_000384.2(APOB):c.42delG (p.Pro15Leufs)	APOB|LOC106560211	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21266776	2	21043904	548057	538566
NM_000384.2(APOB):c.36_41delGGCGCT (p.Ala13_Leu14del)	APOB|LOC106560211	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21266777 - 21266782	2	21043905 - 21043910	548052	538567
NM_000384.2(APOB):c.35_41delTGGCGCT (p.Leu12Argfs)	APOB|LOC106560211	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21266777 - 21266783	2	21043905 - 21043911	548051	538568
NM_000384.2(APOB):c.39del (p.Leu14Cysfs)	APOB|LOC106560211	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	2	21266779	2	21043907	431489	425015
NM_000384.2(APOB):c.35delT (p.Leu12Argfs)	APOB|LOC106560211	Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 28, 2016)	criteria provided, conflicting interpretations	2	21266783	2	21043911	402370	389486
NM_022552.4(DNMT3A):c.1628dup (p.Arg544Profs)	DNMT3A	Tatton-Brown-rahman syndrome	Pathogenic(Last reviewed: Aug 3, 2018)	no assertion criteria provided	2	25467448	2	25244579	559440	550164
NM_018263.5(ASXL2):c.2424delC (p.Thr809Profs)	ASXL2	Shashi-Pena syndrome	Pathogenic(Last reviewed: Jan 16, 2017)	criteria provided, single submitter	2	25966782	2	25743913	268122	263648
NM_194248.2(OTOF):c.[3928_3930dupAAG];[5098G>C]	OTOF	Deafness, autosomal recessive 9	Likely pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	2|2	26686837	2|2	26463969	424790	57417|213537
NC_000002.12:g.32035374_32122619del87246	SPAST|DPY30	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32260443 - 32347688	2	32035374 - 32122619	219058	216748
NC_000002.12:g.32038850_32108653del69804	SPAST|DPY30	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32263919 - 32333722	2	32038850 - 32108653	219095	216785
NC_000002.12:g.32049842_32066177del16336	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32274911 - 32291246	2	32049842 - 32066177	219076	216766
NC_000002.12:g.32057691_32078185del20495	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32282760 - 32303254	2	32057691 - 32078185	219071	216761
NC_000002.12:g.32057783_32070334del12552	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32282852 - 32295403	2	32057783 - 32070334	219063	216753
NC_000002.12:g.32063148_32067182del4035	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32288217 - 32292251	2	32063148 - 32067182	219074	216764
NC_000002.12:g.32063639_32080127del16489	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32288708 - 32305196	2	32063639 - 32080127	219086	216776
NM_014946.3(SPAST):c.-112_415+1779del	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32288789 - 32291094	2	32063720 - 32066025	5674	20713
NC_000002.12:g.32066710_32132126del65417	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32291779 - 32357195	2	32066710 - 32132126	219070	216760
NC_000002.12:g.32066734_32139588del72855	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32291802 - 32364656	2	32066734 - 32139588	219079	216769
NC_000002.12:g.32076979_32247094del170116	SPAST|SLC30A6|NLRC4	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32302047 - 32472162	2	32076979 - 32247094	219064	216754
NC_000002.12:g.32077068_32125989del48922	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32302137 - 32351058	2	32077068 - 32125989	219066	216756
NC_000002.12:g.32083106_32116600del33495	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32308157 - 32341651	2	32083106 - 32116600	219075	216765
NC_000002.12:g.32088102_32183850del95749	SPAST|SLC30A6	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32313171 - 32408919	2	32088102 - 32183850	219061	216751
NC_000002.12:g.32096488_32197021del100534	SPAST|SLC30A6	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32321557 - 32422090	2	32096488 - 32197021	219093	216783
NM_014946.3(SPAST):c.631G>A (p.Val211Ile)	SPAST	Spastic paraplegia 4, autosomal dominant	Likely pathogenic(Last reviewed: Aug 16, 2018)	no assertion criteria provided	2	32323909	2	32098840	560537	551616
NC_000002.12:g.32104654_32148073del43420	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32329723 - 32373142	2	32104654 - 32148073	219059	216749
NC_000002.12:g.32107605_32115865del8261	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32332674 - 32340934	2	32107605 - 32115865	219072	216762
NC_000002.12:g.32113361_32115224del1864	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32338430 - 32340293	2	32113361 - 32115224	219080	216770
NC_000002.12:g.32113664_32125322del11659	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32338733 - 32350391	2	32113664 - 32125322	219090	216780
NC_000002.12:g.32114645_32122725del8081	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32339714 - 32347794	2	32114645 - 32122725	219091	216781
NC_000002.12:g.32115334_32120354del5021	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32340402 - 32345422	2	32115334 - 32120354	219067	216757
NC_000002.12:g.32117629_32178282del60654	SPAST|SLC30A6	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32342697 - 32403350	2	32117629 - 32178282	219062	216752
NC_000002.12:g.32122553_32167306del44754	SPAST|SLC30A6	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32347622 - 32392375	2	32122553 - 32167306	219077	216767
NC_000002.12:g.32125886_32135221del9336	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32350954 - 32360289	2	32125886 - 32135221	219088	216778
NC_000002.12:g.32125992_32134891del8900	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32351059 - 32359958	2	32125992 - 32134891	219092	216782
NM_014946.3(SPAST):c.1169T>A (p.Met390Lys)	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	2	32352087	2	32127018	488605	481473
NC_000002.12:g.32127040_32154579del27540	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32352108 - 32379647	2	32127040 - 32154579	219081	216771
NM_014946.3(SPAST):c.1232T>C (p.Leu411Ser)	SPAST	Spastic paraplegia 4, autosomal dominant	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	2	32353535	2	32128466	561116	552065
NC_000002.12:g.32131874_32147845del15972	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32356943 - 32372914	2	32131874 - 32147845	219065	216755
NC_000002.12:g.32135250_32156159del20910	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32360319 - 32381228	2	32135250 - 32156159	219082	216772
NM_014946.3(SPAST):c.1253_1255del (p.Glu418del)	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Feb 11, 2019)	no assertion criteria provided			2	32136570 - 32136572	617765	609162
NM_014946.3(SPAST):c.1307C>T (p.Ser436Phe)	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Feb 8, 2019)	no assertion criteria provided			2	32136624	617749	609147
NM_014946.3(SPAST):c.1477G>C (p.Asp493His)	SPAST	Spastic paraplegia 4, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Apr 12, 2017)	criteria provided, conflicting interpretations	2	32362241	2	32137172	417628	404606
NM_014946.3(SPAST):c.1477G>T (p.Asp493Tyr)	SPAST	Spastic paraplegia 4, autosomal dominant	Likely pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, single submitter	2	32362241	2	32137172	417627	404605
NM_014946.3(SPAST):c.1484C>T (p.Ala495Val)	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	2	32362248	2	32137179	488606	481474
NM_014946.3(SPAST):c.1496G>A (p.Arg499His)	SPAST	Spastic paraplegia 4, autosomal dominant|not provided|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2018)	criteria provided, conflicting interpretations	2	32366975	2	32141906	240950	238767
NM_014946.3(SPAST):c.1625A>G (p.Asp542Gly)	SPAST	Spastic paraplegia 4, autosomal dominant|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 12, 2017)	criteria provided, conflicting interpretations	2	32370014	2	32144945	217003	213538
NM_014946.3(SPAST):c.1685G>A (p.Arg562Gln)	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jun 24, 2014)	criteria provided, single submitter	2	32370074	2	32145005	217004	213539
NC_000002.12:g.32145356_32177032del31677	SPAST|SLC30A6	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32370423 - 32402099	2	32145356 - 32177032	219078	216768
NC_000002.12:g.32146840_32148799del1960	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32371908 - 32373867	2	32146840 - 32148799	219068	216758
NC_000002.12:g.32147726_32164528del16803	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32372792 - 32389594	2	32147726 - 32164528	219049	216739
NC_000002.12:g.32147734_32171797del24064	SPAST|SLC30A6	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32372803 - 32396866	2	32147734 - 32171797	219085	216775
NC_000002.12:g.32147746_32173488del25743	SPAST|SLC30A6	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32372815 - 32398557	2	32147746 - 32173488	219055	216745
NC_000002.12:g.32147763_32165337del17575	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32372832 - 32390406	2	32147763 - 32165337	219083	216773
NC_000002.12:g.32148610_32159376del10767	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32373679 - 32384445	2	32148610 - 32159376	219048	216738
NC_000002.12:g.32149358_32163762del14405	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32374427 - 32388831	2	32149358 - 32163762	219051	216741
NC_000002.12:g.32151043_32156137del5095	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32376112 - 32381206	2	32151043 - 32156137	219073	216763
NC_000002.12:g.32153490_32156211del2722	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32378559 - 32381280	2	32153490 - 32156211	219053	216743
NC_000002.12:g.32153575_32178196del24622	SPAST|SLC30A6	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32378643 - 32403264	2	32153575 - 32178196	219052	216742
NC_000002.12:g.32153604_32171983del18380	SPAST|SLC30A6	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32378673 - 32397052	2	32153604 - 32171983	219054	216744
NC_000002.12:g.32153843_32159343del5501	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32378898 - 32384398	2	32153843 - 32159343	219050	216740
NC_000002.11:g.32327163_32886455del559293	SPAST|TTC27|SLC30A6|BIRC6|NLRC4|YIPF4	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32327163 - 32886455			219057	216747
NC_000002.11:g.32348594_33632523del1283930	LTBP1|SPAST|TTC27|SLC30A6|BIRC6|NLRC4|YIPF4	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32348594 - 33632523			219087	216777
NC_000002.11:g.32353207_32359908dup	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32353207 - 32359908			219069	216759
NC_000002.11:g.32358735_32362780dup	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32358735 - 32362780			219094	216784
NC_000002.11:g.32362824_32817794del454971	SPAST|SLC30A6|BIRC6|NLRC4|YIPF4	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32362824 - 32817794			219060	216750
NC_000002.11:g.32365580_32371821dup	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32365580 - 32371821			219056	216746
NM_005633.3(SOS1):c.1656G>C (p.Arg552Ser)	SOS1	Noonan syndrome 4|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, multiple submitters, no conflicts	2	39249913	2	39022772	12872	27911
NM_005633.3(SOS1):c.1655G>C (p.Arg552Thr)	SOS1	Noonan syndrome|not provided|Rasopathy|Abnormality of the aortic valve	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	2	39249914	2	39022773	40682	49152
NM_005633.3(SOS1):c.1654A>G (p.Arg552Gly)	SOS1	Gingival fibromatosis 1|Noonan syndrome 4|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	2	39249915	2	39022774	12871	27910
NM_005633.3(SOS1):c.1642A>C (p.Ser548Arg)	SOS1	Noonan syndrome|not provided|Rasopathy|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	2	39249927	2	39022786	40678	49148
NM_005633.3(SOS1):c.1322G>A (p.Cys441Tyr)	SOS1	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	2	39250247	2	39023106	40673	49143
NM_005633.3(SOS1):c.1310T>C (p.Ile437Thr)	SOS1	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	2	39250259	2	39023118	45345	54512
NM_005633.3(SOS1):c.979A>G (p.Ile327Val)	SOS1	Noonan syndrome 4	Uncertain significance(Last reviewed: Jun 11, 2017)	criteria provided, single submitter	2	39262448	2	39035307	444007	437668
NM_005633.3(SOS1):c.929G>A (p.Arg310His)	SOS1	Noonan syndrome|not specified|Gingival fibromatosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	39262577	2	39035436	45381	54548
NM_005633.3(SOS1):c.925G>T (p.Asp309Tyr)	SOS1	Noonan syndrome|not provided	Pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, multiple submitters, no conflicts	2	39262581	2	39035440	45379	54546
NM_005633.3(SOS1):c.806T>C (p.Met269Thr)	SOS1	Noonan syndrome 4|Noonan syndrome|not provided|Rasopathy|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	2	39278343	2	39051202	40662	49132
NM_005633.3(SOS1):c.806T>G (p.Met269Arg)	SOS1	Noonan syndrome 4|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Sep 16, 2017)	criteria provided, multiple submitters, no conflicts	2	39278343	2	39051202	12870	27909
NM_005633.3(SOS1):c.749T>C (p.Val250Ala)	SOS1	not specified|not provided|Rasopathy	Benign(Last reviewed: Apr 3, 2017)	reviewed by expert panel	2	39278400	2	39051259	40660	49130
NM_005633.3(SOS1):c.508A>G (p.Lys170Glu)	SOS1	Noonan syndrome|not provided|Rasopathy|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	2	39283845	2	39056704	40651	49121
NM_005633.3(SOS1):c.322G>A (p.Glu108Lys)	SOS1	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	2	39285837	2	39058696	40649	49119
NM_016932.4(SIX2):c.707C>T (p.Pro236Leu)	SIX2	Congenital anomalies of kidney and urinary tract	Uncertain significance	criteria provided, single submitter	2	45233478	2	45006339	224349	226079
NC_000002.11:g.(?_47369148)_(47369581_?)dup	EPCAM|STPG4	Lynch syndrome	Likely benign(Last reviewed: May 17, 2018)	criteria provided, single submitter	2	47369148 - 47369581	2	47142010 - 47142443	619019	610416
NM_001305625.1(CALM2):c.306C>G (p.Asn102Lys)	CALM2	Long QT syndrome 15	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	2	47388869	2	47161730	488476	481344
NM_002354.2(EPCAM):c.267G>C (p.Gln89His)	EPCAM	Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Conflicting interpretations of pathogenicity(Last reviewed: Nov 15, 2017)	criteria provided, conflicting interpretations	2	47601029	2	47373890	127848	133305
NM_002354.2(EPCAM):c.426-1G>A	EPCAM	Diarrhea 5, with tufting enteropathy, congenital|not provided	Uncertain significance(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	2	47602372	2	47375233	12772	27811
NM_000251.2(MSH2):c.4G>A (p.Ala2Thr)	MSH2	Lynch syndrome I|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Likely benign(Last reviewed: Jun 13, 2018)	reviewed by expert panel	2	47630334	2	47403195	41650	50089
NM_000251.2(MSH2):c.138C>G (p.His46Gln)	MSH2	Lynch syndrome I|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Nov 24, 2015)	reviewed by expert panel	2	47630468	2	47403329	90654	96129
NM_000251.2(MSH2):c.301_306delGAAGTT (p.Glu101_Val102del)	MSH2	Lynch syndrome I|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47635629 - 47635634	2	47408490 - 47408495	91060	96535
NM_000251.2(MSH2):c.339G>A (p.Lys113=)	MSH2	Lynch syndrome I|Lynch syndrome|not specified|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47635667	2	47408528	36576	45238
NM_000251.2(MSH2):c.435T>G (p.Ile145Met)	MSH2	Lynch syndrome I|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47637301	2	47410162	91097	96572
NM_000251.2(MSH2):c.471C>A (p.Gly157=)	MSH2	Lynch syndrome I|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Likely benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47637337	2	47410198	91101	96576
NM_000251.2(MSH2):c.499G>C (p.Asp167His)	MSH2	Lynch syndrome I|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Benign(Last reviewed: Jun 13, 2018)	reviewed by expert panel	2	47637365	2	47410226	91112	96587
NM_000251.2(MSH2):c.645+2T>C	MSH2	Lynch syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, multiple submitters, no conflicts	2	47637513	2	47410374	450032	443255
NM_000251.2(MSH2):c.763A>G (p.Ser255Gly)	MSH2	Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Conflicting interpretations of pathogenicity(Last reviewed: May 9, 2018)	criteria provided, conflicting interpretations	2	47639670	2	47412531	231904	232544
NM_000251.2(MSH2):c.815C>T (p.Ala272Val)	MSH2	Lynch syndrome I|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47641430	2	47414291	41651	50090
NM_000251.2(MSH2):c.913G>A (p.Ala305Thr)	MSH2	Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47641528	2	47414389	91243	96718
NM_000251.2(MSH2):c.929T>G (p.Leu310Arg)	MSH2	Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47641544	2	47414405	91246	96721
NM_000251.2(MSH2):c.942+3A>T	MSH2	Lynch syndrome I|Colorectal cancer, hereditary, nonpolyposis, type 1|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47641560	2	47414421	36580	45242
NM_000251.2(MSH2):c.968C>G (p.Ser323Cys)	MSH2	Lynch syndrome I|Lynch syndrome|not specified|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47643460	2	47416321	91260	96735
NM_000251.2(MSH2):c.1030C>T (p.Gln344Ter)	MSH2	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47643522	2	47416383	36561	45223
NM_000251.2(MSH2):c.1045C>G (p.Pro349Ala)	MSH2	Lynch syndrome|Renal cell carcinoma, papillary, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47643537	2	47416398	90512	95987
NM_000251.2(MSH2):c.1216C>T (p.Arg406Ter)	MSH2	Lynch syndrome I|Carcinoma of colon|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47657020	2	47429881	1755	16794
NM_000251.2(MSH2):c.1226_1227delAG (p.Gln409Argfs)	MSH2	Lynch syndrome I|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47657030 - 47657031	2	47429891 - 47429892	90577	96052
NM_000251.2(MSH2):c.1251_1268del18insAGTT (p.Ile418Valfs)	MSH2	Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	2	47657055 - 47657072	2	47429916 - 47429933	218031	214581
NM_000251.2(MSH2):c.1293_1294insA (p.Leu432Ilefs)	MSH2	Lynch syndrome	Pathogenic(Last reviewed: Jul 7, 2017)	criteria provided, single submitter	2	47672703 - 47672704	2	47445564 - 47445565	517330	496704
NM_000251.2(MSH2):c.1384C>T (p.Gln462Ter)	MSH2	Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	2	47672794	2	47445655	228365	228967
NM_000251.2(MSH2):c.1418C>T (p.Ser473Leu)	MSH2	Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47690201	2	47463062	90660	96135
NM_000251.2(MSH2):c.1520delC (p.Pro507Leufs)	MSH2	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	2	47693806	2	47466667	455503	451137
NM_000251.2(MSH2):c.1637_1638insA (p.Asn547Glufs)	MSH2	Lynch syndrome	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	2	47693923 - 47693924	2	47466784 - 47466785	517418	496760
NM_000251.2(MSH2):c.1662-1G>A	MSH2	Turcot syndrome|Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47698103	2	47470964	90727	96202
NM_000251.2(MSH2):c.1692_1693delCA (p.Asn566Terfs)	MSH2	Lynch syndrome I	Pathogenic(Last reviewed: Jan 24, 2013)	no assertion criteria provided	2	47698134 - 47698135	2	47470995 - 47470996	438795	432377
NM_000251.2(MSH2):c.1705_1706delGA (p.Glu569Ilefs)	MSH2	Lynch syndrome I|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47698147 - 47698148	2	47471008 - 47471009	36569	45231
NM_000251.2(MSH2):c.1748A>G (p.Asn583Ser)	MSH2	Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47698190	2	47471051	41645	50084
NM_000251.2(MSH2):c.1787A>G (p.Asn596Ser)	MSH2	Lynch syndrome I|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47702191	2	47475052	41646	50085
NM_000251.2(MSH2):c.1832T>A (p.Val611Glu)	MSH2	Lynch syndrome	Likely pathogenic(Last reviewed: Feb 7, 2018)	criteria provided, single submitter	2	47702236	2	47475097	549765	540528
NM_000251.2(MSH2):c.1906G>C (p.Ala636Pro)	MSH2	Lynch syndrome I|Colorectal cancer, hereditary, nonpolyposis, type 1|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47702310	2	47475171	1764	16803
NM_000251.2(MSH2):c.1927G>A (p.Glu643Lys)	MSH2	Ovarian cancer|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Jun 15, 2018)	criteria provided, multiple submitters, no conflicts	2	47702331	2	47475192	161299	171076
NM_000251.2(MSH2):c.2038C>T (p.Arg680Ter)	MSH2	Lynch syndrome I|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|Malignant tumor of ascending colon	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47703538	2	47476399	36572	45234
NM_000251.2(MSH2):c.2074G>T (p.Gly692Trp)	MSH2	Lynch syndrome I|Lynch syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 7, 2017)	criteria provided, conflicting interpretations	2	47703574	2	47476435	428464	419395
NM_000251.2(MSH2):c.2113delG (p.Val705Trpfs)	MSH2	Lynch syndrome I|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47703613	2	47476474	1760	16799
NM_000251.2(MSH2):c.2203A>G (p.Ile735Val)	MSH2	Lynch syndrome I|Ovarian cancer|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Jun 7, 2018)	criteria provided, multiple submitters, no conflicts	2	47703703	2	47476564	161300	171077
NM_000251.2(MSH2):c.2437A>G (p.Met813Val)	MSH2	Lynch syndrome I|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Jun 13, 2018)	reviewed by expert panel	2	47705637	2	47478498	90972	96447
NM_000251.2(MSH2):c.2576_2584delAATCGCAAG (p.Glu859_Gln861del)	MSH2	Lynch syndrome I|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jun 8, 2018)	criteria provided, conflicting interpretations	2	47707952 - 47707960	2	47480813 - 47480821	140785	150499
NM_000251.2(MSH2):c.2768T>A (p.Val923Glu)	MSH2	Lynch syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47710051	2	47482912	91043	96518
NM_000179.2(MSH6):c.10C>T (p.Gln4Ter)	MSH6	Endometrial carcinoma|Turcot syndrome|Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	2	48010382	2	47783243	183723	181998
NM_000179.2(MSH6):c.59C>T (p.Ala20Val)	MSH6	Lynch syndrome I|Hereditary nonpolyposis colorectal cancer type 5|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal / endometrial cancer|Hereditary nonpolyposis colon cancer	Likely benign(Last reviewed: Jun 13, 2018)	reviewed by expert panel	2	48010431	2	47783292	89540	95014
NM_000179.2(MSH6):c.261-14C>T	MSH6	Lynch syndrome|not specified|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Feb 1, 2018)	criteria provided, multiple submitters, no conflicts	2	48018052	2	47790913	491912	483406
NM_000179.2(MSH6):c.383G>T (p.Arg128Leu)	MSH6	Lynch syndrome|not specified|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48018188	2	47791049	89473	94947
NM_000179.2(MSH6):c.431G>T (p.Ser144Ile)	MSH6	Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48018236	2	47791097	41596	50035
NM_000179.2(MSH6):c.854G>T (p.Ser285Ile)	MSH6	Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48025976	2	47798837	89571	95045
NM_000179.2(MSH6):c.892C>T (p.Arg298Ter)	MSH6	Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48026014	2	47798875	89574	95048
NM_000179.2(MSH6):c.1346T>C (p.Leu449Pro)	MSH6	Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48026468	2	47799329	89189	94663
NM_000179.2(MSH6):c.1403G>A (p.Arg468His)	MSH6	Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Likely benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48026525	2	47799386	89192	94666
NM_000179.2(MSH6):c.1526T>C (p.Val509Ala)	MSH6	Lynch syndrome I|Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Likely benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48026648	2	47799509	41588	50027
NM_000179.2(MSH6):c.1618_1620delCTT (p.Leu540del)	MSH6	Lynch syndrome|not specified|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	2	48026740 - 48026742	2	47799601 - 47799603	419037	405878
NM_000179.2(MSH6):c.1805C>G (p.Ser602Ter)	MSH6	Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	2	48026927	2	47799788	182659	180062
NM_000179.2(MSH6):c.1822A>G (p.Ile608Val)	MSH6	Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	2	48026944	2	47799805	182626	180063
NM_000179.2(MSH6):c.1993G>T (p.Glu665Ter)	MSH6	Lynch syndrome	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	2	48027115	2	47799976	517315	496280
NM_000179.2(MSH6):c.2194C>T (p.Arg732Ter)	MSH6	Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48027316	2	47800177	89262	94736
NM_000179.2(MSH6):c.2342C>T (p.Pro781Leu)	MSH6	Lynch syndrome|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2018)	criteria provided, conflicting interpretations	2	48027464	2	47800325	433914	427175
NM_000179.2(MSH6):c.2398G>C (p.Val800Leu)	MSH6	Lynch syndrome I|Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer|Hereditary nonpolyposis colon cancer	Likely benign(Last reviewed: Jun 13, 2018)	reviewed by expert panel	2	48027520	2	47800381	89279	94753
NM_000179.2(MSH6):c.2408A>G (p.Asp803Gly)	MSH6	Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48027530	2	47800391	89281	94755
NM_000179.2(MSH6):c.2419G>T (p.Glu807Ter)	MSH6	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, multiple submitters, no conflicts	2	48027541	2	47800402	505828	496281
NM_000179.2(MSH6):c.2561A>T (p.Lys854Met)	MSH6	Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48027683	2	47800544	89289	94763
NM_000179.2(MSH6):c.2633T>C (p.Val878Ala)	MSH6	Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal / endometrial cancer|Hereditary nonpolyposis colon cancer	Benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48027755	2	47800616	8931	23970
NM_000179.2(MSH6):c.2731C>T (p.Arg911Ter)	MSH6	Endometrial carcinoma|Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48027853	2	47800714	89312	94786
NM_000179.2(MSH6):c.2739_2740dup (p.Thr914Ilefs)	MSH6	Lynch syndrome	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	2	48027861 - 48027862	2	47800722 - 47800723	517156	496233
NM_000179.2(MSH6):c.2873_2874del (p.Gln958Profs)	MSH6	Hereditary nonpolyposis colorectal cancer type 5	Pathogenic(Last reviewed: Feb 6, 2018)	no assertion criteria provided	2	48027995 - 48027996	2	47800856 - 47800857	496585	488078
NM_000179.2(MSH6):c.3053_3054delTC (p.Leu1018Hisfs)	MSH6	Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48028175 - 48028176	2	47801036 - 47801037	89334	94808
NM_000179.2(MSH6):c.3259C>T (p.Pro1087Ser)	MSH6	Lynch syndrome|Ovarian cancer|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48030645	2	47803506	89360	94834
NM_000179.2(MSH6):c.3261dupC (p.Phe1088Leufs)	MSH6	Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48030647	2	47803508	89364	94838
NM_000179.2(MSH6):c.3261delC (p.Phe1088Serfs)	MSH6	Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48030647	2	47803508	89363	94837
NM_000179.2(MSH6):c.3299C>T (p.Thr1100Met)	MSH6	Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Inborn genetic diseases|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48030685	2	47803546	89369	94843
NM_000179.2(MSH6):c.3431T>G (p.Met1144Arg)	MSH6	Lynch syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 7, 2018)	criteria provided, conflicting interpretations	2	48030817	2	47803678	220619	221299
NM_000179.2(MSH6):c.3439-2A>G	MSH6	Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Likely pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48032047	2	47804908	89391	94865
NM_000179.2(MSH6):c.3476dupA (p.Tyr1159Terfs)	MSH6	Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, multiple submitters, no conflicts	2	48032086	2	47804947	141918	151632
NM_000179.2(MSH6):c.3513_3514delTA (p.Asp1171Glufs)	MSH6	Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48032123 - 48032124	2	47804984 - 47804985	89403	94877
NM_000179.2(MSH6):c.3722G>A (p.Cys1241Tyr)	MSH6	Lynch syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 7, 2018)	criteria provided, conflicting interpretations	2	48033418	2	47806279	428361	419567
NM_000179.2(MSH6):c.3939_3940dupTC (p.Gln1314Leufs)	MSH6	Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, multiple submitters, no conflicts	2	48033728 - 48033729	2	47806589 - 47806590	182683	180099
NM_000179.2(MSH6):c.3961A>G (p.Arg1321Gly)	MSH6	Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, early onset|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48033750	2	47806611	89490	94964
NM_000179.2(MSH6):c.3991C>T (p.Arg1331Ter)	MSH6	Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48033780	2	47806641	42472	51642
NM_000233.3(LHCGR):c.1732G>T (p.Asp578Tyr)	LHCGR|STON1-GTF2A1L	Gonadotropin-independent familial sexual precocity	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	2	48915204	2	48688065	36468	45131
NM_000233.3(LHCGR):c.1691A>G (p.Asp564Gly)	LHCGR|STON1-GTF2A1L	Gonadotropin-independent familial sexual precocity|not provided	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	2	48915245	2	48688106	14412	29451
NM_001135659.2(NRXN1):c.162G>A (p.Met54Ile)	NRXN1	Ovarian dysgenesis 3	Likely benign	no assertion criteria provided	2	51255250	2	51028112	375625	362439
NM_001039348.2(EFEMP1):c.1033C>T (p.Arg345Trp)	EFEMP1	Doyne honeycomb retinal dystrophy|Malattia leventinese|not provided	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	2	56098226	2	55871091	8072	23111
NM_022173.2(TIA1):c.1070A>G (p.Asn357Ser)	TIA1	Welander distal myopathy|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	70439942	2	70212810	261567	250766
NM_001615.3(ACTG2):c.118C>T (p.Arg40Cys)	ACTG2	Visceral myopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 24, 2015)	criteria provided, multiple submitters, no conflicts	2	74128556	2	73901429	132799	136548
NM_001615.3(ACTG2):c.119G>A (p.Arg40His)	ACTG2	Visceral myopathy|Visceral neuropathy, familial, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	2	74128557	2	73901430	132802	136551
NM_001615.3(ACTG2):c.134T>C (p.Met45Thr)	ACTG2	Visceral myopathy	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	2	74129494	2	73902367	218309	215005
NM_001615.3(ACTG2):c.187C>G (p.Arg63Gly)	ACTG2	Visceral myopathy	Pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, multiple submitters, no conflicts	2	74129547	2	73902420	218310	215006
NM_001615.3(ACTG2):c.255+210C>A	ACTG2	Visceral myopathy	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	2	74129825	2	73902698	218311	215007
NM_001615.3(ACTG2):c.400T>A (p.Tyr134Asn)	ACTG2	Visceral myopathy	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	2	74136215	2	73909088	132805	136554
NM_001615.3(ACTG2):c.443G>T (p.Arg148Leu)	ACTG2	Visceral myopathy	Likely pathogenic(Last reviewed: Mar 28, 2014)	no assertion criteria provided	2	74136258	2	73909131	180620	178786
NM_001615.3(ACTG2):c.532C>T (p.Arg178Cys)	ACTG2	Visceral myopathy|not provided	Pathogenic(Last reviewed: Apr 26, 2016)	criteria provided, multiple submitters, no conflicts	2	74140692	2	73913565	132800	136549
NM_001615.3(ACTG2):c.533G>A (p.Arg178His)	ACTG2	Visceral myopathy|Inborn genetic diseases	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, multiple submitters, no conflicts	2	74140693	2	73913566	132801	136550
NM_001615.3(ACTG2):c.593G>A (p.Gly198Asp)	ACTG2	Visceral myopathy	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	2	74140753	2	73913626	218312	215008
NM_001615.3(ACTG2):c.613G>A (p.Ala205Thr)	ACTG2	Visceral myopathy	Pathogenic(Last reviewed: Aug 21, 2015)	criteria provided, single submitter	2	74140773	2	73913646	369682	353891
NM_001615.3(ACTG2):c.769C>T (p.Arg257Cys)	ACTG2	Visceral myopathy|Visceral neuropathy, familial, autosomal dominant|not provided|Megacystis|Inborn genetic diseases|Chronic intestinal pseudoobstruction	Pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	2	74141962	2	73914835	132803	136552
NM_022912.2(REEP1):c.603delC (p.Ter202Argfs)	REEP1	Spastic paraplegia 31, autosomal dominant	Uncertain significance(Last reviewed: Feb 8, 2019)	no assertion criteria provided			2	86217103	617748	609146
NM_022912.2(REEP1):c.595+1G>A	REEP1	Spastic paraplegia 31, autosomal dominant	Pathogenic(Last reviewed: Jun 4, 2014)	no assertion criteria provided	2	86459747	2	86232624	224884	226729
NM_022912.2(REEP1):c.285G>A (p.Thr95=)	REEP1	Spastic paraplegia 31, autosomal dominant|not specified|Spastic paraplegia, autosomal dominant	Benign(Last reviewed: Apr 15, 2017)	criteria provided, multiple submitters, no conflicts	2	86481835	2	86254712	130108	135554
NM_017849.3(TMEM127):c.308delG (p.Gly103Alafs)	TMEM127	Hereditary Paraganglioma-Pheochromocytoma Syndromes	Likely pathogenic(Last reviewed: Apr 7, 2016)	criteria provided, single submitter	2	96920672	2	96254934	165445	173538
NM_017849.3(TMEM127):c.268G>A (p.Val90Met)	TMEM127	Pheochromocytoma|Hereditary Paraganglioma-Pheochromocytoma Syndromes|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 27, 2018)	criteria provided, conflicting interpretations	2	96920712	2	96254974	136209	139913
NM_017849.3(TMEM127):c.217G>C (p.Gly73Arg)	TMEM127	Pheochromocytoma|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Uncertain significance(Last reviewed: Jan 26, 2018)	criteria provided, single submitter	2	96930903	2	96265165	126965	132478
NM_005270.4(GLI2):c.891delG (p.Gln297Hisfs)	GLI2	Holoprosencephaly 9	Pathogenic(Last reviewed: Jun 19, 2014)	no assertion criteria provided	2	121728014	2	120970438	374323	361163
NM_005270.4(GLI2):c.1426G>C (p.Ala476Pro)	GLI2	Culler-Jones syndrome	Uncertain significance(Last reviewed: Sep 16, 2017)	criteria provided, single submitter	2	121736067	2	120978491	443998	437660
NM_005270.4(GLI2):c.3261dupC (p.Thr1088Hisfs)	GLI2	Holoprosencephaly 9	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	2	121746751	2	120989175	374313	361164
NM_005270.4(GLI2):c.4654A>T (p.Thr1552Ser)	GLI2	Holoprosencephaly 9	Likely pathogenic(Last reviewed: Mar 13, 2015)	no assertion criteria provided	2	121748144	2	120990568	374267	361165
NM_000312.3(PROC):c.52G>A (p.Gly18Ser)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	2	128177570	2	127419994	161337	171062
NM_000312.3(PROC):c.125G>A (p.Arg42His)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Likely pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	2	128178913	2	127421337	161333	171063
NM_000312.3(PROC):c.160A>T (p.Ser54Cys)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	2	128178948	2	127421372	161338	171064
NM_000312.3(PROC):c.322C>A (p.His108Asn)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	2	128180669	2	127423093	161335	171065
NM_000312.3(PROC):c.340G>C (p.Gly114Arg)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	2	128180687	2	127423111	161341	171066
NM_000312.3(PROC):c.565C>T (p.Arg189Trp)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	128183690	2	127426114	161342	171067
NM_000312.3(PROC):c.580C>T (p.Arg194Cys)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Uncertain significance(Last reviewed: Jan 23, 2016)	criteria provided, single submitter	2	128183705	2	127426129	161339	171068
NM_000312.3(PROC):c.631C>T (p.Arg211Trp)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal recessive|Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic/Likely pathogenic(Last reviewed: May 18, 2018)	criteria provided, multiple submitters, no conflicts	2	128183756	2	127426180	659	15698
NM_000312.3(PROC):c.1010C>T (p.Thr337Ile)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	2	128186146	2	127428570	161340	171069
NM_000312.3(PROC):c.1201G>A (p.Asp401Asn)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	2	128186337	2	127428761	161334	171070
NM_000312.3(PROC):c.1234G>A (p.Gly412Ser)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	2	128186370	2	127428794	161336	171071
NM_014795.3(ZEB2):c.3444C>T (p.Tyr1148=)	ZEB2	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	2	145147219	2	144389652	160325	168021
NM_014795.3(ZEB2):c.3146A>C (p.His1049Pro)	ZEB2	Smith-Magenis Syndrome-like	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	2	145147517	2	144389950	254205	248720
NM_014795.3(ZEB2):c.3141G>C (p.Arg1047Ser)	ZEB2	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 16, 2014)	criteria provided, single submitter	2	145147522	2	144389955	160324	168022
NM_014795.3(ZEB2):c.3067+6A>T	ZEB2	Mowat-Wilson syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Aug 22, 2017)	criteria provided, multiple submitters, no conflicts	2	145153973	2	144396406	95633	101531
NM_014795.3(ZEB2):c.2932G>T (p.Asp978Tyr)	ZEB2	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Jul 17, 2012)	criteria provided, single submitter	2	145154114	2	144396547	217029	213524
NM_014795.3(ZEB2):c.2761C>T (p.Arg921Ter)	ZEB2	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, multiple submitters, no conflicts	2	145155993	2	144398426	160323	168023
NM_014795.3(ZEB2):c.2757delG (p.Leu920Tyrfs)	ZEB2	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	2	145155996 - 145155997	2	144398430	561145	552050
NM_014795.3(ZEB2):c.2501delA (p.Lys834Argfs)	ZEB2	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	2	145156253	2	144398686	160322	168024
NM_014795.3(ZEB2):c.2352T>C (p.Ser784=)	ZEB2	Mowat-Wilson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2017)	criteria provided, conflicting interpretations	2	145156402	2	144398835	160321	168025
NM_014795.3(ZEB2):c.2329C>T (p.His777Tyr)	ZEB2	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jan 23, 2014)	criteria provided, single submitter	2	145156425	2	144398858	160320	168026
NM_014795.3(ZEB2):c.2180delT (p.Leu727Tyrfs)	ZEB2	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Dec 10, 2013)	criteria provided, single submitter	2	145156574	2	144399007	217030	213525
NM_014795.3(ZEB2):c.2141C>T (p.Pro714Leu)	ZEB2	Mowat-Wilson syndrome|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	2	145156613	2	144399046	95627	101525
NM_014795.3(ZEB2):c.2083C>T (p.Arg695Ter)	ZEB2	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, multiple submitters, no conflicts	2	145156671	2	144399104	4755	19794
NM_014795.3(ZEB2):c.1653delC (p.Ser552Valfs)	ZEB2	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	2	145157101	2	144399534	189287	187160
NM_014795.3(ZEB2):c.1480C>T (p.Pro494Ser)	ZEB2	Mowat-Wilson syndrome|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Mar 8, 2018)	criteria provided, multiple submitters, no conflicts	2	145157274	2	144399707	95622	101520
NM_014795.3(ZEB2):c.930C>T (p.Tyr310=)	ZEB2	Mowat-Wilson syndrome|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 14, 2017)	criteria provided, multiple submitters, no conflicts	2	145157824	2	144400257	95643	101541
NM_014795.3(ZEB2):c.917-21T>C	ZEB2	not specified	Likely benign	no assertion criteria provided	2	145157858	2	144400291	160330	168030
NM_014795.3(ZEB2):c.904C>T (p.Arg302Ter)	ZEB2	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, multiple submitters, no conflicts	2	145158778	2	144401211	160329	168031
NM_014795.3(ZEB2):c.823C>T (p.Gln275Ter)	ZEB2	Mowat-Wilson syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, multiple submitters, no conflicts	2	145158859	2	144401292	160328	168032
NM_014795.3(ZEB2):c.798G>C (p.Gly266=)	ZEB2	Mowat-Wilson syndrome|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	2	145161492	2	144403925	137944	141647
NM_014795.3(ZEB2):c.747G>A (p.Thr249=)	ZEB2	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 12, 2013)	criteria provided, single submitter	2	145161543	2	144403976	160327	168033
NM_014795.3(ZEB2):c.550_568del (p.Ser184Argfs)	ZEB2|LOC111721705	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	2	145162427 - 145162445	2	144404860 - 144404878	160326	168034
NM_014795.3(ZEB2):c.502C>T (p.Gln168Ter)	ZEB2|LOC111721705	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	2	145162493	2	144404926	561146	552051
NM_014795.3(ZEB2):c.9G>A (p.Gln3=)	ZEB2	Mowat-Wilson syndrome|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 29, 2017)	criteria provided, conflicting interpretations	2	145274909	2	144517342	160331	168036
NM_018328.4(MBD5):c.4235C>A (p.Ser1412Ter)	MBD5	Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	2	149248135	2	148490566	561057	552052
NM_004522.2(KIF5C):c.709G>A (p.Glu237Lys)	KIF5C	not provided|Cortical dysplasia, complex, with other brain malformations 2	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	2	149803532	2	148947018	140740	150453
NM_000726.4(CACNB4):c.1303-3T>C	CACNB4	Idiopathic generalized epilepsy|Juvenile myoclonic epilepsy|Episodic ataxia|not specified	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	2	152695896	2	151839382	128562	134011
NM_000726.4(CACNB4):c.1239G>A (p.Leu413=)	CACNB4	Juvenile myoclonic epilepsy|Episodic ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	152698480	2	151841966	128561	134010
NM_000726.4(CACNB4):c.762T>A (p.Ile254=)	CACNB4	Idiopathic generalized epilepsy|Juvenile myoclonic epilepsy|Episodic ataxia|not specified	Benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	2	152717331	2	151860817	128563	134012
NM_000726.4(CACNB4):c.610delC (p.Gln204Lysfs)	CACNB4	Epilepsy, idiopathic generalized 9	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	2	152727364	2	151870850	374311	361167
NM_001105.4(ACVR1):c.772A>G (p.Arg258Gly)	ACVR1	Progressive myositis ossificans|Brainstem glioma|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: Nov 27, 2012)	criteria provided, single submitter	2	158626898	2	157770386	216885	213526
NM_022168.4(IFIH1):c.2336G>A (p.Arg779His)	IFIH1	Hyperreflexia|not provided|Clonus|Aicardi-Goutieres syndrome 7|Neonatal hypotonia|Abnormal upper motor neuron morphology|Abnormality of the basal ganglia|Developmental regression|Abnormality of the cerebral white matter	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	2	163130423	2	162273913	137622	141325
NM_006922.3(SCN3A):c.626T>C (p.Leu209Pro)	SCN3A	atypical cerebral palsy	Likely pathogenic	criteria provided, single submitter	2	166020196	2	165163686	431726	425209
NM_021007.2(SCN2A):c.56G>A (p.Arg19Lys)	SCN2A	Benign familial neonatal-infantile seizures|not specified|Early Infantile Epileptic Encephalopathy, Autosomal Dominant|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	166152389	2	165295879	130224	135671
NM_021007.2(SCN2A):c.304C>T (p.Arg102Ter)	SCN2A	Early infantile epileptic encephalopathy 11|not provided	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, multiple submitters, no conflicts	2	166153563	2	165297053	29885	38840
NM_021007.2(SCN2A):c.387-10G>A	SCN2A	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11|not specified|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Benign(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	2	166164348	2	165307838	130221	135668
NM_001040143.1(SCN2A):c.634A>G (p.Asn212Asp)	SCN2A	Early infantile epileptic encephalopathy 11	Likely pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	2	166165703	2	165309193	488391	481228
NM_021007.2(SCN2A):c.788C>T (p.Ala263Val)	SCN2A	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11|not provided|Epileptic encephalopathy|SCN2A-related condition	Pathogenic(Last reviewed: Nov 12, 2017)	criteria provided, multiple submitters, no conflicts	2	166166923	2	165310413	29888	38843
NM_021007.2(SCN2A):c.1035-3T>C	SCN2A	Benign familial neonatal-infantile seizures|not specified|not provided|Early Infantile Epileptic Encephalopathy, Autosomal Dominant|History of neurodevelopmental disorder	Benign(Last reviewed: May 6, 2018)	criteria provided, multiple submitters, no conflicts	2	166170127	2	165313617	130216	135663
NM_001040142.1(SCN2A):c.1154delT (p.Phe385Serfs)	SCN2A	Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Jul 2, 2015)	no assertion criteria provided	2	166170249	2	165313739	242977	244064
NM_021007.2(SCN2A):c.1269G>A (p.Val423=)	SCN2A	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11|not specified|not provided|Early Infantile Epileptic Encephalopathy, Autosomal Dominant|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2018)	criteria provided, conflicting interpretations	2	166170504	2	165313994	130211	135658
NM_021007.2(SCN2A):c.1280C>A (p.Ala427Asp)	SCN2A	not provided	Uncertain significance(Last reviewed: Jul 23, 2013)	criteria provided, single submitter	2	166170515	2	165314005	130212	135659
NM_021007.2(SCN2A):c.1785T>C (p.Asp595=)	SCN2A	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11|not specified|Early Infantile Epileptic Encephalopathy, Autosomal Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	2	166179779	2	165323269	130217	135664
NM_021007.2(SCN2A):c.1842G>T (p.Pro614=)	SCN2A	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11|not specified|Early Infantile Epileptic Encephalopathy, Autosomal Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 8, 2018)	criteria provided, multiple submitters, no conflicts	2	166179836	2	165323326	130218	135665
NM_021007.2(SCN2A):c.2229_2230del (p.Lys743Asnfs)	SCN2A	Autistic disorder of childhood onset	Pathogenic(Last reviewed: Mar 13, 2015)	no assertion criteria provided	2	166187919 - 166187920	2	165331409 - 165331410	374268	361168
NM_021007.2(SCN2A):c.2558G>A (p.Arg853Gln)	SCN2A	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	2	166198975	2	165342465	194555	191718
NM_021007.2(SCN2A):c.2635G>A (p.Gly879Arg)	SCN2A	Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	2	166201137	2	165344627	206969	201335
NM_021007.2(SCN2A):c.2687C>T (p.Ala896Val)	SCN2A	Early infantile epileptic encephalopathy 11|Epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, multiple submitters, no conflicts	2	166201189	2	165344679	375508	362318
NM_021007.2(SCN2A):c.2723A>G (p.Lys908Arg)	SCN2A	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11|not specified|not provided|Early Infantile Epileptic Encephalopathy, Autosomal Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	2	166201225	2	165344715	130219	135666
NM_021007.2(SCN2A):c.2960G>T (p.Ser987Ile)	SCN2A	Episodic ataxia|Early infantile epileptic encephalopathy 11|Seizures|not provided|Vertigo	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2016)	criteria provided, multiple submitters, no conflicts	2	166210742	2	165354232	206978	201345
NM_021007.2(SCN2A):c.3374del (p.Glu1125Glyfs)	SCN2A	Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Dec 10, 2013)	criteria provided, single submitter	2	166211156	2	165354646	130220	135667
NM_021007.2(SCN2A):c.3631G>A (p.Glu1211Lys)	SCN2A	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, multiple submitters, no conflicts	2	166223837	2	165367327	29886	38841
NM_021007.2(SCN2A):c.4254+5G>A	SCN2A	not provided	Uncertain significance(Last reviewed: Nov 26, 2013)	criteria provided, single submitter	2	166231481	2	165374971	130222	135669
NM_021007.2(SCN2A):c.4877G>A (p.Arg1626Gln)	SCN2A	Early infantile epileptic encephalopathy 11|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	2	166245193	2	165388683	207017	201391
NM_021007.2(SCN2A):c.4914T>A (p.Arg1638=)	SCN2A	Benign familial neonatal-infantile seizures|not specified|Early Infantile Epileptic Encephalopathy, Autosomal Dominant|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	166245230	2	165388720	130223	135670
NM_021007.2(SCN2A):c.5187A>G (p.Pro1729=)	SCN2A	not specified	Likely benign(Last reviewed: Jun 20, 2013)	criteria provided, single submitter	2	166245503	2	165388993	130215	135662
NM_021007.2(SCN2A):c.5645G>A (p.Arg1882Gln)	SCN2A	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11|not provided|Epileptic encephalopathy	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	2	166245961	2	165389451	196039	193200
NM_021007.2(SCN2A):c.5919C>T (p.Pro1973=)	SCN2A	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Dec 23, 2017)	criteria provided, multiple submitters, no conflicts	2	166246235	2	165389725	130226	135673
NM_001165963.1(SCN1A):c.5864T>C (p.Ile1955Thr)	SCN1A|LOC102724058	Familial hemiplegic migraine|Epilepsy|not specified|not provided|Early infantile epileptic encephalopathy|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	2	166847921	2	165991411	93660	99564
NM_001165963.1(SCN1A):c.5797delC (p.Arg1933Glufs)	SCN1A|LOC102724058	Generalized epilepsy with febrile seizures plus, type 2|not specified|Early infantile epileptic encephalopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jul 19, 2017)	criteria provided, conflicting interpretations	2	166847988	2	165991478	130208	135655
NM_001165963.1(SCN1A):c.5656C>T (p.Arg1886Ter)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy|not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, multiple submitters, no conflicts	2	166848129	2	165991619	189912	187703
NM_001165963.1(SCN1A):c.5436G>A (p.Trp1812Ter)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Nov 25, 2014)	criteria provided, single submitter	2	166848349	2	165991839	217248	213796
NM_001165963.2(SCN1A):c.5351T>A (p.Val1784Asp)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy	Uncertain significance(Last reviewed: Nov 7, 2017)	no assertion criteria provided	2	166848434	2	165991924	488186	481145
NM_001165963.1(SCN1A):c.5351T>C (p.Val1784Ala)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy	Likely pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	2	166848434	2	165991924	374394	361169
NM_006920.4(SCN1A):c.4909C>T (p.Arg1637Cys)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Nov 25, 2014)	criteria provided, single submitter	2	166848843	2	165992333	68641	79533
NM_001165963.1(SCN1A):c.4906C>T (p.Arg1636Ter)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy|not provided	Pathogenic(Last reviewed: Nov 9, 2015)	criteria provided, multiple submitters, no conflicts	2	166848879	2	165992369	189870	187731
NM_001165963.1(SCN1A):c.4887C>T (p.Phe1629=)	SCN1A|LOC102724058	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 27, 2017)	criteria provided, conflicting interpretations	2	166848898	2	165992388	130207	135654
NM_006920.4(SCN1A):c.4690C>T (p.Arg1564Cys)	SCN1A|LOC102724058	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 17, 2017)	criteria provided, conflicting interpretations	2	166850785	2	165994275	68636	79528
NM_001165963.1(SCN1A):c.4547C>A (p.Ser1516Ter)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	2	166852557	2	165996047	206837	201481
NM_001165963.1(SCN1A):c.4477-2A>G	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Mar 27, 2013)	criteria provided, single submitter	2	166852629	2	165996119	217247	213797
NM_006920.5(SCN1A):c.4443+5G>T	SCN1A|LOC102724058	Generalized epilepsy with febrile seizures plus, type 2	Likely pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	2	166854543	2	165998033	488587	481455
NM_001165963.1(SCN1A):c.4476+1A>G	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy|not provided	Pathogenic(Last reviewed: Jun 4, 2014)	criteria provided, multiple submitters, no conflicts	2	166854547	2	165998037	206829	201487
NM_001165963.1(SCN1A):c.4266T>A (p.Tyr1422Ter)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 30, 2014)	criteria provided, single submitter	2	166859000	2	166002490	217246	213798
NM_001165963.2(SCN1A):c.4040T>A (p.Ile1347Asn)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy	Likely pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	2	166859226	2	166002716	488378	481229
NM_001165963.1(SCN1A):c.3985C>T (p.Arg1329Ter)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 29, 2016)	criteria provided, multiple submitters, no conflicts	2	166866246	2	166009736	206816	201506
NM_006920.4(SCN1A):c.3891A>T (p.Glu1297Asp)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy|not specified|not provided|Early infantile epileptic encephalopathy|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Feb 23, 2018)	criteria provided, conflicting interpretations	2	166866307	2	166009797	68534	79426
NM_001165963.1(SCN1A):c.3852delG (p.Trp1284Cysfs)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Aug 16, 2012)	criteria provided, single submitter	2	166868646	2	166012136	217245	213799
NM_001165963.1(SCN1A):c.3733C>T (p.Arg1245Ter)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2|not provided|History of neurodevelopmental disorder	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, multiple submitters, no conflicts	2	166868765	2	166012255	167639	177069
NM_006920.4(SCN1A):c.3690T>C (p.Tyr1230=)	SCN1A|LOC102724058	Familial hemiplegic migraine type 3|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2|Familial hemiplegic migraine|Epilepsy|not specified|Early infantile epileptic encephalopathy|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	2	166868775	2	166012265	36754	45415
NM_001165963.1(SCN1A):c.3657G>A (p.Trp1219Ter)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Jul 17, 2013)	criteria provided, single submitter	2	166870302	2	166013792	217244	213800
NM_001165963.1(SCN1A):c.3637C>T (p.Arg1213Ter)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy|Seizures|not provided	Pathogenic(Last reviewed: Sep 14, 2017)	criteria provided, multiple submitters, no conflicts	2	166870322	2	166013812	189861	187772
NM_001165963.2(SCN1A):c.3512C>T (p.Pro1171Leu)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	2	166872155	2	166015645	561103	552054
NM_001165963.1(SCN1A):c.3306C>A (p.Tyr1102Ter)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Feb 20, 2014)	criteria provided, single submitter	2	166892681	2	166036171	217243	213801
NM_001165963.1(SCN1A):c.3199G>A (p.Ala1067Thr)	SCN1A|LOC102724058	Familial hemiplegic migraine|Epilepsy|Generalized epilepsy with febrile seizures plus|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jan 31, 2017)	criteria provided, multiple submitters, no conflicts	2	166892788	2	166036278	36753	45414
NM_006920.4(SCN1A):c.2804G>A (p.Arg935His)	SCN1A	Severe myoclonic epilepsy in infancy|not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	2	166894395	2	166037885	68523	79415
NM_006920.4(SCN1A):c.2803C>T (p.Arg935Cys)	SCN1A	Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2|not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, multiple submitters, no conflicts	2	166894396	2	166037886	68604	79496
NM_001165963.1(SCN1A):c.2792G>A (p.Arg931His)	SCN1A	Severe myoclonic epilepsy in infancy|not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	2	166894440	2	166037930	189869	187795
NM_001165963.1(SCN1A):c.2589+3A>T	SCN1A	Severe myoclonic epilepsy in infancy|not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, multiple submitters, no conflicts	2	166895930	2	166039420	189938	187803
NM_001165963.1(SCN1A):c.2292T>C (p.Val764=)	SCN1A	Familial hemiplegic migraine type 3|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2|Familial hemiplegic migraine|Epilepsy|Generalized epilepsy with febrile seizures plus|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 15, 2017)	criteria provided, multiple submitters, no conflicts	2	166897864	2	166041354	36752	45413
NM_001165963.1(SCN1A):c.2134C>T (p.Arg712Ter)	SCN1A	Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2|not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, multiple submitters, no conflicts	2	166898844	2	166042334	189886	187817
NM_001165963.1(SCN1A):c.1837C>T (p.Arg613Ter)	SCN1A	Familial hemiplegic migraine type 3|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2|not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	2	166900385	2	166043875	93635	99539
NM_001165963.1(SCN1A):c.1709G>A (p.Ser570Asn)	SCN1A	Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2	Uncertain significance(Last reviewed: Jan 25, 2015)	no assertion criteria provided	2	166900513	2	166044003	374331	361170
NM_001165963.1(SCN1A):c.1662+9C>A	SCN1A	Familial hemiplegic migraine|Epilepsy|not specified|Early infantile epileptic encephalopathy	Benign/Likely benign(Last reviewed: Dec 23, 2017)	criteria provided, multiple submitters, no conflicts	2	166901544	2	166045034	93633	99537
NM_006920.4(SCN1A):c.1625G>A (p.Arg542Gln)	SCN1A	Autistic disorder of childhood onset|Severe myoclonic epilepsy in infancy|not specified|Seizure disorder|Early infantile epileptic encephalopathy|Rolandic epilepsy|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 11, 2017)	criteria provided, conflicting interpretations	2	166901590	2	166045080	68588	79480
NM_001165963.1(SCN1A):c.1264G>A (p.Val422Met)	SCN1A	Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	2	166903393	2	166046883	282973	267210
NM_006920.4(SCN1A):c.1216G>T (p.Val406Phe)	SCN1A	Severe myoclonic epilepsy in infancy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 30, 2015)	criteria provided, conflicting interpretations	2	166903441	2	166046931	68587	79479
NM_001165963.1(SCN1A):c.1212A>G (p.Val404=)	SCN1A	Familial hemiplegic migraine type 3|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2|Familial hemiplegic migraine|Epilepsy|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 15, 2017)	criteria provided, multiple submitters, no conflicts	2	166903445	2	166046935	36751	45412
NM_006920.4(SCN1A):c.1178G>A (p.Arg393His)	SCN1A	Severe myoclonic epilepsy in infancy|not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, multiple submitters, no conflicts	2	166903479	2	166046969	68506	79398
NM_001165963.1(SCN1A):c.1028+1G>T	SCN1A	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Jun 15, 2015)	criteria provided, single submitter	2	166905395	2	166048885	217240	213802
NM_001165963.1(SCN1A):c.992dupT (p.Leu331Phefs)	SCN1A	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Jul 13, 2015)	criteria provided, single submitter	2	166905432	2	166048922	217249	213803
NM_001165963.1(SCN1A):c.756C>T (p.Ile252=)	SCN1A	not provided	Uncertain significance(Last reviewed: Jan 17, 2013)	criteria provided, single submitter	2	166908437	2	166051927	130209	135656
NM_001165963.1(SCN1A):c.602+1G>A	SCN1A	Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2|not provided	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, multiple submitters, no conflicts	2	166911147	2	166054637	197187	194348
NM_001165963.1(SCN1A):c.505T>C (p.Ser169Pro)	SCN1A	Severe myoclonic epilepsy in infancy|not provided	Likely pathogenic(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	2	166911245	2	166054735	206740	201622
NM_001165963.1(SCN1A):c.345T>C (p.Asn115=)	SCN1A	Familial hemiplegic migraine type 3|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2|Familial hemiplegic migraine|Epilepsy|not specified|Early infantile epileptic encephalopathy|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	2	166915118	2	166058608	93643	99547
NM_001165963.1(SCN1A):c.264+5G>A	SCN1A	Severe myoclonic epilepsy in infancy|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, multiple submitters, no conflicts	2	166929863	2	166073353	217242	213804
NM_001165963.1(SCN1A):c.249C>A (p.Tyr83Ter)	SCN1A	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	2	166929883	2	166073373	217241	213805
NM_002977.3(SCN9A):c.5723A>G (p.Asp1908Gly)	SCN9A|SCN1A-AS1	Hereditary sensory and autonomic neuropathy type IIA|Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 7|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia	Benign(Last reviewed: Aug 22, 2017)	criteria provided, multiple submitters, no conflicts	2	167055393	2	166198883	94092	99992
NM_002977.3(SCN9A):c.4890T>C (p.Leu1630=)	SCN9A|SCN1A-AS1	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7|not specified	Benign/Likely benign(Last reviewed: Nov 18, 2017)	criteria provided, multiple submitters, no conflicts	2	167056226	2	166199716	130272	135719
NM_002977.3(SCN9A):c.4787C>T (p.Thr1596Ile)	SCN9A|SCN1A-AS1	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7|not provided	Uncertain significance(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	2	167056329	2	166199819	130271	135718
NM_002977.3(SCN9A):c.4779G>T (p.Val1593=)	SCN9A|SCN1A-AS1	Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|not provided|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia	Benign(Last reviewed: May 4, 2018)	criteria provided, multiple submitters, no conflicts	2	167056337	2	166199827	130270	135717
NM_002977.3(SCN9A):c.4010A>G (p.Tyr1337Cys)	SCN9A|SCN1A-AS1	not provided	Uncertain significance(Last reviewed: Aug 27, 2013)	criteria provided, single submitter	2	167085364	2	166228854	130268	135715
NM_002977.3(SCN9A):c.3769-4A>G	SCN9A|SCN1A-AS1	Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|not provided|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia	Benign(Last reviewed: May 4, 2018)	criteria provided, multiple submitters, no conflicts	2	167089976	2	166233466	130266	135713
NM_002977.3(SCN9A):c.3769-8T>C	SCN9A|SCN1A-AS1	Hereditary sensory and autonomic neuropathy type IIA|Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 7|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia	Benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	2	167089980	2	166233470	130267	135714
NM_002977.3(SCN9A):c.3642C>A (p.Ile1214=)	SCN9A|SCN1A-AS1	Hereditary sensory and autonomic neuropathy type IIA|Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 7|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia	Benign(Last reviewed: Dec 22, 2017)	criteria provided, multiple submitters, no conflicts	2	167094730	2	166238220	130264	135711
NM_002977.3(SCN9A):c.3476T>C (p.Ile1159Thr)	SCN9A|SCN1A-AS1	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 11, 2018)	criteria provided, conflicting interpretations	2	167099130	2	166242620	130263	135710
NM_002977.3(SCN9A):c.3329G>A (p.Arg1110Gln)	SCN9A|SCN1A-AS1	Hereditary sensory and autonomic neuropathy type IIA|Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 7|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|not provided|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia	Benign/Likely benign(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	2	167108385	2	166251875	130262	135709
NM_002977.3(SCN9A):c.3162C>T (p.Ser1054=)	SCN9A|SCN1A-AS1	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 13, 2018)	criteria provided, conflicting interpretations	2	167129065	2	166272555	130261	135708
NM_002977.3(SCN9A):c.2971G>T (p.Val991Leu)	SCN9A|SCN1A-AS1	Primary erythromelalgia|Hereditary sensory and autonomic neuropathy type IIA|Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 7|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia	Conflicting interpretations of pathogenicity(Last reviewed: Aug 22, 2017)	criteria provided, conflicting interpretations	2	167129256	2	166272746	94090	39316
NM_002977.3(SCN9A):c.2969A>G (p.Tyr990Cys)	SCN9A|SCN1A-AS1	Hereditary sensory and autonomic neuropathy type IIA|Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 7|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|not provided|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia|Rolandic epilepsy	Conflicting interpretations of pathogenicity(Last reviewed: Oct 31, 2017)	criteria provided, conflicting interpretations	2	167129258	2	166272748	130260	135707
NM_002977.3(SCN9A):c.2794A>C (p.Met932Leu)	SCN9A|SCN1A-AS1	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7|not specified|Congenital Indifference to Pain	Benign/Likely benign(Last reviewed: Aug 22, 2017)	criteria provided, multiple submitters, no conflicts	2	167133540	2	166277030	94089	39315
NM_002977.3(SCN9A):c.2159T>A (p.Ile720Lys)	SCN9A|SCN1A-AS1	Primary erythromelalgia|Hereditary sensory and autonomic neuropathy type IIA|Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 7|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2018)	criteria provided, conflicting interpretations	2	167137018	2	166280508	30357	39313
NM_002977.3(SCN9A):c.1828C>A (p.Pro610Thr)	SCN9A|SCN1A-AS1	Primary erythromelalgia|Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7|not specified|not provided|Inherited Erythromelalgia	Conflicting interpretations of pathogenicity(Last reviewed: Aug 14, 2018)	criteria provided, conflicting interpretations	2	167141109	2	166284599	21344	34196
NM_002977.3(SCN9A):c.1469G>A (p.Ser490Asn)	SCN9A|SCN1A-AS1	Hereditary sensory and autonomic neuropathy type IIA|Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 7|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|not provided|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia	Benign/Likely benign(Last reviewed: Sep 25, 2017)	criteria provided, multiple submitters, no conflicts	2	167142979	2	166286469	130258	135705
NM_002977.3(SCN9A):c.1287T>A (p.Arg429=)	SCN9A|SCN1A-AS1	Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|not provided|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	2	167144974	2	166288464	130257	135704
NM_002977.3(SCN9A):c.1266A>G (p.Glu422=)	SCN9A|SCN1A-AS1	Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|not provided|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	2	167144995	2	166288485	130256	135703
NM_002977.3(SCN9A):c.1155G>T (p.Val385=)	SCN9A|SCN1A-AS1	Hereditary sensory and autonomic neuropathy type IIA|Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 7|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|not provided|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia	Benign(Last reviewed: Sep 25, 2017)	criteria provided, multiple submitters, no conflicts	2	167145106	2	166288596	130255	135702
NM_002977.3(SCN9A):c.1119T>C (p.Ala373=)	SCN9A|SCN1A-AS1	Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|not provided|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	2	167145142	2	166288632	130254	135701
NM_002977.3(SCN9A):c.444A>G (p.Pro148=)	SCN9A	Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|not provided|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia	Benign(Last reviewed: May 6, 2018)	criteria provided, multiple submitters, no conflicts	2	167163043	2	166306533	130269	135716
NM_002977.3(SCN9A):c.174G>A (p.Gln58=)	SCN9A	Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|not provided|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia	Benign(Last reviewed: May 6, 2018)	criteria provided, multiple submitters, no conflicts	2	167168093	2	166311583	130259	135706
NC_000002.11:g.166892784_166894611del1828	SCN1A	Generalized epilepsy with febrile seizures plus, type 2	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	2	166892784 - 166894611			598759	589821
NM_001322046.1(FASTKD1):c.2230T>A (p.Tyr744Asn)	FASTKD1	Glaucoma 1, open angle, B	Pathogenic(Last reviewed: Jul 20, 2017)	no assertion criteria provided	2	170387959	2	169531449	548952	539434
NM_000079.3(CHRNA1):c.737C>T (p.Ser246Phe)	CHRNA1	Myasthenic syndrome, slow-channel congenital	Pathogenic(Last reviewed: Jun 15, 1999)	no assertion criteria provided	2	175618272	2	174753544	135655	139373
NM_000079.3(CHRNA1):c.737C>A (p.Ser246Tyr)	CHRNA1	Myasthenic syndrome, slow-channel congenital	Pathogenic(Last reviewed: Jun 15, 1999)	no assertion criteria provided	2	175618272	2	174753544	135654	139372
NM_001822.5(CHN1):c.661T>C (p.Tyr221His)	CHN1	Duane syndrome type 2	Pathogenic(Last reviewed: Apr 10, 2017)	criteria provided, single submitter	2	175689213	2	174824485	559835	550557
NM_001256850.1(TTN):c.102454+1G>A	TTN|TTN-AS1	Primary dilated cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	2	179393000	2	178528273	196723	193884
NM_001267550.2(TTN):c.106629delA (p.Ala35544Profs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179393849	2	178529122	223305	225037
NM_001267550.2(TTN):c.106374+1delG	TTN|TTN-AS1	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179394967	2	178530240	223358	225087
NM_001267550.2(TTN):c.105514_105516delTCT (p.Ser35172del)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Familial hypertrophic cardiomyopathy 1|Limb-girdle muscular dystrophy, type 2J|not provided|Left ventricular noncompaction cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2017)	criteria provided, conflicting interpretations	2	179395826 - 179395828	2	178531099 - 178531101	180582	178472
NM_001267550.2(TTN):c.104092C>T (p.Arg34698Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|Familial hypertrophic cardiomyopathy 9	Conflicting interpretations of pathogenicity(Last reviewed: Oct 8, 2014)	criteria provided, conflicting interpretations	2	179397250	2	178532523	167754	176939
NM_001267550.2(TTN):c.103408G>T (p.Glu34470Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179397934	2	178533207	223357	225086
NM_133378.4(TTN):c.95245C>T (p.Gln31749Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jul 2, 2012)	criteria provided, single submitter	2	179398393	2	178533666	47657	56821
NM_001267550.2(TTN):c.102630delA (p.Val34211Terfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179398712	2	178533985	223356	225085
NM_001267550.2(TTN):c.101996G>A (p.Trp33999Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179399346	2	178534619	223304	225036
NM_001267550.2(TTN):c.101098_101099insT (p.Asp33700Valfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Limb-girdle muscular dystrophy, type 2J	Likely pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	2	179400243 - 179400244	2	178535516 - 178535517	223390	225119
NM_001267550.2(TTN):c.101021_101022delGA (p.Arg33674Ilefs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179400320 - 179400321	2	178535593 - 178535594	223331	225062
NM_001267550.2(TTN):c.100445C>A (p.Ser33482Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179401029	2	178536302	223330	225061
NM_133378.4(TTN):c.92322_92326delGTCTT (p.Ser30776Hisfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Sep 12, 2014)	criteria provided, single submitter	2	179401806 - 179401810	2	178537079 - 178537083	165667	172623
NM_133378.4(TTN):c.91330A>T (p.Lys30444Ter)	TTN|TTN-AS1	Dilated cardiomyopathy 1G	Likely pathogenic(Last reviewed: May 15, 2014)	criteria provided, single submitter	2	179403522	2	178538795	208622	205135
NM_001256850.1(TTN):c.94071delA (p.Lys31357Asnfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, multiple submitters, no conflicts	2	179403562	2	178538835	178913	172627
NM_001267550.2(TTN):c.98551C>T (p.Arg32851Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179404241	2	178539514	223261	224992
NM_133378.4(TTN):c.90824G>A (p.Trp30275Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Apr 21, 2013)	criteria provided, single submitter	2	179404264	2	178539537	178936	172630
NM_003319.4(TTN):c.71311C>T (p.Arg23771Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, multiple submitters, no conflicts	2	179404286	2	178539559	223329	225060
NM_001267550.2(TTN):c.98299_98300delAG (p.Arg32767Glyfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	2	179404492 - 179404493	2	178539765 - 178539766	47599	56763
NM_001267550.2(TTN):c.98265_98268dup (p.His32757Asnfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179404524 - 179404527	2	178539797 - 178539800	223303	225035
NM_133378.4(TTN):c.90430G>T (p.Glu30144Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	2	179404658	2	178539931	179162	172633
NM_001256850.1(TTN):c.92569+1G>C	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	2	179406990	2	178542263	180058	173053
NM_001267550.2(TTN):c.97192+4A>G	TTN|TTN-AS1	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179407385	2	178542658	223355	225084
NM_001267550.2(TTN):c.96892C>T (p.Gln32298Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179407808	2	178543081	223362	225091
NM_001267550.2(TTN):c.96460dup (p.Thr32154Asnfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179408240	2	178543513	223328	225059
NM_001267550.2(TTN):c.96268C>T (p.Gln32090Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jun 12, 2015)	criteria provided, single submitter	2	179408603	2	178543876	228308	228582
NM_001256850.1(TTN):c.90492_90493+2delCAGT	TTN|TTN-AS1	Primary dilated cardiomyopathy|not provided	Likely pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, multiple submitters, no conflicts	2	179410545 - 179410548	2	178545818 - 178545821	223302	225034
NM_001267550.2(TTN):c.94852_94858delGCCCGAT (p.Ala31618Tyrfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179411200 - 179411206	2	178546473 - 178546479	223301	225033
NM_001267550.2(TTN):c.94855C>T (p.Arg31619Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179411203	2	178546476	223389	225118
NM_001267550.2(TTN):c.94562dup (p.Thr31522Asnfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179411593	2	178546866	223327	225058
NM_133378.4(TTN):c.86640_86643delAGAA (p.Lys28880Asnfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	2	179411905 - 179411908	2	178547178 - 178547181	165719	172649
NM_001256850.1(TTN):c.88974delT (p.Phe29658Leufs)	TTN|TTN-AS1	Primary dilated cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 25, 2014)	criteria provided, multiple submitters, no conflicts	2	179412456	2	178547729	47535	56699
NM_001256850.1(TTN):c.88243C>T (p.Arg29415Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	2	179413187	2	178548460	223326	225057
NM_133432.3(TTN):c.65863C>T (p.Arg21955Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Wolff-Parkinson-White pattern	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179413670	2	178548943	223300	225032
NM_001256850.1(TTN):c.87361_87365dupAAAAG (p.Ser29122Argfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 8, 2016)	criteria provided, conflicting interpretations	2	179414065 - 179414069	2	178549338 - 178549342	223354	225083
NM_001256850.1(TTN):c.86916dupA (p.Val28973Serfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2016)	criteria provided, multiple submitters, no conflicts	2	179414726	2	178549999	179692	172662
NM_001267550.2(TTN):c.91715dup (p.Asn30572Lysfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Limb-girdle muscular dystrophy, type 2J	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, multiple submitters, no conflicts	2	179414850	2	178550123	223353	225082
NM_133378.4(TTN):c.83772T>G (p.Tyr27924Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Aug 11, 2013)	criteria provided, single submitter	2	179415782	2	178551055	179124	172664
NM_133378.4(TTN):c.83074_83075insT (p.Tyr27692Leufs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Apr 8, 2015)	criteria provided, single submitter	2	179416849	2	178552122	47500	56664
NM_133378.4(TTN):c.82883delA (p.Lys27628Argfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Sep 27, 2011)	criteria provided, single submitter	2	179417040	2	178552313	47498	56662
NM_001267550.2(TTN):c.90322_90323insT (p.Glu30108Valfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179417304 - 179417305	2	178552577 - 178552578	223325	225056
NM_001267550.2(TTN):c.90087_90088delAG (p.Glu30029Aspfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179417539 - 179417540	2	178552812 - 178552813	223299	225031
NM_001256850.1(TTN):c.84977_84980delATTA (p.Asn28326Metfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy|not provided	Likely pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	2	179417724 - 179417727	2	178552997 - 178553000	223324	225055
NM_133378.4(TTN):c.82135C>T (p.Arg27379Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jan 20, 2015)	criteria provided, single submitter	2	179417788	2	178553061	179921	173086
NM_001267550.2(TTN):c.89750dup (p.Val29918Serfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179417877	2	178553150	223298	225030
NM_133378.4(TTN):c.80602+1G>C	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Apr 1, 2016)	criteria provided, single submitter	2	179421574	2	178556847	165765	173091
NM_001267550.2(TTN):c.87887_87890delACTT (p.His29296Profs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179422099 - 179422102	2	178557372 - 178557375	223388	225117
NM_001267550.2(TTN):c.87716delG (p.Gly29239Aspfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G	Conflicting interpretations of pathogenicity(Last reviewed: Jul 14, 2017)	criteria provided, conflicting interpretations	2	179422273	2	178557546	223260	224991
NM_001267550.2(TTN):c.87624C>A (p.Tyr29208Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179422457	2	178557730	223323	225054
NM_133378.4(TTN):c.79812delC (p.Tyr26605Thrfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jun 19, 2014)	criteria provided, single submitter	2	179422565	2	178557838	165770	173094
NM_001267550.2(TTN):c.86967G>A (p.Trp28989Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179423219	2	178558492	223297	225029
NM_001267550.2(TTN):c.86821+2T>A	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 26, 2018)	criteria provided, multiple submitters, no conflicts	2	179424036	2	178559309	47458	56622
NM_133378.4(TTN):c.79095_79098delAAAG (p.Gly26368Terfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, multiple submitters, no conflicts	2	179424057 - 179424060	2	178559330 - 178559333	179417	173096
NM_001267550.2(TTN):c.86641delC (p.His28881Thrfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179424218	2	178559491	223296	225028
NM_001267550.2(TTN):c.86459_86460delCT (p.Ser28820Trpfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179424399 - 179424400	2	178559672 - 178559673	223322	225053
NM_001267550.2(TTN):c.85510G>T (p.Glu28504Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: May 6, 2015)	criteria provided, single submitter	2	179425349	2	178560622	228306	228614
NM_003319.4(TTN):c.57895C>T (p.Arg19299Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, multiple submitters, no conflicts	2	179425769	2	178561042	223295	225027
NM_001267550.2(TTN):c.85008_85011delTAGT (p.Glu28338Hisfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179425848 - 179425851	2	178561121 - 178561124	223352	225081
NM_001267550.2(TTN):c.84376C>T (p.Gln28126Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G	Likely pathogenic(Last reviewed: May 7, 2017)	criteria provided, multiple submitters, no conflicts	2	179426483	2	178561756	223387	225116
NM_133378.4(TTN):c.75899delG (p.Gly25300Glufs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 6, 2014)	criteria provided, single submitter	2	179427256	2	178562529	179642	172688
NM_001267550.2(TTN):c.83515C>T (p.Arg27839Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, multiple submitters, no conflicts	2	179427344	2	178562617	223386	225115
NM_133378.4(TTN):c.75703delG (p.Val25235Serfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Sep 26, 2013)	criteria provided, single submitter	2	179427452	2	178562725	179311	173106
NM_133378.4(TTN):c.75069G>A (p.Trp25023Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 2, 2014)	criteria provided, single submitter	2	179428086	2	178563359	180014	172690
NM_001267550.2(TTN):c.82513delA (p.Ile27505Phefs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179428346	2	178563619	223294	225026
NM_001256850.1(TTN):c.76955_76956delTT (p.Phe25652Cysfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 22, 2014)	criteria provided, multiple submitters, no conflicts	2	179428980 - 179428981	2	178564253 - 178564254	179139	173110
NM_133378.4(TTN):c.73828G>T (p.Glu24610Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jan 16, 2017)	criteria provided, single submitter	2	179429327	2	178564600	47397	56562
NM_133378.4(TTN):c.73817delC (p.Pro24606Leufs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Sep 4, 2017)	criteria provided, single submitter	2	179429338	2	178564611	506135	496247
NM_001267550.2(TTN):c.81518delC (p.Pro27173Hisfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179429341	2	178564614	223321	225052
NM_001267550.2(TTN):c.81321C>G (p.Tyr27107Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, multiple submitters, no conflicts	2	179429538	2	178564811	179759	173112
NM_001267550.2(TTN):c.81262_81269del	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy	Likely pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, multiple submitters, no conflicts	2	179429590 - 179429597	2	178564863 - 178564870	223293	225025
NM_133378.4(TTN):c.73293_73308del (p.Tyr24431Terfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|not provided	Likely pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, multiple submitters, no conflicts	2	179429847 - 179429862	2	178565120 - 178565135	165810	172696
NM_001256850.1(TTN):c.75793C>T (p.Arg25265Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not provided	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, multiple submitters, no conflicts	2	179430143	2	178565416	180010	173115
NM_001267550.2(TTN):c.80635C>T (p.Gln26879Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179430224	2	178565497	223259	224990
NM_001256850.1(TTN):c.75571G>T (p.Glu25191Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|not provided	Likely pathogenic(Last reviewed: Apr 22, 2016)	criteria provided, multiple submitters, no conflicts	2	179430365	2	178565638	228305	228632
NM_133378.4(TTN):c.72123delT (p.Ala24042Profs)	TTN|TTN-AS1	not specified	Uncertain significance(Last reviewed: Sep 5, 2012)	criteria provided, single submitter	2	179431032	2	178566305	47381	56546
NM_001267550.2(TTN):c.79684C>T (p.Arg26562Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J	Likely pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	2	179431175	2	178566448	222861	224228
NM_001267550.2(TTN):c.78991C>T (p.Arg26331Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179431868	2	178567141	223385	225114
NM_001267550.2(TTN):c.78507delT (p.Gly26170Valfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179432352	2	178567625	223292	225024
NM_001267550.2(TTN):c.78184G>T (p.Glu26062Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179432675	2	178567948	223291	225023
NM_001267550.2(TTN):c.78095_78098delGAAA (p.Arg26032Thrfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179432761 - 179432764	2	178568034 - 178568037	223384	225113
NM_133378.4(TTN):c.69717_69718insC (p.Ser23240Glnfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: May 20, 2015)	criteria provided, single submitter	2	179433438	2	178568711	177983	172707
NM_001267550.2(TTN):c.76383_76386delTAAT (p.Asn25462Lysfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179434473 - 179434476	2	178569746 - 178569749	223320	225051
NM_001267550.2(TTN):c.76116_76117insA (p.His25373Thrfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179434742 - 179434743	2	178570015 - 178570016	223319	225050
NM_001267550.2(TTN):c.76115dupA (p.Asn25372Lysfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, multiple submitters, no conflicts	2	179434744	2	178570017	223383	225112
NM_133378.4(TTN):c.67739delG (p.Gly22580Valfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Apr 14, 2016)	criteria provided, single submitter	2	179435416	2	178570689	504935	496251
NM_001267550.2(TTN):c.75123T>A (p.Tyr25041Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179435736	2	178571009	223351	225080
NM_001267550.2(TTN):c.74880_74883dup (p.Pro24962Asnfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179435976 - 179435979	2	178571249 - 178571252	223382	225111
NM_001256850.1(TTN):c.69415C>T (p.Arg23139Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	2	179436521	2	178571794	202405	199026
NM_001267550.2(TTN):c.74306dup (p.Asn24769Lysfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179436553	2	178571826	223290	225022
NM_133378.4(TTN):c.65683delG (p.Ala21895Profs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	2	179437472	2	178572745	517403	496675
NM_001267550.2(TTN):c.73109G>A (p.Trp24370Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179437750	2	178573023	223381	225110
NM_133378.4(TTN):c.65128_65129insA (p.Thr21710Asnfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jun 11, 2015)	criteria provided, single submitter	2	179438027	2	178573300	228304	228653
NM_001267550.2(TTN):c.72669delT (p.Asp24224Ilefs)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J	Pathogenic/Likely pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, multiple submitters, no conflicts	2	179438190	2	178573463	178908	172954
NM_001256850.1(TTN):c.67057_67063delGCATATGinsTA (p.Ala22353Terfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Autosomal recessive centronuclear myopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, multiple submitters, no conflicts	2	179438873 - 179438879	2	178574146 - 178574152	202465	199051
NM_001267550.2(TTN):c.71634delA (p.Ala23879Leufs)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J	Likely pathogenic(Last reviewed: May 2, 2018)	criteria provided, multiple submitters, no conflicts	2	179439225	2	178574498	165852	172818
NM_001267550.2(TTN):c.71602C>T (p.Arg23868Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not provided|Familial dilated cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: May 9, 2018)	criteria provided, multiple submitters, no conflicts	2	179439257	2	178574530	47301	56466
NM_001256850.1(TTN):c.66398G>A (p.Trp22133Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2014)	criteria provided, multiple submitters, no conflicts	2	179439538	2	178574811	165855	172959
NM_001267550.2(TTN):c.70791delA (p.Gly23598Glufs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179440068	2	178575341	223318	225049
NM_133378.4(TTN):c.62571delT (p.Ser20857Argfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Aug 11, 2013)	criteria provided, single submitter	2	179440584	2	178575857	179134	172822
NM_001267550.2(TTN):c.69877G>T (p.Gly23293Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179440982	2	178576255	223380	225109
NM_001267550.2(TTN):c.69843delA (p.Val23282Terfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179441016	2	178576289	223317	225048
NM_001267550.2(TTN):c.69630C>A (p.Tyr23210Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179441341	2	178576614	223289	225021
NM_001267550.2(TTN):c.69491_69492delTG (p.Val23164Glyfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179441479 - 179441480	2	178576752 - 178576753	223379	225108
NM_001267550.2(TTN):c.69412+1G>A	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179441649	2	178576922	223316	225047
NM_133378.4(TTN):c.61120G>A (p.Glu20374Lys)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jan 11, 2018)	criteria provided, multiple submitters, no conflicts	2	179442329	2	178577602	96298	102192
NM_003319.4(TTN):c.41446C>T (p.Arg13816Ter)	TTN|TTN-AS1	Familial hypertrophic cardiomyopathy 9	Likely pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	2	179442512	2	178577785	488396	481230
NM_001256850.1(TTN):c.63526C>T (p.Arg21176Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	2	179442793	2	178578066	165869	172968
NM_133378.4(TTN):c.60491C>A (p.Ser20164Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Nov 25, 2014)	criteria provided, single submitter	2	179443562	2	178578835	180107	172832
NM_001267550.2(TTN):c.67495C>T (p.Arg22499Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|Familial hypertrophic cardiomyopathy 9|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	2	179444429	2	178579702	180573	178478
NM_001267550.2(TTN):c.67159delA (p.Ile22387Terfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179444855	2	178580128	223338	225069
NM_133378.4(TTN):c.58914C>A (p.Cys19638Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Feb 18, 2014)	criteria provided, single submitter	2	179446377	2	178581650	47237	56402
NM_001267550.2(TTN):c.65476G>T (p.Glu21826Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179448433	2	178583706	223378	225107
NM_001267550.2(TTN):c.64453C>T (p.Arg21485Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179450018	2	178585291	223315	225046
NM_001267550.2(TTN):c.64397-1G>C	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Mar 20, 2015)	criteria provided, single submitter	2	179450075	2	178585348	228303	228686
NM_001267550.2(TTN):c.64094-2A>G	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	2	179451536	2	178586809	228302	228688
NM_001267550.2(TTN):c.63601C>T (p.Arg21201Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179452435	2	178587708	223314	225045
NM_001256850.1(TTN):c.58102C>T (p.Arg19368Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2014)	criteria provided, multiple submitters, no conflicts	2	179453427	2	178588700	202518	199141
NM_003319.4(TTN):c.35311C>T (p.Arg11771Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jun 10, 2016)	criteria provided, conflicting interpretations	2	179453946	2	178589219	223258	224989
NM_001256850.1(TTN):c.57294T>A (p.Tyr19098Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, multiple submitters, no conflicts	2	179454235	2	178589508	165916	172994
NM_001256850.1(TTN):c.56953C>T (p.Arg18985Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|Familial hypertrophic cardiomyopathy 9|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	2	179454576	2	178589849	47175	56340
NM_001267550.2(TTN):c.61495C>T (p.Arg20499Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J	Likely pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	2	179454957	2	178590230	223377	225106
NM_001267550.2(TTN):c.60931C>T (p.Arg20311Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179455521	2	178590794	223288	225020
NM_133378.4(TTN):c.52695delA (p.Ser17566Glnfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	2	179456053	2	178591326	178819	172861
NM_133378.4(TTN):c.[38532C>A];[52301A>G]	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Familial hypertrophic cardiomyopathy 9	Likely pathogenic(Last reviewed: Apr 24, 2012)	criteria provided, single submitter	2|2	179456541	2|2	178591814	424805	56322|213530
NM_001267550.2(TTN):c.59627-1G>A	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179457005	2	178592278	223313	225044
NM_001267550.2(TTN):c.59411dup (p.Arg19805Lysfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179457321	2	178592594	223376	225105
NM_001267550.2(TTN):c.59352delT (p.Glu19785Serfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179457380	2	178592653	223375	225104
NM_001267550.2(TTN):c.58732+2T>C	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179458293	2	178593566	223287	225019
NM_001267550.2(TTN):c.58172delA (p.Asp19391Alafs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179458948	2	178594221	223312	225043
NM_001267550.2(TTN):c.57544+4A>G	TTN|TTN-AS1	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179462261	2	178597534	223286	225018
NM_001267550.2(TTN):c.57331C>T (p.Arg19111Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 22, 2015)	criteria provided, conflicting interpretations	2	179462478	2	178597751	47121	56286
NM_001267550.2(TTN):c.56834delG (p.Gly18945Valfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179463603	2	178598876	223374	225103
NM_133378.4(TTN):c.49028_49029insA (p.Asp16343Glufs)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G	Likely pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	2	179463705	2	178598978	47115	56280
NM_001267550.2(TTN):c.56206delA (p.Thr18736Profs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179464422	2	178599695	223373	225102
NM_133378.4(TTN):c.48096G>A (p.Trp16032Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Mar 12, 2014)	criteria provided, single submitter	2	179465831	2	178601104	165964	173860
NM_001267550.2(TTN):c.55525_55531delGACAGGA (p.Asp18509Serfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179466193 - 179466199	2	178601466 - 178601472	223285	225017
NM_001267550.2(TTN):c.55303-1G>A	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179466515	2	178601788	223284	225016
NM_133378.4(TTN):c.46932T>G (p.Tyr15644Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2015)	no assertion criteria provided	2	179468778	2	178604051	47092	56257
NM_001267550.2(TTN):c.53881+5G>A	TTN|TTN-AS1	Primary dilated cardiomyopathy|not provided	Uncertain significance(Last reviewed: Oct 11, 2016)	criteria provided, multiple submitters, no conflicts	2	179470136	2	178605409	223283	225015
NM_001267550.2(TTN):c.53881+1G>T	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179470140	2	178605413	223282	225014
NM_001256850.1(TTN):c.48730G>T (p.Glu16244Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not provided|Familial dilated cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, multiple submitters, no conflicts	2	179470369	2	178605642	165985	173871
NM_001267550.2(TTN):c.53488G>T (p.Gly17830Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179471841	2	178607114	223311	225042
NM_001256850.1(TTN):c.48470delG (p.Gly16157Alafs)	TTN|TTN-AS1	Primary dilated cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 25, 2017)	criteria provided, multiple submitters, no conflicts	2	179471936	2	178607209	202451	199225
NM_001267550.2(TTN):c.52223_52227dup (p.Asp17410Argfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179473511 - 179473515	2	178608784 - 178608788	223281	225013
NM_001267550.2(TTN):c.52128delT (p.Phe17376Leufs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179473610	2	178608883	223257	224988
NM_001267550.2(TTN):c.52035_52036insTT (p.Leu17346Phefs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179474001 - 179474002	2	178609274 - 178609275	223280	225012
NM_133378.4(TTN):c.44035+1G>C	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 4, 2013)	criteria provided, single submitter	2	179474410	2	178609683	179336	173133
NM_133378.4(TTN):c.42914G>A (p.Trp14305Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 23, 2014)	criteria provided, single submitter	2	179476338	2	178611611	47047	56212
NM_001267550.2(TTN):c.50247delT (p.Phe16749Leufs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179477005	2	178612278	223310	225041
NM_001256850.1(TTN):c.45247C>T (p.Arg15083Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|not provided	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, multiple submitters, no conflicts	2	179477082	2	178612355	202378	199274
NM_001256850.1(TTN):c.44725+2delT	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not provided	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, multiple submitters, no conflicts	2	179477886	2	178613159	179411	173141
NM_001267550.2(TTN):c.49458G>A (p.Trp16486Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179478552	2	178613825	223372	225101
NM_001256850.1(TTN):c.44423-1G>A	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	2	179478665	2	178613938	223309	225040
NM_133378.4(TTN):c.41592_41611del (p.Val13865Leufs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Nov 1, 2013)	criteria provided, single submitter	2	179478809 - 179478828	2	178614082 - 178614101	179375	172726
NM_133378.4(TTN):c.41249T>C (p.Ile13750Thr)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 6, 2018)	criteria provided, conflicting interpretations	2	179479288	2	178614561	47025	56190
NM_001267550.2(TTN):c.48761-1G>C	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jun 10, 2015)	criteria provided, single submitter	2	179479481	2	178614754	228300	228748
NM_133378.4(TTN):c.41023C>T (p.Pro13675Ser)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Nov 27, 2017)	criteria provided, conflicting interpretations	2	179479607	2	178614880	47024	56189
NM_001267550.2(TTN):c.48527G>A (p.Trp16176Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179480145	2	178615418	223279	225011
NM_001267550.2(TTN):c.48460+5G>A	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 11, 2017)	criteria provided, conflicting interpretations	2	179480363	2	178615636	178208	172727
NM_001267550.2(TTN):c.47875+1G>A	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179481846	2	178617119	223278	225010
NM_001267550.2(TTN):c.47697C>A (p.Cys15899Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J	Likely pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, multiple submitters, no conflicts	2	179482115	2	178617388	223277	225009
NM_001267550.2(TTN):c.47692C>T (p.Arg15898Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179482120	2	178617393	223371	225100
NM_001267550.2(TTN):c.47142_47143dup (p.Glu15715Valfs)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179483042 - 179483043	2	178618315 - 178618316	223370	225099
NM_133378.4(TTN):c.39078C>A (p.Tyr13026Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, multiple submitters, no conflicts	2	179483495	2	178618768	47004	56169
NM_133378.4(TTN):c.39069T>A (p.Tyr13023Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jul 5, 2013)	criteria provided, single submitter	2	179483504	2	178618777	47003	56168
NM_133378.4(TTN):c.38532C>A	TTN	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179485012	2	178620285	223308	213530
NM_133378.4(TTN):c.38191+1G>A	TTN	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jan 28, 2014)	criteria provided, single submitter	2	179485441	2	178620714	178984	173154
NM_001267550.2(TTN):c.45812T>G (p.Leu15271Ter)	TTN	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179485525	2	178620798	223276	225008
NM_001267550.2(TTN):c.45756dup (p.Tyr15253Ilefs)	TTN	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179485581	2	178620854	224649	226430
NM_001267550.2(TTN):c.45391delA (p.Ile15131Tyrfs)	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179486054	2	178621327	223337	225068
NM_001267550.2(TTN):c.45307C>T (p.Arg15103Ter)	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J	Conflicting interpretations of pathogenicity(Last reviewed: Feb 8, 2018)	criteria provided, conflicting interpretations	2	179486244	2	178621517	46986	56151
NM_001256850.1(TTN):c.40166_40168delAAG (p.Glu13389del)	TTN	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Arrhythmogenic right ventricular dysplasia, familial 1|not provided	Uncertain significance(Last reviewed: Dec 14, 2017)	criteria provided, multiple submitters, no conflicts	2	179486460 - 179486462	2	178621733 - 178621735	202444	199336
NM_133378.4(TTN):c.36660delC (p.Tyr12221Thrfs)	TTN	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Mar 19, 2012)	criteria provided, single submitter	2	179494088	2	178629361	46976	56141
NM_001256850.1(TTN):c.39361C>T (p.Arg13121Ter)	TTN	Primary dilated cardiomyopathy|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2017)	criteria provided, conflicting interpretations	2	179494168	2	178629441	223369	225098
NM_001267550.2(TTN):c.44281+1G>A	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J	Conflicting interpretations of pathogenicity(Last reviewed: Jul 10, 2017)	criteria provided, conflicting interpretations	2	179494967	2	178630240	223307	225039
NM_001256850.1(TTN):c.39358C>T (p.Pro13120Ser)	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Familial hypertrophic cardiomyopathy 9|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	2	179494968	2	178630241	178217	173163
NM_001267550.2(TTN):c.43792delG (p.Val14598Terfs)	TTN	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179495983	2	178631256	223275	225006
NM_001256850.1(TTN):c.38677C>T (p.Gln12893Ter)	TTN	Primary dilated cardiomyopathy|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 8, 2016)	criteria provided, conflicting interpretations	2	179497021	2	178632294	178865	173164
NM_001256850.1(TTN):c.38621dupT (p.Phe12875Ilefs)	TTN	Primary dilated cardiomyopathy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 26, 2015)	criteria provided, conflicting interpretations	2	179497077	2	178632350	202536	199356
NM_001267550.2(TTN):c.42636delA (p.Ala14213Leufs)	TTN	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179498590	2	178633863	223368	225097
NM_001256850.1(TTN):c.37675_37676insG (p.Met12559Serfs)	TTN	Primary dilated cardiomyopathy|Autosomal recessive centronuclear myopathy|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 19, 2017)	criteria provided, conflicting interpretations	2	179498627 - 179498628	2	178633900 - 178633901	452205	443088
NM_001267550.2(TTN):c.41835T>G (p.Tyr13945Ter)	TTN	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179500216	2	178635489	223367	225096
NM_001256850.1(TTN):c.36687delA (p.Val12230Serfs)	TTN	Primary dilated cardiomyopathy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 20, 2013)	criteria provided, conflicting interpretations	2	179500441	2	178635714	46947	56112
NM_003319.4(TTN):c.14288delC (p.Pro4763Glnfs)	TTN	Primary dilated cardiomyopathy|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Oct 13, 2017)	criteria provided, multiple submitters, no conflicts	2	179500815	2	178636088	228299	228771
NM_001267550.2(TTN):c.41473C>T (p.Arg13825Ter)	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 23, 2017)	criteria provided, conflicting interpretations	2	179500825	2	178636098	223274	225005
NM_001267550.2(TTN):c.41447delG (p.Gly13816Alafs)	TTN	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179500851	2	178636124	223273	225004
NM_001267550.2(TTN):c.40558+1G>A	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|Familial hypertrophic cardiomyopathy 9|not specified|not provided	Uncertain significance(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	2	179506963	2	178642236	223256	224987
NM_133378.4(TTN):c.32854G>C (p.Val10952Leu)	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 11, 2018)	criteria provided, conflicting interpretations	2	179506964	2	178642237	130666	136112
NM_001267550.2(TTN):c.39895+1G>T	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J	Uncertain significance(Last reviewed: Oct 3, 2016)	criteria provided, multiple submitters, no conflicts	2	179514543	2	178649816	223350	225079
NM_001267550.2(TTN):c.39044-9T>A	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 19, 2017)	criteria provided, conflicting interpretations	2	179517277	2	178652550	166093	173321
NM_001267550.2(TTN):c.33418+1G>A	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179544980	2	178680253	223272	225003
NM_001267550.2(TTN):c.32888-1delG	TTN	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179547631	2	178682904	223271	225002
NM_001267550.2(TTN):c.32554+1G>C	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179549632	2	178684905	223336	225067
NM_001267550.2(TTN):c.32095+5G>A	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179553775	2	178689048	223335	225066
NM_001256850.1(TTN):c.30812-1G>A	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2017)	criteria provided, conflicting interpretations	2	179554624	2	178689897	46855	56020
NM_001267550.2(TTN):c.31762G>A (p.Val10588Ile)	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J	Uncertain significance(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	2	179556743	2	178692016	223361	225090
NM_001267550.2(TTN):c.31594G>T (p.Val10532Phe)	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179558336	2	178693609	223349	225078
NM_001267550.2(TTN):c.31426+1G>C	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified	Uncertain significance(Last reviewed: Jun 9, 2018)	criteria provided, multiple submitters, no conflicts	2	179559325	2	178694598	46849	56014
NM_001267550.2(TTN):c.30803-2A>G	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179560998	2	178696271	223334	225065
NM_133378.4(TTN):c.26752_26761delACGGCAGAGC (p.Thr8918Cysfs)	TTN	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jun 7, 2013)	criteria provided, single submitter	2	179566913 - 179566922	2	178702186 - 178702195	178672	173340
NM_001267550.2(TTN):c.29062delG (p.Ala9688Glnfs)	TTN	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179571661	2	178706934	223270	225001
NM_001256850.1(TTN):c.28091-2A>C	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2018)	criteria provided, conflicting interpretations	2	179571683	2	178706956	202355	199459
NM_001267550.2(TTN):c.27607G>A (p.Glu9203Lys)	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179577042	2	178712315	223269	225000
NM_001267550.2(TTN):c.27328+5G>A	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 6, 2017)	criteria provided, conflicting interpretations	2	179577419	2	178712692	46793	55958
NM_133378.4(TTN):c.20653G>T (p.Glu6885Ter)	TTN	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Nov 11, 2013)	criteria provided, single submitter	2	179583542	2	178718815	179397	173220
NM_001267550.2(TTN):c.23386C>T (p.Arg7796Ter)	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179584983	2	178720256	223348	225077
NM_001267550.2(TTN):c.21142C>T (p.Arg7048Ter)	TTN	Primary dilated cardiomyopathy|not provided	Uncertain significance(Last reviewed: Feb 8, 2016)	criteria provided, multiple submitters, no conflicts	2	179588844	2	178724117	223333	225064
NM_133378.4(TTN):c.12556C>T (p.Arg4186Ter)	TTN	Dilated cardiomyopathy 1G|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Familial hypertrophic cardiomyopathy 9|not provided	Uncertain significance(Last reviewed: Sep 3, 2015)	criteria provided, single submitter	2	179597615	2	178732888	282527	266764
NM_001267550.2(TTN):c.15776-1G>T	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179598245	2	178733518	223255	224986
NM_133378.4(TTN):c.10361-1G>A	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|Familial hypertrophic cardiomyopathy 9|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	2	179603088	2	178738361	223347	225076
NM_001267550.2(TTN):c.14056delA (p.Thr4686Glnfs)	TTN	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179603904	2	178739177	223366	225095
NM_001267550.2(TTN):c.13900G>T (p.Glu4634Ter)	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J	Conflicting interpretations of pathogenicity(Last reviewed: Oct 12, 2017)	criteria provided, conflicting interpretations	2	179604060	2	178739333	223365	225094
NM_001267550.2(TTN):c.12757C>T (p.Gln4253Ter)	TTN	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179605203	2	178740476	223268	224999
NM_001267550.2(TTN):c.12643_12644delCA (p.Gln4215Valfs)	TTN	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179605316 - 179605317	2	178740589 - 178740590	223267	224998
NM_133432.3(TTN):c.11494G>T (p.Glu3832Ter)	TTN	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Sep 24, 2014)	criteria provided, single submitter	2	179605752	2	178741025	47820	56984
NM_001267550.2(TTN):c.11912G>A (p.Trp3971Ter)	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2017)	criteria provided, conflicting interpretations	2	179606048	2	178741321	223364	225093
NM_133379.4(TTN):c.16529delT (p.Val5510Glyfs)	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179610598	2	178745871	223363	225092
NM_133379.4(TTN):c.16516G>T (p.Glu5506Ter)	TTN	Primary dilated cardiomyopathy|not specified|not provided	Uncertain significance(Last reviewed: Nov 28, 2017)	criteria provided, multiple submitters, no conflicts	2	179610611	2	178745884	166247	173410
NM_133379.4(TTN):c.15305delC (p.Thr5102Ilefs)	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179611822	2	178747095	223265	224996
NM_001267550.2(TTN):c.11311+5184_11311+5194dup	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179612657 - 179612667	2	178747930 - 178747940	223332	225063
NM_133379.4(TTN):c.13939delG (p.Glu4647Lysfs)	TTN	Primary dilated cardiomyopathy|Primary familial hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 30, 2015)	criteria provided, multiple submitters, no conflicts	2	179613188	2	178748461	222870	224241
NM_133379.4(TTN):c.13705G>T (p.Glu4569Ter)	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179613422	2	178748695	223264	224995
NM_133379.4(TTN):c.13660dup (p.Ile4554Asnfs)	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179613467	2	178748740	223263	224994
NM_133379.4(TTN):c.13410dup (p.Gly4471Argfs)	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179613717	2	178748990	223359	225088
NM_133379.4(TTN):c.13022C>G (p.Ser4341Ter)	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179614105	2	178749378	223306	225038
NM_133379.4(TTN):c.10443delA (p.Lys3481Asnfs)	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179616684	2	178751957	223262	224993
NM_133437.4(TTN):c.10670dup (p.Leu3558Thrfs)	TTN	Primary dilated cardiomyopathy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 31, 2016)	criteria provided, conflicting interpretations	2	179621020	2	178756293	202507	199661
NM_001267550.2(TTN):c.11113delA (p.Arg3705Aspfs)	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179621090	2	178756363	223346	225075
NM_001267550.2(TTN):c.10852C>T (p.Gln3618Ter)	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179621351	2	178756624	223254	224985
NM_001267550.2(TTN):c.10799C>A (p.Ser3600Ter)	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179621404	2	178756677	223253	224984
NM_001267550.2(TTN):c.10592C>G (p.Ser3531Ter)	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J	Uncertain significance(Last reviewed: May 24, 2017)	criteria provided, multiple submitters, no conflicts	2	179622355	2	178757628	223345	225074
NM_133378.4(TTN):c.10241_10247delACACGTT (p.Tyr3414Leufs)	TTN	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Apr 26, 2017)	criteria provided, single submitter	2	179623767 - 179623773	2	178759040 - 178759046	228298	228872
NM_001267550.2(TTN):c.9727C>T (p.Gln3243Ter)	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179629515	2	178764788	223252	224983
NM_001267550.2(TTN):c.9164-2A>T	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179632884	2	178768157	223344	225073
NM_133378.4(TTN):c.8307_8308delTG (p.Ala2770Hisfs)	TTN	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: May 20, 2015)	criteria provided, multiple submitters, no conflicts	2	179635211 - 179635212	2	178770484 - 178770485	223266	224997
NM_133378.4(TTN):c.6678_6681delAAAG (p.Lys2227Phefs)	TTN	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jan 4, 2013)	criteria provided, single submitter	2	179639757 - 179639760	2	178775030 - 178775033	47327	56492
NM_001267550.2(TTN):c.6355G>T (p.Glu2119Ter)	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179640236	2	178775509	223343	225072
NM_001256850.1(TTN):c.4724_4728delTGAAA (p.Met1575Serfs)	TTN|LOC101927055	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 13, 2018)	criteria provided, conflicting interpretations	2	179641962 - 179641966	2	178777235 - 178777239	202501	199724
NM_133378.4(TTN):c.4027C>T (p.Gln1343Ter)	TTN|LOC101927055	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jun 5, 2013)	criteria provided, single submitter	2	179643782	2	178779055	166322	173465
NM_133378.4(TTN):c.3100G>A (p.Val1034Met)	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Dec 19, 2017)	criteria provided, conflicting interpretations	2	179647533	2	178782806	46910	56075
NM_001267550.2(TTN):c.3034C>T (p.Arg1012Ter)	TTN	Primary dilated cardiomyopathy|Limb-girdle muscular dystrophy, type 2J	Likely pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, multiple submitters, no conflicts	2	179647599	2	178782872	46899	56064
NM_001256850.1(TTN):c.2926T>C (p.Trp976Arg)	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	2	179647707	2	178782980	12651	27690
NM_001267550.2(TTN):c.2841G>T (p.Ser947=)	TTN	Primary dilated cardiomyopathy|not provided	Uncertain significance(Last reviewed: Nov 1, 2017)	criteria provided, multiple submitters, no conflicts	2	179648447	2	178783720	223342	225071
NM_001267550.2(TTN):c.2494G>T (p.Ala832Ser)	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179649078	2	178784351	223341	225070
NM_001256850.1(TTN):c.1800+1G>A	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Muscular dystrophy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2018)	criteria provided, conflicting interpretations	2	179655434	2	178790707	46689	55854
NM_001267550.2(TTN):c.1245+3A>G	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179659646	2	178794919	223251	224982
NM_001256850.1(TTN):c.325C>T (p.Arg109Ter)	TTN	Primary dilated cardiomyopathy|not specified	Uncertain significance(Last reviewed: Mar 2, 2016)	criteria provided, multiple submitters, no conflicts	2	179665380	2	178800653	223360	225089
NM_002500.4(NEUROD1):c.590C>A (p.Pro197His)	NEUROD1	Maturity onset diabetes mellitus in young|not specified|Monogenic diabetes	Benign/Likely benign(Last reviewed: Oct 6, 2017)	criteria provided, multiple submitters, no conflicts	2	182542998	2	181678271	129763	135209
NM_002500.4(NEUROD1):c.309C>G (p.Arg103=)	NEUROD1	Maturity-onset diabetes of the young, type 6	Pathogenic	no assertion criteria provided	2	182543279	2	181678552	218145	214793
NM_000090.3(COL3A1):c.505C>T (p.Leu169Phe)	COL3A1	Ehlers-Danlos syndrome, type 4|not specified|Aortic aneurysm|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 22, 2018)	criteria provided, conflicting interpretations	2	189851842	2	188987116	161216	171072
NM_000090.3(COL3A1):c.754G>T (p.Gly252Cys)	COL3A1	Ehlers-Danlos syndrome	Likely pathogenic(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	2	189855042	2	188990316	228249	228909
NM_000090.3(COL3A1):c.812G>A (p.Arg271Gln)	COL3A1	Ehlers-Danlos syndrome, type 4|not specified|not provided|Cardiovascular phenotype|Connective tissue disorder	Benign/Likely benign(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	2	189855743	2	188991017	161215	171073
NM_000090.3(COL3A1):c.1173delT (p.Pro392Leufs)	COL3A1	Ehlers-Danlos syndrome	Likely pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	2	189858787	2	188994061	517450	496222
NM_000090.3(COL3A1):c.1509+2T>C	COL3A1	Ehlers-Danlos syndrome	Likely pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	2	189859827	2	188995101	517434	496260
NM_000090.3(COL3A1):c.1550C>T (p.Pro517Leu)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection|not specified|not provided	Likely benign(Last reviewed: Nov 6, 2017)	criteria provided, multiple submitters, no conflicts	2	189860458	2	188995732	161217	171074
NM_000090.3(COL3A1):c.1856C>T (p.Pro619Leu)	COL3A1	Ehlers-Danlos syndrome, type 4|not specified|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jun 19, 2018)	criteria provided, multiple submitters, no conflicts	2	189862102	2	188997376	333057	286480
NM_000090.3(COL3A1):c.2558_2559insATTAGGTGTCAAAGGTGAACGTGGCAG (p.Pro853_Pro854insLeuGlyValLysGlyGluArgGlySer)	COL3A1	Ehlers-Danlos syndrome, type 4	Uncertain significance	no assertion criteria provided	2	189868141 - 189868142	2	189003415 - 189003416	431451	424967
NM_000090.3(COL3A1):c.3133G>A (p.Ala1045Thr)	COL3A1	Ehlers-Danlos syndrome, type 4|not specified|not provided|Cardiovascular phenotype|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jan 24, 2018)	criteria provided, conflicting interpretations	2	189871110	2	189006384	197477	194638
NM_000090.3(COL3A1):c.3626G>C (p.Gly1209Ala)	COL3A1	Ehlers-Danlos syndrome, type 4	Conflicting interpretations of pathogenicity(Last reviewed: Oct 31, 2016)	criteria provided, conflicting interpretations	2	189873750	2	189009024	225283	227191
NM_000090.3(COL3A1):c.3938A>G (p.Lys1313Arg)	COL3A1	Ehlers-Danlos syndrome, type 4|Ehlers-Danlos syndrome|Loeys-Dietz syndrome|not specified|not provided|Cardiovascular phenotype|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2018)	criteria provided, conflicting interpretations	2	189875018	2	189010292	161218	171075
NM_000090.3(COL3A1):c.4096C>T (p.Gln1366Ter)	COL3A1	Ehlers-Danlos syndrome, type 4|Ehlers-Danlos syndrome, type 3	Likely pathogenic(Last reviewed: May 13, 2014)	criteria provided, single submitter	2	189875458	2	189010732	216910	213532
NM_007315.3(STAT1):c.820C>T (p.Arg274Trp)	STAT1	Mycobacterial and viral infections, susceptibility to, autosomal recessive|Immunodeficiency 31C|Immunodeficiency 31a	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, multiple submitters, no conflicts	2	191859911	2	190995185	30083	39038
NM_018897.2(DNAH7):c.10753T>C (p.Phe3585Leu)	DNAH7	Seizures|Hypoplasia of the corpus callosum|Dyspnea|Abnormality of the basal ganglia|Abnormal muscle tone	Pathogenic	no assertion criteria provided	2	196651859	2	195787135	375378	362134
NM_020760.3(HECW2):c.4334A>G (p.Glu1445Gly)	HECW2	not provided|Neurodevelopmental disorder with hypotonia, seizures, and absent language	Uncertain significance(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	2	197084837	2	196220113	242326	243871
NM_002156.4(HSPD1):c.1607C>T (p.Ala536Val)	HSPD1	Spastic paraplegia 13	Likely pathogenic(Last reviewed: Apr 15, 2014)	criteria provided, single submitter	2	198351885	2	197487161	216941	213533
NM_001172509.1(SATB2):c.1375C>T (p.Arg459Ter)	SATB2	Chromosome 2q32-q33 deletion syndrome|Cleft palate, isolated|History of neurodevelopmental disorder	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	2	200193432	2	199328709	522269	512805
NM_015265.3(SATB2):c.1169C>T (p.Thr390Ile)	SATB2	Chromosome 2q32-q33 deletion syndrome	Likely pathogenic(Last reviewed: Jul 22, 2014)	criteria provided, single submitter	2	200213428	2	199348705	216996	213534
NM_033066.2(MPP4):c.946T>C (p.Trp316Arg)	MPP4	Global developmental delay|Seizures|High palate|Wide nasal bridge|Strabismus|Intellectual disability|Global developmental delay|Generalized hypotonia	Pathogenic	no assertion criteria provided	2	202539978	2	201675255	375383	362135
NM_006891.3(CRYGD):c.168C>G (p.Tyr56Ter)	CRYGD|LOC100507443	Cataract 4|Cataract	Conflicting interpretations of pathogenicity(Last reviewed: Nov 6, 2017)	criteria provided, conflicting interpretations	2	208988920	2	208124196	333874	287347
NM_006891.3(CRYGD):c.70C>T (p.Pro24Ser)	CRYGD|LOC100507443	Cataract 4	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	2	208989018	2	208124294	16942	31981
NM_000465.3(BARD1):c.1977A>G (p.Arg659=)	BARD1	Familial cancer of breast|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	2	215595159	2	214730435	127727	133184
NM_000465.3(BARD1):c.1409A>G (p.Asn470Ser)	BARD1	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 23, 2018)	criteria provided, conflicting interpretations	2	215632365	2	214767641	141739	151453
NM_020814.2(MARCH4):c.631A>G (p.Lys211Glu)	MARCH4	Frontotemporal dementia	Uncertain significance	no assertion criteria provided	2	217148338	2	216283615	427847	418804
NM_020814.2(MARCH4):c.39G>C (p.Trp13Cys)	MARCH4	Frontotemporal dementia	Likely benign	no assertion criteria provided	2	217234945	2	216370222	427848	418805
NM_025216.2(WNT10A):c.682T>A (p.Phe228Ile)	WNT10A	Odontoonychodermal dysplasia|Schopf-Schulz-Passarge syndrome|Tooth agenesis, selective, 4|not specified|not provided|Selective tooth agenesis|Inborn genetic diseases|Hypohidrotic ectodermal dysplasia	Conflicting interpretations of pathogenicity(Last reviewed: Aug 17, 2017)	criteria provided, conflicting interpretations	2	219755011	2	218890289	4462	19501
NM_001927.3(DES):c.38C>T (p.Ser13Phe)	DES	Primary dilated cardiomyopathy|Myofibrillar myopathy 1|not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, multiple submitters, no conflicts	2	220283222	2	219418500	44260	53427
NM_001927.3(DES):c.75A>G (p.Pro25=)	DES	Myofibrillar myopathy 1|Cardiomyopathy|not specified|not provided|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	Benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	2	220283259	2	219418537	36002	44666
NM_001927.3(DES):c.93T>C (p.Ser31=)	DES	Myofibrillar myopathy 1|Cardiomyopathy|not specified|not provided|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	Benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	2	220283277	2	219418555	36003	44667
NM_001927.3(DES):c.336_344del (p.Gln113_Leu115del)	DES	Myofibrillar myopathy 1	Pathogenic(Last reviewed: Oct 11, 2016)	no assertion criteria provided	2	220283520 - 220283528	2	219418798 - 219418806	548445	538929
NM_001927.3(DES):c.347A>G (p.Asn116Ser)	DES	Myofibrillar myopathy 1|not provided	Likely pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, multiple submitters, no conflicts	2	220283531	2	219418809	66411	77308
NM_001927.3(DES):c.372G>A (p.Glu124=)	DES	Myofibrillar myopathy 1|not specified|not provided|Muscular dystrophy, limb-girdle, type 2R|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	Benign(Last reviewed: Jul 26, 2018)	criteria provided, multiple submitters, no conflicts	2	220283556	2	219418834	44258	53425
NM_001927.3(DES):c.408C>T (p.Leu136=)	DES	Myofibrillar myopathy 1|not specified|Muscular dystrophy, limb-girdle, type 2R|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	Benign(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	2	220283592	2	219418870	44262	53429
NM_001927.3(DES):c.638C>T (p.Ala213Val)	DES	Myofibrillar myopathy 1|Myofibrillar myopathy|not specified|not provided|Muscular dystrophy, limb-girdle, type 2R|Congenital diaphragmatic hernia|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2018)	criteria provided, conflicting interpretations	2	220284876	2	219420154	44265	53432
NM_001927.3(DES):c.669T>C (p.Ile223=)	DES	Myofibrillar myopathy 1|Cardiomyopathy|not specified|Muscular dystrophy, limb-girdle, type 2R|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	Benign(Last reviewed: Jan 8, 2018)	criteria provided, multiple submitters, no conflicts	2	220285002	2	219420280	36001	44665
NM_001927.3(DES):c.735+1G>C	DES	Myofibrillar myopathy 1	Likely pathogenic(Last reviewed: Mar 5, 2014)	criteria provided, single submitter	2	220285069	2	219420347	163027	173632
NM_001927.3(DES):c.735+1G>A	DES	Myofibrillar myopathy 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	2	220285069	2	219420347	44268	53435
NM_001927.3(DES):c.792C>T (p.Asp264=)	DES	Myofibrillar myopathy 1|not specified|Muscular dystrophy, limb-girdle, type 2R|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	2	220285273	2	219420551	44271	53438
NM_001927.3(DES):c.828C>T (p.Asp276=)	DES	Myofibrillar myopathy 1|not specified|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	Benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	2	220285309	2	219420587	44272	53439
NM_001927.3(DES):c.893C>T (p.Ser298Leu)	DES	Myofibrillar myopathy 1|Cardiomyopathy|not provided|Muscular dystrophy, limb-girdle, type 2R|Dilated cardiomyopathy	Uncertain significance(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	2	220285374	2	219420652	66423	77320
NM_001927.3(DES):c.1014G>C (p.Leu338=)	DES	Myofibrillar myopathy 1|not specified|not provided|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	Benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	2	220285666	2	219420944	44242	53409
NM_001927.3(DES):c.1026C>T (p.Asn342=)	DES	Myofibrillar myopathy 1|not specified|Muscular dystrophy, limb-girdle, type 2R|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	Benign/Likely benign(Last reviewed: Jan 8, 2018)	criteria provided, multiple submitters, no conflicts	2	220286064	2	219421342	44243	53410
NM_001927.3(DES):c.1043A>C (p.Gln348Pro)	DES	Myofibrillar myopathy 1	Pathogenic(Last reviewed: Feb 11, 2019)	no assertion criteria provided	2	220286081	2	219421359	617786	609183
NM_001927.3(DES):c.1104G>A (p.Ala368=)	DES	Myofibrillar myopathy 1|not specified|not provided|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	Benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	2	220286142	2	219421420	44245	53412
NM_001927.3(DES):c.1216C>T (p.Arg406Trp)	DES	Myofibrillar myopathy 1|not provided|Muscular dystrophy, limb-girdle, type 2R	Pathogenic/Likely pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	2	220286254	2	219421532	16826	31865
NM_001927.3(DES):c.1255C>T (p.Pro419Ser)	DES	Myofibrillar myopathy 1|not provided	Likely pathogenic(Last reviewed: Mar 7, 2016)	criteria provided, single submitter	2	220288509	2	219423787	39718	48317
NM_001927.3(DES):c.1360C>T (p.Arg454Trp)	DES	Dilated cardiomyopathy 1I|Primary dilated cardiomyopathy|Myofibrillar myopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Muscular dystrophy, limb-girdle, type 2R	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	2	220290456	2	219425734	66402	77299
NM_001927.3(DES):c.1375G>A (p.Val459Ile)	DES	Primary dilated cardiomyopathy|Myofibrillar myopathy 1|not specified|not provided|Muscular dystrophy, limb-girdle, type 2R|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	220290674	2	219425952	44252	53419
NM_004438.4(EPHA4):c.2242G>A (p.Ala748Thr)	EPHA4	atypical cerebral palsy	Likely pathogenic	criteria provided, single submitter	2	222301223	2	221436503	431727	425211
NM_181459.3(PAX3):c.1230C>G (p.Tyr410Ter)	PAX3	Waardenburg syndrome type 1	Pathogenic(Last reviewed: May 15, 2018)	no assertion criteria provided	2	223066853	2	222202134	545017	535281
NM_181459.3(PAX3):c.1195C>G (p.His399Asp)	PAX3	Waardenburg syndrome type 1	Likely benign(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	2	223066888	2	222202169	488039	481047
NM_181457.3(PAX3):c.944C>A (p.Thr315Lys)	PAX3	Waardenburg syndrome type 1|Craniofacial deafness hand syndrome|Waardenburg syndrome|not specified|Congenital diaphragmatic hernia	Conflicting interpretations of pathogenicity(Last reviewed: Sep 8, 2017)	criteria provided, conflicting interpretations	2	223085955	2	222221236	218940	215772
NM_181457.3(PAX3):c.879_880insG (p.Phe294Valfs)	PAX3	Waardenburg syndrome	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	2	223086019 - 223086020	2	222221300 - 222221301	505425	496265
NM_181457.3(PAX3):c.873_874insC (p.Gly292Argfs)	PAX3	Waardenburg syndrome	Pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	2	223086025 - 223086026	2	222221306 - 222221307	517263	496266
NM_181459.3(PAX3):c.790C>T (p.Gln264Ter)	PAX3	Waardenburg syndrome type 1	Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	2	223096799	2	222232080	488036	481048
NM_181459.3(PAX3):c.727_739del (p.Tyr243Ilefs)	PAX3	Waardenburg syndrome type 1	Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	2	223096850 - 223096862	2	222232131 - 222232143	488033	481049
NM_181457.3(PAX3):c.668G>A (p.Arg223Gln)	PAX3	Waardenburg syndrome	Pathogenic(Last reviewed: Jun 23, 2015)	criteria provided, single submitter	2	223096921	2	222232202	228387	228932
NM_181459.3(PAX3):c.464delG (p.Ser155Thrfs)	PAX3	Waardenburg syndrome type 1	Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	2	223159008	2	222294289	488037	481050
NM_181459.3(PAX3):c.415A>T (p.Lys139Ter)	PAX3	Waardenburg syndrome type 1	Pathogenic(Last reviewed: Mar 10, 2016)	no assertion criteria provided	2	223160283	2	222295564	235094	236857
NM_181459.3(PAX3):c.256A>T (p.Ile86Phe)	PAX3	Waardenburg syndrome type 1	Likely pathogenic(Last reviewed: May 15, 2018)	no assertion criteria provided	2	223161762	2	222297043	545018	535282
NM_181459.3(PAX3):c.149_160del (p.Pro50_Asn53del)	PAX3	Waardenburg syndrome type 1	Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	2	223161858 - 223161869	2	222297139 - 222297150	488035	481051
NM_181459.3(PAX3):c.142G>C (p.Gly48Arg)	PAX3	Waardenburg syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, multiple submitters, no conflicts	2	223161876	2	222297157	488038	481053
NM_181459.3(PAX3):c.142G>T (p.Gly48Cys)	PAX3	Waardenburg syndrome type 1	Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	2	223161876	2	222297157	488032	481052
NM_181459.3(PAX3):c.124G>C (p.Gly42Arg)	PAX3	Waardenburg syndrome type 1	Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, multiple submitters, no conflicts	2	223161894	2	222297175	488034	481054
NM_003590.4(CUL3):c.1377G>A (p.Lys459=)	CUL3	Pseudohypoaldosteronism, type 2	Likely pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, single submitter	2	225368369	2	224503652	266041	260864
t(2;14)(q36.1;q12)	FOXG1|WDFY1	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	2	224764222 - 224765719			426094	414698
NM_000092.4(COL4A4):c.2638_2639delGC (p.Ala880Thrfs)	COL4A4	Alport syndrome, autosomal recessive	Pathogenic	no assertion criteria provided	2	227920738 - 227920739	2	227056022 - 227056023	441259	434902
NM_001284214.1(TRIP12):c.1279delT (p.Ser427Leufs)	TRIP12	TRIP12 associated autism with facial dysmorphology	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	2	230695547	2	229830831	522807	513412
NM_001103146.1(GIGYF2):c.2378C>T (p.Ala793Val)	GIGYF2	Parkinson disease 11	Likely pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	2	233684544	2	232819834	216934	213536
NM_004369.3(COL6A3):c.3844G>A (p.Val1282Met)	COL6A3	Bethlem myopathy 1|Collagen VI-related myopathy|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2016)	criteria provided, conflicting interpretations	2	238280816	2	237372173	266039	260862
NM_004321.7(KIF1A):c.38G>A (p.Arg13His)	KIF1A	Spastic paraplegia 30, autosomal recessive|Hereditary sensory and autonomic neuropathy type IIC|Mental retardation, autosomal dominant 9|not provided|Spastic paraplegia	Pathogenic/Likely pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	2	241737132	2	240797715	209165	205730
NC_000002.11:g.(?_228230759)_(228234864_?)del	TM4SF20	Specific language impairment 5	Pathogenic(Last reviewed: Aug 8, 2013)	criteria provided, single submitter	2	228230759 - 228234864			243063	244144
NM_001127366.2(PAX3):c.(?_-77)_(583_?)+547del	PAX3|CCDC140|LOC107980445	Waardenburg syndrome	Pathogenic(Last reviewed: Oct 7, 2015)	criteria provided, single submitter	2	223158339 - 223163411	2	222293620 - 222298692	228386	228526
NM_022336.3(EDAR):c.(?_509)_(803_?)+34del	RANBP2|EDAR	Hypohidrotic ectodermal dysplasia	Pathogenic(Last reviewed: Mar 9, 2015)	criteria provided, single submitter	2	109526882 - 109529154	2	108910426 - 108912698	228341	228525
NC_000002.12:g.(32083472_32084485)_(32142333_32142854)del	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32308541 - 32367923	2	32083472 - 32142854	219089	216779
NG_008730.1:g.(81616_82892)_(88338_90767)del	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	2	32365295 - 32374446	2	32140226 - 32149377	219084	216774
NM_014461.3(CNTN6):c.566C>A (p.Ser189Ter)	CNTN6	Autistic behavior	Likely pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	3	1337396	3	1295712	548950	539432
NM_002222.5(ITPR1):c.800C>T (p.Thr267Met)	ITPR1	Spinocerebellar ataxia 29|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Feb 9, 2018)	criteria provided, conflicting interpretations	3	4687357	3	4645673	208786	205242
NM_002222.5(ITPR1):c.830G>T (p.Ser277Ile)	ITPR1	Spinocerebellar ataxia 29	Likely pathogenic(Last reviewed: Oct 1, 2013)	criteria provided, single submitter	3	4687387	3	4645703	216945	213552
NM_002222.5(ITPR1):c.1962G>A (p.Lys654=)	ITPR1	not specified|Spinocerebellar Ataxia, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	4712413	3	4670729	129298	134744
NM_002222.5(ITPR1):c.2613A>C (p.Leu871=)	ITPR1	not specified|Spinocerebellar Ataxia, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	4716811	3	4675127	129299	134745
NM_002222.5(ITPR1):c.6507A>G (p.Lys2169=)	ITPR1	not specified|Spinocerebellar Ataxia, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	4829711	3	4788027	129300	134746
NM_002222.5(ITPR1):c.6528A>G (p.Thr2176=)	ITPR1	not specified|Spinocerebellar Ataxia, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	4829732	3	4788048	129301	134747
NM_002222.5(ITPR1):c.6865C>T (p.Leu2289=)	ITPR1	not specified|Spinocerebellar Ataxia, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	4842231	3	4800547	129302	134748
NM_002222.5(ITPR1):c.7446T>C (p.Thr2482=)	ITPR1	not specified|Spinocerebellar Ataxia, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	4856180	3	4814496	129303	134749
NM_002222.5(ITPR1):c.7500G>A (p.Lys2500=)	ITPR1	not specified|Spinocerebellar Ataxia, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	4856234	3	4814550	129304	134750
NM_001099952.2(ITPR1):c.7640G>C (p.Gly2547Ala)	ITPR1	Spinocerebellar ataxia 29	Likely pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	3	4856819	3	4815135	243076	244153
NM_033337.2(CAV3):c.27C>T (p.Leu9=)	CAV3|SSUH2	Limb-girdle muscular dystrophy, type 1C|Caveolinopathy|Long QT syndrome|Distal myopathy, Tateyama type|Romano-Ward syndrome|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Limb-Girdle Muscular Dystrophy, Dominant	Benign/Likely benign(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	3	8775589	3	8733903	31716	40376
NM_033337.2(CAV3):c.80G>A (p.Arg27Gln)	CAV3|SSUH2	Elevated serum creatine phosphokinase|Limb-girdle muscular dystrophy, type 1C|Rippling muscle disease 2|Long QT syndrome|Distal myopathy, Tateyama type|not provided	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	3	8775642	3	8733956	8283	23322
NM_033337.2(CAV3):c.99C>T (p.Asn33=)	CAV3|SSUH2	Limb-girdle muscular dystrophy, type 1C|Caveolinopathy|Long QT syndrome|Distal myopathy, Tateyama type|Romano-Ward syndrome|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Limb-Girdle Muscular Dystrophy, Dominant	Benign/Likely benign(Last reviewed: May 1, 2017)	criteria provided, multiple submitters, no conflicts	3	8775661	3	8733975	31709	40369
NM_033337.2(CAV3):c.123T>C (p.Phe41=)	CAV3	Limb-girdle muscular dystrophy, type 1C|Caveolinopathy|Long QT syndrome|Distal myopathy, Tateyama type|Romano-Ward syndrome|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Limb-Girdle Muscular Dystrophy, Dominant	Benign/Likely benign(Last reviewed: Apr 29, 2017)	criteria provided, multiple submitters, no conflicts	3	8787220	3	8745534	31717	40377
NM_033337.2(CAV3):c.166G>A (p.Gly56Ser)	CAV3	Limb-girdle muscular dystrophy, type 1C|Limb-girdle muscular dystrophy|Long QT syndrome|Distal myopathy, Tateyama type|not specified|not provided|Cardiovascular phenotype|Limb-Girdle Muscular Dystrophy, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Aug 8, 2017)	criteria provided, conflicting interpretations	3	8787263	3	8745577	8278	23317
NM_033337.2(CAV3):c.171G>A (p.Val57=)	CAV3	Limb-girdle muscular dystrophy, type 1C|Caveolinopathy|Long QT syndrome|Distal myopathy, Tateyama type|Romano-Ward syndrome|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Limb-Girdle Muscular Dystrophy, Dominant	Benign/Likely benign(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	3	8787268	3	8745582	31714	40374
NM_000551.3(VHL):c.-75_-55del	VHL	Von Hippel-Lindau syndrome	Likely pathogenic(Last reviewed: Dec 9, 2014)	criteria provided, single submitter	3	10183457 - 10183477	3	10141773 - 10141793	166561	173876
NM_000551.3(VHL):c.154G>A (p.Glu52Lys)	VHL	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 18, 2018)	criteria provided, conflicting interpretations	3	10183685	3	10142001	161402	171078
NM_000551.3(VHL):c.235C>T (p.Arg79Cys)	VHL	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not provided|Polycythemia	Uncertain significance(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	3	10183766	3	10142082	161400	171079
NM_000551.3(VHL):c.242C>T (p.Pro81Leu)	VHL	Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Jun 5, 2017)	criteria provided, multiple submitters, no conflicts	3	10183773	3	10142089	36899	45560
NM_000551.3(VHL):c.256C>T (p.Pro86Ser)	VHL	Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, multiple submitters, no conflicts	3	10183787	3	10142103	178692	173736
NM_000551.3(VHL):c.293A>C (p.Tyr98Ser)	VHL	Pheochromocytoma|Von Hippel-Lindau syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 26, 2016)	no assertion criteria provided	3	10183824	3	10142140	219160	217068
NM_000551.3(VHL):c.319C>G (p.Arg107Gly)	VHL	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Mar 20, 2015)	criteria provided, single submitter	3	10183850	3	10142166	43599	52768
NM_000551.3(VHL):c.320G>C (p.Arg107Pro)	VHL	Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, multiple submitters, no conflicts	3	10183851	3	10142167	36900	45561
NM_000551.3(VHL):c.371C>T (p.Thr124Ile)	VHL|LOC107303340	Von Hippel-Lindau syndrome|not provided	Likely pathogenic(Last reviewed: Jan 23, 2017)	criteria provided, multiple submitters, no conflicts	3	10188228	3	10146544	36902	45563
NM_000551.3(VHL):c.388G>C (p.Val130Leu)	VHL|LOC107303340	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, multiple submitters, no conflicts	3	10188245	3	10146561	2229	17268
NM_000551.3(VHL):c.408delT (p.Phe136Leufs)	VHL|LOC107303340	Von Hippel-Lindau syndrome|not provided	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, multiple submitters, no conflicts	3	10188265	3	10146581	43601	52770
NM_000551.3(VHL):c.479A>T (p.Glu160Val)	VHL|LOC107303340	Pheochromocytoma	Likely pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	3	10191486	3	10149802	219157	217069
NM_000551.3(VHL):c.481C>T (p.Arg161Ter)	VHL|LOC107303340	Von Hippel-Lindau syndrome|Renal cell carcinoma, papillary, 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	3	10191488	3	10149804	2217	17256
NM_000551.3(VHL):c.499C>T (p.Arg167Trp)	VHL|LOC107303340	Erythrocytosis, familial, 2|Pheochromocytoma|Von Hippel-Lindau syndrome|Renal cell carcinoma, papillary, 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	3	10191506	3	10149822	2218	17257
NM_000551.3(VHL):c.500G>A (p.Arg167Gln)	VHL|LOC107303340	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, multiple submitters, no conflicts	3	10191507	3	10149823	2216	17255
NM_000551.3(VHL):c.509T>C (p.Val170Ala)	VHL|LOC107303340	Pheochromocytoma	Likely pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	3	10191516	3	10149832	219159	217070
NM_000551.3(VHL):c.524A>G (p.Tyr175Cys)	VHL|LOC107303340	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	3	10191531	3	10149847	36905	45566
NM_000551.3(VHL):c.538A>G (p.Ile180Val)	VHL|LOC107303340	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	3	10191545	3	10149861	161401	171080
NM_000551.3(VHL):c.548C>G (p.Ser183Trp)	VHL|LOC107303340	Pheochromocytoma	Likely pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	3	10191555	3	10149871	219158	217071
NM_000551.3(VHL):c.556G>A (p.Glu186Lys)	VHL|LOC107303340	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not specified|not provided	Uncertain significance(Last reviewed: Mar 27, 2018)	criteria provided, multiple submitters, no conflicts	3	10191563	3	10149879	161403	171081
NM_000551.3(VHL):c.562C>G (p.Leu188Val)	VHL|LOC107303340	Erythrocytosis, familial, 2|Pheochromocytoma|Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2018)	criteria provided, conflicting interpretations	3	10191569	3	10149885	2225	17264
NM_000551.3(VHL):c.588dupA (p.Asp197Argfs)	VHL|LOC107303340	Pheochromocytoma	Likely pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	3	10191595	3	10149911	219156	217072
NM_000551.3(VHL):c.598C>T (p.Arg200Trp)	VHL|LOC107303340	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Acute leukemia of ambiguous lineage	Conflicting interpretations of pathogenicity(Last reviewed: Jun 28, 2018)	criteria provided, conflicting interpretations	3	10191605	3	10149921	2232	17271
NM_003042.3(SLC6A1):c.131G>A (p.Arg44Gln)	SLC6A1|SLC6A1-AS1	Myoclonic-atonic epilepsy	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	3	11059028	3	11017342	192368	190155
NM_015869.4(PPARG):c.34C>G (p.Pro12Ala)	PPARG	Obesity|Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension|not specified|Familial partial lipodystrophy	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	12393125	3	12351626	130019	135465
NM_015869.4(PPARG):c.1348A>C (p.Lys450Gln)	PPARG	not provided	Uncertain significance(Last reviewed: Oct 17, 2013)	criteria provided, single submitter	3	12475474	3	12433975	130018	135464
NM_015869.4(PPARG):c.1431C>T (p.His477=)	PPARG	Glioma susceptibility 1|Obesity|Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension|not specified|Familial partial lipodystrophy	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	12475557	3	12434058	8139	23178
NM_002880.3(RAF1):c.1472C>T (p.Thr491Ile)	RAF1	Noonan syndrome with multiple lentigines|Noonan syndrome|not provided|Rasopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	3	12627244	3	12585745	21342	34194
NM_002880.3(RAF1):c.1457A>G (p.Asp486Gly)	RAF1	Noonan syndrome|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	3	12627259	3	12585760	40618	49088
NM_002880.3(RAF1):c.1423T>C (p.Phe475Leu)	RAF1	Noonan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	3	12627293	3	12585794	40617	49087
NM_002880.3(RAF1):c.788T>G (p.Val263Gly)	RAF1	Noonan syndrome|not provided|Rasopathy	Likely pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	3	12645681	3	12604182	40607	49077
NM_002880.3(RAF1):c.782C>T (p.Pro261Leu)	RAF1	Noonan syndrome 5|Noonan syndrome|not provided	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	3	12645687	3	12604188	120246	125840
NM_002880.3(RAF1):c.781C>T (p.Pro261Ser)	RAF1	Noonan syndrome 5|Primary familial hypertrophic cardiomyopathy|Noonan syndrome|not provided|Rasopathy|Inborn genetic diseases|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	3	12645688	3	12604189	13958	28997
NM_002880.3(RAF1):c.775T>C (p.Ser259Pro)	RAF1	Noonan syndrome	Likely pathogenic(Last reviewed: Oct 8, 2015)	criteria provided, single submitter	3	12645694	3	12604195	228288	229012
NM_002880.3(RAF1):c.770C>T (p.Ser257Leu)	RAF1	LEOPARD syndrome 2|Malignant melanoma of skin|Noonan syndrome 5|Noonan syndrome with multiple lentigines|Lung adenocarcinoma|Noonan syndrome|not provided|Rasopathy|Cardiomyopathy, dilated, 1NN|Neoplasm of the large intestine|Inborn genetic diseases|Colorectal Neoplasms|Adenocarcinoma of stomach	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	3	12645699	3	12604200	13957	28996
NM_002880.3(RAF1):c.769T>C (p.Ser257Pro)	RAF1	Primary familial hypertrophic cardiomyopathy|Noonan syndrome|not provided|Rasopathy|Cutaneous melanoma	Likely pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	3	12645700	3	12604201	40600	49070
NM_002880.3(RAF1):c.766A>G (p.Arg256Gly)	RAF1	Noonan syndrome|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	3	12645703	3	12604204	44631	53798
NM_002880.3(RAF1):c.524A>G (p.His175Arg)	RAF1	Noonan syndrome	Pathogenic(Last reviewed: May 23, 2013)	criteria provided, single submitter	3	12650322	3	12608823	40594	49064
NM_024334.2(TMEM43):c.504A>T (p.Lys168Asn)	TMEM43	Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	14174427	3	14132927	46148	55313
NM_024334.2(TMEM43):c.536T>C (p.Met179Thr)	TMEM43	Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	14175262	3	14133762	46150	55315
NM_024334.2(TMEM43):c.797G>A (p.Arg266Gln)	TMEM43	Arrhythmogenic right ventricular cardiomyopathy, type 5|Arrhythmogenic right ventricular cardiomyopathy	Uncertain significance(Last reviewed: Nov 14, 2017)	criteria provided, multiple submitters, no conflicts	3	14177323	3	14135823	36872	45533
NM_024334.2(TMEM43):c.853C>T (p.Leu285Phe)	TMEM43	not provided	Uncertain significance(Last reviewed: Oct 23, 2013)	criteria provided, single submitter	3	14177379	3	14135879	130595	136041
NM_024334.2(TMEM43):c.909C>T (p.Ser303=)	TMEM43	Arrhythmogenic right ventricular cardiomyopathy, type 5|Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Aug 15, 2017)	criteria provided, multiple submitters, no conflicts	3	14180706	3	14139206	46154	55319
NM_024334.2(TMEM43):c.1021C>T (p.Arg341Ter)	TMEM43	Cardiomyopathy	Likely pathogenic	criteria provided, single submitter	3	14183113	3	14141613	217494	214104
NM_024334.2(TMEM43):c.1073C>T (p.Ser358Leu)	TMEM43	Arrhythmogenic right ventricular cardiomyopathy, type 5|Arrhythmogenic right ventricular cardiomyopathy|not provided|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	3	14183165	3	14141665	734	15773
NM_001128177.1(THRB):c.1351T>G (p.Phe451Val)	THRB	Thyroid hormone resistance, generalized, autosomal dominant	Likely pathogenic(Last reviewed: Jan 22, 2016)	criteria provided, single submitter	3	24164410	3	24122919	375302	362074
NM_001128177.1(THRB):c.1326_1327delGAinsAT (p.Met442_Lys443delinsIleTer)	THRB	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	3	24164434 - 24164435	3	24122943 - 24122944	545656	536152
NM_001252634.1(THRB):c.1313G>A (p.Arg438His)	THRB	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Jan 20, 2012)	no assertion criteria provided	3	24164448	3	24122957	12559	27598
NM_001128177.1(THRB):c.1286G>A (p.Arg429Gln)	THRB	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	3	24164475	3	24122984	548123	538610
NM_001128177.1(THRB):c.1021C>G (p.Leu341Val)	THRB	Thyroid hormone resistance, generalized, autosomal dominant	Likely pathogenic(Last reviewed: Apr 5, 2017)	no assertion criteria provided	3	24169113	3	24127622	429021	420977
NM_001252634.1(THRB):c.1012C>T (p.Arg338Trp)	THRB	Thyroid hormone resistance, selective pituitary|Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Jun 25, 2013)	no assertion criteria provided	3	24169122	3	24127631	12558	27597
NM_001252634.1(THRB):c.959G>A (p.Arg320His)	THRB	Thyroid hormone resistance, generalized, autosomal dominant|Inborn genetic diseases	Uncertain significance(Last reviewed: Feb 2, 2015)	criteria provided, single submitter	3	24169175	3	24127684	12553	27592
NM_001024847.2(TGFBR2):c.1060G>A (p.Ala354Thr)	TGFBR2	Loeys-Dietz syndrome 1|not specified	Uncertain significance(Last reviewed: Aug 19, 2014)	criteria provided, multiple submitters, no conflicts	3	30713660	3	30672168	161395	171082
NM_003242.5(TGFBR2):c.1151A>G (p.Asn384Ser)	TGFBR2	Loeys-Dietz syndrome	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	3	30713826	3	30672334	36860	45521
NM_003242.5(TGFBR2):c.1159G>A (p.Val387Met)	TGFBR2	Marfan syndrome|Congenital aneurysm of ascending aorta|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|Dilatation of the thoracic aorta|Thoracic aortic dissection	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2018)	criteria provided, conflicting interpretations	3	30713834	3	30672342	44651	53818
NM_003242.5(TGFBR2):c.1238T>A (p.Leu413Gln)	TGFBR2	Loeys-Dietz syndrome 2	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	3	30713913	3	30672421	561131	552072
NM_001024847.2(TGFBR2):c.1456T>C (p.Cys486Arg)	TGFBR2	Loeys-Dietz syndrome 2	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	3	30715723	3	30674231	393299	380155
NM_003242.5(TGFBR2):c.1408T>G (p.Tyr470Asp)	TGFBR2	Loeys-Dietz syndrome 2|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 9, 2015)	criteria provided, multiple submitters, no conflicts	3	30729887	3	30688395	217016	213550
NM_003242.5(TGFBR2):c.1524+1G>A	TGFBR2	Loeys-Dietz syndrome	Likely pathogenic(Last reviewed: Nov 14, 2014)	criteria provided, single submitter	3	30730004	3	30688512	165395	173914
NM_003242.5(TGFBR2):c.1591G>A (p.Ala531Thr)	TGFBR2	Thoracic aortic aneurysm and aortic dissection	Likely pathogenic(Last reviewed: Aug 19, 2014)	criteria provided, single submitter	3	30732978	3	30691486	165399	173916
NM_001024847.2(TGFBR2):c.1732T>A (p.Ser578Thr)	TGFBR2	Marfan syndrome|Congenital aneurysm of ascending aorta|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Cardiovascular phenotype|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	3	30733044	3	30691552	161394	171083
NM_000249.3(MLH1):c.109G>C (p.Glu37Gln)	MLH1	Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Conflicting interpretations of pathogenicity(Last reviewed: Feb 7, 2018)	criteria provided, conflicting interpretations	3	37035147	3	36993656	231565	232880
NM_000249.3(MLH1):c.199G>A (p.Gly67Arg)	MLH1	Lynch syndrome II|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37038192	3	36996701	89992	95466
NM_000249.3(MLH1):c.298C>T (p.Arg100Ter)	MLH1	Lynch syndrome II|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37042536	3	37001045	36550	45212
NM_000249.3(MLH1):c.350C>T (p.Thr117Met)	MLH1	Lynch syndrome I|Lynch syndrome II|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37045935	3	37004444	17094	32133
NM_000249.3(MLH1):c.453G>A (p.Thr151=)	MLH1	Lynch syndrome I|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Jun 13, 2018)	reviewed by expert panel	3	37048554	3	37007063	90229	95703
NM_000249.3(MLH1):c.454-1G>A	MLH1	Lynch syndrome II|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37050304	3	37008813	36553	45215
NM_000249.3(MLH1):c.793C>T (p.Arg265Cys)	MLH1	Lynch syndrome II|Carcinoma of colon|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37058999	3	37017508	29654	38609
NM_000249.3(MLH1):c.803A>G (p.Glu268Gly)	MLH1	Lynch syndrome II|Lynch syndrome|not specified|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37059009	3	37017518	90382	95856
NM_000249.3(MLH1):c.836T>G (p.Val279Gly)	MLH1	Lynch syndrome	Likely benign(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	3	37059042	3	37017551	446501	440016
NM_000249.3(MLH1):c.977T>C (p.Val326Ala)	MLH1	Lynch syndrome I|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37061893	3	37020402	42496	51666
NM_000249.3(MLH1):c.1013A>G (p.Asn338Ser)	MLH1	Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37061929	3	37020438	89605	95079
NM_000249.3(MLH1):c.1148T>C (p.Met383Thr)	MLH1	Lynch syndrome II|Ovarian cancer|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Jun 24, 2018)	criteria provided, multiple submitters, no conflicts	3	37067237	3	37025746	127609	133066
NM_000249.3(MLH1):c.1153C>T (p.Arg385Cys)	MLH1	Lynch syndrome I|Lynch syndrome II|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Nov 24, 2015)	reviewed by expert panel	3	37067242	3	37025751	89653	95127
NM_000249.3(MLH1):c.1321G>A (p.Ala441Thr)	MLH1	Lynch syndrome I|Lynch syndrome II|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37067410	3	37025919	89696	95170
NM_000249.3(MLH1):c.1381A>T (p.Lys461Ter)	MLH1	Lynch syndrome II|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37067470	3	37025979	36540	45202
NM_000249.3(MLH1):c.1474G>A (p.Ala492Thr)	MLH1	Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37070339	3	37028848	89750	95224
NM_000249.3(MLH1):c.1637A>G (p.Lys546Arg)	MLH1	Lynch syndrome II|Lynch syndrome|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2017)	criteria provided, conflicting interpretations	3	37081755	3	37040264	127617	133074
NM_000249.3(MLH1):c.1668-1G>A	MLH1	Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Likely pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37083758	3	37042267	89826	95300
NM_000249.3(MLH1):c.1853A>C (p.Lys618Thr)	MLH1	Lynch syndrome I|Lynch syndrome II|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37089131	3	37047640	89906	95380
NM_000249.3(MLH1):c.1937A>G (p.Tyr646Cys)	MLH1	Lynch syndrome II|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37090048	3	37048557	36545	45207
NM_000249.3(MLH1):c.1963A>G (p.Ile655Val)	MLH1	Endometrial carcinoma|Lynch syndrome II|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Likely benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37090074	3	37048583	41637	50076
NM_000249.3(MLH1):c.1964T>C (p.Ile655Thr)	MLH1	Lynch syndrome II|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37090075	3	37048584	41638	50077
NM_000249.3(MLH1):c.2066A>G (p.Gln689Arg)	MLH1	Lynch syndrome II|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37090471	3	37048980	90016	95490
NM_000249.3(MLH1):c.2252A>G (p.Lys751Arg)	MLH1	Lynch syndrome II|Lynch syndrome|not specified|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Likely benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37092125	3	37050634	90100	95574
NM_000335.4(SCN5A):c.5958C>A (p.Asn1986Lys)	SCN5A	Atrial fibrillation|Atrial fibrillation, familial, 10|Brugada syndrome|not specified|not provided	Uncertain significance(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	3	38591902	3	38550411	30045	39000
NM_000335.4(SCN5A):c.5900T>G (p.Ile1967Ser)	SCN5A	Brugada syndrome	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	3	38591960	3	38550469	68017	78909
NM_000335.4(SCN5A):c.5870G>A (p.Arg1957Gln)	SCN5A	Long QT syndrome|Brugada syndrome|not specified|not provided	Uncertain significance(Last reviewed: Sep 14, 2017)	criteria provided, multiple submitters, no conflicts	3	38591990	3	38550499	68015	78907
NM_000335.4(SCN5A):c.5848G>T (p.Val1950Leu)	SCN5A	Atrial fibrillation|Long QT syndrome|Brugada syndrome|not specified|not provided|Ventricular tachycardia|Ventricular tachycardia|Pulmonary valve stenosis (rare)|Cardiovascular phenotype|Ventricular tachycardia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2018)	criteria provided, conflicting interpretations	3	38592012	3	38550521	36765	45426
NM_198056.2(SCN5A):c.5849A>G (p.Tyr1950Cys)	SCN5A	Brugada syndrome|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: May 12, 2018)	criteria provided, multiple submitters, no conflicts	3	38592014	3	38550523	216841	212332
NM_000335.4(SCN5A):c.5708C>T (p.Ser1903Leu)	SCN5A	Long QT syndrome|Brugada syndrome|not specified|not provided|Death in infancy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Sep 11, 2017)	criteria provided, conflicting interpretations	3	38592152	3	38550661	48310	57473
NM_000335.4(SCN5A):c.5686C>T (p.Arg1896Trp)	SCN5A	Long QT syndrome|Brugada syndrome|not specified|not provided	Uncertain significance(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	3	38592174	3	38550683	68003	78895
NM_000335.4(SCN5A):c.5665G>A (p.Glu1889Lys)	SCN5A	Long QT syndrome|not specified	Uncertain significance(Last reviewed: Aug 21, 2017)	criteria provided, single submitter	3	38592195	3	38550704	375856	362737
NM_198056.2(SCN5A):c.5540G>A (p.Arg1847His)	SCN5A	Brugada syndrome 1|Brugada syndrome|not specified	Uncertain significance(Last reviewed: Aug 28, 2017)	criteria provided, multiple submitters, no conflicts	3	38592323	3	38550832	48309	57472
NM_000335.4(SCN5A):c.5504T>C (p.Ile1835Thr)	SCN5A	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1E|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Mar 20, 2018)	criteria provided, conflicting interpretations	3	38592356	3	38550865	39445	48044
NM_000335.4(SCN5A):c.5474G>A (p.Arg1825His)	SCN5A	Long QT syndrome 3|SUDDEN INFANT DEATH SYNDROME|Brugada syndrome|not specified|Congenital long QT syndrome|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	3	38592386	3	38550895	9389	24428
NM_000335.4(SCN5A):c.5357G>A (p.Ser1786Asn)	SCN5A	Long QT syndrome|Brugada syndrome|not specified|not provided|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2018)	criteria provided, conflicting interpretations	3	38592503	3	38551012	67988	78880
NM_198056.2(SCN5A):c.5350G>A (p.Glu1784Lys)	SCN5A	Brugada syndrome 1|Long QT syndrome 3|Long QT syndrome 1|Sinus node disease|Brugada syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	3	38592513	3	38551022	9377	24416
NM_000335.4(SCN5A):c.5333C>T (p.Thr1778Met)	SCN5A	Long QT syndrome|Brugada syndrome|not specified|Congenital long QT syndrome|Cardiovascular phenotype	Uncertain significance(Last reviewed: Oct 17, 2017)	criteria provided, multiple submitters, no conflicts	3	38592527	3	38551036	67985	78877
NM_000335.4(SCN5A):c.5126C>T (p.Ser1709Leu)	SCN5A	Brugada syndrome 1|Paroxysmal familial ventricular fibrillation 1|Brugada syndrome|not provided|Ventricular fibrillation|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: May 16, 2018)	criteria provided, multiple submitters, no conflicts	3	38592734	3	38551243	9383	24422
NM_198056.2(SCN5A):c.4772G>A (p.Trp1591Ter)	SCN5A	Brugada syndrome	Pathogenic(Last reviewed: Jul 1, 2015)	criteria provided, single submitter	3	38595811	3	38554320	217838	214484
NM_000335.4(SCN5A):c.4591G>A (p.Val1531Ile)	SCN5A	Long QT syndrome|Brugada syndrome|not specified|Congenital long QT syndrome	Likely benign(Last reviewed: Nov 3, 2017)	criteria provided, multiple submitters, no conflicts	3	38595989	3	38554498	67912	78805
NM_198056.2(SCN5A):c.3995delC (p.Pro1332Argfs)	SCN5A	Brugada syndrome	Pathogenic(Last reviewed: Oct 21, 2013)	criteria provided, single submitter	3	38601888	3	38560397	179338	173922
NM_198056.2(SCN5A):c.3963+1G>A	SCN5A	Brugada syndrome|not provided	Likely pathogenic(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	3	38603905	3	38562414	132906	136655
NM_198056.2(SCN5A):c.3956G>T (p.Gly1319Val)	SCN5A	Long QT syndrome 3|Brugada syndrome|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	3	38603913	3	38562422	67838	78731
NM_000335.4(SCN5A):c.3919C>T (p.Leu1307Phe)	SCN5A	Brugada syndrome|not specified|not provided|Brugada syndrome, lidocaine-induced|Cardiovascular phenotype	Benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	3	38603947	3	38562456	67836	38448
NM_000335.4(SCN5A):c.3908C>T (p.Thr1303Met)	SCN5A	Long QT syndrome 3|Long QT syndrome|Brugada syndrome|not specified|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	3	38603958	3	38562467	67835	78729
NM_198056.2(SCN5A):c.3878T>C (p.Phe1293Ser)	SCN5A	Long QT syndrome|Brugada syndrome|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 28, 2017)	criteria provided, conflicting interpretations	3	38603991	3	38562500	67833	78727
NM_000335.4(SCN5A):c.3832G>A (p.Val1278Ile)	SCN5A	Primary dilated cardiomyopathy|Brugada syndrome|not specified	Uncertain significance(Last reviewed: Oct 3, 2017)	criteria provided, multiple submitters, no conflicts	3	38607905	3	38566414	67829	78723
NM_198056.2(SCN5A):c.3795G>T (p.Lys1265Asn)	SCN5A	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	3	38607945	3	38566454	427973	419267
NM_000335.4(SCN5A):c.3296C>T (p.Ala1099Val)	SCN5A|LOC110121269	Long QT syndrome|Brugada syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Uncertain significance(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	3	38620916	3	38579425	67789	78684
NM_000335.4(SCN5A):c.2944T>C (p.Cys982Arg)	SCN5A|LOC110121269	Sudden cardiac death|Brugada syndrome|not specified|not provided	Uncertain significance(Last reviewed: Apr 6, 2018)	criteria provided, multiple submitters, no conflicts	3	38622706	3	38581215	67769	78664
NM_198056.2(SCN5A):c.2582_2583delTT (p.Phe861Trpfs)	SCN5A	Brugada syndrome|not provided	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, multiple submitters, no conflicts	3	38627386 - 38627387	3	38585895 - 38585896	201561	196941
NM_198056.2(SCN5A):c.2533delG (p.Val845Cysfs)	SCN5A	Brugada syndrome|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	3	38627436	3	38585945	201559	196944
NM_000335.4(SCN5A):c.2497G>A (p.Gly833Arg)	SCN5A	Long QT syndrome 3|Long QT syndrome|Brugada syndrome|not specified|not provided	Uncertain significance(Last reviewed: Sep 25, 2017)	criteria provided, multiple submitters, no conflicts	3	38627472	3	38585981	67734	78629
NM_198056.2(SCN5A):c.2466G>A (p.Trp822Ter)	SCN5A	Brugada syndrome	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	3	38627503	3	38586012	505895	496298
NM_198056.2(SCN5A):c.2441G>A (p.Arg814Gln)	SCN5A	Brugada syndrome|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2018)	criteria provided, conflicting interpretations	3	38627528	3	38586037	67732	78627
NM_198056.2(SCN5A):c.2254G>A (p.Gly752Arg)	SCN5A	Brugada syndrome|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, multiple submitters, no conflicts	3	38639228	3	38597737	67723	78618
NM_000335.4(SCN5A):c.2074C>A (p.Gln692Lys)	SCN5A	Brugada syndrome 1|Long QT syndrome 3|Long QT syndrome|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Apr 16, 2018)	criteria provided, conflicting interpretations	3	38639408	3	38597917	67712	78607
NM_000335.4(SCN5A):c.2066G>A (p.Arg689His)	SCN5A	Long QT syndrome|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	Uncertain significance(Last reviewed: Apr 5, 2018)	criteria provided, multiple submitters, no conflicts	3	38639416	3	38597925	67710	78605
NM_198056.2(SCN5A):c.1943C>T (p.Pro648Leu)	SCN5A	Long QT syndrome 3|Long QT syndrome|Brugada syndrome|not specified|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 8, 2018)	criteria provided, conflicting interpretations	3	38640489	3	38598998	48292	57455
NM_198056.2(SCN5A):c.1936delC (p.Gln646Argfs)	SCN5A	Brugada syndrome|not provided	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, multiple submitters, no conflicts	3	38640496	3	38599005	179829	173788
NM_000335.4(SCN5A):c.1855C>T (p.Leu619Phe)	SCN5A	Long QT syndrome|Brugada syndrome|not provided	Likely pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	3	38645238	3	38603747	67693	78588
NM_000335.4(SCN5A):c.1852C>T (p.Leu618Phe)	SCN5A	Brugada syndrome|not specified|not provided|Long QT syndrome, drug-associated|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Feb 20, 2018)	criteria provided, multiple submitters, no conflicts	3	38645241	3	38603750	67692	78587
NM_000335.4(SCN5A):c.1844G>A (p.Gly615Glu)	SCN5A	Long QT syndrome 3|Brugada syndrome|not specified|Congenital long QT syndrome|Death in infancy|Death in early adulthood|Long QT syndrome, drug-associated|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 7, 2018)	criteria provided, conflicting interpretations	3	38645249	3	38603758	67691	78586
NM_198056.2(SCN5A):c.1756_1761delGCCCTC (p.Ala586_Leu587del)	SCN5A	Brugada syndrome|not specified|Sudden unexplained death	Conflicting interpretations of pathogenicity(Last reviewed: Nov 8, 2017)	criteria provided, conflicting interpretations	3	38645332 - 38645337	3	38603841 - 38603846	48291	57454
NM_000335.4(SCN5A):c.1714G>T (p.Ala572Ser)	SCN5A	Long QT syndrome|not specified|Congenital long QT syndrome	Uncertain significance(Last reviewed: Mar 31, 2016)	criteria provided, multiple submitters, no conflicts	3	38645379	3	38603888	67682	78577
NM_000335.4(SCN5A):c.1712G>T (p.Ser571Ile)	SCN5A	Long QT syndrome|Congenital long QT syndrome	Uncertain significance(Last reviewed: Aug 1, 2016)	no assertion criteria provided	3	38645381	3	38603890	67681	78576
NM_198056.2(SCN5A):c.1603C>T (p.Arg535Ter)	SCN5A	Brugada syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, multiple submitters, no conflicts	3	38645490	3	38603999	517279	496342
NM_198056.2(SCN5A):c.1567C>T (p.Arg523Cys)	SCN5A	Brugada syndrome 1|Long QT syndrome 3|Progressive familial heart block type 1A|Paroxysmal familial ventricular fibrillation 1|Dilated cardiomyopathy 1E|Wolff-Parkinson-White pattern|Atrial fibrillation, familial, 10|Brugada syndrome|not specified|Congenital long QT syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 7, 2018)	criteria provided, conflicting interpretations	3	38645526	3	38604035	67667	78562
NM_000335.4(SCN5A):c.1384G>A (p.Glu462Lys)	SCN5A	Long QT syndrome|Brugada syndrome|Congenital long QT syndrome	Uncertain significance(Last reviewed: May 4, 2017)	criteria provided, single submitter	3	38646354	3	38604863	67660	78556
NM_000335.4(SCN5A):c.1336G>A (p.Glu446Lys)	SCN5A	Primary dilated cardiomyopathy|Brugada syndrome|not specified|Cardiovascular phenotype|Dilated cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Apr 5, 2018)	criteria provided, conflicting interpretations	3	38647444	3	38605953	67656	78552
NM_000335.4(SCN5A):c.1282G>A (p.Glu428Lys)	SCN5A	Atrial fibrillation|Atrial fibrillation, familial, 10|not specified	Uncertain significance(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	3	38647498	3	38606007	30048	39003
NM_000335.4(SCN5A):c.865G>A (p.Gly289Ser)	SCN5A	Long QT syndrome|Congenital long QT syndrome	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	3	38651294	3	38609803	68050	78941
NM_198056.2(SCN5A):c.704-2A>G	SCN5A	Brugada syndrome	Likely pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	3	38651457	3	38609966	505834	496299
NM_000335.4(SCN5A):c.694G>A (p.Val232Ile)	SCN5A	Brugada syndrome|not specified|not provided|Brugada syndrome, lidocaine-induced|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2017)	criteria provided, conflicting interpretations	3	38655243	3	38613752	68037	24446
NM_000335.4(SCN5A):c.673C>T (p.Arg225Trp)	SCN5A	Long QT syndrome 3|Cardiac conduction defect, nonspecific|Brugada syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 15, 2017)	criteria provided, conflicting interpretations	3	38655264	3	38613773	68032	78924
NM_000335.4(SCN5A):c.659C>T (p.Thr220Ile)	SCN5A	Long QT syndrome 3|Sick sinus syndrome 1, autosomal recessive|Dilated cardiomyopathy 1E|Brugada syndrome|not specified|not provided|Familial dilated cardiomyopathy|Nodal rhythm|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 17, 2018)	criteria provided, conflicting interpretations	3	38655278	3	38613787	9396	24435
NM_000335.4(SCN5A):c.612-2A>G	SCN5A	Brugada syndrome	Likely pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	3	38655327	3	38613836	162501	172171
NM_198056.2(SCN5A):c.483-1G>A	SCN5A	Brugada syndrome|not provided	Likely pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, multiple submitters, no conflicts	3	38662463	3	38620972	201432	197008
NM_000335.4(SCN5A):c.414G>A (p.Met138Ile)	SCN5A	Atrial fibrillation	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	3	38663959	3	38622468	67865	78758
NM_198056.2(SCN5A):c.393-1C>T	SCN5A	Brugada syndrome	Likely pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	3	38663981	3	38622490	517200	496343
NM_001904.3(CTNNB1):c.14-4A>G	CTNNB1	not specified	Likely benign	no assertion criteria provided	3	41266013	3	41224522	128866	134314
NM_001904.3(CTNNB1):c.283C>T (p.Arg95Ter)	CTNNB1	not provided|Mental retardation, autosomal dominant 19|Inborn genetic diseases	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, multiple submitters, no conflicts	3	41266486	3	41224995	265443	259764
NM_001904.3(CTNNB1):c.495+1G>C	CTNNB1	Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	3	41266699	3	41225208	560987	552074
NM_001904.4(CTNNB1):c.1016_1025delCCACAAGCAGinsT (p.Thr339_Arg342delinsIle)	CTNNB1	Mental retardation, autosomal dominant 19	Likely pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter			3	41227287 - 41227296	598752	589801
NM_001904.3(CTNNB1):c.1163T>C (p.Leu388Pro)	CTNNB1	Mental retardation, autosomal dominant 19	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	3	41274913	3	41233422	560986	552075
NM_001904.3(CTNNB1):c.1271T>G (p.Leu424Arg)	CTNNB1	Mental retardation, autosomal dominant 19	Likely pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	3	41275105	3	41233614	216915	213551
NM_001904.3(CTNNB1):c.1516C>T (p.Leu506=)	CTNNB1	not specified	Likely benign	no assertion criteria provided	3	41275350	3	41233859	128867	134315
NM_001904.3(CTNNB1):c.1785C>T (p.Thr595=)	CTNNB1	not specified	Benign(Last reviewed: Mar 17, 2014)	criteria provided, single submitter	3	41277316	3	41235825	128868	134316
NM_001904.3(CTNNB1):c.2340C>T (p.Asp780=)	CTNNB1	not specified	Benign(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	3	41280827	3	41239336	128869	134317
NM_020208.3(SLC6A20):c.596C>T (p.Thr199Met)	SLC6A20	Hyperglycinuria|Iminoglycinuria, digenic	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	45814094	3	45772602	4845	19884
NM_000258.2(MYL3):c.530A>G (p.Glu177Gly)	MYL3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Apr 17, 2018)	criteria provided, multiple submitters, no conflicts	3	46899903	3	46858413	36648	45310
NM_000258.2(MYL3):c.466G>A (p.Val156Met)	MYL3	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Increased left ventricular wall thickness|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	3	46900980	3	46859490	31778	40438
NM_000258.2(MYL3):c.461G>A (p.Arg154His)	MYL3	Familial hypertrophic cardiomyopathy 8|Familial restrictive cardiomyopathy 1|Familial hypertrophic cardiomyopathy 1|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2017)	criteria provided, conflicting interpretations	3	46900985	3	46859495	14062	29101
NM_000258.2(MYL3):c.460C>T (p.Arg154Cys)	MYL3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	3	46900986	3	46859496	43124	52294
NM_000258.2(MYL3):c.235G>A (p.Val79Ile)	MYL3	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	3	46902238	3	46860748	161329	171084
NM_000258.2(MYL3):c.170C>G (p.Ala57Gly)	MYL3	Familial hypertrophic cardiomyopathy 8|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Sep 6, 2018)	criteria provided, conflicting interpretations	3	46902303	3	46860813	31780	40440
NM_138615.2(DHX30):c.1478G>A (p.Arg493His)	DHX30	Seizures|Short stature|Unsteady gait|Microcephaly|Strabismus|Oculomotor apraxia|NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE	Pathogenic(Last reviewed: May 21, 2018)	no assertion criteria provided	3	47888040	3	47846550	375374	362138
NM_138615.2(DHX30):c.1685A>G (p.His562Arg)	DHX30	Global developmental delay|Hearing impairment|Sleep disturbance|Muscular hypotonia of the trunk|Delayed speech and language development|Microcephaly|Strabismus|Global developmental delay|NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE	Pathogenic	criteria provided, single submitter	3	47888247	3	47846757	402130	389102
NM_138615.2(DHX30):c.2344C>T (p.Arg782Trp)	DHX30	Global developmental delay|Short stature|Failure to thrive|Hirsutism|EEG abnormality|Microcephaly|Intellectual disability|Global developmental delay|Generalized hypotonia|NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE	Pathogenic(Last reviewed: May 21, 2018)	no assertion criteria provided	3	47889727	3	47848237	375373	362139
NM_014966.3(DHX30):c.2606G>A (p.Arg869Gln)	DHX30	NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE	Likely pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	3	47890261	3	47848771	523233	513885
NM_000094.3(COL7A1):c.7867G>T (p.Gly2623Cys)	COL7A1	Pretibial epidermolysis bullosa	Pathogenic(Last reviewed: Sep 1, 1995)	no assertion criteria provided	3	48605531	3	48568098	17429	32468
NM_000094.3(COL7A1):c.6900+4A>G	COL7A1	Generalized dominant dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	3	48610100	3	48572667	374314	361178
NM_017730.3(QRICH1):c.1378C>T (p.Gln460Ter)	QRICH1	VERVERI-BRADY SYNDROME	Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	3	49084640	3	49047207	584433	575488
NM_004656.3(BAP1):c.1717delC (p.Leu573Trpfs)	BAP1	Tumor susceptibility linked to germline BAP1 mutations|Hereditary cancer-predisposing syndrome|BAP1 Cancer Syndrome	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, multiple submitters, no conflicts	3	52437444	3	52403428	221278	222989
NM_003280.2(TNNC1):c.430A>G (p.Asn144Asp)	TNNC1	Dilated cardiomyopathy 1Z|Familial hypertrophic cardiomyopathy 13|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 14, 2017)	criteria provided, conflicting interpretations	3	52485431	3	52451415	181567	179071
NM_003392.4(WNT5A):c.405G>T (p.Thr135=)	WNT5A	Robinow syndrome|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	55508644	3	55474616	160315	168099
NM_003392.4(WNT5A):c.391+11A>G	WNT5A	Robinow syndrome	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	3	55513331	3	55479303	160314	168100
NM_003392.4(WNT5A):c.206G>A (p.Cys69Tyr)	WNT5A	Robinow syndrome	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	3	55513527	3	55479499	162613	172291
NM_003392.4(WNT5A):c.141-8C>G	WNT5A	Robinow syndrome	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	3	55513600	3	55479572	160311	168101
NM_003392.4(WNT5A):c.141-9C>T	WNT5A	Robinow syndrome	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	3	55513601	3	55479573	160313	168102
NM_003392.4(WNT5A):c.141-9C>G	WNT5A	Robinow syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	55513601	3	55479573	160312	168103
NM_003392.4(WNT5A):c.140+14A>G	WNT5A	Robinow syndrome	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	3	55514799	3	55480771	160310	168104
NM_001457.3(FLNB):c.5375_5377delAGG (p.Glu1792del)	FLNB	Patellar hypoplasia|Knee dislocation|Limited knee flexion/extension	Likely pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	3	58129290 - 58129292	3	58143563 - 58143565	599274	590518
NM_000333.3(ATXN7):c.791A>G (p.Lys264Arg)	ATXN7	not specified	Likely benign	no assertion criteria provided	3	63967900	3	63982224	128519	133968
NM_000333.3(ATXN7):c.2137C>T (p.Leu713=)	ATXN7	not specified	Likely benign	no assertion criteria provided	3	63981635	3	63995959	128516	133965
NM_000333.3(ATXN7):c.2178T>C (p.Ser726=)	ATXN7	not specified	Likely benign	no assertion criteria provided	3	63981676	3	63996000	128517	133966
NM_000333.3(ATXN7):c.2584G>A (p.Val862Met)	ATXN7	not specified	Likely benign	no assertion criteria provided	3	63982082	3	63996406	128518	133967
NM_198859.3(PRICKLE2):c.1813G>T (p.Val605Phe)	PRICKLE2|PRICKLE2-AS1	Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Epilepsy, progressive myoclonic 5	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	3	64085449	3	64099773	30733	39690
NM_198859.3(PRICKLE2):c.1551G>A (p.Gln517=)	PRICKLE2	Progressive myoclonic epilepsy|Epilepsy, progressive myoclonic 5|not specified	Benign/Likely benign(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	3	64132615	3	64146939	130032	135478
NM_198859.3(PRICKLE2):c.984C>T (p.Asn328=)	PRICKLE2	Progressive myoclonic epilepsy|not specified	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	64133182	3	64147506	130035	135481
NM_198859.3(PRICKLE2):c.816T>C (p.Asp272=)	PRICKLE2	Progressive myoclonic epilepsy|Epilepsy, progressive myoclonic 5|not specified|not provided	Benign(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	3	64133350	3	64147674	130137	135584
NM_198859.3(PRICKLE2):c.579G>A (p.Pro193=)	PRICKLE2	Progressive myoclonic epilepsy|not specified|not provided	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	3	64142859	3	64157183	130034	135480
NM_198859.3(PRICKLE2):c.380delG (p.Gly127Glufs)	PRICKLE2	Epilepsy, progressive myoclonic 5	Pathogenic(Last reviewed: May 16, 2013)	criteria provided, single submitter	3	64145632	3	64159956	209186	205736
NM_198859.3(PRICKLE2):c.259-6A>G	PRICKLE2	Progressive myoclonic epilepsy|not specified|not provided	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	3	64145759	3	64160083	130033	135479
NM_198859.3(PRICKLE2):c.144+10T>C	PRICKLE2|PRICKLE2-AS3	Epilepsy, progressive myoclonic 5|not specified	Benign(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	3	64184450	3	64198774	130031	135477
NM_198159.2(MITF):c.649C>T (p.Arg217Ter)	MITF	Waardenburg syndrome type 2A	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, multiple submitters, no conflicts	3	69988315	3	69939164	488040	481055
NM_000248.3(MITF):c.383C>G (p.Ser128Ter)	MITF	Waardenburg syndrome	Pathogenic(Last reviewed: Jul 31, 2015)	criteria provided, single submitter	3	69990424	3	69941273	228364	229148
NM_198159.2(MITF):c.773_785dup (p.Asp263Glyfs)	MITF	Waardenburg syndrome	Pathogenic(Last reviewed: Feb 10, 2017)	criteria provided, single submitter	3	69998212 - 69998224	3	69949061 - 69949073	505620	496807
NM_198159.2(MITF):c.979G>T (p.Glu327Ter)	MITF	Waardenburg syndrome type 2A	Pathogenic(Last reviewed: May 15, 2018)	no assertion criteria provided	3	70005647	3	69956496	545016	535280
NM_198159.2(MITF):c.1013+1G>A	MITF	Waardenburg syndrome type 2A	Pathogenic(Last reviewed: May 15, 2018)	no assertion criteria provided	3	70005682	3	69956531	545015	535279
NM_000248.3(MITF):c.763C>T (p.Arg255Ter)	MITF	Waardenburg syndrome type 2A|not provided|Congenital sensorineural hearing impairment	Pathogenic/Likely pathogenic(Last reviewed: May 15, 2018)	criteria provided, multiple submitters, no conflicts	3	70008476	3	69959325	372755	359493
NM_000248.3(MITF):c.808C>T (p.Arg270Ter)	MITF	Waardenburg syndrome	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	3	70008521	3	69959370	228363	229152
NM_032682.5(FOXP1):c.1890-5T>C	FOXP1	not specified|Intellectual Disability with Language Impairment and Autistic Features|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jul 14, 2016)	criteria provided, multiple submitters, no conflicts	3	71008547	3	70959396	129108	134554
NM_032682.5(FOXP1):c.1653-2A>T	FOXP1	Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	3	71019958	3	70970807	561014	552076
NM_032682.5(FOXP1):c.1574G>A (p.Arg525Gln)	FOXP1	Mental retardation with language impairment and with or without autistic features|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	3	71021784	3	70972633	521111	511508
NM_032682.5(FOXP1):c.1541G>A (p.Arg514His)	FOXP1	Mental retardation with language impairment and with or without autistic features|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, multiple submitters, no conflicts	3	71021817	3	70972666	211040	207083
NM_032682.5(FOXP1):c.1348+1G>C	FOXP1	Autistic disorder of childhood onset|Autism|Intellectual disability	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	3	71026978	3	70977827	587696	578654
NM_032682.5(FOXP1):c.1291_1292del (p.Thr431Glyfs)	FOXP1	Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	3	71027034 - 71027036	3	70977884 - 70977885	561013	552077
NM_032682.5(FOXP1):c.1267_1268delGT (p.Val423Hisfs)	FOXP1	Mental retardation with language impairment and with or without autistic features	Likely pathogenic(Last reviewed: Jun 7, 2013)	no assertion criteria provided	3	71027059 - 71027060	3	70977908 - 70977909	156149	165949
NM_032682.5(FOXP1):c.643C>G (p.Pro215Ala)	FOXP1	not specified|Intellectual Disability with Language Impairment and Autistic Features|History of neurodevelopmental disorder	Likely benign(Last reviewed: Jun 19, 2017)	criteria provided, multiple submitters, no conflicts	3	71096114	3	71046963	129109	134555
NM_032682.5(FOXP1):c.98G>C (p.Arg33Pro)	FOXP1	not specified	Likely benign(Last reviewed: Dec 11, 2013)	criteria provided, single submitter	3	71247435	3	71198284	129107	134553
NM_001128929.3(ROBO2):c.97G>T (p.Gly33Ter)	ROBO2	Vesicoureteral reflux 2	Uncertain significance	criteria provided, single submitter	3	75986741	3	75937590	224347	226080
NM_002942.4(ROBO2):c.335C>T (p.Ala112Val)	ROBO2	Vesicoureteral reflux 2	Uncertain significance	criteria provided, single submitter	3	77147438	3	77098287	224346	226081
NM_002942.4(ROBO2):c.2431C>T (p.Arg811Trp)	ROBO2	Vesicoureteral reflux 2|Vesicoureteral reflux	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	77629200	3	77580049	224345	226082
NM_000313.3(PROS1):c.1907A>G (p.Tyr636Cys)	PROS1	Protein S deficiency	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	3	93593213	3	93874369	161348	171085
NM_000313.3(PROS1):c.1762A>G (p.Thr588Ala)	PROS1	Protein S deficiency|Thrombophilia due to protein S deficiency, autosomal recessive	Benign(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	3	93595918	3	93877074	161344	171086
NM_000313.3(PROS1):c.1747A>C (p.Asn583His)	PROS1	Protein S deficiency	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	3	93595933	3	93877089	161349	171087
NM_000313.3(PROS1):c.1594A>G (p.Thr532Ala)	PROS1	Protein S deficiency	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	3	93598057	3	93879213	161350	171088
NM_000313.3(PROS1):c.1528G>A (p.Val510Met)	PROS1	Protein S deficiency|Thrombophilia due to protein S deficiency, autosomal recessive	Benign(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	3	93598123	3	93879279	161343	171089
NM_000313.3(PROS1):c.1331C>T (p.Pro444Leu)	PROS1	Protein S deficiency	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	3	93603733	3	93884889	161351	171090
NM_000313.3(PROS1):c.1095T>G (p.Asn365Lys)	PROS1	Protein S deficiency	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	3	93611837	3	93892993	161352	171091
NM_000313.3(PROS1):c.946C>T (p.Arg316Cys)	PROS1	Protein S deficiency	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	3	93615439	3	93896595	161345	171092
NM_000313.3(PROS1):c.728-1G>A	PROS1	Protein S deficiency	Likely pathogenic(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	3	93617414	3	93898570	162509	172172
NM_000313.3(PROS1):c.698G>A (p.Arg233Lys)	PROS1	Protein S deficiency|Thrombophilia due to protein S deficiency, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	3	93619677	3	93900833	161346	171093
NM_000313.3(PROS1):c.676T>A (p.Cys226Ser)	PROS1	Protein S deficiency	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	3	93619699	3	93900855	161353	171094
NM_000313.3(PROS1):c.431C>A (p.Thr144Asn)	PROS1	Protein S deficiency	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	3	93624903	3	93906059	161347	171095
NM_000313.3(PROS1):c.284G>A (p.Gly95Glu)	PROS1	Protein S deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	93629525	3	93910681	161354	171096
NM_000097.5(CPOX):c.1339C>T (p.Arg447Cys)	CPOX	Hereditary coproporphyria|Coproporphyria	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	3	98299553	3	98580709	459	15498
NM_006070.5(TFG):c.854C>T (p.Pro285Leu)	TFG	Neuropathy, hereditary motor and sensory, Okinawa type|not provided|Spastic paraplegia 57, autosomal recessive	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	3	100467026	3	100748182	37089	45764
NM_033254.3(BOC):c.1667G>A (p.Gly556Glu)	BOC	Holoprosencephaly sequence	Uncertain significance(Last reviewed: May 10, 2017)	criteria provided, single submitter	3	112997069	3	113278222	523664	514312
NM_001690.3(ATP6V1A):c.1123C>A (p.Pro375Thr)	ATP6V1A	EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3	Likely pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	3	113513948	3	113795101	584428	575487
NM_001164342.2(ZBTB20):c.1786C>T (p.His596Tyr)	ZBTB20	Primrose syndrome	Pathogenic	no assertion criteria provided	3	114069139	3	114350292	375372	362137
NM_000388.3(CASR):c.496A>G (p.Ser166Gly)	CASR	Hypocalciuric hypercalcemia, familial, type 1|Familial hypocalciuric hypercalcemia|Hypocalcemia, autosomal dominant 1	Conflicting interpretations of pathogenicity(Last reviewed: Sep 25, 2017)	criteria provided, conflicting interpretations	3	121980378	3	122261531	35800	44464
NM_000388.3(CASR):c.1525G>A (p.Gly509Arg)	CASR	Familial hypocalciuric hypercalcemia	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	3	121994806	3	122275959	35778	44442
NM_000388.3(CASR):c.2243C>A (p.Pro748His)	CASR	Familial hypocalciuric hypercalcemia|not provided	Likely pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, multiple submitters, no conflicts	3	122003044	3	122284197	35788	44452
NM_000388.3(CASR):c.2339C>A (p.Thr780Asn)	CASR	Hypocalciuric hypercalcemia, familial, type 1	Uncertain significance	no assertion criteria provided	3	122003140	3	122284293	431488	424993
NM_183357.2(ADCY5):c.1252C>T (p.Arg418Trp)	ADCY5	Dyskinesia, familial, with facial myokymia|not provided|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	3	123071311	3	123352464	162090	171808
NM_053025.3(MYLK):c.4681G>C (p.Glu1561Gln)	MYLK	Aortic aneurysm, familial thoracic 7|not provided	Uncertain significance(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	3	123359290	3	123640443	427738	417440
NM_053025.3(MYLK):c.4292C>T (p.Pro1431Leu)	MYLK	Aortic aneurysm, familial thoracic 7	Uncertain significance(Last reviewed: Aug 16, 2017)	criteria provided, multiple submitters, no conflicts	3	123368038	3	123649191	225287	227192
NM_053025.3(MYLK):c.3184G>T (p.Ala1062Ser)	MYLK	Aortic aneurysm, familial thoracic 7|not specified|Familial aortic aneurysms	Uncertain significance(Last reviewed: Oct 2, 2017)	criteria provided, multiple submitters, no conflicts	3	123419131	3	123700284	375866	362736
NM_053025.3(MYLK):c.2533C>T (p.Arg845Cys)	MYLK	Aortic aneurysm, familial thoracic 6|Aortic aneurysm, familial thoracic 7|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	3	123419782	3	123700935	226038	227843
NM_053025.3(MYLK):c.2149G>T (p.Asp717Tyr)	MYLK	Aortic aneurysm, familial thoracic 7|Thoracic aortic aneurysm and aortic dissection|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 3, 2018)	criteria provided, conflicting interpretations	3	123426842	3	123707995	216969	213544
NM_053025.3(MYLK):c.1321C>T (p.Pro441Ser)	MYLK	Aortic aneurysm, familial thoracic 7	Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	3	123451938	3	123733091	488557	481425
NM_032638.4(GATA2):c.1122_1125dupCCTC (p.Tyr376Profs)	GATA2	Lymphedema, primary, with myelodysplasia	Pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	3	128200680 - 128200683	3	128481837 - 128481840	216932	213545
NM_032638.4(GATA2):c.1113C>A (p.Asn371Lys)	GATA2	Lymphedema, primary, with myelodysplasia|Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency	Likely pathogenic(Last reviewed: Jul 16, 2013)	criteria provided, single submitter	3	128200692	3	128481849	216931	213546
NM_023067.3(FOXL2):c.102_103insA (p.Gly35Argfs)	FOXL2	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 7, 2016)	no assertion criteria provided	3	138665463	3	138946621	375303	362075
NM_001168379.1(ZIC4):c.1080G>C (p.Ser360=)	ZIC4	not specified	Benign(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	3	147108756	3	147390969	130789	136234
NM_176876.2(P2RY12):c.794G>C (p.Arg265Pro)	P2RY12|MED12L	Platelet-type bleeding disorder 8	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	3	151055840	3	151338052	548443	538927
NM_000340.1(SLC2A2):c.1331G>A (p.Trp444Ter)	SLC2A2	Diabetes mellitus type 2	Affects(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	3	170716025	3	170998236	444009	437670
NM_000340.1(SLC2A2):c.963+1G>A	SLC2A2	Diabetes mellitus type 2	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	3	170723073	3	171005284	444008	437669
NM_006218.3(PIK3CA):c.2740G>A (p.Gly914Arg)	PIK3CA	Megalencephaly cutis marmorata telangiectatica congenita|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	3	178947865	3	179230077	39703	48302
NM_021629.4(GNB4):c.659A>G (p.Gln220Arg)	GNB4	Charcot-Marie-Tooth disease, dominant intermediate F	Likely pathogenic(Last reviewed: May 17, 2017)	no assertion criteria provided			3	179413452	617599	608986
NM_021629.3(GNB4):c.229G>A (p.Gly77Arg)	GNB4	Charcot-Marie-Tooth disease, dominant intermediate F	Conflicting interpretations of pathogenicity(Last reviewed: Jan 31, 2018)	criteria provided, conflicting interpretations	3	179134319	3	179416531	488522	481390
NM_177989.3(ACTL6A):c.553G>C (p.Glu185Gln)	ACTL6A	Global developmental delay|Delayed speech and language development|Global developmental delay	Uncertain significance(Last reviewed: Jun 11, 2017)	criteria provided, single submitter	3	179294612	3	179576824	545508	536013
NM_004301.4(ACTL6A):c.1209+1G>C	ACTL6A	Global developmental delay|Delayed speech and language development|Global developmental delay	Uncertain significance(Last reviewed: Jun 11, 2017)	criteria provided, single submitter	3	179304421	3	179586633	545509	536014
NM_003106.4(SOX2):c.385_386del (p.Gly129Argfs)	SOX2|SOX2-OT	Microphthalmia syndromic 3	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, single submitter			3	181712745 - 181712746	599276	590520
NM_017644.3(KLHL24):c.1A>G (p.Met1Val)	KLHL24	Epidermolysis bullosa simplex, Koebner type|not provided|Epidermolysis bullosa simplex, generalized, with scarring and hair loss	Pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, multiple submitters, no conflicts	3	183368145	3	183650357	264648	259241
NM_017644.3(KLHL24):c.2T>C (p.Met1Thr)	KLHL24	Epidermolysis bullosa simplex, Koebner type|Epidermolysis bullosa simplex, generalized, with scarring and hair loss	Pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, single submitter	3	183368146	3	183650358	370042	354282
NM_017644.3(KLHL24):c.3G>T (p.Met1Ile)	KLHL24	Epidermolysis bullosa simplex, Koebner type|Epidermolysis bullosa simplex, generalized, with scarring and hair loss	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	3	183368147	3	183650359	264647	259240
NM_017644.3(KLHL24):c.3G>A (p.Met1Ile)	KLHL24	Epidermolysis bullosa simplex, Koebner type|Epidermolysis bullosa simplex, generalized, with scarring and hair loss	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	3	183368147	3	183650359	264646	259239
NM_004423.3(DVL3):c.1585delG (p.Ala529Profs)	DVL3	Robinow syndrome|Robinow syndrome, autosomal dominant 3	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	3	183887880	3	184170092	219218	217240
NM_004423.3(DVL3):c.1715-2A>G	DVL3	Robinow syndrome|Robinow syndrome, autosomal dominant 3	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	3	183888105	3	184170317	219219	217241
NM_004423.4(DVL3):c.1715-1G>A	DVL3	Robinow syndrome|Robinow syndrome, autosomal dominant 3	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	3	183888106	3	184170318	219220	217242
NM_004423.3(DVL3):c.1716delC (p.Ser573Valfs)	DVL3	Robinow syndrome|Robinow syndrome, autosomal dominant 3	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	3	183888108	3	184170320	219221	217243
NM_004423.3(DVL3):c.1749delC (p.Ser583Argfs)	DVL3	Robinow syndrome|Robinow syndrome, autosomal dominant 3	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	3	183888141	3	184170353	219222	217244
NM_004366.5(CLCN2):c.515G>A (p.Arg172Gln)	CLCN2	Hyperaldosteronism, familial, type II	Pathogenic(Last reviewed: Sep 25, 2017)	no assertion criteria provided	3	184075850	3	184358062	441164	434794
NM_004366.5(CLCN2):c.71G>A (p.Gly24Asp)	CLCN2	Hyperaldosteronism, familial, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, multiple submitters, no conflicts	3	184076912	3	184359124	427066	414926
NM_003722.4(TP63):c.191+5G>C	TP63	Muscular dystrophy	Uncertain significance(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	3	189455662	3	189737873	495341	486836
NM_003722.4(TP63):c.1037C>G (p.Ala346Gly)	TP63	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	Pathogenic(Last reviewed: Feb 11, 2014)	criteria provided, single submitter	3	189586413	3	189868624	208418	204641
NM_021032.4(FGF12):c.334G>A (p.Gly112Ser)	FGF12	Epileptic encephalopathy, early infantile, 47	Likely pathogenic(Last reviewed: Mar 26, 2017)	criteria provided, single submitter	3	192053230	3	192335441	522854	513415
NM_015560.2(OPA1):c.1146A>G (p.Ile382Met)	OPA1	Abortive cerebellar ataxia|Dominant hereditary optic atrophy|Optic nerve hypoplasia|not provided|Optic Atrophy, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Aug 18, 2017)	criteria provided, conflicting interpretations	3	193361167	3	193643378	50866	59852
NM_015560.2(OPA1):c.2131C>T (p.Arg711Ter)	OPA1	Dominant hereditary optic atrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 18, 2018)	criteria provided, multiple submitters, no conflicts	3	193374986	3	193657197	216979	213549
NM_005781.4(TNK2):c.2930C>T (p.Ala977Val)	TNK2	Parkinson disease, age at onset, susceptibility to|Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	3	195594092	3	195867221	224858	226708
NM_005781.4(TNK2):c.2630G>A (p.Arg877His)	TNK2	Parkinson disease, age at onset, susceptibility to|not specified|Parkinson disease	Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2016)	criteria provided, conflicting interpretations	3	195594494	3	195867623	224859	226709
NM_005781.4(TNK2):c.1912G>A (p.Val638Met)	TNK2	Parkinson disease, age at onset, susceptibility to|Autosomal recessive infantile epilepsy|Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	3	195595212	3	195868341	88849	94418
NM_005781.4(TNK2):c.1088T>C (p.Val363Ala)	TNK2	Parkinson disease, age at onset, susceptibility to|Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	3	195605390	3	195878519	224860	226710
NM_000249.3:c.(?_1732)_(2271_?)del	MLH1	Lynch syndrome	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	3	37089010 - 37092144	3	37047519 - 37050653	517462	496764
NC_000003.11:g.(138925589_138944012)_(139141037_139157532)del	COPB2|MRPS22	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Aug 22, 2017)	no assertion criteria provided	3	138925589 - 139157532			433554	427126
NM_198159.2(MITF):c.(?_938)-102_*(78_?)del	MITF	Waardenburg syndrome	Pathogenic(Last reviewed: Oct 22, 2015)	criteria provided, single submitter	3	70005504 - 70014477	3	69956353 - 69965326	228361	228973
NM_198159.2(MITF):c.(?_355)-1203_*(78_?)del	MITF|LOC107988030	Waardenburg syndrome	Pathogenic(Last reviewed: Jan 4, 2016)	criteria provided, single submitter	3	69985770 - 70014477	3	69936619 - 69965326	228360	228972
NM_022042.3(SLC26A1):c.1487T>G (p.Leu496Arg)	IDUA|SLC26A1	Epileptic encephalopathy	Uncertain significance(Last reviewed: Oct 16, 2014)	no assertion criteria provided	4	983240	4	989452	374260	361181
NM_000142.4(FGFR3):c.742C>T (p.Arg248Cys)	FGFR3	Achondroplasia|Multiple myeloma|Squamous cell carcinoma of the head and neck|Thanatophoric dysplasia type 1|Keratosis, seborrheic|Epidermal nevus|Lung adenocarcinoma|Skeletal dysplasia|Squamous cell lung carcinoma|Skeletal dysplasia with acanthosis nigricans|Short stature|Growth delay|not provided|Short ribs|Narrow chest|Growth delay|Small for gestational age|Bell-shaped thorax|Skeletal dysplasia|Femoral bowing|Bowed humerus|Transitional cell carcinoma of the bladder|Disproportionate short-limb short stature|Lethal short-limbed short stature|Lower limb undergrowth|Upper limb undergrowth|Carcinoma	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, multiple submitters, no conflicts	4	1803564	4	1801837	16332	31371
NM_000142.4(FGFR3):c.1172C>A (p.Ala391Glu)	FGFR3	Crouzon syndrome with acanthosis nigricans|not provided|Craniosynostosis|Inborn genetic diseases|Carcinoma	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, multiple submitters, no conflicts	4	1806153	4	1804426	16329	31368
NM_001099433.1(JAKMIP1):c.1756G>C (p.Asp586His)	JAKMIP1	Smith-Magenis Syndrome-like	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	4	6055827	4	6054100	254206	248721
NM_006005.3(WFS1):c.683G>A (p.Arg228His)	WFS1	Cataract 41|Diabetes mellitus AND insipidus with optic atrophy AND deafness|WFS1-Related Disorders|Diabetes mellitus type 2|Wolfram-like syndrome, autosomal dominant|not specified|not provided	Uncertain significance(Last reviewed: Feb 20, 2018)	criteria provided, multiple submitters, no conflicts	4	6293695	4	6291968	198190	195351
NM_006005.3(WFS1):c.1886G>A (p.Arg629Gln)	WFS1	Nonsyndromic hearing loss and deafness|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 21, 2014)	criteria provided, conflicting interpretations	4	6303408	4	6301681	45443	54610
NM_006005.3(WFS1):c.2051C>T (p.Ala684Val)	WFS1	Diabetes mellitus AND insipidus with optic atrophy AND deafness|Wolfram-like syndrome, autosomal dominant|Nonsyndromic hearing loss and deafness|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, multiple submitters, no conflicts	4	6303573	4	6301846	30556	39513
NM_006005.3(WFS1):c.2054G>C (p.Arg685Pro)	WFS1	Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Feb 28, 2012)	criteria provided, single submitter	4	6303576	4	6301849	45446	54613
NM_006005.3(WFS1):c.2141A>C (p.Asn714Thr)	WFS1	Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Aug 15, 2013)	criteria provided, single submitter	4	6303663	4	6301936	45447	54614
NM_006005.3(WFS1):c.2146G>A (p.Ala716Thr)	WFS1	WFS1-Related Disorders|Nonsyndromic hearing loss and deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, multiple submitters, no conflicts	4	6303668	4	6301941	4520	19559
NM_006005.3(WFS1):c.2389G>A (p.Asp797Asn)	WFS1	Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: May 3, 2017)	criteria provided, single submitter	4	6303911	4	6302184	517360	496379
NM_006005.3(WFS1):c.2470G>A (p.Glu824Lys)	WFS1	not specified|not provided	Uncertain significance(Last reviewed: Nov 2, 2016)	criteria provided, multiple submitters, no conflicts	4	6303992	4	6302265	166612	173982
NM_006005.3(WFS1):c.2508G>C (p.Lys836Asn)	WFS1	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Apr 3, 2016)	criteria provided, single submitter	4	6304030	4	6302303	228313	229205
NM_006005.3(WFS1):c.2590G>A (p.Glu864Lys)	WFS1	WFS1-Related Disorders|Wolfram-like syndrome, autosomal dominant|Nonsyndromic hearing loss and deafness|not provided|DFNA6/14/38 Nonsyndromic Low-Frequency Sensorineural Hearing Loss	Pathogenic/Likely pathogenic(Last reviewed: Jul 21, 2017)	criteria provided, multiple submitters, no conflicts	4	6304112	4	6302385	4526	19565
NM_020041.2(SLC2A9):c.1138C>T (p.Arg380Trp)	SLC2A9	Renal hypouricemia 2	Uncertain significance(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	4	9892311	4	9890687	4596	19635
NM_003924.3(PHOX2B):c.753_767dup (p.Ala260_Gly261insAlaAlaAlaAlaAla)	PHOX2B|LOC110011216	Congenital central hypoventilation	Pathogenic(Last reviewed: May 3, 2016)	criteria provided, single submitter	4	41748002 - 41748016	4	41745985 - 41745999	505021	496319
NM_003924.3(PHOX2B):c.724_744dup (p.Ala260_Gly261insAlaAlaAlaAlaAlaAlaAla)	PHOX2B|LOC110011216	Congenital central hypoventilation	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	4	41748025 - 41748045	4	41746008 - 41746028	506167	496812
NM_003924.3(PHOX2B):c.385G>A (p.Glu129Lys)	PHOX2B	Congenital central hypoventilation	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	4	41749410	4	41747393	561080	552081
NM_000222.2(KIT):c.464C>T (p.Pro155Leu)	KIT	Gastrointestinal stroma tumor|Gastrointestinal stromal tumor, familial	Uncertain significance(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	4	55564576	4	54698410	225286	227193
NM_000222.2(KIT):c.532G>A (p.Ala178Thr)	KIT	Gastrointestinal stroma tumor|not provided|Piebaldism	Conflicting interpretations of pathogenicity(Last reviewed: Jan 10, 2018)	criteria provided, conflicting interpretations	4	55564644	4	54698478	161259	171097
NM_000222.2(KIT):c.821C>T (p.Thr274Met)	KIT	Gastrointestinal stroma tumor|Gastrointestinal stromal tumor, familial|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 4, 2018)	criteria provided, conflicting interpretations	4	55569954	4	54703788	41604	50043
NM_000222.2(KIT):c.952A>G (p.Met318Val)	KIT	Gastrointestinal stroma tumor|Piebaldism	Conflicting interpretations of pathogenicity(Last reviewed: Dec 19, 2017)	criteria provided, conflicting interpretations	4	55573290	4	54707124	161260	171098
NM_000222.2(KIT):c.1232-6C>G	KIT	Gastrointestinal stroma tumor	Conflicting interpretations of pathogenicity(Last reviewed: Apr 6, 2018)	criteria provided, conflicting interpretations	4	55589744	4	54723578	458860	454239
NM_000222.2(KIT):c.2000T>G (p.Leu667Arg)	KIT	Partial albinism	Likely pathogenic	criteria provided, single submitter	4	55595510	4	54729344	393590	380482
NM_005612.4(REST):c.1310T>A (p.Leu437Ter)	REST	Gingival fibromatosis 1|FIBROMATOSIS, GINGIVAL, 5	Likely pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	4	57796334	4	56930168	427772	417660
NM_005612.4(REST):c.2413delC (p.Leu805Phefs)	REST	Gingival fibromatosis 1|FIBROMATOSIS, GINGIVAL, 5	Likely pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	4	57797437	4	56931271	427773	417661
NM_005612.4(REST):c.2865_2866delAA (p.Asn958Serfs)	REST	Gingival fibromatosis 1|FIBROMATOSIS, GINGIVAL, 5	Likely pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	4	57797889 - 57797890	4	56931723 - 56931724	427771	417662
NM_012108.3(STAP1):c.139A>G (p.Thr47Ala)	STAP1	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	4	68436820	4	67571102	189309	187192
NM_031889.2(ENAM):c.92T>G (p.Leu31Arg)	ENAM	Amelogenesis imperfecta - hypoplastic autosomal dominant - local	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2017)	no assertion criteria provided	4	71497424	4	70631707	374930	361835
NM_031889.2(ENAM):c.123+2T>G	ENAM	Amelogenesis imperfecta - hypoplastic autosomal dominant - local	Pathogenic(Last reviewed: Dec 23, 2017)	no assertion criteria provided	4	71497457	4	70631740	517662	508753
NM_000297.3(PKD2):c.1458C>G (p.Tyr486Ter)	PKD2	Polycystic kidney disease 2	Pathogenic	no assertion criteria provided	4	88967932	4	88046780	431056	424583
NM_000297.3(PKD2):c.1492C>T (p.His498Tyr)	PKD2	Polycystic kidney disease 2	Uncertain significance	no assertion criteria provided	4	88967966	4	88046814	559506	550230
NM_000297.3(PKD2):c.2534G>C (p.Arg845Pro)	PKD2	Polycystic kidney disease 2	Uncertain significance	no assertion criteria provided	4	88995975	4	88074823	403719	390696
NM_001130692.1(PPP3CA):c.1182_1185dup (p.Ser396Thrfs)	PPP3CA	EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1	Pathogenic(Last reviewed: Nov 26, 2017)	criteria provided, single submitter	4	101953452 - 101953455	4	101032295 - 101032298	522802	513416
NM_000944.4(PPP3CA):c.1255_1256delAG (p.Ser419Cysfs)	PPP3CA	EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1	Likely pathogenic(Last reviewed: Feb 11, 2018)	no assertion criteria provided	4	101953507 - 101953508	4	101032350 - 101032351	496636	488121
NM_153427.2(PITX2):c.648T>A (p.Cys216Ter)	PITX2	Axenfeld-Rieger syndrome type 1	Pathogenic	no assertion criteria provided	4	111539449	4	110618293	375442	362188
NM_153427.2(PITX2):c.625_626delTC (p.Ser209Argfs)	PITX2	Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Nov 24, 2009)	no assertion criteria provided	4	111539471 - 111539472	4	110618315 - 110618316	375441	362189
NM_153427.2(PITX2):c.555_576del22 (p.Thr186Serfs)	PITX2	Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: May 11, 2015)	no assertion criteria provided	4	111539521 - 111539542	4	110618365 - 110618386	375440	362190
NM_153427.2(PITX2):c.274G>C (p.Ala92Pro)	PITX2	Axenfeld-Rieger syndrome type 1	Uncertain significance(Last reviewed: Nov 7, 2014)	no assertion criteria provided	4	111539823	4	110618667	375439	362191
NM_153427.2(PITX2):c.271C>G (p.Arg91Gly)	PITX2	Axenfeld-Rieger syndrome type 1	Uncertain significance(Last reviewed: Nov 21, 2014)	no assertion criteria provided	4	111539826	4	110618670	375438	362192
NM_153427.2(PITX2):c.184_205del22 (p.Arg62Alafs)	PITX2	Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Oct 12, 2015)	no assertion criteria provided	4	111542367 - 111542388	4	110621211 - 110621232	375436	362193
NM_153427.2(PITX2):c.191C>T (p.Pro64Leu)	PITX2	Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Nov 18, 2014)	no assertion criteria provided	4	111542381	4	110621225	375437	362194
NM_001148.4(ANK2):c.3652C>T (p.Pro1218Ser)	ANK2	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	4	114257793	4	113336637	427962	419268
NM_001148.4(ANK2):c.4373A>G (p.Glu1458Gly)	ANK2	Cardiac arrhythmia, ankyrin B-related|Long QT syndrome 4|Long QT syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 17, 2018)	criteria provided, conflicting interpretations	4	114269433	4	113348277	18056	33095
NM_001148.4(ANK2):c.6078A>T (p.Lys2026Asn)	ANK2	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	4	114275852	4	113354696	427963	419269
NM_001148.4(ANK2):c.10243A>G (p.Thr3415Ala)	ANK2	Congenital long QT syndrome	Uncertain significance	criteria provided, single submitter	4	114280017	4	113358861	219174	217191
t(4;14)(q26;q12)	FOXG1|ARSJ	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	4	114869960 - 114871254			426095	414699
NM_201999.2(ELF2):c.10G>A (p.Ala4Thr)	ELF2	Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome	Likely pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, single submitter	4	140058846	4	139137692	431175	424698
NM_006439.4(MAB21L2):c.145G>A (p.Glu49Lys)	LRBA|MAB21L2	Microphthalmia/coloboma and skeletal dysplasia syndrome	Likely pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	4	151504326	4	150583174	139622	143245
NM_006439.4(MAB21L2):c.151C>T (p.Arg51Cys)	LRBA|MAB21L2	Microphthalmia/coloboma and skeletal dysplasia syndrome	Likely pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	4	151504332	4	150583180	139621	143244
NM_006439.4(MAB21L2):c.152G>A (p.Arg51His)	LRBA|MAB21L2	Microphthalmia/coloboma and skeletal dysplasia syndrome	Likely pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	4	151504333	4	150583181	139620	143243
NM_021973.2(HAND2):c.199G>T (p.Glu67Ter)	HAND2|HAND2-AS1	Dilated cardiomyopathy 1A	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	4	174450242	4	173529091	545687	536179
NM_018359.4(UFSP2):c.1277A>C (p.Asp426Ala)	UFSP2	Beukes hip dysplasia|SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	4	186324694	4	185403540	437868	431489
GRCh37/hg19 4q25(chr4:111528916-111888401)x1	ENPEP|PITX2	Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Jul 12, 2013)	no assertion criteria provided	4	111426357 - 111990971			375444	362211
NC_000004.12:g.(?_110618049)_(110622472_?)del	PITX2	Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Jul 31, 2015)	no assertion criteria provided	4	111539205 - 111543628	4	110618049 - 110622472	375443	362187
NM_004168.3(SDHA):c.1A>G (p.Met1Val)	SDHA	Mitochondrial complex II deficiency|Paragangliomas 5|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, multiple submitters, no conflicts	5	218471	5	218356	239661	239796
NM_004168.3(SDHA):c.91C>T (p.Arg31Ter)	SDHA	Carney triad|Mitochondrial complex II deficiency|Pilocytic astrocytoma, somatic|Pilocytic astrocytoma|Paragangliomas 5|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	5	223624	5	223509	142601	152315
NC_000005.10:g.233478_235340del1863	SDHA	Paragangliomas 5	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	5	233592 - 235454	5	233478 - 235340	545722	536214
NM_001003841.3(SLC6A19):c.1017-4G>A	SLC6A19	Hyperglycinuria|Iminoglycinuria, digenic	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	5	1216900	5	1216785	2021	17060
NM_004172.4(SLC1A3):c.657G>C (p.Glu219Asp)	SLC1A3	Episodic ataxia|not specified	Benign(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	5	36677083	5	36676981	130326	135773
NM_133433.3(NIPBL):c.3G>T (p.Met1Ile)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36953801	5	36953699	159103	168298
NM_133433.3(NIPBL):c.64+1G>A	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Dec 27, 2016)	criteria provided, multiple submitters, no conflicts	5	36953863	5	36953761	159191	168299
NM_133433.3(NIPBL):c.64+3A>C	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36953865	5	36953763	159192	168300
NM_133433.3(NIPBL):c.64+5G>A	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36953867	5	36953765	159193	168301
NM_133433.3(NIPBL):c.65-5A>G	NIPBL	Cornelia de Lange syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	5	36955569	5	36955467	159196	168302
NM_133433.3(NIPBL):c.86delC (p.Pro29Hisfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, multiple submitters, no conflicts	5	36955595	5	36955493	159249	168303
NM_133433.3(NIPBL):c.87A>G (p.Pro29=)	NIPBL	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36955596	5	36955494	159250	168304
NM_133433.3(NIPBL):c.133C>T (p.Arg45Ter)	NIPBL	Cornelia de Lange syndrome 1|not provided	Pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, multiple submitters, no conflicts	5	36955642	5	36955540	99920	105809
NM_133433.3(NIPBL):c.145G>T (p.Glu49Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36955654	5	36955552	159035	168305
NM_133433.3(NIPBL):c.192del (p.Gln64Hisfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36955701	5	36955599	99923	105812
NM_133433.3(NIPBL):c.201_212del (p.His67_Asn70del)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36955710 - 36955721	5	36955608 - 36955619	159042	168306
NM_133433.3(NIPBL):c.206T>C (p.Leu69Pro)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Jan 9, 2014)	criteria provided, single submitter	5	36955715	5	36955613	159045	168307
NM_133433.3(NIPBL):c.294C>T (p.Ala98=)	NIPBL	not specified|Cornelia de Lange Syndrome	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	36958269	5	36958167	159069	168308
NM_133433.3(NIPBL):c.310_317del (p.Pro104Phefs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36958285 - 36958292	5	36958183 - 36958190	159073	168309
NM_133433.3(NIPBL):c.332G>A (p.Ser111Asn)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36958307	5	36958205	159079	168310
NM_133433.3(NIPBL):c.358+1G>T	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36958334	5	36958232	159089	168312
NM_133433.3(NIPBL):c.358+5G>C	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36958338	5	36958236	159090	168313
NM_133433.3(NIPBL):c.456del (p.Ser153Alafs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36961683	5	36961581	159120	168314
NM_133433.3(NIPBL):c.534C>T (p.Tyr178=)	NIPBL	not specified|History of neurodevelopmental disorder	Likely benign(Last reviewed: Mar 21, 2017)	criteria provided, multiple submitters, no conflicts	5	36962300	5	36962198	159146	168315
NM_133433.3(NIPBL):c.535G>A (p.Ala179Thr)	NIPBL	not specified|not provided|Cornelia de Lange Syndrome	Benign/Likely benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	5	36962301	5	36962199	96343	102237
NM_133433.3(NIPBL):c.585C>G (p.Tyr195Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36962351	5	36962249	99935	105824
NM_133433.3(NIPBL):c.598C>T (p.Gln200Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Oct 16, 2013)	criteria provided, single submitter	5	36962364	5	36962262	159167	168316
NM_133433.3(NIPBL):c.610+1G>A	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36962377	5	36962275	159172	168317
NM_133433.3(NIPBL):c.611-10T>C	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36970968	5	36970866	159175	168318
NM_133433.3(NIPBL):c.615G>A (p.Ser205=)	NIPBL	not specified|not provided|Cornelia de Lange Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 13, 2016)	criteria provided, conflicting interpretations	5	36970982	5	36970880	159178	168319
NM_133433.3(NIPBL):c.678G>A (p.Pro226=)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Apr 15, 2013)	criteria provided, single submitter	5	36971045	5	36970943	159209	168320
NM_133433.3(NIPBL):c.737A>G (p.Asp246Gly)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36971104	5	36971002	159229	168321
NM_133433.3(NIPBL):c.771+1G>A	NIPBL	Cornelia de Lange syndrome 1|not provided	Pathogenic(Last reviewed: Oct 5, 2015)	criteria provided, multiple submitters, no conflicts	5	36971139	5	36971037	159235	168322
NM_133433.3(NIPBL):c.772-1G>A	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36972046	5	36971944	159236	168323
NM_133433.3(NIPBL):c.781T>G (p.Ser261Ala)	NIPBL	not specified|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 7, 2016)	criteria provided, multiple submitters, no conflicts	5	36972056	5	36971954	159237	168324
NM_133433.3(NIPBL):c.869-1G>A	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36975877	5	36975775	159248	168325
NM_133433.3(NIPBL):c.892del (p.Gln298Asnfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36975901	5	36975799	159252	168327
NM_133433.3(NIPBL):c.892C>T (p.Gln298Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36975901	5	36975799	159251	168326
NM_133433.3(NIPBL):c.894A>G (p.Gln298=)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36975903	5	36975801	159253	168328
NM_133433.3(NIPBL):c.922C>T (p.Arg308Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36975931	5	36975829	159254	168329
NM_133433.3(NIPBL):c.1003del (p.Glu335Lysfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36976012	5	36975910	159024	168330
NM_133433.3(NIPBL):c.1033_1036del (p.Tyr345Ilefs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36976042 - 36976045	5	36975940 - 36975943	159025	168331
NM_133433.3(NIPBL):c.1056C>T (p.Ser352=)	NIPBL	not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Feb 20, 2017)	criteria provided, multiple submitters, no conflicts	5	36976065	5	36975963	159026	168332
NM_133433.3(NIPBL):c.1057A>T (p.Lys353Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36976066	5	36975964	159027	168333
NM_133433.3(NIPBL):c.1086_1087del (p.Arg364Cysfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36976095 - 36976096	5	36975993 - 36975994	159028	168334
NM_133433.3(NIPBL):c.1150A>G (p.Asn384Asp)	NIPBL	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36976159	5	36976057	159029	168335
NM_133433.3(NIPBL):c.1151A>G (p.Asn384Ser)	NIPBL	not specified|Cornelia de Lange Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	5	36976160	5	36976058	159030	168336
NM_133433.3(NIPBL):c.1183C>T (p.Gln395Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jul 10, 2013)	criteria provided, single submitter	5	36976192	5	36976090	159031	168337
NM_133433.3(NIPBL):c.1212C>T (p.Pro404=)	NIPBL	Cornelia de Lange syndrome 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 8, 2017)	criteria provided, conflicting interpretations	5	36976221	5	36976119	99919	105808
NM_133433.3(NIPBL):c.1297C>T (p.Gln433Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36976306	5	36976204	159032	168338
NM_133433.3(NIPBL):c.1372C>T (p.Gln458Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36976381	5	36976279	159033	168339
NM_133433.3(NIPBL):c.1445_1448del (p.Arg482Asnfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36976454 - 36976457	5	36976352 - 36976355	99921	105810
NM_133433.3(NIPBL):c.1447_1448del (p.Glu483Ilefs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: May 30, 2013)	criteria provided, single submitter	5	36976456 - 36976457	5	36976354 - 36976355	159034	168340
NM_133433.3(NIPBL):c.1477A>G (p.Lys493Glu)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36976486	5	36976384	159036	168341
NM_133433.3(NIPBL):c.1514_1517del (p.Arg505Asnfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36984796 - 36984799	5	36984694 - 36984697	159037	168342
NM_133433.3(NIPBL):c.1526C>G (p.Ser509Cys)	NIPBL	not specified	Likely benign(Last reviewed: Jun 7, 2018)	criteria provided, multiple submitters, no conflicts	5	36984808	5	36984706	99922	105811
NM_133433.3(NIPBL):c.1576C>T (p.Gln526Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36984858	5	36984756	159038	168343
NM_133433.3(NIPBL):c.1591A>G (p.Thr531Ala)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36984873	5	36984771	159039	168344
NM_133433.3(NIPBL):c.1753del (p.Ile585Leufs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36985035	5	36984933	159040	168345
NM_133433.3(NIPBL):c.1885C>T (p.Arg629Ter)	NIPBL	Cornelia de Lange syndrome 1|not provided	Pathogenic(Last reviewed: Oct 5, 2015)	criteria provided, multiple submitters, no conflicts	5	36985167	5	36985065	159041	168346
NM_133433.3(NIPBL):c.1965G>T (p.Glu655Asp)	NIPBL	not specified|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Feb 2, 2017)	criteria provided, multiple submitters, no conflicts	5	36985247	5	36985145	99924	105813
NM_133433.3(NIPBL):c.1985A>G (p.Lys662Arg)	NIPBL	Cornelia de Lange syndrome 1|not specified|not provided|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	5	36985267	5	36985165	96331	102225
NM_015384.4(NIPBL):c.2021A>G (p.Asn674Ser)	NIPBL	Cornelia de Lange syndrome 1|not specified|not provided|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	5	36985303	5	36985201	96333	102227
NM_133433.3(NIPBL):c.2046del (p.Lys682Asnfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36985328	5	36985226	159043	168347
NM_133433.3(NIPBL):c.2065A>T (p.Asn689Tyr)	NIPBL	Cornelia de Lange syndrome 1|Cornelia de Lange Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	36985347	5	36985245	159044	168348
NM_133433.3(NIPBL):c.2093C>G (p.Ser698Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36985375	5	36985273	159046	168349
NM_133433.3(NIPBL):c.2107_2108del (p.Pro703Lysfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36985389 - 36985390	5	36985287 - 36985288	159047	168350
NM_133433.3(NIPBL):c.2108del (p.Pro703Glnfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36985390	5	36985288	159048	168351
NM_133433.3(NIPBL):c.2256A>G (p.Glu752=)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36985538	5	36985436	159049	168352
NM_133433.3(NIPBL):c.2260C>T (p.Arg754Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36985542	5	36985440	159050	168353
NM_133433.3(NIPBL):c.2294G>A (p.Arg765Lys)	NIPBL	Cornelia de Lange syndrome 1|not specified|not provided|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: May 3, 2017)	criteria provided, conflicting interpretations	5	36985576	5	36985474	159051	168354
NM_133433.3(NIPBL):c.2325A>G (p.Lys775=)	NIPBL	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36985607	5	36985505	159052	168355
NM_133433.3(NIPBL):c.2389C>T (p.Arg797Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36985671	5	36985569	159053	168356
NM_133433.3(NIPBL):c.2422C>T (p.Arg808Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36985704	5	36985602	159054	168357
NM_133433.3(NIPBL):c.2447G>A (p.Arg816His)	NIPBL	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 17, 2017)	criteria provided, conflicting interpretations	5	36985729	5	36985627	96334	102228
NM_133433.3(NIPBL):c.2451C>T (p.Asp817=)	NIPBL	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36985733	5	36985631	159055	168358
NM_133433.3(NIPBL):c.2469A>G (p.Lys823=)	NIPBL	Cornelia de Lange syndrome 1|not specified|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Mar 8, 2017)	criteria provided, multiple submitters, no conflicts	5	36985751	5	36985649	96335	102229
NM_133433.3(NIPBL):c.2471C>T (p.Ser824Leu)	NIPBL	Cornelia de Lange syndrome 1|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: May 17, 2017)	criteria provided, conflicting interpretations	5	36985753	5	36985651	159056	168359
NM_133433.3(NIPBL):c.2479_2480delAG (p.Arg827Glyfs)	NIPBL	Cornelia de Lange syndrome 1|not provided	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, multiple submitters, no conflicts	5	36985761 - 36985762	5	36985659 - 36985660	96336	102230
NM_133433.3(NIPBL):c.2489C>G (p.Ser830Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: May 13, 2014)	criteria provided, single submitter	5	36985771	5	36985669	159057	168360
NM_133433.3(NIPBL):c.2494C>T (p.Arg832Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36985776	5	36985674	159058	168361
NM_133433.3(NIPBL):c.2500C>T (p.Arg834Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36985782	5	36985680	159059	168362
NM_133433.3(NIPBL):c.2505G>T (p.Gly835=)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36985787	5	36985685	159060	168363
NM_133433.3(NIPBL):c.2592T>A (p.Asp864Glu)	NIPBL	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36985874	5	36985772	99925	105814
NM_133433.3(NIPBL):c.2602C>T (p.Arg868Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, multiple submitters, no conflicts	5	36985884	5	36985782	96337	102231
NM_133433.3(NIPBL):c.2673C>T (p.Asp891=)	NIPBL	not specified|History of neurodevelopmental disorder	Likely benign(Last reviewed: May 11, 2016)	criteria provided, multiple submitters, no conflicts	5	36985955	5	36985853	159061	168364
NM_133433.3(NIPBL):c.2711del (p.Arg904Asnfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36985993	5	36985891	159062	168365
NM_133433.3(NIPBL):c.2772C>T (p.Asn924=)	NIPBL	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36986054	5	36985952	159063	168366
NM_133433.3(NIPBL):c.2773_2774del (p.Lys925Glufs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jan 7, 2014)	criteria provided, single submitter	5	36986055 - 36986056	5	36985953 - 36985954	159064	168367
NM_133433.3(NIPBL):c.2832T>A (p.Tyr944Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36986114	5	36986012	159065	168368
NM_133433.3(NIPBL):c.2903del (p.Asn968Metfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36986185	5	36986083	159067	168370
NM_133433.3(NIPBL):c.2903A>G (p.Asn968Ser)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36986185	5	36986083	159066	168369
NM_133433.3(NIPBL):c.2931A>G (p.Glu977=)	NIPBL	not specified	Likely benign(Last reviewed: Feb 12, 2016)	criteria provided, multiple submitters, no conflicts	5	36986213	5	36986111	159068	168371
NM_015384.4(NIPBL):c.3015A>G (p.Leu1005=)	NIPBL	Cornelia de Lange syndrome 1|not specified|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Mar 8, 2017)	criteria provided, multiple submitters, no conflicts	5	36986297	5	36986195	96339	102233
NM_133433.3(NIPBL):c.3060_3063delAGAG (p.Glu1021Thrfs)	NIPBL	Cornelia de Lange syndrome 1|not provided	Pathogenic(Last reviewed: Mar 4, 2016)	criteria provided, multiple submitters, no conflicts	5	36986342 - 36986345	5	36986240 - 36986243	159070	168372
NM_133433.3(NIPBL):c.3103C>G (p.Pro1035Ala)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36986385	5	36986283	159071	168373
NM_133433.3(NIPBL):c.3109A>G (p.Lys1037Glu)	NIPBL	Cornelia de Lange syndrome 1|not specified	Uncertain significance(Last reviewed: Mar 21, 2016)	criteria provided, multiple submitters, no conflicts	5	36986391	5	36986289	159072	168374
NM_133433.3(NIPBL):c.3121+11T>G	NIPBL	not specified|Cornelia de Lange Syndrome	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	36986414	5	36986312	159074	168375
NM_133433.3(NIPBL):c.3122-2A>G	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36995722	5	36995620	159075	168376
NM_133433.3(NIPBL):c.3304+5G>A	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36995911	5	36995809	159076	168377
NM_133433.3(NIPBL):c.3305-1G>T	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37000474	5	37000372	159077	168378
NM_133433.3(NIPBL):c.3322A>T (p.Lys1108Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jan 9, 2014)	criteria provided, single submitter	5	37000492	5	37000390	159078	168379
NM_133433.3(NIPBL):c.3369A>C (p.Arg1123Ser)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Apr 9, 2013)	criteria provided, single submitter	5	37000539	5	37000437	159080	168380
NM_133433.3(NIPBL):c.3423A>G (p.Ser1141=)	NIPBL	Cornelia de Lange syndrome 1|not specified|Cornelia de Lange Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	5	37000593	5	37000491	159081	168381
NM_133433.3(NIPBL):c.3440G>A (p.Arg1147Gln)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37000610	5	37000508	159082	168382
NM_133433.3(NIPBL):c.3445C>T (p.Arg1149Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37000615	5	37000513	99926	105815
NM_133433.3(NIPBL):c.3461_3462del (p.Ser1154Terfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37000631 - 37000632	5	37000529 - 37000530	159084	168383
NM_133433.3(NIPBL):c.3503-9T>G	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37000910	5	37000808	159085	168384
NM_133433.3(NIPBL):c.3526_3530del (p.Glu1176Thrfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37000942 - 37000946	5	37000840 - 37000844	159086	168385
NM_133433.3(NIPBL):c.3541A>C (p.Arg1181=)	NIPBL	not specified|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	37000957	5	37000855	159087	168386
NM_133433.3(NIPBL):c.3575-3C>G	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37001088	5	37000986	159088	168387
NM_133433.3(NIPBL):c.3616A>G (p.Ile1206Val)	NIPBL	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37001132	5	37001030	159091	168388
NM_133433.3(NIPBL):c.3660G>A (p.Ala1220=)	NIPBL	not specified	Likely benign(Last reviewed: Feb 18, 2016)	criteria provided, multiple submitters, no conflicts	5	37001176	5	37001074	159092	168389
NM_133433.3(NIPBL):c.3788_3789del (p.Val1263Glufs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37003382 - 37003383	5	37003280 - 37003281	159093	168390
NM_133433.3(NIPBL):c.3804_3818del (p.Leu1269_Ile1273del)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37003398 - 37003412	5	37003296 - 37003310	159094	168391
NM_133433.3(NIPBL):c.3818T>G (p.Ile1273Ser)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37003412	5	37003310	159095	168392
NM_133433.3(NIPBL):c.3851A>G (p.Asn1284Ser)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37003445	5	37003343	159096	168393
NM_133433.3(NIPBL):c.3855+1G>T	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37003450	5	37003348	159097	168394
NM_133433.3(NIPBL):c.3855+5G>A	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37003454	5	37003352	159098	168395
NM_133433.3(NIPBL):c.3856-12A>C	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37006447	5	37006345	159099	168396
NM_133433.3(NIPBL):c.3866_3869del (p.Thr1289Lysfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37006469 - 37006472	5	37006367 - 37006370	159100	168397
NM_133433.3(NIPBL):c.3868G>A (p.Glu1290Lys)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37006471	5	37006369	159101	168398
NM_133433.3(NIPBL):c.3874G>T (p.Glu1292Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37006477	5	37006375	159102	168399
NM_133433.3(NIPBL):c.4017C>A (p.Tyr1339Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: May 10, 2013)	criteria provided, single submitter	5	37006620	5	37006518	159104	168400
NM_133433.3(NIPBL):c.4088-2A>T	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Aug 2, 2013)	criteria provided, single submitter	5	37007423	5	37007321	159105	168401
NM_133433.3(NIPBL):c.4098_4101del (p.Leu1366Phefs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37007435 - 37007438	5	37007333 - 37007336	159106	168402
NM_133433.3(NIPBL):c.4143_4144del (p.Arg1381Serfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37007480 - 37007481	5	37007378 - 37007379	159107	168403
NM_133433.3(NIPBL):c.4240-14T>G	NIPBL	not specified|Cornelia de Lange Syndrome	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	37008096	5	37007994	159108	168404
NM_133433.3(NIPBL):c.4240-7T>C	NIPBL	Cornelia de Lange syndrome 1|not specified	Likely benign(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	5	37008103	5	37008001	159110	168405
NM_133433.3(NIPBL):c.4240-1G>C	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37008109	5	37008007	159109	168406
NM_133433.3(NIPBL):c.4275_4287del (p.Glu1425Aspfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37008145 - 37008157	5	37008043 - 37008055	159111	168407
NM_133433.3(NIPBL):c.4285_4294del (p.Glu1429Cysfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37008155 - 37008164	5	37008053 - 37008062	99928	105817
NM_133433.3(NIPBL):c.4320+1G>A	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37008191	5	37008089	159113	168408
NM_133433.3(NIPBL):c.4320+14A>G	NIPBL	not specified|Cornelia de Lange Syndrome	Likely benign(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	5	37008204	5	37008102	159112	168409
NM_133433.3(NIPBL):c.4321-15A>G	NIPBL	Cornelia de Lange syndrome 1|Cornelia de Lange Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	37008710	5	37008608	159114	168410
NM_133433.3(NIPBL):c.4421G>C (p.Arg1474Thr)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37008825	5	37008723	159115	168411
NM_133433.3(NIPBL):c.4421+7A>G	NIPBL	not specified|Cornelia de Lange Syndrome	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	37008832	5	37008730	96341	102235
NM_133433.3(NIPBL):c.4422G>T (p.Arg1474Ser)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37010189	5	37010087	99929	105818
NM_133433.3(NIPBL):c.4439T>G (p.Met1480Arg)	NIPBL	Cornelia de Lange syndrome 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	5	37010206	5	37010104	159116	168412
NM_133433.3(NIPBL):c.4511T>A (p.Leu1504Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37010278	5	37010176	99930	105819
NM_133433.3(NIPBL):c.4535A>T (p.Asn1512Ile)	NIPBL	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37010302	5	37010200	159117	168413
NM_133433.3(NIPBL):c.4543G>T (p.Glu1515Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37010310	5	37010208	159118	168414
NM_133433.3(NIPBL):c.4561-16C>T	NIPBL	not specified	Benign(Last reviewed: Dec 7, 2016)	criteria provided, multiple submitters, no conflicts	5	37014769	5	37014667	159119	168415
NM_133433.3(NIPBL):c.4561-9T>A	NIPBL	not specified|Cornelia de Lange Syndrome	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	37014776	5	37014674	96342	102236
NM_133433.3(NIPBL):c.4593T>G (p.Tyr1531Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Aug 24, 2016)	criteria provided, multiple submitters, no conflicts	5	37014817	5	37014715	159121	168416
NM_133433.3(NIPBL):c.4606C>T (p.Arg1536Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37014830	5	37014728	2150	17189
NM_133433.3(NIPBL):c.4636del (p.Lys1548Asnfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37014860	5	37014758	159122	168417
NM_133433.3(NIPBL):c.4643+1G>C	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 28, 2013)	criteria provided, single submitter	5	37014868	5	37014766	159123	168418
NM_133433.3(NIPBL):c.4663del (p.Glu1555Lysfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37016159	5	37016057	159124	168419
NM_133433.3(NIPBL):c.4674C>T (p.Tyr1558=)	NIPBL	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37016170	5	37016068	159125	168420
NM_133433.3(NIPBL):c.4684_4687del (p.Phe1562Lysfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37016180 - 37016183	5	37016078 - 37016081	159126	168421
NM_133433.3(NIPBL):c.4712C>A (p.Ser1571Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37016208	5	37016106	159127	168422
NM_133433.3(NIPBL):c.4731A>G (p.Glu1577=)	NIPBL	Cornelia de Lange syndrome 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2015)	criteria provided, conflicting interpretations	5	37016227	5	37016125	159128	168423
NM_133433.3(NIPBL):c.4773G>T (p.Leu1591=)	NIPBL	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37016269	5	37016167	159129	168424
NM_133433.3(NIPBL):c.4777-12T>C	NIPBL	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37017109	5	37017007	159130	168425
NM_133433.3(NIPBL):c.4806_4807del (p.Glu1602Aspfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37017150 - 37017151	5	37017048 - 37017049	99931	105820
NM_133433.3(NIPBL):c.4818_4819del (p.Arg1606Serfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37017162 - 37017163	5	37017060 - 37017061	159131	168426
NM_133433.3(NIPBL):c.4959A>G (p.Lys1653=)	NIPBL	not specified|History of neurodevelopmental disorder	Likely benign(Last reviewed: Mar 21, 2017)	criteria provided, multiple submitters, no conflicts	5	37019451	5	37019349	159132	168427
NM_133433.3(NIPBL):c.5010+9C>A	NIPBL	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37019511	5	37019409	159133	168428
NM_133433.3(NIPBL):c.5033_5039del (p.Ala1678Glyfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37020583 - 37020589	5	37020481 - 37020487	159134	168429
NM_133433.3(NIPBL):c.5167C>T (p.Arg1723Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jun 27, 2013)	criteria provided, single submitter	5	37020717	5	37020615	2146	17185
NM_133433.3(NIPBL):c.5174del (p.Lys1725Serfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37020724	5	37020622	159135	168430
NM_133433.3(NIPBL):c.5211G>A (p.Gln1737=)	NIPBL	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37020761	5	37020659	159136	168431
NM_133433.3(NIPBL):c.5225+13G>A	NIPBL	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37020788	5	37020686	159137	168432
NM_133433.3(NIPBL):c.5226-14A>G	NIPBL	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37020863	5	37020761	159138	168433
NM_133433.3(NIPBL):c.5272C>A (p.Arg1758=)	NIPBL	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37020923	5	37020821	159139	168434
NM_133433.3(NIPBL):c.5327A>T (p.Gln1776Leu)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37020978	5	37020876	159140	168435
NM_133433.3(NIPBL):c.5328+1G>A	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37020980	5	37020878	159141	168436
NM_133433.3(NIPBL):c.5329-15A>G	NIPBL	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37022138	5	37022036	159142	168437
NM_133433.3(NIPBL):c.5329-1G>C	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37022152	5	37022050	159143	168438
NM_133433.3(NIPBL):c.5330T>G (p.Ile1777Ser)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37022154	5	37022052	159144	168439
NM_133433.3(NIPBL):c.5335C>T (p.Arg1779Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37022159	5	37022057	159145	168440
NM_133433.3(NIPBL):c.5365C>T (p.Arg1789Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	5	37022189	5	37022087	159147	168441
NM_133433.3(NIPBL):c.5366G>A (p.Arg1789Gln)	NIPBL	Cornelia de Lange syndrome 1	Conflicting interpretations of pathogenicity(Last reviewed: Aug 27, 2017)	criteria provided, conflicting interpretations	5	37022190	5	37022088	99932	105821
NM_133433.3(NIPBL):c.5389_5392del (p.Ser1797Argfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37022213 - 37022216	5	37022111 - 37022114	159148	168442
NM_133433.3(NIPBL):c.5428-2A>G	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37022344	5	37022242	159149	168443
NM_133433.3(NIPBL):c.5455C>T (p.Arg1819Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37022373	5	37022271	159150	168444
NM_133433.3(NIPBL):c.5456G>A (p.Arg1819Gln)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37022374	5	37022272	99933	105822
NM_133433.3(NIPBL):c.5464G>T (p.Asp1822Tyr)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37022382	5	37022280	159151	168445
NM_133433.3(NIPBL):c.5465A>G (p.Asp1822Gly)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37022383	5	37022281	159152	168446
NM_133433.3(NIPBL):c.5482C>T (p.Arg1828Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37022400	5	37022298	159153	168447
NM_133433.3(NIPBL):c.5483G>A (p.Arg1828Gln)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Mar 21, 2014)	criteria provided, multiple submitters, no conflicts	5	37022401	5	37022299	159154	168448
NM_133433.3(NIPBL):c.5566A>G (p.Arg1856Gly)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37022484	5	37022382	99934	105823
NM_133433.3(NIPBL):c.5690A>G (p.Asn1897Ser)	NIPBL	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37024802	5	37024700	159155	168449
NM_133433.3(NIPBL):c.5709+1G>A	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37024822	5	37024720	159156	168450
NM_133433.3(NIPBL):c.5709+2T>G	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Mar 6, 2014)	criteria provided, single submitter	5	37024823	5	37024721	159157	168451
NM_133433.3(NIPBL):c.5709+7T>G	NIPBL	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37024828	5	37024726	159158	168452
NM_133433.3(NIPBL):c.5732A>C (p.Gln1911Pro)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37026353	5	37026251	159159	168453
NM_133433.3(NIPBL):c.5762A>G (p.Asn1921Ser)	NIPBL	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37026383	5	37026281	159160	168454
NM_133433.3(NIPBL):c.5808+1G>A	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37026430	5	37026328	159161	168455
NM_133433.3(NIPBL):c.5862+1G>A	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37027515	5	37027413	159162	168456
NM_133433.3(NIPBL):c.5874C>T (p.Ser1958=)	NIPBL	not specified|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Jul 13, 2018)	criteria provided, multiple submitters, no conflicts	5	37036492	5	37036390	96348	102242
NM_133433.3(NIPBL):c.5923G>T (p.Val1975Phe)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37036541	5	37036439	159163	168457
NM_133433.3(NIPBL):c.5924_5926del (p.Val1975del)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37036542 - 37036544	5	37036440 - 37036442	159164	168458
NM_133433.3(NIPBL):c.5944A>C (p.Ile1982Leu)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Nov 11, 2013)	criteria provided, single submitter	5	37036562	5	37036460	159165	168459
NM_133433.3(NIPBL):c.5981A>G (p.Asn1994Ser)	NIPBL	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37038713	5	37038611	159166	168460
NM_133433.3(NIPBL):c.6037A>C (p.Ser2013Arg)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37038769	5	37038667	159168	168461
NM_133433.3(NIPBL):c.6067C>A (p.His2023Asn)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37038799	5	37038697	159169	168462
NM_133433.3(NIPBL):c.6068A>G (p.His2023Arg)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37038800	5	37038698	159170	168463
NM_133433.3(NIPBL):c.6071C>A (p.Ala2024Glu)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37038803	5	37038701	159171	168464
NM_133433.3(NIPBL):c.6108+1G>T	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37038841	5	37038739	159173	168465
NM_133433.3(NIPBL):c.6108+7A>G	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37038847	5	37038745	159174	168466
NM_133433.3(NIPBL):c.6109-3T>C	NIPBL	Cornelia de Lange syndrome 1|not specified|not provided|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Aug 31, 2017)	criteria provided, multiple submitters, no conflicts	5	37044446	5	37044344	96349	102243
NM_133433.3(NIPBL):c.6145A>G (p.Lys2049Glu)	NIPBL	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37044485	5	37044383	159176	168467
NM_133433.3(NIPBL):c.6158T>C (p.Leu2053Pro)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37044498	5	37044396	159177	168468
NM_133433.3(NIPBL):c.6170T>C (p.Leu2057Pro)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37044510	5	37044408	159179	168469
NM_133433.3(NIPBL):c.6182C>T (p.Pro2061Leu)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37044522	5	37044420	159180	168470
NM_133433.3(NIPBL):c.6242G>T (p.Gly2081Val)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37044582	5	37044480	159181	168471
NM_133433.3(NIPBL):c.6250-6T>C	NIPBL	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37044732	5	37044630	159182	168472
NM_133433.3(NIPBL):c.6250G>T (p.Val2084Leu)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37044738	5	37044636	159183	168473
NM_133433.3(NIPBL):c.6266T>G (p.Val2089Gly)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37044754	5	37044652	159184	168474
NM_133433.3(NIPBL):c.6316G>C (p.Val2106Leu)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37044804	5	37044702	159185	168475
NM_133433.3(NIPBL):c.6317_6320del (p.Val2106Glyfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37044805 - 37044808	5	37044703 - 37044706	159186	168476
NM_133433.3(NIPBL):c.6322G>A (p.Ala2108Thr)	NIPBL	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 19, 2016)	criteria provided, conflicting interpretations	5	37044810	5	37044708	159187	168477
NM_133433.3(NIPBL):c.6343G>A (p.Gly2115Ser)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: May 19, 2014)	criteria provided, single submitter	5	37044831	5	37044729	159189	168478
NM_133433.3(NIPBL):c.6343+5G>A	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37044836	5	37044734	159188	168479
NM_133433.3(NIPBL):c.6362_6364del (p.Lys2121del)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37045563 - 37045565	5	37045461 - 37045463	159190	168480
NM_133433.3(NIPBL):c.6400C>T (p.Leu2134=)	NIPBL	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 31, 2018)	criteria provided, conflicting interpretations	5	37045601	5	37045499	159194	168481
NM_133433.3(NIPBL):c.6478G>T (p.Asp2160Tyr)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37045679	5	37045577	159195	168482
NM_133433.3(NIPBL):c.6565C>T (p.Gln2189Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37046277	5	37046175	159197	168483
NM_133433.3(NIPBL):c.6568A>G (p.Thr2190Ala)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37046280	5	37046178	159198	168484
NM_133433.3(NIPBL):c.6571A>T (p.Lys2191Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37046283	5	37046181	159199	168485
NM_133433.3(NIPBL):c.6589+9A>T	NIPBL	Cornelia de Lange syndrome 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 2, 2018)	criteria provided, conflicting interpretations	5	37046310	5	37046208	159200	168486
NM_133433.3(NIPBL):c.6590-2A>C	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37048602	5	37048500	159201	168487
NM_133433.3(NIPBL):c.6590G>A (p.Gly2197Glu)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37048604	5	37048502	159202	168488
NM_133433.3(NIPBL):c.6613A>G (p.Ser2205Gly)	NIPBL	not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Aug 4, 2016)	criteria provided, conflicting interpretations	5	37048627	5	37048525	159203	168489
NM_133433.3(NIPBL):c.6631G>T (p.Glu2211Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37048645	5	37048543	99936	105825
NM_133433.3(NIPBL):c.6632_6634del (p.Glu2211del)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37048646 - 37048648	5	37048544 - 37048546	159204	168490
NM_133433.3(NIPBL):c.6641_6647del (p.Asn2214Ilefs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37048655 - 37048661	5	37048553 - 37048559	99937	105826
NM_133433.3(NIPBL):c.6646T>C (p.Tyr2216His)	NIPBL	Cornelia de Lange syndrome 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 4, 2018)	criteria provided, conflicting interpretations	5	37048660	5	37048558	159205	168491
NM_133433.3(NIPBL):c.6648_6649del (p.Tyr2216Terfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37048662 - 37048663	5	37048560 - 37048561	159206	168492
NM_133433.3(NIPBL):c.6653_6655del (p.Asn2218del)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 19, 2013)	criteria provided, single submitter	5	37048667 - 37048669	5	37048565 - 37048567	159207	168493
NM_133433.3(NIPBL):c.6707A>T (p.Asn2236Ile)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Mar 5, 2014)	criteria provided, single submitter	5	37048721	5	37048619	159208	168494
NM_133433.3(NIPBL):c.6892C>T (p.Arg2298Cys)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	5	37049341	5	37049239	159210	168495
NM_133433.3(NIPBL):c.6892C>G (p.Arg2298Gly)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37049341	5	37049239	99938	105827
NM_133433.3(NIPBL):c.6893G>A (p.Arg2298His)	NIPBL	Cornelia de Lange syndrome 1|not provided	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	5	37049342	5	37049240	159211	168496
NM_133433.3(NIPBL):c.6935G>T (p.Gly2312Val)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37049384	5	37049282	159212	168497
NM_133433.3(NIPBL):c.6952C>T (p.Gln2318Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37049401	5	37049299	159213	168498
NM_133433.3(NIPBL):c.6954+1G>A	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37049404	5	37049302	159214	168499
NM_133433.3(NIPBL):c.6993A>G (p.Glu2331=)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37051919	5	37051817	159215	168500
NM_133433.3(NIPBL):c.7011_7012del (p.Lys2337Asnfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37051937 - 37051938	5	37051835 - 37051836	159216	168501
NM_133433.3(NIPBL):c.7012G>C (p.Ala2338Pro)	NIPBL	Cornelia de Lange syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, multiple submitters, no conflicts	5	37051938	5	37051836	159217	168502
NM_133433.3(NIPBL):c.7024C>T (p.Leu2342Phe)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37051950	5	37051848	159218	168503
NM_133433.3(NIPBL):c.7062+2T>C	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37051990	5	37051888	159219	168504
NM_133433.3(NIPBL):c.7102C>T (p.Gln2368Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37052507	5	37052405	159220	168505
NM_133433.3(NIPBL):c.7106del (p.Gln2369Argfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37052511	5	37052409	159221	168506
NM_133433.3(NIPBL):c.7141G>A (p.Gly2381Ser)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37052546	5	37052444	159222	168507
NM_015384.4(NIPBL):c.7150C>T (p.Gln2384Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Nov 3, 2014)	criteria provided, single submitter	5	37052555	5	37052453	369665	353895
NM_133433.3(NIPBL):c.7168G>A (p.Ala2390Thr)	NIPBL	Cornelia de Lange syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2017)	criteria provided, multiple submitters, no conflicts	5	37052573	5	37052471	159223	168508
NM_133433.3(NIPBL):c.7198del (p.Arg2400Valfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37052603	5	37052501	159224	168509
NM_133433.3(NIPBL):c.7219C>T (p.Arg2407Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	5	37052624	5	37052522	96352	102246
NM_133433.3(NIPBL):c.7264-6T>G	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37057282	5	37057180	159225	168510
NM_133433.3(NIPBL):c.7301A>G (p.Asn2434Ser)	NIPBL	Cornelia de Lange syndrome 1|not provided	Likely pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, multiple submitters, no conflicts	5	37057325	5	37057223	99939	105828
NM_133433.3(NIPBL):c.7306G>A (p.Ala2436Thr)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37057330	5	37057228	159226	168511
NM_133433.3(NIPBL):c.7327C>T (p.Gln2443Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37057351	5	37057249	99940	105829
NM_133433.3(NIPBL):c.7336_7338del (p.Pro2446del)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37057360 - 37057362	5	37057258 - 37057260	159227	168512
NM_133433.3(NIPBL):c.7348_7350del (p.Met2450del)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37057372 - 37057374	5	37057270 - 37057272	159228	168513
NM_133433.3(NIPBL):c.7439_7440delGA (p.Arg2480Lysfs)	NIPBL	Cornelia de Lange syndrome 1|not provided	Pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, multiple submitters, no conflicts	5	37059021 - 37059022	5	37058919 - 37058920	159230	168514
NM_133433.3(NIPBL):c.7542_7547del (p.Asp2514_Ser2515del)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Sep 20, 2013)	criteria provided, single submitter	5	37059124 - 37059129	5	37059022 - 37059027	159231	168515
NM_133433.3(NIPBL):c.7625G>A (p.Gly2542Asp)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37059207	5	37059105	159232	168516
NM_133433.3(NIPBL):c.7641C>T (p.Leu2547=)	NIPBL	Cornelia de Lange syndrome 1|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2017)	criteria provided, conflicting interpretations	5	37059223	5	37059121	159233	168517
NM_133433.3(NIPBL):c.7701_7725del (p.Ser2568Metfs)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37060961 - 37060985	5	37060859 - 37060883	159234	168518
NM_133433.3(NIPBL):c.7727A>G (p.Tyr2576Cys)	NIPBL	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37060987	5	37060885	99941	105830
NM_133433.3(NIPBL):c.7789delC (p.Leu2597Cysfs)	NIPBL	Cornelia de Lange syndrome 1|not provided	Pathogenic(Last reviewed: Mar 11, 2016)	criteria provided, multiple submitters, no conflicts	5	37061049	5	37060947	99942	105831
NM_133433.3(NIPBL):c.7830G>C (p.Val2610=)	NIPBL	not specified|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Mar 21, 2017)	criteria provided, multiple submitters, no conflicts	5	37061090	5	37060988	159238	168519
NM_133433.3(NIPBL):c.7849C>T (p.Gln2617Ter)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37061109	5	37061007	159239	168520
NM_133433.3(NIPBL):c.7860+9T>G	NIPBL	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37061129	5	37061027	159240	168521
NM_133433.3(NIPBL):c.8165_8183del (p.Pro2722Argfs)	NIPBL|CPLANE1	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37064744 - 37064762	5	37064642 - 37064660	159241	168522
NM_133433.3(NIPBL):c.8173G>C (p.Ala2725Pro)	NIPBL|CPLANE1	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37064752	5	37064650	159242	168523
NM_133433.3(NIPBL):c.8225G>T (p.Gly2742Val)	NIPBL|CPLANE1	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37064804	5	37064702	159243	168524
NM_133433.3(NIPBL):c.8277_8283del (p.Val2760Glyfs)	NIPBL|CPLANE1	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37064856 - 37064862	5	37064754 - 37064760	159244	168525
NM_133433.3(NIPBL):c.8300_8301del (p.Lys2767Argfs)	NIPBL|CPLANE1	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37064879 - 37064880	5	37064777 - 37064778	159245	168526
NM_133433.3(NIPBL):c.8336C>T (p.Thr2779Met)	NIPBL|CPLANE1	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37064915	5	37064813	159246	168527
NM_133433.3(NIPBL):c.8377C>T (p.Arg2793Ter)	NIPBL|CPLANE1	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, multiple submitters, no conflicts	5	37064956	5	37064854	96355	102249
NM_133433.3(NIPBL):c.8408C>G (p.Ser2803Cys)	NIPBL|CPLANE1	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37064987	5	37064885	159247	168528
NM_133433.3(NIPBL):c.*84del	NIPBL|CPLANE1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37065078	5	37064976	159023	168529
NM_002202.2(ISL1):c.137C>G (p.Ala46Gly)	ISL1	Exstrophy-epispadias complex	Uncertain significance(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	5	50680483	5	51384649	374407	361293
NM_002202.2(ISL1):c.479-4G>A	ISL1	Exstrophy-epispadias complex	Uncertain significance(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	5	50685476	5	51389642	373894	360795
NM_005921.1(MAP3K1):c.770C>T (p.Pro257Leu)	MAP3K1	46,XY sex reversal, type 6	Likely pathogenic(Last reviewed: May 14, 2013)	criteria provided, single submitter	5	56155678	5	56859851	216959	213561
NM_005921.1(MAP3K1):c.1923G>A (p.Met641Ile)	MAP3K1	46,XY sex reversal, type 6	Likely pathogenic(Last reviewed: Mar 13, 2015)	no assertion criteria provided	5	56171095	5	56875268	268092	263526
NM_020928.1(ZSWIM6):c.2737C>T (p.Arg913Ter)	ZSWIM6	ZSWIM6 related intellectual disability|NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	5	60837744	5	61541917	431797	425299
NM_001243953.1(KIF2A):c.382T>C (p.Ser128Pro)	KIF2A	Cortical dysplasia, complex, with other brain malformations 3	Uncertain significance(Last reviewed: Dec 8, 2017)	no assertion criteria provided	5	61648462	5	62352635	523636	514284
NM_001098511.2(KIF2A):c.938G>A (p.Gly313Glu)	KIF2A	Cortical dysplasia, complex, with other brain malformations 3	Likely pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	5	61657134	5	62361307	584429	575489
NM_181523.2(PIK3R1):c.219C>T (p.Tyr73=)	PIK3R1	not specified	Benign/Likely benign(Last reviewed: May 13, 2016)	criteria provided, multiple submitters, no conflicts	5	67522722	5	68226894	159722	168530
NM_181523.2(PIK3R1):c.334+14A>C	PIK3R1	not specified	Benign/Likely benign(Last reviewed: Mar 29, 2016)	criteria provided, multiple submitters, no conflicts	5	67522851	5	68227023	159723	168531
NM_181523.2(PIK3R1):c.621T>C (p.Ile207=)	PIK3R1	SHORT syndrome|not specified|not provided|Agammaglobulinemia 7, autosomal recessive|Immunodeficiency 36	Benign/Likely benign(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	5	67575548	5	68279720	159724	168532
NM_181523.2(PIK3R1):c.978G>A (p.Met326Ile)	PIK3R1	not specified|not provided	Benign/Likely benign(Last reviewed: May 2, 2017)	criteria provided, multiple submitters, no conflicts	5	67588148	5	68292320	135039	138778
NM_181523.2(PIK3R1):c.1106C>T (p.Thr369Ile)	PIK3R1	SHORT syndrome	Likely pathogenic(Last reviewed: May 29, 2014)	criteria provided, single submitter	5	67589015	5	68293187	159719	168533
NM_181523.2(PIK3R1):c.1176C>T (p.Phe392=)	PIK3R1	SHORT syndrome|not specified|Agammaglobulinemia 7, autosomal recessive|Immunodeficiency 36	Benign/Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	5	67589188	5	68293360	159720	168534
NM_181523.2(PIK3R1):c.1460T>C (p.Phe487Ser)	PIK3R1	SHORT syndrome	Likely pathogenic(Last reviewed: Jun 12, 2015)	criteria provided, single submitter	5	67590398	5	68294570	209182	205745
NM_181523.2(PIK3R1):c.1945C>T (p.Arg649Trp)	PIK3R1	SHORT syndrome|not provided|Agammaglobulinemia 7, autosomal recessive|Immunodeficiency 36	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, multiple submitters, no conflicts	5	67592129	5	68296301	60763	75301
NM_181523.2(PIK3R1):c.2109T>C (p.Leu703=)	PIK3R1	SHORT syndrome|not specified|Agammaglobulinemia 7, autosomal recessive|Immunodeficiency 36	Benign/Likely benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	5	67593363	5	68297535	159721	168535
NM_002397.4(MEF2C):c.1403C>T (p.Ser468Phe)	MEF2C|MEF2C-AS2	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	88018440	5	88722623	158885	168540
NM_001193350.1(MEF2C):c.860C>T (p.Ser287Leu)	MEF2C	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	5	88025139	5	88729322	438583	432211
NM_002397.4(MEF2C):c.833delT (p.Leu278Terfs)	MEF2C	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations|not provided	Pathogenic(Last reviewed: Jan 8, 2016)	criteria provided, multiple submitters, no conflicts	5	88026029	5	88730212	158888	168541
NM_001131005.2(MEF2C):c.632-2A>C	MEF2C	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	5	88027720	5	88731903	488545	481413
NM_002397.4(MEF2C):c.585C>T (p.Asn195=)	MEF2C	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2017)	criteria provided, conflicting interpretations	5	88047678	5	88751861	94061	99963
NM_002397.4(MEF2C):c.565C>T (p.Arg189Ter)	MEF2C	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations|not provided	Pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, multiple submitters, no conflicts	5	88047698	5	88751881	158886	168543
NM_002397.4(MEF2C):c.68A>G (p.Lys23Arg)	MEF2C	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Likely pathogenic(Last reviewed: Jul 28, 2014)	criteria provided, single submitter	5	88100605	5	88804788	209171	205746
NM_001131005.2(MEF2C):c.9A>T (p.Arg3Ser)	MEF2C	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Dec 20, 2013)	no assertion criteria provided	5	88119597	5	88823780	218315	215010
NC_000005.10:g.88846693_89051376del204684insG	MEF2C|MEF2C-AS1	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	5	88142510 - 88347193	5	88846693 - 89051376	598760	589802
NM_032119.3(ADGRV1):c.327C>T (p.Asp109=)	ADGRV1	not specified|not provided	Benign(Last reviewed: Jan 24, 2018)	criteria provided, multiple submitters, no conflicts	5	89913740	5	90617923	46314	55479
NM_032119.3(ADGRV1):c.380T>G (p.Leu127Arg)	ADGRV1	not specified|not provided	Benign(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	5	89914925	5	90619108	46321	55486
NM_032119.3(ADGRV1):c.581C>A (p.Pro194His)	ADGRV1	not specified|not provided	Benign(Last reviewed: Apr 11, 2018)	criteria provided, multiple submitters, no conflicts	5	89920969	5	90625152	46341	55506
NM_032119.3(ADGRV1):c.746G>A (p.Arg249Lys)	ADGRV1	not specified|not provided|Usher syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 19, 2018)	criteria provided, conflicting interpretations	5	89923101	5	90627284	46374	55539
NM_032119.3(ADGRV1):c.1086A>G (p.Leu362=)	ADGRV1	not specified	Benign/Likely benign(Last reviewed: Oct 6, 2017)	criteria provided, multiple submitters, no conflicts	5	89923441	5	90627624	158643	168544
NM_032119.4(ADGRV1):c.1652T>C (p.Val551Ala)	ADGRV1	not specified|not provided	Benign(Last reviewed: Jan 30, 2018)	criteria provided, multiple submitters, no conflicts	5	89925169	5	90629352	46286	55451
NM_032119.3(ADGRV1):c.1797A>T (p.Arg599Ser)	ADGRV1	not specified|not provided	Uncertain significance(Last reviewed: Feb 5, 2016)	criteria provided, single submitter	5	89925314	5	90629497	158647	168545
NM_032119.3(ADGRV1):c.1839+7G>A	ADGRV1	not specified|not provided	Benign/Likely benign(Last reviewed: Nov 6, 2017)	criteria provided, multiple submitters, no conflicts	5	89925363	5	90629546	46297	55462
NM_032119.3(ADGRV1):c.1855T>G (p.Leu619Val)	ADGRV1	Febrile seizures, familial, 4|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 15, 2018)	criteria provided, conflicting interpretations	5	89930946	5	90635129	158649	168546
NM_032119.3(ADGRV1):c.2367+8C>T	ADGRV1	not specified	Benign(Last reviewed: May 9, 2013)	criteria provided, multiple submitters, no conflicts	5	89938587	5	90642770	46305	55470
NM_032119.3(ADGRV1):c.2456G>A (p.Ser819Asn)	ADGRV1	Febrile seizures, familial, 4|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 24, 2017)	criteria provided, conflicting interpretations	5	89938761	5	90642944	158650	168547
NM_032119.3(ADGRV1):c.3141A>G (p.Ala1047=)	ADGRV1	not specified	Benign(Last reviewed: Mar 5, 2013)	criteria provided, multiple submitters, no conflicts	5	89943433	5	90647616	46310	55475
NM_032119.4(ADGRV1):c.3151G>T (p.Asp1051Tyr)	ADGRV1	Febrile seizures, familial, 4|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 21, 2017)	criteria provided, conflicting interpretations	5	89943443	5	90647626	46311	55476
NM_032119.3(ADGRV1):c.3191A>C (p.Glu1064Ala)	ADGRV1	Febrile seizures, familial, 4|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 21, 2017)	criteria provided, conflicting interpretations	5	89943483	5	90647666	46312	55477
NM_032119.4(ADGRV1):c.3279G>T (p.Leu1093Phe)	ADGRV1	not specified	Benign(Last reviewed: Jul 21, 2014)	criteria provided, multiple submitters, no conflicts	5	89943571	5	90647754	46313	55478
NM_032119.4(ADGRV1):c.3289G>A (p.Gly1097Ser)	ADGRV1	not specified	Benign(Last reviewed: Jun 30, 2015)	criteria provided, multiple submitters, no conflicts	5	89943581	5	90647764	158651	168548
NM_032119.4(ADGRV1):c.3303A>G (p.Val1101=)	ADGRV1	not specified	Benign(Last reviewed: Aug 12, 2015)	criteria provided, multiple submitters, no conflicts	5	89947434	5	90651617	46315	55480
NM_032119.4(ADGRV1):c.4260A>G (p.Glu1420=)	ADGRV1	not specified	Benign/Likely benign(Last reviewed: Apr 21, 2014)	criteria provided, multiple submitters, no conflicts	5	89949651	5	90653834	46327	55492
NM_032119.4(ADGRV1):c.4506C>T (p.Pro1502=)	ADGRV1	not specified|not provided	Benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	5	89953849	5	90658032	46329	55494
NM_032119.4(ADGRV1):c.5304G>A (p.Glu1768=)	ADGRV1	not specified|not provided	Benign(Last reviewed: Oct 5, 2017)	criteria provided, multiple submitters, no conflicts	5	89971253	5	90675436	46334	55499
NM_032119.3(ADGRV1):c.5525-7C>T	ADGRV1	not specified|not provided	Benign/Likely benign(Last reviewed: Jan 23, 2015)	criteria provided, multiple submitters, no conflicts	5	89977125	5	90681308	46337	55502
NM_032119.3(ADGRV1):c.5665-23T>C	ADGRV1	not specified	Likely benign	no assertion criteria provided	5	89979380	5	90683563	158652	168549
NM_032119.3(ADGRV1):c.5747C>T (p.Thr1916Ile)	ADGRV1	not specified|not provided	Benign(Last reviewed: Jan 24, 2018)	criteria provided, multiple submitters, no conflicts	5	89979485	5	90683668	158653	168550
NM_032119.3(ADGRV1):c.5780C>T (p.Thr1927Met)	ADGRV1	not specified|not provided	Benign(Last reviewed: Jan 14, 2013)	criteria provided, multiple submitters, no conflicts	5	89979518	5	90683701	46339	55504
NM_032119.4(ADGRV1):c.5851G>A (p.Val1951Ile)	ADGRV1	not specified	Benign(Last reviewed: Jun 26, 2014)	criteria provided, multiple submitters, no conflicts	5	89979589	5	90683772	46343	55508
NM_032119.3(ADGRV1):c.5953A>G (p.Asn1985Asp)	ADGRV1	not specified	Benign(Last reviewed: Apr 25, 2014)	criteria provided, multiple submitters, no conflicts	5	89979691	5	90683874	46344	55509
NM_032119.3(ADGRV1):c.5960C>T (p.Pro1987Leu)	ADGRV1	not specified	Benign(Last reviewed: Jun 22, 2014)	criteria provided, multiple submitters, no conflicts	5	89979698	5	90683881	46345	55510
NM_032119.4(ADGRV1):c.6012G>T (p.Leu2004Phe)	ADGRV1	not specified	Benign(Last reviewed: Apr 25, 2014)	criteria provided, multiple submitters, no conflicts	5	89979750	5	90683933	46346	55511
NM_032119.3(ADGRV1):c.6133G>A (p.Gly2045Arg)	ADGRV1	Febrile seizures, familial, 4|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 18, 2018)	criteria provided, conflicting interpretations	5	89979871	5	90684054	46348	55513
NM_032119.3(ADGRV1):c.6289C>T (p.Arg2097Cys)	ADGRV1	not specified	Benign(Last reviewed: Dec 16, 2015)	criteria provided, multiple submitters, no conflicts	5	89981611	5	90685794	46350	55515
NM_032119.4(ADGRV1):c.6695A>G (p.Tyr2232Cys)	ADGRV1	not specified	Benign(Last reviewed: Mar 23, 2010)	criteria provided, multiple submitters, no conflicts	5	89985882	5	90690065	46356	55521
NM_032119.3(ADGRV1):c.6952-10G>A	ADGRV1	not specified	Benign(Last reviewed: Jun 19, 2009)	criteria provided, multiple submitters, no conflicts	5	89988412	5	90692595	46358	55523
NM_032119.3(ADGRV1):c.7034A>G (p.Asn2345Ser)	ADGRV1	not specified	Benign(Last reviewed: Mar 16, 2007)	criteria provided, multiple submitters, no conflicts	5	89988504	5	90692687	46360	55525
NM_032119.4(ADGRV1):c.7176C>T (p.Ser2392=)	ADGRV1	not specified	Benign/Likely benign(Last reviewed: Jul 20, 2015)	criteria provided, multiple submitters, no conflicts	5	89989749	5	90693932	46363	55528
NM_032119.3(ADGRV1):c.7179C>T (p.Asp2393=)	ADGRV1	not specified|not provided	Benign(Last reviewed: Nov 28, 2017)	criteria provided, multiple submitters, no conflicts	5	89989752	5	90693935	46364	55529
NM_032119.3(ADGRV1):c.7206G>A (p.Glu2402=)	ADGRV1	not specified|not provided	Benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	5	89989779	5	90693962	46365	55530
NM_032119.3(ADGRV1):c.7293C>T (p.Ala2431=)	ADGRV1	not specified|not provided	Benign(Last reviewed: Sep 6, 2017)	criteria provided, multiple submitters, no conflicts	5	89989866	5	90694049	46368	55533
NM_032119.3(ADGRV1):c.7751A>G (p.Asn2584Ser)	ADGRV1	not specified	Benign(Last reviewed: Jun 19, 2009)	criteria provided, multiple submitters, no conflicts	5	89990324	5	90694507	46379	55544
NM_032119.3(ADGRV1):c.7813T>G (p.Leu2605Val)	ADGRV1	not specified|not provided	Benign(Last reviewed: Oct 27, 2016)	criteria provided, multiple submitters, no conflicts	5	89990386	5	90694569	46380	55545
NM_032119.4(ADGRV1):c.7945+6C>T	ADGRV1	not specified|not provided	Benign/Likely benign(Last reviewed: Jan 22, 2018)	criteria provided, multiple submitters, no conflicts	5	89990524	5	90694707	46382	55547
NM_032119.3(ADGRV1):c.7945+27C>A	ADGRV1	not specified	Likely benign	no assertion criteria provided	5	89990545	5	90694728	158654	168551
NM_032119.3(ADGRV1):c.8291C>T (p.Ser2764Leu)	ADGRV1	not specified	Benign(Last reviewed: Apr 29, 2014)	criteria provided, multiple submitters, no conflicts	5	90000210	5	90704393	46387	55552
NM_032119.3(ADGRV1):c.8407G>A (p.Ala2803Thr)	ADGRV1	not specified|not provided	Benign/Likely benign(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	5	90001237	5	90705420	46389	55554
NM_032119.4(ADGRV1):c.8538T>G (p.Leu2846=)	ADGRV1	not specified	Benign(Last reviewed: Jan 8, 2013)	criteria provided, multiple submitters, no conflicts	5	90001368	5	90705551	46390	55555
NM_032119.4(ADGRV1):c.8876G>A (p.Arg2959Gln)	ADGRV1	not specified|not provided	Benign(Last reviewed: Sep 14, 2017)	criteria provided, multiple submitters, no conflicts	5	90006849	5	90711032	46400	55565
NM_032119.3(ADGRV1):c.9280G>A (p.Val3094Ile)	ADGRV1	not specified	Benign(Last reviewed: Apr 10, 2012)	criteria provided, single submitter	5	90012379	5	90716562	46403	55568
NM_032119.4(ADGRV1):c.9650C>T (p.Ala3217Val)	ADGRV1	Usher syndrome, type 2C|Febrile seizures, familial, 1|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 7, 2018)	criteria provided, conflicting interpretations	5	90016778	5	90720961	158655	168552
NM_032119.4(ADGRV1):c.9743G>A (p.Gly3248Asp)	ADGRV1	not specified	Benign(Last reviewed: Jan 8, 2013)	criteria provided, multiple submitters, no conflicts	5	90016871	5	90721054	46407	55572
NM_032119.3(ADGRV1):c.9771C>T (p.Ser3257=)	ADGRV1	not specified|not provided	Benign(Last reviewed: Sep 26, 2017)	criteria provided, multiple submitters, no conflicts	5	90020671	5	90724854	46408	55573
NM_032119.3(ADGRV1):c.9907-35A>C	ADGRV1	not specified	Likely benign	no assertion criteria provided	5	90020868	5	90725051	158656	168553
NM_032119.3(ADGRV1):c.9927T>G (p.Pro3309=)	ADGRV1	not specified|not provided	Benign(Last reviewed: May 2, 2017)	criteria provided, multiple submitters, no conflicts	5	90020923	5	90725106	46409	55574
NM_032119.3(ADGRV1):c.10161+26G>T	ADGRV1	not specified	Likely benign	no assertion criteria provided	5	90021499	5	90725682	158642	168554
NM_032119.3(ADGRV1):c.10411G>A (p.Glu3471Lys)	ADGRV1	not specified|not provided	Benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	5	90024735	5	90728918	46248	55413
NM_032119.4(ADGRV1):c.10577T>C (p.Met3526Thr)	ADGRV1	not specified|not provided	Benign(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	5	90040890	5	90745073	46249	55414
NM_032119.3(ADGRV1):c.10872A>G (p.Gln3624=)	ADGRV1	not specified|not provided	Benign(Last reviewed: Jul 11, 2017)	criteria provided, multiple submitters, no conflicts	5	90041510	5	90745693	46252	55417
NM_032119.3(ADGRV1):c.11031C>T (p.Asn3677=)	ADGRV1	not specified	Benign(Last reviewed: Nov 7, 2016)	criteria provided, multiple submitters, no conflicts	5	90046424	5	90750607	46253	55418
NM_032119.3(ADGRV1):c.11338C>T (p.Arg3780Cys)	ADGRV1	Febrile seizures, familial, 4	Uncertain significance(Last reviewed: Oct 24, 2013)	criteria provided, single submitter	5	90049607	5	90753790	158644	168555
NM_032119.3(ADGRV1):c.11472G>A (p.Leu3824=)	ADGRV1	not specified|not provided	Benign(Last reviewed: Mar 8, 2018)	criteria provided, multiple submitters, no conflicts	5	90050894	5	90755077	46255	55420
NM_032119.4(ADGRV1):c.11481T>C (p.Asp3827=)	ADGRV1	not specified|not provided	Benign(Last reviewed: Feb 6, 2018)	criteria provided, multiple submitters, no conflicts	5	90050903	5	90755086	158645	168556
NM_032119.4(ADGRV1):c.11599G>A (p.Glu3867Lys)	ADGRV1	not specified	Benign(Last reviewed: Nov 22, 2015)	criteria provided, multiple submitters, no conflicts	5	90052289	5	90756472	46257	55422
NM_032119.3(ADGRV1):c.11682C>T (p.Pro3894=)	ADGRV1	not specified|not provided	Benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	5	90052372	5	90756555	46258	55423
NM_032119.3(ADGRV1):c.12032G>T (p.Gly4011Val)	ADGRV1	Febrile seizures, familial, 4	Uncertain significance(Last reviewed: Oct 30, 2013)	criteria provided, single submitter	5	90055317	5	90759500	158646	168557
NM_032119.3(ADGRV1):c.12592G>A (p.Val4198Met)	ADGRV1	not specified|not provided	Benign(Last reviewed: Sep 14, 2017)	criteria provided, multiple submitters, no conflicts	5	90073786	5	90777969	46262	55427
NM_032119.3(ADGRV1):c.12927G>A (p.Ala4309=)	ADGRV1	not specified	Benign(Last reviewed: Jun 23, 2017)	criteria provided, multiple submitters, no conflicts	5	90074759	5	90778942	46264	55429
NM_032119.4(ADGRV1):c.13037C>T (p.Pro4346Leu)	ADGRV1	not specified	Benign/Likely benign(Last reviewed: Feb 8, 2016)	criteria provided, multiple submitters, no conflicts	5	90074869	5	90779052	46265	55430
NM_032119.4(ADGRV1):c.13232-7A>G	ADGRV1	not specified	Benign(Last reviewed: Apr 4, 2013)	criteria provided, multiple submitters, no conflicts	5	90078934	5	90783117	46266	55431
NM_032119.4(ADGRV1):c.13590C>T (p.Pro4530=)	ADGRV1	not specified	Benign/Likely benign(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	5	90079811	5	90783994	46267	55432
NM_032119.4(ADGRV1):c.13599A>G (p.Thr4533=)	ADGRV1	not specified	Benign(Last reviewed: Feb 26, 2016)	criteria provided, multiple submitters, no conflicts	5	90079820	5	90784003	46268	55433
NM_032119.4(ADGRV1):c.14029T>C (p.Phe4677Leu)	ADGRV1	not specified|not provided	Benign(Last reviewed: Sep 21, 2017)	criteria provided, multiple submitters, no conflicts	5	90085654	5	90789837	46269	55434
NM_032119.4(ADGRV1):c.14515C>G (p.Gln4839Glu)	ADGRV1	not specified|not provided	Benign(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	5	90087161	5	90791344	46271	55436
NM_032119.3(ADGRV1):c.14905T>C (p.Trp4969Arg)	ADGRV1	not specified|not provided	Benign(Last reviewed: Aug 30, 2017)	criteria provided, multiple submitters, no conflicts	5	90103487	5	90807670	46274	55439
NM_032119.3(ADGRV1):c.16031A>G (p.Glu5344Gly)	ADGRV1	not specified	Benign(Last reviewed: Mar 6, 2013)	criteria provided, multiple submitters, no conflicts	5	90107108	5	90811291	46282	55447
NM_032119.3(ADGRV1):c.16164A>G (p.Arg5388=)	ADGRV1	not specified	Benign(Last reviewed: Aug 27, 2013)	criteria provided, multiple submitters, no conflicts	5	90111521	5	90815704	46283	55448
NM_032119.3(ADGRV1):c.16248C>T (p.Val5416=)	ADGRV1	not specified|not provided	Benign(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	5	90119293	5	90823476	46284	55449
NM_032119.4(ADGRV1):c.16279G>A (p.Val5427Met)	ADGRV1	not specified	Benign(Last reviewed: Jul 15, 2014)	criteria provided, multiple submitters, no conflicts	5	90119324	5	90823507	46285	55450
NM_032119.3(ADGRV1):c.17626G>A (p.Val5876Ile)	ADGRV1	not specified	Benign(Last reviewed: Sep 6, 2018)	criteria provided, multiple submitters, no conflicts	5	90151589	5	90855772	46291	55456
NC_000005.9:g.91064110_93896378del2832269	NR2F1|FAM172A|POU5F2|KIAA0825	Bosch-Boonstra-Schaaf optic atrophy syndrome	Likely pathogenic(Last reviewed: Feb 6, 2014)	criteria provided, single submitter	5	91064110 - 93896378			218937	215771
NM_032119.4(ADGRV1):c.18273A>G (p.Ala6091=)	ADGRV1	Febrile seizures, familial, 4|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 26, 2017)	criteria provided, conflicting interpretations	5	90368384	5	91072567	100602	106479
NM_032119.3(ADGRV1):c.18311-22A>G	ADGRV1	not specified	Likely benign	no assertion criteria provided	5	90398014	5	91102197	158648	168558
NM_032119.3(ADGRV1):c.18475A>G (p.Met6159Val)	ADGRV1	not specified	Benign(Last reviewed: Jul 2, 2015)	criteria provided, multiple submitters, no conflicts	5	90445889	5	91150072	46298	55463
NM_032119.3(ADGRV1):c.18625-7T>C	ADGRV1	not specified	Benign(Last reviewed: Sep 28, 2016)	criteria provided, multiple submitters, no conflicts	5	90449031	5	91153214	46299	55464
NM_032119.3(ADGRV1):c.18741G>A (p.Gly6247=)	ADGRV1	not specified	Benign(Last reviewed: Feb 26, 2016)	criteria provided, multiple submitters, no conflicts	5	90449154	5	91153337	46300	55465
NM_005654.5(NR2F1):c.335G>A (p.Arg112Lys)	NR2F1	Bosch-Boonstra-Schaaf optic atrophy syndrome	Likely pathogenic(Last reviewed: Feb 6, 2014)	criteria provided, single submitter	5	92921064	5	93585358	126496	132020
NM_005654.5(NR2F1):c.339C>A (p.Ser113Arg)	NR2F1	Bosch-Boonstra-Schaaf optic atrophy syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	5	92921068	5	93585362	126494	132018
NM_005654.5(NR2F1):c.344G>C (p.Arg115Pro)	NR2F1	Bosch-Boonstra-Schaaf optic atrophy syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	5	92921073	5	93585367	126493	132017
NM_005654.5(NR2F1):c.382T>C (p.Cys128Arg)	NR2F1	Bosch-Boonstra-Schaaf optic atrophy syndrome	Likely pathogenic(Last reviewed: Dec 3, 2013)	criteria provided, single submitter	5	92921111	5	93585405	216974	213562
NM_005654.5(NR2F1):c.413G>A (p.Cys138Tyr)	NR2F1	Bosch-Boonstra-Schaaf optic atrophy syndrome	Pathogenic	no assertion criteria provided	5	92921142	5	93585436	375371	362143
NM_005654.5(NR2F1):c.755T>C (p.Leu252Pro)	NR2F1	Bosch-Boonstra-Schaaf optic atrophy syndrome	Likely pathogenic(Last reviewed: Feb 6, 2014)	criteria provided, single submitter	5	92923914	5	93588208	126495	132019
NM_001323374.1(CAMK4):c.981+1G>A	CAMK4	not provided|Intellectual disability|Involuntary movements	Conflicting interpretations of pathogenicity(Last reviewed: Jan 24, 2019)	no assertion criteria provided	5	110818636	5	111482938	560302	551352
NM_000038.5(APC):c.70C>T (p.Arg24Ter)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis	Pathogenic/Likely pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, multiple submitters, no conflicts	5	112090657	5	112754960	184702	182313
NM_000038.5(APC):c.295C>T (p.Arg99Trp)	APC	Colorectal cancer, susceptibility to|Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2018)	criteria provided, conflicting interpretations	5	112102960	5	112767263	135695	139407
NM_000038.5(APC):c.388A>G (p.Ser130Gly)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	5	112103053	5	112767356	41505	49944
NM_000038.5(APC):c.449A>G (p.Lys150Arg)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Uncertain significance(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	5	112111352	5	112775655	141928	151642
NM_000038.5(APC):c.607C>G (p.Gln203Glu)	APC	Desmoid disease, hereditary|Familial multiple polyposis syndrome|Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2018)	criteria provided, conflicting interpretations	5	112116562	5	112780865	41509	49948
NM_000038.5(APC):c.1240C>T (p.Arg414Cys)	APC	Gardner syndrome|Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|APC-Associated Polyposis Disorders	Conflicting interpretations of pathogenicity(Last reviewed: May 15, 2018)	criteria provided, conflicting interpretations	5	112154969	5	112819272	797	15836
NM_000038.5(APC):c.1409-2A>G	APC	Familial adenomatous polyposis 1	Likely pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	5	112162803	5	112827106	517442	496347
NM_000038.5(APC):c.1660C>T (p.Arg554Ter)	APC	Colorectal cancer, susceptibility to|Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	5	112164586	5	112828889	807	15846
NM_000038.5(APC):c.1917dupA (p.Arg640Thrfs)	APC	Familial adenomatous polyposis 1	Likely pathogenic(Last reviewed: Apr 28, 2016)	criteria provided, multiple submitters, no conflicts	5	112170821	5	112835124	42240	51410
NM_000038.5(APC):c.2204C>T (p.Ala735Val)	APC	Colorectal cancer, susceptibility to|Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Neoplasm of the liver|Familial adenomatous polyposis	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	5	112173495	5	112837798	41521	49960
NM_000038.5(APC):c.2658G>T (p.Gln886His)	APC	Familial multiple polyposis syndrome|Familial adenomatous polyposis 1|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 15, 2018)	criteria provided, conflicting interpretations	5	112173949	5	112838252	135694	139406
NM_000038.5(APC):c.2805C>A (p.Tyr935Ter)	APC	Colorectal cancer, susceptibility to|Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis	Pathogenic(Last reviewed: May 13, 2018)	criteria provided, multiple submitters, no conflicts	5	112174096	5	112838399	810	15849
NM_000038.5(APC):c.2847G>T (p.Met949Ile)	APC	Familial adenomatous polyposis 1|not specified|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	5	112174138	5	112838441	161206	171099
NM_000038.5(APC):c.2942C>G (p.Pro981Arg)	APC	Familial adenomatous polyposis 1|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 25, 2018)	criteria provided, multiple submitters, no conflicts	5	112174233	5	112838536	127282	132739
NM_000038.5(APC):c.3162delC (p.His1054Glnfs)	APC	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 14, 2013)	criteria provided, single submitter	5	112174453	5	112838756	42241	51411
NM_000038.5(APC):c.3479C>A (p.Thr1160Lys)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2018)	criteria provided, conflicting interpretations	5	112174770	5	112839073	41503	49942
NM_000038.5(APC):c.3927_3931delAAAGA (p.Glu1309Aspfs)	APC	Gastric polyposis|Gardner syndrome|Adenomatous polyposis coli with congenital cholesteatoma|Adenocarcinoma of the colon|Carcinoma of colon|Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome|Duodenal polyposis|Adenomatous colonic polyposis|Intestinal polyp|Hyperplastic colonic polyposis|Familial adenomatous polyposis|Malignant Colorectal Neoplasm	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	5	112175218 - 112175222	5	112839521 - 112839525	816	15855
NM_000038.5(APC):c.4237A>G (p.Met1413Val)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	5	112175528	5	112839831	133510	137249
NM_000038.5(APC):c.4336G>A (p.Ala1446Thr)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Likely benign(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	5	112175627	5	112839930	127294	132751
NM_000038.5(APC):c.4360A>G (p.Lys1454Glu)	APC	Familial multiple polyposis syndrome|Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma|APC-Associated Polyposis Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Jan 10, 2018)	criteria provided, conflicting interpretations	5	112175651	5	112839954	127295	132752
NM_000038.5(APC):c.4420G>A (p.Ala1474Thr)	APC	Familial adenomatous polyposis 1|not specified|Hereditary cancer-predisposing syndrome|Colorectal adenoma|APC-Associated Polyposis Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Jan 22, 2018)	criteria provided, conflicting interpretations	5	112175711	5	112840014	133530	137269
NM_000038.5(APC):c.4717delG (p.Glu1573Lysfs)	APC	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 10, 2015)	no assertion criteria provided	5	112176008	5	112840311	236206	237761
NM_000038.5(APC):c.4732T>G (p.Cys1578Gly)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Conflicting interpretations of pathogenicity(Last reviewed: Jun 29, 2018)	criteria provided, conflicting interpretations	5	112176023	5	112840326	140839	150553
NM_000038.5(APC):c.4918C>T (p.Arg1640Trp)	APC	Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	5	112176209	5	112840512	142246	151960
NM_000038.5(APC):c.5026A>G (p.Arg1676Gly)	APC	Familial multiple polyposis syndrome|Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	5	112176317	5	112840620	127302	132759
NM_000038.5(APC):c.5140G>A (p.Asp1714Asn)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	5	112176431	5	112840734	135706	139418
NM_000038.5(APC):c.5528C>T (p.Pro1843Leu)	APC	Familial multiple polyposis syndrome|Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	5	112176819	5	112841122	127306	132763
NM_000038.5(APC):c.5585_5586insT (p.Leu1862Phefs)	APC	not specified	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	5	112176876 - 112176877	5	112841179 - 112841180	505558	496797
NM_000038.5(APC):c.5801C>T (p.Pro1934Leu)	APC	Familial multiple polyposis syndrome|Colorectal cancer, susceptibility to|Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	5	112177092	5	112841395	135709	139421
NM_000038.5(APC):c.6724A>G (p.Ser2242Gly)	APC	Desmoid disease, hereditary|Familial multiple polyposis syndrome|Carcinoma of colon|Familial adenomatous polyposis 1|Neoplasm of stomach|not specified|not provided|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 8, 2018)	criteria provided, conflicting interpretations	5	112178015	5	112842318	41510	49949
NM_000038.5(APC):c.6985A>G (p.Ile2329Val)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	5	112178276	5	112842579	135716	139428
NM_000038.5(APC):c.7235A>G (p.Lys2412Arg)	APC	Colorectal cancer, susceptibility to|Familial adenomatous polyposis 1	Uncertain significance(Last reviewed: Nov 20, 2015)	criteria provided, multiple submitters, no conflicts	5	112178526	5	112842829	224554	226321
NM_000038.5(APC):c.7399C>A (p.Pro2467Thr)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	5	112178690	5	112842993	127318	132775
NM_000038.5(APC):c.7717A>G (p.Ile2573Val)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	5	112179008	5	112843311	41536	49975
NM_000038.5(APC):c.7778A>G (p.Asn2593Ser)	APC	Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Uncertain significance(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	5	112179069	5	112843372	161205	171100
NM_000038.5(APC):c.8266A>G (p.Ile2756Val)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Conflicting interpretations of pathogenicity(Last reviewed: Jul 5, 2018)	criteria provided, conflicting interpretations	5	112179557	5	112843860	135724	139436
NM_000038.5(APC):c.8383G>A (p.Ala2795Thr)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Uncertain significance(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	5	112179674	5	112843977	141047	150761
NM_002317.7(LOX):c.1044T>A (p.Ser348Arg)	LOX|SRFBP1	Acute aortic dissections|Familial thoracic aortic aneurysms	Pathogenic(Last reviewed: Jan 12, 2016)	no assertion criteria provided	5	121406275 - 121406276	5	122070581	617849	609197
NM_002317.6(LOX):c.893T>G (p.Met298Arg)	LOX|SRFBP1	Thoracic aortic aneurysm and aortic dissection|Aortic aneurysm, familial thoracic 10	Likely pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	5	121409850	5	122074155	228806	229233
NM_002317.5(LOX):c.839G>T (p.Ser280Ile)	LOX|SRFBP1	Aortic aneurysm, familial thoracic 10|Acute aortic dissections|Familial thoracic aortic aneurysms	Pathogenic(Last reviewed: Oct 24, 2016)	no assertion criteria provided	5	121411138	5	122075443	267291	262311
NM_002317.5(LOX):c.800A>C (p.Gln267Pro)	LOX|SRFBP1	Aortic aneurysm, familial thoracic 10|Acute aortic dissections|Familial thoracic aortic aneurysms	Pathogenic(Last reviewed: Oct 24, 2016)	no assertion criteria provided	5	121411177	5	122075482	267293	262313
NM_002317.7(LOX):c.743C>T (p.Thr248Ile)	LOX|SRFBP1	Acute aortic dissections|Familial thoracic aortic aneurysms	Pathogenic(Last reviewed: Jan 12, 2016)	no assertion criteria provided	5	121411233 - 121411234	5	122075539	617848	609198
NM_002317.7(LOX):c.604G>T (p.Gly202Ter)	LOX	Acute aortic dissections|Familial thoracic aortic aneurysms	Pathogenic(Last reviewed: Jan 12, 2016)	no assertion criteria provided	5	121413076 - 121413077	5	122077382	617847	609199
NM_002317.7(LOX):c.460C>T (p.Leu154Phe)	LOX	Acute aortic dissections|Familial thoracic aortic aneurysms	Benign(Last reviewed: Jan 12, 2016)	no assertion criteria provided	5	121413220 - 121413221	5	122077526	617850	609200
NM_002317.5(LOX):c.235G>A (p.Ala79Thr)	LOX	Inborn genetic diseases|Acute aortic dissections|Familial thoracic aortic aneurysms	Uncertain significance(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	5	121413446	5	122077751	521345	511551
NM_002317.5(LOX):c.125G>A (p.Trp42Ter)	LOX	Aortic aneurysm, familial thoracic 10|Acute aortic dissections|Familial thoracic aortic aneurysms	Pathogenic(Last reviewed: Oct 24, 2016)	no assertion criteria provided	5	121413556	5	122077861	267292	262312
NM_005573.3(LMNB1):c.432G>A (p.Ser144=)	LMNB1	not specified|Leukodystrophy, Adult-Onset	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	126140540	5	126804848	129486	134932
NM_001999.3(FBN2):c.8347G>C (p.Glu2783Gln)	FBN2	Congenital contractural arachnodactyly|not specified|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	5	127597445	5	128261753	129054	134500
NM_001999.3(FBN2):c.8274C>T (p.Ser2758=)	FBN2	Congenital contractural arachnodactyly|not specified|not provided|Cardiovascular phenotype	Benign(Last reviewed: Jun 28, 2017)	criteria provided, multiple submitters, no conflicts	5	127597518	5	128261826	129053	134499
NM_001999.3(FBN2):c.8154C>T (p.Leu2718=)	FBN2	Congenital contractural arachnodactyly|not specified|not provided|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	5	127599155	5	128263463	129052	134498
NM_001999.3(FBN2):c.7739C>T (p.Ser2580Leu)	FBN2	Congenital contractural arachnodactyly|not specified|not provided|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Jun 12, 2017)	criteria provided, multiple submitters, no conflicts	5	127609633	5	128273941	129051	134497
NM_001999.3(FBN2):c.7200T>C (p.Ser2400=)	FBN2	Congenital contractural arachnodactyly|not specified|Cardiovascular phenotype	Benign(Last reviewed: Jun 28, 2017)	criteria provided, multiple submitters, no conflicts	5	127614472	5	128278780	129049	134495
NM_001999.3(FBN2):c.7145G>A (p.Arg2382Gln)	FBN2	Congenital contractural arachnodactyly|not specified	Uncertain significance(Last reviewed: Jan 18, 2014)	criteria provided, single submitter	5	127614527	5	128278835	213426	209679
NM_001999.3(FBN2):c.7013-5T>C	FBN2	Congenital contractural arachnodactyly|not specified|not provided|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Jun 16, 2017)	criteria provided, multiple submitters, no conflicts	5	127616014	5	128280322	129048	134494
NM_001999.3(FBN2):c.6948C>A (p.Ile2316=)	FBN2	Congenital contractural arachnodactyly|not specified|not provided|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Jul 27, 2017)	criteria provided, multiple submitters, no conflicts	5	127622474	5	128286782	129047	134493
NM_001999.3(FBN2):c.6931A>G (p.Met2311Val)	FBN2	Congenital contractural arachnodactyly|not specified|not provided|Cardiovascular phenotype	Benign(Last reviewed: May 1, 2017)	criteria provided, multiple submitters, no conflicts	5	127622491	5	128286799	129046	134492
NM_001999.3(FBN2):c.5823T>C (p.His1941=)	FBN2	Congenital contractural arachnodactyly|not specified|not provided|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Mar 22, 2017)	criteria provided, multiple submitters, no conflicts	5	127638759	5	128303067	129044	134490
NM_001999.3(FBN2):c.5675-9C>T	FBN2	Congenital contractural arachnodactyly|not specified	Benign(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	5	127640783	5	128305091	129043	134489
NM_001999.3(FBN2):c.4206C>T (p.Asn1402=)	FBN2	Congenital contractural arachnodactyly|not specified|not provided|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	5	127668620	5	128332928	129042	134488
NM_001999.3(FBN2):c.4098A>C (p.Thr1366=)	FBN2	Congenital contractural arachnodactyly|not specified|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	5	127670412	5	128334720	129041	134487
NM_001999.3(FBN2):c.3973G>A (p.Asp1325Asn)	FBN2	Congenital contractural arachnodactyly	Likely pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	5	127670862	5	128335170	446528	440046
NM_001999.3(FBN2):c.3015G>A (p.Leu1005=)	FBN2	Congenital contractural arachnodactyly|not specified|not provided|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	5	127681251	5	128345559	129040	134486
NM_001999.3(FBN2):c.2893G>A (p.Val965Ile)	FBN2	Congenital contractural arachnodactyly|not specified|not provided|Cardiovascular phenotype	Benign(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	5	127685135	5	128349443	129039	134485
NM_001999.3(FBN2):c.2778C>T (p.Ala926=)	FBN2	Congenital contractural arachnodactyly|not specified|not provided|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Dec 22, 2017)	criteria provided, multiple submitters, no conflicts	5	127686594	5	128350902	129038	134484
NM_001999.3(FBN2):c.2161G>A (p.Gly721Ser)	FBN2	Congenital contractural arachnodactyly|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 21, 2017)	criteria provided, conflicting interpretations	5	127704962	5	128369269	129037	134483
NM_001999.3(FBN2):c.1466-5C>T	FBN2	Congenital contractural arachnodactyly|not specified|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	5	127727853	5	128392160	129035	134481
NM_001999.3(FBN2):c.827-2A>G	FBN2	Congenital contractural arachnodactyly	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	5	127782301	5	128446608	561010	552083
NM_001999.3(FBN2):c.629-9A>G	FBN2	Congenital contractural arachnodactyly|not specified	Benign(Last reviewed: Jul 25, 2017)	criteria provided, multiple submitters, no conflicts	5	127800623	5	128464930	129045	134491
NM_001999.3(FBN2):c.203C>T (p.Ala68Val)	FBN2	Congenital contractural arachnodactyly|not specified|not provided|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Aug 4, 2017)	criteria provided, multiple submitters, no conflicts	5	127873094	5	128537401	94020	99922
NM_001999.3(FBN2):c.183C>G (p.Pro61=)	FBN2	Congenital contractural arachnodactyly|not specified|Cardiovascular phenotype	Benign(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	5	127873114	5	128537421	129036	134482
NM_001999.3(FBN2):c.111G>A (p.Pro37=)	FBN2	Congenital contractural arachnodactyly|not specified|not provided|Cardiovascular phenotype	Benign(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	5	127873186	5	128537493	129034	134480
NM_005732.3(RAD50):c.5C>T (p.Ser2Phe)	RAD50	Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 27, 2018)	criteria provided, conflicting interpretations	5	131893021	5	132557329	527368	521027
NM_000358.2(TGFBI):c.[1637C>A;1652C>A]	TGFBI	Lattice corneal dystrophy Type I	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	5|5	135392443	5|5	136056754	7874	22913|38388
NM_006790.2(MYOT):c.122T>C (p.Ile41Thr)	MYOT	not provided	Uncertain significance(Last reviewed: Jan 4, 2017)	criteria provided, multiple submitters, no conflicts	5	137206462	5	137870773	129682	135128
NM_006790.2(MYOT):c.149A>G (p.Gln50Arg)	MYOT	Spheroid body myopathy|Limb-girdle muscular dystrophy, type 1A|Myofibrillar myopathy 3|not specified|Limb-Girdle Muscular Dystrophy, Dominant|Myofibrillar Myopathy, Dominant	Benign/Likely benign(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	5	137206489	5	137870800	129683	135129
NM_006790.2(MYOT):c.780G>A (p.Ser260=)	MYOT	Spheroid body myopathy|Limb-girdle muscular dystrophy, type 1A|Myofibrillar myopathy 3|not specified|Limb-Girdle Muscular Dystrophy, Dominant|Myofibrillar Myopathy, Dominant	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	5	137217758	5	137882069	129684	135130
NM_005859.4(PURA):c.159dup (p.Leu54Alafs)	PURA	not provided|PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation	Pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, multiple submitters, no conflicts	5	139493925	5	140114340	432233	425622
NM_005859.4(PURA):c.299T>C (p.Leu100Pro)	PURA	Global developmental delay|Seizures|Delayed speech and language development|Intellectual disability|Global developmental delay|Neonatal hypotonia|Mental retardation, autosomal dominant 31	Likely pathogenic(Last reviewed: Aug 5, 2017)	criteria provided, single submitter	5	139494065	5	140114480	156407	166186
NM_005859.4(PURA):c.362_363insCG (p.Gln123Argfs)	PURA	Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	5	139494128 - 139494129	5	140114543 - 140114544	488583	481451
NM_005859.4(PURA):c.724_725insT (p.Phe243Valfs)	PURA	Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	5	139494491	5	140114905 - 140114906	488584	481452
NM_002109.5(HARS):c.1067G>A (p.Ser356Asn)	HARS	Usher syndrome, type 3B|Charcot-Marie-Tooth disease, axonal, type 2w	Uncertain significance(Last reviewed: Sep 2, 2017)	criteria provided, single submitter	5	140056366	5	140676781	446301	439705
NM_002109.5(HARS):c.464T>G (p.Val155Gly)	HARS	Charcot-Marie-Tooth disease, axonal, type 2w	Uncertain significance	no assertion criteria provided	5	140058645	5	140679060	446299	439703
NM_002109.5(HARS):c.397G>T (p.Val133Phe)	HARS	Charcot-Marie-Tooth disease, axonal, type 2w	Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	5	140058712	5	140679127	548118	538605
NM_003122.4(SPINK1):c.194G>A (p.Arg65Gln)	SPINK1	Hereditary pancreatitis|not specified|not provided	Uncertain significance(Last reviewed: Mar 26, 2018)	criteria provided, multiple submitters, no conflicts	5	147207585	5	147828022	36779	45440
NM_005211.3(CSF1R):c.2527_2530delATCCinsGGCA (p.Ile843_Leu844delinsGlyIle)	CSF1R	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Jul 26, 2018)	no assertion criteria provided	5	149435613 - 149435616	5	150056050 - 150056053	549854	540579
NM_005211.3(CSF1R):c.2342C>T (p.Ala781Val)	CSF1R	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Nov 8, 2013)	criteria provided, single submitter	5	149435882	5	150056319	162118	171839
NM_002609.3(PDGFRB):c.1996A>C (p.Asn666His)	PDGFRB	Inborn genetic diseases	Likely pathogenic	criteria provided, single submitter	5	149503840	5	150124277	208692	205249
NM_002609.3(PDGFRB):c.1699A>G (p.Lys567Glu)	PDGFRB	Infantile myofibromatosis 1	Pathogenic(Last reviewed: Dec 1, 2016)	no assertion criteria provided	5	149505116	5	150125553	375237	361944
NM_002609.3(PDGFRB):c.1681C>T (p.Arg561Cys)	PDGFRB	Infantile myofibromatosis 1|not provided|Infantile myofibromatosis	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	5	149505134	5	150125571	55848	70502
NM_001135243.1(TCOF1):c.162A>G (p.Gln54=)	TCOF1	not specified|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	149740772	5	150361209	130563	136009
NM_001135243.1(TCOF1):c.1578C>T (p.Pro526=)	TCOF1	not specified|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	149754991	5	150375428	130562	136008
NM_001135244.1(TCOF1):c.1705G>A (p.Glu569Lys)	TCOF1	Treacher Collins syndrome 1	Likely pathogenic(Last reviewed: Apr 4, 2016)	no assertion criteria provided	5	149755284	5	150375721	433551	427123
NM_001135243.1(TCOF1):c.1761G>T (p.Gly587=)	TCOF1	not specified|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	149755340	5	150375777	130564	136010
NM_001135243.1(TCOF1):c.1842A>G (p.Ser614=)	TCOF1	not specified|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	149755421	5	150375858	130565	136011
NM_001135243.1(TCOF1):c.1993G>C (p.Ala665Pro)	TCOF1	not specified|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	149755744	5	150376181	130566	136012
NM_001135243.1(TCOF1):c.2094A>G (p.Glu698=)	TCOF1	Treacher Collins syndrome 1|not specified|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: Feb 14, 2017)	criteria provided, multiple submitters, no conflicts	5	149755845	5	150376282	130567	136013
NM_001135243.1(TCOF1):c.2245C>T (p.Pro749Ser)	TCOF1	not specified|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	5	149756088	5	150376525	130568	136014
NM_001135243.1(TCOF1):c.2660T>C (p.Val887Ala)	TCOF1	not specified|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	149759096	5	150379533	130569	136015
NM_001135243.1(TCOF1):c.2765C>T (p.Ser922Leu)	TCOF1	Treacher Collins syndrome 1|not specified|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: Feb 14, 2017)	criteria provided, multiple submitters, no conflicts	5	149759201	5	150379638	130570	136016
NM_001135243.1(TCOF1):c.3527C>G (p.Pro1176Arg)	TCOF1	not specified|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	149772280	5	150392717	130571	136017
NM_001135243.1(TCOF1):c.3601-3C>T	TCOF1	not specified|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	149772932	5	150393369	130572	136018
NM_001135243.1(TCOF1):c.4050G>A (p.Ser1350=)	TCOF1	not specified	Likely benign	no assertion criteria provided	5	149776113	5	150396550	130573	136019
NM_001135243.1(TCOF1):c.4169C>T (p.Ala1390Val)	TCOF1	not specified|Treacher Collins Syndrome, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	149776232	5	150396669	130574	136020
NM_001135243.1(TCOF1):c.4292G>C (p.Gly1431Ala)	TCOF1	Treacher Collins syndrome 1|not specified|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	5	149776355	5	150396792	130575	136021
NM_181776.2(SLC36A2):c.260G>T (p.Gly87Val)	SLC36A2	Hyperglycinuria|Iminoglycinuria, digenic	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	5	150723155	5	151343594	2384	17423
NM_000337.5(SGCD):c.32G>A (p.Arg11Gln)	SGCD	Dilated cardiomyopathy 1L|Primary dilated cardiomyopathy|Limb-girdle muscular dystrophy, type 2F|not specified|not provided	Uncertain significance(Last reviewed: Mar 13, 2018)	criteria provided, multiple submitters, no conflicts	5	155771527	5	156344517	196256	193417
NM_000337.5(SGCD):c.226G>T (p.Gly76Cys)	SGCD	Limb-girdle muscular dystrophy, type 2F	Likely benign(Last reviewed: Jun 1, 2014)	no assertion criteria provided	5	155935644	5	156508634	161391	171101
NM_000337.5(SGCD):c.699+72A>C	SGCD	Dilated cardiomyopathy 1L|Primary dilated cardiomyopathy|Limb-girdle muscular dystrophy, type 2F|not specified	Uncertain significance(Last reviewed: Feb 20, 2018)	criteria provided, multiple submitters, no conflicts	5	156184787	5	156757776	165235	174280
NM_000337.5(SGCD):c.848A>G (p.Gln283Arg)	SGCD	Familial hypertrophic cardiomyopathy 1|Limb-girdle muscular dystrophy, type 2F|Delta-sarcoglycanopathy|not specified|not provided|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jul 27, 2017)	criteria provided, conflicting interpretations	5	156186376	5	156759365	43358	52528
NM_021911.2(GABRB2):c.904G>A (p.Val302Met)	GABRB2	not provided|EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2	Likely pathogenic(Last reviewed: Mar 17, 2018)	criteria provided, multiple submitters, no conflicts	5	160758063	5	161331056	427157	414996
NM_000806.5(GABRA1):c.74+9A>T	GABRA1	Juvenile myoclonic epilepsy|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	161277899	5	161850893	129124	134570
NM_000806.5(GABRA1):c.96A>G (p.Gln32=)	GABRA1	Idiopathic generalized epilepsy|Epilepsy, juvenile myoclonic 5|Epilepsy, childhood absence 4|not specified|Seizures|not provided	Benign(Last reviewed: May 23, 2018)	criteria provided, multiple submitters, no conflicts	5	161281185	5	161854179	129125	134571
NM_000806.5(GABRA1):c.156T>C (p.Gly52=)	GABRA1	Juvenile myoclonic epilepsy|not specified|Seizures|not provided	Benign/Likely benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	5	161281245	5	161854239	129123	134569
NM_000806.5(GABRA1):c.789G>A (p.Met263Ile)	GABRA1	Epileptic encephalopathy, early infantile, 19	Likely pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	5	161317989	5	161890983	402327	389307
NM_000806.5(GABRA1):c.1323G>A (p.Thr441=)	GABRA1	Idiopathic generalized epilepsy|Epilepsy, juvenile myoclonic 5|Epilepsy, childhood absence 4|not specified|Seizures	Benign(Last reviewed: Dec 5, 2017)	criteria provided, multiple submitters, no conflicts	5	161324380	5	161897374	93432	99339
NM_000816.3(GABRG2):c.315C>T (p.Asn105=)	GABRG2	Familial febrile seizures 8|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus|not specified|Seizures	Benign(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	5	161522556	5	162095550	129127	134573
NM_000816.3(GABRG2):c.354G>A (p.Ala118=)	GABRG2	Epilepsy, childhood absence 2|Familial febrile seizures 8|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus|not specified|Seizures	Benign/Likely benign(Last reviewed: Dec 20, 2017)	criteria provided, multiple submitters, no conflicts	5	161524670	5	162097664	129128	134574
NM_000816.3(GABRG2):c.588C>T (p.Asn196=)	GABRG2	Familial febrile seizures 8|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus|not specified|Seizures	Benign(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	5	161528280	5	162101274	93434	99341
NM_000816.3(GABRG2):c.717A>G (p.Gln239=)	GABRG2	Epilepsy, childhood absence 2|Familial febrile seizures 8|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus|not specified|Seizures	Benign/Likely benign(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	5	161530980	5	162103974	129129	134575
NM_000816.3(GABRG2):c.1310G>T (p.Arg437Leu)	GABRG2	not provided	Uncertain significance(Last reviewed: Mar 24, 2014)	criteria provided, single submitter	5	161580280	5	162153274	129126	134572
NM_004387.3(NKX2-5):c.783delC (p.Ala262Argfs)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects|Malformation of the heart and great vessels	Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2017)	criteria provided, conflicting interpretations	5	172659764	5	173232761	159257	168105
NM_004387.3(NKX2-5):c.721_728delTACGGCGT (p.Tyr241Glyfs)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	5	172659819 - 172659826	5	173232816 - 173232823	156160	165959
NM_004387.3(NKX2-5):c.618delG (p.Leu207Cysfs)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	5	172659929	5	173232926	156159	165958
NM_004387.3(NKX2-5):c.606G>C (p.Leu202=)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects|not specified|Cardiovascular phenotype	Benign(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	5	172659941	5	173232938	159256	168106
NM_004387.3(NKX2-5):c.543G>A (p.Gln181=)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects|Atrial septal defect|not specified|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	5	172660004	5	173233001	36658	45320
NM_004387.3(NKX2-5):c.471_472delCA (p.Phe157Leufs)	NKX2-5	Malformation of the heart and great vessels	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	172660075 - 172660076	5	173233072 - 173233073	159255	168107
NM_004387.3(NKX2-5):c.461A>G (p.Glu154Gly)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	5	172660086	5	173233083	156158	165957
NM_004387.3(NKX2-5):c.400_402delCGGinsAT (p.Arg134Metfs)	NKX2-5	Atrial septal defect	Likely pathogenic(Last reviewed: Mar 6, 2013)	criteria provided, single submitter	5	172660145 - 172660147	5	173233142 - 173233144	44835	54002
NM_004387.3(NKX2-5):c.111G>A (p.Leu37=)	NKX2-5	not specified	Uncertain significance(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	5	172661976	5	173234973	505440	496426
NM_004387.3(NKX2-5):c.63A>G (p.Glu21=)	NKX2-5	not specified|Cardiovascular phenotype	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	172662024	5	173235021	44837	54004
NM_022455.4(NSD1):c.108A>G (p.Gln36=)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176562212	5	177135211	159259	168108
NM_022455.4(NSD1):c.142A>G (p.Met48Val)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176562246	5	177135245	159265	168109
NM_022455.4(NSD1):c.339C>T (p.Cys113=)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 17, 2018)	criteria provided, multiple submitters, no conflicts	5	176562443	5	177135442	159308	168110
NM_022455.4(NSD1):c.352C>G (p.Pro118Ala)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176562456	5	177135455	159309	168111
NM_022455.4(NSD1):c.395G>C (p.Cys132Ser)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176562499	5	177135498	159317	168112
NM_022455.4(NSD1):c.760C>T (p.Leu254Phe)	NSD1	Beckwith-Wiedemann syndrome|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Oct 20, 2017)	criteria provided, multiple submitters, no conflicts	5	176562864	5	177135863	159441	168113
NM_022455.4(NSD1):c.767C>T (p.Ala256Val)	NSD1	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176562871	5	177135870	159442	168114
NM_022455.4(NSD1):c.1077del (p.Arg359Serfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176631134	5	177204133	159258	168115
NM_022455.4(NSD1):c.1149C>T (p.Ile383=)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1|not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Aug 18, 2017)	criteria provided, conflicting interpretations	5	176631206	5	177204205	159260	168116
NM_022455.4(NSD1):c.1224A>G (p.Gly408=)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176631281	5	177204280	159261	168117
NM_022455.4(NSD1):c.1237-10T>C	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176636627	5	177209626	159262	168118
NM_022455.4(NSD1):c.1262G>A (p.Trp421Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176636662	5	177209661	159263	168119
NM_022455.4(NSD1):c.1428G>A (p.Leu476=)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176636828	5	177209827	159264	168120
NM_022455.4(NSD1):c.1456del (p.Ser486Leufs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176636856	5	177209855	159266	168121
NM_022455.4(NSD1):c.1471G>A (p.Glu491Lys)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176636871	5	177209870	159267	168122
NM_022455.4(NSD1):c.1482C>T (p.Cys494=)	NSD1	Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	176636882	5	177209881	96035	101929
NM_022455.4(NSD1):c.1495G>A (p.Ala499Thr)	NSD1	Beckwith-Wiedemann syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 11, 2017)	criteria provided, conflicting interpretations	5	176636895	5	177209894	159268	168123
NM_022455.4(NSD1):c.1515T>C (p.Asn505=)	NSD1	Beckwith-Wiedemann syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Nov 3, 2017)	criteria provided, multiple submitters, no conflicts	5	176636915	5	177209914	96036	101930
NM_022455.4(NSD1):c.1558G>A (p.Ala520Thr)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|Sotos syndrome 1|not specified|Sotos syndrome|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 18, 2017)	criteria provided, conflicting interpretations	5	176636958	5	177209957	159269	168124
NM_022455.4(NSD1):c.1690G>T (p.Ala564Ser)	NSD1	Beckwith-Wiedemann syndrome|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 9, 2017)	criteria provided, multiple submitters, no conflicts	5	176637090	5	177210089	159270	168125
NM_022455.4(NSD1):c.1749G>A (p.Glu583=)	NSD1	Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	176637149	5	177210148	96038	101932
NM_022455.4(NSD1):c.1792T>C (p.Leu598=)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	5	176637192	5	177210191	96040	101934
NM_022455.4(NSD1):c.1810C>T (p.Arg604Ter)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, multiple submitters, no conflicts	5	176637210	5	177210209	159271	168126
NM_022455.4(NSD1):c.1831C>T (p.Arg611Ter)	NSD1	Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Sep 16, 2015)	criteria provided, multiple submitters, no conflicts	5	176637231	5	177210230	159273	168128
NM_022455.4(NSD1):c.1840G>T (p.Val614Leu)	NSD1	Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	176637240	5	177210239	96042	101936
NM_022455.4(NSD1):c.1980C>T (p.Asn660=)	NSD1	Beckwith-Wiedemann syndrome|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Sep 27, 2017)	criteria provided, multiple submitters, no conflicts	5	176637380	5	177210379	159274	168129
NM_022455.4(NSD1):c.2014_2018del (p.Thr672Glufs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176637414 - 176637418	5	177210413 - 177210417	159275	168130
NM_022455.4(NSD1):c.2048del (p.Lys683Argfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176637448	5	177210447	159276	168131
NM_022455.4(NSD1):c.2049_2053del (p.Ile684Valfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176637449 - 176637453	5	177210448 - 177210452	159277	168132
NM_022455.4(NSD1):c.2064del (p.Arg688Serfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176637464	5	177210463	159278	168133
NM_022455.4(NSD1):c.2071G>A (p.Ala691Thr)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jul 26, 2017)	criteria provided, multiple submitters, no conflicts	5	176637471	5	177210470	159279	168134
NM_022455.4(NSD1):c.2124_2127del (p.His708Glnfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176637524 - 176637527	5	177210523 - 177210526	159280	168135
NM_022455.4(NSD1):c.2169C>T (p.Thr723=)	NSD1	Beckwith-Wiedemann syndrome|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 9, 2017)	criteria provided, multiple submitters, no conflicts	5	176637569	5	177210568	159281	168136
NM_022455.4(NSD1):c.2176T>C (p.Ser726Pro)	NSD1	Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	176637576	5	177210575	96043	101937
NM_022455.4(NSD1):c.2242A>G (p.Asn748Asp)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176637642	5	177210641	159282	168137
NM_022455.4(NSD1):c.2276C>G (p.Ser759Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176637676	5	177210675	159283	168138
NM_022455.4(NSD1):c.2295del (p.Ser766Argfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176637695	5	177210694	159285	168140
NM_022455.4(NSD1):c.2295C>T (p.Asn765=)	NSD1	Beckwith-Wiedemann syndrome|not specified	Benign/Likely benign(Last reviewed: Feb 22, 2018)	criteria provided, multiple submitters, no conflicts	5	176637695	5	177210694	159284	168139
NM_022455.4(NSD1):c.2339C>A (p.Ser780Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176637739	5	177210738	159286	168141
NM_022455.4(NSD1):c.2350C>T (p.Gln784Ter)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1	Likely pathogenic(Last reviewed: Jul 30, 2013)	criteria provided, single submitter	5	176637750	5	177210749	216977	213557
NM_022455.4(NSD1):c.2386_2389delGAAA (p.Glu796Ilefs)	NSD1	Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	5	176637786 - 176637789	5	177210785 - 177210788	159287	168142
NM_022455.4(NSD1):c.2399T>C (p.Met800Thr)	NSD1	Sotos syndrome 1|not provided	Uncertain significance(Last reviewed: Apr 4, 2013)	criteria provided, multiple submitters, no conflicts	5	176637799	5	177210798	96046	101940
NM_022455.4(NSD1):c.2450C>T (p.Ser817Phe)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1|not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2017)	criteria provided, conflicting interpretations	5	176637850	5	177210849	96047	101941
NM_022455.4(NSD1):c.2639del (p.Gly880Glufs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176638039	5	177211038	159288	168143
NM_022455.4(NSD1):c.2654C>A (p.Ser885Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176638054	5	177211053	159289	168144
NM_022455.4(NSD1):c.2696T>C (p.Ile899Thr)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|not specified|Sotos syndrome	Likely benign(Last reviewed: May 18, 2017)	criteria provided, multiple submitters, no conflicts	5	176638096	5	177211095	159290	168145
NM_022455.4(NSD1):c.2827del (p.Asp943Thrfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176638227	5	177211226	159291	168146
NM_022455.4(NSD1):c.2835T>C (p.Ser945=)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|Sotos syndrome 1|not specified|Sotos syndrome|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2017)	criteria provided, conflicting interpretations	5	176638235	5	177211234	96049	101943
NM_022455.4(NSD1):c.2925C>T (p.Ser975=)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176638325	5	177211324	159292	168147
NM_022455.4(NSD1):c.2944G>C (p.Gly982Arg)	NSD1	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176638344	5	177211343	159293	168148
NM_022455.4(NSD1):c.2954_2955delCT (p.Ser985Cysfs)	NSD1	Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	176638354 - 176638355	5	177211353 - 177211354	159294	168149
NM_022455.4(NSD1):c.2956del (p.Ala986Hisfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176638356	5	177211355	159295	168150
NM_022455.4(NSD1):c.3000C>T (p.Ser1000=)	NSD1	Sotos syndrome 1|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 19, 2017)	criteria provided, conflicting interpretations	5	176638400	5	177211399	159296	168151
NM_022455.4(NSD1):c.3038C>G (p.Ser1013Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	5	176638438	5	177211437	488565	481433
NM_022455.4(NSD1):c.3046_3047del (p.Val1016Tyrfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176638446 - 176638447	5	177211445 - 177211446	159297	168152
NM_022455.4(NSD1):c.3067C>T (p.Arg1023Ter)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	5	176638467	5	177211466	159298	168153
NM_022455.4(NSD1):c.3089T>C (p.Leu1030Ser)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176638489	5	177211488	159299	168154
NM_022455.4(NSD1):c.3091C>T (p.Arg1031Ter)	NSD1	Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Apr 11, 2015)	criteria provided, multiple submitters, no conflicts	5	176638491	5	177211490	159300	168155
NM_022455.4(NSD1):c.3106G>C (p.Ala1036Pro)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jul 26, 2017)	criteria provided, multiple submitters, no conflicts	5	176638506	5	177211505	159301	168156
NM_022455.4(NSD1):c.3185_3186del (p.Val1062Aspfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176638585 - 176638586	5	177211584 - 177211585	159302	168157
NM_022455.4(NSD1):c.3187A>G (p.Thr1063Ala)	NSD1	not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	176638587	5	177211586	96053	101947
NM_022455.4(NSD1):c.3214C>T (p.Arg1072Ter)	NSD1	Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	5	176638614	5	177211613	159303	168158
NM_022455.4(NSD1):c.3271C>A (p.Leu1091Ile)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176638671	5	177211670	159304	168159
NM_022455.4(NSD1):c.3293del (p.Thr1098Lysfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176638693	5	177211692	159305	168160
NM_022455.4(NSD1):c.3295del (p.Ser1099Valfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176638695	5	177211694	159306	168161
NM_022455.4(NSD1):c.3383_3384del (p.Ser1128Phefs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176638783 - 176638784	5	177211782 - 177211783	159307	168162
NM_022455.4(NSD1):c.3393C>T (p.Asn1131=)	NSD1	Sotos syndrome 1|not specified|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Oct 7, 2016)	criteria provided, conflicting interpretations	5	176638793	5	177211792	96055	101949
NM_022455.4(NSD1):c.3564G>C (p.Arg1188Ser)	NSD1	Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jun 29, 2017)	criteria provided, multiple submitters, no conflicts	5	176638964	5	177211963	159310	168163
NM_022455.4(NSD1):c.3578_3582del (p.Ser1193Thrfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176638978 - 176638982	5	177211977 - 177211981	159311	168164
NM_022455.4(NSD1):c.3659_3660delAG (p.Glu1220Alafs)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1	Pathogenic(Last reviewed: Dec 25, 2016)	criteria provided, multiple submitters, no conflicts	5	176639059 - 176639060	5	177212058 - 177212059	159312	168165
NM_022455.4(NSD1):c.3705T>C (p.Asn1235=)	NSD1	Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	176639105	5	177212104	96057	101951
NM_022455.4(NSD1):c.3722G>C (p.Ser1241Thr)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Likely benign(Last reviewed: Dec 22, 2017)	criteria provided, multiple submitters, no conflicts	5	176639122	5	177212121	159313	168166
NM_022455.4(NSD1):c.3803G>A (p.Arg1268Gln)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|not specified|Sotos syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2017)	criteria provided, conflicting interpretations	5	176662828	5	177235827	159314	168167
NM_022455.4(NSD1):c.3839G>A (p.Trp1280Ter)	NSD1	Autistic disorder of childhood onset|Cryptorchidism|Hypertelorism|Cleft uvula|Sotos syndrome 1|Seizures|Cognitive impairment|Scoliosis|Patent foramen ovale|Prominent supraorbital ridges|Hypermetropia|Disproportionate tall stature|Pectus carinatum|Highly arched eyebrow|Overfolding of the superior helices|Talipes valgus|Chronic lung disease|Midface retrusion|Cleft palate	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, multiple submitters, no conflicts	5	176662864	5	177235863	159315	168168
NM_022455.4(NSD1):c.3888A>G (p.Lys1296=)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176662913	5	177235912	159316	168169
NM_022455.4(NSD1):c.3958C>T (p.Arg1320Ter)	NSD1	Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, multiple submitters, no conflicts	5	176665274	5	177238273	4143	19182
NM_022455.4(NSD1):c.3964C>T (p.Arg1322Ter)	NSD1	Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, multiple submitters, no conflicts	5	176665280	5	177238279	159318	168170
NM_022455.4(NSD1):c.3992A>G (p.Asp1331Gly)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176665308	5	177238307	159319	168171
NM_022455.4(NSD1):c.4057G>T (p.Glu1353Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176665373	5	177238372	159320	168172
NM_022455.4(NSD1):c.4062C>T (p.Gly1354=)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176665378	5	177238377	159321	168173
NM_022455.4(NSD1):c.4076C>G (p.Ser1359Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176665392	5	177238391	159322	168174
NM_022455.4(NSD1):c.4192+2T>G	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176665510	5	177238509	159323	168175
NM_022455.4(NSD1):c.4301delA (p.Lys1434Serfs)	NSD1	Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, multiple submitters, no conflicts	5	176666865	5	177239864	159324	168176
NM_022455.4(NSD1):c.4302+1G>A	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	5	176666867	5	177239866	561069	552086
NM_022455.4(NSD1):c.4328A>G (p.Asn1443Ser)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176671221	5	177244220	159325	168177
NM_022455.4(NSD1):c.4363A>G (p.Lys1455Glu)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176671256	5	177244255	159326	168178
NM_022455.4(NSD1):c.4376del (p.Gly1459Glufs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176671269	5	177244268	159327	168179
NM_022455.4(NSD1):c.4378+1G>A	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176671272	5	177244271	159328	168180
NM_022455.4(NSD1):c.4378+7A>G	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176671278	5	177244277	159329	168181
NM_022455.4(NSD1):c.4411C>T (p.Arg1471Ter)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1	Pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, multiple submitters, no conflicts	5	176673711	5	177246710	159330	168182
NM_022455.4(NSD1):c.4417C>T (p.Arg1473Ter)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	5	176673717	5	177246716	159331	168183
NM_022455.4(NSD1):c.4444C>T (p.Gln1482Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176673744	5	177246743	159332	168184
NM_022455.4(NSD1):c.4473G>T (p.Ser1491=)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1|not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Nov 16, 2017)	criteria provided, conflicting interpretations	5	176673773	5	177246772	96058	101952
NM_022455.4(NSD1):c.4493C>G (p.Ser1498Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176673793	5	177246792	159333	168185
NM_022455.4(NSD1):c.4498-3A>G	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176675179	5	177248178	159334	168186
NM_022455.4(NSD1):c.4520C>T (p.Thr1507Met)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	5	176675204	5	177248203	159335	168187
NM_022455.4(NSD1):c.4529del (p.Ser1510Thrfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176675213	5	177248212	159336	168188
NM_022455.4(NSD1):c.4564G>T (p.Asp1522Tyr)	NSD1	Sotos syndrome 1|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2017)	criteria provided, conflicting interpretations	5	176675248	5	177248247	159338	168190
NM_022455.4(NSD1):c.4564G>A (p.Asp1522Asn)	NSD1	Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Mar 10, 2017)	criteria provided, multiple submitters, no conflicts	5	176675248	5	177248247	159337	168189
NM_022455.4(NSD1):c.4681C>T (p.Gln1561Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176678770	5	177251769	159340	168192
NM_022455.4(NSD1):c.4705del (p.Glu1569Serfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176678794	5	177251793	159341	168193
NM_022455.4(NSD1):c.4731_4732del (p.Gly1579Lysfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176678820 - 176678821	5	177251819 - 177251820	159342	168194
NM_022455.4(NSD1):c.4745del (p.Ile1582Thrfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176678834	5	177251833	159343	168195
NM_022455.4(NSD1):c.4753G>T (p.Glu1585Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176678842	5	177251841	159344	168196
NM_172349.2(NSD1):c.3964C>T (p.His1322Tyr)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	5	176683957	5	177256956	488392	481233
NM_022455.4(NSD1):c.4817G>A (p.Cys1606Tyr)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176684003	5	177257002	159345	168197
NM_022455.4(NSD1):c.4844A>C (p.Tyr1615Ser)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176684030	5	177257029	159346	168198
NM_022455.4(NSD1):c.4855T>G (p.Cys1619Gly)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176684041	5	177257040	159348	168200
NM_022455.4(NSD1):c.4855T>A (p.Cys1619Ser)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176684041	5	177257040	159347	168199
NM_022455.4(NSD1):c.4883T>C (p.Met1628Thr)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176684069	5	177257068	159349	168201
NM_022455.4(NSD1):c.4892A>G (p.Lys1631Arg)	NSD1	Sotos syndrome 1|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 10, 2017)	criteria provided, conflicting interpretations	5	176684078	5	177257077	96061	101955
NM_022455.4(NSD1):c.4907C>T (p.Ser1636Phe)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176684093	5	177257092	159350	168202
NM_022455.4(NSD1):c.4966G>T (p.Gly1656Cys)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176684152	5	177257151	159353	168203
NM_022455.4(NSD1):c.4966+1G>A	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176684153	5	177257152	159352	168204
NM_022455.4(NSD1):c.4966+15T>C	NSD1	Sotos syndrome 1	Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2016)	criteria provided, conflicting interpretations	5	176684167	5	177257166	159351	168205
NM_022455.4(NSD1):c.4967-2A>T	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176686988	5	177259987	159354	168206
NM_022455.4(NSD1):c.4987C>T (p.Arg1663Cys)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176687010	5	177260009	159355	168207
NM_022455.4(NSD1):c.5021G>A (p.Cys1674Tyr)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: May 31, 2013)	criteria provided, single submitter	5	176687044	5	177260043	159356	168208
NM_022455.4(NSD1):c.5082C>T (p.Thr1694=)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176687105	5	177260104	159357	168209
NM_022455.4(NSD1):c.5098C>T (p.Arg1700Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	5	176687121	5	177260120	159358	168210
NM_022455.4(NSD1):c.5141C>G (p.Ser1714Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176687164	5	177260163	159359	168211
NM_022455.4(NSD1):c.5146+1G>A	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176687170	5	177260169	159360	168212
NM_022455.4(NSD1):c.5198G>A (p.Cys1733Tyr)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176694614	5	177267613	159361	168213
NM_022455.4(NSD1):c.5279_5282delTCTG (p.Val1760Glyfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Jun 11, 2013)	criteria provided, multiple submitters, no conflicts	5	176694695 - 176694698	5	177267694 - 177267697	96062	101956
NM_022455.4(NSD1):c.5303+1G>C	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	5	176694720	5	177267719	159362	168214
NM_022455.4(NSD1):c.5304-1G>C	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, multiple submitters, no conflicts	5	176696602	5	177269601	216978	213558
NM_022455.4(NSD1):c.5309G>A (p.Trp1770Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176696608	5	177269607	159363	168215
NM_022455.4(NSD1):c.5375G>A (p.Gly1792Glu)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176696674	5	177269673	159364	168216
NM_022455.4(NSD1):c.5390T>C (p.Leu1797Pro)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176696689	5	177269688	159365	168217
NM_022455.4(NSD1):c.5392_5398del (p.Phe1798Aspfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176696691 - 176696697	5	177269690 - 177269696	159366	168218
NM_022455.4(NSD1):c.5419A>C (p.Thr1807Pro)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176696718	5	177269717	159367	168219
NM_022455.4(NSD1):c.5425C>T (p.Gln1809Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176696724	5	177269723	159368	168220
NM_022455.4(NSD1):c.5431C>T (p.Arg1811Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	5	176696730	5	177269729	159369	168221
NM_022455.4(NSD1):c.5432G>A (p.Arg1811Gln)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176696731	5	177269730	159370	168222
NM_022455.4(NSD1):c.5471A>G (p.Asp1824Gly)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176696770	5	177269769	159371	168223
NM_022455.4(NSD1):c.5520A>G (p.Glu1840=)	NSD1	Sotos syndrome 1|not specified|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Oct 7, 2016)	criteria provided, conflicting interpretations	5	176700683	5	177273682	96063	101957
NM_022455.4(NSD1):c.5566C>T (p.Gln1856Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176700729	5	177273728	159372	168224
NM_022455.4(NSD1):c.5618_5619delTA (p.Ile1873Lysfs)	NSD1	Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, multiple submitters, no conflicts	5	176700781 - 176700782	5	177273780 - 177273781	159373	168225
NM_022455.4(NSD1):c.5712del (p.Cys1905Valfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176707655	5	177280654	159374	168226
NM_022455.4(NSD1):c.5724delC (p.Ser1909Leufs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	5	176707666 - 176707667	5	177280666	561070	552087
NM_022455.4(NSD1):c.5740C>T (p.Arg1914Cys)	NSD1	Sotos syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 26, 2016)	criteria provided, multiple submitters, no conflicts	5	176707683	5	177280682	159375	168227
NM_022455.4(NSD1):c.5741G>C (p.Arg1914Pro)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176707684	5	177280683	159376	168228
NM_022455.4(NSD1):c.5798A>G (p.Asn1933Ser)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176707741	5	177280740	159377	168229
NM_022455.4(NSD1):c.5800C>T (p.Gln1934Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176707743	5	177280742	159378	168230
NM_022455.4(NSD1):c.5805C>A (p.Cys1935Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176707748	5	177280747	159379	168231
NM_022455.4(NSD1):c.5809T>C (p.Ser1937Pro)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176707752	5	177280751	159380	168232
NM_022455.4(NSD1):c.5862G>C (p.Trp1954Cys)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176707805	5	177280804	159381	168233
NM_022455.4(NSD1):c.5869C>T (p.Arg1957Trp)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176707812	5	177280811	159382	168234
NM_022455.4(NSD1):c.5885T>C (p.Ile1962Thr)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176707828	5	177280827	159383	168235
NM_022455.4(NSD1):c.5893-2A>G	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176709464	5	177282463	159384	168236
NM_022455.4(NSD1):c.5903del (p.Val1968Glyfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176709476	5	177282475	159385	168237
NM_022455.4(NSD1):c.5911del (p.Tyr1971Metfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176709484	5	177282483	159386	168238
NM_022455.4(NSD1):c.5918G>T (p.Gly1973Val)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176709491	5	177282490	159387	168239
NM_022455.4(NSD1):c.5927T>A (p.Ile1976Lys)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176709500	5	177282499	159388	168240
NM_022455.4(NSD1):c.5938G>T (p.Glu1980Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176709511	5	177282510	159389	168241
NM_022455.4(NSD1):c.5950C>T (p.Arg1984Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Sep 1, 2014)	criteria provided, single submitter	5	176709523	5	177282522	209175	205743
NM_022455.4(NSD1):c.5951G>A (p.Arg1984Gln)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	5	176709524	5	177282523	159390	168242
NM_022455.4(NSD1):c.5965C>T (p.Gln1989Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176709538	5	177282537	159391	168243
NM_022455.4(NSD1):c.5989T>C (p.Tyr1997His)	NSD1	Sotos syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, multiple submitters, no conflicts	5	176709562	5	177282561	159392	168244
NM_022455.4(NSD1):c.6001C>T (p.Leu2001=)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1	Conflicting interpretations of pathogenicity(Last reviewed: Jul 24, 2017)	criteria provided, conflicting interpretations	5	176709574	5	177282573	159393	168245
NM_022455.4(NSD1):c.6013C>T (p.Arg2005Ter)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1|not provided	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, multiple submitters, no conflicts	5	176710791	5	177283790	159394	168246
NM_022455.4(NSD1):c.6014G>A (p.Arg2005Gln)	NSD1	Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, multiple submitters, no conflicts	5	176710792	5	177283791	159395	168247
NM_022455.4(NSD1):c.6019A>T (p.Ile2007Phe)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Oct 21, 2014)	criteria provided, single submitter	5	176710797	5	177283796	369685	353894
NM_022455.4(NSD1):c.6043T>C (p.Tyr2015His)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176710821	5	177283820	159396	168248
NM_022455.4(NSD1):c.6049C>T (p.Arg2017Trp)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, multiple submitters, no conflicts	5	176710827	5	177283826	159397	168249
NM_022455.4(NSD1):c.6050G>A (p.Arg2017Gln)	NSD1	Hypertelorism|Preeclampsia|Sotos syndrome 1|Global developmental delay|Scoliosis|Tall stature|Overgrowth|Pointed chin|not provided|Hypoplasia of the corpus callosum|Delayed speech and language development|Macrocephalus|Hypertelorism|High forehead|Osteopenia|Global developmental delay|Delayed gross motor development|Increased body weight|High anterior hairline|Preeclampsia	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	5	176710828	5	177283827	159398	168250
NM_022455.4(NSD1):c.6059A>G (p.Asn2020Ser)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176710837	5	177283836	159399	168251
NM_022455.4(NSD1):c.6070C>T (p.Gln2024Ter)	NSD1	Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, multiple submitters, no conflicts	5	176710848	5	177283847	159400	168252
NM_022455.4(NSD1):c.6080G>C (p.Cys2027Ser)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176710858	5	177283857	159401	168253
NM_022455.4(NSD1):c.6086C>T (p.Thr2029Ile)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176710864	5	177283863	159402	168254
NM_022455.4(NSD1):c.6152-14G>A	NSD1	Sotos syndrome 1|not provided	Uncertain significance(Last reviewed: Mar 18, 2014)	criteria provided, multiple submitters, no conflicts	5	176715806	5	177288805	159403	168255
NM_022455.4(NSD1):c.6157G>T (p.Glu2053Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176715825	5	177288824	159404	168256
NM_022455.4(NSD1):c.6165del (p.Phe2056Serfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176715833	5	177288832	159405	168257
NM_022455.4(NSD1):c.6258+1G>A	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176715927	5	177288926	159406	168258
NM_022455.4(NSD1):c.6259-8A>T	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1	Conflicting interpretations of pathogenicity(Last reviewed: Aug 17, 2017)	criteria provided, conflicting interpretations	5	176718947	5	177291946	159407	168259
NM_022455.4(NSD1):c.6291del (p.Lys2098Asnfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176718987	5	177291986	159408	168260
NM_022455.4(NSD1):c.6307C>T (p.Gln2103Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176719003	5	177292002	159409	168261
NM_022455.4(NSD1):c.6310C>T (p.Gln2104Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176719006	5	177292005	159410	168262
NM_022455.4(NSD1):c.6311_6312del (p.Gln2104Argfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176719007 - 176719008	5	177292006 - 177292007	159411	168263
NM_022455.4(NSD1):c.6349C>T (p.Arg2117Ter)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, multiple submitters, no conflicts	5	176719045	5	177292044	159412	168264
NM_022455.4(NSD1):c.6356A>G (p.Asp2119Gly)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176719052	5	177292051	159413	168265
NM_022455.4(NSD1):c.6366del (p.Phe2122Leufs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176719062	5	177292061	159414	168266
NM_022455.4(NSD1):c.6377A>T (p.Asp2126Val)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176719073	5	177292072	159415	168267
NM_022455.4(NSD1):c.6393C>G (p.Val2131=)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176719089	5	177292088	159416	168268
NM_022455.4(NSD1):c.6413G>A (p.Cys2138Tyr)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Aug 21, 2013)	criteria provided, single submitter	5	176719109	5	177292108	159417	168269
NM_022455.4(NSD1):c.6418A>G (p.Lys2140Glu)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176719114	5	177292113	159418	168270
NM_022455.4(NSD1):c.6421delG (p.Val2141Phefs)	NSD1	Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, multiple submitters, no conflicts	5	176719117	5	177292116	159419	168271
NM_022455.4(NSD1):c.6431del (p.Ala2144Glufs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176719127	5	177292126	159420	168272
NM_022455.4(NSD1):c.6444T>C (p.Asn2148=)	NSD1	Beckwith-Wiedemann syndrome|not specified	Benign/Likely benign(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	5	176719140	5	177292139	96066	101960
NM_022455.4(NSD1):c.6454C>T (p.Arg2152Ter)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, multiple submitters, no conflicts	5	176719150	5	177292149	159421	168273
NM_022455.4(NSD1):c.6455G>A (p.Arg2152Gln)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176719151	5	177292150	159422	168274
NM_022455.4(NSD1):c.6472G>T (p.Glu2158Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176720841	5	177293840	159423	168275
NM_022455.4(NSD1):c.6476G>A (p.Cys2159Tyr)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176720845	5	177293844	159424	168276
NM_022455.4(NSD1):c.6480G>A (p.Pro2160=)	NSD1	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176720849	5	177293848	159425	168277
NM_022455.4(NSD1):c.6485A>C (p.His2162Pro)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176720854	5	177293853	159426	168278
NM_022455.4(NSD1):c.6500G>A (p.Cys2167Tyr)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176720869	5	177293868	159427	168279
NM_022455.4(NSD1):c.6521_6523delTCT (p.Phe2174del)	NSD1	Sotos syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, multiple submitters, no conflicts	5	176720890 - 176720892	5	177293889 - 177293891	159428	168280
NM_022455.4(NSD1):c.6533_6534insC (p.Ser2180Glnfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	5	176720903	5	177293902	243070	244157
NM_022455.4(NSD1):c.6539_6557del (p.Ser2180Ilefs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176720908 - 176720926	5	177293907 - 177293925	159429	168281
NM_022455.4(NSD1):c.6557A>G (p.His2186Arg)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Jun 26, 2014)	criteria provided, single submitter	5	176720926	5	177293925	159430	168282
NM_022455.4(NSD1):c.6559C>T (p.Arg2187Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176720928	5	177293927	159431	168283
NM_022455.4(NSD1):c.6604T>A (p.Cys2202Ser)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176720973	5	177293972	159432	168284
NM_022455.4(NSD1):c.6630_6644del (p.Asn2211_Pro2215del)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176720999 - 176721013	5	177293998 - 177294012	159433	168285
NM_022455.4(NSD1):c.6637C>G (p.Leu2213Val)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176721006	5	177294005	159434	168286
NM_022455.4(NSD1):c.6640G>A (p.Glu2214Lys)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176721009	5	177294008	159435	168287
NM_022455.4(NSD1):c.6656G>A (p.Arg2219His)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176721025	5	177294024	159436	168288
NM_022455.4(NSD1):c.6750G>A (p.Met2250Ile)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	5	176721119	5	177294118	96070	101964
NM_022455.4(NSD1):c.6753A>G (p.Ser2251=)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176721122	5	177294121	159437	168289
NM_022455.4(NSD1):c.6782T>C (p.Met2261Thr)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	5	176721151	5	177294150	96071	101965
NM_022455.4(NSD1):c.6829T>C (p.Leu2277=)	NSD1	Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	176721198	5	177294197	96073	101967
NM_022455.4(NSD1):c.6903G>C (p.Gly2301=)	NSD1	Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	176721272	5	177294271	96074	101968
NM_022455.4(NSD1):c.7391G>A (p.Arg2464His)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176721760	5	177294759	159438	168290
NM_022455.4(NSD1):c.7403G>A (p.Arg2468Gln)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176721772	5	177294771	159439	168291
NM_022455.4(NSD1):c.7560A>G (p.Ala2520=)	NSD1	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176721929	5	177294928	159440	168292
NM_022455.4(NSD1):c.7576C>T (p.Pro2526Ser)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1|not provided	Uncertain significance(Last reviewed: May 23, 2017)	criteria provided, multiple submitters, no conflicts	5	176721945	5	177294944	96077	101971
NM_022455.4(NSD1):c.7597C>G (p.Leu2533Val)	NSD1	Beckwith-Wiedemann syndrome|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 11, 2016)	criteria provided, conflicting interpretations	5	176721966	5	177294965	96078	101972
NM_022455.4(NSD1):c.7636G>A (p.Ala2546Thr)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	5	176722005	5	177295004	96079	101973
NM_022455.4(NSD1):c.7850T>C (p.Leu2617Ser)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|Sotos syndrome 1|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	5	176722219	5	177295218	96082	101976
NM_022455.4(NSD1):c.7908C>T (p.Leu2636=)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	5	176722277	5	177295276	159443	168293
NM_022455.4(NSD1):c.7923T>C (p.Ala2641=)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176722292	5	177295291	159444	168294
NM_022455.4(NSD1):c.7939_7940del (p.Gln2647Valfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176722308 - 176722309	5	177295307 - 177295308	159445	168295
NM_022455.4(NSD1):c.7966C>T (p.Gln2656Ter)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Mar 20, 2014)	criteria provided, single submitter	5	176722335	5	177295334	209176	205744
NM_022455.4(NSD1):c.8036del (p.Pro2679Glnfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176722405	5	177295404	159446	168296
NM_022455.4(NSD1):c.8043del (p.Asn2682Thrfs)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176722412	5	177295411	159447	168297
NM_003052.4(SLC34A1):c.934C>T (p.Gln312Ter)	SLC34A1	Nephrolithiasis/osteoporosis, hypophosphatemic, 1	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	5	176815371	5	177388370	433538	427112
NM_000505.3(F12):c.971_1018+24del	F12|SLC34A1	Hereditary angioneurotic edema with normal C1 esterase inhibitor activity	Pathogenic	no assertion criteria provided	5	176831173 - 176831244	5	177404172 - 177404243	441533	435195
NM_000505.3(F12):c.983C>A (p.Thr328Lys)	F12|SLC34A1	Hereditary angioneurotic edema with normal C1 esterase inhibitor activity|not provided|Hereditary angioneurotic edema	Pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, multiple submitters, no conflicts	5	176831232	5	177404231	1169	16208
NM_000505.3(F12):c.894_911dup (p.Thr305_Pro306insGlnAlaAlaProProThr)	F12|SLC34A1	Hereditary angioneurotic edema with normal C1 esterase inhibitor activity	Pathogenic	no assertion criteria provided	5	176831304 - 176831321	5	177404303 - 177404320	403709	390679
NM_003900.4(SQSTM1):c.1175C>T (p.Pro392Leu)	SQSTM1	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset|Paget disease of bone, familial|not provided|Frontotemporal dementia and/or amyotrophic lateral sclerosis 3|Paget disease of bone	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2018)	criteria provided, conflicting interpretations	5	179263445	5	179836445	8108	23147
NM_198253.2(TERT):c.(?_1574)_(1769_?)del (p.(?))	TERT	Idiopathic fibrosing alveolitis, chronic form|Dyskeratosis congenita autosomal dominant|Dyskeratosis congenita, autosomal dominant, 2	Likely pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	5	1282544 - 1282739	5	1282429 - 1282624	506225	496794
GRCh37/hg19 6p25.3-25.2(chr6:255350-3189972)x3	BPHL|SERPINB1|FOXF2|FOXC1|GMDS|IRF4|NQO2|SERPINB6|SERPINB9|TUBB2A|RIPK1|EXOC2|WRNIP1|DUSP22|FOXQ1|HUS1B|LINC01600|MYLK4	Brachydactyly type E1	Pathogenic(Last reviewed: Jul 9, 2016)	no assertion criteria provided	6	255350 - 3189972			242978	244065
GRCh37/hg19 6p25.3(chr6:951385-1832936)x3	FOXF2|FOXC1|GMDS|FOXQ1	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Jun 9, 2015)	no assertion criteria provided	6	951385 - 1832936			375434	362210
NM_001453.2(FOXC1):c.100_109delGGGGGCGGCT (p.Gly34Thrfs)	FOXC1	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Feb 8, 2015)	no assertion criteria provided	6	1610780 - 1610789	6	1610545 - 1610554	375420	362196
NM_001453.2(FOXC1):c.116_123delCCATGCCG (p.Ala39Glyfs)	FOXC1	Axenfeld-Rieger syndrome type 3	Pathogenic	no assertion criteria provided	6	1610796 - 1610803	6	1610561 - 1610568	375421	362197
NM_001453.3(FOXC1):c.192C>G (p.Tyr64Ter)	FOXC1	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Jan 2, 2017)	criteria provided, single submitter	6	1610872	6	1610637	430705	424244
NM_001453.3(FOXC1):c.256C>T (p.Leu86Phe)	FOXC1	Axenfeld-Rieger syndrome type 3|not provided	Pathogenic(Last reviewed: Jun 30, 2016)	criteria provided, single submitter	6	1610936	6	1610701	265478	259842
NM_001453.3(FOXC1):c.268G>A (p.Ala90Thr)	FOXC1	Axenfeld-Rieger syndrome type 3	Uncertain significance(Last reviewed: Mar 17, 2015)	no assertion criteria provided	6	1610948	6	1610713	375422	362198
NM_001453.3(FOXC1):c.269C>A (p.Ala90Asp)	FOXC1	Axenfeld-Rieger syndrome type 3	Uncertain significance(Last reviewed: Aug 22, 2016)	criteria provided, single submitter	6	1610949	6	1610714	375423	362199
NM_001453.3(FOXC1):c.316C>T (p.Gln106Ter)	FOXC1	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	6	1610996	6	1610761	375424	362200
NM_001453.3(FOXC1):c.457A>C (p.Thr153Pro)	FOXC1	Axenfeld-Rieger syndrome type 3	Uncertain significance(Last reviewed: Jul 7, 2015)	no assertion criteria provided	6	1611137	6	1610902	375425	362201
NM_001453.3(FOXC1):c.487G>T (p.Glu163Ter)	FOXC1	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Oct 7, 2015)	no assertion criteria provided	6	1611167	6	1610932	375426	362202
NM_001453.2(FOXC1):c.599_617del19 (p.Gln200Argfs)	FOXC1	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: May 16, 2016)	criteria provided, single submitter	6	1611279 - 1611297	6	1611044 - 1611062	375427	362203
NM_001453.2(FOXC1):c.666_681del16 (p.Ile223Profs)	FOXC1	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: May 16, 2016)	criteria provided, single submitter	6	1611346 - 1611361	6	1611111 - 1611126	375428	362204
NM_001453.2(FOXC1):c.718_719delCT (p.Leu240Valfs)	FOXC1	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	6	1611398 - 1611399	6	1611163 - 1611164	375429	362205
NM_001453.2(FOXC1):c.925_949del25 (p.Ser309Cysfs)	FOXC1	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Oct 15, 2014)	no assertion criteria provided	6	1611605 - 1611629	6	1611370 - 1611394	375430	362206
NM_001453.3(FOXC1):c.1265C>A (p.Ser422Ter)	FOXC1	Axenfeld-Rieger syndrome type 3	Pathogenic	no assertion criteria provided	6	1611945	6	1611710	375431	362207
NM_001453.3(FOXC1):c.1491C>G (p.Tyr497Ter)	FOXC1	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	6	1612171	6	1611936	375432	362208
NM_001069.2(TUBB2A):c.1033A>T (p.Ile345Phe)	TUBB2A	Cortical dysplasia, complex, with other brain malformations 5	Pathogenic/Likely pathogenic(Last reviewed: Apr 24, 2015)	criteria provided, multiple submitters, no conflicts	6	3154402	6	3154168	212495	207399
NM_001069.2(TUBB2A):c.872A>C (p.Gln291Pro)	TUBB2A	Cortical dysplasia, complex, with other brain malformations 5	Likely pathogenic(Last reviewed: Jan 28, 2014)	criteria provided, single submitter	6	3154563	6	3154329	217024	213570
NM_178012.4(TUBB2B):c.1248C>T (p.Asn416=)	TUBB2B	Polymicrogyria, asymmetric	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	6	3225075	6	3224841	160178	168559
NM_178012.4(TUBB2B):c.1139G>T (p.Arg380Leu)	TUBB2B	Polymicrogyria, asymmetric	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	6	3225184	6	3224950	160177	168560
NM_178012.4(TUBB2B):c.965C>T (p.Ser322Phe)	TUBB2B	Polymicrogyria, asymmetric	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	6	3225358	6	3225124	160187	168561
NM_178012.4(TUBB2B):c.859C>T (p.Pro287Ser)	TUBB2B	Polymicrogyria, asymmetric	Uncertain significance(Last reviewed: Dec 24, 2013)	criteria provided, single submitter	6	3225464	6	3225230	160186	168562
NM_178012.4(TUBB2B):c.767A>G (p.Asn256Ser)	TUBB2B	Polymicrogyria, asymmetric	Conflicting interpretations of pathogenicity(Last reviewed: Nov 12, 2018)	no assertion criteria provided	6	3225556	6	3225322	39721	48320
NM_178012.4(TUBB2B):c.718C>T (p.Leu240=)	TUBB2B	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	6	3225605	6	3225371	160185	168563
NM_178012.4(TUBB2B):c.609C>T (p.Asp203=)	TUBB2B	not specified	Benign(Last reviewed: Apr 1, 2014)	criteria provided, multiple submitters, no conflicts	6	3225714	6	3225480	137855	141558
NM_178012.4(TUBB2B):c.602G>C (p.Cys201Ser)	TUBB2B	not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 12, 2017)	criteria provided, conflicting interpretations	6	3225721	6	3225487	160183	168565
NM_178012.4(TUBB2B):c.564G>T (p.Ser188=)	TUBB2B	not specified	Benign(Last reviewed: Jun 7, 2017)	criteria provided, multiple submitters, no conflicts	6	3225759	6	3225525	137854	141557
NM_178012.4(TUBB2B):c.498C>T (p.Thr166=)	TUBB2B	Polymicrogyria, asymmetric	Uncertain significance(Last reviewed: Feb 20, 2013)	criteria provided, single submitter	6	3225825	6	3225591	160181	168567
NM_178012.4(TUBB2B):c.330C>T (p.Ala110=)	TUBB2B	not specified	Benign/Likely benign(Last reviewed: Feb 14, 2018)	criteria provided, multiple submitters, no conflicts	6	3225993	6	3225759	160180	168568
NM_178012.4(TUBB2B):c.126G>T (p.Leu42Phe)	TUBB2B	Polymicrogyria, asymmetric	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	6	3226835	6	3226601	160179	168569
NM_178012.4(TUBB2B):c.111T>C (p.His37=)	TUBB2B	Polymicrogyria, asymmetric	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	6	3226850	6	3226616	160176	168570
NM_178012.4(TUBB2B):c.33G>C (p.Gln11His)	TUBB2B	Polymicrogyria, asymmetric|not provided	Likely pathogenic(Last reviewed: Jun 8, 2016)	criteria provided, single submitter	6	3227745	6	3227511	431080	424603
NM_001008844.2(DSP):c.88G>A (p.Val30Met)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Arrhythmogenic right ventricular cardiomyopathy|Cardiomyopathy|not specified|not provided|Right ventricular cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	6	7542236	6	7542003	16846	31885
NM_004415.3(DSP):c.208_209dup (p.Ile71Profs)	DSP	Arrhythmogenic right ventricular cardiomyopathy	Likely pathogenic(Last reviewed: Feb 27, 2014)	criteria provided, single submitter	6	7555988 - 7555989	6	7555755 - 7555756	163230	176765
NM_004415.3(DSP):c.226C>T (p.Gln76Ter)	DSP	Cardiomyopathy	Likely pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	6	7556006	6	7555773	505712	496578
NM_004415.3(DSP):c.273delT (p.Glu92Asnfs)	DSP	Cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, multiple submitters, no conflicts	6	7556053	6	7555820	199915	197022
NM_004415.3(DSP):c.478C>T (p.Arg160Ter)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: May 23, 2018)	criteria provided, multiple submitters, no conflicts	6	7559514	6	7559281	44922	54089
NM_004415.3(DSP):c.491_492delCCinsAGCTCGAGTCCCTCG (p.Ala164Glufs)	DSP	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	6	7559527 - 7559528	6	7559294 - 7559295	179249	174521
NM_004415.3(DSP):c.699G>A (p.Trp233Ter)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 16, 2018)	criteria provided, multiple submitters, no conflicts	6	7562986	6	7562753	44946	54113
NM_004415.3(DSP):c.867C>A (p.Cys289Ter)	DSP	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Dec 1, 2014)	criteria provided, single submitter	6	7565681	6	7565448	44978	54145
NM_004415.3(DSP):c.919C>T (p.Gln307Ter)	DSP	Arrhythmogenic right ventricular cardiomyopathy	Likely pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	6	7565733	6	7565500	517382	496476
NM_004415.3(DSP):c.1141-2A>T	DSP	Arrhythmogenic right ventricular cardiomyopathy	Likely pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	6	7568012	6	7567779	517383	496871
NM_004415.3(DSP):c.1146delT (p.Phe382Leufs)	DSP	Primary dilated cardiomyopathy	Pathogenic(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	6	7568019	6	7567786	44852	54019
NM_004415.3(DSP):c.1696G>A (p.Ala566Thr)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Arrhythmogenic right ventricular cardiomyopathy|Keratosis palmoplantaris striata II|not specified|Palmoplantar blistering|Skin fragility with non-scarring blistering|Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jun 18, 2018)	criteria provided, conflicting interpretations	6	7570791	6	7570558	161226	171102
NM_004415.3(DSP):c.1751delA (p.Glu584Glyfs)	DSP	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	6	7571665	6	7571432	179720	173848
NM_001008844.2(DSP):c.1778A>G (p.Asn593Ser)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Arrhythmogenic right ventricular cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2018)	criteria provided, conflicting interpretations	6	7571692	6	7571459	44867	54034
NM_004415.3(DSP):c.1873C>T (p.Gln625Ter)	DSP	Arrhythmogenic right ventricular cardiomyopathy	Likely pathogenic(Last reviewed: Oct 15, 2015)	criteria provided, single submitter	6	7571787	6	7571554	228253	229493
NM_004415.3(DSP):c.2130+1G>A	DSP	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: May 8, 2014)	criteria provided, single submitter	6	7572302	6	7572069	179772	174524
NM_004415.3(DSP):c.2131_2132delAG (p.Ser711Cysfs)	DSP	Primary dilated cardiomyopathy|not provided|Ventricular tachycardia|Left ventricular noncompaction cardiomyopathy|Ventricular tachycardia|Left ventricular noncompaction cardiomyopathy|Ventricular tachycardia	Pathogenic(Last reviewed: May 26, 2016)	criteria provided, single submitter	6	7574319 - 7574320	6	7574086 - 7574087	143947	153685
NM_001008844.2(DSP):c.2422C>T (p.Arg808Cys)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Apr 5, 2018)	criteria provided, conflicting interpretations	6	7575014	6	7574781	44874	54041
NM_004415.3(DSP):c.2436+2T>C	DSP	Arrhythmogenic right ventricular cardiomyopathy|not provided	Likely pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	6	7575030	6	7574797	388661	368743
NM_004415.3(DSP):c.2920delA (p.Thr974Leufs)	DSP	Arrhythmogenic right ventricular cardiomyopathy	Likely pathogenic(Last reviewed: Aug 22, 2014)	criteria provided, single submitter	6	7578054	6	7577821	179980	173851
NM_004415.3(DSP):c.3133C>T (p.Arg1045Ter)	DSP	Arrhythmogenic right ventricular cardiomyopathy, type 8|Cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, multiple submitters, no conflicts	6	7579556	6	7579323	464961	456069
NM_004415.3(DSP):c.3474dup (p.Glu1159Argfs)	DSP	Cardiomyopathy	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	6	7579897	6	7579664	517147	496579
NM_004415.3(DSP):c.3507C>A (p.Tyr1169Ter)	DSP	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Feb 19, 2015)	criteria provided, single submitter	6	7579930	6	7579697	228254	229498
NM_004415.3(DSP):c.3630T>A (p.Tyr1210Ter)	DSP	Cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 29, 2015)	criteria provided, multiple submitters, no conflicts	6	7580053	6	7579820	163265	173854
NM_004415.3(DSP):c.4166G>A (p.Ser1389Asn)	DSP	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	6	7580589	6	7580356	427965	419270
NM_004415.3(DSP):c.4180C>T (p.Gln1394Ter)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, multiple submitters, no conflicts	6	7580603	6	7580370	162505	172173
NM_004415.3(DSP):c.4305_4309delCACTG (p.Thr1436Leufs)	DSP	Arrhythmogenic right ventricular cardiomyopathy, type 8|Cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, multiple submitters, no conflicts	6	7580728 - 7580732	6	7580495 - 7580499	464963	455835
NM_004415.2(DSP):c.4372C>G (p.Arg1458Gly)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Left ventricular noncompaction cardiomyopathy|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 19, 2018)	criteria provided, conflicting interpretations	6	7580795	6	7580562	44906	54073
NM_004415.3(DSP):c.4531C>T (p.Gln1511Ter)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Arrhythmogenic right ventricular cardiomyopathy|not provided	Pathogenic(Last reviewed: Feb 7, 2018)	criteria provided, multiple submitters, no conflicts	6	7580954	6	7580721	44914	54081
NM_004415.2(DSP):c.4609C>T (p.Arg1537Cys)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiovascular phenotype|Sudden unexplained death	Benign/Likely benign(Last reviewed: Jan 8, 2018)	criteria provided, multiple submitters, no conflicts	6	7581032	6	7580799	44917	54084
NM_004415.3(DSP):c.4803G>A (p.Met1601Ile)	DSP	Arrhythmogenic right ventricular cardiomyopathy	Likely pathogenic(Last reviewed: Aug 14, 2015)	criteria provided, single submitter	6	7581226	6	7580993	222578	224326
NM_004415.3(DSP):c.4824dupA (p.Ala1609Serfs)	DSP	Cardiomyopathy	Likely pathogenic(Last reviewed: Aug 9, 2013)	criteria provided, single submitter	6	7581247	6	7581014	163276	173859
NM_004415.3(DSP):c.4999C>T (p.Gln1667Ter)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, multiple submitters, no conflicts	6	7581422	6	7581189	488983	481772
NM_004415.3(DSP):c.5051A>G (p.His1684Arg)	DSP	Progressive familial heart block	Likely pathogenic(Last reviewed: Jan 29, 2017)	criteria provided, single submitter	6	7581474	6	7581241	431487	424552
NM_004415.3(DSP):c.5218G>A (p.Glu1740Lys)	DSP	Primary dilated cardiomyopathy|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Migraine|Skin fragility woolly hair syndrome|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Dilated cardiomyopathy|Migraine|Hemiplegia|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 16, 2018)	criteria provided, conflicting interpretations	6	7581641	6	7581408	44926	54093
NM_004415.3(DSP):c.5324G>T (p.Arg1775Ile)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Arrhythmogenic right ventricular cardiomyopathy|not specified	Uncertain significance(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	6	7581747	6	7581514	161227	171103
NM_004415.3(DSP):c.5378_5379dup (p.Ala1794Argfs)	DSP	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 15, 2013)	criteria provided, single submitter	6	7581801 - 7581802	6	7581568 - 7581569	163231	176766
NM_001008844.2(DSP):c.3716G>A (p.Arg1239His)	DSP	Primary dilated cardiomyopathy|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Arrhythmogenic right ventricular cardiomyopathy|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 15, 2018)	criteria provided, conflicting interpretations	6	7583008	6	7582775	161225	171104
NM_004415.3(DSP):c.5570A>C (p.Lys1857Thr)	DSP	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	6	7583065	6	7582832	427966	419271
NM_004415.3(DSP):c.6881C>G (p.Ala2294Gly)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 28, 2018)	criteria provided, conflicting interpretations	6	7584376	6	7584143	44943	54110
NM_001008844.2(DSP):c.5326G>C (p.Gly1776Arg)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	6	7584618	6	7584385	161228	171105
NM_004415.3(DSP):c.7186T>A (p.Tyr2396Asn)	DSP	Ventricular fibrillation, idiopathic	Uncertain significance(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	6	7584681	6	7584448	217831	214485
NM_004415.3(DSP):c.8014C>G (p.Gln2672Glu)	DSP	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	6	7585509	6	7585276	427967	419272
NM_001042425.1(TFAP2A):c.751A>G (p.Arg251Gly)	TFAP2A|TFAP2A-AS2	Branchiooculofacial syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	6	10404742	6	10404509	17937	32976
NM_001042425.1(TFAP2A):c.637C>A (p.Arg213Ser)	TFAP2A|TFAP2A-AS2	Branchiooculofacial syndrome	Pathogenic	criteria provided, single submitter	6	10404856	6	10404623	192350	190138
NM_001042425.1(TFAP2A):c.629T>A (p.Val210Asp)	TFAP2A|TFAP2A-AS2	Branchiooculofacial syndrome	Pathogenic	criteria provided, single submitter	6	10404864	6	10404631	192351	190139
NM_002114.3(HIVEP1):c.4089G>C (p.Met1363Ile)	HIVEP1	Seizures|Hearing impairment|Obsessive-compulsive behavior|Attention deficit hyperactivity disorder|Attention deficit hyperactivity disorder	Pathogenic	no assertion criteria provided	6	12124117	6	12123884	375377	362144
NM_000332.3(ATXN1):c.2257C>T (p.Pro753Ser)	ATXN1	not specified	Likely benign	no assertion criteria provided	6	16306751	6	16306520	128499	133948
NM_000332.3(ATXN1):c.1212A>G (p.Glu404=)	ATXN1	not specified	Likely benign	no assertion criteria provided	6	16327330	6	16327099	128498	133947
NM_000332.3(ATXN1):c.927T>G (p.Ala309=)	ATXN1	not specified	Likely benign	no assertion criteria provided	6	16327615	6	16327384	128506	133955
NM_000332.3(ATXN1):c.927T>C (p.Ala309=)	ATXN1	not specified	Likely benign	no assertion criteria provided	6	16327615	6	16327384	128505	133954
NM_000332.3(ATXN1):c.675G>C (p.Gln225His)	ATXN1|LOC108663993	not specified	Likely benign	no assertion criteria provided	6	16327867	6	16327636	128504	133953
NM_000332.3(ATXN1):c.645G>T (p.Gln215His)	ATXN1|LOC108663993	not specified	Likely benign	no assertion criteria provided	6	16327897	6	16327666	128503	133952
NM_000332.3(ATXN1):c.639G>T (p.Gln213His)	ATXN1|LOC108663993	not specified	Likely benign	no assertion criteria provided	6	16327903	6	16327672	128502	133951
NM_000332.3(ATXN1):c.633T>G (p.His211Gln)	ATXN1|LOC108663993	not specified	Likely benign	no assertion criteria provided	6	16327909	6	16327678	128501	133950
NM_000332.3(ATXN1):c.474A>G (p.Ala158=)	ATXN1	not specified	Likely benign	no assertion criteria provided	6	16328068	6	16327837	128500	133949
NM_015895.4(GMNN):c.16A>T (p.Lys6Ter)	GMNN	Meier-Gorlin syndrome|Meier-gorlin syndrome 6	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	6	24777490	6	24777262	203999	200397
NM_015895.4(GMNN):c.35_38delTCAA (p.Ile12Lysfs)	GMNN	Meier-Gorlin syndrome|Meier-gorlin syndrome 6	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	6	24777509 - 24777512	6	24777281 - 24777284	204000	200398
NM_015895.4(GMNN):c.50A>G (p.Lys17Arg)	GMNN	Meier-Gorlin syndrome|Meier-gorlin syndrome 6	Likely pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	6	24777524	6	24777296	204001	200399
NM_001293212.1(TUBB):c.920C>T (p.Pro307Leu)	TUBB	not provided|Cortical dysplasia, complex, with other brain malformations 6	Conflicting interpretations of pathogenicity(Last reviewed: May 14, 2018)	criteria provided, conflicting interpretations	6	30691699	6	30723922	438586	432213
NM_019105.6(TNXB):c.12506G>A (p.Arg4169His)	TNXB|LOC106780803	Vesicoureteral reflux 8	Uncertain significance	criteria provided, single submitter	6	32009669	6	32041892	224352	226083
NM_019105.6(TNXB):c.10039G>A (p.Ala3347Thr)	TNXB	Vesicoureteral reflux 8	Uncertain significance	criteria provided, single submitter	6	32016140	6	32048363	224353	226084
NM_019105.6(TNXB):c.6074A>T (p.Asp2025Val)	TNXB	Ehlers-Danlos syndrome, type 3	Likely pathogenic(Last reviewed: Feb 5, 2013)	criteria provided, single submitter	6	32036313	6	32068536	217018	213571
NM_080680.2(COL11A2):c.3100C>T (p.Arg1034Cys)	COL11A2	Deafness, autosomal dominant 13|Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	6	33139540	6	33171763	17124	32163
NM_006772.2(SYNGAP1):c.198C>T (p.Pro66=)	SYNGAP1	Mental retardation, autosomal dominant 5|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	6	33393583	6	33425806	130527	135973
NM_006772.2(SYNGAP1):c.403C>T (p.Arg135Ter)	SYNGAP1	Mental retardation, autosomal recessive 5|Inborn genetic diseases	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	6	33400477	6	33432700	430834	424377
NM_006772.2(SYNGAP1):c.896delG (p.Arg299Profs)	SYNGAP1	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jan 14, 2014)	criteria provided, single submitter	6	33405578	6	33437801	217012	213572
NM_006772.2(SYNGAP1):c.1167_1168delAG (p.Gly391Glnfs)	SYNGAP1	Mental retardation, autosomal dominant 5|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	6	33405849 - 33405850	6	33438072 - 33438073	411566	395445
NM_006772.2(SYNGAP1):c.1536A>G (p.Glu512=)	SYNGAP1	Mental retardation, autosomal dominant 5|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 12, 2017)	criteria provided, multiple submitters, no conflicts	6	33406556	6	33438779	130523	135969
NM_006772.2(SYNGAP1):c.1630C>T (p.Arg544Ter)	SYNGAP1	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	6	33406650	6	33438873	522845	513422
NM_006772.2(SYNGAP1):c.1685del (p.Pro562Argfs)	SYNGAP1	Mental retardation, autosomal dominant 5	Pathogenic	no assertion criteria provided	6	33408514	6	33440737	375621	362435
NM_006772.2(SYNGAP1):c.1713G>A (p.Ser571=)	SYNGAP1	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Sep 28, 2016)	criteria provided, multiple submitters, no conflicts	6	33408542	6	33440765	130524	135970
NM_006772.2(SYNGAP1):c.1783del (p.Leu595Cysfs)	SYNGAP1	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Apr 5, 2013)	criteria provided, single submitter	6	33408612	6	33440835	130525	135971
NM_006772.2(SYNGAP1):c.1851G>A (p.Glu617=)	SYNGAP1	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	6	33408680	6	33440903	130526	135972
NM_006772.2(SYNGAP1):c.1861C>T (p.Arg621Ter)	SYNGAP1	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	6	33408690	6	33440913	411589	395450
NM_006772.2(SYNGAP1):c.1908_1909del (p.Ser637Glnfs)	SYNGAP1	Mental retardation, autosomal dominant 5	Pathogenic	no assertion criteria provided	6	33408737 - 33408738	6	33440960 - 33440961	375615	362429
NM_006772.2(SYNGAP1):c.2438delT (p.Leu813Argfs)	SYNGAP1	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	6	33410767	6	33442990	6394	21433
NM_006772.2(SYNGAP1):c.2561_2577del (p.Leu855Phefs)	SYNGAP1	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	6	33410889 - 33410906	6	33443113 - 33443129	561122	552106
NM_006772.2(SYNGAP1):c.2602del (p.Asp868Thrfs)	SYNGAP1	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Apr 10, 2013)	criteria provided, single submitter	6	33410931	6	33443154	130528	135974
NM_006772.2(SYNGAP1):c.2970C>T (p.Ser990=)	SYNGAP1	Mental retardation, autosomal dominant 5|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	6	33411299	6	33443522	130529	135975
NM_006772.2(SYNGAP1):c.3277C>T (p.Gln1093Ter)	SYNGAP1	Mental retardation, autosomal dominant 5|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	6	33411606	6	33443829	488875	481762
NM_006772.2(SYNGAP1):c.3718C>T (p.Arg1240Ter)	SYNGAP1	Mental retardation, autosomal dominant 5|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, multiple submitters, no conflicts	6	33414487	6	33446710	225077	226901
NM_006245.3(PPP2R5D):c.592G>A (p.Glu198Lys)	MEA1|PPP2R5D	not provided|Inborn genetic diseases|Mental retardation, autosomal dominant 35	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	6	42975003	6	43007265	190286	188114
NM_001253.3(CDC5L):c.1802A>G (p.Lys601Arg)	CDC5L	Congenital anomalies of kidney and urinary tract	Uncertain significance	criteria provided, single submitter	6	44394370	6	44426633	224338	226085
NM_003221.4(TFAP2B):c.650delG (p.Gly217Alafs)	TFAP2B	Char syndrome	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	6	50803822	6	50836109	599040	590168
NM_003221.3(TFAP2B):c.854G>A (p.Arg285Gln)	TFAP2B	Char syndrome	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	6	50805720	6	50838007	8043	23082
NM_018100.3(EFHC1):c.1612C>T (p.Arg538Ter)	EFHC1	Juvenile myoclonic epilepsy|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	6	52344557	6	52479759	205414	202009
NM_001851.4(COL9A1):c.876+2T>A	COL9A1	Multiple epiphyseal dysplasia 6|not specified	Uncertain significance(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	6	70991091	6	70281388	374336	361186
NM_004999.3(MYO6):c.238C>T (p.Arg80Ter)	MYO6	Nonsyndromic hearing loss and deafness|not specified|not provided	Likely pathogenic(Last reviewed: Sep 11, 2018)	reviewed by expert panel	6	76538307	6	75828590	178957	174003
NM_004999.3(MYO6):c.535G>T (p.Asp179Tyr)	MYO6	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, single submitter	6	76545655	6	75835938	517508	496916
NM_004999.3(MYO6):c.737A>G (p.His246Arg)	MYO6	Sensorineural deafness with hypertrophic cardiomyopathy|Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Jul 30, 2015)	criteria provided, single submitter	6	76551016	6	75841299	8581	23620
NM_004999.3(MYO6):c.1383G>C (p.Glu461Asp)	MYO6	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: May 4, 2016)	criteria provided, single submitter	6	76568620	6	75858903	178931	174146
NM_004999.3(MYO6):c.2545C>T (p.Arg849Ter)	MYO6	Deafness, autosomal dominant 22|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	6	76596598	6	75886881	8582	23621
NM_004999.3(MYO6):c.2717C>A (p.Ser906Ter)	MYO6	Deafness, autosomal dominant 22	Pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	6	76599832	6	75890115	544693	535237
NM_004999.3(MYO6):c.2814_2815delAA (p.Arg939Thrfs)	MYO6	Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Jan 3, 2016)	criteria provided, single submitter	6	76599929 - 76599930	6	75890212 - 75890213	228375	229525
NM_004999.3(MYO6):c.3207_3212delTGCTGGinsATCCTACATACTTAAAATTTCTT (p.Ala1070Serfs)	MYO6	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Sep 5, 2014)	criteria provided, single submitter	6	76617352 - 76617357	6	75907635 - 75907640	179643	174151
NM_015021.2(ZNF292):c.6578A>C (p.Tyr2193Ser)	ZNF292	ZNF292-related neurodevelopmental condition	Likely pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	6	87969925	6	87260207	522860	513423
NM_007214.4(SEC63):c.452+1G>A	SEC63	Polycystic liver disease 1	Pathogenic	no assertion criteria provided	6	108243000	6	107921796	225118	226998
NM_007214.4(SEC63):c.220del (p.Val74Terfs)	SEC63	Polycystic liver disease 1	Pathogenic	no assertion criteria provided	6	108250623	6	107929419	225125	227011
NM_003931.2(WASF1):c.1558C>T (p.Gln520Ter)	WASF1	Intellectual disability	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	6	110421847	6	110100644	561981	553119
NM_003931.2(WASF1):c.1516C>T (p.Arg506Ter)	WASF1	Intellectual disability	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	6	110422797	6	110101594	561980	553120
NM_003931.2(WASF1):c.1482delCinsGCCAGG (p.Ile494Metfs)	WASF1	Intellectual disability	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	6	110422831	6	110101628	561982	553121
NM_001105206.2(LAMA4):c.105C>G (p.Asp35Glu)	LAMA4|LOC101927640	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	6	112575248	6	112254046	492988	485932
NM_002667.4(PLN):c.25C>T (p.Arg9Cys)	PLN|CEP85L	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1P|not provided	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, multiple submitters, no conflicts	6	118880109	6	118558946	13636	28675
NM_002667.4(PLN):c.40_42delAGA (p.Arg14del)	PLN|CEP85L	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1P|Arrhythmogenic right ventricular cardiomyopathy, type 9|Cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	6	118880124 - 118880126	6	118558961 - 118558963	44580	53747
NM_002667.4(PLN):c.116T>G (p.Leu39Ter)	PLN|CEP85L	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1P|Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 18|Sudden cardiac death|not provided|Cardiac arrest|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 4, 2018)	criteria provided, multiple submitters, no conflicts	6	118880200	6	118559037	13637	28676
NM_001178035.1(CEP85L):c.191C>T (p.Ser64Phe)	CEP85L	Lissencephaly	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	6	118953666	6	118632503	438602	432212
NM_000165.5(GJA1):c.226C>A (p.Arg76Ser)	GJA1	Oculodentodigital dysplasia|not provided	Likely pathogenic(Last reviewed: May 12, 2016)	criteria provided, multiple submitters, no conflicts	6	121768219	6	121447073	16997	32036
NM_000165.5(GJA1):c.717G>A (p.Arg239=)	GJA1	Hypoplastic left heart syndrome 1|Oculodentodigital dysplasia, autosomal recessive|Oculodentodigital dysplasia|not specified|Syndactyly	Benign/Likely benign(Last reviewed: Jul 9, 2017)	criteria provided, multiple submitters, no conflicts	6	121768710	6	121447564	137482	141185
NM_004100.4(EYA4):c.371-2A>C	EYA4	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: May 21, 2015)	criteria provided, single submitter	6	133782250	6	133461112	228260	229420
NM_004100.4:c.724_(804_?)del	EYA4	Primary dilated cardiomyopathy|Nonsyndromic hearing loss and deafness	Conflicting interpretations of pathogenicity(Last reviewed: Mar 12, 2014)	criteria provided, conflicting interpretations	6	133783902 - 133785996	6	133462764 - 133464858	163445	174483
NM_004100.4(EYA4):c.1739-1G>A	EYA4|TARID	Deafness, autosomal dominant 10	Likely pathogenic(Last reviewed: Jul 2, 2014)	criteria provided, single submitter	6	133846291	6	133525153	208577	205147
NM_015093.5(TAB2):c.679C>T (p.Arg227Ter)	TAB2	Congenital heart defects, multiple types, 2	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	6	149699730	6	149378594	561124	552094
NM_015093.5(TAB2):c.878delC (p.Ser293Tyrfs)	TAB2	Congenital heart defects, multiple types, 2	Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	6	149699929	6	149378793	488614	481482
NM_015093.5(TAB2):c.1321C>T (p.Arg441Ter)	TAB2	Congenital heart defects, multiple types, 2	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	6	149700372	6	149379236	488615	481483
NM_015093.5(TAB2):c.1491T>A (p.Tyr497Ter)	TAB2	Congenital heart defects, multiple types, 2	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	6	149700542	6	149379406	561123	552095
NM_015093.5(TAB2):c.2051G>A (p.Cys684Tyr)	TAB2	Congenital heart defects, multiple types, 2	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	6	149730824	6	149409688	561115	552096
NM_033071.3(SYNE1):c.26077C>A (p.Leu8693Met)	ESR1|SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152443744	6	152122609	130436	135882
NM_033071.3(SYNE1):c.26065G>A (p.Gly8689Ser)	ESR1|SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 7, 2017)	criteria provided, multiple submitters, no conflicts	6	152443756	6	152122621	130435	135881
NM_033071.3(SYNE1):c.26060G>A (p.Arg8687Gln)	ESR1|SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152443761	6	152122626	130434	135880
NM_033071.3(SYNE1):c.25916C>T (p.Thr8639Ile)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152453291	6	152132156	130433	135879
NM_033071.3(SYNE1):c.25858-4A>G	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified|not provided	Benign/Likely benign(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	6	152453353	6	152132218	130432	135878
NM_033071.3(SYNE1):c.24894T>C (p.Arg8298=)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152464839	6	152143704	130430	135876
NM_033071.3(SYNE1):c.24780A>G (p.Glu8260=)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152466674	6	152145539	130429	135875
NM_033071.3(SYNE1):c.24755G>C (p.Gly8252Ala)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Mar 9, 2017)	criteria provided, multiple submitters, no conflicts	6	152469188	6	152148053	130428	135874
NM_033071.3(SYNE1):c.24612G>A (p.Pro8204=)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Mar 9, 2017)	criteria provided, multiple submitters, no conflicts	6	152469331	6	152148196	130427	135873
NM_033071.3(SYNE1):c.24289G>T (p.Ala8097Ser)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152470752	6	152149617	130426	135872
NM_033071.3(SYNE1):c.24012A>G (p.Ala8004=)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	6	152473181	6	152152046	130425	135871
NM_033071.3(SYNE1):c.22596C>T (p.Leu7532=)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Aug 4, 2017)	criteria provided, multiple submitters, no conflicts	6	152529122	6	152207987	130424	135870
NM_033071.3(SYNE1):c.22458C>T (p.Ile7486=)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified|not provided	Benign(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	6	152529260	6	152208125	130423	135869
NM_033071.3(SYNE1):c.22303A>G (p.Ser7435Gly)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Jun 29, 2017)	criteria provided, multiple submitters, no conflicts	6	152532702	6	152211567	130422	135868
NM_033071.3(SYNE1):c.22260G>A (p.Leu7420=)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	6	152534768	6	152213633	130421	135867
NM_033071.3(SYNE1):c.22239A>G (p.Ser7413=)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	6	152534789	6	152213654	130420	135866
NM_033071.3(SYNE1):c.21691T>G (p.Phe7231Val)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Sep 26, 2016)	criteria provided, multiple submitters, no conflicts	6	152540278	6	152219143	130419	135865
NM_033071.3(SYNE1):c.20358A>T (p.Ser6786=)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	6	152555057	6	152233922	130418	135864
NM_033071.3(SYNE1):c.19776T>C (p.His6592=)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	6	152560746	6	152239611	130416	135863
NM_033071.3(SYNE1):c.18588C>T (p.Thr6196=)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	6	152589205	6	152268070	130415	135862
NM_033071.3(SYNE1):c.17532C>T (p.His5844=)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jan 5, 2017)	criteria provided, multiple submitters, no conflicts	6	152615200	6	152294065	130414	135861
NM_033071.3(SYNE1):c.17205G>A (p.Thr5735=)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	6	152623127	6	152301992	130413	135860
NM_033071.3(SYNE1):c.17133+7G>A	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152629617	6	152308482	130412	135859
NM_033071.3(SYNE1):c.17126G>A (p.Arg5709Gln)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	6	152629631	6	152308496	130411	135858
NM_033071.3(SYNE1):c.16064C>T (p.Thr5355Met)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	6	152640110	6	152318975	130410	135857
NM_033071.3(SYNE1):c.15384C>G (p.Ala5128=)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	6	152646279	6	152325144	130409	135856
NM_033071.3(SYNE1):c.14830T>A (p.Leu4944Met)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152647681	6	152326546	130408	135855
NM_033071.3(SYNE1):c.14704C>T (p.Leu4902=)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	6	152650903	6	152329768	130407	135854
NM_033071.3(SYNE1):c.13894G>A (p.Asp4632Asn)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified|not provided	Benign/Likely benign(Last reviewed: Aug 13, 2018)	criteria provided, multiple submitters, no conflicts	6	152651713	6	152330578	130406	135853
NM_033071.3(SYNE1):c.13848G>C (p.Leu4616=)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152651759	6	152330624	130405	135852
NM_033071.3(SYNE1):c.13573T>A (p.Ser4525Thr)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	6	152652034	6	152330899	130404	135851
NM_033071.3(SYNE1):c.13008C>T (p.Asp4336=)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	6	152652599	6	152331464	130403	135850
NM_033071.3(SYNE1):c.12394G>A (p.Glu4132Lys)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Dec 20, 2017)	criteria provided, multiple submitters, no conflicts	6	152655330	6	152334195	130402	135849
NM_033071.3(SYNE1):c.12229G>C (p.Asp4077His)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Aug 4, 2017)	criteria provided, multiple submitters, no conflicts	6	152658062	6	152336927	130401	135848
NM_033071.3(SYNE1):c.12150G>T (p.Lys4050Asn)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jul 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152658141	6	152337006	130400	135847
NM_033071.3(SYNE1):c.12149A>G (p.Lys4050Arg)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152658142	6	152337007	130399	135846
NM_033071.3(SYNE1):c.12063C>T (p.Leu4021=)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152660451	6	152339316	130398	135845
NM_033071.3(SYNE1):c.11967G>T (p.Glu3989Asp)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152665261	6	152344126	130397	135844
NM_033071.3(SYNE1):c.11925G>A (p.Gln3975=)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	6	152665303	6	152344168	130396	135843
NM_033071.3(SYNE1):c.11844G>A (p.Ala3948=)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Jan 10, 2018)	criteria provided, multiple submitters, no conflicts	6	152668215	6	152347080	130395	135842
NM_033071.3(SYNE1):c.11576A>C (p.Lys3859Thr)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	6	152671865	6	152350730	130394	135841
NM_033071.3(SYNE1):c.10881+6T>C	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152675854	6	152354719	130393	135840
NM_033071.3(SYNE1):c.10619G>A (p.Arg3540His)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified|not provided	Benign/Likely benign(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	6	152679518	6	152358383	130391	135838
NM_033071.3(SYNE1):c.10543T>C (p.Leu3515=)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Dec 23, 2017)	criteria provided, multiple submitters, no conflicts	6	152679594	6	152358459	130390	135837
NM_033071.3(SYNE1):c.10228G>A (p.Gly3410Ser)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified|not provided	Benign/Likely benign(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	6	152683397	6	152362262	130389	135836
NM_033071.3(SYNE1):c.10212C>A (p.Gly3404=)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152683413	6	152362278	130388	135835
NM_033071.3(SYNE1):c.10043T>C (p.Val3348Ala)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Dec 19, 2017)	criteria provided, multiple submitters, no conflicts	6	152686105	6	152364970	130387	135834
NM_033071.3(SYNE1):c.9975C>T (p.Ser3325=)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	6	152688371	6	152367236	130455	135901
NM_033071.3(SYNE1):c.9911C>T (p.Thr3304Met)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 26, 2017)	criteria provided, conflicting interpretations	6	152688435	6	152367300	130454	135900
NM_033071.3(SYNE1):c.9516A>G (p.Glu3172=)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Aug 15, 2016)	criteria provided, multiple submitters, no conflicts	6	152694184	6	152373049	130453	135899
NM_033071.3(SYNE1):c.8405C>T (p.Ala2802Val)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152708310	6	152387175	130452	135898
NM_033071.3(SYNE1):c.8357T>G (p.Ile2786Ser)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified|not provided	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	6	152708358	6	152387223	130451	135897
NM_033071.3(SYNE1):c.8198+9C>T	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	6	152711406	6	152390271	130450	135896
NM_033071.3(SYNE1):c.8184C>T (p.Ser2728=)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	6	152711429	6	152390294	130449	135895
NM_033071.3(SYNE1):c.6491A>G (p.Lys2164Arg)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	6	152730273	6	152409138	130448	135894
NM_033071.3(SYNE1):c.5277C>A (p.Ile1759=)	SYNE1	not provided	Uncertain significance(Last reviewed: Mar 6, 2014)	criteria provided, single submitter	6	152746527	6	152425392	130447	135893
NM_033071.3(SYNE1):c.5211T>A (p.Asp1737Glu)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Jul 27, 2017)	criteria provided, multiple submitters, no conflicts	6	152746593	6	152425458	130446	135892
NM_033071.3(SYNE1):c.4778C>A (p.Thr1593Lys)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Jul 17, 2017)	criteria provided, multiple submitters, no conflicts	6	152751278	6	152430143	130445	135891
NM_033071.3(SYNE1):c.3981A>G (p.Thr1327=)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Jul 27, 2017)	criteria provided, multiple submitters, no conflicts	6	152763258	6	152442123	130444	135890
NM_033071.3(SYNE1):c.3911C>T (p.Ala1304Val)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified|not provided	Benign/Likely benign(Last reviewed: Dec 15, 2017)	criteria provided, multiple submitters, no conflicts	6	152763328	6	152442193	130443	135889
NM_033071.3(SYNE1):c.3871C>T (p.Arg1291Trp)	SYNE1	not specified|not provided	Uncertain significance(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	6	152763368	6	152442233	130442	135888
NM_033071.3(SYNE1):c.3825G>A (p.Leu1275=)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	6	152765579	6	152444444	130441	135887
NM_033071.3(SYNE1):c.3690+4C>G	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 29, 2017)	criteria provided, conflicting interpretations	6	152768589	6	152447454	130440	135886
NM_033071.3(SYNE1):c.3327C>T (p.His1109=)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152771849	6	152450714	130439	135885
NM_033071.3(SYNE1):c.3125T>C (p.Val1042Ala)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152772264	6	152451129	130438	135884
NM_033071.3(SYNE1):c.2674T>G (p.Leu892Val)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152777095	6	152455960	130437	135883
NM_033071.3(SYNE1):c.2548C>T (p.Arg850Cys)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Jul 20, 2017)	criteria provided, multiple submitters, no conflicts	6	152779933	6	152458798	130431	135877
NM_033071.3(SYNE1):c.1068+4T>A	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152809527	6	152488392	130392	135839
NM_017519.2(ARID1B):c.17G>A (p.Gly6Asp)	ARID1B	Coffin-Siris syndrome 1	Likely pathogenic(Last reviewed: Mar 26, 2015)	no assertion criteria provided	6	157099080	6	156777946	374256	361185
NM_020732.3(ARID1B):c.363A>G (p.Gln121=)	ARID1B	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 5, 2016)	criteria provided, multiple submitters, no conflicts	6	157099426	6	156778292	126328	131860
NM_020732.3(ARID1B):c.942C>A (p.Gly314=)	ARID1B	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: May 6, 2016)	criteria provided, single submitter	6	157100005	6	156778871	126339	131871
NM_001346813.1(ARID1B):c.1348_1350dup (p.Pro450_Ser451insPro)	ARID1B	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 21, 2017)	criteria provided, multiple submitters, no conflicts	6	157100411 - 157100413	6	156779277 - 156779279	126314	131846
NM_020732.3(ARID1B):c.1375G>A (p.Ala459Thr)	ARID1B	Coffin Siris/Intellectual Disability	Uncertain significance(Last reviewed: Jul 8, 2013)	criteria provided, single submitter	6	157100438	6	156779304	126315	131847
NM_020732.3(ARID1B):c.1618C>T (p.Gln540Ter)	ARID1B	Coffin-Siris syndrome 1|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	6	157150436	6	156829302	520639	511635
NM_020732.3(ARID1B):c.1678A>G (p.Ile560Val)	ARID1B	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	6	157150496	6	156829362	126316	131848
NM_020732.3(ARID1B):c.1737+28T>C	ARID1B	not specified	Likely benign	no assertion criteria provided	6	157150583	6	156829449	126317	131849
NM_020732.3(ARID1B):c.1828C>T (p.Gln610Ter)	ARID1B	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	6	157222561	6	156901427	560948	552097
NM_020732.3(ARID1B):c.1927-3T>A	ARID1B	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jul 7, 2016)	criteria provided, multiple submitters, no conflicts	6	157256597	6	156935463	126318	131850
NM_020732.3(ARID1B):c.2038-35G>A	ARID1B	not specified	Likely benign	no assertion criteria provided	6	157405761	6	157084627	126319	131851
NM_020732.3(ARID1B):c.2172G>A (p.Ala724=)	ARID1B	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 13, 2016)	criteria provided, multiple submitters, no conflicts	6	157405930	6	157084796	126320	131852
NM_020732.3(ARID1B):c.2306_2308delCCGinsTCCGCAGCCACTCC (p.Pro769Leufs)	ARID1B	Blepharophimosis|Absent speech|Thick lower lip vermilion|Thin upper lip vermilion|Long eyelashes|Intellectual disability, moderate	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	6	157431630 - 157431632	6	157110496 - 157110498	242865	243967
NM_020732.3(ARID1B):c.2799G>A (p.Pro933=)	ARID1B	Coffin Siris/Intellectual Disability	Uncertain significance(Last reviewed: Jul 16, 2013)	criteria provided, single submitter	6	157470005	6	157148871	126322	131854
NM_020732.3(ARID1B):c.2896G>A (p.Gly966Ser)	ARID1B	not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2017)	criteria provided, multiple submitters, no conflicts	6	157488190	6	157167056	126323	131855
NM_020732.3(ARID1B):c.2941C>T (p.Gln981Ter)	ARID1B	Blepharophimosis|Absent speech|Thick lower lip vermilion|Thin upper lip vermilion|Long eyelashes|Intellectual disability, moderate	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	6	157488235	6	157167101	242867	243971
NM_020732.3(ARID1B):c.3025+21C>T	ARID1B	not specified	Likely benign	no assertion criteria provided	6	157488340	6	157167206	126324	131856
NM_020732.3(ARID1B):c.3025+38C>T	ARID1B	not specified	Likely benign	no assertion criteria provided	6	157488357	6	157167223	126325	131857
NM_020732.3(ARID1B):c.3096_3100delCAAAG (p.Lys1033Argfs)	ARID1B	Coffin-Siris syndrome 1	Likely pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	6	157495212 - 157495216	6	157174078 - 157174082	430942	424483
GRCh38/hg38 6q25.3(chr6:157179172-157184916)x1	ARID1B	Coffin-Siris syndrome 1	Likely pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	6	157500306 - 157506050	6	157179172 - 157184916	584448	575513
NM_020732.3(ARID1B):c.3208_3209delAA (p.Lys1070Alafs)	ARID1B	Blepharophimosis|Absent speech|Thick lower lip vermilion|Thin upper lip vermilion|Long eyelashes|Intellectual disability, moderate	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	6	157502175 - 157502176	6	157181041 - 157181042	242864	243968
NM_020732.3(ARID1B):c.3223C>T (p.Arg1075Ter)	ARID1B	Coffin-Siris syndrome 1|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	6	157502190	6	157181056	31216	40173
NM_020732.3(ARID1B):c.3228C>G (p.Tyr1076Ter)	ARID1B	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	6	157502195	6	157181061	560949	552098
NM_020732.3(ARID1B):c.3459G>A (p.Glu1153=)	ARID1B	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 1, 2016)	criteria provided, multiple submitters, no conflicts	6	157505478	6	157184344	126326	131858
NM_020732.3(ARID1B):c.3547delC (p.Pro1183Leufs)	ARID1B	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	6	157505566	6	157184432	560950	552099
NM_001346813.1(ARID1B):c.3752dup (p.Pro1252Alafs)	ARID1B	Coffin-Siris syndrome 1	Pathogenic	no assertion criteria provided	6	157510857	6	157189723	524204	514851
NM_020732.3(ARID1B):c.3689+1G>C	ARID1B	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Feb 13, 2015)	no assertion criteria provided	6	157510915	6	157189781	374317	361264
NM_020732.3(ARID1B):c.3737C>A (p.Ser1246Ter)	ARID1B	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	6	157511219	6	157190085	560951	552100
NM_020732.3(ARID1B):c.4009C>T (p.Arg1337Ter)	ARID1B	Coffin-Siris syndrome 1|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, multiple submitters, no conflicts	6	157517445	6	157196311	488469	481337
NM_020732.3(ARID1B):c.4014-7A>G	ARID1B	not specified	Benign(Last reviewed: Aug 15, 2013)	criteria provided, single submitter	6	157519938	6	157198804	126330	131862
NM_020732.3(ARID1B):c.4102C>T (p.Gln1368Ter)	ARID1B	Coffin Siris/Intellectual Disability	Pathogenic(Last reviewed: Feb 17, 2014)	criteria provided, single submitter	6	157520033	6	157198899	126331	131863
NM_020732.3(ARID1B):c.4273dupT (p.Tyr1425Leufs)	ARID1B	Blepharophimosis|not provided|Absent speech|Thick lower lip vermilion|Thin upper lip vermilion|Long eyelashes|Intellectual disability, moderate	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, multiple submitters, no conflicts	6	157522001	6	157200867	242866	243969
NM_020732.3(ARID1B):c.4377del (p.Pro1460Leufs)	ARID1B	Coffin Siris/Intellectual Disability	Pathogenic(Last reviewed: Oct 30, 2013)	criteria provided, single submitter	6	157522105	6	157200971	126332	131864
NM_020732.3(ARID1B):c.4495A>T (p.Met1499Leu)	ARID1B	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 13, 2016)	criteria provided, single submitter	6	157522223	6	157201089	126333	131865
NM_020732.3(ARID1B):c.4536G>A (p.Trp1512Ter)	ARID1B	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	6	157522264	6	157201130	560952	552101
NM_020732.3(ARID1B):c.4632G>A (p.Pro1544=)	ARID1B	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 15, 2016)	criteria provided, multiple submitters, no conflicts	6	157522360	6	157201226	126334	131866
NM_020732.3(ARID1B):c.4870C>T (p.Arg1624Ter)	ARID1B	Coffin-Siris syndrome 1|not provided	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	6	157522598	6	157201464	503753	495270
NM_020732.3(ARID1B):c.4889delA (p.Asp1630Valfs)	ARID1B	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	6	157522616 - 157522617	6	157201483	560953	552102
NM_020732.3(ARID1B):c.5207A>C (p.Glu1736Ala)	ARID1B	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 23, 2016)	criteria provided, multiple submitters, no conflicts	6	157527482	6	157206348	126335	131867
NM_020732.3(ARID1B):c.5776C>T (p.Arg1926Ter)	ARID1B	Coffin-Siris syndrome 1|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	6	157528051	6	157206917	488678	481755
NM_001346813.1(ARID1B):c.6372_6373insACCCTCTGTAAACTCAGTATCCAGGACA (p.Asn2135Profs)	ARID1B	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	6	157528527 - 157528528	6	157207393 - 157207394	488470	481338
NM_020732.3(ARID1B):c.6255_6256delCC (p.Cys2087Terfs)	ARID1B	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Oct 7, 2016)	no assertion criteria provided	6	157528530 - 157528531	6	157207396 - 157207397	267263	262265
NM_020732.3(ARID1B):c.6700delC (p.Leu2234Trpfs)	ARID1B	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	6	157528974 - 157528975	6	157207841	560954	552103
NM_003194.4(TBP):c.223_281del59ins53 (p.?)	TBP|LOC108663996	not provided	Uncertain significance(Last reviewed: Mar 6, 2014)	criteria provided, single submitter	6	170871047 - 170871105	6	170561959 - 170562017	130559	136005
NM_003194.4(TBP):c.228G>A (p.Gln76=)	TBP|LOC108663996	not provided	Uncertain significance(Last reviewed: Mar 6, 2014)	criteria provided, single submitter	6	170871052	6	170561964	130560	136006
NM_003194.4(TBP):c.771T>C (p.Asn257=)	TBP	not specified	Likely benign	no assertion criteria provided	6	170878793	6	170569705	130561	136007
NC_000006.12:g.(?_1610445)_(1612107_?)del	FOXC1	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Mar 24, 2015)	no assertion criteria provided	6	1610680 - 1612342	6	1610445 - 1612107	375435	362195
NC_000006.11:g.(?_157099064)_(158366109_?)del	SNX9|ARID1B|ZDHHC14|TMEM242	Blepharophimosis|Absent speech|Thick lower lip vermilion|Thin upper lip vermilion|Long eyelashes|Intellectual disability, moderate	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	6	157099064 - 158366109			242863	243970
NM_182924.3(MICALL2):c.851C>G (p.Pro284Arg)	MICALL2	Joubert syndrome 1	Pathogenic	no assertion criteria provided	7	1484855	7	1445219	375381	362148
NM_001101.4(ACTB):c.269_271delTCT (p.Phe90del)	ACTB	Baraitser-Winter syndrome 1	Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	7	5568884 - 5568886	7	5529253 - 5529255	488462	481330
NM_000535.6(PMS2):c.2239A>T (p.Arg747Ter)	PMS2	Lynch syndrome	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	7	6018263	7	5978632	504753	497094
NM_000535.6(PMS2):c.2192_2196delTAACT (p.Leu731Cysfs)	PMS2	Hereditary nonpolyposis colorectal cancer type 4|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	7	6018306 - 6018310	7	5978675 - 5978679	91331	96806
NM_000535.5(PMS2):c.2174+1G>A	PMS2	Hereditary nonpolyposis colorectal cancer type 4|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 14, 2014)	reviewed by expert panel	7	6022454	7	5982823	91329	96804
NM_000535.6(PMS2):c.2149G>A (p.Val717Met)	PMS2	Turcot syndrome|Hereditary nonpolyposis colorectal cancer type 4|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Conflicting interpretations of pathogenicity(Last reviewed: Oct 12, 2018)	criteria provided, conflicting interpretations	7	6022480	7	5982849	41709	50148
NM_000535.6(PMS2):c.2117delA (p.Lys706Serfs)	PMS2	Hereditary nonpolyposis colorectal cancer type 4|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary cancer|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	7	6022512	7	5982881	142765	152479
NM_000535.5(PMS2):c.1927C>T (p.Gln643Ter)	PMS2	Turcot syndrome|Lynch syndrome|Pulmonary arterial hypertension|Respiratory insufficiency|not provided|Hereditary cancer-predisposing syndrome|Pulmonary insufficiency|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	7	6026469	7	5986838	91320	96795
NM_000535.6(PMS2):c.1874delT (p.Leu625Terfs)	PMS2	Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 2, 2018)	criteria provided, multiple submitters, no conflicts	7	6026522	7	5986891	186596	182719
NM_000535.6(PMS2):c.1831dup (p.Ile611Asnfs)	PMS2	Burkitt lymphoma|Lynch syndrome I|Acute lymphoid leukemia|Lynch syndrome|not specified|not provided|Glioblastoma|Hereditary cancer-predisposing syndrome|Lymphoma|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	7	6026565	7	5986934	91317	96792
NM_000535.6(PMS2):c.1275_1279delTCTTC (p.Leu426Serfs)	PMS2	Lynch syndrome	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	7	6027117 - 6027121	7	5987486 - 5987490	505722	496497
NM_000535.6(PMS2):c.1261C>T (p.Arg421Ter)	PMS2	Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	7	6027135	7	5987504	91299	96774
NM_000535.6(PMS2):c.1144+1G>A	PMS2	Lynch syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, multiple submitters, no conflicts	7	6029430	7	5989799	162508	172174
NM_000535.6(PMS2):c.1021del (p.Arg341Glyfs)	PMS2	Hereditary nonpolyposis colorectal cancer type 4|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	7	6029554	7	5989923	9240	24279
NM_000535.6(PMS2):c.943C>T (p.Arg315Ter)	PMS2	Hereditary nonpolyposis colorectal cancer type 4|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	7	6031649	7	5992018	91382	96857
NM_000535.6(PMS2):c.903G>A (p.Lys301=)	PMS2	Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Likely pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, multiple submitters, no conflicts	7	6035165	7	5995534	237932	240133
NM_000535.6(PMS2):c.780delC (p.Asp261Metfs)	PMS2	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	7	6036980	7	5997349	91367	96842
NM_000535.6(PMS2):c.765C>A (p.Tyr255Ter)	PMS2	Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	7	6036995	7	5997364	183716	182785
NM_000535.6(PMS2):c.736_741delCCCCCTinsTGTGTGTGAAG (p.Pro246Cysfs)	PMS2	Burkitt lymphoma|Hereditary nonpolyposis colorectal cancer type 4|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Lymphoma	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	7	6037019 - 6037024	7	5997388 - 5997393	91366	96841
NM_000535.6(PMS2):c.400C>T (p.Arg134Ter)	PMS2	Turcot syndrome|Hereditary nonpolyposis colorectal cancer type 4|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	7	6042221	7	6002590	9234	24273
NM_000535.6(PMS2):c.137G>T (p.Ser46Ile)	PMS2	Turcot syndrome|Hereditary nonpolyposis colorectal cancer type 4|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Pituitary carcinoma|Hereditary nonpolyposis colon cancer	Likely pathogenic(Last reviewed: Mar 14, 2014)	reviewed by expert panel	7	6045549	7	6005918	9245	24284
NM_000535.6(PMS2):c.88C>T (p.Gln30Ter)	PMS2	Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, multiple submitters, no conflicts	7	6045598	7	6005967	142650	152364
NM_000535.6(PMS2):c.1A>G (p.Met1Val)	PMS2	Lynch syndrome I|Hereditary nonpolyposis colorectal cancer type 4|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Likely pathogenic(Last reviewed: Jun 30, 2017)	reviewed by expert panel	7	6048650	7	6009019	91323	96798
NM_000474.3(TWIST1):c.352C>G (p.Arg118Gly)	TWIST1	Saethre-Chotzen syndrome	Likely pathogenic	no assertion criteria provided	7	19156593	7	19116970	438352	431983
NM_004403.2(GSDME):c.991-15_991-13delTTC	GSDME	Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	7	24746008 - 24746010	7	24706389 - 24706391	179997	174221
NM_002047.3(GARS):c.998A>T (p.Glu333Val)	GARS	Charcot-Marie-Tooth disease type 2D|Distal hereditary motor neuronopathy type 5	Likely pathogenic(Last reviewed: Aug 6, 2013)	criteria provided, single submitter	7	30651828	7	30612212	216930	213574
NM_002047.3(GARS):c.1904C>T (p.Ser635Leu)	GARS	Charcot-Marie-Tooth disease type 2D	Pathogenic(Last reviewed: Nov 20, 2014)	criteria provided, single submitter	7	30671863	7	30632247	209157	205754
NM_001191058.3(PDE1C):c.958G>T (p.Ala320Ser)	PDE1C	Autosomal dominant non-syndromic sensorineural deafness type DFNA|DEAFNESS, AUTOSOMAL DOMINANT 74	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2018)	no assertion criteria provided	7	31890328	7	31850714	433528	427102
NM_003718.4(CDK13):c.2524A>G (p.Asn842Asp)	CDK13	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	Likely pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	7	40085605	7	40046006	522794	513425
NM_003718.4(CDK13):c.4097G>A (p.Arg1366His)	CDK13	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	Uncertain significance(Last reviewed: May 9, 2018)	no assertion criteria provided	7	40134137	7	40094538	545696	536188
NM_000168.5(GLI3):c.3635delG (p.Gly1212Alafs)	GLI3	Postaxial polydactyly	Pathogenic(Last reviewed: Jun 1, 2016)	no assertion criteria provided	7	42005036	7	41965438	393462	380284
NM_000168.5(GLI3):c.2252delA (p.Asp751Alafs)	GLI3	Postaxial polydactyly	Pathogenic(Last reviewed: May 14, 2015)	no assertion criteria provided	7	42007373	7	41967775	374325	361188
NM_000168.5(GLI3):c.750delC (p.Tyr251Metfs)	GLI3	Greig cephalopolysyndactyly syndrome	Pathogenic(Last reviewed: Oct 19, 2013)	criteria provided, single submitter	7	42085059	7	42045460	523635	514283
NM_000162.3(GCK):c.1358C>T (p.Ser453Leu)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Likely pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, multiple submitters, no conflicts	7	44184775	7	44145176	36200	44864
NM_000162.3(GCK):c.1279_1358del80insTTACA (p.Val427_Ser453delinsLeuGln)	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44184775 - 44184854	7	44145176 - 44145255	36190	44854
NM_000162.3(GCK):c.1307T>A (p.Ile436Asn)	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44184826	7	44145227	36195	44859
NM_000162.3(GCK):c.1240A>G (p.Lys414Glu)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Likely pathogenic(Last reviewed: May 22, 2018)	criteria provided, multiple submitters, no conflicts	7	44185109	7	44145510	36188	44852
NM_000162.3(GCK):c.1160C>T (p.Ala387Val)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Likely pathogenic(Last reviewed: Dec 3, 2015)	criteria provided, multiple submitters, no conflicts	7	44185189	7	44145590	36182	44846
NM_000162.3(GCK):c.1130G>A (p.Arg377His)	GCK	Maturity-onset diabetes of the young,  type 2|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 22, 2017)	criteria provided, conflicting interpretations	7	44185219	7	44145620	36176	44840
NM_033507.2(GCK):c.1033G>T (p.Asp345Tyr)	GCK	Maturity-onset diabetes of the young,  type 2	Uncertain significance(Last reviewed: Jun 25, 2017)	criteria provided, multiple submitters, no conflicts	7	44185319	7	44145720	219179	217193
NM_000162.3(GCK):c.1020-1G>C	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44185330	7	44145731	36170	44834
NM_000162.3(GCK):c.971T>C (p.Leu324Pro)	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44186110	7	44146511	36270	44934
NM_000162.3(GCK):c.944T>A (p.Leu315His)	GCK	Maturity-onset diabetes of the young,  type 2	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44186137	7	44146538	36266	44930
NM_000162.3(GCK):c.907C>T (p.Arg303Trp)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Likely pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, multiple submitters, no conflicts	7	44186174	7	44146575	36264	44928
NM_000162.3(GCK):c.871A>T (p.Lys291Ter)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, multiple submitters, no conflicts	7	44186210	7	44146611	36263	44927
NM_000162.3(GCK):c.787T>C (p.Ser263Pro)	GCK	Maturity-onset diabetes of the young,  type 2|Maternal diabetes|not provided	Likely pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, multiple submitters, no conflicts	7	44187325	7	44147726	36258	44922
NM_000162.3(GCK):c.768G>C (p.Glu256Asp)	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44187344	7	44147745	36255	44919
NM_000162.3(GCK):c.758T>C (p.Val253Ala)	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44187354	7	44147755	36252	44916
NM_000162.3(GCK):c.704T>C (p.Met235Thr)	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44187408	7	44147809	36248	44912
NM_000162.3(GCK):c.683C>T (p.Thr228Met)	GCK	Permanent neonatal diabetes mellitus|Maturity-onset diabetes of the young,  type 2|not provided	Pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, multiple submitters, no conflicts	7	44187429	7	44147830	16134	31173
NM_000162.3(GCK):c.676G>A (p.Val226Met)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Pathogenic(Last reviewed: Oct 11, 2017)	criteria provided, multiple submitters, no conflicts	7	44189362	7	44149763	36243	44907
NM_000162.3(GCK):c.661G>A (p.Glu221Lys)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	7	44189377	7	44149778	36241	44905
NM_000162.3(GCK):c.659G>A (p.Cys220Tyr)	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44189379	7	44149780	36240	44904
NM_000162.3(GCK):c.645C>G (p.Tyr215Ter)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Pathogenic(Last reviewed: Mar 5, 2015)	criteria provided, multiple submitters, no conflicts	7	44189393	7	44149794	36238	44902
NM_000162.3(GCK):c.605T>C (p.Met202Thr)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 3, 2018)	criteria provided, conflicting interpretations	7	44189433	7	44149834	36233	44897
NM_000162.3(GCK):c.563C>T (p.Ala188Val)	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44189584	7	44149985	36229	44893
NM_000162.3(GCK):c.542T>C (p.Val181Ala)	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44189605	7	44150006	36228	44892
NM_000162.3(GCK):c.483G>A (p.Lys161=)	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44190555	7	44150956	36224	44888
NM_000162.3(GCK):c.449T>C (p.Phe150Ser)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 22, 2015)	criteria provided, multiple submitters, no conflicts	7	44190589	7	44150990	36218	44882
NM_000162.3(GCK):c.214G>A (p.Gly72Arg)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, multiple submitters, no conflicts	7	44192019	7	44152420	36209	44873
NM_000162.3(GCK):c.208+11G>A	GCK	Maturity onset diabetes mellitus in young|Maturity-onset diabetes of the young,  type 2|not specified	Conflicting interpretations of pathogenicity(Last reviewed: May 26, 2017)	criteria provided, conflicting interpretations	7	44192889	7	44153290	36206	44870
NM_000162.3(GCK):c.131G>A (p.Gly44Asp)	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44192977	7	44153378	36196	44860
NM_000162.3(GCK):c.76C>T (p.Gln26Ter)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	44193032	7	44153433	36256	44920
NM_000162.3(GCK):c.46-12C>T	GCK	Permanent neonatal diabetes mellitus|Maturity onset diabetes mellitus in young|Maturity-onset diabetes of the young,  type 2|not specified|not provided|Hyperinsulinism, Dominant|Transient Neonatal Diabetes, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jul 27, 2018)	criteria provided, conflicting interpretations	7	44193074	7	44153475	36222	44886
NM_172079.2(CAMK2B):c.416C>T (p.Pro139Leu)	CAMK2B	Intellectual disability|Inborn genetic diseases|MENTAL RETARDATION, AUTOSOMAL DOMINANT 54	Pathogenic/Likely pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, multiple submitters, no conflicts	7	44283125	7	44243526	430922	424467
NM_006060.6(IKZF1):c.64G>A (p.Asp22Asn)	IKZF1	Immunodeficiency, common variable, 13	Likely pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	7	50367257	7	50327661	548932	539419
NM_006060.5(IKZF1):c.584A>G (p.His195Arg)	IKZF1	Immunodeficiency, common variable, 13	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	7	50450400	7	50382702	428611	420430
NM_006060.6(IKZF1):c.814G>A (p.Ala272Thr)	IKZF1	Immunodeficiency, common variable, 13	Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	7	50459525	7	50391827	548705	539189
NM_005228.4(EGFR):c.977G>T (p.Cys326Phe)	EGFR	Cowden syndrome 1	Pathogenic(Last reviewed: Aug 24, 2016)	no assertion criteria provided	7	55223610	7	55155917	254143	248610
NM_015570.3(AUTS2):c.1603C>T (p.His535Tyr)	AUTS2	Mental retardation, autosomal dominant 26	Likely pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	7	70231234	7	70766248	584456	575490
NM_000501.3(ELN):c.131delC (p.Pro44Glnfs)	ELN	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Mar 19, 2013)	criteria provided, single submitter	7	73449742	7	74035412	163382	176776
NM_000501.3(ELN):c.171delG (p.Pro58Leufs)	ELN	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Jul 6, 2016)	criteria provided, single submitter	7	73452044	7	74037714	505162	497857
NM_000501.3(ELN):c.435delG (p.Leu146Cysfs)	ELN	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, single submitter	7	73458216	7	74043886	163383	176777
NM_000501.3(ELN):c.862dup (p.Ala288Glyfs)	ELN	Supravalvar aortic stenosis|not provided	Pathogenic(Last reviewed: Jun 25, 2014)	criteria provided, multiple submitters, no conflicts	7	73466142	7	74051812	163388	176782
NM_000501.3(ELN):c.1097-1G>A	ELN	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Nov 29, 2013)	criteria provided, single submitter	7	73469045	7	74054715	163389	176783
NM_000501.3(ELN):c.1113_1114insA (p.Ala372Serfs)	ELN	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	7	73469062	7	74054732	179271	178268
NM_001278939.1(ELN):c.1150+1G>A	ELN	Cutis laxa, autosomal dominant 1|Hypertelorism|Supravalvar aortic stenosis|not provided|Abnormality of digit|Venous malformation|Dural ectasia	Pathogenic/Likely pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	7	73469100	7	74054770	163391	176785
NM_000501.3(ELN):c.1153delG (p.Ala385Profs)	ELN	Supravalvar aortic stenosis	Likely pathogenic(Last reviewed: Sep 28, 2011)	criteria provided, single submitter	7	73470603	7	74056273	163392	176786
NM_000501.3(ELN):c.1785T>A (p.Tyr595Ter)	ELN	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Jan 7, 2015)	criteria provided, single submitter	7	73475468	7	74061138	163396	176788
NM_001540.4(HSPB1):c.407G>T (p.Arg136Leu)	HSPB1	Charcot-Marie-Tooth disease type 2F|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	7	75933161	7	76303844	217230	213813
NM_001540.4(HSPB1):c.523C>T (p.Gln175Ter)	HSPB1	Charcot-Marie-Tooth disease type 2F|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 29, 2018)	criteria provided, multiple submitters, no conflicts	7	75933395	7	76304078	217231	213814
NM_001110354.1(ZP3):c.400G>A (p.Ala134Thr)	ZP3	Empty follicle syndrome|OOCYTE MATURATION DEFECT 3	Pathogenic(Last reviewed: Oct 9, 2017)	no assertion criteria provided	7	76058919	7	76429602	437933	431554
NM_012301.3(MAGI2):c.4353G>A (p.Ser1451=)	MAGI2	not provided	Uncertain significance(Last reviewed: Jan 10, 2013)	criteria provided, single submitter	7	77648647	7	78019330	129554	135000
NM_012301.3(MAGI2):c.4329C>G (p.Pro1443=)	MAGI2	not specified	Benign(Last reviewed: Mar 1, 2018)	criteria provided, multiple submitters, no conflicts	7	77648671	7	78019354	95514	101413
NM_012301.3(MAGI2):c.4269G>C (p.Pro1423=)	MAGI2	not specified	Benign(Last reviewed: Mar 1, 2018)	criteria provided, multiple submitters, no conflicts	7	77648731	7	78019414	95513	101412
NM_012301.3(MAGI2):c.3915G>A (p.Gln1305=)	MAGI2	not specified	Benign(Last reviewed: Jan 30, 2018)	criteria provided, multiple submitters, no conflicts	7	77649085	7	78019768	95512	101411
NM_012301.3(MAGI2):c.3400C>G (p.Leu1134Val)	MAGI2	not provided	Uncertain significance(Last reviewed: Apr 24, 2013)	criteria provided, single submitter	7	77756537	7	78127220	129553	134999
NM_012301.3(MAGI2):c.3357A>G (p.Leu1119=)	MAGI2	not specified|not provided	Benign(Last reviewed: Apr 20, 2017)	criteria provided, single submitter	7	77756580	7	78127263	129565	135011
NM_012301.3(MAGI2):c.3213G>A (p.Ser1071=)	MAGI2	not specified|not provided	Benign(Last reviewed: Apr 20, 2017)	criteria provided, single submitter	7	77756724	7	78127407	129564	135010
NM_012301.3(MAGI2):c.2793C>T (p.Phe931=)	MAGI2	not specified	Likely benign(Last reviewed: Apr 19, 2013)	criteria provided, single submitter	7	77789394	7	78160077	129552	134998
NM_012301.3(MAGI2):c.2784T>C (p.Asn928=)	MAGI2	not specified|not provided	Benign(Last reviewed: Apr 20, 2017)	criteria provided, single submitter	7	77789403	7	78160086	129563	135009
NM_012301.3(MAGI2):c.2723C>A (p.Pro908His)	MAGI2	not specified	Likely benign	no assertion criteria provided	7	77789464	7	78160147	129562	135008
NM_012301.3(MAGI2):c.2379C>T (p.Leu793=)	MAGI2	not specified|not provided	Benign(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	7	77807352	7	78178035	129561	135007
NM_012301.3(MAGI2):c.2329T>C (p.Leu777=)	MAGI2	not specified|not provided	Benign(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	7	77807402	7	78178085	129560	135006
NM_012301.3(MAGI2):c.2213G>A (p.Arg738Gln)	MAGI2	not specified	Benign/Likely benign(Last reviewed: Aug 21, 2015)	criteria provided, multiple submitters, no conflicts	7	77824247	7	78194930	129559	135005
NM_012301.3(MAGI2):c.1755C>T (p.Pro585=)	MAGI2	not specified	Benign(Last reviewed: May 9, 2013)	criteria provided, multiple submitters, no conflicts	7	77885552	7	78256235	95509	101408
NM_012301.3(MAGI2):c.1713C>T (p.Ser571=)	MAGI2	not provided	Uncertain significance(Last reviewed: Jan 7, 2013)	criteria provided, single submitter	7	77885594	7	78256277	129550	134996
NM_012301.3(MAGI2):c.1014G>A (p.Lys338=)	MAGI2	not specified|not provided	Benign(Last reviewed: Apr 20, 2017)	criteria provided, single submitter	7	78119109	7	78489792	129557	135003
NM_012301.3(MAGI2):c.900A>G (p.Glu300=)	MAGI2	not specified	Likely benign(Last reviewed: May 28, 2015)	criteria provided, single submitter	7	78130959	7	78501642	129567	135013
NM_012301.3(MAGI2):c.893A>G (p.Asn298Ser)	MAGI2	not specified	Benign(Last reviewed: Mar 28, 2013)	criteria provided, single submitter	7	78130966	7	78501649	129556	135002
NM_012301.3(MAGI2):c.878C>T (p.Thr293Ile)	MAGI2	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2014)	criteria provided, conflicting interpretations	7	78130981	7	78501664	129555	135001
NM_012301.3(MAGI2):c.531T>C (p.Thr177=)	MAGI2	not specified|not provided	Benign(Last reviewed: Apr 11, 2018)	criteria provided, multiple submitters, no conflicts	7	78256443	7	78627127	129566	135012
NM_012301.3(MAGI2):c.219C>T (p.Pro73=)	MAGI2|MAGI2-AS3	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 17, 2014)	criteria provided, conflicting interpretations	7	79082418	7	79453102	129558	135004
NM_018849.2(ABCB4):c.2932T>C (p.Ser978Pro)	ABCB4	Cholecystitis	Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter			7	87409385	599183	590360
NM_018849.2(ABCB4):c.2044delG (p.Asp682Metfs)	ABCB4	Cholestasis, intrahepatic, of pregnancy 3	Pathogenic	criteria provided, single submitter			7	87426770	617459	608808
NM_005751.4(AKAP9):c.510G>C (p.Glu170Asp)	AKAP9	Brugada syndrome 1|Long QT syndrome 11|Long QT syndrome|Romano-Ward syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 12, 2017)	criteria provided, conflicting interpretations	7	91622303	7	91992989	190518	188434
NM_005751.4(AKAP9):c.2478A>G (p.Ile826Met)	AKAP9	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	7	91631709	7	92002395	427976	419277
NM_005751.4(AKAP9):c.11682G>T (p.Gln3894His)	AKAP9	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	7	91737943	7	92108629	427961	419278
NM_194456.1(KRIT1):c.146_147delGA (p.Arg49Lysfs)	KRIT1	Cerebral cavernous malformation|not provided	Likely pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	91870422 - 91870423	7	92241108 - 92241109	374400	361189
GRCh37/hg19 7q21.2-22.1(chr7:92445452-99686985)x1	ASNS|AZGP1|CALCR|CDK6|COL1A2|CYP3A7|CYP3A4|CYP3A5|DLX5|DLX6|DYNC1I1|GNG11|GNGT1|NPTX2|OCM2|PDK4|PON1|PON2|PON3|TAC1|ZNF3|ZKSCAN1|ZSCAN21|SEM1|TFPI2|TRRAP|BUD31|SGCE|ATP5MF|ARPC1B|SLC25A13|BET1|ARPC1A|CPSF4|COPS6|PDAP1|LMTK2|PEG10|ZKSCAN5|BRI3|TECPR1|PTCD1|ASB4|SAMD9|PPP1R9A|VPS50|BAIAP2L1|SDHAF3|SMURF1|CYP3A43|CASD1|ZNF655|OR2AE1|ZNF394|TRIM4|BHLHA15|SAMD9L|ZSCAN25|FAM200A|TMEM130|HEPACAM2|ZNF789|GJC3|C7orf76|KPNA7|MIR489|ATP5MF-PTCD1	Split-hand/foot malformation 1	Pathogenic(Last reviewed: Sep 28, 2015)	criteria provided, single submitter	7	92445452 - 99686985			545583	536084
NM_000089.3(COL1A2):c.838G>A (p.Gly280Ser)	COL1A2	Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I|Osteogenesis imperfecta|not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	7	94038679	7	94409367	35957	44621
NM_000089.3(COL1A2):c.875G>T (p.Gly292Val)	COL1A2	Osteogenesis imperfecta type I	Pathogenic	no assertion criteria provided	7	94038716	7	94409404	430639	424019
NM_000089.3(COL1A2):c.1991G>A (p.Gly664Asp)	COL1A2	Osteogenesis imperfecta	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	94047830	7	94418518	35939	44603
NM_000089.3(COL1A2):c.2512G>A (p.Gly838Ser)	COL1A2	Osteogenesis imperfecta, recessive perinatal lethal	Likely pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	7	94052377	7	94423065	369668	353896
NM_000089.3(COL1A2):c.2673G>A (p.Val891=)	COL1A2	Osteogenesis imperfecta, recessive perinatal lethal	Likely pathogenic	no assertion criteria provided	7	94053755	7	94424443	427739	417441
NM_000089.3(COL1A2):c.2957C>T (p.Pro986Leu)	COL1A2	Osteogenesis imperfecta with normal sclerae, dominant form|Osteogenesis imperfecta, recessive perinatal lethal|Osteogenesis imperfecta type III|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I	Conflicting interpretations of pathogenicity(Last reviewed: Aug 4, 2017)	criteria provided, conflicting interpretations	7	94055323	7	94426011	216909	213575
NM_000089.3(COL1A2):c.3034G>A (p.Gly1012Ser)	COL1A2	Osteogenesis imperfecta with normal sclerae, dominant form|Osteogenesis imperfecta, recessive perinatal lethal|Osteogenesis imperfecta type III|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I|Osteogenesis imperfecta	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2018)	criteria provided, multiple submitters, no conflicts	7	94055771	7	94426459	216908	213576
NM_000089.3(COL1A2):c.3089G>A (p.Gly1030Asp)	COL1A2	Osteogenesis imperfecta with normal sclerae, dominant form	Pathogenic	no assertion criteria provided	7	94055826	7	94426514	431081	424604
NM_000089.3(COL1A2):c.3287_3288insTCCCCCTGT (p.Pro1098_Gly1099insValProPro)	COL1A2	Osteogenesis imperfecta type III	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	7	94056958	7	94427646 - 94427647	560982	552120
NM_003919.2(SGCE):c.549_552delTCTT (p.Phe183Leufs)	SGCE|CASD1	Myoclonic dystonia	Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	7	94248180 - 94248183	7	94618868 - 94618871	488594	481462
NM_001753.4(CAV1):c.479_480delTT (p.Phe160Terfs)	CAV1	Lipodystrophy, congenital generalized, type 3|Primary pulmonary hypertension 3|Inborn genetic diseases	Pathogenic	criteria provided, single submitter	7	116199283 - 116199284	7	116559229 - 116559230	208669	205252
NM_000245.3(MET):c.71G>A (p.Gly24Glu)	MET	Renal cell carcinoma, papillary, 1|not specified|Hereditary cancer-predisposing syndrome|Lymphoedema	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	7	116339209	7	116699155	134649	138388
NM_000245.3(MET):c.2975C>T (p.Thr992Ile)	MET	Renal cell carcinoma, papillary, 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Congenital diaphragmatic hernia|Neoplasm|Carcinoma	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	7	116411990	7	116771936	41624	50063
NM_000492.3(CFTR):c.640C>G (p.Leu214Val)	CFTR	Hereditary pancreatitis	Uncertain significance(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	7	117175362	7	117535308	448901	442477
NM_001366110.1(PAX4):c.986A>C (p.His329Pro)	PAX4	Maturity onset diabetes mellitus in young|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	127251188	7	127611134	129878	135324
NM_001366110.1(PAX4):c.599G>A (p.Arg200His)	PAX4	Maturity onset diabetes mellitus in young|not specified|Monogenic diabetes	Benign/Likely benign(Last reviewed: May 19, 2017)	criteria provided, multiple submitters, no conflicts	7	127253550	7	127613496	129875	135321
NM_001366110.1(PAX4):c.543A>G (p.Gln181=)	PAX4	Maturity onset diabetes mellitus in young|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	127253829	7	127613775	129877	135323
NM_001366110.1(PAX4):c.515G>A (p.Arg172Gln)	PAX4	Maturity onset diabetes mellitus in young|not provided	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	127253857	7	127613803	129874	135320
NM_001366110.1(PAX4):c.474C>T (p.Gly158=)	PAX4	Maturity onset diabetes mellitus in young|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	127253898	7	127613844	129876	135322
NM_001366110.1(PAX4):c.421C>T (p.Arg141Trp)	PAX4	Maturity onset diabetes mellitus in young|Diabetes mellitus, ketosis-prone, susceptibility to|not specified|Monogenic diabetes	Benign/Likely benign, risk factor(Last reviewed: Sep 22, 2017)	criteria provided, multiple submitters, no conflicts	7	127254551	7	127614497	13791	28830
NM_001458.4(FLNC):c.147C>T (p.His49=)	FLNC	not specified|not provided	Benign(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	7	128470838	7	128830784	129081	134527
NM_001458.4(FLNC):c.643G>A (p.Val215Met)	FLNC	Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|not specified|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Uncertain significance(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	7	128477255	7	128837201	424399	406963
NM_001458.4(FLNC):c.720T>C (p.Ile240=)	FLNC	not specified|not provided	Benign(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	7	128477472	7	128837418	129096	134542
NM_001458.4(FLNC):c.795T>C (p.Gly265=)	FLNC	not specified|not provided	Benign(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	7	128477547	7	128837493	129099	134545
NM_001458.4(FLNC):c.1032C>T (p.Val344=)	FLNC	not specified|not provided	Benign(Last reviewed: Dec 13, 2017)	criteria provided, multiple submitters, no conflicts	7	128478103	7	128838049	129078	134524
NM_001458.4(FLNC):c.1374C>T (p.Pro458=)	FLNC	Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|not specified|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	7	128478820	7	128838766	129079	134525
NM_001458.4(FLNC):c.1458C>A (p.Pro486=)	FLNC	not specified|not provided	Benign(Last reviewed: Dec 13, 2017)	criteria provided, multiple submitters, no conflicts	7	128480123	7	128840069	129080	134526
NM_001458.4(FLNC):c.1614C>T (p.Tyr538=)	FLNC	Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|not specified|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	7	128480666	7	128840612	129082	134528
NM_001458.4(FLNC):c.2450T>C (p.Ile817Thr)	FLNC	Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|not specified|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Uncertain significance(Last reviewed: May 18, 2018)	criteria provided, multiple submitters, no conflicts	7	128482908	7	128842854	228692	229553
NM_001458.4(FLNC):c.2501C>T (p.Thr834Met)	FLNC	Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|not specified|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	7	128482959	7	128842905	129083	134529
NM_001458.4(FLNC):c.3297A>G (p.Val1099=)	FLNC	not specified|not provided	Benign(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	7	128484816	7	128844762	129084	134530
NM_001458.4(FLNC):c.3547_3548delGCinsCT (p.Ala1183Leu)	FLNC	Cardiomyopathy, familial hypertrophic, 26	Likely pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	7	128485066 - 128485067	7	128845012 - 128845013	430733	424271
NM_001458.4(FLNC):c.3557C>T (p.Ala1186Val)	FLNC	Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	7	128485076	7	128845022	427928	419002
NM_001458.4(FLNC):c.3624G>A (p.Ala1208=)	FLNC	Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|not specified|not provided|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Aug 9, 2018)	criteria provided, multiple submitters, no conflicts	7	128485143	7	128845089	129085	134531
NM_001458.4(FLNC):c.3757G>A (p.Val1253Ile)	FLNC	Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|not specified|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	7	128485276	7	128845222	129086	134532
NM_001458.4(FLNC):c.3838C>T (p.Leu1280=)	FLNC	Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|not specified|not provided|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Nov 30, 2017)	criteria provided, multiple submitters, no conflicts	7	128486091	7	128846037	129087	134533
NM_001458.4(FLNC):c.3973C>T (p.Leu1325=)	FLNC	not specified|not provided	Benign(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	7	128486363	7	128846309	129088	134534
NM_001458.4(FLNC):c.4056C>T (p.Arg1352=)	FLNC	not specified|not provided	Benign(Last reviewed: Dec 13, 2017)	criteria provided, multiple submitters, no conflicts	7	128486446	7	128846392	129089	134535
NM_001458.4(FLNC):c.4431G>A (p.Leu1477=)	FLNC	not specified|not provided	Benign(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	7	128487893	7	128847839	129090	134536
NM_001458.4(FLNC):c.4700G>A (p.Arg1567Gln)	FLNC	not specified|not provided	Benign(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	7	128488734	7	128848680	129091	134537
NM_001458.4(FLNC):c.5377G>A (p.Val1793Met)	FLNC|FLNC-AS1	not provided	Uncertain significance(Last reviewed: Nov 5, 2013)	criteria provided, single submitter	7	128490516	7	128850462	129092	134538
NM_001458.4(FLNC):c.5592C>T (p.Ala1864=)	FLNC|FLNC-AS1	Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|not specified|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	7	128491338	7	128851284	129093	134539
NM_001458.4(FLNC):c.5763T>C (p.Thr1921=)	FLNC|FLNC-AS1	not specified|not provided	Benign(Last reviewed: Dec 13, 2017)	criteria provided, multiple submitters, no conflicts	7	128491603	7	128851549	129094	134540
NM_001458.4(FLNC):c.6771A>G (p.Pro2257=)	FLNC|FLNC-AS1	Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|not specified|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	7	128494510	7	128854456	129095	134541
NM_001458.4(FLNC):c.6892C>T (p.Pro2298Ser)	FLNC|FLNC-AS1	Cardiomyopathy, restrictive	Likely pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	7	128494631	7	128854577	544829	535269
NM_001127487.1(FLNC):c.6988G>A (p.Asp2330Asn)	FLNC|FLNC-AS1	Cardiomyopathy, familial hypertrophic, 26	Uncertain significance(Last reviewed: Sep 10, 2017)	no assertion criteria provided	7	128494918	7	128854864	438581	432202
NM_001458.4(FLNC):c.7221C>T (p.Asp2407=)	FLNC|FLNC-AS1	not specified|not provided	Benign(Last reviewed: Dec 13, 2017)	criteria provided, multiple submitters, no conflicts	7	128495338	7	128855284	129097	134543
NM_001458.4(FLNC):c.7562-15_7637delinsGAGG	FLNC|FLNC-AS1	Patent foramen ovale|Episodic vomiting|Facial asymmetry|Asymmetry of the thorax|Abnormal ventricular septum morphology|Two-raphe bicuspid aortic valve|Abnormal morphology of left ventricular trabeculae	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	7	128497157 - 128497247	7	128857103 - 128857193	599235	590460
NM_001458.4(FLNC):c.7780+10A>G	FLNC|FLNC-AS1	Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|not specified|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	7	128497400	7	128857346	129098	134544
NM_001458.4(FLNC):c.8118C>T (p.Leu2706=)	FLNC|FLNC-AS1	Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|not specified|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	7	128498517	7	128858463	129100	134546
NM_001458.4(FLNC):c.8121T>C (p.Ile2707=)	FLNC|FLNC-AS1	Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|not specified|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	7	128498520	7	128858466	129101	134547
NM_001006630.1(CHRM2):c.1189A>G (p.Ile397Val)	CHRM2|LOC349160	Cardiomyopathy	Uncertain significance	criteria provided, single submitter	7	136700801	7	137016054	219175	217192
NM_004333.4(BRAF):c.2135C>A (p.Ala712Asp)	BRAF	Rasopathy	Likely pathogenic(Last reviewed: Mar 16, 2015)	criteria provided, single submitter	7	140434563	7	140734763	162795	174175
NM_004333.4(BRAF):c.2128-5_2128delTGTAGA	BRAF	Familial hypertrophic cardiomyopathy 4	Pathogenic(Last reviewed: Feb 10, 2016)	criteria provided, single submitter	7	140434570 - 140434575	7	140734770 - 140734775	430737	424284
NM_004333.4(BRAF):c.1914T>A (p.Asp638Glu)	BRAF	Cardiofaciocutaneous syndrome 1|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, multiple submitters, no conflicts	7	140449165	7	140749365	13981	29020
NM_004333.4(BRAF):c.1802A>C (p.Lys601Thr)	BRAF	Chronic lymphocytic leukemia|Malignant melanoma of skin|Lung adenocarcinoma|Rasopathy|Neoplasm of the thyroid gland|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	140453133	7	140753333	44818	53985
NM_004333.4(BRAF):c.1801A>C (p.Lys601Gln)	BRAF	not provided|Rasopathy	Pathogenic(Last reviewed: Apr 12, 2016)	criteria provided, multiple submitters, no conflicts	7	140453134	7	140753334	41446	49884
NM_004333.4(BRAF):c.1787G>T (p.Gly596Val)	BRAF	Multiple myeloma|Lung adenocarcinoma|not provided|Rasopathy|Glioblastoma|Transitional cell carcinoma of the bladder|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	7	140453148	7	140753348	40387	48857
NM_004333.4(BRAF):c.1785T>G (p.Phe595Leu)	BRAF	not provided|Rasopathy|Cutaneous melanoma|Neoplasm|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	7	140453150	7	140753350	177672	174042
NM_004333.4(BRAF):c.1741A>G (p.Asn581Asp)	BRAF	Cardiofaciocutaneous syndrome 1|not provided|Rasopathy|Inborn genetic diseases|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	7	140453987	7	140754187	13979	29018
NM_004333.4(BRAF):c.1720C>T (p.His574Tyr)	BRAF	Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 2, 2013)	criteria provided, single submitter	7	140454008	7	140754208	44810	53977
NM_004333.4(BRAF):c.1695T>G (p.Asp565Glu)	BRAF	not provided|Cardio-facio-cutaneous syndrome	Likely pathogenic(Last reviewed: Jul 22, 2015)	criteria provided, multiple submitters, no conflicts	7	140454033	7	140754233	40383	48853
NM_004333.4(BRAF):c.1600G>C (p.Gly534Arg)	BRAF	Cardiofaciocutaneous syndrome 1|Inborn genetic diseases|Cardio-facio-cutaneous syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, multiple submitters, no conflicts	7	140476806	7	140777006	13980	29019
NM_004333.4(BRAF):c.1593G>C (p.Trp531Cys)	BRAF	Noonan syndrome 1|Noonan syndrome 7|Rasopathy	Pathogenic(Last reviewed: Apr 4, 2014)	criteria provided, single submitter	7	140476813	7	140777013	29808	38763
NM_004333.4(BRAF):c.1592G>T (p.Trp531Leu)	BRAF	Cardiofaciocutaneous syndrome 1	Likely pathogenic(Last reviewed: Aug 6, 2017)	criteria provided, single submitter	7	140476814	7	140777014	40379	48849
NM_004333.4(BRAF):c.1501G>A (p.Glu501Lys)	BRAF	Cardiofaciocutaneous syndrome 1|Noonan syndrome 7|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2015)	criteria provided, multiple submitters, no conflicts	7	140477807	7	140778007	13977	29016
NM_004333.4(BRAF):c.1454T>C (p.Leu485Ser)	BRAF	not provided|Cardio-facio-cutaneous syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	7	140477854	7	140778054	40370	48840
NM_004333.4(BRAF):c.1447A>C (p.Lys483Gln)	BRAF	Cardio-facio-cutaneous syndrome	Likely pathogenic(Last reviewed: Apr 2, 2014)	criteria provided, single submitter	7	140477861	7	140778061	40369	48839
NM_004333.5(BRAF):c.1406G>A (p.Gly469Glu)	BRAF	Cardiofaciocutaneous syndrome 1|Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Squamous cell lung carcinoma|not specified|not provided|Rasopathy|Cutaneous melanoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Cardio-facio-cutaneous syndrome|Colorectal Neoplasms|Adenocarcinoma of prostate	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	7	140481402	7	140781602	13974	29013
NM_004333.4(BRAF):c.1237G>A (p.Val413Met)	BRAF	not specified	Uncertain significance(Last reviewed: Oct 20, 2011)	criteria provided, single submitter	7	140482898	7	140783098	44799	53966
NM_004333.4(BRAF):c.793G>C (p.Gly265Arg)	BRAF	Noonan syndrome|Rasopathy	Likely pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, multiple submitters, no conflicts	7	140501279	7	140801479	44832	53999
NM_004333.4(BRAF):c.785A>C (p.Gln262Pro)	BRAF	not provided|Cardio-facio-cutaneous syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, multiple submitters, no conflicts	7	140501287	7	140801487	44831	53998
NM_004333.4(BRAF):c.770A>G (p.Gln257Arg)	BRAF	Cardiofaciocutaneous syndrome 1|not specified|not provided|Rasopathy|Inborn genetic diseases|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	7	140501302	7	140801502	13973	29012
NM_004333.4(BRAF):c.736G>C (p.Ala246Pro)	BRAF	Cardiofaciocutaneous syndrome 1|Noonan syndrome|not provided|Rasopathy|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	7	140501336	7	140801536	13965	29004
NM_004333.4(BRAF):c.735A>T (p.Leu245Phe)	BRAF	Noonan syndrome with multiple lentigines|not provided|Rasopathy|Cardio-facio-cutaneous syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 28, 2018)	criteria provided, conflicting interpretations	7	140501337	7	140801537	40348	48818
NM_004333.4(BRAF):c.730A>C (p.Thr244Pro)	BRAF	not provided|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	7	140501342	7	140801542	40346	48816
NM_004333.4(BRAF):c.722C>A (p.Thr241Lys)	BRAF	Noonan syndrome	Pathogenic(Last reviewed: Jun 7, 2013)	criteria provided, single submitter	7	140501350	7	140801550	44829	53996
NM_002769.4(PRSS1):c.-30_-28delTCC	PRSS1|TRB	Hereditary pancreatitis	Uncertain significance(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	142457306 - 142457308	7	142749455 - 142749457	36703	45364
NM_002769.4(PRSS1):c.86A>T (p.Asn29Ile)	PRSS1|TRB	Hereditary pancreatitis|not provided	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	7	142458451	7	142750600	11877	26916
NM_002769.4(PRSS1):c.365G>A (p.Arg122His)	PRSS1|TRB	Hereditary pancreatitis|not provided	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	7	142459789	7	142751938	11876	26915
NM_004456.4(EZH2):c.2236A>G (p.Arg746Gly)	EZH2	Weaver syndrome	Likely pathogenic(Last reviewed: May 16, 2013)	criteria provided, single submitter	7	148504758	7	148807666	158584	168571
NM_004456.4(EZH2):c.2213C>A (p.Ala738Asp)	EZH2	Weaver syndrome	Likely pathogenic(Last reviewed: Jul 18, 2017)	no assertion criteria provided	7	148504781	7	148807689	430846	424390
NM_004456.4(EZH2):c.2110+6T>C	EZH2	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	7	148506396	7	148809304	158583	168572
NM_004456.4(EZH2):c.2110+6T>G	EZH2	Weaver syndrome|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	148506396	7	148809304	137273	140976
NM_004456.4(EZH2):c.2050C>T (p.Arg684Cys)	EZH2	Weaver syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	7	148506462	7	148809370	158582	168573
NM_004456.4(EZH2):c.2028T>C (p.Asn676=)	EZH2	Weaver syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Nov 20, 2017)	criteria provided, multiple submitters, no conflicts	7	148507426	7	148810334	158581	168574
NM_004456.4(EZH2):c.1884C>G (p.Gly628=)	EZH2	Weaver syndrome	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	7	148508780	7	148811688	158580	168575
NM_004456.4(EZH2):c.1876G>A (p.Val626Met)	EZH2	Weaver syndrome	Pathogenic(Last reviewed: Apr 9, 2014)	criteria provided, single submitter	7	148508788	7	148811696	158579	168576
NM_004456.4(EZH2):c.1731G>A (p.Pro577=)	EZH2	Weaver syndrome|not specified	Benign/Likely benign(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	7	148511171	7	148814079	158577	168578
NM_004456.4(EZH2):c.1017T>C (p.Phe339=)	EZH2	Weaver syndrome|not specified	Benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	7	148515192	7	148818100	158576	168579
NM_004456.4(EZH2):c.553G>C (p.Asp185His)	EZH2	Weaver syndrome|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	148525904	7	148828812	134224	137963
NM_000238.3(KCNH2):c.3224C>T (p.Pro1075Leu)	KCNH2	Long QT syndrome|Congenital long QT syndrome	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	7	150644071	7	150946983	67481	78377
NM_000238.3(KCNH2):c.3203A>G (p.Gln1068Arg)	KCNH2	Long QT syndrome|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	7	150644092	7	150947004	67480	78376
NM_000238.3(KCNH2):c.3140G>T (p.Arg1047Leu)	KCNH2	Cardiac arrhythmia|Long QT syndrome 2|Long QT syndrome|not specified|not provided|Torsades de pointes|Cardiovascular phenotype|Sudden unexplained death	Conflicting interpretations of pathogenicity(Last reviewed: Jan 22, 2018)	criteria provided, conflicting interpretations	7	150644428	7	150947340	36429	45092
NM_000238.3(KCNH2):c.3139C>T (p.Arg1047Cys)	KCNH2	Long QT syndrome|not specified	Uncertain significance(Last reviewed: Jan 9, 2018)	criteria provided, multiple submitters, no conflicts	7	150644429	7	150947341	161255	171106
NM_000238.3(KCNH2):c.3124C>G (p.Leu1042Val)	KCNH2	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	7	150644444	7	150947356	427971	419273
NM_000238.3(KCNH2):c.2948C>T (p.Thr983Ile)	KCNH2	Long QT syndrome|not specified|not provided|Congenital long QT syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 7, 2018)	criteria provided, conflicting interpretations	7	150644711	7	150947623	67455	78351
NM_000238.3(KCNH2):c.2843G>A (p.Arg948His)	KCNH2	Long QT syndrome 2|not provided|Congenital long QT syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, multiple submitters, no conflicts	7	150644816	7	150947728	67443	78339
NM_000238.3(KCNH2):c.2660G>A (p.Arg887His)	KCNH2	Long QT syndrome 2|Long QT syndrome|not provided|Congenital long QT syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 9, 2018)	criteria provided, conflicting interpretations	7	150645564	7	150948476	67423	78319
NM_000238.3(KCNH2):c.2653C>T (p.Arg885Cys)	KCNH2	Long QT syndrome|Congenital long QT syndrome	Uncertain significance(Last reviewed: Feb 10, 2018)	criteria provided, single submitter	7	150645571	7	150948483	67422	78318
NM_000238.3(KCNH2):c.2606C>T (p.Pro869Leu)	KCNH2	Brugada syndrome 1|not specified	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, multiple submitters, no conflicts	7	150645618	7	150948530	200473	197194
NM_000238.3(KCNH2):c.2536C>G (p.Pro846Ala)	KCNH2	Long QT syndrome 2	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	7	150646000	7	150948912	161254	171107
NM_000238.3(KCNH2):c.2371C>T (p.Arg791Trp)	KCNH2	Long QT syndrome|not specified|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 6, 2017)	criteria provided, conflicting interpretations	7	150647283	7	150950195	67391	78287
NM_000238.3(KCNH2):c.2255G>A (p.Arg752Gln)	KCNH2	Long QT syndrome 2|Long QT syndrome|Congenital long QT syndrome	Likely pathogenic(Last reviewed: Apr 12, 2015)	criteria provided, single submitter	7	150647399	7	150950311	14435	29474
NM_000238.3(KCNH2):c.2254C>T (p.Arg752Trp)	KCNH2	Long QT syndrome|Romano-Ward syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, multiple submitters, no conflicts	7	150647400	7	150950312	67379	78275
NM_000238.3(KCNH2):c.2131A>G (p.Ile711Val)	KCNH2	Long QT syndrome|not provided|Congenital long QT syndrome	Pathogenic(Last reviewed: Nov 26, 2013)	criteria provided, single submitter	7	150648023	7	150950935	67367	78263
NM_000238.3(KCNH2):c.2038del (p.Val680Cysfs)	KCNH2	Long QT syndrome 2	Pathogenic(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	7	150648116	7	150951028	427944	419274
NM_000238.3(KCNH2):c.1952T>G (p.Met651Arg)	KCNH2	Long QT syndrome 2	Likely pathogenic(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	7	150648202	7	150951114	427945	419275
NM_000238.3(KCNH2):c.1786C>G (p.Pro596Ala)	KCNH2	Long QT syndrome 2	Pathogenic(Last reviewed: Nov 4, 2015)	criteria provided, single submitter	7	150648695	7	150951607	218093	214747
NM_000238.3(KCNH2):c.1750G>A (p.Gly584Ser)	KCNH2	Short QT syndrome 1|Long QT syndrome 2|Long QT syndrome|Romano-Ward syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, multiple submitters, no conflicts	7	150648731	7	150951643	67261	78157
NM_000238.3(KCNH2):c.1603G>A (p.Val535Met)	KCNH2	Long QT syndrome 2|Long QT syndrome|Cardiovascular phenotype	Uncertain significance(Last reviewed: Oct 4, 2016)	criteria provided, multiple submitters, no conflicts	7	150648878	7	150951790	161256	171108
NM_000238.3(KCNH2):c.1280A>G (p.Tyr427Cys)	KCNH2	Long QT syndrome 1|Congenital long QT syndrome	Likely pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	7	150649790	7	150952702	67179	78075
NM_000238.3(KCNH2):c.1039C>T (p.Pro347Ser)	KCNH2	Long QT syndrome 2|Long QT syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 17, 2018)	criteria provided, conflicting interpretations	7	150654468	7	150957380	67163	78059
NM_000238.3(KCNH2):c.982C>T (p.Arg328Cys)	KCNH2	Long QT syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2017)	criteria provided, conflicting interpretations	7	150654525	7	150957437	67552	78448
NM_000238.3(KCNH2):c.778G>C (p.Ala260Pro)	KCNH2	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	7	150655285	7	150958197	427970	419276
NM_000238.3(KCNH2):c.560_568delGCGCGGGCG (p.Gly187_Gly189del)	KCNH2	Long QT syndrome 1|Long QT syndrome 2|Long QT syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2018)	criteria provided, conflicting interpretations	7	150655495 - 150655503	7	150958407 - 150958415	200600	197324
NM_000238.3(KCNH2):c.442C>T (p.Arg148Trp)	KCNH2	Long QT syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 22, 2017)	criteria provided, conflicting interpretations	7	150656690	7	150959602	67505	78401
NM_000238.3(KCNH2):c.422C>T (p.Pro141Leu)	KCNH2	Long QT syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 29, 2017)	criteria provided, conflicting interpretations	7	150656710	7	150959622	67504	78400
NM_000238.3(KCNH2):c.343G>A (p.Val115Met)	KCNH2	Long QT syndrome 2|Long QT syndrome|Congenital long QT syndrome	Uncertain significance(Last reviewed: Aug 24, 2016)	criteria provided, single submitter	7	150656789	7	150959701	67496	78392
NM_000238.3(KCNH2):c.197G>A (p.Cys66Tyr)	KCNH2	Long QT syndrome 2	Likely pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	7	150671909	7	150974821	545688	536180
NM_016203.3(PRKAG2):c.1592G>A (p.Arg531Gln)	PRKAG2	Glycogen storage disease of heart, lethal congenital|Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, multiple submitters, no conflicts	7	151257696	7	151560610	6852	21891
NM_016203.3(PRKAG2):c.1454A>C (p.Lys485Thr)	PRKAG2	Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: May 16, 2017)	criteria provided, single submitter	7	151261294	7	151564208	438860	432490
NM_016203.3(PRKAG2):c.1199C>A (p.Thr400Asn)	PRKAG2	Familial hypertrophic cardiomyopathy 6|Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, single submitter	7	151265836	7	151568750	6849	21888
NM_016203.3(PRKAG2):c.905G>A (p.Arg302Gln)	PRKAG2	Glycogen storage disease of heart, lethal congenital|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	7	151273498	7	151576412	6846	21885
NM_016203.3(PRKAG2):c.879C>A (p.Phe293Leu)	PRKAG2	Familial hypertrophic cardiomyopathy 6|Cardiomyopathy	Likely pathogenic(Last reviewed: Feb 9, 2017)	criteria provided, multiple submitters, no conflicts	7	151273524	7	151576438	36698	45359
NM_016203.3(PRKAG2):c.298G>A (p.Gly100Ser)	PRKAG2	Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|not specified|Wolff-Parkinson-White syndrome|PRKAG2 cardiac syndrome|Cardiovascular phenotype|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 6, 2018)	criteria provided, conflicting interpretations	7	151478406	7	151781320	36697	45358
NM_170606.2(KMT2C):c.3917A>G (p.Asp1306Gly)	KMT2C	Intellectual disability	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	7	151902235	7	152205150	561044	552114
NM_170606.2(KMT2C):c.560C>G (p.Ser187Ter)	KMT2C	Intellectual disability	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	7	152012253	7	152315168	561045	552115
NM_005431.1(XRCC2):c.641G>A (p.Arg214Gln)	XRCC2	not provided|Colorectal cancer	Uncertain significance(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	7	152345929	7	152648844	127961	133418
NM_005431.1(XRCC2):c.620A>G (p.Glu207Gly)	XRCC2	not specified|Hereditary cancer-predisposing syndrome|Colon cancer|Hereditary Cancer Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	7	152345950	7	152648865	127960	133417
NM_000193.3(SHH):c.1307C>A (p.Ser436Ter)	SHH	Holoprosencephaly 3	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	7	155595676	7	155802982	545579	536077
NM_000193.3(SHH):c.1284delC (p.Thr429Profs)	SHH	Holoprosencephaly 3	Pathogenic(Last reviewed: May 15, 2014)	no assertion criteria provided	7	155595699	7	155803005	374270	361187
NM_000193.3(SHH):c.1171G>A (p.Ala391Thr)	SHH	Holoprosencephaly 3	Uncertain significance(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	7	155595812	7	155803118	430943	424484
NM_000193.3(SHH):c.796C>T (p.Leu266Phe)	SHH	Holoprosencephaly 3	Likely pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	7	155596187	7	155803493	545580	536079
NM_000193.3(SHH):c.629G>A (p.Gly210Asp)	SHH	Single median maxillary incisor	Uncertain significance(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	7	155596354	7	155803660	545581	536080
NM_000193.3(SHH):c.468C>A (p.Ser156Arg)	SHH	Holoprosencephaly sequence	Uncertain significance(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	7	155599084	7	155806390	545462	535722
GRCh37/hg19 7q36.3(chr7:156460343-156682575)x3	LMBR1|RNF32	Syndactyly, type IV	Pathogenic(Last reviewed: Oct 22, 2017)	no assertion criteria provided	7	156460343 - 156682575			585197	576248
NM_000535.6(PMS2):c.(?_989)-5_(2445_?)+5del	PMS2	Lynch syndrome	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	7	6017214 - 6029591	7	5977583 - 5989960	517372	496586
NM_000501.2(ELN):c.(?_-60)_(*57_?)del	ELN	Supravalvar aortic stenosis	Pathogenic(Last reviewed: Jul 6, 2016)	criteria provided, single submitter	7	73442458 - 73483087			505198	496484
NM_004403.2(GSDME):c.(?_863)-60_(1257_?)+61del	GSDME	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	7	24742318 - 24747933	7	24702699 - 24708314	228250	229531
NM_001715.2(BLK):c.102C>T (p.Asp34=)	BLK	Maturity onset diabetes mellitus in young|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	8	11400835	8	11543326	128525	133974
NM_001715.2(BLK):c.139C>G (p.Leu47Val)	BLK	not provided	Uncertain significance(Last reviewed: Sep 5, 2013)	criteria provided, single submitter	8	11403576	8	11546067	128524	133973
NM_001715.2(BLK):c.211G>A (p.Ala71Thr)	BLK	Maturity onset diabetes mellitus in young|Maturity-onset diabetes of the young, type 11|not specified|Monogenic diabetes	Conflicting interpretations of pathogenicity(Last reviewed: Apr 21, 2017)	criteria provided, conflicting interpretations	8	11405576	8	11548067	12319	27358
NM_001715.2(BLK):c.258G>A (p.Gln86=)	BLK	Maturity onset diabetes mellitus in young|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	8	11405623	8	11548114	128526	133975
NM_001715.2(BLK):c.330T>C (p.Ser110=)	BLK	Maturity onset diabetes mellitus in young|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	8	11406593	8	11549084	128527	133976
NM_001715.2(BLK):c.435C>T (p.Ala145=)	BLK	Maturity onset diabetes mellitus in young|not specified	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	8	11407734	8	11550225	128528	133977
NM_001715.2(BLK):c.843T>C (p.Phe281=)	BLK	Maturity onset diabetes mellitus in young|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	8	11414237	8	11556728	128529	133978
NM_000237.3(LPL):c.904T>C (p.Cys302Arg)	LPL	Hyperapobetalipoproteinemia	Likely pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	8	19813480	8	19955969	424622	411513
NM_000742.3(CHRNA2):c.1324C>T (p.Leu442=)	CHRNA2	Autosomal dominant nocturnal frontal lobe epilepsy|not specified|Seizures|Nocturnal frontal lobe epilepsy	Benign(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	8	27320636	8	27463119	128737	134186
NM_000742.3(CHRNA2):c.1234G>A (p.Glu412Lys)	CHRNA2	not specified|not provided|Nocturnal frontal lobe epilepsy	Conflicting interpretations of pathogenicity(Last reviewed: May 26, 2017)	criteria provided, conflicting interpretations	8	27320726	8	27463209	128736	134185
NM_000742.3(CHRNA2):c.913C>T (p.Leu305=)	CHRNA2	Autosomal dominant nocturnal frontal lobe epilepsy|not specified|Seizures|Nocturnal frontal lobe epilepsy	Benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	8	27321047	8	27463530	128742	134191
NM_000742.3(CHRNA2):c.771C>T (p.Tyr257=)	CHRNA2	Autosomal dominant nocturnal frontal lobe epilepsy|not specified|Seizures|Nocturnal frontal lobe epilepsy	Benign/Likely benign(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	8	27321189	8	27463672	128741	134190
NM_000742.3(CHRNA2):c.373A>G (p.Thr125Ala)	CHRNA2	not specified|Seizures|Nocturnal frontal lobe epilepsy	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	8	27324822	8	27467305	128739	134188
NM_000742.3(CHRNA2):c.351C>T (p.Asp117=)	CHRNA2	not specified|Seizures|Nocturnal frontal lobe epilepsy	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	8	27324844	8	27467327	128738	134187
NM_000742.3(CHRNA2):c.65C>T (p.Thr22Ile)	CHRNA2	not specified|Seizures|Nocturnal frontal lobe epilepsy	Benign(Last reviewed: Jul 7, 2016)	criteria provided, multiple submitters, no conflicts	8	27328511	8	27470994	128740	134189
NM_001831.3(CLU):c.608C>T (p.Thr203Ile)	CLU	Alzheimer's disease	Likely benign	no assertion criteria provided	8	27462662	8	27605145	428612	420431
NM_023110.2(FGFR1):c.2206T>C (p.Cys736Arg)	FGFR1	Kallmann syndrome 2	Uncertain significance(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	8	38271522	8	38414004	478915	472259
NM_023110.2(FGFR1):c.2084C>T (p.Thr695Ile)	FGFR1	Kallmann syndrome 2	Pathogenic(Last reviewed: Oct 24, 2013)	no assertion criteria provided	8	38271772	8	38414254	132648	136396
NM_023110.2(FGFR1):c.1921G>A (p.Asp641Asn)	FGFR1	Hartsfield syndrome	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	8	38272353	8	38414835	517666	508757
NM_023110.2(FGFR1):c.1880G>C (p.Arg627Thr)	FGFR1	Hartsfield syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 9, 2018)	criteria provided, conflicting interpretations	8	38272394	8	38414876	223245	224976
NM_023110.2(FGFR1):c.1869C>G (p.Asp623Glu)	FGFR1	Hartsfield syndrome	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	8	38272405	8	38414887	522553	513166
NM_023110.2(FGFR1):c.1604_1606delTGA (p.Met535del)	FGFR1	Hartsfield syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, multiple submitters, no conflicts	8	38274881 - 38274883	8	38417363 - 38417365	449023	444275
NM_023110.2(FGFR1):c.1604T>A (p.Met535Lys)	FGFR1	Hartsfield syndrome	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	8	38274883	8	38417365	496784	488207
NM_023110.2(FGFR1):c.1460G>A (p.Gly487Asp)	FGFR1	Kallmann syndrome 2|Hartsfield syndrome	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	8	38275480	8	38417962	132647	136395
NM_023110.2(FGFR1):c.880G>A (p.Glu294Lys)	FGFR1	Holoprosencephaly sequence	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	8	38282083	8	38424565	517665	508756
NM_023110.2(FGFR1):c.790A>C (p.Asn264His)	FGFR1	Kallmann syndrome 2	Pathogenic(Last reviewed: Oct 24, 2013)	no assertion criteria provided	8	38282173	8	38424655	132646	136394
NM_023110.2(FGFR1):c.454G>A (p.Ala152Thr)	FGFR1	Hartsfield syndrome	Benign(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	8	38285606	8	38428088	522557	513170
NM_023110.2(FGFR1):c.443G>A (p.Arg148His)	FGFR1	Kallmann syndrome 2|not provided	Uncertain significance(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	8	38285869	8	38428351	132645	136393
NM_023110.2(FGFR1):c.304G>A (p.Val102Ile)	FGFR1	Kallmann syndrome 2|Pfeiffer syndrome|Hartsfield syndrome	Benign(Last reviewed: Feb 26, 2018)	criteria provided, multiple submitters, no conflicts	8	38287254	8	38429736	522603	513216
NM_006766.4(KAT6A):c.4254_4257delTGAG (p.Glu1419Trpfs)	KAT6A	Mental retardation, autosomal dominant 32	Pathogenic(Last reviewed: Nov 30, 2015)	criteria provided, single submitter	8	41791481 - 41791484	8	41933963 - 41933966	369686	353897
NM_006766.5(KAT6A):c.4038del (p.Val1347Phefs)	KAT6A	Mental retardation, autosomal dominant 32	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter			8	41934182	617516	608878
NM_006766.4(KAT6A):c.3505C>T (p.Arg1169Ter)	KAT6A	not provided|Mental retardation, autosomal dominant 32	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	8	41792233	8	41934715	280873	264380
NM_006749.4(SLC20A2):c.1723G>T (p.Glu575Ter)	SLC20A2	Idiopathic basal ganglia calcification 1|Basal ganglia calcification, idiopathic, 3	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	8	42286347	8	42428829	522850	513426
NM_006749.4(SLC20A2):c.1375G>T (p.Glu459Ter)	SLC20A2	Idiopathic basal ganglia calcification 1|Basal ganglia calcification, idiopathic, 3	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	8	42294655	8	42437137	584447	575491
NM_006749.4(SLC20A2):c.136C>T (p.Gln46Ter)	SLC20A2	Idiopathic basal ganglia calcification 1|Basal ganglia calcification, idiopathic, 3	Pathogenic(Last reviewed: Jul 15, 2016)	criteria provided, single submitter	8	42329773	8	42472255	522849	513427
NM_001160223.1(RNF170):c.640A>G (p.Ile214Val)	RNF170	Ataxia, sensory, autosomal dominant	Likely pathogenic(Last reviewed: Mar 6, 2014)	criteria provided, single submitter	8	42711439	8	42856296	130158	135605
NM_006269.1(RP1):c.1267_1656del390insA (p.Ala423Asnfs)	RP1	Leber congenital amaurosis 1	Uncertain significance(Last reviewed: Nov 30, 2017)	criteria provided, single submitter	8	55537709 - 55538098	8	54625149 - 54625538	547180	537667
NM_002655.2(PLAG1):c.1363delC (p.Gln455Serfs)	PLAG1	Russell-Silver syndrome	Pathogenic	no assertion criteria provided	8	57078942	8	56166383	253033	247440
NM_002655.2(PLAG1):c.439delA (p.Ser147Valfs)	PLAG1	Russell-Silver syndrome	Pathogenic	no assertion criteria provided	8	57079866	8	56167307	253204	247619
NM_017780.3(CHD7):c.191_194delCAAA (p.Thr64Serfs)	CHD7	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61654182 - 61654185	8	60741623 - 60741626	158281	168589
NM_017780.3(CHD7):c.216T>C (p.Tyr72=)	CHD7	CHARGE association|Hypogonadism with anosmia|not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2017)	criteria provided, conflicting interpretations	8	61654207	8	60741648	95778	101675
NM_017780.3(CHD7):c.282delT (p.Asn96Thrfs)	CHD7	CHARGE association	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	8	61654272 - 61654273	8	60741714	560976	552125
NM_017780.3(CHD7):c.307T>A (p.Ser103Thr)	CHD7	CHARGE association|Hypogonadism with anosmia|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Oct 16, 2017)	criteria provided, multiple submitters, no conflicts	8	61654298	8	60741739	95782	101679
NM_017780.3(CHD7):c.350G>A (p.Gly117Asp)	CHD7	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61654341	8	60741782	158291	168590
NM_017780.3(CHD7):c.361G>A (p.Gly121Ser)	CHD7	CHARGE association	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61654352	8	60741793	158293	168591
NM_017780.3(CHD7):c.657C>T (p.Gly219=)	CHD7	CHARGE association|Hypogonadism with anosmia|not specified|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Nov 19, 2017)	criteria provided, conflicting interpretations	8	61654648	8	60742089	95805	101702
NM_017780.3(CHD7):c.856A>G (p.Arg286Gly)	CHD7	CHARGE association|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	8	61654847	8	60742288	158328	168592
NM_017780.3(CHD7):c.1246G>T (p.Gly416Ter)	CHD7	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61655237	8	60742678	158278	168593
NM_017780.3(CHD7):c.1480C>T (p.Arg494Ter)	CHD7	CHARGE association|not provided	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	8	61655471	8	60742912	158279	168594
NM_017780.3(CHD7):c.1512A>G (p.Gln504=)	CHD7	CHARGE association	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61655503	8	60742944	158280	168595
NM_017780.3(CHD7):c.1552C>T (p.Gln518Ter)	CHD7	CHARGE association	Pathogenic	no assertion criteria provided	8	61655543	8	60742984	375575	362385
NM_017780.3(CHD7):c.1665+34G>A	CHD7	not specified	Benign(Last reviewed: Dec 14, 2016)	criteria provided, multiple submitters, no conflicts	8	61655690	8	60743131	158324	168596
NM_017780.3(CHD7):c.2096G>A (p.Ser699Asn)	CHD7	CHARGE association	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	8	61693989	8	60781430	560975	552126
NM_017780.3(CHD7):c.2124T>C (p.Ser708=)	CHD7	CHARGE association|Hypogonadism with anosmia|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	8	61707572	8	60795013	95777	101674
NM_017780.3(CHD7):c.2230G>A (p.Gly744Ser)	CHD7	CHARGE association|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	8	61707678	8	60795119	158282	168597
NM_017780.3(CHD7):c.2238+39G>A	CHD7	not specified	Benign(Last reviewed: Dec 14, 2016)	criteria provided, multiple submitters, no conflicts	8	61707725	8	60795166	158325	168598
NM_017780.3(CHD7):c.2613+1G>A	CHD7	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61729061	8	60816502	158283	168599
NM_017780.3(CHD7):c.2614-45A>G	CHD7	not specified	Benign	criteria provided, single submitter	8	61732521	8	60819962	158326	168600
NM_017780.3(CHD7):c.2643T>G (p.Tyr881Ter)	CHD7	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61732595	8	60820036	158284	168601
NM_017780.3(CHD7):c.2815G>T (p.Glu939Ter)	CHD7	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61734466	8	60821907	158285	168602
NM_017780.3(CHD7):c.2830C>A (p.Arg944Ser)	CHD7	CHARGE association	Uncertain significance(Last reviewed: May 3, 2013)	criteria provided, single submitter	8	61734481	8	60821922	158286	168603
NM_017780.3(CHD7):c.2858G>A (p.Trp953Ter)	CHD7	CHARGE association	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	8	61734605	8	60822046	488479	481347
NM_017780.3(CHD7):c.2905_2906delAG (p.Arg969Glyfs)	CHD7	CHARGE association|not provided	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, multiple submitters, no conflicts	8	61734652 - 61734653	8	60822093 - 60822094	158287	168604
NM_017780.3(CHD7):c.3126C>T (p.Asn1042=)	CHD7	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61735230	8	60822671	158288	168605
NM_017780.3(CHD7):c.3201+3A>T	CHD7	CHARGE association	Uncertain significance(Last reviewed: Dec 16, 2013)	criteria provided, single submitter	8	61735308	8	60822749	158289	168606
NM_017780.3(CHD7):c.3408A>G (p.Pro1136=)	CHD7	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61741251	8	60828692	158290	168607
NM_017780.3(CHD7):c.3412C>T (p.Gln1138Ter)	CHD7	CHARGE association	Pathogenic(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	8	61741255	8	60828696	548946	539430
NM_017780.3(CHD7):c.3522+13T>A	CHD7	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, multiple submitters, no conflicts	8	61741378	8	60828819	158292	168608
NM_017780.3(CHD7):c.4318C>T (p.Gln1440Ter)	CHD7	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61750359	8	60837800	158294	168609
NM_017780.3(CHD7):c.4353+3A>G	CHD7	CHARGE association|not provided	Likely pathogenic(Last reviewed: Feb 12, 2018)	criteria provided, multiple submitters, no conflicts	8	61750397	8	60837838	158295	168610
NM_017780.3(CHD7):c.4480C>T (p.Arg1494Ter)	CHD7	CHARGE association|not provided	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	8	61750761	8	60838202	158296	168611
NM_017780.3(CHD7):c.4533+46A>G	CHD7	not specified	Benign	criteria provided, single submitter	8	61750860	8	60838301	158327	168612
NM_017780.3(CHD7):c.4534-13T>G	CHD7	CHARGE association|Hypogonadism with anosmia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 11, 2017)	criteria provided, conflicting interpretations	8	61754190	8	60841631	158297	168613
NM_017780.3(CHD7):c.4634delT (p.Leu1545Terfs)	CHD7	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61754303	8	60841744	158298	168614
NM_017780.3(CHD7):c.4760C>T (p.Pro1587Leu)	CHD7	CHARGE association	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61754521	8	60841962	158299	168615
NM_017780.3(CHD7):c.5051-4C>A	CHD7	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61757805	8	60845246	158300	168616
NM_017780.3(CHD7):c.5165_5166insC (p.Gln1723Profs)	CHD7	Inborn genetic diseases	Pathogenic	criteria provided, single submitter	8	61757924	8	60845365	208735	205257
NM_017780.3(CHD7):c.5199dupT (p.His1734Serfs)	CHD7	CHARGE association	Pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	8	61757957	8	60845398	216901	213580
NM_017780.3(CHD7):c.5307C>T (p.Ala1769=)	CHD7	CHARGE association|Hypogonadism with anosmia|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	8	61761616	8	60849057	95794	101691
NM_017780.3(CHD7):c.5401C>A (p.His1801Asn)	CHD7	Kallmann syndrome 5	Likely pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	8	61761710	8	60849151	430606	423254
NM_017780.3(CHD7):c.5404G>A (p.Gly1802Ser)	CHD7	CHARGE association	Likely pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, single submitter	8	61761713	8	60849154	488387	481235
NM_017780.3(CHD7):c.5405-18C>A	CHD7	CHARGE association	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	8	61763034	8	60850475	428609	420428
NM_017780.3(CHD7):c.5405-17G>A	CHD7	CHARGE association|not provided|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Feb 27, 2018)	criteria provided, conflicting interpretations	8	61763035	8	60850476	195978	193139
NM_017780.3(CHD7):c.5405-13G>A	CHD7	CHARGE association	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	8	61763039	8	60850480	428610	420429
NM_017780.3(CHD7):c.5405-7G>A	CHD7	CHARGE association|not provided	Pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, multiple submitters, no conflicts	8	61763045	8	60850486	95795	101692
NM_017780.3(CHD7):c.5405-2A>G	CHD7	CHARGE association	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	8	61763050	8	60850491	430832	424375
NM_017780.3(CHD7):c.5450T>G (p.Phe1817Cys)	CHD7	CHARGE association	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61763097	8	60850538	158301	168617
NM_017780.3(CHD7):c.5458C>T (p.Arg1820Ter)	CHD7	CHARGE association|not provided	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	8	61763105	8	60850546	158302	168618
NM_017780.3(CHD7):c.5551G>T (p.Glu1851Ter)	CHD7	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61763607	8	60851048	158303	168619
NM_017780.3(CHD7):c.5666-2A>C	CHD7	CHARGE association	Pathogenic(Last reviewed: May 3, 2013)	criteria provided, single submitter	8	61764576	8	60852017	158304	168620
NM_017780.3(CHD7):c.5676_5677insGA (p.Ser1894Argfs)	CHD7	CHARGE association	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	8	61764588 - 61764589	8	60852029 - 60852030	488480	481348
NM_017780.3(CHD7):c.5859G>A (p.Ala1953=)	CHD7	CHARGE association	Uncertain significance(Last reviewed: May 12, 2014)	criteria provided, single submitter	8	61764771	8	60852212	158305	168621
NM_017780.3(CHD7):c.6079C>T (p.Arg2027Ter)	CHD7	CHARGE association|not provided	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	8	61765241	8	60852682	267435	262660
NM_017780.3(CHD7):c.6103+8C>T	CHD7	CHARGE association|Hypogonadism with anosmia|not specified|not provided	Benign(Last reviewed: Jul 25, 2018)	criteria provided, multiple submitters, no conflicts	8	61765273	8	60852714	95799	101696
NM_017780.3(CHD7):c.6135G>A (p.Pro2045=)	CHD7	CHARGE association|Hypogonadism with anosmia|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Mar 2, 2018)	criteria provided, multiple submitters, no conflicts	8	61765419	8	60852860	158306	168622
NM_017780.3(CHD7):c.6157C>T (p.Arg2053Ter)	CHD7	CHARGE association|not provided	Pathogenic(Last reviewed: Dec 30, 2015)	criteria provided, multiple submitters, no conflicts	8	61765441	8	60852882	158307	168623
NM_017780.3(CHD7):c.6250A>G (p.Ser2084Gly)	CHD7	CHARGE association	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61765534	8	60852975	158308	168624
NM_017780.3(CHD7):c.6276G>A (p.Glu2092=)	CHD7	CHARGE association|Hypogonadism with anosmia|not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Jul 25, 2018)	criteria provided, multiple submitters, no conflicts	8	61765560	8	60853001	95802	101699
NM_017780.3(CHD7):c.6282A>G (p.Gly2094=)	CHD7	CHARGE association|Hypogonadism with anosmia|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 6, 2018)	criteria provided, multiple submitters, no conflicts	8	61765566	8	60853007	95803	101700
NM_017780.3(CHD7):c.6287A>G (p.His2096Arg)	CHD7	CHARGE association	Likely pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, multiple submitters, no conflicts	8	61765571	8	60853012	158309	168625
NM_017780.3(CHD7):c.6292delC (p.Arg2098Glufs)	CHD7	CHARGE association	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	8	61765576	8	60853017	403716	390691
NM_017780.3(CHD7):c.6356A>G (p.Asp2119Gly)	CHD7	CHARGE association	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61765640	8	60853081	158310	168626
NM_017780.3(CHD7):c.6478G>A (p.Ala2160Thr)	CHD7	CHARGE association|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	8	61765762	8	60853203	158311	168627
NM_017780.3(CHD7):c.6738G>A (p.Glu2246=)	CHD7	CHARGE association|Hypogonadism with anosmia|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 20, 2017)	criteria provided, multiple submitters, no conflicts	8	61766022	8	60853463	95808	101705
NM_017780.3(CHD7):c.6843T>G (p.Asp2281Glu)	CHD7	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61766989	8	60854430	158312	168628
NM_017780.3(CHD7):c.6850C>T (p.Arg2284Ter)	CHD7	CHARGE association	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, multiple submitters, no conflicts	8	61766996	8	60854437	158313	168629
NM_017780.3(CHD7):c.7165-4A>G	CHD7	CHARGE association	Pathogenic(Last reviewed: Sep 19, 2017)	no assertion criteria provided	8	61769000	8	60856441	444870	438510
NM_017780.3(CHD7):c.7252C>T (p.Arg2418Ter)	CHD7	CHARGE association	Pathogenic(Last reviewed: Apr 18, 2017)	criteria provided, multiple submitters, no conflicts	8	61769091	8	60856532	158314	168630
NM_017780.3(CHD7):c.7285G>T (p.Glu2429Ter)	CHD7	CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, multiple submitters, no conflicts	8	61769124	8	60856565	411189	396545
NM_017780.3(CHD7):c.7294G>T (p.Val2432Leu)	CHD7	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61769133	8	60856574	158315	168631
NM_017780.3(CHD7):c.7356A>G (p.Thr2452=)	CHD7	CHARGE association|Hypogonadism with anosmia|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Aug 23, 2017)	criteria provided, multiple submitters, no conflicts	8	61769195	8	60856636	95811	101708
NM_017780.3(CHD7):c.7384_7387delTCTT (p.Ser2462Glnfs)	CHD7	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61769223 - 61769226	8	60856664 - 60856667	158316	168632
NM_017780.3(CHD7):c.7579A>C (p.Met2527Leu)	CHD7	CHARGE association|Hypogonadism with anosmia|Kallmann syndrome 5|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	8	61769418	8	60856859	158317	168633
NM_017780.3(CHD7):c.7590A>G (p.Lys2530=)	CHD7	CHARGE association|not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2017)	criteria provided, conflicting interpretations	8	61769429	8	60856870	158318	168634
NM_017780.3(CHD7):c.7848G>A (p.Leu2616=)	CHD7	CHARGE association|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2016)	criteria provided, conflicting interpretations	8	61774772	8	60862213	158319	168635
NM_017780.3(CHD7):c.7891C>T (p.Arg2631Ter)	CHD7	CHARGE association|not provided	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	8	61774815	8	60862256	158320	168636
NM_017780.3(CHD7):c.7957C>T (p.Arg2653Ter)	CHD7	CHARGE association|not provided	Pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	8	61774881	8	60862322	158321	168637
NM_017780.3(CHD7):c.8055G>A (p.Trp2685Ter)	CHD7	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61775190	8	60862631	158322	168638
NM_017780.3(CHD7):c.8063T>G (p.Ile2688Arg)	CHD7	CHARGE association	Likely pathogenic(Last reviewed: Feb 5, 2015)	no assertion criteria provided	8	61775198	8	60862639	374318	361191
NM_017780.3(CHD7):c.8416C>G (p.Leu2806Val)	CHD7	CHARGE association|Hypogonadism with anosmia|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	8	61777914	8	60865355	95814	101711
NM_017780.3(CHD7):c.8458_8459delCT (p.Leu2820Valfs)	CHD7	Kallmann syndrome 5	Pathogenic(Last reviewed: Oct 21, 2016)	criteria provided, single submitter	8	61777956 - 61777957	8	60865397 - 60865398	267364	262560
NM_017780.3(CHD7):c.8661G>A (p.Pro2887=)	CHD7	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61778159	8	60865600	158323	168639
NM_017780.3(CHD7):c.8790C>T (p.Ala2930=)	CHD7	CHARGE association|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	8	61778288	8	60865729	158329	168640
NM_000503.5(EYA1):c.1748T>C (p.Leu583Pro)	EYA1	Melnick-Fraser syndrome	Likely pathogenic(Last reviewed: Dec 28, 2012)	criteria provided, single submitter	8	72111606	8	71199371	48106	57270
NM_000503.5(EYA1):c.1579T>A (p.Tyr527Asn)	EYA1	Melnick-Fraser syndrome	Likely pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	8	72127640	8	71215405	48103	57267
NM_000503.5(EYA1):c.1475+1G>C	EYA1	Melnick-Fraser syndrome	Pathogenic(Last reviewed: Feb 17, 2014)	criteria provided, single submitter	8	72127848	8	71215613	163427	174396
NM_000503.5(EYA1):c.1276G>A (p.Gly426Ser)	EYA1	Melnick-Fraser syndrome|Otofaciocervical syndrome 1|Branchiootorenal Spectrum Disorders|Branchiootorenal syndrome with cataract|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 21, 2018)	criteria provided, conflicting interpretations	8	72129011	8	71216776	7938	22977
NM_000503.5(EYA1):c.1090G>T (p.Glu364Ter)	EYA1	Melnick-Fraser syndrome	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	8	72156888	8	71244653	228345	229627
NM_000503.5(EYA1):c.966+5G>A	EYA1	Melnick-Fraser syndrome	Pathogenic	criteria provided, single submitter	8	72183988	8	71271753	7945	22984
NM_000503.5(EYA1):c.896C>A (p.Ser299Ter)	EYA1	Melnick-Fraser syndrome	Pathogenic(Last reviewed: Nov 5, 2015)	criteria provided, single submitter	8	72184063	8	71271828	228347	229628
NM_000503.5(EYA1):c.428G>A (p.Trp143Ter)	EYA1	Melnick-Fraser syndrome	Pathogenic(Last reviewed: Apr 8, 2013)	criteria provided, single submitter	8	72229915	8	71317680	178857	174401
NM_000503.5(EYA1):c.164C>T (p.Thr55Met)	EYA1	Melnick-Fraser syndrome|Branchiootorenal Spectrum Disorders|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 10, 2017)	criteria provided, conflicting interpretations	8	72246370	8	71334135	178689	174402
NM_002677.5(PMP2):c.128T>A (p.Ile43Asn)	PMP2	Peripheral neuropathy|CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G	Likely pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	8	82357170	8	81444935	243087	244158
NM_002485.4(NBN):c.1262T>C (p.Leu421Ser)	NBN	Familial cancer of breast|Microcephaly, normal intelligence and immunodeficiency|Aplastic anemia|Acute lymphoid leukemia|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2018)	criteria provided, conflicting interpretations	8	90967646	8	89955418	127009	132522
NM_001001557.3(GDF6):c.1271A>G (p.Lys424Arg)	GDF6	Klippel-Feil syndrome 1, autosomal dominant|Klippel Feil syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	8	97156888	8	96144660	8373	23412
NM_024915.3(GRHL2):c.1081G>A (p.Val361Met)	GRHL2	not specified	Uncertain significance(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	8	102611362	8	101599134	517614	497107
NM_014112.4(TRPS1):c.1630C>T (p.Arg544Ter)	TRPS1	Trichorhinophalangeal syndrome type 3|Trichorhinophalangeal dysplasia type I|not provided	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, multiple submitters, no conflicts	8	116616566	8	115604339	267746	263045
NM_006265.2(RAD21):c.1808T>C (p.Leu603Pro)	RAD21	Cornelia de Lange syndrome 4	Likely pathogenic(Last reviewed: Oct 16, 2012)	criteria provided, single submitter	8	117859827	8	116847588	216988	213578
NM_006265.2(RAD21):c.1782C>T (p.Ala594=)	RAD21	Cornelia de Lange syndrome 4	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	8	117859853	8	116847614	159807	168580
NM_006265.2(RAD21):c.1774_1776delCAA (p.Gln592del)	RAD21	Cornelia de Lange syndrome 4	Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	8	117859859 - 117859861	8	116847620 - 116847622	545121	535385
NM_006265.2(RAD21):c.1617A>G (p.Glu539=)	RAD21	Cornelia de Lange syndrome 4	Uncertain significance(Last reviewed: Mar 26, 2013)	criteria provided, single submitter	8	117862860	8	116850621	159806	168581
NM_006265.2(RAD21):c.1440T>C (p.Ala480=)	RAD21	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 6, 2017)	criteria provided, multiple submitters, no conflicts	8	117864217	8	116851978	159805	168582
NM_006265.2(RAD21):c.938-11T>C	RAD21	not specified	Benign/Likely benign(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	8	117866718	8	116854479	159809	168583
NM_006265.2(RAD21):c.688+8G>A	RAD21	not specified	Benign(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	8	117869498	8	116857259	159808	168584
NM_000127.2(EXT1):c.1418-2A>G	EXT1	Multiple congenital exostosis	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, multiple submitters, no conflicts	8	118832035	8	117819796	448898	442479
NM_014846.3(WASHC5):c.3291G>A (p.Ala1097=)	WASHC5	Spastic paraplegia 8|not specified|Spastic paraplegia, autosomal dominant	Benign(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	8	126044527	8	125032285	129376	134822
NM_014846.3(WASHC5):c.597A>G (p.Pro199=)	WASHC5	Dandy-Walker like malformation with atrioventricular septal defect|Spastic paraplegia 8|not specified|Spastic paraplegia, autosomal dominant	Benign(Last reviewed: Aug 4, 2017)	criteria provided, multiple submitters, no conflicts	8	126091094	8	125078852	129377	134823
NM_004519.3(KCNQ3):c.1551C>T (p.Ala517=)	KCNQ3	Benign familial neonatal seizures|not specified|Seizures|Benign familial neonatal seizures|Benign Neonatal Epilepsy	Benign/Likely benign(Last reviewed: Nov 20, 2017)	criteria provided, multiple submitters, no conflicts	8	133152340	8	132140093	129348	134794
NM_004519.3(KCNQ3):c.1241A>G (p.Glu414Gly)	KCNQ3	Benign familial neonatal seizures 2|Benign familial neonatal seizures|not specified|Seizures|Benign familial neonatal seizures|Benign Neonatal Epilepsy	Benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	8	133175736	8	132163489	21409	34261
NM_004519.3(KCNQ3):c.1071C>G (p.Leu357=)	KCNQ3	Benign familial neonatal seizures|not specified|Seizures|Benign familial neonatal seizures|Benign Neonatal Epilepsy	Benign(Last reviewed: Jan 23, 2017)	criteria provided, multiple submitters, no conflicts	8	133184914	8	132172667	129347	134793
NM_004519.3(KCNQ3):c.1059C>T (p.Ser353=)	KCNQ3	Benign familial neonatal seizures|not specified|Seizures|Benign familial neonatal seizures	Benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	8	133184926	8	132172679	129346	134792
NM_004519.3(KCNQ3):c.732T>C (p.Gly244=)	KCNQ3	Benign familial neonatal seizures|not specified|Seizures|Benign familial neonatal seizures|Benign Neonatal Epilepsy	Benign(Last reviewed: Jan 23, 2017)	criteria provided, multiple submitters, no conflicts	8	133192449	8	132180202	129350	134796
NM_004519.3(KCNQ3):c.660T>C (p.Asn220=)	KCNQ3	Benign familial neonatal seizures|not specified|Seizures|Benign familial neonatal seizures|Benign Neonatal Epilepsy	Benign(Last reviewed: Jan 23, 2017)	criteria provided, multiple submitters, no conflicts	8	133192521	8	132180274	129349	134795
NM_001282534.1(KCNK9):c.392G>A (p.Arg131His)	KCNK9	Birk Barel mental retardation dysmorphism syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	8	140631234	8	139618991	372887	359719
NM_014957.2(DENND3):c.1920delG (p.Lys640Asnfs)	DENND3	Hirschsprung disease 1	Likely pathogenic(Last reviewed: Sep 26, 2016)	no assertion criteria provided	8	142178509	8	141168410	375278	362049
NM_198488.3(FAM83H):c.926_927delTG (p.Val309Glyfs)	FAM83H	Amelogenesis imperfecta, hypocalcification type	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	8	144810704 - 144810705	8	143728534 - 143728535	488513	481381
NM_078480.2(PUF60):c.1381-2A>G	PUF60	not provided|Verheij syndrome	Likely pathogenic(Last reviewed: Jan 19, 2017)	criteria provided, multiple submitters, no conflicts	8	144898991	8	143816821	374297	361261
NM_172058.3(EYA1):c.(?_1598)-56_*(1968_?)del	EYA1	Melnick-Fraser syndrome	Pathogenic(Last reviewed: Feb 7, 2016)	criteria provided, single submitter	8	72109607 - 72123547	8	71197372 - 71211312	228344	229615
NM_172058.2(EYA1):c.(?_-66)_(*76_?)del	EYA1	Melnick-Fraser syndrome	Pathogenic(Last reviewed: Aug 2, 2012)	criteria provided, single submitter	8	72111499 - 72268758	8	71199264 - 71356523	163426	174260
NM_021951.2(DMRT1):c.332G>T (p.Arg111Met)	DMRT1	46,XY sex reversal, type 4	Likely pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	9	842170	9	842170	393463	380285
NM_003070.4(SMARCA2):c.-5G>A	SMARCA2	Nicolaides-Baraitser syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	2029018	9	2029018	126341	131873
NM_003070.4(SMARCA2):c.174G>A (p.Pro58=)	SMARCA2	Nicolaides-Baraitser syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 18, 2016)	criteria provided, multiple submitters, no conflicts	9	2029196	9	2029196	126343	131875
NM_003070.4(SMARCA2):c.177G>A (p.Thr59=)	SMARCA2	Nicolaides-Baraitser syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	2029199	9	2029199	126344	131876
NM_003070.4(SMARCA2):c.462G>A (p.Gly154=)	SMARCA2	Nicolaides-Baraitser syndrome|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Aug 5, 2016)	criteria provided, multiple submitters, no conflicts	9	2039572	9	2039572	126348	131880
NM_003070.4(SMARCA2):c.482C>T (p.Pro161Leu)	SMARCA2	Coffin Siris/Intellectual Disability	Uncertain significance(Last reviewed: Feb 14, 2014)	criteria provided, single submitter	9	2039592	9	2039592	126350	131882
NM_003070.4(SMARCA2):c.683A>C (p.Gln228Pro)	SMARCA2	Nicolaides-Baraitser syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	2039793	9	2039793	126351	131883
NM_003070.4(SMARCA2):c.690_707dup18 (p.Gln238_Pro239insGlnGlnGlnGlnGlnGln)	SMARCA2	Coffin Siris/Intellectual Disability	Uncertain significance(Last reviewed: Feb 14, 2014)	criteria provided, single submitter	9	2039800 - 2039817	9	2039800 - 2039817	126352	131884
NM_003070.4(SMARCA2):c.705_707delGCA (p.Gln238del)	SMARCA2	Nicolaides-Baraitser syndrome|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Mar 17, 2017)	criteria provided, multiple submitters, no conflicts	9	2039815 - 2039817	9	2039815 - 2039817	126353	131885
NM_003070.4(SMARCA2):c.717G>A (p.Pro239=)	SMARCA2	Nicolaides-Baraitser syndrome|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	2039827	9	2039827	126354	131886
NM_003070.4(SMARCA2):c.1122C>G (p.Thr374=)	SMARCA2	Nicolaides-Baraitser syndrome|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jul 1, 2016)	criteria provided, multiple submitters, no conflicts	9	2054672	9	2054672	126342	131874
NM_003070.4(SMARCA2):c.1600G>T (p.Asp534Tyr)	SMARCA2	Nicolaides-Baraitser syndrome	Likely pathogenic(Last reviewed: Jul 22, 2014)	criteria provided, single submitter	9	2060894	9	2060894	217002	213590
NM_003070.4(SMARCA2):c.1827A>G (p.Pro609=)	SMARCA2	Nicolaides-Baraitser syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	2073292	9	2073292	126345	131877
NM_003070.4(SMARCA2):c.2267C>T (p.Thr756Ile)	SMARCA2	Nicolaides-Baraitser syndrome|not provided	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	2081914	9	2081914	68760	79652
NM_003070.4(SMARCA2):c.2348C>T (p.Ser783Leu)	SMARCA2	Nicolaides-Baraitser syndrome	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	2081995	9	2081995	561113	552140
NM_003070.4(SMARCA2):c.2552A>G (p.Asp851Gly)	SMARCA2	Nicolaides-Baraitser syndrome	Likely pathogenic(Last reviewed: Sep 2, 2016)	no assertion criteria provided	9	2086854	9	2086854	267266	262269
NM_003070.4(SMARCA2):c.3482A>G (p.His1161Arg)	SMARCA2	Nicolaides-Baraitser syndrome	Likely pathogenic(Last reviewed: Jun 3, 2014)	criteria provided, single submitter	9	2115847	9	2115847	217001	213591
NM_003070.4(SMARCA2):c.3672G>A (p.Glu1224=)	SMARCA2	Nicolaides-Baraitser syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	2116037	9	2116037	126346	131878
NM_003070.4(SMARCA2):c.4590C>T (p.Ser1530=)	SMARCA2	Nicolaides-Baraitser syndrome|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	2186224	9	2186224	126347	131879
NM_003070.4(SMARCA2):c.4638C>G (p.Asp1546Glu)	SMARCA2	Nicolaides-Baraitser syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	2191309	9	2191309	126349	131881
GRCh37/hg19 9p23-22.3(chr9:13034407-14653394)x1	NFIB|MPDZ|ZDHHC21	Wide anterior fontanel|Intellectual disability	Pathogenic(Last reviewed: Aug 22, 2018)	no assertion criteria provided	9	13034407 - 14653394			562129	553303
GRCh37/hg19 9p23-22.3(chr9:13106806-14639971)x1	NFIB|MPDZ|ZDHHC21	Intellectual disability|Postnatal microcephaly	Pathogenic(Last reviewed: Aug 22, 2018)	no assertion criteria provided	9	13106806 - 14639971			562128	553302
GRCh37/hg19 9p23-22.2(chr9:13563537-18491752)x1	NFIB|SH3GL2|SNAPC3|CER1|PSIP1|BNC2|CNTLN|ADAMTSL1|TTC39B|FREM1|CCDC171|ZDHHC21	Turricephaly|Intellectual disability	Pathogenic(Last reviewed: Aug 22, 2018)	no assertion criteria provided	9	13563537 - 18491752			562131	553305
GRCh37/hg19 9p23-22.2(chr9:13739630-18023839)x1	NFIB|SH3GL2|SNAPC3|CER1|PSIP1|BNC2|CNTLN|TTC39B|FREM1|CCDC171|ZDHHC21	Oxycephaly|Intellectual disability	Pathogenic(Last reviewed: Aug 22, 2018)	no assertion criteria provided	9	13739630 - 18023839			562132	553306
GRCh38/hg38 9p23-22.3(chr9:13974416-14286260)x1	NFIB	Dolichocephaly|Intellectual disability	Pathogenic(Last reviewed: Aug 22, 2018)	no assertion criteria provided	9	13974415 - 14286259	9	13974416 - 14286260	562127	553301
GRCh38/hg38 9p23-22.3(chr9:14098660-14324148)x1	NFIB	Macrocephalus|Intellectual disability|Macrocephaly	Pathogenic(Last reviewed: Aug 22, 2018)	no assertion criteria provided	9	14098659 - 14324147	9	14098660 - 14324148	562125	553299
GRCh38/hg38 9p23-22.3(chr9:14102176-14386039)x1	NFIB	Intellectual disability|Relative macrocephaly	Pathogenic(Last reviewed: Aug 22, 2018)	no assertion criteria provided	9	14102175 - 14386038	9	14102176 - 14386039	562126	553300
NM_001190737.1(NFIB):c.1063_1076del (p.Ile355Serfs)	NFIB	Macrocephalus|Intellectual disability|Macrocephaly|MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic	criteria provided, single submitter	9	14120608 - 14120621	9	14120609 - 14120622	560029	550745
NM_001190737.1(NFIB):c.1067C>T (p.Ser356Leu)	NFIB	Macrocephalus|Intellectual disability|Macrocephaly	Uncertain significance	criteria provided, single submitter	9	14120617	9	14120618	560030	550746
NM_001190737.2(NFIB):c.758_759dup (p.Asn254Terfs)	NFIB	Macrocephalus|Intellectual disability|Macrocephaly|MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic	criteria provided, single submitter	9	14150191 - 14150192	9	14150192 - 14150193	560028	550744
GRCh37/hg19 9p23-22.2(chr9:14178768-16619009)x1	NFIB|SNAPC3|CER1|PSIP1|BNC2|TTC39B|FREM1|CCDC171|ZDHHC21	Intellectual disability|Progressive macrocephaly	Pathogenic(Last reviewed: Aug 22, 2018)	no assertion criteria provided	9	14178768 - 16619009			562130	553304
NM_001190737.2(NFIB):c.395T>C (p.Leu132Pro)	NFIB	Macrocephalus|Intellectual disability|Macrocephaly|MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic	criteria provided, single submitter	9	14307155	9	14307156	560027	550743
NM_001190737.2(NFIB):c.376A>G (p.Lys126Glu)	NFIB	Macrocephalus|Intellectual disability|Macrocephaly|MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic	criteria provided, single submitter	9	14307174	9	14307175	560026	550742
NM_001190737.2(NFIB):c.341A>C (p.Lys114Thr)	NFIB	Macrocephalus|Intellectual disability|Macrocephaly|MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic	criteria provided, single submitter	9	14307209	9	14307210	560025	550741
NM_001190737.2(NFIB):c.265C>T (p.Arg89Ter)	NFIB	not specified|Macrocephalus|Intellectual disability|Macrocephaly|MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2019)	criteria provided, conflicting interpretations	9	14307285	9	14307286	424344	407647
NM_001190737.1(NFIB):c.109C>T (p.Arg37Ter)	NFIB	Macrocephalus|Intellectual disability|Macrocephaly|MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic	criteria provided, single submitter	9	14307441	9	14307442	560024	550740
NM_144966.5(FREM1):c.1394G>C (p.Gly465Ala)	FREM1	Marles Greenberg Persaud syndrome|not specified|Congenital diaphragmatic hernia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	9	14842658	9	14842660	218939	215773
NM_000459.4(TEK):c.2545C>T (p.Arg849Trp)	TEK	Multiple Cutaneous and Mucosal Venous Malformations	Pathogenic(Last reviewed: Aug 23, 2012)	no assertion criteria provided	9	27206760	9	27206762	9293	24332
NM_000459.4(TEK):c.2690A>C (p.Tyr897Ser)	TEK	Multiple Cutaneous and Mucosal Venous Malformations	Pathogenic(Last reviewed: Aug 23, 2012)	no assertion criteria provided	9	27212708	9	27212710	9294	24333
NM_000459.4(TEK):c.3347T>C (p.Ile1116Thr)	TEK	Multiple Cutaneous and Mucosal Venous Malformations	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	27229202	9	27229204	561130	552141
NC_000009.12:g.34280044_34296296del16253	KIF24	Peripheral neuropathy	Uncertain significance(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	9	34280042 - 34296294	9	34280044 - 34296296	243059	244140
NM_001135005.2(DNAJB5):c.43C>T (p.Pro15Ser)	DNAJB5	Peripheral neuropathy|Skeletal myopathy|Peripheral neuropathy	Likely pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	9	34990670	9	34990673	243086	244161
NM_007126.4(VCP):c.463C>G (p.Arg155Gly)	VCP	Inclusion body myopathy with early-onset paget disease and frontotemporal dementia|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 4, 2017)	criteria provided, multiple submitters, no conflicts	9	35065361	9	35065364	217028	213592
NM_003289.3(TPM2):c.*8G>A	TPM2	not specified|not provided|Arthrogryposis multiplex congenita|Nemaline Myopathy, Dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	35683148	9	35683151	94122	100022
NM_138691.2(TMC1):c.1714G>A (p.Asp572Asn)	TMC1	Deafness, autosomal dominant 36|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Jun 8, 2015)	criteria provided, single submitter	9	75431077	9	72816161	4102	19141
NM_006914.3(RORB):c.1249_1251delACG (p.Thr417del)	RORB	Inborn genetic diseases	Likely pathogenic	criteria provided, single submitter	9	77300403 - 77300405	9	74685487 - 74685489	225116	226917
NM_002140.4(HNRNPK):c.253G>A (p.Glu85Lys)	HNRNPK	not specified|AU-KLINE SYNDROME	Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2018)	criteria provided, conflicting interpretations	9	86590381	9	83975466	452520	444522
NM_031262.3(HNRNPK):c.214-35A>G	HNRNPK	AU-KLINE SYNDROME	Likely pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	9	86590455	9	83975540	522798	513434
NM_001039803.2(CDK20):c.564G>A (p.Trp188Ter)	CDK20	Seizures|Hearing impairment|Obsessive-compulsive behavior|Attention deficit hyperactivity disorder|Attention deficit hyperactivity disorder	Pathogenic	no assertion criteria provided	9	90584834	9	87969919	375376	362151
NM_006415.3(SPTLC1):c.1072G>C (p.Glu358Gln)	SPTLC1	Neuropathy hereditary sensory and autonomic type 1	Likely pathogenic(Last reviewed: Aug 22, 2014)	criteria provided, single submitter	9	94809463	9	92047181	209194	205763
NM_015250.3(BICD2):c.1931C>A (p.Ala644Asp)	BICD2	Spinal muscular atrophy, lower extremity predominant 2, autosomal dominant	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	95480996	9	92718714	560962	552142
NM_001003800.1(BICD2):c.1636_1638delAAT (p.Asn546del)	BICD2	Seizures|Feeding difficulties|Muscle weakness|EEG abnormality|Tapered finger|not provided|Absent speech|Open mouth|Macrocephalus|Decreased fetal movement|Cerebral cortical atrophy|Downturned corners of mouth|Recurrent fractures|Arthrogryposis multiplex congenita|Skeletal muscle atrophy	Likely pathogenic(Last reviewed: Apr 4, 2018)	criteria provided, multiple submitters, no conflicts	9	95481289 - 95481291	9	92719007 - 92719009	422408	407722
t(9;14)(q22.31;q12)	FOXG1	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	9	94269066 - 94269642			426096	414700
NM_000264.4(PTCH1):c.3947A>G (p.Tyr1316Cys)	PTCH1	Gorlin syndrome|Irido-corneo-trabecular dysgenesis|Rieger syndrome|not provided|Hereditary cancer-predisposing syndrome|Rieger anomaly|Peters anomaly|Rieger anomaly	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	9	98209591	9	95447309	132723	136471
NM_000264.4(PTCH1):c.3422C>T (p.Ala1141Val)	PTCH1	Gorlin syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	9	98215787	9	95453505	161355	171114
NM_000264.4(PTCH1):c.3241G>A (p.Val1081Met)	PTCH1	Gorlin syndrome|not specified|Hereditary cancer-predisposing syndrome|Anophthalmia - microphthalmia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 18, 2018)	criteria provided, conflicting interpretations	9	98218623	9	95456341	135097	138836
NM_000264.4(PTCH1):c.3191C>T (p.Thr1064Met)	PTCH1	Gorlin syndrome|Anophthalmia - microphthalmia	Conflicting interpretations of pathogenicity(Last reviewed: May 11, 2018)	criteria provided, conflicting interpretations	9	98218673	9	95456391	221931	223628
NM_000264.3(PTCH1):c.3155C>T (p.Thr1052Met)	PTCH1	Gorlin syndrome|Holoprosencephaly 7|Holoprosencephaly sequence|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jan 9, 2018)	criteria provided, multiple submitters, no conflicts	9	98220308	9	95458026	8224	23263
NM_000264.4(PTCH1):c.2945G>A (p.Arg982Gln)	PTCH1	Gorlin syndrome|Congenital heart disease	Uncertain significance(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	9	98220518	9	95458236	161356	171115
NM_000264.4(PTCH1):c.2695A>G (p.Ile899Val)	PTCH1	Irido-corneo-trabecular dysgenesis	Likely pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	9	98224146	9	95461864	221968	223629
NM_000264.4(PTCH1):c.2332A>C (p.Thr778Pro)	PTCH1|LOC100507346	Anophthalmia - microphthalmia	Likely pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	9	98229626	9	95467344	221969	223630
NM_000264.3(PTCH1):c.2306C>T (p.Thr769Ile)	PTCH1|LOC100507346	Gorlin syndrome	Uncertain significance(Last reviewed: Mar 28, 2017)	criteria provided, multiple submitters, no conflicts	9	98229652	9	95467370	226039	227846
NM_000264.4(PTCH1):c.1234G>T (p.Ala412Ser)	PTCH1	Gorlin syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 13, 2018)	criteria provided, conflicting interpretations	9	98240450	9	95478168	161357	171116
NM_000264.4(PTCH1):c.1216-1G>A	PTCH1	Gorlin syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	98240469	9	95478187	561094	552143
NM_000264.4(PTCH1):c.521C>T (p.Ala174Val)	PTCH1	Gorlin syndrome	Uncertain significance(Last reviewed: Nov 30, 2017)	criteria provided, multiple submitters, no conflicts	9	98248030	9	95485748	225289	227194
NM_000264.3(PTCH1):c.395-1G>A	PTCH1	Gorlin syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2018)	criteria provided, conflicting interpretations	9	98248157	9	95485875	162510	172176
NM_000264.4(PTCH1):c.290delA (p.Asn97Thrfs)	PTCH1	Gorlin syndrome	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	9	98268793	9	95506511	488582	481450
NM_000264.4(PTCH1):c.114delG (p.Leu39Cysfs)	PTCH1	Gorlin syndrome	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	9	98270530	9	95508248	374274	361199
NM_001083603.2(PTCH1):c.4delG (p.Glu2Asnfs)	PTCH1	Anophthalmia - microphthalmia	Likely pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	9	98279099	9	95516817	221923	223631
NM_005458.7(GABBR2):c.1699G>A (p.Ala567Thr)	GABBR2	Rett syndrome|Inborn genetic diseases|NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS	Pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, multiple submitters, no conflicts	9	101133817	9	98371535	446211	439573
NM_024642.4(GALNT12):c.907G>A (p.Asp303Asn)	GALNT12	Adenomatous polyposis coli, attenuated|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 14, 2018)	criteria provided, conflicting interpretations	9	101594229	9	98831947	224569	226331
NM_004612.3(TGFBR1):c.640G>A (p.Gly214Ser)	TGFBR1	Loeys-Dietz syndrome 1	Likely pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	9	101900206	9	99137924	488621	481489
NM_004612.3(TGFBR1):c.848A>G (p.His283Arg)	TGFBR1	Loeys-Dietz syndrome 1|Thoracic aortic aneurysm and aortic dissection	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	9	101904860	9	99142578	477563	459531
NM_001130916.2(TGFBR1):c.1202A>G (p.Asn401Ser)	TGFBR1	Loeys-Dietz syndrome 1|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	9	101911508	9	99149226	161393	171117
NM_021224.5(ZNF462):c.2979_2980delTGinsA (p.Val994Trpfs)	ZNF462	Craniosynostosis|Mental retardation, autosomal dominant|Craniosynostosis	Pathogenic(Last reviewed: Jan 25, 2017)	no assertion criteria provided	9	109689172 - 109689173	9	106926891 - 106926892	402118	389091
NM_021224.5(ZNF462):c.3787C>T (p.Arg1263Ter)	ZNF462	Craniosynostosis|Mental retardation, autosomal dominant|Craniosynostosis	Pathogenic(Last reviewed: Jan 25, 2017)	no assertion criteria provided	9	109689980	9	106927699	402116	389089
NM_021224.5(ZNF462):c.4263delA (p.Glu1422Serfs)	ZNF462	Craniosynostosis|Mental retardation, autosomal dominant|Craniosynostosis	Pathogenic(Last reviewed: Jan 25, 2017)	no assertion criteria provided	9	109690456	9	106928175	402117	389090
NM_000177.4(GSN):c.640G>A (p.Asp214Asn)	GSN	Meretoja syndrome|not provided	Pathogenic(Last reviewed: Apr 13, 2017)	criteria provided, single submitter	9	124073097	9	121310819	16180	31219
NM_004959.4(NR5A1):c.1210T>G (p.Tyr404Asp)	NR5A1	46,XY sex reversal, type 3	Pathogenic(Last reviewed: May 27, 2014)	criteria provided, single submitter	9	127245213	9	124482934	216976	213584
NM_004959.4(NR5A1):c.274C>T (p.Arg92Trp)	NR5A1	46,XY sex reversal, type 3|46,XX sex reversal 4	Conflicting interpretations of pathogenicity(Last reviewed: Feb 16, 2018)	criteria provided, conflicting interpretations	9	127262965	9	124500686	265792	260482
NM_004959.4(NR5A1):c.151G>T (p.Glu51Ter)	NR5A1	46,XY sex reversal, type 3	Pathogenic(Last reviewed: Jul 29, 2014)	criteria provided, single submitter	9	127265451	9	124503172	216975	213585
NM_002316.3(LMX1B):c.139+5G>C	LMX1B	Nail-patella syndrome	Uncertain significance	no assertion criteria provided	9	129376872	9	126614593	427734	417436
NM_001174146.1(LMX1B):c.305A>G (p.Tyr102Cys)	LMX1B	Nail-patella syndrome	Pathogenic	no assertion criteria provided	9	129377827	9	126615548	587694	578652
NM_002316.3(LMX1B):c.543delC (p.Asp182Thrfs)	LMX1B	Nail-patella syndrome	Pathogenic	no assertion criteria provided	9	129453331	9	126691052	427737	417439
NM_001032221.3(STXBP1):c.38-3T>C	STXBP1	not specified|not provided|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	9	130413879	9	127651600	139343	143046
NM_003165.3(STXBP1):c.170-2A>G	STXBP1	Early infantile epileptic encephalopathy 4|not provided	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, multiple submitters, no conflicts	9	130420652	9	127658373	488800	481837
NM_003165.3(STXBP1):c.416C>T (p.Pro139Leu)	STXBP1	Early infantile epileptic encephalopathy 4|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, multiple submitters, no conflicts	9	130423471	9	127661192	207415	202287
NM_003165.3(STXBP1):c.433T>C (p.Tyr145His)	STXBP1	Early infantile epileptic encephalopathy 4	Likely pathogenic(Last reviewed: Dec 11, 2012)	criteria provided, single submitter	9	130425487	9	127663208	160073	168751
NM_003165.3(STXBP1):c.533C>T (p.Thr178Ile)	STXBP1	Early infantile epileptic encephalopathy 4	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	130425587	9	127663308	561118	552130
NM_003165.3(STXBP1):c.578+1G>A	STXBP1	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	130425633	9	127663354	561119	552131
NM_003165.3(STXBP1):c.714C>A (p.Asp238Glu)	STXBP1	Early infantile epileptic encephalopathy 4	Uncertain significance(Last reviewed: May 20, 2014)	criteria provided, single submitter	9	130428495	9	127666216	160074	168752
NM_001032221.3(STXBP1):c.734A>G (p.His245Arg)	STXBP1	Early infantile epileptic encephalopathy 4|not specified|Early infantile epileptic encephalopathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 12, 2017)	criteria provided, conflicting interpretations	9	130428515	9	127666236	160070	168753
NM_001032221.3(STXBP1):c.754_755del (p.Met252Glufs)	STXBP1	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Oct 24, 2013)	criteria provided, single submitter	9	130428535 - 130428536	9	127666256 - 127666257	160071	168754
NM_003165.3(STXBP1):c.846C>T (p.Asp282=)	STXBP1	not specified|not provided|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant|History of neurodevelopmental disorder	Benign(Last reviewed: Sep 29, 2017)	criteria provided, multiple submitters, no conflicts	9	130430410	9	127668131	139348	143051
NM_003165.3(STXBP1):c.1356C>T (p.Thr452=)	STXBP1	not specified|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	9	130439029	9	127676750	139351	143054
NM_003165.3(STXBP1):c.1680C>T (p.Asn560=)	STXBP1	Early infantile epileptic encephalopathy 4|not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jul 8, 2016)	criteria provided, conflicting interpretations	9	130444817	9	127682538	139355	143058
NM_000118.3(ENG):c.1844C>T (p.Ser615Leu)	ENG	Osler hemorrhagic telangiectasia syndrome|not specified|not provided|Haemorrhagic telangiectasia 1|Juvenile Polyposis	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	9	130578230	9	127815951	161229	171109
NM_000118.3(ENG):c.1510G>A (p.Val504Met)	ENG|LOC102723566	Osler hemorrhagic telangiectasia syndrome|not specified|Haemorrhagic telangiectasia 1|Juvenile Polyposis	Conflicting interpretations of pathogenicity(Last reviewed: Dec 21, 2017)	criteria provided, conflicting interpretations	9	130580575	9	127818296	161231	171110
NM_000118.3(ENG):c.1282A>C (p.Asn428His)	ENG|LOC102723566	Osler hemorrhagic telangiectasia syndrome	Uncertain significance(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	9	130581930	9	127819651	226040	227844
NM_000118.3(ENG):c.1274C>T (p.Ala425Val)	ENG|LOC102723566	Haemorrhagic telangiectasia 1	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	9	130581938	9	127819659	161230	171111
NM_000118.3(ENG):c.1273-2A>G	ENG|LOC102723566	Osler hemorrhagic telangiectasia syndrome|not specified|not provided|Haemorrhagic telangiectasia 1	Pathogenic(Last reviewed: Jun 17, 2018)	criteria provided, multiple submitters, no conflicts	9	130581941	9	127819662	162498	172175
NM_000118.3(ENG):c.1015_1024del (p.Ala339Argfs)	ENG	Osler hemorrhagic telangiectasia syndrome	Pathogenic(Last reviewed: Dec 20, 2017)	no assertion criteria provided	9	130586693 - 130586702	9	127824414 - 127824423	478821	472247
NM_000118.3(ENG):c.816+6T>C	ENG	Systemic lupus erythematosus|Osler hemorrhagic telangiectasia syndrome	Pathogenic(Last reviewed: Mar 20, 2017)	no assertion criteria provided	9	130587504	9	127825225	453308	446888
NM_000118.3(ENG):c.640G>A (p.Gly214Ser)	ENG	Primary pulmonary hypertension|Osler hemorrhagic telangiectasia syndrome|Haemorrhagic telangiectasia 1	Uncertain significance(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	9	130588023	9	127825744	161233	171112
NM_000118.3(ENG):c.596G>A (p.Arg199His)	ENG	Osler hemorrhagic telangiectasia syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 28, 2017)	criteria provided, conflicting interpretations	9	130588067	9	127825788	226041	227845
NM_000118.3(ENG):c.581_592del12 (p.Leu194_Arg197del)	ENG	Hereditary hemorrhagic telangiectasia type 1	Likely pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	9	130588071 - 130588082	9	127825792 - 127825803	549762	540529
NM_000118.3(ENG):c.408delA (p.Glu137Serfs)	ENG	Osler hemorrhagic telangiectasia syndrome	Likely pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	9	130588904	9	127826625	518421	508963
NM_000118.3(ENG):c.392C>T (p.Pro131Leu)	ENG	Osler hemorrhagic telangiectasia syndrome|not specified|Haemorrhagic telangiectasia 1	Conflicting interpretations of pathogenicity(Last reviewed: Dec 25, 2017)	criteria provided, conflicting interpretations	9	130588920	9	127826641	161232	171113
NM_001005336.2(DNM1):c.465_467dup (p.Gln155_Ile156insMet)	DNM1	Epileptic encephalopathy, early infantile, 31	Likely pathogenic(Last reviewed: Jan 29, 2015)	no assertion criteria provided	9	130981407 - 130981409	9	128219128 - 128219130	374264	361193
NM_001130438.2(SPTAN1):c.651+37A>C	SPTAN1	not specified	Likely benign	no assertion criteria provided	9	131337661	9	128575382	160023	168756
NM_001130438.2(SPTAN1):c.979C>T (p.Leu327=)	SPTAN1	not specified|Seizures	Benign/Likely benign(Last reviewed: Apr 7, 2017)	criteria provided, multiple submitters, no conflicts	9	131339679	9	128577400	160031	168757
NM_001130438.2(SPTAN1):c.1221+11C>T	SPTAN1	not specified|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	131340535	9	128578256	139268	142971
NM_001130438.2(SPTAN1):c.1389C>T (p.Tyr463=)	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Apr 5, 2013)	criteria provided, single submitter	9	131343266	9	128580987	159994	168759
NM_001130438.2(SPTAN1):c.1462-27T>A	SPTAN1	not specified	Likely benign	no assertion criteria provided	9	131344034	9	128581755	159995	168760
NM_001130438.2(SPTAN1):c.1603C>A (p.Gln535Lys)	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	9	131344788	9	128582509	159996	168761
NM_001130438.2(SPTAN1):c.1677C>G (p.His559Gln)	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	9	131344999	9	128582720	159997	168762
NM_001130438.2(SPTAN1):c.1697G>A (p.Arg566Gln)	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Jun 13, 2014)	criteria provided, single submitter	9	131345019	9	128582740	159998	168763
NM_001130438.2(SPTAN1):c.1737C>T (p.Phe579=)	SPTAN1	not specified|Seizures|not provided|Early infantile epileptic encephalopathy	Benign/Likely benign(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	9	131345059	9	128582780	139272	142975
NM_001130438.2(SPTAN1):c.2064G>A (p.Glu688=)	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Aug 27, 2013)	criteria provided, single submitter	9	131346119	9	128583840	159999	168764
NM_001130438.2(SPTAN1):c.2343C>A (p.Ala781=)	SPTAN1	not specified|Seizures|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	9	131346710	9	128584431	139277	142980
NM_001130438.2(SPTAN1):c.2438-13T>G	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	9	131346987	9	128584708	160000	168765
NM_001130438.2(SPTAN1):c.2560+43G>A	SPTAN1	not specified	Likely benign	no assertion criteria provided	9	131347165	9	128584886	160001	168766
NM_001130438.2(SPTAN1):c.2560+47C>T	SPTAN1	not specified	Likely benign	no assertion criteria provided	9	131347169	9	128584890	160002	168767
NM_001130438.2(SPTAN1):c.2674G>T (p.Ala892Ser)	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	9	131348140	9	128585861	160003	168768
NM_001130438.2(SPTAN1):c.2872-42G>A	SPTAN1	not specified	Likely benign	no assertion criteria provided	9	131351046	9	128588767	160004	168769
NM_001130438.2(SPTAN1):c.2889G>A (p.Thr963=)	SPTAN1	Early infantile epileptic encephalopathy 5|not specified|not provided|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Sep 28, 2017)	criteria provided, conflicting interpretations	9	131351105	9	128588826	160005	168770
NM_001130438.2(SPTAN1):c.3051G>A (p.Pro1017=)	SPTAN1	not specified|Seizures|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Benign/Likely benign(Last reviewed: Oct 10, 2017)	criteria provided, multiple submitters, no conflicts	9	131353800	9	128591521	139282	142985
NM_001130438.2(SPTAN1):c.3193C>T (p.Arg1065Cys)	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Jul 15, 2014)	criteria provided, single submitter	9	131355299	9	128593020	160006	168771
NM_001130438.2(SPTAN1):c.3300G>A (p.Ala1100=)	SPTAN1	not specified|Seizures|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	9	131356538	9	128594259	139283	142986
NM_001130438.2(SPTAN1):c.3415-9G>T	SPTAN1	Early infantile epileptic encephalopathy 5|not specified|Early infantile epileptic encephalopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jan 10, 2017)	criteria provided, conflicting interpretations	9	131360670	9	128598391	160007	168772
NM_001130438.2(SPTAN1):c.3486C>T (p.Leu1162=)	SPTAN1	not specified|Seizures|not provided|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Benign(Last reviewed: May 6, 2018)	criteria provided, multiple submitters, no conflicts	9	131360750	9	128598471	160009	168774
NM_001130438.2(SPTAN1):c.3486C>G (p.Leu1162=)	SPTAN1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	9	131360750	9	128598471	160008	168773
NM_001130438.2(SPTAN1):c.3520-14C>G	SPTAN1	not specified|not provided|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Benign/Likely benign(Last reviewed: Feb 22, 2017)	criteria provided, multiple submitters, no conflicts	9	131361228	9	128598949	139285	142988
NM_001130438.2(SPTAN1):c.3546T>C (p.Asp1182=)	SPTAN1	not specified|Seizures|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Benign/Likely benign(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	9	131362361	9	128600082	160010	168775
NM_001130438.2(SPTAN1):c.3899T>C (p.Ile1300Thr)	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	9	131367609	9	128605330	160011	168776
NM_001130438.2(SPTAN1):c.4199A>T (p.Gln1400Leu)	SPTAN1	Early infantile epileptic encephalopathy 5|not specified|Seizures|not provided|Early infantile epileptic encephalopathy	Conflicting interpretations of pathogenicity(Last reviewed: Apr 18, 2018)	criteria provided, conflicting interpretations	9	131370183	9	128607904	160012	168777
NM_001130438.2(SPTAN1):c.4905+41C>G	SPTAN1	not specified	Likely benign	no assertion criteria provided	9	131374165	9	128611886	160013	168778
NM_001130438.2(SPTAN1):c.5023T>A (p.Phe1675Ile)	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	9	131374505	9	128612226	160014	168779
NM_001130438.2(SPTAN1):c.5149-10C>T	SPTAN1	Early infantile epileptic encephalopathy 5|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 11, 2014)	criteria provided, conflicting interpretations	9	131377901	9	128615622	160015	168780
NM_001130438.2(SPTAN1):c.5406C>G (p.Thr1802=)	SPTAN1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	9	131379967	9	128617688	160016	168781
NM_001130438.2(SPTAN1):c.5406C>T (p.Thr1802=)	SPTAN1	not specified|Seizures|not provided|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Benign(Last reviewed: May 6, 2018)	criteria provided, multiple submitters, no conflicts	9	131379967	9	128617688	139297	143000
NM_001130438.2(SPTAN1):c.5437C>A (p.Arg1813=)	SPTAN1	not specified|Seizures|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Benign/Likely benign(Last reviewed: Aug 12, 2017)	criteria provided, multiple submitters, no conflicts	9	131379998	9	128617719	160017	168782
NM_001130438.2(SPTAN1):c.5478+12G>A	SPTAN1	Early infantile epileptic encephalopathy 5|not specified	Conflicting interpretations of pathogenicity(Last reviewed: May 15, 2013)	criteria provided, conflicting interpretations	9	131380051	9	128617772	139300	143003
NM_001130438.2(SPTAN1):c.5479-41A>C	SPTAN1	not specified	Likely benign	no assertion criteria provided	9	131380225	9	128617946	160018	168783
NM_001130438.2(SPTAN1):c.5523C>T (p.Ile1841=)	SPTAN1	not specified|Seizures|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Benign/Likely benign(Last reviewed: Nov 19, 2017)	criteria provided, multiple submitters, no conflicts	9	131380310	9	128618031	139301	143004
NM_001130438.2(SPTAN1):c.5925G>A (p.Ala1975=)	SPTAN1	not specified|Seizures|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Benign/Likely benign(Last reviewed: Dec 6, 2017)	criteria provided, multiple submitters, no conflicts	9	131386699	9	128624420	139305	143008
NM_001130438.2(SPTAN1):c.5981A>G (p.Glu1994Gly)	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	9	131386755	9	128624476	160019	168784
NM_001130438.2(SPTAN1):c.6042T>G (p.Ser2014=)	SPTAN1	not specified|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	9	131387431	9	128625152	160020	168785
NM_001130438.2(SPTAN1):c.6280-27C>T	SPTAN1	not specified	Likely benign	no assertion criteria provided	9	131388643	9	128626364	160021	168786
NM_001130438.2(SPTAN1):c.6498C>A (p.Arg2166=)	SPTAN1	Early infantile epileptic encephalopathy 5|not specified|Seizures|not provided|Early infantile epileptic encephalopathy	Conflicting interpretations of pathogenicity(Last reviewed: Aug 8, 2018)	criteria provided, conflicting interpretations	9	131388888	9	128626609	160022	168787
NM_001130438.2(SPTAN1):c.6619_6621delGAG (p.Glu2207del)	SPTAN1	Early infantile epileptic encephalopathy 5|not provided	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	9	131389707 - 131389709	9	128627428 - 128627430	160024	168788
NM_001130438.2(SPTAN1):c.6660C>T (p.Asn2220=)	SPTAN1	not specified|Seizures|not provided|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Benign/Likely benign(Last reviewed: Aug 8, 2018)	criteria provided, multiple submitters, no conflicts	9	131389748	9	128627469	139311	143014
NM_001130438.2(SPTAN1):c.6708-47G>A	SPTAN1	not specified	Likely benign	no assertion criteria provided	9	131392553	9	128630274	160025	168789
NM_001130438.2(SPTAN1):c.6708-7C>T	SPTAN1	not specified|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Benign/Likely benign(Last reviewed: Dec 4, 2017)	criteria provided, multiple submitters, no conflicts	9	131392593	9	128630314	139312	143015
NM_001130438.2(SPTAN1):c.6763-7C>T	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	9	131394399	9	128632120	160026	168790
NM_001130438.2(SPTAN1):c.6960-8T>C	SPTAN1	not specified|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Benign/Likely benign(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	9	131394702	9	128632423	160029	168793
NM_001130438.2(SPTAN1):c.7161-9C>T	SPTAN1	Early infantile epileptic encephalopathy 5|not specified|not provided|Early infantile epileptic encephalopathy	Conflicting interpretations of pathogenicity(Last reviewed: Oct 20, 2017)	criteria provided, conflicting interpretations	9	131395078	9	128632799	139316	143019
NM_001130438.2(SPTAN1):c.7309-15T>C	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Sep 7, 2012)	criteria provided, single submitter	9	131395473	9	128633194	160030	168794
NM_001130438.2(SPTAN1):c.7389C>T (p.Thr2463=)	SPTAN1	not specified|Seizures|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Benign/Likely benign(Last reviewed: Jan 10, 2018)	criteria provided, multiple submitters, no conflicts	9	131395568	9	128633289	139320	143023
NC_000009.11:g.130248090_130388197del140108	STXBP1|FAM129B|LRSAM1	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	9	130248090 - 130388197			598748	589818
NM_007313.2(ABL1):c.734A>G (p.Tyr245Cys)	ABL1	Congenital heart disease|Failure to thrive|Abnormality of skeletal morphology|CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME	Pathogenic(Last reviewed: Dec 11, 2016)	criteria provided, single submitter	9	133738277	9	130862890	374795	361696
NM_007313.2(ABL1):c.1066G>A (p.Ala356Thr)	ABL1	Congenital heart disease|Failure to thrive|not provided|Abnormality of skeletal morphology|CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, multiple submitters, no conflicts	9	133748348	9	130872961	374794	361695
NM_000368.4(TSC1):c.3324C>T (p.Gly1108=)	TSC1	Tuberous sclerosis 1|Bladder cancer, somatic|Focal cortical dysplasia type II|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 22, 2017)	criteria provided, multiple submitters, no conflicts	9	135771793	9	132896406	49024	58186
NM_000368.4(TSC1):c.2829C>T (p.Ala943=)	TSC1	Lymphangiomyomatosis|Tuberous sclerosis 1|Bladder cancer, somatic|Focal cortical dysplasia type II|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: May 16, 2017)	criteria provided, multiple submitters, no conflicts	9	135772717	9	132897330	49006	58168
NM_000368.4(TSC1):c.2698C>T (p.Gln900Ter)	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Aug 9, 2013)	criteria provided, single submitter	9	135772925	9	132897538	64826	75755
NM_000368.4(TSC1):c.2675_2676delGA (p.Arg892Lysfs)	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Sep 25, 2014)	criteria provided, single submitter	9	135772947 - 135772948	9	132897560 - 132897561	217251	213816
NM_000368.4(TSC1):c.2672delA (p.Asn891Thrfs)	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	9	135772951	9	132897564	64834	75763
NM_000368.4(TSC1):c.2559_2562delGGTT (p.Leu853Phefs)	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	135776165 - 135776168	9	132900778 - 132900781	48976	58138
NM_000368.3(TSC1):c.2509_2512delAACA (p.Asn837Valfs)	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome|Seizures|not provided|Multiple renal cysts|Cortical tubers	Pathogenic(Last reviewed: Jul 21, 2017)	criteria provided, multiple submitters, no conflicts	9	135776215 - 135776218	9	132900828 - 132900831	48971	58133
NM_000368.4(TSC1):c.2194C>T (p.His732Tyr)	TSC1	Tuberous sclerosis 1|Focal cortical dysplasia type II|Focal cortical dysplasia of Taylor type 2B|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	9	135779052	9	132903665	5103	20142
NM_000368.4(TSC1):c.2074C>T (p.Arg692Ter)	TSC1	Tuberous sclerosis 1|Bladder cancer, somatic|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	9	135779172	9	132903785	48885	58047
NM_000368.4(TSC1):c.2041+1G>A	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Jun 15, 2015)	criteria provided, single submitter	9	135779797	9	132904410	64792	75721
NM_000368.4(TSC1):c.1959dupA (p.Gln654Thrfs)	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Aug 29, 2012)	criteria provided, single submitter	9	135781006	9	132905619	48857	58019
NM_000368.4(TSC1):c.1888_1891delAAAG (p.Lys630Glnfs)	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	9	135781074 - 135781077	9	132905687 - 132905690	5097	20136
NM_000368.4(TSC1):c.1760A>G (p.Lys587Arg)	TSC1	Tuberous sclerosis 1|Focal cortical dysplasia type II|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 22, 2017)	criteria provided, multiple submitters, no conflicts	9	135781205	9	132905818	5099	20138
NM_000368.4(TSC1):c.1698_1704delTGCGGGAinsGC (p.Ala567Argfs)	TSC1	Tuberous sclerosis syndrome	Likely pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	9	135781261 - 135781267	9	132905874 - 132905880	440863	434510
NM_000368.4(TSC1):c.1580_1581del (p.Gln527Argfs)	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Aug 5, 2015)	criteria provided, single submitter	9	135781384 - 135781385	9	132905997 - 132905998	48805	57967
NM_000368.4(TSC1):c.1525C>T (p.Arg509Ter)	TSC1	Lymphangiomyomatosis|Tuberous sclerosis 1|Bladder cancer, somatic|Focal cortical dysplasia type II|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, multiple submitters, no conflicts	9	135781440	9	132906053	48796	57958
NM_000368.4(TSC1):c.1431_1434del (p.Glu478Lysfs)	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: May 30, 2014)	criteria provided, single submitter	9	135782122 - 135782125	9	132906735 - 132906738	48779	57941
NM_000368.4(TSC1):c.1335A>G (p.Glu445=)	TSC1	Tuberous sclerosis 1|Focal cortical dysplasia type II|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	9	135782221	9	132906834	48768	57930
NM_000368.4(TSC1):c.1257del (p.Arg420Glyfs)	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Sep 30, 2014)	criteria provided, single submitter	9	135785964	9	132910577	48753	57915
NM_000368.4(TSC1):c.989_990del (p.Leu330Glnfs)	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Oct 31, 2014)	criteria provided, single submitter	9	135786879 - 135786880	9	132911492 - 132911493	49134	58296
NM_000368.4(TSC1):c.989dupT (p.Ser331Glufs)	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome|not provided|Renal insufficiency|Hereditary cancer-predisposing syndrome|Renal cortical cysts|Cortical dysplasia	Pathogenic(Last reviewed: Dec 14, 2016)	criteria provided, multiple submitters, no conflicts	9	135786880	9	132911493	49135	58297
NM_000368.4(TSC1):c.973C>T (p.Gln325Ter)	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Feb 10, 2016)	criteria provided, multiple submitters, no conflicts	9	135786896	9	132911509	49130	58292
NM_000368.4(TSC1):c.965T>C (p.Met322Thr)	TSC1	Lymphangiomyomatosis|Tuberous sclerosis 1|Bladder cancer, somatic|Focal cortical dysplasia type II|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 12, 2017)	criteria provided, multiple submitters, no conflicts	9	135786904	9	132911517	41700	50139
NM_000368.4(TSC1):c.901_902del (p.Gln301Glufs)	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Dec 18, 2014)	criteria provided, multiple submitters, no conflicts	9	135787680 - 135787681	9	132912293 - 132912294	49120	58282
NM_000368.4(TSC1):c.866C>G (p.Ser289Ter)	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Oct 17, 2014)	criteria provided, single submitter	9	135787716	9	132912329	64822	75751
NM_000368.4(TSC1):c.733C>T (p.Arg245Ter)	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, multiple submitters, no conflicts	9	135796754	9	132921367	49091	58253
NM_000368.4(TSC1):c.682C>T (p.Arg228Ter)	TSC1	Lymphangiomyomatosis|Tuberous sclerosis 1|Focal cortical dysplasia type II|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, multiple submitters, no conflicts	9	135796805	9	132921418	49083	58245
NM_000368.4(TSC1):c.664-1G>C	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Jun 27, 2012)	criteria provided, single submitter	9	135796824	9	132921437	49081	58243
NM_000368.4(TSC1):c.346T>G (p.Leu116Val)	TSC1	Tuberous sclerosis 1|Focal cortical dysplasia type II|Autism spectrum disorder|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2018)	criteria provided, conflicting interpretations	9	135800991	9	132925604	64814	75743
NM_000368.4(TSC1):c.271_272del (p.Ser91Valfs)	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Oct 9, 2013)	criteria provided, single submitter	9	135801065 - 135801066	9	132925678 - 132925679	48996	58158
NM_000368.4(TSC1):c.211-2A>C	TSC1	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Mar 10, 2015)	criteria provided, single submitter	9	135801128	9	132925741	48903	58065
NM_001807.4(CEL):c.362T>G (p.Leu121Arg)	CEL	not specified|Monogenic diabetes	Benign(Last reviewed: Mar 10, 2017)	criteria provided, multiple submitters, no conflicts	9	135940439	9	133065052	128684	134133
NM_001807.4(CEL):c.1719C>T (p.Pro573=)	CEL	not specified	Likely benign	no assertion criteria provided	9	135946599	9	133071212	128685	134134
NM_001807.4(CEL):c.1785delC (p.Val596Cysfs)	CEL	Maturity-onset diabetes of the young, type 8	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	9	135946665	9	133071278	35815	44479
NM_001807.4(CEL):c.1941G>C (p.Gly647=)	CEL	not provided	Uncertain significance(Last reviewed: Jan 17, 2013)	criteria provided, single submitter	9	135946821	9	133071434	128686	134135
NM_001807.4(CEL):c.1969T>G (p.Ser657Ala)	CEL	not provided	Uncertain significance(Last reviewed: Jan 17, 2013)	criteria provided, single submitter	9	135946849	9	133071462	128687	134136
NM_001807.4(CEL):c.1975G>C (p.Ala659Pro)	CEL	not provided|Glomerulonephritis|Autoimmunity|Chronic gastritis|Gastritis|Crescentic glomerulonephritis|Chronic kidney disease|Thyroiditis|Type I diabetes mellitus|Autosomal dominant inheritance|Diabetes mellitus|X-linked dominant inheritance	Uncertain significance(Last reviewed: Feb 24, 2014)	criteria provided, multiple submitters, no conflicts	9	135946855	9	133071468	128688	134137
NM_001807.4(CEL):c.2007C>G (p.Gly669=)	CEL	not specified	Likely benign	no assertion criteria provided	9	135946887	9	133071500	128689	134138
NM_001807.4(CEL):c.2073C>G (p.Gly691=)	CEL	not specified	Benign(Last reviewed: Feb 14, 2014)	criteria provided, single submitter	9	135946953	9	133071566	128690	134139
NM_001807.4(CEL):c.2101T>G (p.Ser701Ala)	CEL	not provided	Uncertain significance(Last reviewed: Jan 17, 2013)	criteria provided, single submitter	9	135946981	9	133071594	128691	134140
NM_000093.4(COL5A1):c.406C>T (p.Pro136Ser)	COL5A1	Ehlers-Danlos syndrome, type 2|Ehlers-Danlos syndrome, classic type	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2017)	criteria provided, conflicting interpretations	9	137591883	9	134700037	209143	205759
NM_000093.4(COL5A1):c.3762delT (p.Gly1255Alafs)	COL5A1	Ehlers-Danlos syndrome, type 2|Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	9	137704468	9	134812622	374262	361194
NM_020822.2(KCNT1):c.59G>C (p.Gly20Ala)	KCNT1	not specified|Seizures|Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5|not provided	Benign/Likely benign(Last reviewed: Jan 8, 2018)	criteria provided, multiple submitters, no conflicts	9	138594163	9	135702317	129366	134812
NM_020822.2(KCNT1):c.711C>G (p.Pro237=)	KCNT1	not specified|Seizures|Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	9	138649179	9	135757333	129367	134813
NM_020822.2(KCNT1):c.800T>C (p.Met267Thr)	KCNT1	Early infantile epileptic encephalopathy 14	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	138650300	9	135758454	561039	552136
NM_020822.2(KCNT1):c.862G>A (p.Gly288Ser)	KCNT1	Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5|not provided	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	9	138651532	9	135759686	126421	131953
NM_020822.2(KCNT1):c.978A>G (p.Pro326=)	KCNT1	not specified|Seizures|Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Benign(Last reviewed: Jan 10, 2018)	criteria provided, multiple submitters, no conflicts	9	138651648	9	135759802	129368	134814
NM_020822.2(KCNT1):c.1066C>T (p.Arg356Trp)	KCNT1	Early infantile epileptic encephalopathy 14|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	9	138656907	9	135765061	389450	370985
NM_020822.2(KCNT1):c.1257C>G (p.Val419=)	KCNT1	not provided	Uncertain significance(Last reviewed: Oct 2, 2013)	criteria provided, single submitter	9	138657526	9	135765680	129352	134798
NM_020822.2(KCNT1):c.1283G>A (p.Arg428Gln)	KCNT1	Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5|not provided	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, multiple submitters, no conflicts	9	138657552	9	135765706	39593	48192
NM_020822.2(KCNT1):c.1421G>A (p.Arg474His)	KCNT1	Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	9	138660694	9	135768848	39595	48194
NM_020822.2(KCNT1):c.1749G>A (p.Ala583=)	KCNT1	not specified|Seizures	Benign(Last reviewed: Jan 8, 2016)	criteria provided, multiple submitters, no conflicts	9	138662273	9	135770427	129353	134799
NM_020822.2(KCNT1):c.1879A>G (p.Ile627Val)	KCNT1	not specified|Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 16, 2017)	criteria provided, conflicting interpretations	9	138662812	9	135770966	129354	134800
NM_020822.2(KCNT1):c.2034C>T (p.Gly678=)	KCNT1	not specified|Seizures|Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 6, 2017)	criteria provided, conflicting interpretations	9	138664586	9	135772740	129355	134801
NM_020822.2(KCNT1):c.2210C>T (p.Thr737Met)	KCNT1	not specified|Seizures|Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Benign(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	9	138664762	9	135772916	129356	134802
NM_020822.2(KCNT1):c.2427G>A (p.Thr809=)	KCNT1	not specified|Seizures|not provided	Benign(Last reviewed: May 6, 2018)	criteria provided, multiple submitters, no conflicts	9	138669261	9	135777415	129357	134803
NM_020822.2(KCNT1):c.2619C>T (p.Gly873=)	KCNT1	not specified|Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Benign(Last reviewed: Oct 9, 2017)	criteria provided, multiple submitters, no conflicts	9	138670558	9	135778712	129359	134805
NM_020822.2(KCNT1):c.2795T>C (p.Phe932Ser)	KCNT1	Early infantile epileptic encephalopathy 14	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	138671270	9	135779424	561038	552137
NM_020822.2(KCNT1):c.2800G>A (p.Ala934Thr)	KCNT1	Early infantile epileptic encephalopathy 14|not provided	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, multiple submitters, no conflicts	9	138671275	9	135779429	39594	48193
NM_020822.2(KCNT1):c.2882G>A (p.Arg961His)	KCNT1	not provided|Focal epilepsy	Conflicting interpretations of pathogenicity(Last reviewed: Aug 14, 2018)	criteria provided, conflicting interpretations	9	138675910	9	135784064	129360	134806
NM_020822.2(KCNT1):c.2943+6C>T	KCNT1	not specified|Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5|not provided	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	9	138675977	9	135784131	129361	134807
NM_020822.2(KCNT1):c.3312G>A (p.Leu1104=)	KCNT1	not specified|Seizures|Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Benign(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	9	138678177	9	135786331	129363	134809
NM_020822.2(KCNT1):c.3388G>A (p.Ala1130Thr)	KCNT1	not specified|Seizures|Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5|not provided	Benign/Likely benign(Last reviewed: Jul 21, 2017)	criteria provided, multiple submitters, no conflicts	9	138678253	9	135786407	129364	134810
NM_020822.2(KCNT1):c.3390G>A (p.Ala1130=)	KCNT1	not specified|Seizures|Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Benign(Last reviewed: Dec 6, 2017)	criteria provided, multiple submitters, no conflicts	9	138678255	9	135786409	129365	134811
NM_017617.5(NOTCH1):c.6348C>G (p.Tyr2116Ter)	NOTCH1	Aortic valve disorder	Pathogenic(Last reviewed: May 5, 2014)	no assertion criteria provided	9	139391843	9	136497391	374271	361195
NM_017617.4(NOTCH1):c.2380delG (p.Glu794Serfs)	NOTCH1	Aortic valve disorder	Likely pathogenic(Last reviewed: Jun 26, 2012)	criteria provided, single submitter	9	139407560	9	136513108	216971	213589
NM_007327.3(GRIN1):c.789A>G (p.Pro263=)	GRIN1	not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	9	140051238	9	137156786	129182	134628
NM_007327.3(GRIN1):c.855G>A (p.Val285=)	GRIN1	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jan 7, 2016)	criteria provided, multiple submitters, no conflicts	9	140051376	9	137156924	129183	134629
NM_007327.3(GRIN1):c.1340C>T (p.Pro447Leu)	GRIN1	not provided	Uncertain significance(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	9	140055741	9	137161289	129178	134624
NM_007327.3(GRIN1):c.1467+8G>A	GRIN1	not specified|not provided	Benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	9	140055876	9	137161424	129179	134625
NM_007327.3(GRIN1):c.1858G>C (p.Gly620Arg)	GRIN1	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, multiple submitters, no conflicts	9	140056962	9	137162510	209159	205760
NM_007327.3(GRIN1):c.1964T>A (p.Leu655Gln)	GRIN1	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	140057142	9	137162690	561020	552138
NM_007327.3(GRIN1):c.2241G>C (p.Val747=)	GRIN1	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	9	140057690	9	137163238	129180	134626
NM_007327.3(GRIN1):c.2244G>C (p.Thr748=)	GRIN1	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	9	140057693	9	137163241	129181	134627
NM_007327.3(GRIN1):c.2479G>A (p.Gly827Arg)	GRIN1	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	140058246	9	137163794	487503	480554
NM_024757.4(EHMT1):c.128C>G (p.Ala43Gly)	EHMT1	Chromosome 9q deletion syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	140611120	9	137716668	96139	102033
NM_024757.4(EHMT1):c.129A>T (p.Ala43=)	EHMT1	Chromosome 9q deletion syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	9	140611121	9	137716669	96140	102034
NM_024757.4(EHMT1):c.148G>A (p.Ala50Thr)	EHMT1	Chromosome 9q deletion syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Dec 20, 2017)	criteria provided, multiple submitters, no conflicts	9	140611140	9	137716688	128976	134423
NM_024757.4(EHMT1):c.309G>A (p.Ala103=)	EHMT1	not provided	Uncertain significance(Last reviewed: Sep 6, 2018)	criteria provided, multiple submitters, no conflicts	9	140611301	9	137716849	128980	134427
NM_024757.4(EHMT1):c.316C>G (p.Gln106Glu)	EHMT1	Chromosome 9q deletion syndrome|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	9	140611308	9	137716856	128981	134428
NM_024757.4(EHMT1):c.391delG (p.Ala131Profs)	EHMT1	Chromosome 9q deletion syndrome	Pathogenic(Last reviewed: Feb 20, 2014)	criteria provided, single submitter	9	140611383	9	137716931	209152	205761
NM_024757.4(EHMT1):c.444T>C (p.Pro148=)	EHMT1	Chromosome 9q deletion syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	140611436	9	137716984	65738	76646
NM_024757.4(EHMT1):c.871C>T (p.Arg291Ter)	EHMT1	Chromosome 9q deletion syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	140637870	9	137743418	3608	18647
NM_024757.4(EHMT1):c.1044G>A (p.Ser348=)	EHMT1	Chromosome 9q deletion syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	140638416	9	137743964	65723	76631
NM_024757.4(EHMT1):c.1089T>C (p.Gly363=)	EHMT1	Chromosome 9q deletion syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	140638461	9	137744009	65724	76632
NM_024757.4(EHMT1):c.1162G>A (p.Ala388Thr)	EHMT1	Chromosome 9q deletion syndrome|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jul 20, 2017)	criteria provided, multiple submitters, no conflicts	9	140638534	9	137744082	128975	134422
NM_024757.4(EHMT1):c.1368C>T (p.Leu456=)	EHMT1	Chromosome 9q deletion syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	140648742	9	137754290	65725	76633
NM_024757.4(EHMT1):c.1434_1435delGT (p.Tyr479Hisfs)	EHMT1	Chromosome 9q deletion syndrome	Pathogenic	criteria provided, single submitter	9	140652396 - 140652397	9	137757944 - 137757945	431703	425215
NM_024757.4(EHMT1):c.1865A>G (p.Asn622Ser)	EHMT1	Chromosome 9q deletion syndrome|not specified|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: May 14, 2018)	criteria provided, conflicting interpretations	9	140671143	9	137776691	128977	134424
NM_024757.4(EHMT1):c.1869C>T (p.Asn623=)	EHMT1	Chromosome 9q deletion syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	9	140671147	9	137776695	96145	102039
NM_024757.4(EHMT1):c.2224delC (p.Leu742Cysfs)	EHMT1	Chromosome 9q deletion syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	140674117 - 140674118	9	137779666	560999	552139
NM_024757.4(EHMT1):c.2426C>T (p.Pro809Leu)	EHMT1	not provided	Uncertain significance(Last reviewed: Mar 18, 2014)	criteria provided, single submitter	9	140685343	9	137790891	128978	134425
NM_024757.4(EHMT1):c.2516G>T (p.Gly839Val)	EHMT1	Chromosome 9q deletion syndrome	Likely pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	9	140693275	9	137798823	522804	513433
NM_024757.4(EHMT1):c.3000C>T (p.Pro1000=)	EHMT1	Chromosome 9q deletion syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	9	140707590	9	137813138	96151	102045
NM_024757.4(EHMT1):c.3087G>A (p.Val1029=)	EHMT1	Chromosome 9q deletion syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	9	140707889	9	137813437	128979	134426
NM_024757.4(EHMT1):c.3375-9A>C	EHMT1	Chromosome 9q deletion syndrome|not specified	Benign(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	9	140711882	9	137817430	96155	102049
NM_024757.4(EHMT1):c.3413G>A (p.Trp1138Ter)	EHMT1	Chromosome 9q deletion syndrome|Autism spectrum disorder	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	9	140711929	9	137817477	221980	223668
NC_000009.12:g.(127502019_127502774)_(127502992_?)del	LRSAM1	Charcot-Marie-Tooth disease type 2P	Likely pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	9	130264298 - 130265271	9	127502019 - 127502992	598943	590030
NM_006624.5(ZMYND11):c.383del (p.Ser128Leufs)	ZMYND11	Mental retardation, autosomal dominant 30	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	10	267241	10	221301	431092	424615
NM_001202468.1(ZMYND11):c.1262G>A (p.Ser421Asn)	ZMYND11	not provided|Intellectual disability|Mental retardation, autosomal dominant 30	Likely pathogenic(Last reviewed: Jan 19, 2016)	criteria provided, single submitter	10	294310	10	248370	225254	227161
NM_001002295.1(GATA3):c.1051-1G>C	GATA3	Stage 5 chronic kidney disease	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	10	8115701	10	8073738	430696	424227
NM_018706.6(DHTKD1):c.2500C>T (p.Arg834Ter)	DHTKD1	not provided|Charcot-Marie-Tooth disease, axonal, type 2Q	Likely pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, multiple submitters, no conflicts	10	12160845	10	12118846	216917	213597
NM_201596.2(CACNB2):c.121-2A>T	CACNB2	Brugada syndrome	Uncertain significance(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	10	18439810	10	18150881	226042	227847
NM_201596.2(CACNB2):c.121-1G>T	CACNB2	Brugada syndrome	Uncertain significance(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	10	18439811	10	18150882	226043	227848
NM_000724.3(CACNB2):c.215C>T (p.Ala72Val)	CACNB2	Brugada syndrome 4|Ventricular fibrillation, idiopathic|not specified|Cardiovascular phenotype	Uncertain significance(Last reviewed: Apr 6, 2018)	criteria provided, multiple submitters, no conflicts	10	18787330	10	18498401	161209	171118
NM_000724.3(CACNB2):c.425C>T (p.Ser142Phe)	CACNB2	Brugada syndrome 4|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 14, 2018)	criteria provided, conflicting interpretations	10	18789874	10	18500945	161210	171119
NM_000724.3(CACNB2):c.476G>C (p.Ser159Thr)	CACNB2	Brugada syndrome 4|Early repolarization associated with ventricular fibrillation|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2018)	criteria provided, conflicting interpretations	10	18795447	10	18506518	161211	171120
NM_000724.3(CACNB2):c.1015G>A (p.Val339Ile)	CACNB2|NSUN6	Brugada syndrome|not specified	Uncertain significance(Last reviewed: Jun 23, 2016)	criteria provided, single submitter	10	18823130	10	18534201	161214	171121
NM_201590.2(CACNB2):c.1114G>A (p.Ala372Thr)	CACNB2|NSUN6	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	10	18825099	10	18536170	427977	419279
NM_000724.3(CACNB2):c.1346C>T (p.Thr449Ile)	CACNB2|NSUN6	Brugada syndrome 4|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 13, 2018)	criteria provided, conflicting interpretations	10	18828181	10	18539252	161212	171122
NM_000724.3(CACNB2):c.1611C>A (p.Asp537Glu)	CACNB2|NSUN6	Brugada syndrome 4|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Aug 11, 2017)	criteria provided, conflicting interpretations	10	18828446	10	18539517	161213	171123
NM_016628.4(WAC):c.1537C>T (p.Arg513Ter)	WAC	Desanto-shinawi syndrome	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	10	28903595	10	28614666	584445	575493
NM_020975.4(RET):c.166C>A (p.Leu56Met)	RET	Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|Hirschsprung disease|not specified|not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	10	43595999	10	43100551	36723	45384
NM_020630.4(RET):c.539G>A (p.Arg180Gln)	RET	Multiple endocrine neoplasia, type 2b|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|Hirschsprung disease	Conflicting interpretations of pathogenicity(Last reviewed: Dec 9, 2017)	criteria provided, conflicting interpretations	10	43597991	10	43102543	161360	171124
NM_020975.4(RET):c.785T>C (p.Val262Ala)	RET	Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|Hirschsprung disease|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	10	43600559	10	43105111	41845	50284
NM_020630.5(RET):c.961G>A (p.Gly321Arg)	RET	Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	10	43601917	10	43106469	24881	36222
NM_020975.4(RET):c.1201A>T (p.Ser401Cys)	RET	Multiple endocrine neoplasia, type 2|Congenital anomalies of kidney and urinary tract	Uncertain significance(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	10	43604616	10	43109168	224354	226087
NM_020975.5(RET):c.1280_1281delTG (p.Val427Glyfs)	RET	Hirschsprung disease 1|Sensorineural hearing loss	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	10	43606671 - 43606672	10	43111223 - 43111224	590798	581736
NM_020630.4(RET):c.1424G>A (p.Arg475Gln)	RET	Multiple endocrine neoplasia, type 2|Hirschsprung disease|not specified	Uncertain significance(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	10	43606815	10	43111367	135188	138927
NM_020975.4(RET):c.1531G>A (p.Glu511Lys)	RET	Multiple endocrine neoplasia, type 2b|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	10	43607555	10	43112107	24883	36224
NM_020630.4(RET):c.1852T>G (p.Cys618Gly)	RET	Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, multiple submitters, no conflicts	10	43609096	10	43113648	13905	28944
NM_020975.4(RET):c.1853G>C (p.Cys618Ser)	RET	Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|not provided	Pathogenic(Last reviewed: Apr 8, 2018)	criteria provided, multiple submitters, no conflicts	10	43609097	10	43113649	13914	28953
NM_020975.4(RET):c.1858T>G (p.Cys620Gly)	RET	Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|not specified|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	10	43609102	10	43113654	24905	36246
NM_020630.4(RET):c.1880-2A>G	RET	Hirschsprung disease 1	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	10	43609926	10	43114478	36725	45386
NM_020975.5(RET):c.1900T>C (p.Cys634Arg)	RET	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Pheochromocytoma|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|not provided|Thyroid carcinoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	10	43609948	10	43114500	13917	28956
NM_020975.4(RET):c.1901G>T (p.Cys634Phe)	RET	Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	10	43609949	10	43114501	13911	28950
NM_020975.4(RET):c.1901G>C (p.Cys634Ser)	RET	Pheochromocytoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: May 4, 2018)	no assertion criteria provided	10	43609949	10	43114501	13910	28949
NM_020975.4(RET):c.1901G>A (p.Cys634Tyr)	RET	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Pheochromocytoma|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|not specified|not provided|Hereditary cancer-predisposing syndrome|Neoplasm	Pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	10	43609949	10	43114501	13909	28948
NM_020975.4(RET):c.1902C>G (p.Cys634Trp)	RET	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Pheochromocytoma|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|not provided|Neoplasm of the thyroid gland	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, multiple submitters, no conflicts	10	43609950	10	43114502	13918	28957
NM_020630.5(RET):c.1942G>A (p.Val648Ile)	RET	Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|MEN2 phenotype: Unknown|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	10	43609990	10	43114542	13949	28988
NM_020975.4(RET):c.1946C>T (p.Ser649Leu)	RET	Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|not specified|not provided|Hereditary cancer-predisposing syndrome|Elevated basal serum calcitonin	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	10	43609994	10	43114546	24928	36269
NM_020630.4(RET):c.1996A>G (p.Lys666Glu)	RET	Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 17, 2018)	criteria provided, conflicting interpretations	10	43610044	10	43114596	24931	36272
NM_020630.4(RET):c.1998G>T (p.Lys666Asn)	RET	Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 4, 2018)	criteria provided, conflicting interpretations	10	43610046	10	43114598	24932	36273
NM_020630.4(RET):c.2081G>A (p.Arg694Gln)	RET	Multiple endocrine neoplasia, type 2b|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|Hirschsprung disease|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 3, 2018)	criteria provided, conflicting interpretations	10	43610129	10	43114681	161358	171125
NM_020630.5(RET):c.2372A>T (p.Tyr791Phe)	RET	Familial cancer of breast|Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Pheochromocytoma|Renal adysplasia|Familial medullary thyroid carcinoma|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|Hirschsprung disease|not specified|not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia|Hirschsprung Disease, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	10	43613908	10	43118460	13936	28975
NM_020975.4(RET):c.[2410G>A;2832C>G]	RET	Medullary thyroid carcinoma	Pathogenic(Last reviewed: Jun 15, 2016)	criteria provided, single submitter	10|10	43614996	10|10	43119548	618965	28984|610366
NM_020975.4(RET):c.2410G>A (p.Val804Met)	RET	Congenital central hypoventilation|Hirschsprung disease 1|Multiple endocrine neoplasia, type 2b|Pheochromocytoma|Renal adysplasia|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|MEN2 phenotype: Unclassified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	10	43614996	10	43119548	37102	28984
NM_020630.4(RET):c.2452G>A (p.Glu818Lys)	RET	Multiple endocrine neoplasia, type 2b|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 14, 2017)	criteria provided, multiple submitters, no conflicts	10	43615038	10	43119590	24943	36284
NM_020630.4(RET):c.2522C>T (p.Pro841Leu)	RET	Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|Hirschsprung disease|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 9, 2018)	criteria provided, multiple submitters, no conflicts	10	43615108	10	43119660	24947	36288
NM_020630.4(RET):c.2656C>T (p.Arg886Trp)	RET	Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|not specified|not provided	Uncertain significance(Last reviewed: Oct 20, 2017)	criteria provided, multiple submitters, no conflicts	10	43615577	10	43120129	24960	36301
NM_020975.4(RET):c.2671T>G (p.Ser891Ala)	RET	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Familial medullary thyroid carcinoma|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|not provided|Multiple endocrine neoplasia IIA	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	10	43615592	10	43120144	13951	28990
NM_020630.4(RET):c.3116C>T (p.Pro1039Leu)	RET	Multiple endocrine neoplasia, type 2b|Multiple endocrine neoplasia, type 2a|Central hypoventilation syndrome, congenital, with hirschsprung disease|Multiple endocrine neoplasia, type 2|Hirschsprung disease|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	10	43622099	10	43126651	13948	28987
NM_020975.5(RET):c.3191T>C (p.Met1064Thr)	RET	Multiple endocrine neoplasia, type 2|Hirschsprung disease|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 2, 2018)	criteria provided, multiple submitters, no conflicts	10	43623563	10	43128115	161359	171126
NM_013266.3(CTNNA3):c.2296_2298delTTG (p.Leu766del)	CTNNA3	Arrhythmogenic right ventricular cardiomyopathy|Arrhythmogenic right ventricular dysplasia, familial, 13	Pathogenic(Last reviewed: Apr 18, 2017)	no assertion criteria provided	10	67726472 - 67726474	10	65966714 - 65966716	100657	106529
NM_032578.3(MYPN):c.458A>G (p.Lys153Arg)	MYPN	Primary dilated cardiomyopathy|not provided|Dilated cardiomyopathy 1KK	Likely pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	10	69881653	10	68121896	31812	40472
NM_032578.3(MYPN):c.802C>T (p.Pro268Ser)	MYPN	Cardiomyopathy, restrictive	Uncertain significance	criteria provided, single submitter	10	69881997	10	68122240	444869	438509
NM_015634.3(KIF1BP):c.78A>G (p.Lys26=)	KIF1BP	Goldberg-Shprintzen megacolon syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 3, 2017)	criteria provided, conflicting interpretations	10	70748666	10	68988910	158699	168842
NM_015634.3(KIF1BP):c.196G>A (p.Gly66Ser)	KIF1BP	Goldberg-Shprintzen megacolon syndrome|not specified|not provided	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	10	70748784	10	68989028	158696	168843
NM_015634.3(KIF1BP):c.518T>C (p.Met173Thr)	KIF1BP	not specified|not provided	Benign(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	10	70760271	10	69000515	158697	168844
NM_015634.3(KIF1BP):c.925G>A (p.Glu309Lys)	KIF1BP	Goldberg-Shprintzen megacolon syndrome	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	10	70770706	10	69010950	158700	168845
NM_015634.3(KIF1BP):c.1023G>A (p.Gln341=)	KIF1BP	not specified	Benign(Last reviewed: Mar 2, 2016)	criteria provided, multiple submitters, no conflicts	10	70775329	10	69015573	158692	168846
NM_015634.3(KIF1BP):c.1653C>T (p.Ala551=)	KIF1BP	Goldberg-Shprintzen megacolon syndrome|not specified|not provided	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	10	70775959	10	69016203	158694	168848
NM_015634.3(KIF1BP):c.1761T>C (p.Pro587=)	KIF1BP	not specified	Benign(Last reviewed: Jan 23, 2017)	criteria provided, multiple submitters, no conflicts	10	70776067	10	69016311	158695	168849
NM_152710.3(TBATA):c.157C>T (p.Arg53Cys)	TBATA	Hirschsprung disease 1	Likely pathogenic(Last reviewed: Sep 26, 2016)	no assertion criteria provided	10	72541677	10	70781921	375275	362046
NM_014000.2(VCL):c.220A>G (p.Met74Val)	VCL	Hypertrophic cardiomyopathy	Likely benign(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	10	75802892	10	74043134	427981	419280
NM_014000.2(VCL):c.1531G>T (p.Asp511Tyr)	VCL	Familial hypertrophic cardiomyopathy 15	Likely pathogenic	criteria provided, single submitter	10	75854207	10	74094449	217497	214108
NM_014000.2(VCL):c.1544-2A>G	VCL	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Apr 23, 2014)	criteria provided, single submitter	10	75855412	10	74095654	166546	175295
NM_014000.2(VCL):c.1713delA (p.Ala573Hisfs)	VCL	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1W	Conflicting interpretations of pathogenicity(Last reviewed: Jul 19, 2017)	criteria provided, conflicting interpretations	10	75855583	10	74095825	468811	460257
NM_014000.2(VCL):c.2046A>T (p.Leu682Phe)	VCL	Dilated cardiomyopathy 1W|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Aug 17, 2017)	criteria provided, multiple submitters, no conflicts	10	75863601	10	74103843	166551	175019
NM_012330.3(KAT6B):c.3544G>A (p.Glu1182Lys)	KAT6B	Mental retardation, autosomal dominant	Likely benign	no assertion criteria provided	10	76784887	10	75025129	377388	364270
NM_012330.3(KAT6B):c.3581delA (p.Gln1194Argfs)	KAT6B	Genitopatellar syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	10	76784923 - 76784924	10	75025166	561036	552145
NM_012330.3(KAT6B):c.3664+1G>A	KAT6B	Young Simpson syndrome	Pathogenic(Last reviewed: May 5, 2015)	criteria provided, single submitter	10	76785008	10	75025250	369663	353900
NM_012330.3(KAT6B):c.3962_3963delAA (p.Gln1321Argfs)	KAT6B|DUPD1	Young Simpson syndrome	Likely pathogenic(Last reviewed: Aug 13, 2013)	criteria provided, single submitter	10	76788544 - 76788545	10	75028786 - 75028787	216946	213599
NM_012330.3(KAT6B):c.4582delA (p.Glu1529Argfs)	KAT6B|DUPD1	Young Simpson syndrome	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	10	76789164	10	75029406	488535	481403
NM_002247.3(KCNMA1):c.3021C>T (p.Thr1007=)	KCNMA1|KCNMA1-AS1	Generalized epilepsy and paroxysmal dyskinesia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	10	78651430	10	76891672	129326	134772
NM_002247.3(KCNMA1):c.2984A>G (p.Asn995Ser)	KCNMA1|KCNMA1-AS1	Generalized epilepsy and paroxysmal dyskinesia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 5, 2018)	criteria provided, conflicting interpretations	10	78651467	10	76891709	265313	259940
NM_002247.3(KCNMA1):c.2536-8T>C	KCNMA1|KCNMA1-AS1	Generalized epilepsy and paroxysmal dyskinesia|not specified	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	10	78704731	10	76944973	129325	134771
NM_002247.3(KCNMA1):c.2352C>T (p.Val784=)	KCNMA1|KCNMA1-AS1	Generalized epilepsy and paroxysmal dyskinesia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 4, 2018)	criteria provided, conflicting interpretations	10	78709083	10	76949325	129324	134770
NM_002247.3(KCNMA1):c.2217T>C (p.Asp739=)	KCNMA1|KCNMA1-AS1	Generalized epilepsy and paroxysmal dyskinesia|not specified	Benign/Likely benign(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	10	78713652	10	76953894	129323	134769
NM_002247.3(KCNMA1):c.2193C>A (p.Asp731Glu)	KCNMA1|KCNMA1-AS1	not provided	Uncertain significance(Last reviewed: Jan 15, 2014)	criteria provided, single submitter	10	78713676	10	76953918	129322	134768
NM_002247.3(KCNMA1):c.2015+7G>A	KCNMA1	Generalized epilepsy and paroxysmal dyskinesia|not specified	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	10	78778764	10	77019006	129321	134767
NM_002247.3(KCNMA1):c.1680C>A (p.Ala560=)	KCNMA1	Generalized epilepsy and paroxysmal dyskinesia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 28, 2017)	criteria provided, conflicting interpretations	10	78832924	10	77073166	129320	134766
NM_002247.3(KCNMA1):c.1578G>T (p.Leu526=)	KCNMA1	Generalized epilepsy and paroxysmal dyskinesia|not specified	Benign/Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	10	78839254	10	77079496	129319	134765
NM_002247.3(KCNMA1):c.1060G>A (p.Gly354Ser)	KCNMA1	Generalized epilepsy and paroxysmal dyskinesia	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	10	78870002	10	77110244	561037	552146
NM_002247.3(KCNMA1):c.1054A>G (p.Thr352Ala)	KCNMA1	Generalized epilepsy and paroxysmal dyskinesia	Likely pathogenic(Last reviewed: Dec 3, 2013)	criteria provided, single submitter	10	78870008	10	77110250	216948	213600
NM_002247.3(KCNMA1):c.687C>T (p.Phe229=)	KCNMA1	Generalized epilepsy and paroxysmal dyskinesia|not specified|not provided	Benign/Likely benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	10	78944590	10	77184832	129328	134774
NM_002247.3(KCNMA1):c.90C>T (p.His30=)	KCNMA1	Generalized epilepsy and paroxysmal dyskinesia|not specified|not provided	Benign/Likely benign(Last reviewed: Nov 30, 2017)	criteria provided, multiple submitters, no conflicts	10	79397311	10	77637553	129329	134775
NM_002247.3(KCNMA1):c.31_54delAGCAGCGGCGGCGGCGGCGGCGGC (p.Ser11_Gly18del)	KCNMA1	Generalized epilepsy and paroxysmal dyskinesia|not provided	Uncertain significance(Last reviewed: Dec 8, 2017)	criteria provided, multiple submitters, no conflicts	10	79397347 - 79397370	10	77637589 - 77637612	129327	134773
NM_033022.3(RPS24):c.148A>C (p.Thr50Pro)	RPS24	Diamond-Blackfan anemia 3	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	10	79795347	10	78035589	549764	540530
NM_007078.2(LDB3):c.91C>T (p.Arg31Trp)	LDB3	Myofibrillar myopathy, ZASP-related|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Nov 13, 2017)	criteria provided, multiple submitters, no conflicts	10	88428539	10	86668782	201857	198308
NM_001080116.1(LDB3):c.290A>G (p.Gln97Arg)	LDB3	Familial hypertrophic cardiomyopathy 1|Myofibrillar myopathy, ZASP-related	Uncertain significance(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	10	88439883	10	86680126	217828	214486
NM_004329.2(BMPR1A):c.1243G>A (p.Glu415Lys)	BMPR1A	Juvenile polyposis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Gastrointestinal polyposis|Juvenile Polyposis	Conflicting interpretations of pathogenicity(Last reviewed: Mar 12, 2018)	criteria provided, conflicting interpretations	10	88681353	10	86921596	41779	50218
NM_004329.2(BMPR1A):c.1327C>T (p.Arg443Cys)	BMPR1A	Juvenile polyposis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Juvenile Polyposis	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	10	88681437	10	86921680	133717	137456
NM_004329.2(BMPR1A):c.1433G>A (p.Arg478His)	BMPR1A	Juvenile polyposis syndrome|Hereditary mixed polyposis syndrome 2|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 26, 2018)	criteria provided, conflicting interpretations	10	88683223	10	86923466	41780	50219
NM_005271.4(GLUD1):c.1493C>T (p.Ser498Leu)	GLUD1	Hyperinsulinism-hyperammonemia syndrome|not provided	Pathogenic(Last reviewed: Aug 14, 2014)	criteria provided, multiple submitters, no conflicts	10	88817449	10	87057692	16122	31161
NM_005271.4(GLUD1):c.1470G>A (p.Thr490=)	GLUD1	not specified|not provided|Hyperinsulinism, Dominant	Benign/Likely benign(Last reviewed: Nov 13, 2017)	criteria provided, multiple submitters, no conflicts	10	88817472	10	87057715	129163	134609
NM_005271.4(GLUD1):c.1060-10T>A	GLUD1	not specified|not provided|Hyperinsulinism, Dominant	Benign/Likely benign(Last reviewed: Nov 20, 2017)	criteria provided, multiple submitters, no conflicts	10	88820592	10	87060835	129162	134608
NM_005271.4(GLUD1):c.942A>G (p.Leu314=)	GLUD1	Hyperinsulinism-hyperammonemia syndrome|not specified|Hyperinsulinism, Dominant	Benign/Likely benign(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	10	88820789	10	87061032	129164	134610
NM_005271.4(GLUD1):c.342T>C (p.His114=)	GLUD1	Hyperinsulinism-hyperammonemia syndrome|not specified|Hyperinsulinism, Dominant	Benign/Likely benign(Last reviewed: Oct 5, 2017)	criteria provided, multiple submitters, no conflicts	10	88854185	10	87094428	129161	134607
NM_000314.6(PTEN):c.-1311T>C	PTEN|KLLN	PTEN hamartoma tumor syndrome|not specified	Benign(Last reviewed: Jun 2, 2017)	reviewed by expert panel	10	89622915	10	87863158	127667	133124
NM_000314.6(PTEN):c.-1170C>T	PTEN|KLLN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 8, 2017)	reviewed by expert panel	10	89623056	10	87863299	127662	133119
NM_000314.7(PTEN):c.-1142C>T	PTEN|KLLN	PTEN hamartoma tumor syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 6, 2018)	reviewed by expert panel	10	89623084	10	87863327	127661	133118
NM_000314.6(PTEN):c.-1059C>G	PTEN|KLLN	PTEN hamartoma tumor syndrome|not specified|not provided	Benign(Last reviewed: Sep 14, 2016)	reviewed by expert panel	10	89623167	10	87863410	189520	172162
NM_000314.6(PTEN):c.-1026C>A	PTEN	PTEN hamartoma tumor syndrome|not specified	Likely benign(Last reviewed: Nov 9, 2016)	reviewed by expert panel	10	89623200	10	87863443	138836	142539
NM_000314.6(PTEN):c.-903G>A	PTEN	PTEN hamartoma tumor syndrome|not specified	Benign(Last reviewed: Sep 14, 2016)	reviewed by expert panel	10	89623323	10	87863566	138837	142540
NM_000314.7(PTEN):c.-798G>C	PTEN	PTEN hamartoma tumor syndrome|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 6, 2018)	reviewed by expert panel	10	89623428	10	87863671	127674	133131
NM_000314.6(PTEN):c.-764G>A	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|not specified	Uncertain significance(Last reviewed: Apr 6, 2018)	reviewed by expert panel	10	89623462	10	87863705	7844	22883
NM_000314.6(PTEN):c.-734G>A	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Feb 6, 2018)	criteria provided, conflicting interpretations	10	89623492	10	87863735	127672	133129
NM_000314.6(PTEN):c.-9C>G	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 9, 2016)	reviewed by expert panel	10	89624218	10	87864461	92808	98715
NM_000314.6(PTEN):c.18A>G (p.Lys6=)	PTEN	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 12, 2016)	reviewed by expert panel	10	89624244	10	87864487	233415	233839
NM_000314.6(PTEN):c.35A>C (p.Asn12Thr)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89624261	10	87864504	427586	416933
NM_000314.6(PTEN):c.40A>G (p.Arg14Gly)	PTEN	PTEN hamartoma tumor syndrome|not provided	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89624266	10	87864509	427589	416934
NM_000314.6(PTEN):c.40dup (p.Arg14Lysfs)	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1	Pathogenic(Last reviewed: Apr 6, 2018)	reviewed by expert panel	10	89624266	10	87864509	7834	22873
NM_000314.6(PTEN):c.44G>A (p.Arg15Lys)	PTEN	PTEN hamartoma tumor syndrome|not provided	Uncertain significance(Last reviewed: Jan 3, 2018)	reviewed by expert panel	10	89624270	10	87864513	404147	397912
NM_000314.6(PTEN):c.50_51delAA (p.Gln17Argfs)	PTEN	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89624276 - 89624277	10	87864519 - 87864520	141654	151368
NM_000314.6(PTEN):c.75G>A (p.Leu25=)	PTEN	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 14, 2016)	reviewed by expert panel	10	89624301	10	87864544	184505	183008
NM_000314.6(PTEN):c.78C>T (p.Thr26=)	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 18, 2017)	reviewed by expert panel	10	89624304	10	87864547	184104	183009
NM_000314.6(PTEN):c.79+35C>T	PTEN	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Sep 14, 2016)	reviewed by expert panel	10	89624340	10	87864583	92827	98734
NC_000010.9:g.87887949_90299688del		Chromosome 10q22.3-q23.2 deletion syndrome	Pathogenic(Last reviewed: Dec 21, 2016)	no assertion criteria provided					441234	434864
NM_000314.6(PTEN):c.80-1G>C	PTEN	PTEN hamartoma tumor syndrome|not provided	Likely pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89653781	10	87894024	189462	187328
NM_000314.6(PTEN):c.103A>G (p.Met35Val)	PTEN	PTEN hamartoma tumor syndrome|not provided|Inborn genetic diseases	Likely pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89653805	10	87894048	231916	233842
NM_000314.6(PTEN):c.131G>A (p.Gly44Asp)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89653833	10	87894076	427582	416935
NM_000314.6(PTEN):c.132C>T (p.Gly44=)	PTEN	PTEN hamartoma tumor syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 9, 2016)	reviewed by expert panel	10	89653834	10	87894077	92813	98720
NM_000314.6(PTEN):c.164+1G>C	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89653867	10	87894110	427583	416936
NM_000314.6(PTEN):c.165-13_165-10delGTTT	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 14, 2016)	reviewed by expert panel	10	89685257 - 89685260	10	87925500 - 87925503	189425	187336
NM_000314.6(PTEN):c.165-2A>G	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|not provided	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	10	89685268	10	87925511	427584	416937
NM_000314.6(PTEN):c.165-1G>A	PTEN	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89685269	10	87925512	187590	183017
NM_000314.6(PTEN):c.182A>G (p.His61Arg)	PTEN	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, multiple submitters, no conflicts	10	89685287	10	87925530	189402	187337
NM_000314.6(PTEN):c.209+3A>T	PTEN	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 8, 2017)	reviewed by expert panel	10	89685317	10	87925560	185989	183020
NM_000314.6(PTEN):c.209+4_209+7delAGTA	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 18, 2017)	reviewed by expert panel	10	89685318 - 89685321	10	87925561 - 87925564	92816	98723
NM_000314.7(PTEN):c.235G>A (p.Ala79Thr)	PTEN	Endometrial carcinoma|Macrocephaly/autism syndrome|Meningioma, familial|Squamous cell carcinoma of the head and neck|Bannayan-Riley-Ruvalcaba syndrome|Malignant tumor of prostate|Follicular thyroid carcinoma|VACTERL association with hydrocephalus|Glioma susceptibility 2|PTEN hamartoma tumor syndrome|Cowden syndrome 1|Cutaneous malignant melanoma 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 6, 2018)	reviewed by expert panel	10	89690828	10	87931071	41682	50121
NM_000314.6(PTEN):c.253+1G>C	PTEN	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, multiple submitters, no conflicts	10	89690847	10	87931090	427585	416938
NM_000314.6(PTEN):c.254-39G>T	PTEN	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 14, 2016)	reviewed by expert panel	10	89692731	10	87932974	92818	98725
NM_000314.6(PTEN):c.284C>T (p.Pro95Leu)	PTEN	PTEN hamartoma tumor syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2018)	criteria provided, conflicting interpretations	10	89692800	10	87933043	189403	187345
NM_000314.6(PTEN):c.304_306dupAAA (p.Lys102_Pro103insLys)	PTEN	PTEN hamartoma tumor syndrome|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 8, 2017)	reviewed by expert panel	10	89692820 - 89692822	10	87933063 - 87933065	142681	152395
NM_000314.6(PTEN):c.316G>T (p.Glu106Ter)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89692832	10	87933075	427579	416939
NM_000314.6(PTEN):c.320A>T (p.Asp107Val)	PTEN	PTEN hamartoma tumor syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 11, 2018)	criteria provided, conflicting interpretations	10	89692836	10	87933079	372481	359885
NM_000314.6(PTEN):c.338G>T (p.Ser113Ile)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Aug 1, 2012)	no assertion criteria provided	10	89692854	10	87933097	139567	143197
NM_000314.6(PTEN):c.360A>C (p.Ala120=)	PTEN	PTEN hamartoma tumor syndrome|not specified|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 14, 2016)	reviewed by expert panel	10	89692876	10	87933119	189426	187351
NM_000314.7(PTEN):c.368A>G (p.His123Arg)	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|not provided	Likely pathogenic(Last reviewed: Apr 6, 2018)	reviewed by expert panel	10	89692884	10	87933127	7816	22855
NM_000314.6(PTEN):c.369C>G (p.His123Gln)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89692885	10	87933128	427587	416940
NM_000314.6(PTEN):c.379G>A (p.Gly127Arg)	PTEN	PTEN hamartoma tumor syndrome|not provided	Likely pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	10	89692895	10	87933138	139568	143198
NM_000314.6(PTEN):c.386G>A (p.Gly129Glu)	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|not provided	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, multiple submitters, no conflicts	10	89692902	10	87933145	7812	22851
NM_000314.6(PTEN):c.388C>T (p.Arg130Ter)	PTEN	Macrocephaly/autism syndrome|PTEN hamartoma tumor syndrome|Cowden syndrome 1|not specified|not provided|Neoplasm of brain|Hereditary cancer-predisposing syndrome|Ovarian Neoplasms	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	10	89692904	10	87933147	7819	22858
NM_000314.6(PTEN):c.389G>A (p.Arg130Gln)	PTEN	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|PTEN hamartoma tumor syndrome|Squamous cell lung carcinoma|Cowden syndrome 1|Renal cell carcinoma, papillary, 1|not provided|Neoplasm of the breast|Glioblastoma|Hereditary cancer-predisposing syndrome|Neoplasm of the large intestine|Neoplasm|Ovarian Neoplasms|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89692905	10	87933148	7829	22868
NM_000314.7(PTEN):c.395G>A (p.Gly132Asp)	PTEN	PTEN hamartoma tumor syndrome|not provided	Likely pathogenic(Last reviewed: Apr 6, 2018)	reviewed by expert panel	10	89692911	10	87933154	92822	98729
NM_000314.6(PTEN):c.401T>C (p.Met134Thr)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89692917	10	87933160	427588	416941
NM_000314.6(PTEN):c.407G>A (p.Cys136Tyr)	PTEN	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89692923	10	87933166	189406	187355
NM_000314.6(PTEN):c.416T>G (p.Leu139Ter)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89692932	10	87933175	427590	416942
NM_000314.6(PTEN):c.420dup (p.His141Thrfs)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89692936	10	87933179	427592	416943
NM_000314.6(PTEN):c.464A>G (p.Tyr155Cys)	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Oct 2, 2017)	criteria provided, conflicting interpretations	10	89692980	10	87933223	404168	398057
NM_000314.7(PTEN):c.469G>T (p.Glu157Ter)	PTEN	Lhermitte-Duclos disease|PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Oct 30, 2018)	reviewed by expert panel	10	89692985	10	87933228	7814	22853
NM_000314.6(PTEN):c.470A>G (p.Glu157Gly)	PTEN	Macrocephaly/autism syndrome|PTEN hamartoma tumor syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 13, 2017)	criteria provided, conflicting interpretations	10	89692986	10	87933229	427593	416944
NM_000314.6(PTEN):c.493-2A>G	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89711873	10	87952116	141485	151199
NM_000314.7(PTEN):c.510T>A (p.Ser170Arg)	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1	Likely pathogenic(Last reviewed: Apr 6, 2018)	reviewed by expert panel	10	89711892	10	87952135	7815	22854
NM_000314.6(PTEN):c.511C>T (p.Gln171Ter)	PTEN	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89711893	10	87952136	189411	187361
NM_000314.6(PTEN):c.517C>T (p.Arg173Cys)	PTEN	PTEN hamartoma tumor syndrome|not specified|not provided|Neoplasm of brain|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89711899	10	87952142	189500	187363
NM_000314.6(PTEN):c.518G>A (p.Arg173His)	PTEN	PTEN hamartoma tumor syndrome|not provided|Neoplasm of brain	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, multiple submitters, no conflicts	10	89711900	10	87952143	376032	362911
NM_000314.6(PTEN):c.520dup (p.Tyr174Leufs)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89711902	10	87952145	427594	416945
NM_000314.7(PTEN):c.520T>A (p.Tyr174Asn)	PTEN	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Apr 6, 2018)	reviewed by expert panel	10	89711902	10	87952145	142220	151934
NM_000314.6(PTEN):c.521A>G (p.Tyr174Cys)	PTEN	PTEN hamartoma tumor syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Sep 26, 2018)	reviewed by expert panel	10	89711903	10	87952146	220007	222000
NM_000314.6(PTEN):c.522T>G (p.Tyr174Ter)	PTEN	PTEN hamartoma tumor syndrome	Likely pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	10	89711904	10	87952147	517520	497173
NM_000314.7(PTEN):c.534_535delTAinsAT (p.Tyr178Ter)	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1	Pathogenic(Last reviewed: Apr 6, 2018)	reviewed by expert panel	10	89711916 - 89711917	10	87952159 - 87952160	7824	22863
NM_000314.6(PTEN):c.564T>A (p.Tyr188Ter)	PTEN	Prostate cancer, somatic|PTEN hamartoma tumor syndrome	Likely pathogenic(Last reviewed: Apr 6, 2018)	reviewed by expert panel	10	89711946	10	87952189	7831	22870
NM_000314.6(PTEN):c.586delC (p.His196Thrfs)	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1	Pathogenic(Last reviewed: Apr 6, 2018)	reviewed by expert panel	10	89711968	10	87952211	7823	22862
NM_000314.6(PTEN):c.605C>T (p.Thr202Ile)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89711987	10	87952230	427595	416946
NM_000314.6(PTEN):c.607_608delAT (p.Ile203Serfs)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, multiple submitters, no conflicts	10	89711989 - 89711990	10	87952232 - 87952233	427596	416947
NM_000314.6(PTEN):c.617_621delTCAGT (p.Phe206Trpfs)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89711999 - 89712003	10	87952242 - 87952246	427597	416948
NM_000314.6(PTEN):c.635-3C>G	PTEN	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2018)	criteria provided, conflicting interpretations	10	89717607	10	87957850	427599	416949
NM_000314.6(PTEN):c.635-1G>A	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89717609	10	87957852	427598	416950
NM_000314.6(PTEN):c.667A>T (p.Lys223Ter)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89717642	10	87957885	427591	416951
NM_000314.6(PTEN):c.697C>T (p.Arg233Ter)	PTEN	Macrocephaly/autism syndrome|Non-small cell lung cancer|PTEN hamartoma tumor syndrome|Cowden syndrome 1|not provided|Neoplasm of the breast|Glioblastoma|Hereditary cancer-predisposing syndrome|Neoplasm of the large intestine|Cowden syndrome|Colorectal Neoplasms	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	10	89717672	10	87957915	7813	22852
NM_000314.6(PTEN):c.733C>T (p.Gln245Ter)	PTEN	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, multiple submitters, no conflicts	10	89717708	10	87957951	186396	183044
NM_000314.6(PTEN):c.737C>T (p.Pro246Leu)	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89717712	10	87957955	142269	151983
NM_000314.7(PTEN):c.766G>T (p.Glu256Ter)	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1	Pathogenic(Last reviewed: Apr 6, 2018)	reviewed by expert panel	10	89717741	10	87957984	7828	22867
NM_000314.6(PTEN):c.801+1delG	PTEN	PTEN hamartoma tumor syndrome	Likely pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89717777	10	87958020	404140	397720
NM_000314.6(PTEN):c.801+23G>A	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1	Likely benign(Last reviewed: Sep 26, 2018)	reviewed by expert panel	10	89717799	10	87958042	92829	98736
NM_000314.6(PTEN):c.802-2A>T	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89720649	10	87960892	142423	152137
NM_000314.6(PTEN):c.821G>T (p.Trp274Leu)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89720670	10	87960913	427600	416952
NM_000314.6(PTEN):c.860C>G (p.Ser287Ter)	PTEN	Macrocephaly/autism syndrome|Bannayan-Riley-Ruvalcaba syndrome|Cowden syndrome 1	Likely pathogenic(Last reviewed: Jul 30, 2013)	criteria provided, single submitter	10	89720709	10	87960952	216987	213602
NM_000314.6(PTEN):c.892C>T (p.Gln298Ter)	PTEN	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89720741	10	87960984	187657	183051
NM_000314.6(PTEN):c.892C>G (p.Gln298Glu)	PTEN	Endometrial carcinoma|Macrocephaly/autism syndrome|Meningioma, familial|Squamous cell carcinoma of the head and neck|Bannayan-Riley-Ruvalcaba syndrome|Malignant tumor of prostate|Follicular thyroid carcinoma|VACTERL association with hydrocephalus|Glioma susceptibility 2|PTEN hamartoma tumor syndrome|Cowden syndrome 1|Cutaneous malignant melanoma 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	10	89720741	10	87960984	127695	133152
NM_000314.6(PTEN):c.964A>T (p.Lys322Ter)	PTEN	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89720813	10	87961056	185213	183056
NM_000314.6(PTEN):c.987_990delTAAA (p.Asn329Lysfs)	PTEN	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89720836 - 89720839	10	87961079 - 87961082	189441	187386
NM_000314.6(PTEN):c.1003C>T (p.Arg335Ter)	PTEN	Macrocephaly/autism syndrome|Proteus-like syndrome|PTEN hamartoma tumor syndrome|Cowden syndrome 1|not provided|Neoplasm of brain|Hereditary cancer-predisposing syndrome|Inborn genetic diseases|PTEN-related disorder	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	10	89720852	10	87961095	7833	22872
NM_000314.6(PTEN):c.1004G>A (p.Arg335Gln)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89720853	10	87961096	427580	416953
NM_000314.6(PTEN):c.1026+1G>A	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89720876	10	87961119	183722	183060
NM_000314.6(PTEN):c.1026+32T>G	PTEN	PTEN hamartoma tumor syndrome|not specified	Benign(Last reviewed: Sep 14, 2016)	reviewed by expert panel	10	89720907	10	87961150	92810	98717
NM_000314.6(PTEN):c.1027-2A>G	PTEN	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, multiple submitters, no conflicts	10	89725042	10	87965285	427581	416954
NM_000314.6(PTEN):c.1048dupA (p.Thr350Asnfs)	PTEN	Macrocephaly/autism syndrome	Pathogenic(Last reviewed: Apr 4, 2014)	criteria provided, single submitter	10	89725065	10	87965308	209187	205765
NM_000314.6(PTEN):c.1052_1054delTAG (p.Val351del)	PTEN	PTEN hamartoma tumor syndrome|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 8, 2017)	reviewed by expert panel	10	89725069 - 89725071	10	87965312 - 87965314	127687	133144
NM_000314.6(PTEN):c.1104T>C (p.Asp368=)	PTEN	PTEN hamartoma tumor syndrome|not specified|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 14, 2016)	reviewed by expert panel	10	89725121	10	87965364	138835	142538
NM_000314.6(PTEN):c.1171C>T (p.Pro391Ser)	PTEN	PTEN hamartoma tumor syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 8, 2017)	reviewed by expert panel	10	89725188	10	87965431	187673	183064
NM_000314.6(PTEN):c.*10delT	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 6, 2018)	reviewed by expert panel	10	89725239	10	87965482	189424	187390
NM_001613.2(ACTA2):c.720G>C (p.Lys240Asn)	ACTA2|ACTA2-AS1	Aortic aneurysm, familial thoracic 6|Thoracic aortic aneurysm and aortic dissection	Likely pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, multiple submitters, no conflicts	10	90699352	10	88939595	162701	175327
NM_001613.2(ACTA2):c.536G>A (p.Arg179His)	ACTA2	Aortic aneurysm, familial thoracic 6|Multisystemic smooth muscle dysfunction syndrome|Moyamoya disease 5|Thoracic aortic aneurysm and aortic dissection|not provided|Cardiovascular phenotype|alterations of great arteries and veins|Connective tissue disorder	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	10	90701066	10	88941309	29598	38552
NM_001613.2(ACTA2):c.353G>A (p.Arg118Gln)	ACTA2	Aortic aneurysm, familial thoracic 6|Thoracic aortic aneurysm and aortic dissection|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	10	90703570	10	88943813	199670	197398
NM_000043.6(FAS):c.197-2A>G	FAS	Autoimmune lymphoproliferative syndrome	Likely pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	10	90767455	10	89007698	598753	589803
NC_000010.10:g.89589557_89642550dup	PTEN|KLLN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89589557 - 89642550			427601	416955
NM_004523.3(KIF11):c.2922G>A (p.Pro974=)	KIF11	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2017)	criteria provided, conflicting interpretations	10	94409743	10	92649986	435616	429150
NM_183374.3(CYP26C1):c.356A>C (p.Gln119Pro)	CYP26C1	Optic nerve hypoplasia	Likely benign	criteria provided, single submitter	10	94821918	10	93062161	496733	488179
NM_183374.3(CYP26C1):c.845_851dup (p.Gln284Hisfs)	CYP26C1	Optic nerve hypoplasia	Likely benign	criteria provided, single submitter	10	94824277 - 94824283	10	93064520 - 93064526	496732	488178
NM_005097.3(LGI1):c.519T>C (p.Asn173=)	LGI1	not provided	Uncertain significance(Last reviewed: Aug 27, 2013)	criteria provided, single submitter	10	95552515	10	93792758	129481	134927
NM_002860.3(ALDH18A1):c.755G>A (p.Arg252Gln)	ALDH18A1	Cutis laxa-corneal clouding-oligophrenia syndrome|Spastic paraplegia 9|Cutis laxa, autosomal dominant 3	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, multiple submitters, no conflicts	10	97392769	10	95633012	217117	213762
NM_001002261.3(ZFYVE27):c.244G>A (p.Val82Ile)	ZFYVE27	not specified|Spastic paraplegia|Spastic paraplegia, autosomal dominant	Benign/Likely benign(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	10	99502897	10	97743140	130785	136231
NM_001002261.3(ZFYVE27):c.378G>A (p.Lys126=)	ZFYVE27	not specified|Spastic paraplegia|Spastic paraplegia, autosomal dominant	Benign/Likely benign(Last reviewed: Jul 25, 2017)	criteria provided, multiple submitters, no conflicts	10	99504595	10	97744838	130786	136232
NM_001002261.3(ZFYVE27):c.413G>T (p.Gly138Val)	ZFYVE27	not specified|Spastic paraplegia, autosomal dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	99504630	10	97744873	130787	136233
NM_003990.4(PAX2):c.76dupG (p.Val26Glyfs)	PAX2	Renal coloboma syndrome|not provided|Focal segmental glomerulosclerosis 7	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	10	102509535	10	100749778	156297	166077
NM_003990.4(PAX2):c.76delG (p.Val26Cysfs)	PAX2	Renal coloboma syndrome	Pathogenic	criteria provided, single submitter	10	102509535	10	100749778	13801	28840
NM_003988.4(PAX2):c.511T>C (p.Ser171Pro)	PAX2	Familial hypoplastic, glomerulocystic kidney	Uncertain significance	criteria provided, single submitter	10	102541017	10	100781260	224355	226086
NM_033164.3(FGF8):c.464A>G (p.Asn155Ser)	FGF8	Holoprosencephaly sequence	Uncertain significance(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	10	103530324	10	101770567	545460	535720
NM_033164.3(FGF8):c.436G>T (p.Val146Phe)	FGF8	Holoprosencephaly sequence	Likely pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	10	103530352	10	101770595	545456	535716
NM_033163.3(FGF8):c.451G>A (p.Gly151Ser)	FGF8	Kallmann syndrome 6	Likely pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	10	103530370	10	101770613	140612	150303
NM_033164.3(FGF8):c.411+1G>A	FGF8	Holoprosencephaly sequence	Likely pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	10	103531219	10	101771462	545517	536021
NM_033163.3(FGF8):c.356C>T (p.Thr119Met)	FGF8	Holoprosencephaly sequence|Semilobar holoprosencephaly	Likely pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	10	103531308	10	101771551	235081	236855
NM_033163.3(FGF8):c.237C>G (p.Leu79=)	FGF8	Kallmann syndrome 6	Likely pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	10	103534589	10	101774832	140613	150304
NM_033163.3(FGF8):c.157-1G>A	FGF8	Holoprosencephaly sequence	Likely pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	10	103534670	10	101774913	545413	535677
NM_033164.3(FGF8):c.130C>T (p.Arg44Trp)	FGF8	Holoprosencephaly sequence	Benign(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	10	103534913	10	101775156	545461	535721
NM_033164.3(FGF8):c.86_103dup (p.Arg34_Glu35insGlyProAlaLeuGlyArg)	FGF8	Holoprosencephaly sequence|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 20, 2018)	criteria provided, conflicting interpretations	10	103534940 - 103534957	10	101775183 - 101775200	545463	535723
NM_016169.3(SUFU):c.111delC (p.Tyr38Thrfs)	SUFU	Medulloblastoma	Pathogenic(Last reviewed: Jan 21, 2014)	criteria provided, single submitter	10	104264020	10	102504263	217007	213595
NM_030912.2(TRIM8):c.1375C>T (p.Gln459Ter)	TRIM8	TRIM8-related epileptic encephalopathy	Likely pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	10	104416830	10	102657073	584442	575492
NC_000010.9:g.102968888_103417760dup		Split-Hand/Foot Malformation	Pathogenic	criteria provided, single submitter					590886	581826
NM_005445.3(SMC3):c.255A>G (p.Ser85=)	SMC3	Cornelia de Lange syndrome 3|not specified|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Nov 20, 2017)	criteria provided, conflicting interpretations	10	112337235	10	110577477	159980	168813
NM_005445.3(SMC3):c.351-9T>C	SMC3	not specified|Cornelia de Lange Syndrome	Benign(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	10	112338377	10	110578619	159986	168814
NM_005445.3(SMC3):c.377A>G (p.Glu126Gly)	SMC3	Cornelia de Lange syndrome 3	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	10	112338412	10	110578654	159987	168815
NM_005445.3(SMC3):c.507C>T (p.Asp169=)	SMC3	Cornelia de Lange syndrome 3	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	10	112340739	10	110580981	159988	168816
NM_005445.3(SMC3):c.548-5_548-4dup	SMC3	Cornelia de Lange syndrome 3|not specified|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Mar 28, 2017)	criteria provided, multiple submitters, no conflicts	10	112341676 - 112341677	10	110581918 - 110581919	159989	168817
NM_005445.3(SMC3):c.587T>C (p.Ile196Thr)	SMC3	Cornelia de Lange syndrome 3	Likely pathogenic(Last reviewed: Aug 30, 2014)	criteria provided, single submitter	10	112341720	10	110581962	209193	205764
NM_005445.3(SMC3):c.707G>C (p.Arg236Pro)	SMC3	Cornelia de Lange syndrome 3	Likely pathogenic(Last reviewed: Feb 24, 2014)	criteria provided, single submitter	10	112341840	10	110582082	159990	168818
NM_005445.3(SMC3):c.724-6dup	SMC3	not specified|Cornelia de Lange Syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	112342314	10	110582556	159991	168819
NM_005445.3(SMC3):c.970-8G>A	SMC3	not specified|Cornelia de Lange Syndrome	Benign(Last reviewed: Apr 22, 2017)	criteria provided, multiple submitters, no conflicts	10	112343591	10	110583833	159992	168820
NM_005445.3(SMC3):c.1092-8T>G	SMC3	Cornelia de Lange syndrome 3|not specified|not provided|Cornelia de Lange Syndrome	Benign/Likely benign(Last reviewed: Jun 23, 2017)	criteria provided, multiple submitters, no conflicts	10	112343933	10	110584175	159965	168821
NM_005445.3(SMC3):c.1280A>G (p.Lys427Arg)	SMC3	Cornelia de Lange syndrome 3|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 1, 2016)	criteria provided, conflicting interpretations	10	112344129	10	110584371	159966	168822
NM_005445.3(SMC3):c.1365T>C (p.Tyr455=)	SMC3	Cornelia de Lange syndrome 3|not specified|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	10	112349422	10	110589664	159967	168823
NM_005445.3(SMC3):c.1581T>C (p.His527=)	SMC3	Cornelia de Lange syndrome 3	Uncertain significance(Last reviewed: Jun 27, 2013)	criteria provided, single submitter	10	112350241	10	110590483	159968	168824
NM_005445.3(SMC3):c.1680T>C (p.Tyr560=)	SMC3	Cornelia de Lange syndrome 3|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Aug 19, 2016)	criteria provided, conflicting interpretations	10	112350758	10	110591000	159969	168825
NM_005445.3(SMC3):c.1964G>A (p.Gly655Asp)	SMC3	Cornelia de Lange syndrome 3	Likely pathogenic(Last reviewed: Jan 13, 2014)	criteria provided, single submitter	10	112356156	10	110596398	159970	168826
NM_005445.3(SMC3):c.2264C>T (p.Pro755Leu)	SMC3	Cornelia de Lange syndrome 3	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	10	112358044	10	110598286	159972	168828
NM_005445.3(SMC3):c.2268+4C>T	SMC3	Cornelia de Lange syndrome 3|not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jun 29, 2017)	criteria provided, conflicting interpretations	10	112358052	10	110598294	159973	168829
NM_005445.3(SMC3):c.2299T>C (p.Leu767=)	SMC3	Cornelia de Lange syndrome 3	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	10	112359442	10	110599684	159974	168830
NM_005445.3(SMC3):c.2329T>C (p.Leu777=)	SMC3	Cornelia de Lange syndrome 3|not specified|not provided|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Apr 23, 2018)	criteria provided, conflicting interpretations	10	112359472	10	110599714	159975	168831
NM_005445.3(SMC3):c.2427+13C>T	SMC3	Cornelia de Lange syndrome 3	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	10	112359583	10	110599825	159977	168833
NM_005445.3(SMC3):c.2493T>C (p.Tyr831=)	SMC3	Cornelia de Lange syndrome 3|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Nov 4, 2016)	criteria provided, conflicting interpretations	10	112360262	10	110600504	159978	168834
NM_005445.3(SMC3):c.2535+15T>G	SMC3	Cornelia de Lange syndrome 3|Cornelia de Lange Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	10	112360319	10	110600561	159979	168835
NM_005445.3(SMC3):c.2710T>C (p.Trp904Arg)	SMC3	Cornelia de Lange syndrome 3	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	10	112361460	10	110601702	159982	168837
NM_005445.3(SMC3):c.2934G>A (p.Lys978=)	SMC3	Cornelia de Lange syndrome 3|not specified|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 29, 2017)	criteria provided, conflicting interpretations	10	112361765	10	110602007	159983	168838
NM_005445.3(SMC3):c.2964T>C (p.Asp988=)	SMC3	Cornelia de Lange syndrome 3	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	10	112361795	10	110602037	159984	168839
NM_005445.3(SMC3):c.3039A>G (p.Ser1013=)	SMC3	not specified|not provided|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	10	112361870	10	110602112	159985	168840
NM_001134363.2(RBM20):c.1244G>A (p.Ser415Asn)	RBM20	Dilated cardiomyopathy 1DD	Uncertain significance(Last reviewed: Jul 4, 2018)	criteria provided, multiple submitters, no conflicts	10	112541611	10	110781853	548140	538625
NM_001134363.2(RBM20):c.1364C>T (p.Ser455Leu)	RBM20	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1DD|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 5, 2018)	criteria provided, conflicting interpretations	10	112544125	10	110784367	43971	53139
NM_001134363.2(RBM20):c.1906C>A (p.Arg636Ser)	RBM20	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1DD|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	10	112572061	10	110812303	270	15309
NM_001134363.2(RBM20):c.1907G>A (p.Arg636His)	RBM20	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1DD|not provided|Familial dilated cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, multiple submitters, no conflicts	10	112572062	10	110812304	271	15310
NM_001134363.2(RBM20):c.1913C>T (p.Pro638Leu)	RBM20	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1S|Dilated cardiomyopathy 1DD|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, multiple submitters, no conflicts	10	112572068	10	110812310	268	15307
NM_001134363.2(RBM20):c.2147G>A (p.Arg716Gln)	RBM20	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1DD|not specified	Uncertain significance(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	10	112572302	10	110812544	43986	53154
NM_001134363.2(RBM20):c.2662G>A (p.Asp888Asn)	RBM20	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1DD|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2018)	criteria provided, conflicting interpretations	10	112581039	10	110821281	43995	53163
NM_001134363.2(RBM20):c.2746G>A (p.Glu916Lys)	RBM20	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: May 9, 2014)	criteria provided, single submitter	10	112581123	10	110821365	179425	174600
NM_007373.3(SHOC2):c.4A>G (p.Ser2Gly)	SHOC2	Noonan syndrome 3|Noonan syndrome-like disorder with loose anagen hair 1|Noonan syndrome|not specified|not provided|Rasopathy|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	10	112724120	10	110964362	6821	21860
NM_004281.3(BAG3):c.72delC (p.Gly25Aspfs)	BAG3	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Feb 6, 2014)	criteria provided, single submitter	10	121411259	10	119651747	162769	174884
NM_004281.3(BAG3):c.367C>T (p.Arg123Ter)	BAG3	Primary dilated cardiomyopathy|Myofibrillar myopathy, BAG3-related|Dilated cardiomyopathy 1HH|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	10	121429549	10	119670037	30397	39354
NM_004281.3(BAG3):c.626C>T (p.Pro209Leu)	BAG3	Myofibrillar myopathy, BAG3-related|Dilated cardiomyopathy 1HH|not provided	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, multiple submitters, no conflicts	10	121431885	10	119672373	5981	21020
NM_004281.3(BAG3):c.634C>A (p.His212Asn)	BAG3	Dilated cardiomyopathy 1HH	Uncertain significance(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	10	121431893	10	119672381	548141	538626
NM_004281.3(BAG3):c.925C>T (p.Arg309Ter)	BAG3	Primary dilated cardiomyopathy|Myofibrillar myopathy, BAG3-related|Dilated cardiomyopathy 1HH|not provided|Familial dilated cardiomyopathy	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, multiple submitters, no conflicts	10	121435991	10	119676479	228322	229744
NM_004281.3(BAG3):c.1363G>A (p.Glu455Lys)	BAG3	Primary dilated cardiomyopathy|Myofibrillar myopathy, BAG3-related|Dilated cardiomyopathy 1HH|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, multiple submitters, no conflicts	10	121436429	10	119676917	44778	53945
NM_001005463.2(EBF3):c.577A>G (p.Lys193Glu)	EBF3	Oromandibular-limb hypogenesis spectrum	Likely pathogenic	no assertion criteria provided	10	131676091	10	129877827	267357	262525
NM_001005463.2(EBF3):c.512G>A (p.Gly171Asp)	EBF3	Neurogenic bladder|Renal dysplasia|Generalized hypotonia|Broad-based gait|Developmental regression	Pathogenic	no assertion criteria provided	10	131755564	10	129957300	375375	362152
NM_001005463.2(EBF3):c.488G>A (p.Arg163Gln)	EBF3	Robin sequence|Global developmental delay|Expressive language delay|Pierre-Robin sequence|Intellectual disability|Inborn genetic diseases|Ataxia|Muscular hypotonia|Hypotonia, ataxia, and delayed development syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	10	131755588	10	129957324	268156	263783
NM_001005463.2(EBF3):c.488G>T (p.Arg163Leu)	EBF3	Global developmental delay|Expressive language delay|not provided|Intellectual disability|Ataxia|Muscular hypotonia|Hypotonia, ataxia, and delayed development syndrome	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, multiple submitters, no conflicts	10	131755588	10	129957324	268155	263782
NC_000010.10:g.(102887490_102977418)_(103439322_103524625)dup	TLX1|FBXW4|BTRC|LBX1|DPCD|POLL|TLX1NB	Split-Hand/Foot Malformation	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	10	102887490 - 103524625			590885	581825
NM_005343.3(HRAS):c.350A>G (p.Lys117Arg)	HRAS|LRRC56	Costello syndrome|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	11	533553	11	533553	12605	27644
NM_005343.3(HRAS):c.175_176delGCinsCT (p.Ala59Leu)	HRAS|LRRC56	Costello syndrome	Likely pathogenic(Last reviewed: Aug 14, 2014)	criteria provided, single submitter	11	533880 - 533881	11	533880 - 533881	179260	174803
NM_005343.3(HRAS):c.37G>T (p.Gly13Cys)	HRAS|LRRC56	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Costello syndrome|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Noonan syndrome|not provided|Rasopathy|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Neoplasm|Colorectal Neoplasms|Uterine cervical neoplasms|Neoplasm of the thyroid gland|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	11	534286	11	534286	12606	27645
NM_005343.3(HRAS):c.35_36delGCinsAA (p.Gly12Glu)	HRAS|LRRC56	Costello syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	11	534287 - 534288	11	534287 - 534288	163690	174805
NM_005343.3(HRAS):c.34G>T (p.Gly12Cys)	HRAS|LRRC56	Liver cancer|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Costello syndrome|Epidermal nevus|Lung adenocarcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|Nevus sebaceous|NEVUS SEBACEOUS, SOMATIC|not provided|Rasopathy|Neoplasm of the breast|Glioblastoma|Bladder carcinoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Nevus sebaceous|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Neoplasm of the thyroid gland|Papillary renal cell carcinoma, sporadic|Adenoid cystic carcinoma|Nasopharyngeal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, multiple submitters, no conflicts	11	534289	11	534289	12613	27652
NM_176795.4(HRAS):c.34G>A (p.Gly12Ser)	HRAS|LRRC56	Liver cancer|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Costello syndrome|Lung adenocarcinoma|Myopathy, congenital, with excess of muscle spindles|Acute myeloid leukemia|Myelodysplastic syndrome|Epidermal nevus with urothelial cancer, somatic|Nevus sebaceous|NEVUS SEBACEOUS, SOMATIC|not provided|Rasopathy|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Nevus sebaceous|Neoplasm of the large intestine|Carcinoma of esophagus|Nevus, woolly hair|Colorectal Neoplasms|Uterine cervical neoplasms|Neoplasm of the thyroid gland|Papillary renal cell carcinoma, sporadic|Adenoid cystic carcinoma|Nasopharyngeal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	11	534289	11	534289	12602	27641
NM_021008.3(DEAF1):c.913_915delAAG (p.Lys305del)	DEAF1	Mental retardation, autosomal dominant 24	Likely pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	11	681045 - 681047	11	681045 - 681047	437397	430957
NM_021008.3(DEAF1):c.791A>C (p.Gln264Pro)	DEAF1	Mental retardation, autosomal dominant 24	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	11	686871	11	686871	133292	137031
NM_021008.3(DEAF1):c.737G>C (p.Arg246Thr)	DEAF1	Mental retardation, autosomal dominant 24	Likely pathogenic(Last reviewed: Oct 2, 2015)	criteria provided, single submitter	11	686925	11	686925	437396	430956
NM_021008.3(DEAF1):c.700T>A (p.Trp234Arg)	DEAF1	Mental retardation, autosomal dominant 24	Likely pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	11	686962	11	686962	437398	430958
NM_021008.3(DEAF1):c.634G>A (p.Gly212Ser)	DEAF1	not provided|Mental retardation, autosomal dominant 24	Pathogenic/Likely pathogenic(Last reviewed: May 12, 2017)	criteria provided, multiple submitters, no conflicts	11	687941	11	687941	375554	362364
NM_003282.3(TNNI2):c.60T>C (p.Ser20=)	TNNI2	Distal arthrogryposis type 2B|Arthrogryposis multiplex congenita distal|not specified|not provided|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	1861760	11	1840530	94120	100020
NM_006757.3(TNNT3):c.414G>A (p.Glu138=)	TNNT3	Arthrogryposis multiplex congenita distal|not specified|not provided|Arthrogryposis multiplex congenita	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	1955609	11	1934379	31870	40530
NM_006757.3(TNNT3):c.636T>C (p.Ile212=)	TNNT3	Arthrogryposis multiplex congenita distal|not specified|not provided|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	1956104	11	1934874	31871	40531
NM_006757.3(TNNT3):c.762C>T (p.Gly254=)	TNNT3	Distal arthrogryposis type 2B|Arthrogryposis multiplex congenita distal|not specified|not provided|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	1959707	11	1938477	31872	40532
NM_000207.2(INS):c.125T>C (p.Val42Ala)	INS|INS-IGF2	Maturity-onset diabetes of the young, type 10	Likely pathogenic	no assertion criteria provided	11	2182077	11	2160847	253331	247779
NM_000207.2(INS):c.94G>A (p.Gly32Ser)	INS|INS-IGF2	Permanent neonatal diabetes mellitus|Diabetes mellitus, insulin-dependent, 2|Neonatal diabetes mellitus	Pathogenic(Last reviewed: Nov 4, 2013)	criteria provided, single submitter	11	2182108	11	2160878	21122	33974
NM_000218.2(KCNQ1):c.458C>T (p.Thr153Met)	KCNQ1	Long QT syndrome|not specified|not provided|Cardiovascular phenotype	Uncertain significance(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	11	2549229	11	2527999	67075	77971
NM_000218.2(KCNQ1):c.532G>A (p.Ala178Thr)	KCNQ1	Long QT syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 14, 2018)	criteria provided, conflicting interpretations	11	2591912	11	2570682	53061	67729
NM_000218.2(KCNQ1):c.535G>A (p.Gly179Ser)	KCNQ1	Long QT syndrome 1|Long QT syndrome|Romano-Ward syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2018)	criteria provided, conflicting interpretations	11	2591915	11	2570685	53063	67731
NM_000218.2(KCNQ1):c.583C>T (p.Arg195Trp)	KCNQ1	Long QT syndrome|Congenital long QT syndrome	Uncertain significance(Last reviewed: Mar 5, 2015)	criteria provided, multiple submitters, no conflicts	11	2591963	11	2570733	67087	77983
NM_000218.2(KCNQ1):c.585delG (p.Lys196Serfs)	KCNQ1	Long QT syndrome|Romano-Ward syndrome|not provided|Jervell and Lange-Nielsen syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, multiple submitters, no conflicts	11	2591965	11	2570735	53076	67744
NM_000218.2(KCNQ1):c.613G>A (p.Val205Met)	KCNQ1	Long QT syndrome 1|Long QT syndrome|Romano-Ward syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	11	2592563	11	2571333	37255	45847
NM_000218.2(KCNQ1):c.674C>T (p.Ser225Leu)	KCNQ1	Long QT syndrome|Romano-Ward syndrome|not provided|Congenital long QT syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, multiple submitters, no conflicts	11	2592624	11	2571394	53083	67751
NM_000218.2(KCNQ1):c.796delC (p.Leu266Cysfs)	KCNQ1	Long QT syndrome 1|not provided	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	11	2594091	11	2572861	53107	67775
NM_000218.2(KCNQ1):c.820A>G (p.Ile274Val)	KCNQ1	SUDDEN INFANT DEATH SYNDROME|Long QT syndrome|not specified|not provided|Congenital long QT syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 5, 2018)	criteria provided, conflicting interpretations	11	2594115	11	2572885	67109	78005
NM_000218.2(KCNQ1):c.826delT (p.Ser276Profs)	KCNQ1	Jervell and Lange-Nielsen syndrome	Likely pathogenic(Last reviewed: Dec 9, 2013)	criteria provided, single submitter	11	2594121	11	2572891	189232	187117
NM_000218.2(KCNQ1):c.877C>T (p.Arg293Cys)	KCNQ1	Long QT syndrome 1|Long QT syndrome|not specified|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 16, 2018)	criteria provided, conflicting interpretations	11	2594172	11	2572942	67117	78013
NM_000218.2(KCNQ1):c.898G>A (p.Ala300Thr)	KCNQ1	Long QT syndrome 1|Long QT syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jun 28, 2018)	criteria provided, conflicting interpretations	11	2594193	11	2572963	3128	18167
NM_000218.2(KCNQ1):c.1032G>A (p.Ala344=)	KCNQ1	Long QT syndrome 1|Long QT syndrome 2|Long QT syndrome|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	11	2604775	11	2583545	3135	18174
NM_000218.2(KCNQ1):c.1096C>T (p.Arg366Trp)	KCNQ1	Long QT syndrome 1|Long QT syndrome|Romano-Ward syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	11	2606505	11	2585275	52955	67623
NM_000218.2(KCNQ1):c.1179G>T (p.Lys393Asn)	KCNQ1	short QT syndrome|Long QT syndrome|Romano-Ward syndrome|not specified|not provided|Familial atrial fibrillation|Jervell and Lange-Nielsen syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 20, 2017)	criteria provided, conflicting interpretations	11	2608850	11	2587620	67020	77916
NM_000218.2(KCNQ1):c.1189C>T (p.Arg397Trp)	KCNQ1	Long QT syndrome 1|Wolff-Parkinson-White pattern|short QT syndrome|Long QT syndrome|Romano-Ward syndrome|not specified|Congenital long QT syndrome|Familial atrial fibrillation|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	11	2608860	11	2587630	52970	67638
NM_000218.2(KCNQ1):c.1352G>A (p.Arg451Gln)	KCNQ1	Long QT syndrome|not specified|not provided	Uncertain significance(Last reviewed: Sep 2, 2016)	criteria provided, single submitter	11	2610043	11	2588813	67029	77925
NM_000218.2(KCNQ1):c.1354C>T (p.Arg452Trp)	KCNQ1	Long QT syndrome|not specified|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Uncertain significance(Last reviewed: Sep 18, 2017)	criteria provided, multiple submitters, no conflicts	11	2610045	11	2588815	52980	67648
NM_000218.2(KCNQ1):c.1378G>A (p.Gly460Ser)	KCNQ1	SUDDEN INFANT DEATH SYNDROME|not provided	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	11	2610069	11	2588839	67031	77927
NM_000218.2(KCNQ1):c.1513C>T (p.Gln505Ter)	KCNQ1|KCNQ1OT1	Long QT syndrome|Romano-Ward syndrome|Long QT syndrome, LQT1 subtype	Pathogenic/Likely pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	11	2683310	11	2662080	52984	67652
NM_000218.2(KCNQ1):c.1552C>T (p.Arg518Ter)	KCNQ1	Long QT syndrome 1|Long QT syndrome 1, recessive|Long QT syndrome|not provided|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	11	2790111	11	2768881	3131	18170
NM_000218.2(KCNQ1):c.1553G>A (p.Arg518Gln)	KCNQ1	Long QT syndrome|not specified|Congenital long QT syndrome	Uncertain significance(Last reviewed: May 16, 2017)	criteria provided, single submitter	11	2790112	11	2768882	67036	77932
NM_000218.2(KCNQ1):c.1576A>G (p.Lys526Glu)	KCNQ1	Long QT syndrome|not specified|Congenital long QT syndrome	Uncertain significance(Last reviewed: Mar 21, 2016)	criteria provided, single submitter	11	2790135	11	2768905	52995	67663
NM_000218.2(KCNQ1):c.1616G>A (p.Arg539Gln)	KCNQ1	Long QT syndrome 1|Long QT syndrome|not specified|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Mar 14, 2017)	criteria provided, conflicting interpretations	11	2797215	11	2775985	67042	77938
NM_000218.2(KCNQ1):c.1781G>A (p.Arg594Gln)	KCNQ1	Long QT syndrome|Romano-Ward syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, multiple submitters, no conflicts	11	2799254	11	2778024	53018	67686
NM_000218.2(KCNQ1):c.1799C>T (p.Thr600Met)	KCNQ1|KCNQ1-AS1	Long QT syndrome|not specified|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Apr 18, 2018)	criteria provided, conflicting interpretations	11	2869001	11	2847771	67057	77953
NM_000218.2(KCNQ1):c.1831G>A (p.Asp611Asn)	KCNQ1|KCNQ1-AS1	Long QT syndrome 1|Long QT syndrome|not provided|Congenital long QT syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	11	2869033	11	2847803	67059	77955
NM_000218.2(KCNQ1):c.1885G>A (p.Gly629Ser)	KCNQ1|KCNQ1-AS1	Brugada syndrome	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	11	2869087	11	2847857	427960	419283
NM_000076.2(CDKN1C):c.708G>A (p.Glu236=)	CDKN1C	Beckwith-Wiedemann syndrome|not specified	Benign/Likely benign(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	11	2906012	11	2884782	158190	168880
NM_000076.2(CDKN1C):c.555T>C (p.Ala185=)	CDKN1C	Beckwith-Wiedemann syndrome|not specified	Benign/Likely benign(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	11	2906165	11	2884935	158189	168881
NM_139132.3(NUP98):c.4985A>G (p.Asn1662Ser)	NUP98	Hirschsprung disease 1	Likely pathogenic(Last reviewed: Sep 27, 2016)	no assertion criteria provided	11	3697585	11	3676355	375277	362048
NM_003156.3(STIM1):c.910C>T (p.Arg304Trp)	STIM1	Myopathy with tubular aggregates|Stormorken syndrome	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	11	4095850	11	4074620	132887	136636
NM_003156.3(STIM1):c.1588C>T (p.Arg530Cys)	STIM1	Myopathy with tubular aggregates|Stormorken syndrome|Immune dysfunction with T-cell inactivation due to calcium entry defect 2	Conflicting interpretations of pathogenicity(Last reviewed: Jul 13, 2017)	criteria provided, conflicting interpretations	11	4112558	11	4091328	461723	461913
NM_000518.4(HBB):c.201delA (p.Val68Cysfs)	HBB|LOC106099062|LOC107133510	Beta-thalassemia, dominant inclusion body type	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	11	5247921	11	5226691	36302	44966
NM_000518.5(HBB):c.118C>T (p.Gln40Ter)	HBB|LOC106099062|LOC107133510	beta^0^ Thalassemia|beta Thalassemia|not specified|not provided	Pathogenic(Last reviewed: Jun 21, 2017)	criteria provided, multiple submitters, no conflicts	11	5248004	11	5226774	15402	30441
NM_000518.5(HBB):c.92+6T>C	HBB|LOC106099062|LOC107133510	Beta-plus-thalassemia|beta Thalassemia|not specified|not provided	Pathogenic(Last reviewed: Sep 17, 2017)	criteria provided, multiple submitters, no conflicts	11	5248154	11	5226924	15450	30489
NM_000525.3(KCNJ11):c.967dup (p.Asp323Glyfs)	KCNJ11	Diabetes mellitus type 2|Maturity-onset diabetes of the young, type 13	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	11	17408672	11	17387125	478917	472261
NM_000525.3(KCNJ11):c.149G>A (p.Arg50Gln)	KCNJ11	Neonatal diabetes mellitus|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, multiple submitters, no conflicts	11	17409490	11	17387943	36431	45094
NM_000352.4(ABCC8):c.4564G>A (p.Val1522Met)	ABCC8	Neonatal diabetes mellitus	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	11	17415288	11	17393741	35622	44287
NM_000352.4(ABCC8):c.4451G>A (p.Gly1484Glu)	ABCC8	Persistent hyperinsulinemic hypoglycemia of infancy	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	11	17415907	11	17394360	35620	44285
NM_000352.4(ABCC8):c.4136G>T (p.Arg1379Leu)	ABCC8	Neonatal diabetes mellitus	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	11	17417461	11	17395914	35615	44280
NM_000352.4(ABCC8):c.3545G>A (p.Arg1182Gln)	ABCC8	Transient neonatal diabetes mellitus 2|Neonatal diabetes mellitus	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, multiple submitters, no conflicts	11	17426071	11	17404524	35611	44276
NM_001112741.1(KCNC1):c.959G>A (p.Arg320His)	KCNC1	Epilepsy, progressive myoclonic 7	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, multiple submitters, no conflicts	11	17793600	11	17772053	162519	172192
NM_001112741.1(KCNC1):c.1262C>T (p.Ala421Val)	KCNC1	not provided|Epilepsy, progressive myoclonic 7	Conflicting interpretations of pathogenicity(Last reviewed: May 21, 2018)	criteria provided, conflicting interpretations	11	17793903	11	17772356	488536	481404
NM_003476.4(CSRP3):c.536C>T (p.Thr179Met)	CSRP3	Familial hypertrophic cardiomyopathy 12|Dilated cardiomyopathy 1M|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 15, 2018)	criteria provided, conflicting interpretations	11	19204266	11	19182719	163007	175833
NM_003476.4(CSRP3):c.437G>A (p.Arg146His)	CSRP3	Familial hypertrophic cardiomyopathy 12|Dilated cardiomyopathy 1M|not specified|Prolonged QT interval	Uncertain significance(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	11	19206570	11	19185023	163009	175694
NM_003476.4(CSRP3):c.93C>G (p.His31Gln)	CSRP3	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	11	19213903	11	19192356	217825	214487
NM_000280.4(PAX6):c.1268A>T (p.Ter423Leu)	PAX6	Aniridia 1|not provided	Pathogenic(Last reviewed: Jan 5, 2016)	criteria provided, multiple submitters, no conflicts	11	31811483	11	31789935	3474	18513
NM_000280.4(PAX6):c.1183+2T>C	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31812256	11	31790708	431009	424510
NM_000280.4(PAX6):c.1183+1G>A	PAX6	Aniridia 1	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	11	31812257	11	31790709	492996	485940
NM_000280.4(PAX6):c.1183G>T (p.Gly395Ter)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31812258	11	31790710	431008	424511
NM_000280.4(PAX6):c.1047_1050delCCAG (p.Ser349Argfs)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31812391 - 31812394	11	31790843 - 31790846	431007	424512
NM_000280.4(PAX6):c.1032+6T>G	PAX6	Aniridia 1	Likely pathogenic	no assertion criteria provided	11	31814980	11	31793432	431006	424513
NM_000280.4(PAX6):c.879delC (p.Ser294Valfs)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31815237	11	31793689	431005	424514
NM_000280.4(PAX6):c.820C>T (p.Gln274Ter)	PAX6	Aniridia 1	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	11	31815296	11	31793748	492995	485941
NM_000280.4(PAX6):c.794G>A (p.Trp265Ter)	PAX6	Aniridia 1|not provided	Pathogenic(Last reviewed: Apr 4, 2018)	criteria provided, single submitter	11	31815322	11	31793774	431004	424515
NM_000280.4(PAX6):c.792dup (p.Trp265Metfs)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31815324	11	31793776	431003	424516
NM_000280.4(PAX6):c.781C>T (p.Arg261Ter)	PAX6	Aniridia 1|Irido-corneo-trabecular dysgenesis|not provided	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	11	31815335	11	31793787	279862	264422
NM_000280.4(PAX6):c.760delA (p.Ile254Tyrfs)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31815585	11	31794037	431002	424517
NM_000280.4(PAX6):c.718C>T (p.Arg240Ter)	PAX6	Aniridia 1|Irido-corneo-trabecular dysgenesis|not provided	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, multiple submitters, no conflicts	11	31815627	11	31794079	3467	18506
NM_000280.4(PAX6):c.683-1G>C	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31815663	11	31794115	431000	424518
NM_000280.4(PAX6):c.682+4delA	PAX6	Aniridia 1	Uncertain significance	no assertion criteria provided	11	31816174	11	31794626	431001	424519
NM_000280.4(PAX6):c.661C>T (p.Gln221Ter)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31816199	11	31794651	430999	424520
NM_000280.4(PAX6):c.607C>T (p.Arg203Ter)	PAX6	Aniridia 1|Irido-corneo-trabecular dysgenesis	Pathogenic(Last reviewed: Feb 7, 2018)	criteria provided, multiple submitters, no conflicts	11	31816253	11	31794705	3466	18505
NM_000280.4(PAX6):c.538C>T (p.Gln180Ter)	PAX6	Aniridia 1	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	11	31816322	11	31794774	492994	485942
NM_000280.4(PAX6):c.511C>T (p.Gln171Ter)	PAX6	Aniridia 1|Irido-corneo-trabecular dysgenesis	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	11	31822251	11	31800703	430998	424521
NM_000280.4(PAX6):c.491delC (p.Pro164Argfs)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31822271	11	31800723	430997	424522
NM_000280.4(PAX6):c.467G>A (p.Trp156Ter)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31822295	11	31800747	430996	424523
NM_000280.4(PAX6):c.449_453delACGGGinsCCGGAAC (p.Asn150Thrfs)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31822309 - 31822313	11	31800761 - 31800765	430995	424524
NM_000280.4(PAX6):c.403C>T (p.Gln135Ter)	PAX6	Aniridia 1|Irido-corneo-trabecular dysgenesis	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	11	31822359	11	31800811	430994	424525
NM_000280.4(PAX6):c.401delA (p.Lys134Serfs)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31822361	11	31800813	430993	424526
NM_000280.4(PAX6):c.367_373delATAAACA (p.Ile123Glufs)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31822389 - 31822395	11	31800841 - 31800847	430992	424527
NM_000280.4(PAX6):c.371delA (p.Asn124Thrfs)	PAX6	Aniridia 1|not provided	Pathogenic(Last reviewed: Sep 19, 2016)	criteria provided, single submitter	11	31822391	11	31800843	279861	264534
NM_000280.4(PAX6):c.357C>G (p.Ser119Arg)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31823109	11	31801561	430991	424528
NM_000280.4(PAX6):c.353delC (p.Pro118Glnfs)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31823113	11	31801565	430990	424529
NM_000280.4(PAX6):c.325G>T (p.Glu109Ter)	PAX6	Aniridia 1|Irido-corneo-trabecular dysgenesis	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	11	31823141	11	31801593	492993	485943
NM_000280.4(PAX6):c.307C>T (p.Arg103Ter)	PAX6	Aniridia 1|not provided	Pathogenic(Last reviewed: Nov 29, 2016)	criteria provided, single submitter	11	31823159	11	31801611	3464	18503
NM_001604.5(PAX6):c.347T>A (p.Ile116Asn)	PAX6	Aniridia 1	Pathogenic(Last reviewed: Jan 18, 2019)	no assertion criteria provided			11	31801613	617617	609013
NM_000280.4(PAX6):c.300G>A (p.Trp100Ter)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31823166	11	31801618	430989	424530
NM_000280.4(PAX6):c.293_298delTTGCTTinsGTTCA (p.Phe98Cysfs)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31823168 - 31823173	11	31801620 - 31801625	430988	424531
NM_000280.4(PAX6):c.291_294dup (p.Ala99Leufs)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31823172 - 31823175	11	31801624 - 31801627	430987	424532
NM_000280.4(PAX6):c.265C>T (p.Gln89Ter)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31823201	11	31801653	430986	424533
NM_000280.4(PAX6):c.244G>T (p.Glu82Ter)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31823222	11	31801674	430985	424534
NM_000280.4(PAX6):c.238_241dup (p.Pro81Hisfs)	PAX6	Aniridia 1	Pathogenic(Last reviewed: Jul 1, 2015)	criteria provided, single submitter	11	31823225 - 31823228	11	31801677 - 31801680	492992	485944
NM_000280.4(PAX6):c.184G>T (p.Glu62Ter)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31823282	11	31801734	430984	424535
NM_000280.4(PAX6):c.164A>C (p.Lys55Thr)	PAX6	Aniridia 1	Likely pathogenic	no assertion criteria provided	11	31823302	11	31801754	430983	424536
NM_000280.4(PAX6):c.151G>A (p.Gly51Arg)	PAX6	Aniridia 1|not provided	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, single submitter	11	31823315	11	31801767	430982	424537
NM_001604.5(PAX6):c.192C>A (p.Asn64Lys)	PAX6	not provided|Anophthalmia - microphthalmia	Conflicting interpretations of pathogenicity(Last reviewed: Feb 27, 2014)	criteria provided, conflicting interpretations	11	31823316	11	31801768	167417	177907
NM_000280.4(PAX6):c.142-5T>G	PAX6	Aniridia 1	Likely pathogenic	no assertion criteria provided	11	31823329	11	31801781	430981	424538
NM_000280.4(PAX6):c.142-14C>G	PAX6	Aniridia 1	Likely pathogenic	no assertion criteria provided	11	31823338	11	31801790	430980	424539
NM_000280.4(PAX6):c.141+4A>G	PAX6	Aniridia 1	Likely pathogenic	no assertion criteria provided	11	31824248	11	31802700	430979	424540
NM_000280.4(PAX6):c.133_141+4del13	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31824248 - 31824260	11	31802700 - 31802712	430977	424541
NM_000280.4(PAX6):c.140A>G (p.Gln47Arg)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31824253	11	31802705	430978	424542
NM_000280.4(PAX6):c.130C>T (p.Arg44Ter)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31824263	11	31802715	430976	424543
NM_000280.4(PAX6):c.125_126delTTinsC (p.Ile42Thrfs)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31824267 - 31824268	11	31802719 - 31802720	430975	424544
NM_000280.4(PAX6):c.114_121delGCCGTGCG (p.Pro39Hisfs)	PAX6	Aniridia 1	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	11	31824272 - 31824279	11	31802724 - 31802731	492991	485945
NM_000280.4(PAX6):c.109dupG (p.Ala37Glyfs)	PAX6	Aniridia 1|not provided	Pathogenic(Last reviewed: Oct 28, 2015)	criteria provided, single submitter	11	31824284	11	31802736	372439	360006
NM_000280.4(PAX6):c.78delG (p.Gln27Argfs)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31824315	11	31802767	430974	424545
NM_000280.4(PAX6):c.19G>C (p.Gly7Arg)	PAX6	Aniridia 1	Likely pathogenic	no assertion criteria provided	11	31824374	11	31802826	430973	424546
NM_000280.4(PAX6):c.3G>T (p.Met1Ile)	PAX6	Aniridia 1	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	11	31827957	11	31806409	492990	485946
NM_000280.4(PAX6):c.1A>C (p.Met1Leu)	PAX6	Aniridia 1|Irido-corneo-trabecular dysgenesis	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	11	31827959	11	31806411	430972	424548
NM_000280.4(PAX6):c.1A>G (p.Met1Val)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31827959	11	31806411	430971	424547
NM_000280.4(PAX6):c.-125dup	PAX6	Aniridia 1|not specified	Likely benign(Last reviewed: Jan 27, 2017)	criteria provided, single submitter	11	31828470	11	31806922	430970	424549
NM_000280.4(PAX6):c.-128-2delA	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31828475	11	31806927	430969	424550
NM_024426.5(WT1):c.1447+5G>A	WT1	Drash syndrome|Frasier syndrome|Diffuse mesangial sclerosis|Wilms tumor 1|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Hereditary nephrotic syndrome|WAGR syndrome	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, multiple submitters, no conflicts	11	32413513	11	32391967	3493	18532
NM_024426.4(WT1):c.896C>T (p.Ser299Phe)	WT1	Frasier syndrome	Likely pathogenic(Last reviewed: Jul 18, 2018)	no assertion criteria provided	11	32439177	11	32417631	78338	89229
NM_000256.3(MYBPC3):c.3815-1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Sep 16, 2018)	criteria provided, conflicting interpretations	11	47353433	11	47331882	42746	51916
NM_000256.3(MYBPC3):c.3811C>T (p.Arg1271Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: May 18, 2018)	criteria provided, multiple submitters, no conflicts	11	47353626	11	47332075	42744	51914
NM_000256.3(MYBPC3):c.3776delA (p.Gln1259Argfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Cardiomyopathy|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	11	47353661	11	47332110	164021	175138
NM_000256.3(MYBPC3):c.3771C>A (p.Asn1257Lys)	MYBPC3	not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Aug 10, 2017)	criteria provided, conflicting interpretations	11	47353666	11	47332115	181022	179175
NM_000256.3(MYBPC3):c.3767_3769delCCA (p.Thr1256del)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, multiple submitters, no conflicts	11	47353668 - 47353670	11	47332117 - 47332119	42741	51911
NM_000256.3(MYBPC3):c.3742_3759dup18 (p.Cys1253_Arg1254insGlyGlyIleTyrValCys)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	11	47353678 - 47353695	11	47332127 - 47332144	8603	23642
NM_000256.3(MYBPC3):c.3753T>G (p.Tyr1251Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	11	47353684	11	47332133	177818	174728
NM_000256.3(MYBPC3):c.3742G>A (p.Gly1248Arg)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jul 11, 2017)	criteria provided, multiple submitters, no conflicts	11	47353695	11	47332144	42739	51909
NM_000256.3(MYBPC3):c.3735delC (p.Phe1246Leufs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, multiple submitters, no conflicts	11	47353702	11	47332151	42737	51907
NM_000256.3(MYBPC3):c.3728C>G (p.Pro1243Arg)	MYBPC3	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Jul 27, 2015)	criteria provided, single submitter	11	47353709	11	47332158	217829	214488
NM_000256.3(MYBPC3):c.3712_3713delCT (p.Leu1238Glyfs)	MYBPC3	Familial hypertrophic cardiomyopathy 1	Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	11	47353724 - 47353725	11	47332173 - 47332174	217836	214489
NM_000256.3(MYBPC3):c.3694A>T (p.Lys1232Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 28, 2011)	criteria provided, single submitter	11	47353743	11	47332192	42733	51903
NM_000256.3(MYBPC3):c.3690_3691delCA (p.Phe1230Leufs)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 5, 2013)	no assertion criteria provided	11	47353746 - 47353747	11	47332195 - 47332196	177899	175141
NM_000256.3(MYBPC3):c.3682C>T (p.Arg1228Cys)	MYBPC3	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 4|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2018)	criteria provided, conflicting interpretations	11	47353755	11	47332204	161306	171133
NM_000256.3(MYBPC3):c.3662_3662del (p.Leu1221Argfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4	Likely pathogenic	criteria provided, single submitter	11	47353775	11	47332224	217479	214109
NM_000256.3(MYBPC3):c.3644_3645insT (p.Lys1216Glnfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	11	47353793	11	47332242	179527	175142
NM_000256.3(MYBPC3):c.3642G>T (p.Trp1214Cys)	MYBPC3	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	11	47353795	11	47332244	492980	485933
NM_000256.3(MYBPC3):c.3642G>A (p.Trp1214Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 4|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, multiple submitters, no conflicts	11	47353795	11	47332244	162506	172177
NM_000256.3(MYBPC3):c.3641G>A (p.Trp1214Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Nov 13, 2015)	criteria provided, multiple submitters, no conflicts	11	47353796	11	47332245	181015	179184
NM_000256.3(MYBPC3):c.3628-41_3628-17delAGCCTGGATGGCTTCCCTCCCTCTC	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	11	47353826 - 47353850	11	47332275 - 47332299	177677	174731
NM_000256.3(MYBPC3):c.3624delC (p.Lys1209Serfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, multiple submitters, no conflicts	11	47354120	11	47332569	42727	51897
NM_000256.3(MYBPC3):c.3624dupC (p.Lys1209Glnfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	11	47354120	11	47332569	42726	51896
NM_000256.3(MYBPC3):c.3600_3609delCTGCTGTGCT (p.Cys1201Serfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	11	47354135 - 47354144	11	47332584 - 47332593	177670	174732
NM_000256.3(MYBPC3):c.3599T>C (p.Leu1200Pro)	MYBPC3	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 4|not specified	Conflicting interpretations of pathogenicity(Last reviewed: May 9, 2017)	criteria provided, conflicting interpretations	11	47354145	11	47332594	42725	51895
NM_000256.3(MYBPC3):c.3512delA (p.Asn1171Thrfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	11	47354232	11	47332681	228371	230202
NM_000256.3(MYBPC3):c.3490+1G>A	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 10, 2012)	criteria provided, single submitter	11	47354364	11	47332813	42715	51885
NM_000256.3(MYBPC3):c.3476_3477delTT (p.Phe1159Tyrfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	11	47354378 - 47354379	11	47332827 - 47332828	177784	174733
NM_000256.3(MYBPC3):c.3414_3415insC (p.Val1139Argfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4	Likely pathogenic	criteria provided, single submitter	11	47354441	11	47332890	217486	214110
NM_000256.3(MYBPC3):c.3413G>A (p.Arg1138His)	MYBPC3	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Sep 13, 2017)	criteria provided, conflicting interpretations	11	47354442	11	47332891	177689	175146
NM_000256.3(MYBPC3):c.3412C>T (p.Arg1138Cys)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	Uncertain significance(Last reviewed: Jun 28, 2011)	criteria provided, single submitter	11	47354443	11	47332892	161307	171134
NM_000256.3(MYBPC3):c.3408C>A (p.Tyr1136Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	11	47354447	11	47332896	36611	45273
NM_000256.3(MYBPC3):c.3372C>A (p.Cys1124Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, multiple submitters, no conflicts	11	47354483	11	47332932	177701	174735
NM_000256.3(MYBPC3):c.3332_3335dupAGTG (p.Trp1112Terfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	Likely pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	11	47354520 - 47354523	11	47332969 - 47332972	177718	178184
NM_000256.3(MYBPC3):c.3335G>A (p.Trp1112Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	11	47354520	11	47332969	177680	175147
NM_000256.3(MYBPC3):c.3331-1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Aug 29, 2013)	criteria provided, single submitter	11	47354525	11	47332974	177742	174736
NM_000256.3(MYBPC3):c.3330+5G>T	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, multiple submitters, no conflicts	11	47354740	11	47333189	42707	51877
NM_000256.3(MYBPC3):c.3330+5G>C	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	11	47354740	11	47333189	42706	51876
NM_000256.3(MYBPC3):c.3330+2T>G	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	11	47354743	11	47333192	8621	23660
NM_000256.3(MYBPC3):c.3300C>A (p.Tyr1100Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 4	Likely pathogenic	criteria provided, single submitter	11	47354775	11	47333224	217485	214111
NM_000256.3(MYBPC3):c.3288delG (p.Glu1096Aspfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	11	47354787	11	47333236	164042	174737
NM_000256.3(MYBPC3):c.3286G>T (p.Glu1096Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	11	47354789	11	47333238	8616	23655
NM_000256.3(MYBPC3):c.3233G>A (p.Trp1078Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 26, 2017)	criteria provided, multiple submitters, no conflicts	11	47354842	11	47333291	42692	51862
NM_000256.3(MYBPC3):c.3226_3227insT (p.Asp1076Valfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	11	47354848 - 47354849	11	47333297 - 47333298	42694	51864
NM_000256.3(MYBPC3):c.3192dupC (p.Lys1065Glnfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, multiple submitters, no conflicts	11	47354883	11	47333332	42693	51863
NM_000256.3(MYBPC3):c.3190+5G>A	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|Heart block|not provided|Hypertrophic cardiomyopathy|Tachycardia|Asymmetric septal hypertrophy|Dyspnea|Ventricular extrasystoles|Noncompaction cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	11	47355103	11	47333552	155808	165560
NM_000256.3(MYBPC3):c.3190+2T>G	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	11	47355106	11	47333555	42691	51861
NM_000256.3(MYBPC3):c.3190+1G>A	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, multiple submitters, no conflicts	11	47355107	11	47333556	177837	175150
NM_000256.3(MYBPC3):c.3166dupG (p.Ala1056Glyfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	11	47355132	11	47333581	164047	175151
NM_000256.3(MYBPC3):c.3137C>T (p.Thr1046Met)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2016)	criteria provided, conflicting interpretations	11	47355161	11	47333610	161301	171135
NM_000256.3(MYBPC3):c.3129C>A (p.Tyr1043Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jan 4, 2013)	criteria provided, single submitter	11	47355169	11	47333618	164048	174740
NM_000256.3(MYBPC3):c.3065G>C (p.Arg1022Pro)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2018)	criteria provided, conflicting interpretations	11	47355233	11	47333682	42682	51852
NM_000256.3(MYBPC3):c.3065G>A (p.Arg1022His)	MYBPC3	Familial hypertrophic cardiomyopathy 1|not specified	Uncertain significance(Last reviewed: Sep 27, 2016)	criteria provided, multiple submitters, no conflicts	11	47355233	11	47333682	42681	51851
NM_000256.3(MYBPC3):c.3049G>A (p.Glu1017Lys)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Sep 5, 2017)	criteria provided, conflicting interpretations	11	47355249	11	47333698	42679	51849
NM_000256.3(MYBPC3):c.2994+2T>C	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Feb 4, 2015)	criteria provided, single submitter	11	47355471	11	47333920	164051	174742
NM_000256.3(MYBPC3):c.2980C>T (p.Leu994Phe)	MYBPC3	not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: May 16, 2018)	criteria provided, multiple submitters, no conflicts	11	47355487	11	47333936	180992	179223
NM_000256.3(MYBPC3):c.2965G>T (p.Glu989Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	11	47355502	11	47333951	164053	174743
NM_000256.3(MYBPC3):c.2953A>T (p.Lys985Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Apr 8, 2015)	criteria provided, multiple submitters, no conflicts	11	47355514	11	47333963	177956	174744
NM_000256.3(MYBPC3):c.2920C>T (p.Gln974Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	11	47355547	11	47333996	164055	174745
NM_000256.3(MYBPC3):c.2906-2A>G	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	11	47355563	11	47334012	177811	174746
NM_000256.3(MYBPC3):c.2905+1G>C	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Aug 30, 2012)	criteria provided, single submitter	11	47356592	11	47335041	42667	51837
NM_000256.3(MYBPC3):c.2905+1G>A	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 21, 2018)	criteria provided, conflicting interpretations	11	47356592	11	47335041	42666	51836
NM_000256.3(MYBPC3):c.2905C>T (p.Gln969Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, multiple submitters, no conflicts	11	47356593	11	47335042	42669	51839
NM_000256.3(MYBPC3):c.2882C>T (p.Pro961Leu)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided	Uncertain significance(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	11	47356616	11	47335065	42665	51835
NM_000256.3(MYBPC3):c.2875_2876delAC (p.Thr959Glyfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Aug 24, 2012)	criteria provided, single submitter	11	47356622 - 47356623	11	47335071 - 47335072	164059	174747
NM_000256.3(MYBPC3):c.2873C>T (p.Thr958Ile)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jun 25, 2018)	criteria provided, conflicting interpretations	11	47356625	11	47335074	42664	51834
NM_000256.3(MYBPC3):c.2870C>G (p.Thr957Ser)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Apr 16, 2018)	criteria provided, conflicting interpretations	11	47356628	11	47335077	36607	45269
NM_000256.3(MYBPC3):c.2864_2865delCT (p.Pro955Argfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: May 12, 2018)	criteria provided, multiple submitters, no conflicts	11	47356633 - 47356634	11	47335082 - 47335083	42663	51833
NM_000256.3(MYBPC3):c.2827C>T (p.Arg943Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	11	47356671	11	47335120	37039	45725
NM_000256.3(MYBPC3):c.2783C>T (p.Ser928Leu)	MYBPC3	not specified|Prolonged QT interval	Uncertain significance(Last reviewed: Jun 27, 2017)	criteria provided, multiple submitters, no conflicts	11	47356715	11	47335164	427958	419284
NM_000256.3(MYBPC3):c.2780_2781delCA (p.Thr927Ilefs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Feb 7, 2018)	criteria provided, multiple submitters, no conflicts	11	47356717 - 47356718	11	47335166 - 47335167	177660	174748
NM_000256.3(MYBPC3):c.2747G>A (p.Trp916Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, multiple submitters, no conflicts	11	47356751	11	47335200	177835	175160
NM_000256.3(MYBPC3):c.2737+2T>A	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 14, 2015)	criteria provided, single submitter	11	47357426	11	47335875	164063	174749
NM_000256.3(MYBPC3):c.2737+1G>C	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	11	47357427	11	47335876	177766	175161
NM_000256.3(MYBPC3):c.2686G>A (p.Val896Met)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Sep 22, 2017)	criteria provided, multiple submitters, no conflicts	11	47357479	11	47335928	42652	51822
NM_000256.3(MYBPC3):c.2670_2671insG (p.Arg891Alafs)	MYBPC3	Familial hypertrophic cardiomyopathy 4	Likely pathogenic	criteria provided, single submitter	11	47357495	11	47335944	217476	214112
NM_000256.3(MYBPC3):c.2618C>A (p.Pro873His)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Oct 13, 2017)	criteria provided, multiple submitters, no conflicts	11	47357547	11	47335996	30143	39099
NM_000256.3(MYBPC3):c.2610dupC (p.Ser871Glnfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	11	47357555	11	47336004	42646	51816
NM_000256.3(MYBPC3):c.2604_2605delTCinsA (p.Ser871Alafs)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 5, 2013)	no assertion criteria provided	11	47357560 - 47357561	11	47336009 - 47336010	177870	175163
NM_000256.3(MYBPC3):c.2558delG (p.Gly853Alafs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	11	47358986	11	47337435	42641	51811
NM_000256.3(MYBPC3):c.2556_2557delCGinsTCT (p.Gly853Leufs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, multiple submitters, no conflicts	11	47358987 - 47358988	11	47337436 - 47337437	42639	51809
NM_000256.3(MYBPC3):c.2556delC (p.Ile852Metfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: May 16, 2013)	criteria provided, multiple submitters, no conflicts	11	47358988	11	47337437	164071	174753
NM_000256.3(MYBPC3):c.2552C>T (p.Ala851Val)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 19, 2017)	criteria provided, multiple submitters, no conflicts	11	47358992	11	47337441	217837	214490
NM_000256.3(MYBPC3):c.2550_2550del (p.Asn850Lysfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4	Likely pathogenic	criteria provided, single submitter	11	47358994	11	47337443	217477	214113
NM_000256.3(MYBPC3):c.2541C>A (p.Tyr847Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 5, 2013)	no assertion criteria provided	11	47359003	11	47337452	177852	175165
NM_000256.3(MYBPC3):c.2541C>G (p.Tyr847Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, multiple submitters, no conflicts	11	47359003	11	47337452	42636	51806
NM_000256.3(MYBPC3):c.2517_2538del (p.Val840Thrfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 26, 2013)	criteria provided, single submitter	11	47359006 - 47359027	11	47337455 - 47337476	164073	174754
NM_000256.3(MYBPC3):c.2534_2538delGCGTC (p.Arg845Leufs)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|Cardiomyopathy	Pathogenic(Last reviewed: Feb 10, 2012)	criteria provided, multiple submitters, no conflicts	11	47359006 - 47359010	11	47337455 - 47337459	42635	51805
NM_000256.3(MYBPC3):c.2524dupT (p.Tyr842Leufs)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 30, 2015)	criteria provided, multiple submitters, no conflicts	11	47359020	11	47337469	42632	51802
NM_000256.3(MYBPC3):c.2504delG (p.Arg835Profs)	MYBPC3	Primary dilated cardiomyopathy	Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	11	47359040	11	47337489	228369	230208
NM_000256.3(MYBPC3):c.2497G>A (p.Ala833Thr)	MYBPC3	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|Paroxysmal atrial fibrillation|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	11	47359047	11	47337496	42626	51796
NM_000256.3(MYBPC3):c.2490dupT (p.His831Serfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, multiple submitters, no conflicts	11	47359054	11	47337503	42625	51795
NM_000256.3(MYBPC3):c.2459G>A (p.Arg820Gln)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, multiple submitters, no conflicts	11	47359085	11	47337534	8617	23656
NM_000256.3(MYBPC3):c.2454G>A (p.Trp818Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, multiple submitters, no conflicts	11	47359090	11	47337539	42622	51792
NM_000256.3(MYBPC3):c.2441_2443delAGA (p.Lys814del)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	11	47359101 - 47359103	11	47337550 - 47337552	177700	174757
NM_000256.3(MYBPC3):c.2437A>T (p.Lys813Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	11	47359107	11	47337556	177641	174758
NM_000256.3(MYBPC3):c.2429G>A (p.Arg810His)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jun 28, 2018)	criteria provided, conflicting interpretations	11	47359115	11	47337564	42620	51790
NM_000256.3(MYBPC3):c.2414-1G>A	MYBPC3	Dilated cardiomyopathy 1A|Familial hypertrophic cardiomyopathy 4	Likely pathogenic(Last reviewed: Sep 18, 2012)	criteria provided, single submitter	11	47359131	11	47337580	216967	213610
NM_000256.3(MYBPC3):c.2394dupT (p.Gly799Trpfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 14, 2015)	criteria provided, multiple submitters, no conflicts	11	47359260	11	47337709	177862	175171
NM_000256.3(MYBPC3):c.2391C>A (p.Tyr797Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 8, 2014)	criteria provided, single submitter	11	47359263	11	47337712	179435	174760
NM_000256.3(MYBPC3):c.2376G>A (p.Trp792Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 4	Likely pathogenic	criteria provided, single submitter	11	47359278	11	47337727	217484	214115
NM_000256.3(MYBPC3):c.2374T>C (p.Trp792Arg)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, multiple submitters, no conflicts	11	47359280	11	47337729	36605	45267
NM_000256.3(MYBPC3):c.2372_2373insG (p.Trp792Valfs)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	11	47359281	11	47337730	42619	51789
NM_000256.3(MYBPC3):c.2371C>T (p.Gln791Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, multiple submitters, no conflicts	11	47359283	11	47337732	217478	214116
NM_000256.3(MYBPC3):c.2320G>A (p.Ala774Thr)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Left ventricular noncompaction 10	Uncertain significance(Last reviewed: May 22, 2017)	criteria provided, multiple submitters, no conflicts	11	47359334	11	47337783	42618	51788
NM_000256.3(MYBPC3):c.2311G>A (p.Val771Met)	MYBPC3	Primary dilated cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not provided|Left ventricular noncompaction 10	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	11	47359343	11	47337792	161308	171136
NM_000256.3(MYBPC3):c.2311dupG (p.Val771Glyfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 26, 2017)	criteria provided, multiple submitters, no conflicts	11	47359343	11	47337792	42615	51785
NM_000256.3(MYBPC3):c.2309-2A>G	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: May 26, 2018)	criteria provided, multiple submitters, no conflicts	11	47359347	11	47337796	42613	51783
NM_000256.3(MYBPC3):c.2308+1G>A	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	11	47360070	11	47338519	42610	51780
NM_000256.3(MYBPC3):c.2269G>A (p.Val757Met)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 21, 2017)	criteria provided, multiple submitters, no conflicts	11	47360110	11	47338559	161309	171137
NM_000256.3(MYBPC3):c.2234A>G (p.Asp745Gly)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Familial hypertrophic cardiomyopathy 4|not specified	Uncertain significance(Last reviewed: Jul 2, 2015)	criteria provided, multiple submitters, no conflicts	11	47360145	11	47338594	30142	39098
NM_000256.3(MYBPC3):c.2182G>T (p.Glu728Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Jun 10, 2014)	criteria provided, multiple submitters, no conflicts	11	47360197	11	47338646	42605	51775
NM_000256.3(MYBPC3):c.2149-1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	11	47360231	11	47338680	177814	174763
NM_000256.3(MYBPC3):c.2148+1G>T	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Likely pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	11	47360874	11	47339323	417931	404802
NM_000256.3(MYBPC3):c.2096delC (p.Pro699Glnfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, multiple submitters, no conflicts	11	47360927	11	47339376	42596	51766
NM_000256.3(MYBPC3):c.2065C>T (p.Gln689Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	11	47361204	11	47339653	216055	212928
NM_000256.3(MYBPC3):c.2048G>A (p.Trp683Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Dec 9, 2011)	criteria provided, single submitter	11	47361221	11	47339670	42591	51761
NM_000256.3(MYBPC3):c.2035C>T (p.Pro679Ser)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	11	47361234	11	47339683	161302	171138
NM_000256.3(MYBPC3):c.2013_2016delCCCTinsGG (p.Pro672Aspfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, multiple submitters, no conflicts	11	47361253 - 47361256	11	47339702 - 47339705	42592	51762
NM_000256.3(MYBPC3):c.2003G>A (p.Arg668His)	MYBPC3	Familial hypertrophic cardiomyopathy 1|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Sep 7, 2017)	criteria provided, conflicting interpretations	11	47361266	11	47339715	164090	175175
NM_000256.3(MYBPC3):c.1999_2000delCTinsG (p.Leu667Aspfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Aug 21, 2017)	criteria provided, multiple submitters, no conflicts	11	47361269 - 47361270	11	47339718 - 47339719	164091	174764
NM_000256.3(MYBPC3):c.1928-2A>G	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, multiple submitters, no conflicts	11	47361343	11	47339792	42585	51755
NM_000256.3(MYBPC3):c.1924C>T (p.Gln642Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jan 10, 2017)	criteria provided, single submitter	11	47362557	11	47341006	177705	175177
NM_000256.3(MYBPC3):c.1897+1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, multiple submitters, no conflicts	11	47362688	11	47341137	42582	51752
NM_000256.3(MYBPC3):c.1869C>A (p.Cys623Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	11	47362717	11	47341166	164095	174766
NM_000256.3(MYBPC3):c.1863delC (p.Phe621Leufs)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 9, 2015)	criteria provided, single submitter	11	47362723	11	47341172	42578	51748
NM_000256.3(MYBPC3):c.1855G>A (p.Glu619Lys)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 26, 2017)	criteria provided, conflicting interpretations	11	47362731	11	47341180	161303	171139
NM_000256.3(MYBPC3):c.1838dupA (p.Asp613Glufs)	MYBPC3	Familial hypertrophic cardiomyopathy 1|not provided	Pathogenic(Last reviewed: Jun 18, 2015)	criteria provided, multiple submitters, no conflicts	11	47362748	11	47341197	181076	179278
NM_000256.3(MYBPC3):c.1828G>A (p.Asp610Asn)	MYBPC3	Primary dilated cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Feb 21, 2018)	criteria provided, multiple submitters, no conflicts	11	47362758	11	47341207	42575	51745
NM_000256.3(MYBPC3):c.1800delA (p.Lys600Asnfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, multiple submitters, no conflicts	11	47362786	11	47341235	42568	51738
NM_000256.3(MYBPC3):c.1790G>A (p.Arg597Gln)	MYBPC3	not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2017)	criteria provided, conflicting interpretations	11	47363542	11	47341991	164098	175179
NM_000256.3(MYBPC3):c.1700_1701delAG (p.Glu567Glyfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, multiple submitters, no conflicts	11	47363631 - 47363632	11	47342080 - 47342081	181072	179294
NM_000256.3(MYBPC3):c.1678delG (p.Asp560Thrfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 5, 2013)	criteria provided, single submitter	11	47363654	11	47342103	177864	174770
NM_000256.3(MYBPC3):c.1641_1642delGT (p.Tyr548Profs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, multiple submitters, no conflicts	11	47363690 - 47363691	11	47342139 - 47342140	92689	98596
NM_000256.3(MYBPC3):c.1628delA (p.Lys543Argfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	11	47363704	11	47342153	177637	174772
NM_000256.3(MYBPC3):c.1624+4A>T	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	11	47364125	11	47342574	42556	51726
NM_000256.3(MYBPC3):c.1624+2T>C	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	11	47364127	11	47342576	164107	175184
NM_000256.3(MYBPC3):c.1624G>C (p.Glu542Gln)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|Familial dilated cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	11	47364129	11	47342578	8608	23647
NM_000256.3(MYBPC3):c.1591G>C (p.Gly531Arg)	MYBPC3	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 29, 2017)	criteria provided, conflicting interpretations	11	47364162	11	47342611	42550	51720
NM_000256.3(MYBPC3):c.1575T>G (p.Tyr525Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2015)	criteria provided, multiple submitters, no conflicts	11	47364178	11	47342627	42547	51717
NM_000256.3(MYBPC3):c.1564G>A (p.Ala522Thr)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Jan 17, 2018)	criteria provided, multiple submitters, no conflicts	11	47364189	11	47342638	42545	51715
NM_000256.3(MYBPC3):c.1519G>A (p.Gly507Arg)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 13, 2017)	criteria provided, conflicting interpretations	11	47364234	11	47342683	42543	51713
NM_000256.3(MYBPC3):c.1513_1515delAAG (p.Lys505del)	MYBPC3	Familial hypertrophic cardiomyopathy 4|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Mar 7, 2018)	criteria provided, conflicting interpretations	11	47364238 - 47364240	11	47342687 - 47342689	177699	174775
NM_000256.3(MYBPC3):c.1505G>A (p.Arg502Gln)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	11	47364248	11	47342697	42541	51711
NM_000256.3(MYBPC3):c.1504C>T (p.Arg502Trp)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jul 10, 2018)	criteria provided, conflicting interpretations	11	47364249	11	47342698	42540	51710
NM_000256.3(MYBPC3):c.1484G>A (p.Arg495Gln)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|MYBPC3-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	11	47364269	11	47342718	164113	174776
NM_000256.3(MYBPC3):c.1483C>G (p.Arg495Gly)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, multiple submitters, no conflicts	11	47364270	11	47342719	42537	51707
NM_000256.3(MYBPC3):c.1468G>A (p.Gly490Arg)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	11	47364285	11	47342734	42536	51706
NM_000256.3(MYBPC3):c.1458-1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	11	47364296	11	47342745	42532	51702
NM_000256.3(MYBPC3):c.1456T>G (p.Trp486Gly)	MYBPC3	not specified	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	11	47364382	11	47342831	42531	51701
NM_000256.3(MYBPC3):c.1444_1445insG (p.Ala482Glyfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 1, 2015)	criteria provided, single submitter	11	47364394	11	47342843	228368	230214
NM_000256.3(MYBPC3):c.1373G>A (p.Arg458His)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	Uncertain significance(Last reviewed: Sep 14, 2012)	criteria provided, single submitter	11	47364465	11	47342914	42527	51697
NM_000256.3(MYBPC3):c.1370C>T (p.Thr457Met)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Likely benign(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	11	47364468	11	47342917	161314	171140
NM_000256.3(MYBPC3):c.1359delT (p.Val454Cysfs)	MYBPC3	Familial hypertrophic cardiomyopathy 1	Pathogenic(Last reviewed: May 1, 2015)	criteria provided, single submitter	11	47364479	11	47342928	217835	214491
NM_000256.3(MYBPC3):c.1358dupC (p.Val454Cysfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2011)	criteria provided, multiple submitters, no conflicts	11	47364480	11	47342929	181147	179321
NM_000256.3(MYBPC3):c.1357_1358delCC (p.Pro453Cysfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	11	47364480 - 47364481	11	47342929 - 47342930	164118	175190
NM_000256.3(MYBPC3):c.1357C>T (p.Pro453Ser)	MYBPC3	Familial hypertrophic cardiomyopathy 4	Likely pathogenic	criteria provided, single submitter	11	47364481	11	47342930	217475	214117
NM_000256.3(MYBPC3):c.1351+1G>A	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, multiple submitters, no conflicts	11	47364571	11	47343020	164119	174779
NM_000256.3(MYBPC3):c.1330delA (p.Ser444Alafs)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jun 17, 2014)	criteria provided, single submitter	11	47364593	11	47343042	179821	175192
NM_000256.3(MYBPC3):c.1321G>A (p.Glu441Lys)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Wolff-Parkinson-White pattern|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	11	47364602	11	47343051	36601	45263
NM_000256.3(MYBPC3):c.1302C>A (p.Tyr434Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 1	Pathogenic(Last reviewed: Mar 6, 2015)	criteria provided, single submitter	11	47364621	11	47343070	217827	214492
NM_000256.3(MYBPC3):c.1286C>T (p.Ala429Val)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 29, 2017)	criteria provided, conflicting interpretations	11	47364637	11	47343086	42518	51688
NM_000256.3(MYBPC3):c.1273C>T (p.Gln425Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 30, 2012)	criteria provided, single submitter	11	47364650	11	47343099	42517	51687
NM_000256.3(MYBPC3):c.1246G>A (p.Gly416Ser)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	11	47364677	11	47343126	42515	51685
NM_000256.3(MYBPC3):c.1235_1236delTT (p.Phe412Terfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	11	47364687 - 47364688	11	47343136 - 47343137	42514	51684
NM_000256.3(MYBPC3):c.1210C>T (p.Gln404Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	11	47365056	11	47343505	177796	174783
NM_000256.3(MYBPC3):c.1153G>A (p.Val385Met)	MYBPC3	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: May 8, 2018)	criteria provided, single submitter	11	47365113	11	47343562	219403	222144
NM_000256.3(MYBPC3):c.1090+1G>T	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Oct 7, 2016)	criteria provided, single submitter	11	47367757	11	47346206	177686	174784
NM_000256.3(MYBPC3):c.1090+1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	11	47367757	11	47346206	177668	175196
NM_000256.3(MYBPC3):c.1075G>T (p.Glu359Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 29, 2015)	criteria provided, single submitter	11	47367773	11	47346222	228367	230216
NM_000256.3(MYBPC3):c.1038_1042dupCGGCA (p.Met348Thrfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|not provided	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, multiple submitters, no conflicts	11	47367806 - 47367810	11	47346255 - 47346259	177698	178182
NM_000256.3(MYBPC3):c.1000G>T (p.Glu334Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 6, 2017)	criteria provided, multiple submitters, no conflicts	11	47367848	11	47346297	177850	174785
NM_000256.3(MYBPC3):c.999C>G (p.Tyr333Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Feb 25, 2016)	criteria provided, multiple submitters, no conflicts	11	47367849	11	47346298	177706	174786
NM_000256.3(MYBPC3):c.993_994insT (p.Glu332Terfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 5, 2013)	criteria provided, single submitter	11	47367855	11	47346304	164134	175198
NM_000256.3(MYBPC3):c.979C>T (p.Gln327Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jul 31, 2014)	criteria provided, single submitter	11	47367869	11	47346318	164135	174787
NM_000256.3(MYBPC3):c.966G>A (p.Trp322Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	11	47367882	11	47346331	164136	175199
NM_000256.3(MYBPC3):c.961G>A (p.Val321Met)	MYBPC3	Primary dilated cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	11	47367887	11	47346336	161310	171141
NM_000256.3(MYBPC3):c.932C>A (p.Ser311Ter)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2016)	criteria provided, multiple submitters, no conflicts	11	47367916	11	47346365	36615	45277
NM_000256.3(MYBPC3):c.927-2A>G	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, multiple submitters, no conflicts	11	47367923	11	47346372	42806	51976
NM_000256.3(MYBPC3):c.927-9G>A	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, multiple submitters, no conflicts	11	47367930	11	47346379	42807	51977
NM_000256.3(MYBPC3):c.927-10C>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2017)	criteria provided, multiple submitters, no conflicts	11	47367931	11	47346380	42805	51975
NM_000256.3(MYBPC3):c.926+1_926+5delGTGAG	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 14, 2016)	criteria provided, single submitter	11	47368173 - 47368177	11	47346622 - 47346626	504898	497618
NM_000256.3(MYBPC3):c.926+1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	11	47368177	11	47346626	517283	497619
NM_000256.3(MYBPC3):c.913_914delTT (p.Phe305Profs)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	11	47368190 - 47368191	11	47346639 - 47346640	42801	51971
NM_000256.3(MYBPC3):c.852-1G>T	MYBPC3	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	11	47369031	11	47347480	162500	172178
NM_000256.3(MYBPC3):c.841C>T (p.Arg281Trp)	MYBPC3	not specified|Catecholaminergic polymorphic ventricular tachycardia	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, multiple submitters, no conflicts	11	47369212	11	47347661	181052	179359
NM_000256.3(MYBPC3):c.836G>C (p.Gly279Ala)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Nov 12, 2017)	criteria provided, multiple submitters, no conflicts	11	47369217	11	47347666	42798	51968
NM_000256.3(MYBPC3):c.833delG (p.Gly278Glufs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, multiple submitters, no conflicts	11	47369220	11	47347669	164140	175201
NM_000256.3(MYBPC3):c.833G>A (p.Gly278Glu)	MYBPC3	Familial hypertrophic cardiomyopathy 4|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Personal and/or Family History of Cardiomyopathy	Benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	11	47369220	11	47347669	42797	51967
NM_000256.3(MYBPC3):c.821+5G>A	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 8, 2018)	criteria provided, conflicting interpretations	11	47369403	11	47347852	42796	51966
NM_000256.3(MYBPC3):c.821+2T>C	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jul 2, 2015)	criteria provided, single submitter	11	47369406	11	47347855	42795	51965
NM_000256.3(MYBPC3):c.821+1G>C	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 21, 2013)	criteria provided, single submitter	11	47369407	11	47347856	178946	175202
NM_000256.3(MYBPC3):c.821+1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	11	47369407	11	47347856	42791	51961
NM_000256.3(MYBPC3):c.818G>A (p.Arg273His)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	Uncertain significance(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	11	47369411	11	47347860	161312	171142
NM_000256.3(MYBPC3):c.787G>A (p.Gly263Arg)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Oct 20, 2017)	criteria provided, multiple submitters, no conflicts	11	47369442	11	47347891	161315	171143
NM_000256.3(MYBPC3):c.772+1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, multiple submitters, no conflicts	11	47369974	11	47348423	42790	51960
NM_000256.3(MYBPC3):c.772G>A (p.Glu258Lys)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	11	47369975	11	47348424	42792	51962
NM_000256.3(MYBPC3):c.710A>C (p.Tyr237Ser)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Aug 4, 2017)	criteria provided, conflicting interpretations	11	47370037	11	47348486	42787	51957
NM_000256.3(MYBPC3):c.682G>A (p.Asp228Asn)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	11	47370065	11	47348514	161304	171144
NM_000256.3(MYBPC3):c.655G>C (p.Val219Leu)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, multiple submitters, no conflicts	11	47370092	11	47348541	42784	51954
NM_000256.3(MYBPC3):c.655-1G>A	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, multiple submitters, no conflicts	11	47370093	11	47348542	42783	51953
NM_000256.3(MYBPC3):c.646G>A (p.Ala216Thr)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 6, 2017)	criteria provided, conflicting interpretations	11	47371333	11	47349782	42779	51949
NM_000256.3(MYBPC3):c.640G>A (p.Asp214Asn)	MYBPC3	Familial hypertrophic cardiomyopathy 4|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 24, 2013)	criteria provided, conflicting interpretations	11	47371339	11	47349788	191705	189889
NM_000256.3(MYBPC3):c.624G>C (p.Gln208His)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Oct 13, 2017)	criteria provided, multiple submitters, no conflicts	11	47371355	11	47349804	42775	51945
NM_000256.3(MYBPC3):c.551dupT (p.Lys185Glufs)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, multiple submitters, no conflicts	11	47371428	11	47349877	42771	51941
NM_000256.3(MYBPC3):c.533delT (p.Val178Glyfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 5, 2013)	no assertion criteria provided	11	47371446	11	47349895	164148	175205
NM_000256.3(MYBPC3):c.530G>A (p.Arg177His)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Dec 13, 2017)	criteria provided, multiple submitters, no conflicts	11	47371449	11	47349898	42767	51937
NM_000256.3(MYBPC3):c.529C>T (p.Arg177Cys)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Apr 17, 2018)	criteria provided, multiple submitters, no conflicts	11	47371450	11	47349899	36613	45275
NM_000256.3(MYBPC3):c.506-2A>C	MYBPC3	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, multiple submitters, no conflicts	11	47371475	11	47349924	42765	51935
NM_000256.3(MYBPC3):c.505+5G>C	MYBPC3	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	11	47371560	11	47350009	164151	175207
NM_000256.3(MYBPC3):c.481C>A (p.Pro161Thr)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Oct 12, 2017)	criteria provided, conflicting interpretations	11	47371589	11	47350038	42759	51929
NM_000256.3(MYBPC3):c.478C>T (p.Arg160Trp)	MYBPC3	Dilated cardiomyopathy 1A|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Apr 5, 2018)	criteria provided, conflicting interpretations	11	47371592	11	47350041	161311	171145
NM_000256.3(MYBPC3):c.466dup (p.Leu156Profs)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Aug 22, 2014)	criteria provided, single submitter	11	47371604	11	47350053	179709	175208
NM_000256.3(MYBPC3):c.461T>C (p.Ile154Thr)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Mar 19, 2018)	criteria provided, multiple submitters, no conflicts	11	47371609	11	47350058	42756	51926
NM_000256.3(MYBPC3):c.459delC (p.Ile154Leufs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	11	47371611	11	47350060	42755	51925
NM_000256.3(MYBPC3):c.350delC (p.Pro117Leufs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	11	47372109	11	47350558	42718	51888
NM_000256.3(MYBPC3):c.333_334insT (p.Glu112Terfs)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	11	47372126	11	47350575	177675	174798
NM_000256.3(MYBPC3):c.306_306del (p.Met103Cysfs)	MYBPC3	Familial hypertrophic cardiomyopathy 4	Likely pathogenic	criteria provided, single submitter	11	47372153	11	47350602	217481	214119
NM_000256.3(MYBPC3):c.237C>G (p.Tyr79Ter)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Mar 30, 2016)	criteria provided, multiple submitters, no conflicts	11	47372845	11	47351294	181132	179400
NM_000256.3(MYBPC3):c.227_228insA (p.Ser78Ilefs)	MYBPC3	Familial hypertrophic cardiomyopathy 4	Likely pathogenic	criteria provided, single submitter	11	47372855	11	47351304	217483	214120
NM_000256.3(MYBPC3):c.223G>A (p.Asp75Asn)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2018)	criteria provided, conflicting interpretations	11	47372859	11	47351308	161313	171146
NM_000256.3(MYBPC3):c.214_215dupGG (p.Pro73Alafs)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Feb 6, 2014)	criteria provided, single submitter	11	47372867 - 47372868	11	47351316 - 47351317	179537	178284
NM_000256.3(MYBPC3):c.177_187delAGAGGGCACAC (p.Glu60Alafs)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, multiple submitters, no conflicts	11	47372895 - 47372905	11	47351344 - 47351354	42565	51735
NM_000256.3(MYBPC3):c.184A>C (p.Thr62Pro)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	11	47372898	11	47351347	42577	51747
NM_000256.3(MYBPC3):c.26-2A>G	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	11	47373058	11	47351507	42644	51814
NM_000256.3(MYBPC3):c.13G>T (p.Gly5Trp)	MYBPC3	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Jul 3, 2015)	criteria provided, single submitter	11	47374186	11	47352635	217839	214493
NM_000256.3(MYBPC3):c.13G>C (p.Gly5Arg)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Left ventricular hypertrophy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, multiple submitters, no conflicts	11	47374186	11	47352635	161305	171147
NM_000256.3(MYBPC3):c.3G>C (p.Met1Ile)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, multiple submitters, no conflicts	11	47374196	11	47352645	42747	51917
NM_003120.2(SPI1):c.43C>G (p.Pro15Ala)	SPI1	SPI1-related eosinophilia syndrome	Uncertain significance(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	11	47399862	11	47378311	522841	513439
NM_000062.2(SERPING1):c.615dup (p.Val206Cysfs)	SERPING1	Hereditary angioedema type 1	Pathogenic(Last reviewed: Aug 16, 2018)	no assertion criteria provided	11	57369572	11	57602099	559595	550316
NM_004183.3(BEST1):c.26T>G (p.Val9Gly)	BEST1	Vitelliform macular dystrophy type 2	Likely pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	11	61719304	11	61951832	438579	432200
NM_004183.3(BEST1):c.324C>G (p.Ser108Arg)	BEST1	Vitelliform macular dystrophy type 2	Uncertain significance(Last reviewed: May 7, 2018)	criteria provided, single submitter	11	61723266	11	61955794	544680	535225
NM_004183.3(BEST1):c.535A>G (p.Asn179Asp)	BEST1	Vitelliform macular dystrophy type 2	Likely pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	11	61724369	11	61956897	438484	432105
NM_004183.3(BEST1):c.544T>C (p.Trp182Arg)	BEST1	Vitelliform macular dystrophy type 2	Uncertain significance(Last reviewed: May 8, 2018)	criteria provided, single submitter	11	61724378	11	61956906	544679	535224
NM_004183.3(BEST1):c.874G>C (p.Glu292Gln)	BEST1	Vitelliform macular dystrophy type 2	Likely pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	11	61726976	11	61959504	544678	535223
NM_004183.3(BEST1):c.888C>G (p.Asn296Lys)	BEST1	Vitelliform macular dystrophy type 2	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	11	61726990	11	61959518	559498	550222
NM_032667.6(BSCL2):c.269C>T (p.Ser90Leu)	BSCL2|HNRNPUL2-BSCL2	Distal hereditary motor neuronopathy type 5|Charcot-Marie-Tooth disease, type 2|Silver spastic paraplegia syndrome|Spastic paraplegia 17|not provided	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	11	62469965	11	62702493	4544	19583
NM_138732.2(NRXN2):c.3641G>T (p.Arg1214Leu)	NRXN2	not provided	Uncertain significance(Last reviewed: Mar 17, 2014)	criteria provided, single submitter	11	64390547	11	64623075	129836	135282
NM_138732.2(NRXN2):c.3207C>T (p.Gly1069=)	NRXN2	not specified	Likely benign	no assertion criteria provided	11	64415767	11	64648295	129835	135281
NM_138732.2(NRXN2):c.2625C>T (p.Ile875=)	NRXN2	not specified	Likely benign	no assertion criteria provided	11	64418900	11	64651428	129833	135279
NM_138732.2(NRXN2):c.1471C>T (p.Arg491Cys)	NRXN2	not provided	Uncertain significance(Last reviewed: Mar 13, 2014)	criteria provided, single submitter	11	64434956	11	64667484	129830	135276
NM_138732.2(NRXN2):c.1067G>A (p.Arg356Gln)	NRXN2	not provided	Uncertain significance(Last reviewed: Mar 17, 2014)	criteria provided, single submitter	11	64453131	11	64685659	129829	135275
NM_138732.2(NRXN2):c.531C>T (p.Gly177=)	NRXN2	not specified	Likely benign	no assertion criteria provided	11	64480641	11	64713169	129837	135283
NM_138732.2(NRXN2):c.246G>A (p.Leu82=)	NRXN2	not specified	Likely benign	no assertion criteria provided	11	64480926	11	64713454	129832	135278
NM_138732.2(NRXN2):c.242T>A (p.Leu81Gln)	NRXN2	not specified	Likely benign	no assertion criteria provided	11	64480930	11	64713458	129831	135277
NM_130799.2(MEN1):c.1621G>A (p.Ala541Thr)	MEN1	Primary hyperparathyroidism|Multiple endocrine neoplasia, type 1|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 16, 2018)	criteria provided, conflicting interpretations	11	64572018	11	64804546	41852	50291
NM_000244.3(MEN1):c.1277G>A (p.Cys426Tyr)	MEN1	Multiple endocrine neoplasia, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	11	64572594	11	64805122	36523	45185
NM_000244.3(MEN1):c.1267G>A (p.Asp423Asn)	MEN1	Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	11	64572604	11	64805132	16703	31742
NM_130799.2(MEN1):c.1174delG (p.Glu392Serfs)	MEN1	Multiple endocrine neoplasia, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	11	64573118	11	64805646	265238	259996
NM_000244.3(MEN1):c.1189dupG (p.Glu397Glyfs)	MEN1	Multiple endocrine neoplasia, type 1	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	11	64573118	11	64805646	36521	45183
NM_130799.2(MEN1):c.1075_1077delGAG (p.Glu359del)	MEN1	Multiple endocrine neoplasia, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Mar 28, 2018)	criteria provided, conflicting interpretations	11	64573215 - 64573217	11	64805743 - 64805745	403799	398859
NM_000244.3(MEN1):c.970dupT (p.Tyr324Leufs)	MEN1	Multiple endocrine neoplasia, type 1	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	11	64573798	11	64806326	36538	45200
NM_130799.2(MEN1):c.762_768dup (p.Leu257Glyfs)	MEN1	Multiple endocrine neoplasia, type 1	Likely pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	11	64575039 - 64575045	11	64807567 - 64807573	440862	434509
NM_000244.3(MEN1):c.773C>A (p.Ser258Ter)	MEN1	Multiple endocrine neoplasia, type 1	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	11	64575049	11	64807577	36536	45198
NM_000244.3(MEN1):c.669+18C>T	MEN1	Multiple endocrine neoplasia, type 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 15, 2017)	criteria provided, conflicting interpretations	11	64575345	11	64807873	36535	45197
NM_000244.3(MEN1):c.578C>T (p.Pro193Leu)	MEN1	Multiple endocrine neoplasia, type 1|not specified|Hereditary cancer-predisposing syndrome|Hyperparathyroidism	Uncertain significance(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	11	64575454	11	64807982	161295	171148
NM_130799.2(MEN1):c.512G>A (p.Arg171Gln)	MEN1	Multiple endocrine neoplasia, type 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia	Conflicting interpretations of pathogenicity(Last reviewed: Aug 22, 2017)	criteria provided, conflicting interpretations	11	64575505	11	64808033	41854	50293
NM_000244.3(MEN1):c.526C>T (p.Arg176Trp)	MEN1	Multiple endocrine neoplasia, type 1|not specified|Hereditary cancer-predisposing syndrome|Hyperparathyroidism	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2018)	criteria provided, conflicting interpretations	11	64575506	11	64808034	161294	171149
NM_130799.2(MEN1):c.307delC (p.Leu103Cysfs)	MEN1	Multiple endocrine neoplasia, type 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, multiple submitters, no conflicts	11	64577275	11	64809803	200996	197559
NM_130799.2(MEN1):c.249_252delGTCT (p.Ile85Serfs)	MEN1	Multiple endocrine neoplasia, type 1|Lipoma, somatic|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	11	64577330 - 64577333	11	64809858 - 64809861	16693	31732
NM_000244.3(MEN1):c.211_212delCC (p.Pro71Alafs)	MEN1	Multiple endocrine neoplasia, type 1|not provided	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	11	64577370 - 64577371	11	64809898 - 64809899	36526	45188
NM_000244.3(MEN1):c.1A>G (p.Met1Val)	MEN1	Multiple endocrine neoplasia, type 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, multiple submitters, no conflicts	11	64577581	11	64810109	36525	45187
NM_018026.3(PACS1):c.102G>A (p.Pro34=)	PACS1	not specified|Schuurs-hoeijmakers syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 8, 2017)	criteria provided, multiple submitters, no conflicts	11	65838059	11	66070588	129868	135314
NM_018026.3(PACS1):c.607C>T (p.Arg203Trp)	PACS1	Hypotelorism|Multiple congenital anomalies|Schuurs-hoeijmakers syndrome|not provided|Horseshoe kidney|Optic disc pallor|Mitral valve prolapse|Aortic root dilatation|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	11	65978677	11	66211206	39581	48180
NM_018026.3(PACS1):c.1993+8C>T	PACS1	not specified	Likely benign	no assertion criteria provided	11	66001418	11	66233947	129869	135315
NM_018026.3(PACS1):c.2061T>A (p.Ser687=)	PACS1	not specified|Schuurs-hoeijmakers syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 8, 2017)	criteria provided, multiple submitters, no conflicts	11	66001670	11	66234199	129870	135316
NM_018026.3(PACS1):c.2293+6G>C	PACS1	not specified	Likely benign	no assertion criteria provided	11	66006323	11	66238852	129871	135317
NM_018026.3(PACS1):c.2777-3T>C	PACS1	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 11, 2016)	criteria provided, single submitter	11	66010633	11	66243162	129872	135318
NM_006946.3(SPTBN2):c.3101T>C (p.Val1034Ala)	SPTBN2	Spinocerebellar ataxia 5|not specified|not provided|Spinocerebellar Ataxia, Dominant	Benign(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	11	66468469	11	66700998	130371	135818
NM_006946.3(SPTBN2):c.1877T>C (p.Leu626Pro)	SPTBN2	Spinocerebellar ataxia 5	Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	11	66472870	11	66705399	488611	481479
NM_006946.3(SPTBN2):c.585C>T (p.Asn195=)	SPTBN2	Spinocerebellar ataxia 5|not specified|Spinocerebellar Ataxia, Dominant	Benign/Likely benign(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	11	66481633	11	66714162	130372	135819
NM_006019.3(TCIRG1):c.2206C>A (p.Arg736Ser)	TCIRG1	Severe congenital neutropenia autosomal dominant|not provided|Congenital neutropenia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 25, 2014)	no assertion criteria provided	11	67817691	11	68050224	127173	132671
NM_002335.3(LRP5):c.592A>T (p.Asn198Tyr)	LRP5	High bone mass	Likely pathogenic	no assertion criteria provided	11	68125221	11	68357753	438745	432371
NM_133266.4(SHANK2):c.3730C>T (p.Arg1244Ter)	SHANK2	not provided	Uncertain significance(Last reviewed: Mar 17, 2014)	criteria provided, single submitter	11	70319030	11	70472925	130305	135752
NM_133266.4(SHANK2):c.2697C>T (p.Ala899=)	SHANK2	not specified	Likely benign	no assertion criteria provided	11	70331937	11	70485832	130304	135751
NM_133266.4(SHANK2):c.1136A>G (p.Tyr379Cys)	SHANK2	not specified	Likely benign	no assertion criteria provided	11	70333498	11	70487393	130303	135750
NM_000260.3(MYO7A):c.652G>A (p.Asp218Asn)	MYO7A	Deafness, autosomal dominant 11|Usher syndrome, type 1	Likely pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	11	76867967	11	77156921	29924	38879
NM_000260.3(MYO7A):c.689C>T (p.Ala230Val)	MYO7A	Deafness, autosomal dominant 11|Usher syndrome, type 1|not specified	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2016)	criteria provided, multiple submitters, no conflicts	11	76868004	11	77156958	178993	178258
NM_032943.4(SYTL2):c.890delG (p.Ser297Thrfs)	SYTL2	Angioedema	Pathogenic	no assertion criteria provided	11	85445479	11	85734436	375385	362153
NM_003797.4(EED):c.1097T>C (p.Met366Thr)	EED	Cohen-Gibson syndrome	Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	11	85988152	11	86277110	584435	575495
NM_000051.3(ATM):c.6116A>T (p.Glu2039Val)	ATM|C11orf65	Familial cancer of breast	Uncertain significance	no assertion criteria provided	11	108186758	11	108316031	417621	404599
NM_000051.3(ATM):c.6198+11T>C	ATM|C11orf65	CUP (carcinoma unknown primary) syndrome	Uncertain significance(Last reviewed: Nov 1, 2017)	no assertion criteria provided	11	108186851	11	108316124	446298	439702
NM_000051.3(ATM):c.6860G>C (p.Gly2287Ala)	ATM|C11orf65	Familial cancer of breast|Ataxia-telangiectasia syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	11	108196837	11	108326110	127428	132885
NM_000051.3(ATM):c.7089+1G>T	ATM|C11orf65	Familial cancer of breast	Likely pathogenic(Last reviewed: Mar 1, 2017)	no assertion criteria provided	11	108198486	11	108327759	403715	390690
NM_000051.3(ATM):c.7271T>G (p.Val2424Gly)	ATM|C11orf65	Familial cancer of breast|Ataxia-telangiectasia syndrome|Ataxia-telangiectasia variant|Breast cancer, susceptibility to|T-cell prolymphocytic leukemia|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic, risk factor(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	11	108199929	11	108329202	3023	18062
NM_000051.3(ATM):c.7638_7646delTAGAATTTC (p.Arg2547_Ser2549del)	ATM|C11orf65	Familial cancer of breast|Ataxia-telangiectasia syndrome|Ataxia-telangiectasia, complementation group E|T-cell prolymphocytic leukemia|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2018)	criteria provided, conflicting interpretations	11	108202614 - 108202622	11	108331887 - 108331895	3019	18058
NC_000011.9:g.111964415_111966592del2178	SDHD	Paragangliomas 1	Uncertain significance(Last reviewed: Aug 19, 2017)	criteria provided, single submitter	11	111964415 - 111966592			598762	589823
NM_003002.3(SDHD):c.112C>T (p.Arg38Ter)	SDHD	Paraganglioma and gastric stromal sarcoma|Pheochromocytoma|Paragangliomas 1|Hereditary Paraganglioma-Pheochromocytoma Syndromes|not provided|Cowden syndrome 3|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, multiple submitters, no conflicts	11	111958640	11	112087916	6893	21932
NM_003002.3(SDHD):c.158C>T (p.Pro53Leu)	SDHD	Paraganglioma and gastric stromal sarcoma|Pheochromocytoma|Paragangliomas 1|Cowden syndrome 3|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	11	111958686	11	112087962	161388	171127
NM_003002.3(SDHD):c.204C>T (p.Ser68=)	SDHD	Paraganglioma and gastric stromal sarcoma|Pheochromocytoma|Paragangliomas 1|not specified|not provided|Cowden syndrome 3|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	11	111959625	11	112088901	44650	53817
NM_003002.3(SDHD):c.242C>T (p.Pro81Leu)	SDHD	Paraganglioma and gastric stromal sarcoma|Pheochromocytoma|Paragangliomas 1|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Paragangliomas 1 with sensorineural hearing loss|not provided|Cowden syndrome 3|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	11	111959663	11	112088939	6896	21935
NM_003002.3(SDHD):c.386delT	SDHD	Pheochromocytoma	Likely pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	11	111965600	11	112094876	219161	217073
NM_004588.4(SCN2B):c.332C>T (p.Ser111Leu)	SCN2B	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	11	118038916	11	118168201	427979	419281
NM_001197104.1(KMT2A):c.89C>G (p.Ala30Gly)	KMT2A	not specified|not provided	Benign/Likely benign(Last reviewed: Jan 24, 2017)	criteria provided, multiple submitters, no conflicts	11	118307316	11	118436601	158711	168850
NM_001197104.1(KMT2A):c.458C>G (p.Ser153Ter)	KMT2A	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Apr 11, 2014)	criteria provided, single submitter	11	118339515	11	118468800	158704	168851
NM_001197104.1(KMT2A):c.602_603insT (p.Lys201Asnfs)	KMT2A	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	11	118342476 - 118342477	11	118471761 - 118471762	440482	434105
NM_001197104.1(KMT2A):c.1433G>A (p.Arg478Gln)	KMT2A	Wiedemann-Steiner syndrome	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	11	118343307	11	118472592	561043	552149
NM_001197104.1(KMT2A):c.1642A>G (p.Thr548Ala)	KMT2A	Wiedemann-Steiner syndrome	Likely benign	no assertion criteria provided	11	118343516	11	118472801	375628	362442
NM_005933.3(KMT2A):c.2318dup (p.Ser774Valfs)	KMT2A	Wiedemann-Steiner syndrome|not provided	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	11	118344192	11	118473477	374257	361201
NM_001197104.1(KMT2A):c.2673_2674del (p.Arg893Glufs)	KMT2A	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Mar 10, 2014)	criteria provided, single submitter	11	118344547 - 118344548	11	118473832 - 118473833	158701	168852
NM_001197104.1(KMT2A):c.3341C>A (p.Ser1114Ter)	KMT2A	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	11	118348688	11	118477973	488383	481237
NM_001197104.1(KMT2A):c.3521T>G (p.Leu1174Ter)	KMT2A	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	11	118348868	11	118478153	522805	513437
NM_001197104.1(KMT2A):c.3651dupG (p.Lys1218Glufs)	KMT2A	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: May 20, 2014)	criteria provided, single submitter	11	118352446	11	118481731	216951	213605
NM_001197104.1(KMT2A):c.4086+1G>A	KMT2A	Wiedemann-Steiner syndrome	Likely pathogenic(Last reviewed: Jun 4, 2013)	criteria provided, single submitter	11	118353211	11	118482496	216953	213606
NM_001197104.1(KMT2A):c.4284A>C (p.Ile1428=)	KMT2A	not specified	Benign(Last reviewed: Nov 19, 2013)	criteria provided, multiple submitters, no conflicts	11	118355642	11	118484927	158702	168853
NM_001197104.1(KMT2A):c.4342T>C (p.Cys1448Arg)	KMT2A	Wiedemann-Steiner syndrome	Likely pathogenic(Last reviewed: Feb 12, 2013)	criteria provided, single submitter	11	118359338	11	118488623	216962	213607
NM_001197104.1(KMT2A):c.4426T>A (p.Cys1476Ser)	KMT2A	Wiedemann-Steiner syndrome	Uncertain significance(Last reviewed: Apr 21, 2014)	criteria provided, single submitter	11	118359422	11	118488707	158703	168854
NM_001197104.1(KMT2A):c.4696+1G>A	KMT2A	Wiedemann-Steiner syndrome	Pathogenic	no assertion criteria provided	11	118360965	11	118490250	375623	362437
NM_001197104.1(KMT2A):c.5494C>A (p.Pro1832Thr)	KMT2A	Wiedemann-Steiner syndrome	Likely pathogenic(Last reviewed: Oct 11, 2013)	criteria provided, single submitter	11	118366545	11	118495830	209168	205767
NM_001197104.1(KMT2A):c.5679A>G (p.Leu1893=)	KMT2A	not specified	Benign(Last reviewed: Nov 19, 2013)	criteria provided, multiple submitters, no conflicts	11	118368665	11	118497950	158705	168855
NM_001197104.1(KMT2A):c.6002_6005del (p.Phe2001Trpfs)	KMT2A	Wiedemann-Steiner syndrome	Pathogenic	no assertion criteria provided	11	118370058 - 118370061	11	118499343 - 118499346	375624	362438
NM_001197104.1(KMT2A):c.6080G>A (p.Gly2027Glu)	KMT2A	Wiedemann-Steiner syndrome	Likely pathogenic	no assertion criteria provided	11	118370550	11	118499835	375619	362433
NM_001197104.1(KMT2A):c.6572G>A (p.Arg2191Gln)	KMT2A	not specified	Likely benign(Last reviewed: Jan 3, 2014)	criteria provided, single submitter	11	118373179	11	118502464	158706	168856
NM_001197104.1(KMT2A):c.7254C>T (p.Asn2418=)	KMT2A	not specified	Benign(Last reviewed: Nov 19, 2013)	criteria provided, multiple submitters, no conflicts	11	118373861	11	118503146	158707	168857
NM_001197104.1(KMT2A):c.7831G>T (p.Glu2611Ter)	KMT2A	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	criteria provided, single submitter	11	118374438	11	118503723	158708	168858
NM_001197104.1(KMT2A):c.8095C>T (p.Arg2699Ter)	KMT2A	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	11	118374702	11	118503987	158709	168859
NM_001197104.1(KMT2A):c.8961T>A (p.Thr2987=)	KMT2A	not specified	Benign(Last reviewed: Nov 19, 2013)	criteria provided, single submitter	11	118375568	11	118504853	158710	168860
NM_001197104.1(KMT2A):c.10334dupC (p.Ser3446Phefs)	KMT2A	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: May 6, 2014)	criteria provided, single submitter	11	118376941	11	118506226	216952	213608
NM_000190.4(HMBS):c.257A>T (p.Glu86Val)	HMBS	Acute intermittent porphyria	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	11	118959973	11	119089263	161252	171128
NM_000190.4(HMBS):c.500G>A (p.Arg167Gln)	HMBS	Acute intermittent porphyria|not provided	Pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	11	118962124	11	119091414	1446	16485
NM_000190.4(HMBS):c.583C>T (p.Arg195Cys)	HMBS	Acute intermittent porphyria	Likely pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	11	118962207	11	119091497	161251	171129
NM_000190.3(HMBS):c.669_698del30 (p.Glu223_Leu232del)	HMBS	Acute intermittent porphyria	Pathogenic	criteria provided, single submitter	11	118963131 - 118963160	11	119092421 - 119092450	522578	513190
NM_000190.4(HMBS):c.674G>A (p.Arg225Gln)	HMBS	Acute intermittent porphyria|not specified	Uncertain significance(Last reviewed: Jun 21, 2017)	criteria provided, single submitter	11	118963136	11	119092426	161253	171130
NM_000190.4(HMBS):c.962G>A (p.Arg321His)	HMBS	Acute intermittent porphyria|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 30, 2017)	criteria provided, conflicting interpretations	11	118963869	11	119093159	161250	171131
NM_000190.4(HMBS):c.1075G>A (p.Asp359Asn)	HMBS	Acute intermittent porphyria	Likely benign(Last reviewed: Jun 1, 2014)	no assertion criteria provided	11	118963982	11	119093272	161249	171132
NM_000190.3:c.1078_1132delGCCCATTAACTGGTTTGTGGGGCACAGATGCCTGGGTTGCTGCTGTCCAGTGCCT	HMBS	Acute intermittent porphyria	Pathogenic(Last reviewed: May 20, 2017)	criteria provided, single submitter	11	118963985 - 118964039	11	119093275 - 119093329	549662	540142
NM_005188.3(CBL):c.1096-1G>T	CBL	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	11	119148875	11	119278165	180815	179156
NM_005188.3(CBL):c.1099C>A (p.Gln367Lys)	CBL	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	Likely pathogenic(Last reviewed: Dec 14, 2015)	criteria provided, single submitter	11	119148879	11	119278169	178870	175344
NM_005188.3(CBL):c.1228-2A>G	CBL	Malignant germ cell tumor of ovary|Juvenile myelomonocytic leukemia|Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia|not provided|Rasopathy	Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2018)	criteria provided, conflicting interpretations	11	119149218	11	119278508	177959	175345
NM_005188.3(CBL):c.1754G>T (p.Arg585Leu)	CBL	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 10, 2013)	criteria provided, conflicting interpretations	11	119156089	11	119285379	179116	175068
NM_015645.4(C1QTNF5):c.489C>G (p.Ser163Arg)	MFRP|C1QTNF5	Late-onset retinal degeneration	Likely pathogenic(Last reviewed: Jun 12, 2012)	criteria provided, single submitter	11	119210284	11	119339574	2126	17165
NM_005422.2(TECTA):c.3107G>A (p.Cys1036Tyr)	TECTA	Sensorineural hearing loss	Likely pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	11	121008295	11	121137586	517663	508754
NM_005422.2(TECTA):c.4527C>G (p.Cys1509Trp)	TECTA	not specified	Uncertain significance(Last reviewed: Sep 18, 2013)	criteria provided, single submitter	11	121028771	11	121158062	165366	175087
NM_005422.2(TECTA):c.6155G>A (p.Cys2052Tyr)	TECTA	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	11	121058696	11	121187987	165373	175093
NM_152722.4(HEPACAM):c.592G>A (p.Asp198Asn)	HEPACAM	Megalencephalic leukoencephalopathy with subcortical cysts 2b, remitting, with or without mental retardation	Uncertain significance(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	11	124793742	11	124923846	522820	513438
NM_032531.3(KIRREL3):c.2151C>T (p.Ser717=)	KIRREL3	not specified	Likely benign	no assertion criteria provided	11	126294661	11	126424766	129426	134872
NM_032531.3(KIRREL3):c.1995C>T (p.Gly665=)	KIRREL3	not specified	Likely benign	no assertion criteria provided	11	126294817	11	126424922	129425	134871
NM_032531.3(KIRREL3):c.1354-6G>C	KIRREL3	not provided	Uncertain significance(Last reviewed: Jan 23, 2014)	criteria provided, single submitter	11	126306910	11	126437015	129423	134869
NM_032531.3(KIRREL3):c.1177G>A (p.Ala393Thr)	KIRREL3	not specified	Likely benign(Last reviewed: Sep 16, 2013)	criteria provided, single submitter	11	126314949	11	126445054	129421	134867
NM_032531.3(KIRREL3):c.655G>A (p.Val219Met)	KIRREL3	not provided	Uncertain significance(Last reviewed: Aug 28, 2013)	criteria provided, single submitter	11	126333139	11	126463244	129422	134868
NM_032531.3(KIRREL3):c.568A>G (p.Ile190Val)	KIRREL3	not specified	Likely benign	no assertion criteria provided	11	126343227	11	126473332	129428	134874
NM_032531.3(KIRREL3):c.346A>C (p.Arg116=)	KIRREL3	not specified	Likely benign	no assertion criteria provided	11	126391297	11	126521402	129427	134873
NM_032531.3(KIRREL3):c.103G>A (p.Ala35Thr)	KIRREL3	not provided	Uncertain significance(Last reviewed: Aug 29, 2013)	criteria provided, single submitter	11	126432760	11	126562865	129419	134865
NM_000890.3(KCNJ5):c.616G>A (p.Ala206Thr)	KCNJ5	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	11	128781784	11	128911889	427972	419282
NM_000256.3:c.(?_26)_(1090_?)del	MYBPC3	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	11	47367758 - 47373056	11	47346207 - 47351505	517190	496552
GRCh37/hg19 11p15.1-13(chr11:21586131-33168232)x1	BDNF|MPPED2|CSTF3|FANCF|FSHB|GAS2|KCNA4|NELL1|PAX6|RCN1|WT1|BBOX1|EIF3M|ELP4|WT1-AS|LIN7C|TCP11L1|LGR4|SLC17A6|ANO3|PRRG4|QSER1|KIF18A|CCDC34|DEPDC7|DNAJC24|ARL14EP|MUC15|SLC5A12|METTL15|IMMP1L|ANO5|SVIP|LINC00294|LUZP2|DCDC1|FIBIN|CCDC73|BDNF-AS|MIR610|CCDC179	Wilms tumor, aniridia, genitourinary anomalies, mental retardation, and obesity syndrome	Pathogenic	no assertion criteria provided	11	21586131 - 33168232			376759	363638
GRCh37/hg19 11p13(chr11:31083877-31704548)x1	ELP4|DNAJC24|IMMP1L|DCDC1	Aniridia 1	Pathogenic	no assertion criteria provided	11	31083877 - 31704548			376758	363637
GRCh37/hg19 11p15.1-13(chr11:18536224-31923308)x1	BDNF|MPPED2|FANCF|FSHB|GAS2|KCNA4|NELL1|PAX6|TSG101|CSRP3|BBOX1|SLC6A5|PRMT3|HTATIP2|ELP4|ZDHHC13|UEVLD|LIN7C|LGR4|SLC17A6|ANO3|E2F8|KIF18A|PTPN5|NAV2|CCDC34|MRGPRX2|DBX1|DNAJC24|ARL14EP|MUC15|SPTY2D1|TMEM86A|SLC5A12|METTL15|IMMP1L|ANO5|SVIP|MRGPRX1|IGSF22|LUZP2|DCDC1|FIBIN|BDNF-AS|MIR610|CCDC179	Aniridia 1	Pathogenic	no assertion criteria provided	11	18536224 - 31923308			376757	363636
GRCh37/hg19 11p13(chr11:31760458-31823847)x1	PAX6|ELP4	Aniridia 1	Pathogenic	no assertion criteria provided	11	31760458 - 31823847			376756	363635
GRCh37/hg19 11p13(chr11:31820789-31824052)x1	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31820789 - 31824052			376755	363634
GRCh37/hg19 11p13(chr11:31186493-31698208)x1	ELP4|DNAJC24|IMMP1L|DCDC1	Aniridia 1	Pathogenic	no assertion criteria provided	11	31186493 - 31698208			376754	363633
GRCh37/hg19 11p14.1-13(chr11:29750813-32752091)x1	MPPED2|FSHB|KCNA4|PAX6|RCN1|WT1|EIF3M|ELP4|WT1-AS|DNAJC24|ARL14EP|IMMP1L|DCDC1|CCDC73	Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome	Pathogenic	no assertion criteria provided	11	29750813 - 32752091			376753	363632
GRCh37/hg19 11p13(chr11:31147306-31714853)x1	ELP4|DNAJC24|IMMP1L|DCDC1	Aniridia 1	Pathogenic	no assertion criteria provided	11	31147306 - 31714853			376752	363631
NM_000256.3:c.(?_2906)_(3627_?)del	MYBPC3	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jul 2, 2015)	criteria provided, single submitter	11	47354117 - 47355561	11	47332566 - 47334010	228366	229955
NM_000719.6(CACNA1C):c.1468G>A (p.Gly490Arg)	CACNA1C	Timothy syndrome|Brugada syndrome 3|Long QT syndrome|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 12, 2017)	criteria provided, conflicting interpretations	12	2659186	12	2550020	17634	32673
NM_000719.6(CACNA1C):c.1553G>A (p.Arg518His)	CACNA1C	Familial hypertrophic cardiomyopathy 1|Long QT syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2017)	criteria provided, conflicting interpretations	12	2675632	12	2566466	372313	360088
NM_000719.6(CACNA1C):c.1582T>G (p.Trp528Gly)	CACNA1C	Primary dilated cardiomyopathy|Sudden cardiac death|Dilated cardiomyopathy	Uncertain significance(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	12	2675661	12	2566495	492985	485934
NM_000719.6(CACNA1C):c.3679G>A (p.Val1227Ile)	CACNA1C	Timothy syndrome|Long QT syndrome|not specified|not provided|Cardiovascular phenotype|Short QT Syndrome 4	Uncertain significance(Last reviewed: Apr 6, 2018)	criteria provided, multiple submitters, no conflicts	12	2719827	12	2610661	234984	236794
NM_000719.6(CACNA1C):c.4087G>C (p.Val1363Leu)	CACNA1C	CACNA1C-related condition	Likely pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	12	2763013	12	2653847	522828	513443
NM_000719.6(CACNA1C):c.5150C>G (p.Ala1717Gly)	CACNA1C|CACNA1C-AS1	Timothy syndrome|Cardiomyopathy, restrictive|Long QT syndrome|Brugada syndrome|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2018)	criteria provided, conflicting interpretations	12	2788668	12	2679502	93411	99318
NM_000719.6(CACNA1C):c.5593G>A (p.Glu1865Lys)	CACNA1C|CACNA1C-AS1	Timothy syndrome|Long QT syndrome|Brugada syndrome|not specified|not provided|Cardiovascular phenotype|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2018)	criteria provided, conflicting interpretations	12	2794921	12	2685755	191566	189341
NM_000719.6(CACNA1C):c.5639G>A (p.Arg1880Gln)	CACNA1C|CACNA1C-AS1	Long QT syndrome|Brugada syndrome|not specified|not provided|Brugada syndrome (shorter-than-normal QT interval)|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	12	2794967	12	2685801	67555	78451
NM_000719.6(CACNA1C):c.6040G>A (p.Val2014Ile)	CACNA1C|CACNA1C-AS1	Brugada syndrome 3|Long QT syndrome|Brugada syndrome|not specified|not provided|Brugada syndrome (shorter-than-normal QT interval)|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Mar 17, 2018)	criteria provided, conflicting interpretations	12	2797868	12	2688702	67556	78452
NM_020638.2(FGF23):c.536G>A (p.Arg179Gln)	FGF23	Autosomal dominant hypophosphatemic rickets	Pathogenic(Last reviewed: Dec 5, 2013)	criteria provided, multiple submitters, no conflicts	12	4479729	12	4370563	36135	44799
NM_020638.2(FGF23):c.535C>T (p.Arg179Trp)	FGF23	Autosomal dominant hypophosphatemic rickets|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, multiple submitters, no conflicts	12	4479730	12	4370564	5026	20065
NM_020638.2(FGF23):c.260G>A (p.Gly87Asp)	FGF23	Tumoral calcinosis, familial, hyperphosphatemic	Likely pathogenic(Last reviewed: Jul 1, 2014)	criteria provided, single submitter	12	4481815	12	4372649	216929	213620
NM_000217.3(KCNA1):c.684T>C (p.Cys228=)	KCNA1	Episodic ataxia type 1|Episodic ataxia|not specified|not provided|Myokymia	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	12	5021228	12	4912062	21128	33980
NM_000217.3(KCNA1):c.804G>C (p.Thr268=)	KCNA1	Episodic ataxia type 1|Episodic ataxia|not specified|not provided|Myokymia	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	12	5021348	12	4912182	21130	33982
NM_000217.3(KCNA1):c.1440T>A (p.Thr480=)	KCNA1	Episodic ataxia type 1|Episodic ataxia|not specified|not provided|Myokymia	Benign(Last reviewed: May 6, 2018)	criteria provided, multiple submitters, no conflicts	12	5021984	12	4912818	129313	134759
NM_002234.3(KCNA5):c.1733G>A (p.Arg578Lys)	KCNA5	Atrial fibrillation, familial, 7|Brugada syndrome 1|not specified	Benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	12	5155046	12	5045880	191573	189357
NM_001065.3(TNFRSF1A):c.362G>A (p.Arg121Gln)	TNFRSF1A	TNF receptor-associated periodic fever syndrome (TRAPS)|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 28, 2018)	criteria provided, conflicting interpretations	12	6442643	12	6333477	217017	213624
NM_001007026.1(ATN1):c.1647G>A (p.Leu549=)	ATN1	not specified	Likely benign	no assertion criteria provided	12	7046077	12	6936914	128461	133910
NM_001007026.1(ATN1):c.2430C>A (p.Arg810=)	ATN1	not specified	Likely benign	no assertion criteria provided	12	7047143	12	6937980	128462	133911
NM_001733.7(C1R):c.890G>A (p.Gly297Asp)	C1R	Ehlers-Danlos syndrome, type 8|Ehlers-Danlos syndrome, periodontal type, 2	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	12	7241461	12	7088865	372129	359036
NM_001733.7(C1R):c.869A>G (p.Asp290Gly)	C1R	Ehlers-Danlos syndrome, type 8|Ehlers-Danlos syndrome, periodontal type, 2	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	12	7241482	12	7088886	267356	262524
NM_001733.7(C1R):c.149_150delTCinsAT (p.Val50Asp)	C1R	Ehlers-Danlos syndrome, type 8|Ehlers-Danlos syndrome, periodontal type, 2	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	12	7244129 - 7244130	12	7091533 - 7091534	372130	359037
NM_144670.5(A2ML1):c.3397A>C (p.Asn1133His)	A2ML1	Noonan syndrome 1	Uncertain significance(Last reviewed: Aug 3, 2018)	no assertion criteria provided	12	9013788	12	8861192	559445	550169
NM_001987.4(ETV6):c.1153-5_1153-1delAACAG	ETV6	Acute lymphoid leukemia|See cases|Thrombocytopenia|Inborn genetic diseases|LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL	Pathogenic(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	12	12038855 - 12038859	12	11885921 - 11885925	190240	188069
NM_002336.2(LRP6):c.4593delC (p.Cys1532Alafs)	LRP6	Tooth agenesis|Orofacial clefting	Pathogenic(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12274309	12	12121375	225147	227046
NM_002336.2(LRP6):c.4298C>T (p.Ser1433Leu)	LRP6	Tooth agenesis|Orofacial clefting	Uncertain significance(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12279639	12	12126705	225160	227047
NM_002336.2(LRP6):c.4136G>A (p.Gly1379Asp)	LRP6	Tooth agenesis|Orofacial clefting	Uncertain significance(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12279801	12	12126867	225159	227048
NM_002336.2(LRP6):c.4082-2A>G	LRP6	Tooth agenesis	Likely pathogenic(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12279857	12	12126923	225153	227049
NM_002336.2(LRP6):c.3398-2A>C	LRP6	Tooth agenesis	Pathogenic(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12291470	12	12138536	225148	227050
NM_002336.2(LRP6):c.3365A>C (p.Asp1122Ala)	LRP6	Orofacial clefting	Uncertain significance(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12300332	12	12147398	225158	227051
NM_002336.2(LRP6):c.2995G>C (p.Gly999Arg)	LRP6	Orofacial clefting	Uncertain significance(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12302087	12	12149153	225157	227052
NM_002336.2(LRP6):c.2994+1G>A	LRP6	Tooth agenesis	Likely pathogenic(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12303769	12	12150835	225152	227053
NM_002336.2(LRP6):c.2058C>G (p.Ile686Met)	LRP6	Orofacial clefting	Uncertain significance(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12315348	12	12162414	225156	227054
NM_002336.2(LRP6):c.1620G>T (p.Leu540Phe)	LRP6	Orofacial clefting	Uncertain significance(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12318155	12	12165221	225155	227055
NM_002336.2(LRP6):c.1609G>A (p.Gly537Arg)	LRP6	Tooth agenesis	Likely pathogenic(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12318166	12	12165232	225151	227056
NM_002336.2(LRP6):c.1406C>T (p.Pro469Leu)	LRP6	Tooth agenesis	Likely pathogenic(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12332883	12	12179949	225150	227057
NM_002336.2(LRP6):c.1004G>T (p.Arg335Leu)	LRP6	Orofacial clefting	Uncertain significance(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12334346	12	12181412	225154	227058
NM_002336.2(LRP6):c.517C>G (p.Arg173Gly)	LRP6	Tooth agenesis	Likely pathogenic(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12356267	12	12203333	225149	227059
NM_004064.4(CDKN1B):c.-80C>T	CDKN1B|GPR19	Primary hyperparathyroidism	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	12	12870694	12	12717760	217125	213770
NM_004064.4(CDKN1B):c.-29_-26delAGAG	CDKN1B	Multiple endocrine neoplasia, type 4|Primary hyperparathyroidism|Multiple endocrine neoplasia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	12	12870745 - 12870748	12	12717811 - 12717814	217126	213771
NM_004064.4(CDKN1B):c.397C>A (p.Pro133Thr)	CDKN1B	Multiple endocrine neoplasia, type 4|Primary hyperparathyroidism|not specified|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	12	12871170	12	12718236	217127	213772
NM_000834.3(GRIN2B):c.4218C>T (p.Phe1406=)	GRIN2B	Mental retardation, autosomal dominant 6|not specified|not provided|Epileptic encephalopathy, early infantile, 27|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	12	13715954	12	13563020	98431	104324
NM_000834.4(GRIN2B):c.4197T>C (p.His1399=)	GRIN2B	not specified|not provided|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	12	13715975	12	13563041	98432	104325
NM_000834.4(GRIN2B):c.3534C>T (p.His1178=)	GRIN2B	not specified|not provided|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	12	13716638	12	13563704	129204	134650
NM_000834.3(GRIN2B):c.2691C>T (p.Asn897=)	GRIN2B	Mental retardation, autosomal dominant 6|not specified|not provided|Epileptic encephalopathy, early infantile, 27|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	12	13717481	12	13564547	98436	104329
NM_000834.3(GRIN2B):c.2664C>T (p.Thr888=)	GRIN2B	not specified|not provided|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	12	13717508	12	13564574	98437	104330
NM_000834.3(GRIN2B):c.2514C>T (p.Cys838=)	GRIN2B	not specified|not provided|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jun 21, 2017)	criteria provided, multiple submitters, no conflicts	12	13720043	12	13567109	129202	134648
NM_000834.4(GRIN2B):c.2471T>G (p.Met824Arg)	GRIN2B	Mental retardation, autosomal dominant 6	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	13720086	12	13567152	561027	552155
NM_000834.4(GRIN2B):c.2450A>G (p.Asn817Ser)	GRIN2B	not provided|Epileptic encephalopathy, early infantile, 27	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	12	13720107	12	13567173	546556	536833
NM_000834.4(GRIN2B):c.2273_2281del (p.Ala758_Thr760del)	GRIN2B	Epileptic encephalopathy, early infantile, 27	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	13722841 - 13722850	12	13569908 - 13569916	561026	552156
NM_000834.4(GRIN2B):c.2071A>G (p.Thr691Ala)	GRIN2B	Mental retardation, autosomal dominant 6	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	13724838	12	13571904	561023	552157
NM_000834.3(GRIN2B):c.2044C>T (p.Arg682Cys)	GRIN2B	Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Jan 21, 2014)	criteria provided, single submitter	12	13724865	12	13571931	29730	38685
NM_000834.4(GRIN2B):c.1937A>G (p.Tyr646Cys)	GRIN2B	Epileptic encephalopathy, early infantile, 27	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	13761610	12	13608676	561025	552158
NM_000834.4(GRIN2B):c.1821G>C (p.Trp607Cys)	GRIN2B	Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: Mar 13, 2015)	no assertion criteria provided	12	13761726	12	13608792	374327	361203
NM_000834.4(GRIN2B):c.1806C>T (p.Ile602=)	GRIN2B	not specified|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	13761741	12	13608807	129201	134647
NM_000834.4(GRIN2B):c.1727_1732delTCTTTG (p.Val576_Phe577del)	GRIN2B	Mental retardation, autosomal dominant 6|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2018)	criteria provided, conflicting interpretations	12	13764707 - 13764712	12	13611773 - 13611778	504225	495730
NM_000834.4(GRIN2B):c.1665C>T (p.Ser555=)	GRIN2B	Mental retardation, autosomal dominant 6|not specified|not provided|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	12	13764774	12	13611840	129200	134646
NM_000834.4(GRIN2B):c.1341C>T (p.Asp447=)	GRIN2B	Mental retardation, autosomal dominant 6|not specified|not provided|Epileptic encephalopathy, early infantile, 27|History of neurodevelopmental disorder	Benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	12	13768586	12	13615652	98440	104333
NM_000834.4(GRIN2B):c.1306T>C (p.Cys436Arg)	GRIN2B	Mental retardation, autosomal dominant 6	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	13769411	12	13616477	561022	552160
NM_000834.4(GRIN2B):c.870C>T (p.Pro290=)	GRIN2B	Mental retardation, autosomal dominant 6|not specified|Epileptic encephalopathy, early infantile, 27|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	12	13906391	12	13753457	129208	134654
NM_000834.4(GRIN2B):c.504C>A (p.Ile168=)	GRIN2B	Mental retardation, autosomal dominant 6|not specified|Epileptic encephalopathy, early infantile, 27|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	12	13906757	12	13753823	129207	134653
NM_000834.4(GRIN2B):c.381C>T (p.His127=)	GRIN2B	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2015)	criteria provided, conflicting interpretations	12	14018762	12	13865828	129206	134652
NM_000834.4(GRIN2B):c.366C>G (p.Pro122=)	GRIN2B	not specified|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jun 7, 2017)	criteria provided, multiple submitters, no conflicts	12	14018777	12	13865843	129205	134651
NM_000834.4(GRIN2B):c.15G>A (p.Ala5=)	GRIN2B	not specified|not provided|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Sep 14, 2017)	criteria provided, multiple submitters, no conflicts	12	14019128	12	13866194	98442	104335
NM_004963.3(GUCY2C):c.410T>C (p.Leu137Ser)	GUCY2C|C12orf60	Duodenal atresia|Asplenia|Duodenal atresia|Reduced number of intrahepatic bile ducts|Abnormal biliary tract morphology	Pathogenic	no assertion criteria provided	12	14836177	12	14683243	375380	362154
NM_005691.3(ABCC9):c.4450-5del	ABCC9	Cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jun 29, 2015)	criteria provided, conflicting interpretations	12	21958999	12	21806065	35634	44299
NM_005691.3(ABCC9):c.3347G>A (p.Arg1116His)	ABCC9	Hypertrichotic osteochondrodysplasia	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	21995374	12	21842440	35533	44204
NM_005691.3(ABCC9):c.2878G>C (p.Glu960Gln)	ABCC9	Prolonged QT interval	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	12	21998755	12	21845821	427957	419285
NM_005691.3(ABCC9):c.878T>C (p.Phe293Ser)	ABCC9	Hypertrichotic osteochondrodysplasia	Likely pathogenic(Last reviewed: Jun 3, 2015)	criteria provided, single submitter	12	22065939	12	21913005	369679	353904
NC_000012.12:g.23279750_23620758del341009	SOX5	Optic nerve hypoplasia	Pathogenic	criteria provided, single submitter	12	23432684 - 23773692	12	23279750 - 23620758	496727	488177
NM_004985.4(KRAS):c.466T>G (p.Phe156Val)	KRAS	Noonan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	12	25362830	12	25209896	45127	54294
NM_004985.4(KRAS):c.458A>T (p.Asp153Val)	KRAS	Noonan syndrome 3|Noonan syndrome|not specified|not provided|Rasopathy|Cardiofaciocutaneous syndrome 2	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	25362838	12	25209904	12587	27626
NM_004985.4(KRAS):c.214A>T (p.Met72Leu)	KRAS	Noonan syndrome	Pathogenic(Last reviewed: Nov 12, 2015)	criteria provided, single submitter	12	25380244	12	25227310	179141	175714
NM_004985.4(KRAS):c.194G>T (p.Ser65Ile)	KRAS	Noonan syndrome 3|Rasopathy	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	25380264	12	25227330	438796	432423
NM_004985.4(KRAS):c.179G>T (p.Gly60Val)	KRAS	Non-small cell lung cancer|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, multiple submitters, no conflicts	12	25380279	12	25227345	163766	175855
NM_004985.4(KRAS):c.178G>C (p.Gly60Arg)	KRAS	not provided|Rasopathy|Cardiofaciocutaneous syndrome 2|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	25380280	12	25227346	12586	27625
NM_004985.4(KRAS):c.173C>T (p.Thr58Ile)	KRAS	Noonan syndrome 3|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	25380285	12	25227351	12588	27627
NM_004985.4(KRAS):c.101C>T (p.Pro34Leu)	KRAS	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	25398218	12	25245284	40454	48924
NM_004985.4(KRAS):c.101C>G (p.Pro34Arg)	KRAS	not provided|Rasopathy|Cardiofaciocutaneous syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	12	25398218	12	25245284	12590	27629
NM_004985.4(KRAS):c.65A>G (p.Gln22Arg)	KRAS	Noonan syndrome 3|Noonan syndrome|not specified|not provided|Rasopathy|Cardiofaciocutaneous syndrome 2	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	25398254	12	25245320	40452	48922
NM_004985.4(KRAS):c.40G>A (p.Val14Ile)	KRAS	Endometrial carcinoma|Noonan syndrome 3|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	25398279	12	25245345	12589	27628
NM_012062.4(DNM1L):c.1048G>A (p.Gly350Arg)	DNM1L	Encephalopathy due to defective mitochondrial and peroxisomal fission 1	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	32875536	12	32722602	253267	247689
NM_012063.3(DNM1L):c.1135G>A (p.Glu379Lys)	DNM1L|YARS2	Encephalopathy due to defective mitochondrial and peroxisomal fission 1	Likely pathogenic(Last reviewed: Jun 23, 2014)	no assertion criteria provided	12	32884003	12	32731069	374321	361204
NM_012062.4(DNM1L):c.1207C>T (p.Arg403Cys)	DNM1L|YARS2	Encephalopathy due to defective mitochondrial and peroxisomal fission 1|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, multiple submitters, no conflicts	12	32884296	12	32731362	214313	211619
NM_004572.3(PKP2):c.2551delA (p.Thr851Argfs)	PKP2	Arrhythmogenic right ventricular cardiomyopathy	Likely pathogenic(Last reviewed: Apr 8, 2015)	criteria provided, single submitter	12	32945604	12	32792670	179315	175720
NM_004572.3(PKP2):c.2509delA (p.Ser837Valfs)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	12	32945646	12	32792712	177995	175861
NM_004572.3(PKP2):c.2431C>A (p.Arg811Ser)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not specified|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 13, 2018)	criteria provided, conflicting interpretations	12	32949101	12	32796167	45068	54235
NM_004572.3(PKP2):c.2203C>T (p.Arg735Ter)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Aug 25, 2016)	criteria provided, multiple submitters, no conflicts	12	32955433	12	32802499	6755	21794
NM_004572.3(PKP2):c.2197_2202delCACACCinsG (p.His733Alafs)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not provided|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	12	32955434 - 32955439	12	32802500 - 32802505	45063	54230
NM_004572.3(PKP2):c.2146-1G>C	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, multiple submitters, no conflicts	12	32955491	12	32802557	6756	21795
NM_004572.3(PKP2):c.2119C>T (p.Gln707Ter)	PKP2	Arrhythmogenic right ventricular cardiomyopathy	Likely pathogenic(Last reviewed: Aug 22, 2012)	criteria provided, single submitter	12	32974316	12	32821382	45059	54226
NM_001005242.2(PKP2):c.1930T>C (p.Ser644Pro)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Apr 24, 2018)	criteria provided, conflicting interpretations	12	32974373	12	32821439	45055	54222
NM_004572.3(PKP2):c.2028G>A (p.Trp676Ter)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	12	32974407	12	32821473	36682	45343
NM_004572.3(PKP2):c.1840delC (p.Leu614Serfs)	PKP2	Arrhythmogenic right ventricular cardiomyopathy|Arrhythmogenic right ventricular dysplasia/cardiomyopathy	Likely pathogenic(Last reviewed: May 10, 2016)	criteria provided, multiple submitters, no conflicts	12	32975532	12	32822598	496256	487607
NM_004572.3(PKP2):c.1821dupT (p.Val608Cysfs)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	12	32975551	12	32822617	45047	54214
NM_004572.3(PKP2):c.1759G>A (p.Val587Ile)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|Cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 22, 2017)	criteria provided, conflicting interpretations	12	32977026	12	32824092	36681	45342
NM_004572.3(PKP2):c.1677dup (p.Gly560Trpfs)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Cardiomyopathy	Likely pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	12	32993973	12	32841039	517335	497223
NM_004572.3(PKP2):c.1643delG (p.Gly548Valfs)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, multiple submitters, no conflicts	12	32994007	12	32841073	202035	198417
NM_004572.3(PKP2):c.1613G>A (p.Trp538Ter)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	12	32994037	12	32841103	36680	45341
NM_004572.3(PKP2):c.1577C>T (p.Thr526Met)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not specified|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2018)	criteria provided, conflicting interpretations	12	32994073	12	32841139	45033	54200
NM_004572.3(PKP2):c.1465G>A (p.Gly489Arg)	PKP2	Arrhythmogenic right ventricular cardiomyopathy	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	12	32996161	12	32843227	161331	171150
NM_004572.3(PKP2):c.1237C>T (p.Arg413Ter)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not provided|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, multiple submitters, no conflicts	12	33003841	12	32850907	45016	54183
NM_004572.3(PKP2):c.1132C>T (p.Gln378Ter)	PKP2	Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Oct 18, 2017)	criteria provided, multiple submitters, no conflicts	12	33021899	12	32868965	45010	54177
NM_004572.3(PKP2):c.1035-1G>A	PKP2	Arrhythmogenic right ventricular cardiomyopathy	Likely pathogenic(Last reviewed: Jul 5, 2017)	criteria provided, single submitter	12	33021997	12	32869063	517431	497224
NM_004572.3(PKP2):c.968_975dup (p.Ala326Argfs)	PKP2	Arrhythmogenic right ventricular cardiomyopathy	Likely pathogenic(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	12	33030839 - 33030846	12	32877905 - 32877912	517359	497007
NM_004572.3(PKP2):c.968_971delAGGCinsGCT (p.Gln323Argfs)	PKP2	Arrhythmogenic right ventricular cardiomyopathy	Likely pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	12	33030843 - 33030846	12	32877909 - 32877912	517446	497639
NM_004572.3(PKP2):c.772A>T (p.Lys258Ter)	PKP2	Arrhythmogenic right ventricular cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2014)	criteria provided, multiple submitters, no conflicts	12	33031042	12	32878108	177984	175729
NM_004572.3(PKP2):c.663C>A (p.Tyr221Ter)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	12	33031151	12	32878217	201976	198441
NM_004572.3(PKP2):c.533dupT (p.His179Alafs)	PKP2	Arrhythmogenic right ventricular cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, multiple submitters, no conflicts	12	33031281	12	32878347	202012	198446
NM_004572.3(PKP2):c.505A>G (p.Ser169Gly)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 6, 2018)	criteria provided, conflicting interpretations	12	33031309	12	32878375	45081	54248
NM_004572.3(PKP2):c.419C>T (p.Ser140Phe)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2018)	criteria provided, conflicting interpretations	12	33031395	12	32878461	45077	54244
NM_004572.3(PKP2):c.337-2A>T	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	12	33031479	12	32878545	188654	186427
NM_001005242.2(PKP2):c.184C>A (p.Gln62Lys)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not specified	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	12	33049482	12	32896548	161332	171151
NM_004572.3(PKP2):c.76G>A (p.Asp26Asn)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Aug 21, 2017)	criteria provided, multiple submitters, no conflicts	12	33049590	12	32896656	45084	54251
NM_198578.3(LRRK2):c.4321C>A (p.Arg1441Ser)	LRRK2	Parkinson disease, late-onset	Pathogenic(Last reviewed: Apr 14, 2016)	no assertion criteria provided	12	40704236	12	40310434	225276	227175
NM_198578.3(LRRK2):c.6055G>A (p.Gly2019Ser)	LRRK2	Parkinson disease 8, autosomal dominant|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Feb 17, 2018)	criteria provided, multiple submitters, no conflicts	12	40734202	12	40340400	1940	16979
NC_000012.12:g.42476400_42505654del29255	PRICKLE1	Progressive myoclonus epilepsy with ataxia	Likely pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	12	42870202 - 42899456	12	42476400 - 42505654	243056	244138
NM_152641.3(ARID2):c.2521C>T (p.Gln841Ter)	ARID2	COFFIN-SIRIS SYNDROME 6	Pathogenic(Last reviewed: May 9, 2018)	no assertion criteria provided	12	46244427	12	45850644	545705	536197
NM_001844.4(COL2A1):c.4316C>T (p.Thr1439Met)	COL2A1	Spondyloperipheral dysplasia|Spondyloepiphyseal dysplasia	Likely pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	12	48367873	12	47974090	17385	32424
NM_001844.5(COL2A1):c.2035A>T (p.Lys679Ter)	COL2A1	Stickler syndrome type 1	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	12	48377182	12	47983399	598754	589804
NM_001844.4(COL2A1):c.1979G>A (p.Gly660Glu)	COL2A1	Achondrogenesis, type II	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	12	48377482	12	47983699	488485	481353
NM_001844.4(COL2A1):c.1452C>T (p.Pro484=)	COL2A1	Stickler syndrome type 1	Likely benign(Last reviewed: Feb 28, 2017)	no assertion criteria provided	12	48380194	12	47986411	403714	390689
NM_003482.3(KMT2D):c.16489_16491delATC (p.Ile5497del)	KMT2D	Kabuki syndrome 1	Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2016)	criteria provided, conflicting interpretations	12	49415856 - 49415858	12	49022073 - 49022075	158745	168898
NM_003482.3(KMT2D):c.16438_16441delAACT (p.Asn5480Valfs)	KMT2D	Kabuki syndrome 1|not provided	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	12	49415906 - 49415909	12	49022123 - 49022126	158744	168899
NM_003482.3(KMT2D):c.16412+13G>A	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Oct 10, 2013)	criteria provided, single submitter	12	49416050	12	49022267	158742	168901
NM_003482.3(KMT2D):c.16411A>T (p.Arg5471Trp)	KMT2D	Kabuki syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49416064	12	49022281	158741	168902
NM_003482.3(KMT2D):c.15978T>G (p.Leu5326=)	KMT2D	not specified|Kabuki syndrome	Benign/Likely benign(Last reviewed: Nov 20, 2017)	criteria provided, multiple submitters, no conflicts	12	49418435	12	49024652	94189	100089
NM_003482.3(KMT2D):c.15943C>T (p.Gln5315Ter)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Sep 19, 2013)	criteria provided, single submitter	12	49418470	12	49024687	158740	168903
NM_003482.3(KMT2D):c.15902_15903del (p.Val5301Alafs)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	49418610 - 49418612	12	49024828 - 49024829	561046	552162
NM_003482.3(KMT2D):c.15844C>T (p.Arg5282Ter)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49418670	12	49024887	158739	168904
NM_003482.3(KMT2D):c.15791G>A (p.Trp5264Ter)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49418723	12	49024940	158738	168905
NM_003482.3(KMT2D):c.15671G>A (p.Arg5224His)	KMT2D	Kabuki syndrome 1|not specified|not provided|Kabuki syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 2, 2017)	criteria provided, conflicting interpretations	12	49420078	12	49026295	134730	138469
NM_003482.3(KMT2D):c.15641G>C (p.Arg5214Pro)	KMT2D	Kabuki syndrome 1	Pathogenic	no assertion criteria provided	12	49420108	12	49026325	523665	514313
NM_003482.3(KMT2D):c.15361G>T (p.Ala5121Ser)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	12	49420388	12	49026605	158737	168906
NM_003482.3(KMT2D):c.15245T>G (p.Val5082Gly)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	12	49420504	12	49026721	158736	168907
NM_003482.3(KMT2D):c.15195G>A (p.Trp5065Ter)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49420554	12	49026771	158735	168908
NM_003482.3(KMT2D):c.15061C>T (p.Arg5021Ter)	KMT2D	Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	12	49420688	12	49026905	158734	168909
NM_003482.3(KMT2D):c.14840C>A (p.Pro4947His)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49420909	12	49027126	158733	168910
NM_003482.3(KMT2D):c.14710C>T (p.Arg4904Ter)	KMT2D	Kabuki syndrome 1|Kabuki syndrome	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, multiple submitters, no conflicts	12	49421039	12	49027256	94176	100076
NM_003482.3(KMT2D):c.14251+18T>C	KMT2D	not specified	Benign(Last reviewed: Mar 16, 2016)	criteria provided, multiple submitters, no conflicts	12	49422826	12	49029043	94173	100073
NM_003482.3(KMT2D):c.14238G>A (p.Arg4746=)	KMT2D	not specified|Kabuki syndrome	Benign(Last reviewed: Jul 11, 2017)	criteria provided, multiple submitters, no conflicts	12	49422857	12	49029074	94172	100072
NM_003482.3(KMT2D):c.14080G>C (p.Glu4694Gln)	KMT2D	Kabuki syndrome 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2016)	criteria provided, conflicting interpretations	12	49423015	12	49029232	134726	138465
NM_003482.3(KMT2D):c.14075+1G>A	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Nov 24, 2014)	criteria provided, single submitter	12	49423183	12	49029400	369674	353905
NM_003482.3(KMT2D):c.13996_13997delAG (p.Arg4666Glyfs)	KMT2D	Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	12	49424065 - 49424066	12	49030282 - 49030283	158732	168911
NM_003482.3(KMT2D):c.13884delC (p.Thr4629Profs)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Jun 23, 2016)	criteria provided, single submitter	12	49424178	12	49030395	267267	262270
NM_003482.3(KMT2D):c.13689C>T (p.Pro4563=)	KMT2D	not specified|Kabuki syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	49424534	12	49030751	94169	100069
NM_003482.3(KMT2D):c.13644C>T (p.Ser4548=)	KMT2D	not specified|Kabuki syndrome	Benign/Likely benign(Last reviewed: Apr 23, 2017)	criteria provided, multiple submitters, no conflicts	12	49424703	12	49030920	94167	100067
NM_003482.3(KMT2D):c.13606C>T (p.Arg4536Ter)	KMT2D	Kabuki syndrome 1|not provided|Kabuki syndrome	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, multiple submitters, no conflicts	12	49424741	12	49030958	158731	168912
NM_003482.3(KMT2D):c.13518del (p.Ser4507Alafs)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Oct 10, 2013)	criteria provided, single submitter	12	49424970	12	49031187	158730	168913
NM_003482.3(KMT2D):c.13450C>T (p.Arg4484Ter)	KMT2D	Kabuki syndrome 1|Inborn genetic diseases	Pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, multiple submitters, no conflicts	12	49425038	12	49031255	158729	168914
NM_003482.3(KMT2D):c.13378_13379insCA (p.His4460Profs)	KMT2D	Kabuki syndrome 1	Likely pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	12	49425109 - 49425110	12	49031326 - 49031327	488540	481408
NM_003482.3(KMT2D):c.13045C>G (p.Pro4349Ala)	KMT2D	Kabuki syndrome 1|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 27, 2017)	criteria provided, conflicting interpretations	12	49425443	12	49031660	94165	100065
NM_003482.3(KMT2D):c.13001C>T (p.Ala4334Val)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: May 22, 2014)	criteria provided, single submitter	12	49425487	12	49031704	158727	168915
NM_003482.3(KMT2D):c.12962C>A (p.Ser4321Ter)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49425526	12	49031743	158726	168916
NM_003482.3(KMT2D):c.12956_12957del (p.Arg4319Thrfs)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49425531 - 49425532	12	49031748 - 49031749	158725	168917
NM_003482.3(KMT2D):c.12913G>A (p.Val4305Ile)	KMT2D	Kabuki syndrome 1|not specified|not provided|Kabuki syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	12	49425575	12	49031792	94162	100062
NM_003482.3(KMT2D):c.12896delG (p.Gly4299Aspfs)	KMT2D	Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	12	49425592	12	49031809	158724	168918
NM_003482.3(KMT2D):c.12844C>T (p.Arg4282Ter)	KMT2D	Kabuki syndrome 1|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	12	49425644	12	49031861	372805	359952
NM_003482.3(KMT2D):c.12768C>T (p.Leu4256=)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	12	49425720	12	49031937	158723	168919
NM_003482.3(KMT2D):c.12592C>T (p.Arg4198Ter)	KMT2D	Kabuki syndrome 1|Inborn genetic diseases|Kabuki syndrome	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	12	49425896	12	49032113	158722	168920
NM_003482.3(KMT2D):c.12510A>G (p.Pro4170=)	KMT2D	not specified|not provided|Kabuki syndrome	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	12	49425978	12	49032195	94158	100058
NM_003482.3(KMT2D):c.12270G>A (p.Gln4090=)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Nov 27, 2013)	criteria provided, single submitter	12	49426218	12	49032435	158721	168921
NM_003482.3(KMT2D):c.12028T>C (p.Ser4010Pro)	KMT2D	not specified|not provided|Kabuki syndrome	Benign/Likely benign(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	12	49426460	12	49032677	94154	100054
NM_003482.3(KMT2D):c.11886A>G (p.Gln3962=)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Nov 27, 2013)	criteria provided, single submitter	12	49426602	12	49032819	158720	168922
NM_003482.3(KMT2D):c.11770C>T (p.Gln3924Ter)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Nov 18, 2016)	criteria provided, single submitter	12	49426718	12	49032935	279603	263871
NM_003482.3(KMT2D):c.11756_11758del (p.Gln3919del)	KMT2D	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49426730 - 49426732	12	49032947 - 49032949	158719	168923
NM_003482.3(KMT2D):c.11610G>A (p.Met3870Ile)	KMT2D	not specified|Kabuki syndrome	Benign/Likely benign(Last reviewed: Nov 18, 2017)	criteria provided, multiple submitters, no conflicts	12	49426878	12	49033095	134717	138456
NM_003482.3(KMT2D):c.11563G>C (p.Ala3855Pro)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	12	49426925	12	49033142	158718	168924
NM_003482.3(KMT2D):c.11475_11478delACAG (p.Gln3826Cysfs)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Dec 15, 2016)	criteria provided, single submitter	12	49427010 - 49427013	12	49033227 - 49033230	375267	361970
NM_003482.3(KMT2D):c.11386del (p.Gln3796Argfs)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Sep 30, 2013)	criteria provided, single submitter	12	49427102	12	49033319	158717	168925
NM_003482.3(KMT2D):c.11290C>T (p.Gln3764Ter)	KMT2D	Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	12	49427198	12	49033415	158716	168926
NM_003482.3(KMT2D):c.11275C>T (p.Gln3759Ter)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Jun 17, 2014)	criteria provided, single submitter	12	49427213	12	49033430	216954	213621
NM_003482.3(KMT2D):c.11263C>T (p.Gln3755Ter)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Dec 2, 2013)	criteria provided, single submitter	12	49427225	12	49033442	158715	168927
NM_003482.3(KMT2D):c.11093_11094insG (p.Phe3699Leufs)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	12	49427395	12	49033611 - 49033612	488541	481409
NM_003482.3(KMT2D):c.11043G>A (p.Gln3681=)	KMT2D	Kabuki syndrome 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	12	49427445	12	49033662	158714	168928
NM_003482.3(KMT2D):c.10993C>G (p.Pro3665Ala)	KMT2D	Kabuki syndrome 1|not specified|not provided|Kabuki syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 28, 2017)	criteria provided, conflicting interpretations	12	49427495	12	49033712	134711	138450
NM_003482.3(KMT2D):c.10836G>A (p.Gln3612=)	KMT2D	not specified|not provided|Kabuki syndrome	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	12	49427652	12	49033869	94142	100042
NM_003482.3(KMT2D):c.10671A>G (p.Pro3557=)	KMT2D	not specified|Kabuki syndrome	Benign/Likely benign(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	12	49427919	12	49034136	94138	100038
NM_003482.3(KMT2D):c.10444C>T (p.Arg3482Trp)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Nov 27, 2013)	criteria provided, single submitter	12	49428256	12	49034473	158713	168929
NM_003482.3(KMT2D):c.10312G>A (p.Val3438Met)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	12	49428638	12	49034855	158712	168930
NM_003482.3(KMT2D):c.10256A>G (p.Asp3419Gly)	KMT2D	Kabuki syndrome 1|not specified|not provided|Kabuki syndrome	Benign/Likely benign(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	12	49428694	12	49034911	94136	100036
NM_003482.3(KMT2D):c.10252G>T (p.Glu3418Ter)	KMT2D	Smith-Magenis Syndrome-like	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	12	49428698	12	49034915	254202	248717
NM_003482.3(KMT2D):c.10192A>G (p.Met3398Val)	KMT2D	Kabuki syndrome 1|not specified|Kabuki syndrome	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	49430947	12	49037164	94135	100035
NM_003482.3(KMT2D):c.9726C>T (p.Ala3242=)	KMT2D	not specified|Kabuki syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	49431413	12	49037630	158793	168931
NM_003482.3(KMT2D):c.9491G>A (p.Arg3164Gln)	KMT2D	not specified	Likely benign(Last reviewed: Jan 6, 2014)	criteria provided, single submitter	12	49431648	12	49037865	158791	168932
NM_003482.3(KMT2D):c.8743C>T (p.Arg2915Ter)	KMT2D	Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	12	49432396	12	49038613	158790	168933
NM_003482.3(KMT2D):c.8626delC (p.Gln2876Serfs)	KMT2D	Complement component c1s deficiency	Pathogenic	criteria provided, single submitter	12	49432513	12	49038730	549852	540577
NM_003482.3(KMT2D):c.8360A>C (p.Asn2787Thr)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	12	49433011	12	49039228	158789	168934
NM_003482.3(KMT2D):c.8171_8175delCCAGC (p.Pro2724Glnfs)	KMT2D	Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	12	49433272 - 49433276	12	49039489 - 49039493	158788	168935
NM_003482.3(KMT2D):c.8091C>T (p.Arg2697=)	KMT2D	not specified|Kabuki syndrome	Benign/Likely benign(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	12	49433356	12	49039573	94257	100157
NM_003482.3(KMT2D):c.8064G>A (p.Glu2688=)	KMT2D	Kabuki syndrome 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Feb 19, 2014)	criteria provided, conflicting interpretations	12	49433383	12	49039600	94256	100156
NM_003482.3(KMT2D):c.8053C>T (p.Arg2685Ter)	KMT2D	Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	12	49433394	12	49039611	158787	168936
NM_003482.3(KMT2D):c.7904G>A (p.Arg2635Gln)	KMT2D	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49433649	12	49039866	158786	168937
NM_003482.3(KMT2D):c.7841C>T (p.Ser2614Leu)	KMT2D	not specified	Likely benign(Last reviewed: Sep 19, 2013)	criteria provided, single submitter	12	49433712	12	49039929	158785	168938
NM_003482.3(KMT2D):c.7670C>T (p.Pro2557Leu)	KMT2D	not specified|not provided|Kabuki syndrome	Benign/Likely benign(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	12	49433883	12	49040100	94250	100150
NM_003482.3(KMT2D):c.7479G>T (p.Gly2493=)	KMT2D	not specified|not provided|Kabuki syndrome	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	12	49434074	12	49040291	94248	100148
NM_003482.3(KMT2D):c.7198C>G (p.Pro2400Ala)	KMT2D	Kabuki syndrome 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 13, 2017)	criteria provided, conflicting interpretations	12	49434355	12	49040572	158784	168939
NM_003482.3(KMT2D):c.7188T>C (p.Cys2396=)	KMT2D	not specified|Kabuki syndrome	Benign/Likely benign(Last reviewed: Nov 18, 2017)	criteria provided, multiple submitters, no conflicts	12	49434365	12	49040582	158783	168940
NM_003482.3(KMT2D):c.7170G>A (p.Pro2390=)	KMT2D	Kabuki syndrome 1|Kabuki syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	12	49434383	12	49040600	158782	168941
NM_003482.3(KMT2D):c.7144C>T (p.Pro2382Ser)	KMT2D	not specified|Kabuki syndrome	Benign(Last reviewed: Jul 23, 2016)	criteria provided, multiple submitters, no conflicts	12	49434409	12	49040626	94247	100147
NM_003482.3(KMT2D):c.7035G>A (p.Leu2345=)	KMT2D	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 18, 2013)	criteria provided, conflicting interpretations	12	49434518	12	49040735	94244	100144
NM_003482.3(KMT2D):c.6844C>T (p.Arg2282Trp)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Aug 16, 2013)	criteria provided, single submitter	12	49434709	12	49040926	158781	168942
NM_003482.3(KMT2D):c.6807C>T (p.Ser2269=)	KMT2D	Kabuki syndrome 1|not specified|Kabuki syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 18, 2017)	criteria provided, conflicting interpretations	12	49434746	12	49040963	158780	168943
NM_003482.3(KMT2D):c.6765G>A (p.Leu2255=)	KMT2D	Kabuki syndrome 1	Likely benign(Last reviewed: Jun 27, 2016)	criteria provided, single submitter	12	49434788	12	49041005	266122	260946
NM_003482.3(KMT2D):c.6670_6674del (p.Gly2224Ilefs)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Apr 30, 2014)	criteria provided, single submitter	12	49434879 - 49434883	12	49041096 - 49041100	158778	168945
NM_003482.3(KMT2D):c.6640G>A (p.Ala2214Thr)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Jan 8, 2014)	criteria provided, single submitter	12	49434913	12	49041130	158777	168946
NM_003482.3(KMT2D):c.6595delT (p.Tyr2199Ilefs)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	12	49434958	12	49041175	94239	100139
NM_003482.3(KMT2D):c.6573G>A (p.Thr2191=)	KMT2D	Kabuki syndrome 1|not specified|Kabuki syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2017)	criteria provided, conflicting interpretations	12	49434980	12	49041197	94238	100138
NM_003482.3(KMT2D):c.6126C>A (p.Cys2042Ter)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Jun 25, 2013)	criteria provided, single submitter	12	49435757	12	49041974	158776	168947
NM_003482.3(KMT2D):c.6086del (p.Pro2029Leufs)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49435895	12	49042112	158775	168948
NM_003482.3(KMT2D):c.6020A>C (p.Glu2007Ala)	KMT2D	not specified	Likely benign(Last reviewed: Sep 19, 2013)	criteria provided, single submitter	12	49435961	12	49042178	158774	168949
NM_003482.3(KMT2D):c.5976G>A (p.Glu1992=)	KMT2D	not specified|Kabuki syndrome	Benign/Likely benign(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	12	49436005	12	49042222	94233	100133
NM_003482.3(KMT2D):c.5952C>A (p.Pro1984=)	KMT2D	not specified	Likely benign(Last reviewed: Mar 2, 2016)	criteria provided, multiple submitters, no conflicts	12	49436029	12	49042246	158773	168950
NM_003482.3(KMT2D):c.5868-8C>T	KMT2D	not specified|Kabuki syndrome	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	49436121	12	49042338	94231	100131
NM_003482.3(KMT2D):c.5592C>A (p.Gly1864=)	KMT2D	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49436911	12	49043128	158772	168951
NM_003482.3(KMT2D):c.5217C>T (p.Gly1739=)	KMT2D	not specified|Kabuki syndrome	Benign/Likely benign(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	12	49437753	12	49043970	94226	100126
NM_003482.3(KMT2D):c.5016T>C (p.Pro1672=)	KMT2D	not specified|Kabuki syndrome	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	49438253	12	49044470	94222	100122
NM_003482.3(KMT2D):c.4739del (p.Pro1580Glnfs)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: May 8, 2013)	criteria provided, single submitter	12	49439705	12	49045922	158771	168952
NM_003482.3(KMT2D):c.4421G>A (p.Cys1474Tyr)	KMT2D	Kabuki syndrome 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 24, 2016)	criteria provided, conflicting interpretations	12	49440205	12	49046422	158770	168953
NM_003482.3(KMT2D):c.4418+5G>A	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Jun 20, 2013)	criteria provided, single submitter	12	49440387	12	49046604	158769	168954
NM_003482.3(KMT2D):c.4343G>A (p.Cys1448Tyr)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49440467	12	49046684	158768	168955
NM_003482.3(KMT2D):c.4221del (p.Cys1408Valfs)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49441763	12	49047980	158767	168956
NM_003482.3(KMT2D):c.4135_4136delAT (p.Met1379Valfs)	KMT2D	Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	12	49441848 - 49441849	12	49048065 - 49048066	94216	100116
NM_003482.3(KMT2D):c.4131G>C (p.Gln1377His)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49442442	12	49048659	158766	168957
NM_003482.3(KMT2D):c.4123C>T (p.Leu1375=)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49442450	12	49048667	158765	168958
NM_003482.3(KMT2D):c.4083G>C (p.Gln1361His)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	12	49442490	12	49048707	158764	168959
NM_003482.3(KMT2D):c.3803A>C (p.Asp1268Ala)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	12	49443568	12	49049785	158761	168961
NM_003482.3(KMT2D):c.3754C>T (p.Arg1252Ter)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	12	49443617	12	49049834	167228	177140
NM_003482.3(KMT2D):c.3695del (p.Pro1232Argfs)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49443676	12	49049893	158760	168962
NM_003482.3(KMT2D):c.3553C>T (p.Gln1185Ter)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49443818	12	49050035	158759	168963
NM_003482.3(KMT2D):c.3121C>T (p.Gln1041Ter)	KMT2D	Kabuki syndrome 1|not provided	Pathogenic(Last reviewed: Mar 13, 2015)	criteria provided, multiple submitters, no conflicts	12	49444250	12	49050467	158758	168964
NM_003482.3(KMT2D):c.2826C>T (p.Ile942=)	KMT2D	not specified|not provided|Kabuki syndrome	Benign(Last reviewed: Aug 28, 2017)	criteria provided, multiple submitters, no conflicts	12	49444545	12	49050762	94206	100106
NM_003482.3(KMT2D):c.2657C>T (p.Pro886Leu)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49444809	12	49051026	158756	168965
NM_003482.3(KMT2D):c.2438C>T (p.Pro813Leu)	KMT2D	not specified|not provided|Kabuki syndrome	Benign(Last reviewed: Aug 28, 2017)	criteria provided, multiple submitters, no conflicts	12	49445028	12	49051245	94202	100102
NM_003482.3(KMT2D):c.2389C>G (p.Leu797Val)	KMT2D	Kabuki syndrome 1	Likely pathogenic(Last reviewed: Dec 16, 2014)	no assertion criteria provided	12	49445077	12	49051294	374296	361205
NM_003482.3(KMT2D):c.2256_2282del (p.Arg755_Pro763del)	KMT2D	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49445184 - 49445210	12	49051401 - 49051427	158753	168967
NM_003482.3(KMT2D):c.2232A>C (p.Ser744=)	KMT2D	not specified|not provided|Kabuki syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	12	49445234	12	49051451	158752	168968
NM_003482.3(KMT2D):c.2215G>A (p.Glu739Lys)	KMT2D	not specified	Likely benign(Last reviewed: May 9, 2014)	criteria provided, single submitter	12	49445251	12	49051468	158751	168969
NM_003482.3(KMT2D):c.2078C>A (p.Pro693His)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	12	49445388	12	49051605	158750	168970
NM_003482.3(KMT2D):c.2074C>A (p.Pro692Thr)	KMT2D	not specified|not provided|Kabuki syndrome	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	49445392	12	49051609	134664	138403
NM_003482.3(KMT2D):c.2062C>T (p.Arg688Cys)	KMT2D	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49445404	12	49051621	158749	168971
NM_003482.3(KMT2D):c.2052T>A (p.Pro684=)	KMT2D	not specified|Kabuki syndrome	Benign/Likely benign(Last reviewed: Nov 17, 2016)	criteria provided, multiple submitters, no conflicts	12	49445414	12	49051631	158748	168972
NM_003482.3(KMT2D):c.1940C>A (p.Pro647Gln)	KMT2D	Kabuki syndrome 1|not specified|not provided|Kabuki syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 4, 2017)	criteria provided, conflicting interpretations	12	49445526	12	49051743	94196	100096
NM_003482.3(KMT2D):c.1938C>G (p.Pro646=)	KMT2D	not specified|Kabuki syndrome	Benign/Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	12	49445528	12	49051745	158747	168973
NM_003482.3(KMT2D):c.1813G>T (p.Glu605Ter)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49445653	12	49051870	158746	168974
NM_003482.3(KMT2D):c.1426G>A (p.Ala476Thr)	KMT2D	not specified|Kabuki syndrome	Benign(Last reviewed: Jul 27, 2017)	criteria provided, multiple submitters, no conflicts	12	49446040	12	49052257	94174	100074
NM_003482.3(KMT2D):c.1329_1332del (p.Pro444Argfs)	KMT2D	Kabuki syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, multiple submitters, no conflicts	12	49446134 - 49446137	12	49052351 - 49052354	158728	168975
NM_003482.3(KMT2D):c.968G>A (p.Cys323Tyr)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	12	49446842	12	49053059	158792	168976
NM_003482.3(KMT2D):c.466G>T (p.Glu156Ter)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Jan 17, 2017)	no assertion criteria provided	12	49448134	12	49054351	375574	362384
NM_003482.3(KMT2D):c.400+1G>C	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49448310	12	49054527	158763	168977
NM_003482.3(KMT2D):c.288G>C (p.Val96=)	KMT2D	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49448423	12	49054640	158757	168978
NM_003482.3(KMT2D):c.256G>T (p.Glu86Ter)	KMT2D	Kabuki syndrome 1	Pathogenic(Last reviewed: Aug 5, 2013)	criteria provided, single submitter	12	49448455	12	49054672	158755	168979
NM_003482.3(KMT2D):c.248G>A (p.Arg83Gln)	KMT2D	not specified|Kabuki syndrome	Benign/Likely benign(Last reviewed: Nov 20, 2017)	criteria provided, multiple submitters, no conflicts	12	49448463	12	49054680	94203	100103
NM_003482.3(KMT2D):c.125C>T (p.Ser42Phe)	KMT2D	Kabuki syndrome 1	Likely pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	12	49448734	12	49054951	438838	432470
NM_006009.3(TUBA1A):c.1274T>A (p.Met425Lys)	TUBA1A	Lissencephaly 3	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49578875	12	49185092	160148	168980
NM_006009.3(TUBA1A):c.1265G>A (p.Arg422His)	TUBA1A	Lissencephaly 3|not provided	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, multiple submitters, no conflicts	12	49578884	12	49185101	7077	22116
NM_006009.3(TUBA1A):c.1224C>A (p.Tyr408Ter)	TUBA1A	Lissencephaly 3	Pathogenic(Last reviewed: Jun 10, 2013)	criteria provided, single submitter	12	49578925	12	49185142	209200	205772
NM_006009.3(TUBA1A):c.1205G>T (p.Arg402Leu)	TUBA1A	Lissencephaly 3	Pathogenic(Last reviewed: Jan 17, 2014)	criteria provided, single submitter	12	49578944	12	49185161	160147	168981
NM_006009.3(TUBA1A):c.1205G>A (p.Arg402His)	TUBA1A	Lissencephaly 3	Pathogenic(Last reviewed: Jun 21, 2013)	criteria provided, single submitter	12	49578944	12	49185161	7071	22110
NM_006009.3(TUBA1A):c.1204C>T (p.Arg402Cys)	TUBA1A	Lissencephaly 3|Limb-girdle muscular dystrophy, type 2D|not provided	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, multiple submitters, no conflicts	12	49578945	12	49185162	160146	168982
NM_006009.3(TUBA1A):c.1204C>A (p.Arg402Ser)	TUBA1A	Lissencephaly 3	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49578945	12	49185162	160145	168983
NM_006009.3(TUBA1A):c.1203A>G (p.Lys401=)	TUBA1A	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49578946	12	49185163	160144	168984
NM_001270399.1(TUBA1A):c.1169G>A (p.Arg390His)	TUBA1A	Lissencephaly 3	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	12	49578980	12	49185197	488628	481496
NM_006009.3(TUBA1A):c.1148C>T (p.Ala383Val)	TUBA1A	Lissencephaly 3|Abnormality of neuronal migration	Likely pathogenic(Last reviewed: Feb 28, 2013)	criteria provided, single submitter	12	49579001	12	49185218	160143	168985
NM_006009.3(TUBA1A):c.1129A>G (p.Met377Val)	TUBA1A	Lissencephaly 3	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49579020	12	49185237	160142	168986
NM_006009.3(TUBA1A):c.1008G>A (p.Lys336=)	TUBA1A	not specified|Lissencephaly, Dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	49579141	12	49185358	160141	168987
NM_006009.3(TUBA1A):c.995T>C (p.Ile332Thr)	TUBA1A	Lissencephaly 3	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49579154	12	49185371	160169	168988
NM_006009.3(TUBA1A):c.991G>A (p.Ala331Thr)	TUBA1A	Lissencephaly 3	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49579158	12	49185375	160168	168989
NM_001270399.1(TUBA1A):c.920C>T (p.Pro307Leu)	TUBA1A	Lissencephaly 3	Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	49579229	12	49185446	438589	432218
NM_006009.3(TUBA1A):c.808G>T (p.Ala270Ser)	TUBA1A	Lissencephaly 3	Likely pathogenic(Last reviewed: Mar 10, 2014)	criteria provided, single submitter	12	49579341	12	49185558	160164	168992
NM_006009.3(TUBA1A):c.791G>A (p.Arg264His)	TUBA1A	Lissencephaly 3|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 19, 2017)	criteria provided, conflicting interpretations	12	49579358	12	49185575	287392	271629
NM_006009.3(TUBA1A):c.790C>T (p.Arg264Cys)	TUBA1A	Lissencephaly 3|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, multiple submitters, no conflicts	12	49579359	12	49185576	7070	22109
NM_006009.3(TUBA1A):c.758C>G (p.Thr253Arg)	TUBA1A	Lissencephaly 3	Uncertain significance(Last reviewed: Mar 5, 2014)	criteria provided, single submitter	12	49579391	12	49185608	160163	168993
NM_006009.3(TUBA1A):c.698A>G (p.Gln233Arg)	TUBA1A	Lissencephaly 3	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49579451	12	49185668	160162	168994
NM_006009.3(TUBA1A):c.562_564dupATC (p.Ile188_Leu189insIle)	TUBA1A	Lissencephaly 3	Uncertain significance(Last reviewed: Aug 22, 2013)	criteria provided, single submitter	12	49579585 - 49579587	12	49185802 - 49185804	160160	168995
NM_006009.3(TUBA1A):c.522G>A (p.Ala174=)	TUBA1A	not specified|Lissencephaly, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	49579627	12	49185844	137850	141553
NM_006009.3(TUBA1A):c.510T>C (p.Ser170=)	TUBA1A	not specified|Lissencephaly, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	49579639	12	49185856	137849	141552
NM_006009.3(TUBA1A):c.481T>G (p.Tyr161Asp)	TUBA1A	Lissencephaly 3	Pathogenic(Last reviewed: May 30, 2014)	criteria provided, single submitter	12	49579668	12	49185885	160158	168997
NM_006009.3(TUBA1A):c.453G>C (p.Ser151=)	TUBA1A	not specified|not provided|Lissencephaly, Dominant	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	12	49579696	12	49185913	160157	168998
NM_006009.3(TUBA1A):c.396C>T (p.Leu132=)	TUBA1A	not specified|Lissencephaly, Dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	49579753	12	49185970	160155	168999
NM_006009.3(TUBA1A):c.352G>A (p.Val118Met)	TUBA1A	Lissencephaly 3	Likely pathogenic(Last reviewed: May 20, 2014)	criteria provided, single submitter	12	49580116	12	49186333	217023	213622
NM_006009.3(TUBA1A):c.288A>G (p.Lys96=)	TUBA1A	not specified|not provided|Lissencephaly, Dominant	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	12	49580180	12	49186397	160154	169000
NM_006009.3(TUBA1A):c.162T>A (p.Ser54Arg)	TUBA1A	Lissencephaly 3	Likely pathogenic(Last reviewed: Jun 28, 2013)	criteria provided, single submitter	12	49580458	12	49186675	160150	169004
NM_006009.3(TUBA1A):c.152C>T (p.Thr51Ile)	TUBA1A	Lissencephaly 3	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49580468	12	49186685	160149	169005
NM_006009.3(TUBA1A):c.96C>T (p.Pro32=)	TUBA1A	Lissencephaly 3	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49580524	12	49186741	160166	169006
NM_006009.3(TUBA1A):c.5G>A (p.Arg2His)	TUBA1A	Lissencephaly 3|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 3, 2015)	criteria provided, multiple submitters, no conflicts	12	49580615	12	49186832	160161	169007
NM_006009.3(TUBA1A):c.4-7C>T	TUBA1A	Lissencephaly 3|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 25, 2017)	criteria provided, conflicting interpretations	12	49580623	12	49186840	160156	169008
NM_014191.3(SCN8A):c.576C>T (p.Asp192=)	SCN8A	not specified|not provided|Early Infantile Epileptic Encephalopathy, Autosomal Dominant|History of neurodevelopmental disorder	Benign(Last reviewed: May 6, 2018)	criteria provided, multiple submitters, no conflicts	12	52080965	12	51687181	130253	135700
NM_014191.3(SCN8A):c.647T>G (p.Val216Gly)	SCN8A	Early infantile epileptic encephalopathy 13	Likely pathogenic(Last reviewed: Oct 3, 2014)	no assertion criteria provided	12	52082574	12	51688790	374298	361206
NM_014191.3(SCN8A):c.1833G>T (p.Arg611=)	SCN8A	not specified|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 4, 2017)	criteria provided, multiple submitters, no conflicts	12	52115527	12	51721743	130242	135689
NM_014191.3(SCN8A):c.2549G>A (p.Arg850Gln)	SCN8A	Early infantile epileptic encephalopathy 13|not provided|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	12	52159459	12	51765675	135651	139369
NM_014191.3(SCN8A):c.3076C>T (p.Arg1026Cys)	SCN8A	not specified|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	12	52162823	12	51769039	130244	135691
NM_014191.3(SCN8A):c.3158T>G (p.Ile1053Ser)	SCN8A	not provided|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	52162905	12	51769121	130245	135692
NM_014191.3(SCN8A):c.4122T>A (p.Thr1374=)	SCN8A	not specified|not provided|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	12	52180505	12	51786721	130246	135693
NM_014191.3(SCN8A):c.4403A>G (p.Asn1468Ser)	SCN8A	Early infantile epileptic encephalopathy 13	Likely pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	12	52183186	12	51789402	374375	361207
NM_014191.3(SCN8A):c.4409A>C (p.Gln1470Pro)	SCN8A	Early infantile epileptic encephalopathy 13	Likely pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	12	52183192	12	51789408	488588	481456
NM_014191.3(SCN8A):c.4509T>C (p.Pro1503=)	SCN8A	not specified|not provided|Early Infantile Epileptic Encephalopathy, Autosomal Dominant|History of neurodevelopmental disorder	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	12	52184271	12	51790487	130247	135694
NM_014191.3(SCN8A):c.4748T>C (p.Ile1583Thr)	SCN8A	not specified|Early infantile epileptic encephalopathy 13|not provided|Early infantile epileptic encephalopathy|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jan 25, 2018)	criteria provided, conflicting interpretations	12	52188378	12	51794594	130248	135695
NM_014191.3(SCN8A):c.4774G>C (p.Val1592Leu)	SCN8A	Early infantile epileptic encephalopathy 13	Likely pathogenic(Last reviewed: Oct 31, 2013)	criteria provided, single submitter	12	52188404	12	51794620	130249	135696
NM_014191.3(SCN8A):c.4779C>T (p.Val1593=)	SCN8A	not specified|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	12	52188409	12	51794625	130250	135697
NM_014191.3(SCN8A):c.5472C>A (p.Pro1824=)	SCN8A	not specified|not provided|Early Infantile Epileptic Encephalopathy, Autosomal Dominant|History of neurodevelopmental disorder	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	12	52200742	12	51806958	130251	135698
NM_014191.3(SCN8A):c.5630A>G (p.Asn1877Ser)	SCN8A	Early infantile epileptic encephalopathy 13|not provided|Focal epilepsy|Early infantile epileptic encephalopathy|Seizures, benign familial infantile, 5	Conflicting interpretations of pathogenicity(Last reviewed: Mar 22, 2018)	criteria provided, conflicting interpretations	12	52200900	12	51807116	130252	135699
NM_000020.2(ACVRL1):c.88C>T (p.Pro30Ser)	ACVRL1	Haemorrhagic telangiectasia 2	Likely benign(Last reviewed: Jun 1, 2014)	no assertion criteria provided	12	52306909	12	51913125	161202	171152
NM_000020.2(ACVRL1):c.578T>C (p.Leu193Pro)	ACVRL1	Hereditary hemorrhagic telangiectasia type 2	Likely pathogenic(Last reviewed: Jun 28, 2018)	no assertion criteria provided	12	52307810	12	51914026	548119	538606
NM_000020.2(ACVRL1):c.890A>G (p.His297Arg)	ACVRL1	not specified|Haemorrhagic telangiectasia 2	Uncertain significance(Last reviewed: Apr 25, 2016)	criteria provided, single submitter	12	52309126	12	51915342	161204	171153
NM_000020.2(ACVRL1):c.1031G>A (p.Cys344Tyr)	ACVRL1	Hereditary hemorrhagic telangiectasia type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	12	52309267	12	51915483	8254	23293
NM_000020.2(ACVRL1):c.1157G>A (p.Arg386His)	ACVRL1	Haemorrhagic telangiectasia 2	Likely pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	12	52309928	12	51916144	161203	171154
NM_000020.2(ACVRL1):c.1445C>T (p.Ala482Val)	ACVRL1	Hereditary hemorrhagic telangiectasia type 2|not specified|Haemorrhagic telangiectasia 2	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2017)	criteria provided, conflicting interpretations	12	52314610	12	51920826	161201	171155
NM_002281.3(KRT81):c.846T>A (p.Tyr282Ter)	KRT81|KRT86	Beaded hair	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	52681822	12	52288038	561048	552164
NM_002272.3(KRT4):c.438_440delCAA (p.Asn146del)	KRT4	White sponge nevus of cannon	Pathogenic(Last reviewed: Dec 1, 1995)	no assertion criteria provided	12	53207403 - 53207405	12	52813619 - 52813621	16918	31957
NM_005811.4(GDF11):c.1008C>G (p.Tyr336Ter)	GDF11	GDF11-associated multiple congenital anomalies and ID	Uncertain significance(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	12	56143450	12	55749666	522835	513444
GRCh38/hg38 12q13.2(chr12:55845043-55851177)x4	MMP19	Cavitary optic disc anomalies	Pathogenic	no assertion criteria provided	12	56238827 - 56244961	12	55845043 - 55851177	180748	178906
NM_003075.4(SMARCC2):c.1833+1G>T	SMARCC2	SMARCC2-related condition	Uncertain significance(Last reviewed: May 10, 2017)	criteria provided, single submitter	12	56566211	12	56172427	522824	513445
NM_012064.4(MIP):c.508dup (p.Leu170Profs)	MIP	Cataract 15, multiple types	Pathogenic(Last reviewed: Dec 16, 2015)	no assertion criteria provided	12	56847392	12	56453608	377392	364277
NM_003483.4(HMGA2):c.189del (p.Ala64Leufs)	HMGA2	Russell-Silver syndrome	Pathogenic	no assertion criteria provided	12	66221858	12	65828078	253035	247442
NM_003483.4(HMGA2):c.193C>T (p.Gln65Ter)	HMGA2	Russell-Silver syndrome	Pathogenic	no assertion criteria provided	12	66221862	12	65828082	253034	247441
NM_173591.3(OTOGL):c.3054_3055insT (p.Leu1019Serfs)	OTOGL	Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	12	80696431 - 80696432	12	80302651 - 80302652	505260	497430
NM_003276.2(TMPO):c.370C>T (p.Leu124Phe)	TMPO	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	12	98921754	12	98527976	427956	419286
NM_002465.3(MYBPC1):c.742G>A (p.Glu248Lys)	MYBPC1	not provided	Pathogenic(Last reviewed: May 6, 2016)	criteria provided, single submitter	12	102036273	12	101642495	225889	227702
NM_130466.3(UBE3B):c.2962G>A (p.Ala988Thr)	UBE3B	Optic nerve hypoplasia	Likely benign	criteria provided, single submitter	12	109971310	12	109533505	496688	488170
NM_021625.4(TRPV4):c.2389G>A (p.Glu797Lys)	TRPV4	Metatrophic dysplasia|Spondylometaphyseal dysplasia, Kozlowski type|Spondyloepiphyseal dysplasia Maroteaux type|Skeletal dysplasia|Neuromuscular Diseases	Pathogenic(Last reviewed: Apr 2, 2014)	no assertion criteria provided	12	110222190	12	109784385	18435	33474
NM_021625.4(TRPV4):c.1445T>C (p.Met482Thr)	TRPV4	Charcot-Marie-Tooth disease type 2C	Uncertain significance	no assertion criteria provided	12	110232180	12	109794375	590924	581868
NM_021625.4(TRPV4):c.1207T>A (p.Ser403Thr)	TRPV4	Metatrophic dysplasia	Pathogenic(Last reviewed: Dec 29, 2016)	no assertion criteria provided	12	110234455	12	109796650	370071	356978
NM_021625.4(TRPV4):c.943C>T (p.Arg315Trp)	TRPV4	Distal spinal muscular atrophy, congenital nonprogressive|Scapuloperoneal spinal muscular atrophy|Charcot-Marie-Tooth disease type 2C|Charcot-Marie-Tooth disease|not provided|Neuromuscular Diseases	Pathogenic(Last reviewed: Sep 30, 2017)	criteria provided, multiple submitters, no conflicts	12	110236628	12	109798823	4999	20038
NM_021625.4(TRPV4):c.806G>A (p.Arg269His)	TRPV4	Distal spinal muscular atrophy, congenital nonprogressive|Charcot-Marie-Tooth disease type 2C|Charcot-Marie-Tooth disease|not provided|Neuromuscular Diseases|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	12	110238470	12	109800665	5000	20039
NM_021625.4(TRPV4):c.694C>T (p.Arg232Cys)	TRPV4	Distal spinal muscular atrophy, congenital nonprogressive|Charcot-Marie-Tooth disease type 2C|Skeletal dysplasia|not provided|Neuromuscular Diseases	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, multiple submitters, no conflicts	12	110240814	12	109803009	30472	39429
NM_000432.3(MYL2):c.488A>C (p.Glu163Ala)	MYL2	Familial hypertrophic cardiomyopathy 10|Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	12	111348894	12	110911090	43480	52650
NM_000432.3(MYL2):c.485G>A (p.Gly162Glu)	MYL2	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	12	111348897	12	110911093	43479	52649
NM_000432.3(MYL2):c.275G>T (p.Gly92Val)	MYL2	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Jul 11, 2014)	criteria provided, single submitter	12	111351128	12	110913324	164476	175389
NM_000432.3(MYL2):c.260G>C (p.Gly87Ala)	MYL2	Primary familial hypertrophic cardiomyopathy|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2017)	criteria provided, conflicting interpretations	12	111352004	12	110914200	43461	52631
NM_000432.3(MYL2):c.173G>A (p.Arg58Gln)	MYL2	Familial hypertrophic cardiomyopathy 10|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	12	111352091	12	110914287	14067	29106
NM_000432.3(MYL2):c.170G>A (p.Gly57Glu)	MYL2	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 13, 2017)	criteria provided, conflicting interpretations	12	111352094	12	110914290	43458	52628
NM_000432.3(MYL2):c.141C>A (p.Asn47Lys)	MYL2	Familial hypertrophic cardiomyopathy 10|Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Death in infancy|Ventricular extrasystoles|Cardiovascular phenotype	Uncertain significance(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	12	111353547	12	110915743	31766	40426
NM_000432.3(MYL2):c.125G>A (p.Gly42Asp)	MYL2	Familial hypertrophic cardiomyopathy 10	Likely pathogenic	criteria provided, single submitter	12	111353563	12	110915759	217490	214121
NM_000432.3(MYL2):c.64G>A (p.Glu22Lys)	MYL2	Familial hypertrophic cardiomyopathy 10|Primary familial hypertrophic cardiomyopathy|not provided|Death in early adulthood	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, multiple submitters, no conflicts	12	111356937	12	110919133	14065	29104
NM_000432.3(MYL2):c.37G>A (p.Ala13Thr)	MYL2	Familial hypertrophic cardiomyopathy 10|Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	12	111356964	12	110919160	14064	29103
NM_002973.3(ATXN2):c.522G>A (p.Gln174=)	ATXN2	Spinocerebellar ataxia 2|not specified	Likely benign(Last reviewed: Feb 7, 2015)	criteria provided, single submitter	12	112036797	12	111598993	128509	133958
NM_002973.3(ATXN2):c.390C>T (p.Arg130=)	ATXN2	Spinocerebellar ataxia 2|not specified	Benign/Likely benign(Last reviewed: Oct 6, 2015)	criteria provided, single submitter	12	112036929	12	111599125	128508	133957
NM_002973.3(ATXN2):c.319C>G (p.Leu107Val)	ATXN2	Spinocerebellar ataxia 2|not specified	Benign/Likely benign(Last reviewed: Feb 7, 2015)	criteria provided, single submitter	12	112037000	12	111599196	128507	133956
NM_002834.4(PTPN11):c.5C>T (p.Thr2Ile)	PTPN11	Noonan syndrome 1|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, multiple submitters, no conflicts	12	112856920	12	112419116	13349	28388
NM_002834.4(PTPN11):c.155C>T (p.Thr52Ile)	PTPN11	Noonan syndrome|not provided	Likely pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	112888139	12	112450335	40484	48954
NM_002834.4(PTPN11):c.172A>C (p.Asn58His)	PTPN11	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, multiple submitters, no conflicts	12	112888156	12	112450352	40486	48956
NM_002834.4(PTPN11):c.174C>G (p.Asn58Lys)	PTPN11	Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	12	112888158	12	112450354	40489	48959
NM_002834.4(PTPN11):c.178G>A (p.Gly60Ser)	PTPN11	Noonan syndrome|not provided	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	12	112888162	12	112450358	40490	48960
NM_002834.4(PTPN11):c.179G>T (p.Gly60Val)	PTPN11	Noonan syndrome 1|not provided	Pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	12	112888163	12	112450359	55797	70453
NM_002834.4(PTPN11):c.182A>C (p.Asp61Ala)	PTPN11	Noonan syndrome	Likely pathogenic(Last reviewed: Aug 9, 2013)	criteria provided, single submitter	12	112888166	12	112450362	179221	175539
NM_002834.4(PTPN11):c.182A>G (p.Asp61Gly)	PTPN11	Noonan syndrome 1|Noonan syndrome|Short stature|Abnormality of cardiovascular system morphology|not provided|Rasopathy	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	12	112888166	12	112450362	13330	28369
NM_002834.4(PTPN11):c.184T>G (p.Tyr62Asp)	PTPN11	Noonan syndrome 1|Noonan syndrome|Failure to thrive|Secundum atrial septal defect|Tricuspid regurgitation|not provided|Rasopathy|Patent ductus arteriosus|Right ventricular hypertrophy|Dysplastic pulmonary valve|Patent ductus arteriosus	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, multiple submitters, no conflicts	12	112888168	12	112450364	13329	28368
NM_002834.4(PTPN11):c.188A>G (p.Tyr63Cys)	PTPN11	Noonan syndrome 3|Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome|not provided|Rasopathy|Lymphoma|B lymphoblastic leukemia lymphoma, no ICD-O subtype	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	112888172	12	112450368	13333	28372
NM_002834.4(PTPN11):c.205G>C (p.Glu69Gln)	PTPN11	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, multiple submitters, no conflicts	12	112888189	12	112450385	40498	48968
NM_002834.4(PTPN11):c.209A>G (p.Lys70Arg)	PTPN11	Noonan syndrome|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, multiple submitters, no conflicts	12	112888193	12	112450389	44603	53770
NM_002834.4(PTPN11):c.211T>C (p.Phe71Leu)	PTPN11	Noonan syndrome 3|Noonan syndrome|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	12	112888195	12	112450391	40499	48969
NM_002834.4(PTPN11):c.214G>A (p.Ala72Thr)	PTPN11	Chronic lymphocytic leukemia|Neuroblastoma|Acute myeloid leukemia|not provided|Rasopathy|Neoplasm of brain	Pathogenic/Likely pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, multiple submitters, no conflicts	12	112888198	12	112450394	177754	175540
NM_002834.4(PTPN11):c.214G>C (p.Ala72Pro)	PTPN11	Noonan syndrome 3|Noonan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, multiple submitters, no conflicts	12	112888198	12	112450394	40500	48970
NM_002834.4(PTPN11):c.214G>T (p.Ala72Ser)	PTPN11	Noonan syndrome 1|LEOPARD syndrome 1|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, multiple submitters, no conflicts	12	112888198	12	112450394	13324	28363
NM_002834.4(PTPN11):c.215C>G (p.Ala72Gly)	PTPN11	Noonan syndrome 3|Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, multiple submitters, no conflicts	12	112888199	12	112450395	13325	28364
NM_002834.4(PTPN11):c.218C>T (p.Thr73Ile)	PTPN11	Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	12	112888202	12	112450398	13334	28373
NM_002834.4(PTPN11):c.228G>T (p.Glu76Asp)	PTPN11	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, multiple submitters, no conflicts	12	112888212	12	112450408	40502	48972
NM_002834.4(PTPN11):c.236A>G (p.Gln79Arg)	PTPN11	Noonan syndrome 3|Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	12	112888220	12	112450416	13340	28379
NM_002834.4(PTPN11):c.317A>C (p.Asp106Ala)	PTPN11	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	12	112888301	12	112450497	40506	48976
NM_002834.4(PTPN11):c.417G>C (p.Glu139Asp)	PTPN11	Noonan syndrome 3|Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome|not specified|not provided|Rasopathy|Hypertrophic cardiomyopathy|Inborn genetic diseases|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	112891083	12	112453279	40513	48983
NM_002834.4(PTPN11):c.417G>T (p.Glu139Asp)	PTPN11	not provided|Rasopathy	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	12	112891083	12	112453279	40512	48982
NM_002834.4(PTPN11):c.598A>T (p.Asn200Tyr)	PTPN11	Noonan syndrome|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, multiple submitters, no conflicts	12	112892440	12	112454636	164998	175541
NM_002834.4(PTPN11):c.661delA (p.Ile221Terfs)	PTPN11	Metachondromatosis	Pathogenic(Last reviewed: Sep 7, 2011)	criteria provided, single submitter	12	112893772	12	112455968	44611	53778
NM_002834.4(PTPN11):c.767A>G (p.Gln256Arg)	PTPN11	Noonan syndrome 1|not specified|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	12	112910758	12	112472954	40518	48988
NM_002834.4(PTPN11):c.774G>T (p.Glu258Asp)	PTPN11	Noonan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 29, 2015)	criteria provided, multiple submitters, no conflicts	12	112910765	12	112472961	44613	53780
NM_002834.4(PTPN11):c.781C>T (p.Leu261Phe)	PTPN11	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	112910772	12	112472968	40520	48990
NM_002834.4(PTPN11):c.794G>A (p.Arg265Gln)	PTPN11	Noonan syndrome 1|Noonan syndrome|not provided|Rasopathy|Inborn genetic diseases|PTPN11-related disorder	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	112910785	12	112472981	40522	48992
NM_002834.4(PTPN11):c.802G>A (p.Gly268Ser)	PTPN11	Noonan syndrome|not provided|Rasopathy	Likely pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	12	112910793	12	112472989	44614	53781
NM_002834.4(PTPN11):c.802G>T (p.Gly268Cys)	PTPN11	Noonan syndrome|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	12	112910793	12	112472989	40523	48993
NM_002834.4(PTPN11):c.836A>G (p.Tyr279Cys)	PTPN11	Noonan syndrome 1|LEOPARD syndrome 1|Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia|Noonan syndrome|not provided|Rasopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2018)	criteria provided, multiple submitters, no conflicts	12	112910827	12	112473023	13328	28367
NM_002834.4(PTPN11):c.844A>G (p.Ile282Val)	PTPN11	Noonan syndrome 1|not provided|Rasopathy|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	12	112910835	12	112473031	40525	48995
NM_002834.4(PTPN11):c.846C>G (p.Ile282Met)	PTPN11	Noonan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, multiple submitters, no conflicts	12	112910837	12	112473033	40526	48996
NM_002834.4(PTPN11):c.922A>G (p.Asn308Asp)	PTPN11	Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome|not provided|Rasopathy|Inborn genetic diseases|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	112915523	12	112477719	13326	28365
NM_002834.4(PTPN11):c.923A>G (p.Asn308Ser)	PTPN11	Noonan syndrome 3|Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: May 9, 2018)	criteria provided, multiple submitters, no conflicts	12	112915524	12	112477720	13327	28366
NM_002834.4(PTPN11):c.1381G>A (p.Ala461Thr)	PTPN11	Noonan syndrome 3|Noonan syndrome with multiple lentigines|LEOPARD syndrome 1|not provided|Rasopathy	Pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, multiple submitters, no conflicts	12	112926248	12	112488444	13342	28381
NM_002834.4(PTPN11):c.1391G>C (p.Gly464Ala)	PTPN11	LEOPARD syndrome 1|not provided|Rasopathy	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	12	112926258	12	112488454	13343	28382
NM_002834.4(PTPN11):c.1403C>T (p.Thr468Met)	PTPN11	Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|Noonan syndrome with multiple lentigines|LEOPARD syndrome 1|Noonan syndrome|not specified|not provided|Rasopathy|Inborn genetic diseases|PTPN11-related disorder	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	112926270	12	112488466	13331	28370
NM_002834.4(PTPN11):c.1471C>T (p.Pro491Ser)	PTPN11	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	12	112926851	12	112489047	40550	49020
NM_002834.4(PTPN11):c.1472C>A (p.Pro491His)	PTPN11	Noonan syndrome|not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, multiple submitters, no conflicts	12	112926852	12	112489048	40551	49021
NM_002834.4(PTPN11):c.1493G>T (p.Arg498Leu)	PTPN11	Noonan syndrome 1|LEOPARD syndrome 1|Scoliosis|not provided|Rasopathy|Abnormal facial shape|Cafe-au-lait spot|Specific learning disability|Intellectual disability, mild	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, multiple submitters, no conflicts	12	112926873	12	112489069	40554	49024
NM_002834.4(PTPN11):c.1502G>A (p.Arg501Lys)	PTPN11	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Aug 26, 2017)	criteria provided, multiple submitters, no conflicts	12	112926882	12	112489078	40555	49025
NM_002834.4(PTPN11):c.1504T>G (p.Ser502Ala)	PTPN11	not provided|Rasopathy	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, multiple submitters, no conflicts	12	112926884	12	112489080	40556	49026
NM_002834.4(PTPN11):c.1504T>A (p.Ser502Thr)	PTPN11	Noonan syndrome 1|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, multiple submitters, no conflicts	12	112926884	12	112489080	13332	28371
NM_002834.4(PTPN11):c.1505C>T (p.Ser502Leu)	PTPN11	Noonan syndrome|not provided	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, multiple submitters, no conflicts	12	112926885	12	112489081	40557	49027
NM_002834.4(PTPN11):c.1507G>A (p.Gly503Arg)	PTPN11	Noonan syndrome 1|Noonan syndrome|not provided|Rasopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	12	112926887	12	112489083	40559	49029
NM_002834.4(PTPN11):c.1507G>C (p.Gly503Arg)	PTPN11	Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, multiple submitters, no conflicts	12	112926887	12	112489083	40558	49028
NM_002834.4(PTPN11):c.1510A>G (p.Met504Val)	PTPN11	Noonan syndrome 1|Noonan syndrome|not provided|Rasopathy|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	112926890	12	112489086	40562	49032
NM_002834.4(PTPN11):c.1517A>C (p.Gln506Pro)	PTPN11	Noonan syndrome with multiple lentigines|LEOPARD syndrome 1|not provided|Rasopathy	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	12	112926897	12	112489093	40563	49033
NM_002834.4(PTPN11):c.1528C>G (p.Gln510Glu)	PTPN11	Noonan syndrome 3|Noonan syndrome 1|LEOPARD syndrome 1|not provided|Rasopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Aug 4, 2018)	criteria provided, multiple submitters, no conflicts	12	112926908	12	112489104	40566	49036
NM_002834.4(PTPN11):c.1529A>C (p.Gln510Pro)	PTPN11	Noonan syndrome 3|Noonan syndrome with multiple lentigines|LEOPARD syndrome 1|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	112926909	12	112489105	13344	28383
NM_000192.3(TBX5):c.1221C>G (p.Tyr407Ter)	TBX5	Ventricular septal defect|Secundum atrial septal defect|Mitral regurgitation|Ventricular septal defect	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	12	114793673	12	114355868	495227	485953
NM_000192.3(TBX5):c.1158_1159insC (p.Ser387Glnfs)	TBX5	Holt-Oram syndrome	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	12	114793736	12	114355930 - 114355931	488620	481488
NM_000192.3(TBX5):c.710G>A (p.Arg237Gln)	TBX5	Holt-Oram syndrome|Aortic valve disease 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, multiple submitters, no conflicts	12	114823326	12	114385521	7993	23032
NM_000192.3(TBX5):c.105delC (p.Ser36Alafs)	TBX5	Holt-Oram syndrome	Pathogenic(Last reviewed: Oct 17, 2014)	criteria provided, single submitter	12	114841599	12	114403794	369677	353903
NM_005996.4(TBX3):c.1920_1921dup (p.Pro641Argfs)	TBX3	Ulnar-mammary syndrome	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	12	115109897 - 115109898	12	114672092 - 114672093	591004	581960
NM_015335.4(MED13L):c.5152_5153del (p.Met1718Glufs)	MED13L	Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic	no assertion criteria provided	12	116420211 - 116420212	12	115982406 - 115982407	375611	362425
NM_015335.4(MED13L):c.4956-2A>C	MED13L	Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Aug 24, 2015)	no assertion criteria provided	12	116420410	12	115982605	374334	361202
NM_015335.4(MED13L):c.4452del (p.Phe1484Leufs)	MED13L	Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic	no assertion criteria provided	12	116422064	12	115984259	375612	362426
NM_015335.4(MED13L):c.2600C>T (p.Thr867Ile)	MED13L	Mental retardation and distinctive facial features with or without cardiac defects	Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	12	116435005	12	115997200	488544	481412
NM_014365.2(HSPB8):c.520_533delTACTCAACATTTGG (p.Tyr174Argfs)	HSPB8	Distal myopathy|Motor neuropathy	Likely pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	12	119631592 - 119631605	12	119193787 - 119193800	584450	575496
NM_000545.6(HNF1A):c.51C>G (p.Leu17=)	HNF1A	Maturity onset diabetes mellitus in young|not specified|not provided	Benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	12	121416622	12	120978819	129234	134680
NM_000545.6(HNF1A):c.79A>C (p.Ile27Leu)	HNF1A	Maturity onset diabetes mellitus in young|Insulin resistance, susceptibility to|SERUM HDL CHOLESTEROL LEVEL, MODIFIER OF|not specified|not provided	Benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	12	121416650	12	120978847	14937	29976
NM_000545.6(HNF1A):c.130delC (p.Leu44Trpfs)	HNF1A	Maturity-onset diabetes of the young, type 3	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	12	121416701	12	120978898	36798	45459
NM_000545.6(HNF1A):c.276C>T (p.Leu92=)	HNF1A	Maturity onset diabetes mellitus in young|not specified	Benign/Likely benign(Last reviewed: Mar 12, 2018)	criteria provided, multiple submitters, no conflicts	12	121416847	12	120979044	129227	134673
NM_000545.6(HNF1A):c.293C>T (p.Ala98Val)	HNF1A	Maturity onset diabetes mellitus in young|not specified|not provided|Monogenic diabetes	Benign/Likely benign(Last reviewed: Sep 29, 2017)	criteria provided, multiple submitters, no conflicts	12	121416864	12	120979061	129233	134679
NM_000545.5(HNF1A):c.598C>T (p.Arg200Trp)	HNF1A	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	12	121431394	12	120993591	36824	45485
NM_000545.6(HNF1A):c.608G>A (p.Arg203His)	HNF1A	Diabetes mellitus type 1|not provided	Likely pathogenic(Last reviewed: Jan 3, 2017)	criteria provided, multiple submitters, no conflicts	12	121431404	12	120993601	129235	134681
NM_000545.6(HNF1A):c.670C>T (p.Pro224Ser)	HNF1A	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	12	121431466	12	120993663	36826	45487
NM_000545.6(HNF1A):c.731G>T (p.Arg244Ile)	HNF1A	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	12	121431984	12	120994181	36828	45489
NM_000545.6(HNF1A):c.790G>T (p.Val264Phe)	HNF1A	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	12	121432043	12	120994240	36830	45491
NM_000545.6(HNF1A):c.803T>C (p.Phe268Ser)	HNF1A	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	12	121432056	12	120994253	36831	45492
NM_000545.6(HNF1A):c.827C>G (p.Ala276Gly)	HNF1A	Maturity-onset diabetes of the young, type 3|not provided	Likely pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, multiple submitters, no conflicts	12	121432080	12	120994277	36832	45493
NM_000545.6(HNF1A):c.864G>C (p.Gly288=)	HNF1A	Maturity onset diabetes mellitus in young|not specified	Benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	12	121432117	12	120994314	129236	134682
NM_000545.6(HNF1A):c.872dupC (p.Gly292Argfs)	HNF1A	Diabetes mellitus type 1|Diabetes mellitus, insulin-dependent, 20|Maturity-onset diabetes of the young, type 3|Hepatic adenomas, familial|not provided|Clear cell carcinoma of kidney	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, multiple submitters, no conflicts	12	121432125	12	120994322	14927	29966
NM_000545.6(HNF1A):c.1114G>A (p.Ala372Thr)	HNF1A	not provided	Uncertain significance(Last reviewed: Jan 17, 2013)	criteria provided, single submitter	12	121434350	12	120996547	129226	134672
NM_000545.5(HNF1A):c.1137delT (p.Val380Serfs)	HNF1A	Maturity-onset diabetes of the young, type 3|Maturity onset diabetes mellitus in young|not provided	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, multiple submitters, no conflicts	12	121434373	12	120996570	435426	429380
NM_000545.6(HNF1A):c.1375C>T (p.Leu459=)	HNF1A	Maturity onset diabetes mellitus in young|not specified|not provided	Benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	12	121435342	12	120997539	129229	134675
NM_000545.6(HNF1A):c.1424C>T (p.Pro475Leu)	HNF1A	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	12	121435391	12	120997588	36801	45462
NM_000545.6(HNF1A):c.1460G>A (p.Ser487Asn)	HNF1A	Maturity onset diabetes mellitus in young|not specified|not provided	Benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	12	121435427	12	120997624	129230	134676
NM_000545.6(HNF1A):c.1501+1G>A	HNF1A	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	12	121435469	12	120997666	430837	424382
NM_000545.6(HNF1A):c.1501+7G>A	HNF1A	Maturity onset diabetes mellitus in young|not specified|not provided	Benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	12	121435475	12	120997672	129231	134677
NM_000545.6(HNF1A):c.1545G>A (p.Thr515=)	HNF1A	Maturity onset diabetes mellitus in young|not specified	Benign/Likely benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	12	121437114	12	120999311	129232	134678
NM_000545.6(HNF1A):c.1624-19G>A	HNF1A	Maturity-onset diabetes of the young, type 3|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2015)	criteria provided, conflicting interpretations	12	121437267	12	120999464	36807	45468
NM_000545.6(HNF1A):c.1624-15G>A	HNF1A	Maturity-onset diabetes of the young, type 3|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2016)	criteria provided, conflicting interpretations	12	121437271	12	120999468	36806	45467
NM_000545.6(HNF1A):c.1663C>T (p.Leu555Phe)	HNF1A	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	12	121437325	12	120999522	36808	45469
NM_023012.5(RSRC2):c.425G>A (p.Arg142Gln)	RSRC2	Obesity|Global developmental delay|Autistic behavior|Seizures|Myopia|Strabismus|Myopia|Global developmental delay|Obesity	Likely pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	12	123001951	12	122517404	242899	243989
NM_012226.4(P2RX2):c.799A>T (p.Ile267Phe)	P2RX2	not specified	Uncertain significance(Last reviewed: Nov 17, 2016)	criteria provided, single submitter	12	133198079	12	132621493	505201	497632
NM_006231.3(POLE):c.3971G>A (p.Arg1324His)	POLE	not specified|not provided|Colorectal cancer, susceptibility to, 12|Colorectal cancer	Uncertain significance(Last reviewed: Jun 17, 2018)	criteria provided, multiple submitters, no conflicts	12	133225926	12	132649340	240495	241375
NM_006231.3(POLE):c.3904C>T (p.Leu1302Phe)	POLE	Colorectal cancer, susceptibility to, 12	Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2018)	criteria provided, conflicting interpretations	12	133225993	12	132649407	473632	462661
NM_006231.3(POLE):c.2214G>C (p.Lys738Asn)	POLE	Colorectal cancer, susceptibility to, 12|Colorectal cancer	Uncertain significance(Last reviewed: Sep 26, 2017)	criteria provided, multiple submitters, no conflicts	12	133244194	12	132667608	226044	227849
NM_006231.3(POLE):c.2089C>G (p.Pro697Ala)	POLE	not specified|Colorectal cancer, susceptibility to, 12|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 8, 2018)	criteria provided, conflicting interpretations	12	133245026	12	132668440	240421	241441
NM_006231.3(POLE):c.1420G>A (p.Val474Ile)	POLE	Colorectal cancer, susceptibility to, 12	Uncertain significance(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	12	133249803	12	132673217	235886	237521
NM_006231.3(POLE):c.941C>G (p.Ser314Ter)	POLE	not specified|Colorectal cancer, susceptibility to, 12|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 27, 2018)	criteria provided, conflicting interpretations	12	133252759	12	132676173	224590	226349
NM_006231.3(POLE):c.861T>A (p.Asp287Glu)	POLE	Familial colorectal cancer|not specified|not provided|Colorectal cancer, susceptibility to, 12|Hereditary cancer-predisposing syndrome|Colorectal cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	12	133253180	12	132676594	221000	222238
NM_006231.3(POLE):c.664C>T (p.Arg222Cys)	POLE	Colorectal cancer, susceptibility to, 12	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2018)	criteria provided, conflicting interpretations	12	133254220	12	132677634	582662	566700
NM_006231.3(POLE):c.16G>C (p.Gly6Arg)	POLE	not specified|not provided|Colorectal cancer, susceptibility to, 12|Hereditary cancer-predisposing syndrome|Colorectal cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2018)	criteria provided, conflicting interpretations	12	133263886	12	132687300	218680	215445
NM_004572.3(PKP2):c.(?_1689)_(1806_?)del (p.(?))	PKP2	Arrhythmogenic right ventricular cardiomyopathy	Likely pathogenic(Last reviewed: Mar 24, 2014)	criteria provided, single submitter	12	32976979 - 32977096	12	32824045 - 32824162	164945	175380
NM_004004.5(GJB2):c.551G>A (p.Arg184Gln)	GJB2	Deafness, autosomal dominant 3a|Hearing impairment|not provided|Hearing loss	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	13	20763170	13	20189031	29662	38617
NM_004004.5(GJB2):c.426C>A (p.Phe142Leu)	GJB2	Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Sep 2, 2011)	criteria provided, single submitter	13	20763295	13	20189156	44750	53917
NM_004004.5(GJB2):c.224G>A (p.Arg75Gln)	GJB2	Deafness, autosomal recessive 1A|Keratoderma palmoplantar deafness|Deafness, autosomal dominant 3a|Nonsyndromic hearing loss and deafness|not provided	Pathogenic(Last reviewed: Jul 29, 2016)	criteria provided, multiple submitters, no conflicts	13	20763497	13	20189358	17027	32066
NM_004004.5(GJB2):c.223C>T (p.Arg75Trp)	GJB2	Deafness, autosomal dominant 3a|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Oct 27, 2014)	criteria provided, single submitter	13	20763498	13	20189359	17011	32050
NM_004004.5(GJB2):c.196G>T (p.Asp66Tyr)	GJB2	Sensorineural hearing loss	Likely pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	13	20763525	13	20189386	586962	578007
NM_004004.5(GJB2):c.176G>A (p.Gly59Asp)	GJB2	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Mar 10, 2015)	criteria provided, single submitter	13	20763545	13	20189406	163520	175766
NM_004004.5(GJB2):c.125_127delAGG (p.Glu42del)	GJB2	Deafness, autosomal dominant 3a	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	13	20763594 - 20763596	13	20189455 - 20189457	590775	581711
NM_004004.5(GJB2):c.66G>T (p.Lys22Asn)	GJB2	Keratoderma palmoplantar deafness	Pathogenic(Last reviewed: Apr 26, 2016)	no assertion criteria provided	13	20763655	13	20189516	242831	243935
NM_006783.4(GJB6):c.31G>A (p.Gly11Arg)	GJB6	Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|Deafness, autosomal dominant 3b|Hidrotic ectodermal dysplasia syndrome|not provided	Pathogenic(Last reviewed: Aug 25, 2017)	criteria provided, multiple submitters, no conflicts	13	20797589	13	20223450	5544	20583
NM_000209.3(PDX1):c.-18C>T	PDX1	Maturity-onset diabetes of the young, type 4|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 14, 2017)	criteria provided, conflicting interpretations	13	28494258	13	27920121	36402	45065
NM_000209.3(PDX1):c.97C>A (p.Pro33Thr)	PDX1	Maturity-onset diabetes of the young, type 4|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 10, 2016)	criteria provided, conflicting interpretations	13	28494372	13	27920235	36414	45077
NM_015932.5(POMP):c.334_335delAT (p.Ile112Trpfs)	POMP	POMP-related condition|PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2	Pathogenic(Last reviewed: Feb 14, 2017)	criteria provided, single submitter	13	29246545 - 29246546	13	28672408 - 28672409	522801	513446
NM_000059.3(BRCA2):c.-41G>A	BRCA2|LOC106721785	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	13	32889803	13	32315666	252427	246784
NM_000059.3(BRCA2):c.-39-1G>A	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic	no assertion criteria provided	13	32890558	13	32316421	403704	390674
NM_000059.3(BRCA2):c.-11C>T	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32890587	13	32316450	125976	131514
NM_000059.3(BRCA2):c.3G>A (p.Met1Ile)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, multiple submitters, no conflicts	13	32890600	13	32316463	51579	66247
NM_000059.3(BRCA2):c.22_23delAG (p.Arg8Alafs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32890619 - 32890620	13	32316482 - 32316483	51267	65935
NM_000059.3(BRCA2):c.26delC (p.Pro9Glnfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32890623	13	32316486	51330	65998
NM_000059.3(BRCA2):c.53G>A (p.Arg18His)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32890650	13	32316513	51855	66523
NM_000059.3(BRCA2):c.67+1G>C	BRCA2	Breast-ovarian cancer, familial 2|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 4, 2016)	criteria provided, multiple submitters, no conflicts	13	32890665	13	32316528	224450	226152
NM_000059.3(BRCA2):c.68-7T>A	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Apr 12, 2018)	reviewed by expert panel	13	32893207	13	32319070	52187	66855
NM_000059.3(BRCA2):c.68-7dupT	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	13	32893207	13	32319070	38065	46621
NM_000059.3(BRCA2):c.71_96del26 (p.Leu24Terfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32893217 - 32893242	13	32319080 - 32319105	125993	131531
NM_000059.3(BRCA2):c.81_83delAAGinsTAAGACT (p.Ser28Lysfs)	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Dec 15, 2017)	reviewed by expert panel	13	32893227 - 32893229	13	32319090 - 32319092	252407	246785
NM_000059.3(BRCA2):c.125A>G (p.Tyr42Cys)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32893271	13	32319134	37734	46290
NM_000059.3(BRCA2):c.145G>T (p.Glu49Ter)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia, complementation group D1|Medulloblastoma|Wilms tumor 1|Malignant tumor of prostate|Tracheoesophageal fistula|Pancreatic cancer 2|Glioma susceptibility 3|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Tracheoesophageal fistula	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32893291	13	32319154	51129	65797
NM_000059.3(BRCA2):c.217C>T (p.Gln73Ter)	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32893363	13	32319226	91770	97247
NM_000059.3(BRCA2):c.223G>C (p.Ala75Pro)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32893369	13	32319232	51258	65926
NM_000059.3(BRCA2):c.231T>G (p.Thr77=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Sep 28, 2016)	reviewed by expert panel	13	32893377	13	32319240	51269	65937
NM_000059.3(BRCA2):c.267G>A (p.Pro89=)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32893413	13	32319276	135794	139506
NM_000059.3(BRCA2):c.316+12A>G	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 24, 2018)	criteria provided, multiple submitters, no conflicts	13	32893474	13	32319337	136568	140271
NM_000059.3(BRCA2):c.440A>G (p.Gln147Arg)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Cancer of the pancreas	Conflicting interpretations of pathogenicity(Last reviewed: Dec 19, 2017)	criteria provided, conflicting interpretations	13	32900252	13	32326115	51644	66312
NM_000059.3(BRCA2):c.464G>A (p.Arg155Lys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Uncertain significance(Last reviewed: May 22, 2017)	criteria provided, multiple submitters, no conflicts	13	32900276	13	32326139	253032	247439
NM_000059.3(BRCA2):c.470_474delAGTCA (p.Lys157Serfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32900282 - 32900286	13	32326145 - 32326149	51701	66369
NM_000059.3(BRCA2):c.475+3A>G	BRCA2	Breast-ovarian cancer, familial 2|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 11, 2016)	criteria provided, conflicting interpretations	13	32900290	13	32326153	51710	66378
NM_000059.3(BRCA2):c.516+14C>T	BRCA2	Familial cancer of breast|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 9, 2018)	criteria provided, multiple submitters, no conflicts	13	32900433	13	32326296	132764	136512
NM_000059.3(BRCA2):c.517-19C>T	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32900617	13	32326480	51799	66467
NM_000059.3(BRCA2):c.517-4C>G	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 6, 2018)	criteria provided, conflicting interpretations	13	32900632	13	32326495	51802	66470
NM_000059.3(BRCA2):c.517-2A>G	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	13	32900634	13	32326497	51801	66469
NM_000059.3(BRCA2):c.517-1G>A	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	13	32900635	13	32326498	51800	66468
NM_000059.3(BRCA2):c.606C>T (p.Pro202=)	BRCA2	Breast-ovarian cancer, familial 2	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32900725	13	32326588	252412	246786
NM_000059.3(BRCA2):c.658_659delGT (p.Val220Ilefs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia, complementation group D1|Medulloblastoma|Wilms tumor 1|Breast-ovarian cancer, familial 1|Glioma susceptibility 3|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32903606 - 32903607	13	32329469 - 32329470	9342	24381
NM_000059.3(BRCA2):c.662_663delTT (p.Phe221Serfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32903610 - 32903611	13	32329473 - 32329474	52138	66806
NM_000059.3(BRCA2):c.695A>G (p.Tyr232Cys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2017)	criteria provided, conflicting interpretations	13	32905069	13	32330932	141345	151059
NM_000059.3(BRCA2):c.700delT (p.Ser234Profs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32905074	13	32330937	38079	46635
NM_000059.3(BRCA2):c.709G>A (p.Asp237Asn)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	13	32905083	13	32330946	91470	96947
NM_000059.3(BRCA2):c.729_732delTGAT (p.Asn243Lysfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32905103 - 32905106	13	32330966 - 32330969	52302	66970
NM_000059.3(BRCA2):c.742G>A (p.Ala248Thr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 18, 2018)	criteria provided, conflicting interpretations	13	32905116	13	32330979	52326	66994
NM_000059.3(BRCA2):c.756_757delCA (p.Asp252Glufs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32905130 - 32905131	13	32330993 - 32330994	38106	46662
NM_000059.3(BRCA2):c.771_775delTCAAA (p.Asn257Lysfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32905145 - 32905149	13	32331008 - 32331012	9326	24365
NM_000059.3(BRCA2):c.773A>G (p.Gln258Arg)	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: Mar 12, 2016)	criteria provided, single submitter	13	32905147	13	32331010	252421	246787
NM_000059.3(BRCA2):c.778_779delGA (p.Glu260Serfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32905152 - 32905153	13	32331015 - 32331016	38119	46675
NM_000059.3(BRCA2):c.787dupA (p.Ser263Lysfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32905161	13	32331024	162101	171818
NM_000059.3(BRCA2):c.818C>A (p.Ser273Ter)	BRCA2	Breast-ovarian cancer, familial 2|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	13	32906433	13	32332296	52523	67191
NM_000059.3(BRCA2):c.865A>C (p.Asn289His)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32906480	13	32332343	41567	50006
NM_000059.3(BRCA2):c.880G>T (p.Glu294Ter)	BRCA2	Breast-ovarian cancer, familial 2|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32906495	13	32332358	52683	67351
NM_000059.3(BRCA2):c.889G>T (p.Glu297Ter)	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Dec 15, 2017)	reviewed by expert panel	13	32906504	13	32332367	252404	246788
NM_000059.3(BRCA2):c.943T>A (p.Cys315Ser)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	13	32906558	13	32332421	38241	46797
NM_000059.3(BRCA2):c.956dupA (p.Asn319Lysfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32906571	13	32332434	52870	67538
NM_000059.3(BRCA2):c.956A>C (p.Asn319Thr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2017)	criteria provided, conflicting interpretations	13	32906571	13	32332434	38248	46804
NM_000059.3(BRCA2):c.964A>C (p.Lys322Gln)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	13	32906579	13	32332442	38258	46814
NM_000059.3(BRCA2):c.971G>C (p.Arg324Thr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 7, 2018)	criteria provided, multiple submitters, no conflicts	13	32906586	13	32332449	38261	46817
NM_000059.3(BRCA2):c.978C>A (p.Ser326Arg)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32906593	13	32332456	52898	67566
NM_000059.3(BRCA2):c.994delA (p.Ile332Phefs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32906609	13	32332472	52924	67592
NM_000059.3(BRCA2):c.1002T>G (p.His334Gln)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 7, 2017)	criteria provided, multiple submitters, no conflicts	13	32906617	13	32332480	252405	246789
NM_000059.3(BRCA2):c.1011C>T (p.Asn337=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32906626	13	32332489	51045	65713
NM_000059.3(BRCA2):c.1029delA (p.Lys343Asnfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32906644	13	32332507	37724	46280
NM_000059.3(BRCA2):c.1103C>A (p.Ser368Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32906718	13	32332581	51064	65732
NM_000059.3(BRCA2):c.1114A>C (p.Asn372His)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Ductal breast carcinoma	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32906729	13	32332592	9329	24368
NM_000059.3(BRCA2):c.1123C>T (p.Pro375Ser)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32906738	13	32332601	51066	65734
NM_000059.3(BRCA2):c.1129G>C (p.Glu377Gln)	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: Apr 1, 2017)	no assertion criteria provided	13	32906744	13	32332607	417620	404598
NM_000059.3(BRCA2):c.1151C>T (p.Ser384Phe)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32906766	13	32332629	41541	49980
NM_000059.3(BRCA2):c.1189_1190insTTAG (p.Gln397Leufs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	13	32906804 - 32906805	13	32332667 - 32332668	51080	65748
NM_000059.3(BRCA2):c.1192delC (p.Leu398Terfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Dec 15, 2017)	reviewed by expert panel	13	32906807	13	32332670	409454	399656
NM_000059.3(BRCA2):c.1205delG (p.Gly402Valfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32906820	13	32332683	37730	46286
NM_000059.3(BRCA2):c.1273_1274delGA (p.Glu425Lysfs)	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: May 18, 2013)	no assertion criteria provided	13	32906888 - 32906889	13	32332751 - 32332752	438768	432383
NM_000059.3(BRCA2):c.1275A>G (p.Glu425=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32906890	13	32332753	51093	65761
NM_000059.3(BRCA2):c.1296_1297delGA (p.Asn433Glnfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32906911 - 32906912	13	32332774 - 32332775	37736	46292
NM_000059.3(BRCA2):c.1310_1313delAAGA (p.Lys437Ilefs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32906925 - 32906928	13	32332788 - 32332791	37737	46293
NM_000059.3(BRCA2):c.1327G>T (p.Glu443Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32906942	13	32332805	51102	65770
NM_000059.3(BRCA2):c.1362delA (p.Lys454Asnfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	13	32906977	13	32332840	51109	65777
NM_000059.3(BRCA2):c.1362A>G (p.Lys454=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32906977	13	32332840	51108	65776
NM_000059.3(BRCA2):c.1365A>G (p.Ser455=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32906980	13	32332843	125943	131481
NM_000059.3(BRCA2):c.1381G>T (p.Glu461Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Dec 15, 2017)	reviewed by expert panel	13	32906996	13	32332859	440457	434081
NM_000059.3(BRCA2):c.1385A>G (p.Glu462Gly)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32907000	13	32332863	37738	46294
NM_000059.3(BRCA2):c.1387A>G (p.Thr463Ala)	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: May 5, 2016)	criteria provided, single submitter	13	32907002	13	32332865	252411	246790
NM_000059.3(BRCA2):c.1389_1390delAG (p.Val464Glyfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32907004 - 32907005	13	32332867 - 32332868	51113	65781
NM_000059.3(BRCA2):c.1395A>C (p.Val465=)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32907010	13	32332873	51116	65784
NM_000059.3(BRCA2):c.1399A>T (p.Lys467Ter)	BRCA2	Breast-ovarian cancer, familial 2|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32907014	13	32332877	51118	65786
NM_000059.3(BRCA2):c.1409A>C (p.Glu470Ala)	BRCA2	Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 28, 2018)	criteria provided, conflicting interpretations	13	32907024	13	32332887	233895	234650
NM_000059.3(BRCA2):c.1427C>G (p.Ser476Cys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 25, 2018)	criteria provided, multiple submitters, no conflicts	13	32907042	13	32332905	37739	46295
NM_000059.3(BRCA2):c.1453A>G (p.Lys485Glu)	BRCA2	Hereditary breast and ovarian cancer syndrome	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	13	32907068	13	32332931	582393	567274
NM_000059.3(BRCA2):c.1460C>A (p.Ala487Glu)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 11, 2018)	criteria provided, conflicting interpretations	13	32907075	13	32332938	37741	46297
NM_000059.3(BRCA2):c.1499delG (p.Gly500Valfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32907114	13	32332977	51135	65803
NM_000059.3(BRCA2):c.1514T>C (p.Ile505Thr)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	13	32907129	13	32332992	41542	49981
NM_000059.3(BRCA2):c.1550A>G (p.Asn517Ser)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	13	32907165	13	32333028	37745	46301
NM_000059.3(BRCA2):c.1568A>G (p.His523Arg)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Cancer of the pancreas	Conflicting interpretations of pathogenicity(Last reviewed: May 21, 2018)	criteria provided, conflicting interpretations	13	32907183	13	32333046	96766	102669
NM_000059.3(BRCA2):c.1574C>G (p.Thr525Ser)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 8, 2016)	criteria provided, multiple submitters, no conflicts	13	32907189	13	32333052	252415	246791
NM_000059.3(BRCA2):c.1631_1632delCT (p.Thr544Serfs)	BRCA2	Breast-ovarian cancer, familial 2|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32907246 - 32907247	13	32333109 - 32333110	51161	65829
NM_000059.3(BRCA2):c.1662T>G (p.Cys554Trp)	BRCA2	Breast-ovarian cancer, familial 2|Carcinoma of male breast|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32907277	13	32333140	51169	65837
NM_000059.3(BRCA2):c.1754delA (p.Lys585Argfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32907369	13	32333232	51184	65852
NM_000059.3(BRCA2):c.1763_1766delATAA (p.Asn588Serfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32907378 - 32907381	13	32333241 - 32333244	51187	65855
NM_000059.3(BRCA2):c.1763A>G (p.Asn588Ser)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2017)	criteria provided, conflicting interpretations	13	32907378	13	32333241	51186	65854
NM_000059.3(BRCA2):c.1773_1776delTTAT (p.Ile591Metfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32907388 - 32907391	13	32333251 - 32333254	51190	65858
NM_000059.3(BRCA2):c.1786G>C (p.Asp596His)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 20, 2017)	criteria provided, conflicting interpretations	13	32907401	13	32333264	51192	65860
NM_000059.3(BRCA2):c.1788T>C (p.Asp596=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32907403	13	32333266	51193	65861
NM_000059.3(BRCA2):c.1792A>G (p.Thr598Ala)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 27, 2018)	criteria provided, conflicting interpretations	13	32907407	13	32333270	41543	49982
NM_000059.3(BRCA2):c.1796_1800delCTTAT (p.Ser599Terfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32907411 - 32907415	13	32333274 - 32333278	37756	46312
NM_000059.3(BRCA2):c.1800T>G (p.Tyr600Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32907415	13	32333278	51199	65867
NM_000059.3(BRCA2):c.1813dupA (p.Ile605Asnfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32907428	13	32333291	37762	46318
NM_000059.3(BRCA2):c.1818G>A (p.Pro606=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32907433	13	32333296	183776	183693
NM_000059.3(BRCA2):c.1831delT (p.Ser611Glnfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32907446	13	32333309	51211	65879
NM_000059.3(BRCA2):c.1832C>G (p.Ser611Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	13	32907447	13	32333310	228323	230442
NM_000059.3(BRCA2):c.1889C>T (p.Thr630Ile)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32907504	13	32333367	37768	46324
NM_000059.3(BRCA2):c.1909+1G>A	BRCA2	Breast-ovarian cancer, familial 2|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	13	32907525	13	32333388	141283	150997
NM_000059.3(BRCA2):c.1909+22delT	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 15, 2018)	criteria provided, conflicting interpretations	13	32907546	13	32333409	132782	136530
NM_000059.3(BRCA2):c.1911T>C (p.Gly637=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32910403	13	32336266	136554	140257
NM_000059.3(BRCA2):c.1929delG (p.Arg645Glufs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32910421	13	32336284	37769	46325
NM_000059.3(BRCA2):c.1938C>T (p.Ser646=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32910430	13	32336293	51230	65898
NM_000059.3(BRCA2):c.1964C>G (p.Pro655Arg)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32910456	13	32336319	37770	46326
NM_000059.3(BRCA2):c.1993A>G (p.Thr665Ala)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 4, 2018)	criteria provided, multiple submitters, no conflicts	13	32910485	13	32336348	141539	151253
NM_000059.3(BRCA2):c.2026T>C (p.Cys676Arg)	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: Apr 19, 2016)	criteria provided, single submitter	13	32910518	13	32336381	37772	46328
NM_000059.3(BRCA2):c.2092delC (p.Leu698Tyrfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32910584	13	32336447	37774	46330
NM_000059.3(BRCA2):c.2138A>T (p.Gln713Leu)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 16, 2018)	criteria provided, conflicting interpretations	13	32910630	13	32336493	51249	65917
NM_000059.3(BRCA2):c.2224C>T (p.Gln742Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32910716	13	32336579	51257	65925
NM_000059.3(BRCA2):c.2229T>C (p.His743=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia, complementation group D1|Fanconi anemia|Medulloblastoma|Wilms tumor 1|Malignant tumor of prostate|Pancreatic cancer 2|Glioma susceptibility 3|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32910721	13	32336584	125979	131517
NM_000059.3(BRCA2):c.2332G>A (p.Val778Ile)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 5, 2018)	criteria provided, conflicting interpretations	13	32910824	13	32336687	89044	94587
NM_000059.3(BRCA2):c.2339C>G (p.Ser780Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32910831	13	32336694	141070	150784
NM_000059.3(BRCA2):c.2350A>G (p.Met784Val)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32910842	13	32336705	41544	49983
NM_000059.3(BRCA2):c.2368G>T (p.Glu790Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32910860	13	32336723	91776	97253
NM_000059.3(BRCA2):c.2376C>A (p.Tyr792Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32910868	13	32336731	51274	65942
NM_000059.3(BRCA2):c.2409T>G (p.Tyr803Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32910901	13	32336764	37784	46340
NM_000059.3(BRCA2):c.2416G>C (p.Asp806His)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32910908	13	32336771	51278	65946
NM_000059.3(BRCA2):c.2426T>G (p.Leu809Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32910918	13	32336781	37786	46342
NM_000059.3(BRCA2):c.2538A>C (p.Ser846=)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32911030	13	32336893	51302	65970
NM_000059.3(BRCA2):c.2558A>G (p.Gln853Arg)	BRCA2	Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 11, 2015)	criteria provided, multiple submitters, no conflicts	13	32911050	13	32336913	142112	151826
NM_000059.3(BRCA2):c.2564_2565delCA (p.Thr855Lysfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32911056 - 32911057	13	32336919 - 32336920	51307	65975
NM_000059.3(BRCA2):c.2680G>A (p.Val894Ile)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32911172	13	32337035	51326	65994
NM_000059.3(BRCA2):c.2743_2747delACTTG (p.Thr915Cysfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32911235 - 32911239	13	32337098 - 32337102	189178	186872
NM_000059.3(BRCA2):c.2786T>C (p.Leu929Ser)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32911278	13	32337141	51343	66011
NM_000059.3(BRCA2):c.2803G>A (p.Asp935Asn)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 10, 2018)	criteria provided, multiple submitters, no conflicts	13	32911295	13	32337158	51349	66017
NM_000059.3(BRCA2):c.2808_2811del (p.Ala938Profs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32911300 - 32911303	13	32337163 - 32337166	9322	24361
NM_000059.3(BRCA2):c.2813C>A (p.Ala938Glu)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	13	32911305	13	32337168	51353	66021
NM_000059.3(BRCA2):c.2830A>T (p.Lys944Ter)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32911322	13	32337185	51355	66023
NM_000059.3(BRCA2):c.2848G>A (p.Val950Ile)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 30, 2018)	criteria provided, multiple submitters, no conflicts	13	32911340	13	32337203	231995	234718
NM_000059.3(BRCA2):c.2883G>A (p.Gln961=)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32911375	13	32337238	51366	66034
NM_000059.3(BRCA2):c.2892A>T (p.Lys964Asn)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified	Uncertain significance(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	13	32911384	13	32337247	133728	137467
NM_000059.3(BRCA2):c.2918C>T (p.Ser973Leu)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	13	32911410	13	32337273	37807	46363
NM_000059.3(BRCA2):c.2919G>A (p.Ser973=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32911411	13	32337274	51370	66038
NM_000059.3(BRCA2):c.2960A>T (p.Asn987Ile)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32911452	13	32337315	51379	66047
NM_000059.3(BRCA2):c.2971A>G (p.Asn991Asp)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32911463	13	32337326	41545	49984
NM_000059.3(BRCA2):c.3032C>G (p.Thr1011Arg)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	13	32911524	13	32337387	37815	46371
NM_000059.3(BRCA2):c.3054G>A (p.Lys1018=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32911546	13	32337409	136558	140261
NM_000059.3(BRCA2):c.3055C>G (p.Leu1019Val)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32911547	13	32337410	37817	46373
NM_000059.3(BRCA2):c.3071_3073delTTA (p.Ile1024del)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	13	32911563 - 32911565	13	32337426 - 32337428	187582	183750
NM_000059.3(BRCA2):c.3075_3076delGAinsTT (p.Lys1025_Lys1026delinsAsnTer)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	13	32911567 - 32911568	13	32337430 - 32337431	89046	94589
NM_000059.3(BRCA2):c.3167_3170delAAAA (p.Gln1056Argfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32911659 - 32911662	13	32337522 - 32337525	51413	66081
NM_000059.3(BRCA2):c.3172A>T (p.Lys1058Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32911664	13	32337527	182196	180588
NM_000059.3(BRCA2):c.3187C>T (p.Gln1063Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	13	32911679	13	32337542	228324	230443
NM_000059.3(BRCA2):c.3245A>G (p.Lys1082Arg)	BRCA2	Breast-ovarian cancer, familial 2|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	13	32911737	13	32337600	51431	66099
NM_000059.3(BRCA2):c.3264T>C (p.Pro1088=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32911756	13	32337619	51435	66103
NM_000059.3(BRCA2):c.3264dupT (p.Gln1089Serfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32911756	13	32337619	37830	46386
NM_000059.3(BRCA2):c.3280A>T (p.Lys1094Ter)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32911772	13	32337635	162102	171819
NM_000059.3(BRCA2):c.3291dupT (p.Asn1098Terfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32911783	13	32337646	162103	171820
NM_000059.3(BRCA2):c.3293delA (p.Asn1098Ilefs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32911785	13	32337648	254515	248949
NM_000059.3(BRCA2):c.3336delA (p.Glu1113Asnfs)	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32911828	13	32337691	91798	97275
NM_000059.3(BRCA2):c.3396A>G (p.Lys1132=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32911888	13	32337751	126010	131548
NM_000059.3(BRCA2):c.3420T>C (p.Ser1140=)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32911912	13	32337775	51461	66129
NM_000059.3(BRCA2):c.3422del (p.Thr1141Asnfs)	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	13	32911914	13	32337777	252426	246792
NM_000059.3(BRCA2):c.3445A>G (p.Met1149Val)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Carcinoma of esophagus	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2018)	criteria provided, conflicting interpretations	13	32911937	13	32337800	51465	66133
NM_000059.3(BRCA2):c.3515C>T (p.Ser1172Leu)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32912007	13	32337870	41546	49985
NM_000059.3(BRCA2):c.3516G>A (p.Ser1172=)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32912008	13	32337871	51481	66149
NM_000059.3(BRCA2):c.3545_3546delTT (p.Phe1182Terfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32912037 - 32912038	13	32337900 - 32337901	37846	46402
NM_000059.3(BRCA2):c.3641delT (p.Val1214Glyfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32912133	13	32337996	162105	171822
NM_000059.3(BRCA2):c.3680_3681delTG (p.Leu1227Glnfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32912172 - 32912173	13	32338035 - 32338036	51504	66172
NM_000059.3(BRCA2):c.3682A>G (p.Asn1228Asp)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32912174	13	32338037	37852	46408
NM_000059.3(BRCA2):c.3689delC (p.Ser1230Leufs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32912181	13	32338044	37853	46409
NM_000059.3(BRCA2):c.3697G>A (p.Ala1233Thr)	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: Apr 15, 2016)	criteria provided, single submitter	13	32912189	13	32338052	51507	66175
NM_000059.3(BRCA2):c.3717delA (p.Lys1239Asnfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32912209	13	32338072	37855	46411
NM_000059.3(BRCA2):c.3807T>C (p.Val1269=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32912299	13	32338162	126022	131560
NM_000059.3(BRCA2):c.3831T>G (p.Asn1277Lys)	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: Apr 18, 2016)	criteria provided, single submitter	13	32912323	13	32338186	252413	246793
NM_000059.3(BRCA2):c.3847_3848delGT (p.Val1283Lysfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32912339 - 32912340	13	32338202 - 32338203	37859	46415
NM_000059.3(BRCA2):c.3860delA (p.Asn1287Ilefs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Tumor susceptibility linked to germline BAP1 mutations|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32912352	13	32338215	51545	66213
NM_000059.3(BRCA2):c.3865_3868delAAAT (p.Lys1289Alafs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32912357 - 32912360	13	32338220 - 32338223	37862	46418
NM_000059.3(BRCA2):c.3869G>A (p.Cys1290Tyr)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32912361	13	32338224	37863	46419
NM_000059.3(BRCA2):c.3871C>T (p.Gln1291Ter)	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32912363	13	32338226	51550	66218
NM_000059.3(BRCA2):c.3922G>T (p.Glu1308Ter)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32912414	13	32338277	37867	46423
NM_000059.3(BRCA2):c.3966_3968delCAA (p.Asn1322del)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	13	32912458 - 32912460	13	32338321 - 32338323	37868	46424
NM_000059.3(BRCA2):c.3975_3978dupTGCT (p.Ala1327Cysfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32912467 - 32912470	13	32338330 - 32338333	51578	66246
NM_000059.3(BRCA2):c.4061C>T (p.Thr1354Met)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32912553	13	32338416	51588	66256
NM_000059.3(BRCA2):c.4067T>C (p.Leu1356Ser)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified	Uncertain significance(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	13	32912559	13	32338422	234278	231871
NM_000059.3(BRCA2):c.4068G>A (p.Leu1356=)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32912560	13	32338423	51589	66257
NM_000059.3(BRCA2):c.4071A>C (p.Leu1357=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32912563	13	32338426	136560	140263
NM_000059.3(BRCA2):c.4090A>C (p.Ile1364Leu)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32912582	13	32338445	51592	66260
NM_000059.3(BRCA2):c.4103delT (p.Leu1368Tyrfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Dec 15, 2017)	reviewed by expert panel	13	32912595	13	32338458	440456	434082
NM_000059.3(BRCA2):c.4131_4132insTGAGGA (p.Thr1378_Gly1712delinsTer)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	13	32912623 - 32912624	13	32338486 - 32338487	126037	131575
NM_000059.3(BRCA2):c.4187A>G (p.Gln1396Arg)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32912679	13	32338542	37886	46442
NM_000059.3(BRCA2):c.4241C>T (p.Thr1414Met)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32912733	13	32338596	51616	66284
NM_000059.3(BRCA2):c.4258delG (p.Asp1420Ilefs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32912750	13	32338613	51617	66285
NM_000059.3(BRCA2):c.4258G>T (p.Asp1420Tyr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32912750	13	32338613	41549	49988
NM_000059.3(BRCA2):c.4284dupT (p.Gln1429Serfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32912776	13	32338639	37892	46448
NM_000059.3(BRCA2):c.4325C>G (p.Ser1442Ter)	BRCA2	Breast-ovarian cancer, familial 2|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32912817	13	32338680	91820	97297
NM_000059.3(BRCA2):c.4380_4381delTT (p.Ser1461Leufs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	13	32912872 - 32912873	13	32338735 - 32338736	51638	66306
NM_000059.3(BRCA2):c.4398_4402delACATT (p.Leu1466Phefs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32912890 - 32912894	13	32338753 - 32338757	51640	66308
NM_000059.3(BRCA2):c.4409_4413delTAAGA (p.Ile1470Lysfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32912901 - 32912905	13	32338764 - 32338768	51643	66311
NM_000059.3(BRCA2):c.4425G>A (p.Met1475Ile)	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: May 18, 2016)	criteria provided, single submitter	13	32912917	13	32338780	252410	246795
NM_000059.3(BRCA2):c.4449delA (p.Asp1484Thrfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32912941	13	32338804	37904	46460
NM_000059.3(BRCA2):c.4478_4481delAAAG (p.Glu1493Valfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Diffuse intrinsic pontine glioma	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32912970 - 32912973	13	32338833 - 32338836	51653	66321
NM_000059.3(BRCA2):c.4527A>C (p.Gln1509His)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	13	32913019	13	32338882	220561	222309
NM_000059.3(BRCA2):c.4551_4554delAGAA (p.Lys1517Asnfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913043 - 32913046	13	32338906 - 32338909	51669	66337
NM_000059.3(BRCA2):c.4563A>G (p.Leu1521=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32913055	13	32338918	132779	136527
NM_000059.3(BRCA2):c.4584C>T (p.Ser1528=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32913076	13	32338939	51677	66345
NM_000059.3(BRCA2):c.4585G>A (p.Gly1529Arg)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32913077	13	32338940	37910	46466
NM_000059.3(BRCA2):c.4587dupG (p.Lys1530Glufs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913079	13	32338942	216856	213047
NM_000059.3(BRCA2):c.4588A>T (p.Lys1530Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913080	13	32338943	51678	66346
NM_000059.3(BRCA2):c.4614T>C (p.Ser1538=)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32913106	13	32338969	51683	66351
NM_000059.3(BRCA2):c.4631delA (p.Asn1544Thrfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913123	13	32338986	37913	46469
NM_000059.3(BRCA2):c.4638dupT (p.Asp1547Terfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Dec 15, 2017)	reviewed by expert panel	13	32913130	13	32338993	51686	66354
NM_000059.3(BRCA2):c.4647_4650delAGAG (p.Lys1549Asnfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913139 - 32913142	13	32339002 - 32339005	51687	66355
NM_000059.3(BRCA2):c.4656T>C (p.Gly1552=)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32913148	13	32339011	51690	66358
NM_000059.3(BRCA2):c.4681C>A (p.His1561Asn)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 14, 2018)	criteria provided, conflicting interpretations	13	32913173	13	32339036	51695	66363
NM_000059.3(BRCA2):c.4740_4741dupTG (p.Glu1581Valfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913232 - 32913233	13	32339095 - 32339096	220160	222311
NM_000059.3(BRCA2):c.4741G>A (p.Glu1581Lys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 30, 2018)	criteria provided, multiple submitters, no conflicts	13	32913233	13	32339096	37920	46476
NM_000059.3(BRCA2):c.4829_4830delTG (p.Val1610Glyfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913321 - 32913322	13	32339184 - 32339185	51721	66389
NM_000059.3(BRCA2):c.4876_4877delAA (p.Asn1626Serfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32913368 - 32913369	13	32339231 - 32339232	37929	46485
NM_000059.3(BRCA2):c.4889C>G (p.Ser1630Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913381	13	32339244	51732	66400
NM_000059.3(BRCA2):c.4933_4935delAAA (p.Lys1645del)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	13	32913425 - 32913427	13	32339288 - 32339290	252422	246796
NM_000059.3(BRCA2):c.4936_4939delGAAA (p.Glu1646Glnfs)	BRCA2	Breast-ovarian cancer, familial 2|Migraine|Obesity|Hereditary breast and ovarian cancer syndrome|Short attention span|Muscle weakness|Headache|not provided|Hereditary cancer-predisposing syndrome|Nephrolithiasis|Striae distensae|Ectopic ossification|Asthma	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913428 - 32913431	13	32339291 - 32339294	37935	46491
NM_000059.3(BRCA2):c.4964dupA (p.Tyr1655Terfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913456	13	32339319	91830	97307
NM_000059.3(BRCA2):c.4965C>A (p.Tyr1655Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913457	13	32339320	51750	66418
NM_000059.3(BRCA2):c.4965C>G (p.Tyr1655Ter)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia, complementation group D1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913457	13	32339320	37936	46492
NM_000059.3(BRCA2):c.5070A>C (p.Lys1690Asn)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32913562	13	32339425	37942	46498
NM_000059.3(BRCA2):c.5073dupA (p.Trp1692Metfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32913565	13	32339428	37943	46499
NM_000059.3(BRCA2):c.5116_5119delAATA (p.Asn1706Leufs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913608 - 32913611	13	32339471 - 32339474	51773	66441
NM_000059.3(BRCA2):c.5157_5161delTTCAA (p.Asn1719Lysfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913649 - 32913653	13	32339512 - 32339516	51780	66448
NM_000059.3(BRCA2):c.5164_5165delAG (p.Ser1722Tyrfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913656 - 32913657	13	32339519 - 32339520	51791	66459
NM_000059.3(BRCA2):c.5171T>C (p.Ile1724Thr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 21, 2018)	criteria provided, conflicting interpretations	13	32913663	13	32339526	51803	66471
NM_000059.3(BRCA2):c.5191C>T (p.His1731Tyr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 7, 2018)	criteria provided, multiple submitters, no conflicts	13	32913683	13	32339546	252409	246797
NM_000059.3(BRCA2):c.5198C>T (p.Ser1733Phe)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32913690	13	32339553	37950	46506
NM_000059.3(BRCA2):c.5199C>T (p.Ser1733=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32913691	13	32339554	51813	66481
NM_000059.3(BRCA2):c.5213_5216delCTTA (p.Thr1738Ilefs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913705 - 32913708	13	32339568 - 32339571	37951	46507
NM_000059.3(BRCA2):c.5217_5220delTTTA (p.Tyr1739Terfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913709 - 32913712	13	32339572 - 32339575	51820	66488
NM_000059.3(BRCA2):c.5224_5229delAACAGT (p.Asn1742_Ser1743del)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Likely benign(Last reviewed: May 29, 2018)	criteria provided, single submitter	13	32913716 - 32913721	13	32339579 - 32339584	51826	66494
NM_000059.3(BRCA2):c.5247T>G (p.Tyr1749Ter)	BRCA2	Breast-ovarian cancer, familial 2	Likely pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	13	32913739	13	32339602	590883	581823
NM_000059.3(BRCA2):c.5268A>G (p.Val1756=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32913760	13	32339623	135803	139515
NM_000059.3(BRCA2):c.5312G>A (p.Gly1771Asp)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32913804	13	32339667	37958	46514
NM_000059.3(BRCA2):c.5331_5333delGAA (p.Lys1777del)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	13	32913823 - 32913825	13	32339686 - 32339688	91411	96888
NM_000059.3(BRCA2):c.5350_5351delAA (p.Asn1784Hisfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32913842 - 32913843	13	32339705 - 32339706	37959	46515
NM_000059.3(BRCA2):c.5352dup (p.Thr1785Hisfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Dec 15, 2017)	reviewed by expert panel	13	32913844	13	32339707	548420	538702
NM_000059.3(BRCA2):c.5386_5387delGA (p.Asp1796Cysfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913878 - 32913879	13	32339741 - 32339742	142629	152343
NM_000059.3(BRCA2):c.5404C>T (p.Gln1802Ter)	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913896	13	32339759	51856	66524
NM_000059.3(BRCA2):c.5410_5411delGT (p.Val1804Lysfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32913902 - 32913903	13	32339765 - 32339766	37963	46519
NM_000059.3(BRCA2):c.5414A>G (p.Asn1805Ser)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 6, 2018)	criteria provided, conflicting interpretations	13	32913906	13	32339769	51858	66526
NM_000059.3(BRCA2):c.5418A>G (p.Glu1806=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32913910	13	32339773	132781	136529
NM_000059.3(BRCA2):c.5576_5579delTTAA (p.Ile1859Lysfs)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia, complementation group D1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32914068 - 32914071	13	32339931 - 32339934	37975	46531
NM_000059.3(BRCA2):c.5609_5610delTCinsAG (p.Phe1870Ter)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia, complementation group D1|Tumor susceptibility linked to germline BAP1 mutations|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32914101 - 32914102	13	32339964 - 32339965	51890	66558
NM_000059.3(BRCA2):c.5614A>T (p.Lys1872Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32914106	13	32339969	37979	46535
NM_000059.3(BRCA2):c.5616_5620delAGTAA (p.Lys1872Asnfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32914108 - 32914112	13	32339971 - 32339975	51892	66560
NM_000059.3(BRCA2):c.5621_5624delTTAA (p.Ile1874Argfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32914113 - 32914116	13	32339976 - 32339979	37980	46536
NM_000059.3(BRCA2):c.5635G>A (p.Glu1879Lys)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 23, 2017)	criteria provided, conflicting interpretations	13	32914127	13	32339990	51895	66563
NM_000059.3(BRCA2):c.5640T>G (p.Asn1880Lys)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2018)	criteria provided, conflicting interpretations	13	32914132	13	32339995	51896	66564
NM_000059.3(BRCA2):c.5655C>A (p.Cys1885Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32914147	13	32340010	37985	46541
NM_000059.3(BRCA2):c.5681dupA (p.Tyr1894Terfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32914173	13	32340036	37988	46544
NM_000059.3(BRCA2):c.5682C>G (p.Tyr1894Ter)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia, complementation group D1|Medulloblastoma|Wilms tumor 1|Malignant tumor of prostate|Tracheoesophageal fistula|Pancreatic cancer 2|Glioma susceptibility 3|Ovarian cancer|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Tracheoesophageal fistula|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32914174	13	32340037	37989	46545
NM_000059.3(BRCA2):c.5704G>A (p.Asp1902Asn)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32914196	13	32340059	51912	66580
NM_000059.3(BRCA2):c.5710C>G (p.Leu1904Val)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32914202	13	32340065	37990	46546
NM_000059.3(BRCA2):c.5715dupT (p.Asn1906Terfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32914207	13	32340070	143024	152738
NM_000059.3(BRCA2):c.5722_5723delCT (p.Leu1908Argfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32914214 - 32914215	13	32340077 - 32340078	9320	24359
NM_000059.3(BRCA2):c.5744C>T (p.Thr1915Met)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32914236	13	32340099	41556	49995
NM_000059.3(BRCA2):c.5752C>T (p.His1918Tyr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32914244	13	32340107	51927	66595
NM_000059.3(BRCA2):c.5782G>A (p.Glu1928Lys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 3, 2018)	criteria provided, multiple submitters, no conflicts	13	32914274	13	32340137	51936	66604
NM_000059.3(BRCA2):c.5785A>G (p.Ile1929Val)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32914277	13	32340140	37997	46553
NM_000059.3(BRCA2):c.5796_5797delTA (p.His1932Glnfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32914288 - 32914289	13	32340151 - 32340152	51940	66608
NM_000059.3(BRCA2):c.5799_5802delCCAA (p.Asn1933Lysfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32914291 - 32914294	13	32340154 - 32340157	37998	46554
NM_000059.3(BRCA2):c.5851_5854delAGTT (p.Ser1951Trpfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32914343 - 32914346	13	32340206 - 32340209	38001	46557
NM_000059.3(BRCA2):c.5855T>A (p.Leu1952Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32914347	13	32340210	38002	46558
NM_000059.3(BRCA2):c.5857G>T (p.Glu1953Ter)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia, complementation group D1|Medulloblastoma|Wilms tumor 1|Malignant tumor of prostate|Tracheoesophageal fistula|Pancreatic cancer 2|Glioma susceptibility 3|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Tracheoesophageal fistula|Breast and/or ovarian cancer|BRCA2-Related Disorders	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32914349	13	32340212	51952	66620
NM_000059.3(BRCA2):c.5864C>A (p.Ser1955Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32914356	13	32340219	51954	66622
NM_000059.3(BRCA2):c.5946delT (p.Ser1982Argfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia, complementation group D1|Pancreatic cancer 2|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|BRCA2-Related Disorders	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32914438	13	32340301	9325	24364
NM_000059.3(BRCA2):c.5962G>A (p.Val1988Ile)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2018)	criteria provided, conflicting interpretations	13	32914454	13	32340317	91430	96907
NM_000059.3(BRCA2):c.5968_5969delGA (p.Asp1990Cysfs)	BRCA2	Breast-ovarian cancer, familial 2|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32914460 - 32914461	13	32340323 - 32340324	51977	66645
NM_000059.3(BRCA2):c.5980C>T (p.Gln1994Ter)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32914472	13	32340335	38011	46567
NM_000059.3(BRCA2):c.5985C>T (p.Asn1995=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32914477	13	32340340	184341	183894
NM_000059.3(BRCA2):c.6037A>T (p.Lys2013Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32914529	13	32340392	38016	46572
NM_000059.3(BRCA2):c.6100C>T (p.Arg2034Cys)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32914592	13	32340455	41558	49997
NM_000059.3(BRCA2):c.6131G>T (p.Gly2044Val)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2018)	criteria provided, conflicting interpretations	13	32914623	13	32340486	38021	46577
NM_000059.3(BRCA2):c.6164delT (p.Phe2055Serfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32914656	13	32340519	52022	66690
NM_000059.3(BRCA2):c.6176G>A (p.Ser2059Asn)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 5, 2017)	criteria provided, multiple submitters, no conflicts	13	32914668	13	32340531	135808	139520
NM_000059.3(BRCA2):c.6275_6276delTT (p.Leu2092Profs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32914767 - 32914768	13	32340630 - 32340631	9318	24357
NM_000059.3(BRCA2):c.6295A>G (p.Arg2099Gly)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 16, 2018)	criteria provided, multiple submitters, no conflicts	13	32914787	13	32340650	91442	96919
NM_000059.3(BRCA2):c.6322C>T (p.Arg2108Cys)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Dec 25, 2017)	criteria provided, conflicting interpretations	13	32914814	13	32340677	41559	49998
NM_000059.3(BRCA2):c.6323G>A (p.Arg2108His)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32914815	13	32340678	38037	46593
NM_000059.3(BRCA2):c.6338A>G (p.Asn2113Ser)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32914830	13	32340693	38039	46595
NM_000059.3(BRCA2):c.6347A>G (p.His2116Arg)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Sep 28, 2016)	reviewed by expert panel	13	32914839	13	32340702	41561	50000
NM_000059.3(BRCA2):c.6405_6409delCTTAA (p.Asn2135Lysfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Cancer of the pancreas	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32914897 - 32914901	13	32340760 - 32340764	38043	46599
NM_000059.3(BRCA2):c.6412G>T (p.Val2138Phe)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2018)	criteria provided, conflicting interpretations	13	32914904	13	32340767	52087	66755
NM_000059.3(BRCA2):c.6443C>A (p.Ser2148Tyr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 22, 2018)	criteria provided, conflicting interpretations	13	32914935	13	32340798	52096	66764
NM_000059.3(BRCA2):c.6447_6448dupTA (p.Lys2150Ilefs)	BRCA2	Breast-ovarian cancer, familial 2|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32914939 - 32914940	13	32340802 - 32340803	52104	66772
NM_000059.3(BRCA2):c.6458delC (p.Pro2153Hisfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32914950	13	32340813	187346	183916
NM_000059.3(BRCA2):c.6468_6469delTC (p.Gln2157Ilefs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32914960 - 32914961	13	32340823 - 32340824	38047	46603
NM_000059.3(BRCA2):c.6513G>C (p.Val2171=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32915005	13	32340868	132780	136528
NM_000059.3(BRCA2):c.6591_6592delTG (p.Glu2198Asnfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32915083 - 32915084	13	32340946 - 32340947	9319	24358
NM_000059.3(BRCA2):c.6641dupC (p.Tyr2215Leufs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32915133	13	32340996	38059	46615
NM_000059.3(BRCA2):c.6644dupA (p.Tyr2215Terfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32915136	13	32340999	52146	66814
NM_000059.3(BRCA2):c.6644_6647delACTC (p.Tyr2215Serfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32915136 - 32915139	13	32340999 - 32341002	38060	46616
NM_000059.3(BRCA2):c.6645C>G (p.Tyr2215Ter)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32915137	13	32341000	126113	131651
NM_000059.3(BRCA2):c.6792G>C (p.Leu2264Phe)	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: Apr 5, 2016)	criteria provided, single submitter	13	32915284	13	32341147	252417	246798
NM_000059.3(BRCA2):c.6815_6816del (p.Arg2272Lysfs)	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	13	32915307 - 32915308	13	32341170 - 32341171	252425	246799
NM_000059.3(BRCA2):c.6821G>T (p.Gly2274Val)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Dec 25, 2017)	criteria provided, conflicting interpretations	13	32915313	13	32341176	52199	66867
NM_000059.3(BRCA2):c.6841+3A>T	BRCA2	Breast-ovarian cancer, familial 2|Breast cancer, susceptibility to|not specified	Uncertain significance(Last reviewed: Oct 6, 2016)	criteria provided, single submitter	13	32915336	13	32341199	52205	66873
NM_000059.3(BRCA2):c.6853A>G (p.Ile2285Val)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32918706	13	32344569	38070	46626
NM_000059.3(BRCA2):c.6944_6947delTAAA (p.Ile2315Lysfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32920970 - 32920973	13	32346833 - 32346836	38075	46631
NM_000059.3(BRCA2):c.6966G>T (p.Met2322Ile)	BRCA2	Breast-ovarian cancer, familial 2|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 17, 2017)	criteria provided, multiple submitters, no conflicts	13	32920992	13	32346855	52229	66897
NM_000059.3(BRCA2):c.6980delT (p.Leu2327Terfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	13	32921006	13	32346869	252419	246800
NM_000059.3(BRCA2):c.6991A>G (p.Thr2331Ala)	BRCA2	Breast-ovarian cancer, familial 2|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	13	32921017	13	32346880	52233	66901
NM_000059.3(BRCA2):c.6998dupT (p.Pro2334Thrfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32921024	13	32346887	219496	222331
NM_000059.3(BRCA2):c.7007G>C (p.Arg2336Pro)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	13	32921033	13	32346896	52241	66909
NM_000059.3(BRCA2):c.7007G>A (p.Arg2336His)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia, complementation group D1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	13	32921033	13	32346896	38077	46633
NM_000059.3(BRCA2):c.7008-62A>G	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	13	32928936	13	32354799	52247	66915
NM_000059.3(BRCA2):c.7017G>C (p.Lys2339Asn)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32929007	13	32354870	52249	66917
NM_000059.3(BRCA2):c.7024C>T (p.Gln2342Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32929014	13	32354877	52250	66918
NM_000059.3(BRCA2):c.7060C>T (p.Gln2354Ter)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32929050	13	32354913	52261	66929
NM_000059.3(BRCA2):c.7069_7070delCT (p.Leu2357Valfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32929059 - 32929060	13	32354922 - 32354923	38082	46638
NM_000059.3(BRCA2):c.7093C>T (p.His2365Tyr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	13	32929083	13	32354946	232713	234919
NM_000059.3(BRCA2):c.7150C>A (p.Gln2384Lys)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32929140	13	32355003	38086	46642
NM_000059.3(BRCA2):c.7185C>T (p.His2395=)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32929175	13	32355038	252408	246801
NM_000059.3(BRCA2):c.7232A>C (p.Lys2411Thr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 11, 2017)	criteria provided, conflicting interpretations	13	32929222	13	32355085	52294	66962
NM_000059.3(BRCA2):c.7242A>G (p.Ser2414=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32929232	13	32355095	126133	131671
NM_000059.3(BRCA2):c.7301delA (p.Lys2434Serfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32929291	13	32355154	185769	183961
NM_000059.3(BRCA2):c.7319A>G (p.His2440Arg)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32929309	13	32355172	41562	50001
NM_000059.3(BRCA2):c.7397C>T (p.Ala2466Val)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32929387	13	32355250	52317	66985
NM_000059.3(BRCA2):c.7413A>G (p.Thr2471=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32929403	13	32355266	230378	234933
NM_000059.3(BRCA2):c.7435+5T>C	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 17, 2017)	criteria provided, multiple submitters, no conflicts	13	32929430	13	32355293	231148	234934
NM_000059.3(BRCA2):c.7435+6G>A	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 23, 2018)	criteria provided, conflicting interpretations	13	32929431	13	32355294	38096	46652
NM_000059.3(BRCA2):c.7436-2A>T	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, multiple submitters, no conflicts	13	32930563	13	32356426	52330	66998
NM_000059.3(BRCA2):c.7469T>C (p.Ile2490Thr)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Sep 28, 2016)	reviewed by expert panel	13	32930598	13	32356461	96852	102755
NM_000059.3(BRCA2):c.7504C>T (p.Arg2502Cys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	13	32930633	13	32356496	41563	50002
NM_000059.3(BRCA2):c.7534C>T (p.Leu2512Phe)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 26, 2017)	criteria provided, conflicting interpretations	13	32930663	13	32356526	52349	67017
NM_000059.3(BRCA2):c.7544C>T (p.Thr2515Ile)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32930673	13	32356536	38102	46658
NM_000059.3(BRCA2):c.7558C>T (p.Arg2520Ter)	BRCA2	Breast-ovarian cancer, familial 2|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32930687	13	32356550	52353	67021
NM_000059.3(BRCA2):c.7601C>T (p.Ala2534Val)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	13	32930730	13	32356593	38109	46665
NM_000059.3(BRCA2):c.7618-1G>A	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32931878	13	32357741	38110	46666
NM_000059.3(BRCA2):c.7626G>A (p.Thr2542=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32931887	13	32357750	52372	67040
NM_000059.3(BRCA2):c.7673_7674delAG (p.Glu2558Valfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32931934 - 32931935	13	32357797 - 32357798	38113	46669
NM_000059.3(BRCA2):c.7758G>A (p.Trp2586Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32932019	13	32357882	38116	46672
NM_000059.3(BRCA2):c.7762_7764delATAinsTT (p.Ile2588Phefs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32932023 - 32932025	13	32357886 - 32357888	233493	234951
NM_000059.3(BRCA2):c.7786G>A (p.Gly2596Arg)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	13	32932047	13	32357910	91492	96969
NM_000059.3(BRCA2):c.7805+6C>G	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	13	32932072	13	32357935	52412	67080
NM_000059.3(BRCA2):c.7806-14T>C	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32936646	13	32362509	126158	131696
NM_000059.3(BRCA2):c.7806-2A>G	BRCA2	Breast-ovarian cancer, familial 2|Neoplasm of ovary|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, multiple submitters, no conflicts	13	32936658	13	32362521	52418	67086
NM_000059.3(BRCA2):c.7822C>G (p.Pro2608Ala)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 20, 2017)	criteria provided, multiple submitters, no conflicts	13	32936676	13	32362539	252423	246802
NM_000059.3(BRCA2):c.7857G>C (p.Trp2619Cys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 6, 2018)	criteria provided, conflicting interpretations	13	32936711	13	32362574	438744	432370
NM_000059.3(BRCA2):c.7878G>C (p.Trp2626Cys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32936732	13	32362595	38125	46681
NM_000059.3(BRCA2):c.7879A>T (p.Ile2627Phe)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32936733	13	32362596	52430	67098
NM_000059.3(BRCA2):c.7913_7917delTTCCT (p.Phe2638Terfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32936767 - 32936771	13	32362630 - 32362634	38126	46682
NM_000059.3(BRCA2):c.7975A>G (p.Arg2659Gly)	BRCA2	Breast-ovarian cancer, familial 2|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 19, 2018)	criteria provided, conflicting interpretations	13	32936829	13	32362692	38130	46686
NM_000059.3(BRCA2):c.7976+23C>T	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified	Likely benign(Last reviewed: Oct 25, 2017)	criteria provided, multiple submitters, no conflicts	13	32936853	13	32362716	52453	67121
NM_000059.3(BRCA2):c.7985C>A (p.Thr2662Lys)	BRCA2	Breast-ovarian cancer, familial 2|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 30, 2018)	criteria provided, conflicting interpretations	13	32937324	13	32363187	96864	102767
NM_000059.3(BRCA2):c.7994A>G (p.Asp2665Gly)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	13	32937333	13	32363196	38134	46690
NM_000059.3(BRCA2):c.8009C>T (p.Ser2670Leu)	BRCA2	Breast-ovarian cancer, familial 2|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 11, 2018)	criteria provided, conflicting interpretations	13	32937348	13	32363211	52471	67139
NM_000059.3(BRCA2):c.8009C>A (p.Ser2670Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	13	32937348	13	32363211	52470	67138
NM_000059.3(BRCA2):c.8042C>G (p.Thr2681Arg)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 13, 2018)	criteria provided, multiple submitters, no conflicts	13	32937381	13	32363244	142520	152234
NM_000059.3(BRCA2):c.8067T>A (p.Cys2689Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32937406	13	32363269	52493	67161
NM_000059.3(BRCA2):c.8111C>T (p.Ser2704Phe)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 17, 2018)	criteria provided, conflicting interpretations	13	32937450	13	32363313	52507	67175
NM_000059.3(BRCA2):c.8125A>G (p.Ser2709Gly)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 30, 2018)	criteria provided, multiple submitters, no conflicts	13	32937464	13	32363327	91501	96978
NM_000059.3(BRCA2):c.8149G>T (p.Ala2717Ser)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32937488	13	32363351	41564	50003
NM_000059.3(BRCA2):c.8182G>A (p.Val2728Ile)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 9, 2018)	criteria provided, multiple submitters, no conflicts	13	32937521	13	32363384	41565	50004
NM_000059.3(BRCA2):c.8187G>T (p.Lys2729Asn)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia, complementation group D1|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32937526	13	32363389	38142	46698
NM_000059.3(BRCA2):c.8243G>A (p.Gly2748Asp)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32937582	13	32363445	52535	67203
NM_000059.3(BRCA2):c.8247_8248delGA (p.Lys2750Aspfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32937586 - 32937587	13	32363449 - 32363450	52536	67204
NM_000059.3(BRCA2):c.8351G>A (p.Arg2784Gln)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 5, 2018)	criteria provided, conflicting interpretations	13	32944558	13	32370421	52559	67227
NM_000059.3(BRCA2):c.8363G>A (p.Trp2788Ter)	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32944570	13	32370433	52564	67232
NM_000059.3(BRCA2):c.8447G>C (p.Gly2816Ala)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Uncertain significance(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	13	32944654	13	32370517	225280	227195
NM_000059.3(BRCA2):c.8460A>C (p.Val2820=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32944667	13	32370530	52594	67262
NM_000059.3(BRCA2):c.8487+1G>A	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32944695	13	32370558	52602	67270
NM_000059.3(BRCA2):c.8487+8G>A	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2017)	criteria provided, conflicting interpretations	13	32944702	13	32370565	38163	46719
NM_000059.3(BRCA2):c.8487+19A>G	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32944713	13	32370576	126178	131716
NM_000059.3(BRCA2):c.8489G>A (p.Trp2830Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32945094	13	32370957	52605	67273
NM_000059.3(BRCA2):c.8501delC (p.Thr2834Asnfs)	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32945106	13	32370969	38166	46722
NM_000059.3(BRCA2):c.8503T>C (p.Ser2835Pro)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign/Likely benign(Last reviewed: Feb 5, 2018)	criteria provided, multiple submitters, no conflicts	13	32945108	13	32370971	52606	67274
NM_000059.3(BRCA2):c.8533dup (p.Arg2845Lysfs)	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Dec 15, 2017)	reviewed by expert panel	13	32945138	13	32371001	438382	432007
NM_000059.3(BRCA2):c.8567A>C (p.Glu2856Ala)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: May 23, 2018)	criteria provided, conflicting interpretations	13	32945172	13	32371035	38168	46724
NM_000059.3(BRCA2):c.8573A>G (p.Gln2858Arg)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 5, 2018)	criteria provided, conflicting interpretations	13	32945178	13	32371041	52625	67293
NM_000059.3(BRCA2):c.8575C>T (p.Gln2859Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32945180	13	32371043	52626	67294
NM_000059.3(BRCA2):c.8581A>T (p.Arg2861Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32945186	13	32371049	91515	96992
NM_000059.3(BRCA2):c.8633-16C>G	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 18, 2017)	criteria provided, conflicting interpretations	13	32950791	13	32376654	52642	67310
NM_000059.3(BRCA2):c.8633-1G>A	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	13	32950806	13	32376669	91731	97208
NM_000059.3(BRCA2):c.8702G>T (p.Gly2901Val)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Uncertain significance(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	13	32950876	13	32376739	252416	246803
NM_000059.3(BRCA2):c.8723T>G (p.Val2908Gly)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 2, 2017)	criteria provided, multiple submitters, no conflicts	13	32950897	13	32376760	52662	67330
NM_000059.3(BRCA2):c.8739C>G (p.Asp2913Glu)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	13	32950913	13	32376776	185201	184047
NM_000059.3(BRCA2):c.8754+1G>A	BRCA2	Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 19, 2016)	criteria provided, multiple submitters, no conflicts	13	32950929	13	32376792	52667	67335
NM_000059.3(BRCA2):c.8754+4A>G	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2017)	criteria provided, conflicting interpretations	13	32950932	13	32376795	52669	67337
NM_000059.3(BRCA2):c.8755-1G>A	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 15, 2016)	reviewed by expert panel	13	32953453	13	32379316	38183	46739
NM_000059.3(BRCA2):c.8830A>T (p.Ile2944Phe)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32953529	13	32379392	41569	50008
NM_000059.3(BRCA2):c.8850G>T (p.Lys2950Asn)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	13	32953549	13	32379412	52692	67360
NM_000059.3(BRCA2):c.8851G>A (p.Ala2951Thr)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Sep 28, 2016)	reviewed by expert panel	13	32953550	13	32379413	41570	50009
NM_000059.3(BRCA2):c.8869C>T (p.Gln2957Ter)	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32953568	13	32379431	38190	46746
NM_000059.3(BRCA2):c.8904delC (p.Val2969Cysfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32953603	13	32379466	38192	46748
NM_000059.3(BRCA2):c.8905G>A (p.Val2969Met)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32953604	13	32379467	52697	67365
NM_000059.3(BRCA2):c.8917C>T (p.Arg2973Cys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32953616	13	32379479	38193	46749
NM_000059.3(BRCA2):c.8930delA (p.Tyr2977Phefs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	13	32953629	13	32379492	225755	227551
NM_000059.3(BRCA2):c.8948_8953+5delATTCAGGTAAG	BRCA2	Breast-ovarian cancer, familial 2|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 23, 2015)	criteria provided, multiple submitters, no conflicts	13	32953647 - 32953657	13	32379510 - 32379520	141449	151163
NM_000059.3(BRCA2):c.8953+1G>T	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32953653	13	32379516	38198	46754
NM_000059.3(BRCA2):c.8953+16C>T	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 22, 2017)	criteria provided, conflicting interpretations	13	32953668	13	32379531	52708	67376
NM_000059.3(BRCA2):c.9004G>A (p.Glu3002Lys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jun 27, 2018)	criteria provided, conflicting interpretations	13	32953937	13	32379800	38201	46757
NM_000059.3(BRCA2):c.9006A>T (p.Glu3002Asp)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, multiple submitters, no conflicts	13	32953939	13	32379802	52725	67393
NM_000059.3(BRCA2):c.9038C>T (p.Thr3013Ile)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 23, 2018)	criteria provided, conflicting interpretations	13	32953971	13	32379834	38205	46761
NM_000059.3(BRCA2):c.9097dupA (p.Thr3033Asnfs)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32954030	13	32379893	38208	46764
NM_000059.3(BRCA2):c.9118-5T>C	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: May 21, 2016)	criteria provided, single submitter	13	32954139	13	32380002	252406	246804
NM_000059.3(BRCA2):c.9196C>T (p.Gln3066Ter)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia, complementation group D1|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32954222	13	32380085	9347	24386
NM_000059.3(BRCA2):c.9227G>A (p.Gly3076Glu)	BRCA2	Breast-ovarian cancer, familial 2|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 29, 2017)	criteria provided, conflicting interpretations	13	32954253	13	32380116	52780	67448
NM_000059.3(BRCA2):c.9235delG (p.Val3079Phefs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32954261	13	32380124	38221	46777
NM_000059.3(BRCA2):c.9235G>A (p.Val3079Ile)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32954261	13	32380124	38220	46776
NM_000059.3(BRCA2):c.9253dupA (p.Thr3085Asnfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32954279	13	32380142	38225	46781
NM_000059.3(BRCA2):c.9257-16T>C	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32968810	13	32394673	52790	67458
NM_000059.3(BRCA2):c.9270C>T (p.Phe3090=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32968839	13	32394702	136573	140276
NM_000059.3(BRCA2):c.9275A>G (p.Tyr3092Cys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2017)	criteria provided, conflicting interpretations	13	32968844	13	32394707	52800	67468
NM_000059.3(BRCA2):c.9276T>G (p.Tyr3092Ter)	BRCA2	Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32968845	13	32394708	52803	67471
NM_000059.3(BRCA2):c.9292T>C (p.Tyr3098His)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32968861	13	32394724	38227	46783
NM_000059.3(BRCA2):c.9294C>G (p.Tyr3098Ter)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32968863	13	32394726	38229	46785
NM_000059.3(BRCA2):c.9311A>G (p.Lys3104Arg)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 24, 2016)	criteria provided, single submitter	13	32968880	13	32394743	417626	404604
NM_000059.3(BRCA2):c.9353T>C (p.Met3118Thr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, multiple submitters, no conflicts	13	32968922	13	32394785	38232	46788
NM_000059.3(BRCA2):c.9364G>A (p.Ala3122Thr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2018)	criteria provided, conflicting interpretations	13	32968933	13	32394796	142215	151929
NM_000059.3(BRCA2):c.9380G>A (p.Trp3127Ter)	BRCA2	Breast-ovarian cancer, familial 2|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32968949	13	32394812	38235	46791
NM_000059.3(BRCA2):c.9382C>T (p.Arg3128Ter)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32968951	13	32394814	52826	67494
NM_000059.3(BRCA2):c.9403delC (p.Leu3135Phefs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	13	32968972	13	32394835	52831	67499
NM_000059.3(BRCA2):c.9501G>C (p.Glu3167Asp)	BRCA2	Breast-ovarian cancer, familial 2|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 6, 2017)	criteria provided, multiple submitters, no conflicts	13	32969070	13	32394933	234895	231906
NM_000059.3(BRCA2):c.9501+3A>T	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	13	32969073	13	32394936	38242	46798
NM_000059.3(BRCA2):c.9501+9A>C	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2017)	criteria provided, conflicting interpretations	13	32969079	13	32394942	38243	46799
NM_000059.3(BRCA2):c.9583A>G (p.Thr3195Ala)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2018)	criteria provided, conflicting interpretations	13	32971116	13	32396979	52872	67540
NM_000059.3(BRCA2):c.9586A>G (p.Lys3196Glu)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2017)	criteria provided, conflicting interpretations	13	32971119	13	32396982	38251	46807
NM_000059.3(BRCA2):c.9617_9619dupAAA (p.Gln3206_Ile3207insLys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Uncertain significance(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	13	32971150 - 32971152	13	32397013 - 32397015	252420	246805
NM_000059.3(BRCA2):c.9634G>C (p.Gly3212Arg)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 16, 2018)	criteria provided, conflicting interpretations	13	32971167	13	32397030	38257	46813
NM_000059.3(BRCA2):c.9648+1G>C	BRCA2	Breast-ovarian cancer, familial 2|not provided	Pathogenic(Last reviewed: Aug 25, 2015)	criteria provided, multiple submitters, no conflicts	13	32971182	13	32397045	182265	180690
NM_000059.3(BRCA2):c.9649-20C>T	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32972279	13	32398142	52884	67552
NM_000059.3(BRCA2):c.9649-19G>A	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32972280	13	32398143	52883	67551
NM_000059.3(BRCA2):c.9666delT (p.Cys3222Trpfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32972316	13	32398179	52888	67556
NM_000059.3(BRCA2):c.9672dupA (p.Tyr3225Ilefs)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia, complementation group D1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32972322	13	32398185	126217	131755
NM_000059.3(BRCA2):c.9699_9702delTATG (p.Cys3233Trpfs)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	13	32972349 - 32972352	13	32398212 - 32398215	38260	46816
NM_000059.3(BRCA2):c.9720T>C (p.Val3240=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32972370	13	32398233	52895	67563
NM_000059.3(BRCA2):c.9728C>T (p.Pro3243Leu)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jun 10, 2018)	criteria provided, conflicting interpretations	13	32972378	13	32398241	38262	46818
NM_000059.3(BRCA2):c.9730G>A (p.Val3244Ile)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32972380	13	32398243	41572	50011
NM_000059.3(BRCA2):c.9776T>C (p.Ile3259Thr)	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: Mar 26, 2016)	criteria provided, single submitter	13	32972426	13	32398289	252418	246806
NM_000059.3(BRCA2):c.9843A>G (p.Pro3281=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32972493	13	32398356	52908	67576
NM_000059.3(BRCA2):c.9875C>T (p.Pro3292Leu)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	13	32972525	13	32398388	52910	67578
NM_000059.3(BRCA2):c.9920A>C (p.Lys3307Thr)	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: Apr 18, 2016)	criteria provided, single submitter	13	32972570	13	32398433	252414	246807
NM_000059.3(BRCA2):c.9949C>T (p.Leu3317=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32972599	13	32398462	184620	184093
NM_000059.3(BRCA2):c.9976A>T (p.Lys3326Ter)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Feb 16, 2016)	reviewed by expert panel	13	32972626	13	32398489	38266	46822
NM_000059.3(BRCA2):c.10045A>G (p.Thr3349Ala)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32972695	13	32398558	37719	46275
NM_000059.3(BRCA2):c.10089A>G (p.Ile3363Met)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	13	32972739	13	32398602	51039	65707
NM_000059.3(BRCA2):c.10110G>A (p.Arg3370=)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	13	32972760	13	32398623	51043	65711
NM_000059.3(BRCA2):c.10111A>G (p.Thr3371Ala)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 24, 2018)	criteria provided, conflicting interpretations	13	32972761	13	32398624	37720	46276
NM_000059.3(BRCA2):c.10234A>G (p.Ile3412Val)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32972884	13	32398747	41540	49979
NM_000321.2(RB1):c.1421+12_1421+32delACTTTTAGTAAAAAATTTTTT	RB1	Retinoblastoma|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	13	48954232 - 48954252	13	48380096 - 48380116	139569	143199
NM_000321.2(RB1):c.1907delT (p.Phe636Serfs)	RB1	Retinoblastoma	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	13	49030432	13	48456296	139570	143200
NM_006346.3(PIBF1):c.1151_1152insGCTTCGCAGATTGAAAACCAACCAAGAAATTGATCA (p.Ile384delinsMetLeuArgArgLeuLysThrAsnGlnGluIleAspHis)	PIBF1	Joubert syndrome	Uncertain significance	no assertion criteria provided	13	73409434 - 73409435	13	72835296 - 72835297	430627	423858
NM_014832.4(TBC1D4):c.3824T>C (p.Val1275Ala)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	75861001	13	75286865	130861	136305
NM_014832.4(TBC1D4):c.3762A>T (p.Glu1254Asp)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	75861063	13	75286927	130860	136304
NM_014832.4(TBC1D4):c.3617A>G (p.Asn1206Ser)	TBC1D4	not specified	Benign(Last reviewed: Sep 5, 2013)	criteria provided, single submitter	13	75863116	13	75288980	130553	135999
NM_014832.4(TBC1D4):c.3440C>T (p.Thr1147Met)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	75866284	13	75292148	130552	135998
NM_014832.4(TBC1D4):c.3356T>C (p.Val1119Ala)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	75866368	13	75292232	130544	135990
NM_014832.4(TBC1D4):c.2901C>T (p.Leu967=)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	75876389	13	75302253	130550	135996
NM_014832.4(TBC1D4):c.2455G>A (p.Val819Ile)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	75884216	13	75310080	130549	135995
NM_014832.4(TBC1D4):c.2384-3C>T	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	75884290	13	75310154	130548	135994
NM_014832.4(TBC1D4):c.2254A>G (p.Thr752Ala)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	75887003	13	75312867	130547	135993
NM_014832.4(TBC1D4):c.2050C>G (p.Arg684Gly)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	75898521	13	75324385	130546	135992
NM_014832.4(TBC1D4):c.1810T>G (p.Tyr604Asp)	TBC1D4	not provided	Uncertain significance(Last reviewed: Nov 4, 2013)	criteria provided, single submitter	13	75900556	13	75326420	130543	135989
NM_014832.4(TBC1D4):c.1611T>G (p.Ser537=)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	75915261	13	75341125	130545	135991
NM_014832.4(TBC1D4):c.1587C>T (p.His529=)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	75915285	13	75341149	130542	135988
NM_014832.4(TBC1D4):c.723G>C (p.Gly241=)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	75936519	13	75362383	130556	136002
NM_014832.4(TBC1D4):c.606C>T (p.Phe202=)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	75936636	13	75362500	130555	136001
NM_014832.4(TBC1D4):c.498+9G>A	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	76055397	13	75481261	130554	136000
NM_014832.4(TBC1D4):c.302C>T (p.Ala101Val)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	76055602	13	75481466	130551	135997
NM_014832.4(TBC1D4):c.84C>G (p.Pro28=)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	76055820	13	75481684	130557	136003
NM_000115.4(EDNRB):c.914G>A (p.Ser305Asn)	EDNRB|EDNRB-AS1	Hirschsprung disease 2|Waardenburg syndrome type 2A|Waardenburg syndrome type 4A|not specified|Hirschsprung Disease, Recessive	Benign/Likely benign, risk factor(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	13	78475230	13	77901095	16638	31677
NM_000115.4(EDNRB):c.618G>A (p.Trp206Ter)	EDNRB|EDNRB-AS1	Waardenburg syndrome	Pathogenic(Last reviewed: Dec 9, 2015)	criteria provided, single submitter	13	78477474	13	77903339	228342	230451
NM_001201397.1(EDNRB):c.327C>A (p.Cys109Ter)	EDNRB	Waardenburg syndrome type 4A	Pathogenic(Last reviewed: May 15, 2018)	no assertion criteria provided	13	78492652	13	77918517	545012	535276
NM_052867.3(NALCN):c.1639A>G (p.Met547Val)	NALCN	Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic	no assertion criteria provided	13	101844393	13	101192042	375369	362155
NM_052867.3(NALCN):c.985A>G (p.Arg329Gly)	NALCN	Congenital contractures of the limbs and face, hypotonia, and developmental delay	Likely pathogenic(Last reviewed: Jul 21, 2015)	criteria provided, single submitter	13	101944403	13	101292052	369675	353906
NM_052867.3(NALCN):c.965T>C (p.Ile322Thr)	NALCN	Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic	no assertion criteria provided	13	101944423	13	101292072	375370	362156
NM_001845.5(COL4A1):c.3555A>G (p.Lys1185=)	COL4A1	Brain small vessel disease with hemorrhage	Likely pathogenic(Last reviewed: Apr 30, 2014)	no assertion criteria provided	13	110825068	13	110172721	374263	361208
NM_001845.5(COL4A1):c.3353G>A (p.Gly1118Asp)	COL4A1	Porencephaly 1	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	13	110826846	13	110174499	560984	552166
NM_001845.5(COL4A1):c.2842G>A (p.Gly948Ser)	COL4A1	Optic nerve hypoplasia	Pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, single submitter	13	110829259	13	110176912	496641	488126
NM_001845.5(COL4A1):c.2662G>A (p.Gly888Arg)	COL4A1	Brain small vessel disease with hemorrhage|Porencephaly 1	Likely pathogenic(Last reviewed: Sep 12, 2013)	criteria provided, single submitter	13	110830243	13	110177896	209141	205773
NM_001845.5(COL4A1):c.1450C>A (p.Pro484Thr)	COL4A1	Optic nerve hypoplasia	Uncertain significance	criteria provided, single submitter	13	110845192	13	110192845	496637	488122
NM_001845.5(COL4A1):c.161C>T (p.Pro54Leu)	COL4A1	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps|Brain small vessel disease with hemorrhage|Porencephalic cyst|not specified|Optic nerve hypoplasia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	13	110866346	13	110213999	196327	193488
NM_001846.3(COL4A2):c.316-1G>C	COL4A2	Porencephaly 2	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	13	111077299	13	110424952	560985	552167
NM_001846.3(COL4A2):c.1948C>T (p.Pro650Ser)	COL4A2	Porencephalic cyst|Optic nerve hypoplasia	Conflicting interpretations of pathogenicity(Last reviewed: Feb 14, 2018)	criteria provided, conflicting interpretations	13	111117923	13	110465576	311138	333616
NM_001846.3(COL4A2):c.2185G>A (p.Gly729Arg)	COL4A2	Optic nerve hypoplasia	Uncertain significance	criteria provided, single submitter	13	111121653	13	110469306	496734	488180
NM_001170629.1(CHD8):c.6518C>A (p.Ser2173Ter)	CHD8	Autism, susceptibility to, 18	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	14	21860919	14	21392760	374261	361211
NM_001170629.1(CHD8):c.4762A>T (p.Arg1588Trp)	CHD8	Autism, susceptibility to, 18	Likely benign	no assertion criteria provided	14	21868195	14	21400036	375626	362440
NM_020920.3(CHD8):c.3541C>T (p.Arg1181Ter)	CHD8	Autism, susceptibility to, 18	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	14	21868764	14	21400605	488481	481349
NM_001170629.1(CHD8):c.2565del (p.Asn855Lysfs)	CHD8	Autism, susceptibility to, 18	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	14	21876635 - 21876636	14	21408477	560977	552171
NM_001170629.1(CHD8):c.2434C>T (p.Arg812Trp)	CHD8	Autism, susceptibility to, 18	Likely pathogenic(Last reviewed: Feb 17, 2015)	no assertion criteria provided	14	21876915	14	21408756	374259	361212
NM_001170629.1(CHD8):c.2317C>T (p.Arg773Ter)	CHD8	Autism, susceptibility to, 18	Likely pathogenic(Last reviewed: Oct 1, 2013)	criteria provided, single submitter	14	21878057	14	21409898	216902	213629
NM_001170629.1(CHD8):c.1744C>T (p.Arg582Ter)	CHD8	Autism, susceptibility to, 18	Likely pathogenic(Last reviewed: May 13, 2014)	criteria provided, single submitter	14	21884039	14	21415880	216903	213630
NM_001170629.1(CHD8):c.161G>T (p.Gly54Val)	CHD8	Autism, susceptibility to, 18	Likely benign	no assertion criteria provided	14	21899642	14	21431483	375627	362441
NM_002471.3(MYH6):c.4241C>T (p.Ser1414Phe)	MYH6	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Jul 14, 2015)	criteria provided, single submitter	14	23857482	14	23388273	217830	214494
NM_002471.3(MYH6):c.3934C>G (p.Gln1312Glu)	MYH6	Cardiomyopathy, restrictive	Uncertain significance	criteria provided, single submitter	14	23858646	14	23389437	617632	609028
NM_002471.3(MYH6):c.3342+10T>C	MYH6	Familial hypertrophic cardiomyopathy 14|not specified	Likely benign(Last reviewed: Nov 17, 2017)	criteria provided, multiple submitters, no conflicts	14	23861761	14	23392552	227587	230474
NM_002471.3(MYH6):c.3220G>A (p.Asp1074Asn)	MYH6	not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, multiple submitters, no conflicts	14	23862152	14	23392943	179023	175568
NM_002471.3(MYH6):c.3192dupC (p.Gln1065Profs)	MYH6	Familial hypertrophic cardiomyopathy 1	Pathogenic(Last reviewed: Apr 21, 2015)	criteria provided, single submitter	14	23862180	14	23392971	217832	214495
NM_002471.3(MYH6):c.1410+1G>A	MYH6	Congenital heart defects	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	14	23869917	14	23400708	561059	552173
NM_000257.3(MYH7):c.5740G>A (p.Glu1914Lys)	MYH7	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1S|Myopathy, distal, 1	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23883018	14	23413809	43088	52258
NM_000257.3(MYH7):c.5726G>C (p.Arg1909Pro)	MYH7	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23883032	14	23413823	43085	52255
NM_000257.3(MYH7):c.5717C>G (p.Ala1906Gly)	MYH7	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jan 6, 2014)	criteria provided, single submitter	14	23883041	14	23413832	43083	52253
NM_000257.3(MYH7):c.5561C>T (p.Thr1854Met)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Aug 29, 2017)	criteria provided, conflicting interpretations	14	23883310	14	23414101	161320	171157
NM_000257.3(MYH7):c.5560-2A>C	MYH7	Myopathy, distal, 1	Likely pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	14	23883313	14	23414104	562179	553353
NM_000257.3(MYH7):c.5536C>T (p.Arg1846Cys)	MYH7	Primary familial hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	14	23884227	14	23415018	161321	171158
NM_000257.3(MYH7):c.5494C>T (p.Arg1832Cys)	MYH7	Primary dilated cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Dilated cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Apr 5, 2018)	criteria provided, conflicting interpretations	14	23884269	14	23415060	161322	171159
NM_000257.3(MYH7):c.5471A>G (p.Asn1824Ser)	MYH7	Prolonged QT interval	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	14	23884292	14	23415083	427959	419287
NM_000257.3(MYH7):c.5452C>T (p.Arg1818Trp)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 18, 2016)	criteria provided, conflicting interpretations	14	23884311	14	23415102	217826	214496
NM_000257.3(MYH7):c.5422G>A (p.Gly1808Ser)	MYH7	Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	14	23884341	14	23415132	217468	214122
NM_000257.3(MYH7):c.5401G>A (p.Glu1801Lys)	MYH7	Primary dilated cardiomyopathy|Myopathy, distal, 1|Cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23884362	14	23415153	43069	52239
NM_000257.3(MYH7):c.5305C>A (p.Leu1769Met)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2014)	no assertion criteria provided	14	23884458	14	23415249	161323	171160
NM_000257.3(MYH7):c.5287G>A (p.Ala1763Thr)	MYH7	Familial hypertrophic cardiomyopathy 1|Myopathy, myosin storage, autosomal recessive|Myosin storage myopathy|Dilated cardiomyopathy 1S|Myopathy, distal, 1|not specified|not provided|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy	Uncertain significance(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	14	23884476	14	23415267	177846	175588
NM_000257.4(MYH7):c.5190G>T (p.Met1730Ile)	MYH7|MHRT	Atrial fibrillation|Tachycardia|Atrial flutter|Abnormal morphology of left ventricular trabeculae	Uncertain significance(Last reviewed: Dec 3, 2018)	criteria provided, single submitter			14	23415474	617741	609143
NM_000257.3(MYH7):c.5186_5188dupAGA (p.Lys1729_Met1730insLys)	MYH7|MHRT	Myopathy, distal, 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	14	23884685 - 23884687	14	23415476 - 23415478	143217	152935
NM_000257.3(MYH7):c.5186_5188delAGA (p.Lys1729del)	MYH7|MHRT	Congenital myopathy with fiber type disproportion|Myopathy, distal, 1|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	14	23884685 - 23884687	14	23415476 - 23415478	42096	51262
NM_000257.3(MYH7):c.5135G>A (p.Arg1712Gln)	MYH7|MHRT	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23884860	14	23415651	36642	45304
NM_000257.3(MYH7):c.5106G>A (p.Ala1702=)	MYH7|MHRT	Myosin storage myopathy|Myopathy, distal, 1|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23884889	14	23415680	43056	52226
NM_000257.3(MYH7):c.5015_5020delCCATCG (p.Ala1672_Ile1673del)	MYH7|MHRT	not specified	Uncertain significance(Last reviewed: Oct 4, 2013)	criteria provided, single submitter	14	23884975 - 23884980	14	23415766 - 23415771	43051	52221
NM_000257.3(MYH7):c.5005_5007delGAG (p.Glu1669del)	MYH7|MHRT	Myopathy, distal, 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	14	23884988 - 23884990	14	23415779 - 23415781	143216	152934
NM_000257.3(MYH7):c.4992C>A (p.Asn1664Lys)	MYH7|MHRT	Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: May 20, 2017)	criteria provided, conflicting interpretations	14	23885003	14	23415794	217461	214123
NM_000257.3(MYH7):c.4985G>C (p.Arg1662Pro)	MYH7|MHRT	Myopathy, distal, 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	14	23885010	14	23415801	143215	152933
NM_000257.3(MYH7):c.4985G>A (p.Arg1662His)	MYH7|MHRT	Primary dilated cardiomyopathy|not specified	Uncertain significance(Last reviewed: May 25, 2017)	criteria provided, single submitter	14	23885010	14	23415801	43049	52219
NM_000257.3(MYH7):c.4954G>T (p.Asp1652Tyr)	MYH7|MHRT	Familial hypertrophic cardiomyopathy 1|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2018)	criteria provided, conflicting interpretations	14	23885041	14	23415832	43047	52217
NM_000257.3(MYH7):c.4937T>C (p.Leu1646Pro)	MYH7|MHRT	Myopathy, distal, 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	14	23885229	14	23416020	143214	152932
NM_000257.3(MYH7):c.4909G>A (p.Ala1637Thr)	MYH7|MHRT	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23885257	14	23416048	43044	52214
NM_000257.3(MYH7):c.4850_4852delAGA (p.Lys1617del)	MYH7|MHRT	Myopathy, distal, 1|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, multiple submitters, no conflicts	14	23885314 - 23885316	14	23416105 - 23416107	190401	188231
NM_000257.3(MYH7):c.4823G>C (p.Arg1608Pro)	MYH7|MHRT	Myopathy, distal, 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	14	23885343	14	23416134	143212	152930
NM_000257.3(MYH7):c.4817G>A (p.Arg1606His)	MYH7|MHRT	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 19, 2018)	criteria provided, conflicting interpretations	14	23885349	14	23416140	43039	52209
NM_000257.3(MYH7):c.4795A>C (p.Thr1599Pro)	MYH7|MHRT	Myopathy, distal, 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	14	23885371	14	23416162	143211	152929
NM_000257.3(MYH7):c.4716C>T (p.Ile1572=)	MYH7|MHRT	Myosin storage myopathy|Myopathy, distal, 1|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23885450	14	23416241	43032	52202
NM_000257.3(MYH7):c.4622A>C (p.Gln1541Pro)	MYH7|MHRT	Myopathy, distal, 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	14	23886099	14	23416890	143210	152928
NM_000257.3(MYH7):c.4571A>G (p.His1524Arg)	MYH7|MHRT	Familial hypertrophic cardiomyopathy 1	Likely pathogenic	criteria provided, single submitter	14	23886150	14	23416941	217469	214124
NM_000257.3(MYH7):c.4566T>C (p.Thr1522=)	MYH7|MHRT	Myosin storage myopathy|Myopathy, distal, 1|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23886155	14	23416946	43027	52197
NM_000257.3(MYH7):c.4522_4524delGAG (p.Glu1508del)	MYH7|MHRT	Myopathy, distal, 1|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, multiple submitters, no conflicts	14	23886197 - 23886199	14	23416988 - 23416990	43023	52193
NM_000257.3(MYH7):c.4498C>T (p.Arg1500Trp)	MYH7|MHRT	Primary dilated cardiomyopathy|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	14	23886383	14	23417174	164284	175594
NM_000257.3(MYH7):c.4442T>C (p.Leu1481Pro)	MYH7|MHRT	Myopathy, distal, 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	14	23886439	14	23417230	143209	152927
NM_000257.3(MYH7):c.4388C>T (p.Ser1463Leu)	MYH7|MHRT	not specified	Uncertain significance(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	14	23886493	14	23417284	517346	497663
NM_000257.3(MYH7):c.4377G>T (p.Lys1459Asn)	MYH7|MHRT	Familial hypertrophic cardiomyopathy 1|Wolff-Parkinson-White pattern|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Likely benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23886504	14	23417295	43012	52182
NM_000257.3(MYH7):c.4354-2A>C	MYH7|MHRT	not specified	Uncertain significance(Last reviewed: Aug 29, 2013)	criteria provided, single submitter	14	23886529	14	23417320	179243	175450
NM_000257.3(MYH7):c.4321G>T (p.Ala1441Ser)	MYH7|MHRT	Myosin storage myopathy|Myopathy, distal, 1|not provided|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Sudden unexplained death|Dilated Cardiomyopathy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23886744	14	23417535	191728	189951
NM_000257.3(MYH7):c.4258C>T (p.Arg1420Trp)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23886807	14	23417598	43003	52173
NM_000257.3(MYH7):c.4135G>A (p.Ala1379Thr)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	14	23887453	14	23418244	42993	52163
NM_000257.3(MYH7):c.4130C>T (p.Thr1377Met)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23887458	14	23418249	42992	52162
NM_000257.3(MYH7):c.4124A>G (p.Tyr1375Cys)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified	Uncertain significance(Last reviewed: Oct 10, 2017)	criteria provided, multiple submitters, no conflicts	14	23887464	14	23418255	164293	175453
NM_000257.3(MYH7):c.4075C>T (p.Arg1359Cys)	MYH7	Familial hypertrophic cardiomyopathy 1|Dilated cardiomyopathy 1S|not specified|not provided	Uncertain significance(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	14	23887513	14	23418304	178082	175599
NM_000257.3(MYH7):c.4066G>A (p.Glu1356Lys)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23887522	14	23418313	164294	175600
NM_000257.3(MYH7):c.4052C>T (p.Thr1351Met)	MYH7	Primary familial hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	14	23887536	14	23418327	161324	171161
NM_000257.3(MYH7):c.4031G>A (p.Arg1344Gln)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2016)	criteria provided, conflicting interpretations	14	23887557	14	23418348	208597	205175
NM_000257.3(MYH7):c.3981C>A (p.Asn1327Lys)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23887607	14	23418398	36641	45303
NM_000257.3(MYH7):c.3748C>T (p.Arg1250Trp)	MYH7	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Aug 1, 2014)	criteria provided, single submitter	14	23888797	14	23419588	164299	175457
NM_000257.3(MYH7):c.3658_3660delGAG (p.Glu1220del)	MYH7	Primary dilated cardiomyopathy|Ebstein's anomaly of the tricuspid valve|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23889120 - 23889122	14	23419911 - 23419913	42968	52138
NM_000257.3(MYH7):c.3645G>C (p.Gln1215His)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 31, 2017)	criteria provided, conflicting interpretations	14	23889135	14	23419926	217463	214125
NM_000257.3(MYH7):c.3578G>A (p.Arg1193His)	MYH7	Primary dilated cardiomyopathy|not specified|not provided|Familial dilated cardiomyopathy	Uncertain significance(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23889202	14	23419993	42965	52135
NM_000257.3(MYH7):c.3474C>T (p.Ser1158=)	MYH7	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2014)	criteria provided, conflicting interpretations	14	23889306	14	23420097	129668	135114
NM_000257.3(MYH7):c.3358G>A (p.Glu1120Lys)	MYH7	Familial hypertrophic cardiomyopathy 1	Likely pathogenic	criteria provided, single submitter	14	23889422	14	23420213	217465	214126
NM_000257.3(MYH7):c.3349G>T (p.Glu1117Ter)	MYH7	Cardiomyopathy	Likely pathogenic(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	14	23889431	14	23420222	162507	172179
NM_000257.3(MYH7):c.3346G>A (p.Glu1116Lys)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2014)	criteria provided, multiple submitters, no conflicts	14	23889434	14	23420225	177676	175459
NM_000257.3(MYH7):c.3325A>G (p.Lys1109Glu)	MYH7	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	14	23890178	14	23420969	492984	485935
NM_000257.3(MYH7):c.3301G>A (p.Gly1101Ser)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	14	23890202	14	23420993	161325	171162
NM_000257.3(MYH7):c.3286G>T (p.Asp1096Tyr)	MYH7	Familial hypertrophic cardiomyopathy 1|Dilated cardiomyopathy 1S|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated cardiomyopathy	Uncertain significance(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23890217	14	23421008	42953	52123
NM_000257.3(MYH7):c.3236G>A (p.Arg1079Gln)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified	Uncertain significance(Last reviewed: Nov 22, 2017)	criteria provided, multiple submitters, no conflicts	14	23891398	14	23422189	177826	175460
NM_000257.3(MYH7):c.3170G>A (p.Gly1057Asp)	MYH7	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	14	23891464	14	23422255	492982	485936
NM_000257.3(MYH7):c.3169G>A (p.Gly1057Ser)	MYH7	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23891465	14	23422256	42950	52120
NM_000257.3(MYH7):c.3158G>A (p.Arg1053Gln)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23891476	14	23422267	155814	165566
NM_000257.3(MYH7):c.3153G>A (p.Ala1051=)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23891481	14	23422272	42946	52116
NM_000257.3(MYH7):c.3133C>T (p.Arg1045Cys)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23891501	14	23422292	177753	175462
NM_000257.3(MYH7):c.2967T>C (p.Ile989=)	MYH7	Myosin storage myopathy|Myopathy, distal, 1|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23892888	14	23423679	42942	52112
NM_000257.3(MYH7):c.2945T>C (p.Met982Thr)	MYH7	Myosin storage myopathy|Myopathy, distal, 1|not specified|not provided|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Increased left ventricular wall thickness|Inborn genetic diseases|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23892910	14	23423701	42941	52111
NM_000257.3(MYH7):c.2893G>A (p.Glu965Lys)	MYH7	Familial hypertrophic cardiomyopathy 1|not provided	Likely pathogenic(Last reviewed: Aug 6, 2015)	criteria provided, multiple submitters, no conflicts	14	23893145	14	23423936	217467	214127
NM_000257.3(MYH7):c.2846A>T (p.Glu949Val)	MYH7	not specified|not provided	Uncertain significance(Last reviewed: May 4, 2018)	criteria provided, multiple submitters, no conflicts	14	23893192	14	23423983	42937	52107
NM_000257.3(MYH7):c.2791_2793delGAG (p.Glu931del)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23893245 - 23893247	14	23424036 - 23424038	42934	52104
NM_000257.3(MYH7):c.2788G>C (p.Glu930Gln)	MYH7	Familial hypertrophic cardiomyopathy 1|Myopathy, myosin storage, autosomal recessive|Myosin storage myopathy|Congenital myopathy with fiber type disproportion|Dilated cardiomyopathy 1S|Primary familial hypertrophic cardiomyopathy|Myopathy, distal, 1|Scapuloperoneal myopathy, MYH7-related|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: May 29, 2018)	criteria provided, multiple submitters, no conflicts	14	23893250	14	23424041	164312	175610
NM_000257.3(MYH7):c.2788G>A (p.Glu930Lys)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	14	23893250	14	23424041	42933	52103
NM_000257.3(MYH7):c.2782G>A (p.Asp928Asn)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	14	23893256	14	23424047	164313	175611
NM_000257.3(MYH7):c.2770G>A (p.Glu924Lys)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	14	23893268	14	23424059	14092	29131
NM_000257.3(MYH7):c.2744T>C (p.Leu915Pro)	MYH7	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Apr 11, 2014)	criteria provided, single submitter	14	23893294	14	23424085	42927	52097
NM_000257.3(MYH7):c.2722C>G (p.Leu908Val)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23893316	14	23424107	14097	29136
NM_000257.3(MYH7):c.2717A>G (p.Asp906Gly)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23893321	14	23424112	14125	29164
NM_000257.3(MYH7):c.2710C>T (p.Arg904Cys)	MYH7	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1S|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Feb 18, 2018)	criteria provided, conflicting interpretations	14	23893328	14	23424119	164316	175612
NM_000257.3(MYH7):c.2681A>G (p.Glu894Gly)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23893357	14	23424148	42922	52092
NM_000257.3(MYH7):c.2678C>T (p.Ala893Val)	MYH7	Primary dilated cardiomyopathy|not specified	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23893979	14	23424770	177763	175468
NM_000257.3(MYH7):c.2655T>A (p.Asn885Lys)	MYH7	Familial hypertrophic cardiomyopathy 1	Likely pathogenic	criteria provided, single submitter	14	23894002	14	23424793	217462	214128
NM_000257.3(MYH7):c.2644C>G (p.Gln882Glu)	MYH7	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, multiple submitters, no conflicts	14	23894013	14	23424804	42921	52091
NM_000257.3(MYH7):c.2631G>T (p.Met877Ile)	MYH7	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 18, 2017)	no assertion criteria provided	14	23894026	14	23424817	417718	404619
NM_000257.3(MYH7):c.2609G>A (p.Arg870His)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Chest pain	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23894048	14	23424839	14120	29159
NM_000257.3(MYH7):c.2608C>T (p.Arg870Cys)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23894049	14	23424840	161326	171163
NM_000257.3(MYH7):c.2578A>G (p.Lys860Glu)	MYH7	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Feb 25, 2015)	criteria provided, single submitter	14	23894079	14	23424870	192312	190102
NM_000257.3(MYH7):c.2572C>T (p.Arg858Cys)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Muscular Diseases|not provided|Hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	14	23894085	14	23424876	164324	175617
NM_000257.3(MYH7):c.2555T>C (p.Met852Thr)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	14	23894102	14	23424893	42916	52086
NM_000257.3(MYH7):c.2546T>C (p.Met849Thr)	MYH7	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	14	23894111	14	23424902	42914	52084
NM_000257.3(MYH7):c.2542_2544delGAG (p.Glu848del)	MYH7	Familial hypertrophic cardiomyopathy 1	Likely pathogenic	criteria provided, single submitter	14	23894113 - 23894115	14	23424904 - 23424906	217466	214129
NM_000257.3(MYH7):c.2539_2541delAAG (p.Lys847del)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23894116 - 23894118	14	23424907 - 23424909	42913	52083
NM_000257.3(MYH7):c.2539A>G (p.Lys847Glu)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23894118	14	23424909	177757	175619
NM_000257.3(MYH7):c.2524A>G (p.Ser842Gly)	MYH7	Familial hypertrophic cardiomyopathy 1	Likely pathogenic	criteria provided, single submitter	14	23894133	14	23424924	217474	214130
NM_000257.3(MYH7):c.2513C>A (p.Pro838Gln)	MYH7	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Aug 27, 2013)	criteria provided, single submitter	14	23894144	14	23424935	164329	175620
NM_000257.3(MYH7):c.2513C>T (p.Pro838Leu)	MYH7	Familial hypertrophic cardiomyopathy 1|Familial restrictive cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23894144	14	23424935	42910	52080
NM_000257.3(MYH7):c.2470G>C (p.Val824Leu)	MYH7	not specified	Uncertain significance(Last reviewed: Oct 24, 2012)	criteria provided, single submitter	14	23894187	14	23424978	42906	52076
NM_000257.3(MYH7):c.2420G>A (p.Arg807His)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified	Uncertain significance(Last reviewed: Mar 28, 2017)	criteria provided, multiple submitters, no conflicts	14	23894494	14	23425285	391904	373042
NM_000257.3(MYH7):c.2389G>A (p.Ala797Thr)	MYH7	Familial hypertrophic cardiomyopathy 1|Myopathy, myosin storage, autosomal recessive|Myosin storage myopathy|Congenital myopathy with fiber type disproportion|Wolff-Parkinson-White pattern|Severe combined immunodeficiency disease|Dilated cardiomyopathy 1S|Primary familial hypertrophic cardiomyopathy|Myopathy, distal, 1|Scapuloperoneal myopathy, MYH7-related|not provided|Immunodeficiency|Hypertrophic cardiomyopathy|Lymphopenia|Abnormality of cellular immune system|Abnormality of T cell physiology|Combined immunodeficiency|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	14	23894525	14	23425316	42901	52071
NM_000257.3(MYH7):c.2360G>A (p.Arg787His)	MYH7	Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|Primary familial hypertrophic cardiomyopathy|Myopathy, distal, 1|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Uncertain significance(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23894554	14	23425345	42900	52070
NM_000257.3(MYH7):c.2359C>T (p.Arg787Cys)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Feb 19, 2018)	criteria provided, multiple submitters, no conflicts	14	23894555	14	23425346	161327	171164
NM_000257.3(MYH7):c.2334C>G (p.Asp778Glu)	MYH7	not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, multiple submitters, no conflicts	14	23894580	14	23425371	265252	260053
NM_000257.3(MYH7):c.2302G>A (p.Gly768Arg)	MYH7	Familial hypertrophic cardiomyopathy 1|Cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, multiple submitters, no conflicts	14	23894612	14	23425403	164337	175624
NM_000257.3(MYH7):c.2291T>A (p.Phe764Tyr)	MYH7	Familial hypertrophic cardiomyopathy 1	Likely pathogenic	criteria provided, single submitter	14	23894623	14	23425414	217473	214131
NM_000257.3(MYH7):c.2225C>A (p.Ala742Glu)	MYH7	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Mar 20, 2015)	criteria provided, single submitter	14	23894965	14	23425756	192310	190103
NM_000257.3(MYH7):c.2221G>T (p.Gly741Trp)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23894969	14	23425760	177665	175480
NM_000257.3(MYH7):c.2221G>A (p.Gly741Arg)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, multiple submitters, no conflicts	14	23894969	14	23425760	42890	52060
NM_000257.3(MYH7):c.2221G>C (p.Gly741Arg)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23894969	14	23425760	14098	29137
NM_000257.3(MYH7):c.2207T>C (p.Ile736Thr)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23894983	14	23425774	164342	175481
NM_000257.3(MYH7):c.2201A>C (p.Gln734Pro)	MYH7	Familial hypertrophic cardiomyopathy 1	Likely pathogenic	criteria provided, single submitter	14	23894989	14	23425780	217464	214132
NM_000257.3(MYH7):c.2198G>A (p.Gly733Glu)	MYH7	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 25, 2014)	criteria provided, single submitter	14	23894992	14	23425783	177628	175482
NM_000257.3(MYH7):c.2191C>T (p.Pro731Ser)	MYH7	Familial hypertrophic cardiomyopathy 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2012)	criteria provided, multiple submitters, no conflicts	14	23894999	14	23425790	181176	179623
NM_000257.3(MYH7):c.2183C>T (p.Ala728Val)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jun 28, 2018)	criteria provided, conflicting interpretations	14	23895007	14	23425798	14111	29150
NM_000257.3(MYH7):c.2171T>A (p.Ile724Asn)	MYH7	not specified	Uncertain significance(Last reviewed: Jan 19, 2014)	criteria provided, single submitter	14	23895019	14	23425810	42887	52057
NM_000257.3(MYH7):c.2167C>G (p.Arg723Gly)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23895023	14	23425814	42885	52055
NM_000257.3(MYH7):c.2167C>T (p.Arg723Cys)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23895023	14	23425814	14095	29134
NM_000257.3(MYH7):c.2156G>C (p.Arg719Pro)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified	Likely pathogenic	criteria provided, single submitter	14	23895179	14	23425970	217460	214133
NM_000257.3(MYH7):c.2156G>A (p.Arg719Gln)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23895179	14	23425970	14107	29146
NM_000257.3(MYH7):c.2155C>T (p.Arg719Trp)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23895180	14	23425971	14104	29143
NM_000257.3(MYH7):c.2146G>A (p.Gly716Arg)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23895189	14	23425980	14105	29144
NM_000257.3(MYH7):c.2123G>C (p.Gly708Ala)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided	Likely pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, multiple submitters, no conflicts	14	23895212	14	23426003	42882	52052
NM_000257.3(MYH7):c.2105T>A (p.Ile702Asn)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	14	23895230	14	23426021	42880	52050
NM_000257.3(MYH7):c.2104A>G (p.Ile702Val)	MYH7	Familial hypertrophic cardiomyopathy 1	Likely pathogenic	criteria provided, single submitter	14	23895231	14	23426022	217470	214134
NM_000257.3(MYH7):c.2093T>C (p.Val698Ala)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 22, 2014)	criteria provided, conflicting interpretations	14	23895242	14	23426033	42878	52048
NM_000257.3(MYH7):c.2087A>G (p.Asn696Ser)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified	Uncertain significance(Last reviewed: May 25, 2017)	criteria provided, multiple submitters, no conflicts	14	23895248	14	23426039	181173	179628
NM_000257.3(MYH7):c.2080C>T (p.Arg694Cys)	MYH7	Myopathy, distal, 1|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 17, 2018)	criteria provided, conflicting interpretations	14	23895255	14	23426046	177627	175630
NM_000257.3(MYH7):c.1988G>A (p.Arg663His)	MYH7	Familial hypertrophic cardiomyopathy 1|Myopathy, myosin storage, autosomal recessive|Myosin storage myopathy|Dilated cardiomyopathy 1S|Primary familial hypertrophic cardiomyopathy|Myopathy, distal, 1|Scapuloperoneal myopathy, MYH7-related|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23896042	14	23426833	42875	52045
NM_000257.3(MYH7):c.1987C>T (p.Arg663Cys)	MYH7	Familial hypertrophic cardiomyopathy 1|Myopathy, myosin storage, autosomal recessive|Myosin storage myopathy|Congenital myopathy with fiber type disproportion|Dilated cardiomyopathy 1S|Primary familial hypertrophic cardiomyopathy|Myopathy, distal, 1|Scapuloperoneal myopathy, MYH7-related|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	14	23896043	14	23426834	42874	52044
NM_000257.3(MYH7):c.1969A>C (p.Lys657Gln)	MYH7	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Nov 15, 2013)	criteria provided, single submitter	14	23896061	14	23426852	164351	175486
NM_000257.3(MYH7):c.1954A>G (p.Arg652Gly)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, multiple submitters, no conflicts	14	23896451	14	23427242	177626	175632
NM_000257.3(MYH7):c.1816G>A (p.Val606Met)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	14	23896866	14	23427657	14091	29130
NM_000257.3(MYH7):c.1767C>T (p.Asn589=)	MYH7	Myosin storage myopathy|Myopathy, distal, 1|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23896915	14	23427706	42864	52034
NM_000257.3(MYH7):c.1757T>C (p.Val586Ala)	MYH7	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Aug 27, 2013)	criteria provided, single submitter	14	23896925	14	23427716	42865	52035
NM_000257.3(MYH7):c.1750G>A (p.Gly584Ser)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, multiple submitters, no conflicts	14	23896932	14	23427723	42862	52032
NM_000257.3(MYH7):c.1750G>C (p.Gly584Arg)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23896932	14	23427723	14090	29129
NM_000257.3(MYH7):c.1727A>G (p.His576Arg)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: May 8, 2018)	criteria provided, conflicting interpretations	14	23896955	14	23427746	177625	175490
NM_000257.3(MYH7):c.1608G>T (p.Glu536Asp)	MYH7	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Jan 28, 2013)	no assertion criteria provided	14	23897074	14	23427865	177671	175636
NM_000257.3(MYH7):c.1605A>G (p.Glu535=)	MYH7	Myosin storage myopathy|Myopathy, distal, 1|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23897077	14	23427868	42853	52023
NM_000257.3(MYH7):c.1594T>C (p.Ser532Pro)	MYH7	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1S|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23897088	14	23427879	14108	29147
NM_000257.3(MYH7):c.1584G>A (p.Met528Ile)	MYH7	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jan 29, 2015)	criteria provided, single submitter	14	23897098	14	23427889	164361	175491
NM_000257.3(MYH7):c.1573G>A (p.Glu525Lys)	MYH7	Dilated cardiomyopathy 1S|Cardiomyopathy|Familial cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	14	23897714	14	23428505	132925	136674
NM_000257.3(MYH7):c.1544T>C (p.Met515Thr)	MYH7	Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|Dilated cardiomyopathy 1S|Myopathy, distal, 1|Scapuloperoneal myopathy, MYH7-related	Likely pathogenic(Last reviewed: Dec 4, 2012)	criteria provided, single submitter	14	23897743	14	23428534	216968	213631
NM_000257.3(MYH7):c.1532T>C (p.Ile511Thr)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Feb 3, 2016)	criteria provided, conflicting interpretations	14	23897755	14	23428546	42848	52018
NM_000257.3(MYH7):c.1505_1516delAGAAGGAGGGCA (p.Lys502_Gly505del)	MYH7	not specified	Uncertain significance(Last reviewed: Oct 30, 2013)	criteria provided, single submitter	14	23897771 - 23897782	14	23428562 - 23428573	179379	175493
NM_000257.4(MYH7):c.1498_1500del (p.Glu500del)	MYH7	Myosin storage myopathy|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	14	23897787 - 23897789	14	23428578 - 23428580	525034	528125
NM_000257.3(MYH7):c.1491G>T (p.Glu497Asp)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, multiple submitters, no conflicts	14	23897796	14	23428587	14124	29163
NM_000257.3(MYH7):c.1479G>C (p.Met493Ile)	MYH7	Familial hypertrophic cardiomyopathy 1	Likely pathogenic	criteria provided, single submitter	14	23897808	14	23428599	217471	214135
NM_000257.3(MYH7):c.1478T>A (p.Met493Lys)	MYH7	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Dec 17, 2016)	criteria provided, single submitter	14	23897809	14	23428600	192308	190104
NM_000257.3(MYH7):c.1436A>G (p.Asn479Ser)	MYH7	not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2018)	criteria provided, conflicting interpretations	14	23897851	14	23428642	177623	175641
NM_000257.3(MYH7):c.1358G>A (p.Arg453His)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23898213	14	23429004	42838	52008
NM_000257.3(MYH7):c.1357C>T (p.Arg453Cys)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23898214	14	23429005	14089	29128
NM_000257.3(MYH7):c.1324C>T (p.Arg442Cys)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 18, 2018)	criteria provided, conflicting interpretations	14	23898247	14	23429038	177897	175497
NM_000257.3(MYH7):c.1318G>A (p.Val440Met)	MYH7	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Mar 13, 2018)	criteria provided, conflicting interpretations	14	23898253	14	23429044	42835	52005
NM_000257.4(MYH7):c.1255C>A (p.Gln419Lys)	MYH7	Dilated cardiomyopathy 1S	Uncertain significance(Last reviewed: Jan 1, 2019)	criteria provided, single submitter			14	23429231	617738	609140
NM_000257.3(MYH7):c.1208G>A (p.Arg403Gln)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23898487	14	23429278	14087	29126
NM_000257.3(MYH7):c.1207C>T (p.Arg403Trp)	MYH7	Familial hypertrophic cardiomyopathy 1|Myopathy, myosin storage, autosomal recessive|Myosin storage myopathy|Congenital myopathy with fiber type disproportion|Dilated cardiomyopathy 1S|Primary familial hypertrophic cardiomyopathy|Myopathy, distal, 1|Scapuloperoneal myopathy, MYH7-related|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23898488	14	23429279	14102	29141
NM_000257.3(MYH7):c.1191G>A (p.Lys397=)	MYH7	Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|Myopathy, distal, 1|not specified|not provided|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2017)	criteria provided, conflicting interpretations	14	23898504	14	23429295	42829	51999
NM_000257.3(MYH7):c.1189A>G (p.Lys397Glu)	MYH7	Familial hypertrophic cardiomyopathy 1|Dilated cardiomyopathy 1S	Likely pathogenic(Last reviewed: Sep 30, 2018)	criteria provided, single submitter	14	23898506	14	23429297	585010	576065
NM_000257.3(MYH7):c.1157A>G (p.Tyr386Cys)	MYH7	Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|not provided	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23898538	14	23429329	164378	175645
NM_000257.3(MYH7):c.1128C>A (p.Asp376Glu)	MYH7	Primary dilated cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 13, 2017)	criteria provided, conflicting interpretations	14	23898994	14	23429785	181170	179662
NM_000257.3(MYH7):c.1128C>T (p.Asp376=)	MYH7	Myosin storage myopathy|Myopathy, distal, 1|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23898994	14	23429785	42823	51993
NM_000257.3(MYH7):c.1106G>A (p.Arg369Gln)	MYH7	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1S|Cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23899016	14	23429807	42822	51992
NM_000257.3(MYH7):c.1095G>A (p.Lys365=)	MYH7	Myosin storage myopathy|Myopathy, distal, 1|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23899027	14	23429818	42821	51991
NM_000257.3(MYH7):c.1062C>T (p.Gly354=)	MYH7	Myosin storage myopathy|Myopathy, distal, 1|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23899060	14	23429851	42819	51989
NM_000257.3(MYH7):c.1013T>A (p.Val338Glu)	MYH7	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	14	23899109	14	23429900	492983	485937
NM_000257.3(MYH7):c.1013T>C (p.Val338Ala)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2015)	criteria provided, conflicting interpretations	14	23899109	14	23429900	42818	51988
NM_000257.3(MYH7):c.1012G>A (p.Val338Met)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2014)	criteria provided, multiple submitters, no conflicts	14	23899110	14	23429901	164381	175502
NM_000257.3(MYH7):c.1003G>T (p.Ala335Ser)	MYH7	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Feb 11, 2013)	criteria provided, single submitter	14	23899119	14	23429910	164382	175648
NM_000257.3(MYH7):c.1002C>T (p.Asn334=)	MYH7	Myosin storage myopathy|Myopathy, distal, 1|not specified|not provided|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23899120	14	23429911	42817	51987
NM_000257.3(MYH7):c.976G>C (p.Ala326Pro)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	14	23899792	14	23430583	43117	52287
NM_000257.3(MYH7):c.975C>T (p.Asp325=)	MYH7	Myosin storage myopathy|Myopathy, distal, 1|not specified|not provided|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23899793	14	23430584	43116	52286
NM_000257.3(MYH7):c.958G>A (p.Val320Met)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jun 28, 2018)	criteria provided, conflicting interpretations	14	23899810	14	23430601	161328	171165
NM_000257.3(MYH7):c.925G>A (p.Asp309Asn)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Oct 16, 2017)	criteria provided, multiple submitters, no conflicts	14	23899843	14	23430634	181402	179672
NM_000257.3(MYH7):c.872C>T (p.Ser291Phe)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2014)	criteria provided, conflicting interpretations	14	23900133	14	23430924	43110	52280
NM_000257.3(MYH7):c.842G>C (p.Arg281Thr)	MYH7	Primary dilated cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 23, 2017)	criteria provided, multiple submitters, no conflicts	14	23900163	14	23430954	181327	179675
NM_000257.3(MYH7):c.799C>G (p.Leu267Val)	MYH7	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Feb 15, 2013)	criteria provided, single submitter	14	23900206	14	23430997	177935	175506
NM_000257.3(MYH7):c.788T>C (p.Ile263Thr)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23900635	14	23431426	43106	52276
NM_000257.3(MYH7):c.755T>G (p.Phe252Cys)	MYH7	Familial hypertrophic cardiomyopathy 1	Likely pathogenic	criteria provided, single submitter	14	23900668	14	23431459	217472	214136
NM_000257.3(MYH7):c.746G>A (p.Arg249Gln)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	14	23900677	14	23431468	14088	29127
NM_000257.3(MYH7):c.732+1G>A	MYH7	Primary dilated cardiomyopathy|Left ventricular noncompaction 5|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy, left ventricular noncompaction	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, multiple submitters, no conflicts	14	23900793	14	23431584	14127	29166
NM_000257.3(MYH7):c.732C>T (p.Phe244=)	MYH7	Myosin storage myopathy|Myopathy, distal, 1|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23900794	14	23431585	43103	52273
NM_000257.3(MYH7):c.715G>A (p.Asp239Asn)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	14	23900811	14	23431602	43100	52270
NM_000257.3(MYH7):c.709C>T (p.Arg237Trp)	MYH7	Primary dilated cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Apr 17, 2018)	criteria provided, conflicting interpretations	14	23900817	14	23431608	43098	52268
NM_000257.3(MYH7):c.611G>T (p.Arg204Leu)	MYH7	Cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: May 9, 2018)	criteria provided, conflicting interpretations	14	23900998	14	23431789	177869	175656
NM_000257.3(MYH7):c.602T>C (p.Ile201Thr)	MYH7	Primary dilated cardiomyopathy|not provided|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Apr 19, 2017)	criteria provided, multiple submitters, no conflicts	14	23901007	14	23431798	43093	52263
NM_000257.3(MYH7):c.596C>T (p.Ala199Val)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	14	23901013	14	23431804	177692	175511
NM_000257.3(MYH7):c.560A>G (p.Asn187Ser)	MYH7	not specified	Uncertain significance(Last reviewed: Jan 9, 2014)	criteria provided, single submitter	14	23901049	14	23431840	43077	52247
NM_000257.3(MYH7):c.556G>C (p.Val186Leu)	MYH7	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Mar 20, 2015)	criteria provided, single submitter	14	23901053	14	23431844	192309	190105
NM_000257.4(MYH7):c.541G>A (p.Gly181Arg)	MYH7	Primary dilated cardiomyopathy|Left ventricular noncompaction cardiomyopathy	Likely pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	14	23901068	14	23431859	619082	610480
NM_000257.3(MYH7):c.507A>T (p.Arg169Ser)	MYH7	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	14	23901711	14	23432502	43055	52225
NM_000257.3(MYH7):c.506G>A (p.Arg169Lys)	MYH7	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	14	23901712	14	23432503	43054	52224
NM_000257.3(MYH7):c.438G>T (p.Lys146Asn)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Mar 21, 2013)	criteria provided, multiple submitters, no conflicts	14	23901912	14	23432703	43013	52183
NM_000257.3(MYH7):c.428G>A (p.Arg143Gln)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23901922	14	23432713	43006	52176
NM_000257.3(MYH7):c.427C>T (p.Arg143Trp)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified|not provided|Hypertrophic cardiomyopathy|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Aug 31, 2017)	criteria provided, conflicting interpretations	14	23901923	14	23432714	164401	175658
NM_000257.3(MYH7):c.189C>T (p.Thr63=)	MYH7	Myosin storage myopathy|Myopathy, distal, 1|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23902753	14	23433544	42869	52039
NM_000257.3(MYH7):c.115G>A (p.Val39Met)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2017)	criteria provided, conflicting interpretations	14	23902827	14	23433618	42827	51997
NM_000257.3(MYH7):c.77C>T (p.Ala26Val)	MYH7	Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|Primary familial hypertrophic cardiomyopathy|Myopathy, distal, 1|not specified|not provided|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23902865	14	23433656	37375	45929
NM_005249.4(FOXG1):c.135_136dup (p.Gln46Profs)	FOXG1	Rett syndrome, congenital variant	Pathogenic(Last reviewed: May 6, 2014)	criteria provided, single submitter	14	29236620 - 29236621	14	28767414 - 28767415	158587	169046
NM_005249.4(FOXG1):c.159_161delCCA (p.His57del)	FOXG1	not specified|History of neurodevelopmental disorder	Likely benign(Last reviewed: Nov 29, 2017)	criteria provided, multiple submitters, no conflicts	14	29236644 - 29236646	14	28767438 - 28767440	158588	169047
NM_005249.4(FOXG1):c.170_179del (p.His57Argfs)	FOXG1	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Feb 10, 2014)	criteria provided, single submitter	14	29236655 - 29236664	14	28767449 - 28767458	158589	169048
NM_005249.4(FOXG1):c.183_206del (p.Ala62_Pro69del)	FOXG1	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, multiple submitters, no conflicts	14	29236668 - 29236691	14	28767462 - 28767485	158590	169049
NM_005249.4(FOXG1):c.209_235del27 (p.Gln70_Pro78del)	FOXG1	Rett syndrome, congenital variant|not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Sep 30, 2017)	criteria provided, conflicting interpretations	14	29236694 - 29236720	14	28767488 - 28767514	158592	169051
NM_005249.4(FOXG1):c.209A>C (p.Gln70Pro)	FOXG1	Rett syndrome, congenital variant|not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2017)	criteria provided, conflicting interpretations	14	29236694	14	28767488	158591	169050
NM_005249.4(FOXG1):c.263_278del16 (p.Arg88Profs)	FOXG1	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	14	29236748 - 29236763	14	28767542 - 28767557	158593	169052
NM_005249.4(FOXG1):c.298del (p.Gln100Serfs)	FOXG1	Rett syndrome, congenital variant|not provided	Pathogenic(Last reviewed: Jan 6, 2015)	criteria provided, multiple submitters, no conflicts	14	29236783	14	28767577	158594	169053
NM_005249.4(FOXG1):c.456G>T (p.Gly152=)	FOXG1	Rett syndrome, congenital variant|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 29, 2018)	criteria provided, conflicting interpretations	14	29236941	14	28767735	158595	169054
NM_005249.4(FOXG1):c.543G>T (p.Lys181Asn)	FOXG1	Rett syndrome, congenital variant	Likely pathogenic(Last reviewed: Sep 2, 2015)	criteria provided, single submitter	14	29237028	14	28767822	369681	353907
NM_005249.4(FOXG1):c.563C>G (p.Ala188Gly)	FOXG1	Rett syndrome, congenital variant	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	14	29237048	14	28767842	158596	169055
NM_005249.4(FOXG1):c.672C>G (p.Gly224=)	FOXG1	Rett syndrome, congenital variant|not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Nov 13, 2017)	criteria provided, conflicting interpretations	14	29237157	14	28767951	158597	169056
NM_005249.4(FOXG1):c.755G>T (p.Gly252Val)	FOXG1	Rett syndrome, congenital variant|not provided	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	14	29237240	14	28768034	158598	169057
NM_005249.4(FOXG1):c.757A>G (p.Asn253Asp)	FOXG1	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	14	29237242	14	28768036	158599	169058
NM_005249.4(FOXG1):c.762C>G (p.Tyr254Ter)	FOXG1	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	14	29237247	14	28768041	158600	169059
NM_005249.4(FOXG1):c.799G>A (p.Gly267Ser)	FOXG1	Rett syndrome, congenital variant|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, multiple submitters, no conflicts	14	29237284	14	28768078	158602	169061
NM_005249.4(FOXG1):c.1086G>A (p.Leu362=)	FOXG1	Rett syndrome, congenital variant|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 25, 2016)	criteria provided, conflicting interpretations	14	29237571	14	28768365	158585	169062
NM_005249.4(FOXG1):c.1218C>G (p.Ser406=)	FOXG1	not specified	Benign(Last reviewed: Oct 16, 2014)	criteria provided, multiple submitters, no conflicts	14	29237703	14	28768497	158586	169063
NM_005249.4(FOXG1):c.1233G>A (p.Ala411=)	FOXG1	Rett syndrome, congenital variant|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jan 10, 2018)	criteria provided, multiple submitters, no conflicts	14	29237718	14	28768512	95264	101163
NM_005249.4(FOXG1):c.1397G>A (p.Gly466Glu)	FOXG1	Rett syndrome, congenital variant	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	14	29237882	14	28768676	561012	552174
NM_005249.4(FOXG1):c.*13C>A	FOXG1	not specified	Benign(Last reviewed: Apr 4, 2014)	criteria provided, multiple submitters, no conflicts	14	29237968	14	28768762	95263	101162
NM_004086.2(COCH):c.151C>T (p.Pro51Ser)	COCH|LOC100506071	Deafness, autosomal dominant 9|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Sep 19, 2018)	reviewed by expert panel	14	31346846	14	30877640	6611	21650
NM_004086.2(COCH):c.355G>A (p.Ala119Thr)	COCH|LOC100506071	Deafness, autosomal dominant 9|Nonsyndromic hearing loss and deafness	Uncertain significance(Last reviewed: Sep 17, 2018)	reviewed by expert panel	14	31348132	14	30878926	6613	21652
NM_004086.2(COCH):c.1625G>T (p.Cys542Phe)	COCH|LOC100506071	Deafness, autosomal dominant 9|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Nov 24, 2015)	criteria provided, single submitter	14	31358969	14	30889763	6614	21653
NM_001079668.2(NKX2-1):c.645C>G (p.Tyr215Ter)	NKX2-1|SFTA3	Choreoathetosis, hypothyroidism, and neonatal respiratory distress	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	14	36987044	14	36517839	561065	552175
NM_006194.3(PAX9):c.3G>A (p.Met1Ile)	PAX9	Tooth agenesis, selective, 3	Pathogenic(Last reviewed: Jun 24, 2017)	no assertion criteria provided	14	37131297	14	36662092	430692	424223
NM_006194.3(PAX9):c.59C>T (p.Pro20Leu)	PAX9	Tooth agenesis, selective, 3	Pathogenic(Last reviewed: Jan 18, 2017)	no assertion criteria provided	14	37132156	14	36662951	375454	362221
NM_015915.4(ATL1):c.84A>G (p.Pro28=)	ATL1	Spastic paraplegia 3|Hereditary sensory neuropathy type 1D|not specified|Spastic paraplegia, autosomal dominant	Benign(Last reviewed: Apr 30, 2017)	criteria provided, multiple submitters, no conflicts	14	51054598	14	50587880	21534	34386
NM_015915.4(ATL1):c.351G>A (p.Glu117=)	ATL1	Spastic paraplegia 3|not specified|Spastic paraplegia, autosomal dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	14	51057727	14	50591009	21530	34382
NM_015915.4(ATL1):c.1206C>A (p.Phe402Leu)	ATL1	Spastic paraplegia 3	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	14	51094835	14	50628117	560958	552176
NM_015915.4(ATL1):c.1222A>T (p.Met408Leu)	ATL1	Spastic paraplegia 3	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	14	51094851	14	50628133	560959	552177
NM_000161.2(GCH1):c.610G>A (p.Val204Ile)	GCH1	not provided|Dystonia, dopa-responsive	Conflicting interpretations of pathogenicity(Last reviewed: Apr 17, 2017)	criteria provided, conflicting interpretations	14	55312502	14	54845784	161248	171166
NM_000161.2(GCH1):c.206C>T (p.Pro69Leu)	GCH1	Dystonia 5, Dopa-responsive type|GTP cyclohydrolase I deficiency|Hyperphenylalaninemia due to tetrahydrobiopterin deficiency|not provided|Dystonia, dopa-responsive	Conflicting interpretations of pathogenicity(Last reviewed: Jun 29, 2018)	criteria provided, conflicting interpretations	14	55369176	14	54902458	161247	171167
NM_172337.2(OTX2):c.649delG (p.Ala217Profs)	OTX2	Microphthalmia syndromic 5	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	14	57268673 - 57268674	14	56801956	561071	552178
NM_005982.3(SIX1):c.746C>A (p.Pro249Gln)	SIX1	not specified	Uncertain significance(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	14	61113110	14	60646392	517597	497038
NM_005982.3(SIX1):c.386A>G (p.Tyr129Cys)	SIX1	Branchiootic syndrome 3|Deafness, autosomal dominant 23|Melnick-Fraser syndrome|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	14	61115522	14	60648804	8308	23347
NM_182914.2(SYNE2):c.399G>C (p.Leu133=)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64408852	14	63942134	130496	135942
NM_182914.2(SYNE2):c.1296C>A (p.Ser432Arg)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	14	64444625	14	63977907	130469	135915
NM_182914.2(SYNE2):c.1721T>C (p.Ile574Thr)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64447776	14	63981058	130486	135932
NM_182914.2(SYNE2):c.2026A>G (p.Lys676Glu)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	14	64450479	14	63983761	130491	135937
NM_182914.2(SYNE2):c.2070A>G (p.Leu690=)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign/Likely benign(Last reviewed: Oct 17, 2017)	criteria provided, multiple submitters, no conflicts	14	64450523	14	63983805	130492	135938
NM_182914.2(SYNE2):c.2409C>A (p.Ser803=)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	14	64457224	14	63990506	130493	135939
NM_182914.2(SYNE2):c.2934A>G (p.Glu978=)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	14	64461914	14	63995196	130494	135940
NM_182914.2(SYNE2):c.3559A>C (p.Ile1187Leu)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	14	64467358	14	64000640	130495	135941
NM_182914.2(SYNE2):c.4177C>T (p.Arg1393Trp)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64469828	14	64003110	130497	135943
NM_182914.2(SYNE2):c.4536A>G (p.Thr1512=)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	14	64473899	14	64007181	130498	135944
NM_182914.2(SYNE2):c.4578-4T>A	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64476680	14	64009962	130499	135945
NM_182914.2(SYNE2):c.5517A>T (p.Leu1839Phe)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	14	64488739	14	64022021	130500	135946
NM_182914.2(SYNE2):c.5906T>C (p.Met1969Thr)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64491695	14	64024977	130501	135947
NM_182914.2(SYNE2):c.6321C>T (p.Ser2107=)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	14	64493365	14	64026647	130502	135948
NM_182914.2(SYNE2):c.6481C>T (p.Leu2161=)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64494278	14	64027560	130503	135949
NM_182914.2(SYNE2):c.6851C>T (p.Ala2284Val)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64496749	14	64030031	130504	135950
NM_182914.2(SYNE2):c.6865T>C (p.Leu2289=)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64496763	14	64030045	130505	135951
NM_182914.2(SYNE2):c.7040C>A (p.Ala2347Glu)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	14	64497894	14	64031176	130506	135952
NM_182914.2(SYNE2):c.7075A>G (p.Ser2359Gly)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	14	64497929	14	64031211	130507	135953
NM_182914.2(SYNE2):c.7076G>A (p.Ser2359Asn)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64497930	14	64031212	130508	135954
NM_182914.2(SYNE2):c.7124T>C (p.Leu2375Pro)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified|not provided	Benign/Likely benign(Last reviewed: Feb 6, 2018)	criteria provided, multiple submitters, no conflicts	14	64497978	14	64031260	130509	135955
NM_182914.2(SYNE2):c.7128A>G (p.Pro2376=)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified|not provided	Benign/Likely benign(Last reviewed: Feb 6, 2018)	criteria provided, multiple submitters, no conflicts	14	64497982	14	64031264	130510	135956
NM_182914.2(SYNE2):c.7183G>A (p.Ala2395Thr)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64498037	14	64031319	130511	135957
NM_182914.2(SYNE2):c.7690A>G (p.Ile2564Val)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	14	64518321	14	64051603	130512	135958
NM_182914.2(SYNE2):c.8404A>G (p.Ser2802Gly)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64519035	14	64052317	130513	135959
NM_182914.2(SYNE2):c.8422C>T (p.Leu2808=)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	14	64519053	14	64052335	130514	135960
NM_182914.2(SYNE2):c.8597C>T (p.Thr2866Met)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign/Likely benign(Last reviewed: Sep 6, 2017)	criteria provided, multiple submitters, no conflicts	14	64519228	14	64052510	130515	135961
NM_182914.2(SYNE2):c.8824A>G (p.Ile2942Val)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64519455	14	64052737	130516	135962
NM_182914.2(SYNE2):c.9023T>C (p.Ile3008Thr)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign/Likely benign(Last reviewed: Sep 6, 2017)	criteria provided, multiple submitters, no conflicts	14	64519654	14	64052936	130517	135963
NM_182914.2(SYNE2):c.9078A>T (p.Glu3026Asp)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	14	64519709	14	64052991	130518	135964
NM_182914.2(SYNE2):c.9389A>G (p.Asn3130Ser)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	14	64520020	14	64053302	130519	135965
NM_182914.2(SYNE2):c.9757G>C (p.Asp3253His)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64522674	14	64055956	130520	135966
NM_182914.2(SYNE2):c.9926A>G (p.His3309Arg)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64522843	14	64056125	130521	135967
NM_182914.2(SYNE2):c.10567A>C (p.Lys3523Gln)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	14	64537498	14	64070780	130456	135902
NM_182914.2(SYNE2):c.10835A>G (p.Gln3612Arg)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign/Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	14	64540823	14	64074105	130457	135903
NM_182914.2(SYNE2):c.11385G>A (p.Lys3795=)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified|not provided	Benign(Last reviewed: Dec 7, 2017)	criteria provided, multiple submitters, no conflicts	14	64548199	14	64081481	130458	135904
NM_182914.2(SYNE2):c.11613A>G (p.Val3871=)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64554517	14	64087799	130459	135905
NM_182914.2(SYNE2):c.11935C>G (p.Leu3979Val)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	14	64557725	14	64091007	130460	135906
NM_182914.2(SYNE2):c.11944A>C (p.Asn3982His)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64557734	14	64091016	130461	135907
NM_182914.2(SYNE2):c.12001T>C (p.Trp4001Arg)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64560091	14	64093373	130462	135908
NM_182914.2(SYNE2):c.12002G>A (p.Trp4001Ter)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64560092	14	64093374	130463	135909
NM_182914.2(SYNE2):c.12043T>C (p.Tyr4015His)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified|not provided	Benign/Likely benign(Last reviewed: Feb 6, 2018)	criteria provided, multiple submitters, no conflicts	14	64560133	14	64093415	130464	135910
NM_182914.2(SYNE2):c.12122G>A (p.Arg4041His)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified|not provided	Benign/Likely benign(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	14	64564680	14	64097962	130465	135911
NM_182914.2(SYNE2):c.12612C>T (p.Gly4204=)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|not specified	Benign(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	14	64580061	14	64113343	130466	135912
NM_182914.2(SYNE2):c.12626T>C (p.Ile4209Thr)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign/Likely benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	14	64580075	14	64113357	130467	135913
NM_182914.2(SYNE2):c.12840+8T>C	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	14	64580297	14	64113579	130468	135914
NM_182914.2(SYNE2):c.13254C>A (p.Asn4418Lys)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign/Likely benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	14	64588825	14	64122107	130470	135916
NM_182914.2(SYNE2):c.13266G>A (p.Gln4422=)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign/Likely benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	14	64588837	14	64122119	130471	135917
NM_182914.2(SYNE2):c.13423-7C>G	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Dec 6, 2017)	criteria provided, multiple submitters, no conflicts	14	64591790	14	64125072	130473	135919
NM_182914.2(SYNE2):c.14430A>G (p.Thr4810=)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified|not provided	Benign/Likely benign(Last reviewed: Sep 27, 2017)	criteria provided, multiple submitters, no conflicts	14	64599072	14	64132354	130474	135920
NM_182914.2(SYNE2):c.14734C>G (p.Pro4912Ala)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified|not provided	Benign/Likely benign(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	14	64604592	14	64137874	130475	135921
NM_182914.2(SYNE2):c.14737G>A (p.Glu4913Lys)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	14	64604595	14	64137877	130476	135922
NM_182914.2(SYNE2):c.14776T>C (p.Leu4926=)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	14	64604634	14	64137916	130477	135923
NM_182914.2(SYNE2):c.14844-5G>C	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64606654	14	64139936	130478	135924
NM_182914.2(SYNE2):c.15543C>T (p.Ile5181=)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64612845	14	64146127	130479	135925
NM_182914.2(SYNE2):c.15556C>A (p.Leu5186Met)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	14	64612858	14	64146140	130480	135926
NM_182914.2(SYNE2):c.15794T>C (p.Val5265Ala)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign/Likely benign(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	14	64625344	14	64158626	130481	135927
NM_182914.2(SYNE2):c.16305G>A (p.Leu5435=)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign/Likely benign(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	14	64630125	14	64163407	130482	135928
NM_182914.2(SYNE2):c.16522T>A (p.Ser5508Thr)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified|not provided	Benign/Likely benign(Last reviewed: Sep 27, 2017)	criteria provided, multiple submitters, no conflicts	14	64632045	14	64165327	130483	135929
NM_182914.2(SYNE2):c.16722A>G (p.Gln5574=)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	14	64634067	14	64167349	130484	135930
NM_182914.2(SYNE2):c.17202C>A (p.Leu5734=)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64637147	14	64170429	130485	135931
NM_182914.2(SYNE2):c.17556+4T>C	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	14	64644205	14	64177487	130487	135933
NM_182914.2(SYNE2):c.17938T>C (p.Leu5980=)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64656855	14	64190137	130488	135934
NM_182914.2(SYNE2):c.19333+5C>T	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64681193	14	64214475	130489	135935
NM_182914.2(SYNE2):c.19857G>T (p.Leu6619=)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64686125	14	64219407	130490	135936
NM_133509.3(RAD51B):c.84G>A (p.Gln28=)	RAD51B	Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	14	68290344	14	67823627	221910	223600
NM_000021.3(PSEN1):c.1141C>T (p.Leu381Phe)	PSEN1	Alzheimer disease, type 3|Alzheimer disease familial 3, with spastic paraparesis	Likely pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	14	73683845	14	73217137	120170	125778
NM_000021.3(PSEN1):c.1141C>G (p.Leu381Val)	PSEN1	Alzheimer disease, type 3|not provided	Pathogenic(Last reviewed: Nov 19, 2013)	criteria provided, single submitter	14	73683845	14	73217137	98101	103993
NM_001040108.1(MLH3):c.4180G>A (p.Ala1394Thr)	MLH3	Colorectal cancer, non-polyposis|MLH3-Related Lynch Syndrome	Uncertain significance(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	14	75485594	14	75018891	161297	171168
NM_001040108.1(MLH3):c.2941G>A (p.Gly981Ser)	MLH3	Colorectal cancer, non-polyposis	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	14	75513418	14	75046715	161298	171169
NM_001040108.1(MLH3):c.2449A>G (p.Ser817Gly)	MLH3	Colorectal cancer, non-polyposis|MLH3-Related Lynch Syndrome	Uncertain significance(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	14	75513910	14	75047207	161296	171170
NM_001040108.1(MLH3):c.713A>G (p.Tyr238Cys)	MLH3	Colorectal cancer	Uncertain significance(Last reviewed: Aug 1, 2016)	no assertion criteria provided	14	75515646	14	75048943	375855	362739
NM_003239.4(TGFB3):c.787G>C (p.Asp263His)	TGFB3	Loeys-Dietz syndrome 5|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	14	76429798	14	75963455	203492	199892
NM_003239.4(TGFB3):c.321dup (p.Phe108Ilefs)	TGFB3	Loeys-Dietz syndrome 5	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	14	76446916	14	75980573	441282	434940
NM_024496.3(IRF2BPL):c.2122delG (p.Ala708Profs)	IRF2BPL	IRF2BPL-related condition	Likely pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	14	77492014	14	77025671	584452	575499
NM_024496.3(IRF2BPL):c.1259T>C (p.Phe420Ser)	IRF2BPL	IRF2BPL-related condition	Likely pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	14	77492877	14	77026534	584438	575500
NM_024496.3(IRF2BPL):c.562C>T (p.Arg188Ter)	IRF2BPL	IRF2BPL-related condition|NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES	Likely pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	14	77493574	14	77027231	559608	550329
NM_024496.3(IRF2BPL):c.519C>G (p.Tyr173Ter)	IRF2BPL	not specified|IRF2BPL-related condition	Conflicting interpretations of pathogenicity(Last reviewed: Oct 30, 2017)	criteria provided, conflicting interpretations	14	77493617	14	77027274	488960	482055
NM_024496.3(IRF2BPL):c.514G>T (p.Glu172Ter)	IRF2BPL	IRF2BPL-related condition	Likely pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	14	77493622	14	77027279	522821	513448
NM_004993.5(ATXN3):c.916G>C (p.Gly306Arg)	ATXN3	Azorean disease|not specified	Benign/Likely benign(Last reviewed: Sep 24, 2015)	no assertion criteria provided	14	92537354	14	92071010	128515	133964
NM_004993.5(ATXN3):c.883A>C (p.Lys295Gln)	ATXN3|LOC108663987	not specified	Likely benign	no assertion criteria provided	14	92537387	14	92071043	128513	133962
NM_004993.5(ATXN3):c.882A>G (p.Gln294=)	ATXN3|LOC108663987	not specified	Likely benign	no assertion criteria provided	14	92537388	14	92071044	128512	133961
NM_004993.5(ATXN3):c.634G>A (p.Val212Met)	ATXN3	not specified	Likely benign	no assertion criteria provided	14	92548785	14	92082441	128511	133960
NM_004993.5(ATXN3):c.492C>T (p.Val164=)	ATXN3	not specified	Likely benign	no assertion criteria provided	14	92549586	14	92083242	128510	133959
NM_177438.2(DICER1):c.5103C>A (p.Tyr1701Ter)	DICER1	Pineoblastoma	Pathogenic(Last reviewed: Jul 15, 2014)	criteria provided, single submitter	14	95560486	14	95094149	225884	227696
NM_177438.2(DICER1):c.4754C>G (p.Ser1585Ter)	DICER1	Pineoblastoma|DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, multiple submitters, no conflicts	14	95562503	14	95096166	225883	227697
NM_177438.2(DICER1):c.4633dupT (p.Ser1545Phefs)	DICER1	Pineoblastoma	Pathogenic(Last reviewed: Jul 15, 2014)	criteria provided, single submitter	14	95562624	14	95096287	225885	227698
NM_177438.2(DICER1):c.4407_4410delTTCT (p.Ser1470Leufs)	DICER1	Pineoblastoma|DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, multiple submitters, no conflicts	14	95562847 - 95562850	14	95096510 - 95096513	225888	227699
NM_177438.2(DICER1):c.4050+1G>A	DICER1	Pineoblastoma|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2014)	criteria provided, multiple submitters, no conflicts	14	95569682	14	95103345	225887	227700
NM_177438.2(DICER1):c.2062C>T (p.R688*)	DICER1	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	14	95578563	14	95112226	254303	248861
NM_177438.2(DICER1):c.1498A>T (p.Lys500Ter)	DICER1	Pineoblastoma	Pathogenic(Last reviewed: Jul 15, 2014)	criteria provided, single submitter	14	95583970	14	95117633	225886	227701
NC_000014.9:g.95696766_96390792dup	BDKRB1|BDKRB2|TCL1A|GSKIP|ATG2B|C14orf132|TUNAR|LOC107984703	Essential thrombocythemia|Myelofibrosis|Acute myeloid leukemia	Likely pathogenic(Last reviewed: Jun 1, 2015)	criteria provided, single submitter	14	96163103 - 96857129	14	95696766 - 96390792	208237	204470
NM_001376.4(DYNC1H1):c.46T>C (p.Leu16=)	DYNC1H1	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, axonal, type 2O|not specified|Spinocerebellar Ataxia, Dominant|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	14	102431074	14	101964737	128938	134385
NM_001376.4(DYNC1H1):c.624G>A (p.Pro208=)	DYNC1H1	Charcot-Marie-Tooth disease, type 2|not specified|Spinocerebellar Ataxia, Dominant|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	102446161	14	101979824	128939	134386
NM_001376.4(DYNC1H1):c.791G>T (p.Arg264Leu)	DYNC1H1	Spinal muscular atrophy|SMA: Spinal muscular atrophy	Pathogenic(Last reviewed: Jun 21, 2013)	criteria provided, single submitter	14	102446717	14	101980380	162033	171752
NM_001376.4(DYNC1H1):c.1544C>T (p.Ala515Val)	DYNC1H1	Mental retardation, autosomal dominant 13	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	14	102452106	14	101985769	560993	552168
NM_001376.5(DYNC1H1):c.1792C>T (p.Arg598Cys)	DYNC1H1	Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant|Charcot-Marie-Tooth disease, axonal, type 2O|not provided|Hereditary motor and sensory neuropathy|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	14	102452354	14	101986017	139652	143271
NM_001376.4(DYNC1H1):c.1817C>T (p.Thr606Ile)	DYNC1H1	Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	14	102452379	14	101986042	560994	552169
NM_001376.4(DYNC1H1):c.2327C>T (p.Pro776Leu)	DYNC1H1	Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 20, 2017)	criteria provided, conflicting interpretations	14	102452889	14	101986552	372934	360017
NM_001376.4(DYNC1H1):c.2511A>G (p.Ala837=)	DYNC1H1	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, axonal, type 2O|not specified|Spinocerebellar Ataxia, Dominant|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Aug 4, 2017)	criteria provided, multiple submitters, no conflicts	14	102453073	14	101986736	128924	134371
NM_001376.4(DYNC1H1):c.2625G>A (p.Ser875=)	DYNC1H1	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, axonal, type 2O|not specified|Spinocerebellar Ataxia, Dominant|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 6, 2017)	criteria provided, multiple submitters, no conflicts	14	102453876	14	101987539	128933	134380
NM_001376.4(DYNC1H1):c.3600A>G (p.Gln1200=)	DYNC1H1	Charcot-Marie-Tooth disease, type 2|not specified|Spinocerebellar Ataxia, Dominant|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	102463407	14	101997070	128935	134382
NM_001376.4(DYNC1H1):c.3909G>A (p.Ala1303=)	DYNC1H1	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, axonal, type 2O|not specified|Spinocerebellar Ataxia, Dominant|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 8, 2018)	criteria provided, multiple submitters, no conflicts	14	102466430	14	102000093	128936	134383
NM_001376.4(DYNC1H1):c.3993C>T (p.Gly1331=)	DYNC1H1	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, axonal, type 2O|not specified|Spinocerebellar Ataxia, Dominant|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	14	102466655	14	102000318	128937	134384
NM_001376.4(DYNC1H1):c.4700G>T (p.Arg1567Leu)	DYNC1H1	Mental retardation, autosomal dominant 13	Likely pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	14	102469031	14	102002694	216921	213627
NM_001376.4(DYNC1H1):c.4808G>C (p.Arg1603Thr)	DYNC1H1	Mental retardation, autosomal dominant 13	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	14	102469227	14	102002890	560995	552170
NM_001376.4(DYNC1H1):c.4868G>A (p.Arg1623Gln)	DYNC1H1	Mental retardation, autosomal dominant 13|not provided	Likely pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, multiple submitters, no conflicts	14	102469287	14	102002950	424046	409059
NM_001376.4(DYNC1H1):c.7137G>A (p.Leu2379=)	DYNC1H1	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, axonal, type 2O|not specified|Spinocerebellar Ataxia, Dominant|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	14	102481564	14	102015227	128940	134387
NM_001376.4(DYNC1H1):c.7224C>T (p.Ala2408=)	DYNC1H1	Charcot-Marie-Tooth disease, axonal, type 2O|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 4, 2017)	criteria provided, conflicting interpretations	14	102481651	14	102015314	128925	134372
NM_001376.4(DYNC1H1):c.7449C>T (p.Ile2483=)	DYNC1H1	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, axonal, type 2O|not specified|Spinocerebellar Ataxia, Dominant|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	14	102482399	14	102016062	128941	134388
NM_001376.4(DYNC1H1):c.7524A>G (p.Leu2508=)	DYNC1H1	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, axonal, type 2O|not specified|Spinocerebellar Ataxia, Dominant|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Aug 4, 2017)	criteria provided, multiple submitters, no conflicts	14	102482736	14	102016399	128942	134389
NM_001376.4(DYNC1H1):c.7632A>G (p.Glu2544=)	DYNC1H1	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, axonal, type 2O|not specified|Spinocerebellar Ataxia, Dominant|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 6, 2017)	criteria provided, multiple submitters, no conflicts	14	102483120	14	102016783	128943	134390
NM_001376.4(DYNC1H1):c.8928A>G (p.Leu2976=)	DYNC1H1	Charcot-Marie-Tooth disease, type 2|not specified|Spinocerebellar Ataxia, Dominant|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	102493761	14	102027424	128944	134391
NM_001376.4(DYNC1H1):c.9069A>G (p.Gly3023=)	DYNC1H1	not provided	Uncertain significance(Last reviewed: Jun 12, 2013)	criteria provided, single submitter	14	102493976	14	102027639	128926	134373
NM_001376.4(DYNC1H1):c.10172C>T (p.Pro3391Leu)	DYNC1H1	Mental retardation, autosomal dominant 13	Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	14	102499494	14	102033157	438584	432219
NM_001376.4(DYNC1H1):c.10280A>C (p.Gln3427Pro)	DYNC1H1	Mental retardation, autosomal dominant 13	Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	14	102499688	14	102033351	488494	481362
NM_001376.4(DYNC1H1):c.10656C>T (p.Tyr3552=)	DYNC1H1	not provided	Uncertain significance(Last reviewed: Jun 4, 2013)	criteria provided, single submitter	14	102500691	14	102034354	128922	134369
NM_001376.4(DYNC1H1):c.10950C>T (p.Asn3650=)	DYNC1H1	Charcot-Marie-Tooth disease, type 2|not specified|Spinocerebellar Ataxia, Dominant|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	102504838	14	102038501	128927	134374
NM_001376.4(DYNC1H1):c.12087C>A (p.His4029Gln)	DYNC1H1	Charcot-Marie-Tooth disease, type 2|not specified|not provided|Spinocerebellar Ataxia, Dominant|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	14	102508056	14	102041719	128928	134375
NM_001376.4(DYNC1H1):c.12102+6G>A	DYNC1H1	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, axonal, type 2O|not specified|Spinocerebellar Ataxia, Dominant|Intellectual Disability, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Dec 21, 2017)	criteria provided, conflicting interpretations	14	102508077	14	102041740	128923	134370
NM_001376.4(DYNC1H1):c.13080T>C (p.Thr4360=)	DYNC1H1	Charcot-Marie-Tooth disease, type 2|not specified|Spinocerebellar Ataxia, Dominant|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	102514227	14	102047890	128929	134376
NM_001376.4(DYNC1H1):c.13372+4C>T	DYNC1H1	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, axonal, type 2O|not specified|Spinocerebellar Ataxia, Dominant|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	14	102515010	14	102048673	128931	134378
NM_001376.4(DYNC1H1):c.13372+9G>A	DYNC1H1	Charcot-Marie-Tooth disease, type 2|not specified|not provided|Spinocerebellar Ataxia, Dominant|Intellectual Disability, Dominant	Benign/Likely benign(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	14	102515015	14	102048678	128932	134379
NM_022489.3(INF2):c.311G>A (p.Cys104Tyr)	INF2	Charcot-Marie-Tooth disease, dominant intermediate E	Likely pathogenic(Last reviewed: Feb 11, 2019)	no assertion criteria provided			14	104701676	617764	609161
NM_144599.4(NIPA1):c.441A>G (p.Thr147=)	NIPA1	Spastic paraplegia 6|not specified|Spastic paraplegia, autosomal dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	23052632	15	22820436	129804	135250
NM_019066.4(MAGEL2):c.3229T>C (p.Leu1077=)	MAGEL2	not specified	Likely benign(Last reviewed: Jan 8, 2014)	criteria provided, single submitter	15	23889661	15	23644514	158813	169072
NM_019066.4(MAGEL2):c.3181_3182delAT (p.Ile1061Hisfs)	MAGEL2	Schaaf-yang syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	15	23889708 - 23889709	15	23644561 - 23644562	89002	94556
NM_019066.4(MAGEL2):c.3151C>A (p.Leu1051Ile)	MAGEL2	not specified	Benign/Likely benign(Last reviewed: Aug 18, 2015)	criteria provided, multiple submitters, no conflicts	15	23889739	15	23644592	158812	169073
NM_019066.4(MAGEL2):c.2612C>T (p.Ala871Val)	MAGEL2	not specified|not provided	Benign/Likely benign(Last reviewed: Jun 15, 2017)	criteria provided, multiple submitters, no conflicts	15	23890278	15	23645131	158811	169074
NM_019066.4(MAGEL2):c.2611G>T (p.Ala871Ser)	MAGEL2	not specified|not provided	Benign/Likely benign(Last reviewed: Jun 15, 2017)	criteria provided, multiple submitters, no conflicts	15	23890279	15	23645132	158810	169075
NM_019066.4(MAGEL2):c.1996dupC (p.Gln666Profs)	MAGEL2	not provided|Schaaf-yang syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: May 12, 2017)	criteria provided, multiple submitters, no conflicts	15	23890894	15	23645747	190122	187954
NM_019066.4(MAGEL2):c.1802delC (p.Pro601Glnfs)	MAGEL2	Schaaf-yang syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	15	23891088	15	23645941	89001	94555
NM_019066.4(MAGEL2):c.383T>C (p.Leu128Pro)	MAGEL2	not specified	Benign/Likely benign(Last reviewed: Oct 5, 2015)	criteria provided, multiple submitters, no conflicts	15	23892507	15	23647360	158814	169076
NM_130838.3(UBE3A):c.2558A>G (p.Ter853=)	UBE3A|SNHG14	Angelman syndrome|not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	15	25584285	15	25339138	96262	102156
NM_130838.1(UBE3A):c.2549G>A (p.Gly850Asp)	UBE3A|SNHG14	Angelman syndrome|not provided	Uncertain significance(Last reviewed: Jan 15, 2014)	criteria provided, multiple submitters, no conflicts	15	25584294	15	25339147	160221	169077
NM_130838.1(UBE3A):c.2507_2510delAAGA (p.Lys836Argfs)	UBE3A|SNHG14	Angelman syndrome|not provided|Inborn genetic diseases|History of neurodevelopmental disorder	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	15	25584333 - 25584336	15	25339186 - 25339189	160220	169078
NM_130838.1(UBE3A):c.2493_2509del17 (p.Ser831Argfs)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	15	25584334 - 25584350	15	25339187 - 25339203	375262	361963
NM_130838.1(UBE3A):c.2503C>T (p.Leu835Phe)	UBE3A|SNHG14	Angelman syndrome|not provided	Likely pathogenic(Last reviewed: Feb 27, 2014)	criteria provided, multiple submitters, no conflicts	15	25584340	15	25339193	156620	166474
NM_130838.1(UBE3A):c.2485T>C (p.Tyr829His)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25584358	15	25339211	160219	169079
NM_130838.1(UBE3A):c.2475_2478delACTT (p.Leu825Phefs)	UBE3A|SNHG14	Angelman syndrome	Likely pathogenic(Last reviewed: Nov 5, 2013)	criteria provided, single submitter	15	25584365 - 25584368	15	25339218 - 25339221	217026	213632
NM_130838.1(UBE3A):c.2406_2408delGAT (p.Met802del)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25585262 - 25585264	15	25340115 - 25340117	155991	165795
NM_130838.1(UBE3A):c.2245G>T (p.Glu749Ter)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Aug 14, 2013)	criteria provided, single submitter	15	25599549	15	25354402	155971	165775
NM_130838.1(UBE3A):c.2220G>C (p.Arg740=)	UBE3A|SNHG14	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25599675	15	25354528	160218	169080
NM_130838.1(UBE3A):c.2071G>A (p.Val691Ile)	UBE3A|SNHG14	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25599824	15	25354677	160217	169081
NM_130838.1(UBE3A):c.2026A>G (p.Asn676Asp)	UBE3A|SNHG14	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25601077	15	25355930	160216	169082
NM_130838.1(UBE3A):c.1821T>C (p.Asp607=)	UBE3A|SNHG14	Angelman syndrome	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25601916	15	25356769	160215	169083
NM_130838.1(UBE3A):c.1805A>G (p.Asn602Ser)	UBE3A|SNHG14	Angelman syndrome|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2016)	criteria provided, conflicting interpretations	15	25601932	15	25356785	160214	169084
NM_130838.1(UBE3A):c.1774_1777delATTG (p.Ile592Alafs)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25601960 - 25601963	15	25356813 - 25356816	160213	169085
NM_130838.1(UBE3A):c.1763A>G (p.Gln588Arg)	UBE3A|SNHG14	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25601974	15	25356827	160212	169086
NM_130838.1(UBE3A):c.1745_1747delCTT (p.Ser582del)	UBE3A|SNHG14	Angelman syndrome	Likely pathogenic(Last reviewed: Nov 14, 2013)	criteria provided, single submitter	15	25601990 - 25601992	15	25356843 - 25356845	155987	165791
NM_130838.1(UBE3A):c.1726_1730delTTTTG (p.Phe576Valfs)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25602007 - 25602011	15	25356860 - 25356864	160211	169087
NM_130838.1(UBE3A):c.1730G>A (p.Trp577Ter)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25602007	15	25356860	155959	165763
NM_130838.3(UBE3A):c.1713A>G (p.Glu571=)	UBE3A|SNHG14	Angelman syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jan 10, 2018)	criteria provided, multiple submitters, no conflicts	15	25602024	15	25356877	96258	102152
NM_130838.1(UBE3A):c.1693+12A>G	UBE3A|SNHG14	Angelman syndrome	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25605518	15	25360371	160210	169088
NM_130838.1(UBE3A):c.1688A>G (p.Asp563Gly)	UBE3A|SNHG14	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25605535	15	25360388	160209	169089
NM_130838.1(UBE3A):c.1682A>G (p.Asn561Ser)	UBE3A|SNHG14	Angelman syndrome	Uncertain significance(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	15	25605541	15	25360394	160208	169090
NM_130838.1(UBE3A):c.1634G>A (p.Gly545Glu)	UBE3A|SNHG14	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25605589	15	25360442	160207	169091
NM_130838.1(UBE3A):c.1599T>A (p.Tyr533Ter)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25605624	15	25360477	160206	169092
NM_130838.1(UBE3A):c.1567G>T (p.Glu523Ter)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25605656	15	25360509	160205	169093
NM_130838.1(UBE3A):c.1461_1468delCTACAGCT (p.Tyr488Serfs)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25615793 - 25615800	15	25370646 - 25370653	160204	169094
NM_130838.1(UBE3A):c.1347_1348delGA (p.Asn450Glnfs)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Jan 31, 2014)	criteria provided, single submitter	15	25615913 - 25615914	15	25370766 - 25370767	160203	169095
NM_130838.1(UBE3A):c.1132A>C (p.Ile378Leu)	UBE3A|SNHG14	Angelman syndrome	Uncertain significance(Last reviewed: Aug 12, 2013)	criteria provided, single submitter	15	25616129	15	25370982	160201	169096
NM_130838.1(UBE3A):c.1116A>T (p.Glu372Asp)	UBE3A|SNHG14	Angelman syndrome|not specified	Uncertain significance(Last reviewed: Oct 30, 2015)	criteria provided, multiple submitters, no conflicts	15	25616145	15	25370998	160200	169097
NM_130838.1(UBE3A):c.1110_1113delTGAA (p.Asn370Lysfs)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25616148 - 25616151	15	25371001 - 25371004	160199	169098
NM_130838.1(UBE3A):c.1090G>T (p.Glu364Ter)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25616171	15	25371024	160198	169099
NM_130838.1(UBE3A):c.964C>T (p.Gln322Ter)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25616297	15	25371150	160228	169100
NM_130838.1(UBE3A):c.829G>T (p.Glu277Ter)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Apr 30, 2013)	criteria provided, single submitter	15	25616432	15	25371285	160227	169101
NM_130838.1(UBE3A):c.755A>G (p.Asn252Ser)	UBE3A|SNHG14	Angelman syndrome|not specified	Uncertain significance(Last reviewed: Sep 20, 2017)	criteria provided, multiple submitters, no conflicts	15	25616506	15	25371359	156141	165941
NM_130838.1(UBE3A):c.505_511delGAAAAGG (p.Glu169Lysfs)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Dec 3, 2013)	criteria provided, single submitter	15	25616750 - 25616756	15	25371603 - 25371609	160226	169102
NM_130838.3(UBE3A):c.417A>T (p.Ala139=)	UBE3A|SNHG14	Angelman syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	15	25616844	15	25371697	96264	102158
NM_130838.1(UBE3A):c.388_399delATTGGAAGAGTT (p.Ile130_Val133del)	UBE3A|SNHG14	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25616862 - 25616873	15	25371715 - 25371726	160225	169103
NM_130838.1(UBE3A):c.398T>G (p.Val133Gly)	UBE3A|SNHG14	Angelman syndrome	Uncertain significance(Last reviewed: Feb 22, 2013)	criteria provided, single submitter	15	25616863	15	25371716	156131	165931
NM_130838.1(UBE3A):c.380delT (p.Ile127Thrfs)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25616881	15	25371734	160224	169104
NM_130838.1(UBE3A):c.317_321delCAGAA (p.Thr106Argfs)	UBE3A|SNHG14	Angelman syndrome|not provided	Pathogenic(Last reviewed: Oct 18, 2016)	criteria provided, multiple submitters, no conflicts	15	25616940 - 25616944	15	25371793 - 25371797	160223	169105
NM_130838.1(UBE3A):c.317C>A (p.Thr106Lys)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25616944	15	25371797	155994	165798
NM_130838.1(UBE3A):c.312_315delCTTA (p.Tyr104Terfs)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, multiple submitters, no conflicts	15	25616946 - 25616949	15	25371799 - 25371802	136192	139896
NM_130838.3(UBE3A):c.313T>C (p.Leu105=)	UBE3A|SNHG14	Angelman syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	15	25616948	15	25371801	96263	102157
NM_130838.1(UBE3A):c.268A>G (p.Met90Val)	UBE3A|SNHG14	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25620645	15	25375498	160222	169106
NM_130838.1(UBE3A):c.116G>A (p.Arg39His)	UBE3A|SNHG14	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25620797	15	25375650	160202	169107
NM_000814.5(GABRB3):c.695G>C (p.Arg232Pro)	GABRB3	Epilepsy, childhood absence 5	Likely pathogenic(Last reviewed: Apr 14, 2014)	criteria provided, single submitter	15	26812868	15	26567721	209156	205778
NM_000746.5(CHRNA7):c.241-1G>A	CHRNA7	Epilepsy, idiopathic generalized 7	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	15	32403990	15	32111789	560979	552180
NM_013372.6(GREM1):c.169A>C (p.Asn57His)	GREM1	Hereditary mixed polyposis syndrome	Uncertain significance(Last reviewed: Aug 1, 2016)	no assertion criteria provided	15	33023060	15	32730859	375861	362740
NM_005159.4(ACTC1):c.793C>G (p.Gln265Glu)	ACTC1|LOC101928174	Familial hypertrophic cardiomyopathy 11|Dilated cardiomyopathy 1R|Atrial septal defect 5|Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 26, 2018)	criteria provided, conflicting interpretations	15	35084306	15	34792105	177786	175955
NM_005159.4(ACTC1):c.301G>A (p.Glu101Lys)	ACTC1|LOC101928174	Familial hypertrophic cardiomyopathy 11|Dilated cardiomyopathy 1R|Atrial septal defect 5|Primary familial hypertrophic cardiomyopathy|Left ventricular noncompaction 4|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	15	35085599	15	34793398	18331	33370
NM_005159.4(ACTC1):c.281A>G (p.Asn94Ser)	ACTC1|LOC101928174	Familial hypertrophic cardiomyopathy 11	Likely pathogenic	criteria provided, single submitter	15	35085619	15	34793418	217487	214137
NM_152594.2(SPRED1):c.423+2T>C	SPRED1	Legius syndrome	Pathogenic(Last reviewed: Jun 24, 2016)	criteria provided, single submitter	15	38617012	15	38324811	505193	497043
NM_152594.2(SPRED1):c.973C>T (p.Arg325Ter)	SPRED1	Legius syndrome	Likely pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	15	38643503	15	38351302	374301	361214
NM_002875.4(RAD51):c.772G>A (p.Glu258Lys)	RAD51	Fanconi anemia, complementation group R	Likely pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	15	41021830	15	40729632	522859	513451
NM_173500.3(TTBK2):c.2592A>G (p.Glu864=)	TTBK2	not specified|Spinocerebellar Ataxia, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	43044852	15	42752654	130647	136093
NM_173500.3(TTBK2):c.23T>C (p.Leu8Pro)	TTBK2	not specified|Spinocerebellar Ataxia, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	43170793	15	42878595	130646	136092
NC_000015.10:g.48410990_48456762del45773	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	15	48703187 - 48748959	15	48410990 - 48456762	560348	551394
NM_000138.4(FBN1):c.8494A>G (p.Ser2832Gly)	FBN1	Marfan syndrome	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	15	48703309	15	48411112	161236	171171
NM_000138.4(FBN1):c.8473_8475delGGA (p.Gly2825del)	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: Aug 26, 2015)	criteria provided, single submitter	15	48703328 - 48703330	15	48411131 - 48411133	178674	176121
NM_000138.4(FBN1):c.8265_8266delTTinsAGGA (p.Ser2755Argfs)	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Jul 18, 2013)	criteria provided, single submitter	15	48703537 - 48703538	15	48411340 - 48411341	179129	175978
NM_000138.4(FBN1):c.8176C>T (p.Arg2726Trp)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Inborn genetic diseases|Geleophysic dysplasia|Ectopia lentis	Conflicting interpretations of pathogenicity(Last reviewed: Dec 14, 2017)	criteria provided, conflicting interpretations	15	48704816	15	48412619	16445	31484
NM_000138.4(FBN1):c.8081G>A (p.Arg2694Gln)	FBN1	Marfan syndrome	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	15	48704911	15	48412714	161240	171172
NM_000138.4(FBN1):c.8080C>T (p.Arg2694Ter)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided|Thoracic aortic Aneurysm and dissection (TAAD)	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, multiple submitters, no conflicts	15	48704912	15	48412715	163461	176122
NM_000138.4(FBN1):c.7906G>A (p.Gly2636Ser)	FBN1	Marfan syndrome|not specified	Uncertain significance(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	15	48707878	15	48415681	393275	373456
NM_000138.4(FBN1):c.7846A>G (p.Ile2616Val)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided|Thoracic aortic Aneurysm and dissection (TAAD)	Uncertain significance(Last reviewed: Oct 25, 2017)	criteria provided, multiple submitters, no conflicts	15	48707938	15	48415741	161237	171173
NM_000138.4(FBN1):c.7754T>C (p.Ile2585Thr)	FBN1	Ectopia lentis, isolated, autosomal dominant|Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome 2|Acromicric dysplasia|Geleophysic dysplasia 2|Thoracic aortic aneurysm and aortic dissection|not specified|Dilatation of ascending aorta|Scoliosis|Tall stature|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Aortic aneurysm|Joint hypermobility|Severe Myopia|Aortic aneurysm|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Cardiovascular phenotype|Marfan lipodystrophy syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 2, 2018)	criteria provided, multiple submitters, no conflicts	15	48712949	15	48420752	163462	175979
NM_000138.4(FBN1):c.7702G>A (p.Val2568Met)	FBN1	Marfan syndrome|not specified	Uncertain significance(Last reviewed: Mar 9, 2014)	criteria provided, single submitter	15	48713001	15	48420804	161238	171174
NM_000138.4(FBN1):c.7660C>T (p.Arg2554Trp)	FBN1	not specified|Marfan syndrome, incomplete	Uncertain significance(Last reviewed: May 10, 2016)	criteria provided, single submitter	15	48713794	15	48421597	161241	171175
NM_000138.4(FBN1):c.7649G>A (p.Cys2550Tyr)	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	15	48713805	15	48421608	590852	581791
NM_000138.4(FBN1):c.7580A>C (p.Glu2527Ala)	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: Feb 29, 2016)	criteria provided, single submitter	15	48713874	15	48421677	42428	51598
NM_000138.4(FBN1):c.7379A>G (p.Lys2460Arg)	FBN1	Marfan syndrome|not specified|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jun 15, 2017)	criteria provided, multiple submitters, no conflicts	15	48717640	15	48425443	161239	171176
NM_000138.4(FBN1):c.7241G>A (p.Arg2414Gln)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Thoracic aortic Aneurysm and dissection (TAAD)	Uncertain significance(Last reviewed: May 11, 2017)	criteria provided, multiple submitters, no conflicts	15	48718025	15	48425828	161234	171177
NM_000138.4(FBN1):c.7168T>C (p.Cys2390Arg)	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	15	48719800	15	48427603	42421	51591
NM_000138.4(FBN1):c.7094G>A (p.Cys2365Tyr)	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	15	48719874	15	48427677	42419	51589
NM_000138.4(FBN1):c.6886C>T (p.Gln2296Ter)	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Jan 29, 2016)	criteria provided, single submitter	15	48720654	15	48428457	177938	176124
NM_000138.4:c.6740_6871del	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	15	48722868 - 48722999	15	48430671 - 48430802	560345	551395
NM_000138.4(FBN1):c.6806T>C (p.Ile2269Thr)	FBN1	Ectopia lentis, isolated, autosomal dominant|Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome 2|Acromicric dysplasia|Geleophysic dysplasia 2|Thoracic aortic aneurysm and aortic dissection|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Cardiovascular phenotype|Marfan lipodystrophy syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 4, 2018)	criteria provided, conflicting interpretations	15	48722933	15	48430736	36107	44771
NM_000138.4(FBN1):c.6700G>A (p.Val2234Met)	FBN1	Marfan syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Cardiovascular phenotype|Geleophysic dysplasia|Ectopia lentis|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	15	48725102	15	48432905	36104	44768
NM_000138.4:c.6497_6616del	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	15	48726791 - 48726910	15	48434594 - 48434713	560346	551396
NM_000138.4(FBN1):c.6354C>G (p.Ile2118Met)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Thoracic aortic Aneurysm and dissection (TAAD)	Likely pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, multiple submitters, no conflicts	15	48729544	15	48437347	180039	175982
NM_000138.4(FBN1):c.6354C>T (p.Ile2118=)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	15	48729544	15	48437347	16449	31488
NM_000138.4:c.6038_6163del	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	15	48733918 - 48734043	15	48441721 - 48441846	560347	551397
NM_000138.4(FBN1):c.5861delT (p.Phe1954Serfs)	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Oct 27, 2016)	criteria provided, single submitter	15	48737629	15	48445432	505296	497682
NM_000138.4(FBN1):c.5788+5G>A	FBN1	Marfan syndrome|Ischemic stroke|Thoracic aortic aneurysm and aortic dissection|Ectopia lentis|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Arachnodactyly|Cutaneous melanoma|Ischemic stroke|Aortic root dilatation|Dissecting aortic dilatation|Melanoma|Severe Myopia|Ectopia lentis	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	15	48738898	15	48446701	42394	51564
NM_000138.4(FBN1):c.5788+5G>T	FBN1	Marfan syndrome	Uncertain significance(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	15	48738898	15	48446701	36095	44759
NM_000138.4(FBN1):c.5588G>A (p.Gly1863Glu)	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	15	48741048	15	48448851	42388	51558
NM_000138.4:c.5225_5296del	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	15	48752443 - 48752514	15	48460246 - 48460317	560344	551398
NM_000138.4(FBN1):c.5244_5245del (p.Cys1748Trpfs)	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	15	48752494 - 48752495	15	48460297 - 48460298	549267	539667
NM_000138.4(FBN1):c.5099A>G (p.Tyr1700Cys)	FBN1	Acromicric dysplasia|not provided	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, multiple submitters, no conflicts	15	48755404	15	48463207	29701	38656
NM_000138.4(FBN1):c.4970_4971insA (p.Cys1658Leufs)	FBN1	Congenital diaphragmatic hernia	Likely pathogenic(Last reviewed: Mar 3, 2015)	criteria provided, single submitter	15	48756190 - 48756191	15	48463993 - 48463994	218938	215774
NM_000138.4(FBN1):c.4786C>T (p.Arg1596Ter)	FBN1	Ectopia lentis, isolated, autosomal dominant|Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome 2|Acromicric dysplasia|Geleophysic dysplasia 2|Thoracic aortic aneurysm and aortic dissection|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Marfan lipodystrophy syndrome	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	15	48758017	15	48465820	36082	44746
NM_000138.4(FBN1):c.4675_4718del (p.Lys1559Leufs)	FBN1	Weill-Marchesani syndrome	Likely pathogenic(Last reviewed: Jan 29, 2016)	criteria provided, single submitter	15	48760164 - 48760207	15	48467967 - 48468010	163474	175985
NM_000138.4(FBN1):c.4615C>T (p.Arg1539Ter)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Cardiovascular phenotype	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, multiple submitters, no conflicts	15	48760267	15	48468070	42366	51536
NM_000138.4(FBN1):c.4588C>T (p.Arg1530Cys)	FBN1	Ectopia lentis, isolated, autosomal dominant|Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome 2|Acromicric dysplasia|Geleophysic dysplasia 2|Thoracic aortic aneurysm and aortic dissection|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Cardiovascular phenotype|Marfan lipodystrophy syndrome|Aortic aneurysm, ascending, and dissection	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	15	48760294	15	48468097	36078	44742
NM_000138.4(FBN1):c.4460-8G>A	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Thoracic aortic Aneurysm and dissection (TAAD)	Pathogenic/Likely pathogenic(Last reviewed: May 19, 2018)	criteria provided, multiple submitters, no conflicts	15	48760739	15	48468542	36075	44739
NM_000138.4(FBN1):c.4444G>A (p.Gly1482Ser)	FBN1	Marfan syndrome|not specified	Uncertain significance(Last reviewed: Nov 18, 2016)	criteria provided, single submitter	15	48762846	15	48470649	373256	360178
NM_000138.4(FBN1):c.4441A>G (p.Ser1481Gly)	FBN1	Ectopia lentis, isolated, autosomal dominant|Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome 2|Acromicric dysplasia|Geleophysic dysplasia 2|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Cardiovascular phenotype|Marfan lipodystrophy syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	15	48762849	15	48470652	36074	44738
NM_000138.4(FBN1):c.4406G>C (p.Arg1469Pro)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Likely pathogenic(Last reviewed: Oct 13, 2011)	criteria provided, single submitter	15	48762884	15	48470687	42361	51531
NM_000138.4(FBN1):c.4270C>G (p.Pro1424Ala)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Cardiovascular phenotype|Acute aortic dissections|Familial thoracic aortic aneurysms	Uncertain significance(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	15	48764814	15	48472617	42355	51525
NM_000138.4(FBN1):c.4222T>C (p.Cys1408Arg)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Thoracic aortic Aneurysm and dissection (TAAD)	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	15	48764862	15	48472665	42351	51521
NM_000138.4(FBN1):c.4168_4171delCTGT (p.Leu1390Alafs)	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	15	48766491 - 48766494	15	48474294 - 48474297	517371	497067
NM_000138.4(FBN1):c.3886T>C (p.Cys1296Arg)	FBN1	Marfan syndrome|not provided	Likely pathogenic(Last reviewed: Jan 18, 2014)	criteria provided, multiple submitters, no conflicts	15	48773930	15	48481733	42344	51514
NM_000138.4(FBN1):c.3797A>T (p.Tyr1266Phe)	FBN1	Marfan syndrome|not provided|Cardiovascular phenotype|Acute aortic dissections|Familial thoracic aortic aneurysms	Uncertain significance(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	15	48776056	15	48483859	161235	171178
NM_000138.4(FBN1):c.3589+31_3589+40dupTTTTATTTTA	FBN1	Marfan syndrome	Uncertain significance(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	15	48779232 - 48779241	15	48487035 - 48487044	36068	44732
NM_000138.4(FBN1):c.3589G>C (p.Asp1197His)	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	15	48779272	15	48487075	179244	176129
NM_000138.4(FBN1):c.3589G>A (p.Asp1197Asn)	FBN1	not specified	Uncertain significance(Last reviewed: Sep 30, 2011)	criteria provided, single submitter	15	48779272	15	48487075	42339	51509
NM_000138.4(FBN1):c.3509G>A (p.Arg1170His)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Marfanoid habitus|Cardiovascular phenotype|Geleophysic dysplasia|Ectopia lentis	Conflicting interpretations of pathogenicity(Last reviewed: Dec 29, 2017)	criteria provided, conflicting interpretations	15	48779352	15	48487155	16451	31490
NM_000138.4(FBN1):c.3463+1G>T	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Jul 5, 2011)	criteria provided, single submitter	15	48779508	15	48487311	42336	51506
NM_000138.4(FBN1):c.3442C>G (p.Pro1148Ala)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|FNB1 POLYMORPHISM|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Cardiovascular phenotype	Benign(Last reviewed: Aug 22, 2017)	criteria provided, multiple submitters, no conflicts	15	48779530	15	48487333	36065	44729
NM_000138.4(FBN1):c.3392A>G (p.Asn1131Ser)	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	15	48779580	15	48487383	42332	51502
NM_000138.4(FBN1):c.3373C>T (p.Arg1125Ter)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided|Thoracic aortic Aneurysm and dissection (TAAD)	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, multiple submitters, no conflicts	15	48779599	15	48487402	179632	176130
NM_000138.4(FBN1):c.3058A>G (p.Thr1020Ala)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|Thoracic aortic Aneurysm and dissection (TAAD)|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 15, 2018)	criteria provided, conflicting interpretations	15	48782072	15	48489875	42325	51495
NM_000138.4(FBN1):c.3037G>A (p.Gly1013Arg)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided|Thoracic aortic Aneurysm and dissection (TAAD)	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, multiple submitters, no conflicts	15	48782093	15	48489896	177648	175987
NM_000138.4(FBN1):c.2956G>A (p.Ala986Thr)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Thoracic aortic Aneurysm and dissection (TAAD)|Cardiovascular phenotype|Geleophysic dysplasia|Ectopia lentis|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2018)	criteria provided, conflicting interpretations	15	48782174	15	48489977	36060	44724
NM_000138.4(FBN1):c.2942G>C (p.Cys981Ser)	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: Sep 9, 2014)	criteria provided, single submitter	15	48782188	15	48489991	179765	176131
NM_000138.4(FBN1):c.2927G>A (p.Arg976His)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Thoracic aortic Aneurysm and dissection (TAAD)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 27, 2017)	criteria provided, conflicting interpretations	15	48782203	15	48490006	42321	51491
NM_000138.4(FBN1):c.2678-15C>A	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Nov 24, 2017)	no assertion criteria provided	15	48786466	15	48494269	446494	440009
NM_000138.4(FBN1):c.2489G>C (p.Cys830Ser)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Thoracic aortic Aneurysm and dissection (TAAD)	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	15	48787716	15	48495519	42310	51480
NM_000138.4(FBN1):c.2448C>G (p.Cys816Trp)	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	15	48787757	15	48495560	42306	51476
NM_000138.4(FBN1):c.2056G>A (p.Ala686Thr)	FBN1	Marfan syndrome	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	15	48796041	15	48503844	161242	171179
NM_000138.4(FBN1):c.1879C>T (p.Arg627Cys)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Thoracic aortic Aneurysm and dissection (TAAD)	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	15	48797303	15	48505106	163480	175988
NM_000138.4(FBN1):c.1793G>C (p.Cys598Ser)	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Jan 18, 2019)	no assertion criteria provided			15	48508626	617616	609012
NM_000138.4(FBN1):c.1714+2delT	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: Jan 29, 2016)	criteria provided, single submitter	15	48802239	15	48510042	228261	230588
NM_000138.4(FBN1):c.1659delT (p.His554Ilefs)	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	15	48802296	15	48510099	562234	553418
NM_000138.4(FBN1):c.1643A>T (p.Asn548Ile)	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	15	48802312	15	48510115	16432	31471
NM_000138.4(FBN1):c.1468+5G>A	FBN1	Ectopia lentis, isolated, autosomal dominant|Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome 2|Acromicric dysplasia|Geleophysic dysplasia 2|Thoracic aortic aneurysm and aortic dissection|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Cardiovascular phenotype|Marfan lipodystrophy syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, multiple submitters, no conflicts	15	48807579	15	48515382	42284	51454
NM_000138.4(FBN1):c.1345G>A (p.Val449Ile)	FBN1	Marfan syndrome|not specified	Uncertain significance(Last reviewed: Apr 25, 2016)	criteria provided, multiple submitters, no conflicts	15	48807707	15	48515510	161243	171180
NM_000138.4(FBN1):c.1335_1336insG (p.Pro446Alafs)	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Sep 17, 2013)	criteria provided, single submitter	15	48807717	15	48515520	179300	176132
NM_000138.4(FBN1):c.1192A>T (p.Arg398Ter)	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Oct 29, 2013)	criteria provided, single submitter	15	48808515	15	48516318	42281	51451
NM_000138.4(FBN1):c.1095C>A (p.Cys365Ter)	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Dec 4, 2015)	criteria provided, single submitter	15	48812908	15	48520711	42282	51452
NM_000138.4(FBN1):c.1051C>T (p.Gln351Ter)	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Sep 13, 2012)	criteria provided, single submitter	15	48812952	15	48520755	42280	51450
NM_000138.4(FBN1):c.1027G>A (p.Gly343Arg)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Cardiovascular phenotype|Geleophysic dysplasia|Ectopia lentis|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: Apr 24, 2018)	criteria provided, conflicting interpretations	15	48812976	15	48520779	161244	171181
NM_000138.4(FBN1):c.871G>T (p.Glu291Ter)	FBN1	Marfan syndrome	Pathogenic(Last reviewed: May 30, 2016)	criteria provided, single submitter	15	48818444	15	48526247	453293	446890
NM_000138.4(FBN1):c.718C>T (p.Arg240Cys)	FBN1	Ectopia lentis, isolated, autosomal dominant|Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome 2|Acromicric dysplasia|Geleophysic dysplasia 2|Thoracic aortic aneurysm and aortic dissection|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Marfan lipodystrophy syndrome	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, multiple submitters, no conflicts	15	48829826	15	48537629	16461	31500
NM_000138.4(FBN1):c.660delC (p.Cys221Valfs)	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Sep 30, 2014)	criteria provided, single submitter	15	48829884	15	48537687	179992	176133
NM_000138.4(FBN1):c.649T>G (p.Trp217Gly)	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	15	48829895	15	48537698	36101	44765
NM_000138.4(FBN1):c.561delT (p.Phe187Leufs)	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: Feb 17, 2014)	criteria provided, single submitter	15	48829983	15	48537786	42389	51559
NM_000138.4(FBN1):c.539-15delA	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Conflicting interpretations of pathogenicity(Last reviewed: May 14, 2014)	criteria provided, conflicting interpretations	15	48830020	15	48537823	36087	44751
NM_000138.4(FBN1):c.510C>G (p.Tyr170Ter)	FBN1	Marfan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, multiple submitters, no conflicts	15	48888508	15	48596311	36085	44749
NM_000138.4(FBN1):c.364C>T (p.Arg122Cys)	FBN1	Marfan syndrome|Marfan syndrome, atypical|High palate|not provided|Arachnodactyly|Lens subluxation|Aortic dissection|Cardiovascular phenotype	Pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	15	48892414	15	48600217	16440	31479
NM_000138.4(FBN1):c.165-40_165-38delCTT	FBN1	Marfan syndrome	Uncertain significance(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	15	48905327 - 48905329	15	48613130 - 48613132	36036	44700
NM_000138.4(FBN1):c.164+2T>C	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: Jul 7, 2014)	criteria provided, single submitter	15	48936801	15	48644604	163485	176134
NM_000138.4(FBN1):c.59A>G (p.Tyr20Cys)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Thoracic aortic Aneurysm and dissection (TAAD)	Conflicting interpretations of pathogenicity(Last reviewed: May 11, 2018)	criteria provided, conflicting interpretations	15	48936908	15	48644711	161245	171182
NM_001080534.2(UNC13C):c.1324_1326del (p.Lys443del)	UNC13C	Alzheimer's disease	Uncertain significance	no assertion criteria provided	15	54306424 - 54306426	15	54014227 - 54014229	427849	418806
NM_207036.1(TCF12):c.1876C>T (p.Arg626Ter)	TCF12	Craniosynostosis 3	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	15	57565358	15	57273160	374377	361216
NM_001018005.1(TPM1):c.46G>C (p.Glu16Gln)	TPM1	Primary familial hypertrophic cardiomyopathy|not provided	Likely pathogenic(Last reviewed: Nov 7, 2012)	criteria provided, single submitter	15	63335074	15	63042875	177702	176135
NM_001018005.1(TPM1):c.62G>T (p.Arg21Leu)	TPM1	Familial hypertrophic cardiomyopathy 3|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 4, 2018)	criteria provided, conflicting interpretations	15	63335090	15	63042891	181678	179749
NM_001018005.1(TPM1):c.114+2T>C	TPM1	Tetralogy of Fallot	Likely pathogenic	no assertion criteria provided	15	63335144	15	63042945	370039	354279
NM_001018005.1(TPM1):c.284T>C (p.Val95Ala)	TPM1	Familial hypertrophic cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, multiple submitters, no conflicts	15	63349227	15	63057028	12457	27496
NM_001018005.1(TPM1):c.337C>G (p.Leu113Val)	TPM1	Primary dilated cardiomyopathy|not provided|Left ventricular noncompaction 9	Likely pathogenic(Last reviewed: Dec 9, 2016)	criteria provided, multiple submitters, no conflicts	15	63349280	15	63057081	43414	52584
NM_001018005.1(TPM1):c.388A>G (p.Ile130Val)	TPM1	Pulmonary atresia with intact ventricular septum	Likely pathogenic	no assertion criteria provided	15	63351775	15	63059576	370041	354281
NM_001018005.1(TPM1):c.457C>G (p.His153Asp)	TPM1	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Apr 21, 2017)	criteria provided, conflicting interpretations	15	63351844	15	63059645	43419	52589
NM_001018005.1(TPM1):c.475G>A (p.Asp159Asn)	TPM1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1Y|not specified|not provided|Left ventricular noncompaction 9|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jan 15, 2019)	criteria provided, conflicting interpretations	15	63351862	15	63059663	43420	52590
NM_001018005.1(TPM1):c.515T>C (p.Ile172Thr)	TPM1	Primary familial hypertrophic cardiomyopathy|not specified|not provided	Uncertain significance(Last reviewed: Mar 21, 2017)	criteria provided, multiple submitters, no conflicts	15	63353090	15	63060891	31879	40539
NM_001018005.1(TPM1):c.523G>A (p.Asp175Asn)	TPM1	Familial hypertrophic cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	15	63353098	15	63060899	12456	27495
NM_000366.5(TPM1):c.559G>C (p.Glu187Gln)	TPM1	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Feb 8, 2013)	no assertion criteria provided	15	63353134	15	63060935	177659	176139
NM_001018005.1(TPM1):c.635A>T (p.Glu212Val)	TPM1	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Mar 28, 2017)	criteria provided, single submitter	15	63353983	15	63061784	492989	485938
NM_001018005.1(TPM1):c.640_645del (p.Tyr214_Ser215del)	TPM1	Hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	15	63354414 - 63354419	15	63062215 - 63062220	427949	419288
NM_001018005.1(TPM1):c.686C>T (p.Ser229Phe)	TPM1	Atrial septal defect 1	Likely pathogenic	no assertion criteria provided	15	63354460	15	63062261	370040	354280
NM_001018005.1(TPM1):c.688G>A (p.Asp230Asn)	TPM1	Primary dilated cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	15	63354462	15	63062263	31884	40544
NM_001018005.1(TPM1):c.851T>C (p.Ile284Thr)	TPM1	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	15	63356341	15	63064142	188708	186532
NM_001101362.2(KBTBD13):c.242C>T (p.Ala81Val)	KBTBD13	not specified|Nemaline Myopathy, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	65369395	15	65077057	129308	134754
NM_001101362.2(KBTBD13):c.378G>T (p.Ala126=)	KBTBD13	not specified|Nemaline Myopathy, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	65369531	15	65077193	129309	134755
NM_001101362.2(KBTBD13):c.794G>A (p.Gly265Asp)	KBTBD13	Nemaline myopathy 6|not specified|Nemaline Myopathy, Dominant	Benign/Likely benign(Last reviewed: Jul 25, 2017)	criteria provided, multiple submitters, no conflicts	15	65369947	15	65077609	129310	134756
NM_001101362.2(KBTBD13):c.798A>G (p.Glu266=)	KBTBD13	not specified|Nemaline Myopathy, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	65369951	15	65077613	129311	134757
NM_001101362.2(KBTBD13):c.954C>G (p.Thr318=)	KBTBD13	Nemaline myopathy 6|not specified|Nemaline Myopathy, Dominant	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	15	65370107	15	65077769	129312	134758
NM_001101362.2(KBTBD13):c.1128G>A (p.Thr376=)	KBTBD13	Nemaline myopathy 6|not specified|Nemaline Myopathy, Dominant	Benign/Likely benign(Last reviewed: Dec 5, 2017)	criteria provided, multiple submitters, no conflicts	15	65370281	15	65077943	129305	134751
NM_001101362.2(KBTBD13):c.1197C>T (p.Arg399=)	KBTBD13	Nemaline myopathy 6|not specified|Nemaline Myopathy, Dominant	Benign/Likely benign(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	15	65370350	15	65078012	129306	134752
NM_001101362.2(KBTBD13):c.1200T>C (p.Gly400=)	KBTBD13	not specified|Nemaline Myopathy, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	65370353	15	65078015	129307	134753
NM_002755.3(MAP2K1):c.169A>C (p.Lys57Gln)	MAP2K1	Rasopathy|Cardio-facio-cutaneous syndrome	Likely pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	15	66727453	15	66435115	40779	49249
NM_002755.3(MAP2K1):c.199G>A (p.Asp67Asn)	MAP2K1	Non-small cell lung cancer|Autism spectrum disorder|not provided|Rasopathy|Cardiofaciocutaneous syndrome 3|Cutaneous melanoma|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	15	66727483	15	66435145	40781	49251
NM_002755.3(MAP2K1):c.364A>G (p.Asn122Asp)	MAP2K1	Rasopathy	Likely pathogenic(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	15	66729156	15	66436818	228273	230599
NM_002755.3(MAP2K1):c.370C>A (p.Pro124Thr)	MAP2K1	Cardiofaciocutaneous syndrome 3	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	15	66729162	15	66436824	40742	49212
NM_002755.3(MAP2K1):c.388T>C (p.Tyr130His)	MAP2K1	Inborn genetic diseases|Cardio-facio-cutaneous syndrome	Likely pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	15	66729180	15	66436842	40747	49217
NM_002755.3(MAP2K1):c.389A>G (p.Tyr130Cys)	MAP2K1	not provided|Rasopathy|Cardiofaciocutaneous syndrome 3|Inborn genetic diseases|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	15	66729181	15	66436843	13351	28390
NM_005902.3(SMAD3):c.803G>A (p.Arg268His)	SMAD3	Thoracic aortic aneurysm and aortic dissection|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 3, 2018)	criteria provided, conflicting interpretations	15	67473723	15	67181385	213766	210283
NM_014249.3(NR2E3):c.166G>A (p.Gly56Arg)	NR2E3	Retinitis pigmentosa 37|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2016)	criteria provided, multiple submitters, no conflicts	15	72103870	15	71811530	5533	20572
NM_005477.2(HCN4):c.1928T>G (p.Leu643Arg)	HCN4	Sudden cardiac death|Sudden cardiac death|Sinus bradycardia	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	15	73617346	15	73325005	427950	419289
NM_005477.2(HCN4):c.724C>T (p.Arg242Cys)	HCN4	Brugada syndrome 8|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, multiple submitters, no conflicts	15	73659888	15	73367547	240173	242115
NM_005477.2(HCN4):c.520C>T (p.Pro174Ser)	HCN4	Brugada syndrome 8|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, multiple submitters, no conflicts	15	73660092	15	73367751	190787	188642
NM_001145357.1(SIN3A):c.848dup (p.His283Glnfs)	SIN3A	Witteveen-kolk syndrome	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	15	75703993	15	75411652	560386	551435
NM_013227.3(ACAN):c.7244A>T (p.Asp2415Val)	ACAN	Osteochondritis dissecans	Uncertain significance(Last reviewed: Jun 7, 2016)	no assertion criteria provided	15	89416167	15	88872936	252934	247337
NM_002666.4(PLIN1):c.1248C>T (p.Phe416=)	PLIN1	not specified	Benign(Last reviewed: Mar 5, 2013)	criteria provided, single submitter	15	90209135	15	89665904	129972	135418
NM_002666.4(PLIN1):c.1139C>T (p.Ala380Val)	PLIN1	not provided|Monogenic diabetes	Conflicting interpretations of pathogenicity(Last reviewed: Feb 3, 2016)	criteria provided, conflicting interpretations	15	90210237	15	89667006	129967	135413
NM_002666.4(PLIN1):c.1119C>T (p.Val373=)	PLIN1	not specified	Likely benign	no assertion criteria provided	15	90210257	15	89667026	129971	135417
NM_002666.4(PLIN1):c.1113T>C (p.Pro371=)	PLIN1	not specified	Likely benign	no assertion criteria provided	15	90210263	15	89667032	129970	135416
NM_002666.4(PLIN1):c.1043C>T (p.Ser348Leu)	PLIN1	not specified|Monogenic diabetes	Benign(Last reviewed: Aug 16, 2016)	criteria provided, multiple submitters, no conflicts	15	90210333	15	89667102	129969	135415
NM_002666.4(PLIN1):c.812C>T (p.Ala271Val)	PLIN1	not specified|Monogenic diabetes	Benign(Last reviewed: Jul 22, 2016)	criteria provided, single submitter	15	90210984	15	89667753	129974	135420
NM_002666.4(PLIN1):c.771+6T>C	PLIN1	not provided	Uncertain significance(Last reviewed: Oct 17, 2013)	criteria provided, single submitter	15	90212725	15	89669494	129968	135414
NM_002666.4(PLIN1):c.580C>G (p.Pro194Ala)	PLIN1	not specified	Likely benign	no assertion criteria provided	15	90213229	15	89669998	129973	135419
NM_002168.3(IDH2):c.1304C>T (p.Thr435Met)	IDH2	not specified|not provided	Likely benign(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	15	90627553	15	90084321	158664	169178
NM_002168.3(IDH2):c.1050C>T (p.Thr350=)	IDH2	D-2-hydroxyglutaric aciduria 2|not specified|not provided	Benign/Likely benign(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	15	90628537	15	90085305	158663	169179
NM_002168.3(IDH2):c.996C>T (p.Ser332=)	IDH2	not specified|not provided	Likely benign(Last reviewed: Oct 31, 2013)	criteria provided, single submitter	15	90628591	15	90085359	158669	169180
NM_002168.3(IDH2):c.993G>A (p.Thr331=)	IDH2	not specified	Likely benign(Last reviewed: Oct 31, 2013)	criteria provided, single submitter	15	90628594	15	90085362	158668	169181
NM_002168.3(IDH2):c.939A>G (p.Gly313=)	IDH2	not specified	Likely benign(Last reviewed: Oct 31, 2013)	criteria provided, single submitter	15	90630372	15	90087140	158667	169182
NM_002168.3(IDH2):c.419G>A (p.Arg140Gln)	IDH2	Multiple myeloma|Squamous cell carcinoma of the head and neck|Acute myeloid leukemia|D-2-hydroxyglutaric aciduria 2|Myelodysplastic syndrome|not provided|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	15	90631934	15	90088702	14716	29755
NM_002168.3(IDH2):c.374-10G>A	IDH2	not specified	Likely benign(Last reviewed: Jun 19, 2014)	criteria provided, single submitter	15	90631989	15	90088757	158666	169183
NM_001271.4(CHD2):c.628G>T (p.Glu210Ter)	CHD2	Epileptic encephalopathy, childhood-onset	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	15	93482884	15	92939654	560974	552185
NM_001271.3(CHD2):c.1937G>A (p.Gly646Glu)	CHD2	Epileptic encephalopathy, childhood-onset	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	15	93499816	15	92956586	560972	552186
NM_001271.3(CHD2):c.2699G>A (p.Arg900Gln)	CHD2	Epileptic encephalopathy, childhood-onset	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	15	93521585	15	92978355	560973	552187
NM_021005.3(NR2F2):c.247G>T (p.Gly83Ter)	NR2F2	Congenital heart defects, multiple types, 4	Pathogenic(Last reviewed: Nov 2, 2017)	no assertion criteria provided	15	96875581	15	96332352	446122	439469
NM_021005.4(NR2F2):c.746G>A (p.Trp249Ter)	NR2F2	Congenital heart defects, multiple types, 4	Uncertain significance(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	15	96877608	15	96334379	598763	589805
NC_000015.9:g.(?_23707435)_(28520316_?)del	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6	Prader-Willi syndrome	Pathogenic	criteria provided, single submitter	15	23707435 - 28520316			375417	362184
NM_000138.4:c.(?_4473)_(8280_?)del	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Sep 7, 2011)	criteria provided, single submitter	15	48703523 - 48760718	15	48411326 - 48468521	163457	175772
NM_001031737.2(CCDC78):c.966C>A (p.Asn322Lys)	CCDC78	Myopathy, centronuclear, 4|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 10, 2017)	criteria provided, conflicting interpretations	16	774193	16	724193	128634	134083
NM_001031737.2(CCDC78):c.937C>T (p.Leu313=)	CCDC78	not specified|Myopathy, centronuclear, 4	Benign(Last reviewed: Dec 6, 2017)	criteria provided, multiple submitters, no conflicts	16	774338	16	724338	128633	134082
NM_001031737.2(CCDC78):c.803C>T (p.Thr268Met)	CCDC78	not specified|Myopathy, centronuclear, 4	Benign(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	16	774472	16	724472	128632	134081
NM_001031737.2(CCDC78):c.754T>C (p.Trp252Arg)	CCDC78	not specified	Benign(Last reviewed: Aug 15, 2013)	criteria provided, multiple submitters, no conflicts	16	774692	16	724692	128631	134080
NM_001031737.2(CCDC78):c.549G>A (p.Leu183=)	CCDC78	not specified|Myopathy, centronuclear, 4	Benign(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	16	775089	16	725089	128629	134078
NM_021098.2(CACNA1H):c.4645A>G (p.Met1549Val)	CACNA1H	Primary hyperaldosteronism|Hyperaldosteronism, familial, type IV	Pathogenic(Last reviewed: Apr 24, 2015)	no assertion criteria provided	16	1262024	16	1212024	189779	187648
NM_015133.4(MAPK8IP3):c.111C>G (p.Tyr37Ter)	MAPK8IP3	MAPK8IP3-related disorder	Likely pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter			16	1706450	598741	589806
NM_000548.4(TSC2):c.45dup (p.Lys16Terfs)	TSC2	Tuberous sclerosis 2	Pathogenic(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	16	2098661	16	2048660	217252	213834
NM_000548.4(TSC2):c.167A>G (p.Asn56Ser)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 16, 2017)	criteria provided, conflicting interpretations	16	2100429	16	2050428	161398	171186
NM_000548.4(TSC2):c.223G>A (p.Glu75Lys)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 6, 2018)	criteria provided, conflicting interpretations	16	2100485	16	2050484	161399	171187
NM_000548.4(TSC2):c.226-2A>G	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Sep 3, 2013)	criteria provided, single submitter	16	2103341	16	2053340	49200	58362
NM_000548.4(TSC2):c.292C>T (p.Arg98Trp)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 28, 2017)	criteria provided, conflicting interpretations	16	2103409	16	2053408	65223	76155
NM_000548.4(TSC2):c.482-3C>T	TSC2	Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Neoplasm of brain|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	16	2105400	16	2055399	49957	59119
NM_000548.4(TSC2):c.569dup (p.Tyr190Terfs)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Jun 10, 2013)	criteria provided, single submitter	16	2105490	16	2055489	50038	59200
NM_000548.4(TSC2):c.598C>T (p.Gln200Ter)	TSC2	Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Jun 3, 2016)	criteria provided, single submitter	16	2105519	16	2055518	49376	58538
NM_000548.4(TSC2):c.646G>T (p.Glu216Ter)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Dec 15, 2014)	criteria provided, single submitter	16	2106243	16	2056242	49380	58542
NM_000548.4(TSC2):c.648+1G>A	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Dec 4, 2013)	criteria provided, single submitter	16	2106246	16	2056245	49410	58572
NM_000548.4(TSC2):c.736A>G (p.Thr246Ala)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified	Uncertain significance(Last reviewed: Mar 8, 2017)	criteria provided, multiple submitters, no conflicts	16	2106732	16	2056731	49384	58546
NM_000548.4(TSC2):c.826_827delAT (p.Met276Valfs)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	16	2107157 - 2107158	16	2057156 - 2057157	49447	58609
NM_000548.4(TSC2):c.848+1G>A	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Oct 13, 2014)	criteria provided, multiple submitters, no conflicts	16	2107180	16	2057179	49922	59084
NM_000548.4(TSC2):c.975+3A>C	TSC2	Tuberous sclerosis 2	Uncertain significance	no assertion criteria provided	16	2108877	16	2058876	430663	424191
NM_000548.3(TSC2):c.1100G>A (p.Arg367Gln)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	16	2110795	16	2060794	41725	50164
NM_000548.4(TSC2):c.1110G>A (p.Gln370=)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Aug 15, 2017)	criteria provided, multiple submitters, no conflicts	16	2110805	16	2060804	49141	58303
NM_000548.4(TSC2):c.1119+1G>C	TSC2	Tuberous sclerosis 2	Pathogenic	no assertion criteria provided	16	2110815	16	2060814	444097	437736
NM_000548.4(TSC2):c.1195G>T (p.Glu399Ter)	TSC2	Tuberous sclerosis 2|not provided	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	16	2111947	16	2061946	280323	264660
NM_000548.4(TSC2):c.1229T>G (p.Leu410Arg)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Likely pathogenic(Last reviewed: Aug 27, 2015)	criteria provided, single submitter	16	2111981	16	2061980	49680	58842
NM_000548.4(TSC2):c.1255C>T (p.Pro419Ser)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Dec 17, 2012)	criteria provided, single submitter	16	2112007	16	2062006	50176	59338
NM_000548.4(TSC2):c.1362-32C>G	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Likely benign(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	16	2112941	16	2062940	49703	58865
NM_000548.4(TSC2):c.1372C>T (p.Arg458Ter)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, multiple submitters, no conflicts	16	2112983	16	2062982	49153	58315
NM_000548.4(TSC2):c.1378G>A (p.Ala460Thr)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	16	2112989	16	2062988	49660	58822
NM_000548.4(TSC2):c.1444-2A>G	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, multiple submitters, no conflicts	16	2114271	16	2064270	49633	58795
NM_000548.4(TSC2):c.1447G>T (p.Glu483Ter)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 28, 2015)	criteria provided, multiple submitters, no conflicts	16	2114276	16	2064275	64885	75815
NM_000548.4(TSC2):c.1543C>T (p.Leu515=)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	16	2114372	16	2064371	65170	76101
NM_000548.4(TSC2):c.1574A>G (p.Asn525Ser)	TSC2	Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 10, 2018)	criteria provided, conflicting interpretations	16	2114403	16	2064402	49681	58843
NM_000548.4(TSC2):c.1578C>T (p.Ser526=)	TSC2	Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	16	2114407	16	2064406	49162	58324
NM_000548.4(TSC2):c.1599+1G>A	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, multiple submitters, no conflicts	16	2114429	16	2064428	49646	58808
NM_000548.4(TSC2):c.1678G>A (p.Val560Met)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 12, 2018)	criteria provided, multiple submitters, no conflicts	16	2115598	16	2065597	65075	76006
NM_000548.4(TSC2):c.1832G>A (p.Arg611Gln)	TSC2	Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	16	2120572	16	2070571	12397	27436
NM_000548.4(TSC2):c.1939G>A (p.Asp647Asn)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 7, 2018)	criteria provided, conflicting interpretations	16	2121610	16	2071609	41731	50170
NM_000548.4(TSC2):c.1959_1960delAG (p.Gly654Leufs)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Jan 14, 2013)	criteria provided, single submitter	16	2121797 - 2121798	16	2071796 - 2071797	65311	76243
NM_000548.4(TSC2):c.2074G>A (p.Val692Ile)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Uncertain significance(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	16	2121912	16	2071911	226045	227853
NM_000548.4(TSC2):c.2108G>A (p.Trp703Ter)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	16	2122252	16	2072251	49736	58898
NM_000548.4(TSC2):c.2251C>T (p.Arg751Ter)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, multiple submitters, no conflicts	16	2122880	16	2072879	50131	59293
NM_000548.4(TSC2):c.2331T>C (p.His777=)	TSC2	Tuberous sclerosis 2|not specified|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Dec 3, 2017)	criteria provided, multiple submitters, no conflicts	16	2122960	16	2072959	130643	136089
NM_000548.4(TSC2):c.2355+2_2355+5del	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Dec 3, 2014)	criteria provided, single submitter	16	2122986 - 2122989	16	2072985 - 2072988	12406	27445
NM_000548.4(TSC2):c.2356-2A>C	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Sep 24, 2014)	criteria provided, single submitter	16	2124199	16	2074198	49205	58367
NM_000548.4(TSC2):c.2410T>C (p.Cys804Arg)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 18, 2015)	criteria provided, multiple submitters, no conflicts	16	2124255	16	2074254	49725	58887
NM_000548.4(TSC2):c.2459_2461delTCA (p.Ile820del)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Likely pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	16	2124304 - 2124306	16	2074303 - 2074305	49592	58754
NM_000548.4(TSC2):c.2476C>A (p.Leu826Met)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2018)	criteria provided, conflicting interpretations	16	2124321	16	2074320	41732	50171
NM_000548.4(TSC2):c.2521G>A (p.Val841Ile)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2016)	criteria provided, conflicting interpretations	16	2124366	16	2074365	237994	242259
NM_000548.4(TSC2):c.2580T>C (p.Phe860=)	TSC2	Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	16	2125834	16	2075833	49573	58735
NM_000548.4(TSC2):c.2639+1G>C	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Aug 8, 2012)	criteria provided, single submitter	16	2125894	16	2075893	49845	59007
NM_000548.4(TSC2):c.2666C>T (p.Ala889Val)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 19, 2017)	criteria provided, conflicting interpretations	16	2126095	16	2076094	49586	58748
NM_000548.4(TSC2):c.2713C>T (p.Arg905Trp)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	16	2126142	16	2076141	12404	27443
NM_000548.4(TSC2):c.3095G>C (p.Arg1032Pro)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2017)	criteria provided, multiple submitters, no conflicts	16	2129161	16	2079160	49241	58403
NM_000548.4(TSC2):c.3126G>C (p.Pro1042=)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	16	2129192	16	2079191	49739	58901
NM_000548.4(TSC2):c.3206_3207delTG (p.Val1069Aspfs)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Feb 5, 2017)	criteria provided, multiple submitters, no conflicts	16	2129351 - 2129352	16	2079350 - 2079351	49246	58408
NM_000548.4(TSC2):c.3401delG (p.Gly1134Alafs)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Jun 18, 2013)	criteria provided, multiple submitters, no conflicts	16	2130169	16	2080168	50076	59238
NM_000548.4(TSC2):c.3412C>T (p.Arg1138Ter)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, multiple submitters, no conflicts	16	2130180	16	2080179	49257	58419
NM_000548.4(TSC2):c.3421G>A (p.Ala1141Thr)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 22, 2018)	criteria provided, conflicting interpretations	16	2130189	16	2080188	49258	58420
NM_000548.4(TSC2):c.3430G>A (p.Val1144Met)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2018)	criteria provided, conflicting interpretations	16	2130198	16	2080197	41733	50172
NM_000548.4(TSC2):c.3598C>T (p.Arg1200Trp)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, multiple submitters, no conflicts	16	2130366	16	2080365	49770	58932
NM_000548.4(TSC2):c.3611G>A (p.Gly1204Glu)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Likely pathogenic(Last reviewed: Mar 24, 2016)	criteria provided, multiple submitters, no conflicts	16	2131596	16	2081595	50148	59310
NM_000548.4(TSC2):c.3696dup (p.Asn1233Terfs)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Jun 27, 2012)	criteria provided, single submitter	16	2131681	16	2081680	49539	58701
NM_000548.4(TSC2):c.3883+8C>G	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Jan 25, 2018)	criteria provided, multiple submitters, no conflicts	16	2132513	16	2082512	50027	59189
NM_000548.4(TSC2):c.3914C>T (p.Pro1305Leu)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 22, 2018)	criteria provided, multiple submitters, no conflicts	16	2133726	16	2083725	41737	50176
NM_000548.4(TSC2):c.3915G>A (p.Pro1305=)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	16	2133727	16	2083726	49280	58442
NM_000548.4(TSC2):c.3986G>A (p.Arg1329His)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	16	2133798	16	2083797	41738	50177
NM_000548.4(TSC2):c.4096G>T (p.Glu1366Ter)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Jan 17, 2013)	criteria provided, single submitter	16	2134319	16	2084318	49555	58717
NM_000548.4(TSC2):c.4115_4116delTG (p.Val1372Glyfs)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Jun 27, 2012)	criteria provided, single submitter	16	2134338 - 2134339	16	2084337 - 2084338	49284	58446
NM_000548.4(TSC2):c.4147_4163dup (p.Pro1389Alafs)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Aug 13, 2012)	criteria provided, single submitter	16	2134370 - 2134386	16	2084369 - 2084385	65019	75949
NM_000548.4(TSC2):c.4180_4181delCT (p.Leu1394Alafs)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Jul 19, 2013)	criteria provided, single submitter	16	2134403 - 2134404	16	2084402 - 2084403	50061	59223
NM_000548.4(TSC2):c.4215C>T (p.Ala1405=)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	16	2134438	16	2084437	49503	58665
NM_000548.4(TSC2):c.4318C>T (p.Gln1440Ter)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, multiple submitters, no conflicts	16	2134541	16	2084540	49524	58686
NM_000548.4(TSC2):c.4375C>T (p.Arg1459Ter)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Nov 23, 2015)	criteria provided, multiple submitters, no conflicts	16	2134598	16	2084597	49986	59148
NM_000548.3(TSC2):c.4536C>T (p.Asp1512=)	TSC2	Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 9, 2018)	criteria provided, multiple submitters, no conflicts	16	2134994	16	2084993	49504	58666
NM_000548.4(TSC2):c.4544_4547delACAA (p.Asn1515Serfs)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Jun 21, 2017)	criteria provided, multiple submitters, no conflicts	16	2135002 - 2135005	16	2085001 - 2085004	49304	58466
NM_000548.4(TSC2):c.4762C>T (p.Gln1588Ter)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, multiple submitters, no conflicts	16	2136293	16	2086292	50097	59259
NM_000548.4(TSC2):c.4842_4844delCAT (p.Ile1614del)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Feb 25, 2015)	criteria provided, single submitter	16	2136373 - 2136375	16	2086372 - 2086374	49325	58487
NM_000548.4(TSC2):c.4912_4914delAAG (p.Lys1638del)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	16	2136795 - 2136797	16	2086794 - 2086796	49893	59055
NM_000548.4(TSC2):c.4934_4935delTT (p.Phe1645Cysfs)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	16	2136817 - 2136818	16	2086816 - 2086817	49981	59143
NM_000548.4(TSC2):c.4983C>T (p.Thr1661=)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	16	2136866	16	2086865	49467	58629
NM_000548.4(TSC2):c.4989+1G>A	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	16	2136873	16	2086872	49468	58630
NM_000548.4(TSC2):c.5138G>C (p.Arg1713Pro)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Likely pathogenic(Last reviewed: Jun 10, 2015)	criteria provided, single submitter	16	2138118	16	2088117	49931	59093
NM_000548.4(TSC2):c.5160+1G>A	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	16	2138141	16	2088140	49425	58587
NM_000548.4(TSC2):c.5161-10A>C	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided	Benign(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	16	2138218	16	2088217	49431	58593
NM_000548.4(TSC2):c.5170C>T (p.Gln1724Ter)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Jan 20, 2015)	criteria provided, single submitter	16	2138237	16	2088236	49950	59112
NM_000548.3(TSC2):c.5202T>C (p.Asp1734=)	TSC2	Lymphangiomyomatosis|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: May 2, 2017)	criteria provided, multiple submitters, no conflicts	16	2138269	16	2088268	49895	59057
NM_000548.4(TSC2):c.5227C>T (p.Arg1743Trp)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	16	2138294	16	2088293	49471	58633
NM_000548.3(TSC2):c.5228G>A (p.Arg1743Gln)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, multiple submitters, no conflicts	16	2138295	16	2088294	49960	59122
NM_000548.4(TSC2):c.5238_5255del18 (p.His1746_Arg1751del)	TSC2	Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	16	2138305 - 2138322	16	2088304 - 2088321	12402	27441
NM_000548.4(TSC2):c.5252_5259+19del	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: May 3, 2013)	criteria provided, single submitter	16	2138319 - 2138345	16	2088318 - 2088344	49366	58528
NM_000548.4(TSC2):c.5259+1del	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, multiple submitters, no conflicts	16	2138327	16	2088326	49417	58579
NM_000548.4(TSC2):c.5321G>C (p.Ser1774Thr)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	16	2138508	16	2088507	41745	50184
NM_000548.4(TSC2):c.5359G>A (p.Gly1787Ser)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	16	2138546	16	2088545	41746	50185
NM_000548.4(TSC2):c.5378G>A (p.Arg1793Gln)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 4, 2018)	criteria provided, conflicting interpretations	16	2138565	16	2088564	49941	59103
NM_000548.3(TSC2):c.5383C>T (p.Arg1795Cys)	TSC2	Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis and lymphangiomyomatosis	Conflicting interpretations of pathogenicity(Last reviewed: Mar 7, 2018)	criteria provided, conflicting interpretations	16	2138570	16	2088569	41748	50187
NM_000548.4(TSC2):c.5397G>C (p.Ser1799=)	TSC2	Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Aug 23, 2016)	criteria provided, multiple submitters, no conflicts	16	2138584	16	2088583	49847	59009
NM_001009944.2(PKD1):c.12499delA (p.Arg4167Glyfs)	PKD1	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Dec 30, 2016)	no assertion criteria provided	16	2140141	16	2090140	488184	481143
NM_001009944.2(PKD1):c.11900_11925del26insAAGCTAGTGA (p.Val3967Glufs)	PKD1	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Aug 29, 2016)	no assertion criteria provided	16	2140963 - 2140988	16	2090962 - 2090987	267265	262268
NM_001009944.2(PKD1):c.11314delG (p.Ala3772Profs)	PKD1|LOC105371049	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Dec 30, 2016)	no assertion criteria provided	16	2142145	16	2092144	488405	481259
NM_001009944.2(PKD1):c.10583G>A (p.Trp3528Ter)	PKD1|LOC105371049	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Aug 3, 2015)	criteria provided, single submitter	16	2144128	16	2094127	369676	353909
NM_001009944.2(PKD1):c.10487delT (p.Leu3496Argfs)	PKD1	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	16	2147161	16	2097160	488344	481173
NM_001009944.2(PKD1):c.10348G>T (p.Glu3450Ter)	PKD1	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Dec 30, 2016)	no assertion criteria provided	16	2147377	16	2097376	488408	481262
NM_001009944.2(PKD1):c.10220+2_10220+3delTG	PKD1	Polycystic kidney disease, adult type	Pathogenic	no assertion criteria provided	16	2147726 - 2147727	16	2097725 - 2097726	427741	417443
NM_001009944.2(PKD1):c.8998dup (p.Arg3000Profs)	PKD1	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	16	2152585	16	2102584	488185	481144
NM_001009944.2(PKD1):c.8704C>T (p.Gln2902Ter)	PKD1	Polycystic kidney disease, adult type|not provided	Pathogenic(Last reviewed: Aug 2, 2016)	criteria provided, single submitter	16	2153354	16	2103353	441260	434903
NM_001009944.2(PKD1):c.7925_7926delTA (p.Ile2642Thrfs)	PKD1	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	16	2155413 - 2155414	16	2105412 - 2105413	549710	540477
NM_001009944.2(PKD1):c.7622delC (p.Pro2541Argfs)	PKD1	Polycystic kidney disease, autosomal dominant	Pathogenic	no assertion criteria provided	16	2156173	16	2106172	559836	550558
NM_001009944.2(PKD1):c.7275C>T (p.Gly2425=)	PKD1	Polycystic kidney disease, adult type|not specified	Conflicting interpretations of pathogenicity(Last reviewed: May 20, 2016)	criteria provided, conflicting interpretations	16	2156613	16	2106612	256999	255587
NM_001009944.2(PKD1):c.7268C>A (p.Ser2423Tyr)	PKD1	Polycystic kidney disease, adult type	Likely pathogenic	no assertion criteria provided	16	2156620	16	2106619	496638	488123
NM_001009944.2(PKD1):c.7226C>T (p.Thr2409Met)	PKD1	Polycystic kidney disease, adult type	Uncertain significance(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	16	2156662	16	2106661	584459	575501
NM_001009944.2(PKD1):c.5986G>A (p.Val1996Met)	PKD1	Polycystic kidney disease, adult type	Uncertain significance	no assertion criteria provided	16	2159182	16	2109181	427735	417437
NM_001009944.2(PKD1):c.5809delT (p.Ser1937Profs)	PKD1	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	16	2159359	16	2109358	488406	481260
NM_001009944.2(PKD1):c.5366C>G (p.Ser1789Ter)	PKD1	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Jan 17, 2019)	no assertion criteria provided			16	2109801	617551	608920
NM_001009944.2(PKD1):c.5021delC (p.Pro1674Argfs)	PKD1	Polycystic kidney disease, adult type	Pathogenic	no assertion criteria provided	16	2160147	16	2110146	433540	427114
NM_001009944.2(PKD1):c.3503dup (p.Val1169Cysfs)	PKD1	Polycystic kidney disease, adult type	Pathogenic	no assertion criteria provided	16	2161665	16	2111664	433550	427122
NM_001009944.2(PKD1):c.1148C>A (p.Ser383Ter)	PKD1	Polycystic kidney disease, adult type	Pathogenic(Last reviewed: Dec 30, 2016)	no assertion criteria provided	16	2167845	16	2117844	488407	481261
NM_000296.3(PKD1):c.856_862del (p.Gly287Terfs)	PKD1	Polycystic kidney disease, adult type|not provided	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, multiple submitters, no conflicts	16	2168131 - 2168137	16	2118130 - 2118136	448020	441880
NM_001009944.2(PKD1):c.696T>G (p.Cys232Trp)	PKD1	Polycystic kidney disease, adult type	Likely pathogenic	no assertion criteria provided	16	2168297	16	2118296	427736	417438
NM_001009944.2(PKD1):c.127C>G (p.Pro43Ala)	PKD1	Polycystic kidney disease, adult type	Uncertain significance	no assertion criteria provided	16	2185564	16	2135563	427740	417442
NM_032271.2(TRAF7):c.1964G>A (p.Arg655Gln)	TRAF7	CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY|TRAF7-related developmental delay, congenital anomalies, and dysmorphic features	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	16	2226351	16	2176350	587685	578643
NM_001199107.1(TBC1D24):c.404C>T (p.Pro135Leu)	TBC1D24	Parkinsonism|Autosomal dominant epilepsy	Pathogenic(Last reviewed: Jan 10, 2017)	no assertion criteria provided	16	2546553	16	2496552	375708	362597
NM_000243.2(MEFV):c.2082G>A (p.Met694Ile)	MEFV	Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|not provided	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, multiple submitters, no conflicts	16	3293405	16	3243405	2539	17578
NM_004380.2(CREBBP):c.7293G>A (p.Thr2431=)	CREBBP	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3777755	16	3727754	158401	169203
NM_004380.2(CREBBP):c.7212A>G (p.Glu2404=)	CREBBP	Rubinstein-Taybi syndrome 1|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 20, 2017)	criteria provided, multiple submitters, no conflicts	16	3777836	16	3727835	95067	100967
NM_004380.2(CREBBP):c.7098G>C (p.Arg2366=)	CREBBP	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3777950	16	3727949	158400	169204
NM_004380.2(CREBBP):c.7040C>T (p.Ala2347Val)	CREBBP	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3778008	16	3728007	158399	169205
NM_004380.2(CREBBP):c.6711C>T (p.Pro2237=)	CREBBP	Rubinstein-Taybi syndrome 1|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 13, 2017)	criteria provided, multiple submitters, no conflicts	16	3778337	16	3728336	95066	100966
NM_004380.2(CREBBP):c.6624A>C (p.Gln2208His)	CREBBP	not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	16	3778424	16	3728423	158398	169206
NM_004380.2(CREBBP):c.6624A>G (p.Gln2208=)	CREBBP	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jul 28, 2016)	criteria provided, multiple submitters, no conflicts	16	3778424	16	3728423	95064	100964
NM_004380.2(CREBBP):c.6621A>G (p.Gln2207=)	CREBBP	Rubinstein-Taybi syndrome 1|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 19, 2017)	criteria provided, multiple submitters, no conflicts	16	3778427	16	3728426	95063	100963
NM_004380.2(CREBBP):c.6609A>G (p.Gln2203=)	CREBBP	not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: May 2, 2016)	criteria provided, multiple submitters, no conflicts	16	3778439	16	3728438	95062	100962
NM_004380.2(CREBBP):c.6449C>T (p.Pro2150Leu)	CREBBP	Rubinstein-Taybi syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3778599	16	3728598	158397	169207
NM_004380.2(CREBBP):c.6130_6171del (p.Ala2044_Gln2057del)	CREBBP	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3778877 - 3778918	16	3728876 - 3728917	158396	169208
NM_004380.2(CREBBP):c.6090G>A (p.Gln2030=)	CREBBP	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 10, 2014)	criteria provided, conflicting interpretations	16	3778958	16	3728957	158395	169209
NM_004380.2(CREBBP):c.6088C>T (p.Gln2030Ter)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3778960	16	3728959	158394	169210
NM_004380.2(CREBBP):c.6003T>C (p.Asn2001=)	CREBBP	not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jul 22, 2016)	criteria provided, multiple submitters, no conflicts	16	3779045	16	3729044	95059	100959
NM_004380.2(CREBBP):c.5988C>T (p.Ala1996=)	CREBBP	Rubinstein-Taybi syndrome 1|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 19, 2017)	criteria provided, multiple submitters, no conflicts	16	3779060	16	3729059	95058	100958
NM_004380.2(CREBBP):c.5933A>G (p.Asn1978Ser)	CREBBP	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: May 8, 2017)	criteria provided, multiple submitters, no conflicts	16	3779115	16	3729114	95057	100957
NM_004380.2(CREBBP):c.5869del (p.Glu1957Lysfs)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3779179	16	3729178	158392	169211
NM_004380.2(CREBBP):c.5834_5844del (p.Pro1945Argfs)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3779204 - 3779214	16	3729203 - 3729213	158390	169212
NM_004380.2(CREBBP):c.5837del (p.Pro1946Hisfs)	CREBBP	Rubinstein-Taybi syndrome 1|not provided	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, multiple submitters, no conflicts	16	3779211	16	3729210	158391	169213
NM_004380.2(CREBBP):c.5829G>A (p.Pro1943=)	CREBBP	not specified|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: May 3, 2016)	criteria provided, conflicting interpretations	16	3779219	16	3729218	158389	169214
NM_004380.2(CREBBP):c.5821C>T (p.Gln1941Ter)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Oct 10, 2013)	criteria provided, single submitter	16	3779227	16	3729226	158388	169215
NM_004380.2(CREBBP):c.5800T>C (p.Ser1934Pro)	CREBBP	Rubinstein-Taybi syndrome 1|not provided	Uncertain significance(Last reviewed: Apr 1, 2015)	criteria provided, multiple submitters, no conflicts	16	3779248	16	3729247	158387	169216
NM_004380.2(CREBBP):c.5719G>A (p.Ala1907Thr)	CREBBP	Rubinstein-Taybi syndrome 1|not specified|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jan 10, 2018)	criteria provided, conflicting interpretations	16	3779329	16	3729328	95056	100956
NM_004380.2(CREBBP):c.5614A>G (p.Met1872Val)	CREBBP	Rubinstein-Taybi syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, multiple submitters, no conflicts	16	3779434	16	3729433	209145	205780
NM_004380.2(CREBBP):c.5454G>A (p.Val1818=)	CREBBP	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Sep 14, 2016)	criteria provided, multiple submitters, no conflicts	16	3779594	16	3729593	158386	169217
NM_004380.2(CREBBP):c.5436C>G (p.Thr1812=)	CREBBP	not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: May 20, 2016)	criteria provided, multiple submitters, no conflicts	16	3779612	16	3729611	95054	100954
NM_004380.2(CREBBP):c.5050T>C (p.Ser1684Pro)	CREBBP	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3781315	16	3731314	158385	169218
NM_004380.2(CREBBP):c.4894T>C (p.Phe1632Leu)	CREBBP	Rubinstein-Taybi syndrome 1	Uncertain significance(Last reviewed: Apr 15, 2013)	criteria provided, single submitter	16	3781471	16	3731470	158383	169220
NM_004380.2(CREBBP):c.4792del (p.Ser1598Alafs)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3781875	16	3731874	158382	169221
NM_004380.2(CREBBP):c.4729-14G>C	CREBBP	not specified	Benign(Last reviewed: Sep 17, 2015)	criteria provided, multiple submitters, no conflicts	16	3781952	16	3731951	158381	169222
NM_004380.2(CREBBP):c.4689del (p.Lys1565Argfs)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3786076	16	3736075	158380	169223
NM_004380.2(CREBBP):c.4560+14A>G	CREBBP	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3786637	16	3736636	158378	169224
NM_004380.2(CREBBP):c.4560+7G>A	CREBBP	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3786644	16	3736643	158379	169225
NM_004380.2(CREBBP):c.4508A>G (p.Tyr1503Cys)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3786703	16	3736702	158377	169226
NM_004380.2(CREBBP):c.4445A>G (p.Tyr1482Cys)	CREBBP	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3786766	16	3736765	158376	169227
NM_004380.2(CREBBP):c.4444T>G (p.Tyr1482Asp)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Oct 10, 2013)	criteria provided, single submitter	16	3786767	16	3736766	158375	169228
NM_004380.2(CREBBP):c.4398T>A (p.Tyr1466Ter)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3786813	16	3736812	158374	169229
NM_004380.2(CREBBP):c.4376A>G (p.Glu1459Gly)	CREBBP	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3788578	16	3738577	158373	169230
NM_004380.2(CREBBP):c.4281-11C>G	CREBBP	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3788684	16	3738683	158372	169231
NM_004380.2(CREBBP):c.4280+8T>C	CREBBP	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 24, 2014)	criteria provided, conflicting interpretations	16	3789571	16	3739570	158371	169232
NM_004380.2(CREBBP):c.4226T>C (p.Phe1409Ser)	CREBBP	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3789633	16	3739632	158370	169233
NM_004380.2(CREBBP):c.4134-1G>T	CREBBP	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: May 13, 2016)	criteria provided, single submitter	16	3789726	16	3739725	268132	263759
NM_004380.2(CREBBP):c.4133+1G>A	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Oct 30, 2013)	criteria provided, single submitter	16	3790399	16	3740398	158369	169234
NM_004380.2(CREBBP):c.4078C>T (p.Arg1360Ter)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3790455	16	3740454	158368	169235
NM_004380.2(CREBBP):c.4045C>T (p.Gln1349Ter)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3790488	16	3740487	158367	169236
NM_004380.2(CREBBP):c.4022G>C (p.Arg1341Pro)	CREBBP	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3790511	16	3740510	158366	169237
NM_004380.2(CREBBP):c.3989A>G (p.Gln1330Arg)	CREBBP	Rubinstein-Taybi syndrome 1	Uncertain significance(Last reviewed: Sep 3, 2013)	criteria provided, single submitter	16	3790544	16	3740543	158365	169238
NM_004380.2(CREBBP):c.3983-2A>G	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Sep 3, 2013)	criteria provided, single submitter	16	3790552	16	3740551	158364	169239
NM_004380.2(CREBBP):c.3914+3G>T	CREBBP	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3795275	16	3745274	158363	169240
NM_004380.2(CREBBP):c.3900C>A (p.Ile1300=)	CREBBP	Rubinstein-Taybi syndrome 1|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 24, 2016)	criteria provided, multiple submitters, no conflicts	16	3795292	16	3745291	158362	169241
NM_004380.2(CREBBP):c.3837-8C>T	CREBBP	not specified	Benign(Last reviewed: Mar 18, 2013)	criteria provided, multiple submitters, no conflicts	16	3795363	16	3745362	95045	100945
NM_004380.2(CREBBP):c.3836+1G>A	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3799627	16	3749626	158361	169242
NM_004380.2(CREBBP):c.3832G>A (p.Glu1278Lys)	CREBBP	Rubinstein-Taybi syndrome 1|not provided	Pathogenic(Last reviewed: Mar 15, 2016)	criteria provided, multiple submitters, no conflicts	16	3799632	16	3749631	9433	24472
NM_004380.2(CREBBP):c.3779+1G>A	CREBBP	Rubinstein-Taybi syndrome 1|not provided	Pathogenic(Last reviewed: Feb 8, 2017)	criteria provided, multiple submitters, no conflicts	16	3801726	16	3751725	158359	169243
NM_004380.2(CREBBP):c.3613G>T (p.Glu1205Ter)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3807374	16	3757373	158358	169244
NM_004380.2(CREBBP):c.3500A>G (p.Tyr1167Cys)	CREBBP	Rubinstein-Taybi syndrome 1	Conflicting interpretations of pathogenicity(Last reviewed: May 8, 2018)	criteria provided, conflicting interpretations	16	3807919	16	3757918	158357	169245
NM_004380.2(CREBBP):c.3369+1G>T	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3808854	16	3758853	158356	169246
NM_004380.2(CREBBP):c.3310C>T (p.Gln1104Ter)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3808914	16	3758913	158355	169247
NM_004380.2(CREBBP):c.2974G>A (p.Val992Ile)	CREBBP	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 18, 2016)	criteria provided, multiple submitters, no conflicts	16	3819261	16	3769260	95040	100940
NM_004380.2(CREBBP):c.2973C>T (p.Asp991=)	CREBBP	not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Nov 8, 2016)	criteria provided, multiple submitters, no conflicts	16	3819262	16	3769261	95039	100939
NM_004380.2(CREBBP):c.2941G>A (p.Ala981Thr)	CREBBP	Rubinstein-Taybi syndrome 1|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: May 17, 2016)	criteria provided, multiple submitters, no conflicts	16	3819294	16	3769293	95037	100937
NM_004380.2(CREBBP):c.2811G>A (p.Pro937=)	CREBBP	Rubinstein-Taybi syndrome 1|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Apr 7, 2016)	criteria provided, conflicting interpretations	16	3820640	16	3770639	95036	100936
NM_004380.2(CREBBP):c.2791C>T (p.Gln931Ter)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3820660	16	3770659	158351	169248
NM_004380.2(CREBBP):c.2784G>A (p.Pro928=)	CREBBP	Rubinstein-Taybi syndrome 1|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 24, 2016)	criteria provided, multiple submitters, no conflicts	16	3820667	16	3770666	158350	169249
NM_004380.2(CREBBP):c.2728A>G (p.Thr910Ala)	CREBBP	Rubinstein-Taybi syndrome 1|not specified|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Mar 17, 2017)	criteria provided, conflicting interpretations	16	3820723	16	3770722	30042	38997
NM_004380.2(CREBBP):c.2679G>A (p.Ser893=)	CREBBP	Rubinstein-Taybi syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3820772	16	3770771	158349	169250
NM_004380.2(CREBBP):c.2606_2607del (p.Leu869Profs)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3820844 - 3820845	16	3770843 - 3770844	158348	169251
NM_004380.2(CREBBP):c.2606T>C (p.Leu869Pro)	CREBBP	Rubinstein-Taybi syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3820845	16	3770844	158347	169252
NM_004380.2(CREBBP):c.2535C>A (p.Cys845Ter)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3820916	16	3770915	158346	169253
NM_004380.2(CREBBP):c.2122_2123del (p.Leu708Valfs)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Sep 19, 2013)	criteria provided, single submitter	16	3827649 - 3827650	16	3777648 - 3777649	158345	169254
NM_004380.2(CREBBP):c.2026del (p.Gln676Lysfs)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3828099	16	3778098	158344	169255
NM_004380.2(CREBBP):c.1955A>C (p.His652Pro)	CREBBP	Rubinstein-Taybi syndrome 1	Uncertain significance(Last reviewed: Nov 27, 2013)	criteria provided, single submitter	16	3828170	16	3778169	158343	169256
NM_004380.2(CREBBP):c.1953T>C (p.Tyr651=)	CREBBP	Rubinstein-Taybi syndrome 1|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 20, 2017)	criteria provided, multiple submitters, no conflicts	16	3828172	16	3778171	158342	169257
NM_004380.2(CREBBP):c.1821del (p.Lys607Asnfs)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3830735	16	3780734	158341	169258
NM_004380.2(CREBBP):c.1651C>A (p.Leu551Ile)	CREBBP	Rubinstein-Taybi syndrome 1|not specified|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jan 30, 2018)	criteria provided, conflicting interpretations	16	3831230	16	3781229	95026	100926
NM_004380.2(CREBBP):c.1590del (p.Asn530Lysfs)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3831291	16	3781290	158339	169259
NM_004380.2(CREBBP):c.1270C>T (p.Arg424Ter)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3842042	16	3792041	158338	169260
NM_004380.2(CREBBP):c.1257G>A (p.Trp419Ter)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3842055	16	3792054	158337	169261
NM_004380.2(CREBBP):c.1211G>C (p.Cys404Ser)	CREBBP	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3843392	16	3793391	158336	169262
NM_004380.2(CREBBP):c.1156C>T (p.Arg386Ter)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3843447	16	3793446	158335	169263
NM_004380.2(CREBBP):c.1149G>A (p.Pro383=)	CREBBP	Rubinstein-Taybi syndrome 1|not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jul 15, 2016)	criteria provided, conflicting interpretations	16	3843454	16	3793453	95023	100923
NM_004380.2(CREBBP):c.1063C>T (p.Gln355Ter)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3843540	16	3793539	158334	169264
NM_004380.2(CREBBP):c.953C>A (p.Ser318Ter)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3860626	16	3810625	158403	169265
NM_004380.2(CREBBP):c.939T>C (p.Asp313=)	CREBBP	Rubinstein-Taybi syndrome 1|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 19, 2017)	criteria provided, multiple submitters, no conflicts	16	3860640	16	3810639	95070	100970
NM_004380.2(CREBBP):c.598C>T (p.Gln200Ter)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3900498	16	3850497	158393	169266
NM_004380.2(CREBBP):c.459G>A (p.Pro153=)	CREBBP	Rubinstein-Taybi syndrome 1|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Nov 30, 2017)	criteria provided, multiple submitters, no conflicts	16	3900637	16	3850636	95049	100949
NM_004380.2(CREBBP):c.383C>G (p.Ser128Cys)	CREBBP	not specified|not provided	Likely benign(Last reviewed: Mar 3, 2017)	criteria provided, multiple submitters, no conflicts	16	3900713	16	3850712	133930	137669
NM_004380.2(CREBBP):c.316C>T (p.Gln106Ter)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jun 27, 2013)	criteria provided, single submitter	16	3900780	16	3850779	158354	169267
NM_004380.2(CREBBP):c.299del (p.Gly100Valfs)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3900797	16	3850796	158353	169268
NM_004380.2(CREBBP):c.286C>T (p.Gln96Ter)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3900810	16	3850809	158352	169269
NM_004380.2(CREBBP):c.164A>G (p.Asn55Ser)	CREBBP	Rubinstein-Taybi syndrome 1	Uncertain significance(Last reviewed: Sep 19, 2013)	criteria provided, single submitter	16	3900932	16	3850931	158340	169270
NM_004380.2(CREBBP):c.86-2A>C	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3901012	16	3851011	158402	169271
NM_004380.2(CREBBP):c.37A>G (p.Lys13Glu)	CREBBP	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3929881	16	3879880	158360	169272
NM_003470.2(USP7):c.2169_2170delAG (p.Arg723Serfs)	USP7	USP7-related condition	Likely pathogenic(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	16	8994885 - 8994886	16	8901028 - 8901029	522827	513461
NM_000833.4(GRIN2A):c.3785C>T (p.Thr1262Ile)	GRIN2A	not provided	Uncertain significance(Last reviewed: Jun 11, 2013)	criteria provided, single submitter	16	9857616	16	9763759	129187	134633
NM_000833.4(GRIN2A):c.3702C>T (p.Phe1234=)	GRIN2A	Epilepsy, focal, with speech disorder and with or without mental retardation|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2017)	criteria provided, conflicting interpretations	16	9857699	16	9763842	129186	134632
NM_000833.4(GRIN2A):c.3619T>C (p.Tyr1207His)	GRIN2A	not provided	Uncertain significance(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	16	9857782	16	9763925	129198	134644
NM_000833.4(GRIN2A):c.3553A>G (p.Lys1185Glu)	GRIN2A	not specified	Likely benign(Last reviewed: Jan 29, 2014)	criteria provided, single submitter	16	9857848	16	9763991	129197	134643
NM_000833.4(GRIN2A):c.2899G>C (p.Val967Leu)	GRIN2A	Epilepsy, focal, with speech disorder and with or without mental retardation|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	16	9858502	16	9764645	129195	134641
NM_000833.4(GRIN2A):c.2883C>T (p.Asn961=)	GRIN2A	Epilepsy, focal, with speech disorder and with or without mental retardation|not specified|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jun 7, 2018)	criteria provided, conflicting interpretations	16	9858518	16	9764661	129194	134640
NM_000833.4(GRIN2A):c.2453C>A (p.Ala818Glu)	GRIN2A	Epilepsy, focal, with speech disorder and with or without mental retardation	Likely pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	16	9862850	16	9768993	495226	486724
NM_000833.4(GRIN2A):c.2452G>A (p.Ala818Thr)	GRIN2A	Epilepsy, focal, with speech disorder and with or without mental retardation	Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2018)	criteria provided, conflicting interpretations	16	9862851	16	9768994	522855	513463
NM_000833.4(GRIN2A):c.2085G>C (p.Arg695=)	GRIN2A	Epilepsy, focal, with speech disorder and with or without mental retardation|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Oct 25, 2016)	criteria provided, multiple submitters, no conflicts	16	9916204	16	9822347	129192	134638
NM_000833.4(GRIN2A):c.1936A>G (p.Thr646Ala)	GRIN2A	Epilepsy, focal, with speech disorder and with or without mental retardation	Likely pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	16	9923351	16	9829494	488524	481392
NM_000833.4(GRIN2A):c.1913C>T (p.Ala638Val)	GRIN2A	Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	16	9923374	16	9829517	561021	552198
NM_000833.4(GRIN2A):c.1667C>T (p.Ser556Phe)	GRIN2A	not specified	Likely benign(Last reviewed: Jan 11, 2013)	criteria provided, single submitter	16	9928072	16	9834215	129184	134630
NM_000833.4(GRIN2A):c.1329-8C>T	GRIN2A	Epilepsy, focal, with speech disorder and with or without mental retardation|not specified	Benign(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	16	9934969	16	9841112	129191	134637
NM_000833.4(GRIN2A):c.1275G>A (p.Leu425=)	GRIN2A	Epilepsy, focal, with speech disorder and with or without mental retardation|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	9943666	16	9849809	129190	134636
NM_000833.4(GRIN2A):c.662A>G (p.Lys221Arg)	GRIN2A	Epilepsy, focal, with speech disorder and with or without mental retardation|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Nov 28, 2017)	criteria provided, multiple submitters, no conflicts	16	10032161	16	9938304	129199	134645
NM_000833.4(GRIN2A):c.547T>A (p.Phe183Ile)	GRIN2A	not specified|not provided|Rolandic epilepsy|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Oct 27, 2017)	criteria provided, conflicting interpretations	16	10032276	16	9938419	129189	134635
NM_002474.2(MYH11):c.5800A>T (p.Thr1934Ser)	MYH11|NDE1	Aortic aneurysm, familial thoracic 6|Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not specified|Cardiovascular phenotype|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	16	15797967	16	15704110	201044	197832
NM_001040113.1(MYH11):c.5294G>A (p.Arg1765Gln)	MYH11|NDE1	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not provided	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, multiple submitters, no conflicts	16	15812194	16	15718337	161316	29170
NM_001040113.1(MYH11):c.5197G>A (p.Ala1733Thr)	MYH11|NDE1	Aortic aneurysm, familial thoracic 4|Familial thoracic aortic aneurysm	Uncertain significance(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	16	15812291	16	15718434	375862	362741
NM_001040113.1(MYH11):c.4963C>T (p.Arg1655Cys)	MYH11|NDE1	Aortic aneurysm, familial thoracic 4|Aortic aneurysm	Uncertain significance(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	16	15814019	16	15720162	161318	171183
NM_001040113.1(MYH11):c.4417A>C (p.Lys1473Gln)	MYH11|NDE1	Aortic aneurysm, familial thoracic 4|Cardiovascular phenotype|Familial thoracic aortic aneurysm	Uncertain significance(Last reviewed: Jul 5, 2017)	criteria provided, multiple submitters, no conflicts	16	15815461	16	15721604	375854	362742
NM_002474.2(MYH11):c.3652-6C>T	MYH11	Aortic aneurysm, familial thoracic 6|Aortic aneurysm, familial thoracic 4|Familial aortopathy|not specified|Connective tissue disorder	Benign/Likely benign(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	16	15820917	16	15727060	36619	45281
NM_001040113.1(MYH11):c.2026C>T (p.Arg676Cys)	MYH11	Aortic aneurysm, familial thoracic 4|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 9, 2018)	criteria provided, conflicting interpretations	16	15844048	16	15750191	161319	171184
NM_001040113.1(MYH11):c.760C>T (p.Arg254Cys)	MYH11	Aortic aneurysm, familial thoracic 4|Loeys-Dietz syndrome|not specified|Altered myosin contractile function|Inborn genetic diseases|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 22, 2017)	criteria provided, conflicting interpretations	16	15872688	16	15778831	161317	171185
NM_001008389.2(UMOD):c.949T>G (p.Cys317Gly)	UMOD	Familial juvenile gout	Likely pathogenic(Last reviewed: Feb 3, 2015)	criteria provided, single submitter	16	20359569	16	20348247	446167	439514
NM_001278614.1(UMOD):c.589G>T (p.Glu197Ter)	UMOD	Uromodulin-associated kidney disease	Pathogenic	no assertion criteria provided	16	20360133	16	20348811	370029	354268
NM_003361.3(UMOD):c.358T>G (p.Cys120Gly)	UMOD	Familial juvenile gout	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	16	20360265	16	20348943	488632	481500
NM_024675.3(PALB2):c.3350+1090_*1278dup	PALB2	Familial cancer of breast	Likely pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	16	23613502 - 23618095	16	23602181 - 23606774	430694	424225
NM_024675.3(PALB2):c.2257C>T (p.Arg753Ter)	PALB2	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	16	23641218	16	23629897	142403	152117
NM_024675.3(PALB2):c.2167_2168delAT (p.Met723Valfs)	PALB2	Familial cancer of breast|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Cancer of the pancreas	Pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	16	23641307 - 23641308	16	23629986 - 23629987	136132	139844
NM_024675.3(PALB2):c.1757_1759dupATG (p.Asp586_Ala587insAsp)	PALB2	Neoplasm of ovary|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 22, 2016)	criteria provided, multiple submitters, no conflicts	16	23641716 - 23641718	16	23630395 - 23630397	403713	390688
NM_024675.3(PALB2):c.1001A>G (p.Tyr334Cys)	PALB2	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome|Hereditary cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jun 26, 2018)	criteria provided, conflicting interpretations	16	23646866	16	23635545	126581	132091
NM_024675.3(PALB2):c.155T>C (p.Val52Ala)	PALB2	Familial cancer of breast|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	16	23649227	16	23637906	246458	244978
NM_145239.2(PRRT2):c.67G>A (p.Glu23Lys)	PRRT2	Dystonia 10|not specified|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Mar 2, 2018)	criteria provided, conflicting interpretations	16	29824442	16	29813121	130039	135485
NM_145239.2(PRRT2):c.412C>G (p.Pro138Ala)	PRRT2	Dystonia 10|not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	16	29824787	16	29813466	130038	135484
NM_145239.2(PRRT2):c.535_538delCAAG (p.Gln179Argfs)	PRRT2	Dystonia 10	Pathogenic(Last reviewed: Feb 4, 2017)	criteria provided, single submitter	16	29824910 - 29824913	16	29813589 - 29813592	522556	513169
NM_145239.2(PRRT2):c.649dupC (p.Arg217Profs)	PRRT2	Seizures, benign familial infantile, 2|Dystonia 10|Infantile convulsions and paroxysmal choreoathetosis, familial|Seizures|not provided|History of neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	16	29825024	16	29813703	65758	76666
NM_001256442.1(PRRT2):c.959C>T (p.Ala320Val)	PRRT2	Seizures, benign familial infantile, 2|Dystonia 10	Pathogenic	criteria provided, single submitter	16	29825733	16	29814412	440911	434539
NM_006662.2(SRCAP):c.132C>T (p.Gly44=)	SRCAP	Floating-Harbor syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 13, 2016)	criteria provided, conflicting interpretations	16	30715462	16	30704141	160032	169195
NM_006662.2(SRCAP):c.189C>G (p.Pro63=)	SRCAP	Floating-Harbor syndrome|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	30715519	16	30704198	160033	169196
NM_006662.2(SRCAP):c.4293C>G (p.Val1431=)	SRCAP	Floating-Harbor syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	30735038	16	30723717	160034	169197
NM_006662.2(SRCAP):c.5303T>C (p.Leu1768Pro)	SRCAP	not specified	Likely benign(Last reviewed: Sep 3, 2013)	criteria provided, single submitter	16	30736048	16	30724727	160036	169199
NM_006662.2(SRCAP):c.7263C>A (p.Arg2421=)	SRCAP	Floating-Harbor syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	30748624	16	30737303	160037	169200
NM_006662.2(SRCAP):c.7303C>T (p.Arg2435Ter)	SRCAP	Floating-Harbor syndrome|not provided	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, multiple submitters, no conflicts	16	30748664	16	30737343	30909	39866
NM_006662.2(SRCAP):c.7330C>T (p.Arg2444Ter)	SRCAP	Floating-Harbor syndrome|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 26, 2017)	criteria provided, multiple submitters, no conflicts	16	30748691	16	30737370	30908	39865
NM_006662.2(SRCAP):c.7993C>T (p.Gln2665Ter)	SRCAP	Floating-Harbor syndrome	Pathogenic(Last reviewed: Nov 15, 2013)	criteria provided, single submitter	16	30749354	16	30738033	160038	169201
NM_006662.2(SRCAP):c.8755C>T (p.Leu2919Phe)	SRCAP	Floating-Harbor syndrome|not specified	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	30750116	16	30738795	160039	169202
NM_002968.2(SALL1):c.469_477delAGCAGCAGC (p.Ser157_Ser159del)	SALL1	Townes-Brocks syndrome 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 30, 2016)	criteria provided, conflicting interpretations	16	51175656 - 51175664	16	51141745 - 51141753	224343	226088
NM_002968.2(SALL1):c.130G>A (p.Val44Ile)	SALL1	Townes-Brocks syndrome 1	Uncertain significance	criteria provided, single submitter	16	51176003	16	51142092	224342	226089
NM_138736.2(GNAO1):c.133G>C (p.Gly45Arg)	GNAO1	Inborn genetic diseases	Pathogenic	criteria provided, single submitter	16	56226500	16	56192588	225047	226954
NM_020988.2(GNAO1):c.607G>A (p.Gly203Arg)	GNAO1	not provided|Early infantile epileptic encephalopathy 17|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	16	56370656	16	56336744	66115	77012
NM_138736.2(GNAO1):c.626G>T (p.Arg209Leu)	GNAO1	Early infantile epileptic encephalopathy 17|Early infantile epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	16	56370675	16	56336763	431699	425224
NM_020988.2(GNAO1):c.662C>A (p.Ala221Asp)	GNAO1	Neurodevelopmental disorder with involuntary movements	Likely pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, single submitter	16	56370711	16	56336799	522843	513460
NM_138736.2(GNAO1):c.692A>G (p.Tyr231Cys)	GNAO1	not provided|Early infantile epileptic encephalopathy 17	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	16	56370741	16	56336829	374381	361222
NM_001129727.2(PLEKHG4):c.1235C>T (p.Thr412Ile)	PLEKHG4	not specified	Likely benign	no assertion criteria provided	16	67316234	16	67282331	129964	135410
NM_001129727.2(PLEKHG4):c.1574A>G (p.Asp525Gly)	PLEKHG4	not specified	Likely benign	no assertion criteria provided	16	67318242	16	67284339	129965	135411
NM_001129727.2(PLEKHG4):c.2489G>A (p.Arg830His)	PLEKHG4	not specified	Likely benign	no assertion criteria provided	16	67320223	16	67286320	129966	135412
NM_006565.3(CTCF):c.1164C>T (p.Ser388=)	CTCF	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 15, 2016)	criteria provided, single submitter	16	67654677	16	67620774	128863	134311
NM_004360.5(CDH1):c.3G>A (p.Met1Ile)	CDH1	Hereditary diffuse gastric cancer|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68771321	16	68737418	239906	242448
NM_004360.5(CDH1):c.48+1G>A	CDH1	Hereditary diffuse gastric cancer|not provided	Pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68771367	16	68737464	449341	445599
NM_004360.5(CDH1):c.79C>T (p.Pro27Ser)	CDH1	Hereditary diffuse gastric cancer|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68772230	16	68738327	239913	242450
NM_004360.5(CDH1):c.88C>A (p.Pro30Thr)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome|Orofacial clefting	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68772239	16	68738336	127933	133390
NM_004360.5(CDH1):c.187C>T (p.Arg63Ter)	CDH1	Hereditary diffuse gastric cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68835596	16	68801693	156496	166261
NM_004360.5(CDH1):c.188G>A (p.Arg63Gln)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68835597	16	68801694	127919	133376
NM_004360.5(CDH1):c.283C>T (p.Gln95Ter)	CDH1	Hereditary diffuse gastric cancer	Pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68835692	16	68801789	463775	465844
NM_004360.5(CDH1):c.286A>G (p.Ile96Val)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68835695	16	68801792	220611	222499
NM_004360.4(CDH1):c.382delC (p.His128Ilefs)	CDH1	Hereditary diffuse gastric cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68835791	16	68801888	486824	477827
NM_004360.5(CDH1):c.535A>G (p.Lys179Glu)	CDH1	Hereditary diffuse gastric cancer|not provided	Uncertain significance(Last reviewed: Nov 22, 2018)	reviewed by expert panel	16	68842599	16	68808696	496233	487892
NM_004360.5(CDH1):c.604G>A (p.Val202Ile)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68842668	16	68808765	133853	137592
NM_004360.5(CDH1):c.635G>T (p.Gly212Val)	CDH1	Hereditary diffuse gastric cancer|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68842699	16	68808796	479488	477773
NM_004360.5(CDH1):c.670C>T (p.Arg224Cys)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome|Anophthalmia - microphthalmia	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68842734	16	68808831	127932	133389
NM_004360.5(CDH1):c.832+1G>T	CDH1	Hereditary diffuse gastric cancer	Pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68844245	16	68810342	239914	242465
NM_004360.5(CDH1):c.892G>A (p.Ala298Thr)	CDH1	Hereditary diffuse gastric cancer|Neoplasm of stomach|not specified|not provided|Hereditary cancer-predisposing syndrome|Colon cancer	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68845646	16	68811743	41787	50226
NM_004360.5(CDH1):c.1003C>T (p.Arg335Ter)	CDH1	Hereditary diffuse gastric cancer|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68845757	16	68811854	136055	139767
NM_004360.5(CDH1):c.1008G>A (p.Glu336=)	CDH1	Hereditary diffuse gastric cancer|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68845762	16	68811859	231647	235390
NM_004360.5(CDH1):c.1008G>T (p.Glu336Asp)	CDH1	Hereditary diffuse gastric cancer|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68845762	16	68811859	18453	33492
NM_004360.5(CDH1):c.1018A>G (p.Thr340Ala)	CDH1	Hereditary diffuse gastric cancer|not specified|Hereditary cancer-predisposing syndrome|Adenocarcinoma of stomach	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68846047	16	68812144	12245	27284
NM_004360.4(CDH1):c.1085delT (p.Val362Glyfs)	CDH1	Hereditary diffuse gastric cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68846114	16	68812211	483264	477802
NM_004360.5(CDH1):c.1118C>T (p.Pro373Leu)	CDH1	Hereditary diffuse gastric cancer|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68846147	16	68812244	142285	151999
NM_004360.5(CDH1):c.1137G>A (p.Thr379=)	CDH1	Hereditary diffuse gastric cancer|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68846166	16	68812263	156499	166264
NM_004360.5(CDH1):c.1138-3C>T	CDH1	Hereditary diffuse gastric cancer|not specified|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68847213	16	68813310	184346	184375
NM_004360.5(CDH1):c.1162G>A (p.Glu388Lys)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68847240	16	68813337	127906	133363
NM_004360.5(CDH1):c.1225T>C (p.Trp409Arg)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68847303	16	68813400	133855	137594
NM_004360.5(CDH1):c.1297G>A (p.Asp433Asn)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68847375	16	68813472	127910	133367
NM_004360.5(CDH1):c.1298A>G (p.Asp433Gly)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68847376	16	68813473	141810	151524
NM_004360.5(CDH1):c.1409C>T (p.Thr470Ile)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68849506	16	68815603	127913	133370
NM_004360.4(CDH1):c.1612delG (p.Asp538Thrfs)	CDH1	Hereditary diffuse gastric cancer	Pathogenic(Last reviewed: Jan 2, 2017)	criteria provided, single submitter	16	68853229	16	68819326	437928	431550
NM_004360.4(CDH1):c.1633C>T (p.Arg545Trp)	CDH1	Familial cancer of breast|Hereditary diffuse gastric cancer	Uncertain significance(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	16	68853250	16	68819347	446218	439582
NM_004360.5(CDH1):c.1679C>G (p.Thr560Arg)	CDH1	Hereditary diffuse gastric cancer|not specified|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68853296	16	68819393	234554	231976
NM_004360.4(CDH1):c.1680G>C (p.Thr560=)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Apr 26, 2018)	criteria provided, multiple submitters, no conflicts	16	68853297	16	68819394	136697	140400
NM_004360.5(CDH1):c.1774G>A (p.Ala592Thr)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68855966	16	68822063	41783	50222
NM_004360.5(CDH1):c.1792C>T (p.Arg598Ter)	CDH1	Hereditary diffuse gastric cancer|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68855984	16	68822081	12241	27280
NM_004360.5(CDH1):c.1849G>A (p.Ala617Thr)	CDH1	Endometrial carcinoma|Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68856041	16	68822138	12232	27271
NM_004360.5(CDH1):c.1888C>G (p.Leu630Val)	CDH1	Hereditary diffuse gastric cancer|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68856080	16	68822177	133846	137585
NM_004360.5(CDH1):c.2104G>A (p.Glu702Lys)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68857469	16	68823566	127921	133378
NM_004360.5(CDH1):c.2195G>A (p.Arg732Gln)	CDH1	Hereditary diffuse gastric cancer|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68862107	16	68828204	406663	402094
NM_004360.5(CDH1):c.2245C>T (p.Arg749Trp)	CDH1	Hereditary diffuse gastric cancer|not provided	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68862157	16	68828254	418841	409709
NM_004360.5(CDH1):c.2396C>G (p.Pro799Arg)	CDH1	Hereditary diffuse gastric cancer|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68863657	16	68829754	140871	150585
NM_004360.4(CDH1):c.2398delC (p.Arg800Alafs)	CDH1	Hereditary diffuse gastric cancer|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68863659	16	68829756	156497	166262
NM_004360.5(CDH1):c.2413G>A (p.Asp805Asn)	CDH1	Hereditary diffuse gastric cancer|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68863674	16	68829771	127925	133382
NM_004360.4(CDH1):c.2430delT (p.Phe810Leufs)	CDH1	Hereditary diffuse gastric cancer|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68863691	16	68829788	187464	184466
NM_004360.5(CDH1):c.2494G>A (p.Val832Met)	CDH1	Hereditary diffuse gastric cancer|Neoplasm of stomach|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68867247	16	68833344	12246	27285
NM_004360.5(CDH1):c.2506G>T (p.Glu836Ter)	CDH1	Hereditary diffuse gastric cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68867259	16	68833356	479504	477938
NM_004360.5(CDH1):c.2512A>G (p.Ser838Gly)	CDH1	Hereditary diffuse gastric cancer|Neoplasm of ovary|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68867265	16	68833362	12233	27272
NM_004360.5(CDH1):c.2635G>A (p.Gly879Ser)	CDH1	Hereditary diffuse gastric cancer|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68867388	16	68833485	127928	133385
NM_001270453.1(WWP2):c.1335-866A>G	WWP2|MIR140	Spondyloepiphyseal dysplasia MIR140 type Nishimura	Pathogenic(Last reviewed: Aug 1, 2017)	no assertion criteria provided	16	69967007	16	69933104	599186	590363
NM_001605.2(AARS):c.986G>A (p.Arg329His)	AARS	Charcot-Marie-Tooth disease, type 2N|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, multiple submitters, no conflicts	16	70302259	16	70268356	8466	23505
NM_015386.2(COG4):c.1546G>A (p.Gly516Arg)	COG4	not specified|COG4 related congenital disorder of glycosylation, autosomal dominant|SAUL-WILSON SYNDROME	Conflicting interpretations of pathogenicity(Last reviewed: Nov 29, 2018)	criteria provided, conflicting interpretations	16	70530270	16	70496367	449730	445607
NM_001361.4(DHODH):c.19A>C (p.Lys7Gln)	DHODH	Miller syndrome|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	72042682	16	72008783	128895	134342
NM_001361.4(DHODH):c.1022C>T (p.Ala341Val)	DHODH	Miller syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	72057421	16	72023522	128894	134341
NM_004933.2(CDH15):c.109G>T (p.Ala37Ser)	CDH15	not specified	Likely benign	no assertion criteria provided	16	89245890	16	89179482	128642	134091
NM_004933.2(CDH15):c.153G>A (p.Pro51=)	CDH15	not specified	Likely benign	no assertion criteria provided	16	89245934	16	89179526	128643	134092
NM_004933.2(CDH15):c.171C>T (p.Asn57=)	CDH15	not specified	Likely benign	no assertion criteria provided	16	89245952	16	89179544	128644	134093
NM_004933.2(CDH15):c.174C>T (p.His58=)	CDH15	not specified	Likely benign	no assertion criteria provided	16	89245955	16	89179547	128645	134094
NM_004933.2(CDH15):c.227G>A (p.Gly76Asp)	CDH15	not provided	Uncertain significance(Last reviewed: Aug 8, 2013)	criteria provided, single submitter	16	89246633	16	89180225	128640	134089
NM_004933.2(CDH15):c.264T>C (p.Asp88=)	CDH15	not specified	Likely benign	no assertion criteria provided	16	89246670	16	89180262	128651	134100
NM_004933.2(CDH15):c.598G>A (p.Glu200Lys)	CDH15	not provided	Uncertain significance(Last reviewed: Oct 16, 2013)	criteria provided, single submitter	16	89251676	16	89185268	128653	134102
NM_004933.2(CDH15):c.615C>T (p.Asp205=)	CDH15	not specified	Likely benign	no assertion criteria provided	16	89251693	16	89185285	128654	134103
NM_004933.2(CDH15):c.671C>T (p.Ala224Val)	CDH15	not provided	Uncertain significance(Last reviewed: Feb 18, 2014)	criteria provided, single submitter	16	89253844	16	89187436	128655	134104
NM_004933.2(CDH15):c.782C>A (p.Thr261Asn)	CDH15	not provided	Uncertain significance(Last reviewed: Feb 11, 2014)	criteria provided, single submitter	16	89253955	16	89187547	128657	134106
NM_004933.2(CDH15):c.788A>G (p.Asp263Gly)	CDH15	not provided	Uncertain significance(Last reviewed: Feb 11, 2014)	criteria provided, single submitter	16	89253961	16	89187553	128658	134107
NM_004933.2(CDH15):c.1023G>A (p.Ser341=)	CDH15	not specified	Likely benign	no assertion criteria provided	16	89256695	16	89190287	128641	134090
NM_004933.2(CDH15):c.1750A>C (p.Lys584Gln)	CDH15	not specified	Benign(Last reviewed: Oct 24, 2013)	criteria provided, single submitter	16	89258747	16	89192339	128646	134095
NM_004933.2(CDH15):c.1971A>G (p.Gln657=)	CDH15	not specified	Likely benign	no assertion criteria provided	16	89259993	16	89193585	128647	134096
NM_004933.2(CDH15):c.2025G>A (p.Pro675=)	CDH15	not specified	Likely benign	no assertion criteria provided	16	89260195	16	89193787	128648	134097
NM_004933.2(CDH15):c.2353G>A (p.Gly785Arg)	CDH15	not specified	Likely benign	no assertion criteria provided	16	89261471	16	89195063	128649	134098
NM_004933.2(CDH15):c.2364C>A (p.Tyr788Ter)	CDH15	not specified	Likely benign	no assertion criteria provided	16	89261482	16	89195074	128650	134099
NM_001256182.1(ANKRD11):c.7751C>A (p.Ala2584Asp)	ANKRD11	KBG syndrome	Likely pathogenic	no assertion criteria provided	16	89337280	16	89270872	375576	362386
NM_013275.5(ANKRD11):c.7569+1G>A	ANKRD11	not provided|Inborn genetic diseases	Pathogenic(Last reviewed: May 3, 2016)	criteria provided, multiple submitters, no conflicts	16	89341500	16	89275092	208695	205298
NM_001256182.1(ANKRD11):c.6212C>G (p.Ser2071Ter)	ANKRD11	KBG syndrome	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	16	89346738	16	89280330	375613	362427
NM_001256182.1(ANKRD11):c.5504del (p.Leu1835Argfs)	ANKRD11	KBG syndrome	Pathogenic	no assertion criteria provided	16	89347446	16	89281038	375614	362428
NM_013275.5(ANKRD11):c.5317G>T (p.Glu1773Ter)	ANKRD11	Astigmatism|Epicanthus|Cryptorchidism|Hypertelorism|Esotropia|Global developmental delay|Retrognathia|Hypermetropia|Wide nasal bridge|Cryptorchidism|Epicanthus|Hypertelorism|Astigmatism|Intellectual disability|Global developmental delay	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	16	89347633	16	89281225	242882	243994
NM_013275.5(ANKRD11):c.5065delC (p.Leu1689Cysfs)	ANKRD11	KBG syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	16	89347884 - 89347885	16	89281477	560942	552191
NM_013275.5(ANKRD11):c.3770_3773del (p.Lys1257Argfs)	ANKRD11	KBG syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	16	89349176 - 89349180	16	89282769 - 89282772	560941	552192
NM_013275.5(ANKRD11):c.3770_3771delAA (p.Lys1257Argfs)	ANKRD11	KBG syndrome|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	16	89349179 - 89349180	16	89282771 - 89282772	265324	260139
NM_001256183.1(ANKRD11):c.3706C>T (p.Gln1236Ter)	ANKRD11	KBG syndrome	Likely pathogenic(Last reviewed: Apr 6, 2018)	no assertion criteria provided	16	89349244	16	89282836	545701	536193
NM_013275.5(ANKRD11):c.3224_3227delAAAG (p.Glu1075Glyfs)	ANKRD11	KBG syndrome|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	16	89349723 - 89349726	16	89283315 - 89283318	420179	409796
NM_013275.5(ANKRD11):c.3122C>A (p.Ser1041Ter)	ANKRD11	KBG syndrome	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	16	89349828	16	89283420	374273	361224
NM_013275.5(ANKRD11):c.2398_2401delGAAA (p.Glu800Asnfs)	ANKRD11	KBG syndrome|not provided	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, multiple submitters, no conflicts	16	89350549 - 89350552	16	89284141 - 89284144	209131	205782
NM_001256182.1(ANKRD11):c.2047_2048del (p.Lys683Alafs)	ANKRD11	KBG syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	16	89350901 - 89350903	16	89284494 - 89284495	560940	552193
NM_013275.5(ANKRD11):c.1948C>T (p.Gln650Ter)	ANKRD11	KBG syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	16	89351002	16	89284594	560939	552194
NM_013275.5(ANKRD11):c.1903_1907delAAACA (p.Lys635Glnfs)	ANKRD11	KBG syndrome|Global developmental delay|Ptosis|not provided|Clinodactyly of the 5th finger|Conductive hearing impairment|Intellectual disability|Global developmental delay|Short foot|Short palm|Unilateral cryptorchidism|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, multiple submitters, no conflicts	16	89351043 - 89351047	16	89284635 - 89284639	279678	264749
NM_013275.5(ANKRD11):c.1462_1463delAG (p.Ser488Trpfs)	ANKRD11	KBG syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, multiple submitters, no conflicts	16	89351487 - 89351488	16	89285079 - 89285080	522136	512246
NM_013275.5(ANKRD11):c.893-1G>C	ANKRD11	KBG syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	16	89352058	16	89285650	560944	552196
NM_013275.5(ANKRD11):c.867C>A (p.Tyr289Ter)	ANKRD11	KBG syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	16	89352472	16	89286064	560943	552197
NM_003119.2(SPG7):c.1529C>T	SPG7	Spastic paraplegia 7|Hereditary spastic paraplegia|Optic nerve hypoplasia|Dysarthria|not provided|Gait ataxia|Cerebral cortical atrophy|Spastic paraparesis|Inborn genetic diseases|Spastic Paraplegia, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Oct 5, 2018)	criteria provided, conflicting interpretations	16	89613145	16	89546737	42016	51184
NM_006086.3(TUBB3):c.58-49C>T	TUBB3	not specified	Likely benign	no assertion criteria provided	16	89998930	16	89932522	160193	169304
NM_006086.3(TUBB3):c.58-22C>T	TUBB3	not specified	Likely benign	no assertion criteria provided	16	89998957	16	89932549	160192	169305
NM_006086.3(TUBB3):c.136C>T (p.Arg46Trp)	TUBB3	Cortical dysplasia, complex, with other brain malformations 1	Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	16	89999057	16	89932649	438582	432220
NM_006086.3(TUBB3):c.167-6C>T	TUBB3	Cortical dysplasia, complex, with other brain malformations 1	Uncertain significance(Last reviewed: May 29, 2013)	criteria provided, single submitter	16	89999870	16	89933462	160190	169306
NM_006086.3(TUBB3):c.277+8C>T	TUBB3	not specified	Benign(Last reviewed: Mar 31, 2014)	criteria provided, multiple submitters, no conflicts	16	89999994	16	89933586	137856	141559
NM_006086.3(TUBB3):c.292G>A (p.Gly98Ser)	TUBB3	Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement|Cortical dysplasia, complex, with other brain malformations 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 18, 2016)	criteria provided, conflicting interpretations	16	90001151	16	89934743	160191	169307
NM_006086.3(TUBB3):c.666C>T (p.Tyr222=)	TUBB3	not specified	Likely benign(Last reviewed: Dec 4, 2015)	criteria provided, multiple submitters, no conflicts	16	90001525	16	89935117	160194	169308
NM_006086.3(TUBB3):c.702C>T (p.Ser234=)	TUBB3	not specified	Benign(Last reviewed: Apr 1, 2014)	criteria provided, single submitter	16	90001561	16	89935153	137857	141560
NM_006086.3(TUBB3):c.728C>T (p.Pro243Leu)	TUBB3	Cortical dysplasia, complex, with other brain malformations 1	Uncertain significance(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	16	90001587	16	89935179	160195	169309
NM_006086.3(TUBB3):c.740A>G (p.Asn247Ser)	TUBB3	Cortical dysplasia, complex, with other brain malformations 1	Uncertain significance(Last reviewed: May 29, 2013)	criteria provided, single submitter	16	90001599	16	89935191	160196	169310
NM_006086.3(TUBB3):c.982G>A (p.Glu328Lys)	TUBB3	Cortical dysplasia, complex, with other brain malformations 1	Likely pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	16	90001841	16	89935433	374309	361225
NM_006086.3(TUBB3):c.993G>A (p.Leu331=)	TUBB3	Cortical dysplasia, complex, with other brain malformations 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	16	90001852	16	89935444	160197	169311
NM_006086.3(TUBB3):c.1170G>A (p.Arg390=)	TUBB3	Cortical dysplasia, complex, with other brain malformations 1	Uncertain significance(Last reviewed: Sep 18, 2013)	criteria provided, single submitter	16	90002029	16	89935621	160188	169312
NM_006086.3(TUBB3):c.1215G>A (p.Glu405=)	TUBB3	not specified	Benign(Last reviewed: Apr 1, 2014)	criteria provided, single submitter	16	90002074	16	89935666	137858	141561
NM_006086.3(TUBB3):c.1331C>T (p.Ser444Leu)	TUBB3	not specified	Likely benign(Last reviewed: Jun 4, 2014)	criteria provided, single submitter	16	90002190	16	89935782	160189	169313
NM_000430.3(PAFAH1B1):c.3G>A (p.Met1Ile)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2541585	17	2638291	159520	169332
NM_000430.3(PAFAH1B1):c.22C>T (p.Arg8Ter)	PAFAH1B1	Lissencephaly 1|Subcortical band heterotopia	Pathogenic(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	17	2541604	17	2638310	8081	23120
NM_000430.3(PAFAH1B1):c.33-3C>T	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2568663	17	2665369	159514	169333
NM_000430.3(PAFAH1B1):c.37C>T (p.Arg13Ter)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2568670	17	2665376	159516	169334
NM_000430.3(PAFAH1B1):c.56T>G (p.Leu19Arg)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2568689	17	2665395	159529	169335
NM_000430.3(PAFAH1B1):c.72T>G (p.Tyr24Ter)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2568705	17	2665411	159543	169336
NM_000430.3(PAFAH1B1):c.84T>G (p.Tyr28Ter)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2568717	17	2665423	159547	169337
NM_000430.3(PAFAH1B1):c.118-14_118-10delTTTAT	PAFAH1B1	Lissencephaly 1	Uncertain significance(Last reviewed: Feb 11, 2017)	no assertion criteria provided	17	2569296 - 2569300	17	2666002 - 2666006	545514	536018
NM_000430.3(PAFAH1B1):c.121G>A (p.Glu41Lys)	PAFAH1B1	Lissencephaly 1|not provided	Likely pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	17	2569313	17	2666019	159503	169338
NM_000430.3(PAFAH1B1):c.136_137del (p.Lys46Valfs)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2569328 - 2569329	17	2666034 - 2666035	159505	169339
NM_000430.3(PAFAH1B1):c.152del (p.Leu51Trpfs)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2569344	17	2666050	159506	169340
NM_000430.3(PAFAH1B1):c.162delA (p.Lys54Asnfs)	PAFAH1B1	Lissencephaly 1|not provided	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, multiple submitters, no conflicts	17	2569354	17	2666060	21180	34032
NM_000430.3(PAFAH1B1):c.163T>A (p.Trp55Arg)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2569355	17	2666061	159507	169341
NM_000430.3(PAFAH1B1):c.192G>C (p.Lys64Asn)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2569384	17	2666090	159511	169342
NM_000430.3(PAFAH1B1):c.192+1G>T	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2569385	17	2666091	159510	169344
NM_000430.3(PAFAH1B1):c.192+1G>A	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2569385	17	2666091	159509	169343
NM_000430.3(PAFAH1B1):c.192+15T>C	PAFAH1B1	Lissencephaly 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2569399	17	2666105	159508	169345
NM_000430.3(PAFAH1B1):c.265C>T (p.Arg89Ter)	PAFAH1B1	Lissencephaly 1|not provided	Pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, multiple submitters, no conflicts	17	2570358	17	2667064	159512	169346
NM_000430.3(PAFAH1B1):c.305dupA (p.Tyr102Terfs)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Mar 24, 2014)	criteria provided, single submitter	17	2570398	17	2667104	159513	169347
NM_000430.3(PAFAH1B1):c.371T>A (p.Val124Asp)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2570464	17	2667170	159515	169348
NM_000430.3(PAFAH1B1):c.386A>T (p.Asp129Val)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2570479	17	2667185	159517	169349
NM_000430.3(PAFAH1B1):c.387T>C (p.Asp129=)	PAFAH1B1	not specified|not provided|Lissencephaly/Subcortical Band Heterotopia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 20, 2017)	criteria provided, conflicting interpretations	17	2570480	17	2667186	159518	169350
NM_000430.3(PAFAH1B1):c.399+1G>A	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2570493	17	2667199	159519	169351
NM_000430.3(PAFAH1B1):c.405G>A (p.Trp135Ter)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2573462	17	2670168	159521	169352
NM_000430.3(PAFAH1B1):c.430C>T (p.Arg144Ter)	PAFAH1B1	Lissencephaly 1|not provided	Pathogenic(Last reviewed: Feb 22, 2016)	criteria provided, multiple submitters, no conflicts	17	2573487	17	2670193	159522	169353
NM_000430.3(PAFAH1B1):c.455_456del (p.Ser152Cysfs)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2573512 - 2573513	17	2670218 - 2670219	159523	169354
NM_000430.3(PAFAH1B1):c.460C>T (p.Gln154Ter)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2573517	17	2670223	159524	169355
NM_000430.3(PAFAH1B1):c.474C>T (p.Phe158=)	PAFAH1B1	not specified|Lissencephaly/Subcortical Band Heterotopia	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	2573531	17	2670237	92998	98905
NM_000430.3(PAFAH1B1):c.484G>A (p.Gly162Ser)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2573541	17	2670247	8079	23118
NM_000430.3(PAFAH1B1):c.503G>A (p.Cys168Tyr)	PAFAH1B1	Lissencephaly 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2573560	17	2670266	159525	169356
NM_000430.3(PAFAH1B1):c.523A>T (p.Lys175Ter)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: May 16, 2013)	criteria provided, single submitter	17	2573580	17	2670286	209180	205783
NM_000430.3(PAFAH1B1):c.524_528del (p.Lys175Metfs)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2573581 - 2573585	17	2670287 - 2670291	159526	169357
NM_000430.3(PAFAH1B1):c.537del (p.Gln180Argfs)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2573594	17	2670300	159527	169358
NM_000430.3(PAFAH1B1):c.568+27C>T	PAFAH1B1	not specified	Benign	criteria provided, single submitter	17	2573652	17	2670358	159528	169359
NM_000430.3(PAFAH1B1):c.569-10T>C	PAFAH1B1	Lissencephaly 1|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	17	2575939	17	2672645	21182	34034
NM_000430.3(PAFAH1B1):c.632C>G (p.Ser211Ter)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2576012	17	2672718	159530	169360
NM_000430.3(PAFAH1B1):c.644_651del (p.Thr215Asnfs)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2576024 - 2576031	17	2672730 - 2672737	159531	169361
NM_000430.3(PAFAH1B1):c.647_648del (p.Ile216Lysfs)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2576027 - 2576028	17	2672733 - 2672734	159532	169362
NM_000430.3(PAFAH1B1):c.657G>A (p.Trp219Ter)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2576037	17	2672743	159533	169363
NM_000430.3(PAFAH1B1):c.658del (p.Glu220Lysfs)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2576038	17	2672744	159534	169364
NM_000430.3(PAFAH1B1):c.664C>T (p.Gln222Ter)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2576044	17	2672750	159535	169365
NM_000430.3(PAFAH1B1):c.671G>A (p.Gly224Asp)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2576051	17	2672757	159538	169366
NM_000430.3(PAFAH1B1):c.671+4A>G	PAFAH1B1	Lissencephaly 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2576055	17	2672761	159536	169367
NM_000430.3(PAFAH1B1):c.671+5G>A	PAFAH1B1	Lissencephaly 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, multiple submitters, no conflicts	17	2576056	17	2672762	159537	169368
NM_000430.3(PAFAH1B1):c.672-10A>C	PAFAH1B1	not specified|Lissencephaly/Subcortical Band Heterotopia	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	2577344	17	2674050	92999	98906
NM_000430.3(PAFAH1B1):c.675C>G (p.Tyr225Ter)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2577357	17	2674063	159539	169369
NM_000430.3(PAFAH1B1):c.687A>T (p.Thr229=)	PAFAH1B1	Lissencephaly 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2577369	17	2674075	159540	169370
NM_000430.3(PAFAH1B1):c.693A>T (p.Thr231=)	PAFAH1B1	not specified|Lissencephaly/Subcortical Band Heterotopia	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	2577375	17	2674081	159541	169371
NM_000430.3(PAFAH1B1):c.716dupT (p.Met239Ilefs)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Dec 31, 2013)	criteria provided, single submitter	17	2577398	17	2674104	159542	169372
NM_000430.3(PAFAH1B1):c.730C>T (p.Gln244Ter)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2577412	17	2674118	159544	169373
NM_000430.3(PAFAH1B1):c.751A>C (p.Ser251Arg)	PAFAH1B1	Lissencephaly 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2577433	17	2674139	159545	169374
NM_000430.3(PAFAH1B1):c.817C>T (p.Arg273Ter)	PAFAH1B1	Lissencephaly 1|not provided	Pathogenic(Last reviewed: Mar 9, 2016)	criteria provided, multiple submitters, no conflicts	17	2577499	17	2674205	8074	23113
NM_000430.3(PAFAH1B1):c.841T>C (p.Cys281Arg)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2577523	17	2674229	159546	169375
NM_000430.3(PAFAH1B1):c.851G>A (p.Trp284Ter)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2577533	17	2674239	159548	169376
NM_000430.3(PAFAH1B1):c.852G>A (p.Trp284Ter)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	17	2577534	17	2674240	561072	552200
NM_000430.3(PAFAH1B1):c.900G>A (p.Glu300=)	PAFAH1B1	Lissencephaly 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2577582	17	2674288	159550	169377
NM_000430.3(PAFAH1B1):c.900+1G>A	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2577583	17	2674289	159549	169378
NM_000430.3(PAFAH1B1):c.910del (p.Ser304Valfs)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: May 22, 2013)	criteria provided, single submitter	17	2579808	17	2676514	159551	169379
NM_000430.3(PAFAH1B1):c.938C>T (p.Ser313Phe)	PAFAH1B1	Lissencephaly 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2579836	17	2676542	159552	169380
NM_000430.3(PAFAH1B1):c.965T>G (p.Met322Arg)	PAFAH1B1	Lissencephaly 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2579863	17	2676569	159553	169381
NM_000430.3(PAFAH1B1):c.1002+1G>A	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, multiple submitters, no conflicts	17	2579901	17	2676607	21175	34027
NM_000430.3(PAFAH1B1):c.1002+5G>A	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2579905	17	2676611	159486	169383
NM_000430.3(PAFAH1B1):c.1009C>T (p.His337Tyr)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2583464	17	2680170	159489	169385
NM_000430.3(PAFAH1B1):c.1009C>G (p.His337Asp)	PAFAH1B1	Lissencephaly 1	Likely pathogenic(Last reviewed: May 1, 2013)	criteria provided, single submitter	17	2583464	17	2680170	159488	169384
NM_000430.3(PAFAH1B1):c.1024_1031del (p.Arg342Serfs)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2583479 - 2583486	17	2680185 - 2680192	159490	169386
NM_000430.3(PAFAH1B1):c.1050delG (p.Lys351Serfs)	PAFAH1B1	Lissencephaly 1|not provided	Pathogenic(Last reviewed: Dec 30, 2015)	criteria provided, multiple submitters, no conflicts	17	2583505	17	2680211	21176	34028
NM_000430.3(PAFAH1B1):c.1059T>C (p.Ile353=)	PAFAH1B1	not specified	Benign(Last reviewed: Feb 16, 2017)	criteria provided, multiple submitters, no conflicts	17	2583514	17	2680220	92996	98903
NM_000430.3(PAFAH1B1):c.1063del (p.Ser355Valfs)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2583518	17	2680224	159491	169387
NM_000430.3(PAFAH1B1):c.1064G>A (p.Ser355Asn)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2583519	17	2680225	159492	169388
NM_000430.3(PAFAH1B1):c.1100del (p.Tyr367Serfs)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2583555	17	2680261	159493	169389
NM_000430.3(PAFAH1B1):c.1111C>T (p.Arg371Ter)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2583566	17	2680272	159494	169390
NM_000430.3(PAFAH1B1):c.1135C>T (p.His379Tyr)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2583590	17	2680296	159495	169391
NM_000430.3(PAFAH1B1):c.1159G>T (p.Asp387Tyr)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2583614	17	2680320	159497	169392
NM_000430.3(PAFAH1B1):c.1159+2T>A	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2583616	17	2680322	159496	169393
NM_000430.3(PAFAH1B1):c.1165C>T (p.His389Tyr)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2585028	17	2681734	159498	169394
NM_000430.3(PAFAH1B1):c.1188C>T (p.Val396=)	PAFAH1B1	Lissencephaly 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2585051	17	2681757	159499	169395
NM_000430.3(PAFAH1B1):c.1193G>A (p.Gly398Asp)	PAFAH1B1	Lissencephaly 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2585056	17	2681762	159500	169396
NM_000430.3(PAFAH1B1):c.1196G>C (p.Ser399Thr)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2585059	17	2681765	159501	169397
NM_000430.3(PAFAH1B1):c.1201G>C (p.Asp401His)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2585064	17	2681770	159502	169398
NM_000430.3(PAFAH1B1):c.1233A>C (p.Ter411Cys)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2585096	17	2681802	159504	169399
NM_000546.5(TP53):c.949C>T (p.Gln317Ter)	TP53	Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, multiple submitters, no conflicts	17	7576897	17	7673579	450344	445901
NM_000546.5(TP53):c.917G>A (p.Arg306Gln)	TP53	Familial cancer of breast|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 8, 2018)	criteria provided, conflicting interpretations	17	7577021	17	7673703	458574	469117
NM_000546.5(TP53):c.869G>A (p.Arg290His)	TP53	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	17	7577069	17	7673751	127825	133282
NM_000546.5(TP53):c.848G>A (p.Arg283His)	TP53	Li-Fraumeni syndrome|not specified|not provided|Astrocytoma|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 21, 2018)	criteria provided, conflicting interpretations	17	7577090	17	7673772	142324	152038
NM_000546.5(TP53):c.847C>T (p.Arg283Cys)	TP53	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm of stomach|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	17	7577091	17	7673773	127824	133281
NM_000546.5(TP53):c.844C>T (p.Arg282Trp)	TP53	Liver cancer|Non-Hodgkin lymphoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Lung adenocarcinoma|Astrocytoma, anaplastic|Li-Fraumeni-like syndrome|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Pleomorphic xanthoastrocytoma	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	17	7577094	17	7673776	12364	27403
NM_000546.5(TP53):c.747G>T (p.Arg249Ser)	TP53	Carcinoma of cervix|Liver cancer|Li-Fraumeni syndrome|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 25, 2018)	criteria provided, conflicting interpretations	17	7577534	17	7674216	12352	27391
NM_000546.5(TP53):c.743G>A (p.Arg248Gln)	TP53	Liver cancer|Chronic lymphocytic leukemia|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Sarcoma|Neoplasm|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Malignant Colorectal Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	17	7577538	17	7674220	12356	27395
NM_000546.5(TP53):c.742C>T (p.Arg248Trp)	TP53	Liver cancer|Chronic lymphocytic leukemia|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Pectus excavatum|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|Short stature|Cognitive impairment|Webbed neck|not provided|Pancytopenia|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Abnormality of the tongue|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Neoplasm|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	17	7577539	17	7674221	12347	27386
NM_000546.5(TP53):c.733G>A (p.Gly245Ser)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Lung adenocarcinoma|Astrocytoma, anaplastic|Li-Fraumeni-like syndrome|Li-Fraumeni syndrome|Squamous cell lung carcinoma|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Adenocarcinoma|Carcinoma of esophagus|Neoplasm|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Atypical teratoid/rhabdoid tumor	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	17	7577548	17	7674230	12365	27404
NM_000546.5(TP53):c.704A>G (p.Asn235Ser)	TP53	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Rhabdomyosarcoma	Conflicting interpretations of pathogenicity(Last reviewed: May 25, 2018)	criteria provided, conflicting interpretations	17	7577577	17	7674259	127821	133278
NM_000546.5(TP53):c.672+2T>A	TP53	Li-Fraumeni syndrome	Likely pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	17	7578175	17	7674857	517509	497494
NM_000546.5(TP53):c.665C>T (p.Pro222Leu)	TP53	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	17	7578184	17	7674866	161397	171191
NM_000546.5(TP53):c.638G>A (p.Arg213Gln)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|not specified|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenoid cystic carcinoma|Nasopharyngeal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma|PARP Inhibitor response	Pathogenic(Last reviewed: Jun 17, 2018)	criteria provided, multiple submitters, no conflicts	17	7578211	17	7674893	135359	139098
NM_000546.5(TP53):c.637C>T (p.Arg213Ter)	TP53	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	17	7578212	17	7674894	43590	52759
NM_000546.5(TP53):c.586C>T (p.Arg196Ter)	TP53	Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, multiple submitters, no conflicts	17	7578263	17	7674945	43589	52758
NM_000546.5(TP53):c.542G>A (p.Arg181His)	TP53	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	17	7578388	17	7675070	142320	152034
NM_000546.5(TP53):c.524G>A (p.Arg175His)	TP53	Malignant tumor of esophagus|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Neoplasm	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	17	7578406	17	7675088	12374	27413
NM_000546.5(TP53):c.473G>A (p.Arg158His)	TP53	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 22, 2018)	criteria provided, multiple submitters, no conflicts	17	7578457	17	7675139	141963	151677
NM_000546.5(TP53):c.470T>C (p.Val157Ala)	TP53	Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma	Likely pathogenic(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	17	7578460	17	7675142	428887	420661
NM_000546.5(TP53):c.467G>A (p.Arg156His)	TP53	Li-Fraumeni syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	17	7578463	17	7675145	127811	133268
NM_000546.5(TP53):c.455C>T (p.Pro152Leu)	TP53	Familial cancer of breast|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	17	7578475	17	7675157	142766	152480
NM_000546.5(TP53):c.184G>T (p.Glu62Ter)	TP53	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter			17	7676185	617472	608821
NM_000180.3(GUCY2D):c.2513G>A (p.Arg838His)	GUCY2D	Cone-rod dystrophy 6|not provided|Retinal dystrophy	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	17	7918019	17	8014701	9357	24396
NM_002472.2(MYH8):c.5208C>T (p.Asp1736=)	MYH8|MYHAS	Hecht syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10296486	17	10393169	129679	135125
NM_002472.2(MYH8):c.5074T>C (p.Trp1692Arg)	MYH8|MYHAS	Hecht syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10297658	17	10394341	129678	135124
NM_002472.2(MYH8):c.4233C>T (p.Asn1411=)	MYH8|MYHAS	Hecht syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10300249	17	10396932	129677	135123
NM_002472.2(MYH8):c.3270C>T (p.Ile1090=)	MYH8|MYHAS	Hecht syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10304261	17	10400944	129674	135120
NM_002472.2(MYH8):c.3117G>A (p.Gly1039=)	MYH8|MYHAS	Hecht syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10304500	17	10401183	129673	135119
NM_002472.2(MYH8):c.2016C>T (p.Phe672=)	MYH8|MYHAS	Hecht syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10310246	17	10406929	129672	135118
NM_002472.2(MYH8):c.1907C>T (p.Ala636Val)	MYH8|MYHAS	Hecht syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10312472	17	10409155	129671	135117
NM_002472.2(MYH8):c.1701G>A (p.Gln567=)	MYH8|MYHAS	Hecht syndrome|not specified	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	17	10312792	17	10409475	129670	135116
NM_002472.2(MYH8):c.805+9C>T	MYH8|MYHAS	not specified	Likely benign	no assertion criteria provided	17	10318424	17	10415107	129681	135127
NM_002472.2(MYH8):c.714T>C (p.Thr238=)	MYH8|MYHAS	Hecht syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10318636	17	10415319	129680	135126
NM_017534.5(MYH2):c.1160C>T (p.Ala387Val)	MYH2|MYHAS	Inclusion body myopathy 3	Uncertain significance(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	17	10442867	17	10539550	374380	361226
NM_002470.3(MYH3):c.5457+3G>A	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10533602	17	10630285	129665	135111
NM_002470.3(MYH3):c.5254G>A (p.Ala1752Thr)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10534960	17	10631643	129664	135110
NM_002470.3(MYH3):c.4731C>T (p.Ile1577=)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10536018	17	10632701	129663	135109
NM_002470.3(MYH3):c.4155A>G (p.Glu1385=)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10538701	17	10635384	129662	135108
NM_002470.3(MYH3):c.4128C>T (p.Tyr1376=)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10538728	17	10635411	129661	135107
NM_002470.3(MYH3):c.3938C>T (p.Thr1313Ile)	MYH3	Freeman-Sheldon syndrome|not specified|not provided|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10539089	17	10635772	129660	135106
NM_002470.3(MYH3):c.3726T>C (p.Ser1242=)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10541363	17	10638046	129659	135105
NM_002470.3(MYH3):c.3574G>A (p.Ala1192Thr)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10541515	17	10638198	129658	135104
NM_002470.3(MYH3):c.3348T>C (p.Ile1116=)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10541741	17	10638424	129657	135103
NM_002470.3(MYH3):c.3138A>C (p.Arg1046=)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10542471	17	10639154	129656	135102
NM_002470.3(MYH3):c.3009G>A (p.Ala1003=)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10542708	17	10639391	129655	135101
NM_002470.3(MYH3):c.3008C>T (p.Ala1003Val)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10542709	17	10639392	129654	135100
NM_002470.3(MYH3):c.2952T>C (p.Ser984=)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10542765	17	10639448	129653	135099
NM_002470.3(MYH3):c.2916A>G (p.Thr972=)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10542886	17	10639569	129652	135098
NM_002470.3(MYH3):c.2610A>G (p.Lys870=)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10543385	17	10640068	129651	135097
NM_002470.3(MYH3):c.2532A>G (p.Ala844=)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10543463	17	10640146	129650	135096
NM_002470.3(MYH3):c.2151C>A (p.Gly717=)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10544416	17	10641099	129649	135095
NM_002470.3(MYH3):c.2106C>T (p.Gly702=)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10544461	17	10641144	129648	135094
NM_002470.3(MYH3):c.699C>T (p.Asn233=)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10551910	17	10648593	129666	135112
NM_002470.3(MYH3):c.6T>C (p.Ser2=)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10558376	17	10655059	129667	135113
NC_000017.10:g.14087933_15500645dup	COX10|PMP22|HS3ST3B1|TEKT3|CDRT15|TVP23C|CDRT4|CDRT1|TVP23C-CDRT4	Charcot-Marie-Tooth disease, type IA	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	17	14087933 - 15500645			598751	589820
NM_000304.3(PMP22):c.449G>T (p.Gly150Val)	PMP22	Charcot-Marie-Tooth disease and deafness|Dejerine-Sottas disease	Pathogenic	no assertion criteria provided	17	15134268	17	15230951	433198	426772
NM_000304.3(PMP22):c.434delT (p.Leu145Argfs)	PMP22	Charcot-Marie-Tooth disease, type IA|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, multiple submitters, no conflicts	17	15134283	17	15230966	217238	213835
NM_000304.3(PMP22):c.353C>T (p.Thr118Met)	PMP22	Hereditary liability to pressure palsies|Charcot-Marie-Tooth disease, type IA|Charcot-Marie-Tooth disease, type 1a, autosomal recessive|Charcot-Marie-Tooth disease, type I|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 4, 2018)	criteria provided, conflicting interpretations	17	15134364	17	15231047	8431	23470
NM_000304.3(PMP22):c.327C>A (p.Cys109Ter)	PMP22	Charcot-Marie-Tooth disease, type IA|not provided	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, multiple submitters, no conflicts	17	15134390	17	15231073	217237	213836
NM_000304.3(PMP22):c.281delG (p.Gly94Alafs)	PMP22	Charcot-Marie-Tooth disease and deafness|Charcot-Marie-Tooth disease, type IA	Pathogenic(Last reviewed: Feb 11, 2019)	no assertion criteria provided	17	15142826	17	15239509	30158	39114
NM_000304.3(PMP22):c.281dupG (p.Arg95Glnfs)	PMP22	Hereditary liability to pressure palsies|Charcot-Marie-Tooth disease type 2E|Charcot-Marie-Tooth disease, type IA	Pathogenic(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	17	15142826	17	15239509	8437	23476
NM_000304.3(PMP22):c.235T>A (p.Ser79Thr)	PMP22	Charcot-Marie-Tooth disease, type IA	Likely pathogenic(Last reviewed: Aug 14, 2015)	criteria provided, single submitter	17	15142872	17	15239555	217236	213837
NM_012452.2(TNFRSF13B):c.310T>C (p.Cys104Arg)	TNFRSF13B	Talipes equinovarus|Common variable immunodeficiency 2|Immunoglobulin A deficiency 2|Skeletal dysplasia|not specified|Micrognathia|Hemivertebrae|not provided|Preaxial foot polydactyly|Respiratory failure|Short femur|Vertebral segmentation defect|Pseudoarthrosis|Chronic lung disease|Interstitial pulmonary abnormality|Coat hanger sign of ribs|Vertebral hypoplasia|Absent epiphyses|Cleft palate|Patent ductus arteriosus|Common Variable Immune Deficiency, Dominant	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Jun 29, 2018)	criteria provided, conflicting interpretations	17	16852187	17	16948873	5302	20341
NM_144997.6(FLCN):c.1523A>G (p.Lys508Arg)	FLCN	Multiple fibrofolliculomas|not specified|not provided|Hereditary cancer-predisposing syndrome|Birt-Hogg-Dub syndrome	Likely benign(Last reviewed: Jan 17, 2018)	criteria provided, multiple submitters, no conflicts	17	17118314	17	17215000	41856	50295
NM_144997.6(FLCN):c.1285delC (p.His429Thrfs)	FLCN	Multiple fibrofolliculomas|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	17	17119709	17	17216395	3364	18403
NM_144606.5(FLCN):c.833C>T (p.Pro278Leu)	FLCN	Multiple fibrofolliculomas	Uncertain significance(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	17	17124889	17	17221575	225284	227196
NM_144606.5(FLCN):c.779G>A (p.Trp260Ter)	FLCN	Multiple fibrofolliculomas|Pneumothorax, primary spontaneous	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	17	17125815	17	17222501	161246	171188
NM_144606.6(FLCN):c.715C>T (p.Arg239Cys)	FLCN	Multiple fibrofolliculomas|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 17, 2018)	criteria provided, conflicting interpretations	17	17125879	17	17222565	134427	138166
NM_144997.5(FLCN):c.446delG (p.Gly149Alafs)	FLCN	Multiple fibrofolliculomas	Likely pathogenic(Last reviewed: Apr 29, 2016)	criteria provided, single submitter	17	17127408	17	17224094	179123	175931
NM_144997.6(FLCN):c.433delG (p.Asp145Metfs)	FLCN	Multiple fibrofolliculomas	Pathogenic	no assertion criteria provided	17	17127421	17	17224107	431057	424584
NC_000017.10:g.17711738_17748468del	SREBF1|RAI1|TOM1L2|MIR33B	Smith-Magenis syndrome	Pathogenic(Last reviewed: Nov 12, 2015)	criteria provided, single submitter	17	17711738 - 17748468			243061	244142
NM_030665.3(RAI1):c.264G>A (p.Gln88=)	RAI1	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 15, 2016)	criteria provided, multiple submitters, no conflicts	17	17696526	17	17793212	96182	102076
NM_030665.3(RAI1):c.269G>C (p.Gly90Ala)	RAI1	Smith-Magenis syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: May 5, 2017)	criteria provided, multiple submitters, no conflicts	17	17696531	17	17793217	96183	102077
NM_030665.3(RAI1):c.493C>A (p.Pro165Thr)	RAI1	Smith-Magenis syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: May 3, 2017)	criteria provided, multiple submitters, no conflicts	17	17696755	17	17793441	96194	102088
NM_030665.3(RAI1):c.610C>T (p.Pro204Ser)	RAI1	not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Nov 17, 2016)	criteria provided, multiple submitters, no conflicts	17	17696872	17	17793558	130083	135529
NM_030665.3(RAI1):c.725C>T (p.Pro242Leu)	RAI1	not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jun 16, 2017)	criteria provided, multiple submitters, no conflicts	17	17696987	17	17793673	96196	102090
NM_030665.3(RAI1):c.836_837delAG (p.Gln279Profs)	RAI1	not provided	Uncertain significance(Last reviewed: Jun 12, 2013)	criteria provided, single submitter	17	17697098 - 17697099	17	17793784 - 17793785	130085	135531
NM_030665.3(RAI1):c.837G>A (p.Gln279=)	RAI1	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 11, 2016)	criteria provided, multiple submitters, no conflicts	17	17697099	17	17793785	96198	102092
NM_030665.3(RAI1):c.840G>A (p.Gln280=)	RAI1	not specified	Benign(Last reviewed: Jun 6, 2013)	criteria provided, multiple submitters, no conflicts	17	17697102	17	17793788	96199	102093
NM_030665.3(RAI1):c.1748G>A (p.Ser583Asn)	RAI1	Smith-Magenis syndrome	Uncertain significance(Last reviewed: Dec 31, 2016)	criteria provided, single submitter	17	17698010	17	17794696	375265	361967
NM_030665.3(RAI1):c.1992G>A (p.Pro664=)	RAI1	Smith-Magenis syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: May 5, 2017)	criteria provided, multiple submitters, no conflicts	17	17698254	17	17794940	96179	102073
NM_030665.3(RAI1):c.2469_2470insG (p.Leu825Alafs)	RAI1	Smith-Magenis syndrome	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	17	17698731 - 17698732	17	17795417 - 17795418	522853	513464
NM_030665.3(RAI1):c.3781_3783delGAG (p.Glu1261del)	RAI1	not specified|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Oct 12, 2017)	criteria provided, conflicting interpretations	17	17700043 - 17700045	17	17796729 - 17796731	96187	102081
NM_030665.3(RAI1):c.3791A>G (p.Glu1264Gly)	RAI1	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 16, 2016)	criteria provided, multiple submitters, no conflicts	17	17700053	17	17796739	130087	135533
NM_030665.3(RAI1):c.4311T>C (p.Pro1437=)	RAI1	Smith-Magenis syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: May 5, 2017)	criteria provided, multiple submitters, no conflicts	17	17700573	17	17797259	96190	102084
NM_030665.3(RAI1):c.4512G>T (p.Leu1504=)	RAI1	Smith-Magenis syndrome|not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	17	17700774	17	17797460	96191	102085
NM_030665.3(RAI1):c.4530C>T (p.Pro1510=)	RAI1	Smith-Magenis syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: May 3, 2017)	criteria provided, multiple submitters, no conflicts	17	17700792	17	17797478	96192	102086
NM_030665.3(RAI1):c.5601T>C (p.Ile1867=)	RAI1	Smith-Magenis syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: May 3, 2017)	criteria provided, multiple submitters, no conflicts	17	17707105	17	17803791	96195	102089
NM_002749.3(MAPK7):c.886G>A (p.Ala296Thr)	MAPK7	Scoliosis, isolated, susceptibility to, 1	Pathogenic	no assertion criteria provided	17	19284408	17	19381095	427639	417075
NM_002749.3(MAPK7):c.1760C>T (p.Pro587Leu)	MAPK7	Scoliosis, isolated, susceptibility to, 1	Pathogenic	no assertion criteria provided	17	19285376	17	19382063	427640	417076
NM_002749.3(MAPK7):c.1943C>T (p.Pro648Leu)	MAPK7	Scoliosis, isolated, susceptibility to, 1	Pathogenic	no assertion criteria provided	17	19285559	17	19382246	427641	417077
NM_000267.3(NF1):c.288+1delG (p.Gln97Asnfs)	NF1	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2016)	criteria provided, multiple submitters, no conflicts	17	29486112	17	31159094	404591	401612
NM_001042492.2(NF1):c.2288T>C (p.Leu763Pro)	NF1	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	17	29554272	17	31227254	68312	79203
NM_000267.3(NF1):c.2503C>T (p.Gln835Ter)	NF1	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	17	29556136	17	31229118	523904	514712
NM_000267.3(NF1):c.2970_2972delAAT (p.Met992del)	NF1	Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|Caf-au-lait macules with pulmonary stenosis|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	17	29556972 - 29556974	17	31229954 - 31229956	363	15402
NM_001042492.2(NF1):c.3060delA (p.Val1021Terfs)	NF1	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	17	29557347	17	31230329	517397	497565
NM_001042492.2(NF1):c.3197+3A>T	NF1	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 6, 2017)	criteria provided, single submitter	17	29557946	17	31230928	522580	513192
NM_001042492.2(NF1):c.3827G>A (p.Arg1276Gln)	NF1	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, multiple submitters, no conflicts	17	29562747	17	31235729	68341	79232
NM_000267.3(NF1):c.4168C>T (p.Leu1390Phe)	NF1	Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	17	29585419	17	31258401	30992	39949
NM_000267.3(NF1):c.4267A>G (p.Lys1423Glu)	NF1	Multiple cafe-au-lait spots|Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome|Axillary freckling|Neurofibromas|Optic nerve glioma	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	17	29585518	17	31258500	336	15375
NM_001042492.2(NF1):c.4332+1delG	NF1	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter			17	31258503	599036	590165
NM_001042492.2(NF1):c.4465A>G (p.Ser1489Gly)	NF1	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	17	29587421	17	31260403	68351	79242
NM_001042492.2(NF1):c.4729C>T (p.Gln1577Ter)	NF1	Neurofibromatosis, type 1|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, multiple submitters, no conflicts	17	29592251	17	31265233	208766	205301
NM_001042492.2(NF1):c.4816_4820delTTTTA (p.Phe1606Leufs)	NF1	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	17	29592338 - 29592342	17	31265320 - 31265324	488562	481430
NM_001042492.2(NF1):c.5157delA (p.Ile1719Metfs)	NF1	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	17	29653159	17	31326141	545724	536216
NM_000267.3(NF1):c.5242C>T (p.Arg1748Ter)	NF1	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	17	29654553	17	31327535	228381	230767
NM_000267.3(NF1):c.5648A>G (p.Asn1883Ser)	NF1	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	17	29657415	17	31330397	220757	222619
NM_000267.3(NF1):c.6277G>T (p.Gly2093Cys)	NF1	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	17	29663845	17	31336827	561056	552201
NM_001042492.2(NF1):c.6818A>G (p.Lys2273Arg)	NF1	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 9, 2014)	criteria provided, single submitter	17	29665156	17	31338138	428947	420824
NM_000267.3(NF1):c.6789_6792delTTAC (p.Tyr2264Thrfs)	NF1	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, multiple submitters, no conflicts	17	29665754 - 29665757	17	31338736 - 31338739	216866	213290
NM_000267.3(NF1):c.6791dupA (p.Tyr2264Terfs)	NF1	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	17	29665756	17	31338738	228382	230771
NM_000267.3(NF1):c.6889dup (p.Val2297Glyfs)	NF1	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	17	29667553	17	31340535	223148	224875
NM_000267.3(NF1):c.7013_7039del27 (p.Val2338_Leu2346del)	NF1	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	17	29670040 - 29670066	17	31343022 - 31343048	522586	513200
NM_001042492.2(NF1):c.7909C>T (p.Arg2637Ter)	NF1	Neurofibromatosis, familial spinal|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|Caf-au-lait macules with pulmonary stenosis|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	17	29684326	17	31357308	184261	184776
NM_000267.3(NF1):c.7919T>A (p.Leu2640Ter)	NF1	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter			17	31358491	617614	609010
NM_015355.4(SUZ12):c.1797A>C (p.Gln599His)	SUZ12	Weaver syndrome	Uncertain significance(Last reviewed: Feb 12, 2018)	criteria provided, single submitter	17	30323819	17	31996800	590939	581883
NM_002878.3(RAD51D):c.394G>A (p.Val132Ile)	RAD51D|RAD51L3-RFFL	Breast-ovarian cancer, familial 4|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	17	33434093	17	35107074	185178	184833
NM_000458.3(HNF1B):c.1132dupC (p.Gln378Profs)	HNF1B	Familial hypoplastic, glomerulocystic kidney	Pathogenic	criteria provided, single submitter	17	36070585	17	37710577	224334	226090
NM_000458.3(HNF1B):c.477delT (p.Met160Terfs)	HNF1B	Familial hypoplastic, glomerulocystic kidney	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	17	36099498	17	37739507	36849	45510
NM_003673.3(TCAP):c.37_39delGAG (p.Glu13del)	TCAP	Familial hypertrophic cardiomyopathy 1|Dilated cardiomyopathy 1N|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 28, 2018)	criteria provided, conflicting interpretations	17	37821649 - 37821651	17	39665396 - 39665398	44707	53874
NM_003673.3(TCAP):c.157C>T (p.Gln53Ter)	TCAP	Primary dilated cardiomyopathy|Limb-girdle muscular dystrophy, type 2G|Dilated cardiomyopathy 1N	Likely pathogenic	criteria provided, single submitter	17	37822015	17	39665762	5525	20564
NM_003673.3(TCAP):c.259C>T (p.Arg87Trp)	TCAP	Primary dilated cardiomyopathy	Likely benign(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	17	37822117	17	39665864	202102	198475
NM_199334.3(THRA):c.54-1G>A	THRA	Hypothyroidism, congenital, nongoitrous, 6	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	17	38233123	17	40076870	561132	552202
NM_000223.3(KRT12):c.404G>C (p.Arg135Thr)	KRT12	Meesman's corneal dystrophy|not provided	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	17	39023035	17	40866783	7921	22960
NM_005557.3(KRT16):c.379C>T (p.Arg127Cys)	KRT16	Pachyonychia congenita 1|Palmoplantar keratoderma, nonepidermolytic, focal|not provided	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	17	39768562	17	41612310	14601	29640
NM_005557.3(KRT16):c.365A>G (p.Gln122Arg)	KRT16	Pachyonychia congenita 1	Likely pathogenic(Last reviewed: Apr 8, 2014)	criteria provided, single submitter	17	39768576	17	41612324	216955	213644
NM_012448.3(STAT5B):c.1433C>T (p.Ala478Val)	STAT5B	Growth hormone insensitivity with immunodeficiency	Pathogenic(Last reviewed: Aug 2, 2017)	no assertion criteria provided	17	40368072	17	42216054	517661	508752
NM_012448.3(STAT5B):c.1421A>G (p.Gln474Arg)	STAT5B	Growth hormone insensitivity with immunodeficiency	Pathogenic(Last reviewed: Aug 2, 2017)	no assertion criteria provided	17	40368084	17	42216066	492931	485862
NM_012448.3(STAT5B):c.530A>C (p.Gln177Pro)	STAT5B	Growth hormone insensitivity with immunodeficiency	Pathogenic(Last reviewed: Aug 2, 2017)	no assertion criteria provided	17	40375420	17	42223402	522611	513224
NM_139276.2(STAT3):c.2147C>T (p.Thr716Met)	STAT3	Hyperimmunoglobulin E syndrome|not provided|Autoimmune disease, multisystem, infantile-onset, 1|STAT3 gain of function	Pathogenic/Likely pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	17	40468917	17	42316899	224848	226683
NM_139276.2(STAT3):c.2134T>C (p.Cys712Arg)	STAT3	Hyperimmunoglobulin E syndrome	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	17	40469210	17	42317192	36791	45452
NM_139276.2(STAT3):c.2107G>A (p.Ala703Thr)	STAT3	Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	17	40469237	17	42317219	224850	226684
NM_139276.2(STAT3):c.1988C>T (p.Thr663Ile)	STAT3	Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	17	40474413	17	42322395	224845	226685
NM_139276.2(STAT3):c.1970A>G (p.Tyr657Cys)	STAT3	Hyperimmunoglobulin E syndrome	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	17	40474431	17	42322413	36790	45451
NM_139276.2(STAT3):c.1261G>A (p.Gly421Arg)	STAT3	not provided|Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, multiple submitters, no conflicts	17	40481448	17	42329430	224844	226686
NM_139276.2(STAT3):c.1260T>G (p.Asn420Lys)	STAT3	Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	17	40481449	17	42329431	224849	226687
NM_139276.2(STAT3):c.1243G>A (p.Glu415Lys)	STAT3	Hyperimmunoglobulin E syndrome|Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, multiple submitters, no conflicts	17	40481466	17	42329448	36784	45445
NM_139276.2(STAT3):c.1057G>T (p.Val353Phe)	STAT3	Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	17	40483542	17	42331524	224847	226688
NM_139276.2(STAT3):c.1032G>C (p.Gln344His)	STAT3	Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	17	40485708	17	42333690	224843	226689
NM_139276.2(STAT3):c.1003C>T (p.Arg335Trp)	STAT3	Hyperimmunoglobulin E syndrome|not provided|STAT3 gain of function	Likely pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, multiple submitters, no conflicts	17	40485737	17	42333719	36783	45444
NM_139276.2(STAT3):c.454C>T (p.Arg152Trp)	STAT3	Hyperimmunoglobulin E syndrome|Autoimmune disease, multisystem, infantile-onset, 1|STAT3 gain of function	Pathogenic(Last reviewed: Jul 8, 2018)	criteria provided, multiple submitters, no conflicts	17	40491346	17	42339328	224846	226690
NM_007294.3(BRCA1):c.*1287C>T	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41196408	17	43044391	132777	136525
NM_007294.3(BRCA1):c.*781C>T	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41196914	17	43044897	132778	136526
NM_007294.3(BRCA1):c.*36C>G	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41197659	17	43045642	125873	131411
NM_007294.3(BRCA1):c.5558A>G (p.Tyr1853Cys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	17	41197729	17	43045712	55627	70294
NM_007294.3(BRCA1):c.5550G>A (p.Leu1850=)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Likely benign(Last reviewed: May 30, 2017)	criteria provided, single submitter	17	41197737	17	43045720	403718	390695
NM_007294.3(BRCA1):c.5536C>T (p.Gln1846Ter)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41197751	17	43045734	55620	70287
NM_007294.3(BRCA1):c.5524_5531delGTAGCACT (p.Val1842Leufs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Dec 15, 2017)	reviewed by expert panel	17	41197756 - 41197763	17	43045739 - 43045746	252389	246808
NM_007294.3(BRCA1):c.5503C>T (p.Arg1835Ter)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41197784	17	43045767	55601	70268
NM_007294.3(BRCA1):c.5497G>A (p.Val1833Met)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	17	41197790	17	43045773	55598	70265
NM_007294.3(BRCA1):c.5468-10C>A	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41197829	17	43045812	55589	70256
NM_007294.3(BRCA1):c.5467+1G>A	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	17	41199659	17	43047642	37673	46229
NM_007294.3(BRCA1):c.5431C>T (p.Gln1811Ter)	BRCA1	Breast-ovarian cancer, familial 1|not provided	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	17	41199696	17	43047679	55577	70244
NM_007294.3(BRCA1):c.5411T>A (p.Val1804Asp)	BRCA1	Breast-ovarian cancer, familial 1|Ovarian cancer|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41199716	17	43047699	55568	70235
NM_007294.3(BRCA1):c.5406+33A>T	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41201105	17	43049088	55561	70228
NM_007294.3(BRCA1):c.5406+8T>C	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41201130	17	43049113	125843	131381
NM_007294.3(BRCA1):c.5406+4_5406+7delAGTA	BRCA1	Hereditary breast and ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 27, 2018)	criteria provided, conflicting interpretations	17	41201131 - 41201134	17	43049114 - 43049117	531285	531540
NM_007294.3(BRCA1):c.5387C>A (p.Ser1796Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41201157	17	43049140	37663	46219
NM_007294.3(BRCA1):c.5359_5363delTGTGGinsAGTGA (p.Cys1787_Gly1788delinsSerAsp)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	17	41201181 - 41201185	17	43049164 - 43049168	187349	184875
NM_007294.3(BRCA1):c.5363G>T (p.Gly1788Val)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41201181	17	43049164	37660	46216
NM_007294.3(BRCA1):c.5339T>C (p.Leu1780Pro)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 6, 2018)	criteria provided, conflicting interpretations	17	41201205	17	43049188	55541	70208
NM_007294.3(BRCA1):c.5335delC (p.Gln1779Asnfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41201209	17	43049192	37657	46213
NM_007294.3(BRCA1):c.5333-1G>A	BRCA1	Breast-ovarian cancer, familial 1	Likely pathogenic(Last reviewed: Aug 12, 2014)	criteria provided, single submitter	17	41201212	17	43049195	55533	70200
NM_007294.3(BRCA1):c.5332+13G>T	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Dec 22, 2017)	criteria provided, multiple submitters, no conflicts	17	41203067	17	43051050	220900	222647
NM_007294.3(BRCA1):c.5329A>T (p.Thr1777Ser)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: Jun 10, 2016)	criteria provided, single submitter	17	41203083	17	43051066	252402	246809
NM_007294.3(BRCA1):c.5310G>A (p.Gly1770=)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	17	41203102	17	43051085	55515	70182
NM_007294.3(BRCA1):c.5278-14C>G	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 15, 2017)	criteria provided, conflicting interpretations	17	41203148	17	43051131	91645	97122
NM_007294.3(BRCA1):c.5277+1delG	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, multiple submitters, no conflicts	17	41209068	17	43057051	91644	97121
NM_007294.3(BRCA1):c.5277+1G>A	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41209068	17	43057051	37654	46210
NM_007294.3(BRCA1):c.5266dupC (p.Gln1756Profs)	BRCA1	Familial cancer of breast|Porokeratosis punctata palmaris et plantaris|Breast-ovarian cancer, familial 1|Neoplasm of ovary|Pancreatic cancer, susceptibility to|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|604370	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41209082	17	43057065	17677	32716
NM_007294.3(BRCA1):c.5252G>A (p.Arg1751Gln)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41209094	17	43057077	55481	70148
NM_007294.3(BRCA1):c.5251C>T (p.Arg1751Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41209095	17	43057078	55480	70147
NM_007294.3(BRCA1):c.5225A>G (p.Asn1742Ser)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 12, 2018)	criteria provided, multiple submitters, no conflicts	17	41209121	17	43057104	219464	222650
NM_007294.3(BRCA1):c.5205delA (p.Val1736Serfs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41209141	17	43057124	140168	150134
NM_007294.3(BRCA1):c.5177_5180delGAAA (p.Arg1726Lysfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41215363 - 41215366	17	43063346 - 43063349	37644	46200
NM_007294.3(BRCA1):c.5153-1G>C	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41215391	17	43063374	37643	46199
NM_007294.3(BRCA1):c.5152+1G>C	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, multiple submitters, no conflicts	17	41215890	17	43063873	37642	46198
NM_007294.3(BRCA1):c.5137delG (p.Val1713Terfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41215906	17	43063889	55411	70078
NM_007294.3(BRCA1):c.5136G>A (p.Trp1712Ter)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41215907	17	43063890	55410	70077
NM_007294.3(BRCA1):c.5123C>A (p.Ala1708Glu)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41215920	17	43063903	55407	70074
NM_007294.3(BRCA1):c.5123C>T (p.Ala1708Val)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Uncertain significance(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	17	41215920	17	43063903	37640	46196
NM_007294.3(BRCA1):c.5117G>C (p.Gly1706Ala)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41215926	17	43063909	55406	70073
NM_007294.3(BRCA1):c.5117G>A (p.Gly1706Glu)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41215926	17	43063909	37638	46194
NM_007294.3(BRCA1):c.5116G>A (p.Gly1706Arg)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2017)	criteria provided, conflicting interpretations	17	41215927	17	43063910	267221	262101
NM_007294.3(BRCA1):c.5109T>G (p.Tyr1703Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41215934	17	43063917	55403	70070
NM_007294.3(BRCA1):c.5096G>A (p.Arg1699Gln)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	17	41215947	17	43063930	37636	46192
NM_007294.3(BRCA1):c.5095C>T (p.Arg1699Trp)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Fanconi anemia, complementation group A|Ovarian cancer|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and colorectal cancer|FANCONI ANEMIA, COMPLEMENTATION GROUP S	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41215948	17	43063931	55396	70063
NM_007294.3(BRCA1):c.5075-2A>G	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Oct 2, 2015)	criteria provided, multiple submitters, no conflicts	17	41215970	17	43063953	252381	246810
NM_007294.3(BRCA1):c.5075-9A>T	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 17, 2017)	criteria provided, conflicting interpretations	17	41215977	17	43063960	125761	131299
NM_007294.3(BRCA1):c.5074+1G>A	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41219624	17	43067607	37629	46185
NM_007294.3(BRCA1):c.5073A>T (p.Thr1691=)	BRCA1	Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter			17	43067609	599302	590564
NM_007294.3(BRCA1):c.5072C>T (p.Thr1691Ile)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, multiple submitters, no conflicts	17	41219627	17	43067610	37628	46184
NM_007294.3(BRCA1):c.5066T>G (p.Met1689Arg)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2018)	criteria provided, conflicting interpretations	17	41219633	17	43067616	37625	46181
NM_007294.3(BRCA1):c.5062_5064delGTT (p.Val1688del)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	17	41219635 - 41219637	17	43067618 - 43067620	55368	70035
NM_007294.3(BRCA1):c.5050_5051delAC (p.Thr1684Tyrfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41219648 - 41219649	17	43067631 - 43067632	252385	246811
NM_007294.3(BRCA1):c.5035_5039delCTAAT (p.Leu1679Tyrfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41219660 - 41219664	17	43067643 - 43067647	37624	46180
NM_007294.3(BRCA1):c.5035delC (p.Leu1679Terfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41219664	17	43067647	55358	70025
NM_007294.3(BRCA1):c.5024C>T (p.Thr1675Ile)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 6, 2017)	criteria provided, conflicting interpretations	17	41219675	17	43067658	240811	242767
NM_007294.3(BRCA1):c.5005G>T (p.Ala1669Ser)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast carcinoma|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2017)	criteria provided, conflicting interpretations	17	41219694	17	43067677	41831	50270
NM_007294.3(BRCA1):c.4992C>T (p.Leu1664=)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	17	41219707	17	43067690	136551	140254
NM_007294.3(BRCA1):c.4988T>A (p.Met1663Lys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 2, 2018)	criteria provided, multiple submitters, no conflicts	17	41219711	17	43067694	55349	70016
NM_007294.3(BRCA1):c.4987-20A>G	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41219732	17	43067715	91635	97112
NM_007294.3(BRCA1):c.4986+3G>C	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, multiple submitters, no conflicts	17	41222942	17	43070925	55341	70008
NM_007294.3(BRCA1):c.4964_4982del19 (p.Ser1655Tyrfs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41222949 - 41222967	17	43070932 - 43070950	37616	46172
NM_007294.3(BRCA1):c.4976del (p.Pro1659Glnfs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	17	41222955	17	43070938	252399	246812
NM_007294.3(BRCA1):c.4956G>A (p.Met1652Ile)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41222975	17	43070958	41830	50269
NM_007294.3(BRCA1):c.4955T>C (p.Met1652Thr)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41222976	17	43070959	37615	46171
NM_007294.3(BRCA1):c.4883T>C (p.Met1628Thr)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41223048	17	43071031	41828	50267
NM_007294.3(BRCA1):c.4882A>G (p.Met1628Val)	BRCA1	Breast-ovarian cancer, familial 1|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 16, 2018)	criteria provided, conflicting interpretations	17	41223049	17	43071032	55306	69973
NM_007294.3(BRCA1):c.4868C>G (p.Ala1623Gly)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 3, 2018)	criteria provided, conflicting interpretations	17	41223063	17	43071046	37614	46170
NM_007294.3(BRCA1):c.4837A>G (p.Ser1613Gly)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41223094	17	43071077	41827	50266
NM_007294.3(BRCA1):c.4807_4821delCCCCAATTGAAAGTT (p.Pro1603_Val1607del)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	17	41223110 - 41223124	17	43071093 - 43071107	37611	46167
NM_007294.3(BRCA1):c.4812A>G (p.Gln1604=)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	17	41223119	17	43071102	55293	69960
NM_007294.3(BRCA1):c.4766G>A (p.Arg1589His)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 19, 2018)	criteria provided, conflicting interpretations	17	41223165	17	43071148	55284	69951
NM_007294.3(BRCA1):c.4760C>G (p.Ser1587Ter)	BRCA1	Breast-ovarian cancer, familial 1|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41223171	17	43071154	55281	69948
NM_007294.3(BRCA1):c.4754_4755delCA (p.Pro1585Argfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41223176 - 41223177	17	43071159 - 43071160	55280	69947
NM_007294.3(BRCA1):c.4691T>C (p.Leu1564Pro)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41223240	17	43071223	55262	69929
NM_007294.3(BRCA1):c.4689C>G (p.Tyr1563Ter)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41223242	17	43071225	37607	46163
NM_007294.3(BRCA1):c.4682C>T (p.Thr1561Ile)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2018)	criteria provided, conflicting interpretations	17	41223249	17	43071232	55259	69926
NM_007294.3(BRCA1):c.4676-7C>T	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2017)	criteria provided, conflicting interpretations	17	41223262	17	43071245	37606	46162
NM_007294.3(BRCA1):c.4675+2T>G	BRCA1	Breast-ovarian cancer, familial 1	Likely pathogenic(Last reviewed: May 18, 2016)	criteria provided, single submitter	17	41226346	17	43074329	252396	246813
NM_007294.3(BRCA1):c.4675G>C (p.Glu1559Gln)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 19, 2016)	criteria provided, multiple submitters, no conflicts	17	41226348	17	43074331	37605	46161
NM_007294.3(BRCA1):c.4649C>T (p.Thr1550Ile)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 23, 2018)	criteria provided, multiple submitters, no conflicts	17	41226374	17	43074357	55251	69918
NM_007294.3(BRCA1):c.4647_4648dupAA (p.Thr1550Lysfs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Mar 9, 2015)	no assertion criteria provided	17	41226375 - 41226376	17	43074358 - 43074359	222899	224600
NM_007294.3(BRCA1):c.4636G>A (p.Asp1546Asn)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41226387	17	43074370	55245	69912
NM_007294.3(BRCA1):c.4625C>G (p.Ser1542Cys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2018)	criteria provided, conflicting interpretations	17	41226398	17	43074381	55242	69909
NM_007294.3(BRCA1):c.4611_4612insG (p.Gln1538Alafs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41226411 - 41226412	17	43074394 - 43074395	55238	69905
NM_007294.3(BRCA1):c.4603G>T (p.Glu1535Ter)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41226420	17	43074403	55236	69903
NM_007294.3(BRCA1):c.4600G>A (p.Val1534Met)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41226423	17	43074406	55235	69902
NM_007294.3(BRCA1):c.4535G>T (p.Ser1512Ile)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41226488	17	43074471	41826	50265
NM_007294.3(BRCA1):c.4524G>A (p.Trp1508Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41226499	17	43074482	55221	69888
NM_007294.3(BRCA1):c.4508C>A (p.Ser1503Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41226515	17	43074498	55219	69886
NM_007294.3(BRCA1):c.4485-1G>T	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, multiple submitters, no conflicts	17	41226539	17	43074522	246501	245028
NM_007294.3(BRCA1):c.4485-1G>A	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, multiple submitters, no conflicts	17	41226539	17	43074522	55213	69880
NM_007294.3(BRCA1):c.4485-6_4485-2dup	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: Apr 23, 2016)	criteria provided, single submitter	17	41226540 - 41226544	17	43074523 - 43074527	252395	246814
NM_007294.3(BRCA1):c.4484+14A>G	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41228491	17	43076474	55210	69877
NM_007294.3(BRCA1):c.4484+6A>C	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: Jun 11, 2016)	criteria provided, single submitter	17	41228499	17	43076482	252403	246815
NM_007294.3(BRCA1):c.4484+1G>A	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	17	41228504	17	43076487	37596	46152
NM_007294.3(BRCA1):c.4484G>T (p.Arg1495Met)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	17	41228505	17	43076488	37598	46154
NM_007294.3(BRCA1):c.4468G>T (p.Glu1490Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41228521	17	43076504	162502	172180
NM_007294.3(BRCA1):c.4458T>G (p.Ser1486Arg)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: Mar 16, 2016)	criteria provided, single submitter	17	41228531	17	43076514	252387	246816
NM_007294.3(BRCA1):c.4401delG (p.Asn1468Ilefs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41228588	17	43076571	141260	150974
NM_007294.3(BRCA1):c.4389_4392dupCCCT (p.Ile1465Profs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Dec 15, 2017)	reviewed by expert panel	17	41228597 - 41228600	17	43076580 - 43076583	252380	246817
NM_007294.3(BRCA1):c.4389C>A (p.Tyr1463Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41228600	17	43076583	55187	69854
NM_007294.3(BRCA1):c.4358-10C>T	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	17	41228641	17	43076624	125710	131248
NM_007294.3(BRCA1):c.4358-2786G>A	BRCA1	Hereditary breast and ovarian cancer syndrome	Likely pathogenic(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	17	41231417	17	43079400	162503	172181
NM_007294.3(BRCA1):c.4357+17A>G	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	17	41234404	17	43082387	125709	131247
NM_007294.3(BRCA1):c.4357+1G>T	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	17	41234420	17	43082403	55178	69845
NM_007294.3(BRCA1):c.4356delA (p.Ala1453Glnfs)	BRCA1	Breast-ovarian cancer, familial 1	Likely pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter			17	43082405	617480	608842
NM_007294.3(BRCA1):c.4327C>G (p.Arg1443Gly)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2017)	criteria provided, conflicting interpretations	17	41234451	17	43082434	17676	32715
NM_007294.3(BRCA1):c.4327C>T (p.Arg1443Ter)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Pancreatic cancer 4|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41234451	17	43082434	17675	32714
NM_007294.3(BRCA1):c.4308T>C (p.Ser1436=)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41234470	17	43082453	125703	131241
NM_007294.3(BRCA1):c.4273C>G (p.Pro1425Ala)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: May 17, 2016)	criteria provided, single submitter	17	41234505	17	43082488	252398	246818
NM_007294.3(BRCA1):c.4258C>T (p.Gln1420Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41234520	17	43082503	55155	69822
NM_007294.3(BRCA1):c.4222C>T (p.Gln1408Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41234556	17	43082539	55145	69812
NM_007294.3(BRCA1):c.4204C>T (p.His1402Tyr)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41234574	17	43082557	55140	69807
NM_007294.3(BRCA1):c.4185+2_4185+22del21insA	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	17	41242939 - 41242959	17	43090922 - 43090942	37574	46130
NM_007294.3(BRCA1):c.4185+10G>A	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 19, 2017)	criteria provided, conflicting interpretations	17	41242951	17	43090934	96927	102830
NM_007294.3(BRCA1):c.4185G>A (p.Gln1395=)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 19, 2016)	criteria provided, multiple submitters, no conflicts	17	41242961	17	43090944	55131	69798
NM_007294.3(BRCA1):c.4183C>T (p.Gln1395Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41242963	17	43090946	55125	69792
NM_007294.3(BRCA1):c.4165_4166delAG (p.Ser1389Terfs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41242980 - 41242981	17	43090963 - 43090964	55117	69784
NM_007294.3(BRCA1):c.4136_4137delCT (p.Ser1379Terfs)	BRCA1	Breast-ovarian cancer, familial 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	17	41243009 - 41243010	17	43090992 - 43090993	55112	69779
NM_007294.3(BRCA1):c.4113G>A (p.Gly1371=)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	17	41243033	17	43091016	136547	140250
NM_007294.3(BRCA1):c.4096+1G>A	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Uncertain significance(Last reviewed: Apr 12, 2018)	reviewed by expert panel	17	41243451	17	43091434	37565	46121
NM_007294.3(BRCA1):c.4065_4068delTCAA (p.Asn1355Lysfs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41243480 - 41243483	17	43091463 - 43091466	17674	32713
NM_007294.3(BRCA1):c.4039A>G (p.Arg1347Gly)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41243509	17	43091492	41821	50260
NM_007294.3(BRCA1):c.4035delA (p.Glu1346Lysfs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41243513	17	43091496	37560	46116
NM_007294.3(BRCA1):c.3931_3934delAACA (p.Asn1311Profs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41243614 - 41243617	17	43091597 - 43091600	55054	69721
NM_007294.3(BRCA1):c.3916_3917delTT (p.Leu1306Aspfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41243631 - 41243632	17	43091614 - 43091615	55049	69716
NM_007294.3(BRCA1):c.3901_3902delAG (p.Ser1301Terfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41243646 - 41243647	17	43091629 - 43091630	55043	69710
NM_007294.3(BRCA1):c.3845A>T (p.Glu1282Val)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 21, 2017)	criteria provided, conflicting interpretations	17	41243703	17	43091686	55027	69694
NM_007294.3(BRCA1):c.3841C>T (p.Gln1281Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41243707	17	43091690	55022	69689
NM_007294.3(BRCA1):c.3815A>G (p.Asn1272Ser)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	17	41243733	17	43091716	232792	235998
NM_007294.3(BRCA1):c.3797G>C (p.Ser1266Thr)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41243751	17	43091734	55009	69676
NM_007294.3(BRCA1):c.3776A>C (p.Asn1259Thr)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 18, 2017)	criteria provided, conflicting interpretations	17	41243772	17	43091755	125651	131189
NM_007294.3(BRCA1):c.3767_3768delCA (p.Thr1256Argfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41243780 - 41243781	17	43091763 - 43091764	182074	180842
NM_007294.3(BRCA1):c.3761_3762insTT (p.Lys1254Asnfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41243786 - 41243787	17	43091769 - 43091770	91614	97091
NM_007294.3(BRCA1):c.3759dupT (p.Lys1254Terfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41243789	17	43091772	54992	69659
NM_007294.3(BRCA1):c.3756_3759delGTCT (p.Ser1253Argfs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41243789 - 41243792	17	43091772 - 43091775	17673	32712
NM_007294.3(BRCA1):c.3748G>A (p.Glu1250Lys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41243800	17	43091783	54987	69654
NM_007294.3(BRCA1):c.3748G>T (p.Glu1250Ter)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41243800	17	43091783	17672	32711
NM_007294.3(BRCA1):c.3718C>T (p.Gln1240Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41243830	17	43091813	54978	69645
NM_007294.3(BRCA1):c.3713C>T (p.Pro1238Leu)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41243835	17	43091818	37543	46099
NM_007294.3(BRCA1):c.3708T>G (p.Asn1236Lys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	17	41243840	17	43091823	54970	69637
NM_007294.3(BRCA1):c.3700_3704delGTAAA (p.Val1234Glnfs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41243844 - 41243848	17	43091827 - 43091831	37542	46098
NM_007294.3(BRCA1):c.3691T>C (p.Phe1231Leu)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	17	41243857	17	43091840	37541	46097
NM_007294.3(BRCA1):c.3675C>A (p.Cys1225Ter)	BRCA1	Breast-ovarian cancer, familial 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	17	41243873	17	43091856	245968	245036
NM_007294.3(BRCA1):c.3661G>T (p.Glu1221Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41243887	17	43091870	54957	69624
NM_007294.3(BRCA1):c.3657G>C (p.Glu1219Asp)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 14, 2018)	criteria provided, conflicting interpretations	17	41243891	17	43091874	37537	46093
NM_007294.3(BRCA1):c.3648dupA (p.Ser1217Ilefs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41243900	17	43091883	37535	46091
NM_007294.3(BRCA1):c.3640G>T (p.Glu1214Ter)	BRCA1	Breast-ovarian cancer, familial 1|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41243908	17	43091891	54949	69616
NM_007294.3(BRCA1):c.3627dupA (p.Glu1210Argfs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Ovarian Serous Surface Papillary Adenocarcinoma	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41243921	17	43091904	37534	46090
NM_007294.3(BRCA1):c.3607C>T (p.Arg1203Ter)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Ovarian cancer|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41243941	17	43091924	17671	32710
NM_007294.3(BRCA1):c.3600G>C (p.Gln1200His)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	17	41243948	17	43091931	54930	69597
NM_007294.3(BRCA1):c.3587C>T (p.Thr1196Ile)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 13, 2017)	criteria provided, multiple submitters, no conflicts	17	41243961	17	43091944	54926	69593
NM_007294.3(BRCA1):c.3548A>G (p.Lys1183Arg)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244000	17	43091983	41818	50257
NM_007294.3(BRCA1):c.3481_3491delGAAGATACTAG (p.Glu1161Phefs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41244057 - 41244067	17	43092040 - 43092050	17684	32723
NM_007294.3(BRCA1):c.3485delA (p.Asp1162Valfs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244063	17	43092046	37531	46087
NM_007294.3(BRCA1):c.3454G>A (p.Asp1152Asn)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2018)	criteria provided, conflicting interpretations	17	41244094	17	43092077	54890	69557
NM_007294.3(BRCA1):c.3436_3439delTGTT (p.Cys1146Leufs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244109 - 41244112	17	43092092 - 43092095	54885	69552
NM_007294.3(BRCA1):c.3418A>G (p.Ser1140Gly)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244130	17	43092113	41817	50256
NM_007294.3(BRCA1):c.3397_3398delTT (p.Leu1133Argfs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41244150 - 41244151	17	43092133 - 43092134	54865	69532
NM_007294.3(BRCA1):c.3365_3366delCA (p.Thr1122Argfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244182 - 41244183	17	43092165 - 43092166	54859	69526
NM_007294.3(BRCA1):c.3351dupT (p.Gln1118Serfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244197	17	43092180	125630	131168
NM_007294.3(BRCA1):c.3331_3334delCAAG (p.Gln1111Asnfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41244214 - 41244217	17	43092197 - 43092200	37523	46079
NM_007294.3(BRCA1):c.3331C>T (p.Gln1111Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244217	17	43092200	54845	69512
NM_007294.3(BRCA1):c.3302G>A (p.Ser1101Asn)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244246	17	43092229	54830	69497
NM_007294.3(BRCA1):c.3292C>T (p.Leu1098Phe)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: Apr 13, 2016)	criteria provided, single submitter	17	41244256	17	43092239	252394	246819
NM_007294.3(BRCA1):c.3285delA (p.Lys1095Asnfs)	BRCA1	Breast-ovarian cancer, familial 1|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244263	17	43092246	54817	69484
NM_007294.3(BRCA1):c.3279delC (p.Tyr1094Ilefs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244269	17	43092252	54816	69483
NM_007294.3(BRCA1):c.3228_3229delAG (p.Gly1077Alafs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41244319 - 41244320	17	43092302 - 43092303	37516	46072
NM_007294.3(BRCA1):c.3119G>A (p.Ser1040Asn)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244429	17	43092412	17670	32709
NM_007294.3(BRCA1):c.3113A>G (p.Glu1038Gly)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Pancreatic cancer 4|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|FANCONI ANEMIA, COMPLEMENTATION GROUP S	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244435	17	43092418	41815	50254
NM_007294.3(BRCA1):c.3083G>A (p.Arg1028His)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244465	17	43092448	37507	46063
NM_007294.3(BRCA1):c.3048_3052dupTGAGA (p.Asn1018Metfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	17	41244496 - 41244500	17	43092479 - 43092483	54763	69430
NM_007294.3(BRCA1):c.3037_3038delGA (p.Glu1013Asnfs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244510 - 41244511	17	43092493 - 43092494	37502	46058
NM_007294.3(BRCA1):c.3024G>A (p.Met1008Ile)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244524	17	43092507	41814	50253
NM_007294.3(BRCA1):c.3022A>G (p.Met1008Val)	BRCA1	Breast-ovarian cancer, familial 1|Malignant tumor of prostate|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244526	17	43092509	54755	69422
NM_007294.3(BRCA1):c.3018_3021delTTCA (p.His1006Glnfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244527 - 41244530	17	43092510 - 43092513	54749	69416
NM_007294.3(BRCA1):c.3005delA (p.Asn1002Thrfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244543	17	43092526	17669	32708
NM_007294.3(BRCA1):c.2923C>T (p.Gln975Ter)	BRCA1	Breast-ovarian cancer, familial 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244625	17	43092608	54722	69389
NM_007294.3(BRCA1):c.2921T>A (p.Leu974Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244627	17	43092610	54719	69386
NM_007294.3(BRCA1):c.2902_2903insTC (p.Pro968Leufs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	17	41244646 - 41244647	17	43092629 - 43092630	91602	97079
NM_007294.3(BRCA1):c.2882delA (p.Asn961Thrfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	17	41244666	17	43092649	266315	261786
NM_007294.3(BRCA1):c.2866_2870delTCTCA (p.Ser956Valfs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41244678 - 41244682	17	43092661 - 43092665	54702	69369
NM_007294.3(BRCA1):c.2834_2836delGTAinsC (p.Ser945Thrfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41244712 - 41244714	17	43092695 - 43092697	54694	69361
NM_007294.3(BRCA1):c.2823delT (p.Asn941Lysfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	17	41244725	17	43092708	266306	261795
NM_007294.3(BRCA1):c.2814A>G (p.Pro938=)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41244734	17	43092717	54688	69355
NM_007294.3(BRCA1):c.2789C>T (p.Pro930Leu)	BRCA1	Breast-ovarian cancer, familial 1|not specified	Uncertain significance(Last reviewed: Jun 7, 2016)	criteria provided, multiple submitters, no conflicts	17	41244759	17	43092742	54680	69347
NM_007294.3(BRCA1):c.2773A>C (p.Ile925Leu)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244775	17	43092758	37489	46045
NM_007294.3(BRCA1):c.2767_2770delGTTA (p.Val923Ilefs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244778 - 41244781	17	43092761 - 43092764	54678	69345
NM_007294.3(BRCA1):c.2733A>G (p.Gly911=)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	17	41244815	17	43092798	54664	69331
NM_007294.3(BRCA1):c.2722G>T (p.Glu908Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244826	17	43092809	54657	69324
NM_007294.3(BRCA1):c.2706_2707dupAT (p.Cys903Tyrfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244841 - 41244842	17	43092824 - 43092825	37483	46039
NM_007294.3(BRCA1):c.2679_2682delGAAA (p.Lys893Asnfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41244866 - 41244869	17	43092849 - 43092852	37481	46037
NM_007294.3(BRCA1):c.2681_2682delAA (p.Lys894Thrfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41244866 - 41244867	17	43092849 - 43092850	17667	32706
NM_007294.3(BRCA1):c.2612C>T (p.Pro871Leu)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244936	17	43092919	41812	50251
NM_007294.3(BRCA1):c.2596C>T (p.Arg866Cys)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244952	17	43092935	41811	50250
NM_007294.3(BRCA1):c.2566T>C (p.Tyr856His)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244982	17	43092965	54604	69271
NM_007294.3(BRCA1):c.2563C>T (p.Gln855Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41244985	17	43092968	37475	46031
NM_007294.3(BRCA1):c.2554C>G (p.Leu852Val)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 7, 2015)	criteria provided, multiple submitters, no conflicts	17	41244994	17	43092977	216656	213323
NM_007294.3(BRCA1):c.2521C>T (p.Arg841Trp)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245027	17	43093010	17681	32720
NM_007294.3(BRCA1):c.2477C>A (p.Thr826Lys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245071	17	43093054	37473	46029
NM_007294.3(BRCA1):c.2458A>G (p.Lys820Glu)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245090	17	43093073	41810	50249
NM_007294.3(BRCA1):c.2457delC (p.Asp821Ilefs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|FANCONI ANEMIA, COMPLEMENTATION GROUP S	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41245091	17	43093074	37471	46027
NM_007294.3(BRCA1):c.2443delA (p.Ile815Phefs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41245105	17	43093088	54572	69239
NM_007294.3(BRCA1):c.2428A>T (p.Asn810Tyr)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245120	17	43093103	54567	69234
NM_007294.3(BRCA1):c.2418delA (p.Ala807Hisfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	17	41245130	17	43093113	252379	246820
NM_007294.3(BRCA1):c.2412G>C (p.Gln804His)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245136	17	43093119	54561	69228
NM_007294.3(BRCA1):c.2411_2412delAG (p.Gln804Leufs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41245136 - 41245137	17	43093119 - 43093120	37466	46022
NM_007294.3(BRCA1):c.2352G>A (p.Ser784=)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	17	41245196	17	43093179	136543	140246
NM_007294.3(BRCA1):c.2347A>G (p.Ile783Val)	BRCA1	Breast-ovarian cancer, familial 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 18, 2018)	criteria provided, conflicting interpretations	17	41245201	17	43093184	54541	69208
NM_007294.3(BRCA1):c.2338C>T (p.Gln780Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41245210	17	43093193	54540	69207
NM_007294.3(BRCA1):c.2331_2332dupTG (p.Gly778Valfs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 15, 2017)	reviewed by expert panel	17	41245216 - 41245217	17	43093199 - 43093200	252382	246821
NM_007294.3(BRCA1):c.2315T>C (p.Val772Ala)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245233	17	43093216	41809	50248
NM_007294.3(BRCA1):c.2312T>C (p.Leu771Ser)	BRCA1	Breast-ovarian cancer, familial 1|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 14, 2017)	criteria provided, multiple submitters, no conflicts	17	41245236	17	43093219	182145	180861
NM_007294.3(BRCA1):c.2311T>C (p.Leu771=)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Pancreatic cancer 4|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|FANCONI ANEMIA, COMPLEMENTATION GROUP S	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41245237	17	43093220	125554	131092
NM_007294.3(BRCA1):c.2309C>A (p.Ser770Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41245239	17	43093222	54527	69194
NM_007294.3(BRCA1):c.2283A>C (p.Glu761Asp)	BRCA1	Hereditary breast and ovarian cancer syndrome	Benign(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	17	41245265	17	43093248	619018	610417
NM_007294.3(BRCA1):c.2241delC (p.Asp749Ilefs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41245307	17	43093290	54510	69177
NM_007294.3(BRCA1):c.2232T>C (p.Ala744=)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	17	41245316	17	43093299	54508	69175
NM_007294.3(BRCA1):c.2225A>G (p.Asn742Ser)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: Nov 4, 2016)	no assertion criteria provided	17	41245323	17	43093306	403717	390694
NM_007294.3(BRCA1):c.2217dupA (p.Val740Serfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41245331	17	43093314	125548	131086
NM_007294.3(BRCA1):c.2215A>T (p.Lys739Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41245333	17	43093316	54503	69170
NM_007294.3(BRCA1):c.2214dupT (p.Lys739Terfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41245334	17	43093317	186881	185031
NM_007294.3(BRCA1):c.2197_2201delGAGAA (p.Glu733Thrfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41245347 - 41245351	17	43093330 - 43093334	54495	69162
NM_007294.3(BRCA1):c.2167A>G (p.Asn723Asp)	BRCA1	Breast-ovarian cancer, familial 1|Malignant tumor of prostate|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245381	17	43093364	37454	46010
NM_007294.3(BRCA1):c.2109A>G (p.Thr703=)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	17	41245439	17	43093422	54461	69128
NM_007294.3(BRCA1):c.2105dupT (p.Leu702Phefs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41245443	17	43093426	37445	46001
NM_007294.3(BRCA1):c.2090delT (p.Phe697Serfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Dec 15, 2017)	reviewed by expert panel	17	41245458	17	43093441	440454	434085
NM_007294.3(BRCA1):c.2082C>T (p.Ser694=)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41245466	17	43093449	125536	131074
NM_007294.3(BRCA1):c.2077G>A (p.Asp693Asn)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245471	17	43093454	41808	50247
NM_007294.3(BRCA1):c.2071delA (p.Arg691Aspfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41245477	17	43093460	37444	46000
NM_007294.3(BRCA1):c.2059C>T (p.Gln687Ter)	BRCA1	Breast-ovarian cancer, familial 1|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41245489	17	43093472	54448	69115
NM_007294.3(BRCA1):c.2043dupT (p.Asn682Terfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41245505	17	43093488	216102	213325
NM_007294.3(BRCA1):c.2002C>T (p.Leu668Phe)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245546	17	43093529	37441	45997
NM_007294.3(BRCA1):c.1971A>G (p.Gln657=)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41245577	17	43093560	54424	69091
NM_007294.3(BRCA1):c.1953_1956delGAAA (p.Lys653Serfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41245592 - 41245595	17	43093575 - 43093578	37435	45991
NM_007294.3(BRCA1):c.1912delG (p.Glu638Asnfs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41245636	17	43093619	54398	69065
NM_007294.3(BRCA1):c.1911T>C (p.Thr637=)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	17	41245637	17	43093620	54396	69063
NM_007294.3(BRCA1):c.1907G>A (p.Cys636Tyr)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 19, 2018)	criteria provided, conflicting interpretations	17	41245641	17	43093624	91570	97047
NM_007294.3(BRCA1):c.1881_1884delCAGT (p.Ser628Glufs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41245664 - 41245667	17	43093647 - 43093650	54379	69046
NM_007294.3(BRCA1):c.1865C>T (p.Ala622Val)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245683	17	43093666	54371	69038
NM_007294.3(BRCA1):c.1846_1848delTCT (p.Ser616del)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	17	41245700 - 41245702	17	43093683 - 43093685	37430	45986
NM_007294.3(BRCA1):c.1842G>T (p.Lys614Asn)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 18, 2017)	criteria provided, multiple submitters, no conflicts	17	41245706	17	43093689	252401	246822
NM_007294.3(BRCA1):c.1823_1826delAGAA (p.Lys608Ilefs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41245722 - 41245725	17	43093705 - 43093708	54361	69028
NM_007294.3(BRCA1):c.1812delA (p.Ala605Hisfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41245736	17	43093719	125513	131051
NM_007300.3(BRCA1):c.1731dup (p.Ser578Ilefs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Aug 7, 2015)	criteria provided, single submitter	17	41245817	17	43093800	425546	413881
NM_007294.3(BRCA1):c.1709C>A (p.Pro570Gln)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified	Uncertain significance(Last reviewed: May 10, 2018)	criteria provided, multiple submitters, no conflicts	17	41245839	17	43093822	245965	245047
NM_007294.3(BRCA1):c.1695dupG (p.Lys566Glufs)	BRCA1	Breast-ovarian cancer, familial 1|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41245853	17	43093836	125507	131045
NM_007294.3(BRCA1):c.1674delA (p.Gly559Valfs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41245874	17	43093857	37425	45981
NM_007294.3(BRCA1):c.1648A>C (p.Asn550His)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245900	17	43093883	37423	45979
NM_007294.3(BRCA1):c.1630C>T (p.Gln544Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41245918	17	43093901	54313	68980
NM_007294.3(BRCA1):c.1600C>T (p.Gln534Ter)	BRCA1	Breast-ovarian cancer, familial 1|not provided	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	17	41245948	17	43093931	54303	68970
NM_007294.3(BRCA1):c.1534C>T (p.Leu512Phe)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 21, 2018)	criteria provided, conflicting interpretations	17	41246014	17	43093997	37420	45976
NM_007294.3(BRCA1):c.1523delC (p.Pro508Leufs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41246025	17	43094008	54285	68952
NM_007294.3(BRCA1):c.1511G>A (p.Arg504His)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41246037	17	43094020	54278	68945
NM_007294.3(BRCA1):c.1504_1508delTTAAA (p.Leu502Alafs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Dysgerminoma|DYSGERMINOMA	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41246040 - 41246044	17	43094023 - 43094027	37417	45973
NM_007294.3(BRCA1):c.1487G>A (p.Arg496His)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41246061	17	43094044	41805	50244
NM_007294.3(BRCA1):c.1486C>T (p.Arg496Cys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41246062	17	43094045	37416	45972
NM_007294.3(BRCA1):c.1480C>T (p.Gln494Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41246068	17	43094051	37415	45971
NM_007294.3(BRCA1):c.1456T>C (p.Phe486Leu)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41246092	17	43094075	54258	68925
NM_007294.3(BRCA1):c.1434delT (p.Glu479Lysfs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41246114	17	43094097	96900	102803
NM_007294.3(BRCA1):c.1427A>G (p.His476Arg)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 14, 2018)	criteria provided, conflicting interpretations	17	41246121	17	43094104	54251	68918
NM_007294.3(BRCA1):c.1386delG (p.Thr464Profs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41246162	17	43094145	54232	68899
NM_007294.3(BRCA1):c.1384G>A (p.Gly462Arg)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	17	41246164	17	43094147	54230	68897
NM_007294.3(BRCA1):c.1381T>C (p.Phe461Leu)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	17	41246167	17	43094150	54227	68894
NM_007294.3(BRCA1):c.1342C>T (p.His448Tyr)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	17	41246206	17	43094189	187241	185067
NM_007294.3(BRCA1):c.1224delA (p.Val409Terfs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|not specified|not provided	Pathogenic(Last reviewed: Dec 15, 2017)	reviewed by expert panel	17	41246324	17	43094307	252436	246851
NM_007294.3(BRCA1):c.1175_1214del40 (p.Leu392Glnfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41246334 - 41246373	17	43094317 - 43094356	17665	32704
NM_007294.3(BRCA1):c.1155G>T (p.Trp385Cys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 25, 2018)	criteria provided, multiple submitters, no conflicts	17	41246393	17	43094376	240771	242800
NM_007294.3(BRCA1):c.1137T>G (p.Ile379Met)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	17	41246411	17	43094394	54143	68810
NM_007294.3(BRCA1):c.1116G>A (p.Trp372Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41246432	17	43094415	54135	68802
NM_007294.3(BRCA1):c.1106_1108delATG (p.Asp369del)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 12, 2018)	criteria provided, conflicting interpretations	17	41246440 - 41246442	17	43094423 - 43094425	54130	68797
NM_007294.3(BRCA1):c.1075C>T (p.Pro359Ser)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 7, 2017)	criteria provided, multiple submitters, no conflicts	17	41246473	17	43094456	252384	246823
NM_007294.3(BRCA1):c.1067A>G (p.Gln356Arg)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Ductal breast carcinoma	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41246481	17	43094464	41803	50242
NM_007294.3(BRCA1):c.1065G>A (p.Lys355=)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	17	41246483	17	43094466	54113	68780
NM_007294.3(BRCA1):c.1016A>G (p.Lys339Arg)	BRCA1	Hereditary breast and ovarian cancer syndrome	Likely benign(Last reviewed: Apr 1, 2018)	criteria provided, single submitter	17	41246532	17	43094515	549761	540531
NM_007294.3(BRCA1):c.1011dupA (p.Val340Glyfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41246532	17	43094515	54102	68769
NM_007294.3(BRCA1):c.981A>G (p.Thr327=)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	17	41246567	17	43094550	55771	70438
NM_007294.3(BRCA1):c.930delG (p.Gln310Hisfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41246618	17	43094601	55759	70426
NM_007294.3(BRCA1):c.891G>A (p.Met297Ile)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41246657	17	43094640	55743	70410
NM_007294.3(BRCA1):c.850C>T (p.Gln284Ter)	BRCA1	Breast-ovarian cancer, familial 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	17	41246698	17	43094681	55738	70405
NM_007294.3(BRCA1):c.848T>G (p.Leu283Ter)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	17	41246700	17	43094683	55737	70404
NM_007294.3(BRCA1):c.828A>G (p.Thr276=)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	17	41246720	17	43094703	184319	185093
NM_007294.3(BRCA1):c.815_824dupAGCCATGTGG (p.Thr276Alafs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	17	41246724 - 41246733	17	43094707 - 43094716	55723	70390
NM_007294.3(BRCA1):c.812T>G (p.Val271Gly)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 22, 2016)	criteria provided, multiple submitters, no conflicts	17	41246736	17	43094719	252383	246824
NM_007294.3(BRCA1):c.811G>A (p.Val271Met)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Cancer of the pancreas	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	17	41246737	17	43094720	55720	70387
NM_007294.3(BRCA1):c.807G>A (p.Leu269=)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	17	41246741	17	43094724	136540	140243
NM_007299.3(BRCA1):c.787+11_787+12delTT	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41246749 - 41246750	17	43094732 - 43094733	37698	46254
NM_007294.3(BRCA1):c.794_795delCT (p.Ser265Cysfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41246753 - 41246754	17	43094736 - 43094737	55707	70374
NM_007294.3(BRCA1):c.765G>A (p.Glu255=)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	17	41246783	17	43094766	136091	139803
NM_007294.3(BRCA1):c.742A>C (p.Thr248Pro)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	17	41246806	17	43094789	252390	246825
NM_007294.3(BRCA1):c.736T>G (p.Leu246Val)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41246812	17	43094795	41835	50274
NM_007294.3(BRCA1):c.715delC (p.His239Ilefs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Dec 15, 2017)	reviewed by expert panel	17	41246833	17	43094816	252397	246826
NM_007294.3(BRCA1):c.697_699delGTA (p.Val233del)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Mar 20, 2014)	no assertion criteria provided	17	41246849 - 41246851	17	43094832 - 43094834	438753	432385
NM_007294.3(BRCA1):c.697_698delGT (p.Val233Asnfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41246850 - 41246851	17	43094833 - 43094834	37695	46251
NM_007294.3(BRCA1):c.694G>A (p.Asp232Asn)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 21, 2018)	criteria provided, conflicting interpretations	17	41246854	17	43094837	55672	70339
NM_007294.3(BRCA1):c.676delT (p.Cys226Valfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41246872	17	43094855	37693	46249
NM_007294.3(BRCA1):c.594-2A>C	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	17	41247941	17	43095924	37686	46242
NM_007294.3(BRCA1):c.591C>T (p.Cys197=)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	17	41249263	17	43097246	55642	70309
NM_007294.3(BRCA1):c.557C>A (p.Ser186Tyr)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41249297	17	43097280	55635	70302
NM_007294.3(BRCA1):c.547+2T>A	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 3, 2016)	reviewed by expert panel	17	41251790	17	43099773	37674	46230
NM_007294.3(BRCA1):c.541G>T (p.Glu181Ter)	BRCA1	Neoplasm of the breast	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	17	41251798	17	43099781	430632	423863
NM_007294.3(BRCA1):c.536A>G (p.Tyr179Cys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41251803	17	43099786	37661	46217
NM_007294.3(BRCA1):c.535T>C (p.Tyr179His)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 23, 2018)	criteria provided, multiple submitters, no conflicts	17	41251804	17	43099787	141458	151172
NM_007294.3(BRCA1):c.514C>T (p.Gln172Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41251825	17	43099808	55420	70087
NM_007294.3(BRCA1):c.512dupT (p.Gln172Thrfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41251827	17	43099810	141091	150805
NM_007294.3(BRCA1):c.478G>A (p.Gly160Arg)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	17	41251861	17	43099844	233928	236161
NM_007294.3(BRCA1):c.470C>G (p.Ser157Cys)	BRCA1	Breast-ovarian cancer, familial 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	17	41251869	17	43099852	55266	69933
NM_007294.3(BRCA1):c.427G>T (p.Glu143Ter)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41256153	17	43104136	37581	46137
NM_007294.3(BRCA1):c.346delG (p.Glu116Asnfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41256234	17	43104217	252400	246827
NM_007294.3(BRCA1):c.343_344delCC (p.Pro115Terfs)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Dec 1, 2018)	no assertion criteria provided			17	43104219 - 43104220	599300	590562
NM_007294.3(BRCA1):c.332A>C (p.Glu111Ala)	BRCA1	Breast-ovarian cancer, familial 1|not specified	Uncertain significance(Last reviewed: Feb 16, 2017)	criteria provided, single submitter	17	41256248	17	43104231	54844	69511
NM_007294.3(BRCA1):c.314A>G (p.Tyr105Cys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41256266	17	43104249	54780	69447
NM_007294.3(BRCA1):c.302-1G>C	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41256279	17	43104262	54751	69418
NM_007294.3(BRCA1):c.302-7T>A	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: Mar 11, 2016)	criteria provided, single submitter	17	41256285	17	43104268	252388	246828
NM_007294.3(BRCA1):c.250G>T (p.Glu84Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41256936	17	43104919	91591	97068
NM_007294.3(BRCA1):c.213-11T>G	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	17	41256984	17	43104967	37449	46005
NM_007294.3(BRCA1):c.213-12A>G	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	17	41256985	17	43104968	37450	46006
NM_007294.3(BRCA1):c.211A>G (p.Arg71Gly)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	17	41258474	17	43106457	17693	32732
NM_007294.3(BRCA1):c.199G>T (p.Asp67Tyr)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41258486	17	43106469	54431	69098
NM_007294.3(BRCA1):c.190T>G (p.Cys64Gly)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, multiple submitters, no conflicts	17	41258495	17	43106478	17660	32699
NM_007294.3(BRCA1):c.182_183delGT (p.Cys61Serfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41258502 - 41258503	17	43106485 - 43106486	54365	69032
NM_007294.3(BRCA1):c.181T>G (p.Cys61Gly)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast carcinoma	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41258504	17	43106487	17661	32700
NM_007294.3(BRCA1):c.172C>T (p.Pro58Ser)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	17	41258513	17	43106496	252393	246829
NM_007294.3(BRCA1):c.169G>C (p.Gly57Arg)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 19, 2017)	criteria provided, multiple submitters, no conflicts	17	41258516	17	43106499	252391	246830
NM_007294.3(BRCA1):c.143delT (p.Met48Serfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41258542	17	43106525	37412	45968
NM_007294.3(BRCA1):c.140G>T (p.Cys47Phe)	BRCA1	Breast-ovarian cancer, familial 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 6, 2016)	criteria provided, conflicting interpretations	17	41258545	17	43106528	54247	68914
NM_007294.3(BRCA1):c.134+2T>C	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, multiple submitters, no conflicts	17	41267741	17	43115724	91547	97024
NM_007294.3(BRCA1):c.131G>T (p.Cys44Phe)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	17	41267746	17	43115729	54200	68867
NM_007294.3(BRCA1):c.130T>A (p.Cys44Ser)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41267747	17	43115730	54191	68858
NM_007294.3(BRCA1):c.122A>T (p.His41Leu)	BRCA1	Breast-ovarian cancer, familial 1|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2017)	criteria provided, conflicting interpretations	17	41267755	17	43115738	230862	236179
NM_007294.3(BRCA1):c.118G>A (p.Asp40Asn)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: Mar 23, 2016)	criteria provided, single submitter	17	41267759	17	43115742	252392	246831
NM_007294.3(BRCA1):c.114G>A (p.Lys38=)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41267763	17	43115746	54146	68813
NM_007294.3(BRCA1):c.103G>T (p.Val35Phe)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	17	41267774	17	43115757	252386	246832
NM_007294.3(BRCA1):c.89T>A (p.Leu30Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	17	41267788	17	43115771	55745	70412
NM_007294.3(BRCA1):c.81-6T>C	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 7, 2017)	criteria provided, conflicting interpretations	17	41267802	17	43115785	37703	46259
NM_007294.3(BRCA1):c.81-12C>G	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 14, 2018)	criteria provided, conflicting interpretations	17	41267808	17	43115791	91666	97143
NM_007294.3(BRCA1):c.81-13C>G	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41267809	17	43115792	37701	46257
NM_007294.3(BRCA1):c.81-14C>T	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	17	41267810	17	43115793	37702	46258
NM_007294.3(BRCA1):c.70_80delTGTCCCATCTG (p.Cys24Serfs)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41276034 - 41276044	17	43124017 - 43124027	55676	70343
NM_007294.3(BRCA1):c.75C>T (p.Pro25=)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	17	41276039	17	43124022	55691	70358
NM_007294.3(BRCA1):c.68_70delAGT (p.Glu23_Cys24delinsGly)	BRCA1	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Jul 30, 2015)	no assertion criteria provided	17	41276044 - 41276046	17	43124027 - 43124029	438781	432386
NM_007294.3(BRCA1):c.68_69dupAG (p.Cys24Serfs)	BRCA1	Breast-ovarian cancer, familial 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	17	41276045 - 41276046	17	43124028 - 43124029	55667	70334
NM_007294.3(BRCA1):c.68_69delAG (p.Glu23Valfs)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Pancreatic cancer 4|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41276047 - 41276048	17	43124030 - 43124031	17662	32701
NM_007294.3(BRCA1):c.65T>C (p.Leu22Ser)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41276049	17	43124032	55656	70323
NM_007294.3(BRCA1):c.34C>T (p.Gln12Ter)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	17	41276080	17	43124063	54902	69569
NM_007294.3(BRCA1):c.21C>T (p.Arg7=)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	17	41276093	17	43124076	136537	140240
NM_007294.3(BRCA1):c.-20+101C>G	BRCA1|LOC111589215	Breast-ovarian cancer, familial 1|not specified	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	17	41277187	17	43125170	189123	186980
NM_014233.3(UBTF):c.628G>A (p.Glu210Lys)	UBTF	UBTF E210K Neuroregression Syndrome|Infantile or childhood onset neurodegenerative disease, global developmental delay, and intellectual disability|NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, multiple submitters, no conflicts	17	42290219	17	44212851	437909	431537
NM_000342.3(SLC4A1):c.118G>A (p.Glu40Lys)	SLC4A1	Spherocytosis type 4|Pseudohyperkalemia Cardiff|Hemolytic anemia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 15, 2017)	criteria provided, conflicting interpretations	17	42338993	17	44261625	17756	32795
NM_004247.3(EFTUD2):c.2551delG (p.Ala851Profs)	EFTUD2	Growth and mental retardation, mandibulofacial dysostosis, microcephaly, and cleft palate	Likely pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	17	42930674	17	44853306	488388	481240
NM_004247.3(EFTUD2):c.2438G>A (p.Arg813Lys)	EFTUD2	Growth and mental retardation, mandibulofacial dysostosis, microcephaly, and cleft palate	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	17	42930913	17	44853545	560998	552204
NM_004247.3(EFTUD2):c.2045+2T>G	EFTUD2	Growth and mental retardation, mandibulofacial dysostosis, microcephaly, and cleft palate	Likely pathogenic(Last reviewed: Apr 29, 2014)	criteria provided, single submitter	17	42934441	17	44857073	216924	213646
NM_004247.3(EFTUD2):c.1732C>T (p.Arg578Ter)	EFTUD2	Growth and mental retardation, mandibulofacial dysostosis, microcephaly, and cleft palate|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	17	42937401	17	44860033	379625	375142
NM_004247.3(EFTUD2):c.1567delC (p.Gln523Argfs)	EFTUD2	Growth and mental retardation, mandibulofacial dysostosis, microcephaly, and cleft palate	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	17	42940121	17	44862753	522863	513468
NM_004247.3(EFTUD2):c.994+6C>T	EFTUD2	Growth and mental retardation, mandibulofacial dysostosis, microcephaly, and cleft palate|not specified	Benign	criteria provided, single submitter	17	42949808	17	44872440	128974	134421
NM_004247.3(EFTUD2):c.762T>C (p.Thr254=)	EFTUD2	Growth and mental retardation, mandibulofacial dysostosis, microcephaly, and cleft palate|not specified	Benign	criteria provided, single submitter	17	42953409	17	44876041	128973	134420
NM_004247.3(EFTUD2):c.426+8G>A	EFTUD2	Growth and mental retardation, mandibulofacial dysostosis, microcephaly, and cleft palate|not specified	Benign	criteria provided, single submitter	17	42961009	17	44883641	128972	134419
NM_002055.4(GFAP):c.1246C>T (p.Arg416Trp)	GFAP	Alexander Disease|not provided	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	17	42985443	17	44908075	16169	31208
NM_002055.4(GFAP):c.989G>C (p.Arg330Pro)	GFAP	Alexander Disease	Uncertain significance(Last reviewed: Apr 4, 2016)	criteria provided, single submitter	17	42988742	17	44911374	522797	513469
NM_002055.4(GFAP):c.215A>G (p.Glu72Gly)	GFAP	Alexander Disease	Likely pathogenic(Last reviewed: Apr 30, 2015)	no assertion criteria provided	17	42992640	17	44915272	374303	361227
NM_002055.4(GFAP):c.208C>T (p.Arg70Trp)	GFAP	Alexander Disease|not provided	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	17	42992647	17	44915279	66460	77357
NM_001193466.1(KANSL1):c.3125delT (p.Leu1042Argfs)	KANSL1	Koolen-de Vries syndrome	Likely pathogenic(Last reviewed: Apr 25, 2014)	criteria provided, single submitter	17	44109035	17	46031669	209164	205784
NM_001193466.1(KANSL1):c.985_995del (p.Leu329Alafs)	KANSL1	Koolen-de Vries syndrome	Likely pathogenic(Last reviewed: Sep 16, 2014)	no assertion criteria provided	17	44248515 - 44248525	17	46171149 - 46171159	374269	361228
NM_001193466.1(KANSL1):c.985_986delTT (p.Leu329Glufs)	KANSL1	Koolen-de Vries syndrome	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	17	44248524 - 44248525	17	46171158 - 46171159	38930	47533
NM_001193466.1(KANSL1):c.531_540del (p.Gly179Leufs)	KANSL1	Koolen-de Vries syndrome	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	17	44248969 - 44248979	17	46171604 - 46171613	561035	552205
NM_001002841.1(MYL4):c.31G>A (p.Glu11Lys)	MYL4	Familial atrial fibrillation|Atrial fibrillation, familial, 18	Pathogenic(Last reviewed: Dec 28, 2016)	no assertion criteria provided	17	45286819	17	47209453	224067	225795
NM_005220.2(DLX3):c.574delG (p.Glu192Argfs)	DLX3	Amelogenesis imperfecta, type IV|Tricho-dento-osseous syndrome	Pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	17	48069171	17	49991807	430607	423255
NM_005220.2(DLX3):c.571_574delGGGG (p.Gly191Argfs)	DLX3	Tricho-dento-osseous syndrome	Pathogenic(Last reviewed: Jun 6, 2008)	no assertion criteria provided	17	48069171 - 48069174	17	49991807 - 49991810	9072	24111
NM_005220.2(DLX3):c.476G>T (p.Arg159Leu)	DLX3	Amelogenesis imperfecta, type IV|Tricho-dento-osseous syndrome	Pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	17	48070804	17	49993440	430609	423257
NM_000088.3(COL1A1):c.3495delT (p.Gly1166Valfs)	COL1A1	Osteogenesis imperfecta type I|not provided	Pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	17	48264412	17	50187051	478914	472258
NM_000088.3(COL1A1):c.3076C>T (p.Arg1026Ter)	COL1A1	Osteogenesis imperfecta type I|Osteogenesis imperfecta|not provided	Pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	17	48266126	17	50188765	35920	44584
NM_000088.3(COL1A1):c.2932C>T (p.Pro978Ser)	COL1A1	Osteogenesis imperfecta type I|Osteogenesis imperfecta|Thoracic aortic aneurysm and aortic dissection|not specified|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	17	48266534	17	50189173	35918	44582
NM_000088.3(COL1A1):c.2866G>A (p.Gly956Arg)	COL1A1	Osteogenesis imperfecta type I	Likely pathogenic(Last reviewed: Feb 4, 2014)	criteria provided, single submitter	17	48266600	17	50189239	209140	205787
NM_000088.3(COL1A1):c.2775delT (p.Gly926Valfs)	COL1A1	Osteogenesis imperfecta type I	Pathogenic(Last reviewed: Oct 5, 2015)	no assertion criteria provided	17	48266792	17	50189431	236248	237811
NM_000088.3(COL1A1):c.2641G>A (p.Gly881Ser)	COL1A1	Osteogenesis imperfecta type I	Pathogenic	no assertion criteria provided	17	48267066	17	50189705	430640	424020
NM_000088.3(COL1A1):c.2172delT (p.Gly725Alafs)	COL1A1	Osteogenesis imperfecta type I	Pathogenic(Last reviewed: Dec 10, 2018)	no assertion criteria provided			17	50191446	599232	590457
NM_000088.3(COL1A1):c.1200+1G>A	COL1A1	Osteogenesis imperfecta	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	17	48272794	17	50195433	35898	44562
NM_000088.3(COL1A1):c.994G>A (p.Gly332Arg)	COL1A1	Osteogenesis imperfecta with normal sclerae, dominant form|Osteogenesis imperfecta type III|Osteogenesis imperfecta type I|Osteogenesis imperfecta|not provided	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	17	48273524	17	50196163	17312	32351
NM_000088.3(COL1A1):c.805G>A (p.Gly269Ser)	COL1A1	Osteogenesis imperfecta	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	17	48274031	17	50196670	35929	44593
NM_000088.3(COL1A1):c.613C>G (p.Pro205Ala)	COL1A1	Osteogenesis imperfecta type I|Osteogenesis imperfecta|not specified|not provided|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: Apr 12, 2018)	criteria provided, conflicting interpretations	17	48275339	17	50197978	218424	215539
NM_000088.3(COL1A1):c.579delT (p.Gly194Valfs)	COL1A1	Osteogenesis imperfecta type I|Osteogenesis imperfecta|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, multiple submitters, no conflicts	17	48275531	17	50198170	35925	44589
NM_058216.2(RAD51C):c.12G>A (p.Lys4=)	RAD51C	Familial cancer of breast|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: May 2, 2016)	criteria provided, single submitter	17	56770016	17	58692655	417815	404700
NM_058216.2(RAD51C):c.307T>G (p.Phe103Val)	RAD51C	Hereditary breast and ovarian cancer syndrome	Uncertain significance(Last reviewed: Jun 13, 2017)	no assertion criteria provided	17	56772453	17	58695092	427903	418977
NM_058216.2(RAD51C):c.706-2A>G	RAD51C	Breast-ovarian cancer, familial 3|Fanconi anemia, complementation group O|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	17	56787218	17	58709857	128209	133666
NM_058216.2(RAD51C):c.790G>A (p.Gly264Ser)	RAD51C	Breast-ovarian cancer, familial 3|Fanconi anemia, complementation group O|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	17	56787304	17	58709943	128211	133668
NM_058216.2(RAD51C):c.1026+5_1026+7delGTA	RAD51C	Breast-ovarian cancer, familial 3|Fanconi anemia, complementation group O|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	17	56809910 - 56809912	17	58732549 - 58732551	128201	133658
NM_005994.3(TBX2):c.59G>A (p.Arg20Gln)	TBX2	TBX2-related condition|VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION	Pathogenic(Last reviewed: Feb 24, 2016)	criteria provided, single submitter	17	59477596	17	61400235	522826	513470
NM_032043.2(BRIP1):c.790C>T (p.Arg264Trp)	BRIP1	Familial cancer of breast|Fanconi anemia, complementation group J|Neoplasm of ovary|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	17	59885956	17	61808595	128195	133652
NM_032043.2(BRIP1):c.689C>T (p.Ser230Leu)	BRIP1	Familial cancer of breast|Fanconi anemia, complementation group J|Neoplasm of ovary|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 28, 2018)	criteria provided, conflicting interpretations	17	59886057	17	61808696	186643	185297
NM_032043.2(BRIP1):c.440delA (p.Tyr147Serfs)	BRIP1	Familial cancer of breast	Pathogenic(Last reviewed: May 1, 2018)	no assertion criteria provided	17	59926557	17	61849196	545670	536166
NM_032043.2(BRIP1):c.139C>G (p.Pro47Ala)	BRIP1	Familial cancer of breast|Fanconi anemia, complementation group J|Neoplasm of ovary|Breast cancer, early-onset|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	17	59937223	17	61859862	4736	19775
NM_000515.4(GH1):c.291+1G>C	GH1|GH-LCR	Autosomal dominant isolated somatotropin deficiency	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	17	61995376	17	63918016	15971	31010
NM_000334.4(SCN4A):c.2009C>A (p.Ser670Tyr)	SCN4A	Potassium aggravated myotonia	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter			17	63959275	617484	608846
NM_004655.3(AXIN2):c.2272G>A (p.Ala758Thr)	AXIN2	Oligodontia-colorectal cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Oligodontia|Colorectal cancer	Conflicting interpretations of pathogenicity(Last reviewed: Feb 23, 2018)	criteria provided, conflicting interpretations	17	63530163	17	65534045	127943	133400
NM_004655.3(AXIN2):c.1168A>G (p.Ser390Gly)	AXIN2	Oligodontia-colorectal cancer syndrome|not specified|not provided|Oligodontia|Colorectal cancer	Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2018)	criteria provided, conflicting interpretations	17	63534353	17	65538235	127934	133391
NM_004459.6(BPTF):c.989delT (p.Leu330Argfs)	BPTF	Global developmental delay|Expressive language delay|Intellectual disability|Global developmental delay|Postnatal microcephaly|NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	17	65850431	17	67854315	431072	424588
NM_182641.3(BPTF):c.2366delA (p.Asn789Thrfs)	BPTF	Global developmental delay|Expressive language delay|Global developmental delay|Postnatal microcephaly|Inborn genetic diseases	Likely pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	17	65889796	17	67893680	431073	424589
NM_004459.6(BPTF):c.2860dup (p.Glu954Glyfs)	BPTF	Global developmental delay|Expressive language delay|Global developmental delay|Postnatal microcephaly|NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	17	65890220	17	67894104	431064	424590
NM_004459.6(BPTF):c.3360_3370+1del	BPTF	Global developmental delay|Expressive language delay|Global developmental delay|Postnatal microcephaly	Pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	17	65905867 - 65905878	17	67909751 - 67909762	431069	424591
NM_004459.6(BPTF):c.5216_5217del (p.Val1739Glyfs)	BPTF	Global developmental delay|Expressive language delay|Global developmental delay|Postnatal microcephaly|NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	17	65908838 - 65908839	17	67912722 - 67912723	431065	424592
NM_004459.6(BPTF):c.5770G>A (p.Ala1924Thr)	BPTF	Global developmental delay|Expressive language delay|Global developmental delay|Postnatal microcephaly	Likely pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	17	65914918	17	67918802	431070	424593
NM_004459.6(BPTF):c.8558T>G (p.Met2853Arg)	BPTF	Global developmental delay|Expressive language delay|Global developmental delay|Postnatal microcephaly|NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	17	65971957	17	67975841	431071	424594
NM_004459.6(BPTF):c.8650A>T (p.Lys2884Ter)	BPTF	Global developmental delay|Expressive language delay|Global developmental delay|Postnatal microcephaly|NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	17	65972049	17	67975933	431066	424595
NM_002734.4(PRKAR1A):c.220C>T (p.Arg74Cys)	PRKAR1A	Carney complex, type 1|Carney complex	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2014)	no assertion criteria provided	17	66518939	17	68522798	12674	27713
NM_002734.4(PRKAR1A):c.623delG (p.Gly208Glufs)	PRKAR1A	Carney complex|not provided	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, multiple submitters, no conflicts	17	66521968	17	68525827	164995	176495
NM_000891.2(KCNJ2):c.277G>A (p.Val93Ile)	KCNJ2	Andersen Tawil syndrome|Short QT syndrome 3|Atrial fibrillation|Atrial fibrillation, familial, 9|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 22, 2018)	criteria provided, conflicting interpretations	17	68171457	17	70175316	30121	39077
NM_000891.2(KCNJ2):c.953A>G (p.Asn318Ser)	KCNJ2	Andersen Tawil syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 6, 2015)	no assertion criteria provided	17	68172133	17	70175992	161257	171189
NM_000891.2(KCNJ2):c.1199C>T (p.Thr400Met)	KCNJ2	Long QT syndrome|not specified|Cardiovascular phenotype	Uncertain significance(Last reviewed: Aug 4, 2017)	criteria provided, multiple submitters, no conflicts	17	68172379	17	70176238	161258	171190
NM_000346.3(SOX9):c.515A>G (p.Tyr172Cys)	SOX9	Camptomelic dysplasia	Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	17	70118943	17	72122802	488603	481471
NM_000346.3(SOX9):c.1372C>T (p.Gln458Ter)	SOX9	Camptomelic dysplasia	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	17	70120370	17	72124229	488604	481472
NM_000346.3(SOX9):c.1427T>C (p.Met476Thr)	SOX9	Camptomelic dysplasia	Likely pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	17	70120425	17	72124284	374384	361229
NM_004252.4(SLC9A3R1):c.657C>G (p.Ile219Met)	SLC9A3R1	Nephrolithiasis/osteoporosis, hypophosphatemic, 2	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	17	72759559	17	74763420	561111	552206
NM_004035.6(ACOX1):c.710A>G (p.Asn237Ser)	ACOX1	ACOX1-related condition	Uncertain significance(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	17	73951711	17	75955630	584427	575503
NM_001256071.2(RNF213):c.12553A>G (p.Lys4185Glu)	RNF213|LOC100294362	Moyamoya disease 2	Likely pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	17	78346336	17	80372536	585198	576249
NM_001256071.2(RNF213):c.12562G>A (p.Ala4188Thr)	RNF213|LOC100294362	Moyamoya disease 2	Uncertain significance(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	17	78346345	17	80372545	585199	576250
NM_001614.4(ACTG1):c.721G>A (p.Glu241Lys)	ACTG1	Deafness, autosomal dominant 20|Nonsyndromic hearing loss and deafness|not provided	Likely pathogenic(Last reviewed: Sep 11, 2016)	criteria provided, single submitter	17	79478295	17	81511269	18322	33361
NM_001614.4(ACTG1):c.617G>A (p.Arg206Gln)	ACTG1	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	17	79478399	17	81511373	517300	508742
NM_001199954.2(ACTG1):c.118C>T (p.His40Tyr)	ACTG1	Baraitser-Winter Syndrome 2	Likely pathogenic(Last reviewed: Sep 24, 2014)	no assertion criteria provided	17	79479263	17	81512237	374385	361230
NM_005052.2(RAC3):c.86C>T (p.Pro29Leu)	RAC3	Intellectual disability|Abnormality of brain morphology	association	no assertion criteria provided	17	79990313	17	82032437	585004	576060
NM_005052.2(RAC3):c.182A>T (p.Gln61Leu)	RAC3	Intellectual disability|Abnormality of brain morphology	association	no assertion criteria provided	17	79990661	17	82032785	585005	576061
NM_001042492.2(NF1):c.(?_-50)_(*68_?)del	EVI2A|EVI2B|NF1|OMG|LOC108281169|LOC108281170|LOC108281180|LOC108281181|LOC108281182|LOC111811965	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	17	29422278 - 29701241	17	31095260 - 31374223	506282	497266
NC_000017.10:g.(65898399_65898404)_(65986981_65986986)del	BPTF	Global developmental delay|Expressive language delay|Global developmental delay|Postnatal microcephaly	Pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	17	65898399 - 65986986			431068	424597
NC_000017.10:g.(65700189_65700200)_(65896331_65896342)del	BPTF|NOL11	Global developmental delay|Expressive language delay|Global developmental delay|Postnatal microcephaly	Pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	17	65700189 - 65896342			431067	424596
NC_000017.10:g.(29111368_?)_(?_30183819)dup	EVI2A|EVI2B|NF1|OMG|CRLF3|COPRS|ADAP2|TEFM|ATAD5|RNF135|RAB11FIP4|MIR193A	Global developmental delay|Seizures|Intellectual disability|Global developmental delay	Likely pathogenic	no assertion criteria provided	17	29111368 - 30183819			374370	361271
NC_000017.10:g.(34360227_34437475)_(36214026_36473024)del	ACACA|LHX1|CCL3|CCL3L1|CCL4|CCL18|TADA2A|HNF1B|ZNHIT3|CCL4L2|DDX52|DUSP14|SYNRG|AATF|DHRS11|GGNBP2|MRM1|MYO19|TBC1D3F|MRPL45|PIGW|C17orf78|CCL4L1|TBC1D3B|TBC1D3C|CCL3L3|TBC1D3|TBC1D3H	Chromosome 17q12 deletion syndrome	Pathogenic(Last reviewed: Feb 27, 2015)	criteria provided, single submitter	17	34360227 - 36473024			209211	205802
NM_173208.2(TGIF1):c.337C>T (p.Arg113Cys)	TGIF1	Holoprosencephaly 4	Uncertain significance(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	18	3457456	18	3457458	545574	536083
NM_006796.2(AFG3L2):c.2011G>A (p.Gly671Arg)	AFG3L2	Spinocerebellar ataxia 28	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	18	12337504	18	12337505	30425	39382
NM_001142966.2(GREB1L):c.982C>T (p.Arg328Ter)	GREB1L	Inner ear Malformation	Pathogenic(Last reviewed: Nov 25, 2017)	no assertion criteria provided	18	19020262	18	21440301	446526	440044
NM_001142966.2(GREB1L):c.4368G>T (p.Gln1456His)	GREB1L	Inner ear Malformation	Pathogenic(Last reviewed: Nov 25, 2017)	no assertion criteria provided	18	19085910	18	21505949	446527	440045
NM_005257.5(GATA6):c.43G>C (p.Gly15Arg)	GATA6	not specified|Atrioventricular septal defect 5|Monogenic diabetes	Benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	18	19751148	18	22171187	129134	134580
NM_005257.5(GATA6):c.851C>G (p.Ala284Gly)	GATA6	not specified|Atrioventricular septal defect 5|Monogenic diabetes	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	18	19751956	18	22171995	129135	134581
NM_005257.5(GATA6):c.968_970delACC (p.His333del)	GATA6	Persistent truncus arteriosus	Benign(Last reviewed: Nov 4, 2013)	criteria provided, single submitter	18	19752073 - 19752075	18	22172112 - 22172114	129132	134578
NM_005257.5(GATA6):c.1620+7A>G	GATA6	not specified	Likely benign	no assertion criteria provided	18	19763011	18	22183050	129133	134579
NM_024422.4(DSC2):c.2603C>T (p.Ser868Phe)	DSC2	Arrhythmogenic right ventricular cardiomyopathy, type 11|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	18	28648084	18	31068118	427964	419290
NM_004949.4(DSC2):c.2471C>T (p.Ser824Leu)	DSC2	Arrhythmogenic right ventricular cardiomyopathy, type 11|Arrhythmogenic right ventricular cardiomyopathy	Uncertain significance(Last reviewed: May 22, 2016)	criteria provided, multiple submitters, no conflicts	18	28648897	18	31068931	161223	171192
NM_004949.4(DSC2):c.2194T>G (p.Leu732Val)	DSC2	Arrhythmogenic right ventricular cardiomyopathy, type 11|Arrhythmogenic right ventricular cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not specified|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 12, 2017)	criteria provided, conflicting interpretations	18	28650748	18	31070782	36005	44669
NM_004949.4(DSC2):c.1073C>T (p.Thr358Ile)	DSC2	Arrhythmogenic right ventricular cardiomyopathy, type 11|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiac arrest|Cardiovascular phenotype	Likely benign(Last reviewed: Mar 23, 2018)	criteria provided, multiple submitters, no conflicts	18	28662896	18	31082930	46160	55325
NM_004949.4(DSC2):c.1018A>G (p.Thr340Ala)	DSC2	Arrhythmogenic right ventricular dysplasia/cardiomyopathy	Likely benign(Last reviewed: Jun 1, 2014)	no assertion criteria provided	18	28662951	18	31082985	161222	171193
NM_024422.4(DSC2):c.846C>G (p.Tyr282Ter)	DSC2	Arrhythmogenic right ventricular cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, multiple submitters, no conflicts	18	28666635	18	31086672	46199	55364
NM_024422.4(DSC2):c.663T>A (p.Tyr221Ter)	DSC2	Arrhythmogenic right ventricular cardiomyopathy, type 11|Arrhythmogenic right ventricular cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 24, 2016)	criteria provided, multiple submitters, no conflicts	18	28667744	18	31087781	162504	172182
NM_004949.4(DSC2):c.96delC (p.Cys32Terfs)	DSC2	Arrhythmogenic right ventricular cardiomyopathy	Likely pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	18	28673580	18	31093617	46204	55369
NM_001942.3(DSG1):c.133C>T (p.Arg45Ter)	DSG1	Keratosis palmoplantaris striata 1	Likely pathogenic(Last reviewed: Oct 11, 2016)	criteria provided, single submitter	18	28906885	18	31326922	495107	486662
NM_001943.4(DSG2):c.137G>A (p.Arg46Gln)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular cardiomyopathy|not provided	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, multiple submitters, no conflicts	18	29099821	18	31519858	16812	31851
NM_001943.4(DSG2):c.146G>A (p.Arg49His)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	18	29099830	18	31519867	16810	31849
NM_001943.4(DSG2):c.166G>A (p.Val56Met)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|Catecholaminergic polymorphic ventricular tachycardia type 1|Arrhythmogenic right ventricular cardiomyopathy|Dilated cardiomyopathy 1BB|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	18	29099850	18	31519887	16818	31857
NM_001943.3(DSG2):c.473T>G (p.Val158Gly)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular dysplasia, familial 1|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	18	29101156	18	31521193	44319	53486
NM_001943.4(DSG2):c.523+1G>C	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|Dilated cardiomyopathy 1BB	Pathogenic(Last reviewed: Sep 17, 2014)	no assertion criteria provided	18	29101207	18	31521244	188450	186568
NM_001943.4(DSG2):c.523+2T>C	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	18	29101208	18	31521245	44321	53488
NM_001943.4(DSG2):c.1174G>A (p.Val392Ile)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular cardiomyopathy|Cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 15, 2017)	criteria provided, conflicting interpretations	18	29111109	18	31531146	36009	44673
NM_001943.4(DSG2):c.1487dupG (p.Cys496Trpfs)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 11, 2017)	criteria provided, conflicting interpretations	18	29116228	18	31536265	178852	176669
NM_001943.4(DSG2):c.1912G>A (p.Gly638Arg)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	18	29121188	18	31541225	161224	171194
NM_001943.4(DSG2):c.2434G>T (p.Gly812Cys)	DSG2|DSG2-AS1	Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular cardiomyopathy|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Mar 6, 2017)	criteria provided, single submitter	18	29125783	18	31545820	16814	31853
NM_001943.4(DSG2):c.2759T>G (p.Val920Gly)	DSG2|DSG2-AS1	Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 28, 2017)	criteria provided, conflicting interpretations	18	29126108	18	31546145	44307	53474
NM_000371.3(TTR):c.148G>A (p.Val50Met)	TTR	Amyloidogenic transthyretin amyloidosis|not provided	Pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	18	29172937	18	31592974	13417	28456
NM_000371.3(TTR):c.208A>C (p.Ser70Arg)	TTR	Amyloidogenic transthyretin amyloidosis	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	18	29175090	18	31595127	36889	45550
NM_000371.3(TTR):c.212_217dup (p.Ser72_Gly73insGluSer)	TTR	Amyloidogenic transthyretin amyloidosis	Pathogenic(Last reviewed: Mar 16, 2018)	no assertion criteria provided	18	29175094 - 29175099	18	31595131 - 31595136	545518	536022
NM_000371.3(TTR):c.238A>G (p.Thr80Ala)	TTR	Amyloidogenic transthyretin amyloidosis|not provided	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	18	29175120	18	31595157	13421	28460
NM_000371.3(TTR):c.424G>A (p.Val142Ile)	TTR	Carpal tunnel syndrome|Dystransthyretinemic euthyroidal hyperthyroxinemia|Amyloidogenic transthyretin amyloidosis|Amyloid Cardiomyopathy, Transthyretin-related|Cardiomyopathy|Anemia|not provided|Pancytopenia|Pneumonia|Bone marrow hypocellularity|Cardiovascular phenotype	Pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	18	29178618	18	31598655	13426	28465
NM_030632.2(ASXL3):c.3039+1G>A	ASXL3	Bainbridge-Ropers syndrome	Pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, single submitter	18	31320408	18	33740444	522818	513473
NM_030632.2(ASXL3):c.3106C>T (p.Arg1036Ter)	ASXL3	not provided|Bainbridge-Ropers syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, multiple submitters, no conflicts	18	31322918	18	33742954	429913	422219
NM_030632.2(ASXL3):c.3349C>T (p.Arg1117Ter)	ASXL3	not provided|Bainbridge-Ropers syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	18	31323161	18	33743197	279694	264817
NM_030632.2(ASXL3):c.4330C>T (p.Arg1444Ter)	ASXL3	Bainbridge-Ropers syndrome|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Apr 12, 2018)	criteria provided, conflicting interpretations	18	31324142	18	33744178	520661	512351
NM_015559.3(SETBP1):c.46G>A (p.Glu16Lys)	SETBP1	Schinzel-Giedion syndrome	Uncertain significance(Last reviewed: May 5, 2014)	criteria provided, single submitter	18	42281357	18	44701392	159883	169418
NM_015559.3(SETBP1):c.540+7405G>A	SETBP1	not specified	Likely benign	no assertion criteria provided	18	42456653	18	44876688	159884	169419
NM_015559.3(SETBP1):c.691G>C (p.Val231Leu)	SETBP1	Schinzel-Giedion syndrome|not specified|not provided	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	18	42529996	18	44950031	159885	169420
NM_015559.3(SETBP1):c.1223C>G (p.Ala408Gly)	SETBP1	Schinzel-Giedion syndrome	Uncertain significance(Last reviewed: May 14, 2014)	criteria provided, single submitter	18	42530528	18	44950563	159868	169422
NM_015559.3(SETBP1):c.1503C>T (p.Pro501=)	SETBP1	Schinzel-Giedion syndrome	Uncertain significance(Last reviewed: Sep 19, 2013)	criteria provided, single submitter	18	42530808	18	44950843	159869	169423
NM_015559.3(SETBP1):c.1932C>T (p.Ser644=)	SETBP1	Schinzel-Giedion syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 29, 2017)	criteria provided, conflicting interpretations	18	42531237	18	44951272	159870	169424
NM_015559.3(SETBP1):c.2602G>C (p.Asp868His)	SETBP1	Schinzel-Giedion syndrome	Likely pathogenic(Last reviewed: May 7, 2014)	criteria provided, single submitter	18	42531907	18	44951942	159871	169425
NM_015559.3(SETBP1):c.2602G>A (p.Asp868Asn)	SETBP1	Schinzel-Giedion syndrome|not provided	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	18	42531907	18	44951942	1032	16071
NM_015559.3(SETBP1):c.2608G>A (p.Gly870Ser)	SETBP1	Chronic myelogenous leukemia|Schinzel-Giedion syndrome	Pathogenic(Last reviewed: Sep 19, 2013)	criteria provided, single submitter	18	42531913	18	44951948	1035	16074
NM_015559.3(SETBP1):c.2612T>C (p.Ile871Thr)	SETBP1	Schinzel-Giedion syndrome|not provided	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	18	42531917	18	44951952	1031	16070
NM_015559.3(SETBP1):c.3301G>A (p.Val1101Ile)	SETBP1	Schinzel-Giedion syndrome|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	42532606	18	44952641	159872	169426
NM_015559.3(SETBP1):c.3388C>A (p.Pro1130Thr)	SETBP1	Schinzel-Giedion syndrome|not specified|not provided	Benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	18	42532693	18	44952728	159873	169427
NM_015559.3(SETBP1):c.3825A>T (p.Ser1275=)	SETBP1	Schinzel-Giedion syndrome	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	18	42533130	18	44953165	159876	169430
NM_015559.3(SETBP1):c.3825A>G (p.Ser1275=)	SETBP1	Schinzel-Giedion syndrome|not specified|not provided	Benign(Last reviewed: May 6, 2018)	criteria provided, multiple submitters, no conflicts	18	42533130	18	44953165	159875	169429
NM_015559.3(SETBP1):c.3825A>C (p.Ser1275=)	SETBP1	Schinzel-Giedion syndrome	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	18	42533130	18	44953165	159874	169428
NM_015559.3(SETBP1):c.4000+10T>A	SETBP1	Schinzel-Giedion syndrome|not specified|not provided	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	18	42533315	18	44953350	159877	169431
NM_015559.3(SETBP1):c.4129G>C (p.Val1377Leu)	SETBP1	Schinzel-Giedion syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	42618578	18	45038613	159878	169432
NM_015559.3(SETBP1):c.4290G>A (p.Val1430=)	SETBP1	not specified	Likely benign(Last reviewed: May 15, 2014)	criteria provided, single submitter	18	42643162	18	45063197	159879	169433
NM_015559.3(SETBP1):c.4398G>T (p.Glu1466Asp)	SETBP1	Schinzel-Giedion syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	42643270	18	45063305	159880	169434
NM_015559.3(SETBP1):c.4554G>A (p.Glu1518=)	SETBP1	Schinzel-Giedion syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	18	42643426	18	45063461	159881	169435
NM_015559.3(SETBP1):c.4640C>A (p.Thr1547Asn)	SETBP1	Schinzel-Giedion syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Nov 28, 2016)	criteria provided, multiple submitters, no conflicts	18	42643512	18	45063547	159882	169436
NM_005359.5(SMAD4):c.189_197delAAATGGAGCins44 (p.?)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48573605 - 48573613	18	51047235 - 51047243	38739	47344
NM_005359.5(SMAD4):c.209A>G (p.Lys70Arg)	SMAD4	Myhre syndrome	Uncertain significance(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	18	48573625	18	51047255	438836	432469
NM_005359.5(SMAD4):c.354G>A (p.Ala118=)	SMAD4	Myhre syndrome|Juvenile polyposis syndrome|Osler hemorrhagic telangiectasia syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Juvenile Polyposis	Benign/Likely benign(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	18	48575160	18	51048790	24799	36140
NM_005359.5(SMAD4):c.373_374insAT (p.Ser125Asnfs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48575179 - 48575180	18	51048809 - 51048810	24800	36141
NM_005359.5(SMAD4):c.375_381dupTGTCTGT (p.Val128Cysfs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48575181 - 48575187	18	51048811 - 51048817	24801	36142
NM_005359.5(SMAD4):c.403C>T (p.Arg135Ter)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48575209	18	51048839	24802	36143
NM_005359.5(SMAD4):c.425-6A>G	SMAD4	Juvenile polyposis syndrome|not specified	Uncertain significance(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	18	48575659	18	51049289	24803	36144
NM_005359.5(SMAD4):c.430_431delTC (p.Ser144Argfs)	SMAD4	Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	18	48575670 - 48575671	18	51049300 - 51049301	24804	36145
NM_005359.5(SMAD4):c.437T>A (p.Leu146Ter)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48575677	18	51049307	24805	36146
NM_005359.5(SMAD4):c.516_527del (p.Ser173_Gly176del)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48581212 - 48581223	18	51054842 - 51054853	24806	36147
NM_005359.5(SMAD4):c.533C>G (p.Ser178Ter)	SMAD4	Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 25, 2015)	criteria provided, single submitter	18	48581229	18	51054859	24807	36148
NM_005359.5(SMAD4):c.538C>T (p.Gln180Ter)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48581234	18	51054864	24808	36149
NM_005359.5(SMAD4):c.608delC (p.Pro203Hisfs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48581304	18	51054934	24809	36150
NM_005359.5(SMAD4):c.692dupG (p.Ser232Glnfs)	SMAD4	Juvenile polyposis syndrome|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	18	48584519	18	51058149	24811	36152
NM_005359.5(SMAD4):c.731_732insGCCC(p.Gln245Profs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	18	48584558 - 48584559	18	51058188 - 51058189	24813	36154
NM_005359.5(SMAD4):c.831_832delAC (p.Pro278Terfs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48584753 - 48584754	18	51058383 - 51058384	24816	36157
NM_005359.5(SMAD4):c.905-52A>G	SMAD4	Juvenile polyposis syndrome	Benign(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48586184	18	51059814	24817	36158
NM_005359.5(SMAD4):c.905-32T=	SMAD4	Juvenile polyposis syndrome	Benign(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48586204	18	51059834	24797	36138
NM_005359.5(SMAD4):c.925_928dupGCAT (p.Phe310Cysfs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48586256 - 48586259	18	51059886 - 51059889	24818	36159
NM_005359.5(SMAD4):c.970T>C (p.Cys324Arg)	SMAD4	Juvenile polyposis syndrome|not specified	Uncertain significance(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	18	48591807	18	51065437	24819	36160
NM_005359.5(SMAD4):c.971delG (p.Cys324Phefs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48591808	18	51065438	24820	36161
NM_005359.5(SMAD4):c.982_983insT (p.Tyr328Leufs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48591819	18	51065449	24821	36162
NM_005359.5(SMAD4):c.989A>G (p.Glu330Gly)	SMAD4	Juvenile polyposis syndrome|not provided|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Feb 24, 2014)	criteria provided, single submitter	18	48591826	18	51065456	24824	36165
NM_005359.5(SMAD4):c.1037delC (p.Pro346Leufs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	18	48591874	18	51065504	24825	36166
NM_005359.5(SMAD4):c.1042_1043delGT (p.Val348Tyrfs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48591879 - 48591880	18	51065509 - 51065510	24826	36167
NM_005359.5(SMAD4):c.1058A>C (p.Tyr353Ser)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48591895	18	51065525	24829	36170
NM_005359.5(SMAD4):c.1081C>A (p.Arg361Ser)	SMAD4	Juvenile polyposis syndrome|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	18	48591918	18	51065548	24822	36163
NM_005359.5(SMAD4):c.1081C>T (p.Arg361Cys)	SMAD4	Juvenile polyposis syndrome|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|JP, JP/HHT, and HHT|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	18	48591918	18	51065548	8543	23582
NM_005359.5(SMAD4):c.1087T>C (p.Cys363Arg)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48591924	18	51065554	24834	36175
NM_005359.5(SMAD4):c.1113delC (p.His371Glnfs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48591950	18	51065580	24838	36179
NM_005359.5(SMAD4):c.1139G>A (p.Arg380Lys)	SMAD4	Juvenile polyposis syndrome	Uncertain significance(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	18	48591976	18	51065606	38283	46838
NM_005359.5(SMAD4):c.1139+1G>A	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48591977	18	51065607	24839	36180
NM_005359.5(SMAD4):c.1162C>T (p.Gln388Ter)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48593411	18	51067041	24842	34298
NM_005359.5(SMAD4):c.1168G>A (p.Glu390Lys)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48593417	18	51067047	24843	36184
NM_005359.5(SMAD4):c.1193G>A (p.Trp398Ter)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48593442	18	51067072	24844	36185
NM_005359.5(SMAD4):c.1236C>G (p.Tyr412Ter)	SMAD4	Juvenile polyposis syndrome|Carcinoma of pancreas	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48593485	18	51067115	24845	36186
NM_005359.5(SMAD4):c.1242delA (p.Asp415Thrfs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48593491	18	51067121	24847	36188
NM_005359.5(SMAD4):c.1245_1248delCAGA (p.Asp415Glufs)	SMAD4	Juvenile polyposis syndrome|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	18	48593494 - 48593497	18	51067124 - 51067127	142253	151967
NM_005359.5(SMAD4):c.1268delG (p.Gly423Glufs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48593517	18	51067147	24849	36190
NM_005359.5(SMAD4):c.1333C>T (p.Arg445Ter)	SMAD4	Juvenile polyposis syndrome|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, multiple submitters, no conflicts	18	48603032	18	51076662	24850	36191
NM_005359.5(SMAD4):c.1342C>T (p.Gln448Ter)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48603041	18	51076671	24851	36192
NM_005359.5(SMAD4):c.1343_1365del (p.Gln448Argfs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48603042 - 48603064	18	51076672 - 51076694	24852	36193
NM_005359.5(SMAD4):c.1361_1364delCACA (p.Ala454Glufs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48603060 - 48603063	18	51076690 - 51076693	24853	36194
NM_005359.5(SMAD4):c.1409_1410insCCCT (p.Gly471Profs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48603108 - 48603109	18	51076738 - 51076739	24854	36195
NM_005359.5(SMAD4):c.1411_1435del (p.Gly471Leufs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48603110 - 48603134	18	51076740 - 51076764	24855	36196
NM_005359.5(SMAD4):c.1421delC (p.Ser474Terfs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48603120	18	51076750	24856	36197
NM_005359.5(SMAD4):c.1472G>T (p.Gly491Val)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48604650	18	51078280	24857	36198
NM_005359.5(SMAD4):c.1478A>C (p.Asp493Ala)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48604656	18	51078286	24858	36199
NM_005359.5(SMAD4):c.1499T>C (p.Ile500Thr)	SMAD4	Myhre syndrome|not provided	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, multiple submitters, no conflicts	18	48604677	18	51078307	30149	39105
NM_005359.5(SMAD4):c.1523G>A (p.Gly508Asp)	SMAD4	Juvenile polyposis syndrome	Likely pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	18	48604701	18	51078331	549766	540532
NM_005359.5(SMAD4):c.1525T>A (p.Trp509Arg)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48604703	18	51078333	24859	36200
NM_005359.5(SMAD4):c.1527G>A (p.Trp509Ter)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48604705	18	51078335	24860	36201
NM_005359.5(SMAD4):c.1529G>T (p.Gly510Val)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48604707	18	51078337	24861	36202
NM_005359.5(SMAD4):c.1544delG (p.Arg515Asnfs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48604722	18	51078352	24862	36203
NM_005359.5(SMAD4):c.1547_1550dupAGAG (p.Ser517Argfs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48604725 - 48604728	18	51078355 - 51078358	24863	36204
NM_005359.5(SMAD4):c.1564_1565delCC (p.Pro522Leufs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48604742 - 48604743	18	51078372 - 51078373	24865	36206
NM_005359.5(SMAD4):c.1571G>T (p.Trp524Leu)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48604749	18	51078379	24866	36207
NM_005359.5(SMAD4):c.1573A>G (p.Ile525Val)	SMAD4	Myhre syndrome|Juvenile polyposis syndrome|Osler hemorrhagic telangiectasia syndrome|not specified|not provided|Gastrointestinal polyposis|Cardiovascular phenotype|Juvenile Polyposis	Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2017)	criteria provided, conflicting interpretations	18	48604751	18	51078381	41788	50227
NM_005359.5(SMAD4):c.1587dup (p.His530Thrfs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48604765	18	51078395	24867	36208
NM_005359.5(SMAD4):c.1588delC (p.His530Thrfs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48604766	18	51078396	24868	36209
NM_005359.5(SMAD4):c.1597C>G (p.Leu533Val)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48604775	18	51078405	24873	36214
NM_005359.5(SMAD4):c.1607dupT (p.Asp537Argfs)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48604785	18	51078415	24877	36218
NM_005215.3(DCC):c.3872G>A (p.Arg1291Gln)	DCC	Colorectal cancer	Uncertain significance(Last reviewed: Aug 1, 2016)	no assertion criteria provided	18	51013302	18	53486932	375864	362743
NM_005215.3(DCC):c.4028G>A (p.Arg1343His)	DCC	Colorectal cancer	Uncertain significance(Last reviewed: Aug 1, 2016)	no assertion criteria provided	18	51025797	18	53499427	375859	362744
NM_001083962.1(TCF4):c.*4+30C>T	TCF4	not specified	Likely benign	no assertion criteria provided	18	52895422	18	55228191	160075	169437
NM_001083962.1(TCF4):c.1965dupC (p.Gly656Argfs)	TCF4	Pitt-Hopkins syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 3, 2015)	criteria provided, multiple submitters, no conflicts	18	52895507	18	55228276	212379	208455
NM_001083962.1(TCF4):c.1941A>G (p.Ser647=)	TCF4	Pitt-Hopkins syndrome|not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	18	52895531	18	55228300	93544	99449
NM_001083962.1(TCF4):c.1840G>C (p.Ala614Pro)	TCF4	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	18	52896117	18	55228886	160081	169438
NM_001083962.1(TCF4):c.1815_1826del (p.Thr606_Leu609del)	TCF4	Pitt-Hopkins syndrome	Likely pathogenic	criteria provided, single submitter	18	52896131 - 52896142	18	55228900 - 55228911	431710	425225
NM_001083962.1(TCF4):c.1777_1779del (p.Arg593del)	TCF4	Pitt-Hopkins syndrome	Uncertain significance(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	18	52896178 - 52896180	18	55228947 - 55228949	160080	169439
NM_001083962.1(TCF4):c.1741G>T (p.Val581Phe)	TCF4	Pitt-Hopkins syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 27, 2018)	criteria provided, conflicting interpretations	18	52896216	18	55228985	160079	169440
NM_001083962.1(TCF4):c.1739G>A (p.Arg580Gln)	TCF4	Pitt-Hopkins syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, multiple submitters, no conflicts	18	52896218	18	55228987	7371	22410
NM_001083962.1(TCF4):c.1733G>C (p.Arg578Pro)	TCF4	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	18	52896224	18	55228993	7374	22413
NM_001083962.1(TCF4):c.1498G>T (p.Gly500Ter)	TCF4	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	18	52899891	18	55232660	160078	169441
NM_001083962.1(TCF4):c.1350G>A (p.Met450Ile)	TCF4	Pitt-Hopkins syndrome	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	18	52921728	18	55254497	160077	169442
NM_003199.2(TCF4):c.1292delG (p.Gly431Valfs)	TCF4	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	18	52921785 - 52921786	18	55254555	561127	552210
NM_001083962.1(TCF4):c.1153C>T (p.Arg385Ter)	TCF4	Pitt-Hopkins syndrome|not provided	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	18	52921925	18	55254694	7372	22411
NM_001083962.1(TCF4):c.1146+1G>A	TCF4	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	18	52924545	18	55257314	160076	169443
NM_001083962.1(TCF4):c.1069+1G>T	TCF4	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jul 10, 2014)	criteria provided, single submitter	18	52927179	18	55259948	209195	205790
NM_001083962.1(TCF4):c.1034delC (p.Pro345Leufs)	TCF4	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	18	52927214 - 52927215	18	55259984	561126	552211
NM_001083962.1(TCF4):c.991-2A>G	TCF4	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Apr 1, 2013)	criteria provided, single submitter	18	52927260	18	55260029	160093	169444
NM_001083962.1(TCF4):c.990G>A (p.Ser330=)	TCF4	Pitt-Hopkins syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	18	52928697	18	55261466	160092	169445
NM_001083962.1(TCF4):c.944C>T (p.Ala315Val)	TCF4	Pitt-Hopkins syndrome|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	18	52928743	18	55261512	160091	169446
NM_001243236.1(TCF4):c.457_461del (p.Gly153Serfs)	TCF4	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	18	52928745 - 52928750	18	55261515 - 55261519	561128	552212
NM_001083962.1(TCF4):c.791del (p.Ser264Thrfs)	TCF4	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	18	52937193	18	55269962	160090	169447
NM_001083962.1(TCF4):c.789+23C>T	TCF4	not specified	Likely benign	no assertion criteria provided	18	52942827	18	55275596	160089	169448
NM_001083962.1(TCF4):c.656-1G>C	TCF4	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	18	52942984	18	55275753	160087	169449
NM_001083962.1(TCF4):c.656-3C>T	TCF4	not specified	Likely benign(Last reviewed: May 4, 2017)	criteria provided, multiple submitters, no conflicts	18	52942986	18	55275755	160088	169450
NM_001083962.1(TCF4):c.655+1G>A	TCF4	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	18	52946781	18	55279550	160086	169451
NM_001083962.1(TCF4):c.550-2A>G	TCF4	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Feb 21, 2012)	criteria provided, single submitter	18	52946889	18	55279658	217015	213650
NM_001083962.1(TCF4):c.469C>T (p.Arg157Ter)	TCF4	Pitt-Hopkins syndrome|not provided	Pathogenic(Last reviewed: Feb 26, 2017)	criteria provided, multiple submitters, no conflicts	18	53018135	18	55350904	160085	169452
NM_001083962.1(TCF4):c.415del (p.Leu139Phefs)	TCF4	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	18	53018189	18	55350958	160084	169453
NM_001083962.1(TCF4):c.305-165C>T	TCF4	not specified	Likely benign	no assertion criteria provided	18	53070914	18	55403683	160083	169454
NM_001083962.1(TCF4):c.223A>G (p.Thr75Ala)	TCF4|TCF4-AS1	not specified|History of neurodevelopmental disorder	Likely benign(Last reviewed: May 30, 2017)	criteria provided, multiple submitters, no conflicts	18	53128331	18	55461100	160082	169455
NM_001083962.1(TCF4):c.145+1G>A	TCF4	Pitt-Hopkins syndrome	Likely pathogenic	criteria provided, single submitter	18	53252510	18	55585279	375416	362183
t(X;18)(p21.1;q21.31)	NEDD4L	Periventricular nodular heterotopia 7	Likely pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided			18	58296256 - 58296259	592171	583207
NM_005912.2(MC4R):c.914G>A (p.Arg305Gln)	MC4R	Obesity	Uncertain significance(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	18	58038669	18	60371436	524206	514853
NM_005912.2(MC4R):c.896C>A (p.Pro299His)	MC4R	Obesity	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	18	58038687	18	60371454	36488	45150
NM_005912.2(MC4R):c.835_836dupTG (p.Phe280Alafs)	MC4R	Obesity	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	18	58038747 - 58038748	18	60371514 - 60371515	36487	45149
NM_005912.2(MC4R):c.806T>A (p.Ile269Asn)	MC4R	Obesity|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 14, 2017)	criteria provided, conflicting interpretations	18	58038777	18	60371544	36486	45148
NM_005912.2(MC4R):c.677T>C (p.Ile226Thr)	MC4R	Obesity	Uncertain significance(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	18	58038906	18	60371673	36485	45147
NM_005912.2(MC4R):c.606C>A (p.Phe202Leu)	MC4R	Obesity|not specified|Monogenic diabetes	Conflicting interpretations of pathogenicity(Last reviewed: Feb 7, 2017)	criteria provided, conflicting interpretations	18	58038977	18	60371744	36484	45146
NM_005912.2(MC4R):c.105C>A (p.Tyr35Ter)	MC4R	Schizophrenia|Obesity|not provided	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	18	58039478	18	60372245	14318	29357
NM_017757.2(ZNF407):c.33T>C (p.Asp11=)	ZNF407	not specified	Likely benign	no assertion criteria provided	18	72343008	18	74631052	130821	136266
NM_017757.2(ZNF407):c.181A>G (p.Ser61Gly)	ZNF407	not specified	Benign(Last reviewed: Feb 16, 2015)	criteria provided, single submitter	18	72343156	18	74631200	130817	136262
NM_017757.2(ZNF407):c.206A>G (p.Asn69Ser)	ZNF407	not specified	Likely benign	no assertion criteria provided	18	72343181	18	74631225	130818	136263
NM_017757.2(ZNF407):c.1077A>G (p.Val359=)	ZNF407	not specified	Likely benign	no assertion criteria provided	18	72344052	18	74632096	130811	136256
NM_017757.2(ZNF407):c.1248T>C (p.Pro416=)	ZNF407	not specified	Likely benign	no assertion criteria provided	18	72344223	18	74632267	130812	136257
NM_017757.2(ZNF407):c.1263C>T (p.Leu421=)	ZNF407	not specified	Likely benign	no assertion criteria provided	18	72344238	18	74632282	130814	136259
NM_017757.2(ZNF407):c.1534G>A (p.Gly512Arg)	ZNF407	not specified	Likely benign	no assertion criteria provided	18	72344509	18	74632553	130815	136260
NM_017757.2(ZNF407):c.1578G>A (p.Thr526=)	ZNF407	not specified	Likely benign	no assertion criteria provided	18	72344553	18	74632597	130816	136261
NM_017757.2(ZNF407):c.2915A>C (p.Asn972Thr)	ZNF407	not specified	Likely benign	no assertion criteria provided	18	72345890	18	74633934	130819	136264
NM_017757.2(ZNF407):c.3075T>C (p.Ser1025=)	ZNF407	not specified	Likely benign	no assertion criteria provided	18	72346050	18	74634094	130820	136265
NM_017757.2(ZNF407):c.4507T>C (p.Leu1503=)	ZNF407	not specified	Benign(Last reviewed: Oct 27, 2015)	criteria provided, single submitter	18	72347482	18	74635526	130823	136268
NM_017757.2(ZNF407):c.4939A>G (p.Met1647Val)	ZNF407	not provided	Uncertain significance(Last reviewed: Mar 21, 2014)	criteria provided, single submitter	18	72589214	18	74877258	130824	136269
NM_017757.2(ZNF407):c.6384G>A (p.Ala2128=)	ZNF407	not specified	Likely benign	no assertion criteria provided	18	72776061	18	75064105	130825	136270
NM_017757.2(ZNF407):c.6444G>A (p.Thr2148=)	ZNF407	not specified	Likely benign	no assertion criteria provided	18	72776121	18	75064165	130826	136271
NM_005359.5(SMAD4):c.788-?_1659+?del	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48584710 - 48604837			24814	36155
NM_005359.5(SMAD4):c.668-?_1659+?del	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48584495 - 48604837			24810	36151
NM_005359.5(SMAD4):c.(?_-17093)_(1659_?)del	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48540028 - 48604837	18	51013658 - 51078467	24795	36136
NM_001972.3(ELANE):c.598-1G>A	ELANE	Cyclical neutropenia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2017)	criteria provided, conflicting interpretations	19	855957	19	855957	228343	231093
NM_000455.4(STK11):c.440_441delGT (p.Arg147Leufs)	STK11	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Dec 16, 2016)	no assertion criteria provided	19	1219388 - 1219389	19	1219389 - 1219390	375445	362212
NM_000455.4(STK11):c.464G>A (p.Gly155Glu)	STK11	Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2018)	criteria provided, conflicting interpretations	19	1219412	19	1219413	492532	485458
NM_000455.4(STK11):c.542A>G (p.Asn181Ser)	STK11	Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, multiple submitters, no conflicts	19	1220449	19	1220450	254654	249194
NM_000455.4(STK11):c.894C>A (p.Phe298Leu)	STK11	Peutz-Jeghers syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	19	1221979	19	1221980	127707	133164
NM_000455.4(STK11):c.921-2A>C	STK11	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Oct 5, 2017)	no assertion criteria provided	19	1222982	19	1222983	440861	434508
NM_000455.4(STK11):c.971C>T (p.Pro324Leu)	STK11	Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	19	1223034	19	1223035	135931	139643
NM_000455.4(STK11):c.1254C>G (p.Cys418Trp)	STK11	Peutz-Jeghers syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	19	1226598	19	1226599	135918	139630
NM_001321463.1(NCLN):c.496C>T (p.Gln166Ter)	NCLN	Hirschsprung disease 1	Likely pathogenic(Last reviewed: Sep 26, 2016)	no assertion criteria provided	19	3193402	19	3193404	375276	362047
NM_001961.3(EEF2):c.2190T>C (p.Tyr730=)	EEF2	not specified	Likely benign	no assertion criteria provided	19	3977486	19	3977488	128959	134406
NM_001961.3(EEF2):c.1632T>C (p.His544=)	EEF2	not specified	Likely benign	no assertion criteria provided	19	3979408	19	3979410	128958	134405
NM_030662.3(MAP2K2):c.937C>T (p.Arg313Trp)	MAP2K2	not provided|Cardiofaciocutaneous syndrome 4	Uncertain significance(Last reviewed: Jun 30, 2016)	criteria provided, single submitter	19	4097324	19	4097326	280685	264952
NM_030662.3(MAP2K2):c.619G>A (p.Glu207Lys)	MAP2K2	not provided|Rasopathy|Cardio-facio-cutaneous syndrome	Likely pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	19	4101103	19	4101105	40813	49283
NM_030662.3(MAP2K2):c.210_212delTGA (p.Asp71del)	MAP2K2	Smith-Magenis Syndrome-like	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	19	4117507 - 4117510	19	4117510 - 4117512	254207	248722
NM_030662.3(MAP2K2):c.181A>G (p.Lys61Glu)	MAP2K2	Cardiofaciocutaneous syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, multiple submitters, no conflicts	19	4117539	19	4117541	40769	49239
NM_006087.3(TUBB4A):c.1228G>A (p.Glu410Lys)	TUBB4A	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	19	6495282	19	6495271	135658	139376
NM_006087.3(TUBB4A):c.1164G>C (p.Met388Ile)	TUBB4A	Leukodystrophy, hypomyelinating, 6	Likely pathogenic(Last reviewed: Nov 5, 2014)	criteria provided, single submitter	19	6495346	19	6495335	209201	205792
NM_006087.3(TUBB4A):c.1062C>G (p.Cys354Trp)	TUBB4A	Leukodystrophy, hypomyelinating, 6	Likely pathogenic(Last reviewed: Apr 18, 2016)	no assertion criteria provided	19	6495448	19	6495437	453295	446894
NM_006087.3(TUBB4A):c.763G>A (p.Val255Ile)	TUBB4A	Leukodystrophy, hypomyelinating, 6|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	19	6495747	19	6495736	217025	213656
NM_006087.3(TUBB4A):c.745G>A (p.Asp249Asn)	TUBB4A	Leukodystrophy, hypomyelinating, 6|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	19	6495765	19	6495754	50985	65656
NM_012335.3(MYO1F):c.1781G>A (p.Arg594Gln)	MYO1F	Bilateral sensorineural hearing impairment	Uncertain significance(Last reviewed: May 22, 2014)	no assertion criteria provided	19	8601851	19	8536967	374265	361233
NM_001130823.2(DNMT1):c.1532A>G (p.Tyr511Cys)	DNMT1	Hereditary sensory neuropathy type IE|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2016)	criteria provided, multiple submitters, no conflicts	19	10265693	19	10155017	29682	38637
NM_001130823.2(DNMT1):c.406C>T (p.Arg136Cys)	DNMT1	Beckwith-Wiedemann syndrome|Hereditary sensory neuropathy type IE|not specified|Dementia, Deafness, and Sensory Neuropathy	Conflicting interpretations of pathogenicity(Last reviewed: May 25, 2018)	criteria provided, conflicting interpretations	19	10291065	19	10180389	234461	232066
NM_001005360.2(DNM2):c.190G>A (p.Val64Ile)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|not specified|Peripheral neuropathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 14, 2017)	criteria provided, conflicting interpretations	19	10870442	19	10759766	133978	137717
NM_001005360.2(DNM2):c.235+6A>G	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|not specified|not provided|Centronuclear Myopathy, Dominant|Charcot-Marie-Tooth, Intermediate	Benign/Likely benign(Last reviewed: Jan 17, 2018)	criteria provided, multiple submitters, no conflicts	19	10870493	19	10759817	158525	169456
NM_001005360.2(DNM2):c.235+12C>A	DNM2	not specified|Myopathy, centronuclear|Centronuclear Myopathy, Dominant|Charcot-Marie-Tooth, Intermediate	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	19	10870499	19	10759823	158524	169457
NM_001005360.2(DNM2):c.238C>T (p.His80Tyr)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|not specified|Centronuclear Myopathy, Dominant|Charcot-Marie-Tooth, Intermediate	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	19	10883157	19	10772481	137130	140833
NM_001005360.2(DNM2):c.822G>A (p.Thr274=)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|not specified|Myopathy, centronuclear	Conflicting interpretations of pathogenicity(Last reviewed: Jul 25, 2017)	criteria provided, conflicting interpretations	19	10893769	19	10783093	158528	169458
NM_001005360.2(DNM2):c.958G>A (p.Asp320Asn)	DNM2	not specified|not provided|Centronuclear Myopathy, Dominant|Charcot-Marie-Tooth, Intermediate	Conflicting interpretations of pathogenicity(Last reviewed: Jan 16, 2018)	criteria provided, conflicting interpretations	19	10897348	19	10786672	158529	169459
NM_001190716.1(DNM2):c.1021G>A (p.Glu341Lys)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B	Likely pathogenic(Last reviewed: Sep 25, 2014)	criteria provided, single submitter	19	10904424	19	10793748	218920	215729
NM_001190716.1(DNM2):c.1072G>A (p.Gly358Arg)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|Charcot-Marie-Tooth disease, type 2M|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, multiple submitters, no conflicts	19	10904475	19	10793799	7287	22326
NM_001005360.2(DNM2):c.1077C>T (p.Gly359=)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|not specified|Centronuclear Myopathy, Dominant|Charcot-Marie-Tooth, Intermediate	Benign/Likely benign(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	19	10904480	19	10793804	137131	140834
NM_001005360.2(DNM2):c.1090C>T (p.Arg364Cys)	DNM2	Myopathy, centronuclear, 1	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	19	10904493	19	10793817	560989	552214
NM_001005360.2(DNM2):c.1102G>A (p.Glu368Lys)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|Myopathy, centronuclear, 1|Muscular Diseases|not provided|Myopathy, centronuclear	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, multiple submitters, no conflicts	19	10904505	19	10793829	7282	22321
NM_001005360.2(DNM2):c.1105C>T (p.Arg369Trp)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|Myopathy, centronuclear, 1|Myopathy, centronuclear	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	19	10904508	19	10793832	7280	22319
NM_001005360.2(DNM2):c.1106G>A (p.Arg369Gln)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|Myopathy, centronuclear, 1|Myopathy, centronuclear	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	19	10904509	19	10793833	7279	22318
NM_001005360.2(DNM2):c.1124T>A (p.Val375Glu)	DNM2	Myopathy, centronuclear	Likely pathogenic(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	19	10904527	19	10793851	158513	169460
NM_001005360.2(DNM2):c.1393C>T (p.Arg465Trp)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|Myopathy, centronuclear, 1|not provided|Myopathy, centronuclear	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, multiple submitters, no conflicts	19	10909219	19	10798543	7281	22320
NM_001005360.2(DNM2):c.1565G>A (p.Arg522His)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|Myopathy, centronuclear, 1|not provided|Myopathy, centronuclear	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	19	10922947	19	10812271	158514	169461
NM_001005360.2(DNM2):c.1567A>G (p.Arg523Gly)	DNM2	not provided	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	19	10922949	19	10812273	158515	169462
NM_001005360.2(DNM2):c.1731G>A (p.Lys577=)	DNM2	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	19	10930715	19	10820039	158516	169463
NM_001005360.2(DNM2):c.1782-11C>T	DNM2	not specified	Benign(Last reviewed: Dec 8, 2015)	criteria provided, multiple submitters, no conflicts	19	10934453	19	10823777	158517	169464
NM_001005360.2(DNM2):c.1827C>T (p.Ser609=)	DNM2	not specified|Myopathy, centronuclear	Conflicting interpretations of pathogenicity(Last reviewed: Feb 20, 2018)	criteria provided, conflicting interpretations	19	10934509	19	10823833	158518	169465
NM_001005360.2(DNM2):c.1856C>T (p.Ser619Leu)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|Myopathy, centronuclear, 1|Severe X-linked myotubular myopathy|not provided|Myopathy, centronuclear	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, multiple submitters, no conflicts	19	10934538	19	10823862	7285	22324
NM_001005360.2(DNM2):c.1862T>C (p.Leu621Pro)	DNM2	Myopathy, centronuclear	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	19	10934544	19	10823868	158519	169466
NM_001005360.2(DNM2):c.1880C>G (p.Pro627Arg)	DNM2	not provided|Myopathy, centronuclear	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, multiple submitters, no conflicts	19	10934562	19	10823886	158520	169467
NM_001005360.2(DNM2):c.1902C>T (p.Asn634=)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|not specified|not provided|Centronuclear Myopathy, Dominant|Charcot-Marie-Tooth, Intermediate	Benign/Likely benign(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	19	10935741	19	10825065	158521	169468
NM_001005360.2(DNM2):c.2106G>C (p.Ser702=)	DNM2	Myopathy, centronuclear	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	19	10939759	19	10829083	158522	169469
NM_001005360.2(DNM2):c.2139T>C (p.Ala713=)	DNM2	not specified|Centronuclear Myopathy, Dominant|Charcot-Marie-Tooth, Intermediate	Benign/Likely benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	19	10939792	19	10829116	158523	169470
NM_001005360.2(DNM2):c.2484G>A (p.Pro828=)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|not specified|not provided	Benign(Last reviewed: Feb 1, 2018)	criteria provided, multiple submitters, no conflicts	19	10940995	19	10830319	158526	169471
NM_001005360.2(DNM2):c.2543+7C>G	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|not specified|not provided|Centronuclear Myopathy, Dominant|Charcot-Marie-Tooth, Intermediate	Benign/Likely benign(Last reviewed: Mar 26, 2018)	criteria provided, multiple submitters, no conflicts	19	10941061	19	10830385	158527	169472
NM_001128849.1(SMARCA4):c.915G>A (p.Pro305=)	SMARCA4	Rhabdoid tumor predisposition syndrome 2|not specified|Hereditary cancer-predisposing syndrome|Coffin-Siris syndrome	Benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	19	11098397	19	10987721	126366	131898
NM_001128849.1(SMARCA4):c.930C>A (p.Arg310=)	SMARCA4	Rhabdoid tumor predisposition syndrome 2|not specified|Hereditary cancer-predisposing syndrome|Coffin-Siris syndrome	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	19	11098412	19	10987736	126367	131899
NM_001128849.1(SMARCA4):c.1114T>C (p.Tyr372His)	SMARCA4	Rhabdoid tumor predisposition syndrome 2|not specified|Hereditary cancer-predisposing syndrome|Coffin-Siris syndrome	Benign/Likely benign(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	19	11098596	19	10987920	126355	131887
NM_001128849.1(SMARCA4):c.1155_1157delTGA (p.Glu386del)	SMARCA4	Rhabdoid tumor predisposition syndrome 2	Pathogenic(Last reviewed: Apr 28, 2014)	no assertion criteria provided	19	11100029 - 11100031	19	10989353 - 10989355	438797	432387
NM_001128849.1(SMARCA4):c.1413G>A (p.Lys471=)	SMARCA4	Rhabdoid tumor predisposition syndrome 2|not specified|Hereditary cancer-predisposing syndrome|Coffin-Siris syndrome	Benign(Last reviewed: Aug 20, 2017)	criteria provided, multiple submitters, no conflicts	19	11101993	19	10991317	126356	131888
NM_001128849.1(SMARCA4):c.1419+8C>T	SMARCA4	Rhabdoid tumor predisposition syndrome 2|not specified|Coffin-Siris syndrome	Benign(Last reviewed: Jan 25, 2018)	criteria provided, multiple submitters, no conflicts	19	11102007	19	10991331	126357	131889
NM_001128849.1(SMARCA4):c.1509A>G (p.Ala503=)	SMARCA4	Rhabdoid tumor predisposition syndrome 2|not specified|Hereditary cancer-predisposing syndrome|Coffin-Siris syndrome	Benign(Last reviewed: Aug 20, 2017)	criteria provided, multiple submitters, no conflicts	19	11105593	19	10994917	126358	131890
NM_001128849.1(SMARCA4):c.1524T>C (p.His508=)	SMARCA4	not specified|Hereditary cancer-predisposing syndrome|Coffin-Siris syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	11105608	19	10994932	126359	131891
NM_003072.3(SMARCA4):c.2653C>T (p.Arg885Cys)	SMARCA4	Mental retardation, autosomal dominant 16|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, multiple submitters, no conflicts	19	11132437	19	11021761	30344	39300
NM_001128849.1(SMARCA4):c.3168+31C>G	SMARCA4	not specified	Likely benign	no assertion criteria provided	19	11136215	19	11025539	126360	131892
NM_001128849.1(SMARCA4):c.3608G>A (p.Arg1203His)	SMARCA4	Mental retardation, autosomal dominant 16|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	19	11144027	19	11033351	449452	446024
NM_001128849.1(SMARCA4):c.4053C>T (p.Asp1351=)	SMARCA4	not specified|Hereditary cancer-predisposing syndrome|Coffin-Siris syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	11145691	19	11035015	126362	131894
NM_001128849.1(SMARCA4):c.4590C>T (p.Tyr1530=)	SMARCA4	Rhabdoid tumor predisposition syndrome 2|not specified|Hereditary cancer-predisposing syndrome|Coffin-Siris syndrome	Benign/Likely benign(Last reviewed: Jan 25, 2018)	criteria provided, multiple submitters, no conflicts	19	11169000	19	11058324	126363	131895
NM_001128849.1(SMARCA4):c.4680C>T (p.Asp1560=)	SMARCA4	Rhabdoid tumor predisposition syndrome 2|not specified|Hereditary cancer-predisposing syndrome|Coffin-Siris syndrome	Benign(Last reviewed: Aug 18, 2017)	criteria provided, multiple submitters, no conflicts	19	11169514	19	11058838	126364	131896
NM_001128849.1(SMARCA4):c.4983T>C (p.Asp1661=)	SMARCA4	not specified|Hereditary cancer-predisposing syndrome|Coffin-Siris syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	11170839	19	11060163	126365	131897
NC_000019.10:g.11077743_11093597del15855	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11188452 - 11204306	19	11077743 - 11093597	369874	354102
NM_000527.4(LDLR):c.-1823_190+566del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11198402 - 11211587	19	11087726 - 11100911	250924	245299
NM_000527.4(LDLR):c.-286C>G	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	19	11199939	19	11089263	430740	424286
NM_000527.4(LDLR):c.-229_-90del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	19	11199996 - 11200135	19	11089320 - 11089459	430741	424287
NM_000527.4(LDLR):c.-188C>T	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11200037	19	11089361	237861	243265
GRCh38/hg38 19p13.2(chr19:11089362-11107515)x1	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11200038 - 11218191	19	11089362 - 11107515	548097	538593
GRCh38/hg38 19p13.2(chr19:11089362-11089616)x1	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11200038 - 11200292	19	11089362 - 11089616	548095	538591
GRCh38/hg38 19p13.2(chr19:11089362-11100346)x1	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11200038 - 11211022	19	11089362 - 11100346	548094	538590
NG_009060.1(LDLR):g.[27134_32618del5485;4982_15965del10984]	LDLR|MIR6886	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19|19	11200038 - 11211021	19|19	11089362 - 11100345	250921	245306|245962
NM_000527.4(LDLR):c.-185_-183delCTT	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200040 - 11200042	19	11089364 - 11089366	250941	245307
NM_000527.4(LDLR):c.-156C>T	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200069	19	11089393	250942	245308
NM_000527.4(LDLR):c.-155_-154delACinsTTCTGCAAACTCCT	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11200070 - 11200071	19	11089394 - 11089395	250943	245309
NM_000527.4(LDLR):c.-153C>T	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11200072	19	11089396	250944	245310
NM_000527.4(LDLR):c.-152C>T	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, multiple submitters, no conflicts	19	11200073	19	11089397	250945	245311
NM_000527.4(LDLR):c.-149C>A	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11200076	19	11089400	250946	245312
NM_000527.4(LDLR):c.-142C>G	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	19	11200083	19	11089407	430742	424288
NM_000527.4(LDLR):c.-140C>A	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11200085	19	11089409	403628	390608
NM_000527.4(LDLR):c.-140C>G	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11200085	19	11089409	250949	245315
NM_000527.4(LDLR):c.-140C>T	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11200085	19	11089409	226300	228113
NM_000527.4(LDLR):c.-139C>G	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11200086	19	11089410	250951	245317
NM_000527.4(LDLR):c.-138T>C	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11200087	19	11089411	250952	245318
NM_000527.4(LDLR):c.-138delT	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11200087	19	11089411	3745	18784
NM_000527.4(LDLR):c.-136C>T	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11200089	19	11089413	250955	245321
NM_000527.4(LDLR):c.-136C>G	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11200089	19	11089413	250954	245320
NM_000527.4(LDLR):c.-135C>G	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2017)	criteria provided, multiple submitters, no conflicts	19	11200090	19	11089414	250956	245322
NM_000527.4(LDLR):c.-121T>C	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11200104	19	11089428	226302	228114
NM_000527.4(LDLR):c.-120C>T	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 27, 2017)	criteria provided, conflicting interpretations	19	11200105	19	11089429	226299	228115
NM_000527.4(LDLR):c.-101T>C	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11200124	19	11089448	250957	245323
NM_000527.4(LDLR):c.-97G>A	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	19	11200128	19	11089452	430743	424289
NM_000527.4(LDLR):c.-28G>C	LDLR	Familial hypercholesterolemia	Likely benign(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	19	11200197	19	11089521	430744	424290
NM_000527.4(LDLR):c.1A>T (p.Met1Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200225	19	11089549	250968	245334
NM_000527.4(LDLR):c.1A>G (p.Met1Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200225	19	11089549	250967	245333
NM_000527.4(LDLR):c.1A>C (p.Met1Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11200225	19	11089549	250966	245332
NM_000527.4(LDLR):c.3G>T (p.Met1Ile)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11200227	19	11089551	250969	245335
NM_000527.4(LDLR):c.6delG (p.Trp4Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	19	11200230	19	11089554	226303	228116
NM_000527.4(LDLR):c.9del (p.Trp4Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11200233	19	11089557	250972	245338
NM_000527.4(LDLR):c.11G>A (p.Trp4Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11200235	19	11089559	250973	245339
NM_000527.4(LDLR):c.12G>A (p.Trp4Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11200236	19	11089560	237860	243266
NM_000527.4(LDLR):c.14_15insCTTTC (p.W6Ffs*201)	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11200238 - 11200239	19	11089562 - 11089563	369864	354076
NM_000527.4(LDLR):c.28T>C (p.Trp10Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11200252	19	11089576	250976	245341
NM_000527.4(LDLR):c.28T>A (p.Trp10Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11200252	19	11089576	250975	245340
NM_000527.4(LDLR):c.28_38delTGGACCGTCGC (p.Trp10Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200252 - 11200262	19	11089576 - 11089586	250974	245342
NM_000527.4(LDLR):c.33_36dup (p.Ala13Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11200257 - 11200260	19	11089581 - 11089584	250977	245343
NM_000527.4(LDLR):c.41dup (p.Leu14Phefs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11200265	19	11089589	250979	245345
NM_000527.4(LDLR):c.41delT (p.Leu14Cysfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200265	19	11089589	250978	245344
NM_000527.4(LDLR):c.44T>A (p.Leu15His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200268	19	11089592	250980	245346
NM_000527.4(LDLR):c.47T>C (p.Leu16Pro)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11200271	19	11089595	250982	245348
NM_000527.4(LDLR):c.58G>A (p.Gly20Arg)	LDLR	Familial hypercholesterolemia|not specified|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 30, 2017)	criteria provided, conflicting interpretations	19	11200282	19	11089606	161272	171195
NM_000527.4(LDLR):c.64delG (p.Ala22Glnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200288	19	11089612	250986	245352
NM_000527.4(LDLR):c.67+1G>T	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11200292	19	11089616	441175	434817
NM_000527.4(LDLR):c.67+1G>A	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11200292	19	11089616	431507	425024
NM_000527.4(LDLR):c.67+2T>A	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11200293	19	11089617	250987	245353
NM_000527.4(LDLR):c.67+3968_940+296dup	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11204259 - 11218486	19	11093583 - 11107810	250989	245355
NG_009060.1:g.9996_22680del12685	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11205052 - 11217736	19	11094376 - 11107060	250990	245356
NM_000527.4(LDLR):c.68-5_68-2del	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210894 - 11210897	19	11100218 - 11100221	250991	245357
NM_000527.4(LDLR):c.68-2A>T	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11210897	19	11100221	250993	245359
NM_000527.4(LDLR):c.68-2A>G	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11210897	19	11100221	250992	245358
GRCh38/hg38 19p13.2(chr19:11100222-11102787)x1	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11210898 - 11213463	19	11100222 - 11102787	548101	538597
GRCh38/hg38 19p13.2(chr19:11100222-11107515)x1	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11210898 - 11218191	19	11100222 - 11107515	548093	538589
NM_000527.4(LDLR):c.68-1G>A	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	19	11210898	19	11100222	369858	354077
NM_000527.4(LDLR):c.68-1G>C	LDLR	Familial hypercholesterolemia|not provided	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, multiple submitters, no conflicts	19	11210898	19	11100222	251005	245360
NM_000527.4(LDLR):c.76delA (p.Arg26Aspfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210907	19	11100231	251007	245362
NM_000527.4(LDLR):c.76A>T (p.Arg26Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210907	19	11100231	251006	245361
NM_000527.4(LDLR):c.77_78del (p.Arg26Metfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11210908 - 11210909	19	11100232 - 11100233	251008	245363
NM_000527.4(LDLR):c.81C>A (p.Cys27Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11210912	19	11100236	251009	245364
NM_000527.4(LDLR):c.81C>G (p.Cys27Trp)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11210912	19	11100236	226304	228117
NM_000527.4(LDLR):c.82G>A (p.Glu28Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	19	11210913	19	11100237	430745	424291
NM_000527.4(LDLR):c.82G>T (p.Glu28Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210913	19	11100237	226305	228118
NM_000527.4(LDLR):c.85A>T (p.Arg29Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210916	19	11100240	251011	245366
NM_000527.4(LDLR):c.90C>T (p.Asn30=)	LDLR	Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2018)	criteria provided, conflicting interpretations	19	11210921	19	11100245	251012	245367
NM_000527.4(LDLR):c.91_104del (p.Glu31Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11210922 - 11210935	19	11100246 - 11100259	441176	434818
NM_000527.4(LDLR):c.91G>T (p.Glu31Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11210922	19	11100246	251014	245369
NM_000527.4(LDLR):c.91G>A (p.Glu31Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210922	19	11100246	251013	245368
NM_000527.4(LDLR):c.93_99delGTTCCAG (p.Glu31Aspfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210924 - 11210930	19	11100248 - 11100254	251015	245370
NM_000527.4(LDLR):c.95T>G (p.Phe32Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210926	19	11100250	251016	245371
NM_000527.4(LDLR):c.97C>T (p.Gln33Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jun 4, 2017)	criteria provided, multiple submitters, no conflicts	19	11210928	19	11100252	3683	18722
NM_000527.4(LDLR):c.99delG (p.Gln33Hisfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210930	19	11100254	251017	245372
NM_000527.4(LDLR):c.100T>G (p.Cys34Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11210931	19	11100255	251018	245373
NM_000527.4(LDLR):c.101G>C (p.Cys34Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210932	19	11100256	251019	245374
NM_000527.4(LDLR):c.102C>A (p.Cys34Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210933	19	11100257	251020	245375
NM_000527.4(LDLR):c.103C>T (p.Gln35Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210934	19	11100258	251021	245376
NM_000527.4(LDLR):c.105_110del (p.Asp36_Gly37del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11210936 - 11210941	19	11100260 - 11100265	438316	431952
NM_000527.4(LDLR):c.108del (p.Asp36Glufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11210939	19	11100263	251023	245378
NM_000527.4(LDLR):c.108C>A (p.Asp36Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210939	19	11100263	251022	245377
NM_000527.4(LDLR):c.114dup (p.Cys39Metfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11210945	19	11100269	251024	245379
NM_000527.4(LDLR):c.116G>T (p.Cys39Phe)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	19	11210947	19	11100271	430746	424292
NM_000527.4(LDLR):c.116_117delGCinsAA (p.Cys39Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11210947 - 11210948	19	11100271 - 11100272	251025	245380
NM_000527.4(LDLR):c.117del (p.Cys39Terfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11210948	19	11100272	251026	245381
NM_000527.4(LDLR):c.118delA (p.Ile40Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210949	19	11100273	251027	245382
NM_000527.4(LDLR):c.126C>A (p.Tyr42Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11210957	19	11100281	251028	245383
NM_000527.4(LDLR):c.131_132dup (p.Val45Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210962 - 11210963	19	11100286 - 11100287	251029	245384
NM_000527.4(LDLR):c.131G>A (p.Trp44Ter)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, multiple submitters, no conflicts	19	11210962	19	11100286	3741	18780
NM_000527.4(LDLR):c.136T>G (p.Cys46Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11210967	19	11100291	251030	245385
NM_000527.4(LDLR):c.137G>A (p.Cys46Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210968	19	11100292	251031	245386
NM_000527.4(LDLR):c.137G>C (p.Cys46Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11210968	19	11100292	3742	18781
NM_000527.4(LDLR):c.138C>A (p.Cys46Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210969	19	11100293	251032	245387
NM_000527.4(LDLR):c.139G>A (p.Asp47Asn)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11210970	19	11100294	251034	245388
NM_000527.4(LDLR):c.139_144del (p.Asp47_Gly48del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11210970 - 11210975	19	11100294 - 11100299	251033	245389
NM_000527.4(LDLR):c.140_153del (p.Asp47Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11210971 - 11210984	19	11100295 - 11100308	441179	434821
NM_000527.4(LDLR):c.148del (p.Ala50Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210979	19	11100303	251036	245392
NM_000527.4(LDLR):c.148G>T (p.Ala50Ser)	LDLR	Familial hypercholesterolemia|not specified|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 30, 2017)	criteria provided, conflicting interpretations	19	11210979	19	11100303	68099	78990
NM_000527.4(LDLR):c.155G>A (p.Cys52Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11210986	19	11100310	251038	245393
NM_000527.4(LDLR):c.157C>T (p.Gln53Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11210988	19	11100312	251039	245394
NM_000527.4(LDLR):c.165C>G (p.Gly55=)	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11210996	19	11100320	369857	354078
NM_000527.4(LDLR):c.166T>C (p.Ser56Pro)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	19	11210997	19	11100321	237864	243267
NM_000527.4(LDLR):c.169G>A (p.Asp57Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211000	19	11100324	251040	245395
NM_000527.4(LDLR):c.171_173delTGA (p.Asp57del)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: May 10, 2018)	criteria provided, conflicting interpretations	19	11211002 - 11211004	19	11100326 - 11100328	251041	245396
NM_000527.4(LDLR):c.172G>A (p.Glu58Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211003	19	11100327	251043	245397
NM_000527.4(LDLR):c.172delG (p.Glu58Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211003	19	11100327	251042	245398
NM_000527.4(LDLR):c.173A>G (p.Glu58Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211004	19	11100328	251044	245399
NM_000527.4(LDLR):c.185_186insT (p.Cys63Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211016 - 11211017	19	11100340 - 11100341	251045	245400
NM_000527.4(LDLR):c.185C>T (p.Thr62Met)	LDLR	Familial hypercholesterolemia|not specified|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 25, 2018)	criteria provided, conflicting interpretations	19	11211016	19	11100340	161273	171196
NM_000527.4(LDLR):c.187T>C (p.Cys63Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11211018	19	11100342	251046	245401
NM_000527.4(LDLR):c.188G>A (p.Cys63Tyr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11211019	19	11100343	251047	245402
NM_000527.4(LDLR):c.190+1G>T	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211022	19	11100346	251049	245404
NM_000527.4(LDLR):c.190+1G>A	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211022	19	11100346	251048	245403
NM_000527.4(LDLR):c.190+2T>G	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211023	19	11100347	251051	245405
NM_000527.4(LDLR):c.190+2_190+3dup	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11211023 - 11211024	19	11100347 - 11100348	251050	245406
NM_000527.4(LDLR):c.190+4A>T	LDLR	Familial hypercholesterolemia|not provided|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2017)	criteria provided, conflicting interpretations	19	11211025	19	11100349	225097	226972
NM_000527.4(LDLR):c.190+984_1846-1160del	LDLR|MIR6886	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11212005 - 11229608	19	11101329 - 11118932	251054	245409
NG_009060.1:g.17772_23765del5994	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11212828 - 11218821	19	11102152 - 11108145	251055	245410
NM_000527.4(LDLR):c.191-2delinsCT	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11213338	19	11102662	251057	245412
NM_000527.4(LDLR):c.191-2A>G	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11213338	19	11102662	226306	228119
GRCh38/hg38 19p13.2(chr19:11102663-11107515)x1	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11213339 - 11218191	19	11102663 - 11107515	548100	538596
NM_000527.4(LDLR):c.191-1G>A	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11213339	19	11102663	251071	245413
NG_009060.1(LDLR):g.[18284_22307del4024;27134_45290dup18157]	LDLR|MIR6886	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19|19	11213340 - 11217363	19|19	11102664 - 11106687	250922	245414|245963
NM_000527.4(LDLR):c.193_201delTCTGTCACCinsGACTTCA (p.Ser65Aspfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213342 - 11213350	19	11102666 - 11102674	251072	245415
NM_000527.4(LDLR):c.195dup (p.Val66Cysfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213344	19	11102668	251075	245418
NM_000527.4(LDLR):c.195_196insAT (p.Val66Metfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	19	11213344 - 11213345	19	11102668 - 11102669	251074	245417
NM_000527.4(LDLR):c.195_196insA (p.Val66Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213344 - 11213345	19	11102668 - 11102669	251073	245416
NM_000527.4(LDLR):c.196_197del (p.Val66Hisfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213345 - 11213346	19	11102669 - 11102670	226307	228120
NM_000527.4(LDLR):c.199dup (p.Thr67Asnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213348	19	11102672	251076	245419
NM_000527.4(LDLR):c.204C>A (p.Cys68Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213353	19	11102677	251077	245420
NM_000527.4(LDLR):c.214delG (p.Asp72Thrfs)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, multiple submitters, no conflicts	19	11213363	19	11102687	251078	245421
NM_000527.4(LDLR):c.223T>A (p.Cys75Ser)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	19	11213372	19	11102696	251079	245422
NM_000527.4(LDLR):c.224G>A (p.Cys75Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213373	19	11102697	226308	228121
NM_000527.4(LDLR):c.225T>G (p.Cys75Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213374	19	11102698	251080	245423
NM_000527.4(LDLR):c.230dup (p.Arg78Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213379	19	11102703	251083	245426
NM_000527.4(LDLR):c.230delG (p.Gly77Alafs)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic/Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, multiple submitters, no conflicts	19	11213379	19	11102703	251082	245425
NM_000527.4(LDLR):c.232del (p.Arg78Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11213381	19	11102705	251084	245427
NM_000527.4(LDLR):c.232C>T (p.Arg78Cys)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213381	19	11102705	161289	171197
NM_000527.4(LDLR):c.233delG (p.R78Lfs*127)	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11213382	19	11102706	369866	354079
NM_000527.4(LDLR):c.233G>A (p.Arg78His)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11213382	19	11102706	251085	245428
NM_000527.4(LDLR):c.236dup (p.Asn80Glnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11213385	19	11102709	251086	245429
NM_000527.4(LDLR):c.240C>A (p.Asn80Lys)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11213389	19	11102713	251087	245430
NM_000527.4(LDLR):c.241C>A (p.Arg81Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213390	19	11102714	251088	245431
NM_000527.4(LDLR):c.241C>T (p.Arg81Cys)	LDLR	Familial hypercholesterolemia|not provided|Early-onset coronary artery disease	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11213390	19	11102714	183083	181222
NM_000527.4(LDLR):c.242dup (p.Cys82Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213391	19	11102715	251089	245432
NM_000527.4(LDLR):c.244T>G (p.Cys82Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11213393	19	11102717	251091	245433
NM_000527.4(LDLR):c.244delT (p.Cys82Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11213393	19	11102717	251090	245434
NM_000527.4(LDLR):c.245G>T (p.Cys82Phe)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: May 12, 2018)	criteria provided, multiple submitters, no conflicts	19	11213394	19	11102718	251093	245436
NM_000527.4(LDLR):c.245G>A (p.Cys82Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11213394	19	11102718	251092	245435
NM_000527.4(LDLR):c.246C>A (p.Cys82Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11213395	19	11102719	226309	228122
NM_000527.4(LDLR):c.251C>G (p.Pro84Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213400	19	11102724	251095	245438
NM_000527.4(LDLR):c.251C>T (p.Pro84Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213400	19	11102724	226310	228123
NM_000527.4(LDLR):c.253C>T (p.Gln85Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11213402	19	11102726	226311	228124
NM_000527.4(LDLR):c.257_265delTCTGGAGGT (p.Phe86_Arg88del)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 18, 2018)	criteria provided, conflicting interpretations	19	11213406 - 11213414	19	11102730 - 11102738	251097	245440
NM_000527.4(LDLR):c.259T>G (p.Trp87Gly)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	19	11213408	19	11102732	3685	18724
NM_000527.4(LDLR):c.260G>A (p.Trp87Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213409	19	11102733	251098	245441
NM_000527.4(LDLR):c.261G>A (p.Trp87Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11213410	19	11102734	251100	245442
NM_000527.4(LDLR):c.261_262delGAinsAG (p.Trp87Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11213410 - 11213411	19	11102734 - 11102735	251099	245443
NM_000527.4(LDLR):c.265T>G (p.Cys89Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11213414	19	11102738	251103	245446
NM_000527.4(LDLR):c.265T>C (p.Cys89Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11213414	19	11102738	251102	245445
NM_000527.4(LDLR):c.266G>A (p.Cys89Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: May 26, 2017)	criteria provided, multiple submitters, no conflicts	19	11213415	19	11102739	226312	228125
NM_000527.4(LDLR):c.267C>G (p.Cys89Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11213416	19	11102740	251104	245447
NM_000527.4(LDLR):c.268G>T (p.Asp90Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11213417	19	11102741	251106	245449
NM_000527.4(LDLR):c.268G>A (p.Asp90Asn)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 15, 2018)	criteria provided, conflicting interpretations	19	11213417	19	11102741	251105	245448
NM_000527.4(LDLR):c.269A>G (p.Asp90Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11213418	19	11102742	226313	228126
NM_000527.4(LDLR):c.270T>A (p.Asp90Glu)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11213419	19	11102743	251107	245450
NM_000527.4(LDLR):c.280G>T (p.Asp94Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213429	19	11102753	251109	245452
NM_000527.4(LDLR):c.283T>G (p.Cys95Gly)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Aug 4, 2017)	criteria provided, conflicting interpretations	19	11213432	19	11102756	251112	245455
NM_000527.4(LDLR):c.283T>C (p.Cys95Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213432	19	11102756	251111	245454
NM_000527.4(LDLR):c.283T>A (p.Cys95Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213432	19	11102756	251110	245453
NM_000527.4(LDLR):c.284G>T (p.Cys95Phe)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, multiple submitters, no conflicts	19	11213433	19	11102757	251114	245457
NM_000527.4(LDLR):c.284G>A (p.Cys95Tyr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11213433	19	11102757	251113	245456
NM_000527.4(LDLR):c.285C>A (p.Cys95Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213434	19	11102758	251115	245458
NM_000527.4(LDLR):c.291C>G (p.Asn97Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11213440	19	11102764	251116	245459
NM_000527.4(LDLR):c.292G>C (p.Gly98Arg)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11213441	19	11102765	251119	245462
NM_000527.4(LDLR):c.292G>A (p.Gly98Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213441	19	11102765	251118	245461
NM_000527.4(LDLR):c.296_297delCA (p.Ser99Terfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213445 - 11213446	19	11102769 - 11102770	251120	245463
NM_000527.4(LDLR):c.296C>G (p.Ser99Ter)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Pathogenic(Last reviewed: May 6, 2017)	criteria provided, multiple submitters, no conflicts	19	11213445	19	11102769	161269	171198
NM_000527.4(LDLR):c.298G>A (p.Asp100Asn)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11213447	19	11102771	251121	245464
NM_000527.4(LDLR):c.299A>T (p.Asp100Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11213448	19	11102772	369854	354080
NM_000527.4(LDLR):c.299A>G (p.Asp100Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213448	19	11102772	251122	245465
NM_000527.4(LDLR):c.300C>A (p.Asp100Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11213449	19	11102773	403629	390609
NM_000527.4(LDLR):c.301G>T (p.Glu101Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11213450	19	11102774	251125	245467
NM_000527.4(LDLR):c.301delG (p.Glu101Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213450	19	11102774	251124	245468
NM_000527.4(LDLR):c.301G>A (p.Glu101Lys)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, multiple submitters, no conflicts	19	11213450	19	11102774	161266	171199
NM_000527.4(LDLR):c.303del (p.Glu101Aspfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213452	19	11102776	251126	245469
NM_000527.4(LDLR):c.304C>T (p.Gln102Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11213453	19	11102777	226314	228127
NM_000527.4(LDLR):c.310T>C (p.Cys104Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213459	19	11102783	251129	245471
NM_000527.4(LDLR):c.310_313del (p.Cys104Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11213459 - 11213462	19	11102783 - 11102786	251128	245472
NM_000527.4(LDLR):c.311G>T (p.Cys104Phe)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11213460	19	11102784	251130	245473
NM_000527.4(LDLR):c.311G>A (p.Cys104Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11213460	19	11102784	226315	228128
NM_000527.4(LDLR):c.312T>G (p.Cys104Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213461	19	11102785	251131	245474
NM_000527.4(LDLR):c.313_313+1delCG	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11213462 - 11213463	19	11102786 - 11102787	226316	228129
NM_000527.4(LDLR):c.313+1G>T	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11213463	19	11102787	251134	245476
NM_001195799.1(LDLR):c.191-2433_191-2432insG	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11213463	19	11102787	251133	245477
NM_000527.4(LDLR):c.313+1G>C	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11213463	19	11102787	228358	230978
NM_000527.4(LDLR):c.313+1G>A	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 21, 2018)	criteria provided, conflicting interpretations	19	11213463	19	11102787	3736	18775
NM_000527.4(LDLR):c.313+2T>A	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11213464	19	11102788	251135	245478
NM_000527.4(LDLR):c.313+2dupT	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11213464	19	11102788	226317	228130
NM_000527.4(LDLR):c.313+2T>C	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 22, 2018)	criteria provided, conflicting interpretations	19	11213464	19	11102788	189296	187193
NM_000527.4(LDLR):c.313+5G>T	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213467	19	11102791	251137	245480
NM_000527.4(LDLR):c.313+5G>A	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11213467	19	11102791	251136	245479
NM_000527.4(LDLR):c.313+6T>C	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11213468	19	11102792	251138	245481
NM_000527.4(LDLR):c.314-446_1187-386dup	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11215450 - 11223568	19	11104774 - 11112892	251140	245483
NM_000527.4(LDLR):c.314-2A>C	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	19	11215894	19	11105218	251142	245485
NM_000527.4(LDLR):c.314-1G>A	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	19	11215895	19	11105219	251148	245486
NM_000527.4(LDLR):c.316_336del (p.Pro106_Asp112del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11215898 - 11215918	19	11105222 - 11105242	251149	245487
NM_000527.4(LDLR):c.318dupC (p.Lys107Glnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11215900	19	11105224	251150	245488
NM_000527.4(LDLR):c.320dup (p.Thr108Aspfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215902	19	11105226	251152	245490
NM_000527.4(LDLR):c.320_332del (p.Lys107Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11215902 - 11215914	19	11105226 - 11105238	251151	245489
NM_000527.4(LDLR):c.324_325delGTinsTC (p.Cys109Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11215906 - 11215907	19	11105230 - 11105231	251154	245492
NM_000527.4(LDLR):c.325T>C (p.Cys109Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11215907	19	11105231	251156	245493
NM_000527.4(LDLR):c.325_337delTGCTCCCAGGACG (p.Cys109Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215907 - 11215919	19	11105231 - 11105243	251155	245494
NM_000527.4(LDLR):c.326G>T (p.Cys109Phe)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11215908	19	11105232	251157	245495
NM_000527.4(LDLR):c.326G>A (p.Cys109Tyr)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	19	11215908	19	11105232	226319	228132
NM_000527.4(LDLR):c.326G>C (p.Cys109Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215908	19	11105232	3743	18782
NM_000527.4(LDLR):c.327dup (p.Ser110Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215909	19	11105233	251158	245496
NM_000527.4(LDLR):c.330C>G (p.Ser110=)	LDLR	Familial hypercholesterolemia|not specified	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11215912	19	11105236	511550	506479
NM_000527.4(LDLR):c.335_344delACGAGTTTCG (p.Asp112Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215917 - 11215926	19	11105241 - 11105250	251159	245497
NM_000527.4(LDLR):c.337G>A (p.Glu113Lys)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Feb 8, 2018)	criteria provided, conflicting interpretations	19	11215919	19	11105243	237872	243268
NM_000527.4(LDLR):c.337G>T (p.Glu113Ter)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, multiple submitters, no conflicts	19	11215919	19	11105243	226320	228133
NM_000527.4(LDLR):c.338_353del (p.Glu113Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11215920 - 11215935	19	11105244 - 11105259	251160	245498
NM_000527.4(LDLR):c.339dup (p.Phe114Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11215921	19	11105245	251161	245499
NM_000527.4(LDLR):c.340_344delTTTCG (p.F114Lfs*13)	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11215922 - 11215926	19	11105246 - 11105250	369870	354081
NM_000527.4(LDLR):c.343C>T (p.Arg115Cys)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11215925	19	11105249	251162	245500
NM_000527.4(LDLR):c.344G>A (p.Arg115His)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11215926	19	11105250	225402	227401
NM_000527.4(LDLR):c.346T>C (p.Cys116Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, multiple submitters, no conflicts	19	11215928	19	11105252	251163	245501
NM_000527.4(LDLR):c.347G>T (p.Cys116Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215929	19	11105253	251166	245502
NM_000527.4(LDLR):c.347_367del21 (p.Cys116_Ile122del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11215929 - 11215949	19	11105253 - 11105273	251165	245504
NM_000527.4(LDLR):c.347_349del (p.Cys116_His117delinsTyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215929 - 11215931	19	11105253 - 11105255	251164	245503
NM_000527.4(LDLR):c.350_372dup (p.Gln125Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11215932 - 11215954	19	11105256 - 11105278	251168	245506
NM_000527.4(LDLR):c.352G>T (p.Asp118Tyr)	LDLR	Familial hypercholesterolemia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11215934	19	11105258	183085	181224
NM_000527.4(LDLR):c.353delA (p.Asp118Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215935	19	11105259	251169	245507
NM_000527.4(LDLR):c.354_356delTGG (p.Asp118_Gly119delinsGlu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215936 - 11215938	19	11105260 - 11105262	251170	245508
NM_000527.4(LDLR):c.356_362delGGAAGTG (p.Gly119Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215938 - 11215944	19	11105262 - 11105268	251171	245509
NM_000527.4(LDLR):c.357delG (p.Lys120Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215939	19	11105263	251172	245510
NM_000527.4(LDLR):c.361T>G (p.Cys121Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215943	19	11105267	251175	245513
NM_000527.4(LDLR):c.361T>C (p.Cys121Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11215943	19	11105267	251174	245512
NM_000527.4(LDLR):c.361T>A (p.Cys121Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215943	19	11105267	251173	245511
NM_000527.4(LDLR):c.362_376del (p.Cys121_Gln125del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11215944 - 11215958	19	11105268 - 11105282	441184	434822
NM_000527.4(LDLR):c.362G>T (p.Cys121Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215944	19	11105268	251177	245515
NM_000527.4(LDLR):c.362G>C (p.Cys121Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215944	19	11105268	251176	245514
NM_000527.4(LDLR):c.362G>A (p.Cys121Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11215944	19	11105268	36463	45126
NM_000527.4(LDLR):c.364A>T (p.Ile122Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215946	19	11105270	251178	245516
NM_000527.4(LDLR):c.366dup (p.Ser123Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215948	19	11105272	251179	245517
NM_000527.4(LDLR):c.369_393del (p.Arg124Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11215951 - 11215975	19	11105275 - 11105299	251183	245521
NM_000527.4(LDLR):c.369_370delTC (p.Arg124Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11215951 - 11215952	19	11105275 - 11105276	251182	245520
NM_000527.4(LDLR):c.370_371insC (p.Arg124Profs)	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11215952	19	11105276	369871	354082
NM_000527.4(LDLR):c.370C>T (p.Arg124Trp)	LDLR	Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 31, 2016)	criteria provided, conflicting interpretations	19	11215952	19	11105276	251185	245523
NM_000527.4(LDLR):c.371_372insC (p.Gln125Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215953 - 11215954	19	11105277 - 11105278	251186	245524
NM_000527.4(LDLR):c.373C>T (p.Gln125Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, multiple submitters, no conflicts	19	11215955	19	11105279	251187	245525
NM_000527.4(LDLR):c.374_375insCTGA (p.Gln125Hisfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11215956 - 11215957	19	11105280 - 11105281	251188	245526
NM_000527.4(LDLR):c.376T>C (p.Phe126Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215958	19	11105282	251189	245527
NM_000527.4(LDLR):c.377T>A (p.Phe126Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215959	19	11105283	251190	245528
NM_000527.4(LDLR):c.380T>A (p.Val127Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215962	19	11105286	251191	245529
NM_000527.4(LDLR):c.382T>C (p.Cys128Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11215964	19	11105288	251193	245530
NM_000527.4(LDLR):c.382_385del (p.Cys128Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11215964 - 11215967	19	11105288 - 11105291	251192	245531
NM_000527.4(LDLR):c.383G>C (p.Cys128Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11215965	19	11105289	403630	390610
NM_000527.4(LDLR):c.383G>T (p.Cys128Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215965	19	11105289	251194	245532
NM_000527.4(LDLR):c.386A>G (p.Asp129Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215968	19	11105292	251195	245533
NM_000527.4(LDLR):c.388T>C (p.Ser130Pro)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11215970	19	11105294	251197	245535
NM_000527.4(LDLR):c.389dup (p.Asp131Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215971	19	11105295	251199	245537
NM_000527.4(LDLR):c.389C>G (p.Ser130Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215971	19	11105295	251198	245536
NM_000527.4(LDLR):c.391G>C (p.Asp131His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215973	19	11105297	251200	245538
NM_000527.4(LDLR):c.397G>A (p.Asp133Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215979	19	11105303	251202	245539
NM_000527.4(LDLR):c.397dup (p.Asp133Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215979	19	11105303	251201	245540
NM_000527.4(LDLR):c.400T>C (p.Cys134Arg)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, multiple submitters, no conflicts	19	11215982	19	11105306	226322	228135
NM_000527.4(LDLR):c.401G>T (p.Cys134Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11215983	19	11105307	251204	245542
NM_000527.4(LDLR):c.401G>A (p.Cys134Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215983	19	11105307	251203	245541
NM_000527.4(LDLR):c.402C>G (p.Cys134Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215984	19	11105308	251205	245543
NM_000527.4(LDLR):c.407A>T (p.Asp136Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11215989	19	11105313	251206	245544
NM_000527.4(LDLR):c.409G>T (p.Gly137Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11215991	19	11105315	251207	245545
NM_000527.4(LDLR):c.409G>A (p.Gly137Ser)	LDLR	Familial hypercholesterolemia|not provided	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11215991	19	11105315	183087	181226
NM_000527.4(LDLR):c.413C>G (p.Ser138Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, multiple submitters, no conflicts	19	11215995	19	11105319	251208	245546
NM_000527.4(LDLR):c.415G>C (p.Asp139His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215997	19	11105321	251210	245548
NM_000527.4(LDLR):c.415G>A (p.Asp139Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11215997	19	11105321	251209	245547
NM_000527.4(LDLR):c.416A>T (p.Asp139Val)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11215998	19	11105322	251212	245550
NM_000527.4(LDLR):c.416A>G (p.Asp139Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11215998	19	11105322	251211	245549
NM_000527.4(LDLR):c.417C>G (p.Asp139Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215999	19	11105323	226323	228136
NM_000527.4(LDLR):c.418G>T (p.Glu140Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216000	19	11105324	251214	245552
NM_000527.4(LDLR):c.418G>A (p.Glu140Lys)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216000	19	11105324	251213	245551
NM_000527.4(LDLR):c.419A>G (p.Glu140Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216001	19	11105325	251215	245553
NM_000527.4(LDLR):c.420G>T (p.Glu140Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216002	19	11105326	251217	245555
NM_000527.4(LDLR):c.420G>C (p.Glu140Asp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	19	11216002	19	11105326	251216	245554
NM_000527.4(LDLR):c.424_430del (p.Ser142Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216006 - 11216012	19	11105330 - 11105336	251218	245556
NM_000527.4(LDLR):c.427T>C (p.Cys143Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11216009	19	11105333	251219	245557
NM_000527.4(LDLR):c.427T>G (p.Cys143Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216009	19	11105333	226324	228137
NM_000527.4(LDLR):c.428G>T (p.Cys143Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11216010	19	11105334	523723	514377
NM_000527.4(LDLR):c.428G>C (p.Cys143Ser)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216010	19	11105334	369851	354083
NM_000527.4(LDLR):c.428G>A (p.Cys143Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216010	19	11105334	251220	245558
NM_000527.4(LDLR):c.429C>A (p.Cys143Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, multiple submitters, no conflicts	19	11216011	19	11105335	226325	228138
NM_000527.4(LDLR):c.431_434dup (p.Leu146Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216013 - 11216016	19	11105337 - 11105340	251221	245559
NM_000527.4(LDLR):c.440_450dup (p.Ala151Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11216022 - 11216032	19	11105346 - 11105356	441185	434823
NM_000527.4(LDLR):c.440C>T (p.Thr147Ile)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216022	19	11105346	251223	245561
NM_000527.4(LDLR):c.442T>C (p.Cys148Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216024	19	11105348	251224	245562
NM_000527.4(LDLR):c.443G>C (p.Cys148Ser)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216025	19	11105349	251227	245564
NM_000527.4(LDLR):c.443G>A (p.Cys148Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216025	19	11105349	251225	245563
NM_000527.4(LDLR):c.444T>G (p.Cys148Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216026	19	11105350	251228	245565
NM_000527.4(LDLR):c.445G>T (p.Gly149Cys)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11216027	19	11105351	251229	245566
NM_000527.4(LDLR):c.450dup (p.Ala151Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216032	19	11105356	251231	245568
NM_000527.4(LDLR):c.451_453del (p.Ala151del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216033 - 11216035	19	11105357 - 11105359	251232	245571
NM_000527.4(LDLR):c.457T>G (p.Phe153Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11216039	19	11105363	251235	245572
NM_000527.4(LDLR):c.458T>G (p.Phe153Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216040	19	11105364	251236	245573
NM_000527.4(LDLR):c.460C>T (p.Gln154Ter)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216042	19	11105366	251237	245574
NM_000527.4(LDLR):c.463T>G (p.Cys155Gly)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11216045	19	11105369	251239	245576
NM_000527.4(LDLR):c.463T>C (p.Cys155Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216045	19	11105369	251238	245575
NM_000527.4(LDLR):c.464G>T (p.Cys155Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216046	19	11105370	251241	245578
NM_000527.4(LDLR):c.464G>A (p.Cys155Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216046	19	11105370	251240	245577
NM_000527.4(LDLR):c.465C>A (p.Cys155Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216047	19	11105371	251242	245579
NM_000527.4(LDLR):c.466_484dup (p.Pro162Glnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216048 - 11216066	19	11105372 - 11105390	251243	245580
NM_000527.4(LDLR):c.467delA (p.N156Tfs*49)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2017)	criteria provided, multiple submitters, no conflicts	19	11216049	19	11105373	369873	354084
NM_000527.4(LDLR):c.470G>A (p.Ser157Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11216052	19	11105376	441186	434824
NM_000527.4(LDLR):c.472delT (p.Ser158Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11216054	19	11105378	251244	245581
NM_000527.4(LDLR):c.473C>G (p.Ser158Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216055	19	11105379	251245	245582
NM_000527.4(LDLR):c.478T>G (p.Cys160Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216060	19	11105384	251248	245585
NM_000527.4(LDLR):c.478T>C (p.Cys160Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216060	19	11105384	251247	245584
NM_000527.4(LDLR):c.479G>T (p.Cys160Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11216061	19	11105385	441187	434825
NM_000527.4(LDLR):c.479_480delGCinsTT (p.Cys160Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11216061 - 11216062	19	11105385 - 11105386	431510	425026
NM_000527.4(LDLR):c.479G>A (p.Cys160Tyr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	19	11216061	19	11105385	251249	245586
NM_000527.4(LDLR):c.482_488del (p.Ile161Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216064 - 11216070	19	11105388 - 11105394	251250	245587
NM_000527.4(LDLR):c.485C>T (p.Pro162Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216067	19	11105391	251251	245588
NM_000527.4(LDLR):c.487C>T (p.Gln163Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11216069	19	11105393	431511	425027
NM_000527.4(LDLR):c.491T>C (p.Leu164Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216073	19	11105397	251252	245589
NM_000527.4(LDLR):c.493T>G (p.Trp165Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216075	19	11105399	251253	245590
NM_000527.4(LDLR):c.495G>A (p.Trp165Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216077	19	11105401	251254	245591
NM_000527.4(LDLR):c.499T>C (p.Cys167Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216081	19	11105405	251255	245592
NM_000527.4(LDLR):c.500G>A (p.Cys167Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216082	19	11105406	251256	245593
NM_000527.4(LDLR):c.501C>G (p.Cys167Trp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216083	19	11105407	251257	245594
NM_000527.4(LDLR):c.501C>A (p.Cys167Ter)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	19	11216083	19	11105407	200918	198011
NM_000527.4(LDLR):c.502G>T (p.Asp168Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216084	19	11105408	251259	245596
NM_000527.4(LDLR):c.502G>C (p.Asp168His)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216084	19	11105408	251258	245595
NM_000527.4(LDLR):c.502G>A (p.Asp168Asn)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	19	11216084	19	11105408	183136	181228
NM_000527.4(LDLR):c.503A>C (p.Asp168Ala)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216085	19	11105409	375785	362677
NM_000527.4(LDLR):c.503A>G (p.Asp168Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216085	19	11105409	251260	245597
NM_000527.4(LDLR):c.504C>A (p.Asp168Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216086	19	11105410	251261	245598
NM_000527.4(LDLR):c.506A>T (p.Asn169Ile)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216088	19	11105412	251262	245599
NM_000527.4(LDLR):c.508_509insC (p.Asp170Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216090 - 11216091	19	11105414 - 11105415	251263	245600
NM_000527.4(LDLR):c.510C>A (p.Asp170Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	19	11216092	19	11105416	403662	390611
NM_000527.4(LDLR):c.513dup (p.Asp172Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216095	19	11105419	251265	245602
NM_000527.4(LDLR):c.513delC (p.Asp172Thrfs)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, multiple submitters, no conflicts	19	11216095	19	11105419	251264	245601
NM_000527.4(LDLR):c.514G>T (p.Asp172Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216096	19	11105420	251268	245605
NM_000527.4(LDLR):c.514G>C (p.Asp172His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216096	19	11105420	251267	245604
NM_000527.4(LDLR):c.514G>A (p.Asp172Asn)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216096	19	11105420	251266	245603
NM_000527.4(LDLR):c.515A>G (p.Asp172Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11216097	19	11105421	251269	245606
NM_000527.4(LDLR):c.516C>G (p.Asp172Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216098	19	11105422	251271	245607
NM_000527.4(LDLR):c.516_524dup (p.Asp175_Gly176insCysGluAsp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216098 - 11216106	19	11105422 - 11105430	251270	245608
NM_000527.4(LDLR):c.517T>G (p.Cys173Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216099	19	11105423	251273	245610
NM_000527.4(LDLR):c.517T>C (p.Cys173Arg)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic/Likely pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, multiple submitters, no conflicts	19	11216099	19	11105423	251272	245609
NM_000527.4(LDLR):c.518G>A (p.Cys173Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216100	19	11105424	251275	245611
NM_000527.4(LDLR):c.518del (p.Cys173Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216100	19	11105424	251274	245612
NM_000527.4(LDLR):c.519C>G (p.Cys173Trp)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	19	11216101	19	11105425	251277	245614
NM_000527.4(LDLR):c.519C>A (p.Cys173Ter)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216101	19	11105425	251276	245613
NM_000527.4(LDLR):c.520G>T (p.E174*)	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11216102	19	11105426	369850	354085
NM_000527.4(LDLR):c.523G>T (p.Asp175Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216105	19	11105429	251278	245615
NM_000527.4(LDLR):c.523G>A (p.Asp175Asn)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11216105	19	11105429	3726	18765
NM_000527.4(LDLR):c.525_536delTGGCTCGGATGA (p.Asp175_Asp178del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216107 - 11216118	19	11105431 - 11105442	251279	245616
NM_000527.4(LDLR):c.526_533dup (p.Asp178Glufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216108 - 11216115	19	11105432 - 11105439	251280	245617
NM_000527.4(LDLR):c.527G>T (p.Gly176Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11216109	19	11105433	251281	245618
NM_000527.4(LDLR):c.529T>C (p.Ser177Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11216111	19	11105435	403631	390612
NM_000527.4(LDLR):c.530C>T (p.Ser177Leu)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, multiple submitters, no conflicts	19	11216112	19	11105436	3686	18725
NM_000527.4(LDLR):c.532G>T (p.Asp178Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216114	19	11105438	251285	245621
NM_000527.4(LDLR):c.532G>C (p.Asp178His)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216114	19	11105438	251284	245620
NM_000527.4(LDLR):c.532G>A (p.Asp178Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216114	19	11105438	251283	245619
NM_000527.4(LDLR):c.532_533insT (p.Asp178Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216114 - 11216115	19	11105438 - 11105439	251282	245622
NM_000527.4(LDLR):c.533A>G (p.Asp178Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216115	19	11105439	251286	245623
NM_000527.4(LDLR):c.533A>T (p.Asp178Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216115	19	11105439	226326	228139
NM_000527.4(LDLR):c.534T>G (p.Asp178Glu)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, multiple submitters, no conflicts	19	11216116	19	11105440	251287	245624
NM_000527.4(LDLR):c.535G>T (p.Glu179Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216117	19	11105441	251289	245626
NM_000527.4(LDLR):c.535G>A (p.Glu179Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216117	19	11105441	251288	245625
NM_000527.4(LDLR):c.536A>G (p.Glu179Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216118	19	11105442	251290	245627
NM_000527.4(LDLR):c.539G>A (p.Trp180Ter)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216121	19	11105445	251291	245628
NM_000527.4(LDLR):c.542C>T (p.Pro181Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11216124	19	11105448	431512	425028
NM_000527.4(LDLR):c.542C>G (p.Pro181Arg)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 25, 2018)	criteria provided, conflicting interpretations	19	11216124	19	11105448	183089	181229
NM_000527.4(LDLR):c.544C>T (p.Gln182Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216126	19	11105450	251292	245629
NM_000527.4(LDLR):c.550T>C (p.Cys184Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216132	19	11105456	251294	245630
NM_000527.4(LDLR):c.551G>A (p.Cys184Tyr)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic/Likely pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, multiple submitters, no conflicts	19	11216133	19	11105457	3739	18778
NM_000527.4(LDLR):c.552T>G (p.Cys184Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216134	19	11105458	251293	245631
NM_000527.4(LDLR):c.554delG (p.Gly186Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216139	19	11105463	251295	245632
NM_000527.4(LDLR):c.558_559insG (p.Leu187Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216140 - 11216141	19	11105464 - 11105465	251296	245633
NM_000527.4(LDLR):c.561_562delTT (p.Tyr188Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216143 - 11216144	19	11105467 - 11105468	251297	245634
NM_000527.4(LDLR):c.562delT (p.Tyr188Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216144	19	11105468	251298	245635
NM_000527.4(LDLR):c.564C>A (p.Tyr188Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216146	19	11105470	251299	245636
NM_000527.4(LDLR):c.564C>G (p.Tyr188Ter)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	19	11216146	19	11105470	3727	18766
NM_000527.4(LDLR):c.568_590del23 (p.Phe190Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216150 - 11216172	19	11105474 - 11105496	251301	245638
NM_000527.4(LDLR):c.571C>T (p.Gln191Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11216153	19	11105477	251302	245639
NM_000527.4(LDLR):c.578delA (p.Asp193Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11216160	19	11105484	251304	245641
NM_000527.4(LDLR):c.578_584delACAGTAG (p.Asp193Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216160 - 11216166	19	11105484 - 11105490	251303	245640
NM_000527.4(LDLR):c.581_582insA (p.Ser194Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216163 - 11216164	19	11105487 - 11105488	251305	245642
NM_000527.4(LDLR):c.583_589delAGCCCCT (p.Ser195Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216165 - 11216171	19	11105489 - 11105495	251306	245643
NM_000527.4(LDLR):c.589T>G (p.Cys197Gly)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, multiple submitters, no conflicts	19	11216171	19	11105495	251308	245645
NM_000527.4(LDLR):c.589T>C (p.Cys197Arg)	LDLR	Familial hypercholesterolemia|not provided	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216171	19	11105495	183091	181231
NM_000527.4(LDLR):c.590G>T (p.Cys197Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216172	19	11105496	251309	245646
NM_000527.4(LDLR):c.590G>A (p.Cys197Tyr)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic/Likely pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, multiple submitters, no conflicts	19	11216172	19	11105496	200919	198012
NM_000527.4(LDLR):c.591C>G (p.Cys197Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216173	19	11105497	251311	245648
NM_000527.4(LDLR):c.591C>A (p.Cys197Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216173	19	11105497	251310	245647
NM_000527.4(LDLR):c.593C>A (p.Ser198Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216175	19	11105499	251312	245649
NM_000527.4(LDLR):c.600delC (p.Phe200Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216182	19	11105506	251316	245653
NM_000527.4(LDLR):c.601G>A (p.Glu201Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216183	19	11105507	251317	245654
NM_000527.4(LDLR):c.605T>C (p.Phe202Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216187	19	11105511	251318	245655
NM_000527.4(LDLR):c.609del (p.Cys204Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216191	19	11105515	251319	245656
NM_000527.4(LDLR):c.611G>T (p.Cys204Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11216193	19	11105517	251322	245659
NM_000527.4(LDLR):c.611G>C (p.Cys204Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216193	19	11105517	251321	245658
NM_000527.4(LDLR):c.611G>A (p.Cys204Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216193	19	11105517	251320	245657
NM_000527.4(LDLR):c.616dup (p.Ser206Lysfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216198	19	11105522	251323	245660
NM_000527.4(LDLR):c.617del (p.Ser206Metfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216199	19	11105523	251324	245661
NM_000527.4(LDLR):c.618_638del (p.Gly207_Ser213del)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216200 - 11216220	19	11105524 - 11105544	265899	260658
NM_000527.4(LDLR):c.618T>G (p.Ser206Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216200	19	11105524	251325	245662
NM_000527.4(LDLR):c.619_639del21 (p.Gly207_Ser213del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216201 - 11216221	19	11105525 - 11105545	251326	245663
NM_000527.4(LDLR):c.621C>T (p.Gly207=)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216203	19	11105527	3747	18786
NM_000527.4(LDLR):c.622G>T (p.Glu208Ter)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2017)	criteria provided, multiple submitters, no conflicts	19	11216204	19	11105528	251329	245666
NM_000527.4(LDLR):c.622G>A (p.Glu208Lys)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, multiple submitters, no conflicts	19	11216204	19	11105528	251328	245665
NM_000527.4(LDLR):c.623_644del22 (p.Glu208Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216205 - 11216226	19	11105529 - 11105550	251330	245667
NM_000527.4(LDLR):c.625_626dupTG (p.Ile210Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11216207 - 11216208	19	11105531 - 11105532	251331	245668
NM_000527.4(LDLR):c.626G>A (p.Cys209Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216208	19	11105532	251332	245669
NM_000527.4(LDLR):c.629T>A (p.Ile210Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216211	19	11105535	251333	245670
NM_000527.4(LDLR):c.631C>T (p.His211Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	19	11216213	19	11105537	251335	245672
NM_000527.4(LDLR):c.631C>G (p.His211Asp)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11216213	19	11105537	251334	245671
NM_000527.4(LDLR):c.632A>T (p.His211Leu)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2017)	criteria provided, conflicting interpretations	19	11216214	19	11105538	251337	245673
NM_000527.4(LDLR):c.632_634del (p.His211_Ser212delinsPro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216214 - 11216216	19	11105538 - 11105540	251336	245674
NM_000527.4(LDLR):c.641G>C (p.Trp214Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216223	19	11105547	251339	245676
NM_000527.4(LDLR):c.642G>A (p.Trp214Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216224	19	11105548	251340	245677
NM_000527.4(LDLR):c.643C>A (p.Arg215Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216225	19	11105549	251342	245678
NM_000527.4(LDLR):c.643_644insATCCACTCAGCTGGC (p.Trp214_Arg215insHisProLeuSerTrp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216225 - 11216226	19	11105549 - 11105550	251341	245679
NM_000527.4(LDLR):c.645_646del (p.Cys216Terfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216227 - 11216228	19	11105551 - 11105552	251343	245680
NM_000527.4(LDLR):c.646T>C (p.Cys216Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216228	19	11105552	251345	245681
NM_000527.4(LDLR):c.646del (p.Cys216Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216228	19	11105552	251344	245682
NM_000527.4(LDLR):c.647G>T (p.Cys216Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216229	19	11105553	251347	245684
NM_000527.4(LDLR):c.647G>A (p.Cys216Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, multiple submitters, no conflicts	19	11216229	19	11105553	251346	245683
NM_000527.4(LDLR):c.648_656del (p.Asp217_Gly219del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216230 - 11216238	19	11105554 - 11105562	251349	245686
NM_000527.4(LDLR):c.648_649del (p.Cys216Terfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216230 - 11216231	19	11105554 - 11105555	251348	245685
NM_000527.4(LDLR):c.648dupT (p.Asp217Terfs)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216230	19	11105554	226328	228141
NM_000527.4(LDLR):c.649_650insT (p.Asp217Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216231 - 11216232	19	11105555 - 11105556	251350	245687
NM_000527.4(LDLR):c.[649_654dupGATGGT;657_661delCCCCG]	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19|19	11216231 - 11216236	19|19	11105555 - 11105560	250923	245688|245692
NM_000527.4(LDLR):c.651_687del37 (p.Asp217Glufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216233 - 11216269	19	11105557 - 11105593	251351	245689
NM_000527.4(LDLR):c.653delG (p.Gly218Valfs)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	19	11216235	19	11105559	68100	78991
NM_000527.4(LDLR):c.654_656delTGG (p.Gly219del)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	19	11216236 - 11216238	19	11105560 - 11105562	226329	228142
NM_000527.4(LDLR):c.655_657delGGC (p.Gly219del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216237 - 11216239	19	11105561 - 11105563	251352	245690
NM_000527.4(LDLR):c.656_661delGCCCCG (p.Gly219_Pro220del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216238 - 11216243	19	11105562 - 11105567	251353	245691
NM_000527.4(LDLR):c.657_661dup (p.Asp221Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216239 - 11216243	19	11105563 - 11105567	251359	245693
NM_000527.4(LDLR):c.660delC (p.Asp221Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216242	19	11105566	226330	228143
NM_000527.4(LDLR):c.661G>T (p.Asp221Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216243	19	11105567	251356	245694
NM_000527.4(LDLR):c.661_677del17 (p.Asp221Terfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216243 - 11216259	19	11105567 - 11105583	251355	245696
NM_000527.4(LDLR):c.661_673dup (p.Lys225Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216243 - 11216255	19	11105567 - 11105579	251354	245695
NM_000527.4(LDLR):c.661G>A (p.Asp221Asn)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	19	11216243	19	11105567	226331	228144
NM_000527.4(LDLR):c.662A>T (p.Asp221Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216244	19	11105568	251357	245697
NM_000527.4(LDLR):c.662A>G (p.Asp221Gly)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, multiple submitters, no conflicts	19	11216244	19	11105568	183092	181233
NM_000527.4(LDLR):c.663_683dup21 (p.Asp227_Glu228insAspCysLysAspLysSerAsp)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic/Likely pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	19	11216245 - 11216265	19	11105569 - 11105589	251358	245698
NM_000527.4(LDLR):c.664T>G (p.Cys222Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216246	19	11105570	251361	245699
NM_000527.4(LDLR):c.664_681del18insCCGACTG (p.Cys222Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216246 - 11216263	19	11105570 - 11105587	251360	245700
NM_000527.4(LDLR):c.664T>C (p.Cys222Arg)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11216246	19	11105570	226332	228145
NM_000527.4(LDLR):c.664_681dup18 (p.Asp227_Glu228insCysLysAspLysSerAsp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216246 - 11216263	19	11105570 - 11105587	3733	18772
NM_000527.4(LDLR):c.665G>T (p.Cys222Phe)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216247	19	11105571	251362	245701
NM_000527.4(LDLR):c.665G>A (p.Cys222Tyr)	LDLR	Familial hypercholesterolemia|not provided	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216247	19	11105571	183093	181234
NM_000527.4(LDLR):c.666C>G (p.Cys222Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216248	19	11105572	251365	245703
NM_000527.4(LDLR):c.666C>A (p.Cys222Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216248	19	11105572	251364	245702
NM_000527.4(LDLR):c.666_687del (p.Cys222Terfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216248 - 11216269	19	11105572 - 11105593	251363	245704
NM_000527.4(LDLR):c.667_693del (p.Lys223_Cys231del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216249 - 11216275	19	11105573 - 11105599	251366	245705
NM_000527.4(LDLR):c.668_681dup (p.Glu228Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216250 - 11216263	19	11105574 - 11105587	251367	245706
NM_000527.4(LDLR):c.669G>C (p.Lys223Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216251	19	11105575	251370	245707
NM_000527.4(LDLR):c.669_680dupGGACAAATCTGA (p.Ser226_Asp227insGluAspLysSer)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Likely pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, multiple submitters, no conflicts	19	11216251 - 11216262	19	11105575 - 11105586	251369	245709
NM_000527.4(LDLR):c.669_679dup (p.Asp227Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216251 - 11216261	19	11105575 - 11105585	251368	245708
NM_000527.4(LDLR):c.670dup (p.Asp224Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216252	19	11105576	251372	245711
NM_000527.4(LDLR):c.670_675delGACAAAinsTTT (p.Asp224_Lys225delinsPhe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216252 - 11216257	19	11105576 - 11105581	251371	245710
NM_000527.4(LDLR):c.670G>A (p.Asp224Asn)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216252	19	11105576	3706	18745
NM_000527.4(LDLR):c.671_675del (p.Asp224Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11216253 - 11216257	19	11105577 - 11105581	441188	434826
NM_000527.4(LDLR):c.671A>T (p.Asp224Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216253	19	11105577	251375	245714
NM_000527.4(LDLR):c.671A>G (p.Asp224Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216253	19	11105577	251374	245713
NM_000527.4(LDLR):c.671A>C (p.Asp224Ala)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216253	19	11105577	251373	245712
NM_000527.4(LDLR):c.672_686del (p.Asp224_Glu228del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11216254 - 11216268	19	11105578 - 11105592	441189	434827
NM_000527.4(LDLR):c.672_683dup (p.Asp227_Glu228insAspLysSerAsp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216254 - 11216265	19	11105578 - 11105589	251376	245715
NM_000527.4(LDLR):c.673_682delAAATCTGACGinsTGCAA (p.Lys225Cysfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216255 - 11216264	19	11105579 - 11105588	251378	245717
NM_000527.4(LDLR):c.673_681dup (p.Asp227_Glu228insLysSerAsp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216255 - 11216263	19	11105579 - 11105587	251377	245716
NM_000527.4(LDLR):c.674_681dup (p.Glu228Asnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216256 - 11216263	19	11105580 - 11105587	251379	245718
NM_000527.4(LDLR):c.675del (p.Lys225Asnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216257	19	11105581	251382	245721
NM_000527.4(LDLR):c.675_689delATCTGACGAGGAAAA (p.Lys225_Glu229del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216257 - 11216271	19	11105581 - 11105595	251381	245720
NM_000527.4(LDLR):c.675_681dup (p.Glu228Ilefs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216257 - 11216263	19	11105581 - 11105587	251380	245719
NM_000527.4(LDLR):c.676T>C (p.Ser226Pro)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11216258	19	11105582	251384	245722
NM_000527.4(LDLR):c.676_684dup (p.Glu228_Glu229insSerAspGlu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216258 - 11216266	19	11105582 - 11105590	251383	245723
NM_000527.4(LDLR):c.677C>G (p.Ser226Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216259	19	11105583	251385	245724
NM_000527.4(LDLR):c.680A>T (p.Asp227Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216262	19	11105586	251388	245725
NM_000527.4(LDLR):c.680_682delACGins14 (p.?)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216262 - 11216264	19	11105586 - 11105588	251387	245727
NM_000527.4(LDLR):c.680_681ins(21)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216262 - 11216263	19	11105586 - 11105587	251386	245726
NM_000527.4(LDLR):c.680_681delAC (p.Asp227Glyfs)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, multiple submitters, no conflicts	19	11216262 - 11216263	19	11105586 - 11105587	3731	18770
NM_000527.4(LDLR):c.681_682insTCAGGGAAACCCGACTGC (p.Asp227_Glu228insSerGlyLysProAspCys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11216263 - 11216264	19	11105587 - 11105588	441190	434828
NM_000527.4(LDLR):c.681C>A (p.Asp227Glu)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11216263	19	11105587	403632	390613
NM_000527.4(LDLR):c.681_683delCGA (p.Asp227del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216263 - 11216265	19	11105587 - 11105589	251390	245729
NM_000527.4(LDLR):c.681_682insTGAG (p.Glu228Terfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216263 - 11216264	19	11105587 - 11105588	251389	245728
NM_000527.4(LDLR):c.681C>G (p.Asp227Glu)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216263	19	11105587	3690	18729
NM_000527.4(LDLR):c.682delGinsTCAAGGAAACCCGACTGCA (p.Glu228delinsSerArgLysProAspCysLys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11216264	19	11105588	441191	434829
NM_000527.4(LDLR):c.682G>C (p.Glu228Gln)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, multiple submitters, no conflicts	19	11216264	19	11105588	251393	245730
NM_000527.4(LDLR):c.682delGinsTGCA (p.Glu228delinsCysLys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216264	19	11105588	251392	245732
NM_000527.4(LDLR):c.682del (p.Glu228Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216264	19	11105588	251391	245731
NM_000527.4(LDLR):c.682G>T (p.Glu228Ter)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	19	11216264	19	11105588	226333	228146
NM_000527.4(LDLR):c.682G>A (p.Glu228Lys)	LDLR	Familial hypercholesterolemia|not provided|Aortic dissection|Carotid artery dissection|Internal carotid artery dissection|Carotid artery occlusion|Stroke	Pathogenic/Likely pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	19	11216264	19	11105588	3691	18730
NM_000527.4(LDLR):c.683_694delAGGAAAACTGCG (p.Glu228_Cys231del)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, multiple submitters, no conflicts	19	11216265 - 11216276	19	11105589 - 11105600	403633	390614
NM_000527.4(LDLR):c.683A>C (p.Glu228Ala)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216265	19	11105589	251394	245733
NM_000527.4(LDLR):c.684G>C (p.Glu228Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11216266	19	11105590	523724	514378
NM_000527.4(LDLR):c.691T>G (p.Cys231Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11216273	19	11105597	251397	245736
NM_000527.4(LDLR):c.691T>C (p.Cys231Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216273	19	11105597	251396	245735
NM_000527.4(LDLR):c.692G>A (p.Cys231Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216274	19	11105598	251398	245737
NM_000527.4(LDLR):c.693C>G (p.Cys231Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216275	19	11105599	251400	245738
NM_000527.4(LDLR):c.693_694+20del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216275 - 11216296	19	11105599 - 11105620	251399	245739
NM_000527.4(LDLR):c.693C>A (p.Cys231Ter)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216275	19	11105599	3730	18769
NM_001195800.1(LDLR):c.314-1792_314-827del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216276 - 11217241	19	11105600 - 11106565	251401	245740
NM_000527.4(LDLR):c.694+1G>T	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216277	19	11105601	251403	245742
NM_000527.4(LDLR):c.694+1G>A	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216277	19	11105601	251402	245741
NM_000527.4(LDLR):c.694+2T>C	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216278	19	11105602	3738	18777
NM_000527.4(LDLR):c.694+4_694+5insT	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216280	19	11105604	251404	245743
NG_009060.1:g.21829_24193del2365	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216885 - 11219249	19	11106209 - 11108573	251407	245746
NM_000527.4(LDLR):c.695-67_1586+371del	LDLR|MIR6886	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11217174 - 11224809	19	11106498 - 11114133	251409	245748
NM_000527.4(LDLR):c.695-6_698del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217235 - 11217244	19	11106559 - 11106568	251411	245750
GRCh38/hg38 19p13.2(chr19:11106564-11107515)x1	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11217240 - 11218191	19	11106564 - 11107515	548092	538588
NM_000527.4(LDLR):c.695-1G>A	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11217240	19	11106564	369859	354087
NM_000527.4(LDLR):c.695-1G>T	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11217240	19	11106564	251415	245751
NM_000527.4(LDLR):c.703dup (p.Thr235Asnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217249	19	11106573	251416	245752
NM_000527.4(LDLR):c.705dup (p.Cys236Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217251	19	11106575	251418	245754
NM_000527.4(LDLR):c.705_791del87 (p.Cys236_Met264del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11217251 - 11217337	19	11106575 - 11106661	251417	245753
NM_000527.4(LDLR):c.706T>C (p.Cys236Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217252	19	11106576	251419	245755
NM_000527.4(LDLR):c.708dup (p.Arg237Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217254	19	11106578	251420	245756
NM_000527.4(LDLR):c.709C>T (p.Arg237Cys)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2018)	criteria provided, conflicting interpretations	19	11217255	19	11106579	251421	245757
NM_000527.4(LDLR):c.718G>T (p.Glu240Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 26, 2016)	criteria provided, multiple submitters, no conflicts	19	11217264	19	11106588	251422	245758
NM_000527.4(LDLR):c.718G>A (p.Glu240Lys)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	19	11217264	19	11106588	200920	198013
NM_000527.4(LDLR):c.722T>C (p.Phe241Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217268	19	11106592	251423	245759
NM_000527.4(LDLR):c.724C>T (p.Gln242Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11217270	19	11106594	251424	245760
NM_000527.4(LDLR):c.727T>C (p.Cys243Arg)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11217273	19	11106597	251425	245761
NM_000527.4(LDLR):c.737G>A (p.Gly246Glu)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11217283	19	11106607	251427	245762
NM_000527.4(LDLR):c.737delG (p.Gly246Glufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217283	19	11106607	251426	245763
NM_000527.4(LDLR):c.742T>G (p.Cys248Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217288	19	11106612	251428	245764
NM_000527.4(LDLR):c.743G>T (p.Cys248Phe)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11217289	19	11106613	251430	245766
NM_000527.4(LDLR):c.743G>A (p.Cys248Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217289	19	11106613	251429	245765
NM_000527.4(LDLR):c.744C>A (p.Cys248Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217290	19	11106614	251431	245767
NM_000527.4(LDLR):c.746T>C (p.Ile249Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217292	19	11106616	251432	245768
NM_000527.4(LDLR):c.752dup (p.Ser252Glnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11217298	19	11106622	251434	245770
NM_000527.4(LDLR):c.757C>T (p.Arg253Trp)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11217303	19	11106627	161261	171200
NM_000527.4(LDLR):c.758G>C (p.Arg253Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217304	19	11106628	251435	245771
NM_000527.4(LDLR):c.760C>T (p.Gln254Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217306	19	11106630	251436	245772
NM_000527.4(LDLR):c.761A>C (p.Gln254Pro)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: May 8, 2017)	criteria provided, multiple submitters, no conflicts	19	11217307	19	11106631	251437	245773
NM_000527.4(LDLR):c.762G>T (p.Gln254His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217308	19	11106632	251439	245774
NM_000527.4(LDLR):c.762_763invGT (p.Cys255Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217308 - 11217309	19	11106632 - 11106633	251438	245775
NM_000527.4(LDLR):c.763T>G (p.Cys255Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217309	19	11106633	251442	245778
NM_000527.4(LDLR):c.763T>C (p.Cys255Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217309	19	11106633	251441	245777
NM_000527.4(LDLR):c.763T>A (p.Cys255Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217309	19	11106633	251440	245776
NM_000527.4(LDLR):c.764G>A (p.Cys255Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217310	19	11106634	251443	245779
NM_000527.4(LDLR):c.767A>G (p.Asp256Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11217313	19	11106637	251444	245780
NM_000527.4(LDLR):c.768C>A (p.Asp256Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11217314	19	11106638	438322	431953
NM_000527.4(LDLR):c.768C>G (p.Asp256Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217314	19	11106638	251445	245781
NM_000527.4(LDLR):c.769C>T (p.Arg257Trp)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 29, 2018)	criteria provided, conflicting interpretations	19	11217315	19	11106639	251446	245782
NM_000527.4(LDLR):c.772G>T (p.Glu258Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11217318	19	11106642	251449	245785
NM_000527.4(LDLR):c.776_777del (p.Tyr259Terfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217322 - 11217323	19	11106646 - 11106647	251450	245786
NM_000527.4(LDLR):c.781del (p.Cys261Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11217327	19	11106651	251451	245787
NM_000527.4(LDLR):c.782G>T (p.Cys261Phe)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Likely pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, multiple submitters, no conflicts	19	11217328	19	11106652	3740	18779
NM_000527.4(LDLR):c.790_793delATGA (p.Met264Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217336 - 11217339	19	11106660 - 11106663	251452	245789
NM_000527.4(LDLR):c.793A>T (p.Ser265Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217339	19	11106663	251454	245790
NM_000527.4(LDLR):c.796G>T (p.Asp266Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217342	19	11106666	251456	245791
NM_000527.4(LDLR):c.796_799delGATG (p.Asp266Lysfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217342 - 11217345	19	11106666 - 11106669	251455	245792
NM_000527.4(LDLR):c.796G>A (p.Asp266Asn)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, multiple submitters, no conflicts	19	11217342	19	11106666	226334	228147
NM_000527.4(LDLR):c.797A>T (p.Asp266Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217343	19	11106667	251458	245794
NM_000527.4(LDLR):c.797A>G (p.Asp266Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217343	19	11106667	251457	245793
NM_000527.4(LDLR):c.798T>A (p.Asp266Glu)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: May 17, 2018)	criteria provided, conflicting interpretations	19	11217344	19	11106668	161287	171201
NM_000527.4(LDLR):c.799G>A (p.Glu267Lys)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11217345	19	11106669	251459	245795
NM_000527.4(LDLR):c.800A>C (p.Glu267Ala)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11217346	19	11106670	251460	245796
NM_000527.4(LDLR):c.801A>T (p.Glu267Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217347	19	11106671	251461	245797
NM_000527.4(LDLR):c.806G>A (p.Gly269Asp)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2017)	criteria provided, conflicting interpretations	19	11217352	19	11106676	161279	171202
NM_000527.4(LDLR):c.808T>C (p.Cys270Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11217354	19	11106678	251463	245799
NM_000527.4(LDLR):c.808T>A (p.Cys270Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217354	19	11106678	251462	245798
NM_000527.4(LDLR):c.809G>A (p.Cys270Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217355	19	11106679	251464	245800
NM_000527.4(LDLR):c.810C>A (p.Cys270Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217356	19	11106680	251465	245801
NM_000527.4(LDLR):c.811G>A (p.Val271Ile)	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11217357	19	11106681	189297	187194
NM_000527.4(LDLR):c.814_817delAATG (p.Asn272Terfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217360 - 11217363	19	11106684 - 11106687	251467	245803
NM_000527.4(LDLR):c.815A>C (p.Asn272Thr)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11217361	19	11106685	251468	245804
NM_000527.4(LDLR):c.817+1G>A	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11217364	19	11106688	251469	245805
NM_000527.4(LDLR):c.817+2T>G	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11217365	19	11106689	441193	434831
NM_000527.4(LDLR):c.817+2T>C	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217365	19	11106689	251470	245806
NM_000527.4(LDLR):c.818-3C>G	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11218065	19	11107389	265900	260659
NM_000527.4(LDLR):c.818-2A>G	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218066	19	11107390	251471	245807
NM_000527.4(LDLR):c.818-1G>A	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11218067	19	11107391	251475	245808
NM_000527.4(LDLR):c.820delA (p.T274Hfs*95)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	19	11218070	19	11107394	369863	354088
NM_000527.4(LDLR):c.820_827delACACTCTG (p.Thr274Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218070 - 11218077	19	11107394 - 11107401	251476	245810
NM_000527.4(LDLR):c.825_826delCT (p.Cys276Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218075 - 11218076	19	11107399 - 11107400	251478	245811
NM_000527.4(LDLR):c.826T>G (p.Cys276Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218076	19	11107400	251480	245813
NM_000527.4(LDLR):c.826T>C (p.Cys276Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11218076	19	11107400	251479	245812
NM_000527.4(LDLR):c.827G>A (p.Cys276Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218077	19	11107401	251481	245814
NM_000527.4(LDLR):c.828C>G (p.Cys276Trp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11218078	19	11107402	251482	245815
NM_000527.4(LDLR):c.828C>A (p.Cys276Ter)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11218078	19	11107402	189298	187195
NM_000527.4(LDLR):c.829G>A (p.Glu277Lys)	LDLR	Familial hypercholesterolemia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 29, 2017)	criteria provided, conflicting interpretations	19	11218079	19	11107403	183097	181238
NM_000527.4(LDLR):c.846C>A (p.Phe282Leu)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11218096	19	11107420	183098	181239
NM_000527.4(LDLR):c.850T>G (p.Cys284Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218100	19	11107424	251485	245818
NM_000527.4(LDLR):c.850T>C (p.Cys284Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218100	19	11107424	251484	245817
NM_000527.4(LDLR):c.858C>A (p.Ser286Arg)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, multiple submitters, no conflicts	19	11218108	19	11107432	251488	245821
NM_000527.4(LDLR):c.859G>T (p.Gly287Cys)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11218109	19	11107433	251489	245822
NM_000527.4(LDLR):c.859G>A (p.Gly287Ser)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218109	19	11107433	161280	171203
NM_000527.4(LDLR):c.862G>T (p.Glu288Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11218112	19	11107436	251490	245823
NM_000527.4(LDLR):c.862G>A (p.Glu288Lys)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2018)	criteria provided, conflicting interpretations	19	11218112	19	11107436	161268	171204
NM_000527.4(LDLR):c.865T>C (p.Cys289Arg)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11218115	19	11107439	251492	245824
NM_000527.4(LDLR):c.865del (p.Cys289Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11218115	19	11107439	251491	245825
NM_000527.4(LDLR):c.869T>G (p.Ile290Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218119	19	11107443	251494	245826
NM_000527.4(LDLR):c.874del (p.Leu292Trpfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218124	19	11107448	251495	245828
NM_000527.4(LDLR):c.875dup (p.Asp293Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11218125	19	11107449	251496	245829
NM_000527.4(LDLR):c.877del (p.Asp293Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218127	19	11107451	251497	245830
NM_000527.4(LDLR):c.880A>G (p.Lys294Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218130	19	11107454	251498	245831
NM_000527.4(LDLR):c.881_882delAA (p.Lys294Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11218131 - 11218132	19	11107455 - 11107456	251499	245832
NM_000527.4(LDLR):c.884del (p.Val295Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218134	19	11107458	251500	245833
NM_000527.4(LDLR):c.887G>C (p.Cys296Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218137	19	11107461	251503	245835
NM_000527.4(LDLR):c.887G>A (p.Cys296Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11218137	19	11107461	251502	245834
NM_000527.4(LDLR):c.887_889delGCAinsAGC (p.Cys296Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218137 - 11218139	19	11107461 - 11107463	251501	245836
NM_000527.4(LDLR):c.888C>A (p.Cys296Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218138	19	11107462	251504	245837
NM_000527.4(LDLR):c.890delA (p.Asn297Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218140	19	11107464	251506	245839
NM_000527.4(LDLR):c.895G>T (p.Ala299Ser)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11218145	19	11107469	251508	245841
NM_000527.4(LDLR):c.895G>A (p.Ala299Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218145	19	11107469	251507	245840
NM_000527.4(LDLR):c.896delC (p.Ala299Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11218146	19	11107470	251509	245842
NM_000527.4(LDLR):c.898A>T (p.Arg300Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218148	19	11107472	251511	245844
NM_000527.4(LDLR):c.898A>G (p.Arg300Gly)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11218148	19	11107472	251510	245843
NM_000527.4(LDLR):c.901G>T (p.Asp301Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218151	19	11107475	251512	245845
NM_000527.4(LDLR):c.902A>G (p.Asp301Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218152	19	11107476	251514	245847
NM_000527.4(LDLR):c.902A>C (p.Asp301Ala)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218152	19	11107476	251513	245846
NM_000527.4(LDLR):c.905delG (p.C302Sfs*67)	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11218155	19	11107479	369867	354089
NM_000527.4(LDLR):c.905G>A (p.Cys302Tyr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11218155	19	11107479	251515	245848
NM_000527.4(LDLR):c.906C>G (p.Cys302Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218156	19	11107480	251516	245849
NM_000527.4(LDLR):c.907C>T (p.Arg303Trp)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: May 16, 2018)	criteria provided, conflicting interpretations	19	11218157	19	11107481	161281	171205
NM_000527.4(LDLR):c.910G>C (p.Asp304His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11218160	19	11107484	440612	434263
NM_000527.4(LDLR):c.910G>T (p.Asp304Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11218160	19	11107484	251517	245850
NM_000527.4(LDLR):c.910G>A (p.Asp304Asn)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	19	11218160	19	11107484	3692	18731
NM_000527.4(LDLR):c.912C>G (p.Asp304Glu)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11218162	19	11107486	226336	228149
NM_000527.4(LDLR):c.914G>A (p.Trp305Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218164	19	11107488	251518	245851
NM_000527.4(LDLR):c.915G>C (p.Trp305Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218165	19	11107489	251521	245854
NM_000527.4(LDLR):c.915G>A (p.Trp305Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218165	19	11107489	251520	245853
NM_000527.4(LDLR):c.916_919dup (p.Asp307Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218166 - 11218169	19	11107490 - 11107493	251522	245855
NM_000527.4(LDLR):c.917C>G (p.Ser306Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11218167	19	11107491	251524	245857
NM_000527.4(LDLR):c.917C>A (p.Ser306Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218167	19	11107491	251523	245856
NM_000527.4(LDLR):c.917C>T (p.Ser306Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11218167	19	11107491	226337	228150
NM_000527.4(LDLR):c.919G>C (p.Asp307His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218169	19	11107493	251526	245859
NM_000527.4(LDLR):c.919G>A (p.Asp307Asn)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11218169	19	11107493	251525	245858
NM_000527.4(LDLR):c.920A>G (p.Asp307Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11218170	19	11107494	523725	514379
NM_000527.4(LDLR):c.921T>G (p.Asp307Glu)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11218171	19	11107495	251527	245860
NM_000527.4(LDLR):c.922G>A (p.Glu308Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218172	19	11107496	251528	245861
NM_000527.4(LDLR):c.925_931delCCCATCA (p.Pro309Lysfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218175 - 11218181	19	11107499 - 11107505	3729	18768
NM_000527.4(LDLR):c.928dup (p.Ile310Asnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11218178	19	11107502	441200	434837
NM_000527.4(LDLR):c.932A>C (p.Lys311Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218182	19	11107506	251531	245863
NM_000527.4(LDLR):c.932_933del (p.Lys311Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11218182 - 11218183	19	11107506 - 11107507	251530	245865
NM_000527.4(LDLR):c.933delA (p.Glu312Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, multiple submitters, no conflicts	19	11218183	19	11107507	251533	245866
NM_000527.4(LDLR):c.934G>T (p.Glu312Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218184	19	11107508	251534	245867
NM_000527.4(LDLR):c.935_936del (p.Glu312Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218185 - 11218186	19	11107509 - 11107510	251535	245868
NM_000527.4(LDLR):c.936_940delGTGCG (p.Cys313Aspfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218186 - 11218190	19	11107510 - 11107514	251536	245869
NM_000527.4(LDLR):c.937T>G (p.Cys313Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218187	19	11107511	251538	245871
NM_000527.4(LDLR):c.937T>C (p.Cys313Arg)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11218187	19	11107511	251537	245870
NM_000527.4(LDLR):c.938G>A (p.Cys313Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	19	11218188	19	11107512	226339	228151
NM_000527.4(LDLR):c.938_939delGCinsAT (p.Cys313Tyr)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218188 - 11218189	19	11107512 - 11107513	226338	228152
NM_000527.4(LDLR):c.939C>G (p.Cys313Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11218189	19	11107513	251540	245873
NM_000527.4(LDLR):c.939C>A (p.Cys313Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11218189	19	11107513	251539	245872
NM_000527.4(LDLR):c.940_940+14del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11218190 - 11218204	19	11107514 - 11107528	375803	362695
NM_000527.4(LDLR):c.940+1G>C	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11218191	19	11107515	251542	245875
NM_000527.4(LDLR):c.940+1G>A	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11218191	19	11107515	251541	245874
NM_000527.4(LDLR):c.940+2T>A	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11218192	19	11107516	251543	245876
NM_000527.4(LDLR):c.940+2T>C	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218192	19	11107516	226340	228153
NC_000019.10:g.11107686_11138384del30699	LDLR|MIR6886	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218362 - 11249060	19	11107686 - 11138384	251546	245879
NG_009060.1:g.23979_27790del3812	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11219035 - 11222846	19	11108359 - 11112170	251547	245880
NM_000527.4(LDLR):c.941-12G>A	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	19	11221316	19	11110640	251552	245885
NM_000527.4(LDLR):c.941-4G>A	LDLR	Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	19	11221324	19	11110648	224619	226399
NM_000527.4(LDLR):c.941-2A>G	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11221326	19	11110650	251554	245887
NM_000527.4(LDLR):c.941-2A>C	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221326	19	11110650	251553	245886
GRCh38/hg38 19p13.2(chr19:11110651-11110772)x3	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11221327 - 11221448	19	11110651 - 11110772	548089	538585
NM_000527.4(LDLR):c.941-1G>A	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, multiple submitters, no conflicts	19	11221327	19	11110651	251564	245888
NM_000527.4(LDLR):c.946_994del49 (p.Asn316Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221333 - 11221381	19	11110657 - 11110705	251565	245889
NM_000527.4(LDLR):c.947A>C (p.Asn316Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11221334	19	11110658	251566	245890
NM_000527.4(LDLR):c.947A>G (p.Asn316Ser)	LDLR	Familial hypercholesterolemia|not provided	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221334	19	11110658	183103	181244
NM_000527.4(LDLR):c.949dup (p.Glu317Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11221336	19	11110660	431517	425031
NM_000527.4(LDLR):c.949G>T (p.Glu317Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11221336	19	11110660	251568	245892
NM_000527.4(LDLR):c.949G>A (p.Glu317Lys)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11221336	19	11110660	251567	245891
NM_000527.4(LDLR):c.951delA (p.Glu317Aspfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221338	19	11110662	251569	245893
NM_000527.4(LDLR):c.952T>C (p.Cys318Arg)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, multiple submitters, no conflicts	19	11221339	19	11110663	251570	245894
NM_000527.4(LDLR):c.953G>T (p.Cys318Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11221340	19	11110664	251572	245896
NM_000527.4(LDLR):c.953G>A (p.Cys318Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11221340	19	11110664	251571	245895
NM_000527.4(LDLR):c.954C>A (p.Cys318Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11221341	19	11110665	523733	514381
NM_000527.4(LDLR):c.961_962delAA (p.Asn321Glnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221348 - 11221349	19	11110672 - 11110673	251573	245897
NM_000527.4(LDLR):c.964_966delAAC (p.Asn322del)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11221351 - 11221353	19	11110675 - 11110677	251574	245898
NM_000527.4(LDLR):c.965A>T (p.Asn322Ile)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11221352	19	11110676	251575	245899
NM_000527.4(LDLR):c.967G>A (p.Gly323Ser)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11221354	19	11110678	161282	171206
NM_000527.4(LDLR):c.968delG (p.Gly323Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221355	19	11110679	251576	245900
NM_000527.4(LDLR):c.969del (p.Gly324Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11221356	19	11110680	251578	245902
NM_000527.4(LDLR):c.970G>A (p.Gly324Ser)	LDLR	Familial hypercholesterolemia|not specified|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Oct 5, 2017)	criteria provided, conflicting interpretations	19	11221357	19	11110681	161263	171207
NM_000527.4(LDLR):c.971delG (p.Gly324Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11221358	19	11110682	251579	245903
NM_000527.4(LDLR):c.974G>A (p.Cys325Tyr)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Likely pathogenic(Last reviewed: May 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11221361	19	11110685	251580	245904
NM_000527.4(LDLR):c.977C>T (p.Ser326Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221364	19	11110688	251582	245906
NM_000527.4(LDLR):c.977C>G (p.Ser326Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11221364	19	11110688	251581	245905
NM_000527.4(LDLR):c.979C>T (p.His327Tyr)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11221366	19	11110690	251583	245907
NM_000527.4(LDLR):c.980dup (p.His327Glnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11221367	19	11110691	251584	245908
NM_000527.4(LDLR):c.981C>A (p.His327Gln)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	19	11221368	19	11110692	403665	390615
NM_000527.4(LDLR):c.985T>G (p.Cys329Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11221372	19	11110696	251585	245909
NM_000527.4(LDLR):c.986G>T (p.Cys329Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11221373	19	11110697	251586	245910
NM_000527.4(LDLR):c.986G>A (p.Cys329Tyr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11221373	19	11110697	226344	228154
NM_000527.4(LDLR):c.987C>G (p.Cys329Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11221374	19	11110698	441207	434839
NM_000527.4(LDLR):c.987C>A (p.Cys329Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11221374	19	11110698	441206	434838
NM_000527.4(LDLR):c.1003G>A (p.Gly335Ser)	LDLR	Familial hypercholesterolemia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 13, 2018)	criteria provided, conflicting interpretations	19	11221390	19	11110714	183105	181246
NM_000527.4(LDLR):c.1004G>T (p.Gly335Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11221391	19	11110715	251587	245911
NM_000527.4(LDLR):c.1007A>G (p.Tyr336Cys)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11221394	19	11110718	251588	245912
NM_000527.4(LDLR):c.1008del (p.Tyr336Terfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11221395	19	11110719	251590	245914
NM_000527.4(LDLR):c.1008C>A (p.Tyr336Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11221395	19	11110719	251589	245913
NM_000527.4(LDLR):c.1009_1032del24 (p.Glu337_Phe344del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221396 - 11221419	19	11110720 - 11110743	251591	245915
NM_000527.4(LDLR):c.1012T>G (p.Cys338Gly)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Likely pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, multiple submitters, no conflicts	19	11221399	19	11110723	251594	245918
NM_000527.4(LDLR):c.1012T>C (p.Cys338Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221399	19	11110723	251593	245917
NM_000527.4(LDLR):c.1012T>A (p.Cys338Ser)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11221399	19	11110723	251592	245916
NM_000527.4(LDLR):c.1013G>T (p.Cys338Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11221400	19	11110724	441208	434840
NM_000527.4(LDLR):c.1013G>A (p.Cys338Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	19	11221400	19	11110724	251595	245919
NM_000527.4(LDLR):c.1014C>A (p.Cys338Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221401	19	11110725	251596	245920
NM_000527.4(LDLR):c.1016T>C (p.Leu339Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11221403	19	11110727	251597	245921
NM_000527.4(LDLR):c.1017dup (p.Cys340Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11221404	19	11110728	251598	245922
NM_000527.4(LDLR):c.1019G>A (p.Cys340Tyr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11221406	19	11110730	251600	245923
NM_000527.4(LDLR):c.1019_1020delGCinsTG (p.Cys340Leu)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11221406 - 11221407	19	11110730 - 11110731	251599	245924
NM_000527.4(LDLR):c.1020C>G (p.Cys340Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221407	19	11110731	251601	245925
NM_000527.4(LDLR):c.1024G>T (p.Asp342Tyr)	LDLR	Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11221411	19	11110735	251603	245927
NM_000527.4(LDLR):c.1024G>A (p.Asp342Asn)	LDLR	Familial hypercholesterolemia|not specified|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 22, 2017)	criteria provided, conflicting interpretations	19	11221411	19	11110735	161274	171208
NM_000527.4(LDLR):c.1027G>T (p.Gly343Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221414	19	11110738	251605	245929
NM_000527.4(LDLR):c.1027G>A (p.Gly343Ser)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 5, 2018)	criteria provided, conflicting interpretations	19	11221414	19	11110738	183106	181247
NM_000527.4(LDLR):c.1028G>A (p.Gly343Asp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11221415	19	11110739	251606	245930
NM_000527.4(LDLR):c.1031del (p.Phe344Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11221418	19	11110742	251607	245931
NM_000527.4(LDLR):c.1033C>T (p.Gln345Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11221420	19	11110744	226341	228155
NM_000527.4(LDLR):c.1034dup (p.Leu346Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11221421	19	11110745	251608	245932
NM_000527.4(LDLR):c.1042del (p.Ala348Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11221429	19	11110753	251610	245934
NM_000527.4(LDLR):c.1042_1043insA (p.Ala348Aspfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221429 - 11221430	19	11110753 - 11110754	251609	245933
NM_000527.4(LDLR):c.1045dup (p.Gln349Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221432	19	11110756	251613	245937
NM_000527.4(LDLR):c.1045del (p.Gln349Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11221432	19	11110756	251612	245936
NM_000527.4(LDLR):c.1045C>T (p.Gln349Ter)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	19	11221432	19	11110756	251611	245935
NM_000527.4(LDLR):c.1046dup (p.Arg350Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11221433	19	11110757	441209	434841
NM_000527.4(LDLR):c.1046delA (p.Gln349Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221433	19	11110757	251614	245938
NM_000527.4(LDLR):c.1048C>T (p.Arg350Ter)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	19	11221435	19	11110759	226342	228156
NM_000527.4(LDLR):c.1049G>C (p.Arg350Pro)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 3, 2017)	criteria provided, conflicting interpretations	19	11221436	19	11110760	226343	228157
NM_000527.4(LDLR):c.1053_1060dup (p.Ile355Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11221440 - 11221447	19	11110764 - 11110771	251615	245939
NM_000527.4(LDLR):c.1054T>C (p.Cys352Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11221441	19	11110765	251618	245941
NM_000527.4(LDLR):c.1054T>A (p.Cys352Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11221441	19	11110765	251617	245940
NG_009060.1:g.26385_27137del753	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221441 - 11222193	19	11110765 - 11111517	251616	245942
NM_000527.4(LDLR):c.1055G>T (p.Cys352Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221442	19	11110766	251619	245943
NM_000527.4(LDLR):c.1055G>A (p.Cys352Tyr)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	19	11221442	19	11110766	36450	45113
NM_000527.4(LDLR):c.1056C>G (p.Cys352Trp)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, multiple submitters, no conflicts	19	11221443	19	11110767	251622	245945
NM_000527.4(LDLR):c.1056C>A (p.Cys352Ter)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11221443	19	11110767	251621	245944
NM_000527.4(LDLR):c.1056_1060+3delCGAAGGTG	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	19	11221443 - 11221450	19	11110767 - 11110774	251620	245946
NM_000527.4(LDLR):c.1057G>A (p.Glu353Lys)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Uncertain significance(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	19	11221444	19	11110768	161275	171209
NM_000527.4(LDLR):c.1060+1G>T	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221448	19	11110772	251624	245948
NM_000527.4(LDLR):c.1060+1G>A	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11221448	19	11110772	251623	245947
NM_000527.4(LDLR):c.1060+2T>G	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11221449	19	11110773	369860	354090
NM_000527.4(LDLR):c.1060+9C>T	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11221456	19	11110780	369861	354091
NM_000527.4(LDLR):c.1060+10G>A	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	19	11221457	19	11110781	251625	245949
NM_000527.4(LDLR):c.1061-8T>C	LDLR	Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 22, 2018)	criteria provided, conflicting interpretations	19	11222182	19	11111506	36451	45114
NM_000527.4(LDLR):c.1061-2A>G	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222188	19	11111512	251632	245956
NM_000527.4(LDLR):c.1061-1G>C	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	19	11222189	19	11111513	251637	245958
NM_000527.4(LDLR):c.1061-1G>A	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11222189	19	11111513	251636	245957
NM_000527.4(LDLR):c.1061A>T (p.Asp354Val)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11222190	19	11111514	251640	245961
NM_000527.4(LDLR):c.1061A>G (p.Asp354Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11222190	19	11111514	251639	245960
NM_000527.4(LDLR):c.1061A>C (p.Asp354Ala)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11222190	19	11111514	251638	245959
NM_000527.4(LDLR):c.1062dup (p.Ile355Tyrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222191	19	11111515	251641	245964
NM_000527.4(LDLR):c.1065C>G (p.Ile355Met)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11222194	19	11111518	403634	390616
NM_000527.4(LDLR):c.1066G>C (p.Asp356His)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11222195	19	11111519	251644	245967
NM_000527.4(LDLR):c.1066G>T (p.Asp356Tyr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11222195	19	11111519	226345	228158
NM_000527.4(LDLR):c.1067del (p.Asp356Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11222196	19	11111520	251646	245969
NM_000527.4(LDLR):c.1067A>C (p.Asp356Ala)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11222196	19	11111520	251645	245968
NM_000527.4(LDLR):c.1069G>A (p.Glu357Lys)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11222198	19	11111522	251649	245971
NM_000527.4(LDLR):c.1069_1086dup (p.Asp362_Thr363insGluCysGlnAspProAsp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11222198 - 11222215	19	11111522 - 11111539	251648	245972
NM_000527.4(LDLR):c.1070delA (p.Glu357Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: May 18, 2016)	criteria provided, single submitter	19	11222199	19	11111523	440486	434113
NM_000527.4(LDLR):c.1070A>G (p.Glu357Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222199	19	11111523	251651	245973
NM_000527.4(LDLR):c.1070_1073dup (p.Cys358Terfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222199 - 11222202	19	11111523 - 11111526	251650	245974
NM_000527.4(LDLR):c.1072T>C (p.Cys358Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222201	19	11111525	251652	245975
NM_000527.4(LDLR):c.1073G>A (p.Cys358Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11222202	19	11111526	226346	228159
NM_000527.4(LDLR):c.1075C>T (p.Gln359Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222204	19	11111528	251653	245976
NM_000527.4(LDLR):c.1085delA (p.Asp362Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11222214	19	11111538	251655	245978
NM_000527.4(LDLR):c.1085A>C (p.Asp362Ala)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11222214	19	11111538	36452	45115
NM_000527.4(LDLR):c.1088C>A (p.Thr363Asn)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11222217	19	11111541	251656	245979
NM_000527.4(LDLR):c.1090T>C (p.Cys364Arg)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	19	11222219	19	11111543	251657	245980
NM_000527.4(LDLR):c.1091G>A (p.Cys364Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11222220	19	11111544	369852	354092
NM_000527.4(LDLR):c.1091G>T (p.Cys364Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222220	19	11111544	251659	245982
NM_000527.4(LDLR):c.1091G>C (p.Cys364Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11222220	19	11111544	251658	245981
NM_000527.4(LDLR):c.1096C>T (p.Gln366Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222225	19	11111549	251660	245983
NM_000527.4(LDLR):c.1097A>G (p.Gln366Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222226	19	11111550	251662	245985
NM_000527.4(LDLR):c.1097A>C (p.Gln366Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222226	19	11111550	251661	245984
NM_000527.4(LDLR):c.1099_1104delCTCTGCinsGT (p.Leu367Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11222228 - 11222233	19	11111552 - 11111557	251663	245986
NM_000527.4(LDLR):c.1102T>C (p.Cys368Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	19	11222231	19	11111555	369848	354093
NM_000527.4(LDLR):c.1102T>G (p.Cys368Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222231	19	11111555	251664	245987
NM_000527.4(LDLR):c.1103G>C (p.Cys368Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11222232	19	11111556	251666	245989
NM_000527.4(LDLR):c.1103G>A (p.Cys368Tyr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 5, 2018)	criteria provided, conflicting interpretations	19	11222232	19	11111556	251665	245988
NM_000527.4(LDLR):c.1104C>A (p.Cys368Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11222233	19	11111557	251667	245990
NM_000527.4(LDLR):c.1109A>C (p.Asn370Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222238	19	11111562	251668	245991
NM_000527.4(LDLR):c.1110C>G (p.Asn370Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222239	19	11111563	251669	245992
NM_000527.4(LDLR):c.1112T>C (p.Leu371Pro)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11222241	19	11111565	403635	390617
NM_000527.4(LDLR):c.1113_1114insTGGG (p.Glu372Trpfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222242 - 11222243	19	11111566 - 11111567	251670	245993
NM_000527.4(LDLR):c.1115_1123delAGGGTGGCTinsCACTGA (p.Glu372_Tyr375delinsAlaLeuAsn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222244 - 11222252	19	11111568 - 11111576	251671	245994
NM_000527.4(LDLR):c.1117G>T (p.Gly373Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11222246	19	11111570	251672	245995
NM_000527.4(LDLR):c.1118G>T (p.Gly373Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222247	19	11111571	251674	245997
NM_000527.4(LDLR):c.1118G>A (p.Gly373Asp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	19	11222247	19	11111571	251673	245996
NM_000527.4(LDLR):c.1118_1121dupGTGG (p.Tyr375Trpfs)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11222247 - 11222250	19	11111571 - 11111574	226347	228160
NM_000527.4(LDLR):c.1120_1123dup (p.Tyr375Trpfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11222249 - 11222252	19	11111573 - 11111576	251676	245999
NM_000527.4(LDLR):c.1123_1124insC (p.Tyr375Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222252 - 11222253	19	11111576 - 11111577	251677	246000
NM_000527.4(LDLR):c.1124A>G (p.Tyr375Cys)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11222253	19	11111577	251679	246002
NM_000527.4(LDLR):c.1124A>C (p.Tyr375Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222253	19	11111577	251678	246001
NM_000527.4(LDLR):c.1129T>G (p.Cys377Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222258	19	11111582	251680	246003
NM_000527.4(LDLR):c.1130G>T (p.Cys377Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11222259	19	11111583	438323	431954
NM_000527.4(LDLR):c.1130G>C (p.Cys377Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222259	19	11111583	251682	246005
NM_000527.4(LDLR):c.1130G>A (p.Cys377Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11222259	19	11111583	251681	246004
NM_000527.4(LDLR):c.1132C>T (p.Gln378Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222261	19	11111585	251683	246006
NM_000527.4(LDLR):c.1133_1186+12del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222262 - 11222327	19	11111586 - 11111651	251684	246007
NM_000527.4(LDLR):c.1133A>C (p.Gln378Pro)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11222262	19	11111586	183108	181249
NM_000527.4(LDLR):c.1135T>C (p.Cys379Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2016)	criteria provided, multiple submitters, no conflicts	19	11222264	19	11111588	251685	246008
NM_000527.4(LDLR):c.1136G>A (p.Cys379Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11222265	19	11111589	251686	246009
NM_000527.4(LDLR):c.1145G>T (p.Gly382Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222274	19	11111598	251687	246010
NM_000527.4(LDLR):c.1150C>T (p.Gln384Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11222279	19	11111603	251688	246011
NM_000527.4(LDLR):c.1151A>C (p.Gln384Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11222280	19	11111604	251690	246012
NM_000527.4(LDLR):c.1151_1159del (p.Gln384_Asp386del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11222280 - 11222288	19	11111604 - 11111612	251689	246013
NM_000527.4(LDLR):c.1154T>G (p.Leu385Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222283	19	11111607	251692	246015
NM_000527.4(LDLR):c.1158_1162dup (p.His388Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11222287 - 11222291	19	11111611 - 11111615	431521	425035
NM_000527.4(LDLR):c.1162dup (p.His388Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11222291	19	11111615	431522	425036
NM_000527.4(LDLR):c.1162delC (p.His388Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222291	19	11111615	226348	228161
NM_000527.4(LDLR):c.1166C>T (p.Thr389Met)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11222295	19	11111619	161283	171210
NM_000527.4(LDLR):c.1168A>T (p.Lys390Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222297	19	11111621	251694	246017
NM_000527.4(LDLR):c.1171G>A (p.Ala391Thr)	LDLR	Familial hypercholesterolemia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 18, 2017)	criteria provided, conflicting interpretations	19	11222300	19	11111624	183138	181250
NM_000527.4(LDLR):c.1173delC (p.Cys392Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222302	19	11111626	251695	246018
NM_000527.4(LDLR):c.1174T>C (p.Cys392Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11222303	19	11111627	251697	246019
NM_000527.4(LDLR):c.1174dup (p.Cys392Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222303	19	11111627	251696	246020
NM_000527.4(LDLR):c.1176C>A (p.Cys392Ter)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11222305	19	11111629	251699	246021
NM_000527.4(LDLR):c.1177A>C (p.Lys393Gln)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11222306	19	11111630	403636	390618
NM_000527.4(LDLR):c.1178del (p.Lys393Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11222307	19	11111631	251698	246022
NM_000527.4(LDLR):c.1179G>C (p.Lys393Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222308	19	11111632	251700	246023
NM_000527.4(LDLR):c.1182delT (p.Val395Trpfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222311	19	11111635	251701	246024
NM_000527.4(LDLR):c.1184_1185del (p.Val395Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11222313 - 11222314	19	11111637 - 11111638	403637	390619
NM_000527.4(LDLR):c.1186G>A (p.Gly396Ser)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11222315	19	11111639	251704	246026
NM_000527.4(LDLR):c.1186delG (p.Gly396Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222315	19	11111639	251703	246027
NM_000527.4(LDLR):c.1186+1G>A	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11222316	19	11111640	251705	246028
NM_000527.4(LDLR):c.1186+5G>A	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11222320	19	11111644	251706	246029
NM_000527.4(LDLR):c.1186+700_2141-545del	LDLR|MIR6886	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11223015 - 11233305	19	11112339 - 11122629	251711	246034
NM_000527.4(LDLR):c.1187-169_2312-790del	LDLR|MIR6886	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11223785 - 11237894	19	11113109 - 11127218	251712	246035
NM_000527.4(LDLR):c.1187-10_1272dup	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11223944 - 11224039	19	11113268 - 11113363	403639	390620
NM_000527.4(LDLR):c.1187-10G>A	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11223944	19	11113268	226349	228162
NM_000527.4(LDLR):c.1187-2A>G	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 13, 2017)	criteria provided, multiple submitters, no conflicts	19	11223952	19	11113276	251713	246036
NM_000527.4(LDLR):c.1187-1G>T	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11223953	19	11113277	251724	246038
NM_000527.4(LDLR):c.1187-1G>A	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11223953	19	11113277	251723	246037
NM_000527.4(LDLR):c.1195G>A (p.Ala399Thr)	LDLR	Familial hypercholesterolemia|not provided	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11223962	19	11113286	183109	181251
NM_000527.4(LDLR):c.1196C>A (p.Ala399Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11223963	19	11113287	226350	228163
NG_009060.1:g.28908_38858del9951	LDLR|MIR6886	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11223964 - 11233914	19	11113288 - 11123238	251726	246040
NM_000527.4(LDLR):c.1200C>A (p.Tyr400Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11223967	19	11113291	251728	246042
NM_000527.4(LDLR):c.1201C>G (p.Leu401Val)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: May 11, 2018)	criteria provided, conflicting interpretations	19	11223968	19	11113292	161267	171211
NM_000527.4(LDLR):c.1202T>A (p.Leu401His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11223969	19	11113293	3735	18774
NM_000527.4(LDLR):c.1204_1205del (p.Phe402Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11223971 - 11223972	19	11113295 - 11113296	403638	390621
NM_000527.4(LDLR):c.1205dup (p.Phe403Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11223972	19	11113296	251729	246043
NM_000527.4(LDLR):c.1206_1207delCT (p.Phe403Hisfs)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11223973 - 11223974	19	11113297 - 11113298	251730	246044
NM_000527.4(LDLR):c.1207T>C (p.Phe403Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11223974	19	11113298	251732	246045
NM_000527.4(LDLR):c.1207_1209del (p.Phe403del)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11223974 - 11223976	19	11113298 - 11113300	251731	246046
NM_000527.4(LDLR):c.1208del (p.Phe403Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11223975	19	11113299	251733	246047
NM_000527.4(LDLR):c.1209del (p.Phe403Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11223976	19	11113300	251734	246048
NM_000527.4(LDLR):c.1210A>T (p.Thr404Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11223977	19	11113301	431523	425037
NM_000527.4(LDLR):c.1210A>C (p.Thr404Pro)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	19	11223977	19	11113301	251735	246049
NM_000527.4(LDLR):c.1211C>T (p.Thr404Ile)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11223978	19	11113302	251736	246050
NM_000527.4(LDLR):c.1215C>G (p.Asn405Lys)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	19	11223982	19	11113306	251738	246052
NM_000527.4(LDLR):c.1216C>T (p.Arg406Trp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11223983	19	11113307	226351	228164
NM_000527.4(LDLR):c.1216C>A (p.Arg406=)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, multiple submitters, no conflicts	19	11223983	19	11113307	3746	18785
NM_000527.4(LDLR):c.1217G>A (p.Arg406Gln)	LDLR	Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11223984	19	11113308	228798	230981
NM_000527.4(LDLR):c.1217G>C (p.Arg406Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11223984	19	11113308	226352	228165
NM_000527.4(LDLR):c.1222G>A (p.Glu408Lys)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2018)	criteria provided, conflicting interpretations	19	11223989	19	11113313	36453	45116
NM_000527.4(LDLR):c.1223A>T (p.Glu408Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11223990	19	11113314	251740	246054
NM_000527.4(LDLR):c.1223A>C (p.Glu408Ala)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11223990	19	11113314	251739	246053
NM_000527.4(LDLR):c.1230G>T (p.Arg410Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11223997	19	11113321	251742	246056
NM_000527.4(LDLR):c.1230G>C (p.Arg410Ser)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	19	11223997	19	11113321	251741	246055
NM_000527.4(LDLR):c.1231A>G (p.Lys411Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11223998	19	11113322	251743	246057
NM_000527.4(LDLR):c.1233delG (p.Met412Terfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224000	19	11113324	251744	246058
NM_000527.4(LDLR):c.1235T>C (p.Met412Thr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224002	19	11113326	251745	246059
NM_000527.4(LDLR):c.1238C>T (p.Thr413Met)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2017)	criteria provided, conflicting interpretations	19	11224005	19	11113329	161276	171212
NM_000527.4(LDLR):c.1241T>G (p.Leu414Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224008	19	11113332	251747	246061
NM_000527.4(LDLR):c.1243G>C (p.Asp415His)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224010	19	11113334	251748	246062
NM_000527.4(LDLR):c.1245_1249dup (p.Ser417Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224012 - 11224016	19	11113336 - 11113340	251751	246065
NM_000527.4(LDLR):c.1246C>T (p.Arg416Trp)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	19	11224013	19	11113337	183110	181252
NM_000527.4(LDLR):c.1247G>T (p.Arg416Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224014	19	11113338	251754	246068
NM_000527.4(LDLR):c.1247G>C (p.Arg416Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11224014	19	11113338	251753	246067
NM_000527.4(LDLR):c.1247G>A (p.Arg416Gln)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, multiple submitters, no conflicts	19	11224014	19	11113338	251752	246066
NM_000527.4(LDLR):c.1252G>T (p.Glu418Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224019	19	11113343	251755	246069
NM_000527.4(LDLR):c.1252G>A (p.Glu418Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11224019	19	11113343	225182	227097
NM_000527.4(LDLR):c.1255T>G (p.Tyr419Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224022	19	11113346	369853	354094
NM_000527.4(LDLR):c.1255T>C (p.Tyr419His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224022	19	11113346	251756	246070
NM_000527.4(LDLR):c.1257C>G (p.Tyr419Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11224024	19	11113348	251758	246072
NM_000527.4(LDLR):c.1257C>A (p.Tyr419Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11224024	19	11113348	251757	246071
NM_000527.4(LDLR):c.1265T>C (p.Leu422Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224032	19	11113356	251759	246073
NM_000527.4(LDLR):c.1268T>C (p.Ile423Thr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11224035	19	11113359	251760	246074
NM_000527.4(LDLR):c.1269C>G (p.Ile423Met)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11224036	19	11113360	431525	425039
NG_009060.1:g.28983_28984ins(96)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224039 - 11224040	19	11113363 - 11113364	251761	246075
NM_000527.4(LDLR):c.1274A>T (p.Asn425Ile)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224041	19	11113365	251762	246076
NM_000527.4(LDLR):c.1285G>T (p.Val429Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11224052	19	11113376	251767	246081
NM_000527.4(LDLR):c.1285G>C (p.Val429Leu)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11224052	19	11113376	226353	228166
NM_000527.4(LDLR):c.1285G>A (p.Val429Met)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, multiple submitters, no conflicts	19	11224052	19	11113376	3694	18733
NM_000527.4(LDLR):c.1291_1331del41 (p.Ala431Terfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224058 - 11224098	19	11113382 - 11113422	251769	246083
NM_000527.4(LDLR):c.1291G>A (p.Ala431Thr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224058	19	11113382	3695	18734
NM_000527.4(LDLR):c.1294C>G (p.Leu432Val)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 6, 2016)	criteria provided, conflicting interpretations	19	11224061	19	11113385	183111	181253
NM_000527.4(LDLR):c.1295T>C (p.Leu432Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224062	19	11113386	251770	246084
NM_000527.4(LDLR):c.1296_1298delGGA (p.Asp433del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224063 - 11224065	19	11113387 - 11113389	251771	246085
NM_000527.4(LDLR):c.1297G>T (p.Asp433Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224064	19	11113388	251772	246086
NM_000527.4(LDLR):c.1297G>C (p.Asp433His)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224064	19	11113388	3732	18771
NM_000527.4(LDLR):c.1301C>T (p.Thr434Met)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11224068	19	11113392	251775	246089
NM_000527.4(LDLR):c.1301C>G (p.Thr434Arg)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11224068	19	11113392	251774	246088
NM_000527.4(LDLR):c.1301C>A (p.Thr434Lys)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11224068	19	11113392	251773	246087
NM_000527.4(LDLR):c.1303delG (p.Glu435Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224070	19	11113394	251776	246090
NM_000527.4(LDLR):c.1306delG (p.Val436Trpfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224073	19	11113397	251777	246091
NM_000527.4(LDLR):c.1309dup (p.Ala437Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224076	19	11113400	251779	246093
NM_000527.4(LDLR):c.1322T>C (p.Ile441Thr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224089	19	11113413	251783	246097
NM_000527.4(LDLR):c.1322T>A (p.Ile441Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224089	19	11113413	251782	246096
NM_000527.4(LDLR):c.1323C>T (p.Ile441=)	LDLR	Familial hypercholesterolemia	Benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11224090	19	11113414	456650	468439
NM_000527.4(LDLR):c.1323C>G (p.Ile441Met)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224090	19	11113414	251784	246098
NM_000527.4(LDLR):c.1324T>C (p.Tyr442His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224091	19	11113415	251786	246100
NM_000527.4(LDLR):c.1324T>A (p.Tyr442Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224091	19	11113415	251785	246099
NM_000527.4(LDLR):c.1325A>G (p.Tyr442Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224092	19	11113416	251787	246101
NM_000527.4(LDLR):c.1326C>G (p.Tyr442Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224093	19	11113417	251788	246102
NM_000527.4(LDLR):c.1328G>C (p.Trp443Ser)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11224095	19	11113419	251790	246104
NM_000527.4(LDLR):c.1328G>A (p.Trp443Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224095	19	11113419	251789	246103
NM_000527.4(LDLR):c.1329G>T (p.Trp443Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224096	19	11113420	251793	246107
NM_000527.4(LDLR):c.1329G>C (p.Trp443Cys)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	19	11224096	19	11113420	251792	246106
NM_000527.4(LDLR):c.1329G>A (p.Trp443Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224096	19	11113420	251791	246105
NM_000527.4(LDLR):c.1330T>C (p.Ser444Pro)	LDLR	Familial hypercholesterolemia|not provided	Likely pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, multiple submitters, no conflicts	19	11224097	19	11113421	226354	228167
NM_000527.4(LDLR):c.1335C>A (p.Asp445Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224102	19	11113426	251794	246108
NM_000527.4(LDLR):c.1336del (p.Leu446Cysfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224103	19	11113427	251795	246109
NM_000527.4(LDLR):c.1339T>C (p.Ser447Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224106	19	11113430	251796	246110
NM_000527.4(LDLR):c.1340C>G (p.Ser447Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224107	19	11113431	251797	246111
NM_000527.4(LDLR):c.1342C>T (p.Gln448Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224109	19	11113433	251798	246112
NM_000527.4(LDLR):c.1343del (p.Gln448Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11224110	19	11113434	251799	246113
NM_000527.4(LDLR):c.1351A>T (p.Ile451Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224118	19	11113442	251800	246114
NM_000527.4(LDLR):c.1352T>C (p.Ile451Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11224119	19	11113443	251801	246115
NM_000527.4(LDLR):c.1358+1G>T	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224126	19	11113450	251803	246117
NM_000527.4(LDLR):c.1358+1G>A	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224126	19	11113450	251802	246116
NM_000527.4(LDLR):c.1358+2T>C	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11224127	19	11113451	369862	354095
NM_000527.4(LDLR):c.1358+2T>A	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	19	11224127	19	11113451	36455	45118
NM_000527.4(LDLR):c.1358+3_1358+8del	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224128 - 11224133	19	11113452 - 11113457	251804	246118
NM_000527.4(LDLR):c.1358+5G>T	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11224130	19	11113454	403640	390622
NM_000527.4(LDLR):c.1359-31_1359-23delinsCGGCT	LDLR|MIR6886	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11224180 - 11224188	19	11113504 - 11113512	251805	246119
NM_000527.4(LDLR):c.1359-5C>G	LDLR|MIR6886	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Oct 31, 2017)	criteria provided, conflicting interpretations	19	11224206	19	11113530	251808	246122
NM_000527.4(LDLR):c.1359-1G>C	LDLR|MIR6886	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224210	19	11113534	251811	246125
NM_000527.4(LDLR):c.1359-1G>A	LDLR|MIR6886	Familial hypercholesterolemia|Hypercholesterolaemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, multiple submitters, no conflicts	19	11224210	19	11113534	162499	172183
NM_000527.4(LDLR):c.1361C>A (p.Thr454Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224213	19	11113537	251812	246126
NM_000527.4(LDLR):c.1363del (p.Gln455Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224215	19	11113539	251814	246128
NM_000527.4(LDLR):c.1363C>T (p.Gln455Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224215	19	11113539	251813	246127
NM_000527.4(LDLR):c.1365delG (p.Gln455Hisfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224217	19	11113541	251815	246129
NM_000527.4(LDLR):c.1367T>A (p.Leu456His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224219	19	11113543	251817	246130
NM_000527.4(LDLR):c.1367_1376del (p.Leu456Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11224219 - 11224228	19	11113543 - 11113552	251816	246131
NM_000527.4(LDLR):c.1371_1374dupCAGA (p.Ala459Glnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, multiple submitters, no conflicts	19	11224223 - 11224226	19	11113547 - 11113550	226355	228168
NM_000527.4(LDLR):c.1374_1375del (p.Arg458Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224226 - 11224227	19	11113550 - 11113551	251818	246132
NM_000527.4(LDLR):c.1377_1380del (p.His460Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11224229 - 11224232	19	11113553 - 11113556	251820	246134
NM_000527.4(LDLR):c.1379_1402del24insCAGCTTGACCCGC (p.His460Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224231 - 11224254	19	11113555 - 11113578	251822	246136
NM_000527.4(LDLR):c.1379_1396del18insCAGCTTA (p.His460Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224231 - 11224248	19	11113555 - 11113572	251821	246135
NM_000527.4(LDLR):c.1392delC (p.Tyr465Metfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	19	11224244	19	11113568	251825	246139
NM_000527.4(LDLR):c.1394A>G (p.Tyr465Cys)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11224246	19	11113570	251826	246140
NM_000527.4(LDLR):c.1403T>A (p.Val468Asp)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11224255	19	11113579	251828	246142
NM_000527.4(LDLR):c.1408A>G (p.Ser470Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11224260	19	11113584	369856	354096
NM_000527.4(LDLR):c.1414G>T (p.Asp472Tyr)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2017)	criteria provided, conflicting interpretations	19	11224266	19	11113590	183116	181258
NM_000527.4(LDLR):c.1415_1418dupACAT (p.Gln474Hisfs)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	19	11224267 - 11224270	19	11113591 - 11113594	251830	246144
NM_000527.4(LDLR):c.1417_1431delATCCAGGCCCCCGAC (p.Ile473_Asp477del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224269 - 11224283	19	11113593 - 11113607	251831	246146
NM_000527.4(LDLR):c.1418T>G (p.Ile473Ser)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11224270	19	11113594	548075	538572
NM_000527.4(LDLR):c.1420C>T (p.Gln474Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224272	19	11113596	251834	246148
NM_000527.4(LDLR):c.1423_1424delGCinsA (p.Ala475Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224275 - 11224276	19	11113599 - 11113600	251835	246149
NM_000527.4(LDLR):c.1424C>T (p.Ala475Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11224276	19	11113600	251836	246150
NM_000527.4(LDLR):c.1426C>T (p.Pro476Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224278	19	11113602	251837	246151
NM_000527.4(LDLR):c.1428dupC (p.Asp477Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	19	11224280	19	11113604	228357	230982
NM_000527.4(LDLR):c.1429G>A (p.Asp477Asn)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11224281	19	11113605	251838	246152
NM_000527.4(LDLR):c.1432G>T (p.Gly478Trp)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11224284	19	11113608	548076	538573
NM_000527.4(LDLR):c.1432G>A (p.Gly478Arg)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Apr 26, 2018)	criteria provided, conflicting interpretations	19	11224284	19	11113608	161277	171213
NM_000527.4(LDLR):c.1434del (p.Leu479Trpfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224286	19	11113610	251839	246153
NM_000527.4(LDLR):c.1436T>C (p.Leu479Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224288	19	11113612	251840	246154
NM_000527.4(LDLR):c.1438G>C (p.Ala480Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224290	19	11113614	251841	246155
NM_000527.4(LDLR):c.1439_1449delCTGTGGACTGG (p.Ala480Aspfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224291 - 11224301	19	11113615 - 11113625	251842	246156
NM_000527.4(LDLR):c.1441G>A (p.Val481Met)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224293	19	11113617	251843	246157
NM_000527.4(LDLR):c.1444G>T (p.Asp482Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224296	19	11113620	251845	246159
NM_000527.4(LDLR):c.1444G>C (p.Asp482His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224296	19	11113620	251844	246158
NM_000527.4(LDLR):c.1444G>A (p.Asp482Asn)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: May 11, 2017)	criteria provided, conflicting interpretations	19	11224296	19	11113620	161284	171214
NM_000527.4(LDLR):c.1445A>G (p.Asp482Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224297	19	11113621	251846	246160
NM_000527.4(LDLR):c.1447T>C (p.Trp483Arg)	LDLR	Familial hypercholesterolemia|not provided	Likely pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, multiple submitters, no conflicts	19	11224299	19	11113623	251847	246161
NM_000527.4(LDLR):c.1448G>A (p.Trp483Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224300	19	11113624	226356	228169
NM_000527.4(LDLR):c.1449G>A (p.Trp483Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11224301	19	11113625	251849	246162
NM_000527.4(LDLR):c.1454A>G (p.His485Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224306	19	11113630	251848	246164
NM_000527.4(LDLR):c.1455C>G (p.His485Gln)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11224307	19	11113631	251851	246165
NM_000527.4(LDLR):c.1461dup (p.Ile488Hisfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11224313	19	11113637	523734	514384
NM_000527.4(LDLR):c.1462_1463insC (p.Ile488Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11224314 - 11224315	19	11113638 - 11113639	523735	514385
NM_000527.4(LDLR):c.1463T>G (p.Ile488Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224315	19	11113639	251858	246172
NM_000527.4(LDLR):c.1463T>C (p.Ile488Thr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 14, 2018)	criteria provided, conflicting interpretations	19	11224315	19	11113639	251857	246171
NM_000527.4(LDLR):c.1463T>A (p.Ile488Asn)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224315	19	11113639	251856	246170
NM_000527.4(LDLR):c.1466A>G (p.Tyr489Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224318	19	11113642	251859	246173
NM_000527.4(LDLR):c.1467C>G (p.Tyr489Ter)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224319	19	11113643	161270	171215
NM_000527.4(LDLR):c.1468T>G (p.Trp490Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224320	19	11113644	251860	246174
NM_000527.4(LDLR):c.1468T>C (p.Trp490Arg)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 15, 2017)	criteria provided, conflicting interpretations	19	11224320	19	11113644	180402	178734
NM_000527.4(LDLR):c.1469G>A (p.Trp490Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224321	19	11113645	226357	228170
NM_000527.4(LDLR):c.1470G>A (p.Trp490Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224322	19	11113646	251861	246175
NM_000527.4(LDLR):c.1471dup (p.Thr491Asnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224323	19	11113647	251862	246176
NM_000527.4(LDLR):c.1472C>A (p.Thr491Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224324	19	11113648	251863	246177
NM_000527.4(LDLR):c.1474del (p.Asp492Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11224326	19	11113650	431528	425042
NM_000527.4(LDLR):c.1474G>C (p.Asp492His)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Conflicting interpretations of pathogenicity(Last reviewed: May 14, 2018)	criteria provided, conflicting interpretations	19	11224326	19	11113650	251864	246178
NM_000527.4(LDLR):c.1474G>A (p.Asp492Asn)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	19	11224326	19	11113650	161285	171216
NM_000527.4(LDLR):c.1475A>G (p.Asp492Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224327	19	11113651	251865	246179
NM_000527.4(LDLR):c.1477_1479delTCTinsAGAGACA (p.Ser493Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224329 - 11224331	19	11113653 - 11113655	251866	246180
NM_000527.4(LDLR):c.1478_1479delCT (p.Ser493Cysfs)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, multiple submitters, no conflicts	19	11224330 - 11224331	19	11113654 - 11113655	222688	224548
NM_000527.4(LDLR):c.1486_1487delGG (p.Gly496Hisfs)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224338 - 11224339	19	11113662 - 11113663	222689	224549
NM_000527.4(LDLR):c.1487G>T (p.Gly496Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11224339	19	11113663	251867	246181
NM_000527.4(LDLR):c.1489A>C (p.Thr497Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224341	19	11113665	251868	246182
NM_000527.4(LDLR):c.1496_1497del (p.Ser499Cysfs)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11224348 - 11224349	19	11113672 - 11113673	251871	246185
NM_000527.4(LDLR):c.1498_1499del (p.Val500Cysfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224350 - 11224351	19	11113674 - 11113675	251872	246186
NM_000527.4(LDLR):c.1502dup (p.Asp502Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224354	19	11113678	251875	246189
NM_000527.4(LDLR):c.1502C>T (p.Ala501Val)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 30, 2017)	criteria provided, conflicting interpretations	19	11224354	19	11113678	251874	246188
NM_000527.4(LDLR):c.1502C>A (p.Ala501Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224354	19	11113678	251873	246187
NM_000527.4(LDLR):c.1510A>T (p.Lys504Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11224362	19	11113686	251878	246192
NM_000527.4(LDLR):c.1514G>A (p.Gly505Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224366	19	11113690	251879	246193
NM_000527.4(LDLR):c.1516_1562del47 (p.Val506Hisfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224368 - 11224414	19	11113692 - 11113738	251880	246195
NM_000527.4(LDLR):c.1520A>C (p.Lys507Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224372	19	11113696	251883	246197
NM_000527.4(LDLR):c.1522delAinsCTGAAT (p.Arg508Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224374	19	11113698	251884	246198
NM_000527.4(LDLR):c.1525A>G (p.Lys509Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224377	19	11113701	251885	246199
NM_000527.4(LDLR):c.1529C>T (p.Thr510Met)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11224381	19	11113705	251886	246200
NM_000527.4(LDLR):c.1532T>G (p.Leu511Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224384	19	11113708	251888	246202
NM_000527.4(LDLR):c.1532T>C (p.Leu511Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224384	19	11113708	251887	246201
NM_000527.4(LDLR):c.1533dupA (p.Phe512Ilefs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11224385	19	11113709	251889	246203
NM_000527.4(LDLR):c.1538G>A (p.Arg513Lys)	LDLR	Familial hypercholesterolemia	Likely benign(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11224390	19	11113714	251890	246204
NM_000527.4(LDLR):c.1546G>A (p.Gly516Ser)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	19	11224398	19	11113722	226359	228172
NM_000527.4(LDLR):c.1549_1555del (p.Ser517Glnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224401 - 11224407	19	11113725 - 11113731	251892	246207
NM_000527.4(LDLR):c.1552A>G (p.Lys518Glu)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11224404	19	11113728	251894	246208
NM_000527.4(LDLR):c.1555C>T (p.Pro519Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11224407	19	11113731	251896	246210
NM_000527.4(LDLR):c.1558A>G (p.Arg520Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224410	19	11113734	251897	246211
NM_000527.4(LDLR):c.1567G>T (p.Val523Leu)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11224419	19	11113743	251900	246213
NM_000527.4(LDLR):c.1567_1575delGTGGTGGAT (p.Val523_Asp525del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224419 - 11224427	19	11113743 - 11113751	251899	246214
NM_000527.4(LDLR):c.1567G>A (p.Val523Met)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224419	19	11113743	3696	18735
NM_000527.4(LDLR):c.1570G>A (p.Val524Met)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11224422	19	11113746	183119	181261
NM_000527.4(LDLR):c.1571T>G (p.Val524Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224423	19	11113747	251901	246215
NM_000527.4(LDLR):c.1573_1586+5del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11224425 - 11224443	19	11113749 - 11113767	431530	425044
NM_000527.4(LDLR):c.1574A>T (p.Asp525Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224426	19	11113750	251902	246216
NM_000527.4(LDLR):c.1576C>A (p.Pro526Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224428	19	11113752	251903	246217
NM_000527.4(LDLR):c.1576C>T (p.Pro526Ser)	LDLR	Familial hypercholesterolemia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2017)	criteria provided, conflicting interpretations	19	11224428	19	11113752	183120	181262
NM_000527.4(LDLR):c.1577C>G (p.Pro526Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224429	19	11113753	251904	246218
NM_000527.4(LDLR):c.1586G>A (p.Gly529Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224438	19	11113762	237863	243273
NM_000527.4(LDLR):c.1586+1G>T	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224439	19	11113763	251906	246220
NM_000527.4(LDLR):c.1586+1G>A	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11224439	19	11113763	251905	246219
NM_000527.4(LDLR):c.1586+2T>C	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224440	19	11113764	251908	246222
NM_000527.4(LDLR):c.1586+2T>A	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224440	19	11113764	251907	246221
NM_000527.4(LDLR):c.1586+5G>A	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 25, 2017)	criteria provided, conflicting interpretations	19	11224443	19	11113767	251909	246223
NM_000527.4(LDLR):c.1586+12C>T	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11224450	19	11113774	431532	425046
NM_000527.4(LDLR):c.1587-11C>T	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11226759	19	11116083	548078	538575
NM_000527.4(LDLR):c.1587-5_1618del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11226765 - 11226801	19	11116089 - 11116125	441215	434858
NM_000527.4(LDLR):c.1587-2A>T	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11226768	19	11116092	251912	246226
NM_000527.4(LDLR):c.1587-2A>G	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226768	19	11116092	251911	246225
GRCh38/hg38 19p13.2(chr19:11116093-11116999)x3	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11226769 - 11227675	19	11116093 - 11116999	548099	538595
GRCh38/hg38 19p13.2(chr19:11116093-11116999)x1	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11226769 - 11227675	19	11116093 - 11116999	548088	538584
NM_000527.4(LDLR):c.1587-1G>A	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226769	19	11116093	251922	246227
NM_000527.4(LDLR):c.1587_1591delCTTCA (p.Phe530Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226770 - 11226774	19	11116094 - 11116098	251923	246228
NM_000527.4(LDLR):c.1592_1627del36 (p.Met531_Ile542del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226775 - 11226810	19	11116099 - 11116134	251924	246229
NM_000527.4(LDLR):c.1592T>G (p.Met531Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11226775	19	11116099	226362	228175
NM_000527.4(LDLR):c.1595A>G (p.Tyr532Cys)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11226778	19	11116102	403641	390623
NM_000527.4(LDLR):c.1596C>G (p.Tyr532Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11226779	19	11116103	441216	434843
NM_000527.4(LDLR):c.1597T>C (p.Trp533Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11226780	19	11116104	251925	246230
NM_000527.4(LDLR):c.1598G>A (p.Trp533Ter)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11226781	19	11116105	251926	246231
NM_000527.4(LDLR):c.1599G>A (p.Trp533Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	19	11226782	19	11116106	251927	246232
NM_000527.4(LDLR):c.1600_1608delACTGACTGG (p.Thr534_Trp536del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226783 - 11226791	19	11116107 - 11116115	251928	246233
NM_000527.4(LDLR):c.1601C>A (p.Thr534Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226784	19	11116108	251929	246234
NM_000527.4(LDLR):c.1603G>T (p.Asp535Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226786	19	11116110	251930	246235
NM_000527.4(LDLR):c.1606T>G (p.Trp536Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11226789	19	11116113	251931	246236
NM_000527.4(LDLR):c.1607G>A (p.Trp536Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11226790	19	11116114	251932	246237
NM_000527.4(LDLR):c.1609G>T (p.Gly537Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11226792	19	11116116	251933	246238
NM_000527.4(LDLR):c.1610del (p.Gly537Glufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11226793	19	11116117	251934	246239
NM_000527.4(LDLR):c.1618G>A (p.Ala540Thr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11226801	19	11116125	226363	228176
NM_000527.4(LDLR):c.1625T>G (p.Ile542Ser)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11226808	19	11116132	251939	246244
NM_000527.4(LDLR):c.1629_1652del (p.Lys543_Asp551delinsAsn)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11226812 - 11226835	19	11116136 - 11116159	251940	246245
NM_000527.4(LDLR):c.1632_1633del (p.Gly546Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11226815 - 11226816	19	11116139 - 11116140	403642	390624
NM_000527.4(LDLR):c.1632del (p.Gly546Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11226815	19	11116139	251941	246246
NM_000527.4(LDLR):c.1633G>T (p.Gly545Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11226816	19	11116140	251944	246249
NM_000527.4(LDLR):c.1633G>C (p.Gly545Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226816	19	11116140	251943	246248
NM_000527.4(LDLR):c.1633G>A (p.Gly545Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11226816	19	11116140	251942	246247
NM_000527.4(LDLR):c.1634G>A (p.Gly545Glu)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11226817	19	11116141	251945	246250
NM_000527.4(LDLR):c.1636G>C (p.Gly546Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226819	19	11116143	251946	246251
NM_000527.4(LDLR):c.1637G>T (p.Gly546Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11226820	19	11116144	251947	246252
NM_000527.4(LDLR):c.1637G>A (p.Gly546Asp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11226820	19	11116144	3697	18736
NM_000527.4(LDLR):c.1640T>C (p.Leu547Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, multiple submitters, no conflicts	19	11226823	19	11116147	251949	246253
NM_000527.4(LDLR):c.1640_1652delTGAATGGTGTGGAinsAGCGTCATCTTCCTGAC (p.Leu547Glnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11226823 - 11226835	19	11116147 - 11116159	251948	246254
NM_000527.4(LDLR):c.1644T>G (p.Asn548Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11226827	19	11116151	251952	246256
NM_000527.4(LDLR):c.1644T>A (p.Asn548Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226827	19	11116151	251951	246255
NM_000527.4(LDLR):c.1644_1645insC (p.Gly549Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226827 - 11226828	19	11116151 - 11116152	251950	246257
NM_000527.4(LDLR):c.1645_1646insC (p.Gly549Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226828 - 11226829	19	11116152 - 11116153	251953	246258
NM_000527.4(LDLR):c.1646G>T (p.Gly549Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226829	19	11116153	251955	246259
NM_000527.4(LDLR):c.1646G>A (p.Gly549Asp)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2018)	criteria provided, multiple submitters, no conflicts	19	11226829	19	11116153	3698	18737
NM_000527.4(LDLR):c.1651delG (p.Asp551Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226834	19	11116158	251956	246260
NM_000527.4(LDLR):c.1655delT (p.Ile552Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226838	19	11116162	251954	246261
NM_000527.4(LDLR):c.1659_1661delCTCinsATACTTTCA (p.Tyr553_Ala860del)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11226842 - 11226844	19	11116166 - 11116168	251958	246263
NM_000527.4(LDLR):c.1661C>A (p.Ser554Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226844	19	11116168	251959	246264
NM_000527.4(LDLR):c.1662_1669dup (p.Thr557Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11226845 - 11226852	19	11116169 - 11116176	251961	246266
NM_000527.4(LDLR):c.1664T>C (p.Leu555Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11226847	19	11116171	251962	246267
NM_000527.4(LDLR):c.1671_1672delTG (p.Glu558Lysfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226854 - 11226855	19	11116178 - 11116179	251963	246268
NM_000527.4(LDLR):c.1672G>T (p.Glu558Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11226855	19	11116179	251964	246269
NM_000527.4(LDLR):c.1673_1676del (p.Glu558Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11226856 - 11226859	19	11116180 - 11116183	431534	425048
NM_000527.4(LDLR):c.1681C>T (p.Gln561Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11226864	19	11116188	251965	246270
NM_000527.4(LDLR):c.1683del (p.Gln561Hisfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226866	19	11116190	251966	246271
NM_000527.4(LDLR):c.1684_1686dup (p.Trp562_Pro563insTrp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226867 - 11226869	19	11116191 - 11116193	251967	246272
NM_000527.4(LDLR):c.1685G>A (p.Trp562Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226868	19	11116192	226364	228177
NM_000527.4(LDLR):c.1686G>A (p.Trp562Ter)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11226869	19	11116193	251969	246273
NM_000527.4(LDLR):c.1686_1693delGCCCAATGinsT (p.Trp562Cysfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226869 - 11226876	19	11116193 - 11116200	251968	246274
NM_000527.4(LDLR):c.1687C>T (p.Pro563Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11226870	19	11116194	251970	246275
NM_000527.4(LDLR):c.1688C>A (p.Pro563His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226871	19	11116195	251971	246276
NM_000527.4(LDLR):c.1689dup (p.Asn564Glnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11226872	19	11116196	251972	246277
NM_000527.4(LDLR):c.1690A>G (p.Asn564Asp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11226873	19	11116197	251973	246278
NM_000527.4(LDLR):c.1690A>C (p.Asn564His)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Apr 4, 2018)	criteria provided, conflicting interpretations	19	11226873	19	11116197	226365	18776
NM_000527.4(LDLR):c.1691A>G (p.Asn564Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, multiple submitters, no conflicts	19	11226874	19	11116198	224616	226401
NM_000527.4(LDLR):c.1693_1696delGGCA (p.Gly565Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11226876 - 11226879	19	11116200 - 11116203	548079	538576
NM_000527.4(LDLR):c.1694G>C (p.Gly565Ala)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11226877	19	11116201	226366	228178
NM_000527.4(LDLR):c.1694G>T (p.Gly565Val)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	19	11226877	19	11116201	3688	18727
NM_000527.4(LDLR):c.1698_1704delCACCCTAinsGCCCAAT (p.Ile566_Leu568delinsMetProAsn)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11226881 - 11226887	19	11116205 - 11116211	251974	246279
NM_000527.4(LDLR):c.1702C>G (p.Leu568Val)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11226885	19	11116209	251976	246280
NM_000527.4(LDLR):c.1702_1705dup (p.Asp569Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226885 - 11226888	19	11116209 - 11116212	251975	246281
NM_000527.4(LDLR):c.1703T>C (p.Leu568Pro)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11226886	19	11116210	251977	246282
NM_000527.4(LDLR):c.1705G>T (p.Asp569Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11226888	19	11116212	251979	246283
NM_000527.4(LDLR):c.1705+1del (p.Asp569Ilefs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11226889	19	11116213	441217	434844
NM_000527.4(LDLR):c.1705+1G>T	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11226889	19	11116213	251981	246286
NM_000527.4(LDLR):c.1705+1G>C	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11226889	19	11116213	251980	246285
NM_000527.4(LDLR):c.1705+1G>A	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, multiple submitters, no conflicts	19	11226889	19	11116213	226367	228179
NM_000527.4(LDLR):c.1705+2_1705+3insC	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11226890 - 11226891	19	11116214 - 11116215	251982	246287
NM_000527.4(LDLR):c.1706-10G>A	LDLR	Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	19	11227525	19	11116849	226368	228180
NM_000527.4(LDLR):c.1706-2A>C	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11227533	19	11116857	251987	246292
NM_000527.4(LDLR):c.1706-2A>T	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11227533	19	11116857	237865	243274
NM_000527.4(LDLR):c.1706-1G>T	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	19	11227534	19	11116858	251993	246294
NM_000527.4(LDLR):c.1706-1G>A	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227534	19	11116858	251992	246293
NM_000527.4(LDLR):c.1715G>A (p.Ser572Asn)	LDLR	Familial hypercholesterolemia	Likely benign(Last reviewed: Mar 22, 2017)	criteria provided, multiple submitters, no conflicts	19	11227544	19	11116868	251994	246295
NM_000527.4(LDLR):c.1715_1719delGTGGCinsA (p.Ser572Asnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227544 - 11227548	19	11116868 - 11116872	226369	228181
NM_000527.4(LDLR):c.1718del (p.Gly573Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227547	19	11116871	251995	246296
NM_000527.4(LDLR):c.1720C>T (p.Arg574Cys)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 11, 2017)	criteria provided, conflicting interpretations	19	11227549	19	11116873	183123	181265
NM_000527.4(LDLR):c.1721G>A (p.Arg574His)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jul 3, 2018)	criteria provided, conflicting interpretations	19	11227550	19	11116874	251996	246297
NM_000527.4(LDLR):c.1721G>T (p.Arg574Leu)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11227550	19	11116874	237867	243275
NM_000527.4(LDLR):c.1723C>T (p.Leu575Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11227552	19	11116876	438324	431955
NM_000527.4(LDLR):c.1727A>G (p.Tyr576Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227556	19	11116880	251999	246300
NM_000527.4(LDLR):c.1727A>C (p.Tyr576Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227556	19	11116880	251998	246299
NM_000527.4(LDLR):c.1729T>C (p.Trp577Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227558	19	11116882	252001	246301
NM_000527.4(LDLR):c.1729T>G (p.Trp577Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 22, 2017)	criteria provided, multiple submitters, no conflicts	19	11227558	19	11116882	252000	246302
NM_000527.4(LDLR):c.1730G>A (p.Trp577Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227559	19	11116883	375821	362713
NM_000527.4(LDLR):c.1730G>C (p.Trp577Ser)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227559	19	11116883	252003	246303
NM_000527.4(LDLR):c.1730_1738delGGGTTGACT (p.Trp577_Asp579del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227559 - 11227567	19	11116883 - 11116891	252002	246304
NM_000527.4(LDLR):c.1731G>T (p.Trp577Cys)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	19	11227560	19	11116884	252004	246305
NM_000527.4(LDLR):c.1731G>A (p.Trp577Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, multiple submitters, no conflicts	19	11227560	19	11116884	226370	228182
NM_000527.4(LDLR):c.1735G>A (p.Asp579Asn)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, multiple submitters, no conflicts	19	11227564	19	11116888	252006	246306
NM_000527.4(LDLR):c.1735G>T (p.Asp579Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227564	19	11116888	226371	228183
NM_000527.4(LDLR):c.1736A>G (p.Asp579Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11227565	19	11116889	252008	246309
NM_000527.4(LDLR):c.1736A>C (p.Asp579Ala)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227565	19	11116889	252007	246308
NM_000527.4(LDLR):c.1737del (p.Ser580Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227566	19	11116890	252010	246311
NM_000527.4(LDLR):c.1737C>G (p.Asp579Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227566	19	11116890	252009	246310
NM_000527.4(LDLR):c.1739C>T (p.Ser580Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11227568	19	11116892	438325	431956
NM_000527.4(LDLR):c.1741A>T (p.Lys581Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11227570	19	11116894	403643	390625
NM_000527.4(LDLR):c.1744C>G (p.Leu582Val)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11227573	19	11116897	548080	538577
NM_000527.4(LDLR):c.1744C>T (p.Leu582Phe)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227573	19	11116897	430786	424330
NM_000527.4(LDLR):c.1745_1746delTT (p.Leu582Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227574 - 11227575	19	11116898 - 11116899	252011	246312
NM_000527.4(LDLR):c.1745T>C (p.Leu582Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11227574	19	11116898	226372	228184
NM_000527.4(LDLR):c.1747C>T (p.His583Tyr)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2018)	criteria provided, conflicting interpretations	19	11227576	19	11116900	200921	198015
NM_000527.4(LDLR):c.1747C>G (p.His583Asp)	LDLR	Familial hypercholesterolemia|not provided	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227576	19	11116900	183124	181266
NM_000527.4(LDLR):c.1748A>G (p.His583Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11227577	19	11116901	252012	246313
NM_000527.4(LDLR):c.1749C>G (p.His583Gln)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11227578	19	11116902	441220	434845
NM_000527.4(LDLR):c.1749C>A (p.His583Gln)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227578	19	11116902	252014	246314
NM_000527.4(LDLR):c.1749_1753del (p.Ser584Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11227578 - 11227582	19	11116902 - 11116906	252013	246315
NM_000527.4(LDLR):c.1750T>C (p.Ser584Pro)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11227579	19	11116903	252015	246316
NM_000527.4(LDLR):c.1752del (p.Ile585Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227581	19	11116905	252016	246317
NM_000527.4(LDLR):c.1754T>C (p.Ile585Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227583	19	11116907	252018	246319
NM_000527.4(LDLR):c.1754T>A (p.Ile585Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227583	19	11116907	252017	246318
NM_000527.4(LDLR):c.1756del (p.Ser586Glnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11227585	19	11116909	252019	246320
NM_000527.4(LDLR):c.1757C>G (p.Ser586Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11227586	19	11116910	441221	434846
NM_000527.4(LDLR):c.1757C>A (p.Ser586Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11227586	19	11116910	438326	431957
NM_000527.4(LDLR):c.1759del (p.Ser587Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227588	19	11116912	252020	246321
NM_000527.4(LDLR):c.1765G>A (p.Asp589Asn)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	19	11227594	19	11116918	252022	246323
NM_000527.4(LDLR):c.1766delA (p.Asp589Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227595	19	11116919	252024	246325
NM_000527.4(LDLR):c.1766_1767delAT (p.Asp589Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227595 - 11227596	19	11116919 - 11116920	252023	246324
NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided|Hypercholesterolaemia	Pathogenic/Likely pathogenic(Last reviewed: May 22, 2018)	criteria provided, multiple submitters, no conflicts	19	11227604	19	11116928	161271	171217
NM_000527.4(LDLR):c.1778dup (p.Asn594Glnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227607	19	11116931	252026	246327
NM_000527.4(LDLR):c.1778del (p.Gly593Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11227607	19	11116931	252025	246326
NM_000527.4(LDLR):c.1779delC (p.Asn594Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227608	19	11116932	252027	246328
NM_000527.4(LDLR):c.1783C>T (p.Arg595Trp)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Oct 24, 2017)	criteria provided, conflicting interpretations	19	11227612	19	11116936	161290	171218
NM_000527.4(LDLR):c.1784G>T (p.Arg595Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227613	19	11116937	252029	246329
NM_000527.4(LDLR):c.1784_1790delGGAAGAC (p.Arg595Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227613 - 11227619	19	11116937 - 11116943	252028	246330
NM_000527.4(LDLR):c.1784G>A (p.Arg595Gln)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 11, 2018)	criteria provided, conflicting interpretations	19	11227613	19	11116937	183126	181268
NM_000527.4(LDLR):c.1786A>T (p.Lys596Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227615	19	11116939	252030	246331
NM_000527.4(LDLR):c.1789del (p.Thr597Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227618	19	11116942	252031	246332
NM_000527.4(LDLR):c.1796T>G (p.Leu599Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227625	19	11116949	252036	246337
NM_000527.4(LDLR):c.1796T>C (p.Leu599Ser)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11227625	19	11116949	252035	246336
NM_000527.4(LDLR):c.1798G>T (p.Glu600Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227627	19	11116951	252037	246338
NM_000527.4(LDLR):c.1800G>C (p.Glu600Asp)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Apr 23, 2018)	criteria provided, conflicting interpretations	19	11227629	19	11116953	431535	425049
NM_000527.4(LDLR):c.1801G>T (p.Asp601Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227630	19	11116954	252039	246340
NM_000527.4(LDLR):c.1801G>C (p.Asp601His)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11227630	19	11116954	252038	246339
NM_000527.4(LDLR):c.1802dup (p.Asp601Glufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227631	19	11116955	252041	246342
NM_000527.4(LDLR):c.1802A>T (p.Asp601Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11227631	19	11116955	252040	246341
NM_000527.4(LDLR):c.1804G>T (p.Glu602Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11227633	19	11116957	431536	425050
NM_000527.4(LDLR):c.1807A>T (p.Lys603Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227636	19	11116960	252042	246343
NM_000527.4(LDLR):c.1813C>T (p.Leu605=)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11227642	19	11116966	252044	246345
NM_000527.4(LDLR):c.1814T>C (p.Leu605Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227643	19	11116967	226374	228186
NM_000527.4(LDLR):c.1815_1825del (p.Ala606Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11227644 - 11227654	19	11116968 - 11116978	252045	246346
NM_000527.4(LDLR):c.1816G>A (p.Ala606Thr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2017)	criteria provided, conflicting interpretations	19	11227645	19	11116969	252046	246347
NM_000527.4(LDLR):c.1816G>T (p.Ala606Ser)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Oct 25, 2017)	criteria provided, conflicting interpretations	19	11227645	19	11116969	161264	171219
NM_000527.4(LDLR):c.1820A>G (p.His607Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227649	19	11116973	252047	246348
NM_000527.4(LDLR):c.1822C>T (p.Pro608Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11227651	19	11116975	252049	246350
NM_000527.4(LDLR):c.1822C>A (p.Pro608Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227651	19	11116975	252048	246349
NM_000527.4(LDLR):c.1823C>T (p.Pro608Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227652	19	11116976	252051	246352
NM_000527.4(LDLR):c.1823C>G (p.Pro608Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11227652	19	11116976	252050	246351
NM_000527.4(LDLR):c.1829C>T (p.Ser610Phe)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227658	19	11116982	252055	246355
NM_000527.4(LDLR):c.1829C>G (p.Ser610Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11227658	19	11116982	252054	246354
NM_000527.4(LDLR):c.1829_1831del (p.Ser610del)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227658 - 11227660	19	11116982 - 11116984	252053	246356
NM_000527.4(LDLR):c.1832dup (p.Leu611Phefs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227661	19	11116985	252056	246357
NM_000527.4(LDLR):c.1833G>T (p.Leu611Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227662	19	11116986	252059	246359
NM_000527.4(LDLR):c.1833G>C (p.Leu611Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11227662	19	11116986	252058	246358
NM_000527.4(LDLR):c.1837G>A (p.Val613Ile)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11227666	19	11116990	161288	171220
NM_000527.4(LDLR):c.1840T>A (p.Phe614Ile)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11227669	19	11116993	252061	246362
NM_000527.4(LDLR):c.1841_1842delTT (p.Phe614Terfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227670 - 11227671	19	11116994 - 11116995	252062	246363
NM_000527.4(LDLR):c.1843G>A (p.Glu615Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11227672	19	11116996	252063	246364
NM_000527.4(LDLR):c.1844A>T (p.Glu615Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11227673	19	11116997	252064	246365
NM_000527.4(LDLR):c.1845G>A (p.Glu615=)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Oct 21, 2017)	criteria provided, conflicting interpretations	19	11227674	19	11116998	252065	246366
NM_000527.4(LDLR):c.1845+1G>T	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11227675	19	11116999	252069	246369
NM_000527.4(LDLR):c.1845+1G>C	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227675	19	11116999	252068	246368
NM_000527.4(LDLR):c.1845+1G>A	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227675	19	11116999	252067	246367
NM_000527.4(LDLR):c.1845+1del	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11227675	19	11116999	252066	246370
NM_000527.4(LDLR):c.1845+2T>C	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11227676	19	11117000	252070	246371
NM_000527.4(LDLR):c.1845+11C>G	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11227685	19	11117009	226375	228187
NM_000527.4(LDLR):c.1845+15C>A	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11227689	19	11117013	252071	246372
NM_000527.4(LDLR):c.1846-10G>T	LDLR	Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 29, 2017)	criteria provided, conflicting interpretations	19	11230758	19	11120082	252072	246373
NM_000527.4(LDLR):c.1846-2A>C	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230766	19	11120090	252073	246374
GRCh38/hg38 19p13.2(chr19:11120091-11120523)x1	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11230767 - 11231199	19	11120091 - 11120523	548091	538587
GRCh38/hg38 19p13.2(chr19:11120091-11123345)x1	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11230767 - 11234021	19	11120091 - 11123345	548090	538586
NM_000527.4(LDLR):c.1846-1G>C	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230767	19	11120091	252080	246376
NM_000527.4(LDLR):c.1846-1G>A	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, multiple submitters, no conflicts	19	11230767	19	11120091	252079	246375
NM_000527.4(LDLR):c.1853T>G (p.Val618Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11230775	19	11120099	375824	362716
NM_000527.4(LDLR):c.1853_1864del (p.Val618_Thr621del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230775 - 11230786	19	11120099 - 11120110	252081	246377
NM_000527.4(LDLR):c.1855T>C (p.Phe619Leu)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11230777	19	11120101	252083	246378
NM_000527.4(LDLR):c.1855_1856insA (p.Phe619Tyrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230777 - 11230778	19	11120101 - 11120102	252082	246379
NM_000527.4(LDLR):c.1856T>G (p.Phe619Cys)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11230778	19	11120102	252085	246381
NM_000527.4(LDLR):c.1856T>C (p.Phe619Ser)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11230778	19	11120102	252084	246380
NM_000527.4(LDLR):c.1858T>C (p.Trp620Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230780	19	11120104	252086	246382
NM_000527.4(LDLR):c.1859G>A (p.Trp620Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11230781	19	11120105	252087	246383
NM_000527.4(LDLR):c.1860G>C (p.Trp620Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11230782	19	11120106	252090	246385
NM_000527.4(LDLR):c.1860G>A (p.Trp620Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: May 17, 2017)	criteria provided, multiple submitters, no conflicts	19	11230782	19	11120106	252089	246384
NM_000527.4(LDLR):c.1860dup (p.Thr621Aspfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230782	19	11120106	252088	246386
NM_000527.4(LDLR):c.1860G>T (p.Trp620Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230782	19	11120106	226376	228189
NM_000527.4(LDLR):c.1862C>G (p.Thr621Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11230784	19	11120108	252091	246387
NM_000527.4(LDLR):c.1864G>A (p.Asp622Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11230786	19	11120110	252092	246388
NM_000527.4(LDLR):c.1865A>G (p.Asp622Gly)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11230787	19	11120111	252094	246390
NM_000527.4(LDLR):c.1865A>C (p.Asp622Ala)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230787	19	11120111	252093	246389
NM_000527.4(LDLR):c.1867A>G (p.Ile623Val)	LDLR	Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 8, 2018)	criteria provided, conflicting interpretations	19	11230789	19	11120113	252096	246391
NM_000527.4(LDLR):c.1867_1868del (p.Ile623Hisfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230789 - 11230790	19	11120113 - 11120114	252095	246392
NM_000527.4(LDLR):c.1868T>C (p.Ile623Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11230790	19	11120114	369855	354097
NM_000527.4(LDLR):c.1871_1873del (p.Ile624del)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11230793 - 11230795	19	11120117 - 11120119	252097	246393
NM_000527.4(LDLR):c.1872delC (p.Asn625Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230794	19	11120118	252098	246394
NM_000527.4(LDLR):c.1875C>T (p.Asn625=)	LDLR	Familial hypercholesterolemia|not specified|not provided	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11230797	19	11120121	68102	78993
NM_000527.4(LDLR):c.1876delG (p.Glu626Lysfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230798	19	11120122	252100	246396
NM_000527.4(LDLR):c.1878delA (p.E626Efs*38)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, multiple submitters, no conflicts	19	11230800	19	11120124	369872	354098
NM_000527.4(LDLR):c.1879G>A (p.Ala627Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11230801	19	11120125	252101	246397
NM_000527.4(LDLR):c.1880C>T (p.Ala627Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11230802	19	11120126	252102	246398
NM_000527.4(LDLR):c.1880C>A (p.Ala627Asp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11230802	19	11120126	226377	228190
NM_000527.4(LDLR):c.1883T>C (p.Ile628Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230805	19	11120129	252103	246399
NM_000527.4(LDLR):c.1885_1886insA (p.Phe629Tyrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11230807 - 11230808	19	11120131 - 11120132	431537	425051
NM_000527.4(LDLR):c.1886T>G (p.Phe629Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230808	19	11120132	252105	246400
NM_000527.4(LDLR):c.1886delT (p.Phe629Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	19	11230808	19	11120132	252104	246401
NM_000527.4(LDLR):c.1887C>T (p.Phe629=)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 8, 2018)	criteria provided, conflicting interpretations	19	11230809	19	11120133	237868	243276
NM_000527.4(LDLR):c.1891_2311+1062del (p.(?))	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11230813 - 11235082	19	11120137 - 11124406	3724	18763
NM_000527.4(LDLR):c.1892C>A (p.Ala631Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230814	19	11120138	252106	246402
NM_000527.4(LDLR):c.1897C>T (p.Arg633Cys)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2018)	criteria provided, multiple submitters, no conflicts	19	11230819	19	11120143	226379	228192
NM_000527.4(LDLR):c.1898G>T (p.Arg633Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230820	19	11120144	252107	246403
NM_000527.4(LDLR):c.1898G>A (p.Arg633His)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 28, 2017)	criteria provided, conflicting interpretations	19	11230820	19	11120144	226380	228193
NM_000527.4(LDLR):c.1900C>T (p.Leu634Phe)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11230822	19	11120146	548081	538578
NM_000527.4(LDLR):c.1904C>T (p.Thr635Ile)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230826	19	11120150	252108	246404
NM_000527.4(LDLR):c.1906G>A (p.Gly636Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230828	19	11120152	252109	246405
NM_000527.4(LDLR):c.1907G>T (p.Gly636Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11230829	19	11120153	438327	431958
NM_000527.4(LDLR):c.1911delC (p.Asp638Metfs)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	19	11230833	19	11120157	369869	354099
NM_000527.4(LDLR):c.1916T>G (p.Val639Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230838	19	11120162	252112	246408
NM_000527.4(LDLR):c.1920C>T (p.Asn640=)	LDLR	Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	19	11230842	19	11120166	237869	243277
NM_000527.4(LDLR):c.1925T>C (p.Leu642Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230847	19	11120171	252113	246409
NM_000527.4(LDLR):c.1934dup (p.Asn645Lysfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11230856	19	11120180	252116	246412
NM_000527.4(LDLR):c.1935_1936insA (p.Leu646Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230857 - 11230858	19	11120181 - 11120182	252117	246413
NM_000527.4(LDLR):c.1936del (p.Leu646Tyrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11230858	19	11120182	252119	246415
NM_000527.4(LDLR):c.1936C>A (p.Leu646Ile)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230858	19	11120182	252118	246414
NM_000527.4(LDLR):c.1942T>G (p.Ser648Ala)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11230864	19	11120188	431538	425052
NM_000527.4(LDLR):c.1942T>C (p.Ser648Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11230864	19	11120188	252120	246416
NM_000527.4(LDLR):c.1945C>T (p.Pro649Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230867	19	11120191	252121	246417
NM_000527.4(LDLR):c.1946dup (p.Glu650Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230868	19	11120192	252124	246420
NM_000527.4(LDLR):c.1946delC (p.Pro649Glnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230868	19	11120192	252123	246419
NM_000527.4(LDLR):c.1948_1952dup (p.Asp651Glufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11230870 - 11230874	19	11120194 - 11120198	252125	246422
NM_000527.4(LDLR):c.1951G>T (p.Asp651Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230873	19	11120197	252127	246423
NM_000527.4(LDLR):c.1951G>A (p.Asp651Asn)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11230873	19	11120197	183128	181270
NM_000527.4(LDLR):c.1952A>T (p.Asp651Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230874	19	11120198	252128	246424
NM_000527.4(LDLR):c.1954_1955delAT (p.Met652Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Apr 29, 2016)	criteria provided, multiple submitters, no conflicts	19	11230876 - 11230877	19	11120200 - 11120201	226381	228194
NM_000527.4(LDLR):c.1957G>T (p.Val653Phe)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	19	11230879	19	11120203	252129	246425
NM_000527.4(LDLR):c.1960C>T (p.Leu654Phe)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11230882	19	11120206	252132	246428
NM_000527.4(LDLR):c.1961_1965dup (p.His656Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11230883 - 11230887	19	11120207 - 11120211	252133	246429
NM_000527.4(LDLR):c.1964delT (p.Phe655Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230886	19	11120210	252134	246430
NM_000527.4(LDLR):c.1965C>G (p.Phe655Leu)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11230887	19	11120211	252135	246431
NM_000527.4(LDLR):c.1966C>A (p.His656Asn)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11230888	19	11120212	252136	246432
NM_000527.4(LDLR):c.1968C>G (p.His656Gln)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230890	19	11120214	252137	246433
NM_000527.4(LDLR):c.1973T>C (p.Leu658Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11230895	19	11120219	252138	246434
NM_000527.4(LDLR):c.1975_1987+16del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230897 - 11230925	19	11120221 - 11120249	252139	246436
NM_000527.4(LDLR):c.1978C>A (p.Gln660Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230900	19	11120224	252143	246439
NM_000527.4(LDLR):c.1979A>G (p.Gln660Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230901	19	11120225	252144	246440
NM_000527.4(LDLR):c.1986_1987delAGinsC (p.Arg662Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230908 - 11230909	19	11120232 - 11120233	252145	246441
NM_000527.4(LDLR):c.1987delG (p.Gly663Glufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230909	19	11120233	252146	246442
NM_000527.4(LDLR):c.1987+1_1987+33del	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230910 - 11230942	19	11120234 - 11120266	252147	246443
NM_000527.4(LDLR):c.1988-52_2006del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230994 - 11231064	19	11120318 - 11120388	252150	246446
NM_000527.4(LDLR):c.1988-2A>T	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11231044	19	11120368	252153	246449
NM_000527.4(LDLR):c.1988-1G>A	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11231045	19	11120369	438329	431959
NM_000527.4(LDLR):c.1988G>A (p.Gly663Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231046	19	11120370	252155	246450
NM_000527.4(LDLR):c.1996_2012del (p.Trp666Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231054 - 11231070	19	11120378 - 11120394	252157	246452
NM_000527.4(LDLR):c.1997G>A (p.Trp666Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11231055	19	11120379	252158	246453
NM_000527.4(LDLR):c.1998G>A (p.Trp666Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11231056	19	11120380	252161	246455
NM_000527.4(LDLR):c.1998delG (p.Trp666Cysfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231056	19	11120380	252160	246456
NM_000527.4(LDLR):c.1999T>C (p.Cys667Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11231057	19	11120381	252163	246458
NM_000527.4(LDLR):c.1999T>A (p.Cys667Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231057	19	11120381	252162	246457
NM_000527.4(LDLR):c.2000G>T (p.Cys667Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231058	19	11120382	252165	246459
NM_000527.4(LDLR):c.2000delG (p.Cys667Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231058	19	11120382	252164	246460
NM_000527.4(LDLR):c.2000G>A (p.Cys667Tyr)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, multiple submitters, no conflicts	19	11231058	19	11120382	3689	18728
NM_000527.4(LDLR):c.2001T>G (p.Cys667Trp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11231059	19	11120383	252168	246462
NM_000527.4(LDLR):c.2001T>A (p.Cys667Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11231059	19	11120383	252167	246461
NM_000527.4(LDLR):c.2001_2007delTGAGAGG (p.Cys667Terfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231059 - 11231065	19	11120383 - 11120389	252166	246463
NM_000527.4(LDLR):c.2011del (p.Thr671Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11231069	19	11120393	441226	434849
NM_000527.4(LDLR):c.2013_2014delCC (p.Leu672Glufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231071 - 11231072	19	11120395 - 11120396	252169	246464
NM_000527.4(LDLR):c.2014delC (p.Leu672Terfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231072	19	11120396	252170	246465
NM_000527.4(LDLR):c.2015del (p.Leu672Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11231073	19	11120397	252171	246466
NM_000527.4(LDLR):c.2023G>A (p.Gly675Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11231081	19	11120405	252173	246468
NM_000527.4(LDLR):c.2026G>C (p.Gly676Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231084	19	11120408	252176	246471
NM_000527.4(LDLR):c.2026G>A (p.Gly676Ser)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11231084	19	11120408	252175	246470
NM_000527.4(LDLR):c.2029T>C (p.Cys677Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	19	11231087	19	11120411	226384	228197
NM_000527.4(LDLR):c.2030G>A (p.Cys677Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231088	19	11120412	252178	246472
NM_000527.4(LDLR):c.2030_2042del (p.Cys677Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11231088 - 11231100	19	11120412 - 11120424	252177	246473
NM_000527.4(LDLR):c.2030G>T (p.Cys677Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231088	19	11120412	226385	228198
NM_000527.4(LDLR):c.2032C>T (p.Gln678Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11231090	19	11120414	252179	246474
NM_000527.4(LDLR):c.2033_2044del (p.Gln678_Cys681del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231091 - 11231102	19	11120415 - 11120426	252180	246475
NM_000527.4(LDLR):c.2035dup (p.Tyr679Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231093	19	11120417	252181	246476
NM_000527.4(LDLR):c.2036dup (p.Tyr679Terfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231094	19	11120418	252182	246477
NM_000527.4(LDLR):c.2037T>A (p.Tyr679Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11231095	19	11120419	252183	246478
NM_000527.4(LDLR):c.2041T>G (p.Cys681Gly)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 13, 2016)	criteria provided, conflicting interpretations	19	11231099	19	11120423	252185	246480
NM_000527.4(LDLR):c.2041T>A (p.Cys681Ser)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11231099	19	11120423	252184	246479
NM_000527.4(LDLR):c.2042G>C (p.Cys681Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231100	19	11120424	252187	246482
NM_000527.4(LDLR):c.2042G>A (p.Cys681Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	19	11231100	19	11120424	252186	246481
NM_000527.4(LDLR):c.2043C>G (p.Cys681Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231101	19	11120425	252188	246483
NM_000527.4(LDLR):c.2043C>A (p.Cys681Ter)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	19	11231101	19	11120425	3699	18738
NM_000527.4(LDLR):c.2045T>C (p.Leu682Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231103	19	11120427	252189	246484
NM_000527.4(LDLR):c.2046_2049delCCCT (p.Ala684Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231104 - 11231107	19	11120428 - 11120431	252190	246485
NM_000527.4(LDLR):c.2050G>A (p.Ala684Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11231108	19	11120432	252192	246486
NM_000527.4(LDLR):c.2050_2063del (p.Ala684Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231108 - 11231121	19	11120432 - 11120445	252191	246487
NM_000527.4(LDLR):c.2053C>T (p.Pro685Ser)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11231111	19	11120435	252194	246489
NM_000527.4(LDLR):c.2053C>A (p.Pro685Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231111	19	11120435	252193	246488
NM_000527.4(LDLR):c.2054C>A (p.Pro685Gln)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11231112	19	11120436	441227	434850
NM_000527.4(LDLR):c.2054delC (p.Pro685Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11231112	19	11120436	252195	246490
NM_000527.4(LDLR):c.2054C>T (p.Pro685Leu)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 15, 2018)	criteria provided, multiple submitters, no conflicts	19	11231112	19	11120436	3702	18741
NM_000527.4(LDLR):c.2055delG (p.Gln686Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231113	19	11120437	252197	246492
NM_000527.4(LDLR):c.2055_2067delGCAGATCAACCCC (p.Gln686Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231113 - 11231125	19	11120437 - 11120449	252196	246491
NM_000527.4(LDLR):c.2056C>T (p.Gln686Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11231114	19	11120438	252199	246493
NM_000527.4(LDLR):c.2056_2068delCAGATCAACCCCC (p.Gln686Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231114 - 11231126	19	11120438 - 11120450	252198	246494
NM_000527.4(LDLR):c.2059A>T (p.Ile687Phe)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	19	11231117	19	11120441	403664	390626
NM_000527.4(LDLR):c.2060dup (p.Asn688Glnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231118	19	11120442	252201	246496
NM_000527.4(LDLR):c.2060del (p.Ile687Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231118	19	11120442	252200	246495
NM_000527.4(LDLR):c.2061dupC (p.Asn688Glnfs)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	19	11231119	19	11120443	68103	78994
NM_000527.4(LDLR):c.2063dup (p.Asn688Lysfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11231121	19	11120445	252203	246498
NM_000527.4(LDLR):c.2063del (p.Asn688Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231121	19	11120445	252202	246497
NM_000527.4(LDLR):c.2068dup (p.His690Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11231126	19	11120450	375830	362722
NM_000527.4(LDLR):c.2068del (p.His690Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11231126	19	11120450	252205	246500
NM_000527.4(LDLR):c.2072C>T (p.Ser691Leu)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11231130	19	11120454	403644	390627
NM_000527.4(LDLR):c.2072C>A (p.Ser691Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11231130	19	11120454	252206	246501
NM_000527.4(LDLR):c.2077_2078del (p.Lys693Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11231135 - 11231136	19	11120459 - 11120460	252207	246502
NM_000527.4(LDLR):c.2080T>G (p.Phe694Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231138	19	11120462	252208	246503
NM_000527.4(LDLR):c.2085_2103del (p.Ala697Cysfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11231143 - 11231161	19	11120467 - 11120485	252209	246504
NM_000527.4(LDLR):c.2087G>A (p.Cys696Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11231145	19	11120469	252210	246505
NM_000527.4(LDLR):c.2088C>T (p.Cys696=)	LDLR	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11231146	19	11120470	548082	538579
NM_000527.4(LDLR):c.2088C>G (p.Cys696Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11231146	19	11120470	252212	246507
NM_000527.4(LDLR):c.2088C>A (p.Cys696Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231146	19	11120470	252211	246506
NM_000527.4(LDLR):c.2089G>C (p.Ala697Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231147	19	11120471	252213	246508
NM_000527.4(LDLR):c.2092T>G (p.Cys698Gly)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11231150	19	11120474	548083	538580
NM_000527.4(LDLR):c.2092del (p.Cys698Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11231150	19	11120474	252214	246509
NM_000527.4(LDLR):c.2093G>T (p.Cys698Phe)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11231151	19	11120475	252216	246511
NM_000527.4(LDLR):c.2093G>A (p.Cys698Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11231151	19	11120475	252215	246510
NM_000527.4(LDLR):c.2096C>T (p.Pro699Leu)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Conflicting interpretations of pathogenicity(Last reviewed: Oct 9, 2017)	criteria provided, conflicting interpretations	19	11231154	19	11120478	252219	246513
NM_000527.4(LDLR):c.2096delC (p.Pro699Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231154	19	11120478	252218	246514
NM_000527.4(LDLR):c.2099A>G (p.Asp700Gly)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11231157	19	11120481	252220	246515
NM_000527.4(LDLR):c.2100C>G (p.Asp700Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231158	19	11120482	252221	246516
NM_000527.4(LDLR):c.2101G>A (p.Gly701Ser)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 7, 2017)	criteria provided, conflicting interpretations	19	11231159	19	11120483	183130	181272
NM_000527.4(LDLR):c.2108_2114dup (p.Arg706Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231166 - 11231172	19	11120490 - 11120496	252223	246518
NM_000527.4(LDLR):c.2108_2111dup (p.Arg706Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231166 - 11231169	19	11120490 - 11120493	252222	246517
NM_000527.4(LDLR):c.2119G>T (p.Asp707Tyr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11231177	19	11120501	252226	246521
NM_000527.4(LDLR):c.2119G>A (p.Asp707Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231177	19	11120501	252225	246520
NM_000527.4(LDLR):c.2120A>T (p.Asp707Val)	LDLR	Familial hypercholesterolemia|not provided	Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, multiple submitters, no conflicts	19	11231178	19	11120502	252227	246522
NM_000527.4(LDLR):c.2131T>A (p.Cys711Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231189	19	11120513	252228	246523
NM_000527.4(LDLR):c.2132G>T (p.Cys711Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231190	19	11120514	252231	246526
NM_000527.4(LDLR):c.2132G>C (p.Cys711Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231190	19	11120514	252230	246525
NM_000527.4(LDLR):c.2132G>A (p.Cys711Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11231190	19	11120514	252229	246524
NM_000527.4(LDLR):c.2133C>A (p.Cys711Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231191	19	11120515	252232	246527
NM_000527.4(LDLR):c.2140G>A (p.Glu714Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231198	19	11120522	252233	246528
NM_000527.4(LDLR):c.2140G>C (p.Glu714Gln)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231198	19	11120522	226386	228199
NM_000527.4(LDLR):c.2140G>T (p.Glu714Ter)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	19	11231198	19	11120522	225183	227098
NM_000527.4(LDLR):c.2140+1G>T	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231199	19	11120523	252235	246530
NM_000527.4(LDLR):c.2140+1G>C	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231199	19	11120523	252234	246529
NM_000527.4(LDLR):c.2140+1G>A	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	19	11231199	19	11120523	3744	18783
NM_000527.4(LDLR):c.2140+2T>C	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11231200	19	11120524	252237	246532
NM_000527.4(LDLR):c.2140+2T>A	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231200	19	11120524	252236	246531
NM_000527.4(LDLR):c.2140+5G>A	LDLR	Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2018)	criteria provided, conflicting interpretations	19	11231203	19	11120527	36460	45123
NM_000527.4(LDLR):c.2140+86C>G	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11231284	19	11120608	30627	39584
NM_000527.4(LDLR):c.2141-2A>G	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11233848	19	11123172	431542	425055
NM_000527.4(LDLR):c.2164C>T (p.Gln722Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11233873	19	11123197	252244	246537
NM_000527.4(LDLR):c.2167G>T (p.E723*)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11233876	19	11123200	369849	354100
NM_000527.4(LDLR):c.2167delG (p.Glu723Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11233876	19	11123200	252245	246538
NM_000527.4(LDLR):c.2175delC (p.Thr726Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11233884	19	11123208	252247	246540
NM_000527.4(LDLR):c.2177C>T (p.Thr726Ile)	LDLR	Familial hypercholesterolemia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 15, 2018)	criteria provided, conflicting interpretations	19	11233886	19	11123210	36461	45124
NM_000527.4(LDLR):c.2178del (p.Val727Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11233887	19	11123211	252248	246541
NM_000527.4(LDLR):c.2180_2184dupTCAGG (p.Leu729Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11233889 - 11233893	19	11123213 - 11123217	403646	390628
NM_000527.4(LDLR):c.2184del (p.Arg728Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11233893	19	11123217	252249	246542
NM_000527.4(LDLR):c.2186dup (p.Val731Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11233895	19	11123219	252250	246543
NM_000527.4(LDLR):c.2187_2197delAAAGGTCAGCT (p.Lys730Hisfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11233896 - 11233906	19	11123220 - 11123230	252251	246544
NM_000527.4(LDLR):c.2191delG (p.Val731Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11233900	19	11123224	252253	246546
NM_000527.4(LDLR):c.2191_2203dup (p.Ala735Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11233900 - 11233912	19	11123224 - 11123236	252252	246545
NM_000527.4(LDLR):c.2201_2202del (p.Thr734Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11233910 - 11233911	19	11123234 - 11123235	252255	246548
NM_000527.4(LDLR):c.2207dup (p.Arg737Lysfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11233916	19	11123240	252256	246549
NM_000527.4(LDLR):c.2215C>T (p.Gln739Ter)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Feb 27, 2018)	criteria provided, conflicting interpretations	19	11233924	19	11123248	252258	246551
NM_000527.4(LDLR):c.2226delC (p.Thr743Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11233935	19	11123259	252260	246553
NM_000527.4(LDLR):c.2230delC (p.Arg744Aspfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11233939	19	11123263	252261	246554
NM_000527.4(LDLR):c.2231G>A (p.Arg744Gln)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 26, 2017)	criteria provided, conflicting interpretations	19	11233940	19	11123264	68104	78995
NM_000527.4(LDLR):c.2242G>A (p.Asp748Asn)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	19	11233951	19	11123275	183133	181275
NM_000527.4(LDLR):c.2252G>A (p.Arg751Gln)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11233961	19	11123285	161286	171221
NM_000527.4(LDLR):c.2253_2256dupGCTG (p.Pro753Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11233962 - 11233965	19	11123286 - 11123289	403647	390629
NM_000527.4(LDLR):c.2259dup (p.Gly754Trpfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	19	11233968	19	11123292	440686	434337
NM_000527.4(LDLR):c.2264_2273delCCACCCCTGG (p.Ala755Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11233973 - 11233982	19	11123297 - 11123306	252263	246556
NM_000527.4(LDLR):c.2266del (p.Thr756Profs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11233975	19	11123299	252264	246557
NM_000527.4(LDLR):c.2270del (p.Pro757Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11233979	19	11123303	430798	424342
NM_000527.4(LDLR):c.2271delT (p.Leu759Serfs)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, multiple submitters, no conflicts	19	11233980	19	11123304	226388	228201
NM_000527.4(LDLR):c.2282_2309del (p.Thr761Lysfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11233991 - 11234018	19	11123315 - 11123342	441230	434853
NM_000527.4(LDLR):c.2282C>T (p.Thr761Met)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11233991	19	11123315	161262	171222
NM_000527.4(LDLR):c.2292delA (p.Ile764Metfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11234001	19	11123325	226390	228203
NM_000527.4(LDLR):c.2297_2298delCA (p.Thr766Asnfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11234006 - 11234007	19	11123330 - 11123331	252268	246562
NM_000527.4(LDLR):c.2299delA (p.Met767Cysfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11234008	19	11123332	252270	246563
NM_000527.4(LDLR):c.2308C>T (p.Gln770Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11234017	19	11123341	252271	246564
NM_000527.4(LDLR):c.2311+1G>T	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11234021	19	11123345	252274	246567
NM_000527.4(LDLR):c.2311+1G>C	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11234021	19	11123345	252273	246566
NM_000527.4(LDLR):c.2311+1G>A	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11234021	19	11123345	252272	246565
NM_000527.4(LDLR):c.2311+2T>G	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11234022	19	11123346	252275	246568
NM_000527.4(LDLR):c.2311+1941_*1216dup	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11235961 - 11243208	19	11125285 - 11132532	252276	246569
NM_000527.4(LDLR):c.2312-3C>A	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic/Likely pathogenic(Last reviewed: Sep 6, 2016)	criteria provided, multiple submitters, no conflicts	19	11238681	19	11128005	226391	228204
GRCh38/hg38 19p13.2(chr19:11128007-11133830)x1	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11238683 - 11244506	19	11128007 - 11133830	548098	538594
NM_000527.4(LDLR):c.2317_2318insTA (p.Gly773Valfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11238689 - 11238690	19	11128013 - 11128014	252285	246572
NM_000527.4(LDLR):c.2318delG (p.Gly773Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11238690	19	11128014	252286	246573
NM_000527.4(LDLR):c.2320G>A (p.Asp774Asn)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	19	11238692	19	11128016	403663	390630
NM_000527.4(LDLR):c.2333_2334insC (p.Arg778Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11238705 - 11238706	19	11128029 - 11128030	252288	246575
NM_000527.4(LDLR):c.2343G>T (p.Glu781Asp)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11238715	19	11128039	252290	246576
NM_000527.4(LDLR):c.2343_2347delGAAGA (p.Lys782Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11238715 - 11238719	19	11128039 - 11128043	252289	246577
NM_000527.4(LDLR):c.2368_2369dup (p.Ser791Cysfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11238740 - 11238741	19	11128064 - 11128065	431549	425060
NM_000527.4(LDLR):c.2375T>C (p.Ile792Thr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11238747	19	11128071	252295	246582
NM_000527.4(LDLR):c.2376del (p.Ile792Metfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11238748	19	11128072	431550	425061
NM_000527.4(LDLR):c.2385del (p.Ile796Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11238757	19	11128081	252297	246584
NM_000527.4(LDLR):c.2388C>T (p.Ile796=)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	19	11238760	19	11128084	406165	403140
NM_000527.4(LDLR):c.2389G>T (p.Val797Leu)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11238761	19	11128085	252298	246585
NM_000527.4(LDLR):c.2389G>A (p.Val797Met)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 28, 2018)	criteria provided, conflicting interpretations	19	11238761	19	11128085	226393	228206
NM_000527.4(LDLR):c.2389+1G>T	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11238762	19	11128086	252300	246587
NM_000527.4(LDLR):c.2389+1G>A	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	19	11238762	19	11128086	252299	246586
NM_000527.4(LDLR):c.2389+2T>G	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11238763	19	11128087	252302	246588
NM_000527.4(LDLR):c.2389+2_2389+5delinsGGCCCCAT	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11238763 - 11238766	19	11128087 - 11128090	252301	246589
NM_000527.4(LDLR):c.2389+5G>A	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11238766	19	11128090	252306	246593
NM_000527.4(LDLR):c.2390-2A>G	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11240187	19	11129511	252313	246600
GRCh38/hg38 19p13.2(chr19:11129512-11133830)x1	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11240188 - 11244506	19	11129512 - 11133830	548096	538592
NM_000527.4(LDLR):c.2390-1G>C	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11240188	19	11129512	252317	246602
NM_000527.4(LDLR):c.2390-1G>A	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11240188	19	11129512	252316	246601
NM_000527.4(LDLR):c.2392_2400del (p.Leu798_Val800del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11240191 - 11240199	19	11129515 - 11129523	252318	246603
NM_000527.4(LDLR):c.2395_2397del (p.Leu799del)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11240194 - 11240196	19	11129518 - 11129520	252319	246604
NM_000527.4(LDLR):c.2396T>G (p.Leu799Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11240195	19	11129519	252320	246605
NM_000527.4(LDLR):c.2397_2412del16 (p.Val800Glyfs)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11240196 - 11240211	19	11129520 - 11129535	252321	246606
NM_000527.4(LDLR):c.2397_2405delCGTCTTCCT (p.Val800_Leu802del)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Apr 4, 2018)	criteria provided, conflicting interpretations	19	11240196 - 11240204	19	11129520 - 11129528	226394	71434
NM_000527.4(LDLR):c.2399_2403delTCTTCinsGGGT (p.Val800Glyfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11240198 - 11240202	19	11129522 - 11129526	252322	246608
NM_000527.4(LDLR):c.2403_2406del (p.Leu802Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11240202 - 11240205	19	11129526 - 11129529	252324	246609
NM_000527.4(LDLR):c.2407_2424del (p.Cys803_Leu808del)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11240206 - 11240223	19	11129530 - 11129547	438330	431960
NM_000527.4(LDLR):c.2407T>C (p.Cys803Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11240206	19	11129530	403648	390631
NM_000527.4(LDLR):c.2408_2409dup (p.Leu804Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11240207 - 11240208	19	11129531 - 11129532	252326	246611
NM_000527.4(LDLR):c.2413G>A (p.Gly805Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11240212	19	11129536	252328	246613
NM_000527.4(LDLR):c.2416dupG (p.Val806Glyfs)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 11, 2018)	criteria provided, conflicting interpretations	19	11240215	19	11129539	252330	246615
NM_000527.4(LDLR):c.2416del (p.Val806Serfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11240215	19	11129539	252329	246614
NM_000527.4(LDLR):c.2417_2418insGG (p.Phe807Alafs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11240216 - 11240217	19	11129540 - 11129541	252332	246618
NM_000527.4(LDLR):c.2417_2418insG (p.Phe807Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11240216 - 11240217	19	11129540 - 11129541	252331	246617
NM_000527.4(LDLR):c.2420_2426delTCCTTCT (p.Phe807Tyrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11240219 - 11240225	19	11129543 - 11129549	252334	246619
NM_000527.4(LDLR):c.2427A>G (p.Leu809=)	LDLR	Familial hypercholesterolemia	Benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11240226	19	11129550	440696	434347
NM_000527.4(LDLR):c.2430G>A (p.Trp810Ter)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, multiple submitters, no conflicts	19	11240229	19	11129553	252335	246620
NM_000527.4(LDLR):c.2431A>T (p.Lys811Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11240230	19	11129554	252336	246621
NM_000527.4(LDLR):c.2438G>A (p.Trp813Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11240237	19	11129561	252337	246622
NM_000527.4(LDLR):c.2439G>A (p.Trp813Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11240238	19	11129562	3703	18742
NM_000527.4(LDLR):c.2441G>A (p.Arg814Gln)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2017)	criteria provided, conflicting interpretations	19	11240240	19	11129564	161278	171223
NM_000527.4(LDLR):c.2446A>T (p.Lys816Ter)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11240245	19	11129569	252338	246623
NM_000527.4(LDLR):c.2447_2450dupAGAA (p.Asn817Lysfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11240246 - 11240249	19	11129570 - 11129573	3705	18744
NM_000527.4(LDLR):c.2448G>C (p.Lys816Asn)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2016)	criteria provided, conflicting interpretations	19	11240247	19	11129571	440698	434349
NM_000527.4(LDLR):c.2473A>G (p.Asn825Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11240272	19	11129596	252340	246625
NM_000527.4(LDLR):c.2475C>A (p.Asn825Lys)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11240274	19	11129598	252341	246626
NM_000527.4(LDLR):c.2475C>G (p.Asn825Lys)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11240274	19	11129598	161265	171224
NM_000527.4(LDLR):c.2476C>A (p.Pro826Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11240275	19	11129599	252343	246627
NM_000527.4(LDLR):c.2478dup (p.Val827Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11240277	19	11129601	252344	246629
NM_000527.4(LDLR):c.2478delC (p.Val827Serfs)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	19	11240277	19	11129601	252342	246628
NM_000527.4(LDLR):c.2479G>A (p.Val827Ile)	LDLR	Familial hypercholesterolemia|not specified|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 2, 2017)	criteria provided, conflicting interpretations	19	11240278	19	11129602	36462	45125
NM_000527.4(LDLR):c.2482T>C (p.Tyr828His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11240281	19	11129605	252345	246630
NM_000527.4(LDLR):c.2483A>C (p.Tyr828Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11240282	19	11129606	226395	228207
NM_000527.4(LDLR):c.2483A>G (p.Tyr828Cys)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11240282	19	11129606	3704	18743
NM_000527.4(LDLR):c.2500_2502delGATinsC (p.Asp834Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11240299 - 11240301	19	11129623 - 11129625	252346	246631
NM_000527.4(LDLR):c.2509del (p.His837Thrfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11240308	19	11129632	252348	246633
NM_000527.4(LDLR):c.2531G>A (p.Gly844Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11240330	19	11129654	3734	18773
NM_000527.4(LDLR):c.2544dup (p.Ser849Leufs)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11240343	19	11129667	252349	246634
NM_000527.4(LDLR):c.2546del (p.Ser849Terfs)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11240345	19	11129669	252351	246636
NM_000527.4(LDLR):c.2546C>A (p.Ser849Ter)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	19	11240345	19	11129669	252350	246635
NM_000527.4(LDLR):c.2547+1G>A	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11240347	19	11129671	252352	246637
NM_000527.4(LDLR):c.2548-2A>G	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11241955	19	11131279	252357	246642
NM_000527.4(LDLR):c.2552delA (p.Gln851Argfs)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11241961	19	11131285	252359	246644
NM_000527.4(LDLR):c.2579C>T (p.Ala860Val)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11241988	19	11131312	374957	361885
GRCh37/hg19 19p13.2(chr19:11210898-11218191)x3	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11210898 - 11218191			548102	538598
NM_006563.4(KLF1):c.954G>C (p.Trp318Cys)	KLF1	BLOOD GROUP--LUTHERAN INHIBITOR	Affects(Last reviewed: Aug 9, 2016)	no assertion criteria provided	19	12995834	19	12885020	253309	247752
NM_006563.4(KLF1):c.421C>T (p.Arg141Ter)	KLF1	BLOOD GROUP--LUTHERAN INHIBITOR	Affects(Last reviewed: Jul 31, 2017)	no assertion criteria provided	19	12996623	19	12885809	518459	509056
NM_002501.3(NFIX):c.338_342dup (p.Arg116Serfs)	NFIX	Sotos syndrome 2	Pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	19	13136145 - 13136149	19	13025331 - 13025335	209174	205791
NM_001271043.2(NFIX):c.440G>A (p.Gly147Glu)	NFIX	Marshall-Smith syndrome	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	19	13136223	19	13025409	487523	480574
NM_052876.3(NACC1):c.892C>T (p.Arg298Trp)	NACC1	not provided|Inborn genetic diseases|Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	19	13246913	19	13136099	417784	404685
NM_001127221.1(CACNA1A):c.6660T>C (p.His2220=)	CACNA1A	Episodic ataxia type 2|not specified|Epileptic encephalopathy, early infantile, 42|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 1, 2018)	criteria provided, multiple submitters, no conflicts	19	13319693	19	13208879	93562	99467
NM_001127221.1(CACNA1A):c.6381C>T (p.Ser2127=)	CACNA1A	Episodic ataxia type 2|not specified|Epileptic encephalopathy, early infantile, 42|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	19	13320274	19	13209460	128558	134007
NM_001127221.1(CACNA1A):c.6345C>G (p.Thr2115=)	CACNA1A	Episodic ataxia type 2|not specified|Epileptic encephalopathy, early infantile, 42|History of neurodevelopmental disorder	Benign(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	19	13320310	19	13209496	128557	134006
NM_001127221.1(CACNA1A):c.5742C>T (p.Ala1914=)	CACNA1A	Episodic ataxia type 2|Familial hemiplegic migraine type 1|not specified|Epileptic encephalopathy, early infantile, 42|History of neurodevelopmental disorder	Benign(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	19	13325415	19	13214601	128555	134004
NM_001127221.1(CACNA1A):c.5035C>T (p.Arg1679Cys)	CACNA1A	Episodic ataxia type 2	Pathogenic(Last reviewed: Feb 11, 2019)	no assertion criteria provided	19	13346463	19	13235649	68434	79325
NM_001127222.1(CACNA1A):c.5015G>C (p.Arg1672Pro)	CACNA1A	Cerebellar ataxia|Intellectual disability|Cerebellar atrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2015)	no assertion criteria provided	19	13346480	19	13235666	375366	362161
NM_001127221.1(CACNA1A):c.4991G>A (p.Arg1664Gln)	CACNA1A	Episodic ataxia type 2|Spinocerebellar ataxia 6|Global developmental delay|not provided|Global developmental delay|Enlarged cisterna magna|Chronic and progressive ataxia|Ataxia _ Neurologic (child onset)|Epileptic encephalopathy, early infantile, 42|History of neurodevelopmental disorder|Non-progressive congenital cerebellar ataxia	Conflicting interpretations of pathogenicity(Last reviewed: Feb 11, 2019)	criteria provided, conflicting interpretations	19	13346507	19	13235693	68432	79323
NM_001127221.1(CACNA1A):c.4177G>A (p.Val1393Met)	CACNA1A	Episodic ataxia type 2|Spinocerebellar ataxia 6|Migraine|Familial hemiplegic migraine type 1|not provided|Inborn genetic diseases|Epileptic encephalopathy, early infantile, 42	Conflicting interpretations of pathogenicity(Last reviewed: Mar 5, 2018)	criteria provided, conflicting interpretations	19	13372340	19	13261526	195935	193096
NM_001127221.1(CACNA1A):c.4058C>T (p.Pro1353Leu)	CACNA1A	Episodic ataxia type 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	19	13373582	19	13262768	420945	410512
NM_001127221.1(CACNA1A):c.4055G>T (p.Arg1352Leu)	CACNA1A	not provided|CACNA1A-related condition	Likely pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, multiple submitters, no conflicts	19	13373585	19	13262771	450236	446050
NM_001127221.1(CACNA1A):c.3864T>C (p.Phe1288=)	CACNA1A	Episodic ataxia type 2|Familial hemiplegic migraine type 1|not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 30, 2017)	criteria provided, multiple submitters, no conflicts	19	13387904	19	13277090	128553	134002
NM_000068.3(CACNA1A):c.3855C>G (p.Tyr1285Ter)	CACNA1A	Episodic ataxia type 2	Pathogenic(Last reviewed: Feb 11, 2019)	no assertion criteria provided			19	13277108	617754	609152
NM_001127221.1(CACNA1A):c.3832C>T (p.Arg1278Ter)	CACNA1A	Episodic ataxia type 2	Pathogenic(Last reviewed: Nov 25, 2014)	no assertion criteria provided	19	13387936	19	13277122	8506	23545
NM_001127221.1(CACNA1A):c.3549C>T (p.Val1183=)	CACNA1A	Episodic ataxia type 2|Familial hemiplegic migraine type 1|not specified|Epileptic encephalopathy, early infantile, 42|History of neurodevelopmental disorder	Benign(Last reviewed: Jul 26, 2017)	criteria provided, multiple submitters, no conflicts	19	13397324	19	13286510	93561	99466
NM_001127221.1(CACNA1A):c.3313G>A (p.Gly1105Ser)	CACNA1A	Episodic ataxia type 2|Familial hemiplegic migraine type 1|not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 23, 2017)	criteria provided, multiple submitters, no conflicts	19	13397560	19	13286746	68428	79319
NM_001127221.1(CACNA1A):c.3240C>T (p.Ala1080=)	CACNA1A	Episodic ataxia type 2|not specified|Epileptic encephalopathy, early infantile, 42|History of neurodevelopmental disorder	Benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	19	13397633	19	13286819	128552	134001
NM_001127221.1(CACNA1A):c.3060G>A (p.Arg1020=)	CACNA1A	Episodic ataxia type 2|Familial hemiplegic migraine type 1|not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 30, 2017)	criteria provided, multiple submitters, no conflicts	19	13409390	19	13298576	128551	134000
NM_001127221.1(CACNA1A):c.3031C>G (p.Pro1011Ala)	CACNA1A	Episodic ataxia type 2|not specified|not provided|Epileptic encephalopathy, early infantile, 42|History of neurodevelopmental disorder	Benign(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	19	13409419	19	13298605	128550	133999
NM_001127221.1(CACNA1A):c.2978A>T (p.Glu993Val)	CACNA1A	Episodic ataxia type 2|Familial hemiplegic migraine type 1|not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 30, 2017)	criteria provided, multiple submitters, no conflicts	19	13409472	19	13298658	68427	79318
NM_001127221.1(CACNA1A):c.2754G>C (p.Glu918Asp)	CACNA1A	Episodic ataxia type 2|Familial hemiplegic migraine type 1|not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 30, 2017)	criteria provided, multiple submitters, no conflicts	19	13409696	19	13298882	68426	79317
NM_001127221.1(CACNA1A):c.2742C>T (p.Pro914=)	CACNA1A	Episodic ataxia type 2|not specified|Epileptic encephalopathy, early infantile, 42|History of neurodevelopmental disorder	Benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	19	13409708	19	13298894	128549	133998
NM_001127221.1(CACNA1A):c.2740C>T (p.Pro914Ser)	CACNA1A	Episodic ataxia type 2|not specified|not provided|Epileptic encephalopathy, early infantile, 42|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	19	13409710	19	13298896	128548	133997
NM_001127221.1(CACNA1A):c.2195A>C (p.Glu732Ala)	CACNA1A	Episodic ataxia type 2|not specified|Epileptic encephalopathy, early infantile, 42|History of neurodevelopmental disorder	Benign(Last reviewed: Jan 27, 2018)	criteria provided, multiple submitters, no conflicts	19	13411451	19	13300637	128547	133996
NM_001127221.1(CACNA1A):c.2147A>C (p.Asn716Thr)	CACNA1A	Epileptic encephalopathy, early infantile, 42	Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	19	13414388	19	13303574	488475	481343
NM_001127221.1(CACNA1A):c.2094G>A (p.Thr698=)	CACNA1A	Episodic ataxia type 2|Familial hemiplegic migraine type 1|not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 30, 2017)	criteria provided, multiple submitters, no conflicts	19	13414594	19	13303780	128546	133995
NM_001127221.1(CACNA1A):c.1779C>G (p.Val593=)	CACNA1A	Episodic ataxia type 2|not specified|Epileptic encephalopathy, early infantile, 42|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	19	13419235	19	13308421	128545	133994
NM_001127221.1(CACNA1A):c.1629G>A (p.Thr543=)	CACNA1A	Episodic ataxia type 2|not specified|Epileptic encephalopathy, early infantile, 42|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	19	13423525	19	13312711	128544	133993
NM_001127221.1(CACNA1A):c.1182G>A (p.Glu394=)	CACNA1A	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jan 8, 2016)	criteria provided, multiple submitters, no conflicts	19	13445208	19	13334394	93559	99464
NM_001127221.1(CACNA1A):c.1038C>T (p.Ile346=)	CACNA1A	not provided	Uncertain significance(Last reviewed: Mar 6, 2014)	criteria provided, single submitter	19	13446664	19	13335850	128543	133992
NM_001127221.1(CACNA1A):c.904G>A (p.Asp302Asn)	CACNA1A	Episodic ataxia type 2|Spinocerebellar ataxia 6	Likely pathogenic(Last reviewed: Sep 9, 2014)	criteria provided, single submitter	19	13470494	19	13359680	216896	213651
NM_001127221.1(CACNA1A):c.876A>G (p.Glu292=)	CACNA1A	Episodic ataxia type 2|Familial hemiplegic migraine type 1|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 30, 2017)	criteria provided, multiple submitters, no conflicts	19	13470522	19	13359708	128560	134009
NM_023035.2(CACNA1A):c.835C>T (p.Arg279Cys)	CACNA1A	Episodic ataxia type 2|Gait ataxia|Epileptic encephalopathy	Pathogenic(Last reviewed: Jan 10, 2018)	no assertion criteria provided	19	13470563	19	13359749	545691	536183
NM_001127221.1(CACNA1A):c.689G>T (p.Gly230Val)	CACNA1A	Familial hemiplegic migraine type 1	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	19	13476226	19	13365412	560966	552215
NM_001127221.1(CACNA1A):c.654G>C (p.Ser218=)	CACNA1A	Episodic ataxia type 2|not specified|not provided|Epileptic encephalopathy, early infantile, 42	Benign/Likely benign(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	19	13476261	19	13365447	128559	134008
NM_001127221.1(CACNA1A):c.579G>A (p.Thr193=)	CACNA1A	Episodic ataxia type 2|Familial hemiplegic migraine type 1|not specified|Epileptic encephalopathy, early infantile, 42|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	19	13482554	19	13371740	128556	134005
NM_001127221.1(CACNA1A):c.462C>T (p.Ala154=)	CACNA1A	Episodic ataxia type 2|Familial hemiplegic migraine type 1|not specified|Epileptic encephalopathy, early infantile, 42|History of neurodevelopmental disorder	Benign(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	19	13563767	19	13452953	128554	134003
NM_000435.2(NOTCH3):c.3691C>T (p.Arg1231Cys)	NOTCH3	Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 26, 2018)	criteria provided, conflicting interpretations	19	15289863	19	15179052	216972	213652
NM_000095.2(COMP):c.1489+2T>A	COMP	Multiple epiphyseal dysplasia 1|Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Uncertain significance(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	19	18896773	19	18785963	430605	423253
NM_000095.2(COMP):c.1126G>T (p.Asp376Tyr)	COMP	Multiple epiphyseal dysplasia 1|Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Likely pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, single submitter	19	18898309	19	18787500	438839	432471
NM_004386.2(NCAN):c.3115G>A (p.Ala1039Thr)	NCAN	Developmental dyslexia	Uncertain significance(Last reviewed: Nov 22, 2016)	no assertion criteria provided	19	19344693	19	19233884	291298	275535
NM_004364.4(CEBPA):c.754G>T (p.Ala252Ser)	CEBPA	Acute myeloid leukemia	Benign(Last reviewed: Oct 21, 2010)	no assertion criteria provided	19	33792567	19	33301661	21404	34256
NM_004364.4(CEBPA):c.713C>A (p.Ala238Glu)	CEBPA	Acute myeloid leukemia	Benign(Last reviewed: Oct 21, 2010)	no assertion criteria provided	19	33792608	19	33301702	21403	34255
NM_004364.4(CEBPA):c.690G>T (p.Thr230=)	CEBPA	Acute myeloid leukemia|not specified	Benign	criteria provided, single submitter	19	33792631	19	33301725	21402	34254
NM_004364.4(CEBPA):c.318_319dupTG (p.Asp107Valfs*54)	CEBPA	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 21, 2010)	no assertion criteria provided	19	33793002 - 33793003	19	33302096 - 33302097	21399	34251
NM_004364.4(CEBPA):c.217_218insC (p.Phe73Serfs)	CEBPA	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 21, 2010)	no assertion criteria provided	19	33793103 - 33793104	19	33302197 - 33302198	21398	34250
NM_004364.4(CEBPA):c.198_201dupCTAC (p.Ile68Leufs*41)	CEBPA	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 21, 2010)	no assertion criteria provided	19	33793120 - 33793123	19	33302214 - 33302217	21397	34249
NM_004364.4(CEBPA):c.141delC (p.Ala48Profs)	CEBPA	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 21, 2010)	no assertion criteria provided	19	33793180	19	33302274	21396	34248
NM_004364.4(CEBPA):c.68dupC (p.His24Alafs)	CEBPA	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 21, 2010)	no assertion criteria provided	19	33793253	19	33302347	21401	34253
NM_004364.4(CEBPA):c.68delC (p.Pro23Argfs)	CEBPA	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 21, 2010)	no assertion criteria provided	19	33793253	19	33302347	17572	32611
NM_199037.4(SCN1B):c.308A>T (p.Asp103Val)	SCN1B	Cardiomyopathy	Pathogenic	no assertion criteria provided	19	35524503	19	35033599	375404	362162
NM_001037.4(SCN1B):c.363C>G (p.Cys121Trp)	SCN1B	Generalized epilepsy with febrile seizures plus, type 1|Brugada syndrome 5|Generalized epilepsy with febrile seizures plus|Seizures|not provided|Atrial fibrillation, familial, 13	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	19	35524558	19	35033654	9252	24291
NM_001037.4(SCN1B):c.412G>A (p.Val138Ile)	SCN1B	Cardiac conduction defect, nonspecific|Brugada syndrome 5|Long QT syndrome|Generalized epilepsy with febrile seizures plus|Brugada syndrome|not specified|Seizures|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jul 20, 2017)	criteria provided, conflicting interpretations	19	35524607	19	35033703	180508	178737
NM_001037.4(SCN1B):c.501T>C (p.Ile167=)	SCN1B	Cardiac conduction defect, nonspecific|Brugada syndrome 5|Generalized epilepsy with febrile seizures plus|Brugada syndrome|not specified|Seizures|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	19	35530073	19	35039169	130210	135657
NM_014727.2(KMT2B):c.514_515insC (p.Thr176Aspfs)	KMT2B	Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	19	36210764	19	35719861 - 35719862	488539	481407
NM_014727.2(KMT2B):c.1633C>T (p.Arg545Ter)	KMT2B	Dystonia 28, childhood-onset	Pathogenic/Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	19	36211882	19	35720980	374871	361776
NM_014727.2(KMT2B):c.7050-2A>G	KMT2B	Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	19	36224662	19	35733761	374872	361777
NM_000540.2(RYR1):c.131G>A (p.Arg44His)	RYR1	Malignant hyperthermia, susceptibility to, 1|not specified|not provided|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Jun 5, 2017)	criteria provided, conflicting interpretations	19	38931470	19	38440830	133046	136794
NM_000540.2(RYR1):c.1453A>G (p.Met485Val)	RYR1	Myopathy, Central Core|Malignant hyperthermia, susceptibility to, 1|Neuromuscular disease, congenital, with uniform type 1 fiber|Malignant hyperthermia susceptibility|Multiminicore Disease|not specified|not provided|Malignant hyperthermia|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Mar 20, 2018)	criteria provided, conflicting interpretations	19	38945887	19	38455247	133076	136823
NM_000540.2(RYR1):c.1589G>A (p.Arg530His)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, multiple submitters, no conflicts	19	38946103	19	38455463	133101	136848
NM_000540.2(RYR1):c.1598G>A (p.Arg533His)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	19	38946112	19	38455472	133103	136850
NM_000540.2(RYR1):c.1840C>T (p.Arg614Cys)	RYR1	Malignant hyperthermia, susceptibility to, 1|Malignant hyperthermia susceptibility|not provided|Inborn genetic diseases|RYR1-Related Disorders	Pathogenic/Likely pathogenic, risk factor(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	19	38948185	19	38457545	12964	28003
NM_000540.2(RYR1):c.2119G>A (p.Gly707Ser)	RYR1	Multiminicore Disease	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	19	38948884	19	38458244	161368	171226
NM_000540.2(RYR1):c.2122G>A (p.Asp708Asn)	RYR1	Malignant hyperthermia, susceptibility to, 1|Congenital myopathy|not specified|not provided|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Jul 17, 2018)	criteria provided, conflicting interpretations	19	38948887	19	38458247	159840	169548
NM_000540.2(RYR1):c.2275A>G (p.Asn759Asp)	RYR1	Malignant hyperthermia, susceptibility to, 1|not specified|not provided|Myopathy, RYR1-associated|RYR1-Related Disorders	Uncertain significance(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	19	38949893	19	38459253	161369	171227
NM_000540.2(RYR1):c.2677G>A (p.Gly893Ser)	RYR1	Myopathy, Central Core|Congenital myopathy|Neuromuscular disease, congenital, with uniform type 1 fiber|Malignant hyperthermia susceptibility|Multiminicore Disease|not specified|not provided|RYR1-Related Disorders	Likely benign(Last reviewed: Dec 24, 2017)	criteria provided, multiple submitters, no conflicts	19	38954162	19	38463522	161362	171228
NM_000540.2(RYR1):c.2797G>A (p.Ala933Thr)	RYR1	Neuromuscular disease, congenital, with uniform type 1 fiber|not specified|not provided|Malignant hyperthermia and exertional rhabdomyolosis|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Aug 2, 2018)	criteria provided, conflicting interpretations	19	38955289	19	38464649	161363	171229
NM_000540.2(RYR1):c.2956C>T (p.Arg986Cys)	RYR1	Malignant hyperthermia, susceptibility to, 1|Congenital myopathy|RYR1-Related Disorders	Uncertain significance(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	19	38956816	19	38466176	161367	171230
NM_000540.2(RYR1):c.3127C>T (p.Arg1043Cys)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-Related Disorders	Uncertain significance(Last reviewed: Oct 21, 2016)	criteria provided, multiple submitters, no conflicts	19	38956987	19	38466347	133124	136871
NM_000540.2(RYR1):c.3800C>G (p.Pro1267Arg)	RYR1	Multiminicore Disease|not provided	Uncertain significance(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	19	38964051	19	38473411	161370	171231
NM_000540.2(RYR1):c.4055C>G (p.Ala1352Gly)	RYR1	Malignant hyperthermia, susceptibility to, 1|Malignant hyperthermia susceptibility|not specified|not provided|RYR1-Related Disorders	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	19	38964306	19	38473666	159846	169554
NM_000540.2(RYR1):c.4178A>G (p.Lys1393Arg)	RYR1	Myopathy, Central Core|Malignant hyperthermia, susceptibility to, 1|Neuromuscular disease, congenital, with uniform type 1 fiber|Malignant hyperthermia susceptibility|Multiminicore Disease|not specified|not provided|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Feb 5, 2018)	criteria provided, conflicting interpretations	19	38965975	19	38475335	93269	99176
NM_000540.2(RYR1):c.4400A>G (p.Lys1467Arg)	RYR1	Malignant hyperthermia equivocal with halotane	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	19	38968456	19	38477816	161371	171232
NM_000540.2(RYR1):c.4405C>T (p.Arg1469Trp)	RYR1	Congenital myopathy|not specified|not provided|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Mar 12, 2018)	criteria provided, conflicting interpretations	19	38968461	19	38477821	161372	171233
NM_000540.2(RYR1):c.4424T>C (p.Met1475Thr)	RYR1	Malignant hyperthermia	Uncertain significance(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	19	38968480	19	38477840	226046	227850
NM_000540.2(RYR1):c.4496_4497delTT (p.Phe1499Cysfs)	RYR1	Minicore myopathy	Pathogenic(Last reviewed: Feb 8, 2019)	no assertion criteria provided			19	38478476 - 38478477	617750	609148
NM_000540.2(RYR1):c.4711A>G (p.Ile1571Val)	RYR1	Malignant hyperthermia, susceptibility to, 1|not specified|not provided|RYR1-Related Disorders	Uncertain significance(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	19	38973933	19	38483293	159851	169559
NM_000540.2(RYR1):c.5036G>A (p.Arg1679His)	RYR1	Myopathy, Central Core|Malignant hyperthermia, susceptibility to, 1|Neuromuscular disease, congenital, with uniform type 1 fiber|Malignant hyperthermia susceptibility|Multiminicore Disease|not specified|not provided|Malignant hyperthermia|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Feb 22, 2018)	criteria provided, conflicting interpretations	19	38976331	19	38485691	161364	171234
NM_000540.2(RYR1):c.5120G>A (p.Arg1707His)	RYR1	not provided|Myopathy, RYR1-associated	Uncertain significance(Last reviewed: Sep 2, 2016)	criteria provided, multiple submitters, no conflicts	19	38976415	19	38485775	161373	171235
NM_000540.2(RYR1):c.5183C>T (p.Ser1728Phe)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 8, 2018)	criteria provided, multiple submitters, no conflicts	19	38976478	19	38485838	133144	136891
NM_000540.2(RYR1):c.6478G>A (p.Gly2160Ser)	RYR1	not specified|Malignant hyperthermia and exertional rhabdomyolosis|RYR1-Related Disorder	Uncertain significance(Last reviewed: Jan 30, 2017)	criteria provided, single submitter	19	38985195	19	38494555	161374	171236
NM_000540.2(RYR1):c.6617C>T (p.Thr2206Met)	RYR1	Malignant hyperthermia, susceptibility to, 1|Malignant hyperthermia susceptibility|Ptosis|not provided|Sacral agenesis|History of neonatal hypotonia|RYR1-Related Disorders	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, multiple submitters, no conflicts	19	38986923	19	38496283	12977	28016
NM_000540.2(RYR1):c.6640G>A (p.Val2214Ile)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-Related Disorders	Uncertain significance(Last reviewed: Jun 5, 2017)	criteria provided, multiple submitters, no conflicts	19	38986946	19	38496306	133168	136915
NM_000540.2(RYR1):c.6721C>T	RYR1	Myopathy, Central Core|Malignant hyperthermia, susceptibility to, 1|Minicore myopathy|not provided|Multi-minicore disease and atypical periodic paralysis|RYR1-Related Disorders	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, multiple submitters, no conflicts	19	38987106	19	38496466	159856	169564
NM_000540.2(RYR1):c.6961A>G (p.Ile2321Val)	RYR1	Myopathy, Central Core|Malignant hyperthermia, susceptibility to, 1|Neuromuscular disease, congenital, with uniform type 1 fiber|Malignant hyperthermia susceptibility|Multiminicore Disease|not specified|not provided|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	19	38989817	19	38499177	133173	136920
NM_000540.2(RYR1):c.7025A>G (p.Asn2342Ser)	RYR1	Malignant hyperthermia, susceptibility to, 1|Malignant hyperthermia susceptibility|not specified|not provided|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	19	38989881	19	38499241	133175	136922
NM_000540.2(RYR1):c.7048G>A (p.Ala2350Thr)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided	Pathogenic(Last reviewed: Aug 29, 2016)	criteria provided, single submitter	19	38990295	19	38499655	133182	136929
NM_000540.2(RYR1):c.7099G>A (p.Ala2367Thr)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided	Likely pathogenic(Last reviewed: Nov 21, 2013)	criteria provided, single submitter	19	38990346	19	38499706	133187	136934
NM_000540.2(RYR1):c.7210G>A (p.Glu2404Lys)	RYR1	Malignant hyperthermia, susceptibility to, 1	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	19	38990457	19	38499817	161379	171237
NM_000540.2(RYR1):c.7291G>A (p.Asp2431Asn)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided	Uncertain significance(Last reviewed: Jul 30, 2016)	criteria provided, single submitter	19	38990624	19	38499984	133194	136941
NM_000540.2(RYR1):c.7300G>A (p.Gly2434Arg)	RYR1	Malignant hyperthermia, susceptibility to, 1|Malignant hyperthermia susceptibility|not provided|RYR1-Related Disorders	Pathogenic(Last reviewed: Jun 2, 2018)	criteria provided, multiple submitters, no conflicts	19	38990633	19	38499993	12970	28009
NM_000540.2(RYR1):c.7360C>T (p.Arg2454Cys)	RYR1	Myopathy, Central Core|Malignant hyperthermia susceptibility|not provided|RYR1-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	19	38991282	19	38500642	133202	136949
NM_000540.2(RYR1):c.7372C>T (p.Arg2458Cys)	RYR1	Malignant hyperthermia, susceptibility to, 1|Malignant hyperthermia susceptibility|not provided	Pathogenic/Likely pathogenic, risk factor(Last reviewed: Jan 17, 2017)	criteria provided, multiple submitters, no conflicts	19	38991294	19	38500654	12971	28010
NM_000540.2(RYR1):c.9356G>A (p.Arg3119His)	RYR1	Myopathy, Central Core|not specified|not provided	Uncertain significance(Last reviewed: Jul 22, 2017)	criteria provided, multiple submitters, no conflicts	19	39003007	19	38512367	133241	136986
NM_000540.2(RYR1):c.9713A>G (p.Glu3238Gly)	RYR1	Myopathy, Central Core|Neuromuscular disease, congenital, with uniform type 1 fiber|Malignant hyperthermia susceptibility|Multiminicore Disease|not specified|not provided|Axial myopathy, late-onset|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Mar 16, 2017)	criteria provided, conflicting interpretations	19	39008026	19	38517386	161365	171238
NM_000540.2(RYR1):c.9758T>C (p.Ile3253Thr)	RYR1	Congenital myopathy|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 15, 2017)	criteria provided, conflicting interpretations	19	39008071	19	38517431	159865	169570
NM_000540.2(RYR1):c.10097G>A (p.Arg3366His)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided|Multiminicore/minicore/multicore disease|RYR1-Related Disorders	Uncertain significance(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	19	39009932	19	38519292	132990	136739
NM_000540.2(RYR1):c.10616G>A (p.Arg3539His)	RYR1	Myopathy, Central Core|Malignant hyperthermia, susceptibility to, 1|not specified|not provided|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Mar 22, 2018)	criteria provided, conflicting interpretations	19	39016132	19	38525492	132997	136745
NM_000540.2(RYR1):c.10621G>A (p.Ala3541Thr)	RYR1	Axial myopathy, late-onset	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	19	39016137	19	38525497	161375	171239
NM_000540.2(RYR1):c.11518G>A (p.Val3840Ile)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-Related Disorders	Uncertain significance(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	19	39026638	19	38535998	133013	136761
NM_000540.2(RYR1):c.11557G>A (p.Glu3853Lys)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided|Muscular dystrophy and arthrogryposis	Uncertain significance(Last reviewed: Oct 20, 2017)	criteria provided, multiple submitters, no conflicts	19	39026677	19	38536037	161376	171240
NM_000540.2(RYR1):c.11763C>A (p.Tyr3921Ter)	RYR1	Congenital myopathy|not provided|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Jul 3, 2018)	criteria provided, conflicting interpretations	19	39034060	19	38543420	161361	171241
NM_000540.2(RYR1):c.11798A>G (p.Tyr3933Cys)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-Related Disorders	Uncertain significance(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	19	39034191	19	38543551	133021	136769
NM_000540.2(RYR1):c.12121C>T (p.Arg4041Trp)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided	Uncertain significance(Last reviewed: Apr 15, 2015)	criteria provided, single submitter	19	39038899	19	38548259	133032	136780
NM_000540.2(RYR1):c.12879G>C (p.Ala4293=)	RYR1	Myopathy, Central Core|Malignant hyperthermia, susceptibility to, 1|Neuromuscular disease, congenital, with uniform type 1 fiber|Malignant hyperthermia susceptibility|Multiminicore Disease|not specified|not provided|Malignant hyperthermia|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Jan 19, 2018)	criteria provided, conflicting interpretations	19	39055853	19	38565213	93249	99156
NM_000540.2(RYR1):c.13505A>G (p.Glu4502Gly)	RYR1	Myopathy, Central Core|Congenital myopathy|Neuromuscular disease, congenital, with uniform type 1 fiber|Malignant hyperthermia susceptibility|Multiminicore Disease|Malignant hypothermia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	19	39057618	19	38566978	161366	171242
NM_000540.2(RYR1):c.13513G>C (p.Asp4505His)	RYR1	Malignant hyperthermia, susceptibility to, 1|Congenital muscular dystrophy|Malignant hyperthermia susceptibility|not specified|Generalized muscle weakness|not provided|Congenital hip dislocation|Malignant hyperthermia|EMG: myopathic abnormalities|Congenital muscular dystrophy|Myopathy, progressive axial with cataracts|Dysplasia of acetabulum|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Mar 29, 2018)	criteria provided, conflicting interpretations	19	39057626	19	38566986	93252	99159
NM_000540.2(RYR1):c.13673G>A (p.Arg4558Gln)	RYR1	Myopathy, Central Core|not provided|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: May 24, 2018)	criteria provided, conflicting interpretations	19	39061260	19	38570620	65984	76892
NM_000540.2(RYR1):c.13760C>T (p.Pro4587Leu)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided	Uncertain significance(Last reviewed: Apr 23, 2015)	criteria provided, single submitter	19	39062672	19	38572032	161377	171243
NM_000540.2(RYR1):c.14468C>T (p.Thr4823Met)	RYR1	Congenital myopathy|not provided	Uncertain significance(Last reviewed: Oct 20, 2017)	criteria provided, single submitter	19	39070725	19	38580085	161378	171244
NM_000540.2(RYR1):c.14524G>A	RYR1	not provided|Myopathy, congenital with cores|RYR1-Related Disorders|Skeletal muscle disease	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2018)	criteria provided, conflicting interpretations	19	39071022	19	38580382	133075	38832
NM_000540.2(RYR1):c.14717C>T (p.Ala4906Val)	RYR1	Myopathy, Central Core|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2014)	no assertion criteria provided	19	39075653	19	38585013	65926	76834
NM_000540.2(RYR1):c.14918C>T (p.Pro4973Leu)	RYR1	Malignant hyperthermia, susceptibility to, 1|Malignant hyperthermia susceptibility|not provided|RYR1-Related Disorders	Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	19	39076780	19	38586140	133098	136845
NM_004924.5(ACTN4):c.719T>C (p.Met240Thr)	ACTN4	Focal segmental glomerulosclerosis 1	Uncertain significance	no assertion criteria provided	19	39200102	19	38709462	427769	417658
NM_001626.5(AKT2):c.960G>A (p.Glu320=)	AKT2	not provided	Uncertain significance(Last reviewed: Feb 19, 2013)	criteria provided, single submitter	19	40742164	19	40236257	128342	133791
NM_001626.5(AKT2):c.861C>A (p.Gly287=)	AKT2	not provided	Uncertain significance(Last reviewed: Feb 19, 2013)	criteria provided, single submitter	19	40742263	19	40236356	128341	133790
NM_001022.3(RPS19):c.367_368dup (p.Thr124Terfs)	RPS19	Diamond-Blackfan anemia 1	Pathogenic(Last reviewed: Sep 18, 2018)	no assertion criteria provided	19	42373779 - 42373780	19	41869709 - 41869710	587695	578653
NM_152296.3(ATP1A3):c.2767G>A (p.Asp923Asn)	ATP1A3	Dystonia 12|Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, multiple submitters, no conflicts	19	42472989	19	41968837	12915	27954
NM_152296.5(ATP1A3):c.2512_2516delAGACTinsTC (p.Arg838_Leu839delinsSer)	ATP1A3	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: Nov 7, 2014)	criteria provided, single submitter	19	42474363 - 42474367	19	41970211 - 41970215	369662	353910
NM_152296.5(ATP1A3):c.2401G>A (p.Asp801Asn)	ATP1A3	Cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorinural hearing loss|Dystonia 12|Alternating hemiplegia of childhood 2|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	19	42474557	19	41970405	37107	45777
NM_152296.4(ATP1A3):c.2319T>C (p.Asn773=)	ATP1A3	Dystonia 12|not specified|Alternating hemiplegia of childhood	Benign/Likely benign(Last reviewed: Dec 22, 2017)	criteria provided, multiple submitters, no conflicts	19	42474639	19	41970487	157925	167772
NM_152296.4(ATP1A3):c.2267G>A (p.Arg756His)	ATP1A3	Dystonia 12|Alternating hemiplegia of childhood 2|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, multiple submitters, no conflicts	19	42474691	19	41970539	161134	170985
NM_152296.4(ATP1A3):c.1323G>A (p.Ala441=)	ATP1A3	Dystonia 12|not specified|Alternating hemiplegia of childhood 2|Alternating hemiplegia of childhood	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2018)	criteria provided, conflicting interpretations	19	42485768	19	41981616	157924	167771
NM_152296.4(ATP1A3):c.974G>A (p.Gly325Asp)	ATP1A3	Cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorinural hearing loss	Likely pathogenic(Last reviewed: Jun 10, 2014)	criteria provided, single submitter	19	42489089	19	41984937	216891	213654
NM_152296.4(ATP1A3):c.666T>G (p.Thr222=)	ATP1A3	Dystonia 12|not specified|not provided|Alternating hemiplegia of childhood	Benign/Likely benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	19	42489516	19	41985364	157926	167773
NM_001256214.1(ATP1A3):c.424G>A (p.Val142Met)	ATP1A3	Juvenile onset psychosis	Pathogenic(Last reviewed: Apr 11, 2016)	criteria provided, single submitter	19	42490354	19	41986202	267411	262636
NM_001039213.4(CEACAM16):c.1186A>G (p.Thr396Ala)	CEACAM16	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Jul 6, 2016)	criteria provided, single submitter	19	45211378	19	44708106	228513	231041
NM_000041.3(APOE):c.[388T>C;478C>T]	APOE	Familial type 3 hyperlipoproteinemia	Pathogenic(Last reviewed: Feb 14, 2017)	no assertion criteria provided	19|19	45411941	19|19	44908684	440870	32903|38488
NM_206900.2(RTN2):c.96T>C (p.Ser32=)	RTN2	not specified	Benign(Last reviewed: Jan 22, 2016)	criteria provided, single submitter	19	45998247	19	45494989	130163	135610
NM_025136.3(OPA3):c.313C>G (p.Gln105Glu)	OPA3	Optic atrophy and cataract, autosomal dominant	Pathogenic(Last reviewed: Mar 31, 2009)	no assertion criteria provided	19	46056999	19	45553741	4241	19280
NM_025136.3(OPA3):c.277G>A (p.Gly93Ser)	OPA3	Optic atrophy and cataract, autosomal dominant	Pathogenic(Last reviewed: Mar 31, 2009)	no assertion criteria provided	19	46057035	19	45553777	4240	19279
NM_025136.3(OPA3):c.231T>C (p.Ala77=)	OPA3	3-Methylglutaconic aciduria type 3|Optic atrophy and cataract, autosomal dominant|not specified|not provided|Optic Atrophy, Dominant	Benign(Last reviewed: Sep 6, 2017)	criteria provided, multiple submitters, no conflicts	19	46057081	19	45553823	21709	34561
NM_175875.4(SIX5):c.1261G>A (p.Val421Ile)	SIX5	Branchiootorenal syndrome 2	Uncertain significance	criteria provided, single submitter	19	46269956	19	45766698	224344	226091
NR_147193.1(DM1-AS):n.337-1285_337-1226CAG[496]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic(Last reviewed: Mar 14, 2018)	no assertion criteria provided	19	46273463	19	45770205	523764	514406
NR_147193.1(DM1-AS):n.337-1285_337-1226CAG[146]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic(Last reviewed: Mar 14, 2018)	no assertion criteria provided	19	46273463	19	45770205	523763	514403
NR_147193.1(DM1-AS):n.337-1285_337-1226CAG[80]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic(Last reviewed: Mar 14, 2018)	no assertion criteria provided	19	46273463	19	45770205	523762	514408
NR_147193.1(DM1-AS):n.337-1285_337-1226CAG[90]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic(Last reviewed: Mar 14, 2018)	no assertion criteria provided	19	46273463	19	45770205	523761	514409
NR_147193.1(DM1-AS):n.337-1285_337-1226CAG[288]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic(Last reviewed: Mar 14, 2018)	no assertion criteria provided	19	46273463	19	45770205	523760	514404
NR_147193.1(DM1-AS):n.337-1285_337-1226CAG[105]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic(Last reviewed: Mar 14, 2018)	no assertion criteria provided	19	46273463	19	45770205	523759	514402
NR_147193.1(DM1-AS):n.337-1285_337-1226CAG[383]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic(Last reviewed: Mar 14, 2018)	no assertion criteria provided	19	46273463	19	45770205	523758	514405
NR_147193.1(DM1-AS):n.337-1285_337-1226CAG[597]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic(Last reviewed: Mar 14, 2018)	no assertion criteria provided	19	46273463	19	45770205	523757	514407
NM_004409.4(DMPK):c.*224CTG[98]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188043	185935
NM_004409.4(DMPK):c.*224CTG[96]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188042	185934
NM_004409.4(DMPK):c.*224CTG[93]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188041	185933
NM_004409.4(DMPK):c.*224CTG[92]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188040	185932
NM_004409.4(DMPK):c.*224CTG[887]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188039	185930
NM_004409.4(DMPK):c.*224CTG[88]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188038	185931
NM_004409.4(DMPK):c.*224CTG[84]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188037	185929
NM_004409.4(DMPK):c.*224CTG[83]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188036	185928
NM_004409.4(DMPK):c.*224CTG[823]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188035	185926
NM_004409.4(DMPK):c.*224CTG[82]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188034	185927
NM_004409.4(DMPK):c.*224CTG[816]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188033	185925
NM_004409.4(DMPK):c.*224CTG[814]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188032	185924
NM_004409.4(DMPK):c.*224CTG[80]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188031	185923
NM_004409.4(DMPK):c.*224CTG[780]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188030	185922
NM_004409.4(DMPK):c.*224CTG[76]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188029	185921
NM_004409.4(DMPK):c.*224CTG[758]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188028	185919
NM_004409.4(DMPK):c.*224CTG[75]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188027	185920
NM_004409.4(DMPK):c.*224CTG[74]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188026	185918
NM_004409.4(DMPK):c.*224CTG[721]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188025	185916
NM_004409.4(DMPK):c.*224CTG[72]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188024	185917
NM_004409.4(DMPK):c.*224CTG[71]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188023	185915
NM_004409.4(DMPK):c.*224CTG[69]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188022	185914
NM_004409.4(DMPK):c.*224CTG[688]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188021	185912
NM_004409.4(DMPK):c.*224CTG[68]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188020	185913
NM_004409.4(DMPK):c.*224CTG[666]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188019	185911
NM_004409.4(DMPK):c.*224CTG[65]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188018	185910
NM_004409.4(DMPK):c.*224CTG[640]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188017	185908
NM_004409.4(DMPK):c.*224CTG[64]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188016	185909
NM_004409.4(DMPK):c.*224CTG[62]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188015	185907
NM_004409.4(DMPK):c.*224CTG[614]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188014	185906
NM_004409.4(DMPK):c.*224CTG[609]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188013	185904
NM_004409.4(DMPK):c.*224CTG[60]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188012	185905
NM_004409.4(DMPK):c.*224CTG[594]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188011	185902
NM_004409.4(DMPK):c.*224CTG[593]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188010	185901
NM_004409.4(DMPK):c.*224CTG[59]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188009	185903
NM_004409.4(DMPK):c.*224CTG[586]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188008	185900
NM_004409.4(DMPK):c.*224CTG[583]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188007	185899
NM_004409.4(DMPK):c.*224CTG[563]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188006	185897
NM_004409.4(DMPK):c.*224CTG[562]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188005	185896
NM_004409.4(DMPK):c.*224CTG[56]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188004	185898
NM_004409.4(DMPK):c.*224CTG[542]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188003	185894
NM_004409.4(DMPK):c.*224CTG[541]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188002	185893
NM_004409.4(DMPK):c.*224CTG[54]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188001	185895
NM_004409.4(DMPK):c.*224CTG[539]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	188000	185891
NM_004409.4(DMPK):c.*224CTG[536]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187999	185890
NM_004409.4(DMPK):c.*224CTG[53]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187998	185892
NM_004409.4(DMPK):c.*224CTG[52]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187997	185889
NM_004409.4(DMPK):c.*224CTG[513]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187996	185888
NM_004409.4(DMPK):c.*224CTG[508]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187995	185886
NM_004409.4(DMPK):c.*224CTG[505]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187994	185885
NM_004409.4(DMPK):c.*224CTG[501]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187993	185884
NM_004409.4(DMPK):c.*224CTG[50]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187992	185887
NM_004409.4(DMPK):c.*224CTG[490]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187991	185883
NM_004409.4(DMPK):c.*224CTG[482]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187990	185882
NM_004409.4(DMPK):c.*224CTG[462]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187989	185880
NM_004409.4(DMPK):c.*224CTG[461]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187988	185879
NM_004409.4(DMPK):c.*224CTG[46]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187987	185881
NM_004409.4(DMPK):c.*224CTG[455]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187986	185878
NM_004409.4(DMPK):c.*224CTG[449]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187985	185877
NM_004409.4(DMPK):c.*224CTG[448]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187984	185876
NM_004409.4(DMPK):c.*224CTG[440]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187983	185875
NM_004409.4(DMPK):c.*224CTG[437]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187982	185874
NM_004409.4(DMPK):c.*224CTG[436]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187981	185873
NM_004409.4(DMPK):c.*224CTG[435]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187980	185872
NM_004409.4(DMPK):c.*224CTG[421]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187979	185871
NM_004409.4(DMPK):c.*224CTG[407]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187978	185870
NM_004409.4(DMPK):c.*224CTG[398]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187977	185869
NM_004409.4(DMPK):c.*224CTG[397]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187976	185868
NM_004409.4(DMPK):c.*224CTG[395]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187975	185867
NM_004409.4(DMPK):c.*224CTG[391]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187974	185866
NM_004409.4(DMPK):c.*224CTG[377]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187973	185865
NM_004409.4(DMPK):c.*224CTG[376]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187972	185864
NM_004409.4(DMPK):c.*224CTG[375]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187971	185863
NM_004409.4(DMPK):c.*224CTG[373]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187970	185862
NM_004409.4(DMPK):c.*224CTG[372]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187969	185861
NM_004409.4(DMPK):c.*224CTG[371]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187968	185860
NM_004409.4(DMPK):c.*224CTG[364]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187967	185859
NM_004409.4(DMPK):c.*224CTG[354]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187966	185858
NM_004409.4(DMPK):c.*224CTG[353]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187965	185857
NM_004409.4(DMPK):c.*224CTG[352]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187964	185856
NM_004409.4(DMPK):c.*224CTG[351]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187963	185855
NM_004409.4(DMPK):c.*224CTG[347]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187962	185854
NM_004409.4(DMPK):c.*224CTG[345]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187961	185853
NM_004409.4(DMPK):c.*224CTG[339]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187960	185852
NM_004409.4(DMPK):c.*224CTG[333]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187959	185851
NM_004409.4(DMPK):c.*224CTG[327]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187958	185850
NM_004409.4(DMPK):c.*224CTG[318]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187957	185849
NM_004409.4(DMPK):c.*224CTG[313]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187956	185848
NM_004409.4(DMPK):c.*224CTG[307]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187955	185847
NM_004409.4(DMPK):c.*224CTG[303]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187954	185846
NM_004409.4(DMPK):c.*224CTG[281]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187953	185845
NM_004409.4(DMPK):c.*224CTG[271]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187952	185844
NM_004409.4(DMPK):c.*224CTG[265]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187951	185843
NM_004409.4(DMPK):c.*224CTG[264]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187950	185842
NM_004409.4(DMPK):c.*224CTG[261]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187949	185841
NM_004409.4(DMPK):c.*224CTG[260]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187948	185840
NM_004409.4(DMPK):c.*224CTG[256]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187947	185839
NM_004409.4(DMPK):c.*224CTG[255]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187946	185838
NM_004409.4(DMPK):c.*224CTG[241]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187945	185837
NM_004409.4(DMPK):c.*224CTG[238]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187944	185836
NM_004409.4(DMPK):c.*224CTG[236]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187943	185835
NM_004409.4(DMPK):c.*224CTG[235]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187942	185834
NM_004409.4(DMPK):c.*224CTG[232]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187941	185833
NM_004409.4(DMPK):c.*224CTG[229]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187940	185832
NM_004409.4(DMPK):c.*224CTG[225]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187939	185831
NM_004409.4(DMPK):c.*224CTG[216]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187938	185830
NM_004409.4(DMPK):c.*224CTG[214]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187937	185829
NM_004409.4(DMPK):c.*224CTG[197]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187936	185828
NM_004409.4(DMPK):c.*224CTG[195]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187935	185827
NM_004409.4(DMPK):c.*224CTG[194]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187934	185826
NM_004409.4(DMPK):c.*224CTG[182]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187933	185825
NM_004409.4(DMPK):c.*224CTG[181]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187932	185824
NM_004409.4(DMPK):c.*224CTG[175]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187931	185823
NM_004409.4(DMPK):c.*224CTG[169]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187930	185822
NM_004409.4(DMPK):c.*224CTG[1681]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187929	185820
NM_004409.4(DMPK):c.*224CTG[168]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187928	185821
NM_004409.4(DMPK):c.*224CTG[160]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187927	185819
NM_004409.4(DMPK):c.*224CTG[158]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187926	185818
NM_004409.4(DMPK):c.*224CTG[1502]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187925	185817
NM_004409.4(DMPK):c.*224_*226[146]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187924	185816
NM_004409.4(DMPK):c.*224CTG[142]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187923	185815
NM_004409.4(DMPK):c.*224CTG[135]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187922	185814
NM_004409.4(DMPK):c.*224CTG[134]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187921	185813
NM_004409.4(DMPK):c.*224CTG[132]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187920	185812
NM_004409.4(DMPK):c.*224CTG[131]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187919	185811
NM_004409.4(DMPK):c.*224CTG[127]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187918	185810
NM_004409.4(DMPK):c.*224CTG[124]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187917	185809
NM_004409.4(DMPK):c.*224CTG[1236]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187916	185807
NM_004409.4(DMPK):c.*224CTG[123]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187915	185808
NM_004409.4(DMPK):c.*224CTG[122]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187914	185806
NM_004409.4(DMPK):c.*224CTG[1189]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187913	185805
NM_004409.4(DMPK):c.*224CTG[1142]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187912	185804
NM_004409.4(DMPK):c.*224CTG[1140]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187911	185803
NM_004409.4(DMPK):c.*224CTG[1080]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187910	185802
NM_004409.4(DMPK):c.*224CTG[107]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187909	185801
NM_004409.4(DMPK):c.*224CTG[103]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187908	185800
NM_004409.4(DMPK):c.*224CTG[102]	DMPK|LOC107075317|LOC109461477|DM1-AS	Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	19	46273463	19	45770205	187907	185799
NM_000554.5(CRX):c.124G>A (p.Glu42Lys)	CRX	Leber congenital amaurosis 7	Likely pathogenic(Last reviewed: May 21, 2013)	criteria provided, single submitter	19	48339523	19	47836266	216914	213655
NM_000554.5(CRX):c.449C>G (p.Ser150Ter)	CRX	Bull's eye maculopathy	Pathogenic(Last reviewed: Sep 25, 2014)	criteria provided, single submitter	19	48342773	19	47839516	218921	215730
NM_000554.5(CRX):c.657delC (p.Tyr221Thrfs)	CRX	Bull's eye maculopathy	Pathogenic(Last reviewed: Sep 25, 2014)	criteria provided, single submitter	19	48342981	19	47839724	218922	215731
NM_000554.5(CRX):c.661delT (p.Tyr221Thrfs)	CRX	Bull's eye maculopathy	Pathogenic(Last reviewed: Sep 25, 2014)	criteria provided, single submitter	19	48342985	19	47839728	218923	215732
NM_000146.3(FTL):c.163T>C (p.Leu55=)	FTL|GYS1	Glycogen storage disease 0, muscle|Hyperferritinemia cataract syndrome|Neuroferritinopathy|not specified|sporadic abdominal aortic aneurysm	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	49469087	19	48965830	156440	166213
NM_000146.3(FTL):c.*8C>T	FTL	Hyperferritinemia cataract syndrome|Neuroferritinopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	19	49470000	19	48966743	158603	169583
NM_017636.3(TRPM4):c.739A>T (p.Asn247Tyr)	TRPM4	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	19	49671936	19	49168679	427974	419291
NM_017636.3(TRPM4):c.1603G>A (p.Glu535Lys)	TRPM4	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	19	49686174	19	49182917	427975	419292
NM_020719.2(PRR12):c.899_900insCCCACCA (p.Pro304Thrfs)	PRR12	Autistic disorder of childhood onset|Motor delay|Iris coloboma|Autism|Delayed speech and language development|Abnormality of vision	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	19	50098491 - 50098492	19	49595234 - 49595235	446256	439635
NM_020719.2(PRR12):c.1918G>T (p.Glu640Ter)	PRR12	Autistic disorder of childhood onset|Motor delay|Iris coloboma|Autism|Delayed speech and language development|Abnormality of vision	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	19	50099510	19	49596253	446254	439633
NM_020719.2(PRR12):c.4502_4505delTGCC (p.Leu1501Argfs)	PRR12	Autistic disorder of childhood onset|Motor delay|Iris coloboma|Autism|Delayed speech and language development|Abnormality of vision	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	19	50104904 - 50104907	19	49601647 - 49601650	446255	439634
NM_001077186.1(MYH14):c.2822G>T (p.Arg941Leu)	MYH14	Peripheral neuropathy, myopathy, hoarseness, and hearing loss	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	19	50771512	19	50268255	30739	39696
NM_001145809.1(MYH14):c.3467+1G>A	MYH14	not specified	Uncertain significance(Last reviewed: Nov 5, 2013)	criteria provided, single submitter	19	50775989	19	50272732	164182	176189
NM_001256849.1(POLD1):c.17G>A (p.Arg6Gln)	POLD1	Colorectal cancer 10|Hereditary cancer-predisposing syndrome|Colorectal cancer	Uncertain significance(Last reviewed: Mar 26, 2018)	criteria provided, multiple submitters, no conflicts	19	50902125	19	50398868	226047	227854
NM_001256849.1(POLD1):c.208G>T (p.Val70Phe)	POLD1	Familial colorectal cancer|Colorectal cancer 10|Carcinoma of colon|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	19	50902633	19	50399376	225288	227197
NM_002691.3(POLD1):c.433G>A (p.Ala145Thr)	POLD1	Colorectal cancer 10|not specified|not provided|Hereditary cancer-predisposing syndrome|Colon cancer	Benign/Likely benign(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	19	50905151	19	50401894	221138	222826
NM_002691.3(POLD1):c.589A>C (p.Ser197Arg)	POLD1	Familial colorectal cancer|Colorectal cancer 10	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2018)	criteria provided, conflicting interpretations	19	50905381	19	50402124	537130	533272
NM_001256849.1(POLD1):c.3035G>A (p.Cys1012Tyr)	POLD1	Colorectal cancer	Uncertain significance(Last reviewed: Aug 1, 2016)	no assertion criteria provided	19	50919948	19	50416691	375857	362745
NM_001256849.1(POLD1):c.3041G>A (p.Gly1014Asp)	POLD1	Colorectal cancer	Uncertain significance(Last reviewed: Aug 1, 2016)	no assertion criteria provided	19	50919954	19	50416697	375858	362746
NM_014225.5(PPP2R1A):c.544C>T (p.Arg182Trp)	PPP2R1A	not provided|Mental retardation, autosomal dominant 36	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	19	52715979	19	52212726	190312	188141
NM_144687.3(NLRP12):c.1504_1506delAAG (p.Lys502del)	NLRP12	Familial cold autoinflammatory syndrome 2	Uncertain significance(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	19	54313407 - 54313409	19	53810153 - 53810155	522838	513478
NM_002739.4(PRKCG):c.72C>T (p.Ala24=)	PRKCG	Spinocerebellar ataxia 14|not specified|Spinocerebellar Ataxia, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	54385820	19	53882566	130037	135483
NM_002739.4(PRKCG):c.567T>C (p.Asn189=)	PRKCG	Spinocerebellar ataxia 14|not specified|not provided|Spinocerebellar Ataxia, Dominant	Benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	19	54394965	19	53891711	130036	135482
NM_000363.4(TNNI3):c.611G>A (p.Arg204His)	TNNI3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	19	55663224	19	55151856	177679	176208
NM_000363.4(TNNI3):c.586G>A (p.Asp196Asn)	TNNI3	Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 7|not provided|Hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: May 22, 2018)	criteria provided, multiple submitters, no conflicts	19	55663249	19	55151881	12422	27461
NM_000363.4(TNNI3):c.575G>A (p.Arg192His)	TNNI3	Familial restrictive cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, multiple submitters, no conflicts	19	55663260	19	55151892	12424	27463
NM_000363.4(TNNI3):c.568G>T (p.Asp190Tyr)	TNNI3	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	19	55663267	19	55151899	165511	176212
NM_000363.4(TNNI3):c.557G>A (p.Arg186Gln)	TNNI3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, multiple submitters, no conflicts	19	55663278	19	55151910	43395	52565
NM_000363.4(TNNI3):c.550G>A (p.Glu184Lys)	TNNI3	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Sep 6, 2013)	no assertion criteria provided	19	55663285	19	55151917	43394	52564
NM_000363.4(TNNI3):c.550-1G>A	TNNI3	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	19	55663286	19	55151918	492986	485939
NM_000363.4(TNNI3):c.544G>A (p.Glu182Lys)	TNNI3	Primary dilated cardiomyopathy|not provided|Dilated cardiomyopathy	Pathogenic(Last reviewed: Sep 10, 2014)	criteria provided, multiple submitters, no conflicts	19	55665403	19	55154035	43392	52562
NM_000363.4(TNNI3):c.508C>T (p.Arg170Trp)	TNNI3	Cardiomyopathy, restrictive|Familial restrictive cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, multiple submitters, no conflicts	19	55665439	19	55154071	179285	176073
NM_000363.4(TNNI3):c.508C>G (p.Arg170Gly)	TNNI3	Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 1FF|Familial hypertrophic cardiomyopathy 7|not specified	Conflicting interpretations of pathogenicity(Last reviewed: May 22, 2013)	criteria provided, conflicting interpretations	19	55665439	19	55154071	165517	176215
NM_000363.4(TNNI3):c.485G>C (p.Arg162Pro)	TNNI3	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	19	55665462	19	55154094	43390	52560
NM_000363.4(TNNI3):c.485G>A (p.Arg162Gln)	TNNI3	Dilated cardiomyopathy 2A|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 1FF|Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 7|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, multiple submitters, no conflicts	19	55665462	19	55154094	43389	52559
NM_000363.4(TNNI3):c.484C>T (p.Arg162Trp)	TNNI3	Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 7|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jul 27, 2018)	criteria provided, conflicting interpretations	19	55665463	19	55154095	161396	171245
NM_000363.4(TNNI3):c.470C>T (p.Ala157Val)	TNNI3	Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 7|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	19	55665477	19	55154109	43388	52558
NM_000363.4(TNNI3):c.434G>A (p.Arg145Gln)	TNNI3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, multiple submitters, no conflicts	19	55665513	19	55154145	43384	52554
NM_000363.4(TNNI3):c.433C>T (p.Arg145Trp)	TNNI3	Familial restrictive cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	19	55665514	19	55154146	12426	27465
NM_000363.4(TNNI3):c.433C>G (p.Arg145Gly)	TNNI3	Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 7|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	19	55665514	19	55154146	12419	27458
NM_000363.4(TNNI3):c.422G>A (p.Arg141Gln)	TNNI3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, multiple submitters, no conflicts	19	55665525	19	55154157	43381	52551
NM_000363.4(TNNI3):c.298C>T (p.Leu100Phe)	TNNI3	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	19	55666183	19	55154815	427955	419293
NM_000527.4(LDLR):c.68-?_1586+?del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11200292 - 11226769			523721	514373
NM_000527.4(LDLR):c.941-?_1186+?del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11218191 - 11223953			441201	434803
NM_000527.4(LDLR):c.314-?_940+?del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11213463 - 11218191			441182	434801
NM_000527.4(LDLR):c.1988-?_2140+?del	LDLR|SMARCA4	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11120302 - 11120522			438328	431950
NC_000019.9:g.(?_11211022)_(11213339_11224439)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11211022 - 11224439			438319	431964
NC_000019.9:g.(?_11211022)_(11213339_11217364)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11211022 - 11217364			438318	431963
NC_000019.9:g.(?_11211022)_(11213339_11216277)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11211022 - 11216277			438317	431962
NC_000019.9:g.(?_11200292)_(11210898_11227675)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11200292 - 11227675			438315	431961
NM_000527.4(LDLR):c.2312-?_2547+?del	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2016)	criteria provided, conflicting interpretations	19	11236353 - 11241151			431547	425022
NM_000527.4(LDLR):c.2312-?_2389+?del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, multiple submitters, no conflicts	19	11236353 - 11239475			431546	425021
NM_000527.4(LDLR):c.2141-?_2389+?del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11233850 - 11239475			431541	425020
NM_000527.4(LDLR):c.941-?_1586+?del	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2016)	criteria provided, conflicting interpretations	19	11218191 - 11225603			431516	425019
NM_000527.4(LDLR):c.695-?_817+?del	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2016)	criteria provided, conflicting interpretations	19	11216759 - 11217715			431513	425018
NM_000527.4(LDLR):c.191-?_940+?del	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2016)	criteria provided, conflicting interpretations	19	11212181 - 11219759			431508	425017
NM_000527.4(LDLR):c.1846-?_2311+?del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jul 4, 2016)	criteria provided, multiple submitters, no conflicts	19	11230768 - 11234020	19	11120092 - 11123344	417369	402817
NM_000527.4(LDLR):c.2312-?_*2514del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, multiple submitters, no conflicts	19	11234021 - 11244506			265906	260656
NM_000527.4(LDLR):c.1061-?_1845+?del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11222190 - 11227674			265901	260654
NM_000527.4(LDLR):c.68-?_313+?del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11200292 - 11215895			265897	260653
NC_000019.9:g.(11238762_11240188)_(11244506_?)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11238762 - 11244506			252315	246741
NC_000019.9:g.(11238762_11240188)_(11240347_11241956)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11238762 - 11241956			252314	246740
NC_000019.9:g.(11234021_11238683)_(11244506_?)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11234021 - 11244506			252284	246739
NC_000019.9:g.(11234021_11238683)_(11242799_?)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11234021 - 11242799			252283	246738
NC_000019.9:g.(11234021_11238683)_(11242212_?)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11234021 - 11242212			252282	246737
NC_000019.9:g.(11234021_11238683)_(11240347_11241956)dup	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11234021 - 11241956			252281	246736
NC_000019.9:g.(11234021_11238683)_(11238762_11240188)del	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11234021 - 11240188			252280	246735
NC_000019.9:g.(11234021_11238683)_(11240347_11241956)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11234021 - 11241956			252279	246734
NC_000019.9:g.(11231199_11233849)_(11244506_?)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231199 - 11244506			252240	246733
FH Tonami 1	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231199 - 11238683			252239	246732
NC_000019.9:g.(11230910_11231045)_(11234021_11238683)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230910 - 11238683			252154	246731
NC_000019.9:g.(11227675_11230767)_(11244506_?)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11227675 - 11244506			252078	246730
FH Bologna 2	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11227675 - 11238683			252077	246729
NC_000019.9:g.(11227675_11230767)_(11234021_11238683)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227675 - 11238683			252076	246728
NC_000019.9:g.(11227675_11230767)_(11231199_11233849)dup	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227675 - 11233849			252075	246727
FH London 1	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11227675 - 11233849			252074	246726
NC_000019.9:g.(11226889_11227534)_(11244506_?)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226889 - 11244506			251991	246725
NC_000019.9:g.(11226889_11227534)_(11238762_11240188)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226889 - 11240188			251990	246724
NC_000019.9:g.(11226889_11227534)_(11227675_11230767)dup	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226889 - 11230767			251989	246723
NC_000019.9:g.(11226889_11227534)_(11227675_11230767)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226889 - 11230767			251988	246722
NC_000019.9:g.(11224439_11226769)_(11244506_?)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224439 - 11244506			251921	246721
NC_000019.9:g.(11224439_11226769)_(11240347_11241956)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224439 - 11241956			251920	246720
NC_000019.9:g.(11224439_11226769)_(11238762_11240188)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224439 - 11240188			251919	246719
NC_000019.9:g.(11224439_11226769)_(11234021_11238683)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224439 - 11238683			251918	246718
NC_000019.9:g.(11224439_11226769)_(11231199_11233849)dup	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224439 - 11233849			251917	246717
NC_000019.9:g.(11224439_11226769)_(11231199_11233849)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224439 - 11233849			251916	246716
NC_000019.9:g.(11224439_11226769)_(11227675_11230767)dup	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11224439 - 11230767			251915	246715
NC_000019.9:g.(11224439_11226769)_(11227675_11230767)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224439 - 11230767			251914	246714
NC_000019.9:g.(11224439_11226769)_(11226889_11227534)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224439 - 11227534			251913	246713
NC_000019.9:g.(11222316_11223953)_(11244506_?)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222316 - 11244506			251722	246712
NC_000019.9:g.(11222316_11223953)_(11231199_11233849)dup	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11222316 - 11233849			251721	246711
NC_000019.9:g.(11222316_11223953)_(11231199_11233849)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222316 - 11233849			251720	246710
NC_000019.9:g.(11222316_11223953)_(11227675_11230767)dup	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222316 - 11230767			251719	246709
NC_000019.9:g.(11222316_11223953)_(11227675_11230767)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222316 - 11230767			251718	246708
NC_000019.9:g.(11222316_11223953)_(11224439_11226769)dup	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222316 - 11226769			251717	246707
NC_000019.9:g.(11222316_11223953)_(11224439_11226769)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11222316 - 11226769			251716	246706
NC_000019.9:g.(11222316_11223953)_(11224126_11224210)dup	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222316 - 11224210			251715	246705
NC_000019.9:g.(11222316_11223953)_(11224126_11224210)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222316 - 11224210			251714	246704
NC_000019.9:g.(11221448_11222189)_(11227675_11230767)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221448 - 11230767			251635	246703
NC_000019.9:g.(11221448_11222189)_(11224439_11226769)dup	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221448 - 11226769			251634	246702
NC_000019.9:g.(11221448_11222189)_(11222316_11223953)del	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11221448 - 11223953			251633	246701
NC_000019.9:g.(11218191_11221327)_(11244506_?)dup	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218191 - 11244506			251563	246700
NC_000019.9:g.(11218191_11221327)_(11234021_11238683)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218191 - 11238683			251562	246699
NC_000019.9:g.(11218191_11221327)_(11231199_11233849)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218191 - 11233849			251561	246698
NC_000019.9:g.(11218191_11221327)_(11227675_11230767)dup	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218191 - 11230767			251560	246697
NC_000019.9:g.(11218191_11221327)_(11227675_11230767)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218191 - 11230767			251559	246696
NC_000019.9:g.(11218191_11221327)_(11224439_11226769)dup	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218191 - 11226769			251558	246695
NC_000019.9:g.(11218191_11221327)_(11224439_11226769)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218191 - 11226769			251557	246694
NC_000019.9:g.(11218191_11221327)_(11222316_11223953)dup	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218191 - 11223953			251556	246693
NC_000019.9:g.(11218191_11221327)_(11221448_11222189)del	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218191 - 11222189			251555	246692
NC_000019.9:g.(11217364_11218067)_(11244506_?)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217364 - 11244506			251474	246691
NC_000019.9:g.(11217364_11218067)_(11222316_11223953)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11217364 - 11223953			251473	246690
NC_000019.9:g.(11217364_11218067)_(11218191_11221327)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217364 - 11221327			251472	246689
NC_000019.9:g.(11216277_11217240)_(11224439_11226769)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216277 - 11226769			251414	246688
NC_000019.9:g.(11216277_11217240)_(11218191_11221327)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216277 - 11221327			251413	246687
NC_000019.9:g.(11216277_11217240)_(11217364_11218067)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216277 - 11218067			251412	246686
NC_000019.9:g.(11213463_11215895)_(11222316_11223953)dup	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11213463 - 11223953			251147	246685
FH Vancouver 6	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11213463 - 11221327			251146	246684
NC_000019.9:g.(11213463_11215895)_(11218191_11221327)dup	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213463 - 11221327			251145	246683
NC_000019.9:g.(11213463_11215895)_(11217364_11218067)dup	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213463 - 11218067			251144	246682
NC_000019.9:g.(11213463_11215895)_(11216277_11217240)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213463 - 11217240			251143	246681
NC_000019.9:g.(11211022_11213339)_(11231199_11233849)dup	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211022 - 11233849			251070	246680
NC_000019.9:g.(11211022_11213339)_(11227675_11230767)dup	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211022 - 11230767			251069	246679
NC_000019.9:g.(11211022_11213339)_(11227675_11230767)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211022 - 11230767			251068	246678
NC_000019.9:g.(11211022_11213339)_(11224439_11226769)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211022 - 11226769			251067	246677
NC_000019.9:g.(11211022_11213339)_(11222316_11223953)dup	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211022 - 11223953			251066	246676
NC_000019.9:g.(11211022_11213339)_(11221448_11222189)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211022 - 11222189			251065	246675
NC_000019.9:g.(11211022_11213339)_(11218191_11221327)dup	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211022 - 11221327			251064	246674
NC_000019.9:g.(11211022_11213339)_(11218191_11221327)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211022 - 11221327			251063	246673
NC_000019.9:g.(11211022_11213339)_(11217364_11218067)dup	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211022 - 11218067			251062	246672
NC_000019.9:g.(11211022_11213339)_(11217364_11218067)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211022 - 11218067			251061	246671
NC_000019.9:g.(11211022_11213339)_(11216277_11217240)dup	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11211022 - 11217240			251060	246670
NC_000019.9:g.(11211022_11213339)_(11216277_11217240)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211022 - 11217240			251059	246669
NC_000019.9:g.(11211022_11213339)_(11213463_11215895)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211022 - 11215895			251058	246668
NC_000019.9:g.(11200292_11210898)_(11240347_11241956)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200292 - 11241956			251004	246667
NC_000019.9:g.(11200292_11210898)_(11234021_11238683)dup	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200292 - 11238683			251003	246666
NC_000019.9:g.(11200292_11210898)_(11231199_11233849)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200292 - 11233849			251002	246665
NC_000019.9:g.(11200292_11210898)_(11227675_11230767)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200292 - 11230767			251001	246664
NC_000019.9:g.(11200292_11210898)_(11226889_11227534)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200292 - 11227534			251000	246663
NC_000019.9:g.(11200292_11210898)_(11224439_11226769)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200292 - 11226769			250999	246662
NC_000019.9:g.(11200292_11210898)_(11222316_11223953)dup	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11200292 - 11223953			250998	246661
NC_000019.9:g.(11200292_11210898)_(11217364_11218067)dup	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200292 - 11218067			250997	246660
NC_000019.9:g.(11200292_11210898)_(11217364_11218067)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200292 - 11218067			250996	246659
NC_000019.9:g.(11200292_11210898)_(11216277_11217240)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200292 - 11217240			250995	246658
NC_000019.9:g.(11200292_11210898)_(11211022_11213339)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200292 - 11213339			250994	246657
NC_000019.9:g.(?_11200038)_(11244576_?)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11200038 - 11244576			250940	246656
NC_000019.9:g.(?_11200038)_(11234021_11238683)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200038 - 11238683			250939	246655
NC_000019.9:g.(?_11200038)_(11231199_11233849)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200038 - 11233849			250938	246654
NC_000019.9:g.(?_11200038)_(11227675_11230767)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200038 - 11230767			250937	246653
NC_000019.9:g.(?_11200038)_(11222316_11223953)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200038 - 11223953			250936	246652
NC_000019.9:g.(?_11200038)_(11221448_11222189)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200038 - 11222189			250935	246651
NC_000019.9:g.(?_11200038)_(11218191_11221327)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11200038 - 11221327			250934	246650
NC_000019.9:g.(?_11200038)_(11211022_11213339)del	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11200038 - 11213339			250933	246649
NC_000019.9:g.(?_11200038)_(11200292_11210898)del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11200038 - 11210898			250932	246648
NC_000019.9:g.(?_11200038)_(11200292_11210898)dup	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200038 - 11210898			250931	246647
NM_000527.4(LDLR):c.2390-?_2547+?del	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2016)	criteria provided, conflicting interpretations	19	11240188 - 11240347			226402	228111
NM_000527.4(LDLR):c.1187-?_1586+?del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, multiple submitters, no conflicts	19	11223953 - 11224439			226401	228105
NM_000527.4(LDLR):c.2141-?_2311+?del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11233849 - 11234021			226399	228109
NM_000527.4(LDLR):c.1587-?_1845+?del	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, multiple submitters, no conflicts	19	11226769 - 11227675			226397	228106
FH Vancouver 3	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211022 - 11223953	19	11100346 - 11113277	3713	18752
FH Vancouver 4	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 28, 2017)	criteria provided, conflicting interpretations	19	11200292 - 11221327	19	11089616 - 11110651	3712	18751
FH French Canadian 5	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200292 - 11215895	19	11089616 - 11105219	3710	18749
FH Cape Town 2	LDLR	Familial hypercholesterolemia|FH LEIDEN 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218191 - 11223953	19	11107515 - 11113277	3701	18740
NM_198994.2(TGM6):c.172A>G (p.Met58Val)	TGM6	Spinocerebellar ataxia 35|not specified|Spinocerebellar Ataxia, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	2375262	20	2394616	130585	136031
NM_198994.2(TGM6):c.1476G>A (p.Lys492=)	TGM6	Spinocerebellar ataxia 35|not specified|Spinocerebellar Ataxia, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	2398017	20	2417371	130584	136030
NM_006392.3(NOP56):c.105T>C (p.Ser35=)	NOP56	not specified	Likely benign	no assertion criteria provided	20	2633936	20	2653290	129807	135253
NM_006392.3(NOP56):c.361A>G (p.Ile121Val)	NOP56	not specified	Likely benign	no assertion criteria provided	20	2635212	20	2654566	129810	135256
NM_006392.3(NOP56):c.1035T>C (p.Thr345=)	NOP56	not specified	Likely benign	no assertion criteria provided	20	2637071	20	2656425	129806	135252
NM_006392.3(NOP56):c.1424T>C (p.Met475Thr)	NOP56	not specified	Likely benign	no assertion criteria provided	20	2638579	20	2657933	129808	135254
NM_006392.3(NOP56):c.1727T>C (p.Val576Ala)	NOP56	not specified	Likely benign	no assertion criteria provided	20	2638882	20	2658236	129809	135255
NM_144773.3(PROKR2):c.97T>C (p.Tyr33His)	PROKR2	Kallmann syndrome 3	Likely pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	20	5294919	20	5314273	267202	262052
NC_000020.11:g.10643851delG	JAG1	Alagille syndrome 1	Likely pathogenic(Last reviewed: Sep 20, 2018)	no assertion criteria provided			20	10643851	619084	610482
NM_000214.3(JAG1):c.2113+1G>T	JAG1	Alagille syndrome 1	Pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	20	10626003	20	10645355	584458	575505
NM_018327.3(SPTLC3):c.448T>C (p.Trp150Arg)	SPTLC3	Peripheral neuropathy|Sensory neuropathy|Peripheral neuropathy	Likely pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	20	13053048	20	13072400	243088	244165
NM_033118.3(MYLK2):c.1189A>G (p.Met397Val)	MYLK2	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	20	30414706	20	31826903	427952	419294
NM_001164603.1(ASXL1):c.217A>T (p.Lys73Ter)	ASXL1	C-like syndrome	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	20	30956891	20	32369088	488471	481339
NM_015338.5(ASXL1):c.1283_1284del (p.Gln428Argfs)	ASXL1	C-like syndrome	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter			20	32433481 - 32433482	598750	589812
NM_015338.5(ASXL1):c.3202C>T (p.Arg1068Ter)	ASXL1	C-like syndrome	Pathogenic	criteria provided, single submitter	20	31023717	20	32435914	431709	425230
NM_015338.5(ASXL1):c.3700C>T (p.Gln1234Ter)	ASXL1	C-like syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	20	31024215	20	32436412	560957	552222
NM_003098.2(SNTA1):c.368C>G (p.Ala123Gly)	SNTA1	Long QT syndrome 2	Likely benign(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	20	32026775	20	33438969	427980	419295
NM_012156.2(EPB41L1):c.555A>G (p.Glu185=)	EPB41L1	not specified	Likely benign	no assertion criteria provided	20	34770258	20	36182336	129001	134447
NM_012156.2(EPB41L1):c.873+7C>G	EPB41L1	not specified	Likely benign	no assertion criteria provided	20	34775692	20	36187770	129002	134448
NM_012156.2(EPB41L1):c.1197C>T (p.Thr399=)	EPB41L1	not specified	Likely benign	no assertion criteria provided	20	34778616	20	36190694	128995	134441
NM_012156.2(EPB41L1):c.1338T>C (p.His446=)	EPB41L1	not specified	Likely benign	no assertion criteria provided	20	34782171	20	36194249	128996	134442
NM_012156.2(EPB41L1):c.1844G>C (p.Ser615Thr)	EPB41L1	Mental retardation, autosomal dominant 11	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	20	34797585	20	36209663	561007	552223
NM_012156.2(EPB41L1):c.1869G>A (p.Thr623=)	EPB41L1	not specified	Likely benign	no assertion criteria provided	20	34797610	20	36209688	128998	134444
NM_012156.2(EPB41L1):c.2060C>T (p.Pro687Leu)	EPB41L1	not specified	Likely benign	no assertion criteria provided	20	34797801	20	36209879	128999	134445
NM_000457.4(HNF4A):c.116-5C>T	HNF4A	Maturity onset diabetes mellitus in young|not specified|not provided|Hyperinsulinism, Dominant	Benign/Likely benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	20	43034693	20	44406053	129239	134685
NM_000457.4(HNF4A):c.201C>T (p.Ala67=)	HNF4A	Maturity onset diabetes mellitus in young|not specified|not provided|Hyperinsulinism, Dominant	Benign/Likely benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	20	43034783	20	44406143	129238	134684
NM_000457.4(HNF4A):c.416C>T (p.Thr139Ile)	HNF4A	Maturity onset diabetes mellitus in young|not specified|Hyperinsulinism, Dominant|Monogenic diabetes	Benign/Likely benign(Last reviewed: Mar 31, 2017)	criteria provided, multiple submitters, no conflicts	20	43042364	20	44413724	129240	134686
NM_000457.4(HNF4A):c.505G>A (p.Val169Ile)	HNF4A	Maturity-onset diabetes of the young,  type 1|Diabetes mellitus type 2|Maturity onset diabetes mellitus in young|not specified|not provided|Hyperinsulinism, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2016)	criteria provided, conflicting interpretations	20	43043159	20	44414519	36353	45017
NM_000457.4(HNF4A):c.991C>T (p.Arg331Cys)	HNF4A	Maturity-onset diabetes of the young,  type 1|not specified|Hyperinsulinemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 21, 2016)	criteria provided, conflicting interpretations	20	43052756	20	44424116	36364	45028
NM_000457.4(HNF4A):c.1333C>T (p.Pro445Ser)	HNF4A	not provided	Uncertain significance(Last reviewed: Jul 23, 2013)	criteria provided, single submitter	20	43058213	20	44429573	129237	134683
NM_000457.4(HNF4A):c.1387A>G (p.Ile463Val)	HNF4A	Maturity-onset diabetes of the young,  type 1|not specified|not provided	Uncertain significance(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	20	43058267	20	44429627	36345	45009
NM_015339.2(ADNP):c.2496_2499delTAAA (p.Asn832Lysfs)	ADNP	not provided|Helsmoortel-van der aa syndrome|History of neurodevelopmental disorder	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, multiple submitters, no conflicts	20	49508752 - 49508755	20	50892215 - 50892218	139632	143255
NM_015339.4(ADNP):c.539_542delTTAG (p.Val180Glyfs)	ADNP	not provided|Helsmoortel-van der aa syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	20	49510709 - 49510712	20	50894172 - 50894175	373314	360425
NM_020436.4(SALL4):c.410dupG (p.Gly138Argfs)	SALL4	Duane-radial ray syndrome	Pathogenic(Last reviewed: Mar 1, 2015)	no assertion criteria provided	20	50408612	20	51792073	218947	215781
NM_001719.2(BMP7):c.900C>G (p.Ser300Arg)	BMP7	Congenital anomalies of kidney and urinary tract	Uncertain significance	criteria provided, single submitter	20	55758836	20	57183780	224336	226092
NM_001719.2(BMP7):c.752C>T (p.Thr251Met)	BMP7	Congenital anomalies of kidney and urinary tract	Uncertain significance	criteria provided, single submitter	20	55777539	20	57202483	224335	226093
NM_001719.2(BMP7):c.334A>G (p.Ser112Gly)	BMP7	Congenital anomalies of kidney and urinary tract	Uncertain significance	criteria provided, single submitter	20	55840845	20	57265789	224337	226094
NM_000516.5(GNAS):c.34C>T (p.Gln12Ter)	GNAS	Pseudohypoparathyroidism|Pseudopseudohypoparathyroidism	Pathogenic(Last reviewed: Oct 7, 2014)	criteria provided, single submitter	20	57466815	20	58891760	209158	205793
NM_000516.5(GNAS):c.432+1G>A	GNAS	Pseudopseudohypoparathyroidism|Inborn genetic diseases	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, multiple submitters, no conflicts	20	57478847	20	58903792	446491	440007
NM_080425.3(GNAS):c.2682C>G (p.Ser894Arg)	GNAS	Pseudopseudohypoparathyroidism	Likely pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter			20	58909718	617752	609150
NM_000516.5(GNAS):c.880C>T (p.Gln294Ter)	GNAS	Pseudohypoparathyroidism|Pseudohypoparathyroidism type 1C	Likely pathogenic(Last reviewed: Mar 11, 2014)	criteria provided, single submitter	20	57485046	20	58909991	216937	213658
NM_001853.4(COL9A3):c.183+4A>C	COL9A3	Multiple epiphyseal dysplasia 3	Likely pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	20	61449909	20	62818557	488486	481354
NM_001853.4(COL9A3):c.369+2T>C	COL9A3	Multiple epiphyseal dysplasia 3	Pathogenic(Last reviewed: Sep 23, 2014)	no assertion criteria provided	20	61452884	20	62821532	374320	361234
NM_000744.6(CHRNA4):c.1659G>A (p.Ala553=)	CHRNA4	Nicotine addiction, protection against|not specified|Seizures|not provided	Benign(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	20	61981104	20	63349752	93428	99335
NM_000744.6(CHRNA4):c.1629C>T (p.Ser543=)	CHRNA4	Nicotine addiction, protection against|not specified|Seizures|not provided	Benign(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	20	61981134	20	63349782	93427	99334
NM_000744.6(CHRNA4):c.1525G>A (p.Ala509Thr)	CHRNA4	not specified|Seizures|not provided|Inborn genetic diseases	Uncertain significance(Last reviewed: Jun 13, 2017)	criteria provided, multiple submitters, no conflicts	20	61981238	20	63349886	128746	134195
NM_000744.6(CHRNA4):c.1353G>A (p.Pro451=)	CHRNA4	Autosomal dominant nocturnal frontal lobe epilepsy|not specified|Seizures	Benign/Likely benign(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	20	61981410	20	63350058	128745	134194
NM_000744.6(CHRNA4):c.1227T>C (p.Cys409=)	CHRNA4	Epilepsy, nocturnal frontal lobe, type 1|not specified|Seizures	Benign(Last reviewed: Jun 7, 2017)	criteria provided, multiple submitters, no conflicts	20	61981536	20	63350184	93425	99332
NM_000744.6(CHRNA4):c.1209G>T (p.Pro403=)	CHRNA4	Epilepsy, nocturnal frontal lobe, type 1|not specified|Seizures	Benign(Last reviewed: Jun 7, 2017)	criteria provided, multiple submitters, no conflicts	20	61981554	20	63350202	93424	99331
NM_000744.6(CHRNA4):c.1143C>T (p.Ala381=)	CHRNA4	Autosomal dominant nocturnal frontal lobe epilepsy|not specified|Seizures	Benign/Likely benign(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	20	61981620	20	63350268	128744	134193
NM_000744.6(CHRNA4):c.1047G>A (p.Leu349=)	CHRNA4	Autosomal dominant nocturnal frontal lobe epilepsy|not specified|Seizures	Benign/Likely benign(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	20	61981716	20	63350364	128743	134192
NM_000744.6(CHRNA4):c.678T>C (p.Cys226=)	CHRNA4	not specified|Seizures|not provided	Benign(Last reviewed: May 24, 2017)	criteria provided, multiple submitters, no conflicts	20	61982085	20	63350733	128750	134199
NM_000744.6(CHRNA4):c.639T>C (p.Asp213=)	CHRNA4	not specified|Seizures|not provided	Benign(Last reviewed: May 24, 2017)	criteria provided, multiple submitters, no conflicts	20	61982124	20	63350772	128749	134198
NM_000744.6(CHRNA4):c.189C>T (p.Leu63=)	CHRNA4	Epilepsy, nocturnal frontal lobe, type 1|not specified|Seizures	Benign(Last reviewed: Apr 11, 2017)	criteria provided, multiple submitters, no conflicts	20	61990939	20	63359587	128747	134196
NM_000744.6(CHRNA4):c.51G>A (p.Leu17=)	CHRNA4|LOC100130587	Epilepsy, nocturnal frontal lobe, type 1|not specified|Seizures	Benign(Last reviewed: Apr 11, 2017)	criteria provided, multiple submitters, no conflicts	20	61992467	20	63361115	93430	99337
NM_000744.6(CHRNA4):c.24G>C (p.Ala8=)	CHRNA4|LOC100130587	Autosomal dominant nocturnal frontal lobe epilepsy|not specified|Seizures|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 22, 2018)	criteria provided, conflicting interpretations	20	61992494	20	63361142	128748	134197
NM_172107.3(KCNQ2):c.2613G>T (p.Arg871Ser)	KCNQ2	Early infantile epileptic encephalopathy 7|not specified|Early infantile epileptic encephalopathy	Likely benign(Last reviewed: Oct 12, 2017)	criteria provided, multiple submitters, no conflicts	20	62038003	20	63406650	129343	134789
NM_172108.4(KCNQ2):c.2332delC (p.Gln778Serfs)	KCNQ2	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	20	62038191	20	63406838	374272	361235
NM_172107.3(KCNQ2):c.2339A>C (p.Asn780Thr)	KCNQ2	Benign familial neonatal seizures 1|not specified|Seizures|KCNQ2-Related Disorders	Benign(Last reviewed: Apr 26, 2017)	criteria provided, multiple submitters, no conflicts	20	62038277	20	63406924	21779	34631
NM_172107.3(KCNQ2):c.2316G>A (p.Pro772=)	KCNQ2	not provided	Uncertain significance(Last reviewed: Apr 5, 2013)	criteria provided, single submitter	20	62038300	20	63406947	129335	134781
NM_172107.3(KCNQ2):c.2296delC (p.Leu766Cysfs)	KCNQ2	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	20	62038320	20	63406967	374390	361236
NM_172107.3(KCNQ2):c.2281G>A (p.Ala761Thr)	KCNQ2	not provided	Uncertain significance(Last reviewed: Aug 8, 2013)	criteria provided, single submitter	20	62038335	20	63406982	129334	134780
NM_172107.3(KCNQ2):c.2264A>G (p.Tyr755Cys)	KCNQ2	not specified|Seizures|Early infantile epileptic encephalopathy	Benign/Likely benign(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	20	62038352	20	63406999	129333	134779
NM_172107.3(KCNQ2):c.2238T>A (p.Pro746=)	KCNQ2	Benign familial neonatal seizures 1|not specified|Seizures|KCNQ2-Related Disorders	Benign(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	20	62038378	20	63407025	129342	134788
NM_172107.3(KCNQ2):c.2235G>A (p.Pro745=)	KCNQ2	not specified|Seizures|KCNQ2-Related Disorders|Early infantile epileptic encephalopathy	Benign(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	20	62038381	20	63407028	129341	134787
NM_172107.3(KCNQ2):c.2127delT (p.Val710Serfs)	KCNQ2	Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy 7|not provided	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	20	62038489	20	63407136	7390	22429
NM_172107.3(KCNQ2):c.2031G>A (p.Arg677=)	KCNQ2	not specified|Seizures|KCNQ2-Related Disorders|Early infantile epileptic encephalopathy	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	20	62038585	20	63407232	129340	134786
NM_172107.3(KCNQ2):c.1800G>A (p.Thr600=)	KCNQ2	not provided	Uncertain significance(Last reviewed: Jan 2, 2014)	criteria provided, single submitter	20	62039853	20	63408500	129339	134785
NM_172107.3(KCNQ2):c.1719C>T (p.Ala573=)	KCNQ2	not specified|Seizures|KCNQ2-Related Disorders|Early infantile epileptic encephalopathy	Benign/Likely benign(Last reviewed: Dec 19, 2017)	criteria provided, multiple submitters, no conflicts	20	62044847	20	63413494	129338	134784
NM_172107.3(KCNQ2):c.1622G>C (p.Arg541Thr)	KCNQ2	Benign familial neonatal seizures 1	Likely pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	20	62045450	20	63414097	488537	481405
NM_172107.3(KCNQ2):c.1545G>C (p.Glu515Asp)	KCNQ2	Benign familial neonatal seizures 1|not specified|Seizures|KCNQ2-Related Disorders|Early infantile epileptic encephalopathy	Conflicting interpretations of pathogenicity(Last reviewed: Nov 6, 2017)	criteria provided, conflicting interpretations	20	62045527	20	63414174	21764	34616
NM_172107.3(KCNQ2):c.1503C>G (p.Ala501=)	KCNQ2	Benign familial neonatal seizures 1|not specified|Seizures|KCNQ2-Related Disorders	Benign(Last reviewed: Apr 26, 2017)	criteria provided, multiple submitters, no conflicts	20	62046278	20	63414925	129337	134783
NM_172107.3(KCNQ2):c.1348G>A (p.Val450Met)	KCNQ2	not specified|Seizures|KCNQ2-Related Disorders|Early infantile epileptic encephalopathy	Benign/Likely benign(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	20	62046433	20	63415080	129332	134778
NM_172107.3(KCNQ2):c.1197delT (p.Ser399Argfs)	KCNQ2	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 28, 2013)	criteria provided, single submitter	20	62059740	20	63428387	129331	134777
NM_172107.3(KCNQ2):c.1185G>A (p.Arg395=)	KCNQ2	not specified|Early infantile epileptic encephalopathy	Benign(Last reviewed: Nov 1, 2017)	criteria provided, multiple submitters, no conflicts	20	62059752	20	63428399	129330	134776
NM_172107.3(KCNQ2):c.912C>T (p.Phe304=)	KCNQ2	not specified|Seizures|KCNQ2-Related Disorders	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	62070966	20	63439613	129345	134791
NM_172107.3(KCNQ2):c.901G>A (p.Gly301Ser)	KCNQ2	Early infantile epileptic encephalopathy 7|Epileptic encephalopathy	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	20	62070977	20	63439624	369770	354006
NM_172107.3(KCNQ2):c.841G>C (p.Gly281Arg)	KCNQ2	Early infantile epileptic encephalopathy 7	Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	20	62071037	20	63439684	488538	481406
NM_172107.3(KCNQ2):c.841G>T (p.Gly281Trp)	KCNQ2	Early infantile epileptic encephalopathy 7|not provided	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, multiple submitters, no conflicts	20	62071037	20	63439684	216949	213659
NM_172107.3(KCNQ2):c.795G>A (p.Ala265=)	KCNQ2	not provided|Early infantile epileptic encephalopathy	Conflicting interpretations of pathogenicity(Last reviewed: Aug 30, 2016)	criteria provided, conflicting interpretations	20	62073780	20	63442427	129336	134782
NM_172107.3(KCNQ2):c.638G>A (p.Arg213Gln)	KCNQ2	Early infantile epileptic encephalopathy 7|not provided|Early infantile epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: May 2, 2018)	criteria provided, multiple submitters, no conflicts	20	62076064	20	63444711	39760	48359
NM_172107.3(KCNQ2):c.601C>T (p.Arg201Cys)	KCNQ2	Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy 7|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	20	62076101	20	63444748	205869	203792
NM_001958.3(EEF1A2):c.796C>T (p.Arg266Trp)	EEF1A2	not provided|Inborn genetic diseases|Epileptic encephalopathy, early infantile, 33	Pathogenic(Last reviewed: Oct 18, 2017)	criteria provided, multiple submitters, no conflicts	20	62122065	20	63490712	449242	446299
NM_001958.3(EEF1A2):c.208G>A (p.Gly70Ser)	EEF1A2	not provided|Intellectual disability|Inborn genetic diseases|Epileptic encephalopathy, early infantile, 33	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	20	62127325	20	63495972	100782	106647
NM_018419.2(SOX18):c.712G>T (p.Glu238*)	TCEA2|SOX18	Glomerulonephritis with sparse hair and telangiectases	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	20	62679962	20	64048609	433539	427113
NM_018419.2(SOX18):c.481C>T (p.Gln161Ter)	TCEA2|SOX18	Hypotrichosis-lymphedema-telangiectasia syndrome	Pathogenic(Last reviewed: Oct 1, 2014)	criteria provided, single submitter	20	62680193	20	64048840	162093	171809
NC_000021.8:g.14714507_29216662dup	APP|ATP5PF|CXADR|GABPA|NCAM2|TMPRSS15|HSPA13|NRIP1|ADAMTS1|BTG3|ADAMTS5|USP25|RBM11|MRPL39|C21orf91|JAM2|SAMSN1|CYYR1|CHODL|LIPI|POTED|MIRLET7C|MIR125B2|MIR155|MIR99A	Alzheimer's disease|Cerebral amyloid angiopathy, APP-related	Pathogenic	no assertion criteria provided	21	14714507 - 29216662			127268	132725
NM_138927.2(SON):c.286C>T (p.Gln96Ter)	SON	Global developmental delay|Failure to thrive|Failure to thrive|Global developmental delay|ZTTK syndrome	Likely pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	21	34921823	21	33549517	252926	247328
NM_138927.2(SON):c.3073dupA (p.Met1025Asnfs)	SON	Global developmental delay|Failure to thrive|Failure to thrive|Global developmental delay|ZTTK syndrome	Likely pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	21	34924610	21	33552304	252927	247329
NM_138927.2(SON):c.3852_3856delGGTAT (p.Met1284Ilefs)	SON	Global developmental delay|Failure to thrive|Failure to thrive|Global developmental delay|ZTTK syndrome	Likely pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	21	34925389 - 34925393	21	33553083 - 33553087	252928	247330
NM_138927.2(SON):c.5753_5756delTTAG (p.Val1918Glufs)	SON	Global developmental delay|Failure to thrive|Failure to thrive|Global developmental delay|Inborn genetic diseases|ZTTK syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, multiple submitters, no conflicts	21	34927290 - 34927293	21	33554984 - 33554987	252929	247331
NM_138927.2(SON):c.6233delC (p.Pro2078Hisfs)	SON	Global developmental delay|Failure to thrive|Failure to thrive|Global developmental delay|ZTTK syndrome	Likely pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	21	34929534	21	33557228	252930	247332
NM_172201.1(KCNE2):c.40G>A (p.Val14Ile)	KCNE2	Long QT syndrome 6|Long QT syndrome|not specified|not provided	Likely benign(Last reviewed: Nov 28, 2017)	criteria provided, multiple submitters, no conflicts	21	35742817	21	34370518	67621	78517
NM_172201.1(KCNE2):c.80G>A (p.Arg27His)	KCNE2	Long QT syndrome 6|Long QT syndrome|Congenital long QT syndrome	Uncertain significance(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	21	35742857	21	34370558	67623	78519
NM_172201.1(KCNE2):c.161T>C (p.Met54Thr)	KCNE2	Cardiac arrhythmia|Long QT syndrome 6|not provided|Congenital long QT syndrome|KCNE2-Related Disorders	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Mar 17, 2018)	criteria provided, conflicting interpretations	21	35742938	21	34370639	6053	21092
NM_172201.1(KCNE2):c.170T>C (p.Ile57Thr)	KCNE2	Cardiac arrhythmia|Long QT syndrome 6|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	21	35742947	21	34370648	6054	21093
NM_172201.1(KCNE2):c.229C>T (p.Arg77Trp)	KCNE2	Long QT syndrome|not specified|Congenital long QT syndrome	Uncertain significance(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	21	35743006	21	34370707	67614	78510
NM_172201.1(KCNE2):c.230G>A (p.Arg77Gln)	KCNE2	Long QT syndrome|Congenital long QT syndrome	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	21	35743007	21	34370708	67616	78512
NM_172201.1(KCNE2):c.285G>T (p.Lys95Asn)	KCNE2	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	21	35743062	21	34370763	427978	419296
NM_000219.5(KCNE1):c.374C>T (p.Thr125Met)	KCNE1	Long QT syndrome|Romano-Ward syndrome|not specified|Congenital long QT syndrome|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 28, 2018)	criteria provided, conflicting interpretations	21	35821559	21	34449261	132679	136427
NM_000219.5(KCNE1):c.325G>A (p.Val109Ile)	KCNE1	Long QT syndrome 5|Long QT syndrome|not specified|not provided	Uncertain significance(Last reviewed: May 22, 2018)	criteria provided, multiple submitters, no conflicts	21	35821608	21	34449310	132678	136426
NM_000219.5(KCNE1):c.273C>G (p.Asp91Glu)	KCNE1	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	21	35821660	21	34449362	427969	419297
NM_000219.5(KCNE1):c.226G>A (p.Asp76Asn)	KCNE1	Jervell and Lange-Nielsen syndrome 2|Jervell and Lange-Nielsen syndrome 1|Long QT syndrome 5|Arrhythmogenic right ventricular cardiomyopathy|Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|not provided|Congenital long QT syndrome|Cardiovascular phenotype|Sudden unexplained death|Jervell and Lange-Nielsen syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	21	35821707	21	34449409	13477	28516
NM_000219.5(KCNE1):c.200G>A (p.Arg67His)	KCNE1	Long QT syndrome|not specified|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Apr 13, 2018)	criteria provided, conflicting interpretations	21	35821733	21	34449435	132661	136409
NM_000219.5(KCNE1):c.29C>T (p.Thr10Met)	KCNE1	Long QT syndrome|not specified|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Apr 5, 2018)	criteria provided, conflicting interpretations	21	35821904	21	34449606	132677	136425
NM_000219.5(KCNE1):c.23C>T (p.Ala8Val)	KCNE1	Long QT syndrome 5|Long QT syndrome|not specified|Congenital long QT syndrome|Cardiovascular phenotype	Uncertain significance(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	21	35821910	21	34449612	132670	136418
NM_001396.4(DYRK1A):c.201_204del (p.Asn68Argfs)	DYRK1A	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter			21	37472874 - 37472877	598757	589813
NM_101395.2(DYRK1A):c.297_301del (p.Leu100Glnfs)	DYRK1A	Mental retardation, autosomal dominant 7	Pathogenic	no assertion criteria provided	21	38850572 - 38850576	21	37478270 - 37478274	375618	362432
NM_001396.3(DYRK1A):c.312C>G (p.Tyr104Ter)	DYRK1A	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	21	38850587	21	37478285	204004	200400
NM_001396.4(DYRK1A):c.452dup (p.Asn151Lysfs)	DYRK1A	Mental retardation, autosomal dominant 7|Inborn genetic diseases	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, multiple submitters, no conflicts	21	38853064	21	37480762	204008	200401
NM_001396.3(DYRK1A):c.461delA (p.Lys154Serfs)	DYRK1A	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	21	38853073	21	37480771	204006	200402
NM_001396.3(DYRK1A):c.563A>T (p.Lys188Ile)	DYRK1A	Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	21	38858815	21	37486513	204009	200403
NM_001396.3(DYRK1A):c.613C>T (p.Arg205Ter)	DYRK1A	Mental retardation, autosomal dominant 7|Feeding difficulties|Deeply set eye|not provided|Microcephaly|Intellectual disability|Absent or delayed speech development	Pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, multiple submitters, no conflicts	21	38858865	21	37486563	162153	171866
NM_001396.3(DYRK1A):c.734T>G (p.Leu245Arg)	DYRK1A	Mental retardation, autosomal dominant 7	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	21	38862546	21	37490244	204010	200404
NM_001396.3(DYRK1A):c.883C>T (p.Leu295Phe)	DYRK1A	Mental retardation, autosomal dominant 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, multiple submitters, no conflicts	21	38862695	21	37490393	204011	200405
NM_001396.4(DYRK1A):c.1037C>T (p.Ser346Phe)	DYRK1A	Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Oct 19, 2016)	criteria provided, single submitter	21	38865404	21	37493102	505359	497342
NM_001396.3(DYRK1A):c.1101_1104delAGAT (p.Asp368Argfs)	DYRK1A	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	21	38868422 - 38868425	21	37496120 - 37496123	204007	200406
NM_001396.4(DYRK1A):c.1162dup (p.Ala388Glyfs)	DYRK1A	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Nov 7, 2013)	criteria provided, single submitter	21	38868483	21	37496181	209151	205794
NM_001396.3(DYRK1A):c.1309C>T (p.Arg437Ter)	DYRK1A	Mental retardation, autosomal dominant 7|Seizures|Feeding difficulties|Deeply set eye|not provided|Microcephaly|Intellectual disability|Absent or delayed speech development	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, multiple submitters, no conflicts	21	38877655	21	37505352	162158	171873
NM_001396.3(DYRK1A):c.1399C>T (p.Arg467Ter)	DYRK1A	Mental retardation, autosomal dominant 7|not provided	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, multiple submitters, no conflicts	21	38877745	21	37505442	204005	200407
NM_001396.3(DYRK1A):c.1400G>A (p.Arg467Gln)	DYRK1A	Mental retardation, autosomal dominant 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, multiple submitters, no conflicts	21	38877746	21	37505443	209150	205795
NM_002240.4(KCNJ6):c.512T>G (p.Leu171Arg)	KCNJ6	Keppen-Lubinsky syndrome	Likely pathogenic	criteria provided, single submitter	21	39086948	21	37714645	431712	425231
GRCh37/hg19 21q22.13-22.2(chr21:37839410..41427526)	DSCAM|DYRK1A|ERG|ETS2|HLCS|HMGN1|KCNJ6|KCNJ15|PCP4|SH3BGR|SIM2|TTC3|WRB|PSMG1|DSCR4|VPS26C|B3GALT5|CLDN14|PIGP|RIPPLY3|BRWD1|DSCR8|LCA5L|IGSF5|LINC00114	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	21	37839410 - 41427526			204003	200409
GRCh37/hg19 21q22.13-22.2(chr21:38741104..40274106)	DYRK1A|ERG|ETS2|KCNJ6|KCNJ15|DSCR4|DSCR8|LINC00114	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	21	38741104 - 40274106			204002	200408
NM_018963.4(BRWD1):c.2352G>A (p.Ser784=)	BRWD1	Autistic disorder of childhood onset	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	21	40619756	21	39247830	560965	552225
NM_000383.3(AIRE):c.682G>T (p.Gly228Trp)	AIRE	Autoimmune polyglandular syndrome type 1, autosomal dominant	Pathogenic(Last reviewed: Feb 28, 2017)	no assertion criteria provided	21	45709569	21	44289686	3313	18352
NM_001848.2(COL6A1):c.809_811delAAC (p.Glu270_Arg271delinsGly)	COL6A1	Bethlem myopathy 1	Likely pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	21	47409002 - 47409004	21	45989088 - 45989090	584434	575508
NM_001848.2(COL6A1):c.850G>A (p.Gly284Arg)	COL6A1	Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|not provided|Ullrich congenital muscular dystrophy 1, autosomal dominant	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, multiple submitters, no conflicts	21	47409043	21	45989129	17180	32219
NM_001848.2(COL6A1):c.930+189C>T	COL6A1	Bethlem myopathy 1|not provided	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	21	47409881	21	45989967	542998	534026
NM_001849.3(COL6A2):c.2096G>A (p.Gly699Asp)	COL6A2	Bethlem myopathy 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 28, 2017)	criteria provided, conflicting interpretations	21	47545825	21	46125911	216911	213661
NM_080647.1(TBX1):c.385G>A (p.Glu129Lys)	TBX1	DiGeorge sequence|Tetralogy of Fallot	Conflicting interpretations of pathogenicity(Last reviewed: Jul 5, 2018)	criteria provided, conflicting interpretations	22	19748778	22	19761255	488618	481486
NM_080647.1(TBX1):c.1374C>G (p.Pro458=)	TBX1	Tetralogy of Fallot	Uncertain significance(Last reviewed: Dec 6, 2018)	no assertion criteria provided			22	19766753	598931	590018
NM_006767.3(LZTR1):c.1739T>C (p.Leu580Pro)	LZTR1	Noonan syndrome 10	Uncertain significance	no assertion criteria provided	22	21348970	22	20994681	559507	550231
NM_006767.3(LZTR1):c.1904C>T (p.Pro635Leu)	LZTR1	Noonan syndrome 10	Likely pathogenic(Last reviewed: Apr 26, 2017)	no assertion criteria provided	22	21349277	22	20994988	433552	427124
NM_003073.4(SMARCB1):c.110G>A (p.Arg37His)	SMARCB1	Mental retardation, autosomal dominant 15|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 15, 2018)	criteria provided, conflicting interpretations	22	24133959	22	23791772	88893	94452
NM_003073.4(SMARCB1):c.897G>A (p.Ser299=)	SMARCB1	not specified|not provided|Hereditary cancer-predisposing syndrome|Coffin-Siris syndrome|Schwannomatosis|Rhabdoid tumor	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	24167513	22	23825326	126368	131900
NM_003073.4(SMARCB1):c.1089G>T (p.Lys363Asn)	SMARCB1	Mental retardation, autosomal dominant 15	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	22	24175861	22	23833674	561114	552228
NM_003073.4(SMARCB1):c.1091_1093delAGA (p.Lys364del)	SMARCB1	Rhabdoid tumor predisposition syndrome 1|Mental retardation, autosomal dominant 15|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	22	24175863 - 24175865	22	23833676 - 23833678	30201	39157
NM_032608.6(MYO18B):c.6660_6670del (p.Arg2220Serfs)	MYO18B	Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism	Likely pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	22	26422600 - 26422610	22	26026634 - 26026644	590293	581234
hg19chr22:g.26995597_27074524dup	CRYBA4|CRYBB1|MIAT	Congenital cataract	Likely pathogenic(Last reviewed: Dec 11, 2016)	no assertion criteria provided	22	26995597 - 27074524			369847	354065
NM_007194.4(CHEK2):c.1555C>T (p.Arg519Ter)	CHEK2	Familial cancer of breast|Breast and colorectal cancer, susceptibility to|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	22	29083962	22	28687974	128064	133521
NM_007194.3(CHEK2):c.1100_1101delCT (p.Thr367Argfs)	CHEK2	Nephroblastoma	Pathogenic(Last reviewed: May 28, 2015)	no assertion criteria provided	22	29091856 - 29091857	22	28695868 - 28695869	438773	432389
NM_007194.3(CHEK2):c.1100delC (p.Thr367Metfs)	CHEK2	Familial cancer of breast|Li-Fraumeni syndrome 2|Osteosarcoma|Malignant tumor of prostate|Breast cancer, susceptibility to|Breast and colorectal cancer, susceptibility to|Li-Fraumeni syndrome|Colitis|not provided|Neoplasm of the breast|Astrocytoma|Hereditary cancer-predisposing syndrome|Inflammation of the large intestine|Hematochezia|Leiomyosarcoma|Thrombocytopenia|Breast cancer|CHEK2-Related Cancer Susceptibility|Hereditary cancer	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	22	29091857	22	28695869	128042	133499
NM_007194.4(CHEK2):c.320-5T>A	CHEK2	Familial cancer of breast|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	22	29121360	22	28725372	128070	133527
NM_000268.3(NF2):c.1786T>C (p.Ter596Gln)	NF2	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	22	30090789	22	29694800	561064	552229
NM_014941.3(MORC2):c.1034G>T (p.Cys345Phe)	MORC2	Charcot-Marie-Tooth disease, axonal, type 2z	Uncertain significance(Last reviewed: Mar 20, 2018)	no assertion criteria provided	22	31333951	22	30937964	545019	535283
NM_001242896.2(DEPDC5):c.2512C>T (p.Arg838Ter)	DEPDC5	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	22	32234828	22	31838842	590901	581846
NM_001135774.1(SYN3):c.1441_1442delCCinsTT (p.Pro481Leu)	SYN3	Global developmental delay|Seizures|Visual impairment|Global developmental delay|Generalized hypotonia|Cerebellar vermis atrophy	Pathogenic	no assertion criteria provided	22	32914195 - 32914196	22	32518208 - 32518209	375384	362165
NM_002473.5(MYH9):c.4546G>T (p.Val1516Leu)	MYH9	Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	22	36685142	22	36289096	164432	176262
GRCh38/hg38 22q13.1(chr22:37805546-37983784)x1	H1F0|POLR2F|SOX10|GALR3|GCAT|EIF3L|C22orf23|MICALL1|ANKRD54|MIR658|MIR659|MIR6820	Waardenburg syndrome type 4C	Pathogenic(Last reviewed: May 15, 2018)	no assertion criteria provided	22	38201553 - 38379791	22	37805546 - 37983784	545010	535274
NM_006941.3(SOX10):c.1205_1209del (p.Tyr402Terfs)	POLR2F|SOX10	Waardenburg syndrome type 4C	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	22	38369694 - 38369698	22	37973687 - 37973691	518422	508964
NM_006941.3(SOX10):c.1169C>G (p.Ser390Ter)	POLR2F|SOX10	Waardenburg syndrome type 2E	Pathogenic(Last reviewed: May 15, 2018)	no assertion criteria provided	22	38369734	22	37973727	545014	535278
NM_006941.3(SOX10):c.1091delA (p.Gln364Argfs)	POLR2F|SOX10	Waardenburg syndrome type 2A	Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	22	38369812	22	37973805	488041	481056
NM_006941.3(SOX10):c.430delC (p.Leu144Cysfs)	POLR2F|SOX10	Waardenburg syndrome type 2A	Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	22	38374141	22	37978134	488042	481057
NM_006941.3(SOX10):c.426G>A (p.Trp142Ter)	POLR2F|SOX10	Waardenburg syndrome	Pathogenic(Last reviewed: Aug 4, 2016)	criteria provided, single submitter	22	38379366	22	37983359	505252	497802
NM_006941.3(SOX10):c.424T>C (p.Trp142Arg)	POLR2F|SOX10	Waardenburg syndrome	Likely pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	22	38379368	22	37983361	505653	497803
NM_006941.3(SOX10):c.415G>T (p.Gly139Cys)	POLR2F|SOX10	Waardenburg syndrome type 2E	Uncertain significance(Last reviewed: May 15, 2018)	no assertion criteria provided	22	38379377	22	37983370	545013	535277
NM_006941.3(SOX10):c.403A>C (p.Ser135Arg)	POLR2F|SOX10	Waardenburg syndrome type 2A	Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	22	38379389	22	37983382	488043	481058
NM_006941.3(SOX10):c.401T>C (p.Leu134Pro)	POLR2F|SOX10	Waardenburg syndrome	Likely pathogenic(Last reviewed: Mar 4, 2016)	criteria provided, single submitter	22	38379391	22	37983384	228291	231229
NM_006941.3(SOX10):c.316C>G (p.Arg106Gly)	POLR2F|SOX10	Waardenburg syndrome type 2E	Likely pathogenic(Last reviewed: Dec 30, 2014)	no assertion criteria provided	22	38379476	22	37983469	374266	361237
NM_006941.3(SOX10):c.44_62del (p.Val15Alafs)	POLR2F|SOX10	Waardenburg syndrome type 2A	Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	22	38379730 - 38379748	22	37983723 - 37983741	488044	481059
NM_001429.3(EP300):c.586A>G (p.Ile196Val)	EP300	Rubinstein-Taybi syndrome 1|Rubinstein-Taybi syndrome 2	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	22	41513682	22	41117678	158567	169822
NM_001429.3(EP300):c.631G>A (p.Gly211Ser)	EP300	Rubinstein-Taybi syndrome 1|Carcinoma of colon|Rubinstein-Taybi syndrome 2|not specified	Benign/Likely benign(Last reviewed: Dec 8, 2017)	criteria provided, multiple submitters, no conflicts	22	41513727	22	41117723	134043	137782
NM_001429.3(EP300):c.942C>T (p.Gly314=)	EP300	Rubinstein-Taybi syndrome 1|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	41523526	22	41127522	158571	169823
NM_001429.3(EP300):c.1529-8T>C	EP300	Rubinstein-Taybi syndrome 2	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	22	41531809	22	41135805	158556	169824
NM_001429.3(EP300):c.2019T>C (p.Pro673=)	EP300	Rubinstein-Taybi syndrome 2	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	22	41537192	22	41141188	158558	169826
NM_001429.3(EP300):c.2053+8G>T	EP300	Rubinstein-Taybi syndrome 1|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	41537234	22	41141230	93732	99635
NM_001429.3(EP300):c.2164dupC (p.Gln722Profs)	EP300	Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	22	41543873	22	41147869	246604	245212
NM_001429.3(EP300):c.2380-15T>C	EP300	Rubinstein-Taybi syndrome 1|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	41545750	22	41149746	158559	169827
NM_001429.3(EP300):c.2756G>A (p.Ser919Asn)	EP300	not specified	Likely benign(Last reviewed: May 19, 2014)	criteria provided, single submitter	22	41546141	22	41150137	158560	169828
NM_001429.3(EP300):c.2989A>G (p.Ile997Val)	EP300	Rubinstein-Taybi syndrome 1|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	41548008	22	41152004	93736	99639
NM_001429.3(EP300):c.2998-12G>A	EP300	Rubinstein-Taybi syndrome 1|Rubinstein-Taybi syndrome 2	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	22	41548198	22	41152194	158561	169829
NM_001429.3(EP300):c.3183T>A (p.Thr1061=)	EP300	Rubinstein-Taybi syndrome 1|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	41551039	22	41155035	93738	99641
NM_001429.3(EP300):c.3348G>A (p.Gln1116=)	EP300	Rubinstein-Taybi syndrome 1|Carcinoma of colon|Rubinstein-Taybi syndrome 2|not specified	Benign(Last reviewed: May 16, 2017)	criteria provided, multiple submitters, no conflicts	22	41553259	22	41157255	158562	169830
NM_001429.3(EP300):c.3426C>T (p.Cys1142=)	EP300	Rubinstein-Taybi syndrome 1|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	41553337	22	41157333	158563	169831
NM_001429.3(EP300):c.3665C>A (p.Pro1222His)	EP300	Rubinstein-Taybi syndrome 2	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	22	41556720	22	41160716	158564	169832
NM_001429.3(EP300):c.3750C>G (p.Cys1250Trp)	EP300	Rubinstein-Taybi syndrome 2	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	22	41560078	22	41164074	561006	552232
NM_001429.3(EP300):c.5061+9C>T	EP300	Rubinstein-Taybi syndrome 1|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	41572541	22	41176537	158566	169833
NM_001429.3(EP300):c.5061+10G>A	EP300	Rubinstein-Taybi syndrome 1|Rubinstein-Taybi syndrome 2|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	22	41572542	22	41176538	158565	169834
NM_001429.3(EP300):c.6001C>T (p.Pro2001Ser)	EP300	Rubinstein-Taybi syndrome 2	Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	22	41573716	22	41177712	438594	432225
NM_001429.3(EP300):c.6372C>T (p.Val2124=)	EP300	Rubinstein-Taybi syndrome 1|Carcinoma of colon|Rubinstein-Taybi syndrome 2|not specified	Benign/Likely benign(Last reviewed: Jun 23, 2017)	criteria provided, multiple submitters, no conflicts	22	41574087	22	41178083	158568	169835
NM_001429.3(EP300):c.6481A>G (p.Met2161Val)	EP300	Rubinstein-Taybi syndrome 1|not specified	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	41574196	22	41178192	134049	137788
NM_001429.3(EP300):c.6636G>A (p.Gln2212=)	EP300	Rubinstein-Taybi syndrome 1|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	41574351	22	41178347	158569	169836
NM_001429.3(EP300):c.7245G>A (p.Ter2415=)	EP300	not specified	Likely benign(Last reviewed: Mar 18, 2013)	criteria provided, single submitter	22	41574960	22	41178956	158570	169837
NM_001429.3(EP300):c.*13_*15delGTA	EP300	Rubinstein-Taybi syndrome 1|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	41574973 - 41574975	22	41178969 - 41178971	158555	169838
NM_001167574.1(UPK3A):c.202G>A (p.Asp68Asn)	UPK3A	Renal adysplasia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	45681971	22	45286090	224348	226095
NM_033517.1(SHANK3):c.1030G>T (p.Val344Leu)	SHANK3	22q13.3 deletion syndrome	Likely pathogenic	no assertion criteria provided	22	51123079	22	50684651	375622	362436
NM_033517.1(SHANK3):c.3679dupG (p.Ala1227Glyfs)	SHANK3	22q13.3 deletion syndrome|Autism spectrum disorder|not provided|Inborn genetic diseases|History of neurodevelopmental disorder	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, multiple submitters, no conflicts	22	51159940	22	50721512	208759	205325
NM_033517.1(SHANK3):c.4029_4030del (p.Ser1343Argfs)	SHANK3	22q13.3 deletion syndrome	Pathogenic	no assertion criteria provided	22	51160290 - 51160291	22	50721862 - 50721863	375586	362396
NM_006941.3(SOX10):c.(?_698)_(1401_?)del (p.(?))	POLR2F|SOX10	Waardenburg syndrome	Pathogenic(Last reviewed: Apr 22, 2015)	criteria provided, single submitter	22	38369502 - 38370205	22	37973495 - 37974198	228398	231133
NM_000451.3(SHOX):c.583C>T (p.Arg195Ter)	SHOX	Short stature, idiopathic, X-linked|not provided	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	Y	551772	X	641037	9872	24911
NM_000216.3(ANOS1):c.2015A>G (p.His672Arg)	ANOS1	Kallmann syndrome 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 5, 2016)	criteria provided, conflicting interpretations	X	8501064	X	8533023	224350	226096
NM_000216.3(ANOS1):c.404C>T (p.Pro135Leu)	ANOS1	Kallmann syndrome 1	Uncertain significance	criteria provided, single submitter	X	8565212	X	8597171	224351	226097
NM_000109.3(DMD):c.9658T>C (p.Phe3220Leu)	DMD	Primary dilated cardiomyopathy|Becker muscular dystrophy|Duchenne muscular dystrophy|not specified|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Nov 20, 2017)	criteria provided, multiple submitters, no conflicts	X	31222203	X	31204086	94856	100756
NM_000109.3(DMD):c.7547G>A (p.Arg2516His)	DMD	Duchenne muscular dystrophy|Muscular dystrophy|not specified|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	X	31747837	X	31729720	161219	171246
NM_000109.3(DMD):c.4425G>A (p.Met1475Ile)	DMD	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Aug 1, 2016)	no assertion criteria provided	X	32407687	X	32389570	375863	362747
NM_001356.4(DDX3X):c.192dup (p.Asp65Argfs)	DDX3X	Mental retardation, X-linked 102	Pathogenic	no assertion criteria provided	X	41200777	X	41341524	375368	362167
NM_001356.4(DDX3X):c.1703C>T (p.Pro568Leu)	DDX3X	Inborn genetic diseases|Mental retardation, X-linked 102	Pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	X	41206199	X	41346946	375367	362169
NM_003688.3(CASK):c.1465C>T (p.Arg489Trp)	CASK	Smith-Magenis Syndrome-like	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	X	41437631	X	41578378	254208	248723
NM_021140.3(KDM6A):c.4005+14T>C	KDM6A	not specified	Benign(Last reviewed: Oct 20, 2015)	criteria provided, multiple submitters, no conflicts	X	44966795	X	45107550	158690	170110
NM_021140.3(KDM6A):c.4052G>A (p.Arg1351Gln)	KDM6A	Kabuki syndrome 2|not provided	Uncertain significance(Last reviewed: Mar 26, 2015)	criteria provided, multiple submitters, no conflicts	X	44969370	X	45110125	158691	170111
NM_203474.1(PORCN):c.268C>T (p.Arg90Ter)	PORCN	Focal dermal hypoplasia	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	X	48369814	X	48511426	242872	244003
NM_007075.3(WDR45):c.55+2_55+3del	WDR45	Neurodegeneration with brain iron accumulation 5	Pathogenic	no assertion criteria provided	X	48935697 - 48935698	X	49078038 - 49078039	375868	362749
NM_018094.4(GSPT2):c.1021G>A (p.Val341Ile)	GSPT2	Autistic disorder of childhood onset|Seizures|Autism|Delayed speech and language development	Pathogenic	no assertion criteria provided	X	51487743	X	51744647	375379	362170
NM_004187.3(KDM5C):c.3068A>G (p.Lys1023Arg)	KDM5C	Smith-Magenis Syndrome-like	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	X	53225150	X	53195968	254201	248716
NM_006306.3(SMC1A):c.116C>G (p.Ser39Ter)	SMC1A	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	X	53442112	X	53415163	374391	361246
NM_018486.2(HDAC8):c.839_843delCTCCAinsGT (p.Thr280_Pro281delinsSer)	HDAC8	Cornelia de Lange syndrome 5	Likely pathogenic(Last reviewed: Feb 13, 2015)	criteria provided, single submitter	X	71684476 - 71684480	X	72464626 - 72464630	369669	353914
NM_000169.2(GLA):c.937G>T (p.Asp313Tyr)	GLA|RPL36A-HNRNPH2	Fabry disease|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Sudden unexplained death	Conflicting interpretations of pathogenicity, other(Last reviewed: Aug 22, 2018)	criteria provided, conflicting interpretations	X	100653420	X	101398432	10738	25777
NM_178151.2(DCX):c.1027-2A>G	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110544973	X	111301745	158424	169848
NM_178151.2(DCX):c.907C>T (p.Arg303Ter)	DCX	Heterotopia|not provided	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, multiple submitters, no conflicts	X	110574171	X	111330943	158511	169849
NM_178151.2(DCX):c.853A>T (p.Lys285Ter)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110574225	X	111330997	158510	169850
NM_178151.2(DCX):c.814C>T (p.Arg272Ter)	DCX	Heterotopia|not provided	Pathogenic(Last reviewed: May 23, 2016)	criteria provided, multiple submitters, no conflicts	X	110574264	X	111331036	158509	169851
NM_178151.2(DCX):c.809-1G>A	DCX	Lissencephaly, X-linked|Heterotopia	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2016)	criteria provided, multiple submitters, no conflicts	X	110574270	X	111331042	158508	169852
NM_178151.2(DCX):c.781C>T (p.Gln261Ter)	DCX	Heterotopia|not provided	Pathogenic(Last reviewed: Sep 2, 2014)	criteria provided, multiple submitters, no conflicts	X	110576306	X	111333078	158507	169853
NM_178151.2(DCX):c.773G>C (p.Arg258Pro)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110576314	X	111333086	158506	169854
NM_178151.2(DCX):c.766A>T (p.Lys256Ter)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110576321	X	111333093	158505	169855
NM_178151.2(DCX):c.751G>T (p.Ala251Ser)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110576336	X	111333108	158504	169856
NM_178151.2(DCX):c.746T>G (p.Phe249Cys)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110576341	X	111333113	158503	169857
NM_178151.2(DCX):c.740_742del (p.Asp247del)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110576345 - 110576347	X	111333117 - 111333119	158502	169858
NM_178151.2(DCX):c.724T>A (p.Phe242Ile)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Aug 27, 2013)	criteria provided, single submitter	X	110576363	X	111333135	158501	169859
NM_178151.2(DCX):c.688A>C (p.Thr230Pro)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644235	X	111401007	158500	169860
NM_178151.2(DCX):c.683T>C (p.Leu228Pro)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644240	X	111401012	158499	169861
NM_178151.2(DCX):c.681del (p.Lys227Asnfs)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644242	X	111401014	158498	169862
NM_178151.2(DCX):c.670del (p.Val224Leufs)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644253	X	111401025	158497	169863
NM_178151.2(DCX):c.667G>A (p.Gly223Arg)	DCX	Heterotopia	Pathogenic(Last reviewed: Jul 7, 2014)	criteria provided, single submitter	X	110644256	X	111401028	158496	169864
NM_178151.2(DCX):c.666del (p.Val224Leufs)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644257	X	111401029	158495	169865
NM_178151.2(DCX):c.651del (p.Ile218Serfs)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644272	X	111401044	158494	169866
NM_178151.2(DCX):c.641T>C (p.Ile214Thr)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644282	X	111401054	158493	169867
NM_178151.2(DCX):c.628G>T (p.Val210Phe)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644295	X	111401067	158492	169868
NM_178151.2(DCX):c.614A>T (p.His205Leu)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644309	X	111401081	158491	169869
NM_178151.2(DCX):c.611C>A (p.Ala204Asp)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644312	X	111401084	158490	169870
NM_178151.2(DCX):c.608C>A (p.Thr203Lys)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644315	X	111401087	158489	169871
NM_178151.2(DCX):c.607A>G (p.Thr203Ala)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644316	X	111401088	158488	169872
NM_178151.2(DCX):c.596T>C (p.Leu199Pro)	DCX	Heterotopia|not provided	Likely pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, multiple submitters, no conflicts	X	110644327	X	111401099	158487	169873
NM_178151.2(DCX):c.588T>C (p.Arg196=)	DCX	not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 24, 2017)	criteria provided, multiple submitters, no conflicts	X	110644335	X	111401107	158486	169874
NM_178151.2(DCX):c.587G>A (p.Arg196His)	DCX	Lissencephaly, X-linked|Subcortical laminar heterotopia, X-linked|Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644336	X	111401108	11609	26648
NM_178151.2(DCX):c.586C>T (p.Arg196Cys)	DCX	Heterotopia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, multiple submitters, no conflicts	X	110644337	X	111401109	158485	169875
NM_178151.2(DCX):c.586C>G (p.Arg196Gly)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644337	X	111401109	158484	169876
NM_178151.2(DCX):c.586C>A (p.Arg196Ser)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644337	X	111401109	158483	169877
NM_178151.2(DCX):c.578_585del (p.Lys193Thrfs)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644338 - 110644345	X	111401110 - 111401117	158482	169878
NM_178151.2(DCX):c.574C>T (p.Arg192Trp)	DCX	Lissencephaly, X-linked|Subcortical laminar heterotopia, X-linked|Heterotopia|not provided	Pathogenic(Last reviewed: Dec 22, 2016)	criteria provided, multiple submitters, no conflicts	X	110644349	X	111401121	11598	26637
NM_178151.2(DCX):c.572C>G (p.Pro191Arg)	DCX	Heterotopia|not provided	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, multiple submitters, no conflicts	X	110644351	X	111401123	158481	169879
NM_178151.2(DCX):c.571C>A (p.Pro191Thr)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644352	X	111401124	158480	169880
NM_178151.2(DCX):c.557G>T (p.Arg186Leu)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644366	X	111401138	158478	169881
NM_178151.2(DCX):c.557G>A (p.Arg186His)	DCX	Lissencephaly, X-linked|Heterotopia	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	X	110644366	X	111401138	158477	169882
NM_178151.2(DCX):c.556C>T (p.Arg186Cys)	DCX	Heterotopia|not provided	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	X	110644367	X	111401139	158476	169883
NM_178151.2(DCX):c.551T>A (p.Ile184Asn)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644372	X	111401144	158475	169884
NM_178151.2(DCX):c.538A>G (p.Lys180Glu)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644385	X	111401157	158474	169885
NM_178151.2(DCX):c.533G>T (p.Arg178Leu)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644390	X	111401162	158473	169886
NM_178151.2(DCX):c.532C>T (p.Arg178Cys)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644391	X	111401163	158472	169887
NM_178151.2(DCX):c.532C>G (p.Arg178Gly)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644391	X	111401163	158471	169888
NM_178151.2(DCX):c.520A>G (p.Lys174Glu)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644403	X	111401175	158470	169889
NM_178151.2(DCX):c.494_504del (p.Ser165Thrfs)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644419 - 110644429	X	111401191 - 111401201	158469	169890
NM_178151.2(DCX):c.478_479del (p.Gln160Valfs)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644444 - 110644445	X	111401216 - 111401217	158468	169891
NM_178151.2(DCX):c.478C>T (p.Gln160Ter)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644445	X	111401217	158467	169892
NM_178151.2(DCX):c.451A>T (p.Lys151Ter)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644472	X	111401244	158466	169893
NM_178151.2(DCX):c.451A>G (p.Lys151Glu)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644472	X	111401244	158465	169894
NM_178151.2(DCX):c.413A>G (p.Tyr138Cys)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644510	X	111401282	158464	169895
NM_178151.2(DCX):c.412T>C (p.Tyr138His)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644511	X	111401283	158463	169896
NM_178151.2(DCX):c.409G>T (p.Glu137Ter)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644514	X	111401286	158462	169897
NM_178151.2(DCX):c.391_393del (p.Asn131del)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644530 - 110644532	X	111401302 - 111401304	158461	169898
NM_178151.2(DCX):c.386C>T (p.Ser129Leu)	DCX	Heterotopia	Pathogenic(Last reviewed: Aug 7, 2013)	criteria provided, single submitter	X	110644537	X	111401309	158460	169899
NM_178151.2(DCX):c.380G>A (p.Cys127Tyr)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644543	X	111401315	158459	169900
NM_178151.2(DCX):c.377T>A (p.Val126Asp)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644546	X	111401318	158458	169901
NM_178151.2(DCX):c.367del (p.Glu123Lysfs)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644556	X	111401328	158457	169902
NM_178151.2(DCX):c.364G>A (p.Gly122Arg)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653263	X	111410035	158456	169903
NM_178151.2(DCX):c.339C>A (p.Ile113=)	DCX	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653288	X	111410060	158455	169904
NM_178151.2(DCX):c.337A>T (p.Ile113Phe)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653290	X	111410062	158454	169905
NM_178151.2(DCX):c.310A>T (p.Ile104Phe)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653317	X	111410089	158453	169906
NM_178151.2(DCX):c.305G>A (p.Arg102His)	DCX	Heterotopia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, multiple submitters, no conflicts	X	110653322	X	111410094	82052	92943
NM_178151.2(DCX):c.304C>T (p.Arg102Cys)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653323	X	111410095	158452	169907
NM_178151.2(DCX):c.301G>A (p.Val101Met)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653326	X	111410098	158451	169908
NM_178151.2(DCX):c.299G>T (p.Gly100Val)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653328	X	111410100	158449	169909
NM_178151.2(DCX):c.299G>A (p.Gly100Glu)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653328	X	111410100	158448	169910
NM_178151.2(DCX):c.290T>G (p.Leu97Arg)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653337	X	111410109	158447	169911
NM_178151.2(DCX):c.272T>C (p.Leu91Pro)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653355	X	111410127	158446	169912
NM_178151.2(DCX):c.266G>C (p.Arg89Pro)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653361	X	111410133	158445	169913
NM_178151.2(DCX):c.265C>T (p.Arg89Ter)	DCX	Heterotopia	Pathogenic(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	X	110653362	X	111410134	158444	169914
NM_178151.2(DCX):c.233G>T (p.Arg78Leu)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653394	X	111410166	158443	169915
NM_178151.2(DCX):c.232C>T (p.Arg78Cys)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653395	X	111410167	158442	169916
NM_178151.2(DCX):c.226C>T (p.Arg76Cys)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	X	110653401	X	111410173	158441	169917
NM_178151.2(DCX):c.218C>T (p.Ser73Phe)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653409	X	111410181	158440	169918
NM_178151.2(DCX):c.210C>A (p.Tyr70Ter)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653417	X	111410189	158439	169919
NM_178151.2(DCX):c.195C>A (p.Phe65Leu)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653432	X	111410204	158438	169920
NM_178151.2(DCX):c.191A>G (p.Tyr64Cys)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653436	X	111410208	158437	169921
NM_178151.2(DCX):c.187C>T (p.Arg63Cys)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653440	X	111410212	158436	169922
NM_178151.2(DCX):c.185A>G (p.Asp62Gly)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653442	X	111410214	158435	169923
NM_178151.2(DCX):c.182G>A (p.Gly61Glu)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653445	X	111410217	158434	169924
NM_178151.2(DCX):c.176G>A (p.Arg59His)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653451	X	111410223	158433	169925
NM_178151.2(DCX):c.170T>G (p.Phe57Cys)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653457	X	111410229	158432	169926
NM_178151.2(DCX):c.167G>C (p.Arg56Pro)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Apr 2, 2014)	criteria provided, single submitter	X	110653460	X	111410232	158431	169927
NM_178151.2(DCX):c.151_154del (p.Lys51Profs)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653473 - 110653476	X	111410245 - 111410248	158430	169928
NM_178151.2(DCX):c.150G>T (p.Lys50Asn)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653477	X	111410249	158429	169929
NM_178151.2(DCX):c.130C>T (p.Gln44Ter)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653497	X	111410269	158428	169930
NM_178151.2(DCX):c.128T>C (p.Leu43Ser)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653499	X	111410271	158427	169931
NM_178151.2(DCX):c.124del (p.Thr42Profs)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653503	X	111410275	158426	169932
NM_178151.2(DCX):c.115C>T (p.Arg39Ter)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653512	X	111410284	158425	169933
NM_178151.2(DCX):c.95G>A (p.Ser32Asn)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653532	X	111410304	158512	169934
NM_178151.2(DCX):c.55C>T (p.Arg19Ter)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653572	X	111410344	158479	169935
NM_178151.2(DCX):c.2T>C (p.Met1Thr)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653625	X	111410397	158450	169936
NM_003491.3(NAA10):c.361C>G (p.Leu121Val)	NAA10	N-terminal acetyltransferase deficiency	Likely pathogenic	criteria provided, single submitter	X	153197549	X	153932096	431708	425234
m.3397A>G	MT-ND1	Alzheimer's disease|Parkinson disease, late-onset	Pathogenic(Last reviewed: Jul 18, 1995)	no assertion criteria provided	MT	3397	MT	3397	9726	24765
